OncotreePrimaryDisease,Drug,F-statistic,p-value,Higher in,name,moa,target
Ovarian Epithelial Tumor,BRD-A00077618-236-07-6::2.5::HTS,7.090324432491756,0.007974194438570992,Other Types,8-bromo-cGMP,PKA activator,PRKG1
Ovarian Epithelial Tumor,BRD-A09062839-003-10-0::2.5::HTS,4.4537103252177355,0.03526832473463533,Other Types,amyleine,local anesthetic,
Ovarian Epithelial Tumor,BRD-A09094913-065-01-0::2.5::HTS,4.151479213274938,0.04207025006376854,Other Types,strychnine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB"
Ovarian Epithelial Tumor,BRD-A11731518-001-01-7::2.5::HTS,4.266388714232553,0.03933795592179016,Other Types,BAY-85-8050,,
Ovarian Epithelial Tumor,BRD-A13561534-003-02-0::2.5::HTS,5.192072836868987,0.02308863043653411,Ovarian Epithelial Tumor,ornithine,NFkB pathway modulator,"ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4"
Ovarian Epithelial Tumor,BRD-A18627414-001-04-9::2.5::HTS,4.354300883007406,0.03736571983670905,Ovarian Epithelial Tumor,cyanocobalamin,"methylmalonyl CoA mutase stimulant, vitamin B","MMAA, MMACHC, MTHFR, MTR, MTRR, MUT"
Ovarian Epithelial Tumor,BRD-A18763547-300-05-5::2.5::HTS,5.010969041636667,0.02558143048252744,Other Types,BAX-channel-blocker,cytochrome C release inhibitor,BAX
Ovarian Epithelial Tumor,BRD-A20348246-001-15-8::2.5::HTS,4.7607989075471675,0.02953072039664269,Other Types,chlormezanone,GABA receptor modulator,"GABRA1, TSPO"
Ovarian Epithelial Tumor,BRD-A23067620-300-01-3::2.5::HTS,3.922655199611277,0.04813377924068148,Other Types,itraconazole,cytochrome P450 inhibitor,CYP51A1
Ovarian Epithelial Tumor,BRD-A24543851-001-05-7::2.5::HTS,5.16377817699756,0.023442943744967016,Other Types,nornicotine,acetylcholine receptor agonist,
Ovarian Epithelial Tumor,BRD-A26334849-001-06-2::2.5::HTS,4.310194993408429,0.03833863544441004,Other Types,propafenone,antiarrhythmic,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A"
Ovarian Epithelial Tumor,BRD-A26690767-066-01-9::2.5::HTS,6.795818243765625,0.009381472162258899,Ovarian Epithelial Tumor,saquinavir,HIV protease inhibitor,CYP3A4
Ovarian Epithelial Tumor,BRD-A27732521-003-08-3::2.5::HTS,4.537643777246744,0.03360362650104395,Ovarian Epithelial Tumor,tolperisone,voltage-gated sodium channel blocker,"CYP2C19, CYP2D6"
Ovarian Epithelial Tumor,BRD-A28044053-001-01-7::2.5::HTS,5.2964231433869715,0.02174152594648891,Ovarian Epithelial Tumor,arotinolol,adrenergic receptor antagonist,ADRB3
Ovarian Epithelial Tumor,BRD-A28329383-001-02-1::2.5::HTS,6.516098092853215,0.01095725394924749,Ovarian Epithelial Tumor,MTPG,glutamate receptor antagonist,"GRM2, GRM3"
Ovarian Epithelial Tumor,BRD-A29281099-003-03-2::2.5::HTS,4.0042478589774335,0.045880227266546364,Other Types,clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2"
Ovarian Epithelial Tumor,BRD-A29731977-001-04-5::2.5::HTS,4.388885216586562,0.03662339662765995,Other Types,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Ovarian Epithelial Tumor,BRD-A30886737-001-02-9::2.5::HTS,15.13413605466709,0.0001122380177002623,Other Types,florfenicol,protein synthesis inhibitor,
Ovarian Epithelial Tumor,BRD-A41714661-001-02-0::2.5::HTS,4.403065674947575,0.03632660449822141,Ovarian Epithelial Tumor,bilobalide,GABA receptor modulator,"GLRA1, GLRA2, GLRB, HTR3A, HTR3B"
Ovarian Epithelial Tumor,BRD-A46393198-003-16-6::2.5::HTS,4.094684289962614,0.04349526009541538,Ovarian Epithelial Tumor,tetramisole,immunostimulant,
Ovarian Epithelial Tumor,BRD-A51831848-001-01-7::2.5::HTS,3.9279181822134412,0.048010764397918244,Ovarian Epithelial Tumor,enflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4"
Ovarian Epithelial Tumor,BRD-A53134341-001-03-2::2.5::HTS,6.719681465060628,0.009796612194727043,Other Types,Ro-106-9920,NFkB pathway inhibitor,
Ovarian Epithelial Tumor,BRD-A55664972-236-02-6::2.5::HTS,6.320219286972076,0.012217722031273505,Ovarian Epithelial Tumor,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Ovarian Epithelial Tumor,BRD-A55913614-316-09-6::2.5::HTS,7.192130457477238,0.007537682883079178,Other Types,primaquine,"antimalarial agent, DNA inhibitor","KRT7, NQO2"
Ovarian Epithelial Tumor,BRD-A57798112-001-03-7::2.5::HTS,4.039040674725056,0.044940848621056406,Ovarian Epithelial Tumor,PD-318088,MEK inhibitor,MAP2K1
Ovarian Epithelial Tumor,BRD-A57900429-003-05-8::2.5::HTS,5.524669756000411,0.019097344848167015,Other Types,hydrastinine,haemostatic agent,
Ovarian Epithelial Tumor,BRD-A65145453-001-06-1::2.5::HTS,9.55470245576118,0.0020951785878925554,Ovarian Epithelial Tumor,ATPA,glutamate receptor agonist,"GRIA2, GRIK1"
Ovarian Epithelial Tumor,BRD-A66116161-001-02-3::2.5::HTS,4.25080103208485,0.03969770146977857,Ovarian Epithelial Tumor,AM-1241,cannabinoid receptor agonist,"CNR1, CNR2"
Ovarian Epithelial Tumor,BRD-A68888262-003-15-1::2.5::HTS,3.865554032268421,0.04978048049346549,Other Types,azelastine,histamine receptor antagonist,HRH1
Ovarian Epithelial Tumor,BRD-A72703248-003-04-9::2.5::HTS,8.273906570760278,0.004175908259570418,Other Types,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Ovarian Epithelial Tumor,BRD-A73709786-001-01-3::2.5::HTS,7.612334914776043,0.005991538097514121,Other Types,LB-100,protein phosphatase inhibitor,
Ovarian Epithelial Tumor,BRD-A77218119-001-03-5::2.5::HTS,5.539164255926053,0.018940763551162264,Other Types,SYM-2206,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Ovarian Epithelial Tumor,BRD-A79768653-001-12-0::2.5::HTS,7.479725478525862,0.006440310385118478,Other Types,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Ovarian Epithelial Tumor,BRD-A84174393-236-07-1::2.5::HTS,4.726477729137038,0.030136046599477793,Ovarian Epithelial Tumor,meloxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Ovarian Epithelial Tumor,BRD-A84575140-001-02-4::2.5::HTS,6.6880068163917805,0.00996412618546021,Other Types,pimobendan,"calcium sensitizer, phosphodiesterase inhibitor",PDE3A
Ovarian Epithelial Tumor,BRD-A86619021-001-04-8::2.5::HTS,7.760792919583551,0.0055211153549231725,Other Types,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Ovarian Epithelial Tumor,BRD-A90272038-001-01-7::2.5::HTS,4.468917778027441,0.034961480343399264,Ovarian Epithelial Tumor,CGP-37849,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Ovarian Epithelial Tumor,BRD-A90799790-001-19-9::2.5::HTS,4.214923379679077,0.040532251662354524,Other Types,isradipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2"
Ovarian Epithelial Tumor,BRD-A92826379-001-01-5::2.5::HTS,5.0851431445120845,0.024517044418828654,Other Types,lupanine,sodium channel blocker,INS
Ovarian Epithelial Tumor,BRD-A94033181-001-01-4::2.5::HTS,6.345488634330218,0.012048372937955402,Ovarian Epithelial Tumor,AZD6765,glutamate receptor antagonist,GRIN1
Ovarian Epithelial Tumor,BRD-A94709349-001-08-3::2.5::HTS,5.124984310237601,0.02396689788391778,Other Types,metaxalone,muscle relaxant,
Ovarian Epithelial Tumor,BRD-A94993966-001-05-1::2.63::HTS,5.635843561163267,0.017946245290642267,Ovarian Epithelial Tumor,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Ovarian Epithelial Tumor,BRD-A98174560-001-02-1::2.5::HTS,6.276869920144901,0.012516169175029597,Ovarian Epithelial Tumor,chloralose,,
Ovarian Epithelial Tumor,BRD-A99388803-001-01-5::2.5::HTS,4.57446697207768,0.03289484330671009,Ovarian Epithelial Tumor,metipranolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Ovarian Epithelial Tumor,BRD-K00337317-001-06-6::2.5::HTS,4.900280648900932,0.027255982742579263,Other Types,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
Ovarian Epithelial Tumor,BRD-K01029106-001-01-4::2.52::HTS,4.813635726792918,0.028647747818546166,Ovarian Epithelial Tumor,picolinic-acid,chelating agent,
Ovarian Epithelial Tumor,BRD-K02898090-001-02-7::2.5::HTS,5.204347240218231,0.02291465929010616,Other Types,kifunensine,mannosidase inhibitor,"MAN1B1, MAN2A1"
Ovarian Epithelial Tumor,BRD-K03095347-001-06-1::2.5::HTS,3.9086060424292968,0.04853479180327417,Ovarian Epithelial Tumor,levosimendan,calcium sensitizer,"KCNJ11, KCNJ8, PDE3A, TNNC1"
Ovarian Epithelial Tumor,BRD-K03390685-001-01-7::2.5::HTS,4.306719320854391,0.0384229958973681,Ovarian Epithelial Tumor,cobimetinib,MEK inhibitor,
Ovarian Epithelial Tumor,BRD-K03739921-001-06-8::2.5::HTS,5.625105141474501,0.01804582854450361,Other Types,hypoxanthine,PARP inhibitor,PNP
Ovarian Epithelial Tumor,BRD-K04394237-001-06-0::2.5::HTS,10.014062277537302,0.0016382891072156851,Ovarian Epithelial Tumor,drospirenone,mineralocorticoid receptor antagonist,"AR, NR3C2, PGR"
Ovarian Epithelial Tumor,BRD-K04657451-001-01-0::2.5::HTS,7.172669439357309,0.007625210843778027,Other Types,D-delta-Tocopherol,,
Ovarian Epithelial Tumor,BRD-K06900071-001-01-2::2.5::HTS,4.000488299213923,0.04597211204672696,Ovarian Epithelial Tumor,tebipenem,bacterial cell wall synthesis inhibitor,CNR1
Ovarian Epithelial Tumor,BRD-K07955840-001-02-3::2.5::HTS,3.9052745947048977,0.048626845239391654,Other Types,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Ovarian Epithelial Tumor,BRD-K08799216-001-05-3::2.5::HTS,4.488312768514492,0.03458420470734295,Other Types,pelitinib,EGFR inhibitor,EGFR
Ovarian Epithelial Tumor,BRD-K09619322-001-03-8::2.5::HTS,4.15138554683655,0.0420717123602089,Ovarian Epithelial Tumor,CD-1530,retinoid receptor agonist,RARG
Ovarian Epithelial Tumor,BRD-K09900591-001-26-7::2.5::HTS,5.982999067483697,0.01476973680115184,Ovarian Epithelial Tumor,caffeic-acid,"HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF"
Ovarian Epithelial Tumor,BRD-K10671814-001-14-8::2.5::HTS,3.9717815114469532,0.04675623808427798,Ovarian Epithelial Tumor,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS
Ovarian Epithelial Tumor,BRD-K11099631-001-07-6::2.5::HTS,3.9529535658502986,0.04729453705442585,Other Types,gadoterate-meglumine,radiopaque medium,
Ovarian Epithelial Tumor,BRD-K11244467-001-08-5::2.5::HTS,4.520375648177448,0.03392872922816806,Other Types,ambazone,DNA damage inducer,
Ovarian Epithelial Tumor,BRD-K11558771-001-13-9::2.5::HTS,6.725606059748301,0.009753263184040713,Other Types,droxinostat,HDAC inhibitor,"HDAC6, HDAC8"
Ovarian Epithelial Tumor,BRD-K11595419-001-01-4::2.5::HTS,4.56954237771469,0.03298073098265984,Other Types,dipeptamin,,
Ovarian Epithelial Tumor,BRD-K11717138-001-30-3::2.5::HTS,7.032576182250369,0.00823970004531374,Ovarian Epithelial Tumor,benzbromarone,chloride channel blocker,ABCC1
Ovarian Epithelial Tumor,BRD-K12068470-001-04-1::2.5::HTS,4.1120120397388185,0.043050945408342534,Other Types,LY2608204,glucokinase activator,GCK
Ovarian Epithelial Tumor,BRD-K12184916-001-15-4::2.5::HTS,5.947849386788747,0.015044841511207808,Other Types,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor","ATR, MTOR, PIK3CA, PIK3CD, PIK3CG"
Ovarian Epithelial Tumor,BRD-K12502280-001-08-0::2.5::HTS,5.039974638947181,0.02517352880335638,Other Types,TG-101348,"FLT3 inhibitor, JAK inhibitor","BRD4, JAK1, JAK2, JAK3, TYK2"
Ovarian Epithelial Tumor,BRD-K12885236-001-02-7::2.5::HTS,6.430926801617645,0.011488631758474753,Other Types,dapivirine,non-nucleoside reverse transcriptase inhibitor,"CYP3A4, CYP3A5"
Ovarian Epithelial Tumor,BRD-K13094524-001-07-5::2.63::HTS,6.21944661262649,0.012940289301111574,Other Types,PFI-1,bromodomain inhibitor,BRD4
Ovarian Epithelial Tumor,BRD-K13238168-001-02-0::2.5::HTS,5.266901183417184,0.022102272612173145,Other Types,haloprogin,other antifungal,
Ovarian Epithelial Tumor,BRD-K13514097-001-05-3::2.5::HTS,6.1885435524628125,0.01314938498678383,Other Types,everolimus,mTOR inhibitor,MTOR
Ovarian Epithelial Tumor,BRD-K13571841-001-14-4::2.5::HTS,7.484483278251574,0.006431525670682506,Other Types,pepstatin,aspartic protease inhibitor,"CTSB, CTSD, CTSL, REN"
Ovarian Epithelial Tumor,BRD-K14796088-003-26-8::2.5::HTS,4.272058537876734,0.03920134279010815,Other Types,berberine,LDL receptor activator,LDLR
Ovarian Epithelial Tumor,BRD-K14965640-001-12-4::2.5::HTS,6.070057669182556,0.014049245954136336,Ovarian Epithelial Tumor,ibuprofen-(s),cyclooxygenase inhibitor,"ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD"
Ovarian Epithelial Tumor,BRD-K15697815-001-16-2::2.5::HTS,4.540828799876913,0.033531302484843824,Ovarian Epithelial Tumor,ursodiol,"nuclear factor erythroid derived, like (NRF2) activator",NR1H4
Ovarian Epithelial Tumor,BRD-K17205817-001-06-1::2.5::HTS,5.700032437078998,0.01729408036226905,Ovarian Epithelial Tumor,sulfametopyrazine,PABA antagonist,
Ovarian Epithelial Tumor,BRD-K18316707-001-02-7::2.5::HTS,6.328804806407941,0.012158383450992882,Ovarian Epithelial Tumor,O-1918,cannabinoid receptor antagonist,
Ovarian Epithelial Tumor,BRD-K18323388-001-01-1::2.5::HTS,5.276820887660781,0.021983195351967872,Ovarian Epithelial Tumor,uridine-triacetate,,
Ovarian Epithelial Tumor,BRD-K18850819-001-04-6::2.5::HTS,4.866712483014516,0.02778344011155965,Ovarian Epithelial Tumor,MK-0752,gamma secretase inhibitor,
Ovarian Epithelial Tumor,BRD-K18895904-001-16-1::2.5::HTS,3.898644900615559,0.04882125982802323,Ovarian Epithelial Tumor,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Ovarian Epithelial Tumor,BRD-K19477839-001-07-6::2.5::HTS,4.145675266251642,0.04221615065565663,Ovarian Epithelial Tumor,SGX523,hepatocyte growth factor receptor inhibitor,MET
Ovarian Epithelial Tumor,BRD-K19540840-001-09-4::2.5::HTS,5.362982724759326,0.02092758288615747,Other Types,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Ovarian Epithelial Tumor,BRD-K20013301-001-02-6::2.5::HTS,4.238260628884223,0.039987113818882015,Ovarian Epithelial Tumor,LY411575,gamma secretase inhibitor,
Ovarian Epithelial Tumor,BRD-K21164796-001-02-8::2.5::HTS,5.942784904290552,0.015088778747464561,Ovarian Epithelial Tumor,beta-naphthol,,
Ovarian Epithelial Tumor,BRD-K21295289-001-01-6::2.5::HTS,4.493985963844254,0.03447061057350572,Ovarian Epithelial Tumor,senicapoc,intermediate conductance potassium channel blocker,KCNN4
Ovarian Epithelial Tumor,BRD-K21547160-001-01-4::2.5::HTS,5.36808278614581,0.020882414445085644,Other Types,sufentanil,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Ovarian Epithelial Tumor,BRD-K21913543-001-02-4::2.5::HTS,4.059158188230879,0.044413303911244664,Other Types,fluorescein,,SLC22A6
Ovarian Epithelial Tumor,BRD-K21937671-001-09-2::2.53::HTS,4.754336556456952,0.0296721169702217,Other Types,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Ovarian Epithelial Tumor,BRD-K22356203-001-01-8::2.5::HTS,8.9537187943993,0.002890621180462333,Other Types,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Ovarian Epithelial Tumor,BRD-K23082237-003-01-5::2.5::HTS,3.952508456812206,0.04729325710290623,Ovarian Epithelial Tumor,butaclamol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A"
Ovarian Epithelial Tumor,BRD-K24048528-001-01-7::2.59::HTS,7.178037171383054,0.007610371002547708,Other Types,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1
Ovarian Epithelial Tumor,BRD-K24507548-001-01-8::2.5::HTS,4.185741356792981,0.04123029245565572,Other Types,cintriamide,,
Ovarian Epithelial Tumor,BRD-K25140590-001-03-0::2.5::HTS,4.112419577316311,0.043043183428185854,Ovarian Epithelial Tumor,CX-516,glutamate receptor modulator,
Ovarian Epithelial Tumor,BRD-K25875056-001-02-0::2.5::HTS,4.403754555232916,0.03630880993094934,Ovarian Epithelial Tumor,SC-9,protein tyrosine kinase activator,PRKCA
Ovarian Epithelial Tumor,BRD-K27141178-003-07-3::2.5::HTS,4.212567944565422,0.04059651897551427,Other Types,SB-203186,serotonin receptor antagonist,HTR4
Ovarian Epithelial Tumor,BRD-K28192623-066-08-1::2.5::HTS,4.640345173942253,0.03165694444475312,Other Types,spiradoline,opioid receptor agonist,OPRK1
Ovarian Epithelial Tumor,BRD-K29668683-300-02-2::2.5::HTS,3.985382111757295,0.046381248525942075,Other Types,BD-1063,sigma receptor antagonist,SIGMAR1
Ovarian Epithelial Tumor,BRD-K29713308-001-01-7::2.5::HTS,3.921785748589953,0.048155830202954206,Ovarian Epithelial Tumor,mebhydrolin,antihistamine,
Ovarian Epithelial Tumor,BRD-K30431096-004-01-3::2.5::HTS,6.934038819024997,0.008696693461545401,Other Types,domiphen,,
Ovarian Epithelial Tumor,BRD-K30977212-001-02-8::2.5::HTS,6.505975052786745,0.011015705485302533,Other Types,PIK-293,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Ovarian Epithelial Tumor,BRD-K32372024-001-01-0::2.5::HTS,4.273756211770191,0.03919758713265456,Ovarian Epithelial Tumor,D-7193,,
Ovarian Epithelial Tumor,BRD-K32405725-001-02-8::2.5::HTS,3.908117998721744,0.04855058198815245,Other Types,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A
Ovarian Epithelial Tumor,BRD-K33690734-001-01-5::2.5::HTS,7.093296259758344,0.007960345830785694,Other Types,5-BDBD,purinergic receptor antagonist,P2RX4
Ovarian Epithelial Tumor,BRD-K33813875-003-01-8::2.5::HTS,5.548684468516741,0.01884727310970934,Other Types,valnemulin,bacterial 50S ribosomal subunit inhibitor,
Ovarian Epithelial Tumor,BRD-K34313798-001-01-6::2.5::HTS,6.5059508784930005,0.011019697900919476,Other Types,LY215490,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1"
Ovarian Epithelial Tumor,BRD-K34341643-001-01-4::2.5::HTS,4.486637047312057,0.034607054250515114,Other Types,glasdegib,hedgehog pathway inhibitor,SMO
Ovarian Epithelial Tumor,BRD-K34776109-001-16-6::2.5::HTS,4.044033238528731,0.04480651619965017,Other Types,glimepiride,insulin secretagogue,"ABCC8, KCNJ1, KCNJ11"
Ovarian Epithelial Tumor,BRD-K35189033-001-26-1::2.5::HTS,6.908356290736265,0.00881480219597282,Ovarian Epithelial Tumor,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Ovarian Epithelial Tumor,BRD-K35629949-001-02-0::2.5::HTS,9.134142665943806,0.0026252215075873346,Other Types,SR-27897,CCK receptor antagonist,CCKAR
Ovarian Epithelial Tumor,BRD-K36660044-001-24-2::2.5::HTS,6.685855564275209,0.00997088852864664,Ovarian Epithelial Tumor,bufexamac,cyclooxygenase inhibitor,"HDAC10, HDAC6"
Ovarian Epithelial Tumor,BRD-K37069697-001-01-3::2.5::HTS,4.1944962505854715,0.04102797115767521,Other Types,fexinidazole,,
Ovarian Epithelial Tumor,BRD-K37203094-001-02-5::2.5::HTS,5.7826730471557655,0.016528148703825414,Ovarian Epithelial Tumor,1-hexadecanol,,
Ovarian Epithelial Tumor,BRD-K37682401-001-09-3::2.44::HTS,6.597128090563311,0.010488092327355307,Ovarian Epithelial Tumor,piromidic-acid,bacterial DNA gyrase inhibitor,
Ovarian Epithelial Tumor,BRD-K37764012-001-04-1::2.5::HTS,5.3427502793122805,0.02117073086957385,Other Types,PF-03758309,p21 activated kinase inhibitor,PAK4
Ovarian Epithelial Tumor,BRD-K38140108-002-01-2::2.5::HTS,4.4667502644031565,0.035001524163048386,Other Types,gadodiamide,radiopaque medium,
Ovarian Epithelial Tumor,BRD-K39467894-001-06-7::2.5::HTS,3.9906535451588354,0.04625541057845656,Ovarian Epithelial Tumor,nithiamide,bacterial DNA inhibitor,
Ovarian Epithelial Tumor,BRD-K39974922-001-04-3::2.5::HTS,4.54430826658137,0.033474170338995794,Ovarian Epithelial Tumor,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Ovarian Epithelial Tumor,BRD-K40255344-001-17-6::2.5::HTS,9.28702904477624,0.002416254241491166,Other Types,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Ovarian Epithelial Tumor,BRD-K41170226-001-13-8::2.5::HTS,7.56231286105276,0.006152758753294116,Other Types,deoxycholic-acid,"biliverdin reductase A activator, G protein-coupled receptor agonist","EFTUD1, FPR1, GPBAR1"
Ovarian Epithelial Tumor,BRD-K41304947-001-03-2::2.5::HTS,4.17249095619314,0.04155141449539759,Other Types,HA-966-(S)-(-),glutamate receptor antagonist,GRIA1
Ovarian Epithelial Tumor,BRD-K41731458-001-15-1::2.5::HTS,7.386362013944084,0.006775529453020447,Other Types,triclosan,antibacterial agent,DNMT1
Ovarian Epithelial Tumor,BRD-K42898655-001-01-8::2.5::HTS,4.016655165145894,0.04553233565830878,Other Types,temsirolimus,mTOR inhibitor,MTOR
Ovarian Epithelial Tumor,BRD-K43187018-001-03-3::2.52::HTS,4.057654240314935,0.04447811308039948,Other Types,GDC-0349,Pim kinase inhibitor,PIK3CA
Ovarian Epithelial Tumor,BRD-K43471985-001-03-0::2.69::HTS,5.174434411308711,0.02332181684486709,Other Types,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Ovarian Epithelial Tumor,BRD-K43621685-001-02-5::2.5::HTS,4.578213723558578,0.03281485265697837,Other Types,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Ovarian Epithelial Tumor,BRD-K45168550-001-01-9::2.5::HTS,5.432013022532168,0.020130177321998764,Other Types,SB-756050,G protein-coupled receptor agonist,GPBAR1
Ovarian Epithelial Tumor,BRD-K45841694-001-11-7::2.65::HTS,4.440120631777297,0.0355747597976754,Ovarian Epithelial Tumor,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14
Ovarian Epithelial Tumor,BRD-K48488978-001-05-3::2.5::HTS,13.042232218257881,0.0003322571380911627,Other Types,YM-201636,PI3K inhibitor,
Ovarian Epithelial Tumor,BRD-K49071277-001-04-7::2.5::HTS,5.622587684604061,0.018069045786088336,Other Types,securinine,"GABA receptor antagonist, TP53 activator",GABRA1
Ovarian Epithelial Tumor,BRD-K49328571-001-15-0::2.5::HTS,10.09904975831444,0.0015664812293381635,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Ovarian Epithelial Tumor,BRD-K49554218-001-01-0::2.5::HTS,4.571583278333621,0.032944954534005706,Other Types,carebastine,histamine receptor antagonist,HRH1
Ovarian Epithelial Tumor,BRD-K49702221-003-01-6::2.5::HTS,5.352949657359883,0.021053693959818164,Other Types,SNAP-94847,,"ADRA1A, DRD2"
Ovarian Epithelial Tumor,BRD-K50817623-303-05-7::2.5::HTS,5.450689815967928,0.019934525359501045,Ovarian Epithelial Tumor,pancuronium,acetylcholine receptor antagonist,"CHRM2, CHRM3, CHRNA1, CHRNA2"
Ovarian Epithelial Tumor,BRD-K51662849-001-05-4::2.5::HTS,6.527857982102598,0.010893341777275176,Ovarian Epithelial Tumor,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Ovarian Epithelial Tumor,BRD-K52113681-003-02-1::2.5::HTS,7.501539313666707,0.0063638160357081565,Other Types,CP-339818,potassium channel blocker,KCNA3
Ovarian Epithelial Tumor,BRD-K54606188-001-13-1::2.5::HTS,6.9277771187238635,0.008719928926141556,Other Types,JQ1-(+),bromodomain inhibitor,"BRD4, BRDT"
Ovarian Epithelial Tumor,BRD-K54665485-001-07-9::2.5::HTS,7.459243653203728,0.0065111662580584215,Ovarian Epithelial Tumor,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA
Ovarian Epithelial Tumor,BRD-K55966568-001-05-4::2.5::HTS,4.140394153069985,0.042341926214085654,Ovarian Epithelial Tumor,orantinib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB"
Ovarian Epithelial Tumor,BRD-K56614220-001-19-0::2.5::HTS,6.546511432824861,0.010770843553357995,Other Types,clofazimine,GK0582 inhibitor,
Ovarian Epithelial Tumor,BRD-K56908511-001-01-2::2.5::HTS,11.909654741741647,0.000607752437722517,Other Types,fluroxene,local anesthetic,
Ovarian Epithelial Tumor,BRD-K57080016-001-15-9::2.5::HTS,4.223576000524056,0.04032767928512114,Ovarian Epithelial Tumor,selumetinib,MEK inhibitor,MAP2K1
Ovarian Epithelial Tumor,BRD-K58299615-001-03-5::2.5::HTS,4.20072451228024,0.040902089886310423,Other Types,Ro-90-7501,,APP
Ovarian Epithelial Tumor,BRD-K58466253-003-14-0::2.5::HTS,9.463477740576373,0.0021995205215740474,Other Types,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
Ovarian Epithelial Tumor,BRD-K58513245-304-02-7::2.5::HTS,5.327413564306792,0.021378091804977656,Ovarian Epithelial Tumor,pamidronate,bone resorption inhibitor,FDPS
Ovarian Epithelial Tumor,BRD-K58937086-001-01-4::2.5::HTS,6.285071579336852,0.012462125883519906,Ovarian Epithelial Tumor,glutathione-monoisopropyl-ester,lipid peroxidase inhibitor,
Ovarian Epithelial Tumor,BRD-K59204667-001-03-1::2.5::HTS,4.199461883100119,0.04090302180850066,Other Types,DBeQ,ATPase inhibitor,CASP3
Ovarian Epithelial Tumor,BRD-K59317601-001-05-5::2.5::HTS,4.533879566509201,0.033664239113664084,Other Types,MLN0128,mTOR inhibitor,"MTOR, PIK3CA, PIK3CD, PIK3CG"
Ovarian Epithelial Tumor,BRD-K59339270-001-02-6::2.5::HTS,4.192624185532428,0.041064520508103344,Ovarian Epithelial Tumor,AH6809,prostanoid receptor antagonist,"PTGDR, PTGER1, PTGER2, PTGER3"
Ovarian Epithelial Tumor,BRD-K59597909-001-17-6::2.5::HTS,6.706106139695169,0.009864726418007912,Ovarian Epithelial Tumor,phenothiazine,dopamine receptor antagonist,
Ovarian Epithelial Tumor,BRD-K60443845-001-08-6::2.5::HTS,8.154484472103762,0.004461046728187326,Other Types,chlormidazole,fungal lanosterol demethylase inhibitor,
Ovarian Epithelial Tumor,BRD-K60997853-001-02-3::2.5::HTS,5.273455006331014,0.02202132449981916,Other Types,PHA-848125,"CDK inhibitor, growth factor receptor inhibitor","CDK2, CDK4, CDK7, NTRK1"
Ovarian Epithelial Tumor,BRD-K61250553-003-32-2::2.5::HTS,7.797401305594269,0.005410282766203557,Other Types,loperamide,opioid receptor agonist,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC"
Ovarian Epithelial Tumor,BRD-K61688984-001-02-9::2.5::HTS,8.532192315689452,0.0036303311243356573,Other Types,RGFP966,HDAC inhibitor,HDAC3
Ovarian Epithelial Tumor,BRD-K62012036-001-14-4::2.44::HTS,6.239320188138873,0.012797584885454585,Ovarian Epithelial Tumor,acitretin,retinoid receptor agonist,"RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3"
Ovarian Epithelial Tumor,BRD-K62304154-001-04-2::2.5::HTS,4.345341841121101,0.037580488514698196,Other Types,deforolimus,mTOR inhibitor,MTOR
Ovarian Epithelial Tumor,BRD-K63068307-001-08-9::2.5::HTS,10.684782277539364,0.0011471909848277822,Other Types,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Ovarian Epithelial Tumor,BRD-K63828191-003-32-1::2.5::HTS,5.06783246261756,0.024759396238289204,Other Types,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2"
Ovarian Epithelial Tumor,BRD-K64538373-001-01-4::2.5::HTS,4.076670243774594,0.043957805427261444,Ovarian Epithelial Tumor,Ro-4987655,MEK inhibitor,MAP2K1
Ovarian Epithelial Tumor,BRD-K64659768-001-12-8::2.5::HTS,5.382494446464581,0.02069962648705447,Ovarian Epithelial Tumor,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,
Ovarian Epithelial Tumor,BRD-K65678996-001-05-5::2.5::HTS,3.938708277434921,0.04768254176808181,Other Types,nefiracetam,"acetylcholine receptor agonist, benzodiazepine receptor agonist",CHRM1
Ovarian Epithelial Tumor,BRD-K65904673-001-01-4::2.5::HTS,4.453594275255191,0.03527070162948143,Ovarian Epithelial Tumor,tandospirone,serotonin receptor agonist,HTR1A
Ovarian Epithelial Tumor,BRD-K66097663-001-01-8::2.5::HTS,4.3585660935245585,0.03727302078112867,Other Types,TMC-353121,RSV fusion inhibitor,
Ovarian Epithelial Tumor,BRD-K66175015-001-09-0::2.5::HTS,5.335812777126052,0.02126365555649812,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Ovarian Epithelial Tumor,BRD-K66808046-065-03-7::2.5::HTS,8.161669659086071,0.004443674330675584,Other Types,oxyquinoline,chelating agent,METAP2
Ovarian Epithelial Tumor,BRD-K67102207-236-07-7::2.5::HTS,4.321846900495987,0.03808559929841155,Ovarian Epithelial Tumor,phenylbutyrate,HDAC inhibitor,HDAC1
Ovarian Epithelial Tumor,BRD-K67173685-001-06-9::2.39::HTS,12.753899590354926,0.0003877340954066558,Other Types,4E1RCat,protein synthesis inhibitor,"EIF4E, EIF4G1"
Ovarian Epithelial Tumor,BRD-K67298865-001-09-0::2.5::HTS,7.092527294226066,0.007963718361304368,Other Types,SB-431542,TGF beta receptor inhibitor,"ACVR1C, TGFBR1"
Ovarian Epithelial Tumor,BRD-K68103045-001-02-9::2.5::HTS,12.626243099659954,0.000412578417226865,Ovarian Epithelial Tumor,CGS-20625,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6"
Ovarian Epithelial Tumor,BRD-K68805147-001-01-8::2.5::HTS,4.1857121470493075,0.041230997468334744,Other Types,pafuramidine,DNA synthesis inhibitor,
Ovarian Epithelial Tumor,BRD-K70401845-003-09-6::2.5::HTS,3.9696558808030074,0.04681224484941044,Other Types,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Ovarian Epithelial Tumor,BRD-K70402238-001-02-8::2.5::HTS,4.010759379412419,0.04569321008955937,Other Types,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Ovarian Epithelial Tumor,BRD-K71075609-003-01-0::2.5::HTS,7.487534829687174,0.006409939298335432,Other Types,dorzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7"
Ovarian Epithelial Tumor,BRD-K71731651-001-04-3::2.5::HTS,4.863290766164357,0.027849966554105442,Other Types,PNU-120596,acetylcholine receptor agonist,CHRNA7
Ovarian Epithelial Tumor,BRD-K71822263-001-03-2::2.5::HTS,4.623774681546149,0.031959208764198076,Other Types,D-Serine,glutamate receptor agonist,"GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3"
Ovarian Epithelial Tumor,BRD-K72222507-003-16-8::2.5::HTS,5.123015443313231,0.02399247576561173,Ovarian Epithelial Tumor,quinapril,angiotensin converting enzyme inhibitor,ACE
Ovarian Epithelial Tumor,BRD-K73381542-003-23-4::2.5::HTS,3.9677348068519116,0.046863562707959175,Other Types,phenylephrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D"
Ovarian Epithelial Tumor,BRD-K73383190-001-02-3::2.56::HTS,4.306505462470862,0.038450512903296485,Other Types,C646,histone acetyltransferase inhibitor,EP300
Ovarian Epithelial Tumor,BRD-K73391359-003-10-2::2.5::HTS,8.977000469345207,0.002856360362211672,Other Types,dimethisoquin,local anesthetic,
Ovarian Epithelial Tumor,BRD-K73397362-001-06-6::2.5::HTS,4.081282069467177,0.04384853791169025,Other Types,purmorphamine,smoothened receptor agonist,SMO
Ovarian Epithelial Tumor,BRD-K74186897-001-12-4::2.5::HTS,6.0203448313502035,0.014465144187995856,Ovarian Epithelial Tumor,cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4"
Ovarian Epithelial Tumor,BRD-K74603273-003-01-1::2.5::HTS,4.566307182135192,0.033045712170172346,Other Types,"ICI-118,551",adrenergic receptor antagonist,"ADRB2, ADRB3"
Ovarian Epithelial Tumor,BRD-K74765201-001-16-7::0.25::HTS,5.720322438045866,0.01709738721985515,Ovarian Epithelial Tumor,tomelukast,leukotriene receptor antagonist,CYSLTR1
Ovarian Epithelial Tumor,BRD-K76805682-001-15-9::2.5::HTS,4.1670669903630735,0.04168697055576014,Ovarian Epithelial Tumor,SB-415286,glycogen synthase kinase inhibitor,"GSK3A, GSK3B, RPS6KB1"
Ovarian Epithelial Tumor,BRD-K76811153-003-01-3::2.5::HTS,4.633229420332433,0.031796014554969644,Other Types,L-Arginine,nitric oxide precursor,"ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4"
Ovarian Epithelial Tumor,BRD-K76841105-001-04-7::2.5::HTS,6.439305119568377,0.011436197235423648,Ovarian Epithelial Tumor,tazarotene,retinoid receptor agonist,"RARA, RARB, RARG, RXRB"
Ovarian Epithelial Tumor,BRD-K77685957-300-09-1::2.5::HTS,3.944390780124506,0.0475274830474705,Other Types,dequalinium,PKC inhibitor,"KCNN1, KCNN3"
Ovarian Epithelial Tumor,BRD-K78342372-001-02-4::2.5::HTS,10.12879591234784,0.0015415529202915527,Ovarian Epithelial Tumor,hematoxylin,,
Ovarian Epithelial Tumor,BRD-K79259477-001-04-9::2.5::HTS,7.035454767619761,0.008217756430845508,Other Types,NVP-BHG712,ephrin inhibitor,EPHB4
Ovarian Epithelial Tumor,BRD-K80431395-001-07-3::2.49::HTS,4.037211947540006,0.04501570371170845,Other Types,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Ovarian Epithelial Tumor,BRD-K82143716-001-19-9::2.5::HTS,8.246253509020676,0.004241042882194834,Other Types,flucytosine,other antifungal,DNMT1
Ovarian Epithelial Tumor,BRD-K83022601-001-01-0::2.5::HTS,5.893985859157043,0.015511354759324521,Other Types,CI-844,,
Ovarian Epithelial Tumor,BRD-K83192048-050-02-7::2.5::HTS,5.237765902254426,0.02247857969192235,Other Types,dimethindene-(S)-(+),acetylcholine receptor antagonist,HRH1
Ovarian Epithelial Tumor,BRD-K83405785-001-01-5::2.5::HTS,4.484220659341159,0.034663011342119125,Other Types,pimavanserin,serotonin receptor inverse agonist,"DRD2, HTR2A"
Ovarian Epithelial Tumor,BRD-K83508485-001-02-7::2.5::HTS,4.785764281317327,0.02911917744893901,Other Types,FK-888,tachykinin antagonist,"TACR1, TACR2"
Ovarian Epithelial Tumor,BRD-K84794093-001-07-5::2.5::HTS,6.814686222719469,0.009292679375642529,Ovarian Epithelial Tumor,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,
Ovarian Epithelial Tumor,BRD-K84996356-001-01-1::2.5::HTS,9.126486664849905,0.002637346569509083,Other Types,AZD3514,androgen receptor modulator,AR
Ovarian Epithelial Tumor,BRD-K85014146-001-02-5::2.5::HTS,4.494846170356157,0.03449911926556416,Other Types,AZD2461,PARP inhibitor,
Ovarian Epithelial Tumor,BRD-K86118762-001-01-8::2.5::HTS,4.325241067037468,0.03801964105041779,Ovarian Epithelial Tumor,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Ovarian Epithelial Tumor,BRD-K86892782-001-17-0::2.5::HTS,4.94348753794875,0.02659763903269874,Ovarian Epithelial Tumor,edoxudine,DNA directed DNA polymerase inhibitor,
Ovarian Epithelial Tumor,BRD-K87048468-003-02-7::2.5::HTS,4.643431023120377,0.03160366241804732,Ovarian Epithelial Tumor,RS-102221,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Ovarian Epithelial Tumor,BRD-K87112191-001-04-5::2.5::HTS,5.882507270222649,0.015607108668992961,Other Types,PP242,mTOR inhibitor,"MTOR, PASK"
Ovarian Epithelial Tumor,BRD-K87774949-001-03-9::2.5::HTS,4.37457534595547,0.03692722896809224,Other Types,istradefylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Ovarian Epithelial Tumor,BRD-K88219015-001-10-8::2.5::HTS,6.363585076267976,0.011931620996844711,Ovarian Epithelial Tumor,asaraldehyde,cyclooxygenase inhibitor,PTGS2
Ovarian Epithelial Tumor,BRD-K89055274-048-22-7::2.5::HTS,4.444250442728555,0.03547402325480433,Other Types,alverine,muscle relaxant,HTR1A
Ovarian Epithelial Tumor,BRD-K89104321-003-14-8::2.5::HTS,4.742086431974218,0.029852255989776047,Other Types,gaboxadol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3"
Ovarian Epithelial Tumor,BRD-K89391146-001-08-0::2.5::HTS,3.8837185240303587,0.049268681218626695,Other Types,RG108,DNA methyltransferase inhibitor,"DNMT1, DNMT3B"
Ovarian Epithelial Tumor,BRD-K89588135-001-01-9::2.5::HTS,5.973441974760265,0.014834832279072643,Other Types,tagatose,phosphorylase inhibitor,PYGL
Ovarian Epithelial Tumor,BRD-K89732114-300-14-7::2.5::HTS,4.65551104513122,0.031383168192309824,Ovarian Epithelial Tumor,trifluoperazine,dopamine receptor antagonist,"ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1"
Ovarian Epithelial Tumor,BRD-K90789829-001-07-8::2.5::HTS,5.51677035835271,0.019183528491658237,Other Types,nefazodone,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Ovarian Epithelial Tumor,BRD-K92446736-003-02-2::2.5::HTS,6.156582152456926,0.01338637977338179,Ovarian Epithelial Tumor,zatebradine,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Ovarian Epithelial Tumor,BRD-K93568044-001-32-0::2.5::HTS,4.880939834922312,0.027564669293614362,Other Types,hydrocortisone,glucocorticoid receptor agonist,
Ovarian Epithelial Tumor,BRD-K94266545-001-24-1::2.5::HTS,4.3699419035923155,0.037030181842257925,Ovarian Epithelial Tumor,ronidazole,antiprotozoal agent,
Ovarian Epithelial Tumor,BRD-K94455792-001-01-8::2.5::HTS,7.551298859104216,0.00619066284639664,Other Types,ICG-001,beta-catenin inhibitor,CTNNB1
Ovarian Epithelial Tumor,BRD-K94485812-001-02-9::2.55::HTS,5.284754221694649,0.021902563201513195,Other Types,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Ovarian Epithelial Tumor,BRD-K95523387-001-09-6::2.5::HTS,7.287015229381508,0.007155708247085925,Other Types,OLDA,TRPV agonist,GPR119
Ovarian Epithelial Tumor,BRD-K95837862-300-01-7::2.5::HTS,4.6317553213709,0.031812909899163765,Ovarian Epithelial Tumor,JDTic,opioid receptor antagonist,OPRK1
Ovarian Epithelial Tumor,BRD-K96029467-003-01-9::2.5::HTS,4.365464900859458,0.037127631481326175,Other Types,alagebrium,glycosylation inhibitor,
Ovarian Epithelial Tumor,BRD-K97464279-001-03-5::2.5::HTS,4.128327551407037,0.042645099299934035,Ovarian Epithelial Tumor,diaveridine,dihydrofolate reductase inhibitor,
Ovarian Epithelial Tumor,BRD-K98203492-003-04-1::2.5::HTS,4.547151039233065,0.033429136922091506,Other Types,GSK-J4,histone lysine demethylase inhibitor,"KDM6A, KDM6B"
Ovarian Epithelial Tumor,BRD-K98548675-001-05-9::2.5::HTS,5.416423099679103,0.02030245696702098,Other Types,parthenolide,NFkB pathway inhibitor,
Ovarian Epithelial Tumor,BRD-K99113996-001-02-0::2.5::HTS,8.647150855574543,0.0034105717143246817,Other Types,AZD2014,mTOR inhibitor,MTOR
Ovarian Epithelial Tumor,BRD-K99174507-003-02-0::2.5::HTS,8.240076413332174,0.004254133687009189,Other Types,cardiogenol-c,cardiomyogenesis inducer,
Ovarian Epithelial Tumor,BRD-K99964838-001-11-9::2.5::HTS,7.956800913602416,0.0049605620870816335,Other Types,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Ovarian Epithelial Tumor,BRD-A00055058-001-01-0::2.325889319::MTS004,4.006925612831963,0.04581438568341654,Other Types,RS-0481,immunostimulant,
Ovarian Epithelial Tumor,BRD-K03765900-001-01-9::2.499986292::MTS004,4.068301241286101,0.04419140063797351,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Ovarian Epithelial Tumor,BRD-K06388517-001-01-2::2.5::MTS004,7.817250912233204,0.005359614740560425,Other Types,lofemizole,cyclooxygenase inhibitor,
Ovarian Epithelial Tumor,BRD-K06519765-001-01-1::2.5::MTS004,4.493086395159488,0.03448859646380928,Ovarian Epithelial Tumor,vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1"
Ovarian Epithelial Tumor,BRD-K07682953-001-01-8::2.499993276::MTS004,7.049270804506059,0.00816425395974608,Ovarian Epithelial Tumor,palosuran,urotensin receptor antagonist,UTS2R
Ovarian Epithelial Tumor,BRD-K11443721-003-01-6::2.403980733::MTS004,5.094131629595656,0.024407235847560358,Ovarian Epithelial Tumor,NE-100,sigma receptor antagonist,SIGMAR1
Ovarian Epithelial Tumor,BRD-K12742203-003-01-7::2.512196931::MTS004,3.9001645335087094,0.04879220597668146,Other Types,moxaverine,phosphodiesterase inhibitor,
Ovarian Epithelial Tumor,BRD-K13533483-001-16-2::2.5::MTS004,6.688694459487694,0.0099641839373283,Ovarian Epithelial Tumor,cyclosporine,calcineurin inhibitor,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
Ovarian Epithelial Tumor,BRD-K20468903-001-01-6::2.49996519::MTS004,6.448597844747099,0.011383856847232086,Ovarian Epithelial Tumor,BNC105,tubulin polymerization inhibitor,
Ovarian Epithelial Tumor,BRD-K22064724-001-01-8::2.499989634::MTS004,4.495134287223588,0.03444766539563102,Ovarian Epithelial Tumor,napabucasin,STAT inhibitor,STAT3
Ovarian Epithelial Tumor,BRD-K25029121-001-05-8::2.446932239::MTS004,4.163557052877612,0.04179026047682228,Ovarian Epithelial Tumor,triclocarban,other antibiotic,
Ovarian Epithelial Tumor,BRD-K27061362-001-01-6::2.499998598::MTS004,4.299973704114958,0.03858819935565988,Ovarian Epithelial Tumor,AMG-337,MET inhibitor,MET
Ovarian Epithelial Tumor,BRD-K27798832-001-01-5::2.350625651::MTS004,5.2301671515298125,0.022585886847603546,Ovarian Epithelial Tumor,cefetamet,bacterial cell wall synthesis inhibitor,
Ovarian Epithelial Tumor,BRD-K28061410-001-06-6::2.5::MTS004,4.381064211174407,0.0368071645288474,Ovarian Epithelial Tumor,beta-lapachone,topoisomerase inhibitor,TOP1
Ovarian Epithelial Tumor,BRD-K36636143-001-01-0::2.518926249::MTS004,7.082152423033077,0.008017722136237327,Ovarian Epithelial Tumor,nolatrexed,thymidylate synthase inhibitor,TYMS
Ovarian Epithelial Tumor,BRD-K37708699-001-01-4::2.530276706::MTS004,7.777479284581448,0.005477496129228598,Other Types,exisulind,phosphodiesterase inhibitor,PDE5A
Ovarian Epithelial Tumor,BRD-K42673188-001-01-1::2.363355746::MTS004,4.1974953328612,0.04096744063565038,Ovarian Epithelial Tumor,verubulin,tubulin polymerization inhibitor,TUBB
Ovarian Epithelial Tumor,BRD-K43230258-001-01-4::2.50004725::MTS004,3.8769609450008216,0.04946493660403725,Other Types,crisaborole,phosphodiesterase inhibitor,PDE4B
Ovarian Epithelial Tumor,BRD-K46843573-001-01-9::2.5::MTS004,4.354371649283073,0.03738341125772292,Other Types,zotarolimus,mTOR inhibitor,FKBP1A
Ovarian Epithelial Tumor,BRD-K54907283-001-01-2::2.4999956::MTS004,4.8980199515609915,0.027306410549542543,Ovarian Epithelial Tumor,AKBA,lipoxygenase inhibitor,ALOX5
Ovarian Epithelial Tumor,BRD-K58529924-001-01-5::2.648577938::MTS004,5.862105937280424,0.01579946380950939,Ovarian Epithelial Tumor,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Ovarian Epithelial Tumor,BRD-K59391348-001-01-7::2.5::MTS004,5.261158142416018,0.02219036966108589,Other Types,lixivaptan,vasopressin receptor antagonist,AVPR2
Ovarian Epithelial Tumor,BRD-K59753975-001-02-6::2.5::MTS004,4.785674551503557,0.029126188294122037,Ovarian Epithelial Tumor,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Ovarian Epithelial Tumor,BRD-K64120610-001-01-4::2.5::MTS004,4.037924797904191,0.04498645832666936,Ovarian Epithelial Tumor,vinflunine,microtubule inhibitor,
Ovarian Epithelial Tumor,BRD-K70262971-001-01-9::2.499966077::MTS004,5.416412351035128,0.02031774150086021,Ovarian Epithelial Tumor,AGN-194310,retinoid receptor antagonist,"RXRA, RXRB, RXRG"
Ovarian Epithelial Tumor,BRD-K83029223-001-01-3::2.500025378::MTS004,6.0794447051117935,0.013987330590203975,Ovarian Epithelial Tumor,litronesib,kinesin-like spindle protein inhibitor,KIF11
Ovarian Epithelial Tumor,BRD-K86864073-001-01-1::2.5::MTS004,4.521394676466106,0.03392813617418291,Ovarian Epithelial Tumor,chloroprocaine,sodium channel blocker,"ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3"
Ovarian Epithelial Tumor,BRD-K89085489-001-23-2::2.499967871::MTS004,3.914409583768745,0.048382494156768825,Other Types,fenretinide,"apoptosis stimulant, retinoid receptor agonist",RARA
Ovarian Epithelial Tumor,BRD-K98557884-001-01-6::2.5::MTS004,8.383099453229994,0.003940844446783169,Ovarian Epithelial Tumor,suritozole,GABA receptor inverse agonist,GABBR1
Colorectal Adenocarcinoma,BRD-A02743701-001-03-6::2.5::HTS,4.89894943231686,0.02727681281873456,Colorectal Adenocarcinoma,cilnidipine,calcium channel blocker,CACNA1B
Colorectal Adenocarcinoma,BRD-A04327189-003-03-3::2.5::HTS,7.100465219701875,0.007937286733203597,Colorectal Adenocarcinoma,synephrine,adrenergic receptor agonist,ADRA1A
Colorectal Adenocarcinoma,BRD-A06352418-001-25-9::2.5::HTS,5.157266436162396,0.023542916325766522,Other Types,terfenadine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2"
Colorectal Adenocarcinoma,BRD-A06352508-001-03-7::2.5::HTS,12.69237243254063,0.00039855542403744663,Other Types,SB-218078,CHK inhibitor,CHEK1
Colorectal Adenocarcinoma,BRD-A06935312-001-04-3::2.5::HTS,4.238969297227926,0.039970556850610725,Colorectal Adenocarcinoma,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
Colorectal Adenocarcinoma,BRD-A08255417-001-14-7::2.5::HTS,4.327105450775065,0.0379657516201536,Colorectal Adenocarcinoma,famprofazone,cyclooxygenase inhibitor,
Colorectal Adenocarcinoma,BRD-A09062839-003-10-0::2.5::HTS,6.111521310174354,0.013726414798397117,Colorectal Adenocarcinoma,amyleine,local anesthetic,
Colorectal Adenocarcinoma,BRD-A10523515-001-07-9::2.5::HTS,8.622231900413716,0.0034580510241688876,Colorectal Adenocarcinoma,GSK429286A,rho associated kinase inhibitor,ROCK1
Colorectal Adenocarcinoma,BRD-A13084692-001-17-3::2.5::HTS,3.979677355733767,0.046542687326583336,Other Types,troglitazone,"insulin sensitizer, PPAR receptor agonist","ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3"
Colorectal Adenocarcinoma,BRD-A14208071-004-19-8::2.5::HTS,5.4775461851594205,0.019614924566180976,Colorectal Adenocarcinoma,oxyphenonium,cholinergic receptor antagonist,CHRM1
Colorectal Adenocarcinoma,BRD-A15435692-003-02-3::2.5::HTS,4.199697615986929,0.040901592380569354,Other Types,BMY-14802,sigma receptor antagonist,HTR1A
Colorectal Adenocarcinoma,BRD-A17462676-003-11-6::2.5::HTS,5.539350613457646,0.01893814857812987,Colorectal Adenocarcinoma,bambuterol,adrenergic receptor agonist,"ADRB2, BCHE"
Colorectal Adenocarcinoma,BRD-A18043272-001-09-9::2.5::HTS,5.204599418934996,0.02290174053055724,Other Types,phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Colorectal Adenocarcinoma,BRD-A21276153-001-01-1::2.5::HTS,5.328980308891043,0.02135907980580224,Colorectal Adenocarcinoma,"2,6-dimethylpiperidine",,
Colorectal Adenocarcinoma,BRD-A22032524-074-06-5::2.5::HTS,4.004607199255747,0.04585643378425223,Colorectal Adenocarcinoma,amlodipine,calcium channel blocker,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1"
Colorectal Adenocarcinoma,BRD-A22152765-003-10-0::2.5::HTS,4.23575852864747,0.04004149055418001,Colorectal Adenocarcinoma,tridihexethyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Colorectal Adenocarcinoma,BRD-A22707317-001-10-8::2.5::HTS,9.180307005794532,0.0025592334777186027,Other Types,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Colorectal Adenocarcinoma,BRD-A22769835-300-05-7::2.5::HTS,7.5780802224209305,0.006100933267652353,Other Types,homochlorcyclizine,antihistamine,HRH1
Colorectal Adenocarcinoma,BRD-A24191444-046-03-9::2.4::HTS,4.313086164104392,0.03830330813309023,Other Types,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Colorectal Adenocarcinoma,BRD-A24514565-001-09-7::2.5::HTS,9.945548337971504,0.0016997484259118558,Colorectal Adenocarcinoma,warfarin,vitamin K antagonist,VKORC1
Colorectal Adenocarcinoma,BRD-A24587114-066-22-5::2.5::HTS,3.948756548730949,0.04739450419052353,Colorectal Adenocarcinoma,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Colorectal Adenocarcinoma,BRD-A27370296-001-03-0::2.5::HTS,4.994569890492602,0.025821989842888,Colorectal Adenocarcinoma,cyclandelate,calcium channel blocker,"CACNA2D1, CES1"
Colorectal Adenocarcinoma,BRD-A27883417-300-01-6::2.5::HTS,13.52552307965353,0.00025862837015201446,Colorectal Adenocarcinoma,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1
Colorectal Adenocarcinoma,BRD-A28301258-001-03-0::2.5::HTS,8.559850746145143,0.003577438976348631,Colorectal Adenocarcinoma,salinomycin,,
Colorectal Adenocarcinoma,BRD-A28940325-001-24-0::2.5::HTS,5.8463836589406535,0.015928948779440903,Other Types,trichlormethiazide,chloride channel blocker,"ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3"
Colorectal Adenocarcinoma,BRD-A29260609-003-26-0::2.5::HTS,7.570040465485135,0.00612748476713481,Other Types,acebutolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Colorectal Adenocarcinoma,BRD-A29426959-050-13-2::2.5::HTS,10.70137614780565,0.0011367772324722436,Colorectal Adenocarcinoma,carbinoxamine,histamine receptor antagonist,HRH1
Colorectal Adenocarcinoma,BRD-A29731977-001-04-5::2.5::HTS,14.800144797497763,0.0001332974422342877,Other Types,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Colorectal Adenocarcinoma,BRD-A29844814-300-01-5::2.5::HTS,5.577244112045064,0.01854038381144367,Colorectal Adenocarcinoma,ABT-202,acetylcholine receptor agonist,
Colorectal Adenocarcinoma,BRD-A29854054-236-12-6::2.5::HTS,4.856071592741294,0.027959648552594158,Other Types,lorglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Colorectal Adenocarcinoma,BRD-A30590053-003-02-9::2.5::HTS,4.787397393186123,0.02907975997699588,Other Types,MR-16728,acetylcholine release enhancer,
Colorectal Adenocarcinoma,BRD-A33168282-003-18-0::2.5::HTS,4.825375169046135,0.028458749262169254,Colorectal Adenocarcinoma,sotalol,adrenergic receptor antagonist,"ADRB1, ADRB2, KCNH2"
Colorectal Adenocarcinoma,BRD-A34205397-001-04-5::2.5::HTS,9.204680813130329,0.002526337547510997,Other Types,suloctidil,adrenergic receptor antagonist,
Colorectal Adenocarcinoma,BRD-A35912562-001-02-8::2.5::HTS,11.255508497313613,0.0008479097756345558,Other Types,pregnenolone-succinate,GABA receptor negative allosteric modulator,
Colorectal Adenocarcinoma,BRD-A35989968-001-04-2::2.5::HTS,4.602958209808658,0.03235082029726828,Other Types,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Colorectal Adenocarcinoma,BRD-A36057565-001-01-0::2.5::HTS,9.888092424557055,0.0017530016428624015,Colorectal Adenocarcinoma,bruceantin,protein synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-A36318220-001-08-8::2.5::HTS,16.190520230349914,6.516675550867987e-05,Colorectal Adenocarcinoma,necrostatin-1,RIPK inhibitor,RIPK1
Colorectal Adenocarcinoma,BRD-A37288617-003-02-2::2.5::HTS,4.377257402766737,0.036869628202248164,Other Types,amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3"
Colorectal Adenocarcinoma,BRD-A37704979-001-10-7::2.5::HTS,5.28841192613516,0.02183675434457145,Colorectal Adenocarcinoma,SB-203580,p38 MAPK inhibitor,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
Colorectal Adenocarcinoma,BRD-A39052811-048-11-0::2.5::HTS,4.238873497093402,0.039972794654596126,Other Types,mosapride,serotonin receptor agonist,HTR4
Colorectal Adenocarcinoma,BRD-A40413915-003-01-2::2.5::HTS,11.408029232990653,0.0007823439111606106,Other Types,NTNCB,neuropeptide receptor antagonist,NPY5R
Colorectal Adenocarcinoma,BRD-A40639672-234-18-0::2.5::HTS,4.538642937192768,0.033584184668127015,Other Types,ketorolac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Colorectal Adenocarcinoma,BRD-A40777960-001-04-2::2.5::HTS,6.248044750896313,0.012719638094024223,Other Types,aminohydroxybutyric-acid,,
Colorectal Adenocarcinoma,BRD-A42270467-001-04-4::2.5::HTS,5.719651913003817,0.017106802455553224,Colorectal Adenocarcinoma,tenatoprazole,ATPase inhibitor,IDO1
Colorectal Adenocarcinoma,BRD-A43082555-001-01-1::2.5::HTS,4.054019628514423,0.04455647186590406,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Colorectal Adenocarcinoma,BRD-A44133049-003-07-8::2.5::HTS,7.230139620334873,0.00738484711409411,Colorectal Adenocarcinoma,azasetron,serotonin receptor antagonist,"HTR3A, HTR3B"
Colorectal Adenocarcinoma,BRD-A44500574-001-01-8::2.5::HTS,5.799042953322749,0.016358219579433425,Colorectal Adenocarcinoma,FLI-06,notch signaling inhibitor,
Colorectal Adenocarcinoma,BRD-A45498368-001-07-1::2.5::HTS,12.561941926621389,0.000426692692559625,Colorectal Adenocarcinoma,WYE-125132,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-A45889380-300-07-1::2.5::HTS,12.840353587533958,0.0003695676033235107,Other Types,mepacrine,"cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B, PLA2G4A, PLA2G6, PLCL1"
Colorectal Adenocarcinoma,BRD-A48430263-003-17-2::2.5::HTS,6.8716007820572536,0.008997789233045736,Other Types,pioglitazone,"insulin sensitizer, PPAR receptor agonist","PPARG, TRPM3"
Colorectal Adenocarcinoma,BRD-A50157456-065-20-6::2.5::HTS,3.964484719287031,0.046963114268899674,Colorectal Adenocarcinoma,terbutaline,adrenergic receptor agonist,ADRB2
Colorectal Adenocarcinoma,BRD-A50311610-300-10-4::2.5::HTS,6.2906593220706615,0.01242650413489818,Other Types,meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3"
Colorectal Adenocarcinoma,BRD-A50764878-003-02-8::2.5::HTS,5.119990822047564,0.024036000604624966,Colorectal Adenocarcinoma,MDL-73005EF,serotonin receptor antagonist,HTR1A
Colorectal Adenocarcinoma,BRD-A53566267-001-01-9::2.5::HTS,4.980397089360635,0.026033841174810952,Colorectal Adenocarcinoma,anecortave-acetate,angiogenesis inhibitor,
Colorectal Adenocarcinoma,BRD-A54236247-003-04-3::2.5::HTS,4.662326729088109,0.031257596544476025,Colorectal Adenocarcinoma,ephedrine-(racemic),adrenergic receptor agonist,"ADRA1A, ADRA2A"
Colorectal Adenocarcinoma,BRD-A55312468-001-04-7::1.24::HTS,16.153773226867585,6.648249590787278e-05,Colorectal Adenocarcinoma,k-strophanthidin,ATPase inhibitor,ATP1A1
Colorectal Adenocarcinoma,BRD-A55664972-236-02-6::2.5::HTS,4.759067481516809,0.029561677219231225,Colorectal Adenocarcinoma,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Colorectal Adenocarcinoma,BRD-A55913614-316-09-6::2.5::HTS,3.993211220970491,0.046165236962291384,Colorectal Adenocarcinoma,primaquine,"antimalarial agent, DNA inhibitor","KRT7, NQO2"
Colorectal Adenocarcinoma,BRD-A56085258-001-01-8::2.5::HTS,5.572332946009677,0.018588206967352288,Colorectal Adenocarcinoma,LGX818,RAF inhibitor,BRAF
Colorectal Adenocarcinoma,BRD-A57798112-001-03-7::2.5::HTS,12.764911215058035,0.0003837835519292943,Other Types,PD-318088,MEK inhibitor,MAP2K1
Colorectal Adenocarcinoma,BRD-A58193911-003-18-7::2.5::HTS,6.818821936881192,0.009271457479258753,Colorectal Adenocarcinoma,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Colorectal Adenocarcinoma,BRD-A59198242-003-02-9::2.5::HTS,5.004244579456705,0.025677256585864585,Colorectal Adenocarcinoma,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Colorectal Adenocarcinoma,BRD-A61850409-001-10-7::2.5::HTS,4.807016693954144,0.028756273925287065,Other Types,alpha-tochopheryl-acetate,antioxidant,
Colorectal Adenocarcinoma,BRD-A63546914-003-02-0::2.5::HTS,4.506258845906461,0.034213865664980914,Colorectal Adenocarcinoma,Ro-04-5595,,GRIN2B
Colorectal Adenocarcinoma,BRD-A64808605-003-02-7::2.5::HTS,7.184521158870929,0.007570468323465866,Other Types,AH11110,adrenergic receptor ligand,ADRA1B
Colorectal Adenocarcinoma,BRD-A65797496-048-09-3::2.5::HTS,4.594424975734379,0.03250466791192327,Other Types,deptropine,histamine receptor antagonist,HRH1
Colorectal Adenocarcinoma,BRD-A68509429-003-03-9::2.5::HTS,4.131462606655313,0.042565924437919234,Colorectal Adenocarcinoma,ethylnorepinephrine,bronchodilator,
Colorectal Adenocarcinoma,BRD-A70649075-008-30-8::2.5::HTS,7.98637969415982,0.004881909971635684,Other Types,sulconazole,sterol demethylase inhibitor,
Colorectal Adenocarcinoma,BRD-A71033472-003-23-9::2.5::HTS,4.981548278429919,0.026016682675141074,Colorectal Adenocarcinoma,fendiline,calcium channel blocker,HTR2B
Colorectal Adenocarcinoma,BRD-A72711497-236-03-8::2.5::HTS,6.196074500973468,0.01309261109137389,Colorectal Adenocarcinoma,lasalocid,bacterial permeability inducer,
Colorectal Adenocarcinoma,BRD-A74975734-004-10-7::2.5::HTS,4.9186539588842475,0.026970900017346176,Other Types,homatropine,acetylcholine receptor antagonist,"CES1, CHRM1"
Colorectal Adenocarcinoma,BRD-A77577770-003-08-9::2.5::HTS,4.143516552475681,0.042262823208009025,Colorectal Adenocarcinoma,palmitoylcarnitine,protein kinase inhibitor,
Colorectal Adenocarcinoma,BRD-A78377521-001-05-5::2.5::HTS,8.75302292179382,0.003223398717255811,Colorectal Adenocarcinoma,monastrol,kinesin inhibitor,KIF11
Colorectal Adenocarcinoma,BRD-A78952587-001-01-5::2.5::HTS,7.076903724605246,0.008034594420045562,Other Types,A740003,purinergic receptor antagonist,P2RX7
Colorectal Adenocarcinoma,BRD-A79768653-001-12-0::2.5::HTS,18.96065999842031,1.5908186860792994e-05,Colorectal Adenocarcinoma,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Colorectal Adenocarcinoma,BRD-A80908310-003-13-8::2.5::HTS,4.633495991054377,0.031781694588979434,Other Types,cloperastine,antitussive,
Colorectal Adenocarcinoma,BRD-A82035391-001-02-7::2.5::HTS,5.722692680874242,0.017075734981604012,Other Types,tolvaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2"
Colorectal Adenocarcinoma,BRD-A84575140-001-02-4::2.5::HTS,6.144041581255739,0.013486536307039228,Colorectal Adenocarcinoma,pimobendan,"calcium sensitizer, phosphodiesterase inhibitor",PDE3A
Colorectal Adenocarcinoma,BRD-A86415025-050-01-0::2.5::HTS,3.8762629021368227,0.049464390621016534,Colorectal Adenocarcinoma,"1-(1,2-Diphenylethyl)piperidine-(+/-)",glutamate receptor antagonist,
Colorectal Adenocarcinoma,BRD-A90547603-001-02-5::2.5::HTS,4.678620521821071,0.030963461586175252,Colorectal Adenocarcinoma,eptifibatide,platelet aggregation inhibitor,"ITGA2B, ITGB3"
Colorectal Adenocarcinoma,BRD-A90695733-001-07-4::2.5::HTS,7.627000823485355,0.005940523558027076,Other Types,manidipine,calcium channel blocker,"CACNA1C, CACNA1D"
Colorectal Adenocarcinoma,BRD-A92630576-050-24-1::2.5::HTS,4.445562399448195,0.03543403610717369,Colorectal Adenocarcinoma,trimebutine,opioid receptor agonist,"OPRD1, OPRK1, OPRM1"
Colorectal Adenocarcinoma,BRD-A93353767-008-02-2::2.5::HTS,9.83831025206501,0.0017988978092866397,Other Types,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1
Colorectal Adenocarcinoma,BRD-A95602221-003-02-1::2.5::HTS,4.507851399121146,0.03418228893158963,Colorectal Adenocarcinoma,celiprolol,adrenergic receptor antagonist,"ADRA2A, ADRB1, ADRB2"
Colorectal Adenocarcinoma,BRD-A96977263-001-03-7::2.5::HTS,5.147058006381732,0.023688606383586067,Colorectal Adenocarcinoma,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1
Colorectal Adenocarcinoma,BRD-K00317371-001-06-1::2.4::HTS,5.965300764146439,0.014916992079727643,Other Types,RITA,MDM inhibitor,MDM2
Colorectal Adenocarcinoma,BRD-K00627859-003-03-7::2.5::HTS,6.009049784496574,0.014538279497939807,Colorectal Adenocarcinoma,tubastatin-a,HDAC inhibitor,HDAC6
Colorectal Adenocarcinoma,BRD-K00673382-001-18-9::2.5::HTS,3.9862924414277314,0.046361639859010186,Other Types,famotidine,histamine receptor antagonist,HRH2
Colorectal Adenocarcinoma,BRD-K01244426-236-12-1::2.5::HTS,13.034110440597752,0.00033346228950754063,Colorectal Adenocarcinoma,cloxacillin,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K01683783-001-02-6::2.5::HTS,11.539410777626006,0.000729908360324945,Colorectal Adenocarcinoma,TAK-901,Aurora kinase inhibitor,AURKB
Colorectal Adenocarcinoma,BRD-K01950558-001-14-7::2.5::HTS,5.549193437880898,0.018834243497585394,Colorectal Adenocarcinoma,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR
Colorectal Adenocarcinoma,BRD-K02475039-001-01-0::2.5::HTS,4.789894979938283,0.02904168560424575,Colorectal Adenocarcinoma,ethopabate,antiprotozoal agent,
Colorectal Adenocarcinoma,BRD-K02950022-001-02-9::2.5::HTS,3.880458211312441,0.04934622866086057,Other Types,BMS-299897,gamma secretase inhibitor,
Colorectal Adenocarcinoma,BRD-K02965346-001-07-5::2.5::HTS,9.05179425280622,0.002743656021007167,Colorectal Adenocarcinoma,SU-11274,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET
Colorectal Adenocarcinoma,BRD-K03243820-001-25-3::2.5::HTS,5.349264115197065,0.021101843378785224,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Colorectal Adenocarcinoma,BRD-K03273112-001-01-8::2.5::HTS,5.798850532763354,0.01635941058559062,Other Types,1-azakenpaullone,glycogen synthase kinase inhibitor,"CCNB1, CDK1, CDK5, GSK3B"
Colorectal Adenocarcinoma,BRD-K03390685-001-01-7::2.5::HTS,8.938691262320576,0.002915902949648342,Other Types,cobimetinib,MEK inhibitor,
Colorectal Adenocarcinoma,BRD-K03549949-001-01-0::2.5::HTS,11.065865071525732,0.0009367432247424107,Colorectal Adenocarcinoma,XL388,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K03564313-001-03-3::2.5::HTS,4.167591171171376,0.041677569865908835,Colorectal Adenocarcinoma,DMNB,DNA dependent protein kinase inhibitor,
Colorectal Adenocarcinoma,BRD-K04414442-001-08-3::2.5::HTS,4.752066332127314,0.029684913613998994,Colorectal Adenocarcinoma,SB-222200,tachykinin antagonist,TACR3
Colorectal Adenocarcinoma,BRD-K04568635-300-01-4::2.5::HTS,7.095798103398654,0.007952227673299464,Colorectal Adenocarcinoma,octenidine,membrane integrity inhibitor,
Colorectal Adenocarcinoma,BRD-K05104363-001-10-0::2.5::HTS,22.325822896491093,2.9395513778464226e-06,Other Types,PD-184352,MEK inhibitor,"MAP2K1, MAP3K1, MAP3K2"
Colorectal Adenocarcinoma,BRD-K06542892-001-01-9::2.5::HTS,7.543578214540417,0.0062197321699154215,Colorectal Adenocarcinoma,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Colorectal Adenocarcinoma,BRD-K06674495-334-03-2::2.5::HTS,5.0760089479757395,0.02464742440810742,Colorectal Adenocarcinoma,nafamostat,serine protease inhibitor,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7"
Colorectal Adenocarcinoma,BRD-K06854232-001-19-9::2.5::HTS,4.671569042881814,0.031098262409576784,Colorectal Adenocarcinoma,AM-580,retinoid receptor agonist,RARA
Colorectal Adenocarcinoma,BRD-K07310275-001-02-5::2.5::HTS,4.379449452731137,0.036826646628077324,Colorectal Adenocarcinoma,PF-04691502,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Colorectal Adenocarcinoma,BRD-K07441213-001-18-9::2.5::HTS,5.386060060149058,0.020657783298533565,Other Types,paroxypropione,gonadotropin inhibitor,
Colorectal Adenocarcinoma,BRD-K07798980-001-01-9::2.5::HTS,5.956601045579242,0.014972808631484147,Colorectal Adenocarcinoma,PSI-6130,RNA polymerase inhibitor,
Colorectal Adenocarcinoma,BRD-K07955840-001-02-3::2.5::HTS,45.187061463083815,4.434816923111054e-11,Colorectal Adenocarcinoma,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Colorectal Adenocarcinoma,BRD-K08251020-001-01-0::2.5::HTS,4.674358755883456,0.03104981998340227,Other Types,falecalcitriol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K08542803-001-03-1::0.8::HTS,5.982370983324972,0.014757932140747285,Colorectal Adenocarcinoma,gambogic-acid,caspase activator,BCL2
Colorectal Adenocarcinoma,BRD-K08619838-300-05-7::2.5::HTS,6.043687592358524,0.014257194388163256,Colorectal Adenocarcinoma,tremorine,acetylcholine receptor agonist,
Colorectal Adenocarcinoma,BRD-K09295674-001-09-8::2.5::HTS,7.300507921352678,0.007103626797807043,Other Types,carzenide,,"CA1, CA12, CA14, CA2, CA6, CA9"
Colorectal Adenocarcinoma,BRD-K09372874-001-01-0::2.5::HTS,4.986685712810455,0.025952806345161242,Colorectal Adenocarcinoma,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
Colorectal Adenocarcinoma,BRD-K09537769-001-04-0::2.5::HTS,5.290010026839091,0.021813628703319776,Colorectal Adenocarcinoma,NU-7026,"DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",PRKDC
Colorectal Adenocarcinoma,BRD-K09659835-003-01-4::2.5::HTS,4.810738191576053,0.0286992713757529,Colorectal Adenocarcinoma,loreclezole,benzodiazepine receptor agonist,"GABRB2, GABRB3"
Colorectal Adenocarcinoma,BRD-K10071630-001-01-0::2.5::HTS,3.9395352938378383,0.04765044057180151,Colorectal Adenocarcinoma,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Colorectal Adenocarcinoma,BRD-K10177585-003-02-4::2.5::HTS,13.015541115285096,0.0003368631776563322,Colorectal Adenocarcinoma,PSB-11,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA3"
Colorectal Adenocarcinoma,BRD-K10706131-046-03-6::2.5::HTS,3.9679636886325103,0.046864225868880796,Colorectal Adenocarcinoma,rivastigmine,acetylcholinesterase inhibitor,"ACHE, BCHE"
Colorectal Adenocarcinoma,BRD-K10961822-001-05-1::2.5::HTS,5.980187348348081,0.014786360228045489,Colorectal Adenocarcinoma,latanoprost,prostanoid receptor agonist,PTGFR
Colorectal Adenocarcinoma,BRD-K11244467-001-08-5::2.5::HTS,13.659832560076175,0.0002405435104779118,Other Types,ambazone,DNA damage inducer,
Colorectal Adenocarcinoma,BRD-K11292736-300-02-8::2.5::HTS,6.81974734774162,0.009259876635672116,Colorectal Adenocarcinoma,ambenonium,cholinesterase inhibitor,ACHE
Colorectal Adenocarcinoma,BRD-K11399644-003-11-3::2.5::HTS,9.684341210936381,0.0019571366496213753,Other Types,phenformin,AMPK activator,"KCNJ8, PRKAA1"
Colorectal Adenocarcinoma,BRD-K11900042-001-14-4::2.5::HTS,4.822097506435702,0.028522461511875215,Other Types,methylthiouracil,,
Colorectal Adenocarcinoma,BRD-K12040459-001-06-0::2.5::HTS,4.414087233189715,0.036092129179887994,Colorectal Adenocarcinoma,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Colorectal Adenocarcinoma,BRD-K12184916-001-15-4::2.5::HTS,34.56830786895416,7.0769038823226724e-09,Colorectal Adenocarcinoma,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor","ATR, MTOR, PIK3CA, PIK3CD, PIK3CG"
Colorectal Adenocarcinoma,BRD-K12244279-001-05-8::2.5::HTS,6.924851115510407,0.008737420127747126,Other Types,MEK1-2-inhibitor,MEK inhibitor,MAP2K2
Colorectal Adenocarcinoma,BRD-K12343256-001-08-9::2.5::HTS,8.654522351696572,0.003397986881614103,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Colorectal Adenocarcinoma,BRD-K12609457-001-03-1::2.5::HTS,5.4066265601198165,0.020430783425796295,Colorectal Adenocarcinoma,exalamide,membrane permeability inhibitor,
Colorectal Adenocarcinoma,BRD-K12762134-001-06-2::2.5::HTS,8.86471684571561,0.003034483374736733,Colorectal Adenocarcinoma,XAV-939,tankyrase inhibitor,"TNKS, TNKS2"
Colorectal Adenocarcinoma,BRD-K13183738-317-10-2::2.5::HTS,6.196423070053619,0.013091625797795515,Colorectal Adenocarcinoma,pentamidine,anti-pneumocystis agent,TRDMT1
Colorectal Adenocarcinoma,BRD-K13211965-003-02-8::2.5::HTS,6.115771284405358,0.013694345208521213,Other Types,L-741742,dopamine receptor antagonist,"DRD3, DRD4, SCN1A, SCN3A"
Colorectal Adenocarcinoma,BRD-K13238168-001-02-0::2.5::HTS,5.124283736009834,0.02397375027603113,Colorectal Adenocarcinoma,haloprogin,other antifungal,
Colorectal Adenocarcinoma,BRD-K13249881-001-02-3::2.5::HTS,4.800794550442511,0.028873963252555798,Other Types,piperazine,benzodiazepine receptor agonist,GABRB3
Colorectal Adenocarcinoma,BRD-K13314656-001-01-0::2.5::HTS,6.343351164714527,0.012067911731927098,Other Types,ebastine,histamine receptor antagonist,"CYP3A4, HRH1"
Colorectal Adenocarcinoma,BRD-K13356952-001-25-1::2.5::HTS,7.387292914881462,0.006777323417403466,Colorectal Adenocarcinoma,methazolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7"
Colorectal Adenocarcinoma,BRD-K13387373-004-14-5::2.5::HTS,11.594810508842341,0.0007092656355043671,Colorectal Adenocarcinoma,thonzonium,ATPase inhibitor,
Colorectal Adenocarcinoma,BRD-K13390322-001-06-3::2.5::HTS,7.0696476688358265,0.008070120287631585,Colorectal Adenocarcinoma,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Colorectal Adenocarcinoma,BRD-K13514097-001-05-3::2.5::HTS,17.152489323886105,3.9848978420006014e-05,Colorectal Adenocarcinoma,everolimus,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K13756951-001-01-4::2.5::HTS,7.657027126619553,0.005841433831675208,Colorectal Adenocarcinoma,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Colorectal Adenocarcinoma,BRD-K14618467-001-04-6::2.5::HTS,4.832345466140965,0.028337564177387635,Other Types,IKK-16,IKK inhibitor,IKBKB
Colorectal Adenocarcinoma,BRD-K14796088-003-26-8::2.5::HTS,5.345909502032532,0.021131483553541955,Colorectal Adenocarcinoma,berberine,LDL receptor activator,LDLR
Colorectal Adenocarcinoma,BRD-K14807180-001-02-5::2.5::HTS,5.351226954005814,0.02107429901632264,Colorectal Adenocarcinoma,SB-221284,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Colorectal Adenocarcinoma,BRD-K14920963-304-02-7::2.5::HTS,8.148771208009286,0.004469792391494517,Colorectal Adenocarcinoma,erythrosine,coloring agent,
Colorectal Adenocarcinoma,BRD-K14993104-001-05-9::2.5::HTS,5.151969885956258,0.023602048324101763,Colorectal Adenocarcinoma,bemegride,chemoreceptor agonist,GABRA1
Colorectal Adenocarcinoma,BRD-K15045219-001-01-8::2.5::HTS,4.092251392302976,0.04356705158452301,Colorectal Adenocarcinoma,salazodine,,
Colorectal Adenocarcinoma,BRD-K15337272-001-01-3::2.5::HTS,4.023974781356678,0.04533661569583899,Colorectal Adenocarcinoma,C-751,,
Colorectal Adenocarcinoma,BRD-K15891719-001-05-1::2.45::HTS,4.404703405690825,0.03631431743236808,Other Types,tenofovir,"HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor",
Colorectal Adenocarcinoma,BRD-K16189898-003-03-3::2.5::HTS,4.164292013673684,0.04175143379083308,Other Types,CHIR-99021,glycogen synthase kinase inhibitor,"CDK1, GSK3A, GSK3B, MAPK1"
Colorectal Adenocarcinoma,BRD-K16474819-001-09-6::2.5::HTS,6.5733966850432894,0.010612170143706297,Colorectal Adenocarcinoma,metacetamol,analgesic agent,
Colorectal Adenocarcinoma,BRD-K16484091-001-01-1::2.5::HTS,5.51950621563811,0.01915074381278501,Colorectal Adenocarcinoma,metocurine,acetylcholine receptor antagonist,"CHRM2, CHRNA2"
Colorectal Adenocarcinoma,BRD-K16508793-001-05-9::2.5::HTS,4.8139024163034225,0.028641876499307713,Other Types,diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Colorectal Adenocarcinoma,BRD-K16898998-001-01-6::2.5::HTS,5.918529501604742,0.015294503744734279,Other Types,bevirimat-dimeglumine,HIV capsid assembly inhibitor,
Colorectal Adenocarcinoma,BRD-K17061841-001-03-5::2.5::HTS,5.994819286192983,0.014652533604957798,Colorectal Adenocarcinoma,stattic,,
Colorectal Adenocarcinoma,BRD-K17075857-001-17-6::2.5::HTS,16.145436441906863,6.667653982087372e-05,Colorectal Adenocarcinoma,chloroxine,opioid receptor antagonist,OPRK1
Colorectal Adenocarcinoma,BRD-K17561142-003-32-5::2.5::HTS,8.180486129796574,0.00439229461325512,Other Types,amiodarone,potassium channel blocker,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2"
Colorectal Adenocarcinoma,BRD-K17743697-066-03-6::2.5::HTS,5.756759130231217,0.016755857186747273,Colorectal Adenocarcinoma,KB-R7943,sodium/calcium exchange inhibitor,"SLC8A1, TRPC3, TRPC5, TRPC6"
Colorectal Adenocarcinoma,BRD-K17849083-001-32-9::2.43::HTS,4.681121465419304,0.030934524937711254,Colorectal Adenocarcinoma,tranilast,angiogenesis inhibitor,"HPGDS, HRH1"
Colorectal Adenocarcinoma,BRD-K17874705-300-03-2::2.5::HTS,4.395739940774949,0.03648919114982594,Colorectal Adenocarcinoma,2-pyridylethylamine,histamine receptor agonist,HRH1
Colorectal Adenocarcinoma,BRD-K18424115-003-01-3::2.5::HTS,6.244792843612747,0.012744306741880505,Colorectal Adenocarcinoma,TG-100572,"src inhibitor, VEGFR inhibitor","KDR, SRC"
Colorectal Adenocarcinoma,BRD-K18518344-001-15-9::2.5::HTS,5.923721575407353,0.015253370087867613,Colorectal Adenocarcinoma,digitoxigenin,ATPase inhibitor,ATP1A1
Colorectal Adenocarcinoma,BRD-K18574842-323-10-8::2.51::HTS,4.145578013325016,0.042241979399538415,Colorectal Adenocarcinoma,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Colorectal Adenocarcinoma,BRD-K18619710-001-14-4::2.5::HTS,12.119732479644119,0.0005382457694060559,Colorectal Adenocarcinoma,digoxigenin,steroid,
Colorectal Adenocarcinoma,BRD-K18673820-001-15-5::2.5::HTS,6.222663385905392,0.012899602921732875,Other Types,folic-acid,folate receptor ligand,"FOLR2, FOLR3, SLC19A1, SLC46A1"
Colorectal Adenocarcinoma,BRD-K18787491-001-08-6::2.5::HTS,7.942512463527363,0.005001183689437595,Other Types,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Colorectal Adenocarcinoma,BRD-K18895904-001-16-1::2.5::HTS,7.644371793831021,0.005884713722131875,Other Types,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Colorectal Adenocarcinoma,BRD-K18961567-001-01-1::2.5::HTS,10.548784557423149,0.0012330197500642966,Colorectal Adenocarcinoma,LY2801653,MET inhibitor,MET
Colorectal Adenocarcinoma,BRD-K19034817-001-01-4::2.5::HTS,9.137812059221385,0.0026187834101454636,Other Types,pacritinib,"FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3"
Colorectal Adenocarcinoma,BRD-K19507340-001-22-1::2.38::HTS,9.06082357065762,0.0027362886799572016,Other Types,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Colorectal Adenocarcinoma,BRD-K19687926-379-07-4::2.5::HTS,6.31394243913465,0.012260044169145856,Other Types,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Colorectal Adenocarcinoma,BRD-K20008181-001-01-3::2.5::HTS,7.643853717330199,0.005886380655059487,Colorectal Adenocarcinoma,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1
Colorectal Adenocarcinoma,BRD-K20285085-001-07-1::2.5::HTS,5.934420224437733,0.01517081771496077,Colorectal Adenocarcinoma,R406,SYK inhibitor,"RET, SYK"
Colorectal Adenocarcinoma,BRD-K20755323-001-05-9::2.5::HTS,31.82681442916324,2.6802619766528398e-08,Colorectal Adenocarcinoma,SKI-II,sphingosine kinase inhibitor,SPHK1
Colorectal Adenocarcinoma,BRD-K21672174-001-03-0::2.5::HTS,7.037172898258466,0.00821038382183073,Colorectal Adenocarcinoma,Ro-28-1675,glucokinase activator,GCK
Colorectal Adenocarcinoma,BRD-K21782625-001-03-2::2.45::HTS,13.845238607655142,0.0002197822895481835,Colorectal Adenocarcinoma,AMG458,MET inhibitor,MET
Colorectal Adenocarcinoma,BRD-K21937671-001-09-2::2.53::HTS,4.940598560060797,0.026662199822813412,Other Types,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Colorectal Adenocarcinoma,BRD-K22025381-003-01-9::2.5::HTS,38.87636371097714,8.906849590918916e-10,Other Types,U-18666A,oxidosqualene cyclase inhibitor,
Colorectal Adenocarcinoma,BRD-K22134346-001-24-9::2.42::HTS,14.19616951577627,0.00018325368793482212,Colorectal Adenocarcinoma,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Colorectal Adenocarcinoma,BRD-K22356203-001-01-8::2.5::HTS,6.289978877981696,0.012422957137418943,Colorectal Adenocarcinoma,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Colorectal Adenocarcinoma,BRD-K22385716-001-02-5::2.5::HTS,5.656463495910164,0.017729223929706238,Colorectal Adenocarcinoma,LY303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","BRD2, BRD3, BRD4"
Colorectal Adenocarcinoma,BRD-K22861715-001-17-4::2.5::HTS,5.769571857948685,0.016645276016530784,Other Types,chrysin,breast cancer resistance protein inhibitor,"AKR1B1, CDK6, CYP19A1, CYP1B1"
Colorectal Adenocarcinoma,BRD-K23228615-001-02-8::2.5::HTS,5.142816452069403,0.023728396885544883,Colorectal Adenocarcinoma,GDC-0980,"mTOR inhibitor, PI3K inhibitor","FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK"
Colorectal Adenocarcinoma,BRD-K23301018-001-11-7::2.63::HTS,12.024100708217377,0.0005680089642055318,Colorectal Adenocarcinoma,broxyquinoline,antiprotozoal agent,
Colorectal Adenocarcinoma,BRD-K23925186-001-02-8::2.51::HTS,6.3373644248673076,0.012116943281351295,Colorectal Adenocarcinoma,oridonin,BCL inhibitor,BCL2
Colorectal Adenocarcinoma,BRD-K24201553-003-11-5::2.5::HTS,6.491637557918298,0.011104802879324166,Other Types,SB-269970,serotonin receptor antagonist,HTR7
Colorectal Adenocarcinoma,BRD-K24556407-001-02-3::2.5::HTS,5.67549754451041,0.017536841256603465,Colorectal Adenocarcinoma,ETP-46464,ATR kinase inhibitor,
Colorectal Adenocarcinoma,BRD-K24566386-001-01-9::2.5::HTS,7.218795981204368,0.007432231883908886,Colorectal Adenocarcinoma,SD-208,TGF beta receptor inhibitor,TGFBR1
Colorectal Adenocarcinoma,BRD-K24593301-001-02-3::2.54::HTS,4.311924479091121,0.0383292509174945,Colorectal Adenocarcinoma,AZD3463,"ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor","ALK, IGF1R"
Colorectal Adenocarcinoma,BRD-K24696047-001-02-3::2.5::HTS,4.440510242356963,0.03554458009313515,Other Types,NVP-AEW541,IGF-1 inhibitor,"IGF1R, INSR"
Colorectal Adenocarcinoma,BRD-K24697665-001-01-4::2.5::HTS,3.892728397645261,0.04901871638808243,Other Types,bucillamine,immunosuppressant,
Colorectal Adenocarcinoma,BRD-K24723746-036-02-5::2.5::HTS,5.585145790872646,0.01845591649533143,Other Types,solifenacin-succinate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Colorectal Adenocarcinoma,BRD-K24943235-001-01-3::2.5::HTS,9.002820154105502,0.0028151834558702528,Other Types,grazoprevir,HCV inhibitor,
Colorectal Adenocarcinoma,BRD-K25015158-001-01-2::2.5::HTS,6.003626783813872,0.014584760150604982,Colorectal Adenocarcinoma,limaprost-alfadex,prostanoid receptor agonist,PTGER1
Colorectal Adenocarcinoma,BRD-K25186396-001-09-6::2.5::HTS,5.436788974403065,0.020074455895914146,Other Types,tangeritin,cell cycle inhibitor,
Colorectal Adenocarcinoma,BRD-K25412176-001-01-9::2.5::HTS,4.620760402934865,0.03201957900180441,Other Types,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Colorectal Adenocarcinoma,BRD-K26060080-065-05-6::2.5::HTS,6.89629162964579,0.008876316575241829,Colorectal Adenocarcinoma,adenine,protein synthesis stimulant,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2"
Colorectal Adenocarcinoma,BRD-K26262077-238-01-5::2.5::HTS,4.9547780106764865,0.02644002469728854,Colorectal Adenocarcinoma,acamprosate,glutamate receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5"
Colorectal Adenocarcinoma,BRD-K26531771-001-01-4::2.5::HTS,5.302214110478154,0.021662774792498295,Other Types,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Colorectal Adenocarcinoma,BRD-K26581543-001-01-6::2.5::HTS,5.7224600904177665,0.017082753629933896,Colorectal Adenocarcinoma,bifendate,,
Colorectal Adenocarcinoma,BRD-K26667523-001-02-5::2.5::HTS,4.029217935347162,0.04520387776121814,Other Types,TAK-733,MEK inhibitor,MAP2K1
Colorectal Adenocarcinoma,BRD-K26739552-003-15-4::2.5::HTS,6.990693604950641,0.008432140897418528,Other Types,fenspiride,bronchodilator,
Colorectal Adenocarcinoma,BRD-K26838195-075-04-9::2.5::HTS,5.337984055653356,0.02122683477299578,Other Types,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Colorectal Adenocarcinoma,BRD-K26901728-001-06-2::2.5::HTS,8.239775767282499,0.00425341419500519,Other Types,lumiracoxib,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Colorectal Adenocarcinoma,BRD-K27182532-001-02-3::2.5::HTS,6.333692678388396,0.01212380919673842,Colorectal Adenocarcinoma,metatinib,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Colorectal Adenocarcinoma,BRD-K27217864-001-22-3::2.5::HTS,4.133948471026284,0.04250648482069207,Colorectal Adenocarcinoma,butamben,sodium channel blocker,
Colorectal Adenocarcinoma,BRD-K27316855-001-13-3::2.44::HTS,5.154128019755319,0.023593311134923318,Other Types,calcitriol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K27316855-001-19-0::2.5::HTS,9.359612262745115,0.0023245080190125497,Other Types,calcitriol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K27911943-001-02-8::2.5::HTS,6.5186276772575535,0.010941864605047896,Other Types,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,
Colorectal Adenocarcinoma,BRD-K27938825-001-02-4::2.5::HTS,6.978420065284394,0.00848078281068913,Colorectal Adenocarcinoma,ASA-404,angiogenesis inhibitor,
Colorectal Adenocarcinoma,BRD-K27955832-001-02-9::2.5::HTS,4.558957961956758,0.033181085375704945,Other Types,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Colorectal Adenocarcinoma,BRD-K28453807-003-11-2::2.5::HTS,5.104107672208552,0.024291425972760926,Colorectal Adenocarcinoma,nitrocaramiphen,cholinergic receptor antagonist,CHRM1
Colorectal Adenocarcinoma,BRD-K28542495-003-13-5::2.5::HTS,6.725410312011911,0.009759832613439132,Other Types,benzydamine,prostanoid receptor antagonist,
Colorectal Adenocarcinoma,BRD-K28824103-001-02-8::2.5::HTS,4.4464473621223615,0.03544432227437759,Colorectal Adenocarcinoma,genipin,choleretic agent,
Colorectal Adenocarcinoma,BRD-K28965160-001-01-1::2.5::HTS,13.968599554439391,0.00020518637968642658,Other Types,BVD-523,MAP kinase inhibitor,
Colorectal Adenocarcinoma,BRD-K29254801-001-14-7::2.5::HTS,8.801350360319717,0.003139255569832492,Colorectal Adenocarcinoma,thiram,,JAK2
Colorectal Adenocarcinoma,BRD-K29415052-050-04-8::2.5::HTS,7.236153383931505,0.007357387972305413,Colorectal Adenocarcinoma,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Colorectal Adenocarcinoma,BRD-K29582677-300-10-6::2.5::HTS,4.299201377544208,0.03860469985079672,Other Types,flunarizine,calcium channel blocker,"CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1"
Colorectal Adenocarcinoma,BRD-K29656036-001-02-5::2.5::HTS,12.04991488945353,0.0005579634769298265,Other Types,MK-8245,stearoyl-CoA desaturase inhibitor,SCD
Colorectal Adenocarcinoma,BRD-K29950728-048-17-4::2.5::HTS,7.497024758455067,0.0063788451294109995,Other Types,clomifene,estrogen receptor antagonist,ESR1
Colorectal Adenocarcinoma,BRD-K30421593-050-04-9::2.5::HTS,4.9023023794115685,0.02722365646306381,Colorectal Adenocarcinoma,timolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Colorectal Adenocarcinoma,BRD-K30685142-001-15-4::2.5::HTS,4.048898445335221,0.04468370533716996,Other Types,levothyroxine,thyroid hormone stimulant,"THRA, THRB"
Colorectal Adenocarcinoma,BRD-K31086665-005-04-6::2.5::HTS,4.764721619560132,0.029464087076090432,Colorectal Adenocarcinoma,NH125,eukaryotic translation elongation factor 2 inhibitor,
Colorectal Adenocarcinoma,BRD-K31111078-001-04-2::2.5::HTS,4.388499558440891,0.03663732215465103,Other Types,dimethyl-fumarate,"nuclear factor erythroid derived, like (NRF2) activator",KEAP1
Colorectal Adenocarcinoma,BRD-K31920458-001-23-6::2.5::HTS,6.875738840369491,0.008985792564906052,Other Types,mestranol,estrogen receptor agonist,ESR1
Colorectal Adenocarcinoma,BRD-K32218650-001-01-6::2.5::HTS,6.787104725941363,0.00942858779712037,Other Types,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119
Colorectal Adenocarcinoma,BRD-K32292990-001-03-6::2.5::HTS,5.812969850331205,0.01623286842892401,Colorectal Adenocarcinoma,CGP-53353,"EGFR inhibitor, PKC inhibitor","EGFR, PRKCB"
Colorectal Adenocarcinoma,BRD-K32311154-001-01-0::2.5::HTS,4.213938779975395,0.04055559951869679,Other Types,nifekalant,potassium channel blocker,
Colorectal Adenocarcinoma,BRD-K32730239-001-01-0::2.5::HTS,4.5028848644504285,0.03427689579174104,Colorectal Adenocarcinoma,SU3327,JNK inhibitor,MAPK8
Colorectal Adenocarcinoma,BRD-K32744045-001-31-2::2.5::HTS,9.653484409538454,0.001985715309744193,Colorectal Adenocarcinoma,disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist","ALDH2, DBH"
Colorectal Adenocarcinoma,BRD-K33622447-066-01-9::2.5::HTS,3.8689888587287875,0.049681198140752475,Other Types,abemaciclib,CDK inhibitor,"CDK4, CDK6"
Colorectal Adenocarcinoma,BRD-K34157611-001-16-0::2.5::HTS,4.319589825201048,0.03813740918390072,Colorectal Adenocarcinoma,cimetidine,histamine receptor antagonist,"HRH2, SLC29A4, SLC47A1, SLC47A2"
Colorectal Adenocarcinoma,BRD-K34533029-001-08-5::2.5::HTS,4.6910555986055025,0.030745893681748616,Other Types,tyrphostin-AG-494,EGFR inhibitor,EGFR
Colorectal Adenocarcinoma,BRD-K34663752-001-09-1::2.5::HTS,5.602776797452286,0.0182723628278351,Colorectal Adenocarcinoma,6-chloromelatonin,melatonin receptor agonist,"MTNR1A, MTNR1B"
Colorectal Adenocarcinoma,BRD-K34870043-001-01-8::2.5::HTS,14.920366163029104,0.0001253726478655173,Colorectal Adenocarcinoma,adoprazine,"dopamine receptor antagonist, serotonin receptor agonist","DRD2, HTR1A"
Colorectal Adenocarcinoma,BRD-K34888156-213-01-4::2.5::HTS,4.076595526477723,0.04396232855095488,Colorectal Adenocarcinoma,theobromine,phosphodiesterase inhibitor,"ADORA1, ADORA2A, PDE4B"
Colorectal Adenocarcinoma,BRD-K35586044-003-15-4::2.5::HTS,6.983071902733324,0.008461986262626023,Colorectal Adenocarcinoma,yohimbine,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
Colorectal Adenocarcinoma,BRD-K35960502-001-20-0::2.5::HTS,11.983365637308749,0.0005779588549952188,Colorectal Adenocarcinoma,niclosamide,"DNA replication inhibitor, STAT inhibitor",STAT3
Colorectal Adenocarcinoma,BRD-K36021395-300-02-4::2.5::HTS,4.756595134173853,0.029606064624588816,Colorectal Adenocarcinoma,ABT-702,adenosine kinase inhibitor,ADK
Colorectal Adenocarcinoma,BRD-K36207157-001-09-6::2.5::HTS,9.844162760334612,0.0017932832771813667,Other Types,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Colorectal Adenocarcinoma,BRD-K36627727-001-05-4::2.5::HTS,4.017231517699029,0.04551860545371337,Colorectal Adenocarcinoma,tamibarotene,retinoid receptor agonist,"RARA, RARB"
Colorectal Adenocarcinoma,BRD-K36889451-001-01-1::2.5::HTS,10.475665507615197,0.001282909193076999,Colorectal Adenocarcinoma,tetramethylthiuram-monosulfide,,
Colorectal Adenocarcinoma,BRD-K36970462-001-01-6::2.5::HTS,3.8733528639515034,0.04955490315168673,Colorectal Adenocarcinoma,tonabersat,"gap junction modulator, nitric oxide production inhibitor",
Colorectal Adenocarcinoma,BRD-K36984403-001-02-7::2.5::HTS,16.074219829223413,6.912775855929803e-05,Other Types,go-6983,protein kinase inhibitor,"PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ"
Colorectal Adenocarcinoma,BRD-K37203094-001-02-5::2.5::HTS,6.468921317639573,0.011261779205453794,Colorectal Adenocarcinoma,1-hexadecanol,,
Colorectal Adenocarcinoma,BRD-K37682401-001-09-3::2.44::HTS,3.945460559887187,0.047514543119175516,Other Types,piromidic-acid,bacterial DNA gyrase inhibitor,
Colorectal Adenocarcinoma,BRD-K37687095-001-06-9::2.5::HTS,6.7940622501487775,0.00938884147550573,Other Types,AZD8330,MEK inhibitor,
Colorectal Adenocarcinoma,BRD-K37720887-001-07-8::2.5::HTS,5.782389875533048,0.01651284885612888,Colorectal Adenocarcinoma,SB-525334,TGF beta receptor inhibitor,TGFBR1
Colorectal Adenocarcinoma,BRD-K38548312-001-01-0::2.5::HTS,5.148700973911422,0.023644043615728277,Colorectal Adenocarcinoma,VER-49009,HSP inhibitor,HSP90AA1
Colorectal Adenocarcinoma,BRD-K38602774-001-03-2::2.5::HTS,5.676402547767396,0.017529091316420258,Other Types,sulisobenzone,,
Colorectal Adenocarcinoma,BRD-K38868394-001-01-3::2.5::HTS,11.361713363943545,0.000802760328691833,Colorectal Adenocarcinoma,MK-0773,androgen receptor modulator,AR
Colorectal Adenocarcinoma,BRD-K39381259-001-01-0::2.5::HTS,14.919079667141416,0.00012538202695634493,Other Types,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1
Colorectal Adenocarcinoma,BRD-K39495750-001-01-2::2.5::HTS,5.738824699562485,0.016941118587436292,Other Types,chlorobutanol,,
Colorectal Adenocarcinoma,BRD-K40175214-001-11-6::2.5::HTS,22.47113318742186,2.7067106457309164e-06,Colorectal Adenocarcinoma,torin-1,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K40715924-001-01-1::2.5::HTS,4.933872212670834,0.02673653703928971,Colorectal Adenocarcinoma,medorinone,,
Colorectal Adenocarcinoma,BRD-K41141507-001-16-2::2.5::HTS,5.8716069728764575,0.015702998312325002,Colorectal Adenocarcinoma,cyproterone-acetate,androgen receptor antagonist,"ADORA1, AR"
Colorectal Adenocarcinoma,BRD-K41143549-003-02-4::2.5::HTS,5.43086789167611,0.020140013579737374,Colorectal Adenocarcinoma,N20C,glutamate receptor antagonist,
Colorectal Adenocarcinoma,BRD-K41213548-001-02-0::2.5::HTS,7.157182099106274,0.007690453055666242,Colorectal Adenocarcinoma,KW-2478,HSP inhibitor,
Colorectal Adenocarcinoma,BRD-K41312087-001-02-7::2.5::HTS,7.742156492507724,0.005577580422526123,Colorectal Adenocarcinoma,GW-441756,growth factor receptor inhibitor,NTRK1
Colorectal Adenocarcinoma,BRD-K41406082-001-16-2::2.5::HTS,4.892922146425713,0.027372059485535883,Colorectal Adenocarcinoma,sulfapyridine,PABA antagonist,
Colorectal Adenocarcinoma,BRD-K41783120-001-02-8::2.5::HTS,16.751036899714965,4.9058403623903326e-05,Other Types,STA-5326,interleukin synthesis inhibitor,IL12A
Colorectal Adenocarcinoma,BRD-K41859756-001-06-8::2.5::HTS,4.925293015120009,0.026870577146061274,Colorectal Adenocarcinoma,NVP-AUY922,HSP inhibitor,"HSP90AA1, HSP90AB1"
Colorectal Adenocarcinoma,BRD-K41876534-001-13-7::2.5::HTS,7.486334222922263,0.006415227169093321,Other Types,tioxolone,carbonic anhydrase inhibitor,CA2
Colorectal Adenocarcinoma,BRD-K42095107-001-17-1::2.5::HTS,5.595877462685329,0.018347442412639862,Colorectal Adenocarcinoma,daidzein,estrogen receptor agonist,"ESRRA, ESRRB, ESRRG, TRPC5"
Colorectal Adenocarcinoma,BRD-K42805893-001-04-9::2.5::HTS,4.032388044847268,0.04511274981210334,Other Types,osimertinib,EGFR inhibitor,EGFR
Colorectal Adenocarcinoma,BRD-K42898655-001-01-8::2.5::HTS,15.595468700641492,8.841058973857342e-05,Colorectal Adenocarcinoma,temsirolimus,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K43002771-034-01-6::2.5::HTS,4.839918358442856,0.02822640612957201,Other Types,SR-33805,calcium channel blocker,
Colorectal Adenocarcinoma,BRD-K43106192-320-11-8::2.5::HTS,7.260643361056285,0.007272679128548867,Other Types,gallamine-triethiodide,acetylcholine receptor antagonist,"ACHE, CHRM2, CHRNA1, CHRNA2"
Colorectal Adenocarcinoma,BRD-K43187018-001-03-3::2.52::HTS,34.124094794965536,9.048775381146186e-09,Colorectal Adenocarcinoma,GDC-0349,Pim kinase inhibitor,PIK3CA
Colorectal Adenocarcinoma,BRD-K43236057-001-07-1::2.6::HTS,21.78344850307739,3.87451742415295e-06,Colorectal Adenocarcinoma,polydatin,ICAM1 expression inhibitor,ICAM1
Colorectal Adenocarcinoma,BRD-K43389698-001-09-9::2.4::HTS,3.8919780598986726,0.04903846763358538,Colorectal Adenocarcinoma,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Colorectal Adenocarcinoma,BRD-K43449605-001-01-0::2.5::HTS,9.643135568561778,0.001997796809473179,Other Types,oncrasin-1,apoptosis stimulant,
Colorectal Adenocarcinoma,BRD-K43586850-001-02-9::2.5::HTS,8.353883671764155,0.003997305638986346,Other Types,lacidipine,calcium channel blocker,CACNA1C
Colorectal Adenocarcinoma,BRD-K43621685-001-02-5::2.5::HTS,6.050735088947018,0.014203186650146471,Colorectal Adenocarcinoma,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Colorectal Adenocarcinoma,BRD-K43802723-340-01-9::2.5::HTS,4.528819029648229,0.033763101638223714,Other Types,AMG-837,free fatty acid receptor agonist,FFAR1
Colorectal Adenocarcinoma,BRD-K44273375-001-25-0::2.5::HTS,8.314192957031322,0.004088731255676291,Other Types,tolnaftate,fungal squalene epoxidase inhibitor,
Colorectal Adenocarcinoma,BRD-K44825564-065-01-4::2.5::HTS,5.673083203218621,0.017580394941312576,Colorectal Adenocarcinoma,ZAPA,,
Colorectal Adenocarcinoma,BRD-K44942604-346-05-4::2.5::HTS,4.202929338356597,0.040826037778660486,Colorectal Adenocarcinoma,pentolinium,cholinergic receptor antagonist,"CHRNA10, CHRNA3, CHRNA4, CHRNB4"
Colorectal Adenocarcinoma,BRD-K44963273-001-06-9::2.5::HTS,5.081927604179377,0.024585557299484216,Other Types,HQK-1001,,
Colorectal Adenocarcinoma,BRD-K45117373-001-02-9::2.5::HTS,7.806228015136849,0.005389533349969374,Colorectal Adenocarcinoma,Y-26763,potassium channel activator,KCNJ8
Colorectal Adenocarcinoma,BRD-K45435259-003-11-1::2.5::HTS,7.142404999942229,0.007747971001939171,Colorectal Adenocarcinoma,SCH-23390,dopamine receptor antagonist,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
Colorectal Adenocarcinoma,BRD-K45746021-003-01-9::2.5::HTS,4.532509589490754,0.03369884981674952,Colorectal Adenocarcinoma,CC-401,JNK inhibitor,MAPK8
Colorectal Adenocarcinoma,BRD-K45875383-001-01-2::2.5::HTS,7.163637811029757,0.007666110979456607,Colorectal Adenocarcinoma,XBD173,benzodiazepine receptor ligand,TSPO
Colorectal Adenocarcinoma,BRD-K46018455-001-27-6::2.5::HTS,4.655859747811287,0.03138314758525703,Other Types,bezafibrate,PPAR receptor agonist,"PPARA, PPARD, PPARG"
Colorectal Adenocarcinoma,BRD-K46392623-001-02-5::2.5::HTS,7.4011354613630935,0.006720115436410657,Colorectal Adenocarcinoma,TG-100713,PI3K inhibitor,
Colorectal Adenocarcinoma,BRD-K46914825-300-01-0::2.5::HTS,4.4895473439799645,0.03454787187253407,Colorectal Adenocarcinoma,zimelidine,selective serotonin reuptake inhibitor (SSRI),"MAOA, MAOB, SLC6A4"
Colorectal Adenocarcinoma,BRD-K46982791-001-09-4::2.5::HTS,7.603328475710465,0.006017238217446149,Colorectal Adenocarcinoma,cloxyquin,potassium channel activator,KCNK18
Colorectal Adenocarcinoma,BRD-K47177710-001-03-1::2.5::HTS,6.6664784355389335,0.010078092926752031,Other Types,DAPT,gamma secretase inhibitor,
Colorectal Adenocarcinoma,BRD-K47631482-003-06-2::2.5::HTS,6.977496022838671,0.008487205124184912,Colorectal Adenocarcinoma,bromhexine,mucolytic agent,
Colorectal Adenocarcinoma,BRD-K47659338-003-02-8::2.5::HTS,4.323422715720209,0.038050632797864956,Colorectal Adenocarcinoma,EMD-386088,serotonin receptor agonist,HTR6
Colorectal Adenocarcinoma,BRD-K48195801-001-01-6::2.5::HTS,3.948896949445697,0.047402240097925395,Other Types,tecastemizole,histamine receptor antagonist,KCNH2
Colorectal Adenocarcinoma,BRD-K48443249-001-01-0::2.5::HTS,4.7254224403165015,0.030138805408197144,Colorectal Adenocarcinoma,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Colorectal Adenocarcinoma,BRD-K49055432-001-04-2::2.5::HTS,4.040570985895185,0.04489955706024681,Other Types,A66,PI3K inhibitor,PIK3CA
Colorectal Adenocarcinoma,BRD-K49111258-003-29-7::2.5::HTS,4.977730662806521,0.0260743482283003,Other Types,prazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7"
Colorectal Adenocarcinoma,BRD-K49236613-001-02-3::2.5::HTS,8.98212048497786,0.0028484969052065537,Other Types,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1
Colorectal Adenocarcinoma,BRD-K49328571-001-15-0::2.5::HTS,17.879735341504944,2.7541506634470097e-05,Colorectal Adenocarcinoma,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Colorectal Adenocarcinoma,BRD-K49545903-003-01-4::2.5::HTS,7.097526918038985,0.007943840397762223,Other Types,"4,4-pentamethylenepiperidine",M2 channel blocker,
Colorectal Adenocarcinoma,BRD-K49657628-001-14-8::2.5::HTS,4.085068477762896,0.04374585427758035,Other Types,tyrphostin-AG-18,"EGFR inhibitor, tyrosine kinase inhibitor",EGFR
Colorectal Adenocarcinoma,BRD-K49807096-003-15-5::2.5::HTS,6.917439479885081,0.008774115037060643,Colorectal Adenocarcinoma,benazepril,angiotensin converting enzyme inhibitor,ACE
Colorectal Adenocarcinoma,BRD-K49865102-001-08-4::2.5::HTS,8.493229864774225,0.003709522242150623,Other Types,PD-0325901,MEK inhibitor,MAP2K1
Colorectal Adenocarcinoma,BRD-K49962337-001-02-9::2.56::HTS,14.955282409665896,0.00012382823442059406,Colorectal Adenocarcinoma,baicalin,beta glucuronidase inhibitor,PREP
Colorectal Adenocarcinoma,BRD-K50000283-001-04-4::2.5::HTS,5.124091426781673,0.023976382194482983,Other Types,PHA-767491,CDC inhibitor,"CDK1, RPS6KB1"
Colorectal Adenocarcinoma,BRD-K50135270-300-02-3::2.5::HTS,4.832384871168597,0.028342809898653436,Other Types,GBR-12935,dopamine uptake inhibitor,"AGTR1, SLC6A3"
Colorectal Adenocarcinoma,BRD-K50406511-001-26-0::2.5::HTS,4.040591880691367,0.0448998692275941,Other Types,hycanthone,RNA synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K50422030-001-05-3::2.5::HTS,3.9861732286647795,0.04636578395777587,Other Types,clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1
Colorectal Adenocarcinoma,BRD-K50631926-001-02-3::2.5::HTS,6.147528592630538,0.01345167694496904,Colorectal Adenocarcinoma,PIK-294,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Colorectal Adenocarcinoma,BRD-K51431759-001-02-9::2.5::HTS,4.192419387885175,0.041076155158136035,Colorectal Adenocarcinoma,dextrose,,
Colorectal Adenocarcinoma,BRD-K51885093-001-11-2::2.5::HTS,5.225568289427351,0.022628485559761116,Colorectal Adenocarcinoma,quinolinic-acid,glutamate receptor agonist,
Colorectal Adenocarcinoma,BRD-K52075040-001-09-7::5.6::HTS,6.986025600263446,0.008447362901215298,Other Types,cerulenin,fatty acid synthase inhibitor,FASN
Colorectal Adenocarcinoma,BRD-K52256627-300-06-6::2.5::HTS,8.94897384991917,0.0028991249881195366,Colorectal Adenocarcinoma,chlorhexidine,membrane integrity inhibitor,
Colorectal Adenocarcinoma,BRD-K52284881-236-02-4::2.5::HTS,6.652007388210451,0.010159273573124633,Colorectal Adenocarcinoma,chiniofon,antiprotozoal agent,
Colorectal Adenocarcinoma,BRD-K53153417-001-10-4::2.5::HTS,4.295960861599887,0.038659087838438015,Other Types,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2
Colorectal Adenocarcinoma,BRD-K53448858-001-07-0::2.5::HTS,4.96668945797086,0.026261869036275302,Colorectal Adenocarcinoma,acadesine,AMPK activator,
Colorectal Adenocarcinoma,BRD-K54028654-001-02-6::2.5::HTS,6.671757344088518,0.010057625620755767,Other Types,cabaletta,pharmacological chaperone,
Colorectal Adenocarcinoma,BRD-K54094468-003-11-1::2.5::HTS,9.161242864145095,0.0025860046199218762,Other Types,remoxipride,dopamine receptor antagonist,"DRD2, DRD3, DRD4, HTR2A, SIGMAR1"
Colorectal Adenocarcinoma,BRD-K54095730-001-03-1::2.5::HTS,6.916848987720123,0.008774825244522826,Colorectal Adenocarcinoma,CMPD-1,p38 MAPK inhibitor,"GNRHR, MAPK14"
Colorectal Adenocarcinoma,BRD-K54759182-003-08-0::2.5::HTS,4.183675797522321,0.04128100845555592,Other Types,dosulepin,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4"
Colorectal Adenocarcinoma,BRD-K54997624-001-06-0::2.5::HTS,7.259136693541551,0.007265023032394685,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Colorectal Adenocarcinoma,BRD-K55677650-003-02-9::2.5::HTS,5.095476472821018,0.02437691712613622,Colorectal Adenocarcinoma,CO-101244,glutamate receptor antagonist,GRIN2B
Colorectal Adenocarcinoma,BRD-K55773932-001-02-0::2.5::HTS,4.340617708336172,0.03766798438896031,Colorectal Adenocarcinoma,BMS-806,HIV attachment inhibitor,
Colorectal Adenocarcinoma,BRD-K56047318-001-06-3::2.5::HTS,6.020137717779097,0.014450419545121326,Colorectal Adenocarcinoma,RHC-80267,triacylglycerol lipase inhibitor,"DAGLA, DAGLB"
Colorectal Adenocarcinoma,BRD-K56291712-001-01-0::2.5::HTS,8.310563090306285,0.0040923240262409535,Colorectal Adenocarcinoma,voxtalisib,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Colorectal Adenocarcinoma,BRD-K56405753-001-02-4::2.5::HTS,7.1196891713619195,0.007844286947019883,Colorectal Adenocarcinoma,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Colorectal Adenocarcinoma,BRD-K56515112-001-21-6::2.5::HTS,4.034005246384843,0.04507414581547385,Other Types,medrysone,glucocorticoid receptor agonist,NR3C1
Colorectal Adenocarcinoma,BRD-K56810756-001-03-0::2.5::HTS,4.550618452727085,0.033339383999486105,Colorectal Adenocarcinoma,fomepizole,alcohol dehydrogenase inhibitor,"ADH1A, ADH1B, ADH1C, AKR1A1, CAT"
Colorectal Adenocarcinoma,BRD-K57080016-001-15-9::2.5::HTS,16.988338853264604,4.328109062096173e-05,Other Types,selumetinib,MEK inhibitor,MAP2K1
Colorectal Adenocarcinoma,BRD-K57313110-001-06-8::2.5::HTS,3.905390012144172,0.04862352961637163,Colorectal Adenocarcinoma,pidolic-acid,,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA"
Colorectal Adenocarcinoma,BRD-K57371763-001-01-7::2.5::HTS,7.792130860344602,0.0054265095339317655,Colorectal Adenocarcinoma,fidaxomicin,RNA polymerase inhibitor,
Colorectal Adenocarcinoma,BRD-K57927309-001-01-7::2.5::HTS,9.150868906106355,0.0026006735203792665,Colorectal Adenocarcinoma,BW-180C,opioid receptor agonist,"OPRD1, OPRM1"
Colorectal Adenocarcinoma,BRD-K58049875-001-04-7::2.5::HTS,7.0852310859378305,0.007996194330943389,Colorectal Adenocarcinoma,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Colorectal Adenocarcinoma,BRD-K58262659-001-09-7::2.5::HTS,4.182580742275173,0.04132652308385117,Other Types,doxifluridine,thymidylate synthase inhibitor,TYMS
Colorectal Adenocarcinoma,BRD-K58568447-001-01-1::2.5::HTS,12.578743136289157,0.00042289807625407267,Other Types,K02288,bone morphogenic protein inhibitor,BMP1
Colorectal Adenocarcinoma,BRD-K58770988-001-01-8::2.5::HTS,13.134865734825636,0.00031629542887523553,Colorectal Adenocarcinoma,NMS-E973,HSP inhibitor,
Colorectal Adenocarcinoma,BRD-K59058747-001-18-3::2.5::HTS,3.9981833315504076,0.04606123010208759,Other Types,acetylcysteine,mucolytic agent,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11"
Colorectal Adenocarcinoma,BRD-K59184148-001-21-6::2.5::HTS,5.154956498197005,0.023563256738070037,Other Types,SB-216763,glycogen synthase kinase inhibitor,"CCNA2, CDK2, GSK3A, GSK3B"
Colorectal Adenocarcinoma,BRD-K59317601-001-05-5::2.5::HTS,16.907266292076198,4.511275104403896e-05,Colorectal Adenocarcinoma,MLN0128,mTOR inhibitor,"MTOR, PIK3CA, PIK3CD, PIK3CG"
Colorectal Adenocarcinoma,BRD-K59527975-236-01-8::2.5::HTS,6.501970137268344,0.011039780465559796,Colorectal Adenocarcinoma,S-Sulfo-L-cysteine-sodium-salt,glutamate receptor agonist,
Colorectal Adenocarcinoma,BRD-K59745944-001-02-0::2.5::HTS,14.143574738349578,0.00018739092545797407,Colorectal Adenocarcinoma,PHT-427,"AKT inhibitor, pyruvate dehydrogenase inhibitor","AKT2, PDPK1"
Colorectal Adenocarcinoma,BRD-K60036103-003-01-6::2.5::HTS,4.0310815433911475,0.04515173324801497,Colorectal Adenocarcinoma,L-NIL,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Colorectal Adenocarcinoma,BRD-K60443845-001-08-6::2.5::HTS,4.683528799020291,0.030891593755557938,Colorectal Adenocarcinoma,chlormidazole,fungal lanosterol demethylase inhibitor,
Colorectal Adenocarcinoma,BRD-K60446698-001-01-2::2.5::HTS,6.351465356441942,0.012006302886837125,Colorectal Adenocarcinoma,ONX-0914,proteasome inhibitor,
Colorectal Adenocarcinoma,BRD-K60585088-001-01-5::2.5::HTS,10.148726657634729,0.0015243904071643875,Other Types,paricalcitol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K60997853-001-02-3::2.5::HTS,7.8443915562626,0.005273974540678137,Colorectal Adenocarcinoma,PHA-848125,"CDK inhibitor, growth factor receptor inhibitor","CDK2, CDK4, CDK7, NTRK1"
Colorectal Adenocarcinoma,BRD-K61237927-001-01-7::2.5::HTS,4.082968932301259,0.04379377529960436,Colorectal Adenocarcinoma,eslicarbazepine-acetate,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Colorectal Adenocarcinoma,BRD-K61279411-001-02-0::2.5::HTS,7.789129642809612,0.005446360563453809,Colorectal Adenocarcinoma,oxaloacetate,glutamate release inhibitor,"CS, SPR"
Colorectal Adenocarcinoma,BRD-K61443650-236-13-1::2.5::HTS,8.559406251386829,0.0035762732820236866,Colorectal Adenocarcinoma,thiomersal,other antibiotic,OXCT1
Colorectal Adenocarcinoma,BRD-K61665160-001-01-5::2.5::HTS,4.101520601743338,0.04332365359671918,Colorectal Adenocarcinoma,BYK-204165,PARP inhibitor,PARP1
Colorectal Adenocarcinoma,BRD-K62196610-001-01-6::2.5::HTS,5.8884201424305616,0.01555992242388047,Colorectal Adenocarcinoma,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Colorectal Adenocarcinoma,BRD-K62304154-001-04-2::2.5::HTS,30.114616196830692,6.275613773960595e-08,Colorectal Adenocarcinoma,deforolimus,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K62387885-001-01-9::2.5::HTS,4.1062950345148215,0.04320071252554935,Colorectal Adenocarcinoma,basimglurant,glutamate receptor antagonist,GRM5
Colorectal Adenocarcinoma,BRD-K62537556-001-02-5::2.5::HTS,4.053069328648003,0.044576031538559144,Other Types,4-IBP,sigma receptor agonist,SIGMAR1
Colorectal Adenocarcinoma,BRD-K62562723-003-02-7::2.5::HTS,7.412605678760705,0.006677969682663655,Colorectal Adenocarcinoma,SR-2640,leukotriene receptor antagonist,CYSLTR1
Colorectal Adenocarcinoma,BRD-K62607865-001-09-7::2.62::HTS,5.272095167523772,0.0220527601016883,Other Types,aztreonam,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K62762455-001-01-3::2.5::HTS,5.468410568415109,0.019719254711698306,Colorectal Adenocarcinoma,RU-58841,androgen receptor antagonist,AR
Colorectal Adenocarcinoma,BRD-K62814476-001-03-3::2.5::HTS,4.916295375908888,0.02700959996730458,Other Types,BMS-265246,CDK inhibitor,"CDK1, CDK2"
Colorectal Adenocarcinoma,BRD-K63001556-001-08-8::2.5::HTS,6.786253331792103,0.009432137616382367,Colorectal Adenocarcinoma,orbifloxacin,bacterial DNA gyrase inhibitor,
Colorectal Adenocarcinoma,BRD-K63504947-001-15-4::2.5::HTS,6.783442479148478,0.00944861172584702,Colorectal Adenocarcinoma,semaxanib,VEGFR inhibitor,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Colorectal Adenocarcinoma,BRD-K63861289-001-19-6::2.5::HTS,6.2866092276349095,0.012448863548309867,Colorectal Adenocarcinoma,molsidomine,guanylate cyclase stimulant,GUCY1A3
Colorectal Adenocarcinoma,BRD-K64341947-003-02-4::2.5::HTS,5.492035709559427,0.019453378538764072,Other Types,CFM-1571,guanylate cyclase activator,
Colorectal Adenocarcinoma,BRD-K64400208-001-08-3::2.5::HTS,4.129637570123832,0.042608130897113135,Other Types,DNQX,glutamate receptor antagonist,"GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B"
Colorectal Adenocarcinoma,BRD-K64538373-001-01-4::2.5::HTS,7.942851215114421,0.004999324192027881,Other Types,Ro-4987655,MEK inhibitor,MAP2K1
Colorectal Adenocarcinoma,BRD-K64800655-001-07-4::2.5::HTS,5.117027047405332,0.024073273012960923,Colorectal Adenocarcinoma,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Colorectal Adenocarcinoma,BRD-K65275554-001-04-7::2.5::HTS,4.075589547115225,0.04398145668765251,Colorectal Adenocarcinoma,NPC-15199,ICAM1 antagonist,PPARG
Colorectal Adenocarcinoma,BRD-K65359424-001-01-3::2.5::HTS,5.5405627326114875,0.018939301428273877,Other Types,eglumetad,glutamate receptor agonist,"GRM2, GRM3, GRM6, GRM8"
Colorectal Adenocarcinoma,BRD-K65820248-001-01-8::2.5::HTS,16.297023764358986,6.18032575818707e-05,Colorectal Adenocarcinoma,SDZ-NKT-343,tachykinin antagonist,TACR1
Colorectal Adenocarcinoma,BRD-K65904673-001-01-4::2.5::HTS,4.601390628400914,0.032375500709718154,Other Types,tandospirone,serotonin receptor agonist,HTR1A
Colorectal Adenocarcinoma,BRD-K65924316-001-03-1::2.5::HTS,5.2407191223913525,0.022439459085955762,Colorectal Adenocarcinoma,serdemetan,MDM inhibitor,MDM2
Colorectal Adenocarcinoma,BRD-K66296774-236-11-3::2.63::HTS,10.336341410769103,0.0013824937966572502,Colorectal Adenocarcinoma,fluvastatin,HMGCR inhibitor,HMGCR
Colorectal Adenocarcinoma,BRD-K66876909-001-12-6::2.5::HTS,6.047782021974181,0.014229453611729509,Other Types,linezolid,bacterial 50S ribosomal subunit inhibitor,"MAOA, MAOB"
Colorectal Adenocarcinoma,BRD-K67100011-003-06-3::2.5::HTS,6.261964051509101,0.012620186713892137,Colorectal Adenocarcinoma,pivmecillinam,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K67304264-001-08-5::2.5::HTS,13.263825668035162,0.0002957353161972167,Colorectal Adenocarcinoma,SKA-31,potassium channel activator,KCNN4
Colorectal Adenocarcinoma,BRD-K67537649-001-04-5::2.5::HTS,7.222429838443261,0.007418598385588784,Colorectal Adenocarcinoma,PQ-401,IGF-1 inhibitor,IGF1R
Colorectal Adenocarcinoma,BRD-K67566344-001-07-5::2.5::HTS,6.761481975330507,0.009563227974344815,Colorectal Adenocarcinoma,ku-0063794,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K67637637-003-12-6::2.5::HTS,4.368107142008688,0.037073021796577184,Colorectal Adenocarcinoma,olopatadine,histamine receptor antagonist,"HRH1, S100A1, S100A12, S100A13, S100A2, S100B"
Colorectal Adenocarcinoma,BRD-K67868012-001-07-6::2.5::HTS,11.115924818832262,0.0009122756650130706,Colorectal Adenocarcinoma,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Colorectal Adenocarcinoma,BRD-K68065987-300-09-1::2.5::HTS,6.483507050289044,0.011158023575186037,Other Types,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Colorectal Adenocarcinoma,BRD-K68264559-045-04-0::2.58::HTS,9.060921930658052,0.002733565168509446,Colorectal Adenocarcinoma,brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Colorectal Adenocarcinoma,BRD-K68553471-003-12-3::2.5::HTS,4.3312939229259255,0.037874005917953146,Other Types,todralazine,antihypertensive agent,
Colorectal Adenocarcinoma,BRD-K68567222-001-01-2::2.5::HTS,15.011058812489381,0.00011964098112814554,Colorectal Adenocarcinoma,BVT-948,tyrosine phosphatase inhibitor,"PTPN1, PTPN11, PTPN2"
Colorectal Adenocarcinoma,BRD-K69035426-001-01-3::2.5::HTS,4.903316911304728,0.02721292842541545,Colorectal Adenocarcinoma,omeprazole-sulfide,ATPase inhibitor,
Colorectal Adenocarcinoma,BRD-K69116396-001-04-1::2.5::HTS,4.232415161439087,0.04012648079930601,Other Types,sertindole,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2"
Colorectal Adenocarcinoma,BRD-K69122748-001-10-1::2.5::HTS,5.882020131632302,0.01561480629324453,Other Types,diacerein,interleukin inhibitor,IL1B
Colorectal Adenocarcinoma,BRD-K69172251-001-08-9::2.5::HTS,5.413857314585607,0.02035491757574931,Colorectal Adenocarcinoma,cisplatin,"DNA alkylating agent, DNA synthesis inhibitor",XIAP
Colorectal Adenocarcinoma,BRD-K69577666-001-01-3::2.5::HTS,5.000265636269716,0.02573511167241635,Colorectal Adenocarcinoma,SGC-0946,histone lysine methyltransferase inhibitor,
Colorectal Adenocarcinoma,BRD-K69688083-004-23-1::2.5::HTS,8.837434337644932,0.00307921391819866,Other Types,mestinon,cholinesterase inhibitor,"ACHE, BCHE"
Colorectal Adenocarcinoma,BRD-K70358946-001-15-7::2.5::HTS,6.5087363716531375,0.01099928670061769,Other Types,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Colorectal Adenocarcinoma,BRD-K70401845-003-09-6::2.5::HTS,18.623040893857834,1.8833355821383263e-05,Colorectal Adenocarcinoma,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Colorectal Adenocarcinoma,BRD-K70792160-003-04-6::2.5::HTS,11.759346720605382,0.000649776247025728,Other Types,10-DEBC,AKT inhibitor,PIM1
Colorectal Adenocarcinoma,BRD-K72687424-001-02-6::2.5::HTS,5.086929492409263,0.02449272608867759,Colorectal Adenocarcinoma,VU0364439,glutamate receptor positive allosteric modulator,GRM4
Colorectal Adenocarcinoma,BRD-K72723676-003-17-8::2.5::HTS,4.535658731513041,0.033633453982383564,Colorectal Adenocarcinoma,benzethonium,sodium channel blocker,SCN10A
Colorectal Adenocarcinoma,BRD-K73234506-235-02-1::2.5::HTS,3.938032425473956,0.047697986422763725,Colorectal Adenocarcinoma,lithium-acetoacetate,,
Colorectal Adenocarcinoma,BRD-K73237276-001-01-0::2.5::HTS,6.4670378680370115,0.011257254873603824,Other Types,tacalcitol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K73323637-003-10-9::2.5::HTS,6.279062287620832,0.012498843060316284,Colorectal Adenocarcinoma,levobunolol-(+),adrenergic receptor antagonist,
Colorectal Adenocarcinoma,BRD-K73391359-003-10-2::2.5::HTS,4.722937222885479,0.03018580223975507,Colorectal Adenocarcinoma,dimethisoquin,local anesthetic,
Colorectal Adenocarcinoma,BRD-K73923631-003-02-9::2.5::HTS,5.993629564962256,0.014663953084387081,Other Types,difloxacin,bacterial DNA gyrase inhibitor,
Colorectal Adenocarcinoma,BRD-K73982490-001-02-9::2.5::HTS,4.66421643157153,0.031227377901085693,Colorectal Adenocarcinoma,BI-78D3,JNK inhibitor,MAPK8
Colorectal Adenocarcinoma,BRD-K73999723-001-11-3::2.5::HTS,4.4282915198373765,0.03579139253724741,Colorectal Adenocarcinoma,telmisartan,angiotensin receptor antagonist,"AGTR1, PPARG"
Colorectal Adenocarcinoma,BRD-K74195153-050-12-1::2.5::HTS,7.031187641657887,0.00824042039072913,Colorectal Adenocarcinoma,irsogladine,phosphodiesterase inhibitor,PDE4A
Colorectal Adenocarcinoma,BRD-K74305673-001-06-2::2.5::HTS,5.270958399372014,0.022057979653275172,Colorectal Adenocarcinoma,IKK-2-inhibitor-V,"IKK inhibitor, NFkB pathway inhibitor",IKBKB
Colorectal Adenocarcinoma,BRD-K75037734-003-13-9::2.5::HTS,13.680765277724989,0.00023971733172980053,Colorectal Adenocarcinoma,carbachol,cholinergic receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Colorectal Adenocarcinoma,BRD-K75352575-001-01-3::2.5::HTS,5.313478225654439,0.021526456781381795,Colorectal Adenocarcinoma,KPT-276,exportin antagonist,XPO1
Colorectal Adenocarcinoma,BRD-K75466013-001-14-4::2.5::HTS,4.994575812215884,0.025823326224258588,Other Types,benzocaine,sodium channel blocker,SCN10A
Colorectal Adenocarcinoma,BRD-K75958547-238-01-0::2.5::HTS,10.29296876880436,0.0014117143921386765,Colorectal Adenocarcinoma,pitavastatin,HMGCR inhibitor,HMGCR
Colorectal Adenocarcinoma,BRD-K76022557-003-02-7::2.5::HTS,14.5032376546893,0.00015564221637124137,Colorectal Adenocarcinoma,r(-)-apomorphine,dopamine receptor agonist,"DRD2, HTR5A"
Colorectal Adenocarcinoma,BRD-K76180386-001-01-6::2.5::HTS,6.292549429854734,0.012406669307038744,Other Types,JIB04,histone lysine demethylase inhibitor,KDM4E
Colorectal Adenocarcinoma,BRD-K76205745-237-16-5::2.5::HTS,20.327871527133983,7.97797566611618e-06,Colorectal Adenocarcinoma,losartan,angiotensin receptor antagonist,AGTR1
Colorectal Adenocarcinoma,BRD-K76568384-001-02-2::2.5::HTS,6.6766080828896195,0.01002257902258444,Colorectal Adenocarcinoma,PHTPP,estrogen receptor antagonist,ESR2
Colorectal Adenocarcinoma,BRD-K76634210-001-14-7::2.5::HTS,5.9635339385956945,0.014925075472507758,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Colorectal Adenocarcinoma,BRD-K76677554-003-02-1::2.5::HTS,3.881966627391417,0.04929783073600789,Colorectal Adenocarcinoma,AJ76-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Colorectal Adenocarcinoma,BRD-K76703230-004-04-1::2.5::HTS,6.51614036501918,0.010955551385533096,Colorectal Adenocarcinoma,YM-155,survivin inhibitor,BIRC5
Colorectal Adenocarcinoma,BRD-K77008974-001-03-2::2.5::HTS,16.135371834958498,6.711298401890601e-05,Colorectal Adenocarcinoma,WYE-354,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K77634909-001-03-5::2.5::HTS,4.860568192435485,0.027884576866873123,Other Types,AEG3482,HSP inducer,
Colorectal Adenocarcinoma,BRD-K77867004-001-02-7::2.5::HTS,6.861758685495629,0.009043843419548824,Colorectal Adenocarcinoma,U-104,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA9"
Colorectal Adenocarcinoma,BRD-K78126613-001-28-5::2.5::HTS,10.181810066016379,0.00149747756360451,Colorectal Adenocarcinoma,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Colorectal Adenocarcinoma,BRD-K78485176-001-07-8::2.5::HTS,16.985049971523377,4.335391509444614e-05,Other Types,olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1
Colorectal Adenocarcinoma,BRD-K79259477-001-04-9::2.5::HTS,12.612933317811661,0.0004153420015135003,Other Types,NVP-BHG712,ephrin inhibitor,EPHB4
Colorectal Adenocarcinoma,BRD-K79315489-001-07-8::2.5::HTS,5.694556130473489,0.017368888540618868,Colorectal Adenocarcinoma,erythritol,,
Colorectal Adenocarcinoma,BRD-K79404599-001-09-3::2.5::HTS,6.843585831597827,0.00913515806358425,Other Types,enzastaurin,PKC inhibitor,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG"
Colorectal Adenocarcinoma,BRD-K79684402-300-02-8::2.5::HTS,8.632526874566388,0.003460729083003611,Colorectal Adenocarcinoma,Ro-10-5824,dopamine receptor agonist,DRD4
Colorectal Adenocarcinoma,BRD-K79930101-300-03-7::2.5::HTS,5.554591912689343,0.018774372614642577,Other Types,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Colorectal Adenocarcinoma,BRD-K80431395-001-07-3::2.49::HTS,4.654991316341476,0.031413759297198494,Colorectal Adenocarcinoma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Colorectal Adenocarcinoma,BRD-K80431395-001-09-9::2.5::HTS,5.847198028534363,0.015939929508455186,Colorectal Adenocarcinoma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Colorectal Adenocarcinoma,BRD-K80639402-003-02-9::2.5::HTS,7.555870610865682,0.006176599128793358,Colorectal Adenocarcinoma,SB-258585,serotonin receptor antagonist,HTR6
Colorectal Adenocarcinoma,BRD-K80778372-001-02-5::2.5::HTS,6.6829376261269875,0.00998840249534908,Other Types,Ro-19-4605,,"GABRA1, GABRA2, GABRA3, GABRA5"
Colorectal Adenocarcinoma,BRD-K81101512-234-01-9::2.5::HTS,3.954704140783937,0.04723383575433479,Colorectal Adenocarcinoma,fosfomycin,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K81316007-001-01-8::2.5::HTS,11.098952987693698,0.0009211215742214422,Colorectal Adenocarcinoma,4-mu-8C,IRE1 inhibitor,ERN1
Colorectal Adenocarcinoma,BRD-K81332461-001-01-4::2.5::HTS,14.708217516255068,0.00014033139188775464,Other Types,maxacalcitol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K81623406-004-08-3::2.5::HTS,6.196298638877198,0.01309464796954039,Colorectal Adenocarcinoma,EIT-hydrobromide,nitric oxide synthase inhibitor,"NOS2, NOS3"
Colorectal Adenocarcinoma,BRD-K81645907-001-01-1::2.5::HTS,4.125956951677995,0.0427305034765235,Colorectal Adenocarcinoma,captamine,,
Colorectal Adenocarcinoma,BRD-K81801188-001-02-8::2.5::HTS,5.150350600166913,0.02362248615371643,Colorectal Adenocarcinoma,PP-121,protein tyrosine kinase inhibitor,"ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC"
Colorectal Adenocarcinoma,BRD-K82091397-001-03-0::2.5::HTS,5.279603342424654,0.021948432445970084,Other Types,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Colorectal Adenocarcinoma,BRD-K82143716-001-19-9::2.5::HTS,7.3617572501213635,0.006871379440402594,Colorectal Adenocarcinoma,flucytosine,other antifungal,DNMT1
Colorectal Adenocarcinoma,BRD-K82244583-001-01-3::2.5::HTS,13.029096390572116,0.0003352859479722565,Other Types,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Colorectal Adenocarcinoma,BRD-K82928892-001-02-5::2.46::HTS,7.605156647880871,0.006021800872205056,Other Types,doxercalciferol,vitamin D receptor agonist,VDR
Colorectal Adenocarcinoma,BRD-K83022601-001-01-0::2.5::HTS,4.729193649263959,0.030078680936723407,Colorectal Adenocarcinoma,CI-844,,
Colorectal Adenocarcinoma,BRD-K83192048-050-02-7::2.5::HTS,6.124401587423712,0.013632151418113962,Colorectal Adenocarcinoma,dimethindene-(S)-(+),acetylcholine receptor antagonist,HRH1
Colorectal Adenocarcinoma,BRD-K83257731-003-23-5::2.5::HTS,4.709296989269087,0.03042106869367666,Colorectal Adenocarcinoma,chloropyramine,histamine receptor antagonist,HRH1
Colorectal Adenocarcinoma,BRD-K83597974-003-22-2::2.5::HTS,7.984336818236692,0.004893351287639497,Other Types,pargyline,monoamine oxidase inhibitor,"MAOA, MAOB"
Colorectal Adenocarcinoma,BRD-K83988098-001-02-0::2.5::HTS,15.461050355591086,9.494222711225417e-05,Colorectal Adenocarcinoma,alvespimycin,HSP inhibitor,HSP90AA1
Colorectal Adenocarcinoma,BRD-K84214706-001-05-7::2.5::HTS,4.577908454948979,0.03281678359645252,Colorectal Adenocarcinoma,7-chlorokynurenic-acid,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C"
Colorectal Adenocarcinoma,BRD-K84466663-001-05-4::2.5::HTS,3.9942357121499446,0.046151500099240135,Colorectal Adenocarcinoma,nelarabine,"DNA synthesis inhibitor, T cell inhibitor",POLA1
Colorectal Adenocarcinoma,BRD-K84937637-001-09-9::2.5::HTS,12.668697528702667,0.0004053704659808664,Colorectal Adenocarcinoma,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Colorectal Adenocarcinoma,BRD-K85140930-001-12-7::2.5::HTS,4.963000410812388,0.026301909068200756,Other Types,aphidicolin,RNA synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K85178109-001-02-3::2.5::HTS,4.959321276628575,0.02634863433968454,Colorectal Adenocarcinoma,fostamatinib,SYK inhibitor,SYK
Colorectal Adenocarcinoma,BRD-K85751432-001-03-3::2.5::HTS,15.442240750992603,9.598945739983676e-05,Other Types,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Colorectal Adenocarcinoma,BRD-K86882815-001-03-2::2.5::HTS,4.255200325149228,0.03960879093435343,Colorectal Adenocarcinoma,cabergoline,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7"
Colorectal Adenocarcinoma,BRD-K86972824-001-02-2::2.5::HTS,4.1101856601693,0.04310565568621859,Colorectal Adenocarcinoma,oltipraz,"nuclear factor erythroid derived, like (NRF2) activator",ANG
Colorectal Adenocarcinoma,BRD-K87112191-001-04-5::2.5::HTS,23.06002427852911,2.018052839050068e-06,Colorectal Adenocarcinoma,PP242,mTOR inhibitor,"MTOR, PASK"
Colorectal Adenocarcinoma,BRD-K87124298-001-03-4::2.5::HTS,21.53107572044418,4.342935427790412e-06,Colorectal Adenocarcinoma,OSI-027,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K87737963-001-06-0::2.5::HTS,6.497682561538289,0.011068029197254227,Colorectal Adenocarcinoma,cyt387,,"JAK1, JAK2, JAK3"
Colorectal Adenocarcinoma,BRD-K87782578-001-01-4::2.5::HTS,5.414268099165462,0.02032919419336479,Colorectal Adenocarcinoma,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,"BTK, YES1"
Colorectal Adenocarcinoma,BRD-K87909389-003-03-4::2.5::HTS,5.660871894977657,0.01768214851931048,Colorectal Adenocarcinoma,alvocidib,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM"
Colorectal Adenocarcinoma,BRD-K88308881-001-06-8::2.5::HTS,5.029794110453106,0.025307362093631127,Colorectal Adenocarcinoma,ethenzamide,analgesic agent,
Colorectal Adenocarcinoma,BRD-K88429204-001-35-1::2.5::HTS,4.79076587431295,0.029025649622227482,Colorectal Adenocarcinoma,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Colorectal Adenocarcinoma,BRD-K88646909-004-16-2::2.5::HTS,5.036415728660082,0.025211688579665856,Colorectal Adenocarcinoma,arecoline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Colorectal Adenocarcinoma,BRD-K88677950-001-03-9::2.5::HTS,20.688690343858603,6.633071396579859e-06,Other Types,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Colorectal Adenocarcinoma,BRD-K88742110-001-07-9::2.5::HTS,6.122423950719424,0.013646152982890939,Colorectal Adenocarcinoma,PCI-34051,HDAC inhibitor,"HDAC1, HDAC10, HDAC6, HDAC8"
Colorectal Adenocarcinoma,BRD-K88807631-001-01-3::2.5::HTS,5.313115576923756,0.021532209895179063,Colorectal Adenocarcinoma,elacridar,P glycoprotein inhibitor,ABCB1
Colorectal Adenocarcinoma,BRD-K89014967-001-04-3::2.5::HTS,17.255967913015184,3.779839452747235e-05,Other Types,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Colorectal Adenocarcinoma,BRD-K89015388-001-01-7::2.5::HTS,14.206804878894381,0.0001812531722662649,Colorectal Adenocarcinoma,GSK923295,centromere associated protein inhibitor,CENPE
Colorectal Adenocarcinoma,BRD-K89152108-236-07-6::2.5::HTS,9.749144690895019,0.0018945036925066972,Colorectal Adenocarcinoma,liothyronine,thyroid hormone stimulant,"THRA, THRB"
Colorectal Adenocarcinoma,BRD-K89299012-001-06-0::2.5::HTS,10.586830750297727,0.0012086277516463548,Colorectal Adenocarcinoma,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Colorectal Adenocarcinoma,BRD-K90374350-001-09-2::2.5::HTS,12.732181993665213,0.0003910456404277675,Colorectal Adenocarcinoma,chlorquinaldol,other antibiotic,
Colorectal Adenocarcinoma,BRD-K90993449-001-02-7::2.5::HTS,6.908935229671445,0.00881325904188958,Colorectal Adenocarcinoma,KRN-633,VEGFR inhibitor,"FLT1, FLT4, KDR"
Colorectal Adenocarcinoma,BRD-K91111634-001-01-2::2.5::HTS,6.743276387573344,0.009657845042495523,Other Types,rotigotine,dopamine receptor agonist,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A"
Colorectal Adenocarcinoma,BRD-K91495480-001-02-2::2.5::HTS,5.808330959897102,0.016270646601866282,Colorectal Adenocarcinoma,AGP-103,membrane permeability inhibitor,
Colorectal Adenocarcinoma,BRD-K92093830-003-30-8::2.5::HTS,11.791517463263611,0.000639112296495535,Colorectal Adenocarcinoma,doxorubicin,topoisomerase inhibitor,TOP2A
Colorectal Adenocarcinoma,BRD-K92723993-001-06-7::2.5::HTS,7.968573883310129,0.004928251174087039,Colorectal Adenocarcinoma,imatinib,"Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET"
Colorectal Adenocarcinoma,BRD-K92976206-001-01-5::2.5::HTS,7.7653735659134755,0.005508317777596215,Colorectal Adenocarcinoma,guanosine,,PNP
Colorectal Adenocarcinoma,BRD-K93123848-001-04-1::2.5::HTS,9.822343987764453,0.001814469700297174,Colorectal Adenocarcinoma,RAF265,"RAF inhibitor, VEGFR inhibitor",BRAF
Colorectal Adenocarcinoma,BRD-K93208532-001-02-5::2.5::HTS,4.38572451443943,0.036688403955822235,Other Types,apremilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Colorectal Adenocarcinoma,BRD-K93231391-300-05-6::2.5::HTS,8.6785023544892,0.0033532827374726064,Other Types,ethambutol,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K93645900-001-11-3::2.5::HTS,5.014371576206811,0.025528154058788746,Other Types,tadalafil,phosphodiesterase inhibitor,"PDE11A, PDE5A"
Colorectal Adenocarcinoma,BRD-K93779381-001-01-9::2.5::HTS,13.818169472350133,0.0002215458276749932,Colorectal Adenocarcinoma,ingenol-mebutate,PKC activator,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG"
Colorectal Adenocarcinoma,BRD-K93880783-001-26-6::2.5::HTS,4.605384833554048,0.0323031184327676,Colorectal Adenocarcinoma,stavudine,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor",
Colorectal Adenocarcinoma,BRD-K94441233-001-13-0::2.6::HTS,7.203350257122106,0.007505216425857022,Colorectal Adenocarcinoma,mevastatin,HMGCR inhibitor,HMGCR
Colorectal Adenocarcinoma,BRD-K94455792-001-01-8::2.5::HTS,7.322282073352702,0.007018818110617319,Colorectal Adenocarcinoma,ICG-001,beta-catenin inhibitor,CTNNB1
Colorectal Adenocarcinoma,BRD-K94649603-001-10-6::2.5::HTS,4.36523052014674,0.03713515507276012,Colorectal Adenocarcinoma,taxifolin,opioid receptor antagonist,ADIPOR2
Colorectal Adenocarcinoma,BRD-K95412502-003-01-5::2.5::HTS,4.134334410437841,0.042490942205057954,Colorectal Adenocarcinoma,istaroxime,ATPase inhibitor,ATP1A1
Colorectal Adenocarcinoma,BRD-K95880107-001-02-4::2.5::HTS,4.023545887619693,0.04534805938214843,Other Types,PH-797804,p38 MAPK inhibitor,"MAPK11, MAPK14"
Colorectal Adenocarcinoma,BRD-K96029467-003-01-9::2.5::HTS,6.640416079717648,0.010225245593623245,Colorectal Adenocarcinoma,alagebrium,glycosylation inhibitor,
Colorectal Adenocarcinoma,BRD-K96194081-001-10-2::2.5::HTS,5.080997347820178,0.0245738124867103,Other Types,cepharanthine,NFkB pathway inhibitor,
Colorectal Adenocarcinoma,BRD-K96233303-001-01-9::2.5::HTS,4.97071848948291,0.026175714908015506,Colorectal Adenocarcinoma,TMS,,
Colorectal Adenocarcinoma,BRD-K96358241-001-01-9::0.94::HTS,3.8771220653909952,0.04944367280619606,Colorectal Adenocarcinoma,harringtonine,protein synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K96631475-001-02-4::2.43::HTS,17.80615361097879,2.8791852363315447e-05,Colorectal Adenocarcinoma,10-deacetylbaccatin,antitumor agent,
Colorectal Adenocarcinoma,BRD-K97019106-005-02-9::2.5::HTS,13.653645506152902,0.0002413184161099846,Colorectal Adenocarcinoma,"4-acetyl-1,1-dimethylpiperazinium",acetylcholine receptor agonist,
Colorectal Adenocarcinoma,BRD-K97072811-001-11-4::2.5::HTS,5.151378929817478,0.023607950388856092,Colorectal Adenocarcinoma,TG-003,CLK inhibitor,"CLK1, CLK4, DYRK1A, DYRK1B"
Colorectal Adenocarcinoma,BRD-K97101532-001-02-8::2.5::HTS,7.377139390026376,0.006809169323837951,Other Types,tezacaftor,CFTR channel agonist,
Colorectal Adenocarcinoma,BRD-K97158071-001-18-1::2.5::HTS,4.596045630821719,0.03247421000819969,Other Types,droperidol,dopamine receptor antagonist,"ADRA1A, DRD2, DRD3, DRD4, HTR2A"
Colorectal Adenocarcinoma,BRD-K97417064-001-02-4::2.5::HTS,9.54431808113036,0.002105573635342788,Colorectal Adenocarcinoma,acedapsone,,
Colorectal Adenocarcinoma,BRD-K97643133-003-09-3::2.5::HTS,3.9693939020555375,0.0468177475578353,Colorectal Adenocarcinoma,amiprilose,CD antagonist,
Colorectal Adenocarcinoma,BRD-K97764662-001-17-3::2.5::HTS,13.448932106200896,0.00026877961138798876,Colorectal Adenocarcinoma,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Colorectal Adenocarcinoma,BRD-K97810537-001-12-8::2.54::HTS,5.575284666463221,0.018577982139384185,Other Types,beclomethasone-dipropionate,glucocorticoid receptor agonist,"GPR97, NR3C1"
Colorectal Adenocarcinoma,BRD-K98384930-003-01-5::2.5::HTS,5.590037506907607,0.018406828314145165,Colorectal Adenocarcinoma,finafloxacin,bacterial DNA gyrase inhibitor,
Colorectal Adenocarcinoma,BRD-K98795921-001-01-7::2.5::HTS,10.122060497281302,0.0015470938362851904,Colorectal Adenocarcinoma,SB-2343,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Colorectal Adenocarcinoma,BRD-K98963219-001-01-2::2.5::HTS,10.962144759838587,0.000990456271913884,Colorectal Adenocarcinoma,ezatiostat,glutathione transferase inhibitor,GSTP1
Colorectal Adenocarcinoma,BRD-K99107520-001-24-1::2.5::HTS,6.426772240863672,0.011513738087941464,Colorectal Adenocarcinoma,felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Colorectal Adenocarcinoma,BRD-K99113996-001-02-0::2.5::HTS,22.8888696199495,2.1963324866090365e-06,Colorectal Adenocarcinoma,AZD2014,mTOR inhibitor,MTOR
Colorectal Adenocarcinoma,BRD-K99170882-001-04-3::2.5::HTS,5.561170439250835,0.018707116759384117,Colorectal Adenocarcinoma,NSC-319726,p53 activator,
Colorectal Adenocarcinoma,BRD-K99383816-001-03-5::2.5::HTS,4.171088463482747,0.04160547153636011,Other Types,ftorafur,thymidylate synthase inhibitor,TYMS
Colorectal Adenocarcinoma,BRD-K99749624-001-07-0::2.5::HTS,5.326881257061143,0.021363113777179324,Other Types,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Colorectal Adenocarcinoma,BRD-K99792991-001-34-9::2.5::HTS,6.858130461534698,0.009063284361685879,Colorectal Adenocarcinoma,hexachlorophene,potassium channel activator,"GLUD1, SDHD"
Colorectal Adenocarcinoma,BRD-K99922388-001-02-0::2.5::HTS,6.428947806304592,0.011499317426296217,Other Types,DPO-1,potassium channel blocker,KCNA5
Colorectal Adenocarcinoma,BRD-K99964838-001-11-9::2.5::HTS,5.7161804670728245,0.017138526568978425,Colorectal Adenocarcinoma,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Colorectal Adenocarcinoma,BRD-M02179497-001-01-1::2.5::HTS,5.3105312155949616,0.021585549163650707,Colorectal Adenocarcinoma,bismuth-oxalate,,
Colorectal Adenocarcinoma,BRD-M08274809-001-01-7::2.5::HTS,4.063723687904973,0.04432173333242298,Colorectal Adenocarcinoma,indium(iii)-isopropoxide,,
Colorectal Adenocarcinoma,BRD-M56276249-001-01-1::2.5::HTS,6.341262182168442,0.01208143737265628,Colorectal Adenocarcinoma,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,
Colorectal Adenocarcinoma,BRD-M80207679-001-01-5::2.5::HTS,12.092513296364789,0.0005471216883079284,Colorectal Adenocarcinoma,nemonapride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Colorectal Adenocarcinoma,BRD-U51753822-000-01-1::2.5::HTS,4.891829365644442,0.027388505605406458,Other Types,phosphatidylcholine,,PCTP
Colorectal Adenocarcinoma,BRD-A08772153-001-02-4::2.500028879::MTS004,9.998997389103934,0.0016543954942378923,Colorectal Adenocarcinoma,SQ-109,bacterial cell wall synthesis inhibitor,FDFT1
Colorectal Adenocarcinoma,BRD-A14577621-001-01-5::2.5::MTS004,3.9023387247363273,0.048729581254617176,Colorectal Adenocarcinoma,peficitinib,JAK inhibitor,"JAK1, JAK2, JAK3"
Colorectal Adenocarcinoma,BRD-A19053834-050-09-5::2.5::MTS004,4.983258673681714,0.02600377455531455,Colorectal Adenocarcinoma,clorotepine,"dopamine receptor antagonist, adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6"
Colorectal Adenocarcinoma,BRD-A19777893-236-01-9::2.596350183::MTS004,17.324515736752513,3.6685023171761105e-05,Colorectal Adenocarcinoma,menadione-bisulfite,vitamin K,"GGCX, VKORC1, VKORC1L1"
Colorectal Adenocarcinoma,BRD-A23124853-001-01-4::2.5::MTS004,3.9146063930926975,0.04837781832695772,Colorectal Adenocarcinoma,PF-06463922,ALK tyrosine kinase receptor inhibitor,"ALK, FES, ROS1"
Colorectal Adenocarcinoma,BRD-A33894669-065-01-9::2.312630829::MTS004,7.351443546876501,0.00691508173303797,Colorectal Adenocarcinoma,hexoprenaline,adrenergic receptor agonist,ADRB2
Colorectal Adenocarcinoma,BRD-A34788695-003-10-2::2.375699424::MTS004,5.1882438243538305,0.023131612256276638,Colorectal Adenocarcinoma,tetracycline,bacterial 30S ribosomal subunit inhibitor,PRNP
Colorectal Adenocarcinoma,BRD-A42881122-001-01-1::2.648380541::MTS004,6.79880369986009,0.009375116002308472,Colorectal Adenocarcinoma,cyamemazine,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C, HTR7"
Colorectal Adenocarcinoma,BRD-A44188509-001-01-2::2.639346634::MTS004,7.837753285934146,0.0053000380968303215,Colorectal Adenocarcinoma,AZD1446,acetylcholine receptor agonist,"CHRNA4, CHRNB2"
Colorectal Adenocarcinoma,BRD-A44971162-001-02-7::2.5::MTS004,4.468609598363425,0.034982633212430746,Colorectal Adenocarcinoma,ODM-201,androgen receptor antagonist,AR
Colorectal Adenocarcinoma,BRD-A46335897-003-27-8::2.499949994::MTS004,12.572371860940311,0.0004255607095661498,Colorectal Adenocarcinoma,promethazine,histamine receptor antagonist,"ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A"
Colorectal Adenocarcinoma,BRD-A48938994-001-14-1::2.5::MTS004,11.439998992164337,0.0007709874725419653,Other Types,monoctanoin,,
Colorectal Adenocarcinoma,BRD-A50675490-001-01-0::2.412483069::MTS004,11.1511583377285,0.0008978671651987437,Colorectal Adenocarcinoma,carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Colorectal Adenocarcinoma,BRD-A59961917-001-01-0::2.5::MTS004,7.961444425059251,0.004955029033562518,Colorectal Adenocarcinoma,BQ-123,endothelin receptor antagonist,EDNRA
Colorectal Adenocarcinoma,BRD-A67182178-001-01-7::2.5::MTS004,10.350479006259814,0.0013721456684511043,Colorectal Adenocarcinoma,toloxatone,monoamine oxidase inhibitor,"MAOA, MAOB"
Colorectal Adenocarcinoma,BRD-A73679382-236-01-8::2.499981367::MTS004,11.427163981431628,0.000776219286032887,Colorectal Adenocarcinoma,MK-571,leukotriene receptor antagonist,"ABCC2, CYSLTR1"
Colorectal Adenocarcinoma,BRD-A74975734-004-09-9::2.5::MTS004,6.994795717630832,0.008413536350620268,Other Types,homatropine,acetylcholine receptor antagonist,"CES1, CHRM1"
Colorectal Adenocarcinoma,BRD-A88254928-001-07-9::2.5::MTS004,5.9020496939654565,0.015449571791771146,Colorectal Adenocarcinoma,albuterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Colorectal Adenocarcinoma,BRD-A88562598-001-01-7::2.500008795::MTS004,7.901260647753635,0.005120094973365158,Colorectal Adenocarcinoma,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Colorectal Adenocarcinoma,BRD-A92262698-001-02-5::2.5::MTS004,9.511365496986826,0.002146677884829068,Colorectal Adenocarcinoma,chlorphenesin,muscle relaxant,
Colorectal Adenocarcinoma,BRD-A93683007-001-01-9::2.5::MTS004,18.24260418645206,2.298920126010564e-05,Colorectal Adenocarcinoma,mabuprofen,cyclooxygenase inhibitor,
Colorectal Adenocarcinoma,BRD-A99899486-004-01-9::2.293696319::MTS004,5.35300040854385,0.021061949842184315,Colorectal Adenocarcinoma,cimetropium,acetylcholine receptor antagonist,CHRM1
Colorectal Adenocarcinoma,BRD-K00634421-001-01-0::2.500042819::MTS004,14.241981424736007,0.00017861054236382036,Colorectal Adenocarcinoma,brivaracetam,voltage-gated sodium channel blocker,SV2A
Colorectal Adenocarcinoma,BRD-K00739965-001-01-9::2.675904798::MTS004,5.979166082859014,0.014795423681662208,Colorectal Adenocarcinoma,guacetisal,immunosuppressant,
Colorectal Adenocarcinoma,BRD-K01662324-001-01-8::2.618953925::MTS004,5.09742555781568,0.024361374862897783,Colorectal Adenocarcinoma,priralfinamide,sodium channel blocker,CACNA1B
Colorectal Adenocarcinoma,BRD-K03765900-001-01-9::2.499986292::MTS004,5.0704938520526674,0.02473898989550986,Colorectal Adenocarcinoma,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Colorectal Adenocarcinoma,BRD-K03894385-001-01-1::2.500025266::MTS004,5.534551415819079,0.019003120498738917,Colorectal Adenocarcinoma,MK-6096,orexin receptor antagonist,"HCRTR1, HCRTR2"
Colorectal Adenocarcinoma,BRD-K04603573-376-01-3::2.542651982::MTS004,14.84148266033307,0.00013103146706784286,Colorectal Adenocarcinoma,"1,12-Besm",polyamine biosynthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K04710043-001-17-8::2.5::MTS004,4.653254837042422,0.031436051891463965,Colorectal Adenocarcinoma,hexamethylenebisacetamide,"AKT inhibitor, differentiation inducer, NFKB pathway inhibitor",AKT1
Colorectal Adenocarcinoma,BRD-K06182768-001-02-3::2.5::MTS004,4.965434410225468,0.026271318137836744,Colorectal Adenocarcinoma,A-366,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Colorectal Adenocarcinoma,BRD-K06388517-001-01-2::2.5::MTS004,5.893850286820424,0.01552025117887517,Colorectal Adenocarcinoma,lofemizole,cyclooxygenase inhibitor,
Colorectal Adenocarcinoma,BRD-K06502269-001-02-6::2.5::MTS004,8.532728729019123,0.0036343041361596782,Colorectal Adenocarcinoma,L-methionine,voltage-gated calcium channel ligand,
Colorectal Adenocarcinoma,BRD-K07070922-001-01-4::2.5::MTS004,5.059293740554778,0.02489706796385461,Colorectal Adenocarcinoma,PF-03049423,phosphodiesterase inhibitor,PDE5A
Colorectal Adenocarcinoma,BRD-K07625016-001-01-2::2.50703254::MTS004,4.449524065292162,0.03537232151645567,Colorectal Adenocarcinoma,norethisterone-enanthate,contraceptive agent,
Colorectal Adenocarcinoma,BRD-K07785030-001-01-6::2.29884119::MTS004,5.339982741242071,0.021218196047193136,Colorectal Adenocarcinoma,7-keto-DHEA,steroid,
Colorectal Adenocarcinoma,BRD-K10415035-001-04-4::2.5::MTS004,6.80756538589225,0.00932933608032575,Colorectal Adenocarcinoma,tasuldine,mucolytic agent,
Colorectal Adenocarcinoma,BRD-K11443721-003-01-6::2.403980733::MTS004,6.306114994129459,0.012324179441592224,Colorectal Adenocarcinoma,NE-100,sigma receptor antagonist,SIGMAR1
Colorectal Adenocarcinoma,BRD-K11792081-001-01-4::2.500009305::MTS004,5.227041574384993,0.022625386311626867,Colorectal Adenocarcinoma,ABT-639,calcium channel blocker,"CACNA1G, CACNA1H, CACNA1I"
Colorectal Adenocarcinoma,BRD-K11851476-003-01-7::2.499993171::MTS004,14.475183629814518,0.00015828402671774178,Colorectal Adenocarcinoma,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Colorectal Adenocarcinoma,BRD-K12852738-001-01-2::2.584725941::MTS004,7.811015478226997,0.00537786942657913,Colorectal Adenocarcinoma,veliflapon,leukotriene synthesis inhibitor,ALOX5AP
Colorectal Adenocarcinoma,BRD-K14171291-001-01-4::2.499985403::MTS004,8.251030282653055,0.004233603660400196,Colorectal Adenocarcinoma,omarigliptin,dipeptidyl peptidase inhibitor,DPP4
Colorectal Adenocarcinoma,BRD-K14571191-001-01-6::2.5::MTS004,9.06471727691548,0.002727991988595381,Colorectal Adenocarcinoma,zometapine,,
Colorectal Adenocarcinoma,BRD-K14658796-003-01-6::2.368766292::MTS004,15.796867420115749,8.014086687552495e-05,Colorectal Adenocarcinoma,drotaverine,phosphodiesterase inhibitor,"CACNA1C, PDE4A"
Colorectal Adenocarcinoma,BRD-K15327298-001-05-5::2.444207768::MTS004,8.590501447582822,0.003523641879040968,Colorectal Adenocarcinoma,fmoc-l-leucine,PPAR receptor agonist,
Colorectal Adenocarcinoma,BRD-K16180792-001-01-7::2.5::MTS004,27.229425523616626,2.582145539548666e-07,Colorectal Adenocarcinoma,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Colorectal Adenocarcinoma,BRD-K16505263-003-02-9::2.49996754::MTS004,4.704441708648071,0.03052125497603301,Colorectal Adenocarcinoma,forodesine,purinergic receptor antagonist,PNP
Colorectal Adenocarcinoma,BRD-K17295893-001-01-0::2.499987615::MTS004,13.481503234460263,0.00026497953714346923,Colorectal Adenocarcinoma,nastorazepide,CCK receptor antagonist,CCKBR
Colorectal Adenocarcinoma,BRD-K18749874-003-08-9::2.5::MTS004,8.183519995851643,0.00439126785407831,Colorectal Adenocarcinoma,melevodopa,"dopamine precursor, dopamine receptor agonist",DDC
Colorectal Adenocarcinoma,BRD-K21237892-376-01-3::2.5::MTS004,3.8612520429384998,0.04992660822146746,Colorectal Adenocarcinoma,semapimod,"cytokine production inhibitor, p38 MAPK inhibitor",MAPK14
Colorectal Adenocarcinoma,BRD-K22518984-001-01-8::2.5::MTS004,9.55155229923324,0.0021009930483972903,Colorectal Adenocarcinoma,metacresol,,INS
Colorectal Adenocarcinoma,BRD-K24221957-003-01-6::2.5::MTS004,6.9666555130382255,0.008544668392239378,Colorectal Adenocarcinoma,pralidoxime-chloride,acetylcholinesterase inhibitor,"ACHE, BCHE"
Colorectal Adenocarcinoma,BRD-K25146005-001-01-0::2.5::MTS004,9.761392445969413,0.001878016911389301,Colorectal Adenocarcinoma,cis-urocanic acid,serotonin receptor agonist,HTR2A
Colorectal Adenocarcinoma,BRD-K25154476-001-01-4::2.5::MTS004,6.7638283194431725,0.009557769009564395,Colorectal Adenocarcinoma,cinflumide,muscle relaxant,
Colorectal Adenocarcinoma,BRD-K25494650-003-01-8::2.660853131::MTS004,5.797618732320564,0.016383402388529443,Colorectal Adenocarcinoma,chlorproguanil,dihydrofolate reductase inhibitor,DHFR
Colorectal Adenocarcinoma,BRD-K25970317-001-01-6::2.50000335::MTS004,26.76515591981828,3.2477154779584533e-07,Colorectal Adenocarcinoma,resibufogenin,Na/K-ATPase inhibitor,
Colorectal Adenocarcinoma,BRD-K27515606-003-01-3::2.5::MTS004,13.732823339857804,0.00023250847125467428,Colorectal Adenocarcinoma,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K27625831-001-02-9::2.499990597::MTS004,7.982752373360079,0.004897572176955321,Colorectal Adenocarcinoma,pleconaril,,
Colorectal Adenocarcinoma,BRD-K27755542-001-01-6::2.49693186::MTS004,18.28253068999474,2.2527885902487073e-05,Colorectal Adenocarcinoma,PF-04937319,glucokinase activator,GCK
Colorectal Adenocarcinoma,BRD-K28061410-001-06-6::2.5::MTS004,5.0559586983526055,0.02494456643710996,Colorectal Adenocarcinoma,beta-lapachone,topoisomerase inhibitor,TOP1
Colorectal Adenocarcinoma,BRD-K28537285-001-01-8::2.499968715::MTS004,16.891113168646992,4.575202535139463e-05,Colorectal Adenocarcinoma,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Colorectal Adenocarcinoma,BRD-K28687144-001-08-7::2.5::MTS004,6.1441199263120305,0.013489870946239048,Colorectal Adenocarcinoma,fosfosal,phosphodiesterase inhibitor,"PTGS1, PTGS2"
Colorectal Adenocarcinoma,BRD-K29626940-001-01-5::2.682001852::MTS004,4.270195936509543,0.039264432101912564,Colorectal Adenocarcinoma,imidafenacin,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Colorectal Adenocarcinoma,BRD-K30159788-001-01-9::2.49998123::MTS004,18.18391765416702,2.3691784439873522e-05,Colorectal Adenocarcinoma,RSV604,RSV replication inhibitor,
Colorectal Adenocarcinoma,BRD-K31417912-001-01-9::2.499995989::MTS004,9.65713523277706,0.001985620948664741,Colorectal Adenocarcinoma,PF-3274167,oxytocin receptor antagonist,"AVPR1A, OXTR"
Colorectal Adenocarcinoma,BRD-K32256160-001-01-9::2.499998021::MTS004,11.350931056611822,0.0008081462939873336,Colorectal Adenocarcinoma,solithromycin,protein synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K32804101-001-01-8::2.5::MTS004,10.326871315615694,0.0013894698140236002,Colorectal Adenocarcinoma,valrocemide,,
Colorectal Adenocarcinoma,BRD-K33240821-001-06-2::2.50000539::MTS004,4.125518577239933,0.04273126307003884,Colorectal Adenocarcinoma,plerixafor,CC chemokine receptor antagonist,"ACKR3, CCR4, CXCR4"
Colorectal Adenocarcinoma,BRD-K33637378-001-01-7::2.500021224::MTS004,8.789378273003923,0.0031642298038822543,Colorectal Adenocarcinoma,flibanserin,serotonin receptor agonist,"DRD4, HTR1A, HTR2A"
Colorectal Adenocarcinoma,BRD-K34068325-066-03-7::2.499970684::MTS004,4.3293881537060255,0.037931354018771186,Colorectal Adenocarcinoma,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4
Colorectal Adenocarcinoma,BRD-K34251960-036-01-6::2.459743274::MTS004,5.990287720995413,0.014702878154711487,Colorectal Adenocarcinoma,cibenzoline,sodium channel blocker,
Colorectal Adenocarcinoma,BRD-K34277641-001-01-2::2.569027627::MTS004,6.5839272414539405,0.010559526939029597,Other Types,L-365260,CCK receptor antagonist,"CCKAR, CCKBR, KCNQ1"
Colorectal Adenocarcinoma,BRD-K34445261-001-02-2::2.334266471::MTS004,5.294715932906939,0.021770951841909744,Colorectal Adenocarcinoma,SLV-320,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Colorectal Adenocarcinoma,BRD-K34508702-001-02-4::2.499975465::MTS004,7.717741085757877,0.005658656713598545,Colorectal Adenocarcinoma,CHF5074,gamma secretase modulator,PSEN1
Colorectal Adenocarcinoma,BRD-K35304636-001-01-0::2.5::MTS004,5.800734828369722,0.016354085532847857,Colorectal Adenocarcinoma,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Colorectal Adenocarcinoma,BRD-K35367061-001-01-1::2.5::MTS004,4.639720381521522,0.03168269930581172,Other Types,LY223982,leukotriene receptor antagonist,LTB4R
Colorectal Adenocarcinoma,BRD-K35626314-003-01-1::2.499986242::MTS004,8.877887941285595,0.0030165791341701313,Colorectal Adenocarcinoma,TRV130,opioid receptor agonist,OPRM1
Colorectal Adenocarcinoma,BRD-K36379990-001-01-1::2.547414282::MTS004,10.464985259088364,0.0012913194456215735,Colorectal Adenocarcinoma,riodipine,calcium channel blocker,
Colorectal Adenocarcinoma,BRD-K38398115-001-01-9::2.418470509::MTS004,10.856718548773568,0.001049203334138474,Colorectal Adenocarcinoma,YM-511,aromatase inhibitor,CYP19A1
Colorectal Adenocarcinoma,BRD-K38564664-001-01-1::2.5::MTS004,7.42269177292975,0.00664975098640314,Colorectal Adenocarcinoma,rolziracetam,,
Colorectal Adenocarcinoma,BRD-K41267922-001-01-4::2.5::MTS004,4.239226144264451,0.039980083920230294,Colorectal Adenocarcinoma,F351,TGF beta receptor inhibitor,TGFB1
Colorectal Adenocarcinoma,BRD-K41592905-001-01-6::2.5::MTS004,9.01508335913901,0.002801798967222503,Colorectal Adenocarcinoma,7-methylxanthine,adenosine receptor antagonist,
Colorectal Adenocarcinoma,BRD-K41662846-003-01-5::2.517380705::MTS004,14.229071085438225,0.00017980803562615166,Colorectal Adenocarcinoma,tecalcet,calcium-sensing receptor agonist,CASR
Colorectal Adenocarcinoma,BRD-K43639297-001-01-9::2.500038533::MTS004,11.160979710919081,0.0008933328567662071,Colorectal Adenocarcinoma,hemoglobin-modulators-1,hemoglobin modulator,
Colorectal Adenocarcinoma,BRD-K43647122-001-01-3::2.5::MTS004,5.89649274581011,0.015499688054995377,Colorectal Adenocarcinoma,nerbacadol,cyclooxygenase inhibitor,
Colorectal Adenocarcinoma,BRD-K45125084-001-01-4::2.5::MTS004,4.677268096530261,0.031003373929783803,Colorectal Adenocarcinoma,zolimidine,mucus protecting agent,
Colorectal Adenocarcinoma,BRD-K46843573-001-01-9::2.5::MTS004,53.81405920596226,8.145049778805656e-13,Colorectal Adenocarcinoma,zotarolimus,mTOR inhibitor,FKBP1A
Colorectal Adenocarcinoma,BRD-K46862739-001-14-3::2.499952208::MTS004,6.745725816388486,0.009654470566616143,Colorectal Adenocarcinoma,metyrapone,cytochrome P450 inhibitor,CYP11B1
Colorectal Adenocarcinoma,BRD-K47690382-001-03-0::2.5::MTS004,13.991185342098364,0.0002033472048940242,Colorectal Adenocarcinoma,bipenamol,dipeptidyl peptidase inhibitor,CTSC
Colorectal Adenocarcinoma,BRD-K47929404-001-01-0::2.500019706::MTS004,9.705971300346627,0.0019346418860097215,Colorectal Adenocarcinoma,vercirnon,CC chemokine receptor antagonist,CCR9
Colorectal Adenocarcinoma,BRD-K48452630-001-01-8::2.5::MTS004,7.6637933199963495,0.005828224132930564,Colorectal Adenocarcinoma,SRT2104,SIRT activator,SIRT1
Colorectal Adenocarcinoma,BRD-K49659468-436-01-2::2.500002467::MTS004,3.888145499150792,0.049138989400470734,Colorectal Adenocarcinoma,TMC647055,RNA polymerase inhibitor,
Colorectal Adenocarcinoma,BRD-K50055394-001-03-6::2.701086832::MTS004,5.2999284525812955,0.021706546551138732,Colorectal Adenocarcinoma,halopemide,phospholipase inhibitor,"PLD1, PLD2"
Colorectal Adenocarcinoma,BRD-K50489389-001-01-8::2.500007911::MTS004,9.021566651810875,0.0027920437646515393,Colorectal Adenocarcinoma,ranirestat,aldose reductase inhibitor,AKR1B1
Colorectal Adenocarcinoma,BRD-K50660797-001-05-1::2.499989832::MTS004,5.514073573655032,0.019224510853447375,Other Types,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,"BACE1, FASN"
Colorectal Adenocarcinoma,BRD-K52579889-001-01-9::2.499985811::MTS004,8.433000788857283,0.0038360685980226485,Colorectal Adenocarcinoma,TGR-1202,PI3K inhibitor,
Colorectal Adenocarcinoma,BRD-K52914072-001-01-5::2.5::MTS004,11.747279053082009,0.0006558616881605482,Colorectal Adenocarcinoma,LTA,,
Colorectal Adenocarcinoma,BRD-K53156626-001-01-3::2.5::MTS004,5.341268511863707,0.021202709996260276,Colorectal Adenocarcinoma,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE
Colorectal Adenocarcinoma,BRD-K53195974-001-01-9::2.298572309::MTS004,8.793198865360804,0.003157717743487972,Colorectal Adenocarcinoma,sipatrigine,voltage-gated sodium channel blocker,"CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A"
Colorectal Adenocarcinoma,BRD-K54519451-001-02-9::2.499971332::MTS004,5.383876185247509,0.020696117312773647,Colorectal Adenocarcinoma,pexidartinib,tyrosine kinase inhibitor,"CSF1R, FLT3, KIT"
Colorectal Adenocarcinoma,BRD-K55808645-001-01-4::2.500006596::MTS004,5.852585977848324,0.015884822066081127,Colorectal Adenocarcinoma,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Colorectal Adenocarcinoma,BRD-K56107812-001-01-7::2.499996486::MTS004,4.072417761451539,0.044084680839193334,Colorectal Adenocarcinoma,carbetocin,oxytocin receptor agonist,OXTR
Colorectal Adenocarcinoma,BRD-K56211775-001-03-8::2.5::MTS004,7.953135720307214,0.004977489629139543,Colorectal Adenocarcinoma,RTA-408,nitric oxide production inhibitor,NFE2L2
Colorectal Adenocarcinoma,BRD-K56740996-001-01-3::2.601527794::MTS004,4.454330142443458,0.035273763982218265,Colorectal Adenocarcinoma,flindokalner,potassium channel agonist,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5"
Colorectal Adenocarcinoma,BRD-K56981171-001-01-0::2.500008954::MTS004,6.8258806505032705,0.009235820257743114,Colorectal Adenocarcinoma,brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR"
Colorectal Adenocarcinoma,BRD-K58277159-001-01-7::2.5::MTS004,4.761296848516071,0.029537704430102844,Other Types,NPC-01,steroid,
Colorectal Adenocarcinoma,BRD-K58810291-001-16-2::2.564588683::MTS004,7.396384610679745,0.006746339246574161,Other Types,clobetasone-butyrate,corticosteroid agonist,NR3C1
Colorectal Adenocarcinoma,BRD-K60284353-001-01-3::2.5::MTS004,4.826643694224886,0.028448029008594444,Colorectal Adenocarcinoma,titanocene-dichloride,apoptosis stimulant,
Colorectal Adenocarcinoma,BRD-K61496577-001-19-4::2.5::MTS004,5.186117113633233,0.02315965889961868,Other Types,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Colorectal Adenocarcinoma,BRD-K61923022-001-02-4::2.499990535::MTS004,4.873968267770545,0.027685140644916506,Colorectal Adenocarcinoma,GDC-0810,selective estrogen receptor destabilizer,ESR1
Colorectal Adenocarcinoma,BRD-K62309135-001-05-2::3.119534994::MTS004,6.974349527416065,0.00850893283060086,Colorectal Adenocarcinoma,L-glutamic-acid,glutamate receptor agonist,"AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT"
Colorectal Adenocarcinoma,BRD-K62374002-001-01-5::2.499972663::MTS004,5.475019002490495,0.0196541827481966,Colorectal Adenocarcinoma,PI3K-IN-2,PI3K inhibitor,
Colorectal Adenocarcinoma,BRD-K65498798-001-01-7::2.5::MTS004,6.9138570791860365,0.008797274048416426,Colorectal Adenocarcinoma,abametapir,metalloproteinase inhibitor,MMP9
Colorectal Adenocarcinoma,BRD-K66295376-001-13-1::2.5::MTS004,6.462006520721986,0.011299303918008556,Other Types,ferulic-acid,antioxidant,"CA1, CA12, CA14, CA2, CA4, CA6, CA9"
Colorectal Adenocarcinoma,BRD-K67186445-001-02-1::2.500004874::MTS004,13.991777832845958,0.0002033225960823415,Colorectal Adenocarcinoma,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE
Colorectal Adenocarcinoma,BRD-K67628093-001-01-9::2.500004949::MTS004,21.639572938366424,4.146155117119447e-06,Colorectal Adenocarcinoma,INCB-3284,CC chemokine receptor antagonist,CCR2
Colorectal Adenocarcinoma,BRD-K68432770-236-23-1::2.500029469::MTS004,8.765410100548438,0.003205142182620466,Colorectal Adenocarcinoma,ampicillin,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K68544925-001-01-1::2.500014712::MTS004,5.852580391313501,0.01588487193363008,Colorectal Adenocarcinoma,avatrombopag,thrombopoietin receptor agonist,MPL
Colorectal Adenocarcinoma,BRD-K70592963-001-31-6::2.5::MTS004,9.903823162924198,0.0017405240220498414,Colorectal Adenocarcinoma,phenindione,vitamin K antagonist,VKORC1
Colorectal Adenocarcinoma,BRD-K70601687-001-01-3::2.500008826::MTS004,4.962213455608415,0.026319830440783877,Other Types,enasidenib,isocitrate dehydrogenase inhibitor,IDH1
Colorectal Adenocarcinoma,BRD-K72264770-001-03-2::2.5::MTS004,11.30642648354857,0.0008273356083168373,Colorectal Adenocarcinoma,BRD4770,histone lysine methyltransferase inhibitor,EHMT2
Colorectal Adenocarcinoma,BRD-K72533376-001-01-2::2.5::MTS004,6.243581152907331,0.012761547345109328,Colorectal Adenocarcinoma,etoposide-phosphate,topoisomerase inhibitor,TOP2A
Colorectal Adenocarcinoma,BRD-K73451719-001-01-2::2.5::MTS004,7.425305351985501,0.006640232773348961,Colorectal Adenocarcinoma,terlipressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2"
Colorectal Adenocarcinoma,BRD-K73504359-001-01-3::2.5::MTS004,19.754565596733663,1.06941865239747e-05,Colorectal Adenocarcinoma,bivalirudin,thrombin inhibitor,F2
Colorectal Adenocarcinoma,BRD-K74671368-001-01-8::2.5::MTS004,7.83964778273614,0.0052945672873880075,Colorectal Adenocarcinoma,idronoxil,XIAP inhibitor,"ENOX2, SPHK1"
Colorectal Adenocarcinoma,BRD-K76634210-001-12-1::2.5::MTS004,5.38231178365293,0.020715188083606558,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Colorectal Adenocarcinoma,BRD-K76719364-001-02-5::2.466617435::MTS004,19.832573552639698,1.0285077057306042e-05,Colorectal Adenocarcinoma,GS-9973,syk inhibitor,SYK
Colorectal Adenocarcinoma,BRD-K77038618-356-01-3::2.500022896::MTS004,8.526957917901147,0.0036456630539161085,Colorectal Adenocarcinoma,garenoxacin,topoisomerase inhibitor,TOP2A
Colorectal Adenocarcinoma,BRD-K77428767-001-01-7::2.5::MTS004,4.211795835598178,0.040627125773931544,Other Types,UNC0224,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Colorectal Adenocarcinoma,BRD-K79821389-001-03-5::2.562009205::MTS004,4.133130544186405,0.04254191054949402,Colorectal Adenocarcinoma,rubitecan,topoisomerase inhibitor,TOP1
Colorectal Adenocarcinoma,BRD-K80359953-001-01-3::2.500041136::MTS004,8.089183088756657,0.004622149301720263,Colorectal Adenocarcinoma,talampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Colorectal Adenocarcinoma,BRD-K80419150-001-02-4::2.5::MTS004,4.940354935442901,0.02665075768931614,Colorectal Adenocarcinoma,debrisoquin,adrenergic neuron blocker,SLC6A2
Colorectal Adenocarcinoma,BRD-K80738081-001-46-8::2.500037854::MTS004,5.327085118209883,0.0213741887077104,Colorectal Adenocarcinoma,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Colorectal Adenocarcinoma,BRD-K81405859-300-01-4::2.5::MTS004,3.950935439369206,0.04735085439794428,Colorectal Adenocarcinoma,JTE-607,cytokine production inhibitor,"IL10, IL1B, IL6, TNF"
Colorectal Adenocarcinoma,BRD-K82967180-001-01-6::2.500024493::MTS004,21.765064391683016,3.891855624183077e-06,Colorectal Adenocarcinoma,LY3023414,"PI3K inhibitor, mTOR inhibitor",MTOR
Colorectal Adenocarcinoma,BRD-K83776863-001-08-9::2.5::MTS004,5.026548162153103,0.02536754659863414,Colorectal Adenocarcinoma,tryptophan,serotonin receptor partial agonist,"CASR, IDO1, SLC36A1, WARS, WARS2"
Colorectal Adenocarcinoma,BRD-K84173274-001-01-6::2.5::MTS004,9.37630880445625,0.0023077550509390636,Colorectal Adenocarcinoma,ufenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Colorectal Adenocarcinoma,BRD-K84281997-003-08-4::2.500011105::MTS004,5.988513889192587,0.014718097733327603,Colorectal Adenocarcinoma,pralidoxime,acetylcholinesterase inhibitor,"ACHE, BCHE"
Colorectal Adenocarcinoma,BRD-K84868168-001-01-0::2.500006364::MTS004,7.417181238076102,0.006670257429787337,Colorectal Adenocarcinoma,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Colorectal Adenocarcinoma,BRD-K87465484-001-02-7::2.5::MTS004,9.092914527178307,0.0026871748063237995,Colorectal Adenocarcinoma,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
Colorectal Adenocarcinoma,BRD-K89085489-001-23-2::2.499967871::MTS004,10.529017822367138,0.0012480337081956395,Colorectal Adenocarcinoma,fenretinide,"apoptosis stimulant, retinoid receptor agonist",RARA
Colorectal Adenocarcinoma,BRD-K89121095-001-01-7::2.499999138::MTS004,13.692071623881818,0.0002374798379220071,Colorectal Adenocarcinoma,tedizolid-phosphate,protein synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K89413285-074-01-5::2.500023482::MTS004,19.44858346310255,1.248530713239713e-05,Colorectal Adenocarcinoma,remimazolam,benzodiazepine receptor agonist,GABBR1
Colorectal Adenocarcinoma,BRD-K91900765-001-07-6::2.500030257::MTS004,5.282544359118154,0.021922828268271737,Colorectal Adenocarcinoma,VX-745,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK14"
Colorectal Adenocarcinoma,BRD-K92073408-001-15-7::2.5::MTS004,3.9387040623595237,0.04769464411772146,Colorectal Adenocarcinoma,norethindrone,progesterone receptor agonist,PGR
Colorectal Adenocarcinoma,BRD-K92908289-001-01-8::2.501017998::MTS004,4.160077376335029,0.041875508209281924,Colorectal Adenocarcinoma,medica-16,ATP citrase lyase inhibitor,FFAR1
Colorectal Adenocarcinoma,BRD-K94830213-001-01-3::2.635005669::MTS004,11.792810207843576,0.0006404383553569161,Colorectal Adenocarcinoma,tofisopam,"phosphodiesterase inhibitor, cytochrome P450 inhibitor","CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A"
Colorectal Adenocarcinoma,BRD-K95362002-001-01-1::2.354783058::MTS004,12.160952802312481,0.0005279118643070623,Colorectal Adenocarcinoma,cipemastat,metalloproteinase inhibitor,"ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9"
Colorectal Adenocarcinoma,BRD-K95941975-001-01-5::2.5::MTS004,8.159258118910392,0.00444949725157962,Colorectal Adenocarcinoma,piperazinedione,DNA synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K96669468-300-01-1::2.5::MTS004,19.31224968385774,1.3371329591065555e-05,Colorectal Adenocarcinoma,pyridoxamine,AGE inhibitor,
Colorectal Adenocarcinoma,BRD-K96691275-001-01-2::2.5::MTS004,4.737312518764605,0.029949319375539175,Colorectal Adenocarcinoma,mebrofenin,,
Colorectal Adenocarcinoma,BRD-K96734425-304-01-7::2.500007729::MTS004,5.979110394189093,0.014795290356999738,Other Types,ceftriaxone,bacterial cell wall synthesis inhibitor,
Colorectal Adenocarcinoma,BRD-K96874295-015-01-0::2.500009134::MTS004,5.300554026235158,0.021698830348415802,Colorectal Adenocarcinoma,gonadorelin,gonadotropin releasing factor hormone receptor agonist,"GNRHR, GNRHR2"
Colorectal Adenocarcinoma,BRD-K99431849-001-01-7::2.500018158::MTS004,9.726845151892956,0.0019129999270253155,Colorectal Adenocarcinoma,peretinoin,retinoid receptor agonist,RXRA
Colorectal Adenocarcinoma,BRD-K99447003-335-04-1::2.37737659::MTS004,20.20538772098721,8.51972463990926e-06,Colorectal Adenocarcinoma,enalaprilat,angiotensin converting enzyme inhibitor,ACE
Colorectal Adenocarcinoma,BRD-K99616396-001-05-1::2.499991421::MTS004,7.5260426373311695,0.006283802480936263,Colorectal Adenocarcinoma,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT1, FLT4, KDR, KIT"
Colorectal Adenocarcinoma,BRD-K99919177-001-01-3::2.5::MTS004,15.252147634905793,0.00010601626948380311,Colorectal Adenocarcinoma,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Melanoma,BRD-A00758722-001-04-9::2.5::HTS,5.432151861639398,0.02013728379609348,Other Types,noretynodrel,progestogen hormone,PGR
Melanoma,BRD-A00993607-003-24-6::2.5::HTS,5.165194103346432,0.023420632448043304,Melanoma,alprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A"
Melanoma,BRD-A04327189-003-03-3::2.5::HTS,6.2233625990030585,0.012905799228007995,Melanoma,synephrine,adrenergic receptor agonist,ADRA1A
Melanoma,BRD-A05674712-001-06-0::2.5::HTS,9.826178869811633,0.0018161390900085469,Melanoma,"mevalonic-d,-l-acid-lactone",,
Melanoma,BRD-A06352418-001-25-9::2.5::HTS,14.237772018215134,0.00017896570362015875,Other Types,terfenadine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2"
Melanoma,BRD-A08545410-311-03-4::2.5::HTS,4.153509499514996,0.04204617623323153,Other Types,doxycycline,metalloproteinase inhibitor,MMP8
Melanoma,BRD-A08840375-001-01-3::2.5::HTS,8.920308426018229,0.0029467713289806634,Other Types,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Melanoma,BRD-A09349126-001-10-7::2.5::HTS,10.865208463785875,0.0010445000688241875,Other Types,norethindrone-acetate,progesterone receptor agonist,
Melanoma,BRD-A09828896-004-11-0::2.5::HTS,4.875992028440605,0.02763720855486243,Melanoma,SKF-81297,dopamine receptor agonist,"DRD1, DRD5"
Melanoma,BRD-A11815689-001-01-1::2.5::HTS,7.12487789216864,0.007823891594127877,Other Types,proscillaridin-a,,
Melanoma,BRD-A12077521-003-01-5::2.5::HTS,5.12575253368526,0.02396992567151737,Other Types,cefepime,bacterial cell wall synthesis inhibitor,
Melanoma,BRD-A12230535-001-06-7::2.5::HTS,12.28445448428565,0.0004947588989703256,Other Types,nutlin-3,MDM inhibitor,"MDM2, TP53"
Melanoma,BRD-A14886633-001-01-6::2.5::HTS,14.531120775221686,0.00015332691806441446,Other Types,norgestrel,progesterone receptor agonist,PGR
Melanoma,BRD-A16350940-001-01-9::2.5::HTS,9.695187907009368,0.0019424229253222883,Other Types,doramectin,,
Melanoma,BRD-A16665823-001-02-0::2.5::HTS,6.2292645811329335,0.012852141136849437,Melanoma,butoconazole,bacterial cell wall synthesis inhibitor,
Melanoma,BRD-A16694057-001-06-8::2.5::HTS,8.335980115434865,0.004038479099750845,Melanoma,BADGE,PPAR receptor antagonist,PPARG
Melanoma,BRD-A19736161-001-06-7::2.5::HTS,4.194224735099477,0.041026072199853846,Melanoma,ondansetron,serotonin receptor antagonist,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1"
Melanoma,BRD-A22106989-001-05-0::2.5::HTS,4.270200772246014,0.039250501114997734,Melanoma,phenothrin,,
Melanoma,BRD-A22707317-001-10-8::2.5::HTS,7.477789881209546,0.006444256050050462,Melanoma,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Melanoma,BRD-A23067620-300-01-3::2.5::HTS,7.089422021324274,0.00797938054378724,Melanoma,itraconazole,cytochrome P450 inhibitor,CYP51A1
Melanoma,BRD-A25687296-300-04-3::2.5::HTS,4.378097515396236,0.036855631705476705,Other Types,emetine,protein synthesis inhibitor,RPS2
Melanoma,BRD-A27376179-001-01-3::2.5::HTS,3.997115593802774,0.04607329827064295,Other Types,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor","FLT3, NTRK1"
Melanoma,BRD-A28301258-001-04-8::2.5::HTS,7.8207155460453235,0.0053533740925085505,Other Types,salinomycin,,
Melanoma,BRD-A28970875-300-04-9::2.5::HTS,5.023350967131493,0.025413976513462506,Other Types,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Melanoma,BRD-A29731977-001-04-5::2.5::HTS,5.024681219169804,0.02538008621003883,Melanoma,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Melanoma,BRD-A31990649-304-02-3::2.5::HTS,5.526007607309919,0.019102676402940437,Melanoma,adenosine-triphosphate,adenosine receptor agonist,"ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7"
Melanoma,BRD-A34255068-001-34-5::2.5::HTS,9.563418022720754,0.002084873904811315,Melanoma,rolipram,phosphodiesterase inhibitor,
Melanoma,BRD-A36057565-001-01-0::2.5::HTS,10.407556220191726,0.001329337697402704,Other Types,bruceantin,protein synthesis inhibitor,
Melanoma,BRD-A36318220-001-08-8::2.5::HTS,8.193344661856687,0.004362008200086485,Other Types,necrostatin-1,RIPK inhibitor,RIPK1
Melanoma,BRD-A36331462-001-02-1::2.5::HTS,5.573671912980118,0.018579109657369662,Other Types,oprozomib,proteasome inhibitor,
Melanoma,BRD-A37441042-003-04-8::2.5::HTS,6.388818043057013,0.011759082718640339,Melanoma,tulobuterol,adrenergic receptor agonist,ADRB2
Melanoma,BRD-A39935389-001-05-9::2.5::HTS,6.480066643244024,0.011176469806368826,Melanoma,teroxirone,DNA inhibitor,
Melanoma,BRD-A40084411-003-07-7::2.5::HTS,6.437713306326843,0.011449355407044665,Melanoma,CGP-12177,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Melanoma,BRD-A44500574-001-01-8::2.5::HTS,4.493749917323789,0.03445976828494147,Other Types,FLI-06,notch signaling inhibitor,
Melanoma,BRD-A45889380-300-07-1::2.5::HTS,19.554825171755198,1.1800615345078878e-05,Melanoma,mepacrine,"cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B, PLA2G4A, PLA2G6, PLCL1"
Melanoma,BRD-A48237631-001-04-8::2.5::HTS,7.633986518417164,0.005918916199745246,Other Types,mitomycin-c,"DNA alkylating agent, DNA synthesis inhibitor",
Melanoma,BRD-A50049929-001-01-9::2.5::HTS,6.025014341912194,0.014410985971444523,Melanoma,oxazepam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3"
Melanoma,BRD-A51964809-003-12-6::2.5::HTS,5.336662066431821,0.021242783073487214,Melanoma,halofantrine,antimalarial agent,"KCNH2, KCNN4"
Melanoma,BRD-A52922642-001-03-7::2.5::HTS,4.352838793042183,0.037397552263882264,Melanoma,gallopamil,L-type calcium channel blocker,ATP2A2
Melanoma,BRD-A53539450-004-01-7::2.5::HTS,5.733373915138578,0.016973260105171608,Melanoma,neo-gilurytmal,,
Melanoma,BRD-A55393291-001-09-9::2.5::HTS,7.353963190522214,0.006897065017030146,Other Types,testosterone,androgen receptor agonist,AR
Melanoma,BRD-A56085258-001-01-8::2.5::HTS,189.48935225800008,2.4115961782121902e-37,Other Types,LGX818,RAF inhibitor,BRAF
Melanoma,BRD-A57798112-001-03-7::2.5::HTS,60.544827946568546,3.5134613001460775e-14,Other Types,PD-318088,MEK inhibitor,MAP2K1
Melanoma,BRD-A57886255-001-01-1::2.5::HTS,19.238803942192252,1.379633616734727e-05,Other Types,golgicide-a,ARF inhibitor,GBF1
Melanoma,BRD-A61221616-001-04-3::2.5::HTS,3.8813260828106024,0.049316506239959666,Other Types,medroxyprogesterone-acetate,progesterone receptor agonist,
Melanoma,BRD-A65440446-001-04-1::2.5::HTS,5.594975499230603,0.01835554553187469,Melanoma,cimaterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Melanoma,BRD-A66419424-001-02-4::2.5::HTS,5.735611039766207,0.016956641770232966,Other Types,ixazomib-citrate,proteasome inhibitor,
Melanoma,BRD-A67101513-001-03-7::2.5::HTS,6.305947145036643,0.01231482112837636,Melanoma,hygromycin-b,polypeptide synthesis inhibitor,
Melanoma,BRD-A68509429-003-03-9::2.5::HTS,5.7104952916281455,0.017194724905207615,Melanoma,ethylnorepinephrine,bronchodilator,
Melanoma,BRD-A68969091-001-12-7::2.57::HTS,5.954486756251558,0.014996864499848746,Other Types,echinomycin,DNA intercalating agent,
Melanoma,BRD-A70083328-001-23-5::2.5::HTS,5.161885084074,0.023471024771442053,Other Types,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Melanoma,BRD-A70649075-008-30-8::2.5::HTS,5.857248706090957,0.0158313787965395,Melanoma,sulconazole,sterol demethylase inhibitor,
Melanoma,BRD-A72716251-001-01-5::0.91::HTS,4.75076590693785,0.029705630357822626,Other Types,peruvoside,cardiac glycoside,
Melanoma,BRD-A73871920-236-03-6::2.5::HTS,16.367106928110353,5.955313177051141e-05,Other Types,nanchangmycin,other antibiotic,
Melanoma,BRD-A81370665-001-03-6::2.5::HTS,11.048910161608111,0.000945180280037974,Melanoma,BI-D1870,ribosomal protein inhibitor,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6"
Melanoma,BRD-A84575140-001-02-4::2.5::HTS,4.964931227261706,0.026272833279473454,Melanoma,pimobendan,"calcium sensitizer, phosphodiesterase inhibitor",PDE3A
Melanoma,BRD-A86414188-003-01-5::2.5::HTS,10.281300256537655,0.001421349876173359,Melanoma,ractopamine,adrenergic receptor agonist,
Melanoma,BRD-A87479750-001-02-7::2.5::HTS,3.9136106097940067,0.04838798910912896,Other Types,tenidap,cyclooxygenase inhibitor,"KCNJ4, PTGS1"
Melanoma,BRD-A90695733-001-07-4::2.5::HTS,4.566523521701364,0.03303919830249778,Melanoma,manidipine,calcium channel blocker,"CACNA1C, CACNA1D"
Melanoma,BRD-A91699651-316-10-9::2.5::HTS,3.983335453646147,0.04643721346003701,Melanoma,chloroquine,antimalarial agent,"GSTA2, MRGPRX1, TLR9, TNF"
Melanoma,BRD-A92537424-001-04-7::2.5::HTS,17.348552799949026,3.600770892021673e-05,Other Types,danazol,"estrogen receptor antagonist, progesterone receptor agonist","AR, CCL2, ESR1, GNRHR, GNRHR2, PGR"
Melanoma,BRD-A92933783-050-01-6::2.5::HTS,4.230842328900343,0.040165082943721855,Melanoma,SM-21,sigma receptor antagonist,PGRMC1
Melanoma,BRD-A93093700-001-02-9::2.5::HTS,4.427237715275363,0.035813319146471886,Other Types,temazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Melanoma,BRD-A93407926-001-01-1::2.5::HTS,4.053907902706732,0.044554064891873066,Melanoma,allopurinol-riboside,anti-leishmanial agent,
Melanoma,BRD-A94543220-001-24-7::2.5::HTS,4.673968363964566,0.03104444762868982,Melanoma,bifonazole,sterol demethylase inhibitor,CYP2B6
Melanoma,BRD-A94624445-236-17-0::2.5::HTS,4.466031890304026,0.03504019393142482,Melanoma,bucladesine,"adenosine receptor agonist, cAMP stimulant",PRKACA
Melanoma,BRD-A99833829-003-27-1::2.5::HTS,4.320871725587668,0.038129916537993906,Melanoma,bethanechol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Melanoma,BRD-K00317371-001-06-1::2.4::HTS,7.042703311077823,0.008198775292411625,Melanoma,RITA,MDM inhibitor,MDM2
Melanoma,BRD-K00535541-001-06-3::2.5::HTS,4.148016883486542,0.04218166930870194,Other Types,9-aminoacridine,,
Melanoma,BRD-K00627859-003-03-7::2.5::HTS,5.100872502962062,0.024299121987175445,Melanoma,tubastatin-a,HDAC inhibitor,HDAC6
Melanoma,BRD-K01095011-001-15-9::2.5::HTS,7.308894485774377,0.007075235384167592,Melanoma,finasteride,5 alpha reductase inhibitor,"AKR1D1, SRD5A1, SRD5A2"
Melanoma,BRD-K01649396-003-07-1::2.5::HTS,8.210754434782922,0.004320961894094895,Melanoma,indatraline,norepinephrine transporter inhibitor,"MAOA, MAOB"
Melanoma,BRD-K01773560-001-02-4::2.59::HTS,4.174174597750096,0.041531272439362533,Melanoma,UNC2250,MER tyrosine kinase inhibitor,MERTK
Melanoma,BRD-K02017404-300-06-2::2.5::HTS,6.462117878017495,0.011289066643788117,Melanoma,NVP-BSK805,JAK inhibitor,JAK2
Melanoma,BRD-K02113016-001-15-4::2.5::HTS,4.590015647763096,0.03259310518896272,Melanoma,olaparib,PARP inhibitor,"PARP1, PARP2"
Melanoma,BRD-K02123250-001-06-7::2.5::HTS,4.122008030714059,0.042806882348350624,Melanoma,JNJ-38877605,tyrosine kinase inhibitor,MET
Melanoma,BRD-K02703275-001-07-5::2.5::HTS,18.566908856829166,1.9411972572381206e-05,Other Types,gedunin,HSP inhibitor,HSP90AA1
Melanoma,BRD-K02715688-001-02-1::2.5::HTS,5.366207995602422,0.020892523186601075,Melanoma,"hydrastine-(1r,-9s)",tyrosine hydroxylase inhibitor,
Melanoma,BRD-K02965346-001-07-5::2.5::HTS,5.037490815820893,0.02519831687804361,Melanoma,SU-11274,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET
Melanoma,BRD-K03109492-001-02-2::2.5::HTS,28.425398337060802,1.4200925776239775e-07,Other Types,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Melanoma,BRD-K03194791-001-04-8::2.5::HTS,9.015764890943275,0.0027973706500239934,Melanoma,roflumilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Melanoma,BRD-K03289018-001-02-7::2.5::HTS,6.362570768329576,0.011930266653236179,Other Types,CCT137690,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Melanoma,BRD-K03294269-001-08-0::2.5::HTS,8.91876024577573,0.00294558289162712,Melanoma,NU6027,CDK inhibitor,"CCNA2, CDK2"
Melanoma,BRD-K03390685-001-01-7::2.5::HTS,24.232777958187153,1.1279131160409474e-06,Other Types,cobimetinib,MEK inhibitor,
Melanoma,BRD-K04394237-001-03-7::2.49::HTS,5.080541924887291,0.024605798288707747,Other Types,drospirenone,mineralocorticoid receptor antagonist,"AR, NR3C2, PGR"
Melanoma,BRD-K04430056-236-02-1::2.5::HTS,5.7840172368303495,0.016500685034708452,Other Types,7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Melanoma,BRD-K04548931-003-16-5::2.5::HTS,12.033979962681157,0.0005624315125867872,Other Types,epirubicin,topoisomerase inhibitor,"CHD1, TOP2A"
Melanoma,BRD-K04568635-300-01-4::2.5::HTS,28.192615077328906,1.5942775848457777e-07,Other Types,octenidine,membrane integrity inhibitor,
Melanoma,BRD-K04833372-001-06-2::2.5::HTS,5.651742261407956,0.01777652088022332,Melanoma,GSK1904529A,"IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR"
Melanoma,BRD-K04956647-003-02-5::2.5::HTS,5.344161124674699,0.021155726466009394,Melanoma,nebivolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Melanoma,BRD-K05104363-001-10-0::2.5::HTS,49.05105807766462,7.459908326965227e-12,Other Types,PD-184352,MEK inhibitor,"MAP2K1, MAP3K1, MAP3K2"
Melanoma,BRD-K05434375-001-06-5::2.5::HTS,6.749372895083072,0.009626192736799436,Melanoma,HA-1004,calcium channel blocker,
Melanoma,BRD-K05674516-001-02-5::2.5::HTS,9.268971282315407,0.002440788680496236,Other Types,sofosbuvir,RNA polymerase inhibitor,
Melanoma,BRD-K05804044-001-06-0::2.5::HTS,126.64343399033845,1.2948029169836458e-26,Other Types,AZ-628,RAF inhibitor,"BRAF, RAF1"
Melanoma,BRD-K06426971-001-02-7::2.5::HTS,10.7404567568407,0.0011133486758008325,Other Types,ryuvidine,histone lysine methyltransferase inhibitor,"CDK2, CDK4"
Melanoma,BRD-K06542892-001-01-9::2.5::HTS,4.51057856949405,0.03413150868240206,Melanoma,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Melanoma,BRD-K06543683-066-02-1::2.5::HTS,6.809849239599053,0.009308500040811463,Other Types,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Melanoma,BRD-K06749501-001-02-1::2.5::HTS,16.49392245307783,5.579372864837098e-05,Other Types,GSK1838705A,insulin growth factor receptor inhibitor,"ALK, IGF1R, INSR, RPS6KA1"
Melanoma,BRD-K07106112-003-03-8::2.5::HTS,20.19645099818242,8.503584186767662e-06,Melanoma,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Melanoma,BRD-K07265709-003-05-6::2.61::HTS,4.342360001230583,0.03765562096635135,Melanoma,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Melanoma,BRD-K07310275-001-02-5::2.5::HTS,5.418959692393778,0.02027645795357268,Other Types,PF-04691502,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Melanoma,BRD-K07487750-001-03-3::2.5::HTS,10.910461176067946,0.0010174688579877153,Melanoma,WHI-P154,JAK inhibitor,"EGFR, JAK1, JAK2, JAK3"
Melanoma,BRD-K07881437-001-04-6::2.41::HTS,16.484844056219394,5.647261974317499e-05,Melanoma,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Melanoma,BRD-K08037784-001-12-6::2.5::HTS,6.60135848273097,0.010457906941515684,Other Types,arbutin,melanin inhibitor,TYR
Melanoma,BRD-K08078237-001-19-8::2.5::HTS,25.049751088725543,7.623931124347903e-07,Other Types,tetrandrine,calcium channel blocker,SLC6A3
Melanoma,BRD-K08248804-001-01-8::2.5::HTS,19.277925845504836,1.3605388664466944e-05,Other Types,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Melanoma,BRD-K08542803-001-03-1::0.8::HTS,9.295481284434857,0.002406296990315213,Other Types,gambogic-acid,caspase activator,BCL2
Melanoma,BRD-K08619574-334-05-4::2.5::HTS,4.152658433844457,0.042038658862187286,Melanoma,thioproperazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A"
Melanoma,BRD-K08799216-001-05-3::2.5::HTS,5.009532961956175,0.02561566311366775,Melanoma,pelitinib,EGFR inhibitor,EGFR
Melanoma,BRD-K08953028-001-09-6::2.5::HTS,6.117143830048179,0.01368651720030958,Melanoma,U-0521,catechol O methyltransferase inhibitor,COMT
Melanoma,BRD-K08999871-213-01-5::2.5::HTS,4.5601650114017405,0.03316825300295116,Melanoma,pipemidic-acid,topoisomerase inhibitor,
Melanoma,BRD-K09090523-001-02-1::2.5::HTS,6.470324154382933,0.01123766391692516,Melanoma,firocoxib,cyclooxygenase inhibitor,PTGS2
Melanoma,BRD-K09353376-001-03-9::2.5::HTS,9.311037240984458,0.0023923283373444002,Melanoma,tariquidar,P glycoprotein inhibitor,ABCB1
Melanoma,BRD-K09416995-001-39-9::2.5::HTS,13.431908653132663,0.0002710389292931887,Other Types,lovastatin,HMGCR inhibitor,"HDAC2, HMGCR, ITGAL, NR1I2"
Melanoma,BRD-K09602097-001-13-6::2.5::HTS,7.8085084609413835,0.005385226815277245,Melanoma,forskolin,adenylyl cyclase activator,"ADCY2, ADCY5, GNAS"
Melanoma,BRD-K09711437-001-04-3::2.5::HTS,6.7053248018188,0.009872345156198654,Other Types,varespladib,secretory phospholipase inhibitor,PLA2G2A
Melanoma,BRD-K09900591-001-26-7::2.5::HTS,7.6344169089412475,0.005926276370251022,Other Types,caffeic-acid,"HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF"
Melanoma,BRD-K09951645-001-06-8::2.5::HTS,112.04495868388052,6.445948246109837e-24,Other Types,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Melanoma,BRD-K10575656-034-01-0::2.5::HTS,4.926514561377161,0.026851760605216605,Melanoma,MRS3777,adenosine receptor antagonist,ADORA2A
Melanoma,BRD-K10705233-001-02-2::2.5::HTS,4.64240480707804,0.03162162223787838,Other Types,GW-405833,cannabinoid receptor agonist,CNR2
Melanoma,BRD-K10799896-001-26-2::2.5::HTS,4.02931623798795,0.04519692001354514,Melanoma,clobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Melanoma,BRD-K10852020-001-04-5::2.5::HTS,4.909217804774375,0.02713079756561306,Other Types,tolcapone,catechol O methyltransferase inhibitor,COMT
Melanoma,BRD-K11267252-001-04-4::2.5::HTS,3.8854393028923786,0.0492176458548516,Melanoma,alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Melanoma,BRD-K11399644-003-11-3::2.5::HTS,5.516911895111821,0.01919433775862031,Melanoma,phenformin,AMPK activator,"KCNJ8, PRKAA1"
Melanoma,BRD-K11433652-001-17-0::2.5::HTS,6.192153835596193,0.01313265151044731,Other Types,aspirin,cyclooxygenase inhibitor,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53"
Melanoma,BRD-K11558771-001-13-9::2.5::HTS,4.261799493574381,0.03944017573461149,Melanoma,droxinostat,HDAC inhibitor,"HDAC6, HDAC8"
Melanoma,BRD-K11911061-003-11-9::2.5::HTS,8.219589818219836,0.004300000647186753,Melanoma,GR-127935,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6"
Melanoma,BRD-K12244279-001-05-8::2.5::HTS,6.3747317703476565,0.011853693813548224,Other Types,MEK1-2-inhibitor,MEK inhibitor,MAP2K2
Melanoma,BRD-K12343256-001-08-9::2.5::HTS,24.6052972023148,9.353751972343101e-07,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Melanoma,BRD-K12609457-001-03-1::2.5::HTS,4.497844477424608,0.034393575317543314,Melanoma,exalamide,membrane permeability inhibitor,
Melanoma,BRD-K12787259-001-04-3::2.5::HTS,8.507132327513045,0.003684963295262703,Melanoma,CX-5461,RNA polymerase inhibitor,
Melanoma,BRD-K12829205-003-02-8::2.5::HTS,10.69378939018357,0.0011450747435749974,Melanoma,mechlorethamine,DNA inhibitor,
Melanoma,BRD-K13050541-001-01-9::2.8::HTS,5.202270062195615,0.02293622523333106,Other Types,acivicin,gamma glutamyltransferase Inhibitors,CTPS1
Melanoma,BRD-K13167095-001-02-9::2.5::HTS,10.33588277110726,0.0013795810054424284,Other Types,AR-42,HDAC inhibitor,HDAC1
Melanoma,BRD-K13183738-317-10-2::2.5::HTS,10.385418792325783,0.0013443857120304186,Other Types,pentamidine,anti-pneumocystis agent,TRDMT1
Melanoma,BRD-K13238168-001-02-0::2.5::HTS,6.055715594494592,0.014160923144417296,Other Types,haloprogin,other antifungal,
Melanoma,BRD-K13314656-001-01-0::2.5::HTS,13.783437411697161,0.00022627756984609201,Melanoma,ebastine,histamine receptor antagonist,"CYP3A4, HRH1"
Melanoma,BRD-K13387373-004-14-5::2.5::HTS,6.581382899496999,0.010567114446742196,Other Types,thonzonium,ATPase inhibitor,
Melanoma,BRD-K13390322-001-06-3::2.5::HTS,5.936369190502862,0.0151500843420947,Other Types,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Melanoma,BRD-K13662825-001-07-5::2.5::HTS,7.728763648445226,0.005616875628651033,Other Types,dinaciclib,CDK inhibitor,"CDK1, CDK2, CDK5, CDK9"
Melanoma,BRD-K13810148-311-03-2::2.5::HTS,6.507871278238628,0.011003629516682283,Other Types,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Melanoma,BRD-K13949769-001-01-7::2.5::HTS,6.859875511737128,0.009053262258137913,Melanoma,tenovin-6,SIRT inhibitor,"SIRT1, SIRT2, SIRT3"
Melanoma,BRD-K14395568-001-16-3::2.5::HTS,4.2526309810076945,0.03965528962626246,Melanoma,NECA,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1"
Melanoma,BRD-K14496212-066-04-8::2.5::HTS,4.971615467568071,0.026172435093800826,Melanoma,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Melanoma,BRD-K14870255-001-02-3::2.5::HTS,4.756105534634036,0.029608426350536572,Melanoma,R-428,AXL kinase inhibitor,AXL
Melanoma,BRD-K15010214-364-02-7::2.5::HTS,3.919326439192475,0.0482431928047538,Other Types,emedastine,histamine receptor antagonist,HRH1
Melanoma,BRD-K15424032-001-03-6::2.5::HTS,4.214096422134192,0.04056024718245491,Melanoma,SB-228357,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Melanoma,BRD-K15600710-066-04-1::2.5::HTS,3.965402237559145,0.04693504522635386,Other Types,obatoclax,BCL inhibitor,BCL2
Melanoma,BRD-K16478699-001-09-2::2.5::HTS,91.74210469076213,3.2731926158398444e-20,Other Types,PLX-4720,RAF inhibitor,"BRAF, KDR"
Melanoma,BRD-K16485616-001-08-9::2.5::HTS,6.073416220068931,0.014025567339575357,Other Types,mocetinostat,HDAC inhibitor,"HDAC1, HDAC11, HDAC2, HDAC3"
Melanoma,BRD-K16508793-001-05-9::2.5::HTS,7.664437726975991,0.005818821793294531,Melanoma,diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Melanoma,BRD-K16664969-001-03-3::2.5::HTS,7.170961415899876,0.007629136176247264,Other Types,GTP-14564,"FLT3 inhibitor, tyrosine kinase inhibitor","CSF1R, FLT3, KIT, PDGFRB"
Melanoma,BRD-K16730910-001-07-3::2.5::HTS,11.195778730079445,0.0008747790946800286,Other Types,regorafenib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK"
Melanoma,BRD-K16803204-001-01-6::2.5::HTS,10.6067546738618,0.0011949133812865656,Melanoma,filgotinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Melanoma,BRD-K17026858-001-01-2::2.5::HTS,7.267216418992926,0.0072370636085577105,Other Types,pibenzimol,DNA inhibitor,
Melanoma,BRD-K17203476-001-01-9::2.5::HTS,15.67629019641424,8.484621307007819e-05,Melanoma,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Melanoma,BRD-K17561142-003-32-5::2.5::HTS,3.9743163665915486,0.04668382045878818,Melanoma,amiodarone,potassium channel blocker,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2"
Melanoma,BRD-K17565903-066-23-1::2.5::HTS,5.897893297492773,0.015474483146933893,Melanoma,pridinol,muscle relaxant,
Melanoma,BRD-K17702546-001-03-2::2.5::HTS,27.054881582127056,2.7747830951549565e-07,Melanoma,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Melanoma,BRD-K17705806-003-04-4::2.5::HTS,25.857160808521613,5.021641869980765e-07,Other Types,JTC-801,opioid receptor antagonist,OPRL1
Melanoma,BRD-K17743697-066-03-6::2.5::HTS,4.380533698660545,0.036807515764782694,Other Types,KB-R7943,sodium/calcium exchange inhibitor,"SLC8A1, TRPC3, TRPC5, TRPC6"
Melanoma,BRD-K17894950-001-14-3::2.5::HTS,4.157178116580672,0.04192747560142834,Other Types,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A"
Melanoma,BRD-K18787491-001-08-6::2.5::HTS,28.165097355128285,1.6138879319600584e-07,Other Types,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Melanoma,BRD-K18849474-001-04-4::2.61::HTS,4.147793123906954,0.04218719880824206,Melanoma,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Melanoma,BRD-K18910433-001-36-6::2.58::HTS,5.008866536775467,0.025633943415177565,Other Types,estradiol,estrogen receptor agonist,"ESR1, ESR2, GPER1, KCNMA1, NR1I2"
Melanoma,BRD-K19085898-001-01-8::2.5::HTS,7.479517007382413,0.006440316671611738,Other Types,darapladib,phospholipase inhibitor,PLA2G7
Melanoma,BRD-K19540840-001-09-4::2.5::HTS,33.42750519549635,1.2277924416741907e-08,Melanoma,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Melanoma,BRD-K19601669-001-03-5::2.5::HTS,7.426592671324559,0.006626942545686546,Melanoma,ruxolitinib-(S),JAK inhibitor,"JAK1, JAK2"
Melanoma,BRD-K19605405-001-02-7::2.5::HTS,7.25027166277066,0.007302418919540941,Melanoma,ZM-241385,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Melanoma,BRD-K19669037-001-01-1::2.5::HTS,27.915176665573682,1.83561882467379e-07,Other Types,GGTI-298,GGTase inhibitor,CDKN1A
Melanoma,BRD-K19687926-379-07-4::2.5::HTS,22.95636126482766,2.1271620854333558e-06,Melanoma,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K20285085-001-07-1::2.5::HTS,24.102658790247528,1.2123485587802338e-06,Melanoma,R406,SYK inhibitor,"RET, SYK"
Melanoma,BRD-K20285085-074-04-5::2.5::HTS,37.0968717036338,2.1664534032371775e-09,Melanoma,R406,SYK inhibitor,"RET, SYK"
Melanoma,BRD-K20482099-001-11-0::2.5::HTS,4.36903074102088,0.03704660665330436,Other Types,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Melanoma,BRD-K20722021-001-02-1::2.5::HTS,41.73031889139323,2.3438808105527327e-10,Other Types,CEP-32496,RAF inhibitor,"BRAF, RAF1"
Melanoma,BRD-K20742498-003-02-9::2.5::HTS,5.989462947983399,0.014698804466254553,Melanoma,RS-39604,serotonin receptor antagonist,HTR4
Melanoma,BRD-K20897876-001-10-0::2.5::HTS,5.1390560416937,0.023777961480519624,Melanoma,castanospermine,glucosidase inhibitor,"GAA, GBA"
Melanoma,BRD-K21361524-001-01-1::2.5::HTS,4.91162645984798,0.027076250980398,Other Types,selinexor,exportin antagonist,XPO1
Melanoma,BRD-K21680192-300-14-4::2.5::HTS,4.802549985472573,0.028833240439149626,Other Types,mitoxantrone,topoisomerase inhibitor,TOP2A
Melanoma,BRD-K21867462-001-02-9::2.5::HTS,4.728284622078546,0.030092909465121574,Other Types,GSK2816126,histone lysine methyltransferase inhibitor,EZH2
Melanoma,BRD-K22025381-003-01-9::2.5::HTS,9.340317964136133,0.002348696776001355,Melanoma,U-18666A,oxidosqualene cyclase inhibitor,
Melanoma,BRD-K22031190-001-23-6::2.5::HTS,4.340494206580722,0.037671511949548674,Other Types,diflunisal,prostanoid receptor antagonist,"PTGS1, PTGS2"
Melanoma,BRD-K22134346-001-22-3::2.5::HTS,9.690577758615408,0.001950438306578919,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Melanoma,BRD-K22385716-001-02-5::2.5::HTS,14.490718647150738,0.00015656448473733335,Other Types,LY303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","BRD2, BRD3, BRD4"
Melanoma,BRD-K22749967-046-02-3::2.5::HTS,8.823103975188896,0.0031026349034516468,Melanoma,ABT-239,histamine receptor antagonist,"HRH1, HRH2, HRH3"
Melanoma,BRD-K22822991-001-02-3::2.5::HTS,3.9199508478954024,0.048224467757304205,Other Types,odanacatib,cathepsin inhibitor,CTSK
Melanoma,BRD-K23082237-003-01-5::2.5::HTS,5.16717327486516,0.023399663420562638,Melanoma,butaclamol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A"
Melanoma,BRD-K23190681-001-01-1::2.5::HTS,15.457774187093246,9.506204984697615e-05,Melanoma,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K23248433-001-01-8::2.5::HTS,27.01062529874317,2.8377123983864155e-07,Other Types,camicinal,motilin receptor agonist,MLNR
Melanoma,BRD-K23403298-003-01-9::2.5::HTS,13.458120740889843,0.00026785351149576276,Melanoma,benzyldimethylhexadecylammonium,cationic surfactant,
Melanoma,BRD-K23779958-001-05-8::2.5::HTS,4.831835902529389,0.02837212674285456,Other Types,dichlorvos,acetylcholinesterase inhibitor,
Melanoma,BRD-K23925186-001-01-0::2.5::HTS,9.772707000935805,0.0018640792466304132,Other Types,oridonin,BCL inhibitor,BCL2
Melanoma,BRD-K23925186-001-02-8::2.51::HTS,10.070458126127985,0.001594403395188846,Other Types,oridonin,BCL inhibitor,BCL2
Melanoma,BRD-K24242599-001-02-8::2.5::HTS,7.6351371296517065,0.005912784256736042,Melanoma,GW-2580,cFMS kinase inhibitor,CSF1R
Melanoma,BRD-K24556098-001-16-7::2.45::HTS,8.45179878575537,0.003800114146260167,Other Types,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Melanoma,BRD-K24556098-001-19-1::2.5::HTS,6.159280894486408,0.013366199299456635,Other Types,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Melanoma,BRD-K24556407-001-02-3::2.5::HTS,4.348611203851987,0.03749217648144989,Melanoma,ETP-46464,ATR kinase inhibitor,
Melanoma,BRD-K24593301-001-02-3::2.54::HTS,6.6294105660131954,0.010302041154259449,Other Types,AZD3463,"ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor","ALK, IGF1R"
Melanoma,BRD-K24603946-001-02-1::2.5::HTS,4.020041410818208,0.04544511692725147,Other Types,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3
Melanoma,BRD-K24844714-001-24-5::2.5::HTS,6.939206459863755,0.008675050699689841,Melanoma,5-fluorouracil,thymidylate synthase inhibitor,"DPYD, TYMS"
Melanoma,BRD-K24869513-001-02-1::2.5::HTS,7.015503528702773,0.008307841590096414,Melanoma,CNX-2006,EGFR inhibitor,EGFR
Melanoma,BRD-K25186396-001-09-6::2.5::HTS,8.444205035174507,0.003808476258242153,Melanoma,tangeritin,cell cycle inhibitor,
Melanoma,BRD-K25279140-001-01-5::2.5::HTS,8.162151706901668,0.004444072244172004,Melanoma,MK-8745,Aurora kinase inhibitor,AURKA
Melanoma,BRD-K25412176-001-01-9::2.5::HTS,3.9667957789961505,0.04689650237244198,Melanoma,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Melanoma,BRD-K25630527-001-03-8::2.5::HTS,11.209630703953522,0.0008682033541119858,Melanoma,LY2784544,JAK inhibitor,"JAK2, JAK3"
Melanoma,BRD-K25991633-001-01-9::2.5::HTS,4.033590280214235,0.04508952119097256,Other Types,BMS-649,retinoid receptor agonist,RXRA
Melanoma,BRD-K26531771-001-02-2::2.35::HTS,9.671640284706392,0.0019723740066900676,Melanoma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Melanoma,BRD-K26548821-003-10-5::2.5::HTS,7.4634043823695455,0.006496336394722339,Melanoma,quinpirol-(-),dopamine receptor agonist,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C"
Melanoma,BRD-K26603252-003-04-9::2.5::HTS,18.597737674367487,1.9156952289460623e-05,Melanoma,PD-153035,EGFR inhibitor,"EGFR, KDR"
Melanoma,BRD-K26657438-001-15-2::2.5::HTS,4.340371036785879,0.037672583989324,Melanoma,imiquimod,"interferon inducer, toll-like receptor agonist","TLR7, TLR8"
Melanoma,BRD-K26667523-001-02-5::2.5::HTS,18.316264220556718,2.2046677582683154e-05,Other Types,TAK-733,MEK inhibitor,MAP2K1
Melanoma,BRD-K26818574-305-04-3::2.5::HTS,71.01839804472633,3.0096023010884587e-16,Other Types,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Melanoma,BRD-K26838195-075-04-9::2.5::HTS,23.544950883233646,1.582816002215112e-06,Melanoma,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K26989966-001-03-5::2.5::HTS,17.631454567606877,3.120251645853497e-05,Melanoma,UNC1999,histone lysine methyltransferase inhibitor,EZH2
Melanoma,BRD-K27062708-001-23-1::2.5::HTS,4.5127327588270525,0.034085692778283674,Melanoma,chlorotrianisene,estrogenic hormone,"ESR1, ESR2"
Melanoma,BRD-K27135764-001-08-7::2.5::HTS,4.801682093431947,0.028847638915109743,Melanoma,xanthone,antimalarial agent,
Melanoma,BRD-K27382019-418-01-9::2.5::HTS,7.434866491853005,0.006600590454354203,Melanoma,piperaquine-phosphate,antimalarial agent,
Melanoma,BRD-K28352084-001-02-3::2.5::HTS,20.356037485496156,7.843359580332684e-06,Melanoma,CH5132799,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Melanoma,BRD-K28965160-001-01-1::2.5::HTS,35.61564586280492,4.291844191849052e-09,Other Types,BVD-523,MAP kinase inhibitor,
Melanoma,BRD-K29254801-001-14-7::2.5::HTS,5.434200875785298,0.02010199504807816,Other Types,thiram,,JAK2
Melanoma,BRD-K29415052-050-04-8::2.5::HTS,6.0625590005013965,0.014106751425945063,Other Types,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Melanoma,BRD-K29656036-001-02-5::2.5::HTS,4.941368755254292,0.026620434758098194,Melanoma,MK-8245,stearoyl-CoA desaturase inhibitor,SCD
Melanoma,BRD-K29918010-003-04-1::2.5::HTS,8.51522922077178,0.003664062705303258,Other Types,glucosamine,glycosylated protein precursor,"IFNG, IL1B, MMP9, NFKB2, TNF"
Melanoma,BRD-K31086665-005-04-6::2.5::HTS,14.685687572740337,0.0001414179777015146,Other Types,NH125,eukaryotic translation elongation factor 2 inhibitor,
Melanoma,BRD-K31092604-003-03-5::2.5::HTS,4.128380381327069,0.042646347946955335,Melanoma,donitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6"
Melanoma,BRD-K31283835-048-04-4::2.5::HTS,12.4504766328639,0.00045277691367180017,Melanoma,tofacitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Melanoma,BRD-K31309378-001-01-5::2.5::HTS,6.6898898751524625,0.00995092170611802,Melanoma,lucitanib,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Melanoma,BRD-K31866293-001-01-6::2.5::HTS,70.91137765434027,3.169181651609753e-16,Other Types,TAK-632,RAF inhibitor,BRAF
Melanoma,BRD-K32285926-001-02-1::2.5::HTS,6.040248000048437,0.014289627089090127,Melanoma,AMG-208,tyrosine kinase inhibitor,MET
Melanoma,BRD-K32289541-001-01-0::2.5::HTS,4.039828958779583,0.0449191549737055,Melanoma,EHop-016,Ras GTPase inhibitor,"RAC1, RAC3"
Melanoma,BRD-K32730239-001-01-0::2.5::HTS,12.463727818322516,0.0004491377380149214,Other Types,SU3327,JNK inhibitor,MAPK8
Melanoma,BRD-K33425534-001-12-5::2.5::HTS,8.986132875641548,0.0028427971311385716,Other Types,exemestane,aromatase inhibitor,CYP19A1
Melanoma,BRD-K34154330-003-06-4::2.5::HTS,12.273767953084128,0.000496069891061052,Melanoma,tracazolate,GABA receptor modulator,GABRA1
Melanoma,BRD-K34328244-001-01-4::2.5::HTS,5.287772859139948,0.02184140032962554,Melanoma,MF-101,estrogen receptor agonist,"CYP19A1, XDH"
Melanoma,BRD-K34411947-001-12-5::2.5::HTS,4.925828184145437,0.026860150309357803,Other Types,streptozotocin,DNA alkylating agent,SLC2A2
Melanoma,BRD-K34663752-001-09-1::2.5::HTS,4.520353612863588,0.03393228721695597,Other Types,6-chloromelatonin,melatonin receptor agonist,"MTNR1A, MTNR1B"
Melanoma,BRD-K35189033-001-26-1::2.5::HTS,4.501687871627024,0.034299911832178016,Other Types,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Melanoma,BRD-K35952844-238-01-2::2.5::HTS,4.266413550896758,0.039345064887243805,Melanoma,calcium-gluceptate,,
Melanoma,BRD-K36198571-001-02-0::2.5::HTS,5.994512908552666,0.014673516333939686,Melanoma,WAY-170523,metalloproteinase inhibitor,MMP13
Melanoma,BRD-K36467523-001-02-8::2.5::HTS,5.012725499031876,0.02555930560620826,Melanoma,bindarit,NFkB pathway inhibitor,"CCL2, CCL7, CCL8"
Melanoma,BRD-K36756879-003-08-7::2.5::HTS,17.08231007698962,4.131362797479134e-05,Melanoma,ethaverine,calcium channel blocker,
Melanoma,BRD-K36775483-001-01-4::2.5::HTS,4.79180621341006,0.02901201131794528,Melanoma,DMeOB,,GRM5
Melanoma,BRD-K36788280-001-01-2::2.5::HTS,8.132277742237713,0.004510622152453673,Other Types,ribociclib,CDK inhibitor,"CDK4, CDK6"
Melanoma,BRD-K36965586-003-08-8::2.5::HTS,10.49215467099779,0.0012701321681969212,Melanoma,m-Chlorophenylbiguanide,,"HTR3A, HTR3B"
Melanoma,BRD-K37249724-001-25-7::2.5::HTS,7.748168713767057,0.005558970389503312,Melanoma,astemizole,histamine receptor antagonist,"HRH1, KCNH1, KCNH2"
Melanoma,BRD-K37516142-001-10-5::2.5::HTS,6.669955274476809,0.010059145431712407,Other Types,idebenone,calcium channel modulator,
Melanoma,BRD-K37561857-001-15-5::2.5::HTS,22.129842891904765,3.2325227814967864e-06,Other Types,zardaverine,phosphodiesterase inhibitor,PDE4D
Melanoma,BRD-K37590257-001-02-8::2.5::HTS,10.009880445327395,0.0016436838799605957,Melanoma,GSK256066,phosphodiesterase inhibitor,PDE4A
Melanoma,BRD-K37687095-001-06-9::2.5::HTS,24.986394665512243,7.725069043335724e-07,Other Types,AZD8330,MEK inhibitor,
Melanoma,BRD-K37720887-001-07-8::2.5::HTS,30.66517526856831,4.730638062578825e-08,Other Types,SB-525334,TGF beta receptor inhibitor,TGFBR1
Melanoma,BRD-K38055836-001-21-1::2.5::HTS,5.008443963055663,0.02561771839465326,Melanoma,ethamivan,respiratory stimulant,
Melanoma,BRD-K38332599-001-01-3::2.5::HTS,6.314896239343936,0.012253021851410927,Other Types,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Melanoma,BRD-K38370968-050-01-3::2.5::HTS,8.146726163809817,0.0044753479285362715,Melanoma,3-AQC,serotonin receptor agonist,HTR3A
Melanoma,BRD-K38473998-001-02-0::2.5::HTS,4.774885040729939,0.029302060078334462,Melanoma,cilomilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4D"
Melanoma,BRD-K39166528-001-01-0::2.5::HTS,9.432653780354142,0.0022352114950134547,Melanoma,ID-8,,
Melanoma,BRD-K39252998-003-01-5::2.5::HTS,5.490643063260438,0.01947644421456757,Other Types,atipamezole,adrenergic receptor antagonist,
Melanoma,BRD-K39484304-001-16-5::2.5::HTS,4.16761886260569,0.04167181850733746,Other Types,triptolide,RNA polymerase inhibitor,RELA
Melanoma,BRD-K39670393-303-02-1::2.5::HTS,4.269461050208783,0.03926083994154176,Melanoma,amthamine,histamine receptor agonist,HRH2
Melanoma,BRD-K39974922-001-04-3::2.5::HTS,3.8857216473640674,0.0492028757598076,Melanoma,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Melanoma,BRD-K39987650-001-24-1::2.5::HTS,10.719562755206162,0.0011258689152203365,Melanoma,bisacodyl,laxative,
Melanoma,BRD-K40109029-001-02-9::2.5::HTS,29.41898606774181,8.673835288618143e-08,Other Types,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1
Melanoma,BRD-K40255344-001-17-6::2.5::HTS,9.84232232577381,0.0017947234134495678,Melanoma,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Melanoma,BRD-K40331046-305-01-5::2.5::HTS,12.576015279742702,0.00042350207961365727,Other Types,CR8-(R),CDK inhibitor,CCNA2
Melanoma,BRD-K40718343-001-02-6::2.5::HTS,29.33307023630163,9.047053592083867e-08,Melanoma,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Melanoma,BRD-K40738845-001-05-0::2.5::HTS,7.969760650140449,0.004930048859568276,Melanoma,BMS-777607,"AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor","AXL, MERTK, MET, MST1R, TYRO3"
Melanoma,BRD-K40758068-001-08-2::2.5::HTS,4.6543881148855935,0.03140982471491717,Melanoma,efavirenz,HIV protease inhibitor,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4"
Melanoma,BRD-K41256143-001-12-7::2.5::HTS,4.457827018491824,0.035195477442874976,Melanoma,dehydroepiandrosterone,protein synthesis stimulant,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1"
Melanoma,BRD-K41312087-001-02-7::2.5::HTS,9.23280804883578,0.002488653339301271,Other Types,GW-441756,growth factor receptor inhibitor,NTRK1
Melanoma,BRD-K41599323-001-02-3::2.5::HTS,5.419062335960763,0.020273358774509618,Melanoma,lonafarnib,farnesyltransferase inhibitor,"FNTA, HRAS, KRAS, NRAS"
Melanoma,BRD-K41783120-001-02-8::2.5::HTS,7.476018875721149,0.006455624133740978,Melanoma,STA-5326,interleukin synthesis inhibitor,IL12A
Melanoma,BRD-K41853443-001-02-9::2.5::HTS,14.384376142514698,0.0001652684806762228,Melanoma,"1,3-dipropyl-8-phenylxanthine",adenosine receptor antagonist,
Melanoma,BRD-K41876534-001-13-7::2.5::HTS,7.676977028011321,0.0057797517742069265,Melanoma,tioxolone,carbonic anhydrase inhibitor,CA2
Melanoma,BRD-K42452249-001-02-5::2.5::HTS,5.603762496856332,0.01826590075444589,Melanoma,EO-1428,p38 MAPK inhibitor,"MAPK11, MAPK14"
Melanoma,BRD-K42495768-001-01-7::2.5::HTS,20.892151274386013,6.0142898945503225e-06,Melanoma,tasisulam,apoptosis stimulant,
Melanoma,BRD-K42805893-001-04-9::2.5::HTS,19.609774952432282,1.1417185827087866e-05,Melanoma,osimertinib,EGFR inhibitor,EGFR
Melanoma,BRD-K42859542-001-03-3::2.5::HTS,7.10627954342997,0.007904427186933755,Melanoma,CFM-2,glutamate receptor antagonist,
Melanoma,BRD-K43389698-001-09-9::2.4::HTS,5.668024049314254,0.017630614187795757,Other Types,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Melanoma,BRD-K43410529-001-02-3::2.5::HTS,45.77094967065343,3.43229778146302e-11,Other Types,MLN2480,RAF inhibitor,
Melanoma,BRD-K43621685-001-02-5::2.5::HTS,6.495493214695383,0.011081987711918682,Melanoma,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Melanoma,BRD-K43797669-001-30-4::2.5::HTS,9.970637400224984,0.0016758992223628987,Melanoma,genistein,tyrosine kinase inhibitor,"CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5"
Melanoma,BRD-K43873574-001-01-8::2.5::HTS,4.40695499329641,0.036239694909329725,Melanoma,ilepcimide,anticonvulsant,
Melanoma,BRD-K44227013-001-06-4::2.5::HTS,20.818547025593606,6.215595687548796e-06,Other Types,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Melanoma,BRD-K44844162-001-01-6::2.5::HTS,6.22321750565953,0.012899789793947274,Melanoma,taselisib,PI3K inhibitor,PIK3CA
Melanoma,BRD-K45014108-003-01-8::2.5::HTS,10.597876560079051,0.001200931246667557,Melanoma,ephedrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2"
Melanoma,BRD-K45168550-001-01-9::2.5::HTS,4.452304233503328,0.0353035635083562,Melanoma,SB-756050,G protein-coupled receptor agonist,GPBAR1
Melanoma,BRD-K45519571-001-01-8::2.5::HTS,8.552946061554481,0.003590823051523077,Melanoma,RN-1747,TRPV agonist,TRPV4
Melanoma,BRD-K45528773-001-07-2::2.59::HTS,10.641620488607106,0.001177165454138038,Other Types,M-344,HDAC inhibitor,
Melanoma,BRD-K46386702-001-02-1::2.5::HTS,24.475538779532602,9.981838809108395e-07,Melanoma,ARRY-334543,EGFR inhibitor,ERBB2
Melanoma,BRD-K46392623-001-02-5::2.5::HTS,6.18544489807807,0.013169565514946857,Other Types,TG-100713,PI3K inhibitor,
Melanoma,BRD-K46863940-001-06-2::2.5::HTS,3.939562670600902,0.04768011032243724,Melanoma,dibenzothiophene,,
Melanoma,BRD-K47000838-001-01-6::1.04::HTS,6.058806262673696,0.014149255433333547,Melanoma,cytochalasin-b,microtubule inhibitor,ACTB
Melanoma,BRD-K47079459-004-04-6::2.5::HTS,7.831448441244242,0.005315910707368755,Melanoma,cetrimonium,,
Melanoma,BRD-K48141473-001-01-7::2.5::HTS,4.945799793095951,0.0265507679211202,Melanoma,cebranopadol,opioid receptor agonist,"OPRL1, OPRM1"
Melanoma,BRD-K48488978-001-05-3::2.5::HTS,13.43104537218131,0.00027133714571891585,Melanoma,YM-201636,PI3K inhibitor,
Melanoma,BRD-K48722258-300-10-2::2.5::HTS,4.128973029466259,0.04263852024980313,Melanoma,dilazep,adenosine reuptake inhibitor,SLC29A1
Melanoma,BRD-K48988407-001-01-2::2.5::HTS,22.834868823870107,2.2662196158379258e-06,Other Types,cytochlor,,
Melanoma,BRD-K49055432-001-04-2::2.5::HTS,5.589447615090998,0.01841049115009092,Melanoma,A66,PI3K inhibitor,PIK3CA
Melanoma,BRD-K49071277-001-04-7::2.5::HTS,5.228571085216187,0.022592488051589314,Melanoma,securinine,"GABA receptor antagonist, TP53 activator",GABRA1
Melanoma,BRD-K49075727-001-08-5::2.5::HTS,14.422051772950425,0.00016228690787681196,Melanoma,nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Melanoma,BRD-K49294207-300-03-8::2.5::HTS,14.037547186813343,0.00019804914709609155,Melanoma,BIBU-1361,EGFR inhibitor,EGFR
Melanoma,BRD-K49328571-001-15-0::2.5::HTS,5.810749876031259,0.016254334199005092,Melanoma,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Melanoma,BRD-K49481516-004-18-3::2.5::HTS,5.430219826509026,0.020149998517932057,Melanoma,galantamine,acetylcholinesterase inhibitor,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG"
Melanoma,BRD-K49522529-001-03-7::2.5::HTS,5.104811029159018,0.024245221998177115,Melanoma,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Melanoma,BRD-K49671696-045-08-5::2.5::HTS,3.981931017684449,0.04648181195354854,Melanoma,ketanserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2"
Melanoma,BRD-K49702221-003-01-6::2.5::HTS,8.289351993293051,0.004142463024142589,Melanoma,SNAP-94847,,"ADRA1A, DRD2"
Melanoma,BRD-K49840922-001-05-1::2.5::HTS,7.834672239757543,0.005304588311074216,Melanoma,etofylline-clofibrate,platelet aggregation inhibitor,PPARA
Melanoma,BRD-K49865102-001-08-4::2.5::HTS,22.153510042124655,3.187728836086771e-06,Other Types,PD-0325901,MEK inhibitor,MAP2K1
Melanoma,BRD-K49962337-001-02-9::2.56::HTS,11.479505345877826,0.0007562023500975174,Melanoma,baicalin,beta glucuronidase inhibitor,PREP
Melanoma,BRD-K50050533-001-02-1::2.5::HTS,4.214122021225221,0.04058106578925252,Melanoma,docosanol,lipase clearing factor inhibitor,TLR7
Melanoma,BRD-K50168500-001-07-9::2.5::HTS,13.537834986501284,0.0002565064683765349,Melanoma,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Melanoma,BRD-K50406511-001-26-0::2.5::HTS,10.695709072103293,0.0011401982164582092,Melanoma,hycanthone,RNA synthesis inhibitor,
Melanoma,BRD-K50495309-001-02-0::2.5::HTS,5.363300867266563,0.020925734607029803,Melanoma,SRC-kinase-inhibitor-I,src inhibitor,"CSK, LCK, RIPK2"
Melanoma,BRD-K51143828-003-03-1::2.5::HTS,4.467564981197737,0.03500556286189414,Other Types,lurasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7"
Melanoma,BRD-K51313569-003-03-3::2.5::HTS,4.017390566223419,0.045516937569180425,Other Types,palbociclib,CDK inhibitor,"CDK4, CDK6"
Melanoma,BRD-K51579475-003-02-4::2.5::HTS,4.275782065257377,0.03911703397423101,Melanoma,dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4"
Melanoma,BRD-K51791723-003-01-7::2.5::HTS,7.51709309420543,0.006307342329644415,Other Types,P276-00,CDK inhibitor,"CDK1, CDK4, CDK9"
Melanoma,BRD-K51911221-001-01-2::2.5::HTS,9.188360243504246,0.002547775564047526,Other Types,nemorubicin,topoisomerase inhibitor,"TOP1, TOP2A"
Melanoma,BRD-K51937257-001-01-4::2.5::HTS,5.148898963105317,0.023646206666428513,Other Types,bilastine,histamine receptor antagonist,HRH1
Melanoma,BRD-K52219182-001-02-4::2.5::HTS,5.020836537300284,0.02543952370712435,Melanoma,ICI-63197,phosphodiesterase inhibitor,
Melanoma,BRD-K52313696-001-12-3::2.5::HTS,4.424572005810435,0.03588781365854214,Melanoma,tacedinaline,HDAC inhibitor,HDAC1
Melanoma,BRD-K52751261-001-06-1::2.5::HTS,10.604954013076714,0.0011964294912978509,Melanoma,TAK-715,p38 MAPK inhibitor,MAPK14
Melanoma,BRD-K52911425-001-09-8::2.5::HTS,10.771858736731158,0.001094505581420034,Melanoma,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Melanoma,BRD-K53220666-001-02-6::2.5::HTS,4.328028628478247,0.03794532919407522,Melanoma,trimetozine,sedative,
Melanoma,BRD-K54006094-051-01-7::2.5::HTS,8.42096473529836,0.0038561775476115166,Melanoma,formoterol,adrenergic receptor agonist,ADRB2
Melanoma,BRD-K54395039-001-01-7::2.5::HTS,12.01171417523949,0.0005690470170343468,Other Types,PR-619,DUB inhibitor,
Melanoma,BRD-K54640016-001-04-7::2.5::HTS,4.064354336542451,0.04427962529349788,Melanoma,WAY-362450,FXR agonist,NR1H4
Melanoma,BRD-K54997624-001-06-0::2.5::HTS,16.075716024776355,6.907468711314997e-05,Melanoma,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Melanoma,BRD-K56032964-001-02-1::2.5::HTS,9.938566771007725,0.0017051396066308012,Melanoma,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Melanoma,BRD-K56277358-001-07-5::2.5::HTS,6.371871032428502,0.01187059080263211,Melanoma,MGCD-265,VEGFR inhibitor,"AXL, MET"
Melanoma,BRD-K56334280-001-05-1::2.5::HTS,4.852406545983453,0.028012718315720893,Melanoma,amonafide,topoisomerase inhibitor,"TOP2A, TOP2B"
Melanoma,BRD-K56343971-001-10-6::2.5::HTS,145.21212037069895,6.609393326934107e-30,Other Types,vemurafenib,RAF inhibitor,"BRAF, RAF1"
Melanoma,BRD-K56405753-001-02-4::2.5::HTS,7.818706891372286,0.005347748489575737,Melanoma,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Melanoma,BRD-K56483981-342-06-4::2.5::HTS,10.054926399717301,0.0016022263171076075,Melanoma,chicago-sky-blue-6b,"glutamate inhibitor, macrophage migration inhibiting factor inhibitor",MIF
Melanoma,BRD-K56614220-001-19-0::2.5::HTS,6.045698494722571,0.014241681972969518,Other Types,clofazimine,GK0582 inhibitor,
Melanoma,BRD-K56957086-001-06-3::2.5::HTS,4.647145131599586,0.03152902930762981,Other Types,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Melanoma,BRD-K57080016-001-15-9::2.5::HTS,68.98973246883723,7.431499208496827e-16,Other Types,selumetinib,MEK inhibitor,MAP2K1
Melanoma,BRD-K57136142-001-02-4::2.5::HTS,4.861607443571107,0.027868668094862173,Melanoma,CCT129202,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Melanoma,BRD-K57169635-001-04-5::2.5::HTS,18.005008985282032,2.576916524590871e-05,Melanoma,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Melanoma,BRD-K57371763-001-01-7::2.5::HTS,7.821579886327297,0.005340009061048979,Melanoma,fidaxomicin,RNA polymerase inhibitor,
Melanoma,BRD-K58049875-001-04-7::2.5::HTS,9.383253243656275,0.0022954066857929006,Other Types,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Melanoma,BRD-K58550667-001-08-7::2.5::HTS,8.45088969615012,0.003794185408369579,Other Types,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT
Melanoma,BRD-K58568447-001-01-1::2.5::HTS,3.9332578625234347,0.04782904839341835,Melanoma,K02288,bone morphogenic protein inhibitor,BMP1
Melanoma,BRD-K59184148-001-21-6::2.5::HTS,4.014146377722245,0.04560655470192426,Melanoma,SB-216763,glycogen synthase kinase inhibitor,"CCNA2, CDK2, GSK3A, GSK3B"
Melanoma,BRD-K59227464-334-02-4::2.5::HTS,9.045378460537066,0.002751422024925413,Melanoma,LY2228820,p38 MAPK inhibitor,MAPK14
Melanoma,BRD-K59317601-001-05-5::2.5::HTS,4.629361589251743,0.03185465968620871,Other Types,MLN0128,mTOR inhibitor,"MTOR, PIK3CA, PIK3CD, PIK3CG"
Melanoma,BRD-K59333713-003-02-0::2.5::HTS,4.417531938791178,0.03601992746085151,Melanoma,niguldipine-(S)-(+),adrenergic receptor antagonist,ADRA1A
Melanoma,BRD-K60287130-001-05-7::2.5::HTS,6.588873014233932,0.010519536547544653,Melanoma,"5,7-dichlorokynurenic-acid",glutamate receptor antagonist,"GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Melanoma,BRD-K60770992-066-25-0::2.47::HTS,14.834508931016915,0.0001317822071832272,Melanoma,pergolide,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Melanoma,BRD-K60914966-001-01-4::2.5::HTS,4.6799339164145275,0.030940759937418096,Melanoma,etosalamide,anti-inflammatory agent,
Melanoma,BRD-K60918217-001-03-8::2.56::HTS,4.172118399112507,0.041590527555667084,Other Types,laquinimod,immunosuppressant,CXCL2
Melanoma,BRD-K60997853-001-02-3::2.5::HTS,7.5615788982539325,0.00615523100719465,Melanoma,PHA-848125,"CDK inhibitor, growth factor receptor inhibitor","CDK2, CDK4, CDK7, NTRK1"
Melanoma,BRD-K61237927-001-01-7::2.5::HTS,4.0451374876985495,0.044778288212470284,Other Types,eslicarbazepine-acetate,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Melanoma,BRD-K61279411-001-02-0::2.5::HTS,3.9433470103697736,0.047573805226920625,Melanoma,oxaloacetate,glutamate release inhibitor,"CS, SPR"
Melanoma,BRD-K61314889-001-05-1::2.5::HTS,10.529622385686345,0.0012456264709710856,Melanoma,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Melanoma,BRD-K61397605-001-03-4::2.5::HTS,5.862374787826353,0.015785829280902663,Other Types,romidepsin,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Melanoma,BRD-K61443650-236-13-1::2.5::HTS,11.607043806354339,0.0007040180742164316,Other Types,thiomersal,other antibiotic,OXCT1
Melanoma,BRD-K61688984-001-02-9::2.5::HTS,19.97884093809996,9.487341370272984e-06,Melanoma,RGFP966,HDAC inhibitor,HDAC3
Melanoma,BRD-K61691541-001-01-1::2.5::HTS,4.068440836179799,0.04417083598682298,Melanoma,PF-03084014,gamma secretase inhibitor,
Melanoma,BRD-K62012036-001-14-4::2.44::HTS,4.309164029805696,0.0383909714944868,Other Types,acitretin,retinoid receptor agonist,"RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3"
Melanoma,BRD-K62200014-003-10-5::2.5::HTS,25.012015986440765,7.670691904529482e-07,Other Types,anagrelide,phosphodiesterase inhibitor,PDE3A
Melanoma,BRD-K62621335-001-01-7::2.5::HTS,7.517219831943625,0.006307257846627701,Melanoma,SRPIN340,serine arginine protein kinase inhibitor,"SRPK1, SRPK2"
Melanoma,BRD-K62627508-001-01-5::2.5::HTS,28.043594736215738,1.7067222746623114e-07,Other Types,idasanutlin,MDM inhibitor,"MDM2, TP53"
Melanoma,BRD-K62810658-001-12-2::2.5::HTS,4.607485156101734,0.032263910936021906,Melanoma,PD-98059,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Melanoma,BRD-K63068307-001-08-9::2.5::HTS,4.013436288452044,0.04562561986559791,Melanoma,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Melanoma,BRD-K63126190-003-01-6::2.5::HTS,7.972785980462514,0.004922579396424806,Melanoma,epinephrine,"adrenergic receptor agonist, neurotransmitter","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF"
Melanoma,BRD-K63150726-001-02-1::2.5::HTS,8.473109149828668,0.0037475142213597252,Melanoma,JTE-907,cannabinoid receptor inverse agonist,CNR2
Melanoma,BRD-K63178091-001-01-1::2.5::HTS,4.794222351189791,0.028966502728304973,Melanoma,telotristat,tryptophan hydroxylase inhibitor,TPH1
Melanoma,BRD-K63504947-001-15-4::2.5::HTS,5.737217114559787,0.016941306360693513,Other Types,semaxanib,VEGFR inhibitor,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Melanoma,BRD-K63784565-001-06-2::2.51::HTS,6.663213658009882,0.01011086190204728,Other Types,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1
Melanoma,BRD-K64052750-001-17-5::2.5::HTS,18.79182491399868,1.7329384229447703e-05,Melanoma,gefitinib,EGFR inhibitor,EGFR
Melanoma,BRD-K64538373-001-01-4::2.5::HTS,30.23387899196858,5.840658825977214e-08,Other Types,Ro-4987655,MEK inhibitor,MAP2K1
Melanoma,BRD-K64636206-001-02-7::2.5::HTS,3.9324727600808034,0.047862868439945874,Melanoma,D-alpha-tocopheryl-succinate,,
Melanoma,BRD-K64755930-003-03-2::2.5::HTS,10.60483787736439,0.00119588254947194,Melanoma,etazolate,phosphodiesterase inhibitor,"GABRB3, PDE4A"
Melanoma,BRD-K64835161-001-02-8::2.5::HTS,6.698764377690576,0.009898916173150517,Melanoma,ML167,"CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B"
Melanoma,BRD-K64888243-001-03-7::2.5::HTS,17.29139900616727,3.709246476025469e-05,Melanoma,AZ960,JAK inhibitor,JAK2
Melanoma,BRD-K64925568-001-01-8::2.5::HTS,25.46539992153365,6.10699984165224e-07,Other Types,AMG-232,MDM inhibitor,MDM2
Melanoma,BRD-K64990126-004-01-1::2.5::HTS,7.277121081600896,0.007193577172749694,Melanoma,scopolamine,acetylcholine receptor antagonist,
Melanoma,BRD-K64994968-001-32-5::2.5::HTS,7.079385841681636,0.008024439685764934,Other Types,progesterone,progesterone receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5"
Melanoma,BRD-K65716359-001-02-1::2.5::HTS,6.36371675875901,0.011926640362898344,Melanoma,exifone,nootropic agent,TYR
Melanoma,BRD-K65856711-001-04-4::2.5::HTS,6.693495675991714,0.009931061440444994,Melanoma,rolipram-S(+),phosphodiesterase inhibitor,
Melanoma,BRD-K65904673-001-01-4::2.5::HTS,3.929314840863406,0.04793962301791785,Melanoma,tandospirone,serotonin receptor agonist,HTR1A
Melanoma,BRD-K66175015-001-09-0::2.5::HTS,18.993100593315408,1.5678552766341497e-05,Melanoma,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Melanoma,BRD-K66715657-050-01-0::2.5::HTS,4.297252327200367,0.03863741452271774,Melanoma,UH-232-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4, HTR1A"
Melanoma,BRD-K67217586-001-08-0::2.5::HTS,4.373687166527715,0.03695948123513424,Other Types,fenthion,cholinesterase inhibitor,
Melanoma,BRD-K67261995-001-11-7::2.5::HTS,7.295286636459091,0.007124027294934287,Melanoma,iodipamide,radiopaque medium,ALB
Melanoma,BRD-K67578145-001-09-7::2.38::HTS,90.80376553160467,5.726354356990228e-20,Other Types,GDC-0879,RAF inhibitor,BRAF
Melanoma,BRD-K67578145-001-12-1::2.5::HTS,92.55432644490206,2.302240817428458e-20,Other Types,GDC-0879,RAF inhibitor,BRAF
Melanoma,BRD-K67901620-001-02-0::2.5::HTS,14.617910734658214,0.00014643300590526587,Melanoma,avasimibe,ACAT inhibitor,CES1
Melanoma,BRD-K68065987-300-09-1::2.5::HTS,9.588034665976531,0.002057761827696141,Melanoma,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Melanoma,BRD-K68174511-001-06-6::2.5::HTS,10.855173396216603,0.001047241330832362,Other Types,torin-2,mTOR inhibitor,MTOR
Melanoma,BRD-K68336408-001-10-9::2.5::HTS,22.153991118963848,3.177765726875938e-06,Melanoma,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Melanoma,BRD-K68408467-065-01-8::2.5::HTS,4.876746303672273,0.027626693020549334,Melanoma,proflavine-hemisulfate,topical anesthetic,F2
Melanoma,BRD-K68488863-001-04-9::2.5::HTS,3.8896500811643793,0.04907614810261911,Melanoma,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC"
Melanoma,BRD-K68553471-003-12-3::2.5::HTS,7.111969399313825,0.007879698773178694,Melanoma,todralazine,antihypertensive agent,
Melanoma,BRD-K68567222-001-01-2::2.5::HTS,5.688084104670119,0.017415184983349874,Other Types,BVT-948,tyrosine phosphatase inhibitor,"PTPN1, PTPN11, PTPN2"
Melanoma,BRD-K68633617-003-02-9::2.5::HTS,7.436237719592076,0.006593793281237219,Other Types,ACDPP,glutamate receptor antagonist,GRM5
Melanoma,BRD-K68938568-001-01-7::2.5::HTS,17.318028937787233,3.659171882493285e-05,Other Types,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Melanoma,BRD-K69608737-001-10-2::2.5::HTS,9.226062060455602,0.0024970813816133346,Melanoma,tacrolimus,calcineurin inhibitor,FKBP1A
Melanoma,BRD-K69650333-003-13-2::2.48::HTS,5.07389840803686,0.024698555007279268,Other Types,idarubicin,topoisomerase inhibitor,TOP2A
Melanoma,BRD-K69650333-003-14-0::2.5::HTS,6.328441714383528,0.012163375477763716,Other Types,idarubicin,topoisomerase inhibitor,TOP2A
Melanoma,BRD-K69694239-001-02-2::2.5::HTS,5.5442033647742255,0.018885006981195884,Other Types,bardoxolone-methyl,"nuclear factor erythroid derived, like (NRF2) activator","PPARG, STAT3"
Melanoma,BRD-K69726342-238-02-4::2.5::HTS,13.660818521896033,0.00024049924617896513,Other Types,atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR"
Melanoma,BRD-K69932463-001-10-6::2.5::HTS,8.614376791676946,0.0034735171111541178,Other Types,AZD8055,mTOR inhibitor,MTOR
Melanoma,BRD-K70088346-001-01-6::2.5::HTS,4.12957966522619,0.042616368034776295,Melanoma,2-chloro-N6-cyclopentyladenosine,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Melanoma,BRD-K70301465-001-02-6::2.5::HTS,18.208807819676043,2.3283994415975813e-05,Melanoma,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK"
Melanoma,BRD-K70401845-003-09-6::2.5::HTS,6.8489405301452795,0.009109011399788368,Melanoma,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Melanoma,BRD-K70914287-300-02-8::2.5::HTS,16.005157479708537,7.165433531411651e-05,Melanoma,BIBX-1382,EGFR inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K70924353-001-01-2::2.5::HTS,4.739857141234408,0.029888375434517465,Other Types,amtolmetin-guacil,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Melanoma,BRD-K71059170-001-11-6::2.5::HTS,6.157317383607111,0.013382477078199667,Melanoma,cefixime,bacterial cell wall synthesis inhibitor,
Melanoma,BRD-K71125014-001-27-1::2.5::HTS,6.0399215091793925,0.014288933891538132,Melanoma,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Melanoma,BRD-K71221037-001-01-6::2.5::HTS,28.424953746549296,1.4148556707526827e-07,Other Types,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Melanoma,BRD-K71467466-001-02-3::2.5::HTS,6.381997738320092,0.011801859145957347,Other Types,KPT-185,exportin antagonist,XPO1
Melanoma,BRD-K72327355-001-14-7::2.5::HTS,11.146374146338108,0.0008985320185392619,Melanoma,baicalein,lipoxygenase inhibitor,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH"
Melanoma,BRD-K72339976-065-03-9::2.5::HTS,7.105795563065238,0.007918864212231673,Melanoma,cefoselis,bacterial cell wall synthesis inhibitor,
Melanoma,BRD-K72420232-001-12-3::2.5::HTS,13.897303283296493,0.00021291867692421995,Melanoma,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K72723676-003-17-8::2.5::HTS,37.0425700021373,2.152126141164134e-09,Other Types,benzethonium,sodium channel blocker,SCN10A
Melanoma,BRD-K73237276-001-01-0::2.5::HTS,3.889589809104579,0.04907789664074512,Melanoma,tacalcitol,vitamin D receptor agonist,VDR
Melanoma,BRD-K73309154-003-02-8::2.5::HTS,12.666415488508715,0.00040376957434122123,Melanoma,OSI-420,EGFR inhibitor,EGFR
Melanoma,BRD-K73368362-001-07-5::2.5::HTS,8.109758685836587,0.004566167209540235,Melanoma,BIX-02189,MEK inhibitor,"MAP2K5, MAPK7"
Melanoma,BRD-K73383190-001-03-1::2.5::HTS,5.419509914919823,0.02026949051564309,Melanoma,C646,histone acetyltransferase inhibitor,EP300
Melanoma,BRD-K73394555-237-01-1::2.5::HTS,4.582568618086849,0.03272840311088226,Melanoma,oxolinic-acid,bacterial DNA gyrase inhibitor,
Melanoma,BRD-K73589491-001-11-2::2.5::HTS,4.676733541526131,0.0309987239098156,Melanoma,nizatidine,histamine receptor antagonist,HRH2
Melanoma,BRD-K73700643-001-11-2::2.5::HTS,4.163472570827376,0.04177148040060239,Melanoma,N-acetyltryptamine,melatonin receptor agonist,
Melanoma,BRD-K73982490-001-02-9::2.5::HTS,12.696519293311377,0.0003980422939827881,Other Types,BI-78D3,JNK inhibitor,MAPK8
Melanoma,BRD-K74305673-001-06-2::2.5::HTS,4.903767221058002,0.0272058983455104,Other Types,IKK-2-inhibitor-V,"IKK inhibitor, NFkB pathway inhibitor",IKBKB
Melanoma,BRD-K74363950-004-01-0::2.5::HTS,6.643795917962077,0.010204720489087602,Other Types,aclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Melanoma,BRD-K74501079-001-18-1::2.5::HTS,4.539462552857819,0.033563387412267394,Melanoma,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR
Melanoma,BRD-K75080769-001-01-6::2.5::HTS,4.336107750453006,0.03776385358941489,Melanoma,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,
Melanoma,BRD-K75466013-001-14-4::2.5::HTS,3.9705231173011746,0.046791810575719676,Melanoma,benzocaine,sodium channel blocker,SCN10A
Melanoma,BRD-K75516118-001-03-3::2.5::HTS,5.261123047199291,0.02218174922947707,Melanoma,rolipram-R(-),phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A"
Melanoma,BRD-K75649340-001-13-1::2.5::HTS,5.5628476405381155,0.018686931071607276,Melanoma,tioguanine,purine antagonist,
Melanoma,BRD-K75958547-238-01-0::2.5::HTS,5.947441241443393,0.015048287865299714,Other Types,pitavastatin,HMGCR inhibitor,HMGCR
Melanoma,BRD-K76022557-003-02-7::2.5::HTS,6.876922220334039,0.008973122058554196,Other Types,r(-)-apomorphine,dopamine receptor agonist,"DRD2, HTR5A"
Melanoma,BRD-K76239644-001-01-8::2.5::HTS,35.93976219888007,3.6524313746130126e-09,Melanoma,BMS-690514,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR"
Melanoma,BRD-K76304753-003-20-3::2.5::HTS,6.272412740751575,0.012557942128477597,Other Types,phenazopyridine,local anesthetic,SCN1A
Melanoma,BRD-K76606751-001-01-7::2.5::HTS,4.192452154575822,0.04106865528386967,Melanoma,mebicar,anxiolytic,
Melanoma,BRD-K76634210-001-14-7::2.5::HTS,13.568979351234358,0.0002531585858978179,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Melanoma,BRD-K76674262-001-03-3::2.5::HTS,4.718878375171743,0.030250474841159992,Other Types,homoharringtonine,protein synthesis inhibitor,RPL3
Melanoma,BRD-K76908866-001-07-6::2.5::HTS,9.099839596146527,0.0026723856660595216,Melanoma,CP-724714,"EGFR inhibitor, protein tyrosine kinase inhibitor",ERBB2
Melanoma,BRD-K76973696-001-12-6::2.01::HTS,9.458223214016945,0.0022057228221855183,Other Types,tryptanthrin,cyclooxygenase inhibitor,IDO1
Melanoma,BRD-K77552740-004-01-0::2.5::HTS,4.720771529783318,0.030225044757880463,Melanoma,tiquizium,acetylcholine receptor antagonist,
Melanoma,BRD-K77597856-003-02-5::2.5::HTS,4.717863857899375,0.03027421172306442,Melanoma,detomidine,adrenergic receptor agonist,ADRA2A
Melanoma,BRD-K77625799-001-07-7::2.5::HTS,28.78855612539567,1.1818479029106878e-07,Melanoma,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Melanoma,BRD-K77627880-001-04-0::2.5::HTS,19.398807305828843,1.2719141127889775e-05,Melanoma,A205804,ICAM1 expression inhibitor,"ICAM1, SELE"
Melanoma,BRD-K77641333-003-27-1::2.5::HTS,7.5530920701099395,0.006183199246340931,Melanoma,naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A"
Melanoma,BRD-K77791657-001-01-1::2.5::HTS,14.04781915169663,0.00019665194068724443,Melanoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Melanoma,BRD-K77791657-003-01-7::2.67::HTS,19.95774436170723,9.691345899155434e-06,Melanoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Melanoma,BRD-K77908580-001-09-6::2.5::HTS,27.783780545736516,1.9395615822624132e-07,Other Types,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9"
Melanoma,BRD-K77943374-001-02-8::2.5::HTS,15.664719129180588,8.531649850501875e-05,Melanoma,NVP-BVU972,MET inhibitor,MET
Melanoma,BRD-K78126613-001-28-5::2.5::HTS,14.671642747194088,0.00014236806442413769,Other Types,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Melanoma,BRD-K78666826-003-01-6::2.5::HTS,4.806523922411584,0.028765167418338688,Melanoma,procaterol,adrenergic receptor agonist,ADRB2
Melanoma,BRD-K78809024-001-05-7::2.5::HTS,101.86582399271977,3.9910968070182265e-22,Other Types,SB-590885,RAF inhibitor,BRAF
Melanoma,BRD-K79095980-001-09-6::2.5::HTS,34.74341689779499,6.496058217991645e-09,Other Types,broxuridine,antimetabolite,
Melanoma,BRD-K79259477-001-04-9::2.5::HTS,20.615574585635017,6.876966866201548e-06,Melanoma,NVP-BHG712,ephrin inhibitor,EPHB4
Melanoma,BRD-K79437791-001-05-7::2.5::HTS,4.103224310515605,0.043277775567543905,Melanoma,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG
Melanoma,BRD-K79584249-001-01-3::2.5::HTS,19.19197711438788,1.414067338659593e-05,Other Types,CGM097,MDM inhibitor,MDM2
Melanoma,BRD-K79612754-001-19-1::2.62::HTS,9.216035010783035,0.0025174158145993162,Melanoma,inosine,neurotrophic agent,"PARP1, PNP"
Melanoma,BRD-K79930101-300-03-7::2.5::HTS,27.3265654159607,2.426736101384947e-07,Melanoma,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Melanoma,BRD-K80036624-001-04-0::2.5::HTS,5.4628552943125195,0.019777561360982396,Melanoma,clopidol,,
Melanoma,BRD-K80431395-001-07-3::2.49::HTS,7.224381600317231,0.007418982767907692,Melanoma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Melanoma,BRD-K80480517-001-02-4::2.5::HTS,10.093771781302978,0.0015699843184715484,Melanoma,repsox,TGF beta receptor inhibitor,TGFBR1
Melanoma,BRD-K81197548-003-01-4::2.5::HTS,7.424183792985781,0.006637148675408105,Other Types,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Melanoma,BRD-K81225797-001-02-3::2.5::HTS,3.917647641941351,0.0482718814736199,Melanoma,SCH-58261,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Melanoma,BRD-K81458380-001-04-9::2.5::HTS,6.8489033728547035,0.009118589028453814,Other Types,CX-4945,casein kinase inhibitor,"CSNK2A1, CSNK2A2, DAPK3, HIPK3"
Melanoma,BRD-K81728688-001-04-4::2.5::HTS,24.58341118535865,9.474930814254815e-07,Melanoma,WZ8040,EGFR inhibitor,EGFR
Melanoma,BRD-K81916719-001-13-9::2.5::HTS,6.540529218031978,0.010816964281891658,Other Types,triclabendazole,microtubule inhibitor,DNMT1
Melanoma,BRD-K82236179-213-01-0::2.5::HTS,4.08838526884901,0.04366783563227012,Melanoma,dicoumarol,NADPH inhibitor,"CRYZ, NQO1, VKORC1"
Melanoma,BRD-K82244583-001-01-3::2.5::HTS,39.479437351104664,6.841239873957526e-10,Other Types,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Melanoma,BRD-K82850175-001-01-1::2.5::HTS,8.188144091163394,0.004373496265843795,Melanoma,navarixin,CC chemokine receptor antagonist,"CXCR1, CXCR2"
Melanoma,BRD-K82967685-300-01-2::2.5::HTS,3.899902975623664,0.04879879705503374,Melanoma,mirodenafil,phosphodiesterase inhibitor,PDE5A
Melanoma,BRD-K83192048-050-02-7::2.5::HTS,3.9560664137143684,0.047195904752246956,Melanoma,dimethindene-(S)-(+),acetylcholine receptor antagonist,HRH1
Melanoma,BRD-K83551379-001-02-6::2.5::HTS,4.413255209596217,0.03611864646144827,Melanoma,levodropropizine,antitussive,
Melanoma,BRD-K83988098-003-03-4::2.5::HTS,7.825028830575903,0.005340802741719396,Other Types,alvespimycin,HSP inhibitor,HSP90AA1
Melanoma,BRD-K84937637-001-09-9::2.5::HTS,4.862939174281317,0.02786980216759309,Melanoma,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Melanoma,BRD-K85178109-001-02-3::2.5::HTS,22.433067344736134,2.763357629482666e-06,Melanoma,fostamatinib,SYK inhibitor,SYK
Melanoma,BRD-K85402309-389-03-2::2.5::HTS,4.184987109057614,0.04125016357474484,Melanoma,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Melanoma,BRD-K85751432-001-03-3::2.5::HTS,68.49618963667152,9.802105059802596e-16,Other Types,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Melanoma,BRD-K86301799-001-34-8::2.5::HTS,7.875589244676536,0.005185960636428609,Melanoma,dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1"
Melanoma,BRD-K86525559-001-07-8::2.52::HTS,5.139323409563323,0.023793318261809873,Melanoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Melanoma,BRD-K86687746-001-01-3::2.5::HTS,4.848841668427269,0.02808206303657688,Other Types,R306465,HDAC inhibitor,
Melanoma,BRD-K86797399-001-05-1::2.55::HTS,5.990757883942884,0.014705655288157062,Other Types,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Melanoma,BRD-K86887724-001-10-6::2.59::HTS,4.40174307766001,0.036367159963008655,Other Types,dofetilide,potassium channel blocker,"KCNH1, KCNH2, KCNJ12, KCNK2"
Melanoma,BRD-K86892782-001-17-0::2.5::HTS,16.155028774633006,6.656361110054469e-05,Other Types,edoxudine,DNA directed DNA polymerase inhibitor,
Melanoma,BRD-K86930074-001-05-0::2.5::HTS,22.51511124404735,2.6659046508131206e-06,Melanoma,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Melanoma,BRD-K87909389-003-03-4::2.5::HTS,5.952977718807913,0.015002162730303682,Other Types,alvocidib,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM"
Melanoma,BRD-K88061624-001-21-4::2.5::HTS,5.572239913030016,0.018611348110742058,Other Types,mizoribine,"immunosuppressant, inosine monophosphate dehydrogenase inhibitor",IMPDH1
Melanoma,BRD-K88568253-011-19-9::2.5::HTS,4.11014274563681,0.04311202067871567,Other Types,iproniazid,monoamine oxidase inhibitor,"MAOA, MAOB"
Melanoma,BRD-K88677950-001-03-9::2.5::HTS,56.64981875642381,2.1018896433400537e-13,Other Types,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Melanoma,BRD-K89014967-001-04-3::2.5::HTS,31.86507880375149,2.635011103299651e-08,Other Types,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Melanoma,BRD-K89055274-048-22-7::2.5::HTS,6.005502521811774,0.014573965578321036,Melanoma,alverine,muscle relaxant,HTR1A
Melanoma,BRD-K89152108-236-07-6::2.5::HTS,5.1146124534673545,0.024139755689399255,Other Types,liothyronine,thyroid hormone stimulant,"THRA, THRB"
Melanoma,BRD-K89299012-001-06-0::2.5::HTS,23.877412275874548,1.3474016037772559e-06,Other Types,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Melanoma,BRD-K89306950-001-12-5::2.5::HTS,4.847037000475032,0.028099283753331566,Melanoma,ML130,NOD1 inhibitor,
Melanoma,BRD-K90027355-001-13-3::2.44::HTS,10.273177285048005,0.001431397839238122,Melanoma,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG"
Melanoma,BRD-K90630139-003-05-9::2.5::HTS,5.081620873577829,0.024576346148626468,Melanoma,butenafine,fungal squalene epoxidase inhibitor,SQLE
Melanoma,BRD-K90789829-001-07-8::2.5::HTS,4.587954788229117,0.03263042254356902,Melanoma,nefazodone,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Melanoma,BRD-K91336023-003-01-0::2.5::HTS,11.974748430242972,0.000580204650985923,Other Types,mesulergine,dopamine receptor agonist,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7"
Melanoma,BRD-K91370081-001-25-1::2.5::HTS,10.1189170499931,0.0015496867280343754,Other Types,anisomycin,DNA synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Melanoma,BRD-K91701654-001-03-1::2.38::HTS,61.37573224757145,2.6099489512146493e-14,Other Types,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Melanoma,BRD-K92015269-300-01-2::2.5::HTS,4.141409350381474,0.04232183529630485,Melanoma,GBR-12783,dopamine uptake inhibitor,
Melanoma,BRD-K92073408-001-16-5::2.5::HTS,10.72242895581306,0.0011238011990991974,Other Types,norethindrone,progesterone receptor agonist,PGR
Melanoma,BRD-K92093830-003-30-8::2.5::HTS,4.477949406166773,0.0347763213768005,Other Types,doxorubicin,topoisomerase inhibitor,TOP2A
Melanoma,BRD-K92150287-066-01-2::2.5::HTS,5.307904072988883,0.02159808134572335,Other Types,exatecan-mesylate,topoisomerase inhibitor,TOP1
Melanoma,BRD-K92241597-001-06-0::2.5::HTS,20.06802249966261,9.057531813940372e-06,Other Types,tosedostat,peptidase inhibitor,"ANPEP, LAP3, NPEPPS"
Melanoma,BRD-K92303087-001-01-6::2.5::HTS,4.112131875361764,0.043047918389094185,Melanoma,oglemilast,phosphodiesterase inhibitor,
Melanoma,BRD-K92778217-001-32-7::2.5::HTS,6.435995282661543,0.011464445104270615,Other Types,mefenamic-acid,cyclooxygenase inhibitor,"KCNQ1, PTGS1, PTGS2, TRPM3"
Melanoma,BRD-K93034159-001-25-8::2.5::HTS,4.454840263724154,0.035245190509592995,Other Types,cladribine,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B"
Melanoma,BRD-K93035859-001-07-6::2.5::HTS,3.937636437813169,0.04770736532063138,Other Types,butylated-hydroxyanisole,antioxidant,
Melanoma,BRD-K93123848-001-04-1::2.5::HTS,40.13186465593938,4.886017214781042e-10,Other Types,RAF265,"RAF inhibitor, VEGFR inhibitor",BRAF
Melanoma,BRD-K94176593-001-09-4::2.5::HTS,14.757048705168238,0.0001364294577171662,Melanoma,TWS-119,glycogen synthase kinase inhibitor,"GSK3B, JUN, MYC"
Melanoma,BRD-K94441233-001-13-0::2.6::HTS,4.196645850994494,0.040997894283329034,Other Types,mevastatin,HMGCR inhibitor,HMGCR
Melanoma,BRD-K94441233-001-17-1::2.5::HTS,16.075773516048198,6.9340878166521e-05,Other Types,mevastatin,HMGCR inhibitor,HMGCR
Melanoma,BRD-K94455792-001-01-8::2.5::HTS,18.92641414709956,1.615683069821849e-05,Other Types,ICG-001,beta-catenin inhibitor,CTNNB1
Melanoma,BRD-K94485812-001-02-9::2.55::HTS,5.529653824661068,0.019063330918172045,Melanoma,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Melanoma,BRD-K95053546-001-03-5::2.5::HTS,4.813983218450052,0.02866471290019957,Melanoma,tempol,free radical scavenger,
Melanoma,BRD-K95142244-001-01-5::2.5::HTS,7.3805946426305,0.006797002571106852,Melanoma,talazoparib,PARP inhibitor,PARP2
Melanoma,BRD-K95309561-001-24-7::2.5::HTS,4.31421035006938,0.03825304768025075,Melanoma,dienestrol,estrogen receptor agonist,ESR1
Melanoma,BRD-K95435023-001-10-1::2.5::HTS,17.633761359830807,3.119932134606573e-05,Other Types,PHA-665752,c-Met inhibitor,MET
Melanoma,BRD-K95523387-001-09-6::2.5::HTS,5.9339340021979545,0.015163361418942745,Other Types,OLDA,TRPV agonist,GPR119
Melanoma,BRD-K95609758-001-03-7::2.5::HTS,4.769352752998734,0.029386367150255124,Melanoma,BMS-191011,potassium channel activator,KCNMA1
Melanoma,BRD-K95785537-001-23-1::2.5::HTS,11.927976999795233,0.0005956499774124576,Melanoma,PP-2,src inhibitor,"ABL1, LCK, LYN, RIPK2, SRC"
Melanoma,BRD-K95901403-001-04-5::2.5::HTS,4.0782729879346435,0.04391387703862076,Other Types,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Melanoma,BRD-K96104201-001-01-5::2.5::HTS,5.432347422758853,0.02012312773360321,Other Types,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,
Melanoma,BRD-K96194081-001-10-2::2.5::HTS,20.142817720196213,8.721971322213438e-06,Melanoma,cepharanthine,NFkB pathway inhibitor,
Melanoma,BRD-K96358241-001-01-9::0.94::HTS,13.879034636598794,0.0002148357842954188,Other Types,harringtonine,protein synthesis inhibitor,
Melanoma,BRD-K96740444-001-02-1::2.5::HTS,4.217575536393322,0.040471083619388754,Melanoma,itopride,dopamine receptor antagonist,"CHRM3, DRD2"
Melanoma,BRD-K97056771-001-13-1::2.5::HTS,4.804445362351437,0.02879589770638734,Melanoma,GNF-2,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Melanoma,BRD-K97365803-001-02-1::2.5::HTS,3.958584851867412,0.04712676181359666,Melanoma,PI-828,PI3K inhibitor,
Melanoma,BRD-K97472745-001-01-8::2.5::HTS,7.964998650208196,0.004937856333896412,Other Types,gestrinone,progesterone receptor antagonist,"AR, ESR1, PGR"
Melanoma,BRD-K97714174-001-01-3::2.5::HTS,4.26814942701218,0.039290919614407505,Melanoma,P22077,ubiquitin specific protease inhibitor,USP7
Melanoma,BRD-K97764662-001-17-3::2.5::HTS,6.370552976849928,0.011881313480624952,Melanoma,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Melanoma,BRD-K97963946-001-01-3::2.5::HTS,6.425536431496219,0.011519222596300593,Melanoma,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET
Melanoma,BRD-K98357249-001-02-9::2.5::HTS,5.272170651680711,0.02204142133308819,Melanoma,IRL-2500,endothelin receptor antagonist,EDNRB
Melanoma,BRD-K98493452-001-14-9::2.5::HTS,4.069556199017602,0.044137632612388795,Other Types,honokiol,AKT inhibitor,"ALOX5, PTGS1, PTGS2"
Melanoma,BRD-K98521173-001-19-4::2.5::HTS,5.1991865121197565,0.022971147729823237,Other Types,desoxycortone,mineralocorticoid receptor agonist,"NR3C1, NR3C2"
Melanoma,BRD-K98572433-001-02-9::2.5::HTS,23.86926009428375,1.3477823664887785e-06,Melanoma,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Melanoma,BRD-K99149715-001-01-6::2.5::HTS,3.989757880862365,0.04626183413748248,Melanoma,plurisin-#1,stearoyl-CoA desaturase inhibitor,SCD
Melanoma,BRD-K99174507-003-02-0::2.5::HTS,4.085550095917161,0.043731742562128695,Melanoma,cardiogenol-c,cardiomyogenesis inducer,
Melanoma,BRD-K99604664-001-01-1::2.5::HTS,10.425713029051561,0.0013152386169834912,Other Types,tanaproget,progesterone receptor agonist,PGR
Melanoma,BRD-K99946902-001-07-5::2.5::HTS,12.040482422749147,0.0005609554306007097,Melanoma,hexylresorcinol,local anesthetic,TYR
Melanoma,BRD-K99964838-001-11-9::2.5::HTS,11.511918686666135,0.0007403803928736458,Melanoma,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Melanoma,BRD-M30288325-001-01-4::2.5::HTS,4.4857786368900925,0.034618695210975534,Melanoma,G-15,estrogen receptor antagonist,GPER1
Melanoma,BRD-M41245765-001-04-2::2.5::HTS,4.749008643882114,0.0297564603221873,Melanoma,lithium-citrate,,
Melanoma,BRD-M89827113-001-01-5::2.5::HTS,4.119341603106244,0.04288002004680708,Melanoma,cromakalim,,KCNJ8
Melanoma,BRD-U48018661-000-01-9::2.5::HTS,4.454154327195444,0.035260821588153524,Melanoma,tyloxapol,NFkB pathway inhibitor,"LPL, NFKB2"
Melanoma,BRD-A02232681-001-01-8::2.5::MTS004,3.998804506190031,0.046033935349019936,Other Types,isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2"
Melanoma,BRD-A19777893-236-01-9::2.596350183::MTS004,37.374784343926315,1.8741297243709473e-09,Other Types,menadione-bisulfite,vitamin K,"GGCX, VKORC1, VKORC1L1"
Melanoma,BRD-A55416093-001-06-4::2.5::MTS004,6.229997445932136,0.012858650319671481,Melanoma,colforsin,adenylyl cyclase activator,"ADCY2, ADCY5"
Melanoma,BRD-A58947127-001-01-6::2.5::MTS004,4.722260271782439,0.030210185704945478,Other Types,AMG319,PI3K inhibitor,PIK3CD
Melanoma,BRD-A72401848-001-02-2::2.551316459::MTS004,4.934468046809344,0.026740831901677514,Melanoma,gadoteridol,radiopaque medium,
Melanoma,BRD-A75975749-001-01-4::2.5::MTS004,105.71331411352155,9.263587323981449e-23,Other Types,bafetinib,"Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor","ABL1, BCR, LYN"
Melanoma,BRD-A86665761-001-01-1::2.5::MTS004,6.229601763978285,0.012860934371017213,Other Types,gabapentin-enacarbil,adrenergic receptor agonist,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8"
Melanoma,BRD-K02988401-001-01-2::2.5::MTS004,15.42924077128301,9.680397724163098e-05,Other Types,UNC0737,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Melanoma,BRD-K03765900-001-01-9::2.499986292::MTS004,24.669831855616472,9.15262473347529e-07,Melanoma,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Melanoma,BRD-K04603573-376-01-3::2.542651982::MTS004,9.650600214748295,0.001992758970011235,Other Types,"1,12-Besm",polyamine biosynthesis inhibitor,
Melanoma,BRD-K06328344-015-01-7::2.500004254::MTS004,6.148325260787982,0.013458768564482412,Melanoma,bremelanotide,melanocortin receptor agonist,"MC1R, MC2R, MC3R, MC4R, MC5R"
Melanoma,BRD-K13060017-001-02-1::2.499994836::MTS004,32.47025732117701,1.9936637577053506e-08,Other Types,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Melanoma,BRD-K13277760-001-01-2::2.5::MTS004,8.286184963830246,0.004153652845297128,Other Types,rifamycin-sv,RNA synthesis inhibitor,
Melanoma,BRD-K13769342-001-01-5::2.50001379::MTS004,4.437378968179444,0.03562266917301555,Other Types,danirixin,CC chemokine receptor antagonist,CXCR2
Melanoma,BRD-K15360631-325-01-4::2.404560312::MTS004,4.428693092781259,0.03580285165567047,Other Types,dehydroepiandrosterone-sulfate,"androgen receptor agonist, estrogen receptor agonist","AR, ESR1, ESR2"
Melanoma,BRD-K16180792-001-01-7::2.5::MTS004,54.63345738131039,5.576435824957953e-13,Other Types,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Melanoma,BRD-K16546375-001-01-4::2.393310671::MTS004,3.8730973773162907,0.04957901534773309,Other Types,bicyclol,NFkB pathway inhibitor,"HSPA1A, HSPB1"
Melanoma,BRD-K17610631-001-03-3::2.421190843::MTS004,7.1338958220717625,0.007792577756873663,Melanoma,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Melanoma,BRD-K21152241-001-07-3::2.5082643::MTS004,15.696474857854037,8.436118808491433e-05,Other Types,enoximone,phosphodiesterase inhibitor,PDE3A
Melanoma,BRD-K22064724-001-01-8::2.499989634::MTS004,9.925219092614665,0.001720772587589477,Other Types,napabucasin,STAT inhibitor,STAT3
Melanoma,BRD-K22149900-001-03-9::2.371298578::MTS004,6.952241346460179,0.00861288251442662,Other Types,ceritinib,ALK tyrosine kinase receptor inhibitor,"ALK, FLT3, IGF1R, INSR, TSSK1B"
Melanoma,BRD-K22514639-001-05-7::2.500015058::MTS004,20.362492465814455,7.871582673556204e-06,Melanoma,EGF816,EGFR inhibitor,EGFR
Melanoma,BRD-K26026438-001-01-0::2.499979456::MTS004,5.32349906448396,0.021418476755234478,Melanoma,tucatinib,EGFR inhibitor,ERBB2
Melanoma,BRD-K26530649-001-01-6::2.568078778::MTS004,4.390760544548355,0.03660102134074075,Melanoma,carboxypyridine-disulfide,,
Melanoma,BRD-K26818574-305-07-6::2.5::MTS004,21.069376923565628,5.516880194100994e-06,Other Types,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Melanoma,BRD-K27293958-001-01-5::2.450321909::MTS004,5.107333697931259,0.024223964879639636,Other Types,tiaramide,anti-inflammatory agent,
Melanoma,BRD-K27755542-001-01-6::2.49693186::MTS004,5.740507522122637,0.01691796655238564,Other Types,PF-04937319,glucokinase activator,GCK
Melanoma,BRD-K28061410-001-06-6::2.5::MTS004,61.335223756404275,2.573550534961709e-14,Other Types,beta-lapachone,topoisomerase inhibitor,TOP1
Melanoma,BRD-K32842773-434-01-8::2.5::MTS004,7.8981024299613924,0.005128573437684501,Other Types,pemetrexed,"dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS"
Melanoma,BRD-K33240821-001-06-2::2.50000539::MTS004,4.141881699178459,0.04232336536646126,Other Types,plerixafor,CC chemokine receptor antagonist,"ACKR3, CCR4, CXCR4"
Melanoma,BRD-K38527262-300-01-0::2.300987371::MTS004,119.99073613108241,2.4080214678938807e-25,Other Types,atiprimod,"JAK inhibitor, STAT inhibitor","JAK2, STAT3"
Melanoma,BRD-K39009484-001-01-4::2.5::MTS004,11.256312494216555,0.0008494974411077337,Melanoma,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Melanoma,BRD-K42816473-001-01-0::2.38330586::MTS004,5.936474001003123,0.0151539480809571,Melanoma,zilpaterol,adrenergic receptor agonist,ADRB2
Melanoma,BRD-K44471774-001-01-8::2.670187358::MTS004,4.51386690055949,0.034075613333917475,Melanoma,bay-w-9798,antioxidant,
Melanoma,BRD-K48452630-001-01-8::2.5::MTS004,7.332655568184823,0.006986731256178933,Melanoma,SRT2104,SIRT activator,SIRT1
Melanoma,BRD-K50010139-001-02-3::2.5::MTS004,24.733015134848547,8.865463574262972e-07,Melanoma,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Melanoma,BRD-K50122911-001-01-2::2.5::MTS004,5.702359595394544,0.017285500795405837,Other Types,boronophenylalanine,,
Melanoma,BRD-K51730347-001-06-4::2.5::MTS004,8.9821088856632,0.0028519547925945445,Other Types,diphencyprone,immunostimulant,
Melanoma,BRD-K56211775-001-03-8::2.5::MTS004,5.579848590906705,0.01852340078298253,Other Types,RTA-408,nitric oxide production inhibitor,NFE2L2
Melanoma,BRD-K56429665-001-09-6::2.500032186::MTS004,6.4513017638181145,0.01136675408947589,Melanoma,calcipotriol,vitamin D receptor agonist,VDR
Melanoma,BRD-K56981171-001-01-0::2.500008954::MTS004,7.175208478258104,0.007617903865334148,Melanoma,brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR"
Melanoma,BRD-K58529924-001-01-5::2.648577938::MTS004,10.707267554497161,0.0011354791035999515,Other Types,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Melanoma,BRD-K59866480-001-07-3::2.379655165::MTS004,4.066460454044697,0.04423828904339722,Melanoma,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Melanoma,BRD-K60130390-001-02-1::2.5::MTS004,19.240789117847193,1.3867941261088779e-05,Melanoma,UNC0642,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Melanoma,BRD-K60421517-001-01-4::2.499975038::MTS004,5.167888748158704,0.023401506554840655,Melanoma,olmutinib,"EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR"
Melanoma,BRD-K67482377-001-01-8::2.500004112::MTS004,6.296889444400008,0.012387174023010846,Melanoma,itacitinib,JAK inhibitor,JAK1
Melanoma,BRD-K73132780-001-01-2::2.5::MTS004,6.783856479884128,0.009452459510675209,Melanoma,pyronaridine,antimalarial agent,
Melanoma,BRD-K76614248-001-01-2::2.707477898::MTS004,5.080590297021066,0.02459671651593966,Melanoma,atizoram,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Melanoma,BRD-K76634210-001-12-1::2.5::MTS004,18.688459911511927,1.834161972830599e-05,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Melanoma,BRD-K79803033-300-01-3::2.5::MTS004,5.179324164519408,0.02324875053458683,Other Types,pozanicline,acetylcholine receptor antagonist,"CHRNA4, CHRNB2"
Melanoma,BRD-K82967180-001-01-6::2.500024493::MTS004,10.630967373103697,0.0011823395624179951,Other Types,LY3023414,"PI3K inhibitor, mTOR inhibitor",MTOR
Melanoma,BRD-K86856088-001-06-9::2.5::MTS004,5.746758401256921,0.01685915133535098,Melanoma,UNC0638,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Melanoma,BRD-K92073408-001-15-7::2.5::MTS004,9.110112342157368,0.002662449239843308,Other Types,norethindrone,progesterone receptor agonist,PGR
Melanoma,BRD-K99919177-001-01-3::2.5::MTS004,5.145672017884957,0.02369909146144813,Other Types,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Bladder Urothelial Carcinoma,BRD-A01412266-001-01-0::2.5::HTS,6.059846152436342,0.014133642815055325,Bladder Urothelial Carcinoma,hydroxypropyl-beta-cyclodextrin,,
Bladder Urothelial Carcinoma,BRD-A01787639-003-16-9::2.5::HTS,4.505493451174802,0.0342290525923219,Other Types,naftopidil,adrenergic receptor antagonist,ADRA1A
Bladder Urothelial Carcinoma,BRD-A02710418-003-11-8::2.5::HTS,4.158930305813246,0.041889539070120545,Other Types,meptazinol,opioid receptor agonist,BCHE
Bladder Urothelial Carcinoma,BRD-A03623303-045-09-5::2.5::HTS,5.179253525141425,0.02323700304359092,Other Types,metoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Bladder Urothelial Carcinoma,BRD-A06426627-001-03-5::2.5::HTS,4.734521059529823,0.029984950010202953,Other Types,diclazuril,antiprotozoal agent,
Bladder Urothelial Carcinoma,BRD-A09722536-002-18-0::2.5::HTS,8.21395881084974,0.004314017310234122,Bladder Urothelial Carcinoma,cyclophosphamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Bladder Urothelial Carcinoma,BRD-A10039652-001-01-2::2.5::HTS,6.076557169478314,0.014016473676353608,Other Types,tipranavir,HIV protease inhibitor,
Bladder Urothelial Carcinoma,BRD-A16665823-001-02-0::2.5::HTS,4.916196384189672,0.02700678465456599,Bladder Urothelial Carcinoma,butoconazole,bacterial cell wall synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-A17300716-001-01-5::2.5::HTS,3.9077625841674752,0.048551921692192655,Bladder Urothelial Carcinoma,dehydroacetic-acid,,
Bladder Urothelial Carcinoma,BRD-A19736161-001-06-7::2.5::HTS,6.113956376833604,0.013706668934312074,Bladder Urothelial Carcinoma,ondansetron,serotonin receptor antagonist,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1"
Bladder Urothelial Carcinoma,BRD-A20239487-001-24-9::2.5::HTS,4.513470858149881,0.034080916043011555,Bladder Urothelial Carcinoma,atenolol-(+/-),adrenergic receptor antagonist,"ADRB1, ADRB2"
Bladder Urothelial Carcinoma,BRD-A20839672-003-01-5::2.5::HTS,7.336528554767874,0.006963760815952766,Bladder Urothelial Carcinoma,cefmenoxime,bacterial cell wall synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-A22267103-003-13-1::2.5::HTS,4.093730247857204,0.04351962771995287,Bladder Urothelial Carcinoma,drofenine,,
Bladder Urothelial Carcinoma,BRD-A24228527-213-01-9::2.5::HTS,4.082941919873998,0.04379618186047791,Bladder Urothelial Carcinoma,ofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Bladder Urothelial Carcinoma,BRD-A25004090-001-08-4::2.5::HTS,5.551584040476476,0.01880879775335534,Bladder Urothelial Carcinoma,erastin,ion channel antagonist,VDAC2
Bladder Urothelial Carcinoma,BRD-A26690767-066-01-9::2.5::HTS,5.016064602623684,0.025506234803128174,Bladder Urothelial Carcinoma,saquinavir,HIV protease inhibitor,CYP3A4
Bladder Urothelial Carcinoma,BRD-A30590053-003-02-9::2.5::HTS,4.639789766060015,0.031663287295483254,Other Types,MR-16728,acetylcholine release enhancer,
Bladder Urothelial Carcinoma,BRD-A31095847-001-02-3::2.5::HTS,4.064636974235767,0.04427227200868403,Other Types,mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2"
Bladder Urothelial Carcinoma,BRD-A42571354-300-12-0::2.5::HTS,5.287952868955187,0.021841792718191113,Bladder Urothelial Carcinoma,cetirizine,histamine receptor antagonist,HRH1
Bladder Urothelial Carcinoma,BRD-A47706533-001-02-6::2.5::HTS,5.419204118949299,0.020273647690495222,Bladder Urothelial Carcinoma,buthionine-sulfoximine,glutathione transferase inhibitor,GCLM
Bladder Urothelial Carcinoma,BRD-A51964809-003-12-6::2.5::HTS,4.0847238831295165,0.04374611915876691,Other Types,halofantrine,antimalarial agent,"KCNH2, KCNN4"
Bladder Urothelial Carcinoma,BRD-A52660433-066-02-1::2.5::HTS,6.43097031123298,0.011496005436342223,Other Types,tetrindole,monoamine oxidase inhibitor,MAOA
Bladder Urothelial Carcinoma,BRD-A53539450-004-01-7::2.5::HTS,4.52664915513612,0.03380714011530019,Other Types,neo-gilurytmal,,
Bladder Urothelial Carcinoma,BRD-A54275602-001-01-0::2.5::HTS,9.7017466038397,0.0019364919254161452,Bladder Urothelial Carcinoma,lanoconazole,sterol demethylase inhibitor,
Bladder Urothelial Carcinoma,BRD-A55913614-316-09-6::2.5::HTS,6.99148767080351,0.008418626293421095,Other Types,primaquine,"antimalarial agent, DNA inhibitor","KRT7, NQO2"
Bladder Urothelial Carcinoma,BRD-A65013509-003-24-4::2.5::HTS,4.057191017558497,0.04446381910737819,Bladder Urothelial Carcinoma,oxybutynin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Bladder Urothelial Carcinoma,BRD-A67363467-001-01-3::2.5::HTS,5.775646026267022,0.016574487911558966,Bladder Urothelial Carcinoma,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,
Bladder Urothelial Carcinoma,BRD-A67975844-001-01-8::2.5::HTS,9.0566131855184,0.0027354740774084806,Bladder Urothelial Carcinoma,NSC-405020,matrix metalloprotease inhibitor,MMP1
Bladder Urothelial Carcinoma,BRD-A68281735-001-18-6::0.25::HTS,4.568255040767573,0.03300219905308286,Bladder Urothelial Carcinoma,REV-5901,"leukotriene receptor antagonist, lipoxygenase inhibitor",ALOX5
Bladder Urothelial Carcinoma,BRD-A69275535-001-01-5::2.5::HTS,4.479023064851917,0.03475387172775657,Bladder Urothelial Carcinoma,pinitol,gamma secretase inhibitor,
Bladder Urothelial Carcinoma,BRD-A69815203-001-07-6::2.5::HTS,4.919696389426251,0.026988531460691665,Other Types,cyclosporin-a,calcineurin inhibitor,PPP3CA
Bladder Urothelial Carcinoma,BRD-A70083328-001-24-3::2.5::HTS,4.825445427379343,0.028467627939972828,Other Types,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Bladder Urothelial Carcinoma,BRD-A71033472-003-23-9::2.5::HTS,7.754797484733,0.005539546686128104,Other Types,fendiline,calcium channel blocker,HTR2B
Bladder Urothelial Carcinoma,BRD-A72703248-003-04-9::2.5::HTS,7.413276184279636,0.006677332085686865,Other Types,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Bladder Urothelial Carcinoma,BRD-A78195072-001-06-2::2.5::HTS,5.121527485250741,0.024011500694165366,Bladder Urothelial Carcinoma,imexon,"apoptosis stimulant, ribonucleotide reductase inhibitor","RRM1, RRM2"
Bladder Urothelial Carcinoma,BRD-A81370665-001-03-6::2.5::HTS,11.905816515262623,0.0006016064082361312,Other Types,BI-D1870,ribosomal protein inhibitor,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6"
Bladder Urothelial Carcinoma,BRD-A81615860-003-01-7::2.5::HTS,6.65247175064997,0.010156199939071697,Bladder Urothelial Carcinoma,fenclonine-(+/-),tryptophan hydroxylase inhibitor,"PAH, TPH1, TPH2"
Bladder Urothelial Carcinoma,BRD-A85025557-001-02-5::2.5::HTS,4.047136990991993,0.044732639291592644,Bladder Urothelial Carcinoma,NCS-382,GABA receptor antagonist,"GABBR1, GABBR2, SLC52A2"
Bladder Urothelial Carcinoma,BRD-A88684804-001-04-3::2.5::HTS,4.646448479972174,0.03154476305164603,Bladder Urothelial Carcinoma,bucetin,analgesic agent,
Bladder Urothelial Carcinoma,BRD-A89196962-300-01-7::2.5::HTS,5.572773260600987,0.018582361021612526,Other Types,dalargin,opioid receptor agonist,OPRM1
Bladder Urothelial Carcinoma,BRD-A90551241-001-10-8::2.5::HTS,4.406052434834916,0.03626032462329092,Bladder Urothelial Carcinoma,lornoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Bladder Urothelial Carcinoma,BRD-A92537424-001-04-7::2.5::HTS,6.373714611306613,0.011856433609831449,Bladder Urothelial Carcinoma,danazol,"estrogen receptor antagonist, progesterone receptor agonist","AR, CCL2, ESR1, GNRHR, GNRHR2, PGR"
Bladder Urothelial Carcinoma,BRD-A93000692-001-08-1::2.5::HTS,5.319442541792071,0.02145230586615207,Other Types,ciglitazone,PPAR receptor agonist,PPARG
Bladder Urothelial Carcinoma,BRD-A93255169-001-28-3::2.5::HTS,5.937347133146624,0.015132672955949764,Bladder Urothelial Carcinoma,thalidomide,tumor necrosis factor production inhibitor,"CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF"
Bladder Urothelial Carcinoma,BRD-A96977263-001-03-7::2.5::HTS,5.980249773999502,0.014792512879779857,Other Types,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1
Bladder Urothelial Carcinoma,BRD-K00091711-001-01-2::2.5::HTS,4.6772731520464985,0.030992926116707013,Bladder Urothelial Carcinoma,RWJ-21757,toll-like receptor agonist,TLR7
Bladder Urothelial Carcinoma,BRD-K00926464-001-01-8::2.5::HTS,4.463006069561747,0.035084891750674044,Bladder Urothelial Carcinoma,IMREG-1,,
Bladder Urothelial Carcinoma,BRD-K01773560-001-02-4::2.59::HTS,6.890469168260023,0.008912068413212114,Other Types,UNC2250,MER tyrosine kinase inhibitor,MERTK
Bladder Urothelial Carcinoma,BRD-K02017404-300-06-2::2.5::HTS,3.8724378408808176,0.04957994767862891,Other Types,NVP-BSK805,JAK inhibitor,JAK2
Bladder Urothelial Carcinoma,BRD-K02867583-300-08-9::2.5::HTS,4.266210607428864,0.03934204699075363,Bladder Urothelial Carcinoma,minaprine,serotonin reuptake inhibitor,"ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4"
Bladder Urothelial Carcinoma,BRD-K02908048-003-06-4::2.5::HTS,10.135660521632886,0.0015356281974530741,Bladder Urothelial Carcinoma,preclamol,dopamine receptor agonist,DRD2
Bladder Urothelial Carcinoma,BRD-K04176066-001-08-3::2.5::HTS,8.422195995505952,0.0038525468898433267,Bladder Urothelial Carcinoma,bergenin,interleukin inhibitor,"IL1B, TNF"
Bladder Urothelial Carcinoma,BRD-K04414442-001-08-3::2.5::HTS,5.183551517411293,0.02318357776497788,Bladder Urothelial Carcinoma,SB-222200,tachykinin antagonist,TACR3
Bladder Urothelial Carcinoma,BRD-K04993719-001-01-7::2.5::HTS,5.265200719712672,0.02212831872797285,Other Types,LY2334737,"antitumor agent, ribonucleotide reductase inhibitor",
Bladder Urothelial Carcinoma,BRD-K05236810-001-19-0::2.5::HTS,4.016224825185682,0.045549048038406315,Other Types,luteolin,glucosidase inhibitor,TOP1
Bladder Urothelial Carcinoma,BRD-K05446112-001-01-8::2.5::HTS,7.521566535358007,0.006292616260612713,Other Types,ledipasvir,HCV inhibitor,
Bladder Urothelial Carcinoma,BRD-K05619559-001-12-7::2.5::HTS,4.066668696643552,0.04421258390298565,Bladder Urothelial Carcinoma,tobramycin,bacterial 30S ribosomal subunit inhibitor,
Bladder Urothelial Carcinoma,BRD-K06557128-001-07-0::2.5::HTS,5.7637972185882544,0.016686611404882486,Bladder Urothelial Carcinoma,voriconazole,cytochrome P450 inhibitor,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1"
Bladder Urothelial Carcinoma,BRD-K07106112-003-03-8::2.5::HTS,9.596360336745823,0.002047892226988379,Other Types,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Bladder Urothelial Carcinoma,BRD-K07487750-001-03-3::2.5::HTS,11.9466774901954,0.0005891287920330483,Other Types,WHI-P154,JAK inhibitor,"EGFR, JAK1, JAK2, JAK3"
Bladder Urothelial Carcinoma,BRD-K08109516-001-07-8::2.5::HTS,5.097621923548713,0.024343583893114397,Bladder Urothelial Carcinoma,L-701324,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Bladder Urothelial Carcinoma,BRD-K09549677-300-03-4::2.5::HTS,5.196304823076845,0.023025625644539003,Other Types,mibefradil,T-type calcium channel blocker,"ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4"
Bladder Urothelial Carcinoma,BRD-K12120659-305-02-2::2.5::HTS,4.483056679156247,0.034679011243993224,Bladder Urothelial Carcinoma,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Bladder Urothelial Carcinoma,BRD-K12343256-001-08-9::2.5::HTS,5.636898697105636,0.017923632003533942,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Bladder Urothelial Carcinoma,BRD-K12614344-003-01-8::2.5::HTS,5.244603943292401,0.022385865340595598,Bladder Urothelial Carcinoma,CGS-21680,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Bladder Urothelial Carcinoma,BRD-K12829205-003-02-8::2.5::HTS,4.8760513154188345,0.02766082804915144,Bladder Urothelial Carcinoma,mechlorethamine,DNA inhibitor,
Bladder Urothelial Carcinoma,BRD-K13514097-001-05-3::2.5::HTS,4.800736325849774,0.02886109452193008,Other Types,everolimus,mTOR inhibitor,MTOR
Bladder Urothelial Carcinoma,BRD-K13646352-001-03-8::2.5::HTS,4.960239792882065,0.026337650559670776,Other Types,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Bladder Urothelial Carcinoma,BRD-K14619660-001-01-5::2.5::HTS,6.817299845298744,0.009271093828371666,Bladder Urothelial Carcinoma,altrenogest,progestogen hormone,PGR
Bladder Urothelial Carcinoma,BRD-K14711741-001-02-1::2.5::HTS,4.707174074857538,0.030455329916065567,Other Types,PF-4708671,ribosomal protein inhibitor,RPS6KB1
Bladder Urothelial Carcinoma,BRD-K14993104-001-05-9::2.5::HTS,5.368923481976419,0.02086099302441255,Other Types,bemegride,chemoreceptor agonist,GABRA1
Bladder Urothelial Carcinoma,BRD-K15424032-001-03-6::2.5::HTS,6.295174148809375,0.012392109990342962,Other Types,SB-228357,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Bladder Urothelial Carcinoma,BRD-K16551401-003-03-4::2.5::HTS,5.0042248298648095,0.025680368106147496,Other Types,PNU-22394,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C, MAOA, MAOB"
Bladder Urothelial Carcinoma,BRD-K16664969-001-03-3::2.5::HTS,5.869580573141602,0.015724328078956202,Other Types,GTP-14564,"FLT3 inhibitor, tyrosine kinase inhibitor","CSF1R, FLT3, KIT, PDGFRB"
Bladder Urothelial Carcinoma,BRD-K17008822-303-02-1::2.5::HTS,4.339062121723346,0.03770542631543179,Other Types,BD-1008,sigma receptor antagonist,
Bladder Urothelial Carcinoma,BRD-K17016787-001-16-7::2.5::HTS,4.6991660215766275,0.030597825673974066,Bladder Urothelial Carcinoma,estriol,estrogen receptor agonist,"ESR1, ESR2"
Bladder Urothelial Carcinoma,BRD-K17565903-066-23-1::2.5::HTS,4.309408396406067,0.03836030746031954,Bladder Urothelial Carcinoma,pridinol,muscle relaxant,
Bladder Urothelial Carcinoma,BRD-K17702546-001-03-2::2.5::HTS,10.104993874014806,0.0015600315380937188,Other Types,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Bladder Urothelial Carcinoma,BRD-K19111024-001-20-9::2.5::HTS,9.94271952652665,0.001704786747042624,Bladder Urothelial Carcinoma,clofibric-acid,PPAR receptor agonist,PPARA
Bladder Urothelial Carcinoma,BRD-K19136521-001-08-9::2.5::HTS,6.156972292385633,0.013385058900698604,Other Types,indirubin-3-monoxime,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B"
Bladder Urothelial Carcinoma,BRD-K19352500-070-12-4::2.5::HTS,5.358207302319123,0.02098764307834179,Bladder Urothelial Carcinoma,prochlorperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4"
Bladder Urothelial Carcinoma,BRD-K19540840-001-09-4::2.5::HTS,15.342359942155376,0.00010071553325433185,Other Types,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Bladder Urothelial Carcinoma,BRD-K19687926-379-07-4::2.5::HTS,12.654109210759897,0.0004066094054210882,Other Types,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Bladder Urothelial Carcinoma,BRD-K21520694-236-02-6::2.5::HTS,5.110180552837226,0.024167564265941657,Bladder Urothelial Carcinoma,sulfacetamide,PABA antagonist,
Bladder Urothelial Carcinoma,BRD-K21728777-001-02-3::2.5::HTS,3.9170196408815463,0.0482906664685957,Other Types,AMG900,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Bladder Urothelial Carcinoma,BRD-K21906513-001-04-0::2.36::HTS,9.173896486746731,0.0025750120987886186,Other Types,UNC669,L3MBTL antagonist,L3MBTL1
Bladder Urothelial Carcinoma,BRD-K23163214-050-15-1::2.5::HTS,4.885705246408395,0.027484230676873677,Bladder Urothelial Carcinoma,dizocilpine-(-),glutamate receptor antagonist,
Bladder Urothelial Carcinoma,BRD-K23190681-001-01-1::2.5::HTS,10.19206657265471,0.0014904772651025645,Other Types,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Bladder Urothelial Carcinoma,BRD-K23204545-001-16-4::2.5::HTS,7.544164668423836,0.006216301226255096,Bladder Urothelial Carcinoma,busulfan,DNA inhibitor,
Bladder Urothelial Carcinoma,BRD-K24548560-342-02-1::2.5::HTS,4.021303077628927,0.04540795146119435,Bladder Urothelial Carcinoma,evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1"
Bladder Urothelial Carcinoma,BRD-K24556098-001-16-7::2.45::HTS,7.636793096751825,0.005918587373339123,Bladder Urothelial Carcinoma,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Bladder Urothelial Carcinoma,BRD-K24566386-001-01-9::2.5::HTS,8.924738326904507,0.0029385883943916363,Other Types,SD-208,TGF beta receptor inhibitor,TGFBR1
Bladder Urothelial Carcinoma,BRD-K24820488-001-01-7::2.5::HTS,13.419355181359096,0.00027272787058055297,Other Types,CH-170,,
Bladder Urothelial Carcinoma,BRD-K24869513-001-02-1::2.5::HTS,9.440689474264088,0.0022250441495397684,Other Types,CNX-2006,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K25312248-001-01-5::2.5::HTS,4.42923523970935,0.03577818041609024,Other Types,matrine,opioid receptor agonist,OPRK1
Bladder Urothelial Carcinoma,BRD-K26603252-003-04-9::2.5::HTS,8.553902788821514,0.003591055027740271,Other Types,PD-153035,EGFR inhibitor,"EGFR, KDR"
Bladder Urothelial Carcinoma,BRD-K27382019-418-01-9::2.5::HTS,7.3668181031687965,0.006851565975146047,Bladder Urothelial Carcinoma,piperaquine-phosphate,antimalarial agent,
Bladder Urothelial Carcinoma,BRD-K27393415-001-01-0::2.5::HTS,6.11103070794425,0.01373449221162639,Bladder Urothelial Carcinoma,xipamide,carbonic anhydrase inhibitor,SLC12A3
Bladder Urothelial Carcinoma,BRD-K27938825-001-02-4::2.5::HTS,4.185463419162313,0.04123949912150762,Bladder Urothelial Carcinoma,ASA-404,angiogenesis inhibitor,
Bladder Urothelial Carcinoma,BRD-K28192623-066-08-1::2.5::HTS,5.09522792028208,0.024378280069654534,Other Types,spiradoline,opioid receptor agonist,OPRK1
Bladder Urothelial Carcinoma,BRD-K28352084-001-02-3::2.5::HTS,11.076792487335473,0.0009317639973489197,Other Types,CH5132799,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Bladder Urothelial Carcinoma,BRD-K28405228-001-06-7::2.5::HTS,5.644141120200799,0.017852943182333027,Other Types,mecarbinate,,
Bladder Urothelial Carcinoma,BRD-K28761384-300-01-0::2.5::HTS,4.596941907395987,0.032457378600230624,Other Types,zuclopenthixol,dopamine receptor antagonist,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A"
Bladder Urothelial Carcinoma,BRD-K28971625-003-01-4::2.5::HTS,4.484507453499311,0.03465474810262063,Other Types,ZD-7114,adrenergic receptor agonist,ADRB3
Bladder Urothelial Carcinoma,BRD-K28982731-001-01-6::2.5::HTS,5.374198140099648,0.02079797523719957,Bladder Urothelial Carcinoma,emoxipin,,
Bladder Urothelial Carcinoma,BRD-K29542628-001-03-9::2.5::HTS,3.8724229974824125,0.04958576477814848,Other Types,1-naphthyl-PP1,src inhibitor,SRC
Bladder Urothelial Carcinoma,BRD-K29582115-066-01-2::2.5::HTS,5.70551865117625,0.0172503401854883,Other Types,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4"
Bladder Urothelial Carcinoma,BRD-K29713308-001-01-7::2.5::HTS,5.076375167140839,0.02464226703475432,Bladder Urothelial Carcinoma,mebhydrolin,antihistamine,
Bladder Urothelial Carcinoma,BRD-K30019776-003-01-5::2.5::HTS,4.874505321852581,0.027685381979171413,Other Types,dexfosfoserine,membrane integrity inhibitor,"CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2"
Bladder Urothelial Carcinoma,BRD-K30649484-003-13-7::2.5::HTS,4.253656312349496,0.039629036181444074,Bladder Urothelial Carcinoma,mafenide,carbonic anhydrase inhibitor,"CA12, CA14, CA2, CA4, CA6, CA9"
Bladder Urothelial Carcinoma,BRD-K31054881-300-04-7::2.5::HTS,4.195266731868379,0.04100355503713525,Bladder Urothelial Carcinoma,BMY-7378,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A"
Bladder Urothelial Carcinoma,BRD-K33583600-001-16-1::2.5::HTS,7.038280861653275,0.00820743005330658,Other Types,isoliquiritigenin,guanylate cyclase activator,GABBR1
Bladder Urothelial Carcinoma,BRD-K33610132-001-02-9::2.5::HTS,12.09678068052428,0.0005448406895865738,Other Types,rociletinib,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K33743361-003-02-6::2.5::HTS,5.52383641777738,0.019103872942111837,Other Types,ML133,potassium channel blocker,
Bladder Urothelial Carcinoma,BRD-K34441861-003-07-0::2.47::HTS,4.028723408948848,0.04524094761923702,Bladder Urothelial Carcinoma,moexipril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Bladder Urothelial Carcinoma,BRD-K34469523-003-03-0::2.5::HTS,4.122899306799396,0.04278712165880315,Bladder Urothelial Carcinoma,levalbuterol,adrenergic receptor agonist,ADRB2
Bladder Urothelial Carcinoma,BRD-K35586044-003-15-4::2.5::HTS,5.272950063813066,0.022033003729182734,Other Types,yohimbine,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
Bladder Urothelial Carcinoma,BRD-K35601925-001-01-9::2.5::HTS,5.823183506152002,0.016139876284678303,Bladder Urothelial Carcinoma,CS-917,fructose biphosphate inhibitor,FBP1
Bladder Urothelial Carcinoma,BRD-K36732695-001-01-9::2.5::HTS,4.95777412046457,0.026370579356078606,Bladder Urothelial Carcinoma,setiptiline,adrenergic receptor antagonist,"HRH1, HTR2A, HTR2C"
Bladder Urothelial Carcinoma,BRD-K36740062-001-06-6::2.5::HTS,6.131415658383158,0.013576622665699698,Other Types,GSK1070916,Aurora kinase inhibitor,"AURKA, AURKB, AURKC, CYP2D6, CYP3A4"
Bladder Urothelial Carcinoma,BRD-K36862742-001-25-6::2.5::HTS,4.3788844870283565,0.03683875638800466,Bladder Urothelial Carcinoma,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,"ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3"
Bladder Urothelial Carcinoma,BRD-K37270826-001-31-8::2.5::HTS,4.146978201219067,0.0421813658884649,Bladder Urothelial Carcinoma,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Bladder Urothelial Carcinoma,BRD-K37289225-001-36-4::2.5::HTS,4.421179535160555,0.03595267916529241,Bladder Urothelial Carcinoma,clozapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Bladder Urothelial Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,4.901915012642503,0.027227554370608607,Other Types,AZD8330,MEK inhibitor,
Bladder Urothelial Carcinoma,BRD-K38183498-001-02-0::2.5::HTS,11.055991925280315,0.0009433690453028593,Other Types,clonazepam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Bladder Urothelial Carcinoma,BRD-K38852836-001-02-1::2.5::HTS,5.9397589555258605,0.015112200754893095,Other Types,ganetespib,HSP inhibitor,HSP90AA1
Bladder Urothelial Carcinoma,BRD-K39841531-001-02-1::2.5::HTS,4.53749754579156,0.0335968579505911,Other Types,TG-101209,JAK inhibitor,"JAK2, JAK3"
Bladder Urothelial Carcinoma,BRD-K40718343-001-02-6::2.5::HTS,10.952036520809786,0.0009948866828257499,Other Types,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Bladder Urothelial Carcinoma,BRD-K41524689-001-23-5::2.5::HTS,3.946246636927968,0.047475481463566394,Bladder Urothelial Carcinoma,paracetamol,cyclooxygenase inhibitor,"FAAH, PTGS1, PTGS2, TRPV1"
Bladder Urothelial Carcinoma,BRD-K41876534-001-13-7::2.5::HTS,6.119273081638685,0.013668610144359482,Other Types,tioxolone,carbonic anhydrase inhibitor,CA2
Bladder Urothelial Carcinoma,BRD-K42436189-001-01-2::2.5::HTS,4.298994285617865,0.03858992299203709,Other Types,AZ20,ATR kinase inhibitor,"ATR, MTOR"
Bladder Urothelial Carcinoma,BRD-K42805893-001-04-9::2.5::HTS,5.1245271364271545,0.02397041956137648,Other Types,osimertinib,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K44844162-001-01-6::2.5::HTS,5.333124838163953,0.021292086546223166,Other Types,taselisib,PI3K inhibitor,PIK3CA
Bladder Urothelial Carcinoma,BRD-K45252063-001-13-6::2.5::HTS,6.2318205390619115,0.012837980405027248,Bladder Urothelial Carcinoma,clofibrate,PPAR receptor agonist,"LPL, PPARA"
Bladder Urothelial Carcinoma,BRD-K45662124-050-01-5::2.5::HTS,3.969565628630543,0.04681560386692408,Bladder Urothelial Carcinoma,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2
Bladder Urothelial Carcinoma,BRD-K46386702-001-02-1::2.5::HTS,4.905477903643111,0.027175543196735073,Other Types,ARRY-334543,EGFR inhibitor,ERBB2
Bladder Urothelial Carcinoma,BRD-K47557313-001-02-7::2.5::HTS,12.09850240448568,0.0005439842565024569,Other Types,LY2109761,TGF beta receptor inhibitor,"TGFBR1, TGFBR2"
Bladder Urothelial Carcinoma,BRD-K47639036-003-06-6::2.5::HTS,4.4849466623912795,0.034642633051110705,Bladder Urothelial Carcinoma,flavoxate,acetylcholine receptor antagonist,"CHRM1, CHRM2"
Bladder Urothelial Carcinoma,BRD-K48619321-004-16-8::2.54::HTS,5.173842613195855,0.023329682971286996,Bladder Urothelial Carcinoma,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Bladder Urothelial Carcinoma,BRD-K48692744-001-02-0::2.5::HTS,4.966103531856968,0.026251500753554317,Bladder Urothelial Carcinoma,NU-1025,PARP inhibitor,PARP1
Bladder Urothelial Carcinoma,BRD-K48812570-001-02-3::2.5::HTS,4.4569312588344046,0.03521378453223733,Other Types,macitentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Bladder Urothelial Carcinoma,BRD-K48996094-001-01-3::2.5::HTS,17.80132792023817,2.866288886672078e-05,Bladder Urothelial Carcinoma,pentacosanoic-acid,,
Bladder Urothelial Carcinoma,BRD-K49055432-001-04-2::2.5::HTS,9.72879657566545,0.0019076579317271682,Other Types,A66,PI3K inhibitor,PIK3CA
Bladder Urothelial Carcinoma,BRD-K49119234-003-02-6::2.5::HTS,4.119330286142492,0.0428733022178091,Other Types,TMPH,,
Bladder Urothelial Carcinoma,BRD-K49215523-001-04-2::2.5::HTS,4.598115447314314,0.03244312420175533,Bladder Urothelial Carcinoma,GSK2636771,PI3K inhibitor,PIK3CB
Bladder Urothelial Carcinoma,BRD-K49236613-001-02-3::2.5::HTS,4.841962670883249,0.028187221566468232,Other Types,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1
Bladder Urothelial Carcinoma,BRD-K49294207-300-03-8::2.5::HTS,8.527124994237202,0.003641850338353513,Other Types,BIBU-1361,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K49554218-001-01-0::2.5::HTS,3.991927245802634,0.046208895841414944,Bladder Urothelial Carcinoma,carebastine,histamine receptor antagonist,HRH1
Bladder Urothelial Carcinoma,BRD-K49880111-236-09-2::2.5::HTS,6.482459806905365,0.011162572323144233,Bladder Urothelial Carcinoma,cephapirin,bacterial cell wall synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-K49962337-001-01-1::2.5::HTS,5.106038075131035,0.0242248018150134,Other Types,baicalin,beta glucuronidase inhibitor,PREP
Bladder Urothelial Carcinoma,BRD-K50071428-001-03-3::2.5::HTS,8.16835191256072,0.004423076768833743,Bladder Urothelial Carcinoma,abiraterone,androgen biosynthesis inhibitor,"CYP11B1, CYP17A1"
Bladder Urothelial Carcinoma,BRD-K50168500-001-07-9::2.5::HTS,18.945341000356496,1.600744944362954e-05,Other Types,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Bladder Urothelial Carcinoma,BRD-K51471001-303-04-7::2.5::HTS,3.9297458131301544,0.04793272103300819,Bladder Urothelial Carcinoma,demecarium,acetylcholinesterase inhibitor,"ACHE, BCHE"
Bladder Urothelial Carcinoma,BRD-K51662849-001-05-4::2.5::HTS,7.1510865400558155,0.00771922185456217,Other Types,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Bladder Urothelial Carcinoma,BRD-K51747290-001-13-1::2.5::HTS,5.1686217375606125,0.023390999561241535,Bladder Urothelial Carcinoma,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Bladder Urothelial Carcinoma,BRD-K52075040-001-09-7::5.6::HTS,5.53136745867468,0.019027622994489124,Other Types,cerulenin,fatty acid synthase inhibitor,FASN
Bladder Urothelial Carcinoma,BRD-K52075715-001-06-7::2.5::HTS,4.048956887584879,0.04467528113180249,Other Types,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Bladder Urothelial Carcinoma,BRD-K52751261-001-06-1::2.5::HTS,4.184185651046394,0.041272037918167706,Other Types,TAK-715,p38 MAPK inhibitor,MAPK14
Bladder Urothelial Carcinoma,BRD-K52911425-001-09-8::2.5::HTS,4.4637643392328235,0.035061463636835655,Other Types,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Bladder Urothelial Carcinoma,BRD-K53979406-003-02-8::2.5::HTS,5.5164413515428405,0.01919877616356224,Bladder Urothelial Carcinoma,ALX-5407,Glycine transporter 1 inhibitor,SLC6A9
Bladder Urothelial Carcinoma,BRD-K54665485-001-07-9::2.5::HTS,4.131503389492559,0.042565756509166996,Bladder Urothelial Carcinoma,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA
Bladder Urothelial Carcinoma,BRD-K54759182-003-08-0::2.5::HTS,5.867421627164986,0.015739412383516487,Bladder Urothelial Carcinoma,dosulepin,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4"
Bladder Urothelial Carcinoma,BRD-K54824716-001-04-0::2.5::HTS,5.692372380413859,0.017371319595730017,Bladder Urothelial Carcinoma,procodazole,immunostimulant,
Bladder Urothelial Carcinoma,BRD-K54997624-001-06-0::2.5::HTS,11.7443010586852,0.0006549406637593285,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Bladder Urothelial Carcinoma,BRD-K56032964-001-02-1::2.5::HTS,4.947483500087821,0.026526572914473908,Other Types,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Bladder Urothelial Carcinoma,BRD-K56156805-001-09-6::2.5::HTS,3.934658323361069,0.047801177429861404,Other Types,benznidazole,DNA synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-K56543881-001-02-7::2.5::HTS,6.753885745964547,0.009601726838849628,Bladder Urothelial Carcinoma,ADX-47273,glutamate receptor modulator,GRM5
Bladder Urothelial Carcinoma,BRD-K57136142-001-02-4::2.5::HTS,9.69166343374385,0.0019460875508465058,Other Types,CCT129202,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Bladder Urothelial Carcinoma,BRD-K57169635-001-04-5::2.5::HTS,4.0591021137226,0.04440962871669328,Other Types,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Bladder Urothelial Carcinoma,BRD-K58299615-001-03-5::2.5::HTS,4.514058935371151,0.034083069907472105,Other Types,Ro-90-7501,,APP
Bladder Urothelial Carcinoma,BRD-K58568447-001-01-1::2.5::HTS,5.290688546958387,0.021807179392399755,Other Types,K02288,bone morphogenic protein inhibitor,BMP1
Bladder Urothelial Carcinoma,BRD-K58819470-001-05-9::2.5::HTS,4.333023332048759,0.037835037000071986,Bladder Urothelial Carcinoma,2-thiouracil,,
Bladder Urothelial Carcinoma,BRD-K59227464-334-02-4::2.5::HTS,8.697366052569633,0.003319286653521529,Other Types,LY2228820,p38 MAPK inhibitor,MAPK14
Bladder Urothelial Carcinoma,BRD-K59875992-001-01-8::2.5::HTS,9.552688208107508,0.0020954385150976597,Other Types,FPL-62064,"cyclooxygenase inhibitor, lipoxygenase inhibitor",
Bladder Urothelial Carcinoma,BRD-K61036791-001-01-6::2.5::HTS,13.796109221642547,0.00022417387648853058,Other Types,rucinol,tyrosinase inhibitor,TYR
Bladder Urothelial Carcinoma,BRD-K62200014-003-10-5::2.5::HTS,6.343227668192808,0.012065095673360334,Bladder Urothelial Carcinoma,anagrelide,phosphodiesterase inhibitor,PDE3A
Bladder Urothelial Carcinoma,BRD-K62326629-001-19-0::2.5::HTS,7.2617445907887195,0.007260834903356533,Other Types,dichlorophen,anticestodal agent,
Bladder Urothelial Carcinoma,BRD-K62537556-001-02-5::2.5::HTS,4.310665448401804,0.03833635259310518,Bladder Urothelial Carcinoma,4-IBP,sigma receptor agonist,SIGMAR1
Bladder Urothelial Carcinoma,BRD-K62737565-003-02-6::2.5::HTS,4.959229182952979,0.026350741332004508,Bladder Urothelial Carcinoma,gabapentin,calcium channel blocker,"ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Bladder Urothelial Carcinoma,BRD-K62996583-001-10-3::2.5::HTS,8.130657391048514,0.004513713768838761,Bladder Urothelial Carcinoma,lidoflazine,calcium channel blocker,"SCN1A, SCN3A, SLC29A1"
Bladder Urothelial Carcinoma,BRD-K63343048-001-12-2::2.5::HTS,3.99433942156567,0.04614507598938232,Bladder Urothelial Carcinoma,orlistat,lipase inhibitor,"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP"
Bladder Urothelial Carcinoma,BRD-K63533170-001-02-9::2.5::HTS,4.556677430989508,0.03322649067284073,Bladder Urothelial Carcinoma,AM-630,cannabinoid receptor antagonist,"CNR1, CNR2"
Bladder Urothelial Carcinoma,BRD-K63932022-001-01-5::2.5::HTS,4.722352307769092,0.030192191336527167,Bladder Urothelial Carcinoma,2'-MeCCPA,adenosine receptor agonist,ADORA1
Bladder Urothelial Carcinoma,BRD-K64052750-001-17-5::2.5::HTS,8.446146663574153,0.0038050095630644755,Other Types,gefitinib,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K64800655-001-07-4::2.5::HTS,4.74242293779621,0.029842735761340278,Other Types,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Bladder Urothelial Carcinoma,BRD-K64994968-001-32-5::2.5::HTS,5.449069172914953,0.019936521293701007,Bladder Urothelial Carcinoma,progesterone,progesterone receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5"
Bladder Urothelial Carcinoma,BRD-K65786282-001-07-5::2.5::HTS,3.916117611351779,0.04831464229135156,Bladder Urothelial Carcinoma,CGP-7930,GABA receptor modulator,GABBR1
Bladder Urothelial Carcinoma,BRD-K65890018-236-01-1::2.5::HTS,7.402979471630612,0.006714777681419165,Other Types,SSR128129E,,
Bladder Urothelial Carcinoma,BRD-K66175015-001-09-0::2.5::HTS,4.6819730254304925,0.030913698750123095,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Bladder Urothelial Carcinoma,BRD-K66527818-001-02-6::2.5::HTS,3.9503626118303217,0.04734614518813838,Bladder Urothelial Carcinoma,VU0364770,glutamate receptor positive allosteric modulator,GRM4
Bladder Urothelial Carcinoma,BRD-K67068943-001-01-0::2.5::HTS,5.2786896675451285,0.021959169520993138,Bladder Urothelial Carcinoma,ORE1001,angiotensin converting enzyme inhibitor,ACE2
Bladder Urothelial Carcinoma,BRD-K67860401-001-05-6::2.5::HTS,6.535852894655647,0.010835273971966649,Bladder Urothelial Carcinoma,AR-A014418,glycogen synthase kinase inhibitor,GSK3B
Bladder Urothelial Carcinoma,BRD-K67868012-001-07-6::2.5::HTS,6.208658392463979,0.012999866493027614,Other Types,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Bladder Urothelial Carcinoma,BRD-K68065987-300-09-1::2.5::HTS,5.772869050545987,0.016603960396140642,Other Types,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Bladder Urothelial Carcinoma,BRD-K68174511-001-06-6::2.5::HTS,4.490888253379718,0.03451387385670153,Other Types,torin-2,mTOR inhibitor,MTOR
Bladder Urothelial Carcinoma,BRD-K68188368-001-09-4::2.5::HTS,4.558176510914513,0.0331968812916703,Bladder Urothelial Carcinoma,nifuroxazide,bacterial DNA inhibitor,
Bladder Urothelial Carcinoma,BRD-K68232413-001-01-2::2.5::HTS,7.260227862476869,0.007261425463924815,Bladder Urothelial Carcinoma,etizolam,benzodiazepine receptor agonist,GABRA1
Bladder Urothelial Carcinoma,BRD-K68336408-001-10-9::2.5::HTS,10.632450532676312,0.0011789779283796079,Other Types,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Bladder Urothelial Carcinoma,BRD-K68488863-001-04-9::2.5::HTS,4.539621700471778,0.03355397874474777,Other Types,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC"
Bladder Urothelial Carcinoma,BRD-K68870568-066-01-5::2.5::HTS,4.693926900224173,0.03069044095600703,Bladder Urothelial Carcinoma,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Bladder Urothelial Carcinoma,BRD-K69070623-003-01-7::2.5::HTS,6.22470609917368,0.012883871407604603,Bladder Urothelial Carcinoma,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L
Bladder Urothelial Carcinoma,BRD-K69600043-328-05-5::2.5::HTS,7.210085444904412,0.007463607796390849,Other Types,thiethylperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD4"
Bladder Urothelial Carcinoma,BRD-K70281171-050-08-9::2.5::HTS,5.2616622287085395,0.022174945427224806,Bladder Urothelial Carcinoma,U-99194,dopamine receptor antagonist,DRD3
Bladder Urothelial Carcinoma,BRD-K70358946-001-15-7::2.5::HTS,4.3970070573455065,0.03644996856484872,Bladder Urothelial Carcinoma,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Bladder Urothelial Carcinoma,BRD-K70401845-003-09-6::2.5::HTS,25.159449942970994,7.096419417122585e-07,Other Types,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Bladder Urothelial Carcinoma,BRD-K70507123-001-09-7::2.5::HTS,7.521621729033968,0.00629136766933078,Bladder Urothelial Carcinoma,doxofylline,adenosine receptor antagonist,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D"
Bladder Urothelial Carcinoma,BRD-K70914287-300-02-8::2.5::HTS,7.016192535060657,0.008305501333018888,Other Types,BIBX-1382,EGFR inhibitor,"EGFR, ERBB2"
Bladder Urothelial Carcinoma,BRD-K71926323-001-14-6::2.52::HTS,8.671410641349738,0.0033721866578180983,Other Types,marbofloxacin,bacterial DNA gyrase inhibitor,
Bladder Urothelial Carcinoma,BRD-K72005722-001-01-2::2.5::HTS,4.763281379621544,0.029487790299323267,Bladder Urothelial Carcinoma,VT-464,cytochrome P450 inhibitor,CYP17A1
Bladder Urothelial Carcinoma,BRD-K72222507-003-16-8::2.5::HTS,14.019879510358292,0.00019959157638569524,Bladder Urothelial Carcinoma,quinapril,angiotensin converting enzyme inhibitor,ACE
Bladder Urothelial Carcinoma,BRD-K72414522-001-06-7::2.5::HTS,5.238197395967368,0.02246766123716943,Other Types,AZD5438,CDK inhibitor,KCNH2
Bladder Urothelial Carcinoma,BRD-K72420232-001-12-3::2.5::HTS,6.024937044398254,0.01441161015068374,Other Types,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Bladder Urothelial Carcinoma,BRD-K72542090-304-02-4::2.5::HTS,9.48302409712189,0.00218215201628016,Other Types,clodronic-acid,bone resorption inhibitor,"SLC25A4, SLC25A5, SLC25A6"
Bladder Urothelial Carcinoma,BRD-K73309154-003-02-8::2.5::HTS,14.516824939496981,0.00015423535873322042,Other Types,OSI-420,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K73368362-001-07-5::2.5::HTS,5.23598203071909,0.0225000539624998,Other Types,BIX-02189,MEK inhibitor,"MAP2K5, MAPK7"
Bladder Urothelial Carcinoma,BRD-K73642618-001-13-3::2.5::HTS,5.902385157624888,0.015435492407528617,Bladder Urothelial Carcinoma,bromopride,dopamine receptor antagonist,DRD2
Bladder Urothelial Carcinoma,BRD-K73771095-001-03-3::2.5::HTS,10.066176519182948,0.0015938547174340549,Bladder Urothelial Carcinoma,geniposidic-acid,cyclooxygenase inhibitor,
Bladder Urothelial Carcinoma,BRD-K75089421-003-24-5::2.5::HTS,5.984575815183382,0.01474249842987535,Bladder Urothelial Carcinoma,procainamide,sodium channel blocker,"DNMT1, SCN5A"
Bladder Urothelial Carcinoma,BRD-K76239644-001-01-8::2.5::HTS,6.590780169969508,0.010509795847129305,Other Types,BMS-690514,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR"
Bladder Urothelial Carcinoma,BRD-K76609936-001-08-4::2.5::HTS,5.838141023408064,0.016011238291420843,Bladder Urothelial Carcinoma,imidacloprid,acetylcholine receptor antagonist,CHRFAM7A
Bladder Urothelial Carcinoma,BRD-K76812510-236-14-8::2.5::HTS,4.023977269753067,0.04534522970972491,Bladder Urothelial Carcinoma,metamizole,"cyclooxygenase inhibitor, opioid receptor agonist",PTGS1
Bladder Urothelial Carcinoma,BRD-K76953762-001-08-5::2.5::HTS,7.073769371914833,0.008049720721955268,Bladder Urothelial Carcinoma,indoramin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C"
Bladder Urothelial Carcinoma,BRD-K77625799-001-07-7::2.5::HTS,4.057299874910297,0.04445669819248482,Other Types,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Bladder Urothelial Carcinoma,BRD-K77947974-001-16-3::2.5::HTS,4.05834785318302,0.044439712938099875,Bladder Urothelial Carcinoma,fluspirilene,dopamine receptor antagonist,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A"
Bladder Urothelial Carcinoma,BRD-K78113049-001-16-2::2.5::HTS,4.030274110560002,0.04517755962960223,Bladder Urothelial Carcinoma,enoxacin,topoisomerase inhibitor,TOP2A
Bladder Urothelial Carcinoma,BRD-K79145749-003-02-2::2.5::HTS,4.008736858715706,0.04575914824855667,Bladder Urothelial Carcinoma,dibenzepine,norepinephrine reputake inhibitor,
Bladder Urothelial Carcinoma,BRD-K79254416-001-22-6::2.5::HTS,3.9915807049718266,0.04621479923696006,Other Types,decitabine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Bladder Urothelial Carcinoma,BRD-K79905821-004-03-6::2.5::HTS,4.465540148813888,0.03503332098949531,Bladder Urothelial Carcinoma,gabazine,GABA receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2"
Bladder Urothelial Carcinoma,BRD-K79930101-300-03-7::2.5::HTS,6.636248030223134,0.010246615141331546,Other Types,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Bladder Urothelial Carcinoma,BRD-K80608265-001-01-6::2.5::HTS,5.244605729359207,0.02241599841680935,Other Types,erteberel,estrogen receptor agonist,"ESR1, ESR2"
Bladder Urothelial Carcinoma,BRD-K81144366-003-19-7::2.5::HTS,8.967126940650314,0.0028702563374136993,Bladder Urothelial Carcinoma,moxisylyte,adrenergic receptor antagonist,
Bladder Urothelial Carcinoma,BRD-K81326768-001-04-0::2.5::HTS,3.8639205776162915,0.049831273555777225,Other Types,zomepirac,prostaglandin synthesis inhibitor,PTGDR2
Bladder Urothelial Carcinoma,BRD-K81332461-001-01-4::2.5::HTS,3.9259189018818343,0.04805488100871827,Other Types,maxacalcitol,vitamin D receptor agonist,VDR
Bladder Urothelial Carcinoma,BRD-K82091397-001-03-0::2.5::HTS,6.271855326720505,0.012553295563011015,Other Types,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Bladder Urothelial Carcinoma,BRD-K82164249-001-03-5::2.5::HTS,6.720948141089366,0.00977890818036264,Bladder Urothelial Carcinoma,andarine,androgen receptor modulator,AR
Bladder Urothelial Carcinoma,BRD-K83023055-001-02-7::2.5::HTS,5.731307771595005,0.016993621404971748,Bladder Urothelial Carcinoma,GR-135531,melatonin receptor agonist,
Bladder Urothelial Carcinoma,BRD-K83192048-050-02-7::2.5::HTS,4.559212209563167,0.03318171404319153,Bladder Urothelial Carcinoma,dimethindene-(S)-(+),acetylcholine receptor antagonist,HRH1
Bladder Urothelial Carcinoma,BRD-K85406984-001-01-0::2.5::HTS,4.034543008447591,0.045076933193044996,Other Types,sobetirome,thyroid hormone receptor agonist,"THRA, THRB"
Bladder Urothelial Carcinoma,BRD-K85503079-001-02-8::2.5::HTS,7.021803205940953,0.008283162039806889,Bladder Urothelial Carcinoma,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, DRD3, DRD4"
Bladder Urothelial Carcinoma,BRD-K85606544-001-09-1::2.5::HTS,6.128088293281803,0.013611314033835129,Other Types,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Bladder Urothelial Carcinoma,BRD-K85849709-001-01-5::2.5::HTS,4.452429569293969,0.035296155788854075,Other Types,AZD2858,glycogen synthase kinase inhibitor,GSK3B
Bladder Urothelial Carcinoma,BRD-K86301799-001-34-8::2.5::HTS,4.145765688350439,0.0422113518770282,Bladder Urothelial Carcinoma,dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1"
Bladder Urothelial Carcinoma,BRD-K86972824-001-02-2::2.5::HTS,4.975014383037945,0.026117119005379146,Bladder Urothelial Carcinoma,oltipraz,"nuclear factor erythroid derived, like (NRF2) activator",ANG
Bladder Urothelial Carcinoma,BRD-K87024524-065-17-7::2.5::HTS,4.212139548946259,0.04061806396462094,Other Types,phenelzine,monoamine oxidase inhibitor,"ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4"
Bladder Urothelial Carcinoma,BRD-K87782578-001-01-4::2.5::HTS,4.603813238394268,0.032330942149332256,Other Types,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,"BTK, YES1"
Bladder Urothelial Carcinoma,BRD-K88219015-001-10-8::2.5::HTS,4.420891881989203,0.03595868975808932,Bladder Urothelial Carcinoma,asaraldehyde,cyclooxygenase inhibitor,PTGS2
Bladder Urothelial Carcinoma,BRD-K88553858-001-02-7::2.5::HTS,4.227134148488285,0.040248015843418666,Bladder Urothelial Carcinoma,benurestat,urease inhibitor,
Bladder Urothelial Carcinoma,BRD-K89104321-003-14-8::2.5::HTS,5.472978092473251,0.01966510453158273,Bladder Urothelial Carcinoma,gaboxadol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3"
Bladder Urothelial Carcinoma,BRD-K89274813-001-02-3::2.5::HTS,6.259568041342023,0.012637072490285756,Bladder Urothelial Carcinoma,DMP-543,acetylcholine release enhancer,
Bladder Urothelial Carcinoma,BRD-K89657519-001-01-8::2.5::HTS,5.20552827216907,0.022893688855072054,Bladder Urothelial Carcinoma,testosterone-enanthate,androgen receptor agonist,AR
Bladder Urothelial Carcinoma,BRD-K89839824-001-05-3::2.5::HTS,4.110720029785731,0.04309040902085616,Other Types,raltitrexed,thymidylate synthase inhibitor,"FPGS, TYMS"
Bladder Urothelial Carcinoma,BRD-K90885812-004-24-2::2.5::HTS,7.694430626932357,0.005724890695820739,Bladder Urothelial Carcinoma,propantheline,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Bladder Urothelial Carcinoma,BRD-K90947825-001-02-7::2.5::HTS,10.00405863940295,0.0016528499631134356,Other Types,carboplatin,"DNA alkylating agent, DNA inhibitor",
Bladder Urothelial Carcinoma,BRD-K91159026-001-01-7::2.5::HTS,4.184929771188074,0.041252383822959475,Bladder Urothelial Carcinoma,telcagepant,calcitonin antagonist,"CALCRL, RAMP1"
Bladder Urothelial Carcinoma,BRD-K91315211-300-05-7::2.5::HTS,4.120631351687152,0.042836322795761814,Bladder Urothelial Carcinoma,betahistine,"histamine receptor agonist, histamine receptor antagonist","HRH1, HRH3"
Bladder Urothelial Carcinoma,BRD-K92382976-050-01-1::2.5::HTS,4.89765377874643,0.027297102372027662,Bladder Urothelial Carcinoma,5-carboxamidotryptamine,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
Bladder Urothelial Carcinoma,BRD-K92577649-300-01-2::2.5::HTS,4.995860576369945,0.02580009879920841,Other Types,GBR-13069,dopamine uptake inhibitor,SLC6A3
Bladder Urothelial Carcinoma,BRD-K92613113-066-02-7::2.5::HTS,4.004572144456012,0.04585738032966928,Other Types,safinamide,"dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor",MAOB
Bladder Urothelial Carcinoma,BRD-K92968657-001-01-6::2.5::HTS,4.323795008843261,0.038035829964611564,Other Types,tirapazamine,DNA inhibitor,
Bladder Urothelial Carcinoma,BRD-K92984783-003-05-7::2.5::HTS,5.60919821034251,0.01820498505973571,Bladder Urothelial Carcinoma,melperone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Bladder Urothelial Carcinoma,BRD-K94485812-001-02-9::2.55::HTS,4.1846077891176785,0.04128763869107548,Bladder Urothelial Carcinoma,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Bladder Urothelial Carcinoma,BRD-K94723713-001-10-6::2.5::HTS,4.971630886389659,0.02616633089242049,Other Types,rutaecarpine,cyclooxygenase inhibitor,PTGS2
Bladder Urothelial Carcinoma,BRD-K94832621-001-02-3::2.5::HTS,13.33569810618068,0.0002849139511879581,Other Types,Y-134,estrogen receptor antagonist,"ESR1, ESR2"
Bladder Urothelial Carcinoma,BRD-K95161686-001-02-8::2.5::HTS,4.947007165657761,0.026535964515634617,Bladder Urothelial Carcinoma,octisalate,,
Bladder Urothelial Carcinoma,BRD-K95880107-001-02-4::2.5::HTS,4.2117150126044205,0.04060838393609205,Other Types,PH-797804,p38 MAPK inhibitor,"MAPK11, MAPK14"
Bladder Urothelial Carcinoma,BRD-K96631475-001-04-0::2.5::HTS,7.873739333837637,0.0051921509313435,Other Types,10-deacetylbaccatin,antitumor agent,
Bladder Urothelial Carcinoma,BRD-K96671969-001-03-1::2.5::HTS,10.939320145561242,0.0010018244207716219,Bladder Urothelial Carcinoma,PA-824,nitric oxide donor,FASN
Bladder Urothelial Carcinoma,BRD-K97365803-001-02-1::2.5::HTS,7.260702996158221,0.007263008377853838,Other Types,PI-828,PI3K inhibitor,
Bladder Urothelial Carcinoma,BRD-K98372770-001-08-2::2.5::HTS,5.024755955841485,0.025382542525027342,Bladder Urothelial Carcinoma,L-165041,PPAR receptor agonist,PPARD
Bladder Urothelial Carcinoma,BRD-K98493452-001-14-9::2.5::HTS,4.322654254066852,0.03806113210959431,Other Types,honokiol,AKT inhibitor,"ALOX5, PTGS1, PTGS2"
Bladder Urothelial Carcinoma,BRD-K98572433-001-02-9::2.5::HTS,8.038910287528436,0.004743714652411446,Other Types,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Bladder Urothelial Carcinoma,BRD-K99092662-001-01-1::2.5::HTS,4.823694863896818,0.02848178140790536,Other Types,PS178990,androgen receptor modulator,AR
Bladder Urothelial Carcinoma,BRD-K99170882-001-04-3::2.5::HTS,5.510935414291914,0.01924635453375971,Other Types,NSC-319726,p53 activator,
Bladder Urothelial Carcinoma,BRD-K99964838-001-11-9::2.5::HTS,7.803689289199038,0.0053923894392471985,Other Types,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Bladder Urothelial Carcinoma,BRD-M30288325-001-01-4::2.5::HTS,14.11026667829651,0.00019048510990849637,Other Types,G-15,estrogen receptor antagonist,GPER1
Bladder Urothelial Carcinoma,BRD-M54096567-001-01-9::2.5::HTS,7.18899999488743,0.0075646454195544,Bladder Urothelial Carcinoma,sodium-gluconate,,
Bladder Urothelial Carcinoma,BRD-M56276249-001-01-1::2.5::HTS,6.428252590872371,0.011510282969098546,Bladder Urothelial Carcinoma,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,
Bladder Urothelial Carcinoma,BRD-M77041484-001-01-8::2.5::HTS,12.857788722303324,0.0003659381191893404,Bladder Urothelial Carcinoma,TBOA-(DL),excitatory amino acid transporter inhibitor,"SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7"
Bladder Urothelial Carcinoma,BRD-M97302542-001-03-6::2.5::HTS,5.665499588574277,0.017655728554212255,Bladder Urothelial Carcinoma,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1
Bladder Urothelial Carcinoma,BRD-A08316590-001-01-3::2.5::MTS004,3.9643101501725613,0.046978941347487174,Bladder Urothelial Carcinoma,broxaterol,adrenergic receptor agonist,ADRB2
Bladder Urothelial Carcinoma,BRD-A16263897-001-06-6::2.5::MTS004,5.228703627909679,0.02260398959897672,Bladder Urothelial Carcinoma,misonidazole,,
Bladder Urothelial Carcinoma,BRD-A34603619-001-01-9::2.427905848::MTS004,6.530543547278239,0.010877107970766594,Bladder Urothelial Carcinoma,tropesin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Bladder Urothelial Carcinoma,BRD-A48938994-001-14-1::2.5::MTS004,4.162201716384509,0.04182253679503705,Bladder Urothelial Carcinoma,monoctanoin,,
Bladder Urothelial Carcinoma,BRD-A59825838-326-01-4::2.499983757::MTS004,7.42506890400354,0.006641093302389483,Bladder Urothelial Carcinoma,netilmicin,protein synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-A78965079-036-01-8::2.640168331::MTS004,7.871493250597047,0.005203465486990981,Other Types,tafenoquine,antimalarial agent,
Bladder Urothelial Carcinoma,BRD-A88254928-001-07-9::2.5::MTS004,4.466101343918536,0.03503358864199481,Bladder Urothelial Carcinoma,albuterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Bladder Urothelial Carcinoma,BRD-A91728607-236-11-9::2.5::MTS004,5.8470038042959835,0.01593411489400899,Bladder Urothelial Carcinoma,citicoline,"membrane permeability enhancer, glutathione transferase stimulant","ACHE, SLC1A2"
Bladder Urothelial Carcinoma,BRD-K02988401-001-01-2::2.5::MTS004,3.8739545392932984,0.049553893697847774,Other Types,UNC0737,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Bladder Urothelial Carcinoma,BRD-K03165895-001-01-9::2.499970324::MTS004,10.750160219239415,0.0011099685259870894,Bladder Urothelial Carcinoma,elafibranor,PPAR receptor agonist,"PPARA, PPARD"
Bladder Urothelial Carcinoma,BRD-K03765900-001-01-9::2.499986292::MTS004,12.498337857289963,0.00044242567074335114,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Bladder Urothelial Carcinoma,BRD-K07409305-001-01-1::2.391201575::MTS004,4.121161138770672,0.0428414949775519,Bladder Urothelial Carcinoma,Org-12962,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C"
Bladder Urothelial Carcinoma,BRD-K11443721-003-01-6::2.403980733::MTS004,6.657204856263497,0.010139550101445452,Bladder Urothelial Carcinoma,NE-100,sigma receptor antagonist,SIGMAR1
Bladder Urothelial Carcinoma,BRD-K11463116-304-03-5::2.500052374::MTS004,5.126005642759694,0.023966464160810542,Bladder Urothelial Carcinoma,eprodisate,"antiamyloidogenic agent, amyloid protein inhibitor",SAA1
Bladder Urothelial Carcinoma,BRD-K12742203-003-01-7::2.512196931::MTS004,4.109451149098754,0.0431367403608237,Bladder Urothelial Carcinoma,moxaverine,phosphodiesterase inhibitor,
Bladder Urothelial Carcinoma,BRD-K13394247-003-01-4::2.499991328::MTS004,7.077499379274146,0.008038727591314953,Bladder Urothelial Carcinoma,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3
Bladder Urothelial Carcinoma,BRD-K13414800-001-01-3::2.499970601::MTS004,4.592769542453084,0.03255413355918298,Bladder Urothelial Carcinoma,vesnarinone,phosphodiesterase inhibitor,"KCNH2, PDE3A"
Bladder Urothelial Carcinoma,BRD-K22514639-001-05-7::2.500015058::MTS004,8.572889446645428,0.0035562477666634747,Other Types,EGF816,EGFR inhibitor,EGFR
Bladder Urothelial Carcinoma,BRD-K22525962-001-05-0::2.500010949::MTS004,4.23571534317182,0.04006217655419597,Bladder Urothelial Carcinoma,dihydrotestosterone,androgen receptor agonist,"AR, HSD17B1"
Bladder Urothelial Carcinoma,BRD-K24610819-003-01-8::2.33438271::MTS004,8.500525167856729,0.003698433898821418,Bladder Urothelial Carcinoma,amibegron,adrenergic receptor agonist,ADRB3
Bladder Urothelial Carcinoma,BRD-K26024145-001-01-9::2.5::MTS004,4.082948650140173,0.04381198719801843,Bladder Urothelial Carcinoma,desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2
Bladder Urothelial Carcinoma,BRD-K27515606-003-01-3::2.5::MTS004,4.780296980280977,0.029216448436668808,Bladder Urothelial Carcinoma,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-K30485548-050-01-6::2.479775098::MTS004,8.329804623542405,0.004056296114802248,Bladder Urothelial Carcinoma,sumanirole,dopamine receptor agonist,DRD2
Bladder Urothelial Carcinoma,BRD-K32256160-001-01-9::2.499998021::MTS004,9.349086174739776,0.002341892855153939,Bladder Urothelial Carcinoma,solithromycin,protein synthesis inhibitor,
Bladder Urothelial Carcinoma,BRD-K34277641-001-01-2::2.569027627::MTS004,7.737630488692715,0.005597550336690183,Bladder Urothelial Carcinoma,L-365260,CCK receptor antagonist,"CCKAR, CCKBR, KCNQ1"
Bladder Urothelial Carcinoma,BRD-K39009484-001-01-4::2.5::MTS004,10.414369643011511,0.001326496274273867,Other Types,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Bladder Urothelial Carcinoma,BRD-K42816473-001-01-0::2.38330586::MTS004,5.686073507842337,0.01744555937514789,Bladder Urothelial Carcinoma,zilpaterol,adrenergic receptor agonist,ADRB2
Bladder Urothelial Carcinoma,BRD-K45906612-001-01-8::2.499991411::MTS004,5.290779456844488,0.02182043228435917,Bladder Urothelial Carcinoma,presatovir,RSV fusion inhibitor,
Bladder Urothelial Carcinoma,BRD-K46625559-001-01-8::2.50003993::MTS004,5.027307541623366,0.0253572879219184,Other Types,ozanimod,sphingosine 1 phosphate receptor agonist,S1PR1
Bladder Urothelial Carcinoma,BRD-K46843573-001-01-9::2.5::MTS004,6.466342678062519,0.011272099388784037,Other Types,zotarolimus,mTOR inhibitor,FKBP1A
Bladder Urothelial Carcinoma,BRD-K50010139-001-02-3::2.5::MTS004,9.073096295333984,0.0027157289822889643,Other Types,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Bladder Urothelial Carcinoma,BRD-K53319039-001-01-8::2.5::MTS004,4.495856369239836,0.03443666088172744,Other Types,estradiol-acetate,estrogen receptor agonist,ESR1
Bladder Urothelial Carcinoma,BRD-K55172746-001-01-3::2.5::MTS004,4.984391227997595,0.02598691925233042,Bladder Urothelial Carcinoma,apricitabine,nucleoside reverse transcriptase inhibitor,
Bladder Urothelial Carcinoma,BRD-K55991142-001-01-6::2.5::MTS004,9.080102259074598,0.0027055186079898742,Bladder Urothelial Carcinoma,alcaftadine,histamine receptor antagonist,HRH1
Bladder Urothelial Carcinoma,BRD-K56807945-001-01-2::2.500001454::MTS004,4.861258083995808,0.027887912071020152,Bladder Urothelial Carcinoma,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,"EGLN1, EGLN2, HIF1A"
Bladder Urothelial Carcinoma,BRD-K56981171-001-01-0::2.500008954::MTS004,9.591662422966818,0.002056573261231786,Other Types,brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR"
Bladder Urothelial Carcinoma,BRD-K57155378-001-01-1::2.499996307::MTS004,4.257900229107068,0.03954639555755533,Bladder Urothelial Carcinoma,TAK-063,phosphodiesterase inhibitor,PDE10A
Bladder Urothelial Carcinoma,BRD-K58529924-001-01-5::2.648577938::MTS004,6.917874843448741,0.008777784890757208,Bladder Urothelial Carcinoma,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Bladder Urothelial Carcinoma,BRD-K60421517-001-01-4::2.499975038::MTS004,6.201467554918107,0.013065084292206373,Other Types,olmutinib,"EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR"
Bladder Urothelial Carcinoma,BRD-K62309135-001-05-2::3.119534994::MTS004,4.3832314474903775,0.03676165751796495,Other Types,L-glutamic-acid,glutamate receptor agonist,"AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT"
Bladder Urothelial Carcinoma,BRD-K66786476-001-01-3::2.500037331::MTS004,7.16818117895853,0.007646978176696726,Bladder Urothelial Carcinoma,pregabalin,voltage-gated calcium channel ligand,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8"
Bladder Urothelial Carcinoma,BRD-K73027814-003-01-0::2.693425643::MTS004,4.426911443466315,0.03583992881961892,Bladder Urothelial Carcinoma,oxyfedrine,adrenergic receptor agonist,
Bladder Urothelial Carcinoma,BRD-K82967180-001-01-6::2.500024493::MTS004,4.546274649722856,0.033441869916141155,Other Types,LY3023414,"PI3K inhibitor, mTOR inhibitor",MTOR
Bladder Urothelial Carcinoma,BRD-K89920762-001-01-4::2.500013597::MTS004,6.145062138718637,0.013482768358910352,Bladder Urothelial Carcinoma,paritaprevir,HCV inhibitor,
Bladder Urothelial Carcinoma,BRD-K90629600-001-01-4::2.5::MTS004,4.787580246675209,0.029094271991951748,Bladder Urothelial Carcinoma,emorfazone,"antiinflammatory agent, cyclooxygenase inhibitor",
Bladder Urothelial Carcinoma,BRD-K92908289-001-01-8::2.501017998::MTS004,4.110639731681983,0.043106674855920464,Bladder Urothelial Carcinoma,medica-16,ATP citrase lyase inhibitor,FFAR1
Non-Small Cell Lung Cancer,BRD-A00520476-001-07-4::2.5::HTS,4.613640995918323,0.032149284308464005,Non-Small Cell Lung Cancer,otenzepad,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Non-Small Cell Lung Cancer,BRD-A01636364-003-15-1::2.5::HTS,9.761980888310173,0.0018742852908999465,Non-Small Cell Lung Cancer,bupivacaine,sodium channel blocker,"KCNA5, PTGER1, SCN10A, SCN4A"
Non-Small Cell Lung Cancer,BRD-A06935312-001-04-3::2.5::HTS,5.370335578554101,0.020843625625074174,Non-Small Cell Lung Cancer,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
Non-Small Cell Lung Cancer,BRD-A10967948-003-06-3::2.5::HTS,7.6283875955827805,0.005941715316329748,Non-Small Cell Lung Cancer,granisetron,serotonin receptor antagonist,HTR3A
Non-Small Cell Lung Cancer,BRD-A12230535-001-06-7::2.5::HTS,4.637757498787643,0.03171863802733105,Non-Small Cell Lung Cancer,nutlin-3,MDM inhibitor,"MDM2, TP53"
Non-Small Cell Lung Cancer,BRD-A13188892-066-21-5::2.5::HTS,4.049420328161778,0.04466739150733407,Non-Small Cell Lung Cancer,doxazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7"
Non-Small Cell Lung Cancer,BRD-A15435692-003-02-3::2.5::HTS,4.6525483282617195,0.031436906595623156,Non-Small Cell Lung Cancer,BMY-14802,sigma receptor antagonist,HTR1A
Non-Small Cell Lung Cancer,BRD-A16347691-001-13-1::2.5::HTS,4.16843325236927,0.04165278436260301,Other Types,thioctic-acid,reducing agent,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6"
Non-Small Cell Lung Cancer,BRD-A17300716-001-01-5::2.5::HTS,5.803587962468131,0.01631412973523089,Non-Small Cell Lung Cancer,dehydroacetic-acid,,
Non-Small Cell Lung Cancer,BRD-A23067620-300-01-3::2.5::HTS,7.559086396555299,0.006165737930376662,Non-Small Cell Lung Cancer,itraconazole,cytochrome P450 inhibitor,CYP51A1
Non-Small Cell Lung Cancer,BRD-A26384407-001-25-1::2.5::HTS,5.5296647293530405,0.019040973919075905,Non-Small Cell Lung Cancer,chlorthalidone,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3"
Non-Small Cell Lung Cancer,BRD-A28301258-001-04-8::2.5::HTS,7.7455398037740295,0.005577406629337132,Non-Small Cell Lung Cancer,salinomycin,,
Non-Small Cell Lung Cancer,BRD-A29485665-001-12-8::2.5::HTS,4.022244627308319,0.045389719435750805,Other Types,bicalutamide,androgen receptor antagonist,AR
Non-Small Cell Lung Cancer,BRD-A36057565-001-01-0::2.5::HTS,5.437685430444061,0.020065556989414368,Other Types,bruceantin,protein synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-A37347161-003-02-6::2.5::HTS,6.958869918083194,0.008572771860912423,Non-Small Cell Lung Cancer,BRL-52537,opioid receptor agonist,OPRK1
Non-Small Cell Lung Cancer,BRD-A40413915-003-01-2::2.5::HTS,6.688729265475133,0.009955022766955632,Non-Small Cell Lung Cancer,NTNCB,neuropeptide receptor antagonist,NPY5R
Non-Small Cell Lung Cancer,BRD-A40639672-234-18-0::2.5::HTS,5.049419089538308,0.02503279097708758,Non-Small Cell Lung Cancer,ketorolac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Non-Small Cell Lung Cancer,BRD-A45107007-001-03-4::2.5::HTS,6.613552605078547,0.010380154088409364,Other Types,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1
Non-Small Cell Lung Cancer,BRD-A47790386-001-03-6::2.61::HTS,3.9375100135376444,0.047766867381560316,Non-Small Cell Lung Cancer,balofloxacin,bacterial DNA gyrase inhibitor,
Non-Small Cell Lung Cancer,BRD-A48430263-003-17-2::2.5::HTS,4.108079477231449,0.04315635955210522,Non-Small Cell Lung Cancer,pioglitazone,"insulin sensitizer, PPAR receptor agonist","PPARG, TRPM3"
Non-Small Cell Lung Cancer,BRD-A49447682-001-02-4::2.5::HTS,5.806354828413336,0.016291634909100995,Non-Small Cell Lung Cancer,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Non-Small Cell Lung Cancer,BRD-A50311610-300-10-4::2.5::HTS,4.399208777500266,0.0364148147595508,Non-Small Cell Lung Cancer,meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3"
Non-Small Cell Lung Cancer,BRD-A50922295-001-01-3::2.5::HTS,4.084612811949648,0.04374897280828,Other Types,valganciclovir,DNA synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-A51407134-001-01-9::2.5::HTS,4.316404023951378,0.03822931520322327,Non-Small Cell Lung Cancer,2-octyldodecan-1-ol,,
Non-Small Cell Lung Cancer,BRD-A51571244-001-01-9::2.5::HTS,5.000172155670426,0.025747991954190714,Other Types,hypoestoxide,IKK inhibitor,"IKBKB, IL1B, TNF"
Non-Small Cell Lung Cancer,BRD-A51714012-003-13-6::2.5::HTS,5.656561496862711,0.017737682567868555,Non-Small Cell Lung Cancer,venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4"
Non-Small Cell Lung Cancer,BRD-A55312468-001-04-7::1.24::HTS,18.61021902769437,1.898997605766969e-05,Other Types,k-strophanthidin,ATPase inhibitor,ATP1A1
Non-Small Cell Lung Cancer,BRD-A57833392-001-01-7::2.5::HTS,4.963738068151864,0.026284913186822644,Other Types,oxymatrine,,
Non-Small Cell Lung Cancer,BRD-A57900429-003-05-8::2.5::HTS,4.049589716046249,0.04466208096875545,Non-Small Cell Lung Cancer,hydrastinine,haemostatic agent,
Non-Small Cell Lung Cancer,BRD-A64610707-001-04-4::2.5::HTS,7.6170029360288956,0.0059724005097985195,Other Types,pranoprofen,cyclooxygenase inhibitor,
Non-Small Cell Lung Cancer,BRD-A65449987-001-10-4::2.5::HTS,5.858988722446976,0.015815902086869418,Non-Small Cell Lung Cancer,flunisolide,cytochrome P450 inhibitor,NR3C1
Non-Small Cell Lung Cancer,BRD-A65797496-048-09-3::2.5::HTS,6.3275363987966715,0.012165485527778222,Non-Small Cell Lung Cancer,deptropine,histamine receptor antagonist,HRH1
Non-Small Cell Lung Cancer,BRD-A69651145-003-07-2::2.5::HTS,4.00696293055983,0.04581712604489211,Non-Small Cell Lung Cancer,minocycline,bacterial 30S ribosomal subunit inhibitor,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA"
Non-Small Cell Lung Cancer,BRD-A72711497-236-03-8::2.5::HTS,6.554103816609118,0.010725521261472993,Non-Small Cell Lung Cancer,lasalocid,bacterial permeability inducer,
Non-Small Cell Lung Cancer,BRD-A78877355-001-03-0::2.5::HTS,5.402741117135386,0.020460635204928263,Non-Small Cell Lung Cancer,nefopam,cyclooxygenase inhibitor,
Non-Small Cell Lung Cancer,BRD-A88369366-001-01-7::2.5::HTS,4.409381204469632,0.03618940482566157,Other Types,trelagliptin,dipeptidyl peptidase inhibitor,DPP4
Non-Small Cell Lung Cancer,BRD-A93236127-001-04-5::2.5::HTS,4.321604387277344,0.03808850537712638,Other Types,digitoxin,ATPase inhibitor,ATP1A1
Non-Small Cell Lung Cancer,BRD-A94033181-001-01-4::2.5::HTS,4.545584298592865,0.03344299785859624,Non-Small Cell Lung Cancer,AZD6765,glutamate receptor antagonist,GRIN1
Non-Small Cell Lung Cancer,BRD-A97104540-004-15-0::2.5::HTS,4.035142374833099,0.04504142255009741,Non-Small Cell Lung Cancer,fenoterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Non-Small Cell Lung Cancer,BRD-A99117172-065-04-0::2.5::HTS,8.066278608254262,0.0046742014922199005,Non-Small Cell Lung Cancer,hydroxychloroquine,antimalarial agent,"TLR7, TLR9"
Non-Small Cell Lung Cancer,BRD-A99833829-003-27-1::2.5::HTS,4.799401091673406,0.028906035585483093,Non-Small Cell Lung Cancer,bethanechol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Non-Small Cell Lung Cancer,BRD-K00673382-001-18-9::2.5::HTS,6.722399670718286,0.009772868470314009,Non-Small Cell Lung Cancer,famotidine,histamine receptor antagonist,HRH2
Non-Small Cell Lung Cancer,BRD-K01174345-001-01-9::2.5::HTS,4.804705250689975,0.0287975166740939,Non-Small Cell Lung Cancer,anamorelin,growth hormone secretagogue receptor agonist,GHSR
Non-Small Cell Lung Cancer,BRD-K02079473-001-01-3::2.5::HTS,4.928096063263441,0.026825239413793334,Non-Small Cell Lung Cancer,oxatomide,histamine receptor antagonist,HRH1
Non-Small Cell Lung Cancer,BRD-K02292852-001-02-1::2.5::HTS,4.557591128728708,0.033211280497706136,Non-Small Cell Lung Cancer,cefoperazone,bacterial cell wall synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-K02314383-001-01-3::2.5::HTS,4.24700292193528,0.039787571955388304,Non-Small Cell Lung Cancer,epitiostanol,androgen receptor agonist,AR
Non-Small Cell Lung Cancer,BRD-K03294269-001-08-0::2.5::HTS,5.5358741874990685,0.018974197678345142,Other Types,NU6027,CDK inhibitor,"CCNA2, CDK2"
Non-Small Cell Lung Cancer,BRD-K04923131-001-15-4::2.5::HTS,5.667776643745918,0.0176176443738107,Non-Small Cell Lung Cancer,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Non-Small Cell Lung Cancer,BRD-K05048137-001-03-9::1.57::HTS,3.866075264107367,0.04977048074631432,Other Types,phytosphingosine,,
Non-Small Cell Lung Cancer,BRD-K05181084-003-03-7::2.5::HTS,7.2085259384892,0.007471557464021742,Non-Small Cell Lung Cancer,NGB-2904,dopamine receptor antagonist,DRD3
Non-Small Cell Lung Cancer,BRD-K05446112-001-01-8::2.5::HTS,6.5097833034587556,0.010994320964390108,Non-Small Cell Lung Cancer,ledipasvir,HCV inhibitor,
Non-Small Cell Lung Cancer,BRD-K05804044-001-06-0::2.5::HTS,10.253748075195505,0.0014419108779988863,Non-Small Cell Lung Cancer,AZ-628,RAF inhibitor,"BRAF, RAF1"
Non-Small Cell Lung Cancer,BRD-K06240250-001-01-6::2.5::HTS,5.264561718880143,0.022135024426962222,Non-Small Cell Lung Cancer,rilpivirine,non-nucleoside reverse transcriptase inhibitor,"NR1I2, SCN10A"
Non-Small Cell Lung Cancer,BRD-K06426971-001-02-7::2.5::HTS,8.8181723523315,0.003110665866281515,Non-Small Cell Lung Cancer,ryuvidine,histone lysine methyltransferase inhibitor,"CDK2, CDK4"
Non-Small Cell Lung Cancer,BRD-K07208025-001-29-7::2.5::HTS,7.168947160094844,0.007636403109556259,Non-Small Cell Lung Cancer,trimethoprim,dihydrofolate reductase inhibitor,"DHFR, TYMS"
Non-Small Cell Lung Cancer,BRD-K07955840-001-02-3::2.5::HTS,4.762177833264144,0.029508025344684812,Other Types,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Non-Small Cell Lung Cancer,BRD-K08248804-001-01-8::2.5::HTS,4.319465896984921,0.03815130699262045,Other Types,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Non-Small Cell Lung Cancer,BRD-K08288352-001-03-6::2.5::HTS,7.294264873731464,0.007132296759331471,Other Types,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,
Non-Small Cell Lung Cancer,BRD-K08893438-001-04-9::2.52::HTS,6.051863888155681,0.014217087577198756,Non-Small Cell Lung Cancer,CCG-50014,G protein signaling inhibitor,"RGS4, RGS8"
Non-Small Cell Lung Cancer,BRD-K09255212-001-16-6::2.5::HTS,4.1115054697437685,0.04308387532932653,Other Types,clioquinol,chelating agent,OPRK1
Non-Small Cell Lung Cancer,BRD-K09877029-001-01-2::2.5::HTS,10.479156636402102,0.0012788012185919642,Other Types,VS-4718,focal adhesion kinase inhibitor,
Non-Small Cell Lung Cancer,BRD-K10906636-001-02-9::2.67::HTS,5.9226345176127655,0.015290650202884297,Non-Small Cell Lung Cancer,silodosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Non-Small Cell Lung Cancer,BRD-K10961822-001-05-1::2.5::HTS,5.14682252809677,0.023683546200099964,Other Types,latanoprost,prostanoid receptor agonist,PTGFR
Non-Small Cell Lung Cancer,BRD-K11267252-001-04-4::2.5::HTS,4.654431291713768,0.03141470769902301,Other Types,alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Non-Small Cell Lung Cancer,BRD-K11911061-003-11-9::2.5::HTS,4.5585798050194,0.03318757491733365,Non-Small Cell Lung Cancer,GR-127935,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6"
Non-Small Cell Lung Cancer,BRD-K12040459-001-06-0::2.5::HTS,12.354802785230936,0.00047563834957003434,Non-Small Cell Lung Cancer,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Non-Small Cell Lung Cancer,BRD-K12568846-001-14-6::2.5::HTS,4.378877472405859,0.03683488075485999,Non-Small Cell Lung Cancer,amidopyrine,analgesic agent,
Non-Small Cell Lung Cancer,BRD-K12614344-003-01-8::2.5::HTS,5.003531997769956,0.02568843446841591,Other Types,CGS-21680,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Non-Small Cell Lung Cancer,BRD-K13238618-001-05-9::2.5::HTS,4.514254693125275,0.03405246031641962,Non-Small Cell Lung Cancer,carsalam,analgesic agent,
Non-Small Cell Lung Cancer,BRD-K14127446-005-22-7::2.5::HTS,4.502813901450339,0.03427988557803176,Other Types,isopropamide-iodide,acetylcholine receptor antagonist,"CHRM3, CHRM4"
Non-Small Cell Lung Cancer,BRD-K14175878-001-01-6::2.5::HTS,3.8781011592086023,0.04943160318144819,Other Types,MK-0812,CC chemokine receptor antagonist,CCR2
Non-Small Cell Lung Cancer,BRD-K14704277-001-22-6::2.5::HTS,5.082191025442914,0.02456051416234139,Non-Small Cell Lung Cancer,cinoxacin,topoisomerase inhibitor,
Non-Small Cell Lung Cancer,BRD-K14763542-001-02-3::2.5::HTS,8.000300285184528,0.0048546915351408,Non-Small Cell Lung Cancer,flurothyl,,
Non-Small Cell Lung Cancer,BRD-K15976406-001-03-3::2.5::HTS,5.40047216474693,0.020488263846006934,Other Types,telbivudine,DNA polymerase inhibitor,TK2
Non-Small Cell Lung Cancer,BRD-K16810791-001-01-0::2.5::HTS,5.067980920803942,0.024757295327425675,Non-Small Cell Lung Cancer,LGK-974,porcupine inhibitor,PORCN
Non-Small Cell Lung Cancer,BRD-K16898998-001-01-6::2.5::HTS,12.344197148032784,0.0004780914377226056,Non-Small Cell Lung Cancer,bevirimat-dimeglumine,HIV capsid assembly inhibitor,
Non-Small Cell Lung Cancer,BRD-K17223896-001-10-0::2.5::HTS,5.274746876253259,0.022007134618153037,Non-Small Cell Lung Cancer,chloroxylenol,ATP synthase inhibitor,
Non-Small Cell Lung Cancer,BRD-K17705806-003-04-4::2.5::HTS,5.159218905092352,0.02350193414834936,Non-Small Cell Lung Cancer,JTC-801,opioid receptor antagonist,OPRL1
Non-Small Cell Lung Cancer,BRD-K17774839-001-02-9::2.5::HTS,5.722329249525011,0.01707805922412994,Non-Small Cell Lung Cancer,JNJ-7777120,histamine receptor antagonist,HRH4
Non-Small Cell Lung Cancer,BRD-K17979676-001-01-2::2.5::HTS,6.01989145330136,0.014460988753880605,Non-Small Cell Lung Cancer,eprobemide,monoamine oxidase inhibitor,MAOA
Non-Small Cell Lung Cancer,BRD-K18619710-001-14-4::2.5::HTS,4.620899206219026,0.032017010314743084,Other Types,digoxigenin,steroid,
Non-Small Cell Lung Cancer,BRD-K18922609-004-23-1::2.5::HTS,5.156404183284271,0.02354380899320369,Non-Small Cell Lung Cancer,neostigmine,acetylcholinesterase inhibitor,ACHE
Non-Small Cell Lung Cancer,BRD-K19669037-001-01-1::2.5::HTS,12.035838582368328,0.000563160813308408,Non-Small Cell Lung Cancer,GGTI-298,GGTase inhibitor,CDKN1A
Non-Small Cell Lung Cancer,BRD-K19687926-379-07-4::2.5::HTS,4.530641213832246,0.03373058649905128,Non-Small Cell Lung Cancer,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Non-Small Cell Lung Cancer,BRD-K19761926-001-03-6::2.45::HTS,4.916753989685653,0.027013791350971355,Non-Small Cell Lung Cancer,eplerenone,cytochrome P450 inhibitor,NR3C2
Non-Small Cell Lung Cancer,BRD-K20001883-001-02-7::2.5::HTS,7.764762512227821,0.005510155343432252,Non-Small Cell Lung Cancer,apabetalone,apolipoprotein expression enhancer,BRD3
Non-Small Cell Lung Cancer,BRD-K20714604-003-02-9::2.5::HTS,5.706248266457902,0.01723534709568692,Non-Small Cell Lung Cancer,RS-56812,serotonin receptor partial agonist,HTR3A
Non-Small Cell Lung Cancer,BRD-K21025364-001-04-9::2.5::HTS,3.864657507651409,0.0498261382641527,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Non-Small Cell Lung Cancer,BRD-K21025364-001-05-6::2.44::HTS,8.249067531124803,0.004241189169027171,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Non-Small Cell Lung Cancer,BRD-K21867462-001-02-9::2.5::HTS,6.699956780314065,0.009894654381554591,Non-Small Cell Lung Cancer,GSK2816126,histone lysine methyltransferase inhibitor,EZH2
Non-Small Cell Lung Cancer,BRD-K22025381-003-01-9::2.5::HTS,9.076950864902175,0.002705704771373372,Non-Small Cell Lung Cancer,U-18666A,oxidosqualene cyclase inhibitor,
Non-Small Cell Lung Cancer,BRD-K22745370-003-02-3::2.5::HTS,4.229566577224825,0.04018668212605483,Non-Small Cell Lung Cancer,2-BFI,imidazoline receptor ligand,"ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB"
Non-Small Cell Lung Cancer,BRD-K22822991-001-02-3::2.5::HTS,4.519099444311655,0.03397244323409299,Non-Small Cell Lung Cancer,odanacatib,cathepsin inhibitor,CTSK
Non-Small Cell Lung Cancer,BRD-K23163214-050-15-1::2.5::HTS,3.981139714133849,0.046497334339543735,Non-Small Cell Lung Cancer,dizocilpine-(-),glutamate receptor antagonist,
Non-Small Cell Lung Cancer,BRD-K23976833-001-01-0::2.5::HTS,5.043155200984425,0.02511469896873242,Other Types,travoprost,prostanoid receptor agonist,PTGFR
Non-Small Cell Lung Cancer,BRD-K24548560-342-02-1::2.5::HTS,4.845423155164653,0.028125355983851907,Non-Small Cell Lung Cancer,evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1"
Non-Small Cell Lung Cancer,BRD-K24697665-001-01-4::2.5::HTS,5.955080074435399,0.015003972632528001,Non-Small Cell Lung Cancer,bucillamine,immunosuppressant,
Non-Small Cell Lung Cancer,BRD-K24790130-001-07-1::2.5::HTS,3.9413071182245956,0.04760326317835543,Non-Small Cell Lung Cancer,tricaprylin,,
Non-Small Cell Lung Cancer,BRD-K24821794-001-01-4::2.5::HTS,4.132058456255843,0.042551055237866085,Non-Small Cell Lung Cancer,SGC-CBP30,bromodomain inhibitor,"CREBBP, EP300"
Non-Small Cell Lung Cancer,BRD-K25140590-001-03-0::2.5::HTS,4.176138497882036,0.041465256837921884,Non-Small Cell Lung Cancer,CX-516,glutamate receptor modulator,
Non-Small Cell Lung Cancer,BRD-K25279140-001-01-5::2.5::HTS,14.031524148483113,0.00019932790037499552,Other Types,MK-8745,Aurora kinase inhibitor,AURKA
Non-Small Cell Lung Cancer,BRD-K25412176-001-01-9::2.5::HTS,12.191224514143487,0.0005184345488281573,Non-Small Cell Lung Cancer,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Non-Small Cell Lung Cancer,BRD-K25630527-001-03-8::2.5::HTS,4.152424930392979,0.042042739063427606,Other Types,LY2784544,JAK inhibitor,"JAK2, JAK3"
Non-Small Cell Lung Cancer,BRD-K25650355-065-02-0::2.5::HTS,5.829247469098812,0.016089677016391815,Non-Small Cell Lung Cancer,physostigmine,cholinesterase inhibitor,"ACHE, BCHE"
Non-Small Cell Lung Cancer,BRD-K25943794-001-02-3::2.5::HTS,4.089730738317864,0.04362452564156844,Non-Small Cell Lung Cancer,blonanserin,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Non-Small Cell Lung Cancer,BRD-K26060080-065-05-6::2.5::HTS,9.015354061212351,0.0027979892773628517,Other Types,adenine,protein synthesis stimulant,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2"
Non-Small Cell Lung Cancer,BRD-K26531771-001-02-2::2.35::HTS,6.630650687606171,0.010294962145755704,Other Types,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Non-Small Cell Lung Cancer,BRD-K26801045-001-02-9::2.5::HTS,5.003956136321164,0.025684318089748866,Non-Small Cell Lung Cancer,pipamperone,dopamine receptor antagonist,"DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A"
Non-Small Cell Lung Cancer,BRD-K26818574-305-04-3::2.5::HTS,5.156930597586512,0.023533307997460815,Non-Small Cell Lung Cancer,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Non-Small Cell Lung Cancer,BRD-K26989966-001-03-5::2.5::HTS,4.544192855257972,0.03346680609058791,Non-Small Cell Lung Cancer,UNC1999,histone lysine methyltransferase inhibitor,EZH2
Non-Small Cell Lung Cancer,BRD-K28042756-001-01-9::5::HTS,5.379045909292385,0.02075291085776144,Non-Small Cell Lung Cancer,,,
Non-Small Cell Lung Cancer,BRD-K29415052-050-04-8::2.5::HTS,5.178363764907441,0.023245413177358443,Other Types,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Non-Small Cell Lung Cancer,BRD-K29895144-001-01-0::2.5::HTS,6.99542624820343,0.008401588051382632,Non-Small Cell Lung Cancer,SKLB1002,VEGFR inhibitor,KDR
Non-Small Cell Lung Cancer,BRD-K29950728-048-17-4::2.5::HTS,6.4543277392772875,0.011340044371452817,Non-Small Cell Lung Cancer,clomifene,estrogen receptor antagonist,ESR1
Non-Small Cell Lung Cancer,BRD-K30563334-001-02-9::2.5::HTS,4.7143345164919115,0.0303358743603394,Non-Small Cell Lung Cancer,rifabutin,protein synthesis inhibitor,"HSP90AA1, HSP90B1"
Non-Small Cell Lung Cancer,BRD-K30867024-003-03-3::2.5::HTS,4.781182219668996,0.029191443465274868,Non-Small Cell Lung Cancer,SB-216641,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Non-Small Cell Lung Cancer,BRD-K31866293-001-01-6::2.5::HTS,8.329455832050687,0.004051689342320805,Non-Small Cell Lung Cancer,TAK-632,RAF inhibitor,BRAF
Non-Small Cell Lung Cancer,BRD-K32289541-001-01-0::2.5::HTS,4.569732008047681,0.03297554812258076,Non-Small Cell Lung Cancer,EHop-016,Ras GTPase inhibitor,"RAC1, RAC3"
Non-Small Cell Lung Cancer,BRD-K32292990-001-03-6::2.5::HTS,4.216275921097396,0.04050688431454768,Non-Small Cell Lung Cancer,CGP-53353,"EGFR inhibitor, PKC inhibitor","EGFR, PRKCB"
Non-Small Cell Lung Cancer,BRD-K32372024-001-01-0::2.5::HTS,4.297301143869029,0.03866298043965785,Other Types,D-7193,,
Non-Small Cell Lung Cancer,BRD-K32730239-001-01-0::2.5::HTS,5.782408584724463,0.016511507007709383,Non-Small Cell Lung Cancer,SU3327,JNK inhibitor,MAPK8
Non-Small Cell Lung Cancer,BRD-K33814251-001-02-2::2.5::HTS,4.84458158135575,0.028146328161199947,Non-Small Cell Lung Cancer,lubiprostone,chloride channel activator,CLCN2
Non-Small Cell Lung Cancer,BRD-K33852358-001-09-9::2.5::HTS,5.278966132375355,0.021957739126366633,Non-Small Cell Lung Cancer,arofylline,phosphodiesterase inhibitor,PDE4A
Non-Small Cell Lung Cancer,BRD-K33864865-001-02-5::2.5::HTS,7.491693859660199,0.006395705157286179,Other Types,LY225910,CCK receptor antagonist,CCKBR
Non-Small Cell Lung Cancer,BRD-K34022604-001-06-6::2.5::HTS,5.771414580931672,0.016613439936460625,Other Types,clofarabine,ribonucleotide reductase inhibitor,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Non-Small Cell Lung Cancer,BRD-K34185671-001-02-8::2.5::HTS,4.745063025179026,0.029803376696338552,Other Types,AMG-517,TRPV antagonist,TRPV1
Non-Small Cell Lung Cancer,BRD-K34685430-050-12-5::2.5::HTS,4.586063996371152,0.03268062551211885,Non-Small Cell Lung Cancer,methylergometrine,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C"
Non-Small Cell Lung Cancer,BRD-K35329391-334-01-7::2.5::HTS,4.084237404181447,0.043762017693159974,Non-Small Cell Lung Cancer,GZD824,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Non-Small Cell Lung Cancer,BRD-K35629949-001-02-0::2.5::HTS,5.412657412207158,0.020352307325263462,Non-Small Cell Lung Cancer,SR-27897,CCK receptor antagonist,CCKAR
Non-Small Cell Lung Cancer,BRD-K36055864-001-19-2::2.5::HTS,13.263262321521402,0.0002958685491855471,Other Types,cycloheximide,protein synthesis inhibitor,RPL3
Non-Small Cell Lung Cancer,BRD-K36984403-001-02-7::2.5::HTS,7.705367469159175,0.00568912579630141,Non-Small Cell Lung Cancer,go-6983,protein kinase inhibitor,"PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ"
Non-Small Cell Lung Cancer,BRD-K37682401-001-09-3::2.44::HTS,9.398355509371571,0.002282942328031324,Non-Small Cell Lung Cancer,piromidic-acid,bacterial DNA gyrase inhibitor,
Non-Small Cell Lung Cancer,BRD-K38350380-001-01-8::2.5::HTS,3.9465904338810227,0.047458637304769936,Non-Small Cell Lung Cancer,FK-3311,cyclooxygenase inhibitor,PTGS2
Non-Small Cell Lung Cancer,BRD-K38548312-001-01-0::2.5::HTS,4.863289742662309,0.027840289887527278,Other Types,VER-49009,HSP inhibitor,HSP90AA1
Non-Small Cell Lung Cancer,BRD-K39484304-001-16-5::2.5::HTS,4.59329471221825,0.03252746062369773,Other Types,triptolide,RNA polymerase inhibitor,RELA
Non-Small Cell Lung Cancer,BRD-K40308497-001-02-0::2.5::HTS,6.251752070316536,0.012692317272841806,Non-Small Cell Lung Cancer,crizotinib-(S),MTH1 inhibitor,NUDT1
Non-Small Cell Lung Cancer,BRD-K40496271-396-01-1::2.34::HTS,6.1720308913905795,0.013287430288428076,Non-Small Cell Lung Cancer,eltrombopag,thrombopoietin receptor agonist,MPL
Non-Small Cell Lung Cancer,BRD-K41779183-001-01-2::2.5::HTS,5.412435229843537,0.020349699539795714,Non-Small Cell Lung Cancer,CB-03-01,androgen receptor antagonist,AR
Non-Small Cell Lung Cancer,BRD-K42452249-001-02-5::2.5::HTS,6.538749639553347,0.010821203137292951,Non-Small Cell Lung Cancer,EO-1428,p38 MAPK inhibitor,"MAPK11, MAPK14"
Non-Small Cell Lung Cancer,BRD-K42495768-001-01-7::2.5::HTS,4.837308464432702,0.028268769889965732,Non-Small Cell Lung Cancer,tasisulam,apoptosis stimulant,
Non-Small Cell Lung Cancer,BRD-K43106192-320-11-8::2.5::HTS,6.299296203773862,0.012376676779111001,Non-Small Cell Lung Cancer,gallamine-triethiodide,acetylcholine receptor antagonist,"ACHE, CHRM2, CHRNA1, CHRNA2"
Non-Small Cell Lung Cancer,BRD-K43586850-001-02-9::2.5::HTS,4.494123084201953,0.034449168755592625,Non-Small Cell Lung Cancer,lacidipine,calcium channel blocker,CACNA1C
Non-Small Cell Lung Cancer,BRD-K43797669-001-30-4::2.5::HTS,5.522008708515634,0.019123641870199288,Non-Small Cell Lung Cancer,genistein,tyrosine kinase inhibitor,"CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5"
Non-Small Cell Lung Cancer,BRD-K44844162-001-01-6::2.5::HTS,6.35251180374105,0.012002337759677108,Non-Small Cell Lung Cancer,taselisib,PI3K inhibitor,PIK3CA
Non-Small Cell Lung Cancer,BRD-K45542189-048-22-1::2.5::HTS,6.775949439462555,0.00948606929275071,Non-Small Cell Lung Cancer,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Non-Small Cell Lung Cancer,BRD-K46766488-003-02-0::2.5::HTS,6.615981677724669,0.010366175958873512,Non-Small Cell Lung Cancer,S-14506,serotonin receptor agonist,HTR1A
Non-Small Cell Lung Cancer,BRD-K46839850-050-04-2::2.5::HTS,4.796689732023043,0.028936717552221783,Non-Small Cell Lung Cancer,cinepazide,calcium channel activator,
Non-Small Cell Lung Cancer,BRD-K47554101-001-01-2::2.5::HTS,6.47605409141586,0.011204844480402744,Non-Small Cell Lung Cancer,eperezolid,bacterial 30S ribosomal subunit inhibitor,
Non-Small Cell Lung Cancer,BRD-K47878171-086-06-0::2.5::HTS,6.080303559726294,0.01400167445752335,Non-Small Cell Lung Cancer,bephenium-hydroxynaphthoate,anthelmintic agent,
Non-Small Cell Lung Cancer,BRD-K48168960-001-19-2::2.5::HTS,4.591678121830346,0.03255635944523594,Non-Small Cell Lung Cancer,propylthiouracil,thyroid peroxidase inhibitor,"DIO1, TPO"
Non-Small Cell Lung Cancer,BRD-K48692744-001-02-0::2.5::HTS,4.499440591871904,0.034351820317675745,Non-Small Cell Lung Cancer,NU-1025,PARP inhibitor,PARP1
Non-Small Cell Lung Cancer,BRD-K49111258-003-29-7::2.5::HTS,4.051429456454949,0.04461639711252806,Non-Small Cell Lung Cancer,prazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7"
Non-Small Cell Lung Cancer,BRD-K49702221-003-01-6::2.5::HTS,5.025554133438218,0.025372389139929803,Non-Small Cell Lung Cancer,SNAP-94847,,"ADRA1A, DRD2"
Non-Small Cell Lung Cancer,BRD-K49945136-001-10-0::2.5::HTS,4.295783781008211,0.03867136947224577,Non-Small Cell Lung Cancer,GR-113808,serotonin receptor antagonist,HTR4
Non-Small Cell Lung Cancer,BRD-K50293352-300-02-1::2.5::HTS,4.042505526534608,0.04484764522561153,Other Types,MM77,serotonin receptor antagonist,HTR1A
Non-Small Cell Lung Cancer,BRD-K50891186-001-04-4::2.5::HTS,5.30160543665278,0.021673553256806213,Non-Small Cell Lung Cancer,GR-103691,dopamine receptor antagonist,DRD3
Non-Small Cell Lung Cancer,BRD-K51199656-003-01-4::2.5::HTS,4.2424677191975,0.039893135708011424,Non-Small Cell Lung Cancer,fluoromethylcholine,,
Non-Small Cell Lung Cancer,BRD-K53205568-001-02-6::2.5::HTS,4.61603524425125,0.032104044096809,Non-Small Cell Lung Cancer,afalanine,dopamine receptor agonist,DRD2
Non-Small Cell Lung Cancer,BRD-K53665955-001-03-0::2.5::HTS,12.816226601016032,0.000373631024204704,Other Types,MK-5108,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Non-Small Cell Lung Cancer,BRD-K54256913-001-08-7::2.5::HTS,6.532669445845061,0.010855403192715848,Other Types,MK-1775,WEE1 kinase inhibitor,WEE1
Non-Small Cell Lung Cancer,BRD-K54634444-001-05-9::2.5::HTS,5.315132028969972,0.021505577990391662,Non-Small Cell Lung Cancer,artesunate,DNA synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-K55567017-001-12-3::2.5::HTS,5.600771731973757,0.018295538400568277,Non-Small Cell Lung Cancer,formononetin,alcohol dehydrogenase inhibitor,"ADH1C, SLC5A2"
Non-Small Cell Lung Cancer,BRD-K56195681-001-01-0::2.5::HTS,4.275075517405822,0.03913235594063075,Non-Small Cell Lung Cancer,losmapimod,p38 MAPK inhibitor,MAPK14
Non-Small Cell Lung Cancer,BRD-K56301217-001-07-4::2.5::HTS,5.320295125094014,0.02144126538221113,Non-Small Cell Lung Cancer,ABT-737,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Non-Small Cell Lung Cancer,BRD-K56908511-001-01-2::2.5::HTS,5.847245858789455,0.015972737976150255,Non-Small Cell Lung Cancer,fluroxene,local anesthetic,
Non-Small Cell Lung Cancer,BRD-K57080016-001-15-9::2.5::HTS,6.082696647317327,0.013948581087329234,Non-Small Cell Lung Cancer,selumetinib,MEK inhibitor,MAP2K1
Non-Small Cell Lung Cancer,BRD-K57853941-304-02-5::2.5::HTS,5.277171036740056,0.021973508958041486,Non-Small Cell Lung Cancer,olsalazine,cyclooxygenase inhibitor,"IFNG, TPMT"
Non-Small Cell Lung Cancer,BRD-K59227464-334-02-4::2.5::HTS,6.88109541463323,0.00894770953367817,Non-Small Cell Lung Cancer,LY2228820,p38 MAPK inhibitor,MAPK14
Non-Small Cell Lung Cancer,BRD-K59522102-001-15-3::2.46::HTS,5.330864062245812,0.021336244242010482,Non-Small Cell Lung Cancer,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Non-Small Cell Lung Cancer,BRD-K59647213-001-10-5::2.5::HTS,4.534652377264561,0.033682474464382536,Other Types,levocarnitine,,
Non-Small Cell Lung Cancer,BRD-K59831625-001-01-6::2.5::HTS,4.843900471441641,0.028149978617392154,Non-Small Cell Lung Cancer,LDN-212854,bone morphogenic protein inhibitor,"ABL1, ACVR1, RIPK2"
Non-Small Cell Lung Cancer,BRD-K60184833-001-05-6::2.5::HTS,3.8598334639966203,0.04995461588904302,Other Types,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR
Non-Small Cell Lung Cancer,BRD-K60230970-001-17-5::2.4::HTS,5.453224716492389,0.019908787493130634,Other Types,MG-132,proteasome inhibitor,PSMB1
Non-Small Cell Lung Cancer,BRD-K60511616-236-08-9::2.5::HTS,4.501310704883695,0.034312171383761504,Non-Small Cell Lung Cancer,pravastatin,HMGCR inhibitor,"HMGCR, SLCO1B1"
Non-Small Cell Lung Cancer,BRD-K61295575-001-03-6::2.5::HTS,5.574466824871071,0.018564579337473932,Non-Small Cell Lung Cancer,blebbistatin-(-),ATPase inhibitor,
Non-Small Cell Lung Cancer,BRD-K62627508-001-01-5::2.5::HTS,5.763380325321186,0.016688771681650838,Non-Small Cell Lung Cancer,idasanutlin,MDM inhibitor,"MDM2, TP53"
Non-Small Cell Lung Cancer,BRD-K64785675-001-04-0::2.5::HTS,4.989649111315001,0.02589202620281752,Non-Small Cell Lung Cancer,TG100-115,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Non-Small Cell Lung Cancer,BRD-K64838454-001-01-0::2.5::HTS,6.000612830900608,0.014610544044496127,Non-Small Cell Lung Cancer,dipraglurant,glutamate receptor negative allosteric modulator,GRM5
Non-Small Cell Lung Cancer,BRD-K64925568-001-01-8::2.5::HTS,6.163758821897673,0.01333278375349977,Non-Small Cell Lung Cancer,AMG-232,MDM inhibitor,MDM2
Non-Small Cell Lung Cancer,BRD-K65503129-001-06-3::2.5::HTS,4.103701646853665,0.04326823465759932,Other Types,CCT018159,HSP inhibitor,"HSP90AA1, HSP90AB1"
Non-Small Cell Lung Cancer,BRD-K66480997-003-10-0::2.5::HTS,3.872780919331987,0.04956636422966105,Non-Small Cell Lung Cancer,isoguvacine,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Non-Small Cell Lung Cancer,BRD-K66788707-001-14-3::2.5::HTS,7.99234884322706,0.004867298561586184,Other Types,fludarabine,ribonucleotide reductase inhibitor,"ADA, RRM1, RRM2"
Non-Small Cell Lung Cancer,BRD-K66808046-065-03-7::2.5::HTS,9.843079173561826,0.0017978647845973321,Non-Small Cell Lung Cancer,oxyquinoline,chelating agent,METAP2
Non-Small Cell Lung Cancer,BRD-K67511046-001-02-3::2.5::HTS,6.095730695187937,0.013859878242649462,Other Types,naloxone,opioid receptor antagonist,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4"
Non-Small Cell Lung Cancer,BRD-K67680372-003-02-6::2.5::HTS,3.8715740502202167,0.049606174153985515,Non-Small Cell Lung Cancer,CI-966,GAT inhibitor,SLC6A1
Non-Small Cell Lung Cancer,BRD-K67783091-001-26-1::2.5::HTS,4.3769737185049165,0.03687974376474916,Non-Small Cell Lung Cancer,haloperidol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1"
Non-Small Cell Lung Cancer,BRD-K68174511-001-06-6::2.5::HTS,4.134413009167476,0.04248898401783718,Other Types,torin-2,mTOR inhibitor,MTOR
Non-Small Cell Lung Cancer,BRD-K68870568-066-01-5::2.5::HTS,6.530592688131612,0.010866510407263259,Non-Small Cell Lung Cancer,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Non-Small Cell Lung Cancer,BRD-K68904758-001-03-5::2.5::HTS,4.280589851171467,0.039013195429258615,Other Types,cephalomannine,DNA polymerase inhibitor,
Non-Small Cell Lung Cancer,BRD-K68997413-001-05-1::2.5::HTS,5.671503147904618,0.017577002853383428,Non-Small Cell Lung Cancer,PF-3845,FAAH inhibitor,FAAH
Non-Small Cell Lung Cancer,BRD-K69776681-001-03-8::2.5::HTS,5.095545989655255,0.02437177647341518,Other Types,volasertib,PLK inhibitor,PLK1
Non-Small Cell Lung Cancer,BRD-K70358946-001-15-7::2.5::HTS,5.530107603470508,0.019037436304930513,Non-Small Cell Lung Cancer,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Non-Small Cell Lung Cancer,BRD-K71164191-001-01-0::2.5::HTS,14.25933916248025,0.00017648281380990656,Other Types,KD-023,ACAT inhibitor,"ACACA, ACACB"
Non-Small Cell Lung Cancer,BRD-K71480163-001-01-4::2.5::HTS,11.01904710961516,0.0009604411840868293,Non-Small Cell Lung Cancer,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Non-Small Cell Lung Cancer,BRD-K73109821-001-20-1::2.5::HTS,4.726072648227069,0.030131298657148038,Non-Small Cell Lung Cancer,diazoxide,potassium channel activator,"ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3"
Non-Small Cell Lung Cancer,BRD-K74339692-001-01-9::2.5::HTS,5.002242094400415,0.02571311640136099,Non-Small Cell Lung Cancer,tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Non-Small Cell Lung Cancer,BRD-K74371986-001-01-7::2.5::HTS,8.928228141825029,0.002933069424148307,Non-Small Cell Lung Cancer,NSI-189,neurotrophic agent,
Non-Small Cell Lung Cancer,BRD-K74913225-001-12-4::2.5::HTS,4.1935625208846385,0.04105559383295807,Non-Small Cell Lung Cancer,brinzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7"
Non-Small Cell Lung Cancer,BRD-K75855670-001-14-2::2.5::HTS,6.498495087348707,0.011063512338205723,Non-Small Cell Lung Cancer,iodoquinol,antiseptic,
Non-Small Cell Lung Cancer,BRD-K76406695-001-02-9::2.5::HTS,12.013460598384638,0.00056882128534226,Non-Small Cell Lung Cancer,CCT128930,AKT inhibitor,"PKIA, PRKACA"
Non-Small Cell Lung Cancer,BRD-K77012840-300-01-6::2.5::HTS,4.039272653795772,0.04493299264420752,Non-Small Cell Lung Cancer,AY-9944,hedgehog pathway modulator,
Non-Small Cell Lung Cancer,BRD-K77627880-001-04-0::2.5::HTS,4.337285638722478,0.03774118389902989,Other Types,A205804,ICAM1 expression inhibitor,"ICAM1, SELE"
Non-Small Cell Lung Cancer,BRD-K77791657-001-01-1::2.5::HTS,3.870288887855664,0.04963948275812824,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Non-Small Cell Lung Cancer,BRD-K77791657-003-01-7::2.67::HTS,8.15921994026868,0.0044530662462432926,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Non-Small Cell Lung Cancer,BRD-K77867004-001-02-7::2.5::HTS,4.200111952146802,0.0408849757053713,Other Types,U-104,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA9"
Non-Small Cell Lung Cancer,BRD-K78177893-001-02-4::2.5::HTS,4.794231754181159,0.0289685605416621,Other Types,A-674563,AKT inhibitor,"AKT1, PKIA, PRKACA"
Non-Small Cell Lung Cancer,BRD-K78303961-001-02-3::2.5::HTS,4.957854682187498,0.026367946395780394,Non-Small Cell Lung Cancer,glycitein,tumor necrosis factor release inhibitor,TNF
Non-Small Cell Lung Cancer,BRD-K78643075-001-11-6::2.5::HTS,8.559716162858923,0.003576679251648227,Non-Small Cell Lung Cancer,bromperidol,dopamine receptor antagonist,DRD2
Non-Small Cell Lung Cancer,BRD-K78692225-001-24-5::2.5::HTS,11.216970764781388,0.0008666775565982494,Non-Small Cell Lung Cancer,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor","AHR, DHODH, PTK2B"
Non-Small Cell Lung Cancer,BRD-K79095980-001-09-6::2.5::HTS,13.774292590882292,0.0002266907635245035,Non-Small Cell Lung Cancer,broxuridine,antimetabolite,
Non-Small Cell Lung Cancer,BRD-K79584249-001-01-3::2.5::HTS,9.054050893751006,0.00274032686495603,Non-Small Cell Lung Cancer,CGM097,MDM inhibitor,MDM2
Non-Small Cell Lung Cancer,BRD-K79930101-300-03-7::2.5::HTS,4.043281193750462,0.044824630389099326,Non-Small Cell Lung Cancer,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Non-Small Cell Lung Cancer,BRD-K81855038-003-13-9::2.5::HTS,5.2716656289482815,0.02204507744201405,Non-Small Cell Lung Cancer,roxatidine-acetate,histamine receptor antagonist,HRH2
Non-Small Cell Lung Cancer,BRD-K82357231-001-17-5::2.5::HTS,4.3748225148042374,0.03692271682877078,Non-Small Cell Lung Cancer,desloratadine,histamine receptor antagonist,HRH1
Non-Small Cell Lung Cancer,BRD-K82467063-001-02-7::2.5::HTS,5.518322916389723,0.01917835144978347,Non-Small Cell Lung Cancer,SB-271046,serotonin receptor antagonist,HTR6
Non-Small Cell Lung Cancer,BRD-K83607951-001-02-2::2.5::HTS,3.987546419582233,0.04632214406844757,Non-Small Cell Lung Cancer,skepinone-l,p38 MAPK inhibitor,MAPK14
Non-Small Cell Lung Cancer,BRD-K86109159-001-02-6::2.5::HTS,3.9078830934425826,0.04854846525305715,Non-Small Cell Lung Cancer,VU0357121,glutamate receptor positive allosteric modulator,GRM5
Non-Small Cell Lung Cancer,BRD-K86118762-001-01-8::2.5::HTS,7.913960011474071,0.005083137210872495,Other Types,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Non-Small Cell Lung Cancer,BRD-K86436199-003-01-3::2.5::HTS,5.324017254322154,0.021402542775418806,Non-Small Cell Lung Cancer,landiolol,adrenergic receptor antagonist,ADRB1
Non-Small Cell Lung Cancer,BRD-K88025533-003-03-3::2.5::HTS,4.899282432724187,0.027272326953103932,Non-Small Cell Lung Cancer,fingolimod,"immunosuppressant, sphingosine phosphate receptor agonist","S1PR1, S1PR5"
Non-Small Cell Lung Cancer,BRD-K88052444-001-08-8::2.5::HTS,5.417355478719993,0.020294912228999918,Non-Small Cell Lung Cancer,urea,hydroxy radical formation stimulant,"ARG1, CA2, CTNNB1"
Non-Small Cell Lung Cancer,BRD-K88506063-001-01-8::2.5::HTS,4.162675873965119,0.041793488606202196,Non-Small Cell Lung Cancer,KD025,rho associated kinase inhibitor,ROCK2
Non-Small Cell Lung Cancer,BRD-K88677950-001-03-9::2.5::HTS,6.673558765520084,0.01003861652716392,Non-Small Cell Lung Cancer,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Non-Small Cell Lung Cancer,BRD-K89015388-001-01-7::2.5::HTS,10.81513073286838,0.001070268711604809,Other Types,GSK923295,centromere associated protein inhibitor,CENPE
Non-Small Cell Lung Cancer,BRD-K89714990-001-01-5::2.5::HTS,4.531895192349061,0.03370608680218288,Non-Small Cell Lung Cancer,tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5
Non-Small Cell Lung Cancer,BRD-K91601245-001-12-0::2.5::HTS,4.533519062319732,0.03368401087029963,Other Types,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT"
Non-Small Cell Lung Cancer,BRD-K92150287-066-01-2::2.5::HTS,4.265460248865235,0.03935928745614047,Other Types,exatecan-mesylate,topoisomerase inhibitor,TOP1
Non-Small Cell Lung Cancer,BRD-K92980438-001-03-3::2.5::HTS,4.880897878795384,0.02758400066571204,Non-Small Cell Lung Cancer,3-bromopyruvate,hexokinase inhibitor,HK2
Non-Small Cell Lung Cancer,BRD-K93918653-001-08-9::2.5::HTS,5.0407228492867535,0.025148254958802123,Non-Small Cell Lung Cancer,quizartinib,FLT3 inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET"
Non-Small Cell Lung Cancer,BRD-K95110148-003-01-5::2.5::HTS,6.425820637329092,0.011518857093431607,Other Types,beta-funaltrexamine,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Non-Small Cell Lung Cancer,BRD-K95260951-050-03-1::2.5::HTS,3.8718231931034777,0.04959445130348917,Non-Small Cell Lung Cancer,asenapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
Non-Small Cell Lung Cancer,BRD-K95435023-001-10-1::2.5::HTS,5.716838731994228,0.01713574596116107,Non-Small Cell Lung Cancer,PHA-665752,c-Met inhibitor,MET
Non-Small Cell Lung Cancer,BRD-K95523387-001-09-6::2.5::HTS,7.510277859179459,0.006330928804831673,Non-Small Cell Lung Cancer,OLDA,TRPV agonist,GPR119
Non-Small Cell Lung Cancer,BRD-K95763993-001-19-3::2.5::HTS,3.950755526858836,0.04733517249552637,Non-Small Cell Lung Cancer,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA
Non-Small Cell Lung Cancer,BRD-K95880107-001-02-4::2.5::HTS,6.597091942830715,0.010471657729362918,Non-Small Cell Lung Cancer,PH-797804,p38 MAPK inhibitor,"MAPK11, MAPK14"
Non-Small Cell Lung Cancer,BRD-K95926480-003-03-6::2.5::HTS,16.044984351222556,7.029867885591901e-05,Non-Small Cell Lung Cancer,SRT1720,SIRT activator,SIRT1
Non-Small Cell Lung Cancer,BRD-K96137854-001-17-1::2.5::HTS,4.980328192968388,0.02603415286693213,Non-Small Cell Lung Cancer,enoxolone,gap junction modulator,HSD11B1
Non-Small Cell Lung Cancer,BRD-K96358241-001-01-9::0.94::HTS,4.84422314120674,0.02814840928192064,Other Types,harringtonine,protein synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-K96631475-001-02-4::2.43::HTS,7.297839381953838,0.007125677415343982,Other Types,10-deacetylbaccatin,antitumor agent,
Non-Small Cell Lung Cancer,BRD-K97010173-001-04-1::2.5::HTS,7.1219760030755905,0.007834809639076918,Non-Small Cell Lung Cancer,deferasirox,chelating agent,CYP3A4
Non-Small Cell Lung Cancer,BRD-K97714174-001-01-3::2.5::HTS,6.994924588173878,0.008402679350617007,Other Types,P22077,ubiquitin specific protease inhibitor,USP7
Non-Small Cell Lung Cancer,BRD-K97764662-001-17-3::2.5::HTS,4.772735121722502,0.029332201689919568,Non-Small Cell Lung Cancer,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Non-Small Cell Lung Cancer,BRD-K97808269-001-02-7::2.5::HTS,6.169304358108291,0.01329311381971993,Non-Small Cell Lung Cancer,2-deoxyglucose,glycolysis inhibitor,"SLC2A1, SLC2A2, SLC2A3, SLC2A4"
Non-Small Cell Lung Cancer,BRD-K98521173-001-19-4::2.5::HTS,5.201751398765444,0.022937597998007292,Other Types,desoxycortone,mineralocorticoid receptor agonist,"NR3C1, NR3C2"
Non-Small Cell Lung Cancer,BRD-K99023089-001-03-7::2.5::HTS,10.304645257300768,0.0014031100577795996,Non-Small Cell Lung Cancer,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Non-Small Cell Lung Cancer,BRD-M80207679-001-01-5::2.5::HTS,4.145181130593273,0.042241616083650776,Non-Small Cell Lung Cancer,nemonapride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Non-Small Cell Lung Cancer,BRD-A40302156-001-01-9::2.503151999::MTS004,5.438520163863372,0.02006474277788916,Non-Small Cell Lung Cancer,A-33903,,
Non-Small Cell Lung Cancer,BRD-A88254928-001-07-9::2.5::MTS004,3.8977164375004896,0.04886282218243314,Other Types,albuterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Non-Small Cell Lung Cancer,BRD-K00634421-001-01-0::2.500042819::MTS004,5.154004257170329,0.023587482835163417,Other Types,brivaracetam,voltage-gated sodium channel blocker,SV2A
Non-Small Cell Lung Cancer,BRD-K11851476-003-01-7::2.499993171::MTS004,4.437110857786742,0.03562735740255754,Other Types,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Non-Small Cell Lung Cancer,BRD-K25970317-001-01-6::2.50000335::MTS004,21.930956584600654,3.5831336684952354e-06,Other Types,resibufogenin,Na/K-ATPase inhibitor,
Non-Small Cell Lung Cancer,BRD-K38527262-300-01-0::2.300987371::MTS004,6.646341960244319,0.010200779455019692,Non-Small Cell Lung Cancer,atiprimod,"JAK inhibitor, STAT inhibitor","JAK2, STAT3"
Non-Small Cell Lung Cancer,BRD-K42816473-001-01-0::2.38330586::MTS004,4.514164239119456,0.034070587854672534,Other Types,zilpaterol,adrenergic receptor agonist,ADRB2
Non-Small Cell Lung Cancer,BRD-K55029398-001-01-6::2.499962393::MTS004,4.023752435519915,0.04536392432061402,Other Types,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2
Non-Small Cell Lung Cancer,BRD-K59866480-001-07-3::2.379655165::MTS004,6.117272648263903,0.013693881626813103,Non-Small Cell Lung Cancer,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Non-Small Cell Lung Cancer,BRD-K67482377-001-01-8::2.500004112::MTS004,8.08064095354251,0.004643658552906948,Other Types,itacitinib,JAK inhibitor,JAK1
Non-Small Cell Lung Cancer,BRD-K72259270-003-25-6::2.444857586::MTS004,3.9133371466820566,0.04841314130011144,Non-Small Cell Lung Cancer,dyclonine,sodium channel blocker,"SCN10A, SCN5A"
Non-Small Cell Lung Cancer,BRD-K75445017-001-01-1::2.5::MTS004,3.977121752490618,0.04662558286580946,Non-Small Cell Lung Cancer,estetrol,selective estrogen receptor modulator (SERM),ESR1
Non-Small Cell Lung Cancer,BRD-K79821389-001-03-5::2.562009205::MTS004,4.858523236166432,0.027932530327571634,Other Types,rubitecan,topoisomerase inhibitor,TOP1
Non-Small Cell Lung Cancer,BRD-K80762071-236-02-5::2.5::MTS004,4.814672068003556,0.028644472194029297,Non-Small Cell Lung Cancer,indocyanine-green,contrast agent,SLCO1B1
Non-Small Cell Lung Cancer,BRD-K81405859-300-01-4::2.5::MTS004,6.937084472707716,0.008685214765601343,Other Types,JTE-607,cytokine production inhibitor,"IL10, IL1B, IL6, TNF"
Non-Small Cell Lung Cancer,BRD-K88854110-001-01-5::2.499975441::MTS004,4.066548083792048,0.04423693359844754,Other Types,taprenepag,prostaglandin receptor agonist,PTGER2
Non-Small Cell Lung Cancer,BRD-K90171280-001-01-4::2.328630918::MTS004,4.53120778387677,0.03373579945834346,Other Types,LY2452473,androgen receptor modulator,AR
Non-Small Cell Lung Cancer,BRD-K92581468-001-01-6::2.389082227::MTS004,7.790654417943702,0.005437922029443338,Non-Small Cell Lung Cancer,ocinaplon,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5"
Non-Small Cell Lung Cancer,BRD-K96734425-304-01-7::2.500007729::MTS004,4.378846694827812,0.03685467961398499,Non-Small Cell Lung Cancer,ceftriaxone,bacterial cell wall synthesis inhibitor,
Non-Small Cell Lung Cancer,BRD-K99431849-001-01-7::2.500018158::MTS004,5.469134398031778,0.019719782387624365,Other Types,peretinoin,retinoid receptor agonist,RXRA
Non-Small Cell Lung Cancer,BRD-K99919177-001-01-3::2.5::MTS004,4.019606400044872,0.04547377758038499,Other Types,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Invasive Breast Carcinoma,BRD-A00218260-001-03-4::2.5::HTS,5.6578947512221935,0.01771491147927436,Other Types,flutrimazole,sterol demethylase inhibitor,
Invasive Breast Carcinoma,BRD-A03506276-001-01-5::2.5::HTS,4.986127905038535,0.02594782521134418,Invasive Breast Carcinoma,XL888,HSP inhibitor,
Invasive Breast Carcinoma,BRD-A03623303-045-09-5::2.5::HTS,8.790799280952733,0.003157175945682412,Invasive Breast Carcinoma,metoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Invasive Breast Carcinoma,BRD-A04352665-001-05-3::2.5::HTS,10.579102763716836,0.0012153092563816424,Other Types,maraviroc,CC chemokine receptor antagonist,CCR5
Invasive Breast Carcinoma,BRD-A08545410-311-03-4::2.5::HTS,5.589253345895079,0.018431979515149056,Invasive Breast Carcinoma,doxycycline,metalloproteinase inhibitor,MMP8
Invasive Breast Carcinoma,BRD-A09349126-001-10-7::2.5::HTS,7.671216577662092,0.005804636812265176,Invasive Breast Carcinoma,norethindrone-acetate,progesterone receptor agonist,
Invasive Breast Carcinoma,BRD-A10523515-001-07-9::2.5::HTS,5.934392371293247,0.015160582358058073,Invasive Breast Carcinoma,GSK429286A,rho associated kinase inhibitor,ROCK1
Invasive Breast Carcinoma,BRD-A10652366-238-04-1::2.5::HTS,5.297732347730396,0.02174160486216533,Invasive Breast Carcinoma,fosfomycin,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-A10739734-003-10-6::2.5::HTS,4.580206620997968,0.03277625352836573,Invasive Breast Carcinoma,efaroxan,adrenergic receptor antagonist,ADORA2A
Invasive Breast Carcinoma,BRD-A12237696-001-04-2::2.5::HTS,4.876721927441389,0.027641413365064968,Other Types,L-Citrulline,nitric oxide stimulant,"ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6"
Invasive Breast Carcinoma,BRD-A13598753-001-01-2::2.5::HTS,7.776342105255582,0.0054737991141504344,Other Types,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1
Invasive Breast Carcinoma,BRD-A14886633-001-01-6::2.5::HTS,5.145958785313716,0.023684504452781627,Invasive Breast Carcinoma,norgestrel,progesterone receptor agonist,PGR
Invasive Breast Carcinoma,BRD-A20348246-001-15-8::2.5::HTS,4.016024549244638,0.04555181452204661,Invasive Breast Carcinoma,chlormezanone,GABA receptor modulator,"GABRA1, TSPO"
Invasive Breast Carcinoma,BRD-A21276153-001-01-1::2.5::HTS,4.241409548773045,0.0399391247594758,Other Types,"2,6-dimethylpiperidine",,
Invasive Breast Carcinoma,BRD-A29520968-001-02-7::2.5::HTS,5.953016585049953,0.015004641312163947,Other Types,acifran,cholesterol inhibitor,"HCAR2, HCAR3"
Invasive Breast Carcinoma,BRD-A30051119-002-01-8::2.5::HTS,8.805997153648052,0.0031318660929877825,Other Types,amikacin,bacterial 30S ribosomal subunit inhibitor,
Invasive Breast Carcinoma,BRD-A32988684-003-08-7::2.5::HTS,6.94732121296196,0.008628434398277384,Invasive Breast Carcinoma,heptaminol,vasoconstrictor,
Invasive Breast Carcinoma,BRD-A34358106-003-01-6::2.5::HTS,5.987125207418629,0.014720313538933626,Invasive Breast Carcinoma,sarpogrelate,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Invasive Breast Carcinoma,BRD-A35623999-001-05-7::2.5::HTS,5.145899022274871,0.023683239045885086,Other Types,CGP-37157,"mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor",SLC8A1
Invasive Breast Carcinoma,BRD-A36331462-001-02-1::2.5::HTS,4.4351981035004355,0.035656069342694864,Invasive Breast Carcinoma,oprozomib,proteasome inhibitor,
Invasive Breast Carcinoma,BRD-A38350138-001-04-9::2.5::HTS,7.419244105958388,0.006661161150679719,Other Types,ketoconazole,sterol demethylase inhibitor,"AR, CYP19A1, CYP21A2, KCNA10"
Invasive Breast Carcinoma,BRD-A39230911-001-10-2::2.5::HTS,4.280713549112772,0.03900541031197567,Other Types,chlorphensin-carbamate,muscle relaxant,
Invasive Breast Carcinoma,BRD-A39791822-001-05-1::2.5::HTS,7.876305842843796,0.005183618474872722,Other Types,hydroxyprogesterone,progesterone receptor agonist,PGR
Invasive Breast Carcinoma,BRD-A42699921-001-03-6::2.6::HTS,6.615794729863677,0.010375007201262566,Invasive Breast Carcinoma,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH
Invasive Breast Carcinoma,BRD-A44863528-001-13-2::2.5::HTS,5.403374385949307,0.020459742626471506,Other Types,proglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Invasive Breast Carcinoma,BRD-A46717658-236-02-5::2.5::HTS,3.9523027896876894,0.04730620478630988,Invasive Breast Carcinoma,azlocillin,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-A48237631-001-04-8::2.5::HTS,17.025699787542187,4.256892615301135e-05,Invasive Breast Carcinoma,mitomycin-c,"DNA alkylating agent, DNA synthesis inhibitor",
Invasive Breast Carcinoma,BRD-A48720949-001-04-0::2.5::HTS,6.006960304489582,0.014555868406198116,Invasive Breast Carcinoma,testosterone-propionate,androgen receptor agonist,AR
Invasive Breast Carcinoma,BRD-A49046702-003-08-3::2.5::HTS,5.864848154897175,0.015764472253280155,Other Types,SKF-89976A,GABA uptake inhibitor,SLC6A1
Invasive Breast Carcinoma,BRD-A50157456-065-20-6::2.5::HTS,8.0030569624197,0.004839941711439994,Invasive Breast Carcinoma,terbutaline,adrenergic receptor agonist,ADRB2
Invasive Breast Carcinoma,BRD-A53539450-004-01-7::2.5::HTS,4.685505342106866,0.030839929005094247,Other Types,neo-gilurytmal,,
Invasive Breast Carcinoma,BRD-A54275602-001-01-0::2.5::HTS,4.83080808215466,0.028370009310546576,Other Types,lanoconazole,sterol demethylase inhibitor,
Invasive Breast Carcinoma,BRD-A55424491-001-19-9::2.5::HTS,14.572804504085907,0.00015014340006584042,Invasive Breast Carcinoma,methotrexate,dihydrofolate reductase inhibitor,DHFR
Invasive Breast Carcinoma,BRD-A55484088-050-02-5::2.5::HTS,5.80170045743876,0.016333195021814337,Invasive Breast Carcinoma,BNTX,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Invasive Breast Carcinoma,BRD-A56085258-001-01-8::2.5::HTS,10.154993133006613,0.0015193104444632603,Invasive Breast Carcinoma,LGX818,RAF inhibitor,BRAF
Invasive Breast Carcinoma,BRD-A57382968-001-29-0::2.5::HTS,3.8601568723083814,0.04993794439854608,Invasive Breast Carcinoma,piroxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Invasive Breast Carcinoma,BRD-A57798112-001-03-7::2.5::HTS,10.925499703634543,0.001009512920916371,Invasive Breast Carcinoma,PD-318088,MEK inhibitor,MAP2K1
Invasive Breast Carcinoma,BRD-A57886255-001-01-1::2.5::HTS,4.281079378018258,0.03899955344325877,Invasive Breast Carcinoma,golgicide-a,ARF inhibitor,GBF1
Invasive Breast Carcinoma,BRD-A61221616-001-04-3::2.5::HTS,10.046368580545307,0.0016095537128024541,Invasive Breast Carcinoma,medroxyprogesterone-acetate,progesterone receptor agonist,
Invasive Breast Carcinoma,BRD-A66419424-001-02-4::2.5::HTS,5.026030802592687,0.025365471447273517,Invasive Breast Carcinoma,ixazomib-citrate,proteasome inhibitor,
Invasive Breast Carcinoma,BRD-A67006024-001-04-8::2.5::HTS,6.829682203040601,0.009222192436483503,Other Types,SNAP,nitric oxide donor,PTPN1
Invasive Breast Carcinoma,BRD-A67101513-001-03-7::2.5::HTS,4.4333159695495405,0.03569022226868801,Invasive Breast Carcinoma,hygromycin-b,polypeptide synthesis inhibitor,
Invasive Breast Carcinoma,BRD-A72716251-001-01-5::0.91::HTS,7.721788817985956,0.0056409718332342505,Invasive Breast Carcinoma,peruvoside,cardiac glycoside,
Invasive Breast Carcinoma,BRD-A73871920-236-03-6::2.5::HTS,4.026212270054944,0.045281264290469976,Invasive Breast Carcinoma,nanchangmycin,other antibiotic,
Invasive Breast Carcinoma,BRD-A74914197-001-02-9::2.5::HTS,15.817233708840615,7.905456608362879e-05,Invasive Breast Carcinoma,pralatrexate,dihydrofolate reductase inhibitor,"DHFR, TYMS"
Invasive Breast Carcinoma,BRD-A89594340-003-11-5::2.5::HTS,4.012765625857765,0.04564363419617804,Other Types,carnitine-(D/L),,
Invasive Breast Carcinoma,BRD-A92872453-001-01-8::2.5::HTS,7.339355107772171,0.0069548434590655074,Invasive Breast Carcinoma,N-acetylmannosamine,,CHIT1
Invasive Breast Carcinoma,BRD-A99833829-003-27-1::2.5::HTS,4.851024843266992,0.028061115212357123,Other Types,bethanechol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Invasive Breast Carcinoma,BRD-K00152668-001-01-5::2.5::HTS,6.977901945957565,0.008484041877456687,Invasive Breast Carcinoma,adarotene,retinoid receptor agonist,"RARB, RARG"
Invasive Breast Carcinoma,BRD-K00535541-001-05-5::2.5::HTS,5.402290157782449,0.020481084479434475,Invasive Breast Carcinoma,9-aminoacridine,,
Invasive Breast Carcinoma,BRD-K00535541-001-06-3::2.5::HTS,10.434453968139179,0.0013138793857099657,Invasive Breast Carcinoma,9-aminoacridine,,
Invasive Breast Carcinoma,BRD-K00673382-001-18-9::2.5::HTS,4.261852741264238,0.039443127324769414,Other Types,famotidine,histamine receptor antagonist,HRH2
Invasive Breast Carcinoma,BRD-K01294196-001-01-5::2.5::HTS,8.2845888985522,0.004154897783899959,Invasive Breast Carcinoma,sucrose-octaacetate,,
Invasive Breast Carcinoma,BRD-K01669786-001-02-2::2.5::HTS,7.786570238533706,0.005453967247556094,Invasive Breast Carcinoma,triapine,ribonucleotide reductase inhibitor,"RRM1, RRM2"
Invasive Breast Carcinoma,BRD-K01773560-001-02-4::2.59::HTS,4.568675114000919,0.03301188611765421,Invasive Breast Carcinoma,UNC2250,MER tyrosine kinase inhibitor,MERTK
Invasive Breast Carcinoma,BRD-K02130563-001-11-4::2.5::HTS,4.256270063287258,0.0395710899962262,Invasive Breast Carcinoma,panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9"
Invasive Breast Carcinoma,BRD-K02407574-001-09-7::2.5::HTS,5.480223820937986,0.019581428657678653,Invasive Breast Carcinoma,parbendazole,tubulin polymerization inhibitor,TUBB
Invasive Breast Carcinoma,BRD-K02950022-001-02-9::2.5::HTS,5.66157551241778,0.017676334801286372,Other Types,BMS-299897,gamma secretase inhibitor,
Invasive Breast Carcinoma,BRD-K03063480-001-05-8::2.5::HTS,5.289437884523205,0.021820727638685106,Invasive Breast Carcinoma,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Invasive Breast Carcinoma,BRD-K03063480-001-06-6::2.42::HTS,6.70137708105429,0.00989940094367051,Invasive Breast Carcinoma,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Invasive Breast Carcinoma,BRD-K03109492-001-02-2::2.5::HTS,11.049586002507109,0.0009456928608443769,Invasive Breast Carcinoma,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Invasive Breast Carcinoma,BRD-K03243820-001-23-8::2.37::HTS,5.313300801041887,0.021550140452634717,Invasive Breast Carcinoma,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Invasive Breast Carcinoma,BRD-K03243820-001-25-3::2.5::HTS,3.878279868770764,0.049419815422772954,Invasive Breast Carcinoma,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Invasive Breast Carcinoma,BRD-K03289018-001-02-7::2.5::HTS,8.321422075532386,0.004068291732262357,Invasive Breast Carcinoma,CCT137690,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Invasive Breast Carcinoma,BRD-K03390685-001-01-7::2.5::HTS,12.891246093562044,0.000359437909606862,Invasive Breast Carcinoma,cobimetinib,MEK inhibitor,
Invasive Breast Carcinoma,BRD-K03449891-001-08-6::2.5::HTS,5.436174336554005,0.020081450958377496,Invasive Breast Carcinoma,foretinib,VEGFR inhibitor,"FLT1, FLT4, KDR, MET"
Invasive Breast Carcinoma,BRD-K05104363-001-10-0::2.5::HTS,5.627945123295452,0.018026424271747277,Invasive Breast Carcinoma,PD-184352,MEK inhibitor,"MAP2K1, MAP3K1, MAP3K2"
Invasive Breast Carcinoma,BRD-K05151076-001-02-6::2.5::HTS,7.2819192298332736,0.007176530265560194,Other Types,ZK-164015,estrogen receptor antagonist,"ESR1, ESR2"
Invasive Breast Carcinoma,BRD-K05464208-001-05-7::2.5::HTS,4.867280495924174,0.02777727722192556,Invasive Breast Carcinoma,JX-401,p38 MAPK inhibitor,MAPK14
Invasive Breast Carcinoma,BRD-K05804044-001-06-0::2.5::HTS,6.557081899334554,0.010709210367092626,Invasive Breast Carcinoma,AZ-628,RAF inhibitor,"BRAF, RAF1"
Invasive Breast Carcinoma,BRD-K05900209-001-03-4::2.47::HTS,7.192875940446555,0.007548546481185988,Other Types,dexlansoprazole,ATPase inhibitor,"ATP4A, ATP4B"
Invasive Breast Carcinoma,BRD-K06542892-001-01-9::2.5::HTS,5.64182595497159,0.017878763457613713,Invasive Breast Carcinoma,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Invasive Breast Carcinoma,BRD-K06593056-001-04-8::2.5::HTS,8.875178065047596,0.0030174202289192558,Other Types,LE-135,retinoid receptor agonist,RARB
Invasive Breast Carcinoma,BRD-K06858286-001-01-3::2.5::HTS,7.481482394256518,0.006432302496225353,Invasive Breast Carcinoma,cabazitaxel,microtubule inhibitor,"TUBA4A, TUBB, TUBB1"
Invasive Breast Carcinoma,BRD-K07202345-001-19-4::2.5::HTS,4.447303199415604,0.035399805069142885,Other Types,frentizole,immunosuppressant,
Invasive Breast Carcinoma,BRD-K07283971-001-01-3::2.5::HTS,6.690241641450854,0.009946683335479822,Other Types,oxyclozanide,,
Invasive Breast Carcinoma,BRD-K07572174-001-39-4::2.48::HTS,4.396727262929949,0.03648308576675024,Invasive Breast Carcinoma,curcumin,"cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH"
Invasive Breast Carcinoma,BRD-K07881437-001-04-6::2.41::HTS,6.613656671516376,0.010392406468457077,Invasive Breast Carcinoma,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Invasive Breast Carcinoma,BRD-K08078237-001-19-8::2.5::HTS,10.106431355159653,0.0015641581827427645,Invasive Breast Carcinoma,tetrandrine,calcium channel blocker,SLC6A3
Invasive Breast Carcinoma,BRD-K09353376-001-03-9::2.5::HTS,10.518258542997277,0.0012567313655698362,Other Types,tariquidar,P glycoprotein inhibitor,ABCB1
Invasive Breast Carcinoma,BRD-K09397065-003-06-1::2.5::HTS,4.116976628528125,0.04294584057691138,Invasive Breast Carcinoma,SR-57227A,serotonin receptor agonist,HTR3A
Invasive Breast Carcinoma,BRD-K09877029-001-01-2::2.5::HTS,8.785445704197913,0.0031658387967975527,Invasive Breast Carcinoma,VS-4718,focal adhesion kinase inhibitor,
Invasive Breast Carcinoma,BRD-K09951645-001-06-8::2.5::HTS,6.278238626258653,0.012516660351196663,Invasive Breast Carcinoma,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Invasive Breast Carcinoma,BRD-K11292736-300-02-8::2.5::HTS,6.370067555217385,0.011884526161487068,Other Types,ambenonium,cholinesterase inhibitor,ACHE
Invasive Breast Carcinoma,BRD-K11630072-001-13-2::2.5::HTS,7.697228343122482,0.005726422426535347,Invasive Breast Carcinoma,carmofur,thymidylate synthase inhibitor,TYMS
Invasive Breast Carcinoma,BRD-K11636097-001-03-1::2.5::HTS,9.965758470606325,0.0016815205784560347,Invasive Breast Carcinoma,JNJ-7706621,CDK inhibitor,"AURKA, AURKB, CDK1, CDK2"
Invasive Breast Carcinoma,BRD-K12329651-001-18-8::2.5::HTS,4.514350635080061,0.034047437943742126,Invasive Breast Carcinoma,androsterone,androgen receptor agonist,
Invasive Breast Carcinoma,BRD-K12343256-001-08-9::2.5::HTS,9.58799590138049,0.002056902952733559,Invasive Breast Carcinoma,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Invasive Breast Carcinoma,BRD-K12630395-001-14-9::2.5::HTS,7.294435502695065,0.007127358515051208,Invasive Breast Carcinoma,harmane,monoamine oxidase inhibitor,"MAOA, MAOB"
Invasive Breast Carcinoma,BRD-K12787259-001-04-3::2.5::HTS,4.751039365393567,0.029712671026799795,Invasive Breast Carcinoma,CX-5461,RNA polymerase inhibitor,
Invasive Breast Carcinoma,BRD-K13049116-001-05-7::2.5::HTS,5.139609662184336,0.023770451818510147,Invasive Breast Carcinoma,BMS-754807,IGF-1 inhibitor,"AKT1, IGF1R"
Invasive Breast Carcinoma,BRD-K13050541-001-01-9::2.8::HTS,10.786453436586958,0.0010870077076524105,Invasive Breast Carcinoma,acivicin,gamma glutamyltransferase Inhibitors,CTPS1
Invasive Breast Carcinoma,BRD-K13167095-001-02-9::2.5::HTS,11.05127620894047,0.0009439982818324983,Invasive Breast Carcinoma,AR-42,HDAC inhibitor,HDAC1
Invasive Breast Carcinoma,BRD-K13646352-001-03-8::2.5::HTS,8.335621101970291,0.004039265230651303,Invasive Breast Carcinoma,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Invasive Breast Carcinoma,BRD-K13949769-001-01-7::2.5::HTS,4.672395060699711,0.03107265431753523,Invasive Breast Carcinoma,tenovin-6,SIRT inhibitor,"SIRT1, SIRT2, SIRT3"
Invasive Breast Carcinoma,BRD-K14385366-001-04-4::2.59::HTS,13.471516609279504,0.00026712299561045775,Invasive Breast Carcinoma,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2
Invasive Breast Carcinoma,BRD-K14560436-001-01-4::2.5::HTS,5.277960944688082,0.021965609910351503,Invasive Breast Carcinoma,TG-02,"CDK inhibitor, FLT3 inhibitor, JAK inhibitor","CDK1, CDK2, CDK7, CDK9, FLT3, JAK2"
Invasive Breast Carcinoma,BRD-K15025317-001-15-1::2.5::HTS,4.930452246526896,0.02679119848837939,Invasive Breast Carcinoma,BAY-11-7082,NFkB pathway inhibitor,RELA
Invasive Breast Carcinoma,BRD-K15108141-001-06-6::2.5::HTS,5.59546445291628,0.018360063801068437,Invasive Breast Carcinoma,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Invasive Breast Carcinoma,BRD-K15179879-001-03-2::2.5::HTS,7.24366326209353,0.007336179676624826,Invasive Breast Carcinoma,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Invasive Breast Carcinoma,BRD-K15196155-001-02-3::2.5::HTS,4.596395150495612,0.03247384096499276,Other Types,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3
Invasive Breast Carcinoma,BRD-K15898725-001-01-7::2.5::HTS,4.80952390937376,0.02871409558956664,Invasive Breast Carcinoma,maytansinol-isobutyrate,,
Invasive Breast Carcinoma,BRD-K16757695-050-02-5::2.5::HTS,10.786487931912028,0.0010862837630394632,Other Types,PRX-08066,serotonin receptor antagonist,HTR2B
Invasive Breast Carcinoma,BRD-K17203476-001-01-9::2.5::HTS,8.249971609215978,0.00422966120261523,Invasive Breast Carcinoma,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Invasive Breast Carcinoma,BRD-K17443395-065-02-2::2.5::HTS,4.04885410672044,0.04467968481977073,Invasive Breast Carcinoma,abacavir,nucleoside reverse transcriptase inhibitor,
Invasive Breast Carcinoma,BRD-K17513304-001-01-9::2.5::HTS,5.472832927204452,0.019664828160518268,Other Types,firategrast,integrin antagonist,ITGA4
Invasive Breast Carcinoma,BRD-K17850764-236-11-9::2.5::HTS,7.035401075318751,0.00822046883914459,Other Types,cloprostenol-(+/-),prostaglandin receptor agonist,"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R"
Invasive Breast Carcinoma,BRD-K17894950-001-14-3::2.5::HTS,6.584629225433288,0.010545272750538582,Other Types,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A"
Invasive Breast Carcinoma,BRD-K17977438-048-02-4::2.5::HTS,4.746572190780088,0.029774455735691274,Invasive Breast Carcinoma,oxelaidin,antitussive,
Invasive Breast Carcinoma,BRD-K18157228-001-01-7::2.5::HTS,8.939358668514457,0.002913511790935301,Invasive Breast Carcinoma,fdcyd,DNA methyltransferase inhibitor,
Invasive Breast Carcinoma,BRD-K18834913-001-01-1::2.5::HTS,18.560663477978412,1.944493428177901e-05,Invasive Breast Carcinoma,LB42708,farnesyltransferase inhibitor,
Invasive Breast Carcinoma,BRD-K18961567-001-01-1::2.5::HTS,8.23356993946136,0.004269183739535423,Invasive Breast Carcinoma,LY2801653,MET inhibitor,MET
Invasive Breast Carcinoma,BRD-K19034817-001-01-4::2.5::HTS,6.048710024933693,0.014218760960148133,Invasive Breast Carcinoma,pacritinib,"FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3"
Invasive Breast Carcinoma,BRD-K19136521-001-08-9::2.5::HTS,7.804674818954063,0.0053914377283714714,Other Types,indirubin-3-monoxime,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B"
Invasive Breast Carcinoma,BRD-K19333160-001-01-3::2.5::HTS,4.471494652327815,0.03490763439806289,Invasive Breast Carcinoma,RKI-1447,rho associated kinase inhibitor,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2"
Invasive Breast Carcinoma,BRD-K19412355-001-01-0::2.5::HTS,6.531825943237246,0.010869364879938023,Other Types,SB-242235,p38 MAPK inhibitor,"HSPB1, MAPK14"
Invasive Breast Carcinoma,BRD-K19605405-001-02-7::2.5::HTS,5.65703803403094,0.017721650771439043,Other Types,ZM-241385,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Invasive Breast Carcinoma,BRD-K19687926-379-07-4::2.5::HTS,4.772142418043554,0.029339207070081436,Other Types,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Invasive Breast Carcinoma,BRD-K20001883-001-02-7::2.5::HTS,6.938748730145293,0.008670639549457017,Other Types,apabetalone,apolipoprotein expression enhancer,BRD3
Invasive Breast Carcinoma,BRD-K20285085-074-04-5::2.5::HTS,6.358797315964826,0.011973187885498912,Invasive Breast Carcinoma,R406,SYK inhibitor,"RET, SYK"
Invasive Breast Carcinoma,BRD-K20482099-001-09-4::2.5::HTS,4.989028146741241,0.025926578806166733,Invasive Breast Carcinoma,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Invasive Breast Carcinoma,BRD-K20655524-003-12-0::2.5::HTS,5.332477729321815,0.02130882241235591,Invasive Breast Carcinoma,mefexamide,psychoactive drug,
Invasive Breast Carcinoma,BRD-K21025364-001-04-9::2.5::HTS,7.920270278361836,0.005067023617573711,Invasive Breast Carcinoma,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Invasive Breast Carcinoma,BRD-K21025364-001-05-6::2.44::HTS,5.9037173553064335,0.015441314906322882,Invasive Breast Carcinoma,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Invasive Breast Carcinoma,BRD-K21884483-001-03-7::2.5::HTS,3.9541674388023984,0.04724700603180766,Other Types,mizolastine,histamine receptor antagonist,HRH1
Invasive Breast Carcinoma,BRD-K22127577-001-03-7::2.58::HTS,3.8596283654727,0.04998528810990264,Invasive Breast Carcinoma,crenolanib,PDGFR tyrosine kinase receptor inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB"
Invasive Breast Carcinoma,BRD-K22134346-001-24-9::2.42::HTS,11.273252958216332,0.0008430151101717228,Invasive Breast Carcinoma,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Invasive Breast Carcinoma,BRD-K22356203-001-01-8::2.5::HTS,6.431347813460899,0.011482028100791734,Other Types,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Invasive Breast Carcinoma,BRD-K22503835-001-11-0::2.5::HTS,4.778715770249556,0.029227651689283284,Invasive Breast Carcinoma,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Invasive Breast Carcinoma,BRD-K22822991-001-02-3::2.5::HTS,4.522560726929553,0.033904377077207795,Other Types,odanacatib,cathepsin inhibitor,CTSK
Invasive Breast Carcinoma,BRD-K23677682-003-01-2::2.5::HTS,10.288858385646227,0.0014145286939717353,Invasive Breast Carcinoma,voreloxin,topoisomerase inhibitor,TOP2A
Invasive Breast Carcinoma,BRD-K24187789-001-01-7::2.5::HTS,6.3192626591124705,0.012223229853944502,Invasive Breast Carcinoma,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Invasive Breast Carcinoma,BRD-K24576554-001-04-8::2.5::HTS,4.438428821372766,0.03558758310115728,Invasive Breast Carcinoma,AT-9283,"Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A"
Invasive Breast Carcinoma,BRD-K24689407-001-06-3::2.5::HTS,10.68286952015888,0.0011477449193275974,Other Types,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Invasive Breast Carcinoma,BRD-K24844714-001-24-5::2.5::HTS,5.606791091896933,0.01824299677976873,Invasive Breast Carcinoma,5-fluorouracil,thymidylate synthase inhibitor,"DPYD, TYMS"
Invasive Breast Carcinoma,BRD-K25412176-001-01-9::2.5::HTS,8.65651535106096,0.0033953176388754735,Other Types,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Invasive Breast Carcinoma,BRD-K25630527-001-03-8::2.5::HTS,5.92413885746025,0.015245297586097547,Invasive Breast Carcinoma,LY2784544,JAK inhibitor,"JAK2, JAK3"
Invasive Breast Carcinoma,BRD-K26531771-001-02-2::2.35::HTS,5.51292302094186,0.019244563650009823,Invasive Breast Carcinoma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Invasive Breast Carcinoma,BRD-K26667523-001-02-5::2.5::HTS,11.434214072206288,0.0007718953470153547,Invasive Breast Carcinoma,TAK-733,MEK inhibitor,MAP2K1
Invasive Breast Carcinoma,BRD-K26818574-305-04-3::2.5::HTS,5.831293076801797,0.016063535391646133,Invasive Breast Carcinoma,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Invasive Breast Carcinoma,BRD-K26997899-001-02-2::2.5::HTS,5.466152389991487,0.01973813765816065,Invasive Breast Carcinoma,D-64131,microtubule inhibitor,TUBB
Invasive Breast Carcinoma,BRD-K27393415-001-01-0::2.5::HTS,7.070205582515319,0.008065124815153096,Other Types,xipamide,carbonic anhydrase inhibitor,SLC12A3
Invasive Breast Carcinoma,BRD-K28210218-236-08-1::2.5::HTS,4.111891893828106,0.04305821506693363,Other Types,cephalothin,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-K28667793-001-28-1::2.5::HTS,4.784025854575918,0.029139198157278026,Invasive Breast Carcinoma,pyrazinamide,fatty acid synthase inhibitor,FASN
Invasive Breast Carcinoma,BRD-K28822270-001-01-1::2.5::HTS,10.286655852166348,0.0014173061285660698,Invasive Breast Carcinoma,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Invasive Breast Carcinoma,BRD-K28907958-001-04-3::2.5::HTS,5.794316009852069,0.016401211974930045,Invasive Breast Carcinoma,CD-437,retinoid receptor agonist,RARG
Invasive Breast Carcinoma,BRD-K28965160-001-01-1::2.5::HTS,5.711283155331215,0.017189486921469977,Invasive Breast Carcinoma,BVD-523,MAP kinase inhibitor,
Invasive Breast Carcinoma,BRD-K29713308-077-04-1::2.5::HTS,7.631089426035129,0.005927603284468927,Invasive Breast Carcinoma,"mebhydroline-1,5-naphtalenedisulfonate",,
Invasive Breast Carcinoma,BRD-K30563334-001-02-9::2.5::HTS,6.643796646163181,0.010207487555018666,Other Types,rifabutin,protein synthesis inhibitor,"HSP90AA1, HSP90B1"
Invasive Breast Carcinoma,BRD-K30577245-001-04-3::2.5::HTS,7.151513013393511,0.007717411046982379,Invasive Breast Carcinoma,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Invasive Breast Carcinoma,BRD-K30577245-341-01-9::2.5::HTS,4.405959556831626,0.03626308967196257,Invasive Breast Carcinoma,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Invasive Breast Carcinoma,BRD-K31866293-001-01-6::2.5::HTS,10.281142806634472,0.001420904419739551,Invasive Breast Carcinoma,TAK-632,RAF inhibitor,BRAF
Invasive Breast Carcinoma,BRD-K32821942-001-21-3::2.5::HTS,6.20480932797481,0.013028878877716839,Invasive Breast Carcinoma,azathioprine,dehydrogenase inhibitor,"HPRT1, IMPDH1, PPAT"
Invasive Breast Carcinoma,BRD-K33211335-004-01-7::2.5::HTS,5.529447545614948,0.01904957002878103,Invasive Breast Carcinoma,dextromethorphan,"glutamate receptor antagonist, sigma receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4"
Invasive Breast Carcinoma,BRD-K33277808-331-01-3::2.5::HTS,4.5392552046754036,0.033562665437046675,Invasive Breast Carcinoma,ouabain,ATPase inhibitor,ATP1A1
Invasive Breast Carcinoma,BRD-K33379087-001-07-5::2.5::HTS,9.394950422768966,0.002282210079710079,Invasive Breast Carcinoma,tivantinib,tyrosine kinase inhibitor,MET
Invasive Breast Carcinoma,BRD-K33882852-003-02-8::2.5::HTS,4.968667739231254,0.02621223719179374,Other Types,ZK-93423,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
Invasive Breast Carcinoma,BRD-K34022604-001-06-6::2.5::HTS,20.962592682452982,5.774710073678071e-06,Invasive Breast Carcinoma,clofarabine,ribonucleotide reductase inhibitor,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Invasive Breast Carcinoma,BRD-K34415467-003-13-0::2.5::HTS,5.516149525274696,0.019190269558788314,Other Types,trimethobenzamide,histamine receptor antagonist,DRD2
Invasive Breast Carcinoma,BRD-K34469523-003-03-0::2.5::HTS,10.59192044103509,0.0012056254342791332,Other Types,levalbuterol,adrenergic receptor agonist,ADRB2
Invasive Breast Carcinoma,BRD-K34851558-001-02-3::2.5::HTS,7.847066954959825,0.005268206130861073,Invasive Breast Carcinoma,parthenolide-(-),NFkB pathway inhibitor,HDAC1
Invasive Breast Carcinoma,BRD-K35189033-001-26-1::2.5::HTS,6.552975331004059,0.0107322452558535,Invasive Breast Carcinoma,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Invasive Breast Carcinoma,BRD-K35520305-001-17-7::2.5::HTS,8.781029895248174,0.0031750527601758613,Invasive Breast Carcinoma,dacarbazine,DNA alkylating agent,"PGD, POLA2"
Invasive Breast Carcinoma,BRD-K35781423-001-01-6::2.5::HTS,7.072683693347617,0.008051257347927016,Other Types,SANT-2,smoothened receptor antagonist,"SHH, SMO"
Invasive Breast Carcinoma,BRD-K36055864-001-19-2::2.5::HTS,12.903307116567573,0.0003569669203771491,Invasive Breast Carcinoma,cycloheximide,protein synthesis inhibitor,RPL3
Invasive Breast Carcinoma,BRD-K36395411-003-02-2::2.5::HTS,6.223143797690791,0.012895116906791466,Invasive Breast Carcinoma,SB-206553,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Invasive Breast Carcinoma,BRD-K36740062-001-06-6::2.5::HTS,10.411105591367733,0.00132628984940099,Invasive Breast Carcinoma,GSK1070916,Aurora kinase inhibitor,"AURKA, AURKB, AURKC, CYP2D6, CYP3A4"
Invasive Breast Carcinoma,BRD-K36965586-003-08-8::2.5::HTS,4.390992050511635,0.03657934074820218,Invasive Breast Carcinoma,m-Chlorophenylbiguanide,,"HTR3A, HTR3B"
Invasive Breast Carcinoma,BRD-K37237504-001-02-7::2.5::HTS,10.696737881369389,0.0011389758787004175,Invasive Breast Carcinoma,CEP-33779,JAK inhibitor,JAK2
Invasive Breast Carcinoma,BRD-K37270826-001-27-6::2.66::HTS,6.409230675733431,0.011636412858980707,Invasive Breast Carcinoma,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Invasive Breast Carcinoma,BRD-K37379014-001-01-2::2.5::HTS,5.606166085773781,0.0182398743898418,Invasive Breast Carcinoma,filanesib,"kinesin inhibitor, kinesin-like spindle protein inhibitor",KIF11
Invasive Breast Carcinoma,BRD-K37618799-001-03-0::2.5::HTS,12.664159313499031,0.00040453665659487633,Other Types,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Invasive Breast Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,15.356746460333898,9.997188635149559e-05,Invasive Breast Carcinoma,AZD8330,MEK inhibitor,
Invasive Breast Carcinoma,BRD-K37890730-001-15-1::2.5::HTS,5.377454843257519,0.020766857958829977,Invasive Breast Carcinoma,camptothecin,topoisomerase inhibitor,TOP1
Invasive Breast Carcinoma,BRD-K38370968-050-01-3::2.5::HTS,7.097347804673604,0.007944624056288112,Other Types,3-AQC,serotonin receptor agonist,HTR3A
Invasive Breast Carcinoma,BRD-K38548312-001-01-0::2.5::HTS,8.285185954372361,0.004149877314849838,Invasive Breast Carcinoma,VER-49009,HSP inhibitor,HSP90AA1
Invasive Breast Carcinoma,BRD-K38852836-001-02-1::2.5::HTS,5.302887215383675,0.02165448618052186,Invasive Breast Carcinoma,ganetespib,HSP inhibitor,HSP90AA1
Invasive Breast Carcinoma,BRD-K39023557-001-01-7::2.5::HTS,3.956456709618714,0.047181492628686504,Other Types,octocrylene,,
Invasive Breast Carcinoma,BRD-K39171998-001-01-1::2.5::HTS,4.778867621225021,0.029225840352185534,Invasive Breast Carcinoma,STF-118804,NAMPT inhibitor,NAMPT
Invasive Breast Carcinoma,BRD-K39467894-001-06-7::2.5::HTS,10.27325759943525,0.0014296434498718498,Other Types,nithiamide,bacterial DNA inhibitor,
Invasive Breast Carcinoma,BRD-K39841531-001-02-1::2.5::HTS,10.104823682187455,0.0015607652381865779,Invasive Breast Carcinoma,TG-101209,JAK inhibitor,"JAK2, JAK3"
Invasive Breast Carcinoma,BRD-K39987650-001-24-1::2.5::HTS,9.76122804942261,0.0018750395812545133,Other Types,bisacodyl,laxative,
Invasive Breast Carcinoma,BRD-K40331046-305-01-5::2.5::HTS,7.0084920875245675,0.008341258659707645,Invasive Breast Carcinoma,CR8-(R),CDK inhibitor,CCNA2
Invasive Breast Carcinoma,BRD-K40654626-236-01-5::2.5::HTS,4.3369388043857935,0.03777469132083416,Invasive Breast Carcinoma,ditiocarb-sodium-trihydrate,immunostimulant,"CA1, CA2, CA4"
Invasive Breast Carcinoma,BRD-K40797222-001-01-8::2.5::HTS,7.9580558717084795,0.004957172684286185,Invasive Breast Carcinoma,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A
Invasive Breast Carcinoma,BRD-K41783120-001-02-8::2.5::HTS,8.628928430623,0.003448345327308369,Invasive Breast Carcinoma,STA-5326,interleukin synthesis inhibitor,IL12A
Invasive Breast Carcinoma,BRD-K41859756-001-06-8::2.5::HTS,7.278537269478946,0.007191029508606628,Invasive Breast Carcinoma,NVP-AUY922,HSP inhibitor,"HSP90AA1, HSP90AB1"
Invasive Breast Carcinoma,BRD-K42205652-001-02-7::2.5::HTS,9.341963656135857,0.0023460454338918007,Invasive Breast Carcinoma,"MNS-(3,4-Methylenedioxy-nitrostyrene)","src inhibitor, syk inhibitor","SRC, SYK"
Invasive Breast Carcinoma,BRD-K42497885-001-01-1::2.5::HTS,6.117978695814049,0.013684522323568054,Invasive Breast Carcinoma,satraplatin,DNA alkylating agent,
Invasive Breast Carcinoma,BRD-K42805893-001-04-9::2.5::HTS,5.378530526927916,0.020743676501651064,Other Types,osimertinib,EGFR inhibitor,EGFR
Invasive Breast Carcinoma,BRD-K42828737-044-09-0::2.5::HTS,9.846445185744589,0.0017920819078729336,Invasive Breast Carcinoma,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET"
Invasive Breast Carcinoma,BRD-K42938903-332-01-1::2.5::HTS,8.31873565642152,0.00408070450629561,Invasive Breast Carcinoma,acetophenazine,dopamine receptor antagonist,"DRD1, DRD2"
Invasive Breast Carcinoma,BRD-K43389675-003-20-9::2.5::HTS,4.289101967469217,0.038817394132671684,Invasive Breast Carcinoma,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Invasive Breast Carcinoma,BRD-K43621685-001-02-5::2.5::HTS,5.052488760542001,0.02498101837465826,Invasive Breast Carcinoma,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Invasive Breast Carcinoma,BRD-K43927145-001-01-2::2.5::HTS,6.1845292845527196,0.013176305619918218,Invasive Breast Carcinoma,BIBN4096,calcitonin antagonist,"CALCA, CALCRL, RAMP1"
Invasive Breast Carcinoma,BRD-K44227013-001-06-4::2.5::HTS,13.51318639702661,0.0002598161698880887,Invasive Breast Carcinoma,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Invasive Breast Carcinoma,BRD-K45086103-001-16-3::2.5::HTS,4.023697980067313,0.045367245400150004,Invasive Breast Carcinoma,sulfaguanidine,bacterial antifolate,
Invasive Breast Carcinoma,BRD-K45216060-001-10-0::2.5::HTS,5.164215827287992,0.023437093636673494,Invasive Breast Carcinoma,mequinol,,TYR
Invasive Breast Carcinoma,BRD-K45216060-001-11-8::2.5::HTS,4.366288093752339,0.03713027111218281,Invasive Breast Carcinoma,mequinol,,TYR
Invasive Breast Carcinoma,BRD-K45551181-001-02-1::2.49::HTS,4.6161381947751225,0.03212658683414267,Invasive Breast Carcinoma,MPI-0479605,mitotic kinase inhibitor,TTK
Invasive Breast Carcinoma,BRD-K46331928-001-05-8::2.5::HTS,6.836394516686914,0.00917328150691988,Invasive Breast Carcinoma,ethynodiol-diacetate,,"ESR1, PGR"
Invasive Breast Carcinoma,BRD-K47150025-001-05-3::2.5::HTS,5.519782705783348,0.01915022899208369,Invasive Breast Carcinoma,KI-8751,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Invasive Breast Carcinoma,BRD-K47323024-003-24-4::2.5::HTS,3.944191384709541,0.04752232081719051,Invasive Breast Carcinoma,methapyrilene,histamine receptor antagonist,HRH1
Invasive Breast Carcinoma,BRD-K47659338-003-02-8::2.5::HTS,4.470542131293128,0.034930140898394,Other Types,EMD-386088,serotonin receptor agonist,HTR6
Invasive Breast Carcinoma,BRD-K47832606-001-30-1::2.5::HTS,4.311407128957448,0.03831810707355517,Invasive Breast Carcinoma,floxuridine,DNA synthesis inhibitor,TYMS
Invasive Breast Carcinoma,BRD-K48443249-001-01-0::2.5::HTS,4.905610236431943,0.027172031956605978,Invasive Breast Carcinoma,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Invasive Breast Carcinoma,BRD-K48488978-001-05-3::2.5::HTS,4.707658169218035,0.030453647743831108,Invasive Breast Carcinoma,YM-201636,PI3K inhibitor,
Invasive Breast Carcinoma,BRD-K48684885-001-04-2::2.5::HTS,4.805800083641342,0.028779387399784064,Invasive Breast Carcinoma,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Invasive Breast Carcinoma,BRD-K48692744-001-02-0::2.5::HTS,4.230283872561557,0.040179048513291044,Other Types,NU-1025,PARP inhibitor,PARP1
Invasive Breast Carcinoma,BRD-K48988407-001-01-2::2.5::HTS,5.271712458762251,0.022048520118963202,Invasive Breast Carcinoma,cytochlor,,
Invasive Breast Carcinoma,BRD-K49049886-001-08-7::2.5::HTS,20.032017572215896,9.248636728293875e-06,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Invasive Breast Carcinoma,BRD-K49328571-001-15-0::2.5::HTS,4.1917908327931075,0.04109297604055393,Invasive Breast Carcinoma,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Invasive Breast Carcinoma,BRD-K49350383-001-13-7::2.5::HTS,8.830757825742799,0.0030910254453696837,Invasive Breast Carcinoma,thioguanine,purine antagonist,"IMPDH1, IMPDH2"
Invasive Breast Carcinoma,BRD-K49519144-001-04-6::2.5::HTS,6.935264987741298,0.008699026660064316,Other Types,LY2140023,glutamate receptor agonist,GRM3
Invasive Breast Carcinoma,BRD-K49865102-001-08-4::2.5::HTS,14.979720785029087,0.00012168842580173421,Invasive Breast Carcinoma,PD-0325901,MEK inhibitor,MAP2K1
Invasive Breast Carcinoma,BRD-K50140147-001-10-1::2.5::HTS,9.29451953079984,0.0024081380566268453,Invasive Breast Carcinoma,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,"ALK, INSR"
Invasive Breast Carcinoma,BRD-K50422030-001-05-3::2.5::HTS,5.541647972846784,0.01891856121963122,Invasive Breast Carcinoma,clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1
Invasive Breast Carcinoma,BRD-K50817623-303-05-7::2.5::HTS,7.020421962924724,0.008300036577800533,Other Types,pancuronium,acetylcholine receptor antagonist,"CHRM2, CHRM3, CHRNA1, CHRNA2"
Invasive Breast Carcinoma,BRD-K50853363-001-02-3::2.5::HTS,4.720307285535402,0.03022931514481415,Invasive Breast Carcinoma,dienogest,progesterone receptor agonist,PGR
Invasive Breast Carcinoma,BRD-K51313569-003-03-3::2.5::HTS,6.982769109075701,0.008461290525448924,Invasive Breast Carcinoma,palbociclib,CDK inhibitor,"CDK4, CDK6"
Invasive Breast Carcinoma,BRD-K51575138-001-13-2::2.5::HTS,15.297210786875144,0.00010308578682754722,Invasive Breast Carcinoma,TPCA-1,IKK inhibitor,IKBKB
Invasive Breast Carcinoma,BRD-K53123955-001-10-5::2.5::HTS,3.905033294709017,0.04864094115254368,Other Types,niridazole,phosphofructokinase inhibitor,
Invasive Breast Carcinoma,BRD-K53417444-003-03-1::2.5::HTS,4.99634544035947,0.025809702782032668,Invasive Breast Carcinoma,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK
Invasive Breast Carcinoma,BRD-K53734668-003-02-0::2.66::HTS,11.65947677346828,0.0006868555557009216,Invasive Breast Carcinoma,PRT062607,syk inhibitor,"FGR, MAP3K9, SYK"
Invasive Breast Carcinoma,BRD-K54262262-001-09-0::2.5::HTS,4.198208981296964,0.040939797130058915,Invasive Breast Carcinoma,monobenzone,melanin inhibitor,TYR
Invasive Breast Carcinoma,BRD-K54759182-003-08-0::2.5::HTS,4.31309718857416,0.03827461561012017,Invasive Breast Carcinoma,dosulepin,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4"
Invasive Breast Carcinoma,BRD-K54790157-001-15-5::2.5::HTS,3.989275437971759,0.046276724170901604,Other Types,trioxsalen,DNA synthesis inhibitor,
Invasive Breast Carcinoma,BRD-K55305701-001-01-2::2.5::HTS,7.134050868492766,0.007782501191736439,Invasive Breast Carcinoma,SC-144,P glycoprotein inhibitor,
Invasive Breast Carcinoma,BRD-K56032964-001-02-1::2.5::HTS,7.011691444105475,0.008326143304552223,Invasive Breast Carcinoma,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Invasive Breast Carcinoma,BRD-K56334280-001-05-1::2.5::HTS,9.323848938492283,0.0023689643494546643,Invasive Breast Carcinoma,amonafide,topoisomerase inhibitor,"TOP2A, TOP2B"
Invasive Breast Carcinoma,BRD-K56405753-001-02-4::2.5::HTS,5.391685880878001,0.020589379302435356,Invasive Breast Carcinoma,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Invasive Breast Carcinoma,BRD-K56957086-001-06-3::2.5::HTS,13.107591820291074,0.000320679032742383,Invasive Breast Carcinoma,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Invasive Breast Carcinoma,BRD-K57080016-001-15-9::2.5::HTS,8.569156533999836,0.003557461817306386,Invasive Breast Carcinoma,selumetinib,MEK inhibitor,MAP2K1
Invasive Breast Carcinoma,BRD-K57136142-001-02-4::2.5::HTS,5.028531364456439,0.025325649972800995,Invasive Breast Carcinoma,CCT129202,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Invasive Breast Carcinoma,BRD-K58122457-001-02-2::2.5::HTS,14.138309302970274,0.00018780240922721645,Invasive Breast Carcinoma,hesperadin,Aurora kinase inhibitor,AURKB
Invasive Breast Carcinoma,BRD-K58435339-001-03-0::2.5::HTS,4.209437640661914,0.040664170529280334,Invasive Breast Carcinoma,AT13387,HSP antagonist,HSP90AA1
Invasive Breast Carcinoma,BRD-K58497451-237-10-7::2.5::HTS,4.040761987184545,0.04489537779589787,Invasive Breast Carcinoma,potassium-p-aminobenzoate,,
Invasive Breast Carcinoma,BRD-K58770988-001-01-8::2.5::HTS,8.512115676262685,0.003669726820695207,Invasive Breast Carcinoma,NMS-E973,HSP inhibitor,
Invasive Breast Carcinoma,BRD-K58930050-050-15-8::2.5::HTS,5.381632007159163,0.020709114965866356,Invasive Breast Carcinoma,dizocilpine-(+),glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Invasive Breast Carcinoma,BRD-K59146805-001-03-7::2.5::HTS,8.301826485650453,0.004112309627762206,Invasive Breast Carcinoma,AZ3146,monopolar spindle 1 kinase inhibitor,
Invasive Breast Carcinoma,BRD-K59369769-001-20-3::2.5::HTS,13.689966605997704,0.00023680514765563444,Invasive Breast Carcinoma,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor","AURKA, AURKB, AURKC, LCK"
Invasive Breast Carcinoma,BRD-K59456551-001-22-6::2.51::HTS,8.648204396693034,0.003417406294210539,Invasive Breast Carcinoma,methotrexate,dihydrofolate reductase inhibitor,DHFR
Invasive Breast Carcinoma,BRD-K60025295-003-06-6::2.5::HTS,3.871244229917477,0.04961585238906899,Invasive Breast Carcinoma,crystal-violet,other antibiotic,
Invasive Breast Carcinoma,BRD-K61032563-001-02-9::2.5::HTS,4.0034802197689565,0.04589381861381644,Other Types,neohesperidin-dihydrochalcone,,
Invasive Breast Carcinoma,BRD-K61177364-003-02-9::2.5::HTS,6.117269821841208,0.013683401902405213,Other Types,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1
Invasive Breast Carcinoma,BRD-K61323504-001-04-0::2.5::HTS,4.837718267418824,0.028257557115248518,Invasive Breast Carcinoma,SB-225002,CC chemokine receptor antagonist,CXCR2
Invasive Breast Carcinoma,BRD-K62008436-001-22-1::2.5::HTS,4.598144382178459,0.0324410048514648,Invasive Breast Carcinoma,paclitaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1"
Invasive Breast Carcinoma,BRD-K62196610-001-01-6::2.5::HTS,4.782893371299683,0.029162709993006884,Invasive Breast Carcinoma,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Invasive Breast Carcinoma,BRD-K62326629-001-19-0::2.5::HTS,5.42421066709306,0.020223382386050877,Invasive Breast Carcinoma,dichlorophen,anticestodal agent,
Invasive Breast Carcinoma,BRD-K62414032-001-12-0::2.5::HTS,6.0108286110858735,0.014521608711562061,Invasive Breast Carcinoma,NMDA,glutamate receptor agonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Invasive Breast Carcinoma,BRD-K62734952-001-01-0::2.5::HTS,7.21084088912057,0.007464410752401834,Invasive Breast Carcinoma,arglabin,farnesyltransferase inhibitor,"FNTA, NFKB1"
Invasive Breast Carcinoma,BRD-K62779383-001-05-5::2.38::HTS,3.9618524560821706,0.04705757170867299,Other Types,cholecalciferol,,VDR
Invasive Breast Carcinoma,BRD-K62810658-001-12-2::2.5::HTS,4.773205049181717,0.029322010723831938,Invasive Breast Carcinoma,PD-98059,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Invasive Breast Carcinoma,BRD-K62814476-001-03-3::2.5::HTS,5.7190530733439235,0.017114374383016027,Invasive Breast Carcinoma,BMS-265246,CDK inhibitor,"CDK1, CDK2"
Invasive Breast Carcinoma,BRD-K62965247-001-04-9::2.5::HTS,7.242360556022567,0.007334240171204658,Invasive Breast Carcinoma,tipifarnib,farnesyltransferase inhibitor,"FNTA, FNTB"
Invasive Breast Carcinoma,BRD-K63630713-001-25-8::2.5::HTS,11.219003695396085,0.0008644124341354112,Other Types,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,"ATP1A1, SLC12A1"
Invasive Breast Carcinoma,BRD-K63750851-001-20-7::2.5::HTS,8.328204144868375,0.004053895846717942,Invasive Breast Carcinoma,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Invasive Breast Carcinoma,BRD-K63861289-001-19-6::2.5::HTS,4.161395039586022,0.041826546536635346,Invasive Breast Carcinoma,molsidomine,guanylate cyclase stimulant,GUCY1A3
Invasive Breast Carcinoma,BRD-K63923597-001-10-0::2.5::HTS,8.478269964034073,0.0037388817517902077,Invasive Breast Carcinoma,barasertib-HQPA,Aurora kinase inhibitor,AURKB
Invasive Breast Carcinoma,BRD-K64381438-001-03-8::2.5::HTS,6.302774682015466,0.012340742023344071,Invasive Breast Carcinoma,ulipristal,progesterone receptor antagonist,PGR
Invasive Breast Carcinoma,BRD-K64538373-001-01-4::2.5::HTS,11.980112342159055,0.0005789472819833448,Invasive Breast Carcinoma,Ro-4987655,MEK inhibitor,MAP2K1
Invasive Breast Carcinoma,BRD-K64866502-001-03-9::2.5::HTS,6.420878241550354,0.01155305027482013,Invasive Breast Carcinoma,CYC116,Aurora kinase inhibitor,"AURKA, AURKB, KDR"
Invasive Breast Carcinoma,BRD-K64881305-001-03-7::2.5::HTS,8.060885795115146,0.00468793235814189,Invasive Breast Carcinoma,ispinesib,kinesin inhibitor,KIF11
Invasive Breast Carcinoma,BRD-K64888243-001-03-7::2.5::HTS,4.180948831665354,0.04134779954477318,Invasive Breast Carcinoma,AZ960,JAK inhibitor,JAK2
Invasive Breast Carcinoma,BRD-K64890080-001-13-8::2.5::HTS,6.833931738115989,0.009188421829864409,Invasive Breast Carcinoma,BI-2536,PLK inhibitor,"BRD4, PLK1, PLK2, PLK3"
Invasive Breast Carcinoma,BRD-K65146499-001-27-9::2.5::HTS,4.255204858500015,0.03961774136753276,Invasive Breast Carcinoma,nabumetone,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Invasive Breast Carcinoma,BRD-K65781196-001-03-0::2.5::HTS,4.050040690605754,0.04465546270854261,Invasive Breast Carcinoma,avanafil,phosphodiesterase inhibitor,PDE5A
Invasive Breast Carcinoma,BRD-K65814004-003-02-9::2.5::HTS,7.517614464170981,0.006307320703372467,Invasive Breast Carcinoma,diphenyleneiodonium,nitric oxide synthase inhibitor,"NOS2, NOS3"
Invasive Breast Carcinoma,BRD-K66296774-236-11-3::2.63::HTS,8.45396103172289,0.003792513104038006,Invasive Breast Carcinoma,fluvastatin,HMGCR inhibitor,HMGCR
Invasive Breast Carcinoma,BRD-K66808046-065-03-7::2.5::HTS,4.7519766285839875,0.02969663883213527,Other Types,oxyquinoline,chelating agent,METAP2
Invasive Breast Carcinoma,BRD-K67536197-003-11-4::2.5::HTS,4.809224710868918,0.02871977588356621,Invasive Breast Carcinoma,cyclocytidine,"DNA synthesis inhibitor, RNA synthesis inhibitor",
Invasive Breast Carcinoma,BRD-K67578145-001-09-7::2.38::HTS,5.238858993751547,0.02248177073473079,Invasive Breast Carcinoma,GDC-0879,RAF inhibitor,BRAF
Invasive Breast Carcinoma,BRD-K67844266-003-01-9::2.5::HTS,5.7116045742981205,0.017182790801832094,Invasive Breast Carcinoma,pevonedistat,nedd activating enzyme inhibitor,"NAE1, UBA3"
Invasive Breast Carcinoma,BRD-K67977190-066-02-3::2.5::HTS,8.028245653179685,0.004775616489496566,Invasive Breast Carcinoma,eprosartan,angiotensin receptor antagonist,AGTR1
Invasive Breast Carcinoma,BRD-K68174511-001-06-6::2.5::HTS,4.271684853012521,0.039209896441753274,Invasive Breast Carcinoma,torin-2,mTOR inhibitor,MTOR
Invasive Breast Carcinoma,BRD-K68346641-001-01-4::2.5::HTS,10.50702002156717,0.001260664839238477,Invasive Breast Carcinoma,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Invasive Breast Carcinoma,BRD-K68346641-001-02-2::2.5::HTS,8.989559688473669,0.0028357903384183137,Invasive Breast Carcinoma,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Invasive Breast Carcinoma,BRD-K68408467-065-01-8::2.5::HTS,7.494895837383423,0.0063848518873579965,Invasive Breast Carcinoma,proflavine-hemisulfate,topical anesthetic,F2
Invasive Breast Carcinoma,BRD-K68474068-001-01-8::2.5::HTS,5.228073293863699,0.02259889316181785,Other Types,MM-102,WDR5/MLL interaction inhibitor,
Invasive Breast Carcinoma,BRD-K68488863-001-04-9::2.5::HTS,8.802763239157574,0.0031361645157321877,Invasive Breast Carcinoma,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC"
Invasive Breast Carcinoma,BRD-K68532323-003-02-8::2.5::HTS,10.832555923624053,0.0010600910234429524,Invasive Breast Carcinoma,SB-743921,kinesin-like spindle protein inhibitor,KIF11
Invasive Breast Carcinoma,BRD-K68633617-003-02-9::2.5::HTS,6.986755287124499,0.008442703955564932,Other Types,ACDPP,glutamate receptor antagonist,GRM5
Invasive Breast Carcinoma,BRD-K68747584-001-02-0::2.5::HTS,13.481257212791718,0.0002640396524389367,Invasive Breast Carcinoma,PF-03814735,Aurora kinase inhibitor,"AURKA, AURKB"
Invasive Breast Carcinoma,BRD-K68867920-051-11-5::2.5::HTS,4.595083616057177,0.032493818840649884,Invasive Breast Carcinoma,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2"
Invasive Breast Carcinoma,BRD-K69577666-001-01-3::2.5::HTS,4.44969092242668,0.03534916741478376,Invasive Breast Carcinoma,SGC-0946,histone lysine methyltransferase inhibitor,
Invasive Breast Carcinoma,BRD-K69600043-328-05-5::2.5::HTS,4.0235869133587165,0.0453469646068129,Invasive Breast Carcinoma,thiethylperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD4"
Invasive Breast Carcinoma,BRD-K69650333-003-14-0::2.5::HTS,5.882469336177715,0.01561086613656809,Invasive Breast Carcinoma,idarubicin,topoisomerase inhibitor,TOP2A
Invasive Breast Carcinoma,BRD-K69932463-001-10-6::2.5::HTS,4.088352357351837,0.043659844972796916,Invasive Breast Carcinoma,AZD8055,mTOR inhibitor,MTOR
Invasive Breast Carcinoma,BRD-K70912147-001-01-8::2.5::HTS,5.25189330157423,0.02229584486410655,Other Types,co-102862,,"SCN4A, SCN9A"
Invasive Breast Carcinoma,BRD-K71266197-236-02-7::2.5::HTS,4.157170092682726,0.04192935561822702,Invasive Breast Carcinoma,PSB-06126,NTPDase inhibitor,ENTPD3
Invasive Breast Carcinoma,BRD-K71281111-001-04-3::2.5::HTS,7.5646266203365995,0.006144971821068083,Invasive Breast Carcinoma,SNX-2112,HSP inhibitor,
Invasive Breast Carcinoma,BRD-K71480163-001-01-4::2.5::HTS,15.087577065004382,0.00011489653551846125,Other Types,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Invasive Breast Carcinoma,BRD-K71512533-066-02-8::2.5::HTS,10.534299998575884,0.001242537063546601,Invasive Breast Carcinoma,SNS-314,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Invasive Breast Carcinoma,BRD-K72231366-001-02-3::2.5::HTS,4.436604854489564,0.035618909369731715,Invasive Breast Carcinoma,TAME,,
Invasive Breast Carcinoma,BRD-K72726508-001-02-1::2.5::HTS,5.421228322341261,0.020252328990738783,Other Types,arcyriaflavin-a,CDK inhibitor,"CCND1, CDK4"
Invasive Breast Carcinoma,BRD-K72827473-001-01-0::2.5::HTS,7.186338422227517,0.00756251414128182,Invasive Breast Carcinoma,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Invasive Breast Carcinoma,BRD-K72912098-001-02-3::2.5::HTS,4.197773069473362,0.04097087313036653,Other Types,telaprevir,HCV inhibitor,"CTSA, PGR"
Invasive Breast Carcinoma,BRD-K73197500-001-02-2::2.5::HTS,4.990771988855335,0.025878202648198612,Invasive Breast Carcinoma,SNX-5422,HSP inhibitor,HSP90AA1
Invasive Breast Carcinoma,BRD-K73293050-001-03-1::2.5::HTS,7.465589633737451,0.006489650203406833,Invasive Breast Carcinoma,WZ-3146,EGFR inhibitor,EGFR
Invasive Breast Carcinoma,BRD-K74186897-001-13-2::2.5::HTS,4.163049646896769,0.041781830655756254,Invasive Breast Carcinoma,cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4"
Invasive Breast Carcinoma,BRD-K74193284-001-04-8::2.5::HTS,7.769371001952157,0.005505367006759077,Invasive Breast Carcinoma,phenylmercuric-acetate,other antifungal,
Invasive Breast Carcinoma,BRD-K75295174-001-05-0::2.5::HTS,5.661052782273712,0.01768770892095399,Invasive Breast Carcinoma,alisertib,Aurora kinase inhibitor,AURKA
Invasive Breast Carcinoma,BRD-K75649340-001-13-1::2.5::HTS,12.565694166495147,0.00042561513611402707,Invasive Breast Carcinoma,tioguanine,purine antagonist,
Invasive Breast Carcinoma,BRD-K75911534-001-01-6::2.5::HTS,4.816335775395583,0.028607039411982844,Invasive Breast Carcinoma,SU014813,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Invasive Breast Carcinoma,BRD-K75958547-238-01-0::2.5::HTS,13.994901122487219,0.000202194685922988,Invasive Breast Carcinoma,pitavastatin,HMGCR inhibitor,HMGCR
Invasive Breast Carcinoma,BRD-K76406695-001-02-9::2.5::HTS,4.586898909990446,0.03264958383444745,Other Types,CCT128930,AKT inhibitor,"PKIA, PRKACA"
Invasive Breast Carcinoma,BRD-K76600340-045-04-9::2.5::HTS,6.375007005068966,0.011850372699946243,Other Types,nicotinyl-alcohol-tartrate,,
Invasive Breast Carcinoma,BRD-K76634210-001-14-7::2.5::HTS,10.056199452991471,0.0016047272679027876,Invasive Breast Carcinoma,idoxuridine,DNA directed DNA polymerase inhibitor,
Invasive Breast Carcinoma,BRD-K76674262-001-03-3::2.5::HTS,10.871252558748019,0.0010383608330660082,Invasive Breast Carcinoma,homoharringtonine,protein synthesis inhibitor,RPL3
Invasive Breast Carcinoma,BRD-K77060810-001-01-5::2.5::HTS,5.025518919737815,0.025367924973020428,Other Types,AZD1283,purinergic receptor antagonist,P2RY12
Invasive Breast Carcinoma,BRD-K77258318-001-04-6::2.5::HTS,4.070809673459422,0.044109403624543284,Invasive Breast Carcinoma,lactulose,laxative,
Invasive Breast Carcinoma,BRD-K77641333-003-27-1::2.5::HTS,8.646546471210282,0.0034116858660877022,Invasive Breast Carcinoma,naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A"
Invasive Breast Carcinoma,BRD-K77791657-001-01-1::2.5::HTS,7.28570890414514,0.007159715129547524,Invasive Breast Carcinoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Invasive Breast Carcinoma,BRD-K77791657-003-01-7::2.67::HTS,4.326853452465261,0.03799725864837368,Invasive Breast Carcinoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Invasive Breast Carcinoma,BRD-K77841042-001-14-1::2.5::HTS,4.292249440434487,0.03875034163833022,Invasive Breast Carcinoma,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Invasive Breast Carcinoma,BRD-K77943374-001-02-8::2.5::HTS,10.47593451219046,0.0012806033506270558,Other Types,NVP-BVU972,MET inhibitor,MET
Invasive Breast Carcinoma,BRD-K78567475-001-01-4::2.5::HTS,6.88231444638156,0.008945991735710125,Invasive Breast Carcinoma,dolastatin-10,tubulin polymerization inhibitor,TUBB
Invasive Breast Carcinoma,BRD-K78960041-001-05-7::2.54::HTS,12.080666598539182,0.0005514085278411745,Invasive Breast Carcinoma,oxaliplatin,DNA inhibitor,
Invasive Breast Carcinoma,BRD-K79131256-001-17-9::2.5::HTS,4.463410180198138,0.03506867352451122,Invasive Breast Carcinoma,albendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Invasive Breast Carcinoma,BRD-K80700417-001-04-2::2.5::HTS,5.936665631238456,0.015139572054796052,Invasive Breast Carcinoma,SGI-1776,Pim kinase inhibitor,"FLT3, PIM1, PIM2, PIM3"
Invasive Breast Carcinoma,BRD-K81197548-003-01-4::2.5::HTS,3.9951120935475535,0.04611702767259902,Invasive Breast Carcinoma,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Invasive Breast Carcinoma,BRD-K81225797-001-02-3::2.5::HTS,12.610122743237682,0.00041601237754347587,Other Types,SCH-58261,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Invasive Breast Carcinoma,BRD-K81330143-001-04-8::2.38::HTS,5.683958442823435,0.017472943572488502,Other Types,tideglusib,glycogen synthase kinase inhibitor,GSK3B
Invasive Breast Carcinoma,BRD-K81458380-001-04-9::2.5::HTS,4.744252804470646,0.029829027585445665,Invasive Breast Carcinoma,CX-4945,casein kinase inhibitor,"CSNK2A1, CSNK2A2, DAPK3, HIPK3"
Invasive Breast Carcinoma,BRD-K81473043-001-14-6::2.5::HTS,6.833028435724753,0.009204180335984082,Invasive Breast Carcinoma,tanespimycin,HSP inhibitor,HSP90AA1
Invasive Breast Carcinoma,BRD-K81694556-003-01-9::2.5::HTS,4.24000485072247,0.03996189952652473,Invasive Breast Carcinoma,VTP-27999,renin inhibitor,REN
Invasive Breast Carcinoma,BRD-K81839095-001-30-1::2.5::HTS,5.981423527012566,0.014785908686290237,Invasive Breast Carcinoma,estrone,"estrogen receptor agonist, estrogenic hormone","ESR1, ESR2"
Invasive Breast Carcinoma,BRD-K82028950-300-02-9::2.5::HTS,6.679035801995389,0.010010023642811974,Invasive Breast Carcinoma,CGH2466,adenosine receptor antagonist,"ADORA1, ADORA2B, ADORA3"
Invasive Breast Carcinoma,BRD-K82164249-001-03-5::2.5::HTS,4.348027003330769,0.037506565734042034,Invasive Breast Carcinoma,andarine,androgen receptor modulator,AR
Invasive Breast Carcinoma,BRD-K82244583-001-01-3::2.5::HTS,9.759642731984545,0.001879772951704009,Invasive Breast Carcinoma,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Invasive Breast Carcinoma,BRD-K83245588-001-01-4::2.5::HTS,5.347369596941998,0.021122523020112062,Invasive Breast Carcinoma,pilsicainide,sodium channel blocker,SCN5A
Invasive Breast Carcinoma,BRD-K83257731-003-23-5::2.5::HTS,6.225653707850327,0.012879113015380791,Invasive Breast Carcinoma,chloropyramine,histamine receptor antagonist,HRH1
Invasive Breast Carcinoma,BRD-K83834509-001-01-1::2.5::HTS,16.889533877871074,4.555698762835453e-05,Invasive Breast Carcinoma,PTC-209,BMI-1 inhibitor,
Invasive Breast Carcinoma,BRD-K83963101-001-06-9::2.5::HTS,6.431906342541903,0.011490021781635244,Invasive Breast Carcinoma,MLN-8054,Aurora kinase inhibitor,AURKA
Invasive Breast Carcinoma,BRD-K83988098-001-02-0::2.5::HTS,5.0319671658916185,0.025279483976924075,Invasive Breast Carcinoma,alvespimycin,HSP inhibitor,HSP90AA1
Invasive Breast Carcinoma,BRD-K84266862-001-03-2::2.5::HTS,4.247177574971484,0.03977930771830165,Invasive Breast Carcinoma,BRL-50481,phosphodiesterase inhibitor,"PDE7A, PDE7B"
Invasive Breast Carcinoma,BRD-K84810405-003-01-1::2.5::HTS,5.028973734439623,0.025333895637891866,Invasive Breast Carcinoma,almorexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Invasive Breast Carcinoma,BRD-K85178109-001-02-3::2.5::HTS,4.6319422772259236,0.03181024050774,Invasive Breast Carcinoma,fostamatinib,SYK inhibitor,SYK
Invasive Breast Carcinoma,BRD-K85307935-236-09-5::2.5::HTS,5.874508761460243,0.015689759794065544,Other Types,novobiocin,bacterial DNA gyrase inhibitor,
Invasive Breast Carcinoma,BRD-K85402309-001-06-6::2.5::HTS,6.600142062980001,0.010457674960860799,Invasive Breast Carcinoma,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Invasive Breast Carcinoma,BRD-K85402309-389-03-2::2.5::HTS,7.163606118222034,0.007657697115774536,Invasive Breast Carcinoma,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Invasive Breast Carcinoma,BRD-K85751432-001-03-3::2.5::HTS,7.142829575896961,0.007751425878405363,Invasive Breast Carcinoma,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Invasive Breast Carcinoma,BRD-K86161929-001-13-3::2.5::HTS,5.80471953603105,0.016306631962268798,Invasive Breast Carcinoma,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Invasive Breast Carcinoma,BRD-K86525559-001-04-5::2.5::HTS,5.657912709674265,0.01772416770742319,Invasive Breast Carcinoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Invasive Breast Carcinoma,BRD-K86525559-001-07-8::2.52::HTS,9.682413901273861,0.0019610516623039197,Invasive Breast Carcinoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Invasive Breast Carcinoma,BRD-K86797399-001-04-4::2.5::HTS,4.75803686744268,0.029593194411526334,Invasive Breast Carcinoma,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Invasive Breast Carcinoma,BRD-K86797399-001-05-1::2.55::HTS,5.553026349817294,0.01881311044830812,Invasive Breast Carcinoma,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Invasive Breast Carcinoma,BRD-K86887724-001-10-6::2.59::HTS,8.352569913405365,0.004006563378978835,Invasive Breast Carcinoma,dofetilide,potassium channel blocker,"KCNH1, KCNH2, KCNJ12, KCNK2"
Invasive Breast Carcinoma,BRD-K86972824-001-01-4::2.5::HTS,4.253303578064304,0.03965268712759731,Other Types,oltipraz,"nuclear factor erythroid derived, like (NRF2) activator",ANG
Invasive Breast Carcinoma,BRD-K87156652-001-12-7::2.5::HTS,8.539727889840217,0.0036186872608173883,Invasive Breast Carcinoma,carbimazole,antithyroid agent,TPO
Invasive Breast Carcinoma,BRD-K87158025-001-01-6::2.5::HTS,10.120271640592387,0.001548119817970097,Other Types,benzamil,sodium channel blocker,"ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1"
Invasive Breast Carcinoma,BRD-K87349602-001-03-8::2.5::HTS,5.022903806069883,0.025403814236244528,Invasive Breast Carcinoma,beta-CCB,benzodiazepine receptor ligand,"GABRA1, GABRG2"
Invasive Breast Carcinoma,BRD-K87700323-003-05-1::2.5::HTS,12.519313434663866,0.0004363800394178948,Invasive Breast Carcinoma,cetylpyridinium,,
Invasive Breast Carcinoma,BRD-K87737963-001-06-0::2.5::HTS,13.61971182551031,0.00024577468603129556,Invasive Breast Carcinoma,cyt387,,"JAK1, JAK2, JAK3"
Invasive Breast Carcinoma,BRD-K88090157-050-10-8::2.5::HTS,4.981631095890194,0.0260140205623575,Invasive Breast Carcinoma,pimethixene,antihistamine,
Invasive Breast Carcinoma,BRD-K88429204-001-35-1::2.5::HTS,9.430132479955256,0.0022382349489372664,Invasive Breast Carcinoma,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Invasive Breast Carcinoma,BRD-K88560311-011-06-3::2.5::HTS,5.746994421078819,0.01684705770785097,Other Types,rucaparib,PARP inhibitor,"PARP1, PARP2"
Invasive Breast Carcinoma,BRD-K88677950-001-03-9::2.5::HTS,6.036757251716725,0.014314286721388372,Invasive Breast Carcinoma,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Invasive Breast Carcinoma,BRD-K88956297-003-01-9::2.5::HTS,9.709302716323231,0.0019297469125722259,Invasive Breast Carcinoma,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,
Invasive Breast Carcinoma,BRD-K89014967-001-04-3::2.5::HTS,10.666383599045947,0.0011580684942060888,Invasive Breast Carcinoma,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Invasive Breast Carcinoma,BRD-K89053832-001-01-0::2.5::HTS,4.938606744959435,0.02666190671984624,Invasive Breast Carcinoma,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Invasive Breast Carcinoma,BRD-K90497590-001-04-2::2.5::HTS,4.3858187047496555,0.03669286091008131,Invasive Breast Carcinoma,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1
Invasive Breast Carcinoma,BRD-K90630139-003-05-9::2.5::HTS,7.053435583678807,0.008142521927425426,Other Types,butenafine,fungal squalene epoxidase inhibitor,SQLE
Invasive Breast Carcinoma,BRD-K91147684-001-01-5::2.5::HTS,4.797698139677042,0.02891533996763485,Invasive Breast Carcinoma,m-THP,,
Invasive Breast Carcinoma,BRD-K91370081-001-25-1::2.5::HTS,5.416763674615768,0.020303665470057623,Invasive Breast Carcinoma,anisomycin,DNA synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Invasive Breast Carcinoma,BRD-K91601245-001-12-0::2.5::HTS,4.219440652664779,0.04043886753518268,Invasive Breast Carcinoma,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT"
Invasive Breast Carcinoma,BRD-K92073408-001-16-5::2.5::HTS,3.9965008473385693,0.04607759057096023,Invasive Breast Carcinoma,norethindrone,progesterone receptor agonist,PGR
Invasive Breast Carcinoma,BRD-K92150287-066-01-2::2.5::HTS,6.068585763388152,0.014063549131160518,Invasive Breast Carcinoma,exatecan-mesylate,topoisomerase inhibitor,TOP1
Invasive Breast Carcinoma,BRD-K92428232-001-10-6::2.5::HTS,4.254603712070124,0.039604628459961606,Invasive Breast Carcinoma,GSK461364,PLK inhibitor,PLK1
Invasive Breast Carcinoma,BRD-K92588747-051-02-7::2.5::HTS,5.9856658941828345,0.014733490273106439,Invasive Breast Carcinoma,2-CMDO,dopamine receptor antagonist,"DRD2, DRD4"
Invasive Breast Carcinoma,BRD-K92731339-227-04-9::2.5::HTS,3.987236240927065,0.04633235052859879,Other Types,perindopril,angiotensin converting enzyme inhibitor,ACE
Invasive Breast Carcinoma,BRD-K92848252-001-01-9::2.5::HTS,7.0444934743511975,0.008176911056459386,Other Types,diminazene-aceturate,angiotensin converting enzyme activator,"AOC1, PRDX5, PRSS1"
Invasive Breast Carcinoma,BRD-K93034159-001-25-8::2.5::HTS,13.372969709213708,0.00027934920605590137,Invasive Breast Carcinoma,cladribine,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B"
Invasive Breast Carcinoma,BRD-K93123848-001-04-1::2.5::HTS,5.392663934675844,0.020579873334461846,Invasive Breast Carcinoma,RAF265,"RAF inhibitor, VEGFR inhibitor",BRAF
Invasive Breast Carcinoma,BRD-K93231391-300-05-6::2.5::HTS,4.681962021066677,0.03090154787869449,Invasive Breast Carcinoma,ethambutol,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-K93460210-001-23-7::2.5::HTS,6.217676601683549,0.012935577082216708,Other Types,lamotrigine,"serotonin receptor antagonist, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Invasive Breast Carcinoma,BRD-K93779381-001-01-9::2.5::HTS,5.855535228014994,0.015844359861171022,Invasive Breast Carcinoma,ingenol-mebutate,PKC activator,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG"
Invasive Breast Carcinoma,BRD-K94441233-001-13-0::2.6::HTS,8.987784288509538,0.0028459008785654827,Invasive Breast Carcinoma,mevastatin,HMGCR inhibitor,HMGCR
Invasive Breast Carcinoma,BRD-K94455792-001-01-8::2.5::HTS,4.335814372939954,0.03777355249226255,Invasive Breast Carcinoma,ICG-001,beta-catenin inhibitor,CTNNB1
Invasive Breast Carcinoma,BRD-K94723713-001-10-6::2.5::HTS,11.899573451335627,0.0006042059717775752,Other Types,rutaecarpine,cyclooxygenase inhibitor,PTGS2
Invasive Breast Carcinoma,BRD-K95573441-001-01-2::2.5::HTS,12.768171644430977,0.000383017972473664,Invasive Breast Carcinoma,PFK-015,phosphofructokinase inhibitor,PFKFB3
Invasive Breast Carcinoma,BRD-K95899059-003-02-8::2.5::HTS,6.135282314861036,0.013548369305841136,Other Types,LY344864,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7"
Invasive Breast Carcinoma,BRD-K95926480-003-03-6::2.5::HTS,4.941257527079066,0.026625742373607614,Invasive Breast Carcinoma,SRT1720,SIRT activator,SIRT1
Invasive Breast Carcinoma,BRD-K96042922-001-09-8::2.5::HTS,5.591967592241057,0.018381857898679323,Invasive Breast Carcinoma,etanidazole,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-K96123349-236-02-8::2.5::HTS,6.945627841986814,0.008634408743622738,Invasive Breast Carcinoma,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH
Invasive Breast Carcinoma,BRD-K96188950-001-16-9::2.5::HTS,5.443005276911389,0.02000514858632755,Invasive Breast Carcinoma,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA
Invasive Breast Carcinoma,BRD-K96259238-001-01-4::2.5::HTS,8.779894729319617,0.0031753356773580226,Invasive Breast Carcinoma,Y-320,interleukin inhibitor,IL17A
Invasive Breast Carcinoma,BRD-K97045029-001-04-3::2.5::HTS,4.988546080440662,0.025908386306590415,Invasive Breast Carcinoma,pranlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF"
Invasive Breast Carcinoma,BRD-K97365803-001-02-1::2.5::HTS,5.597149999413177,0.01833488447867826,Invasive Breast Carcinoma,PI-828,PI3K inhibitor,
Invasive Breast Carcinoma,BRD-K99023089-001-03-7::2.5::HTS,13.309529714522814,0.00028877769086932224,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Invasive Breast Carcinoma,BRD-K99383816-001-03-5::2.5::HTS,5.957091505306777,0.014979097952375951,Invasive Breast Carcinoma,ftorafur,thymidylate synthase inhibitor,TYMS
Invasive Breast Carcinoma,BRD-K99475619-001-01-2::2.5::HTS,4.379647185116782,0.03683152505379928,Invasive Breast Carcinoma,genz-644282,topoisomerase inhibitor,TOP1
Invasive Breast Carcinoma,BRD-K99545815-001-06-3::2.5::HTS,4.1144711793991275,0.04298887306567651,Invasive Breast Carcinoma,PF-562271,focal adhesion kinase inhibitor,"PTK2, PTK2B"
Invasive Breast Carcinoma,BRD-K99922388-001-02-0::2.5::HTS,7.998846943542303,0.004848888768979881,Invasive Breast Carcinoma,DPO-1,potassium channel blocker,KCNA5
Invasive Breast Carcinoma,BRD-K99964838-001-11-9::2.5::HTS,4.692063048586998,0.030723460097974456,Invasive Breast Carcinoma,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Invasive Breast Carcinoma,BRD-A23124853-001-01-4::2.5::MTS004,3.904565327844997,0.04866553508038495,Invasive Breast Carcinoma,PF-06463922,ALK tyrosine kinase receptor inhibitor,"ALK, FES, ROS1"
Invasive Breast Carcinoma,BRD-K02988401-001-01-2::2.5::MTS004,7.988355389607105,0.004882990342021708,Invasive Breast Carcinoma,UNC0737,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Invasive Breast Carcinoma,BRD-K04701033-001-04-7::2.499987566::MTS004,9.410836905800945,0.002265439217066508,Invasive Breast Carcinoma,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Invasive Breast Carcinoma,BRD-K06455935-001-01-3::2.499992329::MTS004,3.9370639578442335,0.04774081608051748,Invasive Breast Carcinoma,daprodustat,hypoxia inducible factor inhibitor,EGLN1
Invasive Breast Carcinoma,BRD-K06519765-001-01-1::2.5::MTS004,5.935325459918868,0.015163114203101942,Invasive Breast Carcinoma,vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1"
Invasive Breast Carcinoma,BRD-K08255599-365-01-1::2.656154742::MTS004,4.893140215769326,0.02738296694837121,Other Types,frovatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D"
Invasive Breast Carcinoma,BRD-K13060017-001-02-1::2.499994836::MTS004,4.031837848707137,0.04514777286980493,Invasive Breast Carcinoma,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Invasive Breast Carcinoma,BRD-K13533483-001-16-2::2.5::MTS004,7.0936050892382205,0.007967753917127127,Invasive Breast Carcinoma,cyclosporine,calcineurin inhibitor,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
Invasive Breast Carcinoma,BRD-K13769342-001-01-5::2.50001379::MTS004,10.19175383097438,0.001493144278080992,Other Types,danirixin,CC chemokine receptor antagonist,CXCR2
Invasive Breast Carcinoma,BRD-K17610631-001-03-3::2.421190843::MTS004,4.204774250588165,0.04079338879634325,Invasive Breast Carcinoma,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Invasive Breast Carcinoma,BRD-K18898553-001-01-1::2.5::MTS004,3.8625937293563273,0.04988699942154426,Invasive Breast Carcinoma,salvianolic-acid-B,"metalloproteinase inhibitor, EGFR inhibitor",MMP9
Invasive Breast Carcinoma,BRD-K20463415-300-01-4::2.499966791::MTS004,15.770637065896695,8.120855502011293e-05,Invasive Breast Carcinoma,LY2606368,CHK inhibitor,CHEK1
Invasive Breast Carcinoma,BRD-K25154476-001-01-4::2.5::MTS004,4.928486784096127,0.026832675295645106,Other Types,cinflumide,muscle relaxant,
Invasive Breast Carcinoma,BRD-K26026438-001-01-0::2.499979456::MTS004,12.842390845658185,0.0003696383875419358,Other Types,tucatinib,EGFR inhibitor,ERBB2
Invasive Breast Carcinoma,BRD-K26818574-305-07-6::2.5::MTS004,6.086634093592975,0.013930596540083934,Invasive Breast Carcinoma,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Invasive Breast Carcinoma,BRD-K30968378-001-01-9::2.500026128::MTS004,5.021935502127359,0.025435317309773647,Invasive Breast Carcinoma,INT-747,FXR agonist,
Invasive Breast Carcinoma,BRD-K38527262-300-01-0::2.300987371::MTS004,4.163619300984024,0.041788737142188385,Invasive Breast Carcinoma,atiprimod,"JAK inhibitor, STAT inhibitor","JAK2, STAT3"
Invasive Breast Carcinoma,BRD-K42673188-001-01-1::2.363355746::MTS004,4.364615281672094,0.03716115605652305,Invasive Breast Carcinoma,verubulin,tubulin polymerization inhibitor,TUBB
Invasive Breast Carcinoma,BRD-K43639297-001-01-9::2.500038533::MTS004,3.8853819104260343,0.04922026619830551,Other Types,hemoglobin-modulators-1,hemoglobin modulator,
Invasive Breast Carcinoma,BRD-K45906612-001-01-8::2.499991411::MTS004,5.669396600903657,0.017610380973571284,Other Types,presatovir,RSV fusion inhibitor,
Invasive Breast Carcinoma,BRD-K55696337-003-24-4::2.50001813::MTS004,8.933171248352352,0.0029280834892494224,Invasive Breast Carcinoma,topotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Invasive Breast Carcinoma,BRD-K59753975-001-02-6::2.5::MTS004,3.8833650527138737,0.04927802487194974,Invasive Breast Carcinoma,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Invasive Breast Carcinoma,BRD-K59866480-001-07-3::2.379655165::MTS004,4.621740180560123,0.03201350099401999,Invasive Breast Carcinoma,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Invasive Breast Carcinoma,BRD-K64034691-001-01-9::2.499981916::MTS004,7.0758373512354735,0.008046088547690169,Other Types,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Invasive Breast Carcinoma,BRD-K64120610-001-01-4::2.5::MTS004,3.9983414836214974,0.0460464863697805,Invasive Breast Carcinoma,vinflunine,microtubule inhibitor,
Invasive Breast Carcinoma,BRD-K68544925-001-01-1::2.500014712::MTS004,5.3266141720466615,0.021380611206882227,Other Types,avatrombopag,thrombopoietin receptor agonist,MPL
Invasive Breast Carcinoma,BRD-K72280606-001-01-2::2.499993939::MTS004,17.922275871832728,2.7052484336650618e-05,Invasive Breast Carcinoma,gilteritinib,FLT3 inhibitor,FLT3
Invasive Breast Carcinoma,BRD-K81405859-300-01-4::2.5::MTS004,9.51886135320154,0.002138080462719146,Invasive Breast Carcinoma,JTE-607,cytokine production inhibitor,"IL10, IL1B, IL6, TNF"
Invasive Breast Carcinoma,BRD-K82118441-001-03-7::2.646883368::MTS004,4.425085662577886,0.03587796620114956,Other Types,pyrantel,nicotinic receptor agonist,
Invasive Breast Carcinoma,BRD-K84036904-001-08-8::2.500018826::MTS004,4.967632314605784,0.02623750142912313,Invasive Breast Carcinoma,17-alpha-methyltestosterone,aromatase inhibitor,AR
Invasive Breast Carcinoma,BRD-K86873305-236-14-7::2.448463554::MTS004,8.868374587848379,0.0030323259712317302,Other Types,piperacillin,bacterial cell wall synthesis inhibitor,
Invasive Breast Carcinoma,BRD-K89490285-001-08-1::2.521612095::MTS004,5.080203891583079,0.024601398966403867,Invasive Breast Carcinoma,bentazepam,benzodiazepine receptor agonist,
Invasive Breast Carcinoma,BRD-K96471533-001-09-0::2.592774962::MTS004,4.185606636449469,0.041253404713325566,Invasive Breast Carcinoma,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
Pancreatic Adenocarcinoma,BRD-A00827783-001-24-6::2.5::HTS,5.499557757363085,0.019371337327407284,Pancreatic Adenocarcinoma,dyphylline,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B"
Pancreatic Adenocarcinoma,BRD-A01593789-001-03-1::2.5::HTS,11.966768785326437,0.0005829433274234313,Other Types,chlormadinone-acetate,5 alpha reductase inhibitor,PGR
Pancreatic Adenocarcinoma,BRD-A01643550-001-04-9::2.5::HTS,4.124106618575298,0.042766653941228694,Pancreatic Adenocarcinoma,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Pancreatic Adenocarcinoma,BRD-A04203391-001-08-3::2.5::HTS,4.273676470977436,0.03916433091999289,Other Types,piricapiron,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A
Pancreatic Adenocarcinoma,BRD-A04327189-001-15-1::2.5::HTS,4.224166947374195,0.040317059688774005,Other Types,synephrine,adrenergic receptor agonist,ADRA1A
Pancreatic Adenocarcinoma,BRD-A06352508-001-03-7::2.5::HTS,4.077416130231903,0.04393769242065889,Pancreatic Adenocarcinoma,SB-218078,CHK inhibitor,CHEK1
Pancreatic Adenocarcinoma,BRD-A06627858-236-03-0::2.5::HTS,5.7137036236435454,0.01716365610931733,Pancreatic Adenocarcinoma,monensin,bacterial permeability inducer,
Pancreatic Adenocarcinoma,BRD-A07563059-035-01-3::2.5::HTS,3.9237706648843265,0.04810119959023837,Other Types,bopindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B"
Pancreatic Adenocarcinoma,BRD-A07704283-001-01-3::2.5::HTS,5.781686559585515,0.01652056431172727,Other Types,isofloxythepin,dopamine receptor antagonist,
Pancreatic Adenocarcinoma,BRD-A07780951-065-10-0::2.58::HTS,6.868171186084585,0.009028192208475163,Other Types,metaproterenol,adrenergic receptor agonist,ADRB2
Pancreatic Adenocarcinoma,BRD-A07815743-001-01-1::2.5::HTS,7.442925443120876,0.006569663842252238,Other Types,kakonein,"GABA receptor antagonist, serotonin receptor antagonist",
Pancreatic Adenocarcinoma,BRD-A09554849-236-07-6::2.5::HTS,4.472842493562515,0.03488113334890273,Other Types,8-bromo-cAMP,PKA activator,
Pancreatic Adenocarcinoma,BRD-A09925278-003-05-6::2.5::HTS,4.17654960517996,0.04145277457038806,Other Types,etilefrine,adrenergic receptor agonist,"ADRA1A, ADRB1"
Pancreatic Adenocarcinoma,BRD-A10903566-003-07-7::2.5::HTS,3.8969702128126986,0.0488834198625095,Other Types,imiloxan,adrenergic receptor antagonist,"ADRA2A, ADRA2B"
Pancreatic Adenocarcinoma,BRD-A12230535-001-06-7::2.5::HTS,11.93722332815818,0.0005935719901749868,Pancreatic Adenocarcinoma,nutlin-3,MDM inhibitor,"MDM2, TP53"
Pancreatic Adenocarcinoma,BRD-A14240607-003-26-1::2.5::HTS,4.3069561031872405,0.038424451564241124,Other Types,octopamine,trace amine associated receptor agonist,"F10, TAAR1"
Pancreatic Adenocarcinoma,BRD-A17883755-001-06-1::2.5::HTS,5.202144882492123,0.022933792451642194,Pancreatic Adenocarcinoma,lenalidomide,anticancer agent,"CDH5, CRBN, PTGS2, TNF, TNFSF11"
Pancreatic Adenocarcinoma,BRD-A22267103-003-13-1::2.5::HTS,7.240891648313934,0.007340164264728957,Other Types,drofenine,,
Pancreatic Adenocarcinoma,BRD-A24191444-046-02-1::2.5::HTS,5.006647285949365,0.02564692637774771,Other Types,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Pancreatic Adenocarcinoma,BRD-A25234499-001-18-3::2.5::HTS,4.162270553343224,0.041804255236724465,Pancreatic Adenocarcinoma,aminoglutethimide,glucocorticoid receptor antagonist,"CYP11A1, CYP19A1"
Pancreatic Adenocarcinoma,BRD-A25608658-001-01-1::2.5::HTS,5.922770730406101,0.015259247298380404,Pancreatic Adenocarcinoma,narasin,antiprotozoal agent,
Pancreatic Adenocarcinoma,BRD-A27732521-003-08-3::2.5::HTS,3.9036695421945864,0.048683804881451014,Other Types,tolperisone,voltage-gated sodium channel blocker,"CYP2C19, CYP2D6"
Pancreatic Adenocarcinoma,BRD-A27883417-300-01-6::2.5::HTS,11.091651323146198,0.000925757650220756,Pancreatic Adenocarcinoma,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1
Pancreatic Adenocarcinoma,BRD-A28301258-001-03-0::2.5::HTS,5.686287088737768,0.017433448979731387,Pancreatic Adenocarcinoma,salinomycin,,
Pancreatic Adenocarcinoma,BRD-A28301258-001-04-8::2.5::HTS,7.26058474503139,0.007272913221297744,Pancreatic Adenocarcinoma,salinomycin,,
Pancreatic Adenocarcinoma,BRD-A29281099-003-03-2::2.5::HTS,3.9793103794327016,0.04655904450748922,Other Types,clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2"
Pancreatic Adenocarcinoma,BRD-A30815329-001-10-5::2.5::HTS,5.788558276022976,0.01645737972282017,Other Types,felodipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2"
Pancreatic Adenocarcinoma,BRD-A31454688-001-01-6::2.5::HTS,7.485890120112088,0.006420813682904533,Other Types,monostearin,,
Pancreatic Adenocarcinoma,BRD-A34255068-001-34-5::2.5::HTS,4.709746767321669,0.03041622522307261,Other Types,rolipram,phosphodiesterase inhibitor,
Pancreatic Adenocarcinoma,BRD-A35379661-001-04-6::2.5::HTS,7.389298959093544,0.006769871454643514,Other Types,sphingosylphosphorylcholine,gene expression stimulant,GPR12
Pancreatic Adenocarcinoma,BRD-A36057565-001-01-0::2.5::HTS,5.465545731199888,0.019751280557301017,Pancreatic Adenocarcinoma,bruceantin,protein synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-A37704979-001-10-7::2.5::HTS,4.524564837770513,0.033850356227750775,Other Types,SB-203580,p38 MAPK inhibitor,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
Pancreatic Adenocarcinoma,BRD-A39390670-236-10-7::2.5::HTS,4.983281754429855,0.025988022364375682,Pancreatic Adenocarcinoma,rabeprazole,"ATPase inhibitor, gastrin inhibitor",ATP4A
Pancreatic Adenocarcinoma,BRD-A40940854-001-01-1::2.5::HTS,3.8788916404345533,0.049391960642877375,Pancreatic Adenocarcinoma,ibuproxam,"cyclooxygenase inhibitor, prostaglandin inhibitor",ALOX5
Pancreatic Adenocarcinoma,BRD-A44448661-001-04-8::2.5::HTS,4.115257131257673,0.04296905438169117,Pancreatic Adenocarcinoma,pentobarbital,"barbiturate antiepileptic, GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Pancreatic Adenocarcinoma,BRD-A44936478-001-01-1::2.5::HTS,3.864467939480591,0.04984241862515561,Other Types,cephalosporin-c-zn,bacterial cell wall synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-A45153512-001-01-0::2.5::HTS,5.639194921666214,0.017908481142153355,Other Types,bimatoprost,prostanoid receptor agonist,"AKR1C3, PTGER1, PTGER3, PTGFR"
Pancreatic Adenocarcinoma,BRD-A46717658-236-02-5::2.5::HTS,6.691344471112951,0.009945718966449862,Other Types,azlocillin,bacterial cell wall synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-A49544621-003-02-8::2.5::HTS,6.416546024721366,0.011584982419898618,Other Types,AC-7954-(+/-),urotensin receptor agonist,UTS2R
Pancreatic Adenocarcinoma,BRD-A50998626-001-02-1::2.5::HTS,9.228752749321297,0.0024944873827939646,Other Types,palomid-529,"AKT inhibitor, mTOR inhibitor",MTOR
Pancreatic Adenocarcinoma,BRD-A51831848-001-01-7::2.5::HTS,4.963501373544816,0.026309856699396512,Other Types,enflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4"
Pancreatic Adenocarcinoma,BRD-A52660433-066-02-1::2.5::HTS,4.658778416416029,0.031335970086488155,Other Types,tetrindole,monoamine oxidase inhibitor,MAOA
Pancreatic Adenocarcinoma,BRD-A53539450-004-01-7::2.5::HTS,5.0384931483864905,0.025179647370440546,Pancreatic Adenocarcinoma,neo-gilurytmal,,
Pancreatic Adenocarcinoma,BRD-A54927599-001-16-9::2.5::HTS,5.4509639191242965,0.019915127877561497,Pancreatic Adenocarcinoma,KF-38789,P selectin inhibitor,SELP
Pancreatic Adenocarcinoma,BRD-A56152450-001-02-0::2.5::HTS,7.216399135856416,0.0074515925526393535,Other Types,dimercaprol,chelating agent,
Pancreatic Adenocarcinoma,BRD-A57798112-001-03-7::2.5::HTS,15.591755868564132,8.867308211409925e-05,Other Types,PD-318088,MEK inhibitor,MAP2K1
Pancreatic Adenocarcinoma,BRD-A57886255-001-01-1::2.5::HTS,4.129545360364375,0.042614656043503736,Pancreatic Adenocarcinoma,golgicide-a,ARF inhibitor,GBF1
Pancreatic Adenocarcinoma,BRD-A58564983-001-04-6::2.5::HTS,4.8982599706831715,0.027284727733506202,Other Types,selamectin,nematocide,
Pancreatic Adenocarcinoma,BRD-A64610707-001-04-4::2.5::HTS,5.450925784352515,0.01991233907038188,Pancreatic Adenocarcinoma,pranoprofen,cyclooxygenase inhibitor,
Pancreatic Adenocarcinoma,BRD-A64977602-001-15-9::2.5::HTS,5.419210450646366,0.020273574897988162,Pancreatic Adenocarcinoma,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Pancreatic Adenocarcinoma,BRD-A67748489-001-10-0::2.5::HTS,10.387638444518064,0.00134320878072475,Pancreatic Adenocarcinoma,K-858,kinesin-like spindle protein inhibitor,KIF11
Pancreatic Adenocarcinoma,BRD-A68631409-001-05-4::2.5::HTS,5.008527890270506,0.025619336837592006,Pancreatic Adenocarcinoma,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1
Pancreatic Adenocarcinoma,BRD-A70858459-001-01-7::2.5::HTS,7.496350313492503,0.006379056873463885,Pancreatic Adenocarcinoma,estramustine,DNA alkylating agent,"ESR1, ESR2, MAP1A, MAP2"
Pancreatic Adenocarcinoma,BRD-A72711497-236-03-8::2.5::HTS,6.077754498397919,0.013988296392091072,Pancreatic Adenocarcinoma,lasalocid,bacterial permeability inducer,
Pancreatic Adenocarcinoma,BRD-A73871920-236-03-6::2.5::HTS,10.728091054226006,0.0011207902968540704,Pancreatic Adenocarcinoma,nanchangmycin,other antibiotic,
Pancreatic Adenocarcinoma,BRD-A80017228-001-25-7::2.5::HTS,5.068269729861715,0.0247538974749562,Other Types,bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,"CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3"
Pancreatic Adenocarcinoma,BRD-A83644949-236-01-6::2.5::HTS,4.140886612422871,0.04234177993832424,Other Types,ardeparin,thrombin inhibitor,"SERPINC1, SERPIND1"
Pancreatic Adenocarcinoma,BRD-A85667082-001-12-7::2.5::HTS,5.782387940308643,0.016512866844553907,Other Types,fulvestrant,estrogen receptor antagonist,"ESR1, ESR2, GPER1"
Pancreatic Adenocarcinoma,BRD-A86248581-001-01-4::2.5::HTS,5.832843650508047,0.01606144513490118,Other Types,tetrahydrouridine,cytidine deaminase inhibitor,CDA
Pancreatic Adenocarcinoma,BRD-A86619021-001-04-8::2.5::HTS,4.654869892009722,0.031392473923222156,Pancreatic Adenocarcinoma,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Pancreatic Adenocarcinoma,BRD-A86871940-001-01-9::2.5::HTS,7.11395557513302,0.007879858308192005,Other Types,nicaraven,free radical scavenger,
Pancreatic Adenocarcinoma,BRD-A87983072-001-01-1::2.5::HTS,8.805302395336636,0.0031325699977017684,Pancreatic Adenocarcinoma,benzotript,CCK receptor antagonist,"CCKAR, CCKBR"
Pancreatic Adenocarcinoma,BRD-A89337244-001-02-9::2.5::HTS,6.026396074044217,0.014399833159459877,Other Types,PD-102807,acetylcholine receptor antagonist,CHRM4
Pancreatic Adenocarcinoma,BRD-A90515964-001-16-5::2.5::HTS,7.007427825936936,0.008346982999497944,Pancreatic Adenocarcinoma,guaifenesin,expectorant,
Pancreatic Adenocarcinoma,BRD-A91822151-001-05-0::2.5::HTS,5.869331886083346,0.01573122598573104,Other Types,picrotin,GABA receptor antagonist,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB"
Pancreatic Adenocarcinoma,BRD-A93000692-001-08-1::2.5::HTS,3.950891194079662,0.047332249333170165,Other Types,ciglitazone,PPAR receptor agonist,PPARG
Pancreatic Adenocarcinoma,BRD-A94624445-236-17-0::2.5::HTS,5.996138328833817,0.01465893882226523,Other Types,bucladesine,"adenosine receptor agonist, cAMP stimulant",PRKACA
Pancreatic Adenocarcinoma,BRD-A94756469-001-04-7::2.5::HTS,4.358813978694969,0.037267640738640966,Pancreatic Adenocarcinoma,digoxin,ATPase inhibitor,ATP1A1
Pancreatic Adenocarcinoma,BRD-A96456596-001-02-2::2.5::HTS,4.713748821658169,0.030340077209052237,Other Types,FPL-55712,leukotriene receptor antagonist,
Pancreatic Adenocarcinoma,BRD-K00259736-001-16-4::2.5::HTS,6.50589037678207,0.011019581741972208,Pancreatic Adenocarcinoma,colchicine,microtubule inhibitor,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8"
Pancreatic Adenocarcinoma,BRD-K00674894-001-01-4::2.5::HTS,4.405665876052257,0.03628431584771828,Other Types,orteronel,"androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor",CYP17A1
Pancreatic Adenocarcinoma,BRD-K01507359-001-22-9::2.5::HTS,6.964542686513826,0.00855967535543005,Pancreatic Adenocarcinoma,rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3"
Pancreatic Adenocarcinoma,BRD-K01674964-300-06-3::2.5::HTS,3.9846508723882237,0.04640561319975124,Other Types,histamine,histamine receptor agonist,"HRH1, HRH2, HRH3, HRH4"
Pancreatic Adenocarcinoma,BRD-K01773560-001-02-4::2.59::HTS,4.33996480712653,0.03769923761385989,Pancreatic Adenocarcinoma,UNC2250,MER tyrosine kinase inhibitor,MERTK
Pancreatic Adenocarcinoma,BRD-K02292852-001-02-1::2.5::HTS,4.667278156646915,0.03117068076916395,Other Types,cefoperazone,bacterial cell wall synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-K02637541-001-18-0::2.5::HTS,7.8008286714507005,0.005402763145291165,Other Types,celecoxib,cyclooxygenase inhibitor,"CA12, PDPK1, PTGS2"
Pancreatic Adenocarcinoma,BRD-K03289018-001-02-7::2.5::HTS,12.32009693188688,0.0004840365267755989,Pancreatic Adenocarcinoma,CCT137690,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Pancreatic Adenocarcinoma,BRD-K03390685-001-01-7::2.5::HTS,12.282128241270522,0.0004943064778050141,Other Types,cobimetinib,MEK inhibitor,
Pancreatic Adenocarcinoma,BRD-K04111260-001-10-0::2.5::HTS,3.884437144915976,0.04923295620395086,Other Types,raclopride,dopamine receptor antagonist,"DRD2, DRD3, HTR1A"
Pancreatic Adenocarcinoma,BRD-K04264130-001-01-4::2.5::HTS,3.9658997357596526,0.04691863709219298,Other Types,favipiravir,RNA polymerase inhibitor,
Pancreatic Adenocarcinoma,BRD-K05104363-001-10-0::2.5::HTS,10.890096305588271,0.0010307144752158702,Other Types,PD-184352,MEK inhibitor,"MAP2K1, MAP3K1, MAP3K2"
Pancreatic Adenocarcinoma,BRD-K05446112-001-01-8::2.5::HTS,8.701123100388358,0.0033137591244990156,Other Types,ledipasvir,HCV inhibitor,
Pancreatic Adenocarcinoma,BRD-K05673000-236-12-1::2.5::HTS,5.887650530711266,0.015563774676152215,Other Types,dicloxacillin,bacterial cell wall synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-K06147391-300-06-8::2.5::HTS,4.64120100176612,0.031641296817598086,Other Types,telenzepine,acetylcholine receptor antagonist,CHRM1
Pancreatic Adenocarcinoma,BRD-K06542892-001-01-9::2.5::HTS,5.167706509818019,0.023395334575277094,Other Types,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Pancreatic Adenocarcinoma,BRD-K06674495-334-03-2::2.5::HTS,5.180733697330162,0.02321740424385027,Pancreatic Adenocarcinoma,nafamostat,serine protease inhibitor,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7"
Pancreatic Adenocarcinoma,BRD-K06980535-003-25-9::2.5::HTS,4.314811063322143,0.03825495531951968,Other Types,promazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C"
Pancreatic Adenocarcinoma,BRD-K08111712-001-16-7::2.5::HTS,10.784867749186413,0.001087921298736207,Pancreatic Adenocarcinoma,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55
Pancreatic Adenocarcinoma,BRD-K08251020-001-01-0::2.5::HTS,7.62825188716935,0.005939623107799271,Other Types,falecalcitriol,vitamin D receptor agonist,VDR
Pancreatic Adenocarcinoma,BRD-K08542803-001-03-1::0.8::HTS,5.576013061843094,0.018551423387531706,Pancreatic Adenocarcinoma,gambogic-acid,caspase activator,BCL2
Pancreatic Adenocarcinoma,BRD-K08998509-001-02-4::2.5::HTS,6.045904064211887,0.014241126740644004,Pancreatic Adenocarcinoma,fananserin,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A
Pancreatic Adenocarcinoma,BRD-K09090523-001-02-1::2.5::HTS,5.431309908932413,0.020134327298459802,Other Types,firocoxib,cyclooxygenase inhibitor,PTGS2
Pancreatic Adenocarcinoma,BRD-K10673031-004-02-0::2.5::HTS,3.8929339047863394,0.04898186112182356,Pancreatic Adenocarcinoma,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Pancreatic Adenocarcinoma,BRD-K11373525-003-02-1::2.5::HTS,4.180501212142033,0.04136115494385551,Other Types,ZD-7155,angiotensin receptor antagonist,AGTR1
Pancreatic Adenocarcinoma,BRD-K11640013-236-10-1::2.5::HTS,4.154322287238886,0.042002780179012156,Pancreatic Adenocarcinoma,sulfamethazine,PABA antagonist,
Pancreatic Adenocarcinoma,BRD-K12014493-001-02-2::2.5::HTS,6.3928666072534,0.011749392650489835,Other Types,betaine,nitric oxide donor,
Pancreatic Adenocarcinoma,BRD-K12040459-001-06-0::2.5::HTS,5.025516101871133,0.025369374594407766,Pancreatic Adenocarcinoma,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Pancreatic Adenocarcinoma,BRD-K12047401-001-01-5::2.5::HTS,9.742377345684163,0.0018992312058784449,Other Types,palifosfamide,DNA alkylating agent,
Pancreatic Adenocarcinoma,BRD-K12120659-305-02-2::2.5::HTS,5.561626212090403,0.018706046613185486,Pancreatic Adenocarcinoma,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Pancreatic Adenocarcinoma,BRD-K12251893-065-04-7::2.5::HTS,9.570656828240633,0.002076809862584744,Pancreatic Adenocarcinoma,vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB"
Pancreatic Adenocarcinoma,BRD-K12343256-001-08-9::2.5::HTS,16.443616269833303,5.725023329119179e-05,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Pancreatic Adenocarcinoma,BRD-K12539581-001-23-7::2.5::HTS,4.102277997572628,0.04329757631852872,Pancreatic Adenocarcinoma,nocodazole,tubulin polymerization inhibitor,HPGDS
Pancreatic Adenocarcinoma,BRD-K12807006-001-18-5::2.5::HTS,3.9968346341488115,0.04606939734542382,Pancreatic Adenocarcinoma,kaempferol,"bone resorption inhibitor, estrogen-related receptor inverse agonist","AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1"
Pancreatic Adenocarcinoma,BRD-K12867552-001-04-7::2.5::HTS,6.079118401574467,0.013989305524508524,Pancreatic Adenocarcinoma,PCI-24781,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6"
Pancreatic Adenocarcinoma,BRD-K12885236-001-02-7::2.5::HTS,5.407700484593699,0.020408293672045705,Pancreatic Adenocarcinoma,dapivirine,non-nucleoside reverse transcriptase inhibitor,"CYP3A4, CYP3A5"
Pancreatic Adenocarcinoma,BRD-K13167095-001-02-9::2.5::HTS,5.454749015501585,0.019866087183936648,Pancreatic Adenocarcinoma,AR-42,HDAC inhibitor,HDAC1
Pancreatic Adenocarcinoma,BRD-K13169950-001-14-4::2.5::HTS,10.033284873859596,0.0016220457247781118,Pancreatic Adenocarcinoma,NSC-3852,HDAC inhibitor,HDAC1
Pancreatic Adenocarcinoma,BRD-K13183738-317-10-2::2.5::HTS,9.787125059702376,0.0018492690989589775,Pancreatic Adenocarcinoma,pentamidine,anti-pneumocystis agent,TRDMT1
Pancreatic Adenocarcinoma,BRD-K13302470-001-02-7::2.5::HTS,4.293840948386035,0.03870611907729283,Other Types,KY02111,Wnt pathway inhibitor,DKK1
Pancreatic Adenocarcinoma,BRD-K13486660-001-01-0::2.5::HTS,4.603329945718293,0.03233768020138947,Other Types,sulfacarbamide,,
Pancreatic Adenocarcinoma,BRD-K13810148-311-03-2::2.5::HTS,10.328480283369512,0.0013850236858527567,Pancreatic Adenocarcinoma,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Pancreatic Adenocarcinoma,BRD-K13994703-003-15-8::2.5::HTS,4.815167395014562,0.02862476098612316,Other Types,propranolol-(S),adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1"
Pancreatic Adenocarcinoma,BRD-K14401183-001-10-7::2.5::HTS,5.125614786246203,0.02396104673912945,Other Types,avobenzone,UV blocker,TYR
Pancreatic Adenocarcinoma,BRD-K15025317-001-15-1::2.5::HTS,4.75251361511607,0.029675742070847996,Pancreatic Adenocarcinoma,BAY-11-7082,NFkB pathway inhibitor,RELA
Pancreatic Adenocarcinoma,BRD-K15164005-001-05-6::2.5::HTS,5.195171179472739,0.023029186913434866,Pancreatic Adenocarcinoma,apoptosis-activator-II,carboxylesterase inhibitor,"BCHE, CES1"
Pancreatic Adenocarcinoma,BRD-K15179513-001-03-4::2.5::HTS,4.085912568335787,0.04372243558078104,Other Types,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
Pancreatic Adenocarcinoma,BRD-K15898725-001-01-7::2.5::HTS,6.287296749458174,0.012443071896263294,Pancreatic Adenocarcinoma,maytansinol-isobutyrate,,
Pancreatic Adenocarcinoma,BRD-K16485616-001-08-9::2.5::HTS,6.880480078989114,0.008954187782894536,Pancreatic Adenocarcinoma,mocetinostat,HDAC inhibitor,"HDAC1, HDAC11, HDAC2, HDAC3"
Pancreatic Adenocarcinoma,BRD-K16810791-001-01-0::2.5::HTS,4.14875612799694,0.042133231261008736,Other Types,LGK-974,porcupine inhibitor,PORCN
Pancreatic Adenocarcinoma,BRD-K17555800-003-01-5::2.5::HTS,8.152193811881046,0.004460330660960229,Pancreatic Adenocarcinoma,talmapimod,p38 MAPK inhibitor,"MAPK11, MAPK14"
Pancreatic Adenocarcinoma,BRD-K18135438-001-16-7::2.5::HTS,5.403517994306031,0.020454818770643896,Pancreatic Adenocarcinoma,chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4"
Pancreatic Adenocarcinoma,BRD-K18157228-001-01-7::2.5::HTS,5.135190978684378,0.023826324466776745,Pancreatic Adenocarcinoma,fdcyd,DNA methyltransferase inhibitor,
Pancreatic Adenocarcinoma,BRD-K18323388-001-01-1::2.5::HTS,13.078380602440948,0.00032600162563219836,Other Types,uridine-triacetate,,
Pancreatic Adenocarcinoma,BRD-K19111024-001-20-9::2.5::HTS,10.377915274978188,0.0013522874017172204,Pancreatic Adenocarcinoma,clofibric-acid,PPAR receptor agonist,PPARA
Pancreatic Adenocarcinoma,BRD-K19284129-001-02-6::2.5::HTS,4.3421546953383325,0.037650308992514925,Other Types,salvinorin-a,opioid receptor agonist,"OPRD1, OPRK1, OPRM1"
Pancreatic Adenocarcinoma,BRD-K21071223-001-02-8::2.5::HTS,5.451405342638913,0.019908852726502214,Other Types,VP-20629,beta amyloid antagonist,"PLA2G2E, SLC36A1"
Pancreatic Adenocarcinoma,BRD-K21361524-001-01-1::2.5::HTS,4.84896994975567,0.028068089483280302,Pancreatic Adenocarcinoma,selinexor,exportin antagonist,XPO1
Pancreatic Adenocarcinoma,BRD-K21520694-236-02-6::2.5::HTS,8.036288100932852,0.0047498935278202006,Other Types,sulfacetamide,PABA antagonist,
Pancreatic Adenocarcinoma,BRD-K21548250-003-19-1::2.5::HTS,4.452615358905876,0.03529556169108565,Other Types,moracizine,sodium channel blocker,SCN5A
Pancreatic Adenocarcinoma,BRD-K21718444-001-06-8::2.5::HTS,5.3860894450747505,0.020654872982474023,Pancreatic Adenocarcinoma,KW-2449,"Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor","ABL1, AURKA, AURKB, FLT3"
Pancreatic Adenocarcinoma,BRD-K22503835-001-11-0::2.5::HTS,6.132482518465664,0.013566926707409398,Pancreatic Adenocarcinoma,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Pancreatic Adenocarcinoma,BRD-K22662557-300-01-7::2.5::HTS,4.845071406075067,0.028134691563064293,Pancreatic Adenocarcinoma,WIN-64338,bradykinin receptor antagonist,BDKRB2
Pancreatic Adenocarcinoma,BRD-K23082237-003-01-5::2.5::HTS,6.926162947183049,0.008731094026563897,Other Types,butaclamol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A"
Pancreatic Adenocarcinoma,BRD-K23363278-001-02-1::2.5::HTS,9.119364145483148,0.0026440554967634266,Pancreatic Adenocarcinoma,CYT-997,tubulin polymerization inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K23672206-001-01-4::2.5::HTS,5.430490948342708,0.020144960423730394,Pancreatic Adenocarcinoma,BCI-540,glutamate receptor agonist,
Pancreatic Adenocarcinoma,BRD-K23677682-003-01-2::2.5::HTS,4.572814433833692,0.032913678232905016,Pancreatic Adenocarcinoma,voreloxin,topoisomerase inhibitor,TOP2A
Pancreatic Adenocarcinoma,BRD-K23925186-001-02-8::2.51::HTS,7.555741525357838,0.0061867182758499105,Pancreatic Adenocarcinoma,oridonin,BCL inhibitor,BCL2
Pancreatic Adenocarcinoma,BRD-K24187789-001-01-7::2.5::HTS,4.6547723574660615,0.031392712269937,Pancreatic Adenocarcinoma,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Pancreatic Adenocarcinoma,BRD-K24297741-001-05-2::2.5::HTS,5.076721407823223,0.024658764423815323,Other Types,urethane,local anesthetic,
Pancreatic Adenocarcinoma,BRD-K24771047-001-01-6::2.5::HTS,3.8884098055370866,0.04911747192999312,Other Types,ampalex,glutamate receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Pancreatic Adenocarcinoma,BRD-K24821794-001-01-4::2.5::HTS,6.4314010567800235,0.011483630159128783,Pancreatic Adenocarcinoma,SGC-CBP30,bromodomain inhibitor,"CREBBP, EP300"
Pancreatic Adenocarcinoma,BRD-K25114078-003-08-1::2.5::HTS,4.081402735072777,0.043834076829822786,Other Types,aminoguanidine,nitric oxide synthase inhibitor,NOS2
Pancreatic Adenocarcinoma,BRD-K25340465-001-11-1::2.58::HTS,4.074886438908844,0.04403020734733024,Pancreatic Adenocarcinoma,OSI-930,"KIT inhibitor, VEGFR inhibitor","KDR, KIT"
Pancreatic Adenocarcinoma,BRD-K25486274-300-01-0::2.5::HTS,6.3297982429299475,0.012151652670541618,Other Types,DRF053-(R),CDK inhibitor,CSNK1A1
Pancreatic Adenocarcinoma,BRD-K26581543-001-01-6::2.5::HTS,6.378986848755422,0.011826648734374124,Pancreatic Adenocarcinoma,bifendate,,
Pancreatic Adenocarcinoma,BRD-K26667523-001-02-5::2.5::HTS,14.13528240143736,0.00018819795984901017,Other Types,TAK-733,MEK inhibitor,MAP2K1
Pancreatic Adenocarcinoma,BRD-K26756394-001-02-2::2.5::HTS,10.050140164115204,0.0016067721881672084,Pancreatic Adenocarcinoma,VE-821,ATR kinase inhibitor,ATR
Pancreatic Adenocarcinoma,BRD-K26997899-001-02-2::2.5::HTS,5.883925637519019,0.015593551037864058,Pancreatic Adenocarcinoma,D-64131,microtubule inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K27184429-300-01-3::2.5::HTS,4.667066249056348,0.031168390292926562,Pancreatic Adenocarcinoma,levocetirizine,histamine receptor antagonist,HRH1
Pancreatic Adenocarcinoma,BRD-K27316855-001-13-3::2.44::HTS,4.932105295469614,0.02678573511715653,Other Types,calcitriol,vitamin D receptor agonist,VDR
Pancreatic Adenocarcinoma,BRD-K27955832-001-02-9::2.5::HTS,6.108180348664056,0.0137526311542451,Pancreatic Adenocarcinoma,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Pancreatic Adenocarcinoma,BRD-K28059174-334-01-2::2.5::HTS,4.086488930943149,0.043714684914977826,Other Types,INCB-003284,CC chemokine receptor antagonist,
Pancreatic Adenocarcinoma,BRD-K28183345-003-11-4::2.5::HTS,16.577778821586154,5.339805963830893e-05,Pancreatic Adenocarcinoma,proguanil,dihydrofolate reductase inhibitor,DHFR
Pancreatic Adenocarcinoma,BRD-K28761384-300-01-0::2.5::HTS,4.518648709772127,0.03396271007383845,Other Types,zuclopenthixol,dopamine receptor antagonist,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A"
Pancreatic Adenocarcinoma,BRD-K28822270-001-01-1::2.5::HTS,9.616922974011331,0.002026013396457456,Pancreatic Adenocarcinoma,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Pancreatic Adenocarcinoma,BRD-K28824103-001-02-8::2.5::HTS,9.387371212354651,0.002296417823347823,Pancreatic Adenocarcinoma,genipin,choleretic agent,
Pancreatic Adenocarcinoma,BRD-K28965160-001-01-1::2.5::HTS,6.767120615424709,0.009533429950480274,Other Types,BVD-523,MAP kinase inhibitor,
Pancreatic Adenocarcinoma,BRD-K29359156-001-30-1::2.5::HTS,5.75641919104035,0.016753163850150948,Pancreatic Adenocarcinoma,ebselen,"cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor",ALB
Pancreatic Adenocarcinoma,BRD-K29905972-001-06-3::2.5::HTS,3.866226718943764,0.04976602172570613,Pancreatic Adenocarcinoma,axitinib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, FLT1, FLT4, KDR, PLK4"
Pancreatic Adenocarcinoma,BRD-K29968218-001-03-2::2.5::HTS,9.269151287843304,0.002441156468167625,Pancreatic Adenocarcinoma,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Pancreatic Adenocarcinoma,BRD-K30553453-001-13-2::2.5::HTS,3.860946658457373,0.04992172347561307,Pancreatic Adenocarcinoma,hesperetin,ACAT inhibitor,"DGAT1, MTTP, SOAT1, SOAT2"
Pancreatic Adenocarcinoma,BRD-K30933884-001-01-0::2.5::HTS,6.399309840502629,0.011690097280076991,Pancreatic Adenocarcinoma,UNBS-5162,CC chemokine receptor antagonist,
Pancreatic Adenocarcinoma,BRD-K31553034-001-03-0::2.5::HTS,5.450434737620934,0.019917243913536414,Pancreatic Adenocarcinoma,zibotentan,endothelin receptor antagonist,EDNRA
Pancreatic Adenocarcinoma,BRD-K32007074-001-02-9::3.16::HTS,3.874180190618079,0.049546330046243266,Other Types,enocitabine,DNA synthesis inhibitor,"CMPK1, RRM1, TYMS"
Pancreatic Adenocarcinoma,BRD-K32285926-001-02-1::2.5::HTS,3.868807915712678,0.04969190105796569,Other Types,AMG-208,tyrosine kinase inhibitor,MET
Pancreatic Adenocarcinoma,BRD-K32292990-001-03-6::2.5::HTS,4.152690986564621,0.042042946347177694,Other Types,CGP-53353,"EGFR inhibitor, PKC inhibitor","EGFR, PRKCB"
Pancreatic Adenocarcinoma,BRD-K32730239-001-01-0::2.5::HTS,7.253233231584351,0.007289775097473612,Pancreatic Adenocarcinoma,SU3327,JNK inhibitor,MAPK8
Pancreatic Adenocarcinoma,BRD-K33226500-001-01-0::2.5::HTS,4.673910801263224,0.031053905188235073,Other Types,indinavir,HIV protease inhibitor,"CYP3A4, CYP3A5, CYP3A7"
Pancreatic Adenocarcinoma,BRD-K33379087-001-07-5::2.5::HTS,4.181827300094654,0.041333313564042407,Pancreatic Adenocarcinoma,tivantinib,tyrosine kinase inhibitor,MET
Pancreatic Adenocarcinoma,BRD-K33425534-001-12-5::2.5::HTS,6.8951497701889695,0.008882787494849997,Pancreatic Adenocarcinoma,exemestane,aromatase inhibitor,CYP19A1
Pancreatic Adenocarcinoma,BRD-K33588785-001-01-9::2.5::HTS,4.9995897905696385,0.02576488509641937,Other Types,obidoxime,cholinesterase reactivator,ACHE
Pancreatic Adenocarcinoma,BRD-K33690734-001-01-5::2.5::HTS,5.864096788118912,0.01576998779465387,Pancreatic Adenocarcinoma,5-BDBD,purinergic receptor antagonist,P2RX4
Pancreatic Adenocarcinoma,BRD-K33809398-001-01-8::2.5::HTS,5.418536348021954,0.0203010066880747,Other Types,SCMC-Lys,mucolytic agent,GSTP1
Pancreatic Adenocarcinoma,BRD-K34157611-001-16-0::2.5::HTS,5.749234753495537,0.016827011851421932,Other Types,cimetidine,histamine receptor antagonist,"HRH2, SLC29A4, SLC47A1, SLC47A2"
Pancreatic Adenocarcinoma,BRD-K35960502-001-20-0::2.5::HTS,5.299707714961077,0.02169694946747254,Pancreatic Adenocarcinoma,niclosamide,"DNA replication inhibitor, STAT inhibitor",STAT3
Pancreatic Adenocarcinoma,BRD-K37590257-001-02-8::2.5::HTS,9.137854305839308,0.0026212820114895176,Other Types,GSK256066,phosphodiesterase inhibitor,PDE4A
Pancreatic Adenocarcinoma,BRD-K37682401-001-09-3::2.44::HTS,4.811321014362001,0.028708612765172625,Other Types,piromidic-acid,bacterial DNA gyrase inhibitor,
Pancreatic Adenocarcinoma,BRD-K37687095-001-06-9::2.5::HTS,14.084297270743676,0.0001929664633719953,Other Types,AZD8330,MEK inhibitor,
Pancreatic Adenocarcinoma,BRD-K37694030-003-12-7::2.5::HTS,6.123869949885421,0.013631911693002386,Pancreatic Adenocarcinoma,doxepin,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4"
Pancreatic Adenocarcinoma,BRD-K37714784-305-02-1::2.5::HTS,4.171684422946343,0.04157271208061266,Other Types,ABT-724,dopamine receptor agonist,DRD4
Pancreatic Adenocarcinoma,BRD-K37846922-001-09-4::0.25::HTS,5.659684691394421,0.01770199443597673,Pancreatic Adenocarcinoma,"3,3'-diindolylmethane","CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor","AR, HIF1A, IFNG, PI3"
Pancreatic Adenocarcinoma,BRD-K38323065-001-19-9::2.5::HTS,4.0185882222585505,0.04548486611641846,Pancreatic Adenocarcinoma,phenacetin,cyclooxygenase inhibitor,PTGS1
Pancreatic Adenocarcinoma,BRD-K38332599-001-01-3::2.5::HTS,7.529434224184731,0.006264860308192336,Pancreatic Adenocarcinoma,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Pancreatic Adenocarcinoma,BRD-K38548312-001-01-0::2.5::HTS,4.612354559932494,0.03217165980817601,Pancreatic Adenocarcinoma,VER-49009,HSP inhibitor,HSP90AA1
Pancreatic Adenocarcinoma,BRD-K38580127-003-15-4::2.5::HTS,6.346611676492779,0.012044961491273848,Other Types,serotonin,growth factor receptor activator,"DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1"
Pancreatic Adenocarcinoma,BRD-K38860038-001-01-2::2.5::HTS,12.302697600148639,0.0004891428261085062,Pancreatic Adenocarcinoma,JK-184,hedgehog pathway inhibitor,
Pancreatic Adenocarcinoma,BRD-K38903228-001-13-5::2.5::HTS,4.066805851821542,0.04420902071016817,Pancreatic Adenocarcinoma,hesperidin,flavanone glycoside,CACNA1B
Pancreatic Adenocarcinoma,BRD-K39079086-001-07-6::2.5::HTS,4.365300662944365,0.03713363873075706,Other Types,cinchonidine,P glycoprotein inhibitor,
Pancreatic Adenocarcinoma,BRD-K39670393-303-02-1::2.5::HTS,5.2231232931099925,0.02266001803725766,Other Types,amthamine,histamine receptor agonist,HRH2
Pancreatic Adenocarcinoma,BRD-K40366680-001-03-3::2.5::HTS,4.09323926789552,0.04353131781636609,Pancreatic Adenocarcinoma,CAY10505,PI3K inhibitor,PIK3CG
Pancreatic Adenocarcinoma,BRD-K40496271-396-01-1::2.34::HTS,3.942964379708521,0.04758454221922627,Pancreatic Adenocarcinoma,eltrombopag,thrombopoietin receptor agonist,MPL
Pancreatic Adenocarcinoma,BRD-K40654626-236-01-5::2.5::HTS,7.278180268175477,0.007202988334660176,Pancreatic Adenocarcinoma,ditiocarb-sodium-trihydrate,immunostimulant,"CA1, CA2, CA4"
Pancreatic Adenocarcinoma,BRD-K41278234-001-03-0::2.5::HTS,4.895773315042421,0.027329501087589598,Pancreatic Adenocarcinoma,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Pancreatic Adenocarcinoma,BRD-K41298358-395-03-4::2.46::HTS,3.9619769367135595,0.047054119292032036,Other Types,tetraethylenepentamine,superoxide dismutase inhibitor,"SOD1, SOD2"
Pancreatic Adenocarcinoma,BRD-K41524689-001-23-5::2.5::HTS,7.608295986853786,0.006004785244016438,Other Types,paracetamol,cyclooxygenase inhibitor,"FAAH, PTGS1, PTGS2, TRPV1"
Pancreatic Adenocarcinoma,BRD-K41599323-001-02-3::2.5::HTS,6.362973795139856,0.01192857470959582,Pancreatic Adenocarcinoma,lonafarnib,farnesyltransferase inhibitor,"FNTA, HRAS, KRAS, NRAS"
Pancreatic Adenocarcinoma,BRD-K42098891-003-20-5::2.5::HTS,9.79603804521718,0.0018423556271750495,Other Types,protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4"
Pancreatic Adenocarcinoma,BRD-K42191735-001-05-3::2.5::HTS,7.195984365161732,0.007521719917092147,Pancreatic Adenocarcinoma,buparlisib,PI3K inhibitor,"PIK3CA, PIK3CG"
Pancreatic Adenocarcinoma,BRD-K42417338-045-01-9::2.5::HTS,5.509598092813532,0.0192686110272823,Other Types,butorphanol-(+)-tartrate,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Pancreatic Adenocarcinoma,BRD-K42497885-001-01-1::2.5::HTS,5.239514489917328,0.02246036672346623,Pancreatic Adenocarcinoma,satraplatin,DNA alkylating agent,
Pancreatic Adenocarcinoma,BRD-K44273375-001-25-0::2.5::HTS,8.566055329695368,0.003567536557022933,Other Types,tolnaftate,fungal squalene epoxidase inhibitor,
Pancreatic Adenocarcinoma,BRD-K45168550-001-01-9::2.5::HTS,6.998381662030255,0.00839083147157033,Pancreatic Adenocarcinoma,SB-756050,G protein-coupled receptor agonist,GPBAR1
Pancreatic Adenocarcinoma,BRD-K45909031-001-01-5::2.5::HTS,11.960349281968202,0.0005849125008832297,Pancreatic Adenocarcinoma,WZ4003,AMPK inhibitor,"NUAK1, NUAK2"
Pancreatic Adenocarcinoma,BRD-K46428823-001-02-5::2.5::HTS,4.460426223928643,0.03513344292653176,Other Types,liothyronine-(isomer),,
Pancreatic Adenocarcinoma,BRD-K46766488-003-02-0::2.5::HTS,4.276970644421085,0.03909569301291368,Other Types,S-14506,serotonin receptor agonist,HTR1A
Pancreatic Adenocarcinoma,BRD-K47192521-001-05-4::0.25::HTS,7.846906238762399,0.005267701904475571,Pancreatic Adenocarcinoma,icosapent,platelet aggregation inhibitor,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1"
Pancreatic Adenocarcinoma,BRD-K47832606-001-30-1::2.5::HTS,4.997277218665321,0.025784852702226465,Pancreatic Adenocarcinoma,floxuridine,DNA synthesis inhibitor,TYMS
Pancreatic Adenocarcinoma,BRD-K47869605-001-32-0::2.5::HTS,4.455821276430353,0.035236483659747714,Pancreatic Adenocarcinoma,podophyllotoxin,"microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB"
Pancreatic Adenocarcinoma,BRD-K48443249-001-01-0::2.5::HTS,9.06602175173423,0.0027216610257802397,Pancreatic Adenocarcinoma,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Pancreatic Adenocarcinoma,BRD-K48894757-001-01-8::2.5::HTS,5.028068770008061,0.025340281170229875,Other Types,laropiprant,prostanoid receptor antagonist,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R"
Pancreatic Adenocarcinoma,BRD-K49215523-001-04-2::2.5::HTS,6.157738270758054,0.013380403965935837,Pancreatic Adenocarcinoma,GSK2636771,PI3K inhibitor,PIK3CB
Pancreatic Adenocarcinoma,BRD-K49865102-001-08-4::2.5::HTS,19.113605345110773,1.472702072655321e-05,Other Types,PD-0325901,MEK inhibitor,MAP2K1
Pancreatic Adenocarcinoma,BRD-K50417881-003-17-4::2.5::HTS,5.034494683494357,0.025241534021887727,Other Types,eticlopride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Pancreatic Adenocarcinoma,BRD-K50677762-001-01-5::2.5::HTS,4.4707634111341115,0.03492565518692859,Pancreatic Adenocarcinoma,oxiracetam,acetylcholine receptor agonist,
Pancreatic Adenocarcinoma,BRD-K50817623-303-05-7::2.5::HTS,4.433877532395957,0.0357039670114172,Pancreatic Adenocarcinoma,pancuronium,acetylcholine receptor antagonist,"CHRM2, CHRM3, CHRNA1, CHRNA2"
Pancreatic Adenocarcinoma,BRD-K51143828-003-03-1::2.5::HTS,4.924473875642201,0.02689680963635551,Other Types,lurasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7"
Pancreatic Adenocarcinoma,BRD-K52075715-001-06-7::2.5::HTS,4.140395123732926,0.04234022606735252,Pancreatic Adenocarcinoma,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Pancreatic Adenocarcinoma,BRD-K52256627-300-06-6::2.5::HTS,8.99948507235033,0.002821330138911475,Pancreatic Adenocarcinoma,chlorhexidine,membrane integrity inhibitor,
Pancreatic Adenocarcinoma,BRD-K52313696-001-12-3::2.5::HTS,7.456049174136112,0.006529311010425148,Pancreatic Adenocarcinoma,tacedinaline,HDAC inhibitor,HDAC1
Pancreatic Adenocarcinoma,BRD-K52911425-001-09-8::2.5::HTS,5.490699717647687,0.019465600075374463,Other Types,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Pancreatic Adenocarcinoma,BRD-K53083666-001-01-0::2.5::HTS,4.4567197308660145,0.03522401242481242,Other Types,"1,5-dicaffeoylquinic-acid",,
Pancreatic Adenocarcinoma,BRD-K53561341-001-07-5::2.5::HTS,7.0877323909435095,0.007985183860958589,Pancreatic Adenocarcinoma,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
Pancreatic Adenocarcinoma,BRD-K53665955-001-03-0::2.5::HTS,3.8948741802357256,0.04892749081021005,Pancreatic Adenocarcinoma,MK-5108,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Pancreatic Adenocarcinoma,BRD-K54095730-001-03-1::2.5::HTS,6.1226103764776925,0.013643116505981701,Pancreatic Adenocarcinoma,CMPD-1,p38 MAPK inhibitor,"GNRHR, MAPK14"
Pancreatic Adenocarcinoma,BRD-K54262262-001-09-0::2.5::HTS,9.665590366364901,0.001974475717415756,Pancreatic Adenocarcinoma,monobenzone,melanin inhibitor,TYR
Pancreatic Adenocarcinoma,BRD-K54824716-001-04-0::2.5::HTS,8.30532077249606,0.00410507089834433,Other Types,procodazole,immunostimulant,
Pancreatic Adenocarcinoma,BRD-K54997624-001-06-0::2.5::HTS,6.131416384127242,0.013573438055552518,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Pancreatic Adenocarcinoma,BRD-K56156805-001-09-6::2.5::HTS,4.7265561346168505,0.030129106233585494,Pancreatic Adenocarcinoma,benznidazole,DNA synthesis inhibitor,
Pancreatic Adenocarcinoma,BRD-K57080016-001-15-9::2.5::HTS,12.692330225807419,0.00039833479259140025,Other Types,selumetinib,MEK inhibitor,MAP2K1
Pancreatic Adenocarcinoma,BRD-K57136142-001-02-4::2.5::HTS,4.228446872146689,0.04021714110282921,Pancreatic Adenocarcinoma,CCT129202,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Pancreatic Adenocarcinoma,BRD-K57179821-001-15-4::2.5::HTS,4.266509270504301,0.03933185361852962,Other Types,crotamiton,antipruritic,
Pancreatic Adenocarcinoma,BRD-K57371763-001-01-7::2.5::HTS,5.005187627565236,0.025664100265825607,Pancreatic Adenocarcinoma,fidaxomicin,RNA polymerase inhibitor,
Pancreatic Adenocarcinoma,BRD-K57718010-001-11-9::2.5::HTS,5.318050066833409,0.02146864107330803,Other Types,pentylenetetrazol,GABA receptor antagonist,
Pancreatic Adenocarcinoma,BRD-K57927309-001-01-7::2.5::HTS,4.433872466628241,0.035679486069711,Other Types,BW-180C,opioid receptor agonist,"OPRD1, OPRM1"
Pancreatic Adenocarcinoma,BRD-K58049875-001-04-7::2.5::HTS,15.007389520472723,0.00011979628144550806,Pancreatic Adenocarcinoma,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Pancreatic Adenocarcinoma,BRD-K58501140-002-01-0::2.5::HTS,7.906977644711643,0.00509705700364499,Pancreatic Adenocarcinoma,TAK-875,insulin secretagogue,FFAR1
Pancreatic Adenocarcinoma,BRD-K58513245-304-02-7::2.5::HTS,3.8866616034493195,0.049192757250792356,Other Types,pamidronate,bone resorption inhibitor,FDPS
Pancreatic Adenocarcinoma,BRD-K58770988-001-01-8::2.5::HTS,7.606416351033555,0.006006394813019132,Pancreatic Adenocarcinoma,NMS-E973,HSP inhibitor,
Pancreatic Adenocarcinoma,BRD-K59369769-001-20-3::2.5::HTS,4.095531131410095,0.043469395524796034,Pancreatic Adenocarcinoma,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor","AURKA, AURKB, AURKC, LCK"
Pancreatic Adenocarcinoma,BRD-K59831625-001-01-6::2.5::HTS,4.909457909668639,0.02710996056593119,Pancreatic Adenocarcinoma,LDN-212854,bone morphogenic protein inhibitor,"ABL1, ACVR1, RIPK2"
Pancreatic Adenocarcinoma,BRD-K61195623-001-01-4::2.5::HTS,3.8755668633574247,0.049484757079443754,Pancreatic Adenocarcinoma,combretastatin-A-4,tubulin polymerization inhibitor,
Pancreatic Adenocarcinoma,BRD-K61323504-001-04-0::2.5::HTS,7.67216486941941,0.005796679504110909,Pancreatic Adenocarcinoma,SB-225002,CC chemokine receptor antagonist,CXCR2
Pancreatic Adenocarcinoma,BRD-K61443650-236-13-1::2.5::HTS,15.63622111678339,8.657632337083119e-05,Pancreatic Adenocarcinoma,thiomersal,other antibiotic,OXCT1
Pancreatic Adenocarcinoma,BRD-K61585876-001-01-0::2.5::HTS,5.862153364928044,0.01578552309690331,Pancreatic Adenocarcinoma,3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,"GRM1, GRM5"
Pancreatic Adenocarcinoma,BRD-K61642990-001-01-0::2.5::HTS,4.735578953209427,0.029966676925444986,Pancreatic Adenocarcinoma,FERb-033,EGFR inhibitor,ERBB2
Pancreatic Adenocarcinoma,BRD-K61691541-001-01-1::2.5::HTS,8.524182706033676,0.0036463544973728756,Other Types,PF-03084014,gamma secretase inhibitor,
Pancreatic Adenocarcinoma,BRD-K62200014-003-10-5::2.5::HTS,7.867993318401625,0.005209410041095587,Pancreatic Adenocarcinoma,anagrelide,phosphodiesterase inhibitor,PDE3A
Pancreatic Adenocarcinoma,BRD-K62427771-001-01-0::2.5::HTS,4.271933928871346,0.039210807343668046,Pancreatic Adenocarcinoma,AS-77,potassium channel blocker,"KCNA3, KCNA5, KCNN4"
Pancreatic Adenocarcinoma,BRD-K62627508-001-01-5::2.5::HTS,10.7588860568531,0.0011022909719728543,Pancreatic Adenocarcinoma,idasanutlin,MDM inhibitor,"MDM2, TP53"
Pancreatic Adenocarcinoma,BRD-K62696033-001-01-4::2.5::HTS,8.528684613324952,0.0036369720475188964,Pancreatic Adenocarcinoma,G-1,G protein-coupled receptor agonist,GPER1
Pancreatic Adenocarcinoma,BRD-K62965247-001-04-9::2.5::HTS,6.834267434943962,0.009184512519286068,Pancreatic Adenocarcinoma,tipifarnib,farnesyltransferase inhibitor,"FNTA, FNTB"
Pancreatic Adenocarcinoma,BRD-K63126190-003-01-6::2.5::HTS,9.108144301373692,0.0026639213170411864,Other Types,epinephrine,"adrenergic receptor agonist, neurotransmitter","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF"
Pancreatic Adenocarcinoma,BRD-K63516691-003-02-0::2.5::HTS,4.96390071084383,0.026282463986935536,Other Types,T-0156,phosphodiesterase inhibitor,PDE5A
Pancreatic Adenocarcinoma,BRD-K63630713-001-25-8::2.5::HTS,8.288636402929146,0.004142669671392895,Pancreatic Adenocarcinoma,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,"ATP1A1, SLC12A1"
Pancreatic Adenocarcinoma,BRD-K63712959-001-01-8::2.5::HTS,4.550340488190762,0.0333486402634507,Pancreatic Adenocarcinoma,temoporfin,radical formation stimulant,
Pancreatic Adenocarcinoma,BRD-K63874012-001-02-9::2.5::HTS,5.210694185056045,0.022821020714950808,Pancreatic Adenocarcinoma,thioperamide,histamine receptor antagonist,"HRH3, HRH4"
Pancreatic Adenocarcinoma,BRD-K64538373-001-01-4::2.5::HTS,13.42731940235768,0.0002716870395286908,Other Types,Ro-4987655,MEK inhibitor,MAP2K1
Pancreatic Adenocarcinoma,BRD-K64716392-001-01-3::2.5::HTS,4.933411705944218,0.026742158852688904,Other Types,nedocromil,histamine receptor antagonist,"CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR"
Pancreatic Adenocarcinoma,BRD-K64866502-001-03-9::2.5::HTS,6.413083368599172,0.011603277126810092,Pancreatic Adenocarcinoma,CYC116,Aurora kinase inhibitor,"AURKA, AURKB, KDR"
Pancreatic Adenocarcinoma,BRD-K64925568-001-01-8::2.5::HTS,16.47632970095746,5.6312032532789904e-05,Pancreatic Adenocarcinoma,AMG-232,MDM inhibitor,MDM2
Pancreatic Adenocarcinoma,BRD-K65814004-003-02-9::2.5::HTS,11.806225720202123,0.0006345921975777128,Pancreatic Adenocarcinoma,diphenyleneiodonium,nitric oxide synthase inhibitor,"NOS2, NOS3"
Pancreatic Adenocarcinoma,BRD-K65924316-001-03-1::2.5::HTS,4.216618410980062,0.04049877248417595,Pancreatic Adenocarcinoma,serdemetan,MDM inhibitor,MDM2
Pancreatic Adenocarcinoma,BRD-K65928735-001-04-3::2.5::HTS,4.6149165427415255,0.03212558597748242,Pancreatic Adenocarcinoma,AZD1480,JAK inhibitor,"JAK1, JAK2, JAK3"
Pancreatic Adenocarcinoma,BRD-K66353228-001-14-6::2.5::HTS,5.877131747549974,0.015655456145312364,Other Types,zoxazolamine,myorelaxant,
Pancreatic Adenocarcinoma,BRD-K66465025-001-05-1::2.5::HTS,4.119744957265279,0.042860301672776095,Other Types,ACPC,glutamate receptor antagonist,
Pancreatic Adenocarcinoma,BRD-K67277431-002-10-5::2.5::HTS,5.431305284435319,0.020139565534708682,Pancreatic Adenocarcinoma,picotamide,"thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXA2R
Pancreatic Adenocarcinoma,BRD-K68095457-001-10-1::2.5::HTS,8.225748885704828,0.004287346515377373,Other Types,palmitoylethanolamide,cannabinoid receptor agonist,"CNR2, GPR119, GPR55"
Pancreatic Adenocarcinoma,BRD-K68553471-003-12-3::2.5::HTS,5.319659942222576,0.021452272959681544,Other Types,todralazine,antihypertensive agent,
Pancreatic Adenocarcinoma,BRD-K69726342-238-02-4::2.5::HTS,4.391786577855412,0.03656082813272252,Pancreatic Adenocarcinoma,atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR"
Pancreatic Adenocarcinoma,BRD-K70401845-003-09-6::2.5::HTS,4.394409941030526,0.0365050754823116,Pancreatic Adenocarcinoma,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Pancreatic Adenocarcinoma,BRD-K70402238-001-02-8::2.5::HTS,10.60920055973819,0.0011934873833191384,Pancreatic Adenocarcinoma,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Pancreatic Adenocarcinoma,BRD-K71103788-003-12-0::2.5::HTS,4.493323679988419,0.03447147649263565,Other Types,duloxetine,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4"
Pancreatic Adenocarcinoma,BRD-K71823332-001-03-7::2.5::HTS,4.355435638010764,0.03734754021270164,Pancreatic Adenocarcinoma,epothilone-a,microtubule stabilizing agent,
Pancreatic Adenocarcinoma,BRD-K72723676-003-17-8::2.5::HTS,5.048237146249415,0.025041820307214458,Pancreatic Adenocarcinoma,benzethonium,sodium channel blocker,SCN10A
Pancreatic Adenocarcinoma,BRD-K72827473-001-01-0::2.5::HTS,6.109198257034858,0.013744268336310296,Other Types,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Pancreatic Adenocarcinoma,BRD-K72951360-001-01-4::2.5::HTS,7.294140163462642,0.007129662528503224,Pancreatic Adenocarcinoma,valrubicin,"DNA inhibitor, topoisomerase inhibitor",TOP2A
Pancreatic Adenocarcinoma,BRD-K74057757-001-01-9::2.5::HTS,6.281299858025807,0.012483249914075487,Pancreatic Adenocarcinoma,indibulin,tubulin polymerization inhibitor,
Pancreatic Adenocarcinoma,BRD-K75295174-001-05-0::2.5::HTS,4.914589450303447,0.027041239314482223,Pancreatic Adenocarcinoma,alisertib,Aurora kinase inhibitor,AURKA
Pancreatic Adenocarcinoma,BRD-K76180386-001-01-6::2.5::HTS,4.138695438847603,0.04238495577473979,Pancreatic Adenocarcinoma,JIB04,histone lysine demethylase inhibitor,KDM4E
Pancreatic Adenocarcinoma,BRD-K76304753-003-20-3::2.5::HTS,5.05154874129119,0.02500827089837005,Pancreatic Adenocarcinoma,phenazopyridine,local anesthetic,SCN1A
Pancreatic Adenocarcinoma,BRD-K76568384-001-02-2::2.5::HTS,4.140738995463331,0.04233675572525596,Pancreatic Adenocarcinoma,PHTPP,estrogen receptor antagonist,ESR2
Pancreatic Adenocarcinoma,BRD-K76674262-001-03-3::2.5::HTS,7.046823392408823,0.008165607616839978,Pancreatic Adenocarcinoma,homoharringtonine,protein synthesis inhibitor,RPL3
Pancreatic Adenocarcinoma,BRD-K76845197-001-05-4::2.5::HTS,7.096514185746295,0.00794705367547533,Other Types,sulfanitran,,
Pancreatic Adenocarcinoma,BRD-K77484724-001-02-0::2.5::HTS,5.382757374561931,0.02070925772239719,Other Types,adefovir,DNA polymerase inhibitor,
Pancreatic Adenocarcinoma,BRD-K77685957-300-09-1::2.5::HTS,6.136683781744808,0.013542128404920275,Pancreatic Adenocarcinoma,dequalinium,PKC inhibitor,"KCNN1, KCNN3"
Pancreatic Adenocarcinoma,BRD-K77908580-001-09-6::2.5::HTS,12.562947819425405,0.00042634728038787865,Pancreatic Adenocarcinoma,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9"
Pancreatic Adenocarcinoma,BRD-K77987382-001-13-2::2.5::HTS,5.422269903723392,0.020235249146104826,Pancreatic Adenocarcinoma,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Pancreatic Adenocarcinoma,BRD-K78010432-001-21-5::2.5::HTS,4.497280144376215,0.03439407593404756,Pancreatic Adenocarcinoma,furosemide,diuretic,"CA2, GPR35, SLC12A1, SLC12A2"
Pancreatic Adenocarcinoma,BRD-K78455053-001-01-2::2.5::HTS,4.082473285634049,0.04380398003742226,Pancreatic Adenocarcinoma,wnt-c59,porcupine inhibitor,PORCN
Pancreatic Adenocarcinoma,BRD-K78567475-001-01-4::2.5::HTS,10.135053877443907,0.0015367233834992042,Pancreatic Adenocarcinoma,dolastatin-10,tubulin polymerization inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K79239947-001-06-8::2.5::HTS,3.9368459514263665,0.04773228302455969,Pancreatic Adenocarcinoma,PF-573228,focal adhesion kinase inhibitor,"CDK1, CDK2, CDK7, GSK3B, IKBKB"
Pancreatic Adenocarcinoma,BRD-K79584249-001-01-3::2.5::HTS,6.691759261625374,0.009939696049560146,Pancreatic Adenocarcinoma,CGM097,MDM inhibitor,MDM2
Pancreatic Adenocarcinoma,BRD-K79612754-001-19-1::2.62::HTS,4.154819441109972,0.04201393010968331,Pancreatic Adenocarcinoma,inosine,neurotrophic agent,"PARP1, PNP"
Pancreatic Adenocarcinoma,BRD-K80431395-001-07-3::2.49::HTS,4.483414687368722,0.0346921361339427,Other Types,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Pancreatic Adenocarcinoma,BRD-K80431395-001-09-9::2.5::HTS,4.971905540935047,0.026182751028037483,Other Types,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Pancreatic Adenocarcinoma,BRD-K81128206-003-24-4::2.5::HTS,3.871070227283885,0.04961654524184831,Other Types,edrophonium,acetylcholinesterase inhibitor,"ACHE, BCHE"
Pancreatic Adenocarcinoma,BRD-K81197548-003-01-4::2.5::HTS,5.247173682478271,0.02235447506330844,Pancreatic Adenocarcinoma,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Pancreatic Adenocarcinoma,BRD-K81330143-001-04-8::2.38::HTS,5.2428010352917935,0.02243140211714528,Pancreatic Adenocarcinoma,tideglusib,glycogen synthase kinase inhibitor,GSK3B
Pancreatic Adenocarcinoma,BRD-K81418486-001-47-5::2.5::HTS,5.639550400305688,0.01791603949865719,Pancreatic Adenocarcinoma,vorinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9"
Pancreatic Adenocarcinoma,BRD-K82244583-001-01-3::2.5::HTS,12.962762859751317,0.0003470848287665329,Other Types,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Pancreatic Adenocarcinoma,BRD-K82522873-001-01-1::2.5::HTS,4.74601003558586,0.029793298639377883,Pancreatic Adenocarcinoma,N6022,alcohol dehydrogenase inhibitor,ADH5
Pancreatic Adenocarcinoma,BRD-K84937637-001-09-9::2.5::HTS,4.307510719799086,0.03842798770050659,Pancreatic Adenocarcinoma,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Pancreatic Adenocarcinoma,BRD-K85119730-001-28-9::2.5::HTS,6.374946435199039,0.011856369443676212,Other Types,tolbutamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ11, KCNJ8"
Pancreatic Adenocarcinoma,BRD-K85402309-001-06-6::2.5::HTS,7.6166434506911385,0.005974613551949313,Pancreatic Adenocarcinoma,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Pancreatic Adenocarcinoma,BRD-K85751432-001-03-3::2.5::HTS,13.43481215782042,0.00027112054945695337,Other Types,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Pancreatic Adenocarcinoma,BRD-K86003836-001-10-5::2.5::HTS,4.256544516170581,0.03956140771339152,Pancreatic Adenocarcinoma,flubendazole,tubulin polymerization inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K86797399-001-04-4::2.5::HTS,9.600576828295738,0.0020465982264313756,Pancreatic Adenocarcinoma,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Pancreatic Adenocarcinoma,BRD-K86930074-001-05-0::2.5::HTS,6.475529261454697,0.011211108557883962,Pancreatic Adenocarcinoma,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Pancreatic Adenocarcinoma,BRD-K87112191-001-04-5::2.5::HTS,6.0003779357321845,0.01460802746848561,Pancreatic Adenocarcinoma,PP242,mTOR inhibitor,"MTOR, PASK"
Pancreatic Adenocarcinoma,BRD-K87827419-001-16-8::2.5::HTS,4.9213648805857595,0.02693711957679175,Pancreatic Adenocarcinoma,melphalan,"DNA alkylating agent, DNA inhibitor",
Pancreatic Adenocarcinoma,BRD-K88544581-001-06-1::2.5::HTS,5.373071399989489,0.02080805766454865,Pancreatic Adenocarcinoma,CI-976,ACAT inhibitor,"ACAT1, CES1"
Pancreatic Adenocarcinoma,BRD-K88560311-011-06-3::2.5::HTS,3.9694481361605467,0.0468232353817066,Pancreatic Adenocarcinoma,rucaparib,PARP inhibitor,"PARP1, PARP2"
Pancreatic Adenocarcinoma,BRD-K88677950-001-03-9::2.5::HTS,11.384711856610831,0.0007919302917560103,Other Types,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Pancreatic Adenocarcinoma,BRD-K88807631-001-01-3::2.5::HTS,5.986704518120557,0.014722111995417998,Pancreatic Adenocarcinoma,elacridar,P glycoprotein inhibitor,ABCB1
Pancreatic Adenocarcinoma,BRD-K89014967-001-04-3::2.5::HTS,12.467768535366377,0.0004483142920822966,Other Types,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Pancreatic Adenocarcinoma,BRD-K89208535-051-01-5::2.5::HTS,4.4807534918394225,0.0347197802951596,Other Types,indacaterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Pancreatic Adenocarcinoma,BRD-K89561498-001-01-7::2.5::HTS,4.7206992651096416,0.030222485048986378,Pancreatic Adenocarcinoma,SN-38,topoisomerase inhibitor,TOP1
Pancreatic Adenocarcinoma,BRD-K89714990-001-01-5::2.5::HTS,8.337177335536516,0.004034761084942297,Pancreatic Adenocarcinoma,tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5
Pancreatic Adenocarcinoma,BRD-K90630139-003-05-9::2.5::HTS,19.115109978551036,1.4739382705249467e-05,Other Types,butenafine,fungal squalene epoxidase inhibitor,SQLE
Pancreatic Adenocarcinoma,BRD-K90647725-001-07-3::2.5::HTS,4.260085083308647,0.03950780693754393,Pancreatic Adenocarcinoma,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
Pancreatic Adenocarcinoma,BRD-K91370081-001-25-1::2.5::HTS,9.601836613101861,0.0020424366037962893,Pancreatic Adenocarcinoma,anisomycin,DNA synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Pancreatic Adenocarcinoma,BRD-K91544578-001-03-8::2.5::HTS,5.581317429420295,0.018493438161996154,Other Types,nikethamide,immunostimulant,
Pancreatic Adenocarcinoma,BRD-K91623615-001-05-0::2.46::HTS,10.600670143278734,0.0012029939276615221,Pancreatic Adenocarcinoma,ABT-751,tubulin polymerization inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K92049597-001-20-8::2.5::HTS,4.6675733798135886,0.031161534190146903,Pancreatic Adenocarcinoma,triamterene,sodium channel blocker,"SCNN1A, SCNN1B, SCNN1D, SCNN1G"
Pancreatic Adenocarcinoma,BRD-K92213669-001-01-3::2.5::HTS,3.990212139356713,0.046292908661891334,Pancreatic Adenocarcinoma,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP
Pancreatic Adenocarcinoma,BRD-K92731339-227-04-9::2.5::HTS,11.455353766000178,0.0007630634901579753,Pancreatic Adenocarcinoma,perindopril,angiotensin converting enzyme inhibitor,ACE
Pancreatic Adenocarcinoma,BRD-K92760278-001-07-3::2.43::HTS,5.6016949897885535,0.0183029387459381,Other Types,riboflavin,vitamin B2,"BLVRB, RFK"
Pancreatic Adenocarcinoma,BRD-K94455792-001-01-8::2.5::HTS,4.695740130782816,0.03065986527063338,Pancreatic Adenocarcinoma,ICG-001,beta-catenin inhibitor,CTNNB1
Pancreatic Adenocarcinoma,BRD-K94720315-001-10-4::2.5::HTS,5.321686409480244,0.021427582969954735,Pancreatic Adenocarcinoma,chromocarb,antispasmodic,
Pancreatic Adenocarcinoma,BRD-K95523387-001-09-6::2.5::HTS,6.9692963551659695,0.008523585721668482,Pancreatic Adenocarcinoma,OLDA,TRPV agonist,GPR119
Pancreatic Adenocarcinoma,BRD-K96055017-003-02-7::2.5::HTS,3.9779658390902375,0.04658179070024918,Other Types,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,
Pancreatic Adenocarcinoma,BRD-K96233303-001-01-9::2.5::HTS,4.333281645933255,0.037827714374814296,Pancreatic Adenocarcinoma,TMS,,
Pancreatic Adenocarcinoma,BRD-K96259238-001-01-4::2.5::HTS,4.072489359708865,0.04406418304315779,Pancreatic Adenocarcinoma,Y-320,interleukin inhibitor,IL17A
Pancreatic Adenocarcinoma,BRD-K97365803-001-02-1::2.5::HTS,17.012602797960398,4.286560769238417e-05,Other Types,PI-828,PI3K inhibitor,
Pancreatic Adenocarcinoma,BRD-K97440753-066-18-1::2.5::HTS,5.600198450229738,0.01829656655179103,Other Types,dihydroergocristine,"adrenergic receptor antagonist, prolactin inhibitor","ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
Pancreatic Adenocarcinoma,BRD-K97810537-001-13-6::2.5::HTS,3.9768571993632857,0.04663285105281168,Other Types,beclomethasone-dipropionate,glucocorticoid receptor agonist,"GPR97, NR3C1"
Pancreatic Adenocarcinoma,BRD-K98155362-001-07-7::2.5::HTS,6.023309769860944,0.014425872169384957,Pancreatic Adenocarcinoma,GR46611,serotonin receptor agonist,HTR1D
Pancreatic Adenocarcinoma,BRD-K98384930-003-01-5::2.5::HTS,14.13622116572233,0.00018810642051754294,Pancreatic Adenocarcinoma,finafloxacin,bacterial DNA gyrase inhibitor,
Pancreatic Adenocarcinoma,BRD-K98530306-003-18-3::2.5::HTS,4.271629609064097,0.03921444384119369,Other Types,clonidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Pancreatic Adenocarcinoma,BRD-K99023089-001-03-7::2.5::HTS,8.435793566667783,0.003824537515697372,Pancreatic Adenocarcinoma,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Pancreatic Adenocarcinoma,BRD-K99170882-001-04-3::2.5::HTS,13.579587435587289,0.00025095583062554743,Pancreatic Adenocarcinoma,NSC-319726,p53 activator,
Pancreatic Adenocarcinoma,BRD-K99498722-001-02-6::2.5::HTS,5.991626296414648,0.014683210481359234,Pancreatic Adenocarcinoma,plinabulin,tubulin polymerization inhibitor,
Pancreatic Adenocarcinoma,BRD-K99615199-001-18-5::2.5::HTS,10.219688326313339,0.0014681448437726034,Other Types,medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR"
Pancreatic Adenocarcinoma,BRD-K99749624-001-07-0::2.5::HTS,5.263610941335168,0.02214567073322061,Pancreatic Adenocarcinoma,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Pancreatic Adenocarcinoma,BRD-M54096567-001-01-9::2.5::HTS,3.962159559037554,0.047049054825437225,Pancreatic Adenocarcinoma,sodium-gluconate,,
Pancreatic Adenocarcinoma,BRD-A00842753-001-01-9::2.5::MTS004,4.811588026891953,0.028696101453955836,Pancreatic Adenocarcinoma,oleuropein,estrogen receptor agonist,GPER1
Pancreatic Adenocarcinoma,BRD-A04971881-003-01-3::2.65294603::MTS004,4.656440447243674,0.031379112162653225,Pancreatic Adenocarcinoma,cloranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Pancreatic Adenocarcinoma,BRD-A14577621-001-01-5::2.5::MTS004,6.758601539308321,0.009585927752490137,Pancreatic Adenocarcinoma,peficitinib,JAK inhibitor,"JAK1, JAK2, JAK3"
Pancreatic Adenocarcinoma,BRD-A18992208-003-02-7::2.5::MTS004,5.29985659923317,0.021707433016146783,Other Types,lercanidipine,calcium channel blocker,"CACNA2D1, CACNG1"
Pancreatic Adenocarcinoma,BRD-A44181516-001-01-8::2.666476303::MTS004,8.08592370202204,0.004630662025979883,Pancreatic Adenocarcinoma,flumecinol,,
Pancreatic Adenocarcinoma,BRD-A59961917-001-01-0::2.5::MTS004,4.159211185481226,0.04189675728138088,Pancreatic Adenocarcinoma,BQ-123,endothelin receptor antagonist,EDNRA
Pancreatic Adenocarcinoma,BRD-A60498477-001-01-2::2.508127434::MTS004,5.5186738802823925,0.019175215411546338,Pancreatic Adenocarcinoma,tolamolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Pancreatic Adenocarcinoma,BRD-K00634421-001-01-0::2.500042819::MTS004,4.169316627808648,0.04164955974226943,Pancreatic Adenocarcinoma,brivaracetam,voltage-gated sodium channel blocker,SV2A
Pancreatic Adenocarcinoma,BRD-K01638814-011-01-4::2.587084236::MTS004,5.256008767593078,0.02225618398213391,Pancreatic Adenocarcinoma,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A
Pancreatic Adenocarcinoma,BRD-K02750403-001-01-4::2.499962046::MTS004,4.302334000815962,0.03853512517805955,Pancreatic Adenocarcinoma,piboserod,serotonin receptor antagonist,"HTR2B, HTR4"
Pancreatic Adenocarcinoma,BRD-K04701033-001-04-7::2.499987566::MTS004,5.288040812268928,0.021853718869557736,Pancreatic Adenocarcinoma,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Pancreatic Adenocarcinoma,BRD-K06519765-001-01-1::2.5::MTS004,10.425277680523859,0.0013186909501539715,Pancreatic Adenocarcinoma,vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1"
Pancreatic Adenocarcinoma,BRD-K07625016-001-01-2::2.50703254::MTS004,3.9199105115379784,0.04822656144047966,Other Types,norethisterone-enanthate,contraceptive agent,
Pancreatic Adenocarcinoma,BRD-K11463116-304-03-5::2.500052374::MTS004,4.351983656143979,0.0374354238036611,Other Types,eprodisate,"antiamyloidogenic agent, amyloid protein inhibitor",SAA1
Pancreatic Adenocarcinoma,BRD-K14658796-003-01-6::2.368766292::MTS004,6.026009551846766,0.014412100590853592,Other Types,drotaverine,phosphodiesterase inhibitor,"CACNA1C, PDE4A"
Pancreatic Adenocarcinoma,BRD-K15327298-001-05-5::2.444207768::MTS004,6.989576184624136,0.008439134119711747,Pancreatic Adenocarcinoma,fmoc-l-leucine,PPAR receptor agonist,
Pancreatic Adenocarcinoma,BRD-K15360631-325-01-4::2.404560312::MTS004,6.785750356331839,0.009443037566336748,Pancreatic Adenocarcinoma,dehydroepiandrosterone-sulfate,"androgen receptor agonist, estrogen receptor agonist","AR, ESR1, ESR2"
Pancreatic Adenocarcinoma,BRD-K16180792-001-01-7::2.5::MTS004,5.81221676795755,0.016248810711038956,Pancreatic Adenocarcinoma,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Pancreatic Adenocarcinoma,BRD-K18878288-001-06-4::2.457947881::MTS004,4.343270445119234,0.037625850880498087,Other Types,schisandrol-b,lipid peroxidase inhibitor,
Pancreatic Adenocarcinoma,BRD-K25146005-001-01-0::2.5::MTS004,6.280873226742202,0.01249828492130676,Other Types,cis-urocanic acid,serotonin receptor agonist,HTR2A
Pancreatic Adenocarcinoma,BRD-K27293958-001-01-5::2.450321909::MTS004,4.287419914959297,0.0388717814780116,Pancreatic Adenocarcinoma,tiaramide,anti-inflammatory agent,
Pancreatic Adenocarcinoma,BRD-K28537285-001-01-8::2.499968715::MTS004,10.910762314151574,0.0010195067766386827,Pancreatic Adenocarcinoma,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Pancreatic Adenocarcinoma,BRD-K32842773-434-01-8::2.5::MTS004,4.50626648214271,0.03422605624628003,Pancreatic Adenocarcinoma,pemetrexed,"dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS"
Pancreatic Adenocarcinoma,BRD-K33133047-001-01-8::2.5::MTS004,4.088952426292425,0.043658756495479296,Pancreatic Adenocarcinoma,dapiprazole,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Pancreatic Adenocarcinoma,BRD-K42673188-001-01-1::2.363355746::MTS004,7.280446738385545,0.007189446936335049,Pancreatic Adenocarcinoma,verubulin,tubulin polymerization inhibitor,TUBB
Pancreatic Adenocarcinoma,BRD-K46843573-001-01-9::2.5::MTS004,4.854775195038375,0.027991932891562668,Pancreatic Adenocarcinoma,zotarolimus,mTOR inhibitor,FKBP1A
Pancreatic Adenocarcinoma,BRD-K49659468-436-01-2::2.500002467::MTS004,4.237274207480723,0.04002570394012828,Pancreatic Adenocarcinoma,TMC647055,RNA polymerase inhibitor,
Pancreatic Adenocarcinoma,BRD-K56807945-001-01-2::2.500001454::MTS004,4.31503782915768,0.038249899112755587,Other Types,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,"EGLN1, EGLN2, HIF1A"
Pancreatic Adenocarcinoma,BRD-K59256312-066-15-7::2.431061328::MTS004,5.356548064953938,0.02102027504840748,Other Types,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Pancreatic Adenocarcinoma,BRD-K59753975-001-02-6::2.5::MTS004,5.232627047873537,0.02255356421210891,Pancreatic Adenocarcinoma,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Pancreatic Adenocarcinoma,BRD-K59866480-001-07-3::2.379655165::MTS004,4.705619396957083,0.030500538325579075,Other Types,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Pancreatic Adenocarcinoma,BRD-K60241851-001-11-9::2.5::MTS004,4.237285468694162,0.040025440589685615,Pancreatic Adenocarcinoma,isodibut,aldehyde reductase inhibitor,
Pancreatic Adenocarcinoma,BRD-K60421517-001-01-4::2.499975038::MTS004,7.943078464117973,0.005004816320027699,Pancreatic Adenocarcinoma,olmutinib,"EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR"
Pancreatic Adenocarcinoma,BRD-K64120610-001-01-4::2.5::MTS004,4.761764741443535,0.02952974908656322,Pancreatic Adenocarcinoma,vinflunine,microtubule inhibitor,
Pancreatic Adenocarcinoma,BRD-K65900713-003-01-0::2.686421113::MTS004,6.5227695418915514,0.010924680806062945,Pancreatic Adenocarcinoma,caroverine,"glutamate receptor antagonist, calcium channel blocker",
Pancreatic Adenocarcinoma,BRD-K70330032-001-01-1::2.50000853::MTS004,4.744486053201831,0.029825020610570747,Other Types,JNJ-42165279,FAAH inhibitor,FAAH
Pancreatic Adenocarcinoma,BRD-K72264770-001-03-2::2.5::MTS004,5.246467838596216,0.02237732649701923,Pancreatic Adenocarcinoma,BRD4770,histone lysine methyltransferase inhibitor,EHMT2
Pancreatic Adenocarcinoma,BRD-K72533376-001-01-2::2.5::MTS004,7.034940830769358,0.008229410930220065,Pancreatic Adenocarcinoma,etoposide-phosphate,topoisomerase inhibitor,TOP2A
Pancreatic Adenocarcinoma,BRD-K74236984-001-04-8::2.5::MTS004,6.383158610582005,0.011806486133110574,Pancreatic Adenocarcinoma,UNC0321,histone lysine methyltransferase inhibitor,EHMT2
Pancreatic Adenocarcinoma,BRD-K76634210-001-12-1::2.5::MTS004,5.766651133338467,0.016671394784738214,Pancreatic Adenocarcinoma,idoxuridine,DNA directed DNA polymerase inhibitor,
Pancreatic Adenocarcinoma,BRD-K78666663-001-01-6::2.499978008::MTS004,7.7301884848285685,0.005620690722208734,Pancreatic Adenocarcinoma,lemborexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Pancreatic Adenocarcinoma,BRD-K82908348-001-01-9::2.434467427::MTS004,5.812248523956731,0.0162485205226963,Other Types,darglitazone,PPAR receptor antagonist,PPARG
Pancreatic Adenocarcinoma,BRD-K83029223-001-01-3::2.500025378::MTS004,6.001376637859439,0.014612377566819448,Pancreatic Adenocarcinoma,litronesib,kinesin-like spindle protein inhibitor,KIF11
Pancreatic Adenocarcinoma,BRD-K92581468-001-01-6::2.389082227::MTS004,5.042800890413508,0.025132885659067405,Other Types,ocinaplon,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5"
Pancreatic Adenocarcinoma,BRD-K99431849-001-01-7::2.500018158::MTS004,4.428166648403562,0.03581294225873783,Pancreatic Adenocarcinoma,peretinoin,retinoid receptor agonist,RXRA
Diffuse Glioma,BRD-A00578795-001-04-3::2.5::HTS,5.221080339018819,0.022686400504966054,Other Types,zaltoprofen,cyclooxygenase inhibitor,
Diffuse Glioma,BRD-A00827783-001-24-6::2.5::HTS,10.157262105738903,0.0015179137033664368,Other Types,dyphylline,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B"
Diffuse Glioma,BRD-A01098288-001-02-9::2.5::HTS,4.781225951731094,0.02919532247323297,Other Types,azelnidipine,calcium channel blocker,CACNA1C
Diffuse Glioma,BRD-A01907367-001-01-7::2.5::HTS,4.223186576416787,0.040341011604334044,Other Types,FK-33-824,opioid receptor agonist,OPRM1
Diffuse Glioma,BRD-A03932035-004-04-3::2.5::HTS,5.597582216603989,0.01833811654751388,Other Types,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Diffuse Glioma,BRD-A04322457-003-17-9::2.5::HTS,8.08694018822437,0.004622269388207453,Other Types,isoprenaline,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3"
Diffuse Glioma,BRD-A05523972-001-01-5::2.5::HTS,4.305117095698493,0.038456428489379864,Other Types,telmesteine,mucolytic agent,
Diffuse Glioma,BRD-A06352418-001-25-9::2.5::HTS,6.095156348431974,0.013864332320216692,Diffuse Glioma,terfenadine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2"
Diffuse Glioma,BRD-A07232941-001-02-7::2.5::HTS,4.27333457823063,0.03917625841095086,Other Types,8-M-PDOT,melatonin receptor agonist,"MTNR1A, MTNR1B"
Diffuse Glioma,BRD-A08545410-003-08-6::2.5::HTS,5.61137882892889,0.0181813672093193,Other Types,doxycycline,metalloproteinase inhibitor,MMP8
Diffuse Glioma,BRD-A09349126-001-10-7::2.5::HTS,7.158538313412441,0.007688068647947964,Other Types,norethindrone-acetate,progesterone receptor agonist,
Diffuse Glioma,BRD-A09370961-001-01-0::2.5::HTS,5.463056199892779,0.019787778599182886,Other Types,ioxilan,radiopaque medium,
Diffuse Glioma,BRD-A09467419-003-22-4::2.5::HTS,4.561181802664838,0.03315451498164736,Other Types,mebeverine,acetylcholine receptor antagonist,CHRM1
Diffuse Glioma,BRD-A09722536-002-18-0::2.5::HTS,8.102646033796741,0.004582965982890278,Other Types,cyclophosphamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Diffuse Glioma,BRD-A10523515-001-07-9::2.5::HTS,4.229078858229128,0.040202285932228896,Other Types,GSK429286A,rho associated kinase inhibitor,ROCK1
Diffuse Glioma,BRD-A10652366-238-04-1::2.5::HTS,5.923178869817416,0.015273591705044696,Other Types,fosfomycin,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-A11776908-065-01-5::2.5::HTS,6.871477292154287,0.008997104617398772,Other Types,enilconazole,sterol demethylase inhibitor,"CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2"
Diffuse Glioma,BRD-A12230535-001-06-7::2.5::HTS,4.783194319924538,0.02916778163191725,Other Types,nutlin-3,MDM inhibitor,"MDM2, TP53"
Diffuse Glioma,BRD-A12454076-001-01-9::2.5::HTS,4.981557473701792,0.02603847533774574,Other Types,L-Hydroxyproline,,
Diffuse Glioma,BRD-A12994259-001-02-1::2.5::HTS,4.263931313153874,0.03940738914641899,Diffuse Glioma,pomalidomide,"angiogenesis inhibitor, tumor necrosis factor production inhibitor","CRBN, PTGS2, TNF"
Diffuse Glioma,BRD-A15297126-001-04-3::2.5::HTS,4.484118110248941,0.03466844654778422,Diffuse Glioma,fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-A15909516-001-06-6::2.5::HTS,8.878723278230222,0.003010289120426247,Other Types,rebamipide,free radical scavenger,FPR1
Diffuse Glioma,BRD-A15931911-001-03-8::2.5::HTS,7.703348229738,0.005696398569934363,Other Types,bucladesine,"adenosine receptor agonist, cAMP stimulant",PRKACA
Diffuse Glioma,BRD-A18056626-003-22-3::2.5::HTS,5.8969133127739735,0.01548300323474766,Other Types,methacholine,acetylcholine receptor agonist,"CHRM2, CHRM3, CHRM4"
Diffuse Glioma,BRD-A18763547-300-05-5::2.5::HTS,4.418470498554208,0.03600028135310203,Diffuse Glioma,BAX-channel-blocker,cytochrome C release inhibitor,BAX
Diffuse Glioma,BRD-A19736161-001-06-7::2.5::HTS,4.441759691741294,0.03551239626745261,Other Types,ondansetron,serotonin receptor antagonist,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1"
Diffuse Glioma,BRD-A19958636-065-04-4::2.5::HTS,4.344809134174664,0.037576934614325014,Other Types,tuaminoheptane,,
Diffuse Glioma,BRD-A20644369-001-08-6::2.5::HTS,4.610542198567067,0.03220615947732834,Diffuse Glioma,canrenone,mineralocorticoid receptor antagonist,NR3C2
Diffuse Glioma,BRD-A20781140-001-01-7::2.5::HTS,8.929034918664758,0.0029329536598795974,Other Types,plovamer-acetate,,"TAT, TH, YARS, YARS2"
Diffuse Glioma,BRD-A22256192-003-22-7::2.5::HTS,7.254860764765615,0.007282875789588209,Other Types,terazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7"
Diffuse Glioma,BRD-A22707317-001-10-8::2.5::HTS,8.007531936774335,0.004825416303582213,Diffuse Glioma,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Diffuse Glioma,BRD-A23072235-050-18-5::2.5::HTS,5.775171073015584,0.016598712764332453,Other Types,pheniramine,histamine receptor antagonist,HRH1
Diffuse Glioma,BRD-A23359898-003-10-0::2.5::HTS,7.789483553416037,0.005435002867252283,Other Types,sibutramine,serotonin-norepinephrine reuptake inhibitor (SNRI),"SLC6A2, SLC6A3, SLC6A4"
Diffuse Glioma,BRD-A24228527-213-01-9::2.5::HTS,7.159718332476556,0.00767528112702816,Other Types,ofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Diffuse Glioma,BRD-A24560335-300-01-2::2.5::HTS,4.2180135682550235,0.04046574602764735,Diffuse Glioma,efatutazone,PPAR receptor agonist,PPARG
Diffuse Glioma,BRD-A25569250-001-03-3::2.5::HTS,5.435515590248366,0.02008895081708831,Other Types,KI-16425,lysophosphatidic acid receptor antagonist,"LPAR1, LPAR3"
Diffuse Glioma,BRD-A27290375-330-01-1::2.5::HTS,3.9724272466349286,0.0467384452289608,Other Types,atropine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Diffuse Glioma,BRD-A28044053-001-01-7::2.5::HTS,4.351959999216108,0.037425700275138016,Other Types,arotinolol,adrenergic receptor antagonist,ADRB3
Diffuse Glioma,BRD-A29644307-050-17-0::2.5::HTS,5.491749897440927,0.019454027822031827,Diffuse Glioma,nomifensine,"dopamine uptake inhibitor, noradrenaline uptake inhibitor","DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3"
Diffuse Glioma,BRD-A29731977-001-04-5::2.5::HTS,5.852874425318083,0.015869783169752724,Diffuse Glioma,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Diffuse Glioma,BRD-A29734509-011-13-6::2.5::HTS,7.670732734996834,0.0057978319357197125,Other Types,disopyramide,sodium channel blocker,"CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A"
Diffuse Glioma,BRD-A31521121-001-26-4::2.5::HTS,3.9792283610331776,0.04660378875134112,Other Types,methocarbamol,muscle relaxant,CA1
Diffuse Glioma,BRD-A32597168-001-03-6::2.5::HTS,15.018540771492102,0.00011925197978606078,Other Types,letosteine,mucolytic agent,
Diffuse Glioma,BRD-A34716233-004-03-5::2.5::HTS,5.199307968862149,0.022972920373860027,Other Types,AMPA-(RS),glutamate receptor agonist,GRIN1
Diffuse Glioma,BRD-A36010170-001-04-0::2.5::HTS,7.301462619382939,0.00709990310107021,Diffuse Glioma,amcinonide,glucocorticoid receptor agonist,"ANXA1, NR3C1"
Diffuse Glioma,BRD-A36217750-001-16-3::2.5::HTS,6.864823745992068,0.009030680132925973,Other Types,sulfinpyrazone,uricosuric blocker,"ABCC1, ABCC2, FPR1, SLC22A12"
Diffuse Glioma,BRD-A37704979-001-10-7::2.5::HTS,7.026763910479781,0.008258458417878789,Diffuse Glioma,SB-203580,p38 MAPK inhibitor,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
Diffuse Glioma,BRD-A39255369-001-03-1::2.5::HTS,4.1345317282617895,0.04248770430889854,Other Types,DCPIB,"chloride channel blocker, gap junction modulator, glutamate inhibitor",SLC1A2
Diffuse Glioma,BRD-A41692738-001-07-6::2.5::HTS,4.502120766660533,0.034296057473781935,Other Types,TGX-221,PI3K inhibitor,"PIK3CB, PIK3CD"
Diffuse Glioma,BRD-A41714661-001-02-0::2.5::HTS,7.563809315073024,0.006149821880696094,Other Types,bilobalide,GABA receptor modulator,"GLRA1, GLRA2, GLRB, HTR3A, HTR3B"
Diffuse Glioma,BRD-A41774846-001-01-4::2.5::HTS,5.683190311899978,0.017459127723920106,Diffuse Glioma,algestone-acetophenide,,
Diffuse Glioma,BRD-A42167015-003-10-2::2.5::HTS,4.874557261282448,0.02766071320893341,Other Types,carteolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Diffuse Glioma,BRD-A44500574-001-01-8::2.5::HTS,4.79849153239851,0.028897648144880883,Diffuse Glioma,FLI-06,notch signaling inhibitor,
Diffuse Glioma,BRD-A46179541-311-02-0::2.5::HTS,4.863717166774276,0.02783861763520788,Other Types,doxapram,potassium channel blocker,"KCNK3, KCNK9"
Diffuse Glioma,BRD-A46186775-369-02-0::2.5::HTS,4.419561783352408,0.03597745251681205,Diffuse Glioma,hydrocortisone-phosphate,,"ANXA1, NOS2, NR3C1"
Diffuse Glioma,BRD-A46876182-003-02-8::2.5::HTS,6.062652261036798,0.014108166476917858,Other Types,levobunolol-(+/-),adrenergic receptor antagonist,
Diffuse Glioma,BRD-A47790386-001-03-6::2.61::HTS,4.927423451908309,0.026881506055534795,Other Types,balofloxacin,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-A48237631-001-04-8::2.5::HTS,4.195213827906276,0.041010747627687374,Diffuse Glioma,mitomycin-c,"DNA alkylating agent, DNA synthesis inhibitor",
Diffuse Glioma,BRD-A49035384-003-30-5::2.5::HTS,4.271248596368747,0.03923330553837672,Other Types,methacycline,protein synthesis inhibitor,
Diffuse Glioma,BRD-A49358627-001-14-6::2.5::HTS,5.47157874006436,0.019680698056420157,Diffuse Glioma,ciprofibrate,PPAR receptor agonist,PPARA
Diffuse Glioma,BRD-A50737080-001-03-0::2.5::HTS,6.942525700267253,0.008650882758867223,Diffuse Glioma,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR"
Diffuse Glioma,BRD-A51407134-001-01-9::2.5::HTS,6.333276447263801,0.012144563638321256,Other Types,2-octyldodecan-1-ol,,
Diffuse Glioma,BRD-A51571244-001-01-9::2.5::HTS,7.0931225767692085,0.007966452425746482,Diffuse Glioma,hypoestoxide,IKK inhibitor,"IKBKB, IL1B, TNF"
Diffuse Glioma,BRD-A51747092-003-03-0::2.5::HTS,4.1981982734008065,0.04093495197504829,Other Types,moprolol,adrenergic receptor antagonist,
Diffuse Glioma,BRD-A55464252-001-01-2::2.5::HTS,5.112318650085353,0.024150730397904357,Other Types,3-(4-methylbenzylidene)camphor,endocrine disruptor,
Diffuse Glioma,BRD-A56085258-001-01-8::2.5::HTS,4.468616412864068,0.03496441591492912,Diffuse Glioma,LGX818,RAF inhibitor,BRAF
Diffuse Glioma,BRD-A56152450-001-02-0::2.5::HTS,6.739501720110409,0.009692692590752817,Other Types,dimercaprol,chelating agent,
Diffuse Glioma,BRD-A56359832-001-11-1::2.5::HTS,8.334916881252788,0.004038626686352129,Other Types,zileuton,"leukotriene synthesis inhibitor, lipoxygenase inhibitor",ALOX5
Diffuse Glioma,BRD-A56371469-001-03-3::2.5::HTS,4.63082363456012,0.03182927744841345,Other Types,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1
Diffuse Glioma,BRD-A56675431-001-12-3::2.5::HTS,7.194320850476418,0.007530549672852293,Other Types,althiazide,diuretic,
Diffuse Glioma,BRD-A56987319-001-12-9::2.5::HTS,6.122579740149123,0.013641754078298684,Other Types,SQ-22536,adenylyl cyclase inhibitor,ADCY1
Diffuse Glioma,BRD-A57382968-001-29-0::2.5::HTS,8.115657125502501,0.004549208915570027,Diffuse Glioma,piroxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Diffuse Glioma,BRD-A57798112-001-03-7::2.5::HTS,14.210054777357712,0.00018094823132209944,Diffuse Glioma,PD-318088,MEK inhibitor,MAP2K1
Diffuse Glioma,BRD-A57886255-001-01-1::2.5::HTS,10.198214806283362,0.0014851698125221923,Other Types,golgicide-a,ARF inhibitor,GBF1
Diffuse Glioma,BRD-A57957888-001-08-0::2.5::HTS,4.757773139607915,0.029583721521946015,Other Types,citiolone,"lipotropic, mucolytic agent",
Diffuse Glioma,BRD-A59001851-001-02-1::2.5::HTS,4.248086481897641,0.03977369004208832,Other Types,ginkgolide-b,platelet activating factor receptor antagonist,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B"
Diffuse Glioma,BRD-A61221616-001-04-3::2.5::HTS,15.36263384559798,9.966916515087713e-05,Diffuse Glioma,medroxyprogesterone-acetate,progesterone receptor agonist,
Diffuse Glioma,BRD-A62057054-001-03-1::2.5::HTS,5.494380638970685,0.019426939911290752,Other Types,MDL-11939,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Diffuse Glioma,BRD-A62421304-004-18-9::2.5::HTS,4.8620156840183535,0.027862133828295704,Other Types,mepenzolate,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Diffuse Glioma,BRD-A64011898-001-01-0::2.5::HTS,4.889422363705179,0.027435283243086292,Other Types,androstenone,steroid,
Diffuse Glioma,BRD-A64227845-004-09-3::2.5::HTS,6.234990193203999,0.012810098033631437,Diffuse Glioma,SKF-77434,dopamine receptor agonist,DRD1
Diffuse Glioma,BRD-A66116161-001-02-3::2.5::HTS,4.749710859663974,0.029723688385994734,Other Types,AM-1241,cannabinoid receptor agonist,"CNR1, CNR2"
Diffuse Glioma,BRD-A67616246-001-07-9::2.5::HTS,5.561066447031505,0.01870883617288056,Diffuse Glioma,levomequitazine,histamine receptor antagonist,HRH1
Diffuse Glioma,BRD-A68083442-001-01-6::2.5::HTS,7.3854433151407095,0.0067819160678182795,Other Types,pranidipine,calcium channel blocker,CACNA1C
Diffuse Glioma,BRD-A68493689-001-01-9::2.5::HTS,5.367893330665024,0.02087450800241181,Diffuse Glioma,simeprevir,HCV inhibitor,"CYP1A2, CYP3A4"
Diffuse Glioma,BRD-A69815203-001-07-6::2.5::HTS,4.478031346549487,0.03481337207283908,Diffuse Glioma,cyclosporin-a,calcineurin inhibitor,PPP3CA
Diffuse Glioma,BRD-A70649075-008-30-8::2.5::HTS,6.156894925252435,0.013383510345746061,Diffuse Glioma,sulconazole,sterol demethylase inhibitor,
Diffuse Glioma,BRD-A72390365-001-15-2::2.5::HTS,3.9010456545168144,0.04874673619719063,Other Types,choline-alfoscerate,acetylcholine precursor,GM2A
Diffuse Glioma,BRD-A72703248-003-04-9::2.5::HTS,8.730208792068623,0.0032621235372744172,Diffuse Glioma,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Diffuse Glioma,BRD-A72711497-236-03-8::2.5::HTS,6.732449769769012,0.009715473502752116,Other Types,lasalocid,bacterial permeability inducer,
Diffuse Glioma,BRD-A73427433-240-01-3::2.5::HTS,4.616130969467066,0.03211743814365821,Other Types,adaprev,TGF beta receptor inhibitor,"IGF2R, M6PR"
Diffuse Glioma,BRD-A74391928-051-01-3::2.5::HTS,6.7498169614700165,0.009621607392512506,Other Types,ibutilide,potassium channel blocker,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6"
Diffuse Glioma,BRD-A75369945-001-01-2::2.5::HTS,6.349470475084494,0.012022691533905634,Other Types,vitamin-b12,,
Diffuse Glioma,BRD-A76672327-003-02-0::2.5::HTS,7.319761300082086,0.007033153456664358,Other Types,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,
Diffuse Glioma,BRD-A78341343-001-01-6::2.5::HTS,4.961224065537283,0.02631708213895289,Other Types,regadenoson,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Diffuse Glioma,BRD-A78377521-001-05-5::2.5::HTS,5.593771634139254,0.01836928319493086,Other Types,monastrol,kinesin inhibitor,KIF11
Diffuse Glioma,BRD-A78391468-001-02-8::2.5::HTS,5.289249240248358,0.021826359098662103,Diffuse Glioma,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-A78877355-001-03-0::2.5::HTS,6.49056009676347,0.011110026525487307,Other Types,nefopam,cyclooxygenase inhibitor,
Diffuse Glioma,BRD-A80871782-004-06-9::2.5::HTS,5.339643848804907,0.021206828851734666,Other Types,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1
Diffuse Glioma,BRD-A81233518-004-16-1::2.5::HTS,4.5944006944595825,0.03250665743231085,Other Types,glycopyrrolate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Diffuse Glioma,BRD-A81370665-001-03-6::2.5::HTS,8.617773499158135,0.003465159119998174,Diffuse Glioma,BI-D1870,ribosomal protein inhibitor,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6"
Diffuse Glioma,BRD-A83644949-236-01-6::2.5::HTS,9.900465625303395,0.0017424566135965966,Other Types,ardeparin,thrombin inhibitor,"SERPINC1, SERPIND1"
Diffuse Glioma,BRD-A84389633-001-05-7::2.5::HTS,5.5815898100450525,0.01848998388441788,Other Types,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,"HTR3A, HTR3B"
Diffuse Glioma,BRD-A86044036-001-26-5::2.5::HTS,4.473690649885328,0.034867989509977576,Other Types,flurbiprofen-(+/-),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Diffuse Glioma,BRD-A86216746-046-02-6::2.5::HTS,4.042762287605166,0.044855022352997376,Other Types,varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Diffuse Glioma,BRD-A87673115-001-04-1::2.5::HTS,11.260365202643538,0.0008468474348344074,Other Types,moguisteine,ATP-sensitive potassium channel inhibitor,
Diffuse Glioma,BRD-A87983072-001-01-1::2.5::HTS,7.598048394663223,0.006034643350309382,Other Types,benzotript,CCK receptor antagonist,"CCKAR, CCKBR"
Diffuse Glioma,BRD-A90551241-001-10-8::2.5::HTS,7.175648117671417,0.007607907014157878,Other Types,lornoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Diffuse Glioma,BRD-A90625545-001-02-0::2.5::HTS,5.388165805187473,0.020632468616673307,Other Types,clinofibrate,lipase clearing factor inhibitor,LPL
Diffuse Glioma,BRD-A91452556-001-04-0::2.5::HTS,4.026409776355584,0.04527513660794379,Other Types,estradiol-cypionate,estrogen receptor agonist,ESR1
Diffuse Glioma,BRD-A91831168-003-02-5::2.5::HTS,4.479716340791556,0.034744670154995085,Diffuse Glioma,tetrahydropapaverine,,
Diffuse Glioma,BRD-A92439610-001-05-7::2.5::HTS,4.605461182716774,0.032299377591802486,Diffuse Glioma,triamcinolone-acetonide,"glucocorticoid receptor agonist, immunosuppressant",NR3C1
Diffuse Glioma,BRD-A93000692-001-08-1::2.5::HTS,8.685127823173008,0.0033415418865438383,Other Types,ciglitazone,PPAR receptor agonist,PPARG
Diffuse Glioma,BRD-A94523291-304-02-7::2.5::HTS,7.18755445627556,0.007558629590297736,Diffuse Glioma,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-A94993966-001-05-1::2.63::HTS,6.227596247295512,0.012875338162074987,Other Types,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Diffuse Glioma,BRD-A95340155-001-09-7::2.5::HTS,6.286324515277818,0.012448307175558242,Other Types,methyclothiazide,chloride reabsorption inhibitor,"CA1, CA2, CA4, SLC12A1, SLC12A3"
Diffuse Glioma,BRD-A96292436-003-16-1::2.5::HTS,7.630604404540029,0.005926779761866571,Other Types,eflornithine,ornithine decarboxylase inhibitor,"ARG2, ODC1"
Diffuse Glioma,BRD-A97674275-001-11-8::2.5::HTS,4.336545209647378,0.03775422822464992,Other Types,ranolazine,sodium channel blocker,"SCN10A, SCN4A, SCN5A, SCN9A"
Diffuse Glioma,BRD-A98378129-001-02-2::2.5::HTS,6.302806106141019,0.012342629248183962,Other Types,talniflumate,cyclooxygenase inhibitor,CLCA1
Diffuse Glioma,BRD-A99939097-001-24-2::2.5::HTS,6.7440155502916275,0.00965389316993471,Other Types,carisoprodol,acetylcholine receptor antagonist,CYP2C19
Diffuse Glioma,BRD-K00077635-304-01-2::2.5::HTS,4.204559016731933,0.04078289673419746,Other Types,estramustine-phosphate,"DNA synthesis inhibitor, microtubule inhibitor","ESR1, ESR2, MAP1A, MAP2"
Diffuse Glioma,BRD-K00312224-001-09-5::2.5::HTS,4.87595810750958,0.027643619620423613,Other Types,PPT,estrogen receptor agonist,ESR1
Diffuse Glioma,BRD-K00317371-001-06-1::2.4::HTS,4.154597790286233,0.04201938453521919,Diffuse Glioma,RITA,MDM inhibitor,MDM2
Diffuse Glioma,BRD-K00337317-001-06-6::2.5::HTS,5.096320905112032,0.024362371967894803,Diffuse Glioma,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
Diffuse Glioma,BRD-K00573984-003-01-5::2.5::HTS,4.652468839287095,0.03143990817114292,Other Types,delapril,angiotensin converting enzyme inhibitor,ACE
Diffuse Glioma,BRD-K01377300-001-01-1::2.5::HTS,9.612211380847457,0.002029710478073378,Other Types,CZC24832,PI3K inhibitor,PIK3CG
Diffuse Glioma,BRD-K01577834-001-15-1::2.5::HTS,6.185713858625082,0.013179972437074862,Other Types,adenosine,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4"
Diffuse Glioma,BRD-K02123250-001-06-7::2.5::HTS,7.3325151886654165,0.006981385518181493,Other Types,JNJ-38877605,tyrosine kinase inhibitor,MET
Diffuse Glioma,BRD-K02389548-001-02-5::2.5::HTS,16.65560543787786,5.139801299762095e-05,Diffuse Glioma,RG2833,HDAC inhibitor,"HDAC1, HDAC3"
Diffuse Glioma,BRD-K02703275-001-07-5::2.5::HTS,7.296754590165253,0.007119432481598546,Diffuse Glioma,gedunin,HSP inhibitor,HSP90AA1
Diffuse Glioma,BRD-K03164761-001-02-1::2.5::HTS,5.441201088953462,0.02002174908669314,Other Types,thiazovivin,rho associated kinase inhibitor,
Diffuse Glioma,BRD-K03294269-001-08-0::2.5::HTS,4.789442036799811,0.02904556135227041,Diffuse Glioma,NU6027,CDK inhibitor,"CCNA2, CDK2"
Diffuse Glioma,BRD-K03390685-001-01-7::2.5::HTS,11.227069095548085,0.0008610401595866266,Diffuse Glioma,cobimetinib,MEK inhibitor,
Diffuse Glioma,BRD-K03549949-001-01-0::2.5::HTS,12.385416377880771,0.00046774861189444807,Diffuse Glioma,XL388,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K04430056-236-02-1::2.5::HTS,7.337715219310737,0.006961868392561985,Diffuse Glioma,7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Diffuse Glioma,BRD-K04923131-001-15-4::2.5::HTS,8.193273170508816,0.004364194246242938,Other Types,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Diffuse Glioma,BRD-K05104363-001-10-0::2.5::HTS,6.864792128496622,0.009038892682439141,Diffuse Glioma,PD-184352,MEK inhibitor,"MAP2K1, MAP3K1, MAP3K2"
Diffuse Glioma,BRD-K05528470-305-02-2::2.5::HTS,4.270984061912069,0.03922840077050097,Other Types,L-745870,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7"
Diffuse Glioma,BRD-K05677083-001-05-4::2.5::HTS,4.962701422716909,0.026320309349150684,Other Types,PACOCF3,phospholipase inhibitor,PLA2G4A
Diffuse Glioma,BRD-K05804044-001-06-0::2.5::HTS,8.244776056784362,0.00424244678228221,Diffuse Glioma,AZ-628,RAF inhibitor,"BRAF, RAF1"
Diffuse Glioma,BRD-K05907307-001-07-1::2.5::HTS,4.587752677294146,0.03263346088527621,Other Types,nonivamide,TRPV agonist,TRPV1
Diffuse Glioma,BRD-K06147391-300-06-8::2.5::HTS,5.179657546247707,0.023231651737345156,Other Types,telenzepine,acetylcholine receptor antagonist,CHRM1
Diffuse Glioma,BRD-K06234293-001-04-2::2.5::HTS,4.008153920712356,0.04576947660581983,Other Types,LY364947,"TGF beta receptor inhibitor, p38 MAPK inhibitor",TGFBR1
Diffuse Glioma,BRD-K06408664-001-03-5::2.5::HTS,4.357955597492948,0.03728950262484356,Diffuse Glioma,fludrocortisone-acetate,,"AR, NR3C1, NR3C2"
Diffuse Glioma,BRD-K06644925-001-03-0::2.5::HTS,4.788547972029868,0.029062719666779688,Other Types,oleamide,cannabinoid receptor agonist,"HTR7, PLA2G2A"
Diffuse Glioma,BRD-K06900071-001-01-2::2.5::HTS,5.672664492607005,0.01756609286404792,Other Types,tebipenem,bacterial cell wall synthesis inhibitor,CNR1
Diffuse Glioma,BRD-K07106112-003-03-8::2.5::HTS,17.58132519540489,3.2018501646091106e-05,Diffuse Glioma,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Diffuse Glioma,BRD-K07220430-001-19-2::2.5::HTS,4.810158731345397,0.028705092170814035,Diffuse Glioma,cinnarazine,calcium channel blocker,
Diffuse Glioma,BRD-K07359318-001-03-9::2.45::HTS,3.88917096572531,0.04911986873041179,Other Types,benfotiamine,antioxidant,AGER
Diffuse Glioma,BRD-K07487750-001-03-3::2.5::HTS,4.424268185234051,0.035878368448608235,Diffuse Glioma,WHI-P154,JAK inhibitor,"EGFR, JAK1, JAK2, JAK3"
Diffuse Glioma,BRD-K07762753-001-04-4::2.5::HTS,4.771821183861987,0.029347638453106933,Diffuse Glioma,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor","CDK1, CDK2, CDK5, CDK6"
Diffuse Glioma,BRD-K08109215-001-06-4::2.5::HTS,13.878545363958148,0.00021557665566175575,Diffuse Glioma,I-BET-762,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Diffuse Glioma,BRD-K08223200-001-01-1::2.5::HTS,5.351530908241197,0.02107066193417824,Other Types,WAY-200070,estrogen receptor agonist,"ERBB2, ERBB3, ERBB4, ESR2"
Diffuse Glioma,BRD-K08303368-001-10-0::2.5::HTS,9.93112928003758,0.0017187083080120369,Other Types,chlorpyrifos,acetylcholinesterase inhibitor,ACHE
Diffuse Glioma,BRD-K08640512-003-02-3::2.5::HTS,16.477287728021643,5.635136054927055e-05,Other Types,RS-100329,adrenergic receptor antagonist,"ADRA1A, ADRA1D"
Diffuse Glioma,BRD-K08799216-001-05-3::2.5::HTS,7.517510121723538,0.0063132179174666715,Diffuse Glioma,pelitinib,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K08837089-236-01-6::2.5::HTS,5.163480890724391,0.023443527100472716,Diffuse Glioma,actinoquinol,,
Diffuse Glioma,BRD-K08859203-001-01-9::2.5::HTS,7.842758302670202,0.005289803203595801,Other Types,DU-728,structural glycoprotein antagonist,"ITGA2B, ITGB3"
Diffuse Glioma,BRD-K08924299-003-06-1::2.5::HTS,3.9080408489648777,0.048564795794119736,Other Types,palonosetron,serotonin receptor antagonist,HTR3A
Diffuse Glioma,BRD-K09255212-001-16-6::2.5::HTS,5.299410768937007,0.021712934128745625,Other Types,clioquinol,chelating agent,OPRK1
Diffuse Glioma,BRD-K09397065-003-06-1::2.5::HTS,9.474503741938173,0.0021894714333962166,Other Types,SR-57227A,serotonin receptor agonist,HTR3A
Diffuse Glioma,BRD-K09416995-001-39-9::2.5::HTS,18.181859081328955,2.3584990718083783e-05,Other Types,lovastatin,HMGCR inhibitor,"HDAC2, HMGCR, ITGAL, NR1I2"
Diffuse Glioma,BRD-K09877029-001-01-2::2.5::HTS,5.4679064206286645,0.019720415042303117,Diffuse Glioma,VS-4718,focal adhesion kinase inhibitor,
Diffuse Glioma,BRD-K10196357-003-02-0::2.5::HTS,4.503469459605432,0.034275748246986926,Other Types,besifloxacin,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K10575656-034-01-0::2.5::HTS,6.695709250493772,0.009917966387219729,Other Types,MRS3777,adenosine receptor antagonist,ADORA2A
Diffuse Glioma,BRD-K10799896-001-26-2::2.5::HTS,4.13214146998587,0.04254813727268569,Diffuse Glioma,clobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Diffuse Glioma,BRD-K10843433-001-23-5::2.58::HTS,10.533835299580332,0.0012466783768396532,Other Types,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Diffuse Glioma,BRD-K11244467-001-08-5::2.5::HTS,6.203031235597636,0.013040794899466017,Diffuse Glioma,ambazone,DNA damage inducer,
Diffuse Glioma,BRD-K11267252-001-04-4::2.5::HTS,7.051613896907949,0.00815372197026317,Diffuse Glioma,alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Diffuse Glioma,BRD-K11663430-001-02-3::2.5::HTS,15.934535136774251,7.431698401552536e-05,Diffuse Glioma,pyroxamide,HDAC inhibitor,HDAC1
Diffuse Glioma,BRD-K11742128-003-23-4::2.5::HTS,6.550752645293402,0.010746917190361907,Other Types,triprolidine,histamine receptor antagonist,HRH1
Diffuse Glioma,BRD-K11756522-001-09-9::2.5::HTS,4.740159016466683,0.029885425920786392,Diffuse Glioma,furazolidone,bacterial DNA inhibitor,
Diffuse Glioma,BRD-K11853856-001-01-7::2.5::HTS,5.61483715987337,0.018145885911902835,Other Types,PJ-34,PARP inhibitor,"EEF2, PARP1, PARP15, PARP3"
Diffuse Glioma,BRD-K12040459-001-06-0::2.5::HTS,14.15240535389036,0.00018643534004977514,Other Types,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Diffuse Glioma,BRD-K12343256-001-08-9::2.5::HTS,15.555095330456766,9.034219037373289e-05,Diffuse Glioma,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Diffuse Glioma,BRD-K12568846-001-14-6::2.5::HTS,7.364842853913584,0.006855271690237032,Other Types,amidopyrine,analgesic agent,
Diffuse Glioma,BRD-K12614344-003-01-8::2.5::HTS,4.116707313392912,0.04293419493408929,Other Types,CGS-21680,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Diffuse Glioma,BRD-K12735121-001-01-4::2.5::HTS,10.121593685093595,0.0015497988226546228,Other Types,TG-100801,"src inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, SRC"
Diffuse Glioma,BRD-K12932420-001-02-3::2.5::HTS,11.976214919543994,0.00058254213585776,Other Types,YM-976,phosphodiesterase inhibitor,PDE4A
Diffuse Glioma,BRD-K13050303-001-17-3::2.5::HTS,3.9701887178911623,0.04682695978566855,Other Types,uridine,dopamine receptor agonist,"LSM6, TYMP"
Diffuse Glioma,BRD-K13474508-001-01-2::2.5::HTS,4.329525333386591,0.037917201537011815,Other Types,"L-655,708",GABA receptor inverse agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRG2"
Diffuse Glioma,BRD-K13606314-001-01-3::2.5::HTS,4.25715948224756,0.03954390849494281,Diffuse Glioma,P5091,ubiquitin specific protease inhibitor,USP7
Diffuse Glioma,BRD-K13646352-001-03-8::2.5::HTS,8.052630202212661,0.004710235894081438,Other Types,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Diffuse Glioma,BRD-K13829090-303-02-9::2.5::HTS,4.500396658254161,0.03432639192356862,Other Types,IEM1460,glutamate receptor antagonist,GRIA2
Diffuse Glioma,BRD-K14116214-001-09-6::2.5::HTS,5.842162239994659,0.015966224629709685,Other Types,sulfamonomethoxine,bacterial antifolate,
Diffuse Glioma,BRD-K14395568-001-16-3::2.5::HTS,10.875603255317218,0.0010368768500352602,Other Types,NECA,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1"
Diffuse Glioma,BRD-K14496212-066-04-8::2.5::HTS,3.875050448538959,0.0495142731817482,Other Types,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Diffuse Glioma,BRD-K14763542-001-02-3::2.5::HTS,15.03088039037705,0.0001190980428508826,Other Types,flurothyl,,
Diffuse Glioma,BRD-K15010214-364-02-7::2.5::HTS,5.619915126578673,0.018108973320516992,Other Types,emedastine,histamine receptor antagonist,HRH1
Diffuse Glioma,BRD-K15086322-050-01-3::2.5::HTS,7.941538415640756,0.005003837645678201,Other Types,JNJ-10191584,histamine receptor antagonist,HRH4
Diffuse Glioma,BRD-K15424032-001-03-6::2.5::HTS,8.132865988862637,0.0045097734077883265,Diffuse Glioma,SB-228357,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Diffuse Glioma,BRD-K15891719-001-05-1::2.45::HTS,5.062004762320952,0.024866933281300085,Diffuse Glioma,tenofovir,"HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor",
Diffuse Glioma,BRD-K16195444-003-26-0::2.5::HTS,6.940904399561519,0.008657788411305852,Other Types,oxymetazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C"
Diffuse Glioma,BRD-K16277217-001-10-9::2.5::HTS,4.029476201027361,0.045219001301902526,Other Types,piperacetazine,dopamine receptor antagonist,
Diffuse Glioma,BRD-K17075857-001-17-6::2.5::HTS,5.374517296820939,0.02079226758122742,Other Types,chloroxine,opioid receptor antagonist,OPRK1
Diffuse Glioma,BRD-K17203476-001-01-9::2.5::HTS,3.9852669524322164,0.046383529599753975,Other Types,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Diffuse Glioma,BRD-K17205817-001-06-1::2.5::HTS,5.496440836043898,0.019402423951544796,Other Types,sulfametopyrazine,PABA antagonist,
Diffuse Glioma,BRD-K17443395-065-02-2::2.5::HTS,4.045385092468768,0.04477091220071932,Other Types,abacavir,nucleoside reverse transcriptase inhibitor,
Diffuse Glioma,BRD-K17702546-001-03-2::2.5::HTS,6.108344941805077,0.013749773630937321,Diffuse Glioma,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Diffuse Glioma,BRD-K17743125-001-08-4::2.5::HTS,4.5097452406326735,0.034140030048172426,Diffuse Glioma,belinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Diffuse Glioma,BRD-K17774839-001-02-9::2.5::HTS,4.0869177403182295,0.04368979464026645,Other Types,JNJ-7777120,histamine receptor antagonist,HRH4
Diffuse Glioma,BRD-K17953908-001-01-7::2.5::HTS,4.270302829297815,0.03924318393946637,Other Types,LY2886721,beta-secretase inhibitor,BACE1
Diffuse Glioma,BRD-K18157228-001-01-7::2.5::HTS,4.864095657278155,0.02782667846591307,Other Types,fdcyd,DNA methyltransferase inhibitor,
Diffuse Glioma,BRD-K18172896-001-02-5::2.5::HTS,5.378156802746446,0.020751296728310848,Other Types,eltanolone,membrane integrity inhibitor,"GABRA1, GABRB2, GABRG2"
Diffuse Glioma,BRD-K18375018-376-02-3::2.5::HTS,9.285929368150779,0.002418667264226581,Other Types,spermine,,"CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5"
Diffuse Glioma,BRD-K18424115-003-01-3::2.5::HTS,5.578268986134446,0.01852964783203765,Other Types,TG-100572,"src inhibitor, VEGFR inhibitor","KDR, SRC"
Diffuse Glioma,BRD-K18574842-323-10-8::2.51::HTS,14.201619565203103,0.00018273763622914829,Diffuse Glioma,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Diffuse Glioma,BRD-K18849474-001-04-4::2.61::HTS,5.628310937069653,0.01803001952493512,Diffuse Glioma,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Diffuse Glioma,BRD-K18922609-004-23-1::2.5::HTS,4.579579788640473,0.03279127548813286,Other Types,neostigmine,acetylcholinesterase inhibitor,ACHE
Diffuse Glioma,BRD-K19034817-001-01-4::2.5::HTS,14.13633928488783,0.0001879609753302267,Diffuse Glioma,pacritinib,"FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3"
Diffuse Glioma,BRD-K19333160-001-01-3::2.5::HTS,15.729446599691684,8.259402754526249e-05,Other Types,RKI-1447,rho associated kinase inhibitor,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2"
Diffuse Glioma,BRD-K19477839-001-07-6::2.5::HTS,4.853370972294212,0.028003059949902907,Other Types,SGX523,hepatocyte growth factor receptor inhibitor,MET
Diffuse Glioma,BRD-K19540840-001-09-4::2.5::HTS,4.24597377847965,0.03980316441446793,Diffuse Glioma,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Diffuse Glioma,BRD-K19687926-379-07-4::2.5::HTS,9.754542087612625,0.0018815830571539667,Diffuse Glioma,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K20001883-001-02-7::2.5::HTS,8.727670937388476,0.003267320990619699,Diffuse Glioma,apabetalone,apolipoprotein expression enhancer,BRD3
Diffuse Glioma,BRD-K20285085-001-07-1::2.5::HTS,9.937049257033232,0.0017099496751803946,Other Types,R406,SYK inhibitor,"RET, SYK"
Diffuse Glioma,BRD-K20482099-001-09-4::2.5::HTS,4.028420897051066,0.04524899672953068,Other Types,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Diffuse Glioma,BRD-K20738689-001-01-2::2.5::HTS,4.104340169463914,0.043252024368009456,Other Types,dazmegrel,thromboxane synthase inhibitor,TBXAS1
Diffuse Glioma,BRD-K20920669-304-09-1::2.5::HTS,4.291020886445764,0.038770674040348306,Other Types,cromoglicic-acid,immunosuppressant,"KCNMA1, S100P"
Diffuse Glioma,BRD-K21025364-001-05-6::2.44::HTS,5.96685912779379,0.014903965342248325,Diffuse Glioma,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Diffuse Glioma,BRD-K21547160-001-01-4::2.5::HTS,7.305254533819138,0.007092188156150694,Other Types,sufentanil,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Diffuse Glioma,BRD-K21782625-001-02-4::2.5::HTS,4.058790647716365,0.044438081750442365,Other Types,AMG458,MET inhibitor,MET
Diffuse Glioma,BRD-K21906513-001-04-0::2.36::HTS,9.915624997067018,0.0017315217711522297,Other Types,UNC669,L3MBTL antagonist,L3MBTL1
Diffuse Glioma,BRD-K22024824-001-03-7::2.5::HTS,4.880982476441313,0.027560308421576644,Other Types,RG4733,gamma secretase inhibitor,PSEN1
Diffuse Glioma,BRD-K22025381-003-01-9::2.5::HTS,17.426396490705834,3.463230072658712e-05,Diffuse Glioma,U-18666A,oxidosqualene cyclase inhibitor,
Diffuse Glioma,BRD-K22134346-001-22-3::2.5::HTS,17.66683983033199,3.0806380997878445e-05,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Diffuse Glioma,BRD-K22134346-001-24-9::2.42::HTS,22.227957947616577,3.1022261521690425e-06,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Diffuse Glioma,BRD-K22356203-001-01-8::2.5::HTS,4.579851465271986,0.032779903859893336,Diffuse Glioma,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Diffuse Glioma,BRD-K22503835-001-11-0::2.5::HTS,7.461455353677,0.0065025587023123275,Diffuse Glioma,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Diffuse Glioma,BRD-K23163214-050-15-1::2.5::HTS,8.519806526368216,0.003654485682722653,Other Types,dizocilpine-(-),glutamate receptor antagonist,
Diffuse Glioma,BRD-K23190681-001-01-1::2.5::HTS,15.731735616452275,8.256854832474386e-05,Diffuse Glioma,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K23586533-001-03-6::2.5::HTS,8.995500536304469,0.0028314760098524907,Other Types,clindamycin,protein synthesis inhibitor,
Diffuse Glioma,BRD-K23952234-236-01-8::2.5::HTS,6.944078601503035,0.008645167775723278,Other Types,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1
Diffuse Glioma,BRD-K24556098-001-19-1::2.5::HTS,5.0180870973964575,0.025477439181642008,Other Types,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Diffuse Glioma,BRD-K24556407-001-02-3::2.5::HTS,4.091671116676784,0.04357056089773275,Diffuse Glioma,ETP-46464,ATR kinase inhibitor,
Diffuse Glioma,BRD-K24576554-001-04-8::2.5::HTS,5.463328197842047,0.019774816623117517,Other Types,AT-9283,"Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A"
Diffuse Glioma,BRD-K24696047-001-02-3::2.5::HTS,6.475351160128341,0.011208240651336417,Diffuse Glioma,NVP-AEW541,IGF-1 inhibitor,"IGF1R, INSR"
Diffuse Glioma,BRD-K24715592-406-02-1::2.53::HTS,10.975254692750147,0.0009866360867849058,Other Types,ethacridine-lactate-monohydrate,DNA intercalating agent,
Diffuse Glioma,BRD-K25649279-001-02-0::2.5::HTS,8.006080128316293,0.004831674940395167,Other Types,2-iodomelatonin,melatonin receptor agonist,"MTNR1A, MTNR1B, NQO2"
Diffuse Glioma,BRD-K25723200-001-02-7::2.5::HTS,6.264671986796915,0.012607928216351679,Other Types,azilsartan-medoxomil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Diffuse Glioma,BRD-K26531771-001-02-2::2.35::HTS,4.715245237507826,0.030340849352231174,Diffuse Glioma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Diffuse Glioma,BRD-K26548821-003-10-5::2.5::HTS,4.641187650858237,0.03164154085831731,Other Types,quinpirol-(-),dopamine receptor agonist,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C"
Diffuse Glioma,BRD-K26603252-003-04-9::2.5::HTS,16.142099529445478,6.700633056019525e-05,Diffuse Glioma,PD-153035,EGFR inhibitor,"EGFR, KDR"
Diffuse Glioma,BRD-K26657438-001-15-2::2.5::HTS,5.903595920960383,0.015423868895671473,Other Types,imiquimod,"interferon inducer, toll-like receptor agonist","TLR7, TLR8"
Diffuse Glioma,BRD-K26667523-001-02-5::2.5::HTS,14.75058230993032,0.000136885898457349,Diffuse Glioma,TAK-733,MEK inhibitor,MAP2K1
Diffuse Glioma,BRD-K26838195-075-04-9::2.5::HTS,18.027371360196298,2.547756639399836e-05,Diffuse Glioma,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K27062708-001-23-1::2.5::HTS,5.763471466026842,0.016691449188513913,Diffuse Glioma,chlorotrianisene,estrogenic hormone,"ESR1, ESR2"
Diffuse Glioma,BRD-K27135764-001-08-7::2.5::HTS,5.054437809053621,0.024955314551944007,Other Types,xanthone,antimalarial agent,
Diffuse Glioma,BRD-K27141178-003-07-3::2.5::HTS,6.3657782939223955,0.011913967436625624,Diffuse Glioma,SB-203186,serotonin receptor antagonist,HTR4
Diffuse Glioma,BRD-K27182532-001-02-3::2.5::HTS,5.319576451329062,0.021450024767307695,Other Types,metatinib,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Diffuse Glioma,BRD-K27217864-001-22-3::2.5::HTS,4.684896958487235,0.030854564642478866,Diffuse Glioma,butamben,sodium channel blocker,
Diffuse Glioma,BRD-K27316855-001-13-3::2.44::HTS,9.433333992889864,0.002240564707712577,Diffuse Glioma,calcitriol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K27316855-001-19-0::2.5::HTS,7.4999790518306435,0.006366742877835347,Diffuse Glioma,calcitriol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K27938825-001-02-4::2.5::HTS,4.134310496235062,0.04249405939254685,Other Types,ASA-404,angiogenesis inhibitor,
Diffuse Glioma,BRD-K27955832-001-02-9::2.5::HTS,6.371830514102209,0.0118703622366346,Other Types,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Diffuse Glioma,BRD-K28059174-334-01-2::2.5::HTS,6.210514039614179,0.012994846160388226,Other Types,INCB-003284,CC chemokine receptor antagonist,
Diffuse Glioma,BRD-K28343777-001-01-6::2.5::HTS,4.938958857765435,0.026660851367448717,Other Types,20-hydroxyecdysone,ecdysone receptor modulator,
Diffuse Glioma,BRD-K28352084-001-02-3::2.5::HTS,13.083673470931728,0.00032490240671775774,Diffuse Glioma,CH5132799,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K28456624-001-01-1::2.5::HTS,7.159769457290674,0.007676260822517518,Diffuse Glioma,seocalcitol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K28822270-001-01-1::2.5::HTS,4.624484920995124,0.031950727944659744,Diffuse Glioma,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Diffuse Glioma,BRD-K28824103-001-04-4::2.5::HTS,5.642036429262429,0.017874163946160437,Other Types,genipin,choleretic agent,
Diffuse Glioma,BRD-K28965160-001-01-1::2.5::HTS,17.14381810829907,4.005646261361238e-05,Diffuse Glioma,BVD-523,MAP kinase inhibitor,
Diffuse Glioma,BRD-K29834313-001-01-4::2.5::HTS,4.7865215245556225,0.02910037022428146,Other Types,myricitrin,PKC inhibitor,"NOS1, PRKCA"
Diffuse Glioma,BRD-K30652337-004-02-1::2.5::HTS,9.238344501675618,0.002480660493182947,Other Types,eletriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7"
Diffuse Glioma,BRD-K30867024-003-03-3::2.5::HTS,6.0434048333218024,0.014264381868047005,Diffuse Glioma,SB-216641,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Diffuse Glioma,BRD-K31309378-001-01-5::2.5::HTS,28.654289953789856,1.2708081951804308e-07,Other Types,lucitanib,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Diffuse Glioma,BRD-K31627533-001-09-5::2.5::HTS,5.454466392704967,0.019873066735371696,Diffuse Glioma,rimexolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-K31682896-001-24-0::2.5::HTS,4.52278653674206,0.0338852607744273,Other Types,sulfamethizole,bacterial antifolate,
Diffuse Glioma,BRD-K31698212-001-02-9::2.5::HTS,5.617626329242216,0.01811792410590501,Diffuse Glioma,icotinib,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K31731454-237-02-5::2.5::HTS,20.233418384042192,8.361058790515836e-06,Other Types,pemirolast,mediator release inhibitor,HRH1
Diffuse Glioma,BRD-K31928526-001-02-1::2.5::HTS,3.913731657705203,0.04838541269094791,Other Types,barasertib,Aurora kinase inhibitor,"AURKA, AURKB"
Diffuse Glioma,BRD-K32107296-001-16-9::2.5::HTS,12.723493992768022,0.0003923539794230426,Other Types,temozolomide,DNA alkylating agent,MGMT
Diffuse Glioma,BRD-K32164935-001-30-8::2.5::HTS,4.636373542986744,0.031731990883787836,Diffuse Glioma,tolazamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ10, KCNJ11"
Diffuse Glioma,BRD-K32247306-001-29-4::2.5::HTS,5.740289248276256,0.016912012431408482,Diffuse Glioma,primidone,GABA receptor antagonist,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Diffuse Glioma,BRD-K32501161-300-06-2::2.5::HTS,4.345210129350338,0.03757228426600464,Diffuse Glioma,vanoxerine,dopamine uptake inhibitor,SLC6A3
Diffuse Glioma,BRD-K32821942-001-21-3::2.5::HTS,4.500909180543001,0.03431540488169645,Diffuse Glioma,azathioprine,dehydrogenase inhibitor,"HPRT1, IMPDH1, PPAT"
Diffuse Glioma,BRD-K33141550-003-05-7::2.5::HTS,4.332375766525105,0.037847689362664444,Other Types,L-NAME,nitric oxide synthase inhibitor,NOS3
Diffuse Glioma,BRD-K33183200-303-02-4::2.5::HTS,9.664455388603772,0.0019742672534011512,Other Types,imetit,histamine receptor agonist,"HRH3, HRH4"
Diffuse Glioma,BRD-K33425534-001-12-5::2.5::HTS,4.34350579246479,0.03760960337512594,Other Types,exemestane,aromatase inhibitor,CYP19A1
Diffuse Glioma,BRD-K33483813-001-10-0::2.5::HTS,4.9389412619419835,0.026661120305386175,Other Types,actarit,interleukin receptor agonist,
Diffuse Glioma,BRD-K33610132-001-02-9::2.5::HTS,6.653803335248004,0.010151477246516532,Diffuse Glioma,rociletinib,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K33622447-066-01-9::2.5::HTS,7.181081374888907,0.007585199659178288,Diffuse Glioma,abemaciclib,CDK inhibitor,"CDK4, CDK6"
Diffuse Glioma,BRD-K33681278-036-01-2::2.5::HTS,4.347916904945131,0.03751899611763123,Other Types,prucalopride,serotonin receptor agonist,HTR4
Diffuse Glioma,BRD-K33892651-001-02-4::2.5::HTS,4.229095610071685,0.04020105749676745,Other Types,ML347,ALK tyrosine kinase receptor inhibitor,"ACVR1, ACVRL1, BMPR1A"
Diffuse Glioma,BRD-K34058848-304-03-1::2.5::HTS,9.374465978043947,0.0023064438272455525,Other Types,cefonicid,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K34411947-001-12-5::2.5::HTS,13.122611341967806,0.0003184210228003872,Other Types,streptozotocin,DNA alkylating agent,SLC2A2
Diffuse Glioma,BRD-K35245662-001-01-2::2.5::HTS,7.886031917097548,0.005155580314536605,Diffuse Glioma,ciclesonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-K35430135-003-02-3::2.5::HTS,4.400904644724834,0.03636743143339659,Other Types,SR-59230A,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Diffuse Glioma,BRD-K36016295-001-04-5::2.5::HTS,4.870984848366589,0.027721185338257546,Diffuse Glioma,KU-60019,ATM kinase inhibitor,ATM
Diffuse Glioma,BRD-K36116267-001-15-3::2.5::HTS,4.230431080738821,0.0401705206170205,Other Types,pyrithyldione,psychoactive drug,
Diffuse Glioma,BRD-K36363294-001-04-2::2.5::HTS,8.91521971707462,0.0029565257924704168,Diffuse Glioma,I-BET151,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Diffuse Glioma,BRD-K36739687-001-03-0::2.5::HTS,7.358127500673328,0.006882060291186218,Other Types,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR
Diffuse Glioma,BRD-K36927236-001-32-6::2.5::HTS,6.45951126862708,0.01130593065591342,Other Types,glyburide,"ATP channel blocker, insulin secretagogue, sulfonylurea","ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1"
Diffuse Glioma,BRD-K37561857-001-15-5::2.5::HTS,6.691045782801114,0.009947364811941778,Other Types,zardaverine,phosphodiesterase inhibitor,PDE4D
Diffuse Glioma,BRD-K37618799-001-03-0::2.5::HTS,12.577040517080512,0.00042339566570224937,Diffuse Glioma,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Diffuse Glioma,BRD-K37682401-001-09-3::2.44::HTS,5.377331969592902,0.020780896030694152,Other Types,piromidic-acid,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K37687095-001-06-9::2.5::HTS,16.28056385642474,6.218335787532262e-05,Diffuse Glioma,AZD8330,MEK inhibitor,
Diffuse Glioma,BRD-K37714784-305-02-1::2.5::HTS,4.708960051394526,0.030425473274617667,Other Types,ABT-724,dopamine receptor agonist,DRD4
Diffuse Glioma,BRD-K37991163-003-13-4::2.5::HTS,6.2183375376149685,0.012938205170178716,Other Types,paroxetine,selective serotonin reuptake inhibitor (SSRI),"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4"
Diffuse Glioma,BRD-K38003476-001-09-1::2.5::HTS,8.50515680421393,0.003682806845738242,Diffuse Glioma,clocortolone-pivalate,steroid,"NR3C1, PLA2G1B"
Diffuse Glioma,BRD-K38158531-001-02-1::2.5::HTS,3.8946815439966063,0.04894301798310928,Other Types,traxoprodil,glutamate receptor antagonist,GRIN2B
Diffuse Glioma,BRD-K38473998-001-02-0::2.5::HTS,8.632793738966697,0.003441151605618255,Other Types,cilomilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4D"
Diffuse Glioma,BRD-K38938675-001-01-4::2.5::HTS,3.9697234956828265,0.046817413711482715,Diffuse Glioma,morniflumate,anti-inflammatory agent,
Diffuse Glioma,BRD-K39805756-001-01-6::2.5::HTS,5.003758266936394,0.025687227313223968,Other Types,TPPS4,,
Diffuse Glioma,BRD-K39974922-001-04-3::2.5::HTS,5.30131146700512,0.021684605263315504,Other Types,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Diffuse Glioma,BRD-K39983086-001-06-1::2.45::HTS,8.247931003142286,0.004249986287851747,Diffuse Glioma,loteprednol,"glucocorticoid receptor agonist, phospholipase inhibitor",NR3C1
Diffuse Glioma,BRD-K40255344-001-17-6::2.5::HTS,6.599821839649844,0.010455804534670888,Diffuse Glioma,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Diffuse Glioma,BRD-K40654626-236-01-5::2.5::HTS,14.175469041287684,0.00018522722508167625,Other Types,ditiocarb-sodium-trihydrate,immunostimulant,"CA1, CA2, CA4"
Diffuse Glioma,BRD-K40718343-001-02-6::2.5::HTS,21.79819508349581,3.7921949745646555e-06,Diffuse Glioma,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Diffuse Glioma,BRD-K40738845-001-05-0::2.5::HTS,11.982346797955554,0.0005791179380679871,Other Types,BMS-777607,"AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor","AXL, MERTK, MET, MST1R, TYRO3"
Diffuse Glioma,BRD-K40992116-001-09-7::2.5::HTS,5.984699191149867,0.014749008397469498,Other Types,parachlorophenol,antiinfective drug,
Diffuse Glioma,BRD-K41234004-001-03-1::0.03::HTS,4.384627408178103,0.03671585426209773,Other Types,icomucret,mucin production enhancer,LTB4R2
Diffuse Glioma,BRD-K41278234-001-03-0::2.5::HTS,11.002757081892145,0.0009694044443064888,Diffuse Glioma,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K41524689-001-23-5::2.5::HTS,5.857901907573351,0.015832588009958865,Other Types,paracetamol,cyclooxygenase inhibitor,"FAAH, PTGS1, PTGS2, TRPV1"
Diffuse Glioma,BRD-K41567364-001-04-6::2.5::HTS,4.130113389751927,0.04260303304045815,Diffuse Glioma,SB-334867,orexin receptor antagonist,"HCRTR1, HCRTR2"
Diffuse Glioma,BRD-K41783120-001-02-8::2.5::HTS,17.81789144526624,2.8470082792827783e-05,Diffuse Glioma,STA-5326,interleukin synthesis inhibitor,IL12A
Diffuse Glioma,BRD-K41866823-001-01-3::2.5::HTS,6.728165077418362,0.009744957698499968,Other Types,2-hydroxyethyl-salicylate,,
Diffuse Glioma,BRD-K42563464-001-01-9::2.5::HTS,7.261550227056362,0.007261610234018225,Other Types,YM-58483,calcium channel blocker,"TRPC3, TRPC5, TRPM4"
Diffuse Glioma,BRD-K42756753-001-01-9::2.5::HTS,3.9688786025143856,0.04685261449141979,Other Types,epiandrosterone,steroid,G6PD
Diffuse Glioma,BRD-K42805893-001-04-9::2.5::HTS,12.965296914101751,0.00034539378718566956,Diffuse Glioma,osimertinib,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K42973005-001-04-0::2.5::HTS,7.358641393650241,0.006879378925257089,Other Types,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Diffuse Glioma,BRD-K42991124-001-03-0::2.5::HTS,5.64638674003149,0.01784707703964097,Other Types,creatinol-phosphate,,
Diffuse Glioma,BRD-K43164539-001-11-5::2.5::HTS,5.493645382391265,0.01944337087468773,Other Types,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Diffuse Glioma,BRD-K43471985-001-03-0::2.69::HTS,6.676289098090347,0.010037893581310176,Diffuse Glioma,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Diffuse Glioma,BRD-K43471985-001-05-5::2.5::HTS,8.134980319424118,0.00450283039501391,Diffuse Glioma,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Diffuse Glioma,BRD-K43797669-001-30-4::2.5::HTS,4.413803007213918,0.03609409519379441,Other Types,genistein,tyrosine kinase inhibitor,"CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5"
Diffuse Glioma,BRD-K44227013-001-06-4::2.5::HTS,6.364459377374529,0.011920199138197578,Diffuse Glioma,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Diffuse Glioma,BRD-K44442813-001-12-9::2.5::HTS,5.942870754753589,0.015085829223898332,Other Types,pidotimod,"interferon receptor agonist, interleukin receptor agonist",
Diffuse Glioma,BRD-K44665581-001-01-8::2.5::HTS,9.279594543055579,0.002426707856029571,Diffuse Glioma,bromosporine,bromodomain inhibitor,
Diffuse Glioma,BRD-K44827188-001-06-0::2.5::HTS,4.065253238850465,0.044253644263975024,Diffuse Glioma,vismodegib,"hedgehog pathway inhibitor, smoothened receptor antagonist",SMO
Diffuse Glioma,BRD-K44844162-001-01-6::2.5::HTS,5.39147609410003,0.02059830638016999,Diffuse Glioma,taselisib,PI3K inhibitor,PIK3CA
Diffuse Glioma,BRD-K44963273-001-06-9::2.5::HTS,5.20263956535022,0.02295009708347898,Other Types,HQK-1001,,
Diffuse Glioma,BRD-K45114938-236-01-8::2.35::HTS,4.430724226197083,0.03577211529765188,Other Types,mezlocillin,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K45117373-001-02-9::2.5::HTS,3.9511055258338432,0.04733961903107934,Other Types,Y-26763,potassium channel activator,KCNJ8
Diffuse Glioma,BRD-K45152786-001-08-4::2.5::HTS,5.437575640255627,0.02007075985905581,Other Types,merbarone,topoisomerase inhibitor,TOP2A
Diffuse Glioma,BRD-K45163704-001-01-5::2.5::HTS,4.016214864936136,0.04557310781316534,Other Types,midafotel,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Diffuse Glioma,BRD-K45216060-001-11-8::2.5::HTS,4.40355975775357,0.03633400861201305,Other Types,mequinol,,TYR
Diffuse Glioma,BRD-K45330754-001-21-7::2.5::HTS,4.371870699510793,0.03699354688715187,Diffuse Glioma,diethylstilbestrol,estrogen receptor agonist,"ESR1, ESR2, ESRRB, ESRRG"
Diffuse Glioma,BRD-K45401373-001-20-9::2.5::HTS,4.716717110214229,0.030315125158714387,Diffuse Glioma,betulinic-acid,"apoptosis stimulant, NFkB pathway inhibitor",GPBAR1
Diffuse Glioma,BRD-K45503887-001-01-1::2.5::HTS,5.3877867132512325,0.020641469270898306,Other Types,delivert,angiotensin receptor agonist,"AGTR1, AGTR2"
Diffuse Glioma,BRD-K45664306-001-19-6::2.52::HTS,6.379082193716254,0.01183930648858646,Diffuse Glioma,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-K46331928-001-05-8::2.5::HTS,5.781627559758434,0.01651935121152385,Other Types,ethynodiol-diacetate,,"ESR1, PGR"
Diffuse Glioma,BRD-K46386702-001-02-1::2.5::HTS,8.644252328359702,0.003417142664036827,Diffuse Glioma,ARRY-334543,EGFR inhibitor,ERBB2
Diffuse Glioma,BRD-K46493214-001-06-7::2.5::HTS,4.086543969751216,0.043702782341891705,Other Types,saccharin,DNA polymerase inhibitor,"CA1, CA12, CA2, CA9"
Diffuse Glioma,BRD-K46654563-238-01-0::2.5::HTS,10.449735584326694,0.0012998786325339178,Other Types,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE
Diffuse Glioma,BRD-K46731503-050-01-8::2.5::HTS,3.993175516674585,0.04616792833455575,Other Types,fesoterodine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Diffuse Glioma,BRD-K46742498-003-11-0::2.5::HTS,6.180549377822762,0.013209841330085995,Other Types,alosetron,serotonin receptor antagonist,HTR3A
Diffuse Glioma,BRD-K46766488-003-02-0::2.5::HTS,5.1169642140681,0.024079652669021,Other Types,S-14506,serotonin receptor agonist,HTR1A
Diffuse Glioma,BRD-K46863940-001-06-2::2.5::HTS,8.469846803439175,0.0037631910603442256,Other Types,dibenzothiophene,,
Diffuse Glioma,BRD-K46937689-001-15-0::2.5::HTS,9.66378925321048,0.0019776447908352404,Other Types,phenazone,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Diffuse Glioma,BRD-K47000838-001-01-6::1.04::HTS,4.571476993915396,0.03295757264307639,Other Types,cytochalasin-b,microtubule inhibitor,ACTB
Diffuse Glioma,BRD-K47639036-003-06-6::2.5::HTS,6.94740569684425,0.0086310271823326,Other Types,flavoxate,acetylcholine receptor antagonist,"CHRM1, CHRM2"
Diffuse Glioma,BRD-K47780086-001-07-9::2.5::HTS,6.62995292629505,0.010287567268803836,Other Types,penciclovir,DNA directed DNA polymerase inhibitor,
Diffuse Glioma,BRD-K48488978-001-05-3::2.5::HTS,10.073579156624639,0.0015877322361954214,Diffuse Glioma,YM-201636,PI3K inhibitor,
Diffuse Glioma,BRD-K48830578-001-01-9::2.5::HTS,7.1219232396494485,0.007837838916870371,Other Types,OMDM-2,FAAH inhibitor,GPR119
Diffuse Glioma,BRD-K49049886-001-08-7::2.5::HTS,4.443366863351898,0.035485649883414926,Diffuse Glioma,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Diffuse Glioma,BRD-K49055432-001-04-2::2.5::HTS,4.509680825769193,0.03414287646624057,Diffuse Glioma,A66,PI3K inhibitor,PIK3CA
Diffuse Glioma,BRD-K49197823-001-09-8::2.5::HTS,5.1821853156331725,0.02320025531193607,Other Types,CV-1808,adenosine receptor agonist,ADORA2A
Diffuse Glioma,BRD-K49294207-300-03-8::2.5::HTS,13.822975409155331,0.00022137012634318537,Diffuse Glioma,BIBU-1361,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K49522529-001-02-9::2.53::HTS,5.155508277521441,0.023574753505382615,Diffuse Glioma,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Diffuse Glioma,BRD-K49522529-001-03-7::2.5::HTS,11.203184971750556,0.0008716643793952229,Diffuse Glioma,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Diffuse Glioma,BRD-K49671696-045-08-5::2.5::HTS,4.4220175941768645,0.03593019845354774,Other Types,ketanserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2"
Diffuse Glioma,BRD-K49811169-004-06-6::2.5::HTS,7.313400832392562,0.007053507949214972,Other Types,NSC-9965,acetylcholine receptor antagonist,"CHRNA4, CHRNB2"
Diffuse Glioma,BRD-K49865102-001-08-4::2.5::HTS,14.187967937006219,0.0001832293072975459,Diffuse Glioma,PD-0325901,MEK inhibitor,MAP2K1
Diffuse Glioma,BRD-K49880111-236-09-2::2.5::HTS,4.54195986727893,0.033510906321484596,Other Types,cephapirin,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K49962337-001-02-9::2.56::HTS,11.475442345665185,0.0007578217676655068,Other Types,baicalin,beta glucuronidase inhibitor,PREP
Diffuse Glioma,BRD-K50031829-001-01-6::2.5::HTS,5.653298006099056,0.017762769251808048,Other Types,PF-04447943,phosphodiesterase inhibitor,PDE9A
Diffuse Glioma,BRD-K50168500-001-07-9::2.5::HTS,10.344079315687923,0.0013742611271908452,Diffuse Glioma,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Diffuse Glioma,BRD-K50388907-001-30-4::2.5::HTS,15.385982248563465,9.896015162958991e-05,Diffuse Glioma,fenofibrate,PPAR receptor agonist,"MMP25, PPARA"
Diffuse Glioma,BRD-K50495309-001-02-0::2.5::HTS,9.27058085742947,0.00243828159613254,Diffuse Glioma,SRC-kinase-inhibitor-I,src inhibitor,"CSK, LCK, RIPK2"
Diffuse Glioma,BRD-K50564936-001-01-6::2.5::HTS,14.088566345984301,0.00019287957846534414,Diffuse Glioma,E-2012,gamma secretase modulator,"APH1A, APH1B, PSENEN"
Diffuse Glioma,BRD-K50938786-003-11-8::2.5::HTS,5.404530097572501,0.02044051534726994,Other Types,ropivacaine,sodium channel blocker,SCN10A
Diffuse Glioma,BRD-K51263939-001-08-6::2.5::HTS,5.845533481319169,0.01593656450663781,Other Types,sarcosine,Glycine transporter 1 inhibitor,SLC6A9
Diffuse Glioma,BRD-K51544265-001-04-2::2.5::HTS,7.477078888285148,0.006452628381759291,Other Types,cabozantinib,"RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET"
Diffuse Glioma,BRD-K51662849-001-08-8::2.61::HTS,8.554403616776957,0.003595586668225916,Other Types,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Diffuse Glioma,BRD-K52256627-300-06-6::2.5::HTS,9.594944445214812,0.002049444878531832,Other Types,chlorhexidine,membrane integrity inhibitor,
Diffuse Glioma,BRD-K52313696-001-12-3::2.5::HTS,7.576440833552087,0.006112896655158534,Diffuse Glioma,tacedinaline,HDAC inhibitor,HDAC1
Diffuse Glioma,BRD-K52618540-001-09-9::2.5::HTS,5.4941349360771685,0.019442641869703497,Other Types,inositol,insulin sensitizer,"CDIPT, GBA"
Diffuse Glioma,BRD-K52959329-238-01-9::2.5::HTS,8.085334194758353,0.0046248375095320066,Other Types,mitiglinide,insulin secretagogue,"ABCC8, KCNJ10, PPARG"
Diffuse Glioma,BRD-K53097745-001-01-5::2.5::HTS,4.107248553899777,0.04317145193110701,Other Types,pterostilbene,"cyclooxygenase inhibitor, PPAR receptor agonist",PTGS2
Diffuse Glioma,BRD-K53318339-001-24-9::2.5::HTS,5.424540333913908,0.02022434343241363,Other Types,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C"
Diffuse Glioma,BRD-K53734668-003-04-6::2.5::HTS,5.5771005914083975,0.018538791935042386,Diffuse Glioma,PRT062607,syk inhibitor,"FGR, MAP3K9, SYK"
Diffuse Glioma,BRD-K53814070-310-01-3::2.5::HTS,9.00427336552764,0.0028167531146775344,Other Types,ripasudil,rho associated kinase inhibitor,"ROCK1, ROCK2"
Diffuse Glioma,BRD-K54187111-001-08-4::2.51::HTS,9.42849685801505,0.002246377016030367,Diffuse Glioma,dichlorisone-acetate,,
Diffuse Glioma,BRD-K54187111-001-09-2::2.5::HTS,4.8123559537764145,0.028668100031298452,Diffuse Glioma,dichlorisone-acetate,,
Diffuse Glioma,BRD-K54330070-001-15-4::2.5::HTS,4.492983524488281,0.034478278252394516,Diffuse Glioma,SB-202190,p38 MAPK inhibitor,"AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1"
Diffuse Glioma,BRD-K54496168-003-01-2::2.5::HTS,9.595565814391813,0.0020496658438606,Other Types,propacetamol,cyclooxygenase inhibitor,PTGS2
Diffuse Glioma,BRD-K54606188-001-13-1::2.5::HTS,13.827770240545007,0.00022044391756081033,Diffuse Glioma,JQ1-(+),bromodomain inhibitor,"BRD4, BRDT"
Diffuse Glioma,BRD-K54936858-001-01-6::2.5::HTS,4.445274541996427,0.03545884870581625,Other Types,DMP-777,elastase inhibitor,MPO
Diffuse Glioma,BRD-K54997624-001-06-0::2.5::HTS,14.429428038986801,0.00016137104189842657,Diffuse Glioma,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K55127134-300-11-2::2.5::HTS,5.082402816078819,0.02455754237841414,Diffuse Glioma,fluphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7"
Diffuse Glioma,BRD-K56277358-001-07-5::2.5::HTS,5.96031023035931,0.014941124440920007,Other Types,MGCD-265,VEGFR inhibitor,"AXL, MET"
Diffuse Glioma,BRD-K56405753-001-02-4::2.5::HTS,5.399199377623141,0.020501789451519054,Other Types,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Diffuse Glioma,BRD-K56707426-001-02-0::2.5::HTS,4.25886691838423,0.03951112003265719,Other Types,nitarsone,,
Diffuse Glioma,BRD-K56751279-300-01-4::2.5::HTS,11.603120951421156,0.0007058188642671065,Other Types,Y-39983,rho associated kinase inhibitor,"ROCK1, ROCK2"
Diffuse Glioma,BRD-K57080016-001-15-9::2.5::HTS,10.746034837056698,0.0011095905870561677,Diffuse Glioma,selumetinib,MEK inhibitor,MAP2K1
Diffuse Glioma,BRD-K57169635-001-04-5::2.5::HTS,8.966656299735364,0.0028705467838655873,Diffuse Glioma,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Diffuse Glioma,BRD-K57313110-001-06-8::2.5::HTS,4.336999670975493,0.03774747305153944,Other Types,pidolic-acid,,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA"
Diffuse Glioma,BRD-K57597776-001-01-2::2.5::HTS,4.535998795108301,0.03362761675297926,Diffuse Glioma,org-27569,cannabinoid receptor modulator,CNR1
Diffuse Glioma,BRD-K58049875-001-04-7::2.5::HTS,6.595743765134387,0.010481349182599112,Other Types,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Diffuse Glioma,BRD-K58501140-002-01-0::2.5::HTS,4.3738205756659685,0.03694505907378136,Other Types,TAK-875,insulin secretagogue,FFAR1
Diffuse Glioma,BRD-K58772419-001-07-0::2.5::HTS,4.550554999715698,0.033343714422123104,Other Types,AZD6482,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K59204667-001-03-1::2.5::HTS,14.372469545855106,0.0001662903090838104,Diffuse Glioma,DBeQ,ATPase inhibitor,CASP3
Diffuse Glioma,BRD-K59506194-015-04-9::2.5::HTS,4.356416755226171,0.037321312608647926,Other Types,targinine,nitric oxide synthase inhibitor,NOS3
Diffuse Glioma,BRD-K59522102-001-14-6::2.5::HTS,8.441748617902693,0.003817664356662669,Other Types,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Diffuse Glioma,BRD-K59574735-001-11-8::2.5::HTS,4.686205945858376,0.03082746385160687,Other Types,ubenimex,leukotriene synthesis inhibitor,"LTA4H, RNPEP"
Diffuse Glioma,BRD-K59597909-001-17-6::2.5::HTS,7.889699416186105,0.005149771842074897,Other Types,phenothiazine,dopamine receptor antagonist,
Diffuse Glioma,BRD-K59831625-001-01-6::2.5::HTS,6.849405278980315,0.009105813981596699,Other Types,LDN-212854,bone morphogenic protein inhibitor,"ABL1, ACVR1, RIPK2"
Diffuse Glioma,BRD-K59998349-003-01-4::2.5::HTS,4.903473312956662,0.027210486522253295,Other Types,aminolevulinic-acid-benzyl-ester,,
Diffuse Glioma,BRD-K60585088-001-01-5::2.5::HTS,5.080552170398371,0.024581440304318615,Diffuse Glioma,paricalcitol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K61097567-001-08-5::2.5::HTS,5.148613376345315,0.023650059037115034,Other Types,SB-218795,tachykinin antagonist,TACR3
Diffuse Glioma,BRD-K61228301-001-01-2::2.5::HTS,7.496153117414289,0.00638010034673974,Diffuse Glioma,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Diffuse Glioma,BRD-K61279411-001-02-0::2.5::HTS,5.4493037340280255,0.019950181317051795,Other Types,oxaloacetate,glutamate release inhibitor,"CS, SPR"
Diffuse Glioma,BRD-K61452026-001-04-6::2.5::HTS,18.900463430910495,1.6351080489655176e-05,Diffuse Glioma,emtricitabine,nucleoside reverse transcriptase inhibitor,
Diffuse Glioma,BRD-K61496577-001-20-2::2.5::HTS,4.095798976891876,0.04346595213467189,Diffuse Glioma,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Diffuse Glioma,BRD-K61567297-001-01-9::2.5::HTS,8.893930783650458,0.0029852654580220105,Diffuse Glioma,resatorvid,toll-like receptor antagonist,TLR4
Diffuse Glioma,BRD-K61642990-001-01-0::2.5::HTS,4.1787524056293295,0.041406071128974944,Diffuse Glioma,FERb-033,EGFR inhibitor,ERBB2
Diffuse Glioma,BRD-K62213621-001-01-6::2.5::HTS,4.160241555782504,0.0418573742121311,Diffuse Glioma,dihydroartemisinin,antimalarial agent,
Diffuse Glioma,BRD-K62310379-001-10-5::2.5::HTS,9.958893865713183,0.0016880092584660887,Diffuse Glioma,fluticasone-propionate,glucocorticoid receptor agonist,"NR3C1, NR3C2, PGR, PLA2G4A"
Diffuse Glioma,BRD-K62412084-001-07-1::2.5::HTS,9.483669998789583,0.0021743688187526155,Diffuse Glioma,para-toluenesulfonamide,,"CA12, CA2, CA6, CA9"
Diffuse Glioma,BRD-K62427771-001-01-0::2.5::HTS,4.031595576875711,0.045140696468535094,Other Types,AS-77,potassium channel blocker,"KCNA3, KCNA5, KCNN4"
Diffuse Glioma,BRD-K62581435-001-03-8::2.5::HTS,8.454888155680768,0.0037844126949487,Other Types,3-MPPI,adrenergic receptor ligand,ADRA1A
Diffuse Glioma,BRD-K62929068-001-16-5::2.5::HTS,5.493497341433242,0.019436032540383053,Other Types,6-benzylaminopurine,purinergic receptor activator,
Diffuse Glioma,BRD-K63001556-001-08-8::2.5::HTS,6.318532419200751,0.012229724402805436,Other Types,orbifloxacin,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K63001556-001-09-6::2.57::HTS,4.0011752599555575,0.04597066100379061,Other Types,orbifloxacin,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K63068307-001-08-9::2.5::HTS,6.899392873393335,0.008861124848283487,Diffuse Glioma,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K63178091-001-01-1::2.5::HTS,4.406917863707036,0.03623967949633972,Diffuse Glioma,telotristat,tryptophan hydroxylase inhibitor,TPH1
Diffuse Glioma,BRD-K63516691-003-02-0::2.5::HTS,11.092973021680717,0.0009242492875723977,Other Types,T-0156,phosphodiesterase inhibitor,PDE5A
Diffuse Glioma,BRD-K63750851-001-20-7::2.5::HTS,8.966958505661928,0.00287051673136632,Diffuse Glioma,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Diffuse Glioma,BRD-K63806092-236-02-6::2.5::HTS,5.483257848658258,0.019547809070843008,Other Types,sitaxentan,endothelin receptor antagonist,EDNRA
Diffuse Glioma,BRD-K63828191-003-32-1::2.5::HTS,4.711146587461238,0.030385638728229983,Diffuse Glioma,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2"
Diffuse Glioma,BRD-K64052750-001-17-5::2.5::HTS,9.811559782512576,0.0018261211620081489,Diffuse Glioma,gefitinib,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K64538373-001-01-4::2.5::HTS,20.411980842281917,7.62793925499575e-06,Diffuse Glioma,Ro-4987655,MEK inhibitor,MAP2K1
Diffuse Glioma,BRD-K64659768-001-12-8::2.5::HTS,4.2328338853365235,0.04011330687941156,Other Types,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,
Diffuse Glioma,BRD-K64800655-001-07-4::2.5::HTS,5.116948842789868,0.024074347898014554,Diffuse Glioma,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Diffuse Glioma,BRD-K65170927-001-01-6::2.5::HTS,6.483336191854671,0.011162562529190003,Other Types,aprepitant,tachykinin antagonist,TACR1
Diffuse Glioma,BRD-K65377893-001-07-4::2.58::HTS,5.321580494081271,0.02144902911993877,Other Types,7-aminocephalosporanic-acid,beta lactamase inhibitor,
Diffuse Glioma,BRD-K65856711-001-04-4::2.5::HTS,9.168793998416563,0.0025767818666084337,Other Types,rolipram-S(+),phosphodiesterase inhibitor,
Diffuse Glioma,BRD-K65877271-001-01-8::2.5::HTS,6.30401884938597,0.01233428721747713,Diffuse Glioma,halobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Diffuse Glioma,BRD-K65890018-236-01-1::2.5::HTS,3.976555488977665,0.046623989432096356,Other Types,SSR128129E,,
Diffuse Glioma,BRD-K65992024-001-01-5::2.5::HTS,4.251620962376895,0.0396761807924522,Other Types,pirenoxine,AGE inhibitor,
Diffuse Glioma,BRD-K66094457-001-01-5::2.5::HTS,4.399681495107345,0.03641077734540107,Other Types,CPP,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Diffuse Glioma,BRD-K66175015-001-09-0::2.5::HTS,11.552825142698552,0.0007258526577211661,Diffuse Glioma,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Diffuse Glioma,BRD-K66296774-236-11-3::2.63::HTS,9.083064127950985,0.002701213798964071,Other Types,fluvastatin,HMGCR inhibitor,HMGCR
Diffuse Glioma,BRD-K66896231-001-08-1::2.5::HTS,4.738112666463863,0.02991843485779831,Other Types,ipidacrine,acetylcholinesterase inhibitor,ACHE
Diffuse Glioma,BRD-K66937583-001-01-2::2.5::HTS,6.458731143254923,0.011310837236003122,Other Types,lodoxamide,histamine receptor antagonist,
Diffuse Glioma,BRD-K67277431-002-10-5::2.5::HTS,3.9640809900439926,0.04697519136026644,Other Types,picotamide,"thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXA2R
Diffuse Glioma,BRD-K67304264-001-08-5::2.5::HTS,3.8863947604173514,0.04917156247695781,Other Types,SKA-31,potassium channel activator,KCNN4
Diffuse Glioma,BRD-K67566344-001-07-5::2.5::HTS,5.990659582127183,0.014691171080113965,Diffuse Glioma,ku-0063794,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K67977190-066-02-3::2.5::HTS,5.261673313711031,0.022178934377098253,Other Types,eprosartan,angiotensin receptor antagonist,AGTR1
Diffuse Glioma,BRD-K68174511-001-06-6::2.5::HTS,6.286499349339704,0.012447093151511344,Diffuse Glioma,torin-2,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K68336408-001-10-9::2.5::HTS,10.641379136213239,0.0011734066637894575,Diffuse Glioma,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Diffuse Glioma,BRD-K68538666-001-12-3::2.5::HTS,9.849589216419073,0.0017885818753171378,Other Types,aceclofenac,prostanoid receptor antagonist,PTGS2
Diffuse Glioma,BRD-K68938568-001-01-7::2.5::HTS,10.322429147031622,0.0013897621125986109,Other Types,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Diffuse Glioma,BRD-K69470111-236-08-9::2.5::HTS,6.939834418054923,0.008668919586097607,Other Types,montelukast,leukotriene receptor antagonist,"ALOX5, CYSLTR1"
Diffuse Glioma,BRD-K69688083-004-23-1::2.5::HTS,5.505663153721212,0.01930576660132349,Diffuse Glioma,mestinon,cholinesterase inhibitor,"ACHE, BCHE"
Diffuse Glioma,BRD-K69726342-238-02-4::2.5::HTS,10.122596162128737,0.001545759993538487,Other Types,atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR"
Diffuse Glioma,BRD-K70053378-001-01-1::2.5::HTS,4.069237793048649,0.044166175499358896,Other Types,SM-108,,
Diffuse Glioma,BRD-K70301465-001-02-6::2.5::HTS,18.84123155560861,1.6890369891465204e-05,Diffuse Glioma,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK"
Diffuse Glioma,BRD-K70327191-001-02-2::2.5::HTS,4.576477773072237,0.032847834301594984,Other Types,benzoxiquine,antiinfective drug,
Diffuse Glioma,BRD-K70402238-001-02-8::2.5::HTS,5.2826238758755775,0.021907428392369387,Diffuse Glioma,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Diffuse Glioma,BRD-K70463136-001-01-5::2.5::HTS,3.920823987698029,0.04818054853643789,Diffuse Glioma,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A
Diffuse Glioma,BRD-K70912147-001-01-8::2.5::HTS,8.182797382353044,0.004387929513544341,Other Types,co-102862,,"SCN4A, SCN9A"
Diffuse Glioma,BRD-K70914287-300-02-8::2.5::HTS,8.701688859264173,0.0033120235685152946,Diffuse Glioma,BIBX-1382,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K71059170-001-11-6::2.5::HTS,5.048101645365395,0.02504588167673253,Other Types,cefixime,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K71164191-001-01-0::2.5::HTS,12.025958399662645,0.0005653994073706904,Diffuse Glioma,KD-023,ACAT inhibitor,"ACACA, ACACB"
Diffuse Glioma,BRD-K71221037-001-01-6::2.5::HTS,4.2905949139205015,0.038781128162799564,Other Types,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Diffuse Glioma,BRD-K71289571-001-11-4::2.5::HTS,4.687581987828218,0.030802996624475335,Other Types,zafirlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2"
Diffuse Glioma,BRD-K71499074-001-12-9::2.5::HTS,4.603376981854433,0.03233756423002961,Other Types,diclofenamide,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA4, CA7"
Diffuse Glioma,BRD-K71799949-001-36-4::2.5::HTS,4.4801539184922525,0.03473107287024703,Other Types,carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Diffuse Glioma,BRD-K72005722-001-01-2::2.5::HTS,6.142394927236371,0.013491398568324629,Diffuse Glioma,VT-464,cytochrome P450 inhibitor,CYP17A1
Diffuse Glioma,BRD-K72222507-003-16-8::2.5::HTS,5.1903850088453085,0.023088003953023715,Other Types,quinapril,angiotensin converting enzyme inhibitor,ACE
Diffuse Glioma,BRD-K72231366-001-02-3::2.5::HTS,6.372281740463038,0.011865900605500659,Other Types,TAME,,
Diffuse Glioma,BRD-K72327355-001-14-7::2.5::HTS,8.893748930660598,0.0029873700424469522,Other Types,baicalein,lipoxygenase inhibitor,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH"
Diffuse Glioma,BRD-K72420232-001-12-3::2.5::HTS,5.438083540912778,0.02005973097734772,Diffuse Glioma,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K72723676-003-17-8::2.5::HTS,4.027104435488246,0.04525750181861386,Diffuse Glioma,benzethonium,sodium channel blocker,SCN10A
Diffuse Glioma,BRD-K72827473-001-01-0::2.5::HTS,6.017845283134267,0.014465692536475503,Diffuse Glioma,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Diffuse Glioma,BRD-K73073971-001-01-7::2.5::HTS,5.44101372014355,0.02002323940461737,Diffuse Glioma,ZLN005,,
Diffuse Glioma,BRD-K73191876-001-11-2::2.5::HTS,6.0825748919546125,0.01395828147196441,Other Types,alizarin,,
Diffuse Glioma,BRD-K73196317-003-14-8::2.5::HTS,4.957222589683719,0.02637891560617025,Other Types,urapidil,adrenergic receptor antagonist,HTR1A
Diffuse Glioma,BRD-K73234506-235-02-1::2.5::HTS,7.850123046816863,0.005259111510694238,Other Types,lithium-acetoacetate,,
Diffuse Glioma,BRD-K73237276-001-01-0::2.5::HTS,7.469904738386863,0.006472161194291902,Diffuse Glioma,tacalcitol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K73251053-003-22-2::2.5::HTS,6.112777944917929,0.013717832158967687,Other Types,clorgiline,monoamine oxidase inhibitor,MAOA
Diffuse Glioma,BRD-K73293050-001-03-1::2.5::HTS,4.901064632282543,0.02724664291948839,Diffuse Glioma,WZ-3146,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K73309154-003-02-8::2.5::HTS,14.554181550118292,0.0001512833731968868,Diffuse Glioma,OSI-420,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K73381198-001-01-1::2.5::HTS,4.802270067482104,0.02883939215876103,Other Types,5-fluoro-3-pyridyl-methanol,,
Diffuse Glioma,BRD-K73394555-237-01-1::2.5::HTS,4.26729426948934,0.03931054413915466,Other Types,oxolinic-acid,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K73771095-001-03-3::2.5::HTS,5.391123664223745,0.02060111144026472,Diffuse Glioma,geniposidic-acid,cyclooxygenase inhibitor,
Diffuse Glioma,BRD-K74186897-001-12-4::2.5::HTS,7.920799757425535,0.005070015777365352,Other Types,cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4"
Diffuse Glioma,BRD-K74195153-050-12-1::2.5::HTS,5.059180641134435,0.024889168411441735,Other Types,irsogladine,phosphodiesterase inhibitor,PDE4A
Diffuse Glioma,BRD-K74305673-001-06-2::2.5::HTS,4.015104380616488,0.04558261054653856,Diffuse Glioma,IKK-2-inhibitor-V,"IKK inhibitor, NFkB pathway inhibitor",IKBKB
Diffuse Glioma,BRD-K74363950-004-01-0::2.5::HTS,5.966874002795518,0.014885100154292143,Other Types,aclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Diffuse Glioma,BRD-K74371986-001-01-7::2.5::HTS,4.014854051343016,0.045590213535550754,Other Types,NSI-189,neurotrophic agent,
Diffuse Glioma,BRD-K74765201-001-16-7::0.25::HTS,5.325460523643067,0.02137841733382719,Other Types,tomelukast,leukotriene receptor antagonist,CYSLTR1
Diffuse Glioma,BRD-K74913225-001-12-4::2.5::HTS,10.03344615760853,0.001623166151356839,Other Types,brinzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7"
Diffuse Glioma,BRD-K75855670-001-14-2::2.5::HTS,11.95222526578957,0.0005874905943091597,Other Types,iodoquinol,antiseptic,
Diffuse Glioma,BRD-K75958547-238-01-0::2.5::HTS,16.43293990671135,5.753744350146954e-05,Other Types,pitavastatin,HMGCR inhibitor,HMGCR
Diffuse Glioma,BRD-K76037122-001-02-5::2.5::HTS,3.8736699315147947,0.04954030740064085,Other Types,guanidine,HSP inhibitor,"ALDH2, DLG4, GAMT, RNASE1"
Diffuse Glioma,BRD-K76064317-001-07-3::2.5::HTS,5.480181409723493,0.019583775453035395,Other Types,tyrphostin-AG-1296,FLT3 inhibitor,FLT3
Diffuse Glioma,BRD-K76205745-237-16-5::2.5::HTS,4.559233631555756,0.03318290343704973,Other Types,losartan,angiotensin receptor antagonist,AGTR1
Diffuse Glioma,BRD-K76239644-001-01-8::2.5::HTS,10.231715225781011,0.0014586334241567039,Diffuse Glioma,BMS-690514,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR"
Diffuse Glioma,BRD-K76304753-003-20-3::2.5::HTS,4.584031251049961,0.032719906142509046,Other Types,phenazopyridine,local anesthetic,SCN1A
Diffuse Glioma,BRD-K76677554-003-02-1::2.5::HTS,10.276856821392807,0.0014235912132283639,Other Types,AJ76-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Diffuse Glioma,BRD-K77008974-001-03-2::2.5::HTS,14.394145109177233,0.0001645860259914401,Diffuse Glioma,WYE-354,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K77251551-304-02-9::2.5::HTS,4.500891769149526,0.03431418843483726,Other Types,sodium-picosulfate,,
Diffuse Glioma,BRD-K77258318-001-04-6::2.5::HTS,10.303161191303072,0.0014044962552432405,Other Types,lactulose,laxative,
Diffuse Glioma,BRD-K77484724-001-02-0::2.5::HTS,7.317539501860689,0.007044525354532129,Other Types,adefovir,DNA polymerase inhibitor,
Diffuse Glioma,BRD-K77554836-001-14-0::2.5::HTS,4.527857177953464,0.033794680618042854,Diffuse Glioma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-K77625799-001-07-7::2.5::HTS,7.4958247560070355,0.00638018881896269,Diffuse Glioma,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Diffuse Glioma,BRD-K77641333-003-27-1::2.5::HTS,12.78881602665994,0.0003787427925069781,Other Types,naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A"
Diffuse Glioma,BRD-K77791657-001-01-1::2.5::HTS,6.375155292246424,0.011846922855767123,Diffuse Glioma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Diffuse Glioma,BRD-K77791657-003-01-7::2.67::HTS,8.107362713791796,0.0045802463833982485,Diffuse Glioma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Diffuse Glioma,BRD-K77908580-001-09-6::2.5::HTS,5.926307823999831,0.015227856150076364,Diffuse Glioma,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9"
Diffuse Glioma,BRD-K78010432-001-21-5::2.5::HTS,3.964043291207242,0.04697444297147827,Other Types,furosemide,diuretic,"CA2, GPR35, SLC12A1, SLC12A2"
Diffuse Glioma,BRD-K78118466-001-03-3::2.5::HTS,5.01704981074433,0.02548905614136189,Other Types,LY2157299,TGF beta receptor inhibitor,TGFBR1
Diffuse Glioma,BRD-K78809024-001-05-7::2.5::HTS,8.813821366289973,0.003117051027922854,Diffuse Glioma,SB-590885,RAF inhibitor,BRAF
Diffuse Glioma,BRD-K79095980-001-09-6::2.5::HTS,4.2659976983171015,0.039341135244829906,Diffuse Glioma,broxuridine,antimetabolite,
Diffuse Glioma,BRD-K79116891-003-15-1::2.5::HTS,7.09169080308544,0.00796819502386886,Other Types,proxymetacaine,sodium channel blocker,"SCN10A, SCN5A"
Diffuse Glioma,BRD-K79259477-001-04-9::2.5::HTS,16.884912599037428,4.565360116335057e-05,Diffuse Glioma,NVP-BHG712,ephrin inhibitor,EPHB4
Diffuse Glioma,BRD-K79315489-001-07-8::2.5::HTS,9.114924828678765,0.0026578780396353434,Other Types,erythritol,,
Diffuse Glioma,BRD-K79404599-001-09-3::2.5::HTS,6.433170552445024,0.011470387545425249,Other Types,enzastaurin,PKC inhibitor,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG"
Diffuse Glioma,BRD-K79595931-312-01-3::2.5::HTS,7.130057664261116,0.007803630086378397,Other Types,bavisant,histamine receptor antagonist,HRH3
Diffuse Glioma,BRD-K79930101-300-03-7::2.5::HTS,23.506371093699773,1.6135702657987105e-06,Diffuse Glioma,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Diffuse Glioma,BRD-K80060353-303-03-9::2.46::HTS,5.760347000189647,0.016737100777399365,Other Types,IEM1754,glutamate receptor antagonist,GRIA1
Diffuse Glioma,BRD-K80262108-001-07-0::2.5::HTS,4.668511321766676,0.0311446657458331,Other Types,amifampridine,potassium channel blocker,
Diffuse Glioma,BRD-K80343549-001-02-6::2.5::HTS,4.551110150644445,0.03334837442884227,Diffuse Glioma,TAK-285,EGFR inhibitor,ERBB2
Diffuse Glioma,BRD-K80431395-001-07-3::2.49::HTS,11.598872604122734,0.0007101589905183091,Diffuse Glioma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Diffuse Glioma,BRD-K80431395-001-09-9::2.5::HTS,14.391827591556574,0.0001656520988498456,Diffuse Glioma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Diffuse Glioma,BRD-K80608265-001-01-6::2.5::HTS,4.603434199209926,0.03237212559306429,Diffuse Glioma,erteberel,estrogen receptor agonist,"ESR1, ESR2"
Diffuse Glioma,BRD-K81074237-001-02-3::2.5::HTS,5.293464868726379,0.021781543855670875,Other Types,azilsartan,angiotensin receptor antagonist,"AGTR1, AGTR2"
Diffuse Glioma,BRD-K81128206-003-24-4::2.5::HTS,7.8679709498752874,0.005205967841733069,Diffuse Glioma,edrophonium,acetylcholinesterase inhibitor,"ACHE, BCHE"
Diffuse Glioma,BRD-K81144366-003-19-7::2.5::HTS,6.422777363234411,0.011537894838343813,Other Types,moxisylyte,adrenergic receptor antagonist,
Diffuse Glioma,BRD-K81225797-001-02-3::2.5::HTS,3.9260911375257908,0.04803181895116786,Diffuse Glioma,SCH-58261,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Diffuse Glioma,BRD-K81272440-236-13-5::2.5::HTS,5.421846948879743,0.020250500145036522,Other Types,dantrolene,calcium channel blocker,"RYR1, RYR3"
Diffuse Glioma,BRD-K81326768-001-04-0::2.5::HTS,5.7819779333022066,0.01651667842582202,Diffuse Glioma,zomepirac,prostaglandin synthesis inhibitor,PTGDR2
Diffuse Glioma,BRD-K81728688-001-04-4::2.5::HTS,3.9629840285129374,0.04700200806916803,Diffuse Glioma,WZ8040,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K82091397-001-03-0::2.5::HTS,7.605003444201634,0.006012770123223551,Diffuse Glioma,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Diffuse Glioma,BRD-K82143716-001-19-9::2.5::HTS,4.621799860269756,0.03200349678188358,Other Types,flucytosine,other antifungal,DNMT1
Diffuse Glioma,BRD-K82244583-001-01-3::2.5::HTS,17.19767972709292,3.912516334060609e-05,Diffuse Glioma,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Diffuse Glioma,BRD-K82731415-001-07-0::2.5::HTS,5.7934016358563785,0.016413767546293714,Other Types,olomoucine,CDK inhibitor,"CDK1, CDK2, CDK5, MAPK1"
Diffuse Glioma,BRD-K82846253-001-15-4::2.5::HTS,5.955176564633376,0.014998822783235902,Other Types,repaglinide,insulin secretagogue,"ABCC8, KCNJ11, PPARG"
Diffuse Glioma,BRD-K82928847-001-04-7::2.5::HTS,10.046835269532975,0.001611624942613925,Diffuse Glioma,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Diffuse Glioma,BRD-K82928892-001-02-5::2.46::HTS,8.145860688126366,0.004485480818044257,Diffuse Glioma,doxercalciferol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K82941592-238-04-5::2.5::HTS,7.50248986891805,0.006365342586007193,Other Types,rosuvastatin,HMGCR inhibitor,HMGCR
Diffuse Glioma,BRD-K82967685-300-01-2::2.5::HTS,8.35543879310959,0.004000340385310354,Other Types,mirodenafil,phosphodiesterase inhibitor,PDE5A
Diffuse Glioma,BRD-K83022601-001-01-0::2.5::HTS,4.197430494351455,0.04095759054268267,Other Types,CI-844,,
Diffuse Glioma,BRD-K83186168-001-01-8::2.5::HTS,3.9533997460106587,0.047278370158989565,Other Types,AZD1981,CRTH receptor antagonist,PTGDR2
Diffuse Glioma,BRD-K83834509-001-01-1::2.5::HTS,4.33889877582307,0.03770491311999003,Diffuse Glioma,PTC-209,BMI-1 inhibitor,
Diffuse Glioma,BRD-K84011460-051-01-7::2.5::HTS,6.532597397172605,0.010864709583593896,Other Types,nizofenone,ion channel antagonist,
Diffuse Glioma,BRD-K84163249-001-01-9::2.5::HTS,4.581343060191832,0.03277082315303269,Diffuse Glioma,ercalcitriol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K84214706-001-05-7::2.5::HTS,6.893848808946247,0.008884880062174515,Other Types,7-chlorokynurenic-acid,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C"
Diffuse Glioma,BRD-K84466663-001-05-4::2.5::HTS,6.278289566670781,0.012512522518946974,Other Types,nelarabine,"DNA synthesis inhibitor, T cell inhibitor",POLA1
Diffuse Glioma,BRD-K84564571-001-02-4::2.5::HTS,9.977050402667874,0.0016727079780314595,Other Types,telatinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Diffuse Glioma,BRD-K84698278-001-03-4::2.5::HTS,7.190907469707256,0.007552006936547396,Other Types,agomelatine,"melatonin receptor agonist, serotonin receptor antagonist","HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B"
Diffuse Glioma,BRD-K84748119-050-01-1::2.5::HTS,4.37762335759895,0.0368749225383219,Other Types,vicriviroc,CC chemokine receptor antagonist,CCR5
Diffuse Glioma,BRD-K85178109-001-02-3::2.5::HTS,7.71806702483816,0.005651110744371874,Other Types,fostamatinib,SYK inhibitor,SYK
Diffuse Glioma,BRD-K85333151-003-13-4::2.5::HTS,8.535025148069245,0.0036297940527137587,Other Types,ramifenazone,cyclooxygenase inhibitor,
Diffuse Glioma,BRD-K85337334-004-02-6::2.5::HTS,9.59365177163772,0.0020541941119181146,Other Types,otilonium,acetylcholine receptor antagonist,CACNA1C
Diffuse Glioma,BRD-K85479953-001-11-3::2.5::HTS,6.210102177556729,0.012993549607382061,Diffuse Glioma,STF-62247,autophagy inducer,
Diffuse Glioma,BRD-K85606544-001-09-1::2.5::HTS,9.509719386908214,0.002148570607986646,Diffuse Glioma,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Diffuse Glioma,BRD-K85751432-001-03-3::2.5::HTS,11.893335799687378,0.0006068319767418258,Diffuse Glioma,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Diffuse Glioma,BRD-K85920262-001-02-1::2.5::HTS,12.700055609871406,0.00039695776896971275,Diffuse Glioma,WAY-600,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K86118762-001-01-8::2.5::HTS,11.968043465300948,0.0005837224512238129,Diffuse Glioma,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Diffuse Glioma,BRD-K86161929-001-11-7::2.52::HTS,4.226933599260832,0.04027833014576111,Other Types,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-K86930074-001-05-0::2.5::HTS,5.373327189368488,0.020815559113059625,Other Types,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Diffuse Glioma,BRD-K87112191-001-04-5::2.5::HTS,4.972697141782925,0.02614606078486684,Diffuse Glioma,PP242,mTOR inhibitor,"MTOR, PASK"
Diffuse Glioma,BRD-K87124298-001-03-4::2.5::HTS,8.885171765103246,0.0030002958004759573,Diffuse Glioma,OSI-027,mTOR inhibitor,MTOR
Diffuse Glioma,BRD-K87535339-001-01-6::2.53::HTS,5.168278211863415,0.023387710013353186,Other Types,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,
Diffuse Glioma,BRD-K87990216-001-10-2::2.5::HTS,11.893396637910854,0.0006059342986029541,Other Types,piretanide,glucocorticoid receptor agonist,"SLC12A1, SLC12A2"
Diffuse Glioma,BRD-K88090157-050-10-8::2.5::HTS,8.687060266945979,0.0033387797471010295,Other Types,pimethixene,antihistamine,
Diffuse Glioma,BRD-K88186167-001-04-8::2.5::HTS,5.060951666484243,0.024856974000045554,Other Types,GW-4064,FXR agonist,NR1H4
Diffuse Glioma,BRD-K89014967-001-04-3::2.5::HTS,19.591890210141596,1.1539502920147616e-05,Diffuse Glioma,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Diffuse Glioma,BRD-K89055274-048-22-7::2.5::HTS,5.166570720846343,0.02341331614640208,Other Types,alverine,muscle relaxant,HTR1A
Diffuse Glioma,BRD-K89104321-003-14-8::2.5::HTS,4.93375480374191,0.026738337000194786,Other Types,gaboxadol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3"
Diffuse Glioma,BRD-K89162000-001-06-4::2.5::HTS,7.550195609313699,0.006194052951866894,Other Types,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB"
Diffuse Glioma,BRD-K89210380-001-13-7::2.5::HTS,4.431762415045631,0.03573311663292008,Other Types,biotin,vitamin B,"ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6"
Diffuse Glioma,BRD-K89299012-001-06-0::2.5::HTS,4.8023928081610645,0.02883735609273051,Other Types,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Diffuse Glioma,BRD-K89306950-001-12-5::2.5::HTS,4.130226377665257,0.04259342116911461,Other Types,ML130,NOD1 inhibitor,
Diffuse Glioma,BRD-K89348303-001-14-7::2.5::HTS,6.061013179128482,0.014120580944033538,Other Types,ramipril,angiotensin converting enzyme inhibitor,ACE
Diffuse Glioma,BRD-K89665618-003-02-5::2.5::HTS,5.661436024482502,0.01768077765223049,Other Types,1-deoxymannojirimycin,alpha mannosidase inhibitor,MAN2A1
Diffuse Glioma,BRD-K89712525-001-02-1::2.57::HTS,8.467668630152374,0.0037682136036429024,Other Types,2-oxoglutaric-acid,,OXGR1
Diffuse Glioma,BRD-K90027355-001-13-3::2.44::HTS,14.381747210849342,0.00016648348529700176,Diffuse Glioma,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG"
Diffuse Glioma,BRD-K90168339-001-08-6::2.5::HTS,5.10239690714612,0.02427797676353128,Other Types,thiophanate,,
Diffuse Glioma,BRD-K90333595-003-21-4::2.5::HTS,5.744657737410854,0.016864528067649882,Other Types,phentolamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Diffuse Glioma,BRD-K90374350-001-09-2::2.5::HTS,5.087904512786412,0.024488293604327988,Other Types,chlorquinaldol,other antibiotic,
Diffuse Glioma,BRD-K90647725-001-07-3::2.5::HTS,4.009985137578918,0.04574433903750159,Diffuse Glioma,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
Diffuse Glioma,BRD-K90993449-001-02-7::2.5::HTS,10.27178654608946,0.0014281365662580298,Other Types,KRN-633,VEGFR inhibitor,"FLT1, FLT4, KDR"
Diffuse Glioma,BRD-K91601245-001-12-0::2.5::HTS,9.15105337714379,0.002602754291387464,Diffuse Glioma,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT"
Diffuse Glioma,BRD-K91701654-001-03-1::2.38::HTS,6.644116796391687,0.01021841468289028,Diffuse Glioma,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Diffuse Glioma,BRD-K91822704-003-07-2::2.5::HTS,5.462113352321368,0.01979365197926896,Other Types,torcitabine,DNA polymerase inhibitor,"DCK, TK2"
Diffuse Glioma,BRD-K92107055-001-01-9::2.5::HTS,4.935871625768801,0.02670232826420307,Other Types,pimecrolimus,calcineurin inhibitor,"FKBP1A, MTOR"
Diffuse Glioma,BRD-K92446736-003-02-2::2.5::HTS,7.254353507084746,0.007286055696080556,Other Types,zatebradine,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Diffuse Glioma,BRD-K92758126-001-18-8::1.44::HTS,5.962403638944466,0.014922477695041592,Other Types,MD-920,NFkB pathway inhibitor,AADACL2
Diffuse Glioma,BRD-K92838188-001-01-9::2.5::HTS,3.906533080349274,0.048591589282012876,Other Types,rifaximin,RNA synthesis inhibitor,NR1I2
Diffuse Glioma,BRD-K92988025-001-01-9::2.5::HTS,4.813192322577183,0.0286777474840324,Other Types,perflubron,contrast agent,
Diffuse Glioma,BRD-K93188295-300-02-2::2.5::HTS,5.617365632771963,0.01812180225925801,Other Types,ARC-239,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C"
Diffuse Glioma,BRD-K93231391-300-05-6::2.5::HTS,4.369941897071248,0.03702696128065707,Other Types,ethambutol,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K93468883-001-02-0::2.5::HTS,7.804086375435536,0.005390581230897541,Other Types,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K93767137-001-01-1::2.5::HTS,4.242269899083157,0.03989104915319949,Other Types,oseltamivir-carboxylate,neuraminidase inhibitor,
Diffuse Glioma,BRD-K93869735-001-01-1::2.5::HTS,7.082641479390638,0.008015563218164731,Other Types,taltirelin,thyrotropin releasing hormone receptor agonist,TRHR
Diffuse Glioma,BRD-K94144010-001-13-9::2.5::HTS,5.661814606610529,0.01767395028839682,Other Types,cotinine,nicotine metabolite,
Diffuse Glioma,BRD-K94353609-001-21-6::2.5::HTS,9.302462035805993,0.002397297272221794,Diffuse Glioma,fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-K94379058-001-06-8::2.5::HTS,8.365431666127687,0.00397506786081026,Other Types,BML-190,cannabinoid receptor inverse agonist,CNR2
Diffuse Glioma,BRD-K94441233-001-13-0::2.6::HTS,19.563551564009366,1.1822637449659482e-05,Other Types,mevastatin,HMGCR inhibitor,HMGCR
Diffuse Glioma,BRD-K94441233-001-17-1::2.5::HTS,24.630823631745542,9.297115961597198e-07,Other Types,mevastatin,HMGCR inhibitor,HMGCR
Diffuse Glioma,BRD-K94485812-001-02-9::2.55::HTS,5.890102706521429,0.015559779364231457,Diffuse Glioma,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Diffuse Glioma,BRD-K94720315-001-10-4::2.5::HTS,7.803686413669959,0.005393366602291547,Other Types,chromocarb,antispasmodic,
Diffuse Glioma,BRD-K94723713-001-10-6::2.5::HTS,4.616129969499504,0.03210539332873214,Diffuse Glioma,rutaecarpine,cyclooxygenase inhibitor,PTGS2
Diffuse Glioma,BRD-K94780074-001-06-7::2.5::HTS,4.835804373732664,0.02830751246008641,Other Types,S-Nitrosoglutathione,nitric oxide stimulant,PTPN1
Diffuse Glioma,BRD-K95053546-001-02-7::2.5::HTS,5.4026530587872,0.02046811536862365,Other Types,tempol,free radical scavenger,
Diffuse Glioma,BRD-K95435023-001-10-1::2.5::HTS,8.032234124070667,0.004762789517326286,Other Types,PHA-665752,c-Met inhibitor,MET
Diffuse Glioma,BRD-K95739795-001-03-7::2.5::HTS,4.698748581195942,0.03060369498209247,Other Types,tetrabenazine,vesicular monoamine transporter inhibitor,"DRD2, SLC18A1, SLC18A2"
Diffuse Glioma,BRD-K95851186-001-07-8::2.5::HTS,5.813398597570245,0.016225465687180345,Other Types,CGP-13501,GABA receptor modulator,GABBR1
Diffuse Glioma,BRD-K96006502-001-02-6::2.5::HTS,4.307094038385514,0.03841460057343601,Diffuse Glioma,deflazacort,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-K96042922-001-09-8::2.5::HTS,6.618752529638471,0.010346546234241047,Other Types,etanidazole,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K96259238-001-01-4::2.5::HTS,5.763301595316191,0.01669009537316681,Other Types,Y-320,interleukin inhibitor,IL17A
Diffuse Glioma,BRD-K96319534-003-03-9::2.5::HTS,9.530501965880386,0.0021204879535357064,Other Types,phentermine,"dopamine uptake inhibitor, serotonin reuptake inhibitor","MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4"
Diffuse Glioma,BRD-K96550715-001-02-6::2.5::HTS,4.887077727925132,0.027461861357444117,Other Types,linagliptin,dipeptidyl peptidase inhibitor,DPP4
Diffuse Glioma,BRD-K96615647-001-01-2::2.5::HTS,12.984992654819305,0.0003418611881880095,Other Types,AV-608,tachykinin antagonist,TACR1
Diffuse Glioma,BRD-K96720755-001-02-6::2.5::HTS,5.075571326779712,0.02465150391388354,Other Types,relcovaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Diffuse Glioma,BRD-K96809896-300-02-3::2.5::HTS,12.198169283906676,0.0005165498687998099,Diffuse Glioma,SKF-86002,p38 MAPK inhibitor,"ALOX5, MAPK14"
Diffuse Glioma,BRD-K97056771-001-13-1::2.5::HTS,10.92091637141964,0.0010114110832990446,Other Types,GNF-2,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Diffuse Glioma,BRD-K97714174-001-01-3::2.5::HTS,5.591451236925028,0.018387222283005492,Diffuse Glioma,P22077,ubiquitin specific protease inhibitor,USP7
Diffuse Glioma,BRD-K97808269-001-02-7::2.5::HTS,5.723342579671475,0.01707305291240476,Other Types,2-deoxyglucose,glycolysis inhibitor,"SLC2A1, SLC2A2, SLC2A3, SLC2A4"
Diffuse Glioma,BRD-K98372770-001-08-2::2.5::HTS,4.220419221847864,0.04040886547423514,Diffuse Glioma,L-165041,PPAR receptor agonist,PPARD
Diffuse Glioma,BRD-K98548675-001-05-9::2.5::HTS,4.080236622038046,0.04386156270048106,Diffuse Glioma,parthenolide,NFkB pathway inhibitor,
Diffuse Glioma,BRD-K98572433-001-02-9::2.5::HTS,26.052518470203513,4.5587724353950756e-07,Diffuse Glioma,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Diffuse Glioma,BRD-K98769987-001-23-7::2.5::HTS,7.854182819433785,0.005250426877658733,Other Types,flumazenil,benzodiazepine receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
Diffuse Glioma,BRD-K99170882-001-04-3::2.5::HTS,4.409852179571158,0.03618029899393469,Diffuse Glioma,NSC-319726,p53 activator,
Diffuse Glioma,BRD-K99308954-304-02-4::2.5::HTS,11.524278887103609,0.0007385873312468147,Other Types,sodium-monofluorophosphate,,PYGM
Diffuse Glioma,BRD-K99615199-001-18-5::2.5::HTS,5.2466052427084025,0.02236170929529519,Diffuse Glioma,medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR"
Diffuse Glioma,BRD-K99964838-001-11-9::2.5::HTS,10.828272165134534,0.0010624993618706421,Diffuse Glioma,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Diffuse Glioma,BRD-M41245765-001-04-2::2.5::HTS,8.36136686727559,0.003990768244925722,Other Types,lithium-citrate,,
Diffuse Glioma,BRD-M54096567-001-01-9::2.5::HTS,4.840525441463247,0.028230844515884854,Other Types,sodium-gluconate,,
Diffuse Glioma,BRD-M56276249-001-01-1::2.5::HTS,5.567610212814461,0.018647348380457673,Other Types,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,
Diffuse Glioma,BRD-A10188456-001-04-9::2.5::MTS004,4.911146292855267,0.027100805774058646,Diffuse Glioma,dexamethasone,glucocorticoid receptor agonist,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2"
Diffuse Glioma,BRD-A13116749-003-01-6::2.713967431::MTS004,8.254101525681394,0.004226556636680894,Other Types,mabuterol,adrenergic receptor agonist,ADRB2
Diffuse Glioma,BRD-A48376327-003-01-5::2.426818202::MTS004,4.451918741920218,0.03532232144017032,Other Types,igmesine,sigma receptor agonist,SIGMAR1
Diffuse Glioma,BRD-A50675490-001-01-0::2.412483069::MTS004,5.203213599961119,0.02293446499976654,Other Types,carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Diffuse Glioma,BRD-A56892734-001-09-4::2.5::MTS004,4.496168075110113,0.03442702250285312,Other Types,omeprazole-magnesium,proton pump inhibitor,"ATP4A, ATP4B"
Diffuse Glioma,BRD-A73385064-001-01-5::2.603473418::MTS004,5.561233960836228,0.01871860820804268,Diffuse Glioma,beclomethasone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Diffuse Glioma,BRD-A78965079-036-01-8::2.640168331::MTS004,3.883547959295324,0.04927269752068062,Diffuse Glioma,tafenoquine,antimalarial agent,
Diffuse Glioma,BRD-A84810646-001-01-6::2.500007302::MTS004,6.209962444382204,0.013003262890845559,Other Types,ginsenoside-rd,calcium channel blocker,
Diffuse Glioma,BRD-A88562598-001-01-7::2.500008795::MTS004,6.757172205707427,0.009593511944047192,Other Types,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Diffuse Glioma,BRD-A92177080-001-02-1::2.5::MTS004,5.338202695174839,0.021239654627513056,Diffuse Glioma,betamethasone-acetate,glucocorticoid receptor agonist,NR3C1
Diffuse Glioma,BRD-A92341659-001-04-0::2.499993321::MTS004,10.883557204466443,0.0010342867726358296,Other Types,prulifloxacin,bacterial DNA gyrase inhibitor,
Diffuse Glioma,BRD-K02152879-414-02-1::2.500013375::MTS004,5.949674261311875,0.015042144830606778,Diffuse Glioma,sivelestat,elastase inhibitor,"CELA1, ELANE"
Diffuse Glioma,BRD-K02528732-001-02-4::2.425128585::MTS004,7.161219864301009,0.007676737409790291,Diffuse Glioma,fluorometholone-acetate,,NR3C1
Diffuse Glioma,BRD-K03765900-001-01-9::2.499986292::MTS004,12.04817369255924,0.0005600749252317192,Diffuse Glioma,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Diffuse Glioma,BRD-K04701033-001-04-7::2.499987566::MTS004,4.935485951265599,0.026725234460675828,Diffuse Glioma,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Diffuse Glioma,BRD-K06519765-001-01-1::2.5::MTS004,4.23755225247204,0.04001920221936947,Other Types,vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1"
Diffuse Glioma,BRD-K13060017-001-02-1::2.499994836::MTS004,10.570123250239675,0.0012211115176694563,Other Types,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Diffuse Glioma,BRD-K13394247-003-01-4::2.499991328::MTS004,6.5760114863418115,0.010606512852303334,Other Types,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3
Diffuse Glioma,BRD-K14171291-001-01-4::2.499985403::MTS004,4.535880608061505,0.03364461416564284,Other Types,omarigliptin,dipeptidyl peptidase inhibitor,DPP4
Diffuse Glioma,BRD-K14571191-001-01-6::2.5::MTS004,8.580592382936826,0.003541472928696498,Other Types,zometapine,,
Diffuse Glioma,BRD-K16180792-001-01-7::2.5::MTS004,3.9035851276974767,0.04869277072517052,Other Types,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Diffuse Glioma,BRD-K17295893-001-01-0::2.499987615::MTS004,5.267008376268909,0.022117365787958535,Other Types,nastorazepide,CCK receptor antagonist,CCKBR
Diffuse Glioma,BRD-K20468903-001-01-6::2.49996519::MTS004,4.62740666713782,0.03190885998640468,Other Types,BNC105,tubulin polymerization inhibitor,
Diffuse Glioma,BRD-K21077415-001-01-5::2.656085278::MTS004,4.618349267192933,0.03207629152985116,Other Types,AMG-319,PI3K inhibitor,PIK3CD
Diffuse Glioma,BRD-K21152241-001-07-3::2.5082643::MTS004,5.498501864671398,0.019394648676667087,Other Types,enoximone,phosphodiesterase inhibitor,PDE3A
Diffuse Glioma,BRD-K21191422-001-01-5::2.499985534::MTS004,6.975215772367447,0.008504868722184852,Other Types,selexipag,"platelet aggregation inhibitor, IP1 prostacyclin receptor agonist",PTGIR
Diffuse Glioma,BRD-K22514639-001-05-7::2.500015058::MTS004,7.367958287638283,0.006852325190870787,Diffuse Glioma,EGF816,EGFR inhibitor,EGFR
Diffuse Glioma,BRD-K22588750-001-07-0::2.654665484::MTS004,6.075986366240791,0.014014426647637041,Other Types,gidazepam,GABA benzodiazepine site receptor agonist,
Diffuse Glioma,BRD-K23848629-401-03-7::2.5::MTS004,7.05971682192485,0.008117407410225316,Diffuse Glioma,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1
Diffuse Glioma,BRD-K24666289-001-04-9::2.499988887::MTS004,6.442903847768125,0.011419959069718398,Diffuse Glioma,copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Diffuse Glioma,BRD-K25570267-001-01-4::2.436963824::MTS004,5.826574908742112,0.01611815014539254,Other Types,ezutromid,utrophin enhancer,UTRN
Diffuse Glioma,BRD-K25970317-001-01-6::2.50000335::MTS004,12.705755575864025,0.0003969703130019194,Other Types,resibufogenin,Na/K-ATPase inhibitor,
Diffuse Glioma,BRD-K26026438-001-01-0::2.499979456::MTS004,10.285466613831252,0.001420542848993214,Diffuse Glioma,tucatinib,EGFR inhibitor,ERBB2
Diffuse Glioma,BRD-K27293958-001-01-5::2.450321909::MTS004,7.8048106208762364,0.005396445140441015,Other Types,tiaramide,anti-inflammatory agent,
Diffuse Glioma,BRD-K27515606-003-01-3::2.5::MTS004,21.294885923758358,4.9264162861043485e-06,Other Types,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
Diffuse Glioma,BRD-K29812331-011-01-7::2.472474424::MTS004,6.9209275831487576,0.008763462216510387,Other Types,dimemorfan,sigma receptor agonist,SIGMAR1
Diffuse Glioma,BRD-K30968378-001-01-9::2.500026128::MTS004,7.007053275472536,0.008356872928659876,Other Types,INT-747,FXR agonist,
Diffuse Glioma,BRD-K34251960-036-01-6::2.459743274::MTS004,5.671572872060945,0.01758813571168869,Other Types,cibenzoline,sodium channel blocker,
Diffuse Glioma,BRD-K36636143-001-01-0::2.518926249::MTS004,5.431463967211853,0.020145135833937348,Other Types,nolatrexed,thymidylate synthase inhibitor,TYMS
Diffuse Glioma,BRD-K39009484-001-01-4::2.5::MTS004,10.652339557593773,0.0011691509942808628,Diffuse Glioma,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Diffuse Glioma,BRD-K42140276-402-01-4::2.500009363::MTS004,4.1976327483812605,0.04096414755281801,Other Types,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
Diffuse Glioma,BRD-K44164034-003-01-1::2.54181785::MTS004,5.644890247848674,0.017855513751426574,Other Types,pumosetrag,serotonin receptor agonist,"HTR3A, HTR4"
Diffuse Glioma,BRD-K44471774-001-01-8::2.670187358::MTS004,6.5295194523364435,0.010883295519917307,Diffuse Glioma,bay-w-9798,antioxidant,
Diffuse Glioma,BRD-K49659468-436-01-2::2.500002467::MTS004,10.910029792566256,0.0010199019196243703,Other Types,TMC647055,RNA polymerase inhibitor,
Diffuse Glioma,BRD-K50010139-001-02-3::2.5::MTS004,9.93289621056333,0.0017137412148532385,Diffuse Glioma,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Diffuse Glioma,BRD-K51784806-001-01-6::2.297010706::MTS004,4.190258612201814,0.04114216034661758,Other Types,alacepril,angiotensin converting enzyme inhibitor,ACE
Diffuse Glioma,BRD-K55029398-001-01-6::2.499962393::MTS004,5.466071625320041,0.019754695162942905,Diffuse Glioma,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2
Diffuse Glioma,BRD-K56211775-001-03-8::2.5::MTS004,7.05404146157655,0.008143262992413719,Other Types,RTA-408,nitric oxide production inhibitor,NFE2L2
Diffuse Glioma,BRD-K56429665-001-09-6::2.500032186::MTS004,6.613310734015316,0.010388810021049598,Diffuse Glioma,calcipotriol,vitamin D receptor agonist,VDR
Diffuse Glioma,BRD-K56912469-003-02-0::2.499992214::MTS004,9.128021694405998,0.0026367220838210913,Other Types,SAR407899,rho associated kinase inhibitor,ROCK1
Diffuse Glioma,BRD-K56981171-001-01-0::2.500008954::MTS004,4.168455940213619,0.04167055372469201,Diffuse Glioma,brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR"
Diffuse Glioma,BRD-K57427145-001-01-6::2.5::MTS004,5.701877802100594,0.017290195091007623,Other Types,ripazepam,benzodiazepine receptor agonist,GABRA1
Diffuse Glioma,BRD-K57774929-001-01-3::2.643351543::MTS004,4.5205349881320975,0.03394419588314442,Diffuse Glioma,foropafant,platelet activating factor receptor antagonist,PTAFR
Diffuse Glioma,BRD-K57886322-001-16-6::2.5::MTS004,11.555873925379608,0.000725438046635929,Diffuse Glioma,fluocinonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6, SMO"
Diffuse Glioma,BRD-K58810291-001-16-2::2.564588683::MTS004,10.475004416161152,0.0012843288835110414,Diffuse Glioma,clobetasone-butyrate,corticosteroid agonist,NR3C1
Diffuse Glioma,BRD-K59753975-001-02-6::2.5::MTS004,5.6511208803911686,0.017792207809790798,Other Types,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Diffuse Glioma,BRD-K60284353-001-01-3::2.5::MTS004,4.429070240102378,0.03579414749959679,Other Types,titanocene-dichloride,apoptosis stimulant,
Diffuse Glioma,BRD-K61496577-001-19-4::2.5::MTS004,4.249757483752583,0.039735782636617735,Diffuse Glioma,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Diffuse Glioma,BRD-K62374002-001-01-5::2.499972663::MTS004,15.920610888089263,7.519180625430504e-05,Diffuse Glioma,PI3K-IN-2,PI3K inhibitor,
Diffuse Glioma,BRD-K66845263-001-03-0::2.5::MTS004,5.117687700778931,0.024080492868015037,Other Types,sophocarpine,,
Diffuse Glioma,BRD-K70504253-001-01-3::2.500017504::MTS004,5.334268406951228,0.02128716273343551,Other Types,fruquintinib,VEGFR inhibitor,KDR
Diffuse Glioma,BRD-K70592963-001-31-6::2.5::MTS004,5.0331586485850055,0.025271828597258836,Other Types,phenindione,vitamin K antagonist,VKORC1
Diffuse Glioma,BRD-K70601687-001-01-3::2.500008826::MTS004,7.234945079064771,0.007371819926051921,Diffuse Glioma,enasidenib,isocitrate dehydrogenase inhibitor,IDH1
Diffuse Glioma,BRD-K72259270-003-25-6::2.444857586::MTS004,9.787434210224507,0.00185207730616087,Other Types,dyclonine,sodium channel blocker,"SCN10A, SCN5A"
Diffuse Glioma,BRD-K72280606-001-01-2::2.499993939::MTS004,5.396685072429103,0.02054629239146542,Diffuse Glioma,gilteritinib,FLT3 inhibitor,FLT3
Diffuse Glioma,BRD-K77320845-001-01-2::2.29566066::MTS004,4.155035643875662,0.041998442514913414,Other Types,secoisolariciresinol-diglucoside,antioxidant,
Diffuse Glioma,BRD-K79821389-001-03-5::2.562009205::MTS004,10.88796549597908,0.0010319983308971783,Diffuse Glioma,rubitecan,topoisomerase inhibitor,TOP1
Diffuse Glioma,BRD-K80353807-001-25-3::2.5::MTS004,6.6020538425711575,0.010453874088316719,Other Types,khellin,vasodilator,
Diffuse Glioma,BRD-K80359953-001-01-3::2.500041136::MTS004,7.334887883393519,0.006977776227237884,Other Types,talampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Diffuse Glioma,BRD-K80859331-001-01-5::2.5::MTS004,3.9715386795359087,0.04678016069500122,Diffuse Glioma,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Diffuse Glioma,BRD-K84868168-001-01-0::2.500006364::MTS004,8.712232673773789,0.003298692025025795,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Diffuse Glioma,BRD-K87465484-001-02-7::2.5::MTS004,4.3606561734561184,0.03724776386163872,Other Types,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
Diffuse Glioma,BRD-K89920762-001-01-4::2.500013597::MTS004,4.804301124035886,0.028815794713245423,Other Types,paritaprevir,HCV inhibitor,
Diffuse Glioma,BRD-K90563805-001-02-6::2.5::MTS004,5.6819714311138165,0.017485308635895088,Other Types,natamycin,fungal ergosterol inhibitor,
Diffuse Glioma,BRD-K91900765-001-07-6::2.500030257::MTS004,5.43227481014224,0.02013656666462452,Other Types,VX-745,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK14"
Diffuse Glioma,BRD-K94072573-001-09-9::2.5::MTS004,8.703124575189687,0.00331468770464156,Other Types,medronic-acid,bone resorption inhibitor,
Diffuse Glioma,BRD-K95941975-001-01-5::2.5::MTS004,4.208321982951335,0.040708838685888045,Other Types,piperazinedione,DNA synthesis inhibitor,
Diffuse Glioma,BRD-K96669468-300-01-1::2.5::MTS004,4.863605069083389,0.027850353191186006,Other Types,pyridoxamine,AGE inhibitor,
Diffuse Glioma,BRD-K96691275-001-01-2::2.5::MTS004,4.371879946124576,0.03700524738829778,Other Types,mebrofenin,,
Diffuse Glioma,BRD-K98557884-001-01-6::2.5::MTS004,5.303967448117065,0.02165677730443367,Other Types,suritozole,GABA receptor inverse agonist,GABBR1
Diffuse Glioma,BRD-K99506538-001-03-8::2.5::MTS004,5.541846498538846,0.01892489166420099,Other Types,xenalipin,,
Diffuse Glioma,BRD-K99616396-001-05-1::2.499991421::MTS004,9.837446143581849,0.001803278606630684,Other Types,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT1, FLT4, KDR, KIT"
Diffuse Glioma,BRD-K99919177-001-01-3::2.5::MTS004,5.213313761153544,0.022802920693606576,Other Types,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Ewing Sarcoma,BRD-A00147595-001-01-5::2.5::HTS,5.015317605506591,0.025517847663150923,Other Types,balaglitazone,"insulin sensitizer, PPAR receptor partial agonist",PPARG
Ewing Sarcoma,BRD-A01636364-003-15-1::2.5::HTS,3.8799369929162046,0.04936143930221713,Other Types,bupivacaine,sodium channel blocker,"KCNA5, PTGER1, SCN10A, SCN4A"
Ewing Sarcoma,BRD-A03216249-003-24-3::2.5::HTS,5.030202966940529,0.025302861084530753,Other Types,mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A
Ewing Sarcoma,BRD-A05523972-001-01-5::2.5::HTS,4.572595614521759,0.032921717846292324,Other Types,telmesteine,mucolytic agent,
Ewing Sarcoma,BRD-A06627858-236-03-0::2.5::HTS,4.588302843516592,0.032623075701118893,Other Types,monensin,bacterial permeability inducer,
Ewing Sarcoma,BRD-A06935312-001-04-3::2.5::HTS,5.280523844153868,0.021934937617001854,Other Types,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
Ewing Sarcoma,BRD-A07164067-001-01-2::2.5::HTS,4.946473568767059,0.026542647435478683,Ewing Sarcoma,meluadrine,,
Ewing Sarcoma,BRD-A07780951-001-08-9::2.5::HTS,9.888062480127639,0.0017525388390225913,Other Types,metaproterenol,adrenergic receptor agonist,ADRB2
Ewing Sarcoma,BRD-A07780951-065-10-0::2.58::HTS,6.105223813983628,0.013794121620819503,Other Types,metaproterenol,adrenergic receptor agonist,ADRB2
Ewing Sarcoma,BRD-A08187463-001-12-9::2.5::HTS,17.7032023847377,3.0241497967173905e-05,Other Types,racecadotril,enkephalinase inhibitor,MME
Ewing Sarcoma,BRD-A08840375-001-01-3::2.5::HTS,8.670209317941271,0.0033723036887120176,Other Types,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Ewing Sarcoma,BRD-A09722536-002-18-0::2.5::HTS,5.9670645931231405,0.014885173800800792,Other Types,cyclophosphamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Ewing Sarcoma,BRD-A10039652-001-01-2::2.5::HTS,9.952729383964932,0.0016977835126686224,Other Types,tipranavir,HIV protease inhibitor,
Ewing Sarcoma,BRD-A10652366-238-04-1::2.5::HTS,5.103421542982319,0.024285706606395025,Other Types,fosfomycin,bacterial cell wall synthesis inhibitor,
Ewing Sarcoma,BRD-A11070335-236-02-1::2.5::HTS,4.503338639730168,0.03426630946747081,Other Types,carbazochrome,,
Ewing Sarcoma,BRD-A11662333-001-03-3::2.5::HTS,4.283458148571267,0.038972619525923964,Other Types,meparfylon,,
Ewing Sarcoma,BRD-A13323580-001-04-8::2.5::HTS,4.260365433911999,0.039489514461991775,Other Types,perillyl-alcohol,"apoptosis stimulant, farnesyltransferase inhibitor",FNTA
Ewing Sarcoma,BRD-A13964793-001-02-6::2.5::HTS,5.264472739307603,0.02213614509410714,Ewing Sarcoma,TC1,beta-secretase inhibitor,BACE1
Ewing Sarcoma,BRD-A16347691-001-13-1::2.5::HTS,5.051413735032869,0.024994977397042782,Other Types,thioctic-acid,reducing agent,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6"
Ewing Sarcoma,BRD-A17883755-001-06-1::2.5::HTS,6.577486402444993,0.010587168969280643,Other Types,lenalidomide,anticancer agent,"CDH5, CRBN, PTGS2, TNF, TNFSF11"
Ewing Sarcoma,BRD-A18043272-001-09-9::2.5::HTS,6.604287758160515,0.010430844000233048,Other Types,phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Ewing Sarcoma,BRD-A18696154-003-22-6::2.5::HTS,6.0123472375795295,0.014525811908064939,Other Types,idazoxan,adrenergic receptor antagonist,ADRA2A
Ewing Sarcoma,BRD-A24587114-066-22-5::2.5::HTS,6.210513704337779,0.012988467419345034,Other Types,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Ewing Sarcoma,BRD-A25004090-001-08-4::2.5::HTS,8.731594417698188,0.003259444659564234,Other Types,erastin,ion channel antagonist,VDAC2
Ewing Sarcoma,BRD-A25608658-001-01-1::2.5::HTS,3.868497943920184,0.049695627539549335,Other Types,narasin,antiprotozoal agent,
Ewing Sarcoma,BRD-A28329383-001-02-1::2.5::HTS,6.477148443719494,0.011197046228087898,Other Types,MTPG,glutamate receptor antagonist,"GRM2, GRM3"
Ewing Sarcoma,BRD-A29426959-050-13-2::2.5::HTS,7.011829789873925,0.008326744651451837,Other Types,carbinoxamine,histamine receptor antagonist,HRH1
Ewing Sarcoma,BRD-A30403214-001-03-3::0.25::HTS,5.544408462937598,0.018886528727906828,Other Types,edelfosine,phospholipase inhibitor,
Ewing Sarcoma,BRD-A30582499-003-05-1::2.5::HTS,8.451462750004845,0.0037976444766341664,Other Types,tiletamine,glutamate receptor antagonist,
Ewing Sarcoma,BRD-A31811760-001-06-7::2.5::HTS,7.84933275156401,0.005262350594525749,Ewing Sarcoma,miltefosine,membrane integrity inhibitor,PLA2G1B
Ewing Sarcoma,BRD-A34255068-001-34-5::2.5::HTS,6.049168430381838,0.014217301567727141,Other Types,rolipram,phosphodiesterase inhibitor,
Ewing Sarcoma,BRD-A34751532-001-06-9::2.5::HTS,4.64921254238401,0.03149675149662273,Other Types,homosalate,HSP inducer,
Ewing Sarcoma,BRD-A36267905-003-18-4::2.5::HTS,5.739477189771573,0.0169277862160397,Other Types,buphenine,adrenergic receptor agonist,ADRB2
Ewing Sarcoma,BRD-A39935389-001-05-9::2.5::HTS,27.38766107990909,2.3589699648440152e-07,Other Types,teroxirone,DNA inhibitor,
Ewing Sarcoma,BRD-A40787240-066-04-6::2.5::HTS,5.103809673922798,0.024266879301669455,Other Types,gemifloxacin,bacterial DNA gyrase inhibitor,
Ewing Sarcoma,BRD-A40940854-001-01-1::2.5::HTS,4.478026125274399,0.034776360353234996,Other Types,ibuproxam,"cyclooxygenase inhibitor, prostaglandin inhibitor",ALOX5
Ewing Sarcoma,BRD-A41995253-001-04-5::2.5::HTS,4.8838362592750695,0.027515191254105797,Other Types,brucine,glycine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Ewing Sarcoma,BRD-A42699921-001-03-6::2.6::HTS,9.420207161051064,0.002254295843046361,Other Types,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH
Ewing Sarcoma,BRD-A43671941-003-11-9::2.5::HTS,3.9899986250386665,0.04625614209806929,Other Types,oxprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Ewing Sarcoma,BRD-A43885598-001-08-1::2.5::HTS,6.506217405824654,0.011030833369576805,Other Types,SID-7969543,steroidogenic factor antagonist,NR5A1
Ewing Sarcoma,BRD-A43930669-003-02-8::2.5::HTS,5.913485178001426,0.01533901050535402,Other Types,L-368899,oxytocin receptor antagonist,"AVPR1A, AVPR2, OXTR"
Ewing Sarcoma,BRD-A44696962-001-01-4::2.5::HTS,5.939094988827683,0.015120619844948762,Other Types,acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,"HSD11B1, HSD11B2"
Ewing Sarcoma,BRD-A45498368-001-07-1::2.5::HTS,7.062778885242689,0.008095726597403811,Other Types,WYE-125132,mTOR inhibitor,MTOR
Ewing Sarcoma,BRD-A46186775-369-02-0::2.5::HTS,6.4085784216039885,0.011630917480446229,Other Types,hydrocortisone-phosphate,,"ANXA1, NOS2, NR3C1"
Ewing Sarcoma,BRD-A47449001-004-13-7::2.5::HTS,4.08505811443881,0.04373753324628431,Other Types,ipratropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Ewing Sarcoma,BRD-A47494775-003-11-3::2.5::HTS,7.897593546810922,0.005125082849972783,Other Types,dipivefrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE"
Ewing Sarcoma,BRD-A48237631-001-04-8::2.5::HTS,5.718076825076789,0.017125002565872998,Other Types,mitomycin-c,"DNA alkylating agent, DNA synthesis inhibitor",
Ewing Sarcoma,BRD-A48720949-001-04-0::2.5::HTS,8.34220560150691,0.004024048645237654,Other Types,testosterone-propionate,androgen receptor agonist,AR
Ewing Sarcoma,BRD-A51355958-003-01-9::2.5::HTS,4.531494465929985,0.03371707654268111,Other Types,nebracetam,acetylcholine receptor agonist,CHRM1
Ewing Sarcoma,BRD-A51714012-003-13-6::2.5::HTS,6.214032233578693,0.012973193763157155,Other Types,venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4"
Ewing Sarcoma,BRD-A51820102-008-28-9::2.5::HTS,8.746099587241638,0.003234499292147613,Other Types,econazole,"lanosterol demethylase inhibitor, sterol demethylase inhibitor","CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5"
Ewing Sarcoma,BRD-A54927599-001-16-9::2.5::HTS,12.344982925826855,0.0004784253559326062,Other Types,KF-38789,P selectin inhibitor,SELP
Ewing Sarcoma,BRD-A55424491-001-19-9::2.5::HTS,16.72887896134307,4.955542388511085e-05,Other Types,methotrexate,dihydrofolate reductase inhibitor,DHFR
Ewing Sarcoma,BRD-A61676498-001-06-6::2.5::HTS,7.453774236486076,0.006529632446296764,Other Types,climbazole,enzyme inducer,
Ewing Sarcoma,BRD-A62209527-001-04-5::2.5::HTS,4.960338441032086,0.026332567502077533,Ewing Sarcoma,ZM-226600,Kir6 channel (KATP) activator,
Ewing Sarcoma,BRD-A64977602-001-15-9::2.5::HTS,5.744157852147722,0.016872211641350908,Other Types,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Ewing Sarcoma,BRD-A65145453-001-06-1::2.5::HTS,4.111863747890593,0.04306410919469685,Other Types,ATPA,glutamate receptor agonist,"GRIA2, GRIK1"
Ewing Sarcoma,BRD-A65767837-001-04-4::2.5::HTS,6.966318440563989,0.008538441412472727,Other Types,hydrocortisone-acetate,glucocorticoid receptor agonist,"NR3C1, NR3C2"
Ewing Sarcoma,BRD-A67516570-001-02-8::2.5::HTS,4.521832708623727,0.03390399808207629,Other Types,lafutidine,histamine receptor antagonist,HRH2
Ewing Sarcoma,BRD-A68493689-001-01-9::2.5::HTS,4.462620444585679,0.0350911253995162,Ewing Sarcoma,simeprevir,HCV inhibitor,"CYP1A2, CYP3A4"
Ewing Sarcoma,BRD-A68589262-001-04-3::2.5::HTS,3.8698220809441177,0.04966760412918352,Other Types,troxipide,glucosamine synthetase stimulant,
Ewing Sarcoma,BRD-A68631409-001-05-4::2.5::HTS,5.663488096879055,0.01765909304900553,Other Types,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1
Ewing Sarcoma,BRD-A73871920-236-03-6::2.5::HTS,7.831212230611283,0.005312983399494348,Other Types,nanchangmycin,other antibiotic,
Ewing Sarcoma,BRD-A74914197-001-02-9::2.5::HTS,14.138285964121547,0.00018797290596918263,Other Types,pralatrexate,dihydrofolate reductase inhibitor,"DHFR, TYMS"
Ewing Sarcoma,BRD-A75479906-001-02-4::2.5::HTS,11.127085022428211,0.0009069098787142036,Other Types,rimantadine,"antiviral, RNA synthesis inhibitor",
Ewing Sarcoma,BRD-A77218119-001-03-5::2.5::HTS,5.197662626376359,0.022993115968802328,Ewing Sarcoma,SYM-2206,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Ewing Sarcoma,BRD-A78952587-001-01-5::2.5::HTS,3.8973517801444855,0.048858579178508846,Ewing Sarcoma,A740003,purinergic receptor antagonist,P2RX7
Ewing Sarcoma,BRD-A84174393-236-07-1::2.5::HTS,6.583469491082015,0.01056220916216823,Other Types,meloxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Ewing Sarcoma,BRD-A86216746-046-02-6::2.5::HTS,5.525644415606299,0.01909643392685248,Other Types,varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Ewing Sarcoma,BRD-A86619021-001-04-8::2.5::HTS,5.994255340590653,0.014659912744086732,Other Types,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Ewing Sarcoma,BRD-A87130939-001-07-9::2.5::HTS,4.556838721867421,0.033239645701209665,Other Types,masoprocol,lipoxygenase inhibitor,ALOX5
Ewing Sarcoma,BRD-A88080608-001-04-2::2.5::HTS,4.0907950252050105,0.043594687945874656,Other Types,equilin,estrogen receptor agonist,HSD17B1
Ewing Sarcoma,BRD-A90547603-001-02-5::2.5::HTS,10.185912551496568,0.0014946401806663174,Other Types,eptifibatide,platelet aggregation inhibitor,"ITGA2B, ITGB3"
Ewing Sarcoma,BRD-A91366704-001-01-9::2.5::HTS,7.355932394093502,0.0068903560624541,Other Types,eprinomectin,benzodiazepine receptor agonist,
Ewing Sarcoma,BRD-A91733352-300-04-5::2.5::HTS,12.51022752239326,0.0004383981153512963,Other Types,camylofine-chlorhydrate,,
Ewing Sarcoma,BRD-A93093700-001-02-9::2.5::HTS,13.535831165391338,0.0002565655873356178,Other Types,temazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Ewing Sarcoma,BRD-A93236127-001-04-5::2.5::HTS,4.0822392769470595,0.04381425801179073,Other Types,digitoxin,ATPase inhibitor,ATP1A1
Ewing Sarcoma,BRD-A93699261-236-03-4::2.5::HTS,4.291538172760847,0.03878753836534182,Other Types,sodium-danshensu,,
Ewing Sarcoma,BRD-K00317371-001-06-1::2.4::HTS,9.058739216278099,0.0027393563160489974,Other Types,RITA,MDM inhibitor,MDM2
Ewing Sarcoma,BRD-K01669786-001-02-2::2.5::HTS,6.058728395419168,0.01415640228052579,Other Types,triapine,ribonucleotide reductase inhibitor,"RRM1, RRM2"
Ewing Sarcoma,BRD-K01773560-001-02-4::2.59::HTS,6.8231645303743935,0.009249696698015149,Other Types,UNC2250,MER tyrosine kinase inhibitor,MERTK
Ewing Sarcoma,BRD-K02113016-001-15-4::2.5::HTS,33.26445063931252,1.3370323566211416e-08,Other Types,olaparib,PARP inhibitor,"PARP1, PARP2"
Ewing Sarcoma,BRD-K02389548-001-02-5::2.5::HTS,7.468365903103781,0.006479421399941424,Other Types,RG2833,HDAC inhibitor,"HDAC1, HDAC3"
Ewing Sarcoma,BRD-K02407574-001-09-7::2.5::HTS,11.43941167655542,0.0007690456558634768,Other Types,parbendazole,tubulin polymerization inhibitor,TUBB
Ewing Sarcoma,BRD-K02764365-001-13-6::2.5::HTS,13.135664894953923,0.00031601851433219955,Other Types,methiazole,anthelmintic agent,
Ewing Sarcoma,BRD-K03063480-001-05-8::2.5::HTS,9.068205685904235,0.0027178300756173415,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Ewing Sarcoma,BRD-K03063480-001-06-6::2.42::HTS,6.116584485433008,0.013705580431603614,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Ewing Sarcoma,BRD-K03109492-001-02-2::2.5::HTS,6.378848951903342,0.011826546043422627,Other Types,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Ewing Sarcoma,BRD-K03243820-001-23-8::2.37::HTS,20.101228728684088,9.015566535893987e-06,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Ewing Sarcoma,BRD-K03243820-001-25-3::2.5::HTS,20.73502133754052,6.508818242703447e-06,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Ewing Sarcoma,BRD-K03353589-236-01-4::2.5::HTS,5.433899173767128,0.0201054334223004,Other Types,ecabet,"gastrin inhibitor, urease inhibitor",NOXO1
Ewing Sarcoma,BRD-K03390685-001-01-7::2.5::HTS,8.189744547238826,0.004371982488264182,Ewing Sarcoma,cobimetinib,MEK inhibitor,
Ewing Sarcoma,BRD-K03406345-001-27-8::2.5::HTS,7.747466185786278,0.005561433075981458,Other Types,azacitidine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Ewing Sarcoma,BRD-K04704168-003-14-3::2.5::HTS,6.7680153068165465,0.009527367022894117,Other Types,clemizole,HCV inhibitor,
Ewing Sarcoma,BRD-K04833372-001-06-2::2.5::HTS,5.462017857021489,0.019789501516130552,Other Types,GSK1904529A,"IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR"
Ewing Sarcoma,BRD-K04956647-003-02-5::2.5::HTS,4.694151451578743,0.030688736869075778,Other Types,nebivolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Ewing Sarcoma,BRD-K05236810-001-19-0::2.5::HTS,41.37074697012797,2.7168134036713456e-10,Other Types,luteolin,glucosidase inhibitor,TOP1
Ewing Sarcoma,BRD-K05395900-322-05-4::2.5::HTS,5.185876957211556,0.02315217910423553,Other Types,nicotine,acetylcholine receptor agonist,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1"
Ewing Sarcoma,BRD-K05524748-003-04-4::2.5::HTS,9.078932571723836,0.0027081402788903175,Other Types,dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A"
Ewing Sarcoma,BRD-K05658747-001-02-9::2.5::HTS,4.875610588695306,0.027647651657215836,Other Types,raltegravir,HIV integrase inhibitor,
Ewing Sarcoma,BRD-K05674516-001-02-5::2.5::HTS,4.946470037788652,0.026544135691356004,Other Types,sofosbuvir,RNA polymerase inhibitor,
Ewing Sarcoma,BRD-K05850076-001-01-5::2.5::HTS,5.090033885871663,0.02445211250564149,Other Types,sotagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Ewing Sarcoma,BRD-K06543683-066-02-1::2.5::HTS,5.1695387393176695,0.023364701357746976,Other Types,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Ewing Sarcoma,BRD-K06749501-001-02-1::2.5::HTS,22.258446173074187,3.0157930325318818e-06,Other Types,GSK1838705A,insulin growth factor receptor inhibitor,"ALK, IGF1R, INSR, RPS6KA1"
Ewing Sarcoma,BRD-K07265709-003-05-6::2.61::HTS,15.21999589575771,0.0001080486353602672,Other Types,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Ewing Sarcoma,BRD-K07442505-001-03-6::2.5::HTS,6.105382254215398,0.013773117015089044,Ewing Sarcoma,BAM7,BAX activator,BAX
Ewing Sarcoma,BRD-K07507905-236-02-6::2.5::HTS,6.9794731659694005,0.008476272720417007,Other Types,BRL-37344,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Ewing Sarcoma,BRD-K07572174-001-39-4::2.48::HTS,31.4833483912242,3.250994162565837e-08,Other Types,curcumin,"cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH"
Ewing Sarcoma,BRD-K07736136-001-04-6::2.51::HTS,4.628867980503233,0.03189119041677888,Other Types,VX-702,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK14"
Ewing Sarcoma,BRD-K07753030-003-17-6::2.5::HTS,4.640329354669546,0.031657233754464435,Other Types,acecainide,polarization inhibitor,SCN5A
Ewing Sarcoma,BRD-K08542803-001-03-1::0.8::HTS,5.267919024451241,0.02209278336088085,Other Types,gambogic-acid,caspase activator,BCL2
Ewing Sarcoma,BRD-K08547377-394-03-5::2.5::HTS,6.38529559940957,0.011791918104467412,Other Types,irinotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Ewing Sarcoma,BRD-K08586861-001-01-1::2.5::HTS,8.555039994093471,0.003590999061544864,Other Types,ramatroban,prostanoid receptor antagonist,"PTGDR2, TBXA2R"
Ewing Sarcoma,BRD-K08893438-001-04-9::2.52::HTS,4.647662777184114,0.031555659515305694,Other Types,CCG-50014,G protein signaling inhibitor,"RGS4, RGS8"
Ewing Sarcoma,BRD-K09416995-001-39-9::2.5::HTS,5.652353233843865,0.017768564268081485,Other Types,lovastatin,HMGCR inhibitor,"HDAC2, HMGCR, ITGAL, NR1I2"
Ewing Sarcoma,BRD-K09443272-001-03-3::2.5::HTS,10.367855535194368,0.0013568608853286794,Other Types,PHA-680632,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Ewing Sarcoma,BRD-K09635314-001-03-4::2.5::HTS,4.14701821017212,0.042184660763406406,Other Types,m-3M3FBS,,"PLCB2, PLCB3, PLCD1, PLCG1, PLCG2"
Ewing Sarcoma,BRD-K09785578-001-01-2::2.5::HTS,4.134956886280375,0.042479653521083155,Other Types,bakuchiol,DNA polymerase inhibitor,HIF1A
Ewing Sarcoma,BRD-K09877029-001-01-2::2.5::HTS,4.400734663237155,0.0363718286539098,Other Types,VS-4718,focal adhesion kinase inhibitor,
Ewing Sarcoma,BRD-K11094367-001-10-1::2.5::HTS,3.938880285313144,0.047672360535532254,Other Types,acetanilide,hydrogen peroxide decomposition inhibitor,
Ewing Sarcoma,BRD-K11196887-001-22-0::2.49::HTS,6.110033014836156,0.013755877612630911,Other Types,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A
Ewing Sarcoma,BRD-K11558771-001-13-9::2.5::HTS,22.41595228645245,2.7871291578343403e-06,Other Types,droxinostat,HDAC inhibitor,"HDAC6, HDAC8"
Ewing Sarcoma,BRD-K11590034-002-03-4::2.49::HTS,6.394790768963242,0.011735711902907842,Other Types,morin,cytochrome P450 inhibitor,"ADORA2A, ESR2, FASN, MCL1, SLC22A12"
Ewing Sarcoma,BRD-K11636097-001-03-1::2.5::HTS,5.63621284765298,0.01793301703955503,Other Types,JNJ-7706621,CDK inhibitor,"AURKA, AURKB, CDK1, CDK2"
Ewing Sarcoma,BRD-K12040459-001-06-0::2.5::HTS,5.945625749532609,0.01506530231952925,Other Types,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Ewing Sarcoma,BRD-K12184916-001-15-4::2.5::HTS,7.634481601299827,0.00591456474247788,Other Types,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor","ATR, MTOR, PIK3CA, PIK3CD, PIK3CG"
Ewing Sarcoma,BRD-K12251893-065-04-7::2.5::HTS,6.028985137637734,0.014378959216987858,Other Types,vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB"
Ewing Sarcoma,BRD-K12343256-001-08-9::2.5::HTS,11.037276842323518,0.0009514377404053943,Ewing Sarcoma,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Ewing Sarcoma,BRD-K12502280-001-08-0::2.5::HTS,5.829999516123047,0.01608714664681832,Other Types,TG-101348,"FLT3 inhibitor, JAK inhibitor","BRD4, JAK1, JAK2, JAK3, TYK2"
Ewing Sarcoma,BRD-K12539581-001-23-7::2.5::HTS,9.97731266054657,0.0016699411692416648,Other Types,nocodazole,tubulin polymerization inhibitor,HPGDS
Ewing Sarcoma,BRD-K12807006-001-18-5::2.5::HTS,18.430014998034697,2.0778767430887833e-05,Other Types,kaempferol,"bone resorption inhibitor, estrogen-related receptor inverse agonist","AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1"
Ewing Sarcoma,BRD-K12829205-003-02-8::2.5::HTS,16.645461455537298,5.202105400456171e-05,Other Types,mechlorethamine,DNA inhibitor,
Ewing Sarcoma,BRD-K12968785-001-13-3::2.5::HTS,3.931013264459037,0.04790411194365993,Other Types,bergapten,,
Ewing Sarcoma,BRD-K13044802-213-20-7::2.5::HTS,16.7083488188138,4.994524705962667e-05,Other Types,ciclopirox,membrane integrity inhibitor,ATP1A1
Ewing Sarcoma,BRD-K13049116-001-05-7::2.5::HTS,8.20367104547786,0.004339044702980689,Other Types,BMS-754807,IGF-1 inhibitor,"AKT1, IGF1R"
Ewing Sarcoma,BRD-K13094524-001-07-5::2.63::HTS,7.763592110055154,0.005522748185989105,Other Types,PFI-1,bromodomain inhibitor,BRD4
Ewing Sarcoma,BRD-K13169950-001-14-4::2.5::HTS,8.329605660277341,0.004052460491246378,Other Types,NSC-3852,HDAC inhibitor,HDAC1
Ewing Sarcoma,BRD-K13495773-001-11-4::2.5::HTS,8.77203817739327,0.003192203086041039,Other Types,creatinine,,
Ewing Sarcoma,BRD-K13514097-001-05-3::2.5::HTS,3.9695098896860976,0.04681888822903454,Other Types,everolimus,mTOR inhibitor,MTOR
Ewing Sarcoma,BRD-K13756951-001-01-4::2.5::HTS,6.876142642347131,0.008972232160383913,Other Types,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Ewing Sarcoma,BRD-K14329163-001-03-9::2.5::HTS,4.153042133815315,0.04210525952237284,Ewing Sarcoma,BAY-K-8644-(s)-(-),L-type calcium channel activator,CACNA1C
Ewing Sarcoma,BRD-K14529030-001-01-9::2.5::HTS,7.052671917707672,0.0081430037027126,Other Types,meisoindigo,STAT inhibitor,STAT3
Ewing Sarcoma,BRD-K15025317-001-15-1::2.5::HTS,8.147227409084806,0.004474129263581019,Other Types,BAY-11-7082,NFkB pathway inhibitor,RELA
Ewing Sarcoma,BRD-K15108141-001-06-6::2.5::HTS,7.676127459663357,0.005788724451872875,Other Types,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Ewing Sarcoma,BRD-K15179513-001-03-4::2.5::HTS,10.47349816707299,0.0012833086383670653,Other Types,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
Ewing Sarcoma,BRD-K15179879-001-03-2::2.5::HTS,3.973904326719187,0.04671405801096645,Other Types,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Ewing Sarcoma,BRD-K15409150-001-05-8::2.5::HTS,6.571126945348463,0.010634796125923524,Other Types,penfluridol,T-type calcium channel blocker,CACNA1G
Ewing Sarcoma,BRD-K15891719-001-05-1::2.45::HTS,3.8602580581672483,0.04996667436200599,Ewing Sarcoma,tenofovir,"HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor",
Ewing Sarcoma,BRD-K15898725-001-01-7::2.5::HTS,5.584329153995296,0.0184632064487142,Other Types,maytansinol-isobutyrate,,
Ewing Sarcoma,BRD-K16730910-001-07-3::2.5::HTS,4.2022089108066485,0.040836499324165984,Ewing Sarcoma,regorafenib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK"
Ewing Sarcoma,BRD-K17075857-001-18-4::2.5::HTS,35.41833191050496,4.793269692450252e-09,Other Types,chloroxine,opioid receptor antagonist,OPRK1
Ewing Sarcoma,BRD-K17203476-001-01-9::2.5::HTS,9.285627557103227,0.002418465404729557,Other Types,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Ewing Sarcoma,BRD-K17378184-300-05-9::2.5::HTS,5.239470557854485,0.02245541371780061,Other Types,BP-897,dopamine receptor agonist,"ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B"
Ewing Sarcoma,BRD-K17415526-001-03-5::2.5::HTS,4.623136677239068,0.03197563352856413,Other Types,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR
Ewing Sarcoma,BRD-K17497770-001-03-6::2.5::HTS,24.267707603423794,1.1057971110625806e-06,Other Types,butein,"EGFR inhibitor, src inhibitor",ACE
Ewing Sarcoma,BRD-K17743125-001-08-4::2.5::HTS,5.729281686463661,0.017012445205347677,Other Types,belinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Ewing Sarcoma,BRD-K17850764-236-11-9::2.5::HTS,7.188890894004347,0.007554260119394547,Other Types,cloprostenol-(+/-),prostaglandin receptor agonist,"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R"
Ewing Sarcoma,BRD-K18157228-001-01-7::2.5::HTS,9.210363405678189,0.00251823079621591,Other Types,fdcyd,DNA methyltransferase inhibitor,
Ewing Sarcoma,BRD-K18163608-001-05-6::2.48::HTS,8.209601055348397,0.004332960391532888,Other Types,HA14-1,BCL inhibitor,BCL2
Ewing Sarcoma,BRD-K18250272-003-11-0::2.5::HTS,5.117217737759109,0.024086952307180186,Ewing Sarcoma,propoxycaine,local anesthetic,
Ewing Sarcoma,BRD-K18375018-376-02-3::2.5::HTS,22.006941202534037,3.4221265617085675e-06,Other Types,spermine,,"CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5"
Ewing Sarcoma,BRD-K18574842-323-10-8::2.51::HTS,5.849606863567936,0.015917728370283674,Other Types,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Ewing Sarcoma,BRD-K18678457-003-02-8::2.5::HTS,4.390455843671255,0.03658914354260505,Other Types,ZD-7288,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Ewing Sarcoma,BRD-K18948558-001-01-9::2.5::HTS,5.997144107682575,0.014633445729779955,Other Types,clevudine,DNA polymerase inhibitor,
Ewing Sarcoma,BRD-K19111024-001-20-9::2.5::HTS,7.18588696416089,0.007572882580008293,Other Types,clofibric-acid,PPAR receptor agonist,PPARA
Ewing Sarcoma,BRD-K19295594-015-14-3::2.29::HTS,9.444605874570167,0.0022270797217860956,Other Types,gossypol,"BCL inhibitor, MCL1 inhibitor",BCL2
Ewing Sarcoma,BRD-K19438463-001-05-5::2.5::HTS,4.16620278261457,0.04171147357920423,Other Types,CNQX,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Ewing Sarcoma,BRD-K19615002-001-02-3::2.5::HTS,7.238953947704846,0.007347986501177282,Other Types,creatine,,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8"
Ewing Sarcoma,BRD-K19972289-001-01-4::2.5::HTS,7.435120085722866,0.006597470870089829,Other Types,octinoxate,,
Ewing Sarcoma,BRD-K20372197-001-03-1::2.5::HTS,16.53123332464692,5.5148823980809786e-05,Other Types,droxidopa,norepinephrine precursor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH"
Ewing Sarcoma,BRD-K20755323-001-05-9::2.5::HTS,24.823801027714968,8.387337970480371e-07,Other Types,SKI-II,sphingosine kinase inhibitor,SPHK1
Ewing Sarcoma,BRD-K20958582-001-01-4::2.5::HTS,4.382892778817744,0.03675537956080311,Other Types,TH-302,DNA alkylating agent,
Ewing Sarcoma,BRD-K21025364-001-05-6::2.44::HTS,6.730378470189943,0.009741750658531936,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Ewing Sarcoma,BRD-K21160401-065-01-0::2.5::HTS,12.301920869432958,0.0004886701863453563,Other Types,dextroamphetamine,monoamine oxidase inhibitor,"ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1"
Ewing Sarcoma,BRD-K21615095-001-08-4::2.5::HTS,5.222131350273874,0.022696816232594664,Other Types,acetohydroxamic-acid,urease inhibitor,MMP12
Ewing Sarcoma,BRD-K21718444-001-06-8::2.5::HTS,27.47613848666625,2.2542219178852576e-07,Other Types,KW-2449,"Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor","ABL1, AURKA, AURKB, FLT3"
Ewing Sarcoma,BRD-K21728777-001-02-3::2.5::HTS,13.4587175042689,0.0002672407740767479,Other Types,AMG900,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Ewing Sarcoma,BRD-K21908111-001-01-8::2.5::HTS,4.400974006299788,0.03636837803600735,Other Types,AZD1208,Pim kinase inhibitor,"PIM1, PIM2, PIM3"
Ewing Sarcoma,BRD-K21937671-001-09-2::2.53::HTS,7.994618226208703,0.004872482736131297,Other Types,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Ewing Sarcoma,BRD-K22009844-001-12-5::2.5::HTS,8.308988246892252,0.004095821365629755,Other Types,phenprobamate,muscle relaxant,
Ewing Sarcoma,BRD-K22134346-001-22-3::2.5::HTS,11.127436357153648,0.0009091854280829688,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Ewing Sarcoma,BRD-K22134346-001-24-9::2.42::HTS,8.061276408885993,0.004696386747343735,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Ewing Sarcoma,BRD-K22503835-001-11-0::2.5::HTS,12.557452598285284,0.00042763549386320776,Other Types,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Ewing Sarcoma,BRD-K23228615-001-02-8::2.5::HTS,9.40165428660208,0.002274021448325504,Other Types,GDC-0980,"mTOR inhibitor, PI3K inhibitor","FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK"
Ewing Sarcoma,BRD-K23248433-001-01-8::2.5::HTS,4.790758359165261,0.029024300304531746,Other Types,camicinal,motilin receptor agonist,MLNR
Ewing Sarcoma,BRD-K23301018-001-11-7::2.63::HTS,11.104010651617209,0.0009217606773332454,Other Types,broxyquinoline,antiprotozoal agent,
Ewing Sarcoma,BRD-K23677682-003-01-2::2.5::HTS,23.933346881697226,1.3042190251081176e-06,Other Types,voreloxin,topoisomerase inhibitor,TOP2A
Ewing Sarcoma,BRD-K23925186-001-01-0::2.5::HTS,5.750889685940975,0.016810136038530894,Other Types,oridonin,BCL inhibitor,BCL2
Ewing Sarcoma,BRD-K24187789-001-01-7::2.5::HTS,7.648246893433919,0.005870552808054347,Other Types,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Ewing Sarcoma,BRD-K24601397-001-01-1::2.5::HTS,3.8789633954657106,0.04939254808628947,Other Types,phlorizin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A11, SLC5A2, SLC5A3"
Ewing Sarcoma,BRD-K24696047-001-02-3::2.5::HTS,5.576893433319063,0.01854405879563215,Other Types,NVP-AEW541,IGF-1 inhibitor,"IGF1R, INSR"
Ewing Sarcoma,BRD-K24697665-001-01-4::2.5::HTS,6.4945649495176125,0.011103537300196933,Other Types,bucillamine,immunosuppressant,
Ewing Sarcoma,BRD-K25015158-001-01-2::2.5::HTS,4.288179705879046,0.03884078341494716,Other Types,limaprost-alfadex,prostanoid receptor agonist,PTGER1
Ewing Sarcoma,BRD-K25312248-001-01-5::2.5::HTS,4.794611757510642,0.028965217109033003,Other Types,matrine,opioid receptor agonist,OPRK1
Ewing Sarcoma,BRD-K25340465-001-11-1::2.58::HTS,13.946282449167915,0.00020856778072359902,Other Types,OSI-930,"KIT inhibitor, VEGFR inhibitor","KDR, KIT"
Ewing Sarcoma,BRD-K25486274-300-01-0::2.5::HTS,3.9558901566104265,0.04719462967993615,Ewing Sarcoma,DRF053-(R),CDK inhibitor,CSNK1A1
Ewing Sarcoma,BRD-K25630527-001-03-8::2.5::HTS,33.09776880971658,1.4409355854531451e-08,Other Types,LY2784544,JAK inhibitor,"JAK2, JAK3"
Ewing Sarcoma,BRD-K25835157-001-01-4::2.5::HTS,9.304727814170839,0.002393989576742618,Other Types,PRT062070,"JAK inhibitor, syk inhibitor",SYK
Ewing Sarcoma,BRD-K26531771-001-02-2::2.35::HTS,6.764424067324571,0.009559968986897874,Other Types,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Ewing Sarcoma,BRD-K26603252-003-04-9::2.5::HTS,3.8922763661740163,0.04901263069405229,Ewing Sarcoma,PD-153035,EGFR inhibitor,"EGFR, KDR"
Ewing Sarcoma,BRD-K26667523-001-02-5::2.5::HTS,13.212470413119094,0.00030399423007069213,Ewing Sarcoma,TAK-733,MEK inhibitor,MAP2K1
Ewing Sarcoma,BRD-K26712974-001-01-5::2.5::HTS,7.512434736997467,0.006322400611761252,Other Types,VX-765,caspase inhibitor,CASP1
Ewing Sarcoma,BRD-K26997899-001-02-2::2.5::HTS,14.047700131480115,0.00019666408132318995,Other Types,D-64131,microtubule inhibitor,TUBB
Ewing Sarcoma,BRD-K28360340-001-08-3::2.31::HTS,4.5303472934642235,0.03376122645774549,Other Types,TW-37,BCL inhibitor,"BCL2, BCL2L1, MCL1"
Ewing Sarcoma,BRD-K28570407-001-02-0::2.5::HTS,6.168392746332904,0.013300423234636077,Other Types,A-803467,sodium channel blocker,SCN10A
Ewing Sarcoma,BRD-K28822270-001-01-1::2.5::HTS,9.974700687936298,0.0016735189737736905,Other Types,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Ewing Sarcoma,BRD-K28863208-001-02-0::2.5::HTS,4.878246273837234,0.027605844192264025,Other Types,PNU-282987,cholinergic receptor agonist,CHRNA7
Ewing Sarcoma,BRD-K28982731-001-01-6::2.5::HTS,5.312974607795408,0.021533935178992075,Other Types,emoxipin,,
Ewing Sarcoma,BRD-K29254801-001-14-7::2.5::HTS,4.352929246345615,0.03739962871383001,Other Types,thiram,,JAK2
Ewing Sarcoma,BRD-K29458283-001-29-9::2.5::HTS,10.905320961041381,0.001020692566785182,Other Types,chlorambucil,DNA inhibitor,
Ewing Sarcoma,BRD-K29905972-001-06-3::2.5::HTS,11.492732277922189,0.0007484498048564417,Other Types,axitinib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, FLT1, FLT4, KDR, PLK4"
Ewing Sarcoma,BRD-K29968218-001-03-2::2.5::HTS,5.927167525796854,0.015223892566778953,Other Types,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Ewing Sarcoma,BRD-K30019776-003-01-5::2.5::HTS,3.8613653184899146,0.049933961503756015,Other Types,dexfosfoserine,membrane integrity inhibitor,"CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2"
Ewing Sarcoma,BRD-K30572193-001-02-0::2.5::HTS,5.656681513342617,0.017722215673496935,Other Types,CTEP,glutamate receptor antagonist,GRM5
Ewing Sarcoma,BRD-K30577245-341-01-9::2.5::HTS,5.405068949557446,0.020436830999829424,Other Types,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Ewing Sarcoma,BRD-K30933884-001-01-0::2.5::HTS,6.096156786490217,0.013845476752191655,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Ewing Sarcoma,BRD-K31283835-048-04-4::2.5::HTS,4.244454672534494,0.03984770067375127,Other Types,tofacitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Ewing Sarcoma,BRD-K31560319-001-01-5::2.5::HTS,4.597996879790324,0.032439880527721336,Other Types,olvanil,TRPV agonist,"CNR1, GPR119, TRPV1"
Ewing Sarcoma,BRD-K31928526-001-02-1::2.5::HTS,18.630991748815333,1.8774091177193024e-05,Other Types,barasertib,Aurora kinase inhibitor,"AURKA, AURKB"
Ewing Sarcoma,BRD-K32007074-001-02-9::3.16::HTS,4.11500029289147,0.04299564869714295,Other Types,enocitabine,DNA synthesis inhibitor,"CMPK1, RRM1, TYMS"
Ewing Sarcoma,BRD-K32730239-001-01-0::2.5::HTS,17.756346140498998,2.9271048432777484e-05,Other Types,SU3327,JNK inhibitor,MAPK8
Ewing Sarcoma,BRD-K33127281-001-05-6::2.5::HTS,11.96975765260016,0.0005823340828333996,Other Types,adapalene,retinoid receptor agonist,"RARA, RARB, RARG, RXRA, RXRB, RXRG"
Ewing Sarcoma,BRD-K33379087-001-07-5::2.5::HTS,8.640645897183141,0.0034250567337587297,Other Types,tivantinib,tyrosine kinase inhibitor,MET
Ewing Sarcoma,BRD-K33483813-001-10-0::2.5::HTS,6.916729721673858,0.00877668916941746,Other Types,actarit,interleukin receptor agonist,
Ewing Sarcoma,BRD-K33588785-001-01-9::2.5::HTS,5.175599350063398,0.023301093040833314,Ewing Sarcoma,obidoxime,cholinesterase reactivator,ACHE
Ewing Sarcoma,BRD-K33809398-001-01-8::2.5::HTS,4.003537655192109,0.045916288674593464,Other Types,SCMC-Lys,mucolytic agent,GSTP1
Ewing Sarcoma,BRD-K34533029-001-08-5::2.5::HTS,7.678608195020962,0.005775620599797759,Other Types,tyrphostin-AG-494,EGFR inhibitor,EGFR
Ewing Sarcoma,BRD-K35719256-001-02-6::2.5::HTS,8.321131188212886,0.004069747782578345,Other Types,rotundine,serotonin receptor agonist,"DRD1, DRD2, DRD3, HTR1A"
Ewing Sarcoma,BRD-K35775715-001-03-1::2.5::HTS,4.287933928817852,0.03884139207677243,Ewing Sarcoma,liranaftate,fungal squalene epoxidase inhibitor,
Ewing Sarcoma,BRD-K36016295-001-04-5::2.5::HTS,6.3869826612361456,0.011773102252603673,Other Types,KU-60019,ATM kinase inhibitor,ATM
Ewing Sarcoma,BRD-K36198571-001-02-0::2.5::HTS,5.15580161395088,0.023569290905866794,Ewing Sarcoma,WAY-170523,metalloproteinase inhibitor,MMP13
Ewing Sarcoma,BRD-K36222532-001-01-8::2.5::HTS,6.125968222949104,0.013627458265586654,Other Types,broxaldine,,
Ewing Sarcoma,BRD-K36269323-300-02-6::2.5::HTS,5.771621164636231,0.016616826258879332,Other Types,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,"NOS2, NOS3"
Ewing Sarcoma,BRD-K36660044-001-24-2::2.5::HTS,5.516215126590485,0.019189557137186786,Other Types,bufexamac,cyclooxygenase inhibitor,"HDAC10, HDAC6"
Ewing Sarcoma,BRD-K36740062-001-06-6::2.5::HTS,12.587848792742133,0.0004210688452504968,Other Types,GSK1070916,Aurora kinase inhibitor,"AURKA, AURKB, AURKC, CYP2D6, CYP3A4"
Ewing Sarcoma,BRD-K36788280-001-01-2::2.5::HTS,9.32135513223538,0.0023737043914976493,Other Types,ribociclib,CDK inhibitor,"CDK4, CDK6"
Ewing Sarcoma,BRD-K37687095-001-06-9::2.5::HTS,11.362976223837777,0.000800686365179201,Ewing Sarcoma,AZD8330,MEK inhibitor,
Ewing Sarcoma,BRD-K37764012-001-04-1::2.5::HTS,4.219086193248743,0.040435346793546226,Other Types,PF-03758309,p21 activated kinase inhibitor,PAK4
Ewing Sarcoma,BRD-K37798499-001-27-2::2.5::HTS,15.972652160253723,7.290872289430136e-05,Other Types,etoposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Ewing Sarcoma,BRD-K37991163-003-13-4::2.5::HTS,5.47007859000653,0.01970455499523784,Other Types,paroxetine,selective serotonin reuptake inhibitor (SSRI),"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4"
Ewing Sarcoma,BRD-K38548312-001-01-0::2.5::HTS,4.257891659460593,0.03952946463610173,Other Types,VER-49009,HSP inhibitor,HSP90AA1
Ewing Sarcoma,BRD-K38860038-001-01-2::2.5::HTS,5.716937090835348,0.01713600581453474,Other Types,JK-184,hedgehog pathway inhibitor,
Ewing Sarcoma,BRD-K38868394-001-01-3::2.5::HTS,4.624355736942074,0.031959453593953586,Other Types,MK-0773,androgen receptor modulator,AR
Ewing Sarcoma,BRD-K39079086-001-07-6::2.5::HTS,4.884454745039138,0.027507625349727248,Ewing Sarcoma,cinchonidine,P glycoprotein inhibitor,
Ewing Sarcoma,BRD-K39371216-001-01-3::2.5::HTS,8.200240930661792,0.00434627141639518,Other Types,cyacetacide,,
Ewing Sarcoma,BRD-K39841531-001-02-1::2.5::HTS,10.102377492370456,0.001562801006076914,Other Types,TG-101209,JAK inhibitor,"JAK2, JAK3"
Ewing Sarcoma,BRD-K40255344-001-17-6::2.5::HTS,6.935116268318247,0.0086846633556128,Other Types,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Ewing Sarcoma,BRD-K40496271-396-01-1::2.34::HTS,33.60246672948399,1.1641357955221896e-08,Other Types,eltrombopag,thrombopoietin receptor agonist,MPL
Ewing Sarcoma,BRD-K40621224-001-06-7::2.5::HTS,7.531357547229491,0.0062586177985330515,Ewing Sarcoma,pentetic-acid,chelating agent,PGD
Ewing Sarcoma,BRD-K41278234-001-03-0::2.5::HTS,5.600361608764629,0.018299777628370456,Other Types,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Ewing Sarcoma,BRD-K41438959-001-01-7::2.5::HTS,8.36331429882584,0.003976920961091449,Other Types,perampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Ewing Sarcoma,BRD-K41599323-001-02-3::2.5::HTS,9.895820633945144,0.0017444920481637179,Other Types,lonafarnib,farnesyltransferase inhibitor,"FNTA, HRAS, KRAS, NRAS"
Ewing Sarcoma,BRD-K41783120-001-02-8::2.5::HTS,8.437726902423513,0.003824031072271593,Other Types,STA-5326,interleukin synthesis inhibitor,IL12A
Ewing Sarcoma,BRD-K41876534-001-13-7::2.5::HTS,35.806702039775196,3.902292318498596e-09,Other Types,tioxolone,carbonic anhydrase inhibitor,CA2
Ewing Sarcoma,BRD-K42191735-001-05-3::2.5::HTS,6.1039590516246065,0.01378356157021358,Other Types,buparlisib,PI3K inhibitor,"PIK3CA, PIK3CG"
Ewing Sarcoma,BRD-K42495768-001-01-7::2.5::HTS,25.442888548991405,6.212337300829041e-07,Other Types,tasisulam,apoptosis stimulant,
Ewing Sarcoma,BRD-K42497885-001-01-1::2.5::HTS,14.154212225331726,0.00018663283077599365,Other Types,satraplatin,DNA alkylating agent,
Ewing Sarcoma,BRD-K42679050-001-02-1::2.5::HTS,7.1038355816306265,0.007919597596741795,Ewing Sarcoma,Y-27152,potassium channel activator,KCNJ8
Ewing Sarcoma,BRD-K42756753-001-01-9::2.5::HTS,14.370185569875966,0.0001671150342935293,Other Types,epiandrosterone,steroid,G6PD
Ewing Sarcoma,BRD-K42828737-044-09-0::2.5::HTS,6.425573810980041,0.011522902122795628,Other Types,sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET"
Ewing Sarcoma,BRD-K43149758-001-22-7::2.5::HTS,9.978802909145545,0.0016698612167586756,Other Types,myricetin,"androgen receptor agonist, cytochrome P450 inhibitor",PIK3CG
Ewing Sarcoma,BRD-K43187018-001-03-3::2.52::HTS,5.855499090154511,0.015865121344717136,Other Types,GDC-0349,Pim kinase inhibitor,PIK3CA
Ewing Sarcoma,BRD-K43192255-048-03-6::2.5::HTS,4.653840418822666,0.031411142550383936,Other Types,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7
Ewing Sarcoma,BRD-K43236057-001-07-1::2.6::HTS,13.196311137953565,0.000307887562100716,Other Types,polydatin,ICAM1 expression inhibitor,ICAM1
Ewing Sarcoma,BRD-K43873574-001-01-8::2.5::HTS,6.17352657327974,0.013258618641385892,Ewing Sarcoma,ilepcimide,anticonvulsant,
Ewing Sarcoma,BRD-K44408410-001-17-6::2.5::HTS,26.53698108882931,3.583533848407104e-07,Other Types,2-methoxyestradiol,hypoxia inducible factor inhibitor,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB"
Ewing Sarcoma,BRD-K44844162-001-01-6::2.5::HTS,5.07251982367802,0.02470014505102873,Ewing Sarcoma,taselisib,PI3K inhibitor,PIK3CA
Ewing Sarcoma,BRD-K45014108-003-01-8::2.5::HTS,10.682479794991535,0.0011482249226952262,Other Types,ephedrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2"
Ewing Sarcoma,BRD-K45216060-001-10-0::2.5::HTS,8.753340447713843,0.0032216442175695215,Other Types,mequinol,,TYR
Ewing Sarcoma,BRD-K45238818-001-02-6::2.5::HTS,3.8636391784620585,0.04983957049901364,Other Types,succinic-acid,,"ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE"
Ewing Sarcoma,BRD-K45528773-001-07-2::2.59::HTS,6.1304763160735884,0.013599556436686132,Other Types,M-344,HDAC inhibitor,
Ewing Sarcoma,BRD-K45551181-001-02-1::2.49::HTS,15.566593927311574,9.041248024859336e-05,Other Types,MPI-0479605,mitotic kinase inhibitor,TTK
Ewing Sarcoma,BRD-K45909031-001-01-5::2.5::HTS,4.501626384257311,0.03430270887063726,Other Types,WZ4003,AMPK inhibitor,"NUAK1, NUAK2"
Ewing Sarcoma,BRD-K46392623-001-02-5::2.5::HTS,6.016637025260281,0.014474406410290987,Other Types,TG-100713,PI3K inhibitor,
Ewing Sarcoma,BRD-K46742498-003-11-0::2.5::HTS,3.9516027677612837,0.04731852718513169,Other Types,alosetron,serotonin receptor antagonist,HTR3A
Ewing Sarcoma,BRD-K46982791-001-09-4::2.5::HTS,7.772138383586193,0.005487027289109992,Other Types,cloxyquin,potassium channel activator,KCNK18
Ewing Sarcoma,BRD-K47000838-001-01-6::1.04::HTS,5.766730746949204,0.01667001795341867,Other Types,cytochalasin-b,microtubule inhibitor,ACTB
Ewing Sarcoma,BRD-K47150025-001-05-3::2.5::HTS,9.861949287763704,0.0017766527552787962,Other Types,KI-8751,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Ewing Sarcoma,BRD-K47598052-001-15-8::2.5::HTS,5.1440738707848865,0.02371349335228912,Ewing Sarcoma,PP-1,src inhibitor,"HCK, RET"
Ewing Sarcoma,BRD-K47832606-001-30-1::2.5::HTS,5.192572969588382,0.023063308990832865,Other Types,floxuridine,DNA synthesis inhibitor,TYMS
Ewing Sarcoma,BRD-K47978074-001-02-4::2.5::HTS,8.462495238019637,0.003773100187278803,Other Types,trometamol,,"AMD1, CANT1, DCN, NEIL1, VEGFA"
Ewing Sarcoma,BRD-K48443249-001-01-0::2.5::HTS,5.099401245469412,0.024318857098319668,Other Types,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Ewing Sarcoma,BRD-K48578705-001-16-8::2.5::HTS,6.460076852996664,0.011308346232934882,Ewing Sarcoma,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Ewing Sarcoma,BRD-K48619321-004-16-8::2.54::HTS,4.86494174418232,0.02783778000080377,Other Types,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Ewing Sarcoma,BRD-K48684885-001-04-2::2.5::HTS,5.504740266611536,0.019316489287873117,Other Types,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Ewing Sarcoma,BRD-K49350383-001-13-7::2.5::HTS,15.729179141212404,8.271337904263242e-05,Other Types,thioguanine,purine antagonist,"IMPDH1, IMPDH2"
Ewing Sarcoma,BRD-K49669041-001-08-4::2.5::HTS,11.789500081996831,0.0006401980901914758,Other Types,BX-912,pyruvate dehydrogenase kinase inhibitor,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1"
Ewing Sarcoma,BRD-K49738308-065-04-9::2.5::HTS,4.271384642615672,0.03924626129215109,Other Types,agmatine,nitric oxide synthase inhibitor,"ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH"
Ewing Sarcoma,BRD-K49865102-001-08-4::2.5::HTS,10.404229787841366,0.0013318269356304437,Ewing Sarcoma,PD-0325901,MEK inhibitor,MAP2K1
Ewing Sarcoma,BRD-K50398167-236-22-7::2.5::HTS,4.172040332827746,0.041570834140508064,Other Types,meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2"
Ewing Sarcoma,BRD-K50406511-001-26-0::2.5::HTS,10.999458649342532,0.000970769439811817,Other Types,hycanthone,RNA synthesis inhibitor,
Ewing Sarcoma,BRD-K50677762-001-01-5::2.5::HTS,5.26577111332205,0.022121812572443295,Other Types,oxiracetam,acetylcholine receptor agonist,
Ewing Sarcoma,BRD-K50836978-001-02-5::2.5::HTS,8.025133964326974,0.004779709152938044,Ewing Sarcoma,purvalanol-a,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC"
Ewing Sarcoma,BRD-K50853363-001-02-3::2.5::HTS,18.28098408192751,2.2426082746565562e-05,Other Types,dienogest,progesterone receptor agonist,PGR
Ewing Sarcoma,BRD-K50891186-001-04-4::2.5::HTS,8.545210442838423,0.003605108340878751,Other Types,GR-103691,dopamine receptor antagonist,DRD3
Ewing Sarcoma,BRD-K51313569-003-03-3::2.5::HTS,7.620652910086263,0.005960490393510457,Other Types,palbociclib,CDK inhibitor,"CDK4, CDK6"
Ewing Sarcoma,BRD-K51544265-001-04-2::2.5::HTS,4.108450126473496,0.04315663989385533,Ewing Sarcoma,cabozantinib,"RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET"
Ewing Sarcoma,BRD-K51575138-001-13-2::2.5::HTS,9.200710137037362,0.0025309224344120525,Other Types,TPCA-1,IKK inhibitor,IKBKB
Ewing Sarcoma,BRD-K51662849-001-05-4::2.5::HTS,7.647340203172819,0.005880488951974014,Other Types,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Ewing Sarcoma,BRD-K51747290-001-12-3::2.5::HTS,5.481531195515376,0.019589445301549775,Other Types,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Ewing Sarcoma,BRD-K52075715-001-06-7::2.5::HTS,8.944865729471509,0.002904440359203548,Other Types,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Ewing Sarcoma,BRD-K52313696-001-12-3::2.5::HTS,16.80625233706893,4.77790437036525e-05,Other Types,tacedinaline,HDAC inhibitor,HDAC1
Ewing Sarcoma,BRD-K52396582-001-06-7::2.5::HTS,4.532394569913479,0.03369712159508348,Other Types,CF102,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Ewing Sarcoma,BRD-K52459643-001-17-7::2.5::HTS,4.55150853833284,0.03332608985686292,Other Types,alprostadil,prostanoid receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR"
Ewing Sarcoma,BRD-K53097745-001-01-5::2.5::HTS,33.20855250532351,1.3654672558717272e-08,Other Types,pterostilbene,"cyclooxygenase inhibitor, PPAR receptor agonist",PTGS2
Ewing Sarcoma,BRD-K53561341-001-07-5::2.5::HTS,9.075186851732019,0.0027084863613723764,Other Types,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
Ewing Sarcoma,BRD-K53665955-001-03-0::2.5::HTS,10.337520844909672,0.001379062436176222,Other Types,MK-5108,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Ewing Sarcoma,BRD-K53972329-001-07-0::2.5::HTS,7.06036399887172,0.008108147123494485,Other Types,ruxolitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Ewing Sarcoma,BRD-K54006094-051-01-7::2.5::HTS,15.589427685703503,8.879825675215247e-05,Other Types,formoterol,adrenergic receptor agonist,ADRB2
Ewing Sarcoma,BRD-K54095730-001-03-1::2.5::HTS,4.82571055507823,0.0284495308874231,Other Types,CMPD-1,p38 MAPK inhibitor,"GNRHR, MAPK14"
Ewing Sarcoma,BRD-K54262262-001-09-0::2.5::HTS,15.184793155652288,0.00010947934040137022,Other Types,monobenzone,melanin inhibitor,TYR
Ewing Sarcoma,BRD-K54529596-001-26-3::2.5::HTS,5.392681606424641,0.020600764019865426,Other Types,captopril,angiotensin converting enzyme inhibitor,"ACE, LTA4H, MMP2, MMP9"
Ewing Sarcoma,BRD-K54634444-001-05-9::2.5::HTS,4.929804121274631,0.0267968213313181,Other Types,artesunate,DNA synthesis inhibitor,
Ewing Sarcoma,BRD-K54665485-001-07-9::2.5::HTS,5.586593838400393,0.018440820170366027,Other Types,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA
Ewing Sarcoma,BRD-K54847683-001-04-0::2.5::HTS,11.851525191696293,0.0006218518662098588,Other Types,equol,estrogen receptor agonist,"ESR1, ESR2"
Ewing Sarcoma,BRD-K55305701-001-01-2::2.5::HTS,13.58314135121754,0.00025032912630968985,Other Types,SC-144,P glycoprotein inhibitor,
Ewing Sarcoma,BRD-K55462201-001-07-3::2.5::HTS,42.92892282803875,1.2936443672819254e-10,Other Types,AM-404,"cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist","CNR1, CNR2, FAAH, TRPV1"
Ewing Sarcoma,BRD-K55773932-001-02-0::2.5::HTS,5.695239088408689,0.017343261098416572,Other Types,BMS-806,HIV attachment inhibitor,
Ewing Sarcoma,BRD-K56115039-003-02-1::2.5::HTS,3.9836605009163937,0.04643006226477448,Other Types,BU226,imidazoline receptor ligand,
Ewing Sarcoma,BRD-K56301217-001-07-4::2.5::HTS,7.919438784679186,0.005061945799168148,Other Types,ABT-737,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Ewing Sarcoma,BRD-K56334280-001-05-1::2.5::HTS,11.617766111538351,0.000700053470044695,Other Types,amonafide,topoisomerase inhibitor,"TOP2A, TOP2B"
Ewing Sarcoma,BRD-K56543881-001-02-7::2.5::HTS,4.256869484458219,0.0395538993549191,Ewing Sarcoma,ADX-47273,glutamate receptor modulator,GRM5
Ewing Sarcoma,BRD-K57033106-003-19-7::2.5::HTS,8.203258361036937,0.004342361046054613,Other Types,tripelennamine,histamine receptor antagonist,HRH1
Ewing Sarcoma,BRD-K57136142-001-02-4::2.5::HTS,16.219751627006577,6.422625604611971e-05,Other Types,CCT129202,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Ewing Sarcoma,BRD-K57275767-001-02-4::2.61::HTS,4.12835154050234,0.042670565284977986,Other Types,geniposide,GLP receptor agonist,GLP1R
Ewing Sarcoma,BRD-K58049875-001-04-7::2.5::HTS,6.142811282787972,0.013489314072796719,Other Types,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Ewing Sarcoma,BRD-K58122457-001-02-2::2.5::HTS,4.3318227994227465,0.037862334659984294,Other Types,hesperadin,Aurora kinase inhibitor,AURKB
Ewing Sarcoma,BRD-K59146805-001-03-7::2.5::HTS,14.059859810915587,0.00019549535622105245,Other Types,AZ3146,monopolar spindle 1 kinase inhibitor,
Ewing Sarcoma,BRD-K59317601-001-05-5::2.5::HTS,5.988072706103457,0.014708071893144454,Other Types,MLN0128,mTOR inhibitor,"MTOR, PIK3CA, PIK3CD, PIK3CG"
Ewing Sarcoma,BRD-K59369769-001-20-3::2.5::HTS,10.897041536341062,0.0010242768761169695,Other Types,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor","AURKA, AURKB, AURKC, LCK"
Ewing Sarcoma,BRD-K59456551-001-22-6::2.51::HTS,9.459613922004138,0.0022092531324671505,Other Types,methotrexate,dihydrofolate reductase inhibitor,DHFR
Ewing Sarcoma,BRD-K60005752-001-01-9::2.5::HTS,5.014076228131664,0.025534569282526953,Other Types,S-111,PARP inhibitor,PARP1
Ewing Sarcoma,BRD-K60585088-001-01-5::2.5::HTS,4.1624350565970865,0.04179854569634734,Ewing Sarcoma,paricalcitol,vitamin D receptor agonist,VDR
Ewing Sarcoma,BRD-K61228301-001-01-2::2.5::HTS,11.555774218982853,0.0007235545920255349,Other Types,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Ewing Sarcoma,BRD-K61323504-001-04-0::2.5::HTS,12.939166704568256,0.000350665733337888,Other Types,SB-225002,CC chemokine receptor antagonist,CXCR2
Ewing Sarcoma,BRD-K61443650-236-13-1::2.5::HTS,11.888652324271312,0.0006070587546225316,Other Types,thiomersal,other antibiotic,OXCT1
Ewing Sarcoma,BRD-K61688984-001-02-9::2.5::HTS,43.8669227856153,8.280525043051836e-11,Other Types,RGFP966,HDAC inhibitor,HDAC3
Ewing Sarcoma,BRD-K61734568-003-02-1::2.5::HTS,12.983761884672854,0.0003423381271754832,Other Types,"2,3-DCPE",Bcl-XL downregulator,BCL2L1
Ewing Sarcoma,BRD-K61988078-001-01-2::2.5::HTS,3.9055218407504184,0.048620626913416634,Other Types,moxidectin,chloride channel antagonist,
Ewing Sarcoma,BRD-K62213621-001-01-6::2.5::HTS,7.410458232012698,0.006688766240792288,Other Types,dihydroartemisinin,antimalarial agent,
Ewing Sarcoma,BRD-K62696033-001-01-4::2.5::HTS,19.072971330303268,1.4995742876569938e-05,Other Types,G-1,G protein-coupled receptor agonist,GPER1
Ewing Sarcoma,BRD-K62736196-015-11-0::2.41::HTS,5.056334155396625,0.024947632429789163,Ewing Sarcoma,guanaben-acetate,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Ewing Sarcoma,BRD-K62965247-001-04-9::2.5::HTS,6.294083462468169,0.012397075402118261,Other Types,tipifarnib,farnesyltransferase inhibitor,"FNTA, FNTB"
Ewing Sarcoma,BRD-K63675182-003-23-6::2.5::HTS,11.727411115639457,0.0006611999064169069,Other Types,triflupromazine,dopamine receptor antagonist,"CHRM1, CHRM2, DRD1, DRD2, HTR2B"
Ewing Sarcoma,BRD-K63750851-001-20-7::2.5::HTS,8.100245298881322,0.004588070528656139,Other Types,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Ewing Sarcoma,BRD-K63923597-001-10-0::2.5::HTS,9.970406529169882,0.0016773565975403224,Other Types,barasertib-HQPA,Aurora kinase inhibitor,AURKB
Ewing Sarcoma,BRD-K64538373-001-01-4::2.5::HTS,5.234817068799231,0.022512952375840577,Ewing Sarcoma,Ro-4987655,MEK inhibitor,MAP2K1
Ewing Sarcoma,BRD-K64835161-001-02-8::2.5::HTS,12.539842029684733,0.00043159464624421877,Other Types,ML167,"CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B"
Ewing Sarcoma,BRD-K64866502-001-03-9::2.5::HTS,16.10444611898732,6.818621815146171e-05,Other Types,CYC116,Aurora kinase inhibitor,"AURKA, AURKB, KDR"
Ewing Sarcoma,BRD-K64881305-001-03-7::2.5::HTS,5.427347283971735,0.020179612662214207,Other Types,ispinesib,kinesin inhibitor,KIF11
Ewing Sarcoma,BRD-K64888243-001-03-7::2.5::HTS,20.022065090819442,9.276330132064276e-06,Other Types,AZ960,JAK inhibitor,JAK2
Ewing Sarcoma,BRD-K65544384-001-15-8::2.5::HTS,5.538560660728673,0.018948475479592778,Other Types,4-aminohippuric-acid,,SLC22A6
Ewing Sarcoma,BRD-K65639003-001-09-0::2.5::HTS,5.843166758210955,0.01595952469182774,Ewing Sarcoma,icariin,phosphodiesterase inhibitor,PDE5A
Ewing Sarcoma,BRD-K65716359-001-02-1::2.5::HTS,6.199852719247655,0.013068146882912917,Other Types,exifone,nootropic agent,TYR
Ewing Sarcoma,BRD-K65814004-003-02-9::2.5::HTS,10.61843451643679,0.0011882783159335418,Other Types,diphenyleneiodonium,nitric oxide synthase inhibitor,"NOS2, NOS3"
Ewing Sarcoma,BRD-K65924316-001-03-1::2.5::HTS,10.629480896688124,0.0011813353504866327,Other Types,serdemetan,MDM inhibitor,MDM2
Ewing Sarcoma,BRD-K66296774-236-11-3::2.63::HTS,5.18092468219528,0.023227555056686947,Other Types,fluvastatin,HMGCR inhibitor,HMGCR
Ewing Sarcoma,BRD-K66412701-066-01-6::2.5::HTS,7.119937694379797,0.007843213504166127,Other Types,pazufloxacin,topoisomerase inhibitor,
Ewing Sarcoma,BRD-K67017579-001-28-1::2.5::HTS,4.662041869530241,0.03126273785895085,Other Types,cilostazol,phosphodiesterase inhibitor,"PDE3A, PDE3B"
Ewing Sarcoma,BRD-K67536197-003-11-4::2.5::HTS,5.263293512400472,0.022150335642891116,Other Types,cyclocytidine,"DNA synthesis inhibitor, RNA synthesis inhibitor",
Ewing Sarcoma,BRD-K67831364-003-03-3::2.5::HTS,5.792048989282098,0.016420419966308945,Other Types,ZM-323881,VEGFR inhibitor,KDR
Ewing Sarcoma,BRD-K68164687-001-01-6::2.5::HTS,5.14661746396025,0.023671483678366752,Other Types,epothilone-b,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Ewing Sarcoma,BRD-K68188368-001-09-4::2.5::HTS,31.90251410635691,2.585327053096076e-08,Other Types,nifuroxazide,bacterial DNA inhibitor,
Ewing Sarcoma,BRD-K68202742-001-16-5::2.63::HTS,8.392831159199094,0.003923349814102659,Other Types,trichostatin-a,HDAC inhibitor,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Ewing Sarcoma,BRD-K68264559-045-04-0::2.58::HTS,6.844736355722941,0.009139609593038821,Other Types,brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Ewing Sarcoma,BRD-K68346641-001-02-2::2.5::HTS,11.93064851407921,0.0005939580681553507,Other Types,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Ewing Sarcoma,BRD-K68405354-001-06-4::2.5::HTS,4.559681998735721,0.03316485801960306,Other Types,spaglumic-acid,glutamate receptor antagonist,GRM3
Ewing Sarcoma,BRD-K68488863-001-04-9::2.5::HTS,10.288302919402451,0.0014152233004276749,Other Types,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC"
Ewing Sarcoma,BRD-K68502831-001-01-2::2.5::HTS,13.15946685656046,0.0003138495256718608,Other Types,dianhydrogalactitol,DNA alkylating agent,
Ewing Sarcoma,BRD-K68532323-003-02-8::2.5::HTS,8.751435556067017,0.0032242468963541615,Other Types,SB-743921,kinesin-like spindle protein inhibitor,KIF11
Ewing Sarcoma,BRD-K68747584-001-02-0::2.5::HTS,17.658652848006714,3.0756654394332445e-05,Other Types,PF-03814735,Aurora kinase inhibitor,"AURKA, AURKB"
Ewing Sarcoma,BRD-K68997413-001-05-1::2.5::HTS,5.903448318756082,0.015425712121124086,Ewing Sarcoma,PF-3845,FAAH inhibitor,FAAH
Ewing Sarcoma,BRD-K69469734-003-02-5::2.5::HTS,3.8763527416954027,0.04947615923812074,Other Types,trospium,acetylcholine receptor antagonist,CHRM1
Ewing Sarcoma,BRD-K69726342-238-02-4::2.5::HTS,13.697444218599571,0.00023596450899843118,Other Types,atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR"
Ewing Sarcoma,BRD-K69776681-001-03-8::2.5::HTS,6.661401489587058,0.01010558527943695,Other Types,volasertib,PLK inhibitor,PLK1
Ewing Sarcoma,BRD-K71075609-003-01-0::2.5::HTS,6.392907564572337,0.011731351105326106,Other Types,dorzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7"
Ewing Sarcoma,BRD-K71125014-001-27-1::2.5::HTS,4.813373157012428,0.02865133371733484,Other Types,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Ewing Sarcoma,BRD-K71164191-001-01-0::2.5::HTS,3.9678153853997014,0.04686832309406772,Other Types,KD-023,ACAT inhibitor,"ACACA, ACACB"
Ewing Sarcoma,BRD-K71512533-066-02-8::2.5::HTS,10.482403981572531,0.0012772528320518475,Other Types,SNS-314,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Ewing Sarcoma,BRD-K72384124-001-08-0::2.5::HTS,6.159947675946991,0.013360689578633709,Other Types,sulbentine,other antifungal,
Ewing Sarcoma,BRD-K72703948-001-10-1::2.5::HTS,5.304304730316457,0.021642315371172508,Other Types,ZM-447439,Aurora kinase inhibitor,"AURKA, AURKB"
Ewing Sarcoma,BRD-K72723676-003-17-8::2.5::HTS,4.137522744064587,0.0424158001611481,Other Types,benzethonium,sodium channel blocker,SCN10A
Ewing Sarcoma,BRD-K72728560-001-01-4::2.5::HTS,6.171632005267024,0.013273713783444718,Other Types,dimetridazole,bacterial DNA inhibitor,
Ewing Sarcoma,BRD-K72815923-034-01-2::2.5::HTS,11.936793118399336,0.0005921196753382323,Other Types,xanomeline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Ewing Sarcoma,BRD-K72827473-001-01-0::2.5::HTS,13.450219321701173,0.0002683389027654524,Other Types,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Ewing Sarcoma,BRD-K73107279-003-12-5::2.5::HTS,4.994357191286178,0.025828713998103225,Other Types,levamisole,acetylcholine receptor agonist,"ALPL, ALPPL2, CHRNA3"
Ewing Sarcoma,BRD-K73982490-001-02-9::2.5::HTS,3.9931066045342596,0.04617680898129708,Other Types,BI-78D3,JNK inhibitor,MAPK8
Ewing Sarcoma,BRD-K74057757-001-01-9::2.5::HTS,6.597639622675335,0.010468475233966166,Other Types,indibulin,tubulin polymerization inhibitor,
Ewing Sarcoma,BRD-K74717603-001-02-2::2.5::HTS,5.047346267561983,0.02505109492644777,Other Types,etravirine,non-nucleoside reverse transcriptase inhibitor,"CYP2C19, CYP2C9, CYP3A4"
Ewing Sarcoma,BRD-K75009076-001-02-1::2.43::HTS,6.269818599990488,0.012581735719502772,Other Types,SCH-900776,CHK inhibitor,"CDK2, CHEK1"
Ewing Sarcoma,BRD-K75295174-001-05-0::2.5::HTS,8.786582846518225,0.003166766234794948,Other Types,alisertib,Aurora kinase inhibitor,AURKA
Ewing Sarcoma,BRD-K75649340-001-13-1::2.5::HTS,9.391496187373791,0.0022845218225477906,Other Types,tioguanine,purine antagonist,
Ewing Sarcoma,BRD-K75855670-001-14-2::2.5::HTS,11.61596121626083,0.00070114877775925,Other Types,iodoquinol,antiseptic,
Ewing Sarcoma,BRD-K76617868-003-11-9::2.5::HTS,4.262688133640371,0.03941642523703144,Other Types,fasudil,rho associated kinase inhibitor,"PKIA, PRKACA, ROCK1, ROCK2"
Ewing Sarcoma,BRD-K76634210-001-14-7::2.5::HTS,14.032335093827221,0.00019905653082169156,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Ewing Sarcoma,BRD-K76805682-001-15-9::2.5::HTS,3.887502890264341,0.049140244365508096,Other Types,SB-415286,glycogen synthase kinase inhibitor,"GSK3A, GSK3B, RPS6KB1"
Ewing Sarcoma,BRD-K77484724-001-02-0::2.5::HTS,5.951561698353713,0.015025628774850176,Other Types,adefovir,DNA polymerase inhibitor,
Ewing Sarcoma,BRD-K77791657-001-01-1::2.5::HTS,4.943241112489989,0.02658974196669537,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Ewing Sarcoma,BRD-K77791657-003-01-7::2.67::HTS,6.321484681423915,0.012224598577372842,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Ewing Sarcoma,BRD-K77908580-001-09-6::2.5::HTS,12.47187306096513,0.0004471639588029475,Other Types,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9"
Ewing Sarcoma,BRD-K77987382-001-13-2::2.5::HTS,19.52187539334009,1.1936200675123849e-05,Other Types,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Ewing Sarcoma,BRD-K78055238-001-01-8::2.5::HTS,14.029817406030604,0.00019884450204141354,Other Types,LY2090314,glycogen synthase kinase inhibitor,GSK3B
Ewing Sarcoma,BRD-K78122587-300-02-7::2.5::HTS,7.0152895948778955,0.008310048281019205,Other Types,NNC-55-0396,T-type calcium channel blocker,"CATSPER1, CATSPER2, CATSPER3, CATSPER4"
Ewing Sarcoma,BRD-K78303961-001-02-3::2.5::HTS,14.98295805352507,0.00012122113525546838,Other Types,glycitein,tumor necrosis factor release inhibitor,TNF
Ewing Sarcoma,BRD-K78431006-001-10-2::2.5::HTS,10.949448218733377,0.000996250533364333,Other Types,crizotinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Ewing Sarcoma,BRD-K78496197-001-03-9::2.5::HTS,7.188752794408721,0.007553648784084422,Other Types,SCS,,
Ewing Sarcoma,BRD-K78960041-001-05-7::2.54::HTS,7.962063022960008,0.004956734891126641,Other Types,oxaliplatin,DNA inhibitor,
Ewing Sarcoma,BRD-K79095980-001-09-6::2.5::HTS,7.3094239717139535,0.007067424476140394,Other Types,broxuridine,antimetabolite,
Ewing Sarcoma,BRD-K79131256-001-17-9::2.5::HTS,16.083432387779485,6.880163274643558e-05,Other Types,albendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Ewing Sarcoma,BRD-K79254416-001-22-6::2.5::HTS,12.856823856658476,0.0003658465013620813,Other Types,decitabine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Ewing Sarcoma,BRD-K79315489-001-07-8::2.5::HTS,7.8575201423489816,0.005247069893430337,Other Types,erythritol,,
Ewing Sarcoma,BRD-K79425933-001-09-3::2.5::HTS,4.085956808901014,0.04372129978612345,Other Types,benperidol,dopamine receptor antagonist,DRD2
Ewing Sarcoma,BRD-K79437791-001-05-7::2.5::HTS,5.035314084344902,0.02522757970423022,Other Types,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG
Ewing Sarcoma,BRD-K79612754-001-19-1::2.62::HTS,16.980713984164645,4.383643851762694e-05,Other Types,inosine,neurotrophic agent,"PARP1, PNP"
Ewing Sarcoma,BRD-K79892937-001-02-5::2.5::HTS,5.341968537000107,0.02118143556526253,Other Types,phenolsulfonphthalein,,
Ewing Sarcoma,BRD-K79966802-034-01-2::2.5::HTS,4.3484272785187,0.03749782213970107,Other Types,rivanicline,acetylcholine receptor agonist,"CHRNA4, CHRNB2, CXCL8"
Ewing Sarcoma,BRD-K80639402-003-02-9::2.5::HTS,4.889685618961104,0.02742515522603438,Other Types,SB-258585,serotonin receptor antagonist,HTR6
Ewing Sarcoma,BRD-K81197548-003-01-4::2.5::HTS,4.038248278039094,0.04496093295825969,Other Types,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Ewing Sarcoma,BRD-K81376179-001-04-8::2.5::HTS,9.366298246430398,0.00231637778629696,Other Types,TCS-359,FLT3 inhibitor,FLT3
Ewing Sarcoma,BRD-K81418486-001-47-5::2.5::HTS,8.090611415098362,0.0046221173237526855,Other Types,vorinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9"
Ewing Sarcoma,BRD-K82236108-001-04-9::2.5::HTS,8.203087574617882,0.004339272972767554,Other Types,"N-methyl-(-)ephedrine-[1r,2s]",,
Ewing Sarcoma,BRD-K82767007-001-01-1::2.5::HTS,6.493071370865793,0.011102329029615594,Other Types,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Ewing Sarcoma,BRD-K82928847-001-04-7::2.5::HTS,5.4342555702066395,0.020108561802341853,Other Types,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Ewing Sarcoma,BRD-K83003151-057-02-4::2.35::HTS,12.823878089802747,0.0003738311205346452,Other Types,alogliptin,dipeptidyl peptidase inhibitor,DPP4
Ewing Sarcoma,BRD-K83245588-001-01-4::2.5::HTS,4.491511248811541,0.034511785329708236,Ewing Sarcoma,pilsicainide,sodium channel blocker,SCN5A
Ewing Sarcoma,BRD-K83834509-001-01-1::2.5::HTS,9.192797355549931,0.002542315884948979,Other Types,PTC-209,BMI-1 inhibitor,
Ewing Sarcoma,BRD-K83963101-001-06-9::2.5::HTS,11.668795657297345,0.0006834967931835625,Other Types,MLN-8054,Aurora kinase inhibitor,AURKA
Ewing Sarcoma,BRD-K84937637-001-09-9::2.5::HTS,7.101615627252778,0.007937101664461498,Other Types,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Ewing Sarcoma,BRD-K85014146-001-02-5::2.5::HTS,6.100384326762844,0.013854844330838438,Other Types,AZD2461,PARP inhibitor,
Ewing Sarcoma,BRD-K85090592-008-22-7::2.5::HTS,6.305465928659069,0.012338212258699003,Other Types,pilocarpine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Ewing Sarcoma,BRD-K85402309-001-06-6::2.5::HTS,6.117640896350168,0.013682712098516982,Other Types,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Ewing Sarcoma,BRD-K85402309-389-03-2::2.5::HTS,9.008008443532155,0.002807761544745977,Other Types,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Ewing Sarcoma,BRD-K85849709-001-01-5::2.5::HTS,9.005105233620112,0.0028125882389984248,Other Types,AZD2858,glycogen synthase kinase inhibitor,GSK3B
Ewing Sarcoma,BRD-K85925969-001-17-4::2.5::HTS,5.178275158547313,0.02325762008708416,Other Types,zalcitabine,nucleoside reverse transcriptase inhibitor,
Ewing Sarcoma,BRD-K86003836-001-10-5::2.5::HTS,14.104575272649534,0.00019108159106799274,Other Types,flubendazole,tubulin polymerization inhibitor,TUBB
Ewing Sarcoma,BRD-K86118762-001-01-8::2.5::HTS,9.573215994459991,0.0020760122567067257,Other Types,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Ewing Sarcoma,BRD-K86301799-001-34-8::2.5::HTS,5.713515889061084,0.017166068132080756,Other Types,dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1"
Ewing Sarcoma,BRD-K86727142-001-12-4::2.5::HTS,4.612297917299718,0.03217581192618189,Other Types,embelin,"HCV inhibitor, XIAP inhibitor",XIAP
Ewing Sarcoma,BRD-K86892782-001-17-0::2.5::HTS,12.715780017630323,0.00039441091244618885,Other Types,edoxudine,DNA directed DNA polymerase inhibitor,
Ewing Sarcoma,BRD-K87048468-003-02-7::2.5::HTS,5.134559737602191,0.023839741573195874,Other Types,RS-102221,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Ewing Sarcoma,BRD-K87512222-019-01-7::2.5::HTS,5.5481569490482086,0.01884405075219042,Other Types,taltobulin,tubulin polymerization inhibitor,
Ewing Sarcoma,BRD-K87737963-001-06-0::2.5::HTS,11.71425863213049,0.0006657082712324599,Other Types,cyt387,,"JAK1, JAK2, JAK3"
Ewing Sarcoma,BRD-K87827419-001-16-8::2.5::HTS,29.226680921043798,9.63814711999104e-08,Other Types,melphalan,"DNA alkylating agent, DNA inhibitor",
Ewing Sarcoma,BRD-K87990216-001-10-2::2.5::HTS,4.748146762515301,0.029748210936624588,Other Types,piretanide,glucocorticoid receptor agonist,"SLC12A1, SLC12A2"
Ewing Sarcoma,BRD-K88405679-003-03-1::2.5::HTS,7.473959457747363,0.006458870499579933,Other Types,thonzylamine,antihistamine,
Ewing Sarcoma,BRD-K88429204-001-35-1::2.5::HTS,5.691535953090164,0.01737891825244191,Other Types,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Ewing Sarcoma,BRD-K88506063-001-01-8::2.5::HTS,5.983343227181068,0.014748780770762615,Other Types,KD025,rho associated kinase inhibitor,ROCK2
Ewing Sarcoma,BRD-K89014967-001-04-3::2.5::HTS,8.269697166129035,0.004185456923099875,Ewing Sarcoma,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Ewing Sarcoma,BRD-K89015388-001-01-7::2.5::HTS,12.607664544085228,0.00041666697592077637,Other Types,GSK923295,centromere associated protein inhibitor,CENPE
Ewing Sarcoma,BRD-K89053832-001-01-0::2.5::HTS,11.229766709193497,0.0008592151766552207,Other Types,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Ewing Sarcoma,BRD-K89299012-001-06-0::2.5::HTS,3.9499688069949377,0.047365936998200645,Ewing Sarcoma,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Ewing Sarcoma,BRD-K89839824-001-05-3::2.5::HTS,17.49625057578871,3.346430440309198e-05,Other Types,raltitrexed,thymidylate synthase inhibitor,"FPGS, TYMS"
Ewing Sarcoma,BRD-K90333595-003-21-4::2.5::HTS,4.97929334630664,0.026046047326655008,Other Types,phentolamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Ewing Sarcoma,BRD-K90374350-001-09-2::2.5::HTS,12.878023383567767,0.0003623716638677185,Other Types,chlorquinaldol,other antibiotic,
Ewing Sarcoma,BRD-K90382497-001-10-7::2.5::HTS,7.88919070677486,0.005149247635233026,Other Types,GW-843682X,PLK inhibitor,"PLK1, PLK3"
Ewing Sarcoma,BRD-K90789829-001-07-8::2.5::HTS,6.05254555434778,0.014188791616964555,Other Types,nefazodone,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Ewing Sarcoma,BRD-K91301684-003-05-5::2.5::HTS,4.419569199664618,0.035973303826584146,Other Types,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor",SIGMAR1
Ewing Sarcoma,BRD-K91601245-001-12-0::2.5::HTS,6.0346739891699634,0.014337699734758808,Other Types,mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT"
Ewing Sarcoma,BRD-K91623615-001-05-0::2.46::HTS,6.005246154632109,0.014586761591431437,Other Types,ABT-751,tubulin polymerization inhibitor,TUBB
Ewing Sarcoma,BRD-K92428153-001-04-4::2.5::HTS,4.465539101600623,0.03502693108661984,Other Types,mycophenolate-mofetil,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Ewing Sarcoma,BRD-K92446736-003-02-2::2.5::HTS,6.785275447548998,0.009436798409361132,Other Types,zatebradine,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Ewing Sarcoma,BRD-K92991072-001-04-9::2.5::HTS,17.061258093755114,4.194537218094728e-05,Other Types,PAC-1,caspase activator,CASP3
Ewing Sarcoma,BRD-K93034159-001-25-8::2.5::HTS,5.944383923355489,0.015074129618381348,Other Types,cladribine,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B"
Ewing Sarcoma,BRD-K93754473-048-20-2::2.5::HTS,6.729630601351141,0.00973020928105612,Other Types,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
Ewing Sarcoma,BRD-K93918653-001-08-9::2.5::HTS,5.188394798072521,0.023114883041631406,Other Types,quizartinib,FLT3 inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET"
Ewing Sarcoma,BRD-K94441233-001-13-0::2.6::HTS,7.533224970438007,0.006263391575528235,Other Types,mevastatin,HMGCR inhibitor,HMGCR
Ewing Sarcoma,BRD-K94720315-001-10-4::2.5::HTS,5.954563509894285,0.014989935401652062,Other Types,chromocarb,antispasmodic,
Ewing Sarcoma,BRD-K95142244-001-01-5::2.5::HTS,21.931357021432834,3.5500005509285522e-06,Other Types,talazoparib,PARP inhibitor,PARP2
Ewing Sarcoma,BRD-K95523387-001-09-6::2.5::HTS,24.704958892689923,8.897393358194664e-07,Other Types,OLDA,TRPV agonist,GPR119
Ewing Sarcoma,BRD-K95573441-001-01-2::2.5::HTS,5.743101427907264,0.016881075602508157,Other Types,PFK-015,phosphofructokinase inhibitor,PFKFB3
Ewing Sarcoma,BRD-K95785537-001-23-1::2.5::HTS,6.405880975416853,0.01165240793209087,Ewing Sarcoma,PP-2,src inhibitor,"ABL1, LCK, LYN, RIPK2, SRC"
Ewing Sarcoma,BRD-K95901403-001-04-5::2.5::HTS,10.462781263295673,0.0012898437766596096,Ewing Sarcoma,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Ewing Sarcoma,BRD-K96123349-236-02-8::2.5::HTS,4.989800424728969,0.02588978276890015,Other Types,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH
Ewing Sarcoma,BRD-K96137854-001-17-1::2.5::HTS,4.288969464865989,0.03882039543180942,Other Types,enoxolone,gap junction modulator,HSD11B1
Ewing Sarcoma,BRD-K96188950-001-16-9::2.5::HTS,18.205095188986437,2.3341401314948123e-05,Other Types,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA
Ewing Sarcoma,BRD-K96233303-001-01-9::2.5::HTS,12.101378969364559,0.000543019867664153,Other Types,TMS,,
Ewing Sarcoma,BRD-K96259238-001-01-4::2.5::HTS,13.35345595092726,0.00028224674343519404,Other Types,Y-320,interleukin inhibitor,IL17A
Ewing Sarcoma,BRD-K96631475-001-02-4::2.43::HTS,14.891612428074023,0.00012795907099640786,Other Types,10-deacetylbaccatin,antitumor agent,
Ewing Sarcoma,BRD-K96799727-001-06-6::2.5::HTS,6.0763662679050885,0.014000248380821883,Other Types,pifithrin-mu,HSP inhibitor,"HSPA1A, TP53"
Ewing Sarcoma,BRD-K96936751-001-01-4::2.5::HTS,5.504271855880579,0.01931659278551736,Other Types,bretazenil,GABA benzodiazepine site receptor partial agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6"
Ewing Sarcoma,BRD-K97010173-001-04-1::2.5::HTS,8.270167413618681,0.004183279357237141,Other Types,deferasirox,chelating agent,CYP3A4
Ewing Sarcoma,BRD-K97163964-001-03-3::2.5::HTS,4.180110351656945,0.041370620731849966,Other Types,L-Aspartic-Acid,metallic radical formation stimulant,"ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13"
Ewing Sarcoma,BRD-K97399794-001-15-3::2.5::HTS,10.105096578422721,0.0015602411512660587,Other Types,quercetin,polar auxin transport inhibitor,"ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1"
Ewing Sarcoma,BRD-K97746869-001-27-0::2.5::HTS,4.343687712847392,0.03759743668562071,Other Types,chlorpropamide,ATP channel blocker,"ABCC8, KCNJ10, KCNJ11"
Ewing Sarcoma,BRD-K97799481-001-16-0::2.5::HTS,6.030189594872536,0.014364885913968398,Other Types,theophylline,adenosine receptor antagonist,
Ewing Sarcoma,BRD-K98203492-003-04-1::2.5::HTS,9.279306821052822,0.002432068951249407,Other Types,GSK-J4,histone lysine demethylase inhibitor,"KDM6A, KDM6B"
Ewing Sarcoma,BRD-K99170882-001-04-3::2.5::HTS,7.745220054964387,0.005567927840537287,Other Types,NSC-319726,p53 activator,
Ewing Sarcoma,BRD-K99498722-001-02-6::2.5::HTS,6.002126445925495,0.014597031338753586,Other Types,plinabulin,tubulin polymerization inhibitor,
Ewing Sarcoma,BRD-K99545815-001-06-3::2.5::HTS,8.45427333718248,0.003785672951220827,Other Types,PF-562271,focal adhesion kinase inhibitor,"PTK2, PTK2B"
Ewing Sarcoma,BRD-K99946902-001-07-5::2.5::HTS,11.447016118415924,0.0007665174476185312,Other Types,hexylresorcinol,local anesthetic,TYR
Ewing Sarcoma,BRD-A00055058-001-01-0::2.325889319::MTS004,7.935453865680734,0.005025302117877624,Ewing Sarcoma,RS-0481,immunostimulant,
Ewing Sarcoma,BRD-A23418262-001-01-5::2.519094866::MTS004,4.560132411386242,0.033174658481645775,Other Types,floctafenine,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Ewing Sarcoma,BRD-A53077924-001-01-2::2.499990763::MTS004,5.501943538833993,0.019357584810169966,Ewing Sarcoma,tianeptine,selective serotonin reuptake enhancer (SSRE),"OPRD1, OPRK1, OPRM1"
Ewing Sarcoma,BRD-A60498477-001-01-2::2.508127434::MTS004,7.091132604564759,0.007978607597581795,Ewing Sarcoma,tolamolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Ewing Sarcoma,BRD-A65562236-001-01-2::2.499987842::MTS004,8.083780944274151,0.004636057922136142,Ewing Sarcoma,solamargine,apoptosis inhibitor,
Ewing Sarcoma,BRD-A75975749-001-01-4::2.5::MTS004,4.199936207383447,0.04090988765399054,Ewing Sarcoma,bafetinib,"Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor","ABL1, BCR, LYN"
Ewing Sarcoma,BRD-A79052425-003-01-5::2.5::MTS004,9.544299072865625,0.002109164823606842,Ewing Sarcoma,SIB-1553A,acetylcholine receptor agonist,CHRNB4
Ewing Sarcoma,BRD-A88562598-001-01-7::2.500008795::MTS004,5.956647806050627,0.01498342482778966,Ewing Sarcoma,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Ewing Sarcoma,BRD-K02554563-001-01-6::2.5::MTS004,4.762952850949593,0.029509558328469507,Ewing Sarcoma,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR
Ewing Sarcoma,BRD-K03765900-001-01-9::2.499986292::MTS004,4.8679833231726715,0.02778121290980006,Ewing Sarcoma,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Ewing Sarcoma,BRD-K04603573-376-01-3::2.542651982::MTS004,5.222803071998057,0.022680768731109816,Ewing Sarcoma,"1,12-Besm",polyamine biosynthesis inhibitor,
Ewing Sarcoma,BRD-K04701033-001-04-7::2.499987566::MTS004,4.053584035743104,0.04457425279416568,Other Types,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Ewing Sarcoma,BRD-K06467130-304-02-7::2.5::MTS004,4.964762206133571,0.026280667758740696,Ewing Sarcoma,CL316243,adrenergic receptor agonist,"ADRB3, UCP1, UCP2, UCP3"
Ewing Sarcoma,BRD-K07625016-001-01-2::2.50703254::MTS004,8.62157280712929,0.0034641819056678035,Ewing Sarcoma,norethisterone-enanthate,contraceptive agent,
Ewing Sarcoma,BRD-K09735259-001-01-3::2.500007896::MTS004,14.648458259225004,0.00014475840939482616,Ewing Sarcoma,elbasvir,HCV inhibitor,
Ewing Sarcoma,BRD-K13664493-316-02-5::2.500014041::MTS004,6.384653007349154,0.011796669059765045,Other Types,naphthoquine-phosphate,antimalarial agent,
Ewing Sarcoma,BRD-K16505263-003-02-9::2.49996754::MTS004,4.211589574185182,0.040631128203093274,Ewing Sarcoma,forodesine,purinergic receptor antagonist,PNP
Ewing Sarcoma,BRD-K17610631-001-03-3::2.421190843::MTS004,12.795627329937293,0.0003787117249106496,Other Types,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Ewing Sarcoma,BRD-K17641316-001-04-8::2.500015146::MTS004,4.780778479868627,0.029208354782926948,Ewing Sarcoma,decoquinate,antiprotozoal agent,
Ewing Sarcoma,BRD-K21077415-001-01-5::2.656085278::MTS004,4.21772262419099,0.04048569229105042,Ewing Sarcoma,AMG-319,PI3K inhibitor,PIK3CD
Ewing Sarcoma,BRD-K21152241-001-07-3::2.5082643::MTS004,4.136450000329522,0.04245830889427825,Ewing Sarcoma,enoximone,phosphodiesterase inhibitor,PDE3A
Ewing Sarcoma,BRD-K25029121-001-05-8::2.446932239::MTS004,3.9250774476551302,0.048079697816939354,Ewing Sarcoma,triclocarban,other antibiotic,
Ewing Sarcoma,BRD-K26530649-001-01-6::2.568078778::MTS004,13.944304289831749,0.0002083880910541603,Other Types,carboxypyridine-disulfide,,
Ewing Sarcoma,BRD-K27061362-001-01-6::2.499998598::MTS004,6.972572273499694,0.008517277306888385,Ewing Sarcoma,AMG-337,MET inhibitor,MET
Ewing Sarcoma,BRD-K28537285-001-01-8::2.499968715::MTS004,5.24599799319477,0.02238259187052176,Other Types,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Ewing Sarcoma,BRD-K29812331-011-01-7::2.472474424::MTS004,6.006542838815981,0.014570137099115978,Ewing Sarcoma,dimemorfan,sigma receptor agonist,SIGMAR1
Ewing Sarcoma,BRD-K32842773-434-01-8::2.5::MTS004,7.095841204504178,0.007957518360148028,Other Types,pemetrexed,"dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS"
Ewing Sarcoma,BRD-K33240821-001-06-2::2.50000539::MTS004,5.811257837756225,0.01625757600129064,Other Types,plerixafor,CC chemokine receptor antagonist,"ACKR3, CCR4, CXCR4"
Ewing Sarcoma,BRD-K35626314-003-01-1::2.499986242::MTS004,6.077773559910731,0.01399983768981233,Ewing Sarcoma,TRV130,opioid receptor agonist,OPRM1
Ewing Sarcoma,BRD-K37708699-001-01-4::2.530276706::MTS004,5.643084875666237,0.01787371174357364,Ewing Sarcoma,exisulind,phosphodiesterase inhibitor,PDE5A
Ewing Sarcoma,BRD-K41662846-003-01-5::2.517380705::MTS004,5.605436106735129,0.018257617085656763,Ewing Sarcoma,tecalcet,calcium-sensing receptor agonist,CASR
Ewing Sarcoma,BRD-K50813454-001-01-9::2.592830582::MTS004,3.910177332662881,0.04850450604265215,Ewing Sarcoma,amflutizole,xanthine oxidase inhibitor,XDH
Ewing Sarcoma,BRD-K52960356-001-15-5::2.499955314::MTS004,5.916351364692657,0.015325431725815785,Ewing Sarcoma,acetohexamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ10, KCNJ11"
Ewing Sarcoma,BRD-K54955827-001-02-2::2.49997945::MTS004,33.3368356449831,1.309833647578598e-08,Other Types,niraparib,PARP inhibitor,PARP1
Ewing Sarcoma,BRD-K55808645-001-01-4::2.500006596::MTS004,7.197249484894817,0.007526140169636263,Ewing Sarcoma,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Ewing Sarcoma,BRD-K56912469-003-02-0::2.499992214::MTS004,3.8967069839062916,0.04889102274327524,Ewing Sarcoma,SAR407899,rho associated kinase inhibitor,ROCK1
Ewing Sarcoma,BRD-K57886322-001-16-6::2.5::MTS004,4.09830202190215,0.043419839773264114,Other Types,fluocinonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6, SMO"
Ewing Sarcoma,BRD-K58277159-001-01-7::2.5::MTS004,3.900014002984854,0.048795596487644526,Other Types,NPC-01,steroid,
Ewing Sarcoma,BRD-K59256312-066-15-7::2.431061328::MTS004,9.684813088443628,0.001956643080829084,Ewing Sarcoma,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Ewing Sarcoma,BRD-K59866480-001-07-3::2.379655165::MTS004,14.009900137446904,0.00020138434589607988,Other Types,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Ewing Sarcoma,BRD-K60241851-001-11-9::2.5::MTS004,6.655769391201644,0.010147126869932206,Ewing Sarcoma,isodibut,aldehyde reductase inhibitor,
Ewing Sarcoma,BRD-K70504253-001-01-3::2.500017504::MTS004,19.224540426244257,1.397766508715369e-05,Ewing Sarcoma,fruquintinib,VEGFR inhibitor,KDR
Ewing Sarcoma,BRD-K73881242-003-04-6::2.500023768::MTS004,4.7370884382706695,0.029953185538638488,Ewing Sarcoma,arbidol,cytochrome P450 inhibitor,CYP3A4
Ewing Sarcoma,BRD-K74671368-001-01-8::2.5::MTS004,29.162010867946595,9.99863502559944e-08,Other Types,idronoxil,XIAP inhibitor,"ENOX2, SPHK1"
Ewing Sarcoma,BRD-K74759733-065-01-4::2.5::MTS004,4.7444713993833,0.029825272331638574,Ewing Sarcoma,isepamicin,protein synthesis inhibitor,
Ewing Sarcoma,BRD-K80076813-001-08-8::2.356620242::MTS004,5.674720454215331,0.01755758967617364,Other Types,diftalone,cyclooxygenase inhibitor,
Ewing Sarcoma,BRD-K80738081-001-46-8::2.500037854::MTS004,4.478445598112112,0.03478271074680423,Ewing Sarcoma,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Ewing Sarcoma,BRD-K86171477-001-01-3::2.5::MTS004,4.600782470874699,0.03240365149196991,Ewing Sarcoma,eltoprazine,serotonin receptor agonist,"HTR1A, HTR1B"
Ewing Sarcoma,BRD-K89085489-001-23-2::2.499967871::MTS004,33.741290281600314,1.0769759876131574e-08,Other Types,fenretinide,"apoptosis stimulant, retinoid receptor agonist",RARA
Ewing Sarcoma,BRD-K90069354-001-03-7::2.5::MTS004,5.124161961364415,0.023992429367791848,Other Types,isovaleramide,alcohol dehydrogenase inhibitor,
Ewing Sarcoma,BRD-K92413528-001-06-9::2.5::MTS004,4.960921946909745,0.02633854094742003,Ewing Sarcoma,procysteine,glutathione synthase stimulant,
Ewing Sarcoma,BRD-K92908289-001-01-8::2.501017998::MTS004,7.8478728287350386,0.005271225097035354,Ewing Sarcoma,medica-16,ATP citrase lyase inhibitor,FFAR1
Ewing Sarcoma,BRD-K98054437-001-09-9::2.494413182::MTS004,4.667049719111781,0.031186725156146032,Ewing Sarcoma,epalrestat,aldose reductase inhibitor,AKR1B1
Ewing Sarcoma,BRD-M63173034-001-03-6::2.64076472::MTS004,6.019477870312243,0.014464928438965258,Ewing Sarcoma,clonixin-lysinate,cyclooxygenase inhibitor,
Renal Cell Carcinoma,BRD-A01643550-001-04-9::2.5::HTS,12.50489004978706,0.0004408454267092335,Renal Cell Carcinoma,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-A02180903-001-04-5::2.5::HTS,4.615716373744193,0.032110735279243144,Other Types,betamethasone,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-A03216249-003-24-3::2.5::HTS,10.372036762452485,0.0013542570782720277,Renal Cell Carcinoma,mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A
Renal Cell Carcinoma,BRD-A06935312-001-04-3::2.5::HTS,5.76318860865179,0.016692331194365837,Other Types,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-A07000685-001-04-4::2.5::HTS,4.177790789549711,0.04142684244462171,Other Types,hydrocortisone-hemisuccinate,,
Renal Cell Carcinoma,BRD-A07600638-060-05-2::2.5::HTS,4.425885128353588,0.035860444116238566,Other Types,meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-A08302182-001-01-7::2.5::HTS,15.288755303401766,0.00010370536004289068,Other Types,etonogestrel,progesterone receptor agonist,"ESR1, PGR"
Renal Cell Carcinoma,BRD-A08545410-003-07-8::2.38::HTS,4.699502472995499,0.030617420551742883,Renal Cell Carcinoma,doxycycline,metalloproteinase inhibitor,MMP8
Renal Cell Carcinoma,BRD-A08840375-001-01-3::2.5::HTS,4.895932347434789,0.027332981861124626,Renal Cell Carcinoma,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Renal Cell Carcinoma,BRD-A09554849-236-07-6::2.5::HTS,7.91198513176609,0.005084102641105738,Other Types,8-bromo-cAMP,PKA activator,
Renal Cell Carcinoma,BRD-A13084692-001-17-3::2.5::HTS,4.379483253796726,0.03682919515661959,Other Types,troglitazone,"insulin sensitizer, PPAR receptor agonist","ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3"
Renal Cell Carcinoma,BRD-A15415227-003-02-9::2.5::HTS,6.812407908833575,0.009294032806612803,Other Types,GW-1929,PPAR receptor agonist,PPARG
Renal Cell Carcinoma,BRD-A16700644-003-04-4::2.5::HTS,4.0686198339327575,0.044166190786876725,Renal Cell Carcinoma,isoxsuprine,adrenergic receptor agonist,ADRB2
Renal Cell Carcinoma,BRD-A18074780-003-02-0::2.5::HTS,19.78690171498115,1.045649893383702e-05,Other Types,AGN-192403,imidazoline receptor ligand,NISCH
Renal Cell Carcinoma,BRD-A18233884-003-02-7::2.5::HTS,5.5292728539747396,0.01905145268992462,Other Types,bevantolol,adrenergic receptor antagonist,"ADRA1A, ADRB1, ADRB2"
Renal Cell Carcinoma,BRD-A18611368-001-01-5::2.5::HTS,4.392340920669162,0.036551457393322564,Other Types,tazobactam,beta lactamase inhibitor,
Renal Cell Carcinoma,BRD-A20239487-001-24-9::2.5::HTS,6.315908550974357,0.01225493605305845,Other Types,atenolol-(+/-),adrenergic receptor antagonist,"ADRB1, ADRB2"
Renal Cell Carcinoma,BRD-A22380646-236-05-8::2.51::HTS,5.226207475363388,0.022625624066187077,Other Types,pantoprazole,ATPase inhibitor,ATP4A
Renal Cell Carcinoma,BRD-A22707317-001-10-8::2.5::HTS,6.008102806114142,0.014544902858521645,Renal Cell Carcinoma,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Renal Cell Carcinoma,BRD-A23072235-050-18-5::2.5::HTS,10.239985838641081,0.0014570387040138664,Other Types,pheniramine,histamine receptor antagonist,HRH1
Renal Cell Carcinoma,BRD-A25004090-001-08-4::2.5::HTS,3.8690280130998898,0.04968004747226123,Other Types,erastin,ion channel antagonist,VDAC2
Renal Cell Carcinoma,BRD-A26032986-050-02-1::2.5::HTS,5.567551278160878,0.01863913616158094,Renal Cell Carcinoma,zaldaride,calmodulin antagonist,CALM1
Renal Cell Carcinoma,BRD-A27376179-001-01-3::2.5::HTS,7.473655801257203,0.00646398603475958,Renal Cell Carcinoma,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor","FLT3, NTRK1"
Renal Cell Carcinoma,BRD-A27883417-300-01-6::2.5::HTS,16.583540941076464,5.344650083117659e-05,Renal Cell Carcinoma,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1
Renal Cell Carcinoma,BRD-A27924917-001-03-3::2.5::HTS,4.854820990546014,0.027976061631588767,Other Types,2-hydroxysaclofen,GABA receptor antagonist,"GABBR1, GABBR2"
Renal Cell Carcinoma,BRD-A28044053-001-01-7::2.5::HTS,6.25692431028806,0.012659885033974933,Other Types,arotinolol,adrenergic receptor antagonist,ADRB3
Renal Cell Carcinoma,BRD-A28958257-001-01-2::2.5::HTS,4.450773367435365,0.03532695125280936,Other Types,centpropazine,inositol monophosphatase inhibitor,
Renal Cell Carcinoma,BRD-A28970875-300-04-9::2.5::HTS,18.03318329082434,2.5569579833416553e-05,Renal Cell Carcinoma,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Renal Cell Carcinoma,BRD-A30886737-001-02-9::2.5::HTS,6.736238274328383,0.009696453096726588,Renal Cell Carcinoma,florfenicol,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-A31095847-001-02-3::2.5::HTS,8.972587479642462,0.0028631556956046533,Renal Cell Carcinoma,mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2"
Renal Cell Carcinoma,BRD-A33168282-003-18-0::2.5::HTS,4.705536450466235,0.030491702298626744,Other Types,sotalol,adrenergic receptor antagonist,"ADRB1, ADRB2, KCNH2"
Renal Cell Carcinoma,BRD-A33711280-003-03-1::2.5::HTS,4.631853691178745,0.0318103370563483,Other Types,metixene,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Renal Cell Carcinoma,BRD-A34006693-001-15-4::2.5::HTS,6.072627291111532,0.014033972315648114,Other Types,suprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-A37347161-003-02-6::2.5::HTS,12.055410794876288,0.0005563558144836511,Other Types,BRL-52537,opioid receptor agonist,OPRK1
Renal Cell Carcinoma,BRD-A37390343-003-03-5::2.5::HTS,6.109069318013829,0.013745792114525451,Other Types,amorolfine,membrane integrity inhibitor,
Renal Cell Carcinoma,BRD-A41304429-001-14-8::2.5::HTS,6.06017853238371,0.014127182717582598,Other Types,practolol,adrenergic receptor antagonist,ADRB1
Renal Cell Carcinoma,BRD-A41451487-001-11-2::2.5::HTS,5.569530665069896,0.018626473834989922,Other Types,PK-11195,benzodiazepine receptor antagonist,TSPO
Renal Cell Carcinoma,BRD-A41692738-001-07-6::2.5::HTS,13.628013855849527,0.00024487921723154453,Other Types,TGX-221,PI3K inhibitor,"PIK3CB, PIK3CD"
Renal Cell Carcinoma,BRD-A43809092-003-02-1::2.5::HTS,4.3013274417700975,0.03854401156893531,Other Types,clobutinol,antitussive,
Renal Cell Carcinoma,BRD-A44500574-001-01-8::2.5::HTS,18.5666110344868,1.9391986352816448e-05,Other Types,FLI-06,notch signaling inhibitor,
Renal Cell Carcinoma,BRD-A47449001-004-13-7::2.5::HTS,4.534349569632089,0.033655072551972094,Other Types,ipratropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Renal Cell Carcinoma,BRD-A47953250-001-01-7::2.5::HTS,4.546743784981391,0.03343278706255998,Renal Cell Carcinoma,ecamsule-triethanolamine,,
Renal Cell Carcinoma,BRD-A49225603-045-10-0::2.5::HTS,5.223354994306281,0.02266037104469164,Other Types,alimemazine,histamine receptor agonist,HRH1
Renal Cell Carcinoma,BRD-A49447682-001-02-4::2.5::HTS,14.075963132134108,0.00019397145162982452,Other Types,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Renal Cell Carcinoma,BRD-A49765801-001-04-1::2.5::HTS,5.419038099419656,0.020278801267170733,Other Types,fludroxycortide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Renal Cell Carcinoma,BRD-A51571244-001-01-9::2.5::HTS,7.88922268612375,0.005151109760130067,Renal Cell Carcinoma,hypoestoxide,IKK inhibitor,"IKBKB, IL1B, TNF"
Renal Cell Carcinoma,BRD-A52588987-004-08-2::2.5::HTS,16.558647071521758,5.3961851401661264e-05,Other Types,SKF-83566,dopamine receptor antagonist,"DRD1, DRD5"
Renal Cell Carcinoma,BRD-A53134341-001-03-2::2.5::HTS,8.873037341360547,0.0030257074090145938,Renal Cell Carcinoma,Ro-106-9920,NFkB pathway inhibitor,
Renal Cell Carcinoma,BRD-A53813595-001-01-8::2.5::HTS,9.001568380731454,0.0028170815028660126,Other Types,PGL5001,JNK inhibitor,"MAPK10, MAPK8, MAPK9"
Renal Cell Carcinoma,BRD-A54927599-001-16-9::2.5::HTS,3.9928754772655233,0.04618309541424064,Renal Cell Carcinoma,KF-38789,P selectin inhibitor,SELP
Renal Cell Carcinoma,BRD-A55393291-001-09-9::2.5::HTS,7.727369602656136,0.005621809830571268,Other Types,testosterone,androgen receptor agonist,AR
Renal Cell Carcinoma,BRD-A56858165-001-04-4::2.5::HTS,8.662789403244918,0.003383088259670668,Other Types,cefadroxil,bacterial cell wall synthesis inhibitor,"SLC15A1, SLC15A2, SLC22A6, SLC22A8"
Renal Cell Carcinoma,BRD-A57798112-001-03-7::2.5::HTS,5.762877558826726,0.016695255261214518,Renal Cell Carcinoma,PD-318088,MEK inhibitor,MAP2K1
Renal Cell Carcinoma,BRD-A57957888-001-08-0::2.5::HTS,4.6260713037992325,0.031919119619780896,Other Types,citiolone,"lipotropic, mucolytic agent",
Renal Cell Carcinoma,BRD-A58193911-003-18-7::2.5::HTS,34.30203742291672,8.212746650867903e-09,Renal Cell Carcinoma,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Renal Cell Carcinoma,BRD-A61850409-001-10-7::2.5::HTS,8.045362341052805,0.0047276877999423185,Other Types,alpha-tochopheryl-acetate,antioxidant,
Renal Cell Carcinoma,BRD-A63444178-001-01-5::2.5::HTS,5.44822697128754,0.01994154450411383,Other Types,ME0328,PARP inhibitor,PARP3
Renal Cell Carcinoma,BRD-A64698388-003-01-7::2.5::HTS,8.820526893027624,0.0031095651786694637,Other Types,levo-phencynonate,acetylcholine receptor antagonist,CHRM1
Renal Cell Carcinoma,BRD-A64808605-003-02-7::2.5::HTS,6.59175122813228,0.010504133082249012,Other Types,AH11110,adrenergic receptor ligand,ADRA1B
Renal Cell Carcinoma,BRD-A64977602-001-15-9::2.5::HTS,18.80939978602146,1.714956343500132e-05,Other Types,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Renal Cell Carcinoma,BRD-A65248799-001-01-7::2.5::HTS,6.088266762186387,0.013905686140441268,Other Types,EMD-53998,phosphodiesterase inhibitor,TNNC1
Renal Cell Carcinoma,BRD-A65449987-001-10-4::2.5::HTS,8.48912569988232,0.0037159331037616198,Other Types,flunisolide,cytochrome P450 inhibitor,NR3C1
Renal Cell Carcinoma,BRD-A66920069-001-01-3::2.5::HTS,9.79775739317994,0.0018379672374101966,Other Types,fenigam,benzodiazepine receptor agonist,"GABBR1, GABBR2"
Renal Cell Carcinoma,BRD-A67097164-001-18-7::2.5::HTS,3.9197783600060503,0.04821740074837317,Other Types,ifosfamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1"
Renal Cell Carcinoma,BRD-A67181951-001-01-2::2.5::HTS,4.4018190790999245,0.03634809537704797,Other Types,gadobutrol,radiopaque medium,
Renal Cell Carcinoma,BRD-A67482312-001-02-6::2.5::HTS,6.806805003218044,0.009325065642966325,Other Types,4-P-PDOT,melatonin receptor antagonist,"MTNR1A, MTNR1B"
Renal Cell Carcinoma,BRD-A67514145-003-05-8::2.5::HTS,4.65899013801555,0.031326480029066794,Other Types,furaltadone,bacterial DNA inhibitor,
Renal Cell Carcinoma,BRD-A68281735-001-18-6::0.25::HTS,4.702522493018293,0.030538644813344583,Other Types,REV-5901,"leukotriene receptor antagonist, lipoxygenase inhibitor",ALOX5
Renal Cell Carcinoma,BRD-A68589262-001-04-3::2.5::HTS,4.177246785402045,0.04144951521746233,Other Types,troxipide,glucosamine synthetase stimulant,
Renal Cell Carcinoma,BRD-A69636825-003-04-7::2.5::HTS,4.682750318255946,0.030888997576039065,Other Types,diltiazem,calcium channel blocker,"CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5"
Renal Cell Carcinoma,BRD-A70268693-050-01-2::2.5::HTS,3.8923423255399663,0.04900523803716301,Other Types,PG-9,acetylcholine receptor agonist,
Renal Cell Carcinoma,BRD-A72703248-003-04-9::2.5::HTS,5.071358753244463,0.024713009753841747,Renal Cell Carcinoma,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Renal Cell Carcinoma,BRD-A72711497-236-03-8::2.5::HTS,19.362611222964773,1.2946056723219001e-05,Other Types,lasalocid,bacterial permeability inducer,
Renal Cell Carcinoma,BRD-A75479906-001-02-4::2.5::HTS,5.479428207470864,0.019590254644540207,Other Types,rimantadine,"antiviral, RNA synthesis inhibitor",
Renal Cell Carcinoma,BRD-A77218119-001-03-5::2.5::HTS,9.033517619446307,0.00276968510772422,Other Types,SYM-2206,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Renal Cell Carcinoma,BRD-A78391468-001-02-8::2.5::HTS,6.127290913273238,0.013607444445475677,Other Types,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-A81370665-001-03-6::2.5::HTS,6.621202430286358,0.010332492720479251,Renal Cell Carcinoma,BI-D1870,ribosomal protein inhibitor,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6"
Renal Cell Carcinoma,BRD-A81541225-001-06-8::2.5::HTS,11.16526863375313,0.0008896075365041558,Renal Cell Carcinoma,oligomycin-a,"ATP synthase inhibitor, ATPase inhibitor",ATP5A1
Renal Cell Carcinoma,BRD-A83937277-001-10-5::2.5::HTS,3.938511307777458,0.047699125665657566,Other Types,mephenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Renal Cell Carcinoma,BRD-A87435144-001-01-6::2.5::HTS,3.9863119016027477,0.046355847402438456,Renal Cell Carcinoma,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1
Renal Cell Carcinoma,BRD-A89164055-001-03-3::2.5::HTS,4.947047504505236,0.026533916613955492,Other Types,sorbinil,aldose reductase inhibitor,AKR1B1
Renal Cell Carcinoma,BRD-A92933783-050-01-6::2.5::HTS,5.030588250215833,0.025299430287367603,Other Types,SM-21,sigma receptor antagonist,PGRMC1
Renal Cell Carcinoma,BRD-A94323479-001-02-8::2.5::HTS,4.414816405881306,0.03607283551767505,Other Types,ki16198,lipoprotein antagonist,LPA
Renal Cell Carcinoma,BRD-A98990573-003-01-3::2.5::HTS,3.9405807448595143,0.0476280969995895,Other Types,epinastine,histamine receptor antagonist,"ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7"
Renal Cell Carcinoma,BRD-A99117172-065-04-0::2.5::HTS,4.096478555211897,0.04344861557068935,Other Types,hydroxychloroquine,antimalarial agent,"TLR7, TLR9"
Renal Cell Carcinoma,BRD-A99939097-001-24-2::2.5::HTS,5.9088259008523085,0.015378632305541996,Other Types,carisoprodol,acetylcholine receptor antagonist,CYP2C19
Renal Cell Carcinoma,BRD-K00317371-001-06-1::2.4::HTS,4.404459295308533,0.03631947041914675,Other Types,RITA,MDM inhibitor,MDM2
Renal Cell Carcinoma,BRD-K00494077-066-01-9::2.5::HTS,8.707164438281927,0.0033074681148524757,Renal Cell Carcinoma,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A
Renal Cell Carcinoma,BRD-K00911143-001-01-9::2.5::HTS,4.1095477971412695,0.04311747775488355,Other Types,brexpiprazole,dopamine receptor partial agonist,DRD2
Renal Cell Carcinoma,BRD-K01109406-001-03-7::2.5::HTS,7.666575444133035,0.0058137246952582565,Renal Cell Carcinoma,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD
Renal Cell Carcinoma,BRD-K01244426-236-12-1::2.5::HTS,4.879694202823216,0.027580700792135423,Other Types,cloxacillin,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K01649396-003-07-1::2.5::HTS,3.9408395869618627,0.04761552171514854,Other Types,indatraline,norepinephrine transporter inhibitor,"MAOA, MAOB"
Renal Cell Carcinoma,BRD-K01683783-001-02-6::2.5::HTS,15.416798384213221,9.700711499224126e-05,Renal Cell Carcinoma,TAK-901,Aurora kinase inhibitor,AURKB
Renal Cell Carcinoma,BRD-K01980392-003-11-6::2.5::HTS,4.674687568106791,0.031031562425190094,Other Types,guvacine,GABA uptake inhibitor,"SLC6A1, SLC6A11, SLC6A12, SLC6A13"
Renal Cell Carcinoma,BRD-K02113016-001-15-4::2.5::HTS,11.710050020039805,0.0006674359326301103,Renal Cell Carcinoma,olaparib,PARP inhibitor,"PARP1, PARP2"
Renal Cell Carcinoma,BRD-K02314383-001-01-3::2.5::HTS,4.3961086364725315,0.03647552289805208,Other Types,epitiostanol,androgen receptor agonist,AR
Renal Cell Carcinoma,BRD-K02475039-001-01-0::2.5::HTS,7.264741635768624,0.007244581294592178,Other Types,ethopabate,antiprotozoal agent,
Renal Cell Carcinoma,BRD-K02637541-001-18-0::2.5::HTS,4.006108876759148,0.045822845816667394,Other Types,celecoxib,cyclooxygenase inhibitor,"CA12, PDPK1, PTGS2"
Renal Cell Carcinoma,BRD-K02715688-001-02-1::2.5::HTS,4.21669908426883,0.04049433375671303,Other Types,"hydrastine-(1r,-9s)",tyrosine hydroxylase inhibitor,
Renal Cell Carcinoma,BRD-K02733959-236-07-7::2.5::HTS,6.688645644935738,0.009955029011151079,Other Types,cefuroxime,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K02764365-001-13-6::2.5::HTS,6.679872016706598,0.01000174249996098,Renal Cell Carcinoma,methiazole,anthelmintic agent,
Renal Cell Carcinoma,BRD-K02953697-001-09-2::2.5::HTS,5.048179687544439,0.02504547621672607,Other Types,naringin,cytochrome P450 inhibitor,SLCO1A2
Renal Cell Carcinoma,BRD-K03109492-001-02-2::2.5::HTS,10.235145958497203,0.0014566881202500875,Renal Cell Carcinoma,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Renal Cell Carcinoma,BRD-K03155172-001-02-2::2.5::HTS,5.336316957309878,0.021248893089327023,Other Types,GSK3787,PPAR receptor antagonist,PPARD
Renal Cell Carcinoma,BRD-K03294269-001-08-0::2.5::HTS,9.914974269282482,0.0017264307395675525,Other Types,NU6027,CDK inhibitor,"CCNA2, CDK2"
Renal Cell Carcinoma,BRD-K03353589-236-01-4::2.5::HTS,4.230241720439043,0.04017496732439069,Other Types,ecabet,"gastrin inhibitor, urease inhibitor",NOXO1
Renal Cell Carcinoma,BRD-K03406345-001-27-8::2.5::HTS,7.361536161068818,0.006869570567712651,Renal Cell Carcinoma,azacitidine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Renal Cell Carcinoma,BRD-K04414442-001-08-3::2.5::HTS,8.600048339136773,0.003501032749500328,Other Types,SB-222200,tachykinin antagonist,TACR3
Renal Cell Carcinoma,BRD-K04552268-001-02-4::5::HTS,6.338109154146031,0.01210587332803024,Renal Cell Carcinoma,4-pyrimidinecarbonitrile,,
Renal Cell Carcinoma,BRD-K04568635-300-01-4::2.5::HTS,5.2873910582819095,0.021852786944652848,Renal Cell Carcinoma,octenidine,membrane integrity inhibitor,
Renal Cell Carcinoma,BRD-K04657451-001-01-0::2.5::HTS,5.35207897398655,0.02106814424741376,Other Types,D-delta-Tocopherol,,
Renal Cell Carcinoma,BRD-K04833372-001-06-2::2.5::HTS,5.157131632329399,0.02353404297550221,Renal Cell Carcinoma,GSK1904529A,"IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR"
Renal Cell Carcinoma,BRD-K04851519-001-06-8::2.5::HTS,6.337064895154885,0.01210203633162737,Other Types,aloe-emodin,anticancer agent,CASP8
Renal Cell Carcinoma,BRD-K04923131-001-15-4::2.5::HTS,12.511173804015046,0.0004385563593095802,Other Types,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Renal Cell Carcinoma,BRD-K05048137-001-03-9::1.57::HTS,7.079191087665722,0.00802447646265465,Other Types,phytosphingosine,,
Renal Cell Carcinoma,BRD-K05445342-001-05-3::2.57::HTS,4.349669291339318,0.03749570491495636,Other Types,WP1066,STAT inhibitor,STAT3
Renal Cell Carcinoma,BRD-K05524748-003-04-4::2.5::HTS,5.421535123901881,0.020261590649558125,Renal Cell Carcinoma,dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A"
Renal Cell Carcinoma,BRD-K06388322-312-02-6::2.5::HTS,4.21123987938142,0.040623829238964106,Other Types,pramipexole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Renal Cell Carcinoma,BRD-K06543683-066-02-1::2.5::HTS,17.45810622707763,3.407666178885073e-05,Renal Cell Carcinoma,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Renal Cell Carcinoma,BRD-K06753942-001-14-5::2.5::HTS,6.886994665719933,0.008922019086376918,Renal Cell Carcinoma,nobiletin,MEK inhibitor,MAP2K1
Renal Cell Carcinoma,BRD-K07265709-003-05-6::2.61::HTS,9.652383390159054,0.001992777645797179,Renal Cell Carcinoma,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Renal Cell Carcinoma,BRD-K07572174-001-39-4::2.48::HTS,12.247389029686424,0.0005052832155948979,Renal Cell Carcinoma,curcumin,"cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH"
Renal Cell Carcinoma,BRD-K07881437-001-03-8::2.5::HTS,9.680427541338473,0.001961049127465041,Renal Cell Carcinoma,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Renal Cell Carcinoma,BRD-K07881437-001-04-6::2.41::HTS,7.505802267368677,0.006358087161597426,Renal Cell Carcinoma,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Renal Cell Carcinoma,BRD-K07955840-001-02-3::2.5::HTS,16.26116115868748,6.286240123062278e-05,Renal Cell Carcinoma,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Renal Cell Carcinoma,BRD-K08109215-001-06-4::2.5::HTS,9.923660504026383,0.0017222036565281795,Renal Cell Carcinoma,I-BET-762,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Renal Cell Carcinoma,BRD-K08248804-001-01-8::2.5::HTS,6.6619520436203805,0.010112419387455227,Renal Cell Carcinoma,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Renal Cell Carcinoma,BRD-K08525451-003-05-2::2.5::HTS,6.026412960449832,0.014399696913999775,Renal Cell Carcinoma,sarafloxacin,bacterial DNA gyrase inhibitor,
Renal Cell Carcinoma,BRD-K08547377-394-03-5::2.5::HTS,6.002373399559593,0.014603626376027157,Renal Cell Carcinoma,irinotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Renal Cell Carcinoma,BRD-K08791496-001-01-0::2.5::HTS,5.027344234350009,0.02536057893154656,Other Types,fenaclon,,
Renal Cell Carcinoma,BRD-K09426783-300-01-0::2.5::HTS,6.7234303329439555,0.009773869542727433,Renal Cell Carcinoma,TAS-103,topoisomerase inhibitor,TOP1
Renal Cell Carcinoma,BRD-K09443272-001-03-3::2.5::HTS,19.135389432876796,1.4533501392414464e-05,Renal Cell Carcinoma,PHA-680632,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Renal Cell Carcinoma,BRD-K09537769-001-04-0::2.5::HTS,5.869870935748024,0.015717197237288972,Other Types,NU-7026,"DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",PRKDC
Renal Cell Carcinoma,BRD-K09602097-001-13-6::2.5::HTS,3.9572521828100906,0.04717481695655154,Other Types,forskolin,adenylyl cyclase activator,"ADCY2, ADCY5, GNAS"
Renal Cell Carcinoma,BRD-K09877029-001-01-2::2.5::HTS,7.515550752280961,0.006312672247528594,Renal Cell Carcinoma,VS-4718,focal adhesion kinase inhibitor,
Renal Cell Carcinoma,BRD-K10362825-001-03-4::2.5::HTS,7.721657060232325,0.005650570027153122,Renal Cell Carcinoma,teniposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Renal Cell Carcinoma,BRD-K10598093-303-06-1::2.5::HTS,6.98317263671835,0.008483905398552205,Other Types,hexamethonium,cholinergic receptor antagonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6"
Renal Cell Carcinoma,BRD-K10706131-046-03-6::2.5::HTS,3.8934423302304175,0.04897158940261033,Other Types,rivastigmine,acetylcholinesterase inhibitor,"ACHE, BCHE"
Renal Cell Carcinoma,BRD-K10799896-001-26-2::2.5::HTS,11.371099822485032,0.0007975427941110611,Other Types,clobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Renal Cell Carcinoma,BRD-K10878147-001-02-2::2.5::HTS,5.596042286916057,0.018341405120629754,Other Types,OAC1,Oct activator,
Renal Cell Carcinoma,BRD-K10974103-001-21-1::2.5::HTS,3.9308111912365704,0.04789992840964695,Other Types,diloxanide,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-K11071038-001-01-7::2.5::HTS,6.561109889606942,0.010694590232618617,Other Types,ICI-162846,histamine receptor antagonist,HRH2
Renal Cell Carcinoma,BRD-K11094367-001-10-1::2.5::HTS,3.992682792464321,0.046183933912654865,Other Types,acetanilide,hydrogen peroxide decomposition inhibitor,
Renal Cell Carcinoma,BRD-K11124378-001-04-6::2.5::HTS,5.910332564826337,0.015366189416786094,Other Types,ceftibuten,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K11636097-001-03-1::2.5::HTS,4.626794536248818,0.03190811048785571,Renal Cell Carcinoma,JNJ-7706621,CDK inhibitor,"AURKA, AURKB, CDK1, CDK2"
Renal Cell Carcinoma,BRD-K11663430-001-02-3::2.5::HTS,5.0609501802842844,0.024859072192307628,Renal Cell Carcinoma,pyroxamide,HDAC inhibitor,HDAC1
Renal Cell Carcinoma,BRD-K11696279-003-02-3::2.5::HTS,4.895331219835374,0.027332788050443483,Other Types,BU-239,"imidazoline receptor ligand, imidazoline receptor agonist",
Renal Cell Carcinoma,BRD-K11717138-001-30-3::2.5::HTS,5.916665688889943,0.015322728205272697,Other Types,benzbromarone,chloride channel blocker,ABCC1
Renal Cell Carcinoma,BRD-K11742128-003-23-4::2.5::HTS,3.9351884460704785,0.04777633700023719,Other Types,triprolidine,histamine receptor antagonist,HRH1
Renal Cell Carcinoma,BRD-K11900042-001-14-4::2.5::HTS,4.437199920080512,0.03562551451790998,Other Types,methylthiouracil,,
Renal Cell Carcinoma,BRD-K12120659-305-02-2::2.5::HTS,4.892483613198173,0.027382626499226986,Other Types,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Renal Cell Carcinoma,BRD-K12614344-003-01-8::2.5::HTS,4.704184342944038,0.030509387603817714,Other Types,CGS-21680,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Renal Cell Carcinoma,BRD-K12885236-001-02-7::2.5::HTS,6.607382254276519,0.010415748689328975,Renal Cell Carcinoma,dapivirine,non-nucleoside reverse transcriptase inhibitor,"CYP3A4, CYP3A5"
Renal Cell Carcinoma,BRD-K12994359-001-18-4::2.5::HTS,10.110485550467319,0.0015589926592988602,Other Types,valdecoxib,cyclooxygenase inhibitor,"CA12, PTGS2"
Renal Cell Carcinoma,BRD-K13049116-001-05-7::2.5::HTS,7.717918881552951,0.005652907201989281,Renal Cell Carcinoma,BMS-754807,IGF-1 inhibitor,"AKT1, IGF1R"
Renal Cell Carcinoma,BRD-K13050303-001-18-1::2.5::HTS,6.639623732562865,0.010231134414282916,Other Types,uridine,dopamine receptor agonist,"LSM6, TYMP"
Renal Cell Carcinoma,BRD-K13094524-001-07-5::2.63::HTS,10.809075264228323,0.0010772717587737577,Renal Cell Carcinoma,PFI-1,bromodomain inhibitor,BRD4
Renal Cell Carcinoma,BRD-K13112821-001-17-4::2.5::HTS,10.204883957555156,0.0014803416064787744,Renal Cell Carcinoma,artemisinin,DNA synthesis inhibitor,CYP2B6
Renal Cell Carcinoma,BRD-K13183738-317-10-2::2.5::HTS,6.315075040039357,0.012252811142553268,Renal Cell Carcinoma,pentamidine,anti-pneumocystis agent,TRDMT1
Renal Cell Carcinoma,BRD-K13387373-004-14-5::2.5::HTS,25.992166207651696,4.7125637825868724e-07,Renal Cell Carcinoma,thonzonium,ATPase inhibitor,
Renal Cell Carcinoma,BRD-K13474508-001-01-2::2.5::HTS,9.13063839447538,0.0026301715379703746,Other Types,"L-655,708",GABA receptor inverse agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRG2"
Renal Cell Carcinoma,BRD-K13511380-001-01-4::2.5::HTS,11.284209774010371,0.0008354548610953641,Other Types,naringin-dihydrochalcone,cytochrome P450 inhibitor,
Renal Cell Carcinoma,BRD-K13646352-001-03-8::2.5::HTS,9.35606003317125,0.002329915315413074,Other Types,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Renal Cell Carcinoma,BRD-K13756951-001-01-4::2.5::HTS,17.091236501000218,4.1063925526666276e-05,Renal Cell Carcinoma,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Renal Cell Carcinoma,BRD-K14401183-001-10-7::2.5::HTS,4.937929149774984,0.026676594383191636,Other Types,avobenzone,UV blocker,TYR
Renal Cell Carcinoma,BRD-K14529030-001-01-9::2.5::HTS,8.529019113400086,0.0036378596677096135,Renal Cell Carcinoma,meisoindigo,STAT inhibitor,STAT3
Renal Cell Carcinoma,BRD-K14705039-001-16-4::2.5::HTS,5.963048526133653,0.014918746550696096,Other Types,sulfathiazole,dihydropteroate synthase inhibitor,
Renal Cell Carcinoma,BRD-K14796088-003-26-8::2.5::HTS,18.683203188236433,1.825627601794116e-05,Renal Cell Carcinoma,berberine,LDL receptor activator,LDLR
Renal Cell Carcinoma,BRD-K14870255-001-02-3::2.5::HTS,7.976455811797173,0.004907143120543005,Other Types,R-428,AXL kinase inhibitor,AXL
Renal Cell Carcinoma,BRD-K15025317-001-15-1::2.5::HTS,5.2691376273961525,0.022079484390438053,Renal Cell Carcinoma,BAY-11-7082,NFkB pathway inhibitor,RELA
Renal Cell Carcinoma,BRD-K15502390-001-20-9::2.5::HTS,4.638413061370407,0.031690001561508876,Other Types,nevirapine,non-nucleoside reverse transcriptase inhibitor,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5"
Renal Cell Carcinoma,BRD-K16508793-001-05-9::2.5::HTS,3.873049114263909,0.049561139934960086,Other Types,diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Renal Cell Carcinoma,BRD-K17075857-001-18-4::2.5::HTS,4.221174007733567,0.04040408913246021,Renal Cell Carcinoma,chloroxine,opioid receptor antagonist,OPRK1
Renal Cell Carcinoma,BRD-K17203476-001-01-9::2.5::HTS,3.9532228625458266,0.04726806242129996,Renal Cell Carcinoma,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Renal Cell Carcinoma,BRD-K17500877-001-02-1::2.5::HTS,4.655252709936405,0.03138940764332481,Other Types,bropirimine,interferon inducer,
Renal Cell Carcinoma,BRD-K18779551-003-07-8::2.5::HTS,6.723000482662041,0.009766006342427047,Other Types,bifemelane,acetylcholine release enhancer,"MAOA, MAOB"
Renal Cell Carcinoma,BRD-K18834913-001-01-1::2.5::HTS,4.996002359197061,0.02580011300295926,Renal Cell Carcinoma,LB42708,farnesyltransferase inhibitor,
Renal Cell Carcinoma,BRD-K18850819-001-04-6::2.5::HTS,4.526926566249347,0.03380015087845824,Other Types,MK-0752,gamma secretase inhibitor,
Renal Cell Carcinoma,BRD-K18910433-001-43-2::2.5::HTS,6.931251513235721,0.008706599689264795,Other Types,estradiol,estrogen receptor agonist,"ESR1, ESR2, GPER1, KCNMA1, NR1I2"
Renal Cell Carcinoma,BRD-K19061412-001-02-4::2.5::HTS,5.998865494266616,0.014623739280454056,Renal Cell Carcinoma,mubritinib,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Renal Cell Carcinoma,BRD-K19318328-001-01-3::2.5::HTS,4.016557451409603,0.045587005374580575,Renal Cell Carcinoma,FR-139317,endothelin receptor antagonist,EDNRA
Renal Cell Carcinoma,BRD-K19655798-001-01-9::2.5::HTS,3.8991227879432118,0.04880927465489649,Other Types,compound-401,DNA dependent protein kinase inhibitor,"MTOR, PRKDC"
Renal Cell Carcinoma,BRD-K20008181-001-01-3::2.5::HTS,5.830063144713545,0.01607754994036354,Renal Cell Carcinoma,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1
Renal Cell Carcinoma,BRD-K20152659-001-04-6::2.5::HTS,6.514943279990962,0.01096284123682317,Other Types,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,"PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-K20431737-001-08-1::2.5::HTS,4.758739663695653,0.02956725875371621,Other Types,benzoylpas,,
Renal Cell Carcinoma,BRD-K20722021-001-02-1::2.5::HTS,7.385728039846239,0.006785873450737769,Renal Cell Carcinoma,CEP-32496,RAF inhibitor,"BRAF, RAF1"
Renal Cell Carcinoma,BRD-K20745393-003-01-0::2.5::HTS,7.2469303856162295,0.007317005796046351,Other Types,olprinone,phosphodiesterase inhibitor,PDE3A
Renal Cell Carcinoma,BRD-K20958582-001-01-4::2.5::HTS,13.33487597581578,0.00028521831190819215,Renal Cell Carcinoma,TH-302,DNA alkylating agent,
Renal Cell Carcinoma,BRD-K21372554-003-01-7::2.5::HTS,3.942763675190254,0.047567688264091385,Other Types,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K21528677-001-03-6::2.5::HTS,5.751842787524006,0.01680231350836098,Other Types,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Renal Cell Carcinoma,BRD-K21673112-003-01-3::2.5::HTS,7.978724342657918,0.004903532658771062,Other Types,BF2.649,histamine receptor antagonist,HRH3
Renal Cell Carcinoma,BRD-K21718444-001-06-8::2.5::HTS,5.6902558022799905,0.017389690589223676,Renal Cell Carcinoma,KW-2449,"Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor","ABL1, AURKA, AURKB, FLT3"
Renal Cell Carcinoma,BRD-K21910317-001-12-3::2.5::HTS,5.331851847038545,0.021304174244553185,Other Types,"2,4-dinitrophenol",ATP synthase inhibitor,APP
Renal Cell Carcinoma,BRD-K21937671-001-10-0::2.5::HTS,4.877602812942384,0.02761238234896646,Other Types,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Renal Cell Carcinoma,BRD-K22097830-001-01-9::2.5::HTS,8.281861385234675,0.004158763868473605,Other Types,OCO-1112,cholesterol inhibitor,
Renal Cell Carcinoma,BRD-K22356203-001-01-8::2.5::HTS,3.9614050551044655,0.04703879182471784,Other Types,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Renal Cell Carcinoma,BRD-K22385716-001-02-5::2.5::HTS,4.102389476894075,0.043301567075823784,Other Types,LY303511,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","BRD2, BRD3, BRD4"
Renal Cell Carcinoma,BRD-K22503835-001-11-0::2.5::HTS,10.688097969650844,0.0011445669104888292,Renal Cell Carcinoma,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Renal Cell Carcinoma,BRD-K22749967-046-02-3::2.5::HTS,6.158065310103259,0.013375285228869115,Other Types,ABT-239,histamine receptor antagonist,"HRH1, HRH2, HRH3"
Renal Cell Carcinoma,BRD-K23190681-001-01-1::2.5::HTS,10.51614352053505,0.0012545725018527187,Renal Cell Carcinoma,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Renal Cell Carcinoma,BRD-K23952234-236-01-8::2.5::HTS,8.430044366536514,0.0038377941127778785,Other Types,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1
Renal Cell Carcinoma,BRD-K24312986-001-01-2::2.5::HTS,5.242433398259605,0.022414208711239225,Other Types,tecovirimat,orthopoxvirus egress inhibitor,
Renal Cell Carcinoma,BRD-K24556098-001-19-1::2.5::HTS,8.605865077321202,0.0034887797430037865,Other Types,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Renal Cell Carcinoma,BRD-K24616672-003-20-1::2.5::HTS,4.402422389785801,0.03633856713445362,Other Types,procaine,HMGCR inhibitor,"CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3"
Renal Cell Carcinoma,BRD-K24689407-001-06-3::2.5::HTS,5.238284725324072,0.022467210389170454,Other Types,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Renal Cell Carcinoma,BRD-K24715592-406-02-1::2.53::HTS,10.508156192543796,0.001263484343372323,Renal Cell Carcinoma,ethacridine-lactate-monohydrate,DNA intercalating agent,
Renal Cell Carcinoma,BRD-K25114078-003-08-1::2.5::HTS,7.2179306204587155,0.007432630168770361,Other Types,aminoguanidine,nitric oxide synthase inhibitor,NOS2
Renal Cell Carcinoma,BRD-K25224017-001-25-0::2.5::HTS,7.070540957682248,0.008062808487682043,Other Types,pirenperone,serotonin receptor antagonist,"HTR2A, HTR7"
Renal Cell Carcinoma,BRD-K25279140-001-01-5::2.5::HTS,3.886823050670478,0.04918219848795535,Renal Cell Carcinoma,MK-8745,Aurora kinase inhibitor,AURKA
Renal Cell Carcinoma,BRD-K25340465-001-11-1::2.58::HTS,8.965781128725594,0.0028797909387224016,Renal Cell Carcinoma,OSI-930,"KIT inhibitor, VEGFR inhibitor","KDR, KIT"
Renal Cell Carcinoma,BRD-K25630527-001-03-8::2.5::HTS,6.802558942562055,0.009344808431878874,Renal Cell Carcinoma,LY2784544,JAK inhibitor,"JAK2, JAK3"
Renal Cell Carcinoma,BRD-K25650355-065-02-0::2.5::HTS,3.992226856676283,0.04620613267880866,Other Types,physostigmine,cholinesterase inhibitor,"ACHE, BCHE"
Renal Cell Carcinoma,BRD-K25835157-001-01-4::2.5::HTS,11.456899787404362,0.0007622586438058018,Renal Cell Carcinoma,PRT062070,"JAK inhibitor, syk inhibitor",SYK
Renal Cell Carcinoma,BRD-K25943794-001-02-3::2.5::HTS,9.236285847080298,0.002484619474542043,Other Types,blonanserin,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Renal Cell Carcinoma,BRD-K26168087-001-09-7::2.5::HTS,4.713833483805975,0.03034463875421563,Other Types,magnolol,PPAR receptor agonist,"GABRA1, PPARG"
Renal Cell Carcinoma,BRD-K26531771-001-02-2::2.35::HTS,7.267468627393081,0.007245474055398149,Renal Cell Carcinoma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Renal Cell Carcinoma,BRD-K26634012-001-04-9::2.5::HTS,8.660455185420894,0.00339011561712837,Renal Cell Carcinoma,tilmicosin,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K26667523-001-02-5::2.5::HTS,3.996169768084841,0.04609180964211093,Renal Cell Carcinoma,TAK-733,MEK inhibitor,MAP2K1
Renal Cell Carcinoma,BRD-K26833429-001-02-8::2.5::HTS,7.389673853073591,0.006765447302361406,Renal Cell Carcinoma,costunolide,telomerase inhibitor,
Renal Cell Carcinoma,BRD-K26838195-075-04-9::2.5::HTS,3.970942574214423,0.046775024424062624,Renal Cell Carcinoma,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Renal Cell Carcinoma,BRD-K27217864-001-22-3::2.5::HTS,4.373363354807231,0.03695895201412421,Renal Cell Carcinoma,butamben,sodium channel blocker,
Renal Cell Carcinoma,BRD-K27305650-001-16-6::2.5::HTS,5.351059625516688,0.021074974435054794,Other Types,LY294002,"mTOR inhibitor, PI3K inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1"
Renal Cell Carcinoma,BRD-K27316855-001-13-3::2.44::HTS,10.199687537655418,0.0014884373584923068,Renal Cell Carcinoma,calcitriol,vitamin D receptor agonist,VDR
Renal Cell Carcinoma,BRD-K27406233-001-07-7::2.5::HTS,6.1025557224698685,0.013797056046088644,Other Types,acetyl-l-leucine,,
Renal Cell Carcinoma,BRD-K27955832-001-02-9::2.5::HTS,4.066004370413611,0.04423239944044792,Other Types,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Renal Cell Carcinoma,BRD-K28029915-001-02-2::2.5::HTS,5.284849354413632,0.02188104116121951,Other Types,dolasetron,serotonin receptor antagonist,HTR3A
Renal Cell Carcinoma,BRD-K28120222-001-08-4::2.5::HTS,4.8526643989910685,0.02801442943992094,Renal Cell Carcinoma,parthenolide-(alternate-stereo),NFkB pathway inhibitor,"IKBKB, RELA"
Renal Cell Carcinoma,BRD-K28143534-003-25-9::2.5::HTS,11.849571588082478,0.0006198961089668566,Other Types,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Renal Cell Carcinoma,BRD-K28405228-001-06-7::2.5::HTS,5.374124594140581,0.02080080503318866,Other Types,mecarbinate,,
Renal Cell Carcinoma,BRD-K28494619-001-28-2::2.5::HTS,5.1405934323875115,0.023755037908081544,Other Types,sulfamethoxazole,PABA antagonist,
Renal Cell Carcinoma,BRD-K28667793-001-28-1::2.5::HTS,5.307354839098774,0.021602171241953155,Other Types,pyrazinamide,fatty acid synthase inhibitor,FASN
Renal Cell Carcinoma,BRD-K28761384-300-01-0::2.5::HTS,3.8797828003160264,0.049361532451265885,Renal Cell Carcinoma,zuclopenthixol,dopamine receptor antagonist,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A"
Renal Cell Carcinoma,BRD-K28861668-001-01-9::2.5::HTS,5.550787727796778,0.018817269802850225,Other Types,A922500,diacylglycerol O acyltransferase inhibitor,DGAT1
Renal Cell Carcinoma,BRD-K28965160-001-01-1::2.5::HTS,10.292404288054087,0.0014129787686819586,Renal Cell Carcinoma,BVD-523,MAP kinase inhibitor,
Renal Cell Carcinoma,BRD-K28982731-001-01-6::2.5::HTS,4.533011492351017,0.03368507882431111,Other Types,emoxipin,,
Renal Cell Carcinoma,BRD-K29656036-001-02-5::2.5::HTS,9.755365583269661,0.001880586760067593,Renal Cell Carcinoma,MK-8245,stearoyl-CoA desaturase inhibitor,SCD
Renal Cell Carcinoma,BRD-K29713308-077-04-1::2.5::HTS,4.404779304262257,0.036290424117646526,Other Types,"mebhydroline-1,5-naphtalenedisulfonate",,
Renal Cell Carcinoma,BRD-K29905972-001-06-3::2.5::HTS,8.446187045536107,0.003804391031967113,Renal Cell Carcinoma,axitinib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, FLT1, FLT4, KDR, PLK4"
Renal Cell Carcinoma,BRD-K30126819-304-02-7::2.5::HTS,4.335862181299275,0.037771685301265456,Other Types,dimesna,tubulin polymerization inhibitor,
Renal Cell Carcinoma,BRD-K30237152-300-02-5::2.5::HTS,5.8023120496661855,0.016331678277574348,Other Types,1400W,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Renal Cell Carcinoma,BRD-K30431096-004-01-3::2.5::HTS,4.637711079210223,0.03171380226567019,Renal Cell Carcinoma,domiphen,,
Renal Cell Carcinoma,BRD-K30758549-001-01-8::2.5::HTS,4.895974213495969,0.027346432066791812,Other Types,isopropyl-palmitate,cosmetic moisturizer,
Renal Cell Carcinoma,BRD-K31086665-005-04-6::2.5::HTS,5.200672429328006,0.022953714738885866,Renal Cell Carcinoma,NH125,eukaryotic translation elongation factor 2 inhibitor,
Renal Cell Carcinoma,BRD-K31843556-001-04-1::2.5::HTS,5.657053143718754,0.01772332604429127,Renal Cell Carcinoma,T-0070907,PPAR receptor antagonist,PPARG
Renal Cell Carcinoma,BRD-K31866293-001-01-6::2.5::HTS,19.045611060839846,1.5209737557976073e-05,Renal Cell Carcinoma,TAK-632,RAF inhibitor,BRAF
Renal Cell Carcinoma,BRD-K31928526-001-02-1::2.5::HTS,11.339605972123525,0.0008110971042690683,Renal Cell Carcinoma,barasertib,Aurora kinase inhibitor,"AURKA, AURKB"
Renal Cell Carcinoma,BRD-K32372024-001-01-0::2.5::HTS,5.712608208624787,0.01719714865003106,Renal Cell Carcinoma,D-7193,,
Renal Cell Carcinoma,BRD-K32730239-001-01-0::2.5::HTS,7.917904683695533,0.005067106641643264,Renal Cell Carcinoma,SU3327,JNK inhibitor,MAPK8
Renal Cell Carcinoma,BRD-K32830106-001-02-6::2.5::HTS,3.9069655564049897,0.04857917638597995,Other Types,guanfacine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Renal Cell Carcinoma,BRD-K32830106-003-20-4::2.5::HTS,5.62541056926905,0.018042716768658,Other Types,guanfacine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Renal Cell Carcinoma,BRD-K33510429-001-03-1::2.5::HTS,5.881941186908493,0.015632520715286178,Other Types,vanillylacetone,,
Renal Cell Carcinoma,BRD-K33610132-001-02-9::2.5::HTS,13.59416833587022,0.00024926715149724765,Renal Cell Carcinoma,rociletinib,EGFR inhibitor,EGFR
Renal Cell Carcinoma,BRD-K33622447-066-01-9::2.5::HTS,15.885048158949203,7.624694895195429e-05,Other Types,abemaciclib,CDK inhibitor,"CDK4, CDK6"
Renal Cell Carcinoma,BRD-K33813875-003-01-8::2.5::HTS,9.136750623713555,0.0026228373383436763,Renal Cell Carcinoma,valnemulin,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K33814251-001-02-2::2.5::HTS,5.23233124378613,0.022548235297673053,Other Types,lubiprostone,chloride channel activator,CLCN2
Renal Cell Carcinoma,BRD-K33852358-001-09-9::2.5::HTS,6.7008007387908055,0.00989095094726313,Other Types,arofylline,phosphodiesterase inhibitor,PDE4A
Renal Cell Carcinoma,BRD-K33882852-003-02-8::2.5::HTS,22.727485623985395,2.3911356435649143e-06,Renal Cell Carcinoma,ZK-93423,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
Renal Cell Carcinoma,BRD-K34032314-001-04-1::2.5::HTS,5.58759233994041,0.018430417947903642,Other Types,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-K34073885-001-09-3::2.54::HTS,6.42848642454604,0.011518340578498572,Renal Cell Carcinoma,tanshinone-i,AP inhibitor,IFNG
Renal Cell Carcinoma,BRD-K34341643-001-01-4::2.5::HTS,11.126181304243786,0.0009083807410861964,Other Types,glasdegib,hedgehog pathway inhibitor,SMO
Renal Cell Carcinoma,BRD-K34388247-236-08-2::2.5::HTS,4.529403368269217,0.0337555760120571,Other Types,methicillin,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K34672903-001-01-7::2.5::HTS,4.04129444327449,0.04487959759520071,Other Types,HEMADO,,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Renal Cell Carcinoma,BRD-K34776109-001-16-6::2.5::HTS,9.48928984263245,0.0021681960002323595,Other Types,glimepiride,insulin secretagogue,"ABCC8, KCNJ1, KCNJ11"
Renal Cell Carcinoma,BRD-K34801930-001-01-9::2.5::HTS,3.890516316607649,0.04905190518585588,Other Types,AZD5069,CC chemokine receptor antagonist,CXCR2
Renal Cell Carcinoma,BRD-K34851558-001-02-3::2.5::HTS,9.224183783792977,0.0025008216640296085,Renal Cell Carcinoma,parthenolide-(-),NFkB pathway inhibitor,HDAC1
Renal Cell Carcinoma,BRD-K35079116-001-03-3::2.5::HTS,5.7409904419653195,0.016900576578884413,Other Types,asiatic-acid,apoptosis stimulant,PYGM
Renal Cell Carcinoma,BRD-K35170555-001-09-5::2.5::HTS,6.339354759362706,0.012103519054788448,Other Types,caprylic-acid,,
Renal Cell Carcinoma,BRD-K35240538-001-26-2::2.5::HTS,7.907893522516378,0.005101630623101219,Other Types,methylprednisolone,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-K35245662-001-01-2::2.5::HTS,5.775259060756147,0.016577517374686476,Other Types,ciclesonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Renal Cell Carcinoma,BRD-K35498378-001-06-1::2.5::HTS,5.267419827771046,0.022097728633228526,Other Types,alrestatin,aldose reductase inhibitor,AKR1B1
Renal Cell Carcinoma,BRD-K35952844-236-01-6::2.5::HTS,4.644300401915939,0.03159333039386206,Renal Cell Carcinoma,sodium-glucoheptonate,,
Renal Cell Carcinoma,BRD-K36040345-001-01-1::2.5::HTS,6.417764200958121,0.01156916108314042,Other Types,TXA127,angiotensin receptor agonist,
Renal Cell Carcinoma,BRD-K36363294-001-04-2::2.5::HTS,14.362661962095366,0.00016776661795592,Renal Cell Carcinoma,I-BET151,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Renal Cell Carcinoma,BRD-K36386086-001-01-1::2.5::HTS,9.271958795041273,0.00243788550043037,Renal Cell Carcinoma,dolutegravir,HIV integrase inhibitor,"CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1"
Renal Cell Carcinoma,BRD-K36467523-001-02-8::2.5::HTS,4.502743598635491,0.034285281328282194,Other Types,bindarit,NFkB pathway inhibitor,"CCL2, CCL7, CCL8"
Renal Cell Carcinoma,BRD-K36739687-001-03-0::2.5::HTS,4.744269460401428,0.02981398186713981,Other Types,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR
Renal Cell Carcinoma,BRD-K36864847-303-02-5::2.5::HTS,5.47697263046778,0.01961939907395659,Other Types,BD-1047,adrenergic receptor antagonist,SIGMAR1
Renal Cell Carcinoma,BRD-K37270826-001-31-8::2.5::HTS,10.888764225646423,0.0010293363659936569,Other Types,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Renal Cell Carcinoma,BRD-K37618799-001-03-0::2.5::HTS,6.703867773411087,0.009871870214389315,Renal Cell Carcinoma,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Renal Cell Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,4.1993263665349305,0.04090377392593938,Renal Cell Carcinoma,AZD8330,MEK inhibitor,
Renal Cell Carcinoma,BRD-K37720887-001-07-8::2.5::HTS,9.53275526232447,0.0021188357274622193,Renal Cell Carcinoma,SB-525334,TGF beta receptor inhibitor,TGFBR1
Renal Cell Carcinoma,BRD-K37764012-001-04-1::2.5::HTS,4.596147902767312,0.03247382135439696,Renal Cell Carcinoma,PF-03758309,p21 activated kinase inhibitor,PAK4
Renal Cell Carcinoma,BRD-K37798499-001-27-2::2.5::HTS,5.546569787849564,0.018862832614114085,Renal Cell Carcinoma,etoposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Renal Cell Carcinoma,BRD-K38458514-001-01-8::2.5::HTS,5.992496665416345,0.01468468564609526,Other Types,diazooxonorleucine,glutamate receptor antagonist,
Renal Cell Carcinoma,BRD-K38548312-001-01-0::2.5::HTS,8.607678891993386,0.0034848622438185903,Renal Cell Carcinoma,VER-49009,HSP inhibitor,HSP90AA1
Renal Cell Carcinoma,BRD-K38687824-001-02-5::2.5::HTS,4.881482550559494,0.02755239687551606,Other Types,beta-amyloid-synthesis-inhibitor,beta amyloid synthesis inhibitor,APP
Renal Cell Carcinoma,BRD-K38938675-001-01-4::2.5::HTS,5.428355957538504,0.02017195320398956,Other Types,morniflumate,anti-inflammatory agent,
Renal Cell Carcinoma,BRD-K39120595-304-04-7::2.5::HTS,4.478717540917554,0.03476241023692225,Other Types,bithionol,autotaxin inhibitor,"ESR1, ESR2, MCL1"
Renal Cell Carcinoma,BRD-K39252998-003-01-5::2.5::HTS,10.022128016090083,0.0016329877161673078,Renal Cell Carcinoma,atipamezole,adrenergic receptor antagonist,
Renal Cell Carcinoma,BRD-K39371216-001-01-3::2.5::HTS,4.226472577038713,0.04026358519700167,Other Types,cyacetacide,,
Renal Cell Carcinoma,BRD-K39381259-001-01-0::2.5::HTS,4.955019525615646,0.026413668390720083,Renal Cell Carcinoma,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1
Renal Cell Carcinoma,BRD-K39983086-001-06-1::2.45::HTS,7.918016794709539,0.00508387777066416,Other Types,loteprednol,"glucocorticoid receptor agonist, phospholipase inhibitor",NR3C1
Renal Cell Carcinoma,BRD-K40109029-001-02-9::2.5::HTS,9.349137961968717,0.0023370309428521648,Renal Cell Carcinoma,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1
Renal Cell Carcinoma,BRD-K40255344-001-17-6::2.5::HTS,5.229684174994516,0.022575507028811347,Renal Cell Carcinoma,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Renal Cell Carcinoma,BRD-K41213548-001-02-0::2.5::HTS,39.79977184602018,5.81934232723478e-10,Renal Cell Carcinoma,KW-2478,HSP inhibitor,
Renal Cell Carcinoma,BRD-K41234004-001-03-1::0.03::HTS,3.9837610666966614,0.04642731119931479,Other Types,icomucret,mucin production enhancer,LTB4R2
Renal Cell Carcinoma,BRD-K41256143-001-12-7::2.5::HTS,6.693805034433508,0.009932171310740959,Other Types,dehydroepiandrosterone,protein synthesis stimulant,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1"
Renal Cell Carcinoma,BRD-K41278234-001-03-0::2.5::HTS,13.407660563361626,0.00027461437374353846,Renal Cell Carcinoma,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Renal Cell Carcinoma,BRD-K41410256-304-02-2::2.5::HTS,4.103096330046104,0.04329063084905337,Other Types,balsalazide,cyclooxygenase inhibitor,"ALOX5, PPARG, PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-K41445866-001-18-8::2.5::HTS,4.4878759537957675,0.034575024491899434,Other Types,alfaxalone,"chloride channel agonist, benzodiazepine receptor agonist",GABBR1
Renal Cell Carcinoma,BRD-K42095107-001-17-1::2.5::HTS,4.2678741067458565,0.039305538655140984,Other Types,daidzein,estrogen receptor agonist,"ESRRA, ESRRB, ESRRG, TRPC5"
Renal Cell Carcinoma,BRD-K42260897-001-09-2::2.5::HTS,9.289625274035554,0.0024150787365671417,Other Types,ezetimibe,"cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1"
Renal Cell Carcinoma,BRD-K42497885-001-01-1::2.5::HTS,5.081796179070602,0.024573885131224472,Renal Cell Carcinoma,satraplatin,DNA alkylating agent,
Renal Cell Carcinoma,BRD-K42500029-001-03-5::2.5::HTS,11.527318157948157,0.0007344848938193854,Other Types,CGP-57380,MAP kinase inhibitor,"AURKB, LCK, MKNK1, MKNK2, SGK1"
Renal Cell Carcinoma,BRD-K42679050-001-02-1::2.5::HTS,6.44812850381522,0.011383222385778035,Other Types,Y-27152,potassium channel activator,KCNJ8
Renal Cell Carcinoma,BRD-K42805893-001-04-9::2.5::HTS,3.879664824545106,0.04936497625756775,Renal Cell Carcinoma,osimertinib,EGFR inhibitor,EGFR
Renal Cell Carcinoma,BRD-K43164539-001-11-5::2.5::HTS,6.754943364909012,0.009601571424900437,Other Types,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Renal Cell Carcinoma,BRD-K43187796-001-02-3::2.5::HTS,6.7161032941347205,0.009802944038628077,Other Types,3-indolebutyric-acid,,"B2M, HLA-A, TRAC, TRBC1"
Renal Cell Carcinoma,BRD-K43236057-001-07-1::2.6::HTS,20.459851187252553,7.526792556467709e-06,Renal Cell Carcinoma,polydatin,ICAM1 expression inhibitor,ICAM1
Renal Cell Carcinoma,BRD-K43305603-004-02-8::2.5::HTS,4.45885105325513,0.03516399496338766,Other Types,rocuronium,acetylcholine receptor antagonist,"CHRM2, CHRNA2, HTR3A"
Renal Cell Carcinoma,BRD-K43449605-001-01-0::2.5::HTS,9.515483647491251,0.002139082950157112,Other Types,oncrasin-1,apoptosis stimulant,
Renal Cell Carcinoma,BRD-K43471985-001-05-5::2.5::HTS,8.16793231339963,0.004422925265462994,Renal Cell Carcinoma,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Renal Cell Carcinoma,BRD-K43873574-001-01-8::2.5::HTS,3.878309734886639,0.0494063046587004,Other Types,ilepcimide,anticonvulsant,
Renal Cell Carcinoma,BRD-K43887077-003-26-3::2.5::HTS,4.4199144251331886,0.03597912187283302,Other Types,dopamine,dopamine receptor agonist,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4"
Renal Cell Carcinoma,BRD-K44084986-300-08-4::2.5::HTS,10.616814147551775,0.0011893002422940792,Renal Cell Carcinoma,Y-27632,rho associated kinase inhibitor,"PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2"
Renal Cell Carcinoma,BRD-K44408410-001-17-6::2.5::HTS,7.8777387284709794,0.005178316177514165,Renal Cell Carcinoma,2-methoxyestradiol,hypoxia inducible factor inhibitor,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB"
Renal Cell Carcinoma,BRD-K44665581-001-01-8::2.5::HTS,9.285596431824656,0.0024189009559702213,Renal Cell Carcinoma,bromosporine,bromodomain inhibitor,
Renal Cell Carcinoma,BRD-K44777625-001-03-5::2.5::HTS,11.55721448391552,0.0007230057738015242,Other Types,FH1,hepatocyte function enhancer,
Renal Cell Carcinoma,BRD-K44844162-001-01-6::2.5::HTS,6.1767703244403585,0.013238835548352066,Renal Cell Carcinoma,taselisib,PI3K inhibitor,PIK3CA
Renal Cell Carcinoma,BRD-K45086103-001-15-5::2.5::HTS,5.46487118123259,0.019755621214852557,Other Types,sulfaguanidine,bacterial antifolate,
Renal Cell Carcinoma,BRD-K45114938-236-01-8::2.35::HTS,4.412101036383723,0.036161232957228284,Other Types,mezlocillin,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K45117373-001-02-9::2.5::HTS,4.207156469760141,0.040730398079012,Other Types,Y-26763,potassium channel activator,KCNJ8
Renal Cell Carcinoma,BRD-K45152786-001-08-4::2.5::HTS,5.1085017813242315,0.024201959692680713,Renal Cell Carcinoma,merbarone,topoisomerase inhibitor,TOP2A
Renal Cell Carcinoma,BRD-K45163704-001-01-5::2.5::HTS,8.374955624409802,0.0039609083668703995,Other Types,midafotel,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Renal Cell Carcinoma,BRD-K45168550-001-01-9::2.5::HTS,8.356885972560868,0.003993521159990385,Other Types,SB-756050,G protein-coupled receptor agonist,GPBAR1
Renal Cell Carcinoma,BRD-K45245728-335-01-4::2.5::HTS,6.079575037220934,0.013978392506333252,Other Types,ursodeoxycholyltaurine,cholesterol inhibitor,
Renal Cell Carcinoma,BRD-K45401373-001-20-9::2.5::HTS,4.243269839154559,0.03989575235341917,Renal Cell Carcinoma,betulinic-acid,"apoptosis stimulant, NFkB pathway inhibitor",GPBAR1
Renal Cell Carcinoma,BRD-K45528773-001-06-4::2.5::HTS,5.260879328326332,0.022193889338503338,Renal Cell Carcinoma,M-344,HDAC inhibitor,
Renal Cell Carcinoma,BRD-K45542189-048-22-1::2.5::HTS,4.917197950179058,0.026994160690143806,Other Types,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Renal Cell Carcinoma,BRD-K46331928-001-05-8::2.5::HTS,4.464988178620738,0.035039721100162693,Other Types,ethynodiol-diacetate,,"ESR1, PGR"
Renal Cell Carcinoma,BRD-K46386702-001-02-1::2.5::HTS,5.288781035999046,0.021832171215773657,Renal Cell Carcinoma,ARRY-334543,EGFR inhibitor,ERBB2
Renal Cell Carcinoma,BRD-K47150025-001-05-3::2.5::HTS,3.9959789150257676,0.04609348923449513,Renal Cell Carcinoma,KI-8751,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Renal Cell Carcinoma,BRD-K47278471-003-26-3::2.5::HTS,4.803748079813731,0.028811134284249917,Other Types,diphenhydramine,histamine receptor antagonist,HRH1
Renal Cell Carcinoma,BRD-K47598052-001-15-8::2.5::HTS,4.102820669573343,0.043294976284016976,Other Types,PP-1,src inhibitor,"HCK, RET"
Renal Cell Carcinoma,BRD-K48061146-066-01-7::2.5::HTS,4.339850049874969,0.03769483964806662,Other Types,benztropine-mesylate,acetylcholine receptor antagonist,"CHRM1, HRH1, SLC6A3"
Renal Cell Carcinoma,BRD-K48213016-001-01-8::2.5::HTS,4.897812326129526,0.027299017416445512,Other Types,CC-930,JNK inhibitor,
Renal Cell Carcinoma,BRD-K48300629-001-14-5::2.5::HTS,4.250339152642188,0.03971010379684571,Other Types,zonisamide,"sodium channel blocker, T-type calcium channel blocker","CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A"
Renal Cell Carcinoma,BRD-K48443249-001-01-0::2.5::HTS,6.240356412711185,0.012773310432725334,Renal Cell Carcinoma,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Renal Cell Carcinoma,BRD-K48619321-004-16-8::2.54::HTS,4.733318187322876,0.030026558955216442,Other Types,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Renal Cell Carcinoma,BRD-K49049886-001-08-7::2.5::HTS,4.529711789478504,0.03375192094627381,Renal Cell Carcinoma,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Renal Cell Carcinoma,BRD-K49055432-001-04-2::2.5::HTS,9.33216885794371,0.0023591847039234016,Renal Cell Carcinoma,A66,PI3K inhibitor,PIK3CA
Renal Cell Carcinoma,BRD-K49075727-001-08-5::2.5::HTS,7.536443449921126,0.006243348079629631,Other Types,nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Renal Cell Carcinoma,BRD-K49215523-001-04-2::2.5::HTS,13.884894569499352,0.0002143688682247239,Other Types,GSK2636771,PI3K inhibitor,PIK3CB
Renal Cell Carcinoma,BRD-K49328571-001-15-0::2.5::HTS,12.177051168771085,0.0005224454311483602,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Renal Cell Carcinoma,BRD-K49350383-001-13-7::2.5::HTS,6.052145731336881,0.0141947207882927,Renal Cell Carcinoma,thioguanine,purine antagonist,"IMPDH1, IMPDH2"
Renal Cell Carcinoma,BRD-K49555808-001-03-9::2.5::HTS,16.357256973226885,6.00108283129989e-05,Renal Cell Carcinoma,BMS-707035,HIV integrase inhibitor,
Renal Cell Carcinoma,BRD-K49669041-001-08-4::2.5::HTS,7.600485387077692,0.006027647675835465,Renal Cell Carcinoma,BX-912,pyruvate dehydrogenase kinase inhibitor,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1"
Renal Cell Carcinoma,BRD-K49685476-001-15-9::2.5::HTS,4.007174784091112,0.045795866085260165,Renal Cell Carcinoma,TTNPB,retinoid receptor agonist,"RARA, RARB, RARG"
Renal Cell Carcinoma,BRD-K49962337-001-02-9::2.56::HTS,37.26219047439978,2.0015031372353698e-09,Other Types,baicalin,beta glucuronidase inhibitor,PREP
Renal Cell Carcinoma,BRD-K50000283-001-04-4::2.5::HTS,9.411188763034723,0.002260520467942589,Renal Cell Carcinoma,PHA-767491,CDC inhibitor,"CDK1, RPS6KB1"
Renal Cell Carcinoma,BRD-K50031829-001-01-6::2.5::HTS,8.468887735166195,0.0037587175942672504,Other Types,PF-04447943,phosphodiesterase inhibitor,PDE9A
Renal Cell Carcinoma,BRD-K50050533-001-02-1::2.5::HTS,8.697449387296828,0.003327770514780799,Other Types,docosanol,lipase clearing factor inhibitor,TLR7
Renal Cell Carcinoma,BRD-K50168500-001-07-9::2.5::HTS,6.5175644567507955,0.010946885635466018,Renal Cell Carcinoma,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Renal Cell Carcinoma,BRD-K50388907-001-30-4::2.5::HTS,5.538742088529161,0.018958140931987954,Renal Cell Carcinoma,fenofibrate,PPAR receptor agonist,"MMP25, PPARA"
Renal Cell Carcinoma,BRD-K50631926-001-02-3::2.5::HTS,4.249738253243268,0.03971571444376847,Other Types,PIK-294,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Renal Cell Carcinoma,BRD-K50677762-001-01-5::2.5::HTS,4.346286322487853,0.03754708029071924,Renal Cell Carcinoma,oxiracetam,acetylcholine receptor agonist,
Renal Cell Carcinoma,BRD-K50850824-237-04-8::2.5::HTS,10.415035536559868,0.0013274936768049796,Renal Cell Carcinoma,acesulfame-potassium,,
Renal Cell Carcinoma,BRD-K51313569-003-03-3::2.5::HTS,6.123129174451276,0.013639157809580226,Other Types,palbociclib,CDK inhibitor,"CDK4, CDK6"
Renal Cell Carcinoma,BRD-K51318897-001-15-3::2.5::HTS,5.026014374020062,0.025375292162328113,Renal Cell Carcinoma,fenbendazole,tubulin polymerization inhibitor,TUBB
Renal Cell Carcinoma,BRD-K51541829-050-01-0::2.5::HTS,8.426094304901488,0.003844683049281994,Other Types,Ro-25-6981,,GRIN2B
Renal Cell Carcinoma,BRD-K51579475-003-02-4::2.5::HTS,11.44433740953264,0.0007671414895853256,Other Types,dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4"
Renal Cell Carcinoma,BRD-K51671335-001-10-6::2.5::HTS,4.037952137617563,0.044967903422321376,Other Types,levosulpiride,dopamine receptor antagonist,"CA1, CA12, CA7, DRD2, DRD3"
Renal Cell Carcinoma,BRD-K52075040-001-09-7::5.6::HTS,11.441444494518223,0.0007689585960401582,Renal Cell Carcinoma,cerulenin,fatty acid synthase inhibitor,FASN
Renal Cell Carcinoma,BRD-K52559566-001-02-9::2.5::HTS,4.4306085883743895,0.03575623915194285,Other Types,monosodium-alpha-luminol,,
Renal Cell Carcinoma,BRD-K52756523-001-24-7::2.5::HTS,4.286147260475912,0.038883553051427655,Other Types,dirithromycin,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K53414658-001-08-2::2.5::HTS,7.643968018684222,0.005891335370612956,Renal Cell Carcinoma,tivozanib,VEGFR inhibitor,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Renal Cell Carcinoma,BRD-K53523901-001-04-4::2.5::HTS,9.521436047590615,0.0021322741296645707,Renal Cell Carcinoma,arctigenin,MEK inhibitor,"CHUK, MAP2K1"
Renal Cell Carcinoma,BRD-K53765467-001-02-1::2.5::HTS,4.034789711091153,0.04504905906368559,Other Types,empagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Renal Cell Carcinoma,BRD-K54187111-001-08-4::2.51::HTS,5.993604948155471,0.014682212935414713,Other Types,dichlorisone-acetate,,
Renal Cell Carcinoma,BRD-K54262262-001-09-0::2.5::HTS,16.792393413021795,4.797168250211452e-05,Other Types,monobenzone,melanin inhibitor,TYR
Renal Cell Carcinoma,BRD-K54606188-001-13-1::2.5::HTS,6.324808307410966,0.012184001130713213,Renal Cell Carcinoma,JQ1-(+),bromodomain inhibitor,"BRD4, BRDT"
Renal Cell Carcinoma,BRD-K54634444-001-05-9::2.5::HTS,7.401696095161007,0.006718774886526568,Renal Cell Carcinoma,artesunate,DNA synthesis inhibitor,
Renal Cell Carcinoma,BRD-K55191674-237-18-3::2.5::HTS,7.915605306677802,0.005074083661319352,Other Types,benzylpenicillin,penicillin binding protein inhibitor,
Renal Cell Carcinoma,BRD-K55424922-003-02-8::2.5::HTS,4.095685711710979,0.04346798990514719,Other Types,anpirtoline,serotonin receptor agonist,HTR1B
Renal Cell Carcinoma,BRD-K55512740-001-01-6::2.5::HTS,3.893038445944831,0.04897795509434217,Other Types,MK-8033,c-Met inhibitor,MET
Renal Cell Carcinoma,BRD-K55773932-001-02-0::2.5::HTS,5.483380457094548,0.01954895610022507,Other Types,BMS-806,HIV attachment inhibitor,
Renal Cell Carcinoma,BRD-K56032964-001-02-1::2.5::HTS,4.3870591921153705,0.036661522065095174,Renal Cell Carcinoma,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Renal Cell Carcinoma,BRD-K56291712-001-01-0::2.5::HTS,4.227872803502694,0.040226494920943025,Other Types,voxtalisib,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Renal Cell Carcinoma,BRD-K56334280-001-05-1::2.5::HTS,4.363678512785367,0.03716222693369791,Renal Cell Carcinoma,amonafide,topoisomerase inhibitor,"TOP2A, TOP2B"
Renal Cell Carcinoma,BRD-K56405753-001-02-4::2.5::HTS,6.938562686676536,0.008668153425917422,Other Types,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Renal Cell Carcinoma,BRD-K56614220-001-19-0::2.5::HTS,6.818977468414871,0.009261186713640257,Renal Cell Carcinoma,clofazimine,GK0582 inhibitor,
Renal Cell Carcinoma,BRD-K56707426-001-02-0::2.5::HTS,3.9927762053311735,0.0461840250620748,Other Types,nitarsone,,
Renal Cell Carcinoma,BRD-K56908511-001-01-2::2.5::HTS,3.9724277161822767,0.046816691022966095,Other Types,fluroxene,local anesthetic,
Renal Cell Carcinoma,BRD-K57080016-001-15-9::2.5::HTS,5.582834619368847,0.01847697952921235,Renal Cell Carcinoma,selumetinib,MEK inhibitor,MAP2K1
Renal Cell Carcinoma,BRD-K57304726-003-06-9::2.5::HTS,5.238440449187934,0.02246322712323353,Other Types,PRE-084,sigma receptor agonist,SIGMAR1
Renal Cell Carcinoma,BRD-K57432881-003-21-8::2.5::HTS,5.767707736584162,0.016646992786299546,Other Types,tiapride,dopamine receptor antagonist,"DRD2, DRD3"
Renal Cell Carcinoma,BRD-K57569181-001-27-5::2.5::HTS,6.863499350594424,0.009035146300000753,Other Types,pentoxifylline,phosphodiesterase inhibitor,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF"
Renal Cell Carcinoma,BRD-K57631554-003-06-2::2.5::HTS,6.245410467240692,0.01273579184414135,Other Types,5-aminolevulinic-acid,oxidizing agent,ALAD
Renal Cell Carcinoma,BRD-K58049875-001-04-7::2.5::HTS,9.306350084807633,0.002392102350847126,Renal Cell Carcinoma,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Renal Cell Carcinoma,BRD-K58114536-001-01-6::2.5::HTS,6.799066325028425,0.00936288274495108,Other Types,rasagiline,monoamine oxidase inhibitor,"BCL2, MAOB"
Renal Cell Carcinoma,BRD-K58466253-003-14-0::2.5::HTS,10.531474152730842,0.0012444025089950828,Renal Cell Carcinoma,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
Renal Cell Carcinoma,BRD-K58568447-001-01-1::2.5::HTS,4.685240664631073,0.030845395407735295,Renal Cell Carcinoma,K02288,bone morphogenic protein inhibitor,BMP1
Renal Cell Carcinoma,BRD-K58772419-001-07-0::2.5::HTS,11.440095813891968,0.0007691341919757498,Other Types,AZD6482,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Renal Cell Carcinoma,BRD-K58968598-001-03-6::2.5::HTS,4.008113010312507,0.04577595470486617,Other Types,sucralose,,
Renal Cell Carcinoma,BRD-K59146805-001-03-7::2.5::HTS,4.74793590445704,0.029749579468034748,Renal Cell Carcinoma,AZ3146,monopolar spindle 1 kinase inhibitor,
Renal Cell Carcinoma,BRD-K59197931-001-04-5::2.5::HTS,4.58814880803942,0.032624437003363156,Other Types,naproxen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-K59433843-001-01-7::2.5::HTS,5.469104018589239,0.019706411053294553,Other Types,ICI-192605,thromboxane receptor antagonist,TBXA2R
Renal Cell Carcinoma,BRD-K59436580-001-01-7::2.5::HTS,11.907384359856142,0.0006011108490402019,Renal Cell Carcinoma,tedizolid,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K59524082-001-01-3::2.5::HTS,5.66467214469615,0.017643674309462145,Other Types,maribavir,"cytomegalovirus inhibitor, protein kinase inhibitor",PYGM
Renal Cell Carcinoma,BRD-K60005752-001-01-9::2.5::HTS,8.11235187423193,0.004558262139666361,Other Types,S-111,PARP inhibitor,PARP1
Renal Cell Carcinoma,BRD-K60038276-001-09-0::2.5::HTS,6.876406380377949,0.008973062579514525,Other Types,irbesartan,angiotensin receptor antagonist,"AGTR1, JUN, SLC10A1"
Renal Cell Carcinoma,BRD-K60230970-001-17-5::2.4::HTS,4.083737553882432,0.04380585187803042,Other Types,MG-132,proteasome inhibitor,PSMB1
Renal Cell Carcinoma,BRD-K60341624-001-02-2::2.5::HTS,5.0954753932434445,0.024372759274447948,Renal Cell Carcinoma,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR
Renal Cell Carcinoma,BRD-K60443845-001-08-6::2.5::HTS,18.385491212895904,2.138086751418106e-05,Renal Cell Carcinoma,chlormidazole,fungal lanosterol demethylase inhibitor,
Renal Cell Carcinoma,BRD-K60511616-236-08-9::2.5::HTS,4.914795131878343,0.027032853152178345,Other Types,pravastatin,HMGCR inhibitor,"HMGCR, SLCO1B1"
Renal Cell Carcinoma,BRD-K61228301-001-01-2::2.5::HTS,12.494761995209863,0.0004418993198901018,Renal Cell Carcinoma,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Renal Cell Carcinoma,BRD-K61250484-001-02-3::2.5::HTS,7.883184337408608,0.005164218017314226,Renal Cell Carcinoma,FPH1-(BRD-6125),hepatocyte function enhancer,
Renal Cell Carcinoma,BRD-K61314889-001-04-4::2.5::HTS,7.96787154816998,0.004930136547170227,Other Types,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Renal Cell Carcinoma,BRD-K61314889-001-05-1::2.5::HTS,9.015786833150198,0.0027973376133728018,Other Types,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Renal Cell Carcinoma,BRD-K61323504-001-04-0::2.5::HTS,4.623542490171279,0.03196970302077196,Renal Cell Carcinoma,SB-225002,CC chemokine receptor antagonist,CXCR2
Renal Cell Carcinoma,BRD-K61496577-001-20-2::2.5::HTS,4.186384743405255,0.04121810254684833,Other Types,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Renal Cell Carcinoma,BRD-K61536336-001-01-7::2.5::HTS,5.46516090294702,0.01975111196069055,Renal Cell Carcinoma,SB-366791,TRPV antagonist,TRPV1
Renal Cell Carcinoma,BRD-K61585876-001-01-0::2.5::HTS,5.143077677970432,0.023717983428976047,Other Types,3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,"GRM1, GRM5"
Renal Cell Carcinoma,BRD-K61717546-001-04-3::2.5::HTS,3.916386751716744,0.04831226785280856,Other Types,fleroxacin,topoisomerase inhibitor,
Renal Cell Carcinoma,BRD-K61734568-003-02-1::2.5::HTS,13.456243903480905,0.00026762825599374265,Renal Cell Carcinoma,"2,3-DCPE",Bcl-XL downregulator,BCL2L1
Renal Cell Carcinoma,BRD-K61802864-001-08-8::2.5::HTS,10.385995413119149,0.0013438384765998815,Other Types,chlorindione,,
Renal Cell Carcinoma,BRD-K61936403-001-01-7::2.5::HTS,3.9456570706677816,0.04748477610622384,Other Types,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D
Renal Cell Carcinoma,BRD-K62213621-001-01-6::2.5::HTS,14.418789049593169,0.00016250041729164188,Renal Cell Carcinoma,dihydroartemisinin,antimalarial agent,
Renal Cell Carcinoma,BRD-K62277907-001-01-6::1.2::HTS,4.782609044679496,0.02916748232735089,Other Types,PYM50028,neurotrophic agent,
Renal Cell Carcinoma,BRD-K62326629-001-19-0::2.5::HTS,4.2373142536368595,0.040018605501131004,Other Types,dichlorophen,anticestodal agent,
Renal Cell Carcinoma,BRD-K62412084-001-07-1::2.5::HTS,9.77147498691083,0.0018639656824468573,Other Types,para-toluenesulfonamide,,"CA12, CA2, CA6, CA9"
Renal Cell Carcinoma,BRD-K62627508-001-01-5::2.5::HTS,12.115930165065599,0.000538888580263034,Other Types,idasanutlin,MDM inhibitor,"MDM2, TP53"
Renal Cell Carcinoma,BRD-K62685538-001-01-7::2.5::HTS,6.1233579926763815,0.013640110716170993,Other Types,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR
Renal Cell Carcinoma,BRD-K63068307-001-08-9::2.5::HTS,5.018494534982262,0.02547363572340924,Other Types,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Renal Cell Carcinoma,BRD-K63915849-001-03-7::2.5::HTS,4.578606066001709,0.03280662455799222,Other Types,AS-604850,PI3K inhibitor,"PIK3CA, PIK3CG"
Renal Cell Carcinoma,BRD-K64800655-001-07-4::2.5::HTS,8.70649377861219,0.0033029630725299173,Renal Cell Carcinoma,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Renal Cell Carcinoma,BRD-K64835161-001-02-8::2.5::HTS,5.076246706330463,0.024642683797534704,Other Types,ML167,"CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B"
Renal Cell Carcinoma,BRD-K64881305-001-03-7::2.5::HTS,4.891120620912809,0.027399649792386772,Renal Cell Carcinoma,ispinesib,kinesin inhibitor,KIF11
Renal Cell Carcinoma,BRD-K64888243-001-03-7::2.5::HTS,4.037470201612045,0.044979793409278525,Renal Cell Carcinoma,AZ960,JAK inhibitor,JAK2
Renal Cell Carcinoma,BRD-K64925568-001-01-8::2.5::HTS,10.71629812223838,0.0011278191868303053,Other Types,AMG-232,MDM inhibitor,MDM2
Renal Cell Carcinoma,BRD-K65904673-001-01-4::2.5::HTS,3.8895245007467034,0.04907979136016813,Other Types,tandospirone,serotonin receptor agonist,HTR1A
Renal Cell Carcinoma,BRD-K65928735-001-04-3::2.5::HTS,4.71974542691248,0.030239108132927413,Renal Cell Carcinoma,AZD1480,JAK inhibitor,"JAK1, JAK2, JAK3"
Renal Cell Carcinoma,BRD-K65991129-001-02-9::2.5::HTS,9.200228624463456,0.0025348924552566756,Other Types,SB-705498,TRPV antagonist,TRPV1
Renal Cell Carcinoma,BRD-K66175015-001-09-0::2.5::HTS,6.192793811974402,0.0131240854900217,Renal Cell Carcinoma,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Renal Cell Carcinoma,BRD-K66412701-066-01-6::2.5::HTS,5.030116287682689,0.025299199085560678,Other Types,pazufloxacin,topoisomerase inhibitor,
Renal Cell Carcinoma,BRD-K66538826-001-07-2::2.5::HTS,15.47851706047178,9.409271274112749e-05,Renal Cell Carcinoma,amuvatinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor","KIT, MET"
Renal Cell Carcinoma,BRD-K66850609-001-07-4::2.5::HTS,8.86966144480458,0.003024579412096099,Other Types,voglibose,glucosidase inhibitor,MGAM
Renal Cell Carcinoma,BRD-K67017579-001-28-1::2.5::HTS,5.848385540610418,0.015911031165356387,Other Types,cilostazol,phosphodiesterase inhibitor,"PDE3A, PDE3B"
Renal Cell Carcinoma,BRD-K67100011-003-06-3::2.5::HTS,5.308381353983274,0.021588912368619668,Other Types,pivmecillinam,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K67578145-001-09-7::2.38::HTS,8.045644522316547,0.004736460036370642,Renal Cell Carcinoma,GDC-0879,RAF inhibitor,BRAF
Renal Cell Carcinoma,BRD-K67680372-003-02-6::2.5::HTS,3.979528940086632,0.046543233851997774,Other Types,CI-966,GAT inhibitor,SLC6A1
Renal Cell Carcinoma,BRD-K67789209-001-01-0::2.5::HTS,3.8761144702715398,0.04947048770745738,Other Types,adatanserin,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR2A"
Renal Cell Carcinoma,BRD-K67966701-001-12-4::2.5::HTS,4.41648575180498,0.03605684021742047,Other Types,lisinopril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Renal Cell Carcinoma,BRD-K67977190-066-02-3::2.5::HTS,4.065238685834198,0.04426369243144482,Renal Cell Carcinoma,eprosartan,angiotensin receptor antagonist,AGTR1
Renal Cell Carcinoma,BRD-K68188368-001-09-4::2.5::HTS,4.313674342309475,0.03826418328920956,Renal Cell Carcinoma,nifuroxazide,bacterial DNA inhibitor,
Renal Cell Carcinoma,BRD-K68346641-001-02-2::2.5::HTS,3.9881561081254153,0.04630464305478278,Renal Cell Carcinoma,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Renal Cell Carcinoma,BRD-K68395654-001-03-1::2.5::HTS,11.95855106513139,0.0005851632019788942,Renal Cell Carcinoma,EVP4593,NFkB pathway inhibitor,
Renal Cell Carcinoma,BRD-K68405354-001-07-2::2.5::HTS,4.714574261945263,0.030327134029818282,Other Types,spaglumic-acid,glutamate receptor antagonist,GRM3
Renal Cell Carcinoma,BRD-K68532323-003-02-8::2.5::HTS,6.216871858833357,0.012941392101955634,Renal Cell Carcinoma,SB-743921,kinesin-like spindle protein inhibitor,KIF11
Renal Cell Carcinoma,BRD-K68620903-001-11-4::2.5::HTS,7.373160808805223,0.006825891319157924,Other Types,dydrogesterone,progesterone receptor agonist,PGR
Renal Cell Carcinoma,BRD-K68770713-001-01-8::2.5::HTS,3.966329987657339,0.046913852852871224,Other Types,azosemide,electrolyte reabsorption inhibitor,"SLC12A1, SLC12A2"
Renal Cell Carcinoma,BRD-K68938568-001-01-7::2.5::HTS,7.02208086439596,0.008278576764562234,Renal Cell Carcinoma,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Renal Cell Carcinoma,BRD-K68997413-001-05-1::2.5::HTS,7.037346853403569,0.008210005554765362,Renal Cell Carcinoma,PF-3845,FAAH inhibitor,FAAH
Renal Cell Carcinoma,BRD-K69001009-001-02-8::2.5::HTS,11.651937988628317,0.0006882505727291363,Other Types,golvatinib,VEGFR inhibitor,"KDR, MET"
Renal Cell Carcinoma,BRD-K69236721-001-02-7::2.5::HTS,5.888852419276701,0.015551569410792105,Other Types,lumacaftor,CFTR channel agonist,CFTR
Renal Cell Carcinoma,BRD-K69726595-001-01-2::2.5::HTS,7.065912721070961,0.00808094842581102,Renal Cell Carcinoma,mericitabine,HCV inhibitor,
Renal Cell Carcinoma,BRD-K69776681-001-03-8::2.5::HTS,8.914232605216522,0.0029532237079845083,Renal Cell Carcinoma,volasertib,PLK inhibitor,PLK1
Renal Cell Carcinoma,BRD-K70163715-300-05-7::2.42::HTS,5.433631396063597,0.020132421700033435,Other Types,vatalanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR, PDGFRB"
Renal Cell Carcinoma,BRD-K70327167-348-13-4::2.5::HTS,5.774457621200819,0.016586165520814232,Other Types,suramin,DNA synthesis inhibitor,"F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5"
Renal Cell Carcinoma,BRD-K70358946-001-15-7::2.5::HTS,4.052309409961452,0.04458901309581478,Renal Cell Carcinoma,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Renal Cell Carcinoma,BRD-K70402238-001-02-8::2.5::HTS,6.40768117982543,0.011635743228916834,Renal Cell Carcinoma,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Renal Cell Carcinoma,BRD-K70463136-001-01-5::2.5::HTS,15.474504860698492,9.412850911163843e-05,Renal Cell Carcinoma,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A
Renal Cell Carcinoma,BRD-K70592483-001-01-0::2.5::HTS,12.850293653429778,0.00036720632174290166,Other Types,phenylacetylglutamine,"DNA methylase inhibitor, protein synthesis inhibitor",
Renal Cell Carcinoma,BRD-K71055333-224-05-8::2.5::HTS,5.770058232584077,0.016634485705859518,Other Types,etamsylate,haemostatic agent,
Renal Cell Carcinoma,BRD-K71058253-001-01-9::2.5::HTS,4.858466243617365,0.027916808397602563,Renal Cell Carcinoma,luliconazole,sterol demethylase inhibitor,
Renal Cell Carcinoma,BRD-K71221037-001-01-6::2.5::HTS,16.128204998716846,6.726869042847209e-05,Renal Cell Carcinoma,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Renal Cell Carcinoma,BRD-K71799949-001-36-4::2.5::HTS,5.593986899540978,0.018362108224735937,Other Types,carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Renal Cell Carcinoma,BRD-K71822263-001-03-2::2.5::HTS,6.118751472049873,0.013671001255349488,Renal Cell Carcinoma,D-Serine,glutamate receptor agonist,"GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3"
Renal Cell Carcinoma,BRD-K72106461-001-02-1::2.5::HTS,4.763157088687915,0.029515083246449966,Other Types,SYM-2081,kainate receptor antagonist,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2"
Renal Cell Carcinoma,BRD-K72167406-001-02-1::2.5::HTS,8.104331473957602,0.004587794337031655,Renal Cell Carcinoma,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K72222507-003-16-8::2.5::HTS,5.134606887670082,0.023834267760972347,Other Types,quinapril,angiotensin converting enzyme inhibitor,ACE
Renal Cell Carcinoma,BRD-K72327355-001-14-7::2.5::HTS,54.29797161709906,6.294943042186488e-13,Other Types,baicalein,lipoxygenase inhibitor,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH"
Renal Cell Carcinoma,BRD-K72339976-065-04-7::2.5::HTS,4.747419499297988,0.029764473390750296,Other Types,cefoselis,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K72687424-001-02-6::2.5::HTS,3.867894434175223,0.04971248612665572,Other Types,VU0364439,glutamate receptor positive allosteric modulator,GRM4
Renal Cell Carcinoma,BRD-K72723676-003-17-8::2.5::HTS,27.10455547863119,2.715611970686828e-07,Renal Cell Carcinoma,benzethonium,sodium channel blocker,SCN10A
Renal Cell Carcinoma,BRD-K72815923-034-01-2::2.5::HTS,6.123941983644138,0.01363189236770325,Renal Cell Carcinoma,xanomeline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Renal Cell Carcinoma,BRD-K72951360-001-01-4::2.5::HTS,12.852119034959337,0.00036685646750069835,Renal Cell Carcinoma,valrubicin,"DNA inhibitor, topoisomerase inhibitor",TOP2A
Renal Cell Carcinoma,BRD-K73319509-001-08-0::2.5::HTS,4.797907990113531,0.02890587382595356,Other Types,PF-04217903,c-Met inhibitor,MET
Renal Cell Carcinoma,BRD-K73700643-001-11-2::2.5::HTS,4.94710371767553,0.026530929340725123,Other Types,N-acetyltryptamine,melatonin receptor agonist,
Renal Cell Carcinoma,BRD-K74339692-001-01-9::2.5::HTS,8.759510078214591,0.0032121341372277823,Other Types,tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Renal Cell Carcinoma,BRD-K74990253-001-02-8::2.5::HTS,8.590018999282911,0.003517549625262172,Other Types,BW-373U86,opioid receptor agonist,OPRD1
Renal Cell Carcinoma,BRD-K75080769-001-01-6::2.5::HTS,10.309560656726369,0.0013990336630365849,Other Types,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,
Renal Cell Carcinoma,BRD-K75089421-003-24-5::2.5::HTS,4.82758581895032,0.028422606099709636,Other Types,procainamide,sodium channel blocker,"DNMT1, SCN5A"
Renal Cell Carcinoma,BRD-K75699339-057-08-1::2.5::HTS,4.147820795142171,0.04215633437325244,Other Types,rizatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Renal Cell Carcinoma,BRD-K75868704-001-05-3::2.5::HTS,4.146672094332607,0.04218724172957208,Other Types,iopamidol,radiopaque medium,
Renal Cell Carcinoma,BRD-K76304753-003-20-3::2.5::HTS,4.014047319984582,0.045623695153401735,Other Types,phenazopyridine,local anesthetic,SCN1A
Renal Cell Carcinoma,BRD-K76606751-001-01-7::2.5::HTS,9.59086570378586,0.002053036608363806,Other Types,mebicar,anxiolytic,
Renal Cell Carcinoma,BRD-K76810206-001-08-1::2.5::HTS,8.936155456507475,0.0029181023472359614,Other Types,nicergoline,adrenergic receptor antagonist,ADRA1A
Renal Cell Carcinoma,BRD-K76908866-001-07-6::2.5::HTS,7.9833725413746945,0.004889300416167073,Renal Cell Carcinoma,CP-724714,"EGFR inhibitor, protein tyrosine kinase inhibitor",ERBB2
Renal Cell Carcinoma,BRD-K76973696-001-12-6::2.01::HTS,5.293727839752824,0.021772845128200793,Renal Cell Carcinoma,tryptanthrin,cyclooxygenase inhibitor,IDO1
Renal Cell Carcinoma,BRD-K77552740-004-01-0::2.5::HTS,4.3356208915971415,0.0377827632100085,Other Types,tiquizium,acetylcholine receptor antagonist,
Renal Cell Carcinoma,BRD-K77554836-001-11-6::2.57::HTS,6.788745858339046,0.009432244199384376,Other Types,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Renal Cell Carcinoma,BRD-K77641333-003-27-1::2.5::HTS,4.148118874900339,0.04214897022943771,Other Types,naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A"
Renal Cell Carcinoma,BRD-K77685957-300-09-1::2.5::HTS,5.914422033863202,0.015337859599626406,Renal Cell Carcinoma,dequalinium,PKC inhibitor,"KCNN1, KCNN3"
Renal Cell Carcinoma,BRD-K77791657-001-01-1::2.5::HTS,6.074345630577028,0.014013950509438905,Renal Cell Carcinoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Renal Cell Carcinoma,BRD-K77791657-003-01-7::2.67::HTS,7.422592117133162,0.0066545030989896385,Renal Cell Carcinoma,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Renal Cell Carcinoma,BRD-K77908580-001-09-6::2.5::HTS,9.083838610078741,0.002695486555516,Renal Cell Carcinoma,entinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC9"
Renal Cell Carcinoma,BRD-K77943374-001-02-8::2.5::HTS,5.041643356009084,0.025132932596880438,Other Types,NVP-BVU972,MET inhibitor,MET
Renal Cell Carcinoma,BRD-K77950083-001-03-3::2.5::HTS,5.422793534714924,0.02023436338967973,Other Types,UPF-1069,PARP inhibitor,PARP2
Renal Cell Carcinoma,BRD-K77987382-001-13-2::2.5::HTS,4.502216271504927,0.034287840292042945,Renal Cell Carcinoma,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Renal Cell Carcinoma,BRD-K78055238-001-01-8::2.5::HTS,5.096598723473068,0.024362708410472007,Other Types,LY2090314,glycogen synthase kinase inhibitor,GSK3B
Renal Cell Carcinoma,BRD-K78096648-001-05-7::2.5::HTS,6.299950107627728,0.012359151439813925,Renal Cell Carcinoma,oxiperomide,dopamine receptor antagonist,
Renal Cell Carcinoma,BRD-K78126613-001-28-5::2.5::HTS,4.993175099633206,0.025839801068631853,Renal Cell Carcinoma,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Renal Cell Carcinoma,BRD-K78431006-001-10-2::2.5::HTS,7.981848689084405,0.004892754085075581,Renal Cell Carcinoma,crizotinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Renal Cell Carcinoma,BRD-K78496197-001-03-9::2.5::HTS,4.244950411643837,0.039831104217413135,Renal Cell Carcinoma,SCS,,
Renal Cell Carcinoma,BRD-K78666826-003-01-6::2.5::HTS,4.31795542037457,0.03816961403249557,Other Types,procaterol,adrenergic receptor agonist,ADRB2
Renal Cell Carcinoma,BRD-K78789465-001-02-4::2.5::HTS,14.764442964387683,0.00013580453817805212,Other Types,pentagastrin,CCK receptor agonist,CCKBR
Renal Cell Carcinoma,BRD-K78844995-001-02-6::2.5::HTS,4.070795807684885,0.04411410617540704,Other Types,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,
Renal Cell Carcinoma,BRD-K78960041-001-05-7::2.54::HTS,7.437955252714845,0.0065987289854509985,Renal Cell Carcinoma,oxaliplatin,DNA inhibitor,
Renal Cell Carcinoma,BRD-K79239947-001-06-8::2.5::HTS,8.184082786611743,0.004385446120089748,Renal Cell Carcinoma,PF-573228,focal adhesion kinase inhibitor,"CDK1, CDK2, CDK7, GSK3B, IKBKB"
Renal Cell Carcinoma,BRD-K79259477-001-04-9::2.5::HTS,3.908492961665226,0.04853272232854254,Other Types,NVP-BHG712,ephrin inhibitor,EPHB4
Renal Cell Carcinoma,BRD-K79584249-001-01-3::2.5::HTS,19.281939722221175,1.3511210283133959e-05,Other Types,CGM097,MDM inhibitor,MDM2
Renal Cell Carcinoma,BRD-K79612754-001-19-1::2.62::HTS,4.407129848314494,0.03626313877018778,Renal Cell Carcinoma,inosine,neurotrophic agent,"PARP1, PNP"
Renal Cell Carcinoma,BRD-K79633074-001-01-8::2.5::HTS,5.078289742841892,0.024611862621498774,Other Types,xilobam,,
Renal Cell Carcinoma,BRD-K79711234-001-18-3::2.5::HTS,9.862820186441551,0.0017759893752440847,Renal Cell Carcinoma,thiamphenicol,bacterial 50S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K79759585-048-04-8::2.5::HTS,8.675631884624556,0.0033611817155360015,Other Types,sildenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
Renal Cell Carcinoma,BRD-K80262108-001-07-0::2.5::HTS,7.158696955186291,0.007678806146016655,Other Types,amifampridine,potassium channel blocker,
Renal Cell Carcinoma,BRD-K80267133-001-17-7::2.5::HTS,8.868901338234588,0.0030312200870646335,Renal Cell Carcinoma,aminosalicylate,cyclooxygenase inhibitor,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-K80353138-001-12-1::2.5::HTS,4.161150689586548,0.04183168869799124,Other Types,silibinin,cytochrome P450 inhibitor,ALOX5
Renal Cell Carcinoma,BRD-K80431395-001-07-3::2.49::HTS,8.994981509446697,0.002834903895103529,Renal Cell Carcinoma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Renal Cell Carcinoma,BRD-K80431395-001-09-9::2.5::HTS,7.345280069288929,0.006943014881771077,Renal Cell Carcinoma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Renal Cell Carcinoma,BRD-K80935598-001-01-1::2.5::HTS,7.374904933464279,0.006818991900708851,Other Types,AZ191,DYRK inhibitor,DYRK1B
Renal Cell Carcinoma,BRD-K81647657-001-04-3::2.5::HTS,5.66557457979471,0.01763350152579865,Other Types,3-methyladenine,PI3K inhibitor,PI3
Renal Cell Carcinoma,BRD-K82244583-001-01-3::2.5::HTS,5.426945346515917,0.020196793097458855,Renal Cell Carcinoma,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Renal Cell Carcinoma,BRD-K82357231-001-17-5::2.5::HTS,10.553127950658554,0.001229288610408618,Other Types,desloratadine,histamine receptor antagonist,HRH1
Renal Cell Carcinoma,BRD-K82484965-003-03-5::2.5::HTS,4.574676406266888,0.03288209550909163,Other Types,carmoxirole,dopamine receptor agonist,DRD2
Renal Cell Carcinoma,BRD-K82731415-001-07-0::2.5::HTS,4.6279004218572375,0.03188929215508296,Other Types,olomoucine,CDK inhibitor,"CDK1, CDK2, CDK5, MAPK1"
Renal Cell Carcinoma,BRD-K82746043-001-15-1::2.5::HTS,6.526386549148971,0.01089193376859309,Other Types,navitoclax,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Renal Cell Carcinoma,BRD-K82818427-001-02-2::2.39::HTS,18.780035007029714,1.7567497651244713e-05,Renal Cell Carcinoma,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Renal Cell Carcinoma,BRD-K82818427-001-04-8::2.5::HTS,11.768111616819551,0.0006470294733500682,Renal Cell Carcinoma,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Renal Cell Carcinoma,BRD-K82928847-001-04-7::2.5::HTS,13.392008943460466,0.00027722538855975526,Renal Cell Carcinoma,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Renal Cell Carcinoma,BRD-K83036479-001-09-2::2.5::HTS,5.561013280046633,0.01871064420805287,Other Types,salicylanilide,other antibiotic,
Renal Cell Carcinoma,BRD-K83064458-001-23-0::2.5::HTS,6.64866880803643,0.01017902023958635,Other Types,etofylline,adenosine receptor antagonist,ADORA1
Renal Cell Carcinoma,BRD-K83508485-001-02-7::2.5::HTS,5.43320433386147,0.020120546450832968,Renal Cell Carcinoma,FK-888,tachykinin antagonist,"TACR1, TACR2"
Renal Cell Carcinoma,BRD-K83963101-001-06-9::2.5::HTS,6.03146885499731,0.014367512038703834,Renal Cell Carcinoma,MLN-8054,Aurora kinase inhibitor,AURKA
Renal Cell Carcinoma,BRD-K84466663-001-05-4::2.5::HTS,5.9064805732526375,0.015406396171988534,Other Types,nelarabine,"DNA synthesis inhibitor, T cell inhibitor",POLA1
Renal Cell Carcinoma,BRD-K84683831-001-01-0::2.5::HTS,6.844182202633105,0.009139193411207102,Renal Cell Carcinoma,radezolid,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor",
Renal Cell Carcinoma,BRD-K84810405-003-01-1::2.5::HTS,4.741862762917927,0.029871733842585017,Other Types,almorexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Renal Cell Carcinoma,BRD-K84925803-001-01-9::2.5::HTS,4.147852870470919,0.042169275733343385,Other Types,T-5224,AP inhibitor,JUN
Renal Cell Carcinoma,BRD-K85146014-314-05-4::2.5::HTS,5.061815754424762,0.024871185162033203,Renal Cell Carcinoma,foscarnet,DNA polymerase inhibitor,
Renal Cell Carcinoma,BRD-K85849709-001-01-5::2.5::HTS,5.052766100385259,0.024976356331967715,Other Types,AZD2858,glycogen synthase kinase inhibitor,GSK3B
Renal Cell Carcinoma,BRD-K85925969-001-17-4::2.5::HTS,6.002600776378561,0.014597686226659556,Renal Cell Carcinoma,zalcitabine,nucleoside reverse transcriptase inhibitor,
Renal Cell Carcinoma,BRD-K86003836-001-10-5::2.5::HTS,5.476126214247241,0.019629437728124064,Renal Cell Carcinoma,flubendazole,tubulin polymerization inhibitor,TUBB
Renal Cell Carcinoma,BRD-K86109159-001-02-6::2.5::HTS,12.019246184272488,0.0005668003663967108,Other Types,VU0357121,glutamate receptor positive allosteric modulator,GRM5
Renal Cell Carcinoma,BRD-K86161929-001-13-3::2.5::HTS,4.814689825971655,0.028630386724238857,Other Types,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-K86436199-003-01-3::2.5::HTS,7.653759339110594,0.005855283150836148,Other Types,landiolol,adrenergic receptor antagonist,ADRB1
Renal Cell Carcinoma,BRD-K86600316-003-02-0::2.5::HTS,4.015292901483022,0.0455714351570135,Other Types,RS-79948,adrenergic receptor antagonist,ADRA2A
Renal Cell Carcinoma,BRD-K86727142-001-12-4::2.5::HTS,8.23663349492725,0.004261805610523308,Renal Cell Carcinoma,embelin,"HCV inhibitor, XIAP inhibitor",XIAP
Renal Cell Carcinoma,BRD-K86797399-001-05-1::2.55::HTS,7.2076840987980395,0.007487362914082325,Other Types,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Renal Cell Carcinoma,BRD-K86930074-001-05-0::2.5::HTS,6.756976738137454,0.009590772553310426,Other Types,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Renal Cell Carcinoma,BRD-K87048468-003-02-7::2.5::HTS,9.97934833033961,0.0016695339522984252,Other Types,RS-102221,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Renal Cell Carcinoma,BRD-K87510569-001-02-8::2.5::HTS,5.328813880054459,0.021340321320689207,Other Types,RS-504393,CC chemokine receptor antagonist,"CCL2, CCR2"
Renal Cell Carcinoma,BRD-K87535339-001-01-6::2.53::HTS,6.317192295883306,0.012241950209778484,Other Types,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,
Renal Cell Carcinoma,BRD-K88308881-001-06-8::2.5::HTS,9.176528434107134,0.0025650523663182747,Other Types,ethenzamide,analgesic agent,
Renal Cell Carcinoma,BRD-K88358234-003-04-8::2.5::HTS,5.061068272846057,0.02485739407006517,Other Types,xaliproden,serotonin receptor agonist,HTR1A
Renal Cell Carcinoma,BRD-K88568253-011-19-9::2.5::HTS,12.911494464377801,0.0003560968228398857,Renal Cell Carcinoma,iproniazid,monoamine oxidase inhibitor,"MAOA, MAOB"
Renal Cell Carcinoma,BRD-K88611939-001-22-4::2.5::HTS,4.273468042526576,0.039171553621677055,Other Types,aniracetam,glutamate receptor agonist,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A"
Renal Cell Carcinoma,BRD-K88625236-001-04-2::2.5::HTS,8.590484184998264,0.00351766015346499,Renal Cell Carcinoma,nonoxynol-9,membrane integrity inhibitor,
Renal Cell Carcinoma,BRD-K88677950-001-03-9::2.5::HTS,4.08647691862873,0.04370450310009994,Renal Cell Carcinoma,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Renal Cell Carcinoma,BRD-K88682005-001-15-8::2.5::HTS,6.769911892528013,0.009519617854348982,Other Types,chlorothiazide,diuretic,"CA1, CA2, CA4, SLC12A3"
Renal Cell Carcinoma,BRD-K88807631-001-01-3::2.5::HTS,5.273971645396322,0.02201684174844882,Other Types,elacridar,P glycoprotein inhibitor,ABCB1
Renal Cell Carcinoma,BRD-K89015388-001-01-7::2.5::HTS,13.909943784407465,0.00021141675539994366,Renal Cell Carcinoma,GSK923295,centromere associated protein inhibitor,CENPE
Renal Cell Carcinoma,BRD-K89272762-001-12-7::2.5::HTS,5.187659300072331,0.02312255932120922,Other Types,NPPB,chloride channel blocker,"ANO1, CLCN2, CLCN7, TRPA1"
Renal Cell Carcinoma,BRD-K89714990-001-01-5::2.5::HTS,23.14116023842995,1.9396232505515102e-06,Other Types,tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5
Renal Cell Carcinoma,BRD-K90195324-003-02-5::2.5::HTS,4.7401286368716,0.029884447044682634,Other Types,bazedoxifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2"
Renal Cell Carcinoma,BRD-K90382497-001-10-7::2.5::HTS,8.153177349842837,0.004460278233740604,Renal Cell Carcinoma,GW-843682X,PLK inhibitor,"PLK1, PLK3"
Renal Cell Carcinoma,BRD-K90497590-001-04-2::2.5::HTS,19.135165292205883,1.4553325132942826e-05,Renal Cell Carcinoma,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1
Renal Cell Carcinoma,BRD-K91159026-001-01-7::2.5::HTS,6.928436031499697,0.00871801539137434,Other Types,telcagepant,calcitonin antagonist,"CALCRL, RAMP1"
Renal Cell Carcinoma,BRD-K91701654-001-03-1::2.38::HTS,5.138551698043282,0.02380379217295591,Renal Cell Carcinoma,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Renal Cell Carcinoma,BRD-K91825936-001-01-2::2.5::HTS,9.658908038736714,0.0019801349978777675,Renal Cell Carcinoma,ZK811752,CC chemokine receptor antagonist,CCR1
Renal Cell Carcinoma,BRD-K92073408-001-16-5::2.5::HTS,5.937301896112586,0.015134166161032966,Other Types,norethindrone,progesterone receptor agonist,PGR
Renal Cell Carcinoma,BRD-K92241597-001-06-0::2.5::HTS,12.496346708749009,0.00044134795462332605,Renal Cell Carcinoma,tosedostat,peptidase inhibitor,"ANPEP, LAP3, NPEPPS"
Renal Cell Carcinoma,BRD-K92844263-001-09-8::2.5::HTS,9.509347840895318,0.002145568871781967,Other Types,triacetin,,
Renal Cell Carcinoma,BRD-K92848252-001-01-9::2.5::HTS,6.5096946480892734,0.010993430355822452,Other Types,diminazene-aceturate,angiotensin converting enzyme activator,"AOC1, PRDX5, PRSS1"
Renal Cell Carcinoma,BRD-K92984783-003-05-7::2.5::HTS,6.056530372030659,0.01415553603767946,Other Types,melperone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Renal Cell Carcinoma,BRD-K93231391-300-05-6::2.5::HTS,4.852860247146895,0.02800541670942999,Other Types,ethambutol,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K93255255-001-02-1::2.5::HTS,6.242204718875463,0.012761687711820372,Other Types,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Renal Cell Carcinoma,BRD-K93468883-001-02-0::2.5::HTS,7.61524804443886,0.005976428423119921,Other Types,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Renal Cell Carcinoma,BRD-K93880783-001-26-6::2.5::HTS,6.162695590089873,0.013340710077917362,Other Types,stavudine,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor",
Renal Cell Carcinoma,BRD-K94144010-001-13-9::2.5::HTS,4.3322245867292954,0.03785347053563522,Other Types,cotinine,nicotine metabolite,
Renal Cell Carcinoma,BRD-K94239562-001-05-5::2.5::HTS,3.9929846558440145,0.046178355087647505,Other Types,paeonol,anti-inflammatory agent,
Renal Cell Carcinoma,BRD-K94288301-001-01-7::2.5::HTS,7.398689050070786,0.006729139642149662,Other Types,letermovir,CMV terminase inhibitor,
Renal Cell Carcinoma,BRD-K94455792-001-01-8::2.5::HTS,24.521279870185285,9.752622324401433e-07,Renal Cell Carcinoma,ICG-001,beta-catenin inhibitor,CTNNB1
Renal Cell Carcinoma,BRD-K94830329-001-03-0::2.5::HTS,5.074696910117072,0.024663825432304717,Other Types,ataluren,"CFTR channel agonist, dystrophin stimulant",DMD
Renal Cell Carcinoma,BRD-K95142244-001-01-5::2.5::HTS,11.74883793574436,0.0006535417005860637,Renal Cell Carcinoma,talazoparib,PARP inhibitor,PARP2
Renal Cell Carcinoma,BRD-K95161686-001-02-8::2.5::HTS,3.90378333000681,0.04867059100150226,Other Types,octisalate,,
Renal Cell Carcinoma,BRD-K95435023-001-10-1::2.5::HTS,5.444229841458531,0.019989973210960507,Other Types,PHA-665752,c-Met inhibitor,MET
Renal Cell Carcinoma,BRD-K95573441-001-01-2::2.5::HTS,5.266136943914947,0.02211386411809892,Renal Cell Carcinoma,PFK-015,phosphofructokinase inhibitor,PFKFB3
Renal Cell Carcinoma,BRD-K95609758-001-03-7::2.5::HTS,13.48013824725261,0.00026427872401785257,Other Types,BMS-191011,potassium channel activator,KCNMA1
Renal Cell Carcinoma,BRD-K95785345-300-14-8::2.5::HTS,6.094760489790655,0.013854703827477402,Other Types,thiamine,vitamin B,"SLC19A2, SLC19A3, TPK1"
Renal Cell Carcinoma,BRD-K95901403-001-04-5::2.5::HTS,7.123339424011122,0.007829325671438802,Other Types,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Renal Cell Carcinoma,BRD-K95926480-003-03-6::2.5::HTS,10.067339062672092,0.0015928674774309264,Other Types,SRT1720,SIRT activator,SIRT1
Renal Cell Carcinoma,BRD-K96123349-236-02-8::2.5::HTS,17.757408995732995,2.923173380212786e-05,Renal Cell Carcinoma,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH
Renal Cell Carcinoma,BRD-K96153583-001-05-1::2.52::HTS,5.343703460808717,0.02118273834405278,Renal Cell Carcinoma,cidofovir,DNA polymerase inhibitor,
Renal Cell Carcinoma,BRD-K96259238-001-01-4::2.5::HTS,3.8615647583823405,0.04989900135319638,Other Types,Y-320,interleukin inhibitor,IL17A
Renal Cell Carcinoma,BRD-K96358241-001-01-9::0.94::HTS,7.976841458034673,0.004907635077837123,Renal Cell Carcinoma,harringtonine,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-K96631475-001-02-4::2.43::HTS,24.11262793705498,1.213294465097962e-06,Renal Cell Carcinoma,10-deacetylbaccatin,antitumor agent,
Renal Cell Carcinoma,BRD-K96631475-001-04-0::2.5::HTS,12.613234272910434,0.0004156351268449784,Renal Cell Carcinoma,10-deacetylbaccatin,antitumor agent,
Renal Cell Carcinoma,BRD-K97072811-001-11-4::2.5::HTS,15.422667048857452,9.66943944940007e-05,Other Types,TG-003,CLK inhibitor,"CLK1, CLK4, DYRK1A, DYRK1B"
Renal Cell Carcinoma,BRD-K97399794-001-15-3::2.5::HTS,5.078064878840691,0.02461640212839098,Other Types,quercetin,polar auxin transport inhibitor,"ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1"
Renal Cell Carcinoma,BRD-K97417064-001-02-4::2.5::HTS,5.122988391539399,0.023994218315568926,Other Types,acedapsone,,
Renal Cell Carcinoma,BRD-K97440753-066-18-1::2.5::HTS,5.368631662880522,0.020860569754152854,Renal Cell Carcinoma,dihydroergocristine,"adrenergic receptor antagonist, prolactin inhibitor","ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
Renal Cell Carcinoma,BRD-K97564742-050-32-7::2.5::HTS,3.871448906296301,0.04960543253041749,Other Types,mepyramine,histamine receptor antagonist,HRH1
Renal Cell Carcinoma,BRD-K97764662-001-17-3::2.5::HTS,5.26759921404676,0.02209881686800275,Other Types,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Renal Cell Carcinoma,BRD-K97963946-001-01-3::2.5::HTS,7.117592089730672,0.007853350852688026,Other Types,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET
Renal Cell Carcinoma,BRD-K98548675-001-05-9::2.5::HTS,10.845601062609024,0.001052564674511823,Renal Cell Carcinoma,parthenolide,NFkB pathway inhibitor,
Renal Cell Carcinoma,BRD-K99121711-003-19-7::2.5::HTS,6.903113400850384,0.00883952238276507,Other Types,cinchocaine,sodium channel blocker,"CALM1, SCN10A, SCN5A"
Renal Cell Carcinoma,BRD-K99170882-001-04-3::2.5::HTS,8.258488386932873,0.004210711914494775,Other Types,NSC-319726,p53 activator,
Renal Cell Carcinoma,BRD-K99504665-001-01-2::2.5::HTS,8.678375187976624,0.0033535131172862916,Other Types,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,"GNRHR, LHCGR"
Renal Cell Carcinoma,BRD-K99545815-001-06-3::2.5::HTS,3.9728742514849773,0.04672179311556132,Renal Cell Carcinoma,PF-562271,focal adhesion kinase inhibitor,"PTK2, PTK2B"
Renal Cell Carcinoma,BRD-K99604664-001-01-1::2.5::HTS,7.200854326809745,0.007501597998778407,Renal Cell Carcinoma,tanaproget,progesterone receptor agonist,PGR
Renal Cell Carcinoma,BRD-K99749624-001-07-0::2.5::HTS,6.792115828403084,0.00940026886438543,Other Types,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Renal Cell Carcinoma,BRD-K99964838-001-11-9::2.5::HTS,6.996213012631011,0.008397530021253246,Other Types,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Renal Cell Carcinoma,BRD-M30288325-001-01-4::2.5::HTS,5.986990243713721,0.014718647318770874,Other Types,G-15,estrogen receptor antagonist,GPER1
Renal Cell Carcinoma,BRD-M97302542-001-03-6::2.5::HTS,6.472617508643449,0.01123867098529799,Renal Cell Carcinoma,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1
Renal Cell Carcinoma,BRD-A02232681-001-01-8::2.5::MTS004,6.720044667467094,0.009792207046214375,Other Types,isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2"
Renal Cell Carcinoma,BRD-A09911125-001-01-4::2.5::MTS004,4.462311478393907,0.03511072787169222,Other Types,prolylleucylglycinamide,melanocyte-stimulating hormone release inhibitor,
Renal Cell Carcinoma,BRD-A10188456-001-04-9::2.5::MTS004,10.543118939114086,0.001238730860801549,Other Types,dexamethasone,glucocorticoid receptor agonist,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2"
Renal Cell Carcinoma,BRD-A16263897-001-06-6::2.5::MTS004,18.765527137944,1.7633536796625517e-05,Other Types,misonidazole,,
Renal Cell Carcinoma,BRD-A18992208-003-02-7::2.5::MTS004,9.701783410525113,0.001938791961026226,Other Types,lercanidipine,calcium channel blocker,"CACNA2D1, CACNG1"
Renal Cell Carcinoma,BRD-A21280314-001-06-8::2.5::MTS004,10.795207215054962,0.0010838025225749605,Other Types,nifenalol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Renal Cell Carcinoma,BRD-A25492003-003-14-1::2.568211596::MTS004,5.522002809026327,0.019139141336477268,Other Types,chlortetracycline,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-A27274504-001-01-6::2.400106631::MTS004,6.229441571617018,0.012862084275363325,Other Types,butofilolol,adrenergic receptor antagonist,
Renal Cell Carcinoma,BRD-A33479817-003-03-7::2.490825408::MTS004,9.528549553120717,0.0021270204009814866,Other Types,terodiline,cholinergic receptor antagonist,
Renal Cell Carcinoma,BRD-A34603619-001-01-9::2.427905848::MTS004,6.146027651975688,0.013475494127298236,Other Types,tropesin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-A35667010-001-01-8::2.5::MTS004,6.241653290690447,0.012774728467552093,Other Types,propylhexedrine,adrenergic receptor agonist,"SLC18A2, TAAR1"
Renal Cell Carcinoma,BRD-A42423104-001-01-4::2.495664958::MTS004,11.906085988956523,0.0006034398618993857,Other Types,benproperine,antitussive,SCN5A
Renal Cell Carcinoma,BRD-A44971162-001-02-7::2.5::MTS004,5.068002085629602,0.02477423410660356,Other Types,ODM-201,androgen receptor antagonist,AR
Renal Cell Carcinoma,BRD-A48420483-001-02-3::2.5::MTS004,4.2770547244353345,0.03910668980204436,Other Types,bupranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Renal Cell Carcinoma,BRD-A56241705-003-01-2::2.639158457::MTS004,9.042377718715468,0.0027611946868155357,Other Types,trimethoquinol,adrenergic receptor antagonist,"ADRB2, ADRB3"
Renal Cell Carcinoma,BRD-A58947127-001-01-6::2.5::MTS004,7.3321202737194895,0.006988783757626606,Other Types,AMG319,PI3K inhibitor,PIK3CD
Renal Cell Carcinoma,BRD-A59825838-326-01-4::2.499983757::MTS004,5.839379626588604,0.01600254242682622,Other Types,netilmicin,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-A63431791-001-01-9::2.5::MTS004,8.804114241832963,0.003138937256755053,Other Types,sulbactam-pivoxil,beta lactamase inhibitor,
Renal Cell Carcinoma,BRD-A71765060-001-01-4::2.5::MTS004,13.850551458274081,0.00021872969487949205,Other Types,picartamide,H+/K+-ATPase inhibitor,ATP4A
Renal Cell Carcinoma,BRD-A72988804-001-11-1::2.5::MTS004,7.104276842124421,0.007920649284191882,Other Types,tiaprofenic-acid,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-A73385064-001-01-5::2.603473418::MTS004,16.735867805169438,4.95288724728114e-05,Other Types,beclomethasone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Renal Cell Carcinoma,BRD-A73566563-001-01-6::2.5::MTS004,4.724227915658633,0.030175141224015975,Other Types,tiprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Renal Cell Carcinoma,BRD-A78277353-001-01-9::2.492599937::MTS004,5.657028073430122,0.017733014652968643,Other Types,metazosin,adrenergic receptor antagonist,ADRA1A
Renal Cell Carcinoma,BRD-A79052425-003-01-5::2.5::MTS004,5.302132535423236,0.02167937272707274,Other Types,SIB-1553A,acetylcholine receptor agonist,CHRNB4
Renal Cell Carcinoma,BRD-A89082344-001-08-7::2.500026693::MTS004,9.216403120175496,0.0025146905421278287,Other Types,perifosine,AKT inhibitor,AKT1
Renal Cell Carcinoma,BRD-A92177080-001-02-1::2.5::MTS004,9.076361169947116,0.0027109659335544703,Other Types,betamethasone-acetate,glucocorticoid receptor agonist,NR3C1
Renal Cell Carcinoma,BRD-A99899486-004-01-9::2.293696319::MTS004,9.33774748964044,0.002355965867717644,Other Types,cimetropium,acetylcholine receptor antagonist,CHRM1
Renal Cell Carcinoma,BRD-K00634421-001-01-0::2.500042819::MTS004,17.217526854481758,3.874170256334165e-05,Renal Cell Carcinoma,brivaracetam,voltage-gated sodium channel blocker,SV2A
Renal Cell Carcinoma,BRD-K01291782-001-01-1::2.50002964::MTS004,12.560241855219545,0.0004283334017035549,Other Types,molidustat,hypoxia inducible factor inhibitor,EGLN2
Renal Cell Carcinoma,BRD-K01638814-011-01-4::2.587084236::MTS004,3.9649740881983484,0.04696149796542269,Other Types,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A
Renal Cell Carcinoma,BRD-K01666412-001-02-0::2.5::MTS004,10.0220527925506,0.0016341913062632937,Other Types,L-proline,glutamate receptor agonist,"EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7"
Renal Cell Carcinoma,BRD-K02275692-300-02-6::2.499989889::MTS004,12.488773444639586,0.00044457736347988013,Other Types,cefotiam,bacterial cell wall synthesis inhibitor,
Renal Cell Carcinoma,BRD-K02528732-001-02-4::2.425128585::MTS004,5.848145012969038,0.01592451494019802,Other Types,fluorometholone-acetate,,NR3C1
Renal Cell Carcinoma,BRD-K02750403-001-01-4::2.499962046::MTS004,5.49149770610217,0.019472360896534237,Other Types,piboserod,serotonin receptor antagonist,"HTR2B, HTR4"
Renal Cell Carcinoma,BRD-K04603573-376-01-3::2.542651982::MTS004,3.86424967479095,0.049839113146267086,Other Types,"1,12-Besm",polyamine biosynthesis inhibitor,
Renal Cell Carcinoma,BRD-K04710043-001-17-8::2.5::MTS004,5.411594376699362,0.020373315668363538,Other Types,hexamethylenebisacetamide,"AKT inhibitor, differentiation inducer, NFKB pathway inhibitor",AKT1
Renal Cell Carcinoma,BRD-K06388517-001-01-2::2.5::MTS004,5.867461892656158,0.015751992984798995,Other Types,lofemizole,cyclooxygenase inhibitor,
Renal Cell Carcinoma,BRD-K06455935-001-01-3::2.499992329::MTS004,31.838598559159546,2.7118245753738744e-08,Other Types,daprodustat,hypoxia inducible factor inhibitor,EGLN1
Renal Cell Carcinoma,BRD-K07785030-001-01-6::2.29884119::MTS004,13.124874673843575,0.0003189617587904631,Other Types,7-keto-DHEA,steroid,
Renal Cell Carcinoma,BRD-K08255599-365-01-1::2.656154742::MTS004,5.365068599449269,0.02091886427387846,Other Types,frovatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D"
Renal Cell Carcinoma,BRD-K09821361-066-25-8::2.499990088::MTS004,8.761208306359737,0.003212414664103601,Other Types,deferoxamine-mesylate,chelating agent,
Renal Cell Carcinoma,BRD-K10995081-001-27-9::2.316458322::MTS004,6.787069565460382,0.009435676203493826,Other Types,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Renal Cell Carcinoma,BRD-K11452913-001-01-9::2.5000112::MTS004,5.1360795158753705,0.02382911571093476,Other Types,evatanepag,prostaglandin inhibitor,"PTGER2, PTGER4"
Renal Cell Carcinoma,BRD-K11851476-003-01-7::2.499993171::MTS004,13.506624638393737,0.0002614963821759993,Renal Cell Carcinoma,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Renal Cell Carcinoma,BRD-K12852738-001-01-2::2.584725941::MTS004,9.329265217932532,0.0023667075808786573,Other Types,veliflapon,leukotriene synthesis inhibitor,ALOX5AP
Renal Cell Carcinoma,BRD-K12906202-001-06-2::2.5::MTS004,4.269490037106263,0.03927972509956122,Other Types,carbendazim,"microtubule inhibitor, tubulin polymerization inhibitor","TP53, TUBB"
Renal Cell Carcinoma,BRD-K13060017-001-02-1::2.499994836::MTS004,4.2099847201443925,0.04066927561029924,Renal Cell Carcinoma,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Renal Cell Carcinoma,BRD-K13414800-001-01-3::2.499970601::MTS004,10.406806309548216,0.0013316915722454941,Other Types,vesnarinone,phosphodiesterase inhibitor,"KCNH2, PDE3A"
Renal Cell Carcinoma,BRD-K13664493-316-02-5::2.500014041::MTS004,4.913550458382755,0.02706424072163527,Other Types,naphthoquine-phosphate,antimalarial agent,
Renal Cell Carcinoma,BRD-K14571191-001-01-6::2.5::MTS004,11.972932937519243,0.0005825484936317654,Other Types,zometapine,,
Renal Cell Carcinoma,BRD-K15327298-001-05-5::2.444207768::MTS004,5.189397102565001,0.02311861763954684,Other Types,fmoc-l-leucine,PPAR receptor agonist,
Renal Cell Carcinoma,BRD-K16505263-003-02-9::2.49996754::MTS004,19.9117364584619,9.878948728025971e-06,Other Types,forodesine,purinergic receptor antagonist,PNP
Renal Cell Carcinoma,BRD-K18749874-003-08-9::2.5::MTS004,8.266833196231321,0.004197171611583817,Other Types,melevodopa,"dopamine precursor, dopamine receptor agonist",DDC
Renal Cell Carcinoma,BRD-K18898553-001-01-1::2.5::MTS004,10.150095766087022,0.001526459831847568,Other Types,salvianolic-acid-B,"metalloproteinase inhibitor, EGFR inhibitor",MMP9
Renal Cell Carcinoma,BRD-K20093108-001-02-3::2.5::MTS004,8.975942678196704,0.0028614349656695412,Other Types,BMS-587101,integrin antagonist,"ITGAL, ITGB2"
Renal Cell Carcinoma,BRD-K21077415-001-01-5::2.656085278::MTS004,7.4807390452463745,0.006441606723381232,Other Types,AMG-319,PI3K inhibitor,PIK3CD
Renal Cell Carcinoma,BRD-K21191422-001-01-5::2.499985534::MTS004,3.872213078794074,0.04960494645446246,Other Types,selexipag,"platelet aggregation inhibitor, IP1 prostacyclin receptor agonist",PTGIR
Renal Cell Carcinoma,BRD-K22149900-001-03-9::2.371298578::MTS004,3.873174015222449,0.04957581602350505,Other Types,ceritinib,ALK tyrosine kinase receptor inhibitor,"ALK, FLT3, IGF1R, INSR, TSSK1B"
Renal Cell Carcinoma,BRD-K22525962-001-05-0::2.500010949::MTS004,4.029012101815033,0.04522286754204224,Other Types,dihydrotestosterone,androgen receptor agonist,"AR, HSD17B1"
Renal Cell Carcinoma,BRD-K23791635-001-01-3::2.499966688::MTS004,6.124469118075386,0.0136394580063386,Other Types,AFN-1252,FABI inhibitor,
Renal Cell Carcinoma,BRD-K24452555-001-01-7::2.599377769::MTS004,7.1437615192414246,0.007750392044589997,Other Types,methylprednisolone-aceponate,"anti-inflammatory agent, glucocorticoid receptor agonist",NR3C1
Renal Cell Carcinoma,BRD-K24864897-001-01-0::2.5::MTS004,9.036137606751156,0.002770245404149326,Other Types,JNJ-26990990,anticonvulsant,
Renal Cell Carcinoma,BRD-K25243230-001-01-2::2.5::MTS004,5.987911039804848,0.014722478113960609,Other Types,oxytocin,oxytocin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Renal Cell Carcinoma,BRD-K25970317-001-01-6::2.50000335::MTS004,4.059611683907937,0.044417571806807735,Other Types,resibufogenin,Na/K-ATPase inhibitor,
Renal Cell Carcinoma,BRD-K26818574-305-07-6::2.5::MTS004,5.271154651923599,0.022064558737046283,Other Types,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Renal Cell Carcinoma,BRD-K27061362-001-01-6::2.499998598::MTS004,4.038539937967149,0.04497111629326973,Other Types,AMG-337,MET inhibitor,MET
Renal Cell Carcinoma,BRD-K27625831-001-02-9::2.499990597::MTS004,4.448403125074955,0.03539449267557066,Other Types,pleconaril,,
Renal Cell Carcinoma,BRD-K27885593-001-06-8::2.500027849::MTS004,5.216384445366759,0.022763083846871774,Other Types,corosolic-acid,"PKC inhibitor, protein tyrosine kinase inhibitor","HSD11B1, PTPN1"
Renal Cell Carcinoma,BRD-K28061410-001-06-6::2.5::MTS004,4.0563176699558365,0.044502703887533544,Renal Cell Carcinoma,beta-lapachone,topoisomerase inhibitor,TOP1
Renal Cell Carcinoma,BRD-K29570907-001-07-3::2.420672872::MTS004,5.63816634562648,0.017923387602098856,Other Types,sulmetozine,gastrin inhibitor,GAST
Renal Cell Carcinoma,BRD-K29626940-001-01-5::2.682001852::MTS004,5.498244964180934,0.019398143354939442,Other Types,imidafenacin,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Renal Cell Carcinoma,BRD-K30764557-001-01-5::2.5::MTS004,6.75819958415985,0.00958758182021152,Other Types,miocamycin,other antibiotic,
Renal Cell Carcinoma,BRD-K32256160-001-01-9::2.499998021::MTS004,4.885061736322675,0.027510199872122183,Other Types,solithromycin,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-K32804101-001-01-8::2.5::MTS004,7.506884105955354,0.006350047850220332,Other Types,valrocemide,,
Renal Cell Carcinoma,BRD-K32891457-001-15-5::2.719791572::MTS004,4.366810742885174,0.03711370223256852,Other Types,cortodoxone,androgen receptor antagonist,AR
Renal Cell Carcinoma,BRD-K33131085-001-07-2::2.644499841::MTS004,5.044726018734391,0.025105993378440106,Other Types,gentiopicrin,glutamate receptor downregulator,GRIN2B
Renal Cell Carcinoma,BRD-K33245965-001-03-4::2.50001558::MTS004,4.44728917368042,0.03541825049756014,Other Types,BMS-833923,smoothened receptor antagonist,SMO
Renal Cell Carcinoma,BRD-K33637378-001-01-7::2.500021224::MTS004,8.547284986735017,0.003606085783804019,Other Types,flibanserin,serotonin receptor agonist,"DRD4, HTR1A, HTR2A"
Renal Cell Carcinoma,BRD-K34251960-036-01-6::2.459743274::MTS004,6.362417421919632,0.011943076960102564,Other Types,cibenzoline,sodium channel blocker,
Renal Cell Carcinoma,BRD-K34277641-001-01-2::2.569027627::MTS004,6.07218727382725,0.014043674529577723,Other Types,L-365260,CCK receptor antagonist,"CCKAR, CCKBR, KCNQ1"
Renal Cell Carcinoma,BRD-K34445261-001-02-2::2.334266471::MTS004,9.271732597167269,0.002440893494473479,Other Types,SLV-320,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Renal Cell Carcinoma,BRD-K34508702-001-02-4::2.499975465::MTS004,6.89309114957907,0.008898715079469103,Other Types,CHF5074,gamma secretase modulator,PSEN1
Renal Cell Carcinoma,BRD-K35304636-001-01-0::2.5::MTS004,13.585874983269983,0.0002509460283086855,Other Types,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Renal Cell Carcinoma,BRD-K36524108-065-04-0::2.500001799::MTS004,8.034874801965042,0.004760653101300514,Other Types,paromomycin,bacterial 30S ribosomal subunit inhibitor,
Renal Cell Carcinoma,BRD-K38398115-001-01-9::2.418470509::MTS004,7.628543571298165,0.005941576023403268,Other Types,YM-511,aromatase inhibitor,CYP19A1
Renal Cell Carcinoma,BRD-K39560679-001-01-1::2.500010466::MTS004,4.283374143596166,0.03896275363737626,Other Types,eluxadoline,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Renal Cell Carcinoma,BRD-K41267922-001-01-4::2.5::MTS004,8.704014440740226,0.0033130960579577616,Other Types,F351,TGF beta receptor inhibitor,TGFB1
Renal Cell Carcinoma,BRD-K41592905-001-01-6::2.5::MTS004,9.28408441101595,0.002424769228039078,Other Types,7-methylxanthine,adenosine receptor antagonist,
Renal Cell Carcinoma,BRD-K41662846-003-01-5::2.517380705::MTS004,4.33042012742115,0.03790943184176125,Other Types,tecalcet,calcium-sensing receptor agonist,CASR
Renal Cell Carcinoma,BRD-K42066335-001-01-0::2.499995517::MTS004,3.9020409154478997,0.04873720606926474,Other Types,lorediplon,GABA receptor modulator,GABRA1
Renal Cell Carcinoma,BRD-K42140276-402-01-4::2.500009363::MTS004,5.247403097986439,0.022364703387527933,Other Types,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
Renal Cell Carcinoma,BRD-K42504537-001-01-6::2.500037177::MTS004,9.96939516591336,0.001680709700754599,Other Types,norelgestromin,,PGR
Renal Cell Carcinoma,BRD-K43316319-001-01-8::2.356803189::MTS004,6.941581803695901,0.00866368757255591,Other Types,MK-2295,TRPV antagonist,TRPV1
Renal Cell Carcinoma,BRD-K43837174-003-01-3::2.479237222::MTS004,5.6798309450516244,0.017506424033560165,Other Types,pruvanserin,serotonin receptor antagonist,"HTR2A, HTR2C"
Renal Cell Carcinoma,BRD-K43890836-001-01-6::2.5::MTS004,16.03871828023605,7.077174852129584e-05,Other Types,gemcadiol,antilipemic,
Renal Cell Carcinoma,BRD-K43975632-001-01-1::2.499995729::MTS004,12.805184207678495,0.00037682705336034066,Other Types,terutroban,prostanoid receptor antagonist,TBXA2R
Renal Cell Carcinoma,BRD-K44164034-003-01-1::2.54181785::MTS004,9.329927122368636,0.00236607746020343,Other Types,pumosetrag,serotonin receptor agonist,"HTR3A, HTR4"
Renal Cell Carcinoma,BRD-K46862739-001-14-3::2.499952208::MTS004,4.143781663525746,0.04227717905167671,Other Types,metyrapone,cytochrome P450 inhibitor,CYP11B1
Renal Cell Carcinoma,BRD-K47492008-001-02-7::2.5::MTS004,4.086551782502505,0.04371940688780456,Other Types,alclofenac,cyclooxygenase inhibitor,PTGS1
Renal Cell Carcinoma,BRD-K48429278-001-01-3::2.5::MTS004,8.156938948363386,0.004455104488854575,Other Types,pipotiazine-palmitate,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, DRD2, HTR1A, HTR2A"
Renal Cell Carcinoma,BRD-K50055394-001-03-6::2.701086832::MTS004,7.008353313278923,0.008350442186679024,Other Types,halopemide,phospholipase inhibitor,"PLD1, PLD2"
Renal Cell Carcinoma,BRD-K50122911-001-01-2::2.5::MTS004,9.066542432714865,0.0027253160080131095,Other Types,boronophenylalanine,,
Renal Cell Carcinoma,BRD-K50660797-001-05-1::2.499989832::MTS004,5.4977740808371145,0.019402638590774627,Other Types,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,"BACE1, FASN"
Renal Cell Carcinoma,BRD-K52914072-001-01-5::2.5::MTS004,5.008798059082041,0.025626436294676865,Other Types,LTA,,
Renal Cell Carcinoma,BRD-K53156626-001-01-3::2.5::MTS004,4.821044838915241,0.028539725295999442,Other Types,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE
Renal Cell Carcinoma,BRD-K53195974-001-01-9::2.298572309::MTS004,10.178730420991,0.0015035280103270416,Other Types,sipatrigine,voltage-gated sodium channel blocker,"CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A"
Renal Cell Carcinoma,BRD-K53809807-304-02-4::2.7277447::MTS004,6.040156904575521,0.014297774047960735,Other Types,fosphenytoin,sodium channel blocker,SCN5A
Renal Cell Carcinoma,BRD-K54519451-001-02-9::2.499971332::MTS004,12.614098631032808,0.00041637909978196403,Other Types,pexidartinib,tyrosine kinase inhibitor,"CSF1R, FLT3, KIT"
Renal Cell Carcinoma,BRD-K54863166-001-01-9::2.693644572::MTS004,7.562701307482863,0.006159011528692379,Other Types,darusentan,endothelin receptor antagonist,EDNRA
Renal Cell Carcinoma,BRD-K55029398-001-01-6::2.499962393::MTS004,5.306952636376329,0.021620776910693883,Other Types,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2
Renal Cell Carcinoma,BRD-K55172746-001-01-3::2.5::MTS004,11.98237779079234,0.0005796677233992739,Other Types,apricitabine,nucleoside reverse transcriptase inhibitor,
Renal Cell Carcinoma,BRD-K56211775-001-03-8::2.5::MTS004,8.584872015744931,0.003533561125838599,Other Types,RTA-408,nitric oxide production inhibitor,NFE2L2
Renal Cell Carcinoma,BRD-K56912469-003-02-0::2.499992214::MTS004,17.26833876358649,3.7740443832073525e-05,Other Types,SAR407899,rho associated kinase inhibitor,ROCK1
Renal Cell Carcinoma,BRD-K57155378-001-01-1::2.499996307::MTS004,6.54976360895423,0.010761650121765356,Other Types,TAK-063,phosphodiesterase inhibitor,PDE10A
Renal Cell Carcinoma,BRD-K57427145-001-01-6::2.5::MTS004,4.11525242176487,0.04298929109098378,Other Types,ripazepam,benzodiazepine receptor agonist,GABRA1
Renal Cell Carcinoma,BRD-K57774929-001-01-3::2.643351543::MTS004,9.873624325754573,0.001768794744300584,Other Types,foropafant,platelet activating factor receptor antagonist,PTAFR
Renal Cell Carcinoma,BRD-K58529924-001-01-5::2.648577938::MTS004,4.370089951559743,0.03704294225095114,Renal Cell Carcinoma,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Renal Cell Carcinoma,BRD-K58810291-001-16-2::2.564588683::MTS004,4.284022197044638,0.0389480245879858,Other Types,clobetasone-butyrate,corticosteroid agonist,NR3C1
Renal Cell Carcinoma,BRD-K59866480-001-07-3::2.379655165::MTS004,4.177353319426495,0.04145316155271048,Renal Cell Carcinoma,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Renal Cell Carcinoma,BRD-K60284353-001-01-3::2.5::MTS004,11.385445241784899,0.000793474689015845,Other Types,titanocene-dichloride,apoptosis stimulant,
Renal Cell Carcinoma,BRD-K60762818-003-26-0::2.467864576::MTS004,5.86175347234142,0.015803207149974765,Other Types,desipramine,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1"
Renal Cell Carcinoma,BRD-K60798049-001-03-8::2.665505334::MTS004,6.845185642851309,0.009137340766727745,Other Types,fanetizole,neutrophil superoxide production,
Renal Cell Carcinoma,BRD-K62040061-001-01-0::2.500015381::MTS004,7.99329823023119,0.004869875542981947,Other Types,toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB"
Renal Cell Carcinoma,BRD-K62490786-001-01-1::2.495325825::MTS004,4.658069123279706,0.031348803100035065,Other Types,ibrolipim,lipoprotein lipase activator,LPL
Renal Cell Carcinoma,BRD-K63018010-001-01-7::2.500011413::MTS004,8.147827339392776,0.0044772043119987665,Other Types,relebactam,beta lactamase inhibitor,
Renal Cell Carcinoma,BRD-K66845263-001-03-0::2.5::MTS004,9.432283701176992,0.0022395536106437166,Other Types,sophocarpine,,
Renal Cell Carcinoma,BRD-K68408772-001-05-4::2.420640995::MTS004,5.59562028056164,0.01835910622323708,Renal Cell Carcinoma,carboxyamidotriazole,calcium channel blocker,CXCL8
Renal Cell Carcinoma,BRD-K68764924-001-03-2::2.5::MTS004,11.580626276022995,0.0007159534813657957,Other Types,pantethine,coenzyme A precursor,
Renal Cell Carcinoma,BRD-K70504253-001-01-3::2.500017504::MTS004,4.833079929770793,0.028342998299984684,Other Types,fruquintinib,VEGFR inhibitor,KDR
Renal Cell Carcinoma,BRD-K70592963-001-31-6::2.5::MTS004,7.917889665007753,0.0050735971170750875,Other Types,phenindione,vitamin K antagonist,VKORC1
Renal Cell Carcinoma,BRD-K71977764-001-01-2::2.5::MTS004,5.854122959751867,0.015870493083144185,Other Types,piroximone,phosphodiesterase inhibitor,PDE3A
Renal Cell Carcinoma,BRD-K72259270-003-25-6::2.444857586::MTS004,4.627028739578098,0.031915827886114564,Other Types,dyclonine,sodium channel blocker,"SCN10A, SCN5A"
Renal Cell Carcinoma,BRD-K73451719-001-01-2::2.5::MTS004,6.11884702270901,0.013681830646333075,Other Types,terlipressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2"
Renal Cell Carcinoma,BRD-K73504359-001-01-3::2.5::MTS004,8.794723942704971,0.003154870528357505,Other Types,bivalirudin,thrombin inhibitor,F2
Renal Cell Carcinoma,BRD-K73753850-003-01-6::2.499957259::MTS004,11.961571382074524,0.0005860331032373702,Other Types,hexaminolevulinate,,
Renal Cell Carcinoma,BRD-K74759733-065-01-4::2.5::MTS004,4.177532631201073,0.04144881081729976,Other Types,isepamicin,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-K76927775-001-11-8::2.500019441::MTS004,6.950965404563563,0.008618947702669286,Other Types,nitrofurantoin,DNA inhibitor,
Renal Cell Carcinoma,BRD-K78666663-001-01-6::2.499978008::MTS004,5.43399653554951,0.020116928904291263,Other Types,lemborexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Renal Cell Carcinoma,BRD-K80419150-001-02-4::2.5::MTS004,7.443435964778839,0.006574587234228231,Other Types,debrisoquin,adrenergic neuron blocker,SLC6A2
Renal Cell Carcinoma,BRD-K80738081-001-46-8::2.500037854::MTS004,4.027323822601634,0.04526779678565962,Other Types,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Renal Cell Carcinoma,BRD-K83029223-001-01-3::2.500025378::MTS004,4.442326712343384,0.035520457308959835,Renal Cell Carcinoma,litronesib,kinesin-like spindle protein inhibitor,KIF11
Renal Cell Carcinoma,BRD-K83776863-001-08-9::2.5::MTS004,7.346446743009918,0.006933662833794952,Other Types,tryptophan,serotonin receptor partial agonist,"CASR, IDO1, SLC36A1, WARS, WARS2"
Renal Cell Carcinoma,BRD-K84036904-001-08-8::2.500018826::MTS004,6.4338153690050826,0.011477828116377617,Other Types,17-alpha-methyltestosterone,aromatase inhibitor,AR
Renal Cell Carcinoma,BRD-K84281997-003-08-4::2.500011105::MTS004,13.529305316188017,0.0002584771555910474,Other Types,pralidoxime,acetylcholinesterase inhibitor,"ACHE, BCHE"
Renal Cell Carcinoma,BRD-K84459715-001-01-6::2.403005639::MTS004,5.037377154336358,0.02521094251668694,Other Types,zopolrestat,,
Renal Cell Carcinoma,BRD-K84868168-001-01-0::2.500006364::MTS004,15.060933249470947,0.0001170138677608234,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Renal Cell Carcinoma,BRD-K84971356-001-01-4::2.632189712::MTS004,11.107724720481542,0.0009188122000090601,Other Types,etafenone,calcium channel blocker,
Renal Cell Carcinoma,BRD-K86410485-046-01-0::2.499987354::MTS004,5.983021931527904,0.014763477014141747,Other Types,eliglustat,Glycosyl transferase inhibitor,UGCG
Renal Cell Carcinoma,BRD-K87316765-001-01-4::2.499975056::MTS004,3.95485074480658,0.04724259925157794,Other Types,prinaberel,estrogen receptor agonist,"ESR2, NCOA1"
Renal Cell Carcinoma,BRD-K89121095-001-01-7::2.499999138::MTS004,8.39276475011846,0.003920268752854794,Renal Cell Carcinoma,tedizolid-phosphate,protein synthesis inhibitor,
Renal Cell Carcinoma,BRD-K91244729-003-01-3::2.316613157::MTS004,5.444489141673855,0.019996996564395877,Other Types,propiverine,acetylcholine receptor antagonist,CHRM1
Renal Cell Carcinoma,BRD-K91543828-001-02-0::2.500044381::MTS004,4.678863117836688,0.030974855911166072,Other Types,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Renal Cell Carcinoma,BRD-K92413528-001-06-9::2.5::MTS004,6.970421228557896,0.008526938937790768,Other Types,procysteine,glutathione synthase stimulant,
Renal Cell Carcinoma,BRD-K92426617-001-06-3::2.5::MTS004,9.35661131573401,0.002332254809349495,Other Types,esaprazole,,
Renal Cell Carcinoma,BRD-K92581468-001-01-6::2.389082227::MTS004,5.08590942024561,0.02452135945920404,Other Types,ocinaplon,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5"
Renal Cell Carcinoma,BRD-K92908289-001-01-8::2.501017998::MTS004,8.887111842093919,0.0030018704452618645,Other Types,medica-16,ATP citrase lyase inhibitor,FFAR1
Renal Cell Carcinoma,BRD-K93900986-001-15-0::2.613957824::MTS004,4.343568592955338,0.0376201934168069,Other Types,stetaderm,,
Renal Cell Carcinoma,BRD-K94146583-001-01-6::2.500085506::MTS004,7.028831233691889,0.008256722197515389,Other Types,didox,ribonucleotide reductase inhibitor,RRM1
Renal Cell Carcinoma,BRD-K96206066-001-07-9::2.591957442::MTS004,6.953353639540007,0.00860759880592972,Other Types,difenpiramide,"cyclooxygenase inhibitor, prostaglandin inhibitor",
Renal Cell Carcinoma,BRD-K96471533-001-09-0::2.592774962::MTS004,10.359482614864511,0.0013655964469498649,Other Types,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
Renal Cell Carcinoma,BRD-K97939847-001-12-0::2.5::MTS004,6.155632349583882,0.013403351877770435,Other Types,cridanimod,progesterone receptor agonist,PGR
Renal Cell Carcinoma,BRD-K98557884-001-01-6::2.5::MTS004,4.906580620575572,0.027171867032497354,Other Types,suritozole,GABA receptor inverse agonist,GABBR1
Renal Cell Carcinoma,BRD-K99447003-335-04-1::2.37737659::MTS004,3.9611639842099335,0.04706614856536896,Other Types,enalaprilat,angiotensin converting enzyme inhibitor,ACE
Esophagogastric Adenocarcinoma,BRD-A01098288-001-02-9::2.5::HTS,7.391354480295851,0.006762244405018653,Esophagogastric Adenocarcinoma,azelnidipine,calcium channel blocker,CACNA1C
Esophagogastric Adenocarcinoma,BRD-A01493904-003-12-1::2.5::HTS,4.246148408899591,0.039801572762731545,Other Types,WB-4101,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A"
Esophagogastric Adenocarcinoma,BRD-A01563671-001-02-7::2.5::HTS,8.88692219837477,0.002998381010935768,Esophagogastric Adenocarcinoma,cleviprex,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1S"
Esophagogastric Adenocarcinoma,BRD-A04506385-001-01-2::2.5::HTS,7.319270552297096,0.007033487627263237,Esophagogastric Adenocarcinoma,stepronin,mucolytic agent,
Esophagogastric Adenocarcinoma,BRD-A06352418-001-25-9::2.5::HTS,6.269265695122555,0.012579452652064062,Other Types,terfenadine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2"
Esophagogastric Adenocarcinoma,BRD-A06916187-001-02-9::2.5::HTS,5.677938926138021,0.017513906711646845,Esophagogastric Adenocarcinoma,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1
Esophagogastric Adenocarcinoma,BRD-A07440155-003-25-4::2.5::HTS,5.693092083409661,0.01736486974818423,Esophagogastric Adenocarcinoma,labetalol,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2"
Esophagogastric Adenocarcinoma,BRD-A07780951-065-10-0::2.58::HTS,3.908549629451014,0.04856279939179061,Esophagogastric Adenocarcinoma,metaproterenol,adrenergic receptor agonist,ADRB2
Esophagogastric Adenocarcinoma,BRD-A09533288-003-31-2::2.5::HTS,4.653065915483552,0.03144195526337688,Esophagogastric Adenocarcinoma,verapamil,calcium channel blocker,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-A10523515-001-07-9::2.5::HTS,5.284855314743697,0.02188096698967096,Esophagogastric Adenocarcinoma,GSK429286A,rho associated kinase inhibitor,ROCK1
Esophagogastric Adenocarcinoma,BRD-A10652366-238-04-1::2.5::HTS,9.24146571112365,0.0024832928518229154,Esophagogastric Adenocarcinoma,fosfomycin,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-A12994259-001-02-1::2.5::HTS,5.0713658289554475,0.024725920362406017,Other Types,pomalidomide,"angiogenesis inhibitor, tumor necrosis factor production inhibitor","CRBN, PTGS2, TNF"
Esophagogastric Adenocarcinoma,BRD-A13598753-001-01-2::2.5::HTS,4.003246079535757,0.04589578250578133,Esophagogastric Adenocarcinoma,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1
Esophagogastric Adenocarcinoma,BRD-A19958636-065-04-4::2.5::HTS,5.452875381352317,0.019890352268072016,Esophagogastric Adenocarcinoma,tuaminoheptane,,
Esophagogastric Adenocarcinoma,BRD-A20348246-001-15-8::2.5::HTS,6.271213775788591,0.012555217568927626,Other Types,chlormezanone,GABA receptor modulator,"GABRA1, TSPO"
Esophagogastric Adenocarcinoma,BRD-A22256192-003-22-7::2.5::HTS,5.255412714882631,0.02224856458812815,Esophagogastric Adenocarcinoma,terazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7"
Esophagogastric Adenocarcinoma,BRD-A24228527-213-01-9::2.5::HTS,4.452141097252071,0.03530286839577444,Esophagogastric Adenocarcinoma,ofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Esophagogastric Adenocarcinoma,BRD-A24397426-001-10-4::2.5::HTS,9.325170451761077,0.0023788181785657538,Other Types,nadifloxacin,bacterial DNA gyrase inhibitor,
Esophagogastric Adenocarcinoma,BRD-A24587114-066-22-5::2.5::HTS,4.28559476411335,0.03889609181553739,Esophagogastric Adenocarcinoma,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Esophagogastric Adenocarcinoma,BRD-A28044053-001-01-7::2.5::HTS,4.085028472882532,0.04374775779318132,Esophagogastric Adenocarcinoma,arotinolol,adrenergic receptor antagonist,ADRB3
Esophagogastric Adenocarcinoma,BRD-A28958257-001-01-2::2.5::HTS,7.799276114973047,0.005404750106010641,Esophagogastric Adenocarcinoma,centpropazine,inositol monophosphatase inhibitor,
Esophagogastric Adenocarcinoma,BRD-A29349577-001-23-0::2.5::HTS,4.939413384213936,0.026651730528654227,Esophagogastric Adenocarcinoma,dropropizine,antitussive,
Esophagogastric Adenocarcinoma,BRD-A29426959-050-13-2::2.5::HTS,7.180926223207906,0.0075862402624988145,Esophagogastric Adenocarcinoma,carbinoxamine,histamine receptor antagonist,HRH1
Esophagogastric Adenocarcinoma,BRD-A31521121-001-26-4::2.5::HTS,8.565835738044976,0.0035802941666136477,Esophagogastric Adenocarcinoma,methocarbamol,muscle relaxant,CA1
Esophagogastric Adenocarcinoma,BRD-A32597168-001-03-6::2.5::HTS,9.775383564760624,0.0018617561029411428,Esophagogastric Adenocarcinoma,letosteine,mucolytic agent,
Esophagogastric Adenocarcinoma,BRD-A34358106-003-01-6::2.5::HTS,4.173322100197358,0.04153793061978664,Other Types,sarpogrelate,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Esophagogastric Adenocarcinoma,BRD-A37492983-001-10-3::2.5::HTS,5.510745288154076,0.019245938545071204,Esophagogastric Adenocarcinoma,iocetamic-acid,radiopaque medium,
Esophagogastric Adenocarcinoma,BRD-A39935389-001-05-9::2.5::HTS,5.268229970743102,0.022087545353568994,Other Types,teroxirone,DNA inhibitor,
Esophagogastric Adenocarcinoma,BRD-A40777960-001-04-2::2.5::HTS,10.522094556297617,0.0012502254903980288,Esophagogastric Adenocarcinoma,aminohydroxybutyric-acid,,
Esophagogastric Adenocarcinoma,BRD-A43809092-003-02-1::2.5::HTS,5.2225530187820866,0.02267275840476807,Esophagogastric Adenocarcinoma,clobutinol,antitussive,
Esophagogastric Adenocarcinoma,BRD-A43882281-001-15-5::2.5::HTS,21.495302510843906,4.442573332156641e-06,Esophagogastric Adenocarcinoma,pinacidil,"ATP channel activator, potassium channel activator","ABCC8, ABCC9"
Esophagogastric Adenocarcinoma,BRD-A43885598-001-08-1::2.5::HTS,6.192598739078773,0.01313568381180483,Esophagogastric Adenocarcinoma,SID-7969543,steroidogenic factor antagonist,NR5A1
Esophagogastric Adenocarcinoma,BRD-A45044890-236-02-3::2.5::HTS,5.34256229871509,0.02117494718832734,Other Types,methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,
Esophagogastric Adenocarcinoma,BRD-A45153512-001-01-0::2.5::HTS,3.947631630135112,0.047437629757013294,Esophagogastric Adenocarcinoma,bimatoprost,prostanoid receptor agonist,"AKR1C3, PTGER1, PTGER3, PTGFR"
Esophagogastric Adenocarcinoma,BRD-A46179541-311-02-0::2.5::HTS,4.5576705219959495,0.033211343761608815,Other Types,doxapram,potassium channel blocker,"KCNK3, KCNK9"
Esophagogastric Adenocarcinoma,BRD-A46717658-236-02-5::2.5::HTS,3.9395421026634554,0.04766362882646062,Esophagogastric Adenocarcinoma,azlocillin,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-A47449001-004-13-7::2.5::HTS,4.185159702082822,0.041244333790899326,Other Types,ipratropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Esophagogastric Adenocarcinoma,BRD-A49172652-001-27-1::2.5::HTS,3.9346927796863387,0.04778943536670009,Other Types,lansoprazole,ATPase inhibitor,"ATP4A, ATP4B"
Esophagogastric Adenocarcinoma,BRD-A53566267-001-01-9::2.5::HTS,6.656188843760904,0.010136667720469119,Esophagogastric Adenocarcinoma,anecortave-acetate,angiogenesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-A53576514-048-14-3::2.5::HTS,5.476740189131537,0.019623245526313754,Other Types,orphenadrine,acetylcholine receptor antagonist,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2"
Esophagogastric Adenocarcinoma,BRD-A55464252-001-01-2::2.5::HTS,5.765804812298985,0.016675593871915494,Esophagogastric Adenocarcinoma,3-(4-methylbenzylidene)camphor,endocrine disruptor,
Esophagogastric Adenocarcinoma,BRD-A56152450-001-02-0::2.5::HTS,8.463362863748108,0.003776413738068794,Esophagogastric Adenocarcinoma,dimercaprol,chelating agent,
Esophagogastric Adenocarcinoma,BRD-A57886255-001-01-1::2.5::HTS,5.1181658716612635,0.024061054021834467,Other Types,golgicide-a,ARF inhibitor,GBF1
Esophagogastric Adenocarcinoma,BRD-A59198242-003-02-9::2.5::HTS,4.934040372966185,0.026731092332198995,Esophagogastric Adenocarcinoma,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Esophagogastric Adenocarcinoma,BRD-A59337442-051-05-3::2.5::HTS,4.120767396993484,0.04283290455614711,Other Types,xamoterol,adrenergic receptor agonist,ADRB1
Esophagogastric Adenocarcinoma,BRD-A60217728-001-11-2::2.5::HTS,4.128254651666778,0.04264692240294931,Esophagogastric Adenocarcinoma,iohexol,radiopaque medium,
Esophagogastric Adenocarcinoma,BRD-A64011898-001-01-0::2.5::HTS,4.09550744455325,0.04348386474863433,Esophagogastric Adenocarcinoma,androstenone,steroid,
Esophagogastric Adenocarcinoma,BRD-A64977602-001-15-9::2.5::HTS,6.296189787943837,0.012382521043770887,Esophagogastric Adenocarcinoma,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-A67097164-001-18-7::2.5::HTS,4.588309934565493,0.03262764700664157,Esophagogastric Adenocarcinoma,ifosfamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1"
Esophagogastric Adenocarcinoma,BRD-A68589262-001-04-3::2.5::HTS,4.324942546703095,0.03802367788031695,Esophagogastric Adenocarcinoma,troxipide,glucosamine synthetase stimulant,
Esophagogastric Adenocarcinoma,BRD-A69651145-003-07-2::2.5::HTS,4.616205070930066,0.0321193940423034,Esophagogastric Adenocarcinoma,minocycline,bacterial 30S ribosomal subunit inhibitor,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA"
Esophagogastric Adenocarcinoma,BRD-A69777949-001-24-2::2.5::HTS,12.00435084266253,0.0005724667962498172,Esophagogastric Adenocarcinoma,flumequine,topoisomerase inhibitor,
Esophagogastric Adenocarcinoma,BRD-A71407503-001-01-8::2.5::HTS,5.891408734352935,0.01553266835118377,Esophagogastric Adenocarcinoma,inimur,other antifungal,
Esophagogastric Adenocarcinoma,BRD-A72066420-001-04-5::2.5::HTS,5.4498323321104385,0.019926606657601376,Other Types,mifobate,PPAR receptor antagonist,PPARG
Esophagogastric Adenocarcinoma,BRD-A73556557-001-06-4::2.5::HTS,4.552925373372177,0.033294102261384316,Esophagogastric Adenocarcinoma,tagatose,phosphorylase inhibitor,PYGL
Esophagogastric Adenocarcinoma,BRD-A73709786-001-01-3::2.5::HTS,4.882463807937863,0.027545075532727187,Other Types,LB-100,protein phosphatase inhibitor,
Esophagogastric Adenocarcinoma,BRD-A75369945-001-01-2::2.5::HTS,5.4179704785668275,0.020291081134941335,Other Types,vitamin-b12,,
Esophagogastric Adenocarcinoma,BRD-A75817871-001-06-7::2.5::HTS,4.1322910178432615,0.042548671041410996,Esophagogastric Adenocarcinoma,blebbistatin-(+/-),ATPase inhibitor,MYH2
Esophagogastric Adenocarcinoma,BRD-A78723049-001-01-2::2.5::HTS,10.500277822376116,0.0012655829673781044,Esophagogastric Adenocarcinoma,cefotetan,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-A79803969-003-16-1::2.5::HTS,4.169647153526962,0.04162741719490963,Esophagogastric Adenocarcinoma,memantine,glutamate receptor antagonist,"CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A"
Esophagogastric Adenocarcinoma,BRD-A81615860-003-01-7::2.5::HTS,6.902924153213375,0.008841714710204987,Esophagogastric Adenocarcinoma,fenclonine-(+/-),tryptophan hydroxylase inhibitor,"PAH, TPH1, TPH2"
Esophagogastric Adenocarcinoma,BRD-A85216385-003-02-4::2.5::HTS,3.922107853732101,0.04814491247070485,Other Types,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,"CHRM1, SLC6A2, SLC6A3, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-A85548292-001-01-8::2.5::HTS,4.6846079492949455,0.03087236896320944,Other Types,piketoprofen,cyclooxygenase inhibitor,
Esophagogastric Adenocarcinoma,BRD-A85667082-001-12-7::2.5::HTS,4.3110200362913655,0.03832427354248526,Other Types,fulvestrant,estrogen receptor antagonist,"ESR1, ESR2, GPER1"
Esophagogastric Adenocarcinoma,BRD-A86044036-001-26-5::2.5::HTS,11.20015389450074,0.0008735705681854275,Esophagogastric Adenocarcinoma,flurbiprofen-(+/-),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Esophagogastric Adenocarcinoma,BRD-A86216746-046-02-6::2.5::HTS,4.6807365184288,0.030938158281270403,Esophagogastric Adenocarcinoma,varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Esophagogastric Adenocarcinoma,BRD-A87435144-001-01-6::2.5::HTS,4.407558207589128,0.03622778615942074,Other Types,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1
Esophagogastric Adenocarcinoma,BRD-A90551241-001-10-8::2.5::HTS,5.3694097874715965,0.020853932793729407,Esophagogastric Adenocarcinoma,lornoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Esophagogastric Adenocarcinoma,BRD-A91822151-001-05-0::2.5::HTS,5.11931425068951,0.02405304648481527,Esophagogastric Adenocarcinoma,picrotin,GABA receptor antagonist,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB"
Esophagogastric Adenocarcinoma,BRD-A92096630-001-02-8::2.5::HTS,11.486636689893935,0.0007508579623838204,Esophagogastric Adenocarcinoma,shikimic-acid,,
Esophagogastric Adenocarcinoma,BRD-A94323479-001-02-8::2.5::HTS,6.017411972416097,0.014468120760483467,Esophagogastric Adenocarcinoma,ki16198,lipoprotein antagonist,LPA
Esophagogastric Adenocarcinoma,BRD-A94756469-001-04-7::2.5::HTS,5.226957086296905,0.022610594923806286,Other Types,digoxin,ATPase inhibitor,ATP1A1
Esophagogastric Adenocarcinoma,BRD-A96529864-001-01-3::2.5::HTS,4.404044557994788,0.03630108187854922,Esophagogastric Adenocarcinoma,isosteviol,,
Esophagogastric Adenocarcinoma,BRD-A96977263-001-03-7::2.5::HTS,4.56376196683021,0.033114427305010206,Other Types,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1
Esophagogastric Adenocarcinoma,BRD-K01567962-001-23-0::2.5::HTS,7.384603323693327,0.006782804887090137,Esophagogastric Adenocarcinoma,pyrazolanthrone,JNK inhibitor,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK"
Esophagogastric Adenocarcinoma,BRD-K01614093-001-02-6::2.5::HTS,5.468150710872097,0.01973698138596979,Esophagogastric Adenocarcinoma,dihydromyricetin,,
Esophagogastric Adenocarcinoma,BRD-K02017404-300-06-2::2.5::HTS,5.681460888464122,0.01747854858122249,Esophagogastric Adenocarcinoma,NVP-BSK805,JAK inhibitor,JAK2
Esophagogastric Adenocarcinoma,BRD-K02314383-001-01-3::2.5::HTS,4.439154156314139,0.03557422002091032,Other Types,epitiostanol,androgen receptor agonist,AR
Esophagogastric Adenocarcinoma,BRD-K02953697-001-09-2::2.5::HTS,4.780220872527569,0.029206839904806898,Esophagogastric Adenocarcinoma,naringin,cytochrome P450 inhibitor,SLCO1A2
Esophagogastric Adenocarcinoma,BRD-K03063480-001-05-8::2.5::HTS,5.024017422934443,0.02538763214774604,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Esophagogastric Adenocarcinoma,BRD-K05181084-003-03-7::2.5::HTS,4.148980036544866,0.042131061465954016,Other Types,NGB-2904,dopamine receptor antagonist,DRD3
Esophagogastric Adenocarcinoma,BRD-K05236810-001-19-0::2.5::HTS,3.9631067182119994,0.04699684128963998,Esophagogastric Adenocarcinoma,luteolin,glucosidase inhibitor,TOP1
Esophagogastric Adenocarcinoma,BRD-K05977355-001-19-0::2.5::HTS,5.304287571722483,0.02164185891589185,Other Types,fluconazole,sterol demethylase inhibitor,CYP51A1
Esophagogastric Adenocarcinoma,BRD-K07507905-236-02-6::2.5::HTS,4.06462892303641,0.04426902185521233,Esophagogastric Adenocarcinoma,BRL-37344,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Esophagogastric Adenocarcinoma,BRD-K07736136-001-04-6::2.51::HTS,4.986071480445794,0.025970489689094826,Esophagogastric Adenocarcinoma,VX-702,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK14"
Esophagogastric Adenocarcinoma,BRD-K07857022-002-01-1::2.5::HTS,4.309126305716011,0.038362537009900395,Esophagogastric Adenocarcinoma,alvimopan,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Esophagogastric Adenocarcinoma,BRD-K07940445-310-02-9::2.5::HTS,4.804498636643114,0.0287972168365117,Other Types,quinine,hemozoin biocrystallization inhibitor,"GP9, KCNB2, KCNN4, SLC29A4"
Esophagogastric Adenocarcinoma,BRD-K08033334-003-04-3::2.5::HTS,4.933863847435163,0.026736665280016097,Esophagogastric Adenocarcinoma,lincomycin,bacterial 30S ribosomal subunit inhibitor,
Esophagogastric Adenocarcinoma,BRD-K08111712-001-16-7::2.5::HTS,18.42064609601578,2.0908236392523856e-05,Other Types,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55
Esophagogastric Adenocarcinoma,BRD-K08248804-001-01-8::2.5::HTS,5.911512565854832,0.015367112771598898,Other Types,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Esophagogastric Adenocarcinoma,BRD-K08273968-001-19-0::2.5::HTS,5.7587711271044135,0.016735686811903797,Other Types,griseofulvin,tubulin polymerization inhibitor,KRT12
Esophagogastric Adenocarcinoma,BRD-K08303368-001-10-0::2.5::HTS,4.192835065411057,0.04109699583491312,Other Types,chlorpyrifos,acetylcholinesterase inhibitor,ACHE
Esophagogastric Adenocarcinoma,BRD-K08493205-001-04-9::2.5::HTS,5.094762954694601,0.024384755252185163,Esophagogastric Adenocarcinoma,salicyl-alcohol,,
Esophagogastric Adenocarcinoma,BRD-K08640512-003-02-3::2.5::HTS,4.117040153643619,0.042932667121715035,Esophagogastric Adenocarcinoma,RS-100329,adrenergic receptor antagonist,"ADRA1A, ADRA1D"
Esophagogastric Adenocarcinoma,BRD-K08799216-001-05-3::2.5::HTS,3.9391347135930213,0.047681586027675756,Other Types,pelitinib,EGFR inhibitor,EGFR
Esophagogastric Adenocarcinoma,BRD-K08998509-001-02-4::2.5::HTS,3.882612198647434,0.04928253436162315,Esophagogastric Adenocarcinoma,fananserin,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A
Esophagogastric Adenocarcinoma,BRD-K09372874-001-01-0::2.5::HTS,4.143591006204443,0.04228099344278643,Other Types,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
Esophagogastric Adenocarcinoma,BRD-K09757388-065-04-0::2.5::HTS,9.717171666601773,0.0019197228450807899,Esophagogastric Adenocarcinoma,atazanavir,HIV protease inhibitor,
Esophagogastric Adenocarcinoma,BRD-K09951645-001-06-8::2.5::HTS,3.9964800944356424,0.046096979023896846,Esophagogastric Adenocarcinoma,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Esophagogastric Adenocarcinoma,BRD-K10843433-001-22-7::2.5::HTS,5.264894253344764,0.02214326187904253,Esophagogastric Adenocarcinoma,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Esophagogastric Adenocarcinoma,BRD-K11129031-001-27-5::2.5::HTS,4.060518367731972,0.044398581405871024,Esophagogastric Adenocarcinoma,gemfibrozil,lipoprotein lipase activator,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1"
Esophagogastric Adenocarcinoma,BRD-K11215326-001-03-7::2.31::HTS,6.034283271815125,0.014351456167034171,Other Types,tazemetostat,histone lysine methyltransferase inhibitor,EZH2
Esophagogastric Adenocarcinoma,BRD-K11244467-001-08-5::2.5::HTS,4.015880345478898,0.04555310582177019,Other Types,ambazone,DNA damage inducer,
Esophagogastric Adenocarcinoma,BRD-K12932420-001-02-3::2.5::HTS,6.3886046105468415,0.0117767329097592,Esophagogastric Adenocarcinoma,YM-976,phosphodiesterase inhibitor,PDE4A
Esophagogastric Adenocarcinoma,BRD-K13050303-001-18-1::2.5::HTS,5.431031579965538,0.020140078758160568,Esophagogastric Adenocarcinoma,uridine,dopamine receptor agonist,"LSM6, TYMP"
Esophagogastric Adenocarcinoma,BRD-K13314656-001-01-0::2.5::HTS,4.583274309427631,0.03272927755625115,Other Types,ebastine,histamine receptor antagonist,"CYP3A4, HRH1"
Esophagogastric Adenocarcinoma,BRD-K13511380-001-01-4::2.5::HTS,5.463588909591918,0.019771896193983875,Esophagogastric Adenocarcinoma,naringin-dihydrochalcone,cytochrome P450 inhibitor,
Esophagogastric Adenocarcinoma,BRD-K13566078-001-02-3::2.5::HTS,5.289844234603133,0.021817652363070872,Other Types,BMS-345541,IKK inhibitor,"CHUK, IKBKB"
Esophagogastric Adenocarcinoma,BRD-K13926615-003-03-3::2.5::HTS,3.9483002932090385,0.04740378240995819,Other Types,vardenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H"
Esophagogastric Adenocarcinoma,BRD-K14127446-005-22-7::2.5::HTS,4.695949141518153,0.030656928400715686,Esophagogastric Adenocarcinoma,isopropamide-iodide,acetylcholine receptor antagonist,"CHRM3, CHRM4"
Esophagogastric Adenocarcinoma,BRD-K14705039-001-16-4::2.5::HTS,4.681823091771288,0.030907807855245193,Esophagogastric Adenocarcinoma,sulfathiazole,dihydropteroate synthase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K15179513-001-03-4::2.5::HTS,5.719549815071105,0.017109583900130884,Esophagogastric Adenocarcinoma,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
Esophagogastric Adenocarcinoma,BRD-K15563106-001-18-0::2.5::HTS,9.242240278186141,0.0024766869785747487,Esophagogastric Adenocarcinoma,phloretin,sodium/glucose cotransporter inhibitor,"AQP9, CLCN3, SLC23A1"
Esophagogastric Adenocarcinoma,BRD-K15933101-003-06-1::2.5::HTS,6.7040506685028864,0.00987315986350974,Esophagogastric Adenocarcinoma,ropinirole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Esophagogastric Adenocarcinoma,BRD-K15976406-001-03-3::2.5::HTS,5.478169595892918,0.019605474574444455,Esophagogastric Adenocarcinoma,telbivudine,DNA polymerase inhibitor,TK2
Esophagogastric Adenocarcinoma,BRD-K17203476-001-01-9::2.5::HTS,5.8884428338467325,0.015555148348534206,Esophagogastric Adenocarcinoma,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Esophagogastric Adenocarcinoma,BRD-K17743125-001-08-4::2.5::HTS,10.326812345959995,0.0013865257495728367,Other Types,belinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Esophagogastric Adenocarcinoma,BRD-K19333160-001-01-3::2.5::HTS,5.374450742321778,0.02079434433144477,Esophagogastric Adenocarcinoma,RKI-1447,rho associated kinase inhibitor,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2"
Esophagogastric Adenocarcinoma,BRD-K19388745-003-01-7::2.5::HTS,5.535174379462504,0.018984806641162894,Esophagogastric Adenocarcinoma,colforsin-daproate,adenylyl cyclase activator,
Esophagogastric Adenocarcinoma,BRD-K19939891-001-05-4::2.5::HTS,9.252686944996872,0.0024612278559509784,Esophagogastric Adenocarcinoma,TIC10,"AKT inhibitor, TRAIL modulator","AKT1, MAPK1"
Esophagogastric Adenocarcinoma,BRD-K19972289-001-01-4::2.5::HTS,7.050638317942051,0.008150075272602478,Esophagogastric Adenocarcinoma,octinoxate,,
Esophagogastric Adenocarcinoma,BRD-K20168442-004-06-3::2.5::HTS,3.972919009481788,0.04672489979356587,Esophagogastric Adenocarcinoma,vecuronium,acetylcholine receptor antagonist,CHRNA2
Esophagogastric Adenocarcinoma,BRD-K20548681-001-01-3::2.5::HTS,6.504727246258239,0.011022874965727705,Esophagogastric Adenocarcinoma,SCP-1,analgesic agent,
Esophagogastric Adenocarcinoma,BRD-K21672174-001-03-0::2.5::HTS,4.55422743660267,0.033272098025953066,Esophagogastric Adenocarcinoma,Ro-28-1675,glucokinase activator,GCK
Esophagogastric Adenocarcinoma,BRD-K21937671-001-10-0::2.5::HTS,5.961421976113871,0.014931252398221417,Esophagogastric Adenocarcinoma,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Esophagogastric Adenocarcinoma,BRD-K22134346-001-24-9::2.42::HTS,4.879041881897118,0.02761339545656555,Esophagogastric Adenocarcinoma,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Esophagogastric Adenocarcinoma,BRD-K23190681-001-01-1::2.5::HTS,4.451374310811072,0.03532100728896001,Other Types,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Esophagogastric Adenocarcinoma,BRD-K23403298-003-01-9::2.5::HTS,6.92840490047017,0.008723780111496873,Other Types,benzyldimethylhexadecylammonium,cationic surfactant,
Esophagogastric Adenocarcinoma,BRD-K23586533-001-03-6::2.5::HTS,4.420345567262371,0.03597605468878894,Esophagogastric Adenocarcinoma,clindamycin,protein synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K24696047-001-02-3::2.5::HTS,10.685499215897917,0.0011467549706023563,Esophagogastric Adenocarcinoma,NVP-AEW541,IGF-1 inhibitor,"IGF1R, INSR"
Esophagogastric Adenocarcinoma,BRD-K24968862-001-01-0::2.5::HTS,5.180819888877921,0.02321288613590085,Other Types,SB-683698,integrin antagonist,"ITGA4, ITGAV, ITGB1, ITGB7"
Esophagogastric Adenocarcinoma,BRD-K25412176-001-01-9::2.5::HTS,6.913011959972896,0.00879472593402764,Other Types,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Esophagogastric Adenocarcinoma,BRD-K26531771-001-02-2::2.35::HTS,7.071391868589328,0.008070259776651125,Other Types,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Esophagogastric Adenocarcinoma,BRD-K26823213-001-02-9::2.5::HTS,4.369786703430032,0.03703679479631563,Other Types,GW-842166,cannabinoid receptor agonist,CNR2
Esophagogastric Adenocarcinoma,BRD-K26838195-075-04-9::2.5::HTS,5.04342770036159,0.02510729709234183,Other Types,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Esophagogastric Adenocarcinoma,BRD-K28824103-001-02-8::2.5::HTS,5.701249518856969,0.017303499195983115,Other Types,genipin,choleretic agent,
Esophagogastric Adenocarcinoma,BRD-K28965160-001-01-1::2.5::HTS,5.062241532965181,0.02484423901274347,Other Types,BVD-523,MAP kinase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K28971625-003-01-4::2.5::HTS,7.2470922942533935,0.007319522587608497,Esophagogastric Adenocarcinoma,ZD-7114,adrenergic receptor agonist,ADRB3
Esophagogastric Adenocarcinoma,BRD-K29173907-001-09-2::2.5::HTS,6.8697993993975714,0.009004592517317864,Other Types,isoflupredone-acetate,,NR3C1
Esophagogastric Adenocarcinoma,BRD-K29834313-001-01-4::2.5::HTS,8.36334800837184,0.003979009117817631,Esophagogastric Adenocarcinoma,myricitrin,PKC inhibitor,"NOS1, PRKCA"
Esophagogastric Adenocarcinoma,BRD-K30237152-300-02-5::2.5::HTS,9.776856390481917,0.001860291596954802,Esophagogastric Adenocarcinoma,1400W,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Esophagogastric Adenocarcinoma,BRD-K31054881-300-04-7::2.5::HTS,4.553625141540122,0.033283704598505444,Esophagogastric Adenocarcinoma,BMY-7378,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A"
Esophagogastric Adenocarcinoma,BRD-K32292990-001-03-6::2.5::HTS,4.34232267817541,0.03763387202638192,Esophagogastric Adenocarcinoma,CGP-53353,"EGFR inhibitor, PKC inhibitor","EGFR, PRKCB"
Esophagogastric Adenocarcinoma,BRD-K33151569-003-09-7::2.5::HTS,4.720418706650285,0.030228131807366786,Esophagogastric Adenocarcinoma,deoxyepinephrine,"adrenergic receptor agonist, dopamine receptor agonist","ADRA1A, DRD1, DRD2"
Esophagogastric Adenocarcinoma,BRD-K33226500-001-01-0::2.5::HTS,6.381999393840798,0.011807333731134576,Esophagogastric Adenocarcinoma,indinavir,HIV protease inhibitor,"CYP3A4, CYP3A5, CYP3A7"
Esophagogastric Adenocarcinoma,BRD-K33588785-001-01-9::2.5::HTS,7.065939595109552,0.008091387367145915,Esophagogastric Adenocarcinoma,obidoxime,cholinesterase reactivator,ACHE
Esophagogastric Adenocarcinoma,BRD-K33610132-001-02-9::2.5::HTS,7.420765123857864,0.006651441871403124,Other Types,rociletinib,EGFR inhibitor,EGFR
Esophagogastric Adenocarcinoma,BRD-K33814251-001-02-2::2.5::HTS,4.436612091749625,0.03562679176017121,Other Types,lubiprostone,chloride channel activator,CLCN2
Esophagogastric Adenocarcinoma,BRD-K33892651-001-02-4::2.5::HTS,3.921503830416638,0.04816296507731508,Esophagogastric Adenocarcinoma,ML347,ALK tyrosine kinase receptor inhibitor,"ACVR1, ACVRL1, BMPR1A"
Esophagogastric Adenocarcinoma,BRD-K34073885-001-09-3::2.54::HTS,3.9058635902165095,0.04863889355272613,Other Types,tanshinone-i,AP inhibitor,IFNG
Esophagogastric Adenocarcinoma,BRD-K34685430-050-12-5::2.5::HTS,5.1579833546540845,0.023533294754367086,Esophagogastric Adenocarcinoma,methylergometrine,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C"
Esophagogastric Adenocarcinoma,BRD-K34713073-001-01-3::2.5::HTS,7.974674970581111,0.004912510248536469,Esophagogastric Adenocarcinoma,PD-123319,angiotensin antagonist,AGTR2
Esophagogastric Adenocarcinoma,BRD-K34776109-001-16-6::2.5::HTS,4.2611735578775125,0.03945294499738086,Esophagogastric Adenocarcinoma,glimepiride,insulin secretagogue,"ABCC8, KCNJ1, KCNJ11"
Esophagogastric Adenocarcinoma,BRD-K35952844-238-01-2::2.5::HTS,4.1434007940634485,0.042280321958280825,Esophagogastric Adenocarcinoma,calcium-gluceptate,,
Esophagogastric Adenocarcinoma,BRD-K36207157-001-07-0::2.52::HTS,5.353351730008633,0.021065589919465503,Other Types,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Esophagogastric Adenocarcinoma,BRD-K36467523-001-02-8::2.5::HTS,4.839786275198574,0.02822399413739015,Esophagogastric Adenocarcinoma,bindarit,NFkB pathway inhibitor,"CCL2, CCL7, CCL8"
Esophagogastric Adenocarcinoma,BRD-K36927236-001-32-6::2.5::HTS,4.740734005173472,0.02987552660122528,Other Types,glyburide,"ATP channel blocker, insulin secretagogue, sulfonylurea","ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1"
Esophagogastric Adenocarcinoma,BRD-K37385792-003-02-1::2.5::HTS,7.623280378029526,0.005956867782455675,Esophagogastric Adenocarcinoma,conivaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2"
Esophagogastric Adenocarcinoma,BRD-K37561857-001-15-5::2.5::HTS,6.0633062704997505,0.014109644693051749,Esophagogastric Adenocarcinoma,zardaverine,phosphodiesterase inhibitor,PDE4D
Esophagogastric Adenocarcinoma,BRD-K37618799-001-03-0::2.5::HTS,5.214399567790375,0.022776248697577994,Other Types,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Esophagogastric Adenocarcinoma,BRD-K37687095-001-06-9::2.5::HTS,5.230142646199271,0.022569613700508254,Other Types,AZD8330,MEK inhibitor,
Esophagogastric Adenocarcinoma,BRD-K37714784-305-02-1::2.5::HTS,8.264523941053207,0.00419638712686792,Esophagogastric Adenocarcinoma,ABT-724,dopamine receptor agonist,DRD4
Esophagogastric Adenocarcinoma,BRD-K37872686-003-01-9::2.5::HTS,4.108170485010429,0.04316193440274477,Esophagogastric Adenocarcinoma,tirofiban,"platelet aggregation inhibitor, structural glycoprotein antagonist","ITGA2B, ITGB3"
Esophagogastric Adenocarcinoma,BRD-K38305202-001-17-4::2.5::HTS,4.242860092982772,0.03987895014352063,Esophagogastric Adenocarcinoma,domperidone,dopamine receptor antagonist,"DRD2, DRD3"
Esophagogastric Adenocarcinoma,BRD-K39166528-001-01-0::2.5::HTS,5.941122718421394,0.015102302133873138,Other Types,ID-8,,
Esophagogastric Adenocarcinoma,BRD-K39987650-001-24-1::2.5::HTS,11.063607892771143,0.0009383878841703721,Other Types,bisacodyl,laxative,
Esophagogastric Adenocarcinoma,BRD-K40227168-001-12-9::1.7::HTS,4.220447103056955,0.0404150798458233,Esophagogastric Adenocarcinoma,vinburnine,adrenergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Esophagogastric Adenocarcinoma,BRD-K40366680-001-03-3::2.5::HTS,5.914992693634662,0.015326031661080073,Esophagogastric Adenocarcinoma,CAY10505,PI3K inhibitor,PIK3CG
Esophagogastric Adenocarcinoma,BRD-K40787673-001-02-1::2.5::HTS,4.726994856243872,0.03011836593800099,Esophagogastric Adenocarcinoma,lacitol,osmosis stimulant,
Esophagogastric Adenocarcinoma,BRD-K41143549-003-02-4::2.5::HTS,4.87020444103953,0.027731402289872344,Esophagogastric Adenocarcinoma,N20C,glutamate receptor antagonist,
Esophagogastric Adenocarcinoma,BRD-K41185545-001-02-3::2.5::HTS,4.1261747709152425,0.042708536018836715,Esophagogastric Adenocarcinoma,ambrisentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Esophagogastric Adenocarcinoma,BRD-K41213548-001-02-0::2.5::HTS,6.391370182501024,0.01174845046637653,Other Types,KW-2478,HSP inhibitor,
Esophagogastric Adenocarcinoma,BRD-K41278234-001-03-0::2.5::HTS,16.814777717280755,4.739041534602394e-05,Other Types,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Esophagogastric Adenocarcinoma,BRD-K41434598-003-01-9::2.5::HTS,7.532356996251936,0.006259514510337633,Esophagogastric Adenocarcinoma,org-9768,adrenergic receptor antagonist,ADRA2A
Esophagogastric Adenocarcinoma,BRD-K41783120-001-02-8::2.5::HTS,16.896098408520622,4.555268356978127e-05,Other Types,STA-5326,interleukin synthesis inhibitor,IL12A
Esophagogastric Adenocarcinoma,BRD-K42098891-003-20-5::2.5::HTS,5.046157465021329,0.025079512701527768,Esophagogastric Adenocarcinoma,protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-K42260897-001-09-2::2.5::HTS,4.18334878625371,0.041297377470057677,Esophagogastric Adenocarcinoma,ezetimibe,"cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1"
Esophagogastric Adenocarcinoma,BRD-K42417338-045-01-9::2.5::HTS,11.093007140163195,0.0009250946626784987,Esophagogastric Adenocarcinoma,butorphanol-(+)-tartrate,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Esophagogastric Adenocarcinoma,BRD-K42500029-001-03-5::2.5::HTS,4.935100034605165,0.026716282989685418,Esophagogastric Adenocarcinoma,CGP-57380,MAP kinase inhibitor,"AURKB, LCK, MKNK1, MKNK2, SGK1"
Esophagogastric Adenocarcinoma,BRD-K42756753-001-01-9::2.5::HTS,8.18849912046261,0.004379414361207148,Esophagogastric Adenocarcinoma,epiandrosterone,steroid,G6PD
Esophagogastric Adenocarcinoma,BRD-K43106192-320-11-8::2.5::HTS,7.226729085540674,0.007409420747563197,Other Types,gallamine-triethiodide,acetylcholine receptor antagonist,"ACHE, CHRM2, CHRNA1, CHRNA2"
Esophagogastric Adenocarcinoma,BRD-K44009692-001-02-3::2.5::HTS,5.7638441630763735,0.016688543131082683,Esophagogastric Adenocarcinoma,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
Esophagogastric Adenocarcinoma,BRD-K44366189-001-01-9::2.5::HTS,5.502881433016252,0.019331803596601842,Other Types,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Esophagogastric Adenocarcinoma,BRD-K44777625-001-03-5::2.5::HTS,6.217245070738127,0.012939211481627555,Esophagogastric Adenocarcinoma,FH1,hepatocyte function enhancer,
Esophagogastric Adenocarcinoma,BRD-K44824027-001-02-1::2.5::HTS,4.590936327051752,0.03257341279249787,Esophagogastric Adenocarcinoma,beclamide,anticonvulsant,
Esophagogastric Adenocarcinoma,BRD-K45114938-236-01-8::2.35::HTS,7.651368692424785,0.005872790495399579,Esophagogastric Adenocarcinoma,mezlocillin,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K45542189-048-22-1::2.5::HTS,6.399843475579964,0.011688107690338399,Other Types,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Esophagogastric Adenocarcinoma,BRD-K45746021-003-01-9::2.5::HTS,5.683578798276663,0.01746131652899822,Esophagogastric Adenocarcinoma,CC-401,JNK inhibitor,MAPK8
Esophagogastric Adenocarcinoma,BRD-K46018455-001-27-6::2.5::HTS,7.770770299834558,0.005494808210010742,Esophagogastric Adenocarcinoma,bezafibrate,PPAR receptor agonist,"PPARA, PPARD, PPARG"
Esophagogastric Adenocarcinoma,BRD-K46290096-001-01-1::2.5::HTS,3.9203781972351033,0.04820032668357513,Esophagogastric Adenocarcinoma,preladenant,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Esophagogastric Adenocarcinoma,BRD-K46317332-003-17-8::2.5::HTS,5.506784353329669,0.019291627941626994,Esophagogastric Adenocarcinoma,proadifen,nitric oxide synthase inhibitor,NOS1
Esophagogastric Adenocarcinoma,BRD-K46331928-001-06-6::2.38::HTS,4.404172194109633,0.036315836975240746,Esophagogastric Adenocarcinoma,ethynodiol-diacetate,,"ESR1, PGR"
Esophagogastric Adenocarcinoma,BRD-K47029922-003-10-9::2.5::HTS,6.127024505443092,0.013611083880430436,Esophagogastric Adenocarcinoma,tranylcypromine,monoamine oxidase inhibitor,"KDM1A, MAOA, MAOB"
Esophagogastric Adenocarcinoma,BRD-K47031502-001-01-6::2.5::HTS,4.4548727184271115,0.03525589382441926,Esophagogastric Adenocarcinoma,eupatilin,mucus protecting agent,
Esophagogastric Adenocarcinoma,BRD-K47949423-001-03-1::2.56::HTS,5.590819813532884,0.018415680876537822,Esophagogastric Adenocarcinoma,mirabegron,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Esophagogastric Adenocarcinoma,BRD-K48329353-001-01-3::2.5::HTS,5.40744215094915,0.02040933869516744,Other Types,"6,_7-dehydro-17-acetoxy-progesterone",steroidal progestin,
Esophagogastric Adenocarcinoma,BRD-K48488978-001-05-3::2.5::HTS,10.885699137508185,0.001031464299071159,Other Types,YM-201636,PI3K inhibitor,
Esophagogastric Adenocarcinoma,BRD-K48619321-004-16-8::2.54::HTS,4.836374918314769,0.02829823554513323,Esophagogastric Adenocarcinoma,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Esophagogastric Adenocarcinoma,BRD-K48722258-300-10-2::2.5::HTS,7.844901285569739,0.005277061069519123,Esophagogastric Adenocarcinoma,dilazep,adenosine reuptake inhibitor,SLC29A1
Esophagogastric Adenocarcinoma,BRD-K49049886-001-08-7::2.5::HTS,5.815547516834181,0.016209347437424453,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Esophagogastric Adenocarcinoma,BRD-K49119234-003-02-6::2.5::HTS,5.325533127548028,0.02138278173329223,Esophagogastric Adenocarcinoma,TMPH,,
Esophagogastric Adenocarcinoma,BRD-K49504902-001-01-6::2.5::HTS,7.973651622315464,0.004919617825350866,Esophagogastric Adenocarcinoma,SEP-227900,D-Amino Acid Oxidase Inhibitor,DAO
Esophagogastric Adenocarcinoma,BRD-K49519144-001-04-6::2.5::HTS,3.971173498736858,0.0467997961380982,Esophagogastric Adenocarcinoma,LY2140023,glutamate receptor agonist,GRM3
Esophagogastric Adenocarcinoma,BRD-K49545903-003-01-4::2.5::HTS,7.247147212398007,0.007316133921402781,Esophagogastric Adenocarcinoma,"4,4-pentamethylenepiperidine",M2 channel blocker,
Esophagogastric Adenocarcinoma,BRD-K50293352-300-02-1::2.5::HTS,4.054095697101921,0.04454307044371212,Esophagogastric Adenocarcinoma,MM77,serotonin receptor antagonist,HTR1A
Esophagogastric Adenocarcinoma,BRD-K50422030-001-05-3::2.5::HTS,4.301825596116122,0.03853448765408563,Esophagogastric Adenocarcinoma,clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1
Esophagogastric Adenocarcinoma,BRD-K50785021-001-02-1::2.5::HTS,4.530671754735386,0.03372687158969503,Esophagogastric Adenocarcinoma,cyclamic-acid,,
Esophagogastric Adenocarcinoma,BRD-K50866992-003-10-3::2.5::HTS,6.689176995986309,0.009953928050991923,Esophagogastric Adenocarcinoma,tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4"
Esophagogastric Adenocarcinoma,BRD-K50938287-036-13-8::2.5::HTS,5.029625159476877,0.025309808150330966,Other Types,sumatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7"
Esophagogastric Adenocarcinoma,BRD-K51087630-001-01-6::2.5::HTS,7.507007018499832,0.006349620578008917,Esophagogastric Adenocarcinoma,tirasemtiv,troponin activator,
Esophagogastric Adenocarcinoma,BRD-K51324732-001-01-0::2.5::HTS,4.431474617864328,0.03572923111595238,Other Types,meglitinide,potassium channel blocker,CCR2
Esophagogastric Adenocarcinoma,BRD-K51544265-001-04-2::2.5::HTS,4.583413947756607,0.03272663386480175,Other Types,cabozantinib,"RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET"
Esophagogastric Adenocarcinoma,BRD-K51579475-003-02-4::2.5::HTS,3.860371384573002,0.04993248379606932,Esophagogastric Adenocarcinoma,dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-K52113681-003-02-1::2.5::HTS,4.608930127862892,0.03224087706823287,Other Types,CP-339818,potassium channel blocker,KCNA3
Esophagogastric Adenocarcinoma,BRD-K52219182-001-02-4::2.5::HTS,10.053554530955308,0.001604613508492942,Esophagogastric Adenocarcinoma,ICI-63197,phosphodiesterase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K52911425-001-09-8::2.5::HTS,5.3961215714458906,0.020537622646455707,Other Types,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Esophagogastric Adenocarcinoma,BRD-K53532120-003-11-1::2.5::HTS,4.353941378327729,0.03738005268002272,Other Types,U-50488-(-),opioid receptor agonist,OPRK1
Esophagogastric Adenocarcinoma,BRD-K53814070-310-01-3::2.5::HTS,8.375070531436185,0.003956308333950609,Esophagogastric Adenocarcinoma,ripasudil,rho associated kinase inhibitor,"ROCK1, ROCK2"
Esophagogastric Adenocarcinoma,BRD-K54142781-003-11-8::2.5::HTS,4.306083233203892,0.038433123632030095,Esophagogastric Adenocarcinoma,cirazoline,adrenergic receptor agonist,ADRA1A
Esophagogastric Adenocarcinoma,BRD-K54187111-001-09-2::2.5::HTS,4.120297575628497,0.042845559032805444,Other Types,dichlorisone-acetate,,
Esophagogastric Adenocarcinoma,BRD-K54770957-001-04-3::2.5::HTS,7.358997165954017,0.006883335132669215,Esophagogastric Adenocarcinoma,etoricoxib,cyclooxygenase inhibitor,PTGS2
Esophagogastric Adenocarcinoma,BRD-K54847683-001-03-2::2.5::HTS,4.693609151085933,0.03071331607836508,Esophagogastric Adenocarcinoma,equol,estrogen receptor agonist,"ESR1, ESR2"
Esophagogastric Adenocarcinoma,BRD-K55044200-001-15-3::2.5::HTS,5.672866302580196,0.017561104896662506,Other Types,amoxicillin,penicillin binding protein inhibitor,"CYP2C19, SLC15A1, SLC15A2, SLC22A6"
Esophagogastric Adenocarcinoma,BRD-K55567017-001-12-3::2.5::HTS,8.599563471046482,0.0035014415688164185,Esophagogastric Adenocarcinoma,formononetin,alcohol dehydrogenase inhibitor,"ADH1C, SLC5A2"
Esophagogastric Adenocarcinoma,BRD-K56032964-001-02-1::2.5::HTS,5.376323060461831,0.02077096631448461,Other Types,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Esophagogastric Adenocarcinoma,BRD-K57275767-001-03-2::2.5::HTS,6.655842716899827,0.010139540276371846,Esophagogastric Adenocarcinoma,geniposide,GLP receptor agonist,GLP1R
Esophagogastric Adenocarcinoma,BRD-K57569181-001-27-5::2.5::HTS,4.14988262301804,0.042105424077370564,Esophagogastric Adenocarcinoma,pentoxifylline,phosphodiesterase inhibitor,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF"
Esophagogastric Adenocarcinoma,BRD-K58794715-001-01-8::2.5::HTS,6.864009218880799,0.009036052459952527,Esophagogastric Adenocarcinoma,bentiromide,,HPN
Esophagogastric Adenocarcinoma,BRD-K59037100-001-14-7::2.5::HTS,6.635460173368939,0.01025109382237092,Esophagogastric Adenocarcinoma,oxybenzone,lipase inhibitor,LIPE
Esophagogastric Adenocarcinoma,BRD-K59284035-001-07-9::2.5::HTS,4.44430065382481,0.0354672207398686,Esophagogastric Adenocarcinoma,chrysophanic-acid,EGFR inhibitor,"EGFR, MTOR"
Esophagogastric Adenocarcinoma,BRD-K59998349-003-01-4::2.5::HTS,6.846398137154868,0.00912531849936281,Esophagogastric Adenocarcinoma,aminolevulinic-acid-benzyl-ester,,
Esophagogastric Adenocarcinoma,BRD-K60005752-001-01-9::2.5::HTS,8.080371786498302,0.00463821637983758,Esophagogastric Adenocarcinoma,S-111,PARP inhibitor,PARP1
Esophagogastric Adenocarcinoma,BRD-K60038276-001-09-0::2.5::HTS,4.052732648634185,0.044580497023530896,Esophagogastric Adenocarcinoma,irbesartan,angiotensin receptor antagonist,"AGTR1, JUN, SLC10A1"
Esophagogastric Adenocarcinoma,BRD-K60060639-005-02-2::2.5::HTS,7.624281780470464,0.005948673237963004,Other Types,N-methyllidocaine-iodide,antiarrhythmic medication,
Esophagogastric Adenocarcinoma,BRD-K60160658-003-11-2::2.5::HTS,4.346237396002763,0.03754163213209897,Other Types,tiagabine,GABA uptake inhibitor,SLC6A1
Esophagogastric Adenocarcinoma,BRD-K60184833-001-05-6::2.5::HTS,7.062501723982139,0.008098601843179795,Esophagogastric Adenocarcinoma,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR
Esophagogastric Adenocarcinoma,BRD-K60212747-236-01-1::2.5::HTS,3.9028346883479865,0.04872498558927162,Other Types,neridronic-acid,bone resorption inhibitor,FDPS
Esophagogastric Adenocarcinoma,BRD-K61032563-001-02-9::2.5::HTS,3.949306897742482,0.04738264941369868,Esophagogastric Adenocarcinoma,neohesperidin-dihydrochalcone,,
Esophagogastric Adenocarcinoma,BRD-K61192372-001-08-9::2.5::HTS,6.3617795727067525,0.011937009609188658,Esophagogastric Adenocarcinoma,capecitabine,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS
Esophagogastric Adenocarcinoma,BRD-K61228301-001-01-2::2.5::HTS,9.923439788059794,0.0017191194972081148,Other Types,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Esophagogastric Adenocarcinoma,BRD-K61237927-001-01-7::2.5::HTS,4.943776373320653,0.0265837178218764,Other Types,eslicarbazepine-acetate,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Esophagogastric Adenocarcinoma,BRD-K61665160-001-01-5::2.5::HTS,7.2380934615216,0.0073526304337213555,Esophagogastric Adenocarcinoma,BYK-204165,PARP inhibitor,PARP1
Esophagogastric Adenocarcinoma,BRD-K61802864-001-08-8::2.5::HTS,4.352109410682169,0.03741667493071686,Esophagogastric Adenocarcinoma,chlorindione,,
Esophagogastric Adenocarcinoma,BRD-K62186992-334-02-8::2.5::HTS,7.562426399263898,0.006157352256980183,Esophagogastric Adenocarcinoma,hydroxystilbamidine,,
Esophagogastric Adenocarcinoma,BRD-K62353271-001-04-7::2.5::HTS,4.191291623167972,0.04115006874659872,Esophagogastric Adenocarcinoma,baclofen-(R),benzodiazepine receptor agonist,"GABBR1, GABBR2"
Esophagogastric Adenocarcinoma,BRD-K62696033-001-01-4::2.5::HTS,5.208098569884616,0.022856799351652163,Esophagogastric Adenocarcinoma,G-1,G protein-coupled receptor agonist,GPER1
Esophagogastric Adenocarcinoma,BRD-K62782754-337-02-5::2.5::HTS,3.98538146675254,0.046392812989782095,Esophagogastric Adenocarcinoma,tiotropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Esophagogastric Adenocarcinoma,BRD-K62996583-001-10-3::2.5::HTS,4.089115725390358,0.04363769282518569,Esophagogastric Adenocarcinoma,lidoflazine,calcium channel blocker,"SCN1A, SCN3A, SLC29A1"
Esophagogastric Adenocarcinoma,BRD-K63504947-001-15-4::2.5::HTS,4.562284807964677,0.03312274428550912,Other Types,semaxanib,VEGFR inhibitor,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Esophagogastric Adenocarcinoma,BRD-K63736853-001-04-8::2.5::HTS,5.696762046204124,0.017335697895178415,Esophagogastric Adenocarcinoma,acipimox,cholesterol inhibitor,HCAR2
Esophagogastric Adenocarcinoma,BRD-K64381438-001-03-8::2.5::HTS,10.092378491525272,0.001572366436741847,Other Types,ulipristal,progesterone receptor antagonist,PGR
Esophagogastric Adenocarcinoma,BRD-K65377893-001-07-4::2.58::HTS,4.0035864730801904,0.04591496939519874,Other Types,7-aminocephalosporanic-acid,beta lactamase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K65544384-001-15-8::2.5::HTS,4.769581628212494,0.02938324249738055,Esophagogastric Adenocarcinoma,4-aminohippuric-acid,,SLC22A6
Esophagogastric Adenocarcinoma,BRD-K65667145-001-14-0::2.5::HTS,10.543322519337696,0.0012442017205499631,Esophagogastric Adenocarcinoma,kinetin,cell division inducer,
Esophagogastric Adenocarcinoma,BRD-K65877271-001-01-8::2.5::HTS,4.751049315241074,0.02970695152811053,Other Types,halobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Esophagogastric Adenocarcinoma,BRD-K65890018-236-01-1::2.5::HTS,7.524436320781915,0.0062823817329958,Esophagogastric Adenocarcinoma,SSR128129E,,
Esophagogastric Adenocarcinoma,BRD-K66030860-001-03-6::2.5::HTS,4.18035706755606,0.04136719095536092,Esophagogastric Adenocarcinoma,salidroside,beta amyloid protein neurotoxicity inhibitor,APP
Esophagogastric Adenocarcinoma,BRD-K66175015-001-09-0::2.5::HTS,4.744909160112793,0.029812196817643945,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Esophagogastric Adenocarcinoma,BRD-K66296774-236-11-3::2.63::HTS,6.076322865053032,0.014011208023725798,Esophagogastric Adenocarcinoma,fluvastatin,HMGCR inhibitor,HMGCR
Esophagogastric Adenocarcinoma,BRD-K66465025-001-05-1::2.5::HTS,7.4701075670279025,0.006472517314254418,Esophagogastric Adenocarcinoma,ACPC,glutamate receptor antagonist,
Esophagogastric Adenocarcinoma,BRD-K66808046-065-03-7::2.5::HTS,5.565463688144979,0.018673914197852266,Other Types,oxyquinoline,chelating agent,METAP2
Esophagogastric Adenocarcinoma,BRD-K66896231-001-08-1::2.5::HTS,5.87523998493895,0.015670971327053553,Esophagogastric Adenocarcinoma,ipidacrine,acetylcholinesterase inhibitor,ACHE
Esophagogastric Adenocarcinoma,BRD-K67868012-001-07-6::2.5::HTS,11.868711738652372,0.0006134559497155622,Other Types,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Esophagogastric Adenocarcinoma,BRD-K68065987-300-09-1::2.5::HTS,8.735998087588744,0.0032529097156319474,Other Types,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Esophagogastric Adenocarcinoma,BRD-K68188368-001-09-4::2.5::HTS,4.8570752161804425,0.027940584917117334,Other Types,nifuroxazide,bacterial DNA inhibitor,
Esophagogastric Adenocarcinoma,BRD-K68264559-045-02-4::2.5::HTS,4.50725635831389,0.03419408367045326,Esophagogastric Adenocarcinoma,brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Esophagogastric Adenocarcinoma,BRD-K68408467-065-01-8::2.5::HTS,4.607745177737867,0.032258286508510196,Other Types,proflavine-hemisulfate,topical anesthetic,F2
Esophagogastric Adenocarcinoma,BRD-K68502831-001-01-2::2.5::HTS,6.48469075987859,0.011163529790162805,Other Types,dianhydrogalactitol,DNA alkylating agent,
Esophagogastric Adenocarcinoma,BRD-K68558722-001-04-0::2.5::HTS,5.090105014982777,0.02444902623203246,Esophagogastric Adenocarcinoma,deracoxib,cyclooxygenase inhibitor,PTGS2
Esophagogastric Adenocarcinoma,BRD-K68938568-001-01-7::2.5::HTS,5.095120958961229,0.02437769412003462,Other Types,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Esophagogastric Adenocarcinoma,BRD-K69216798-001-01-9::2.5::HTS,8.354296552474416,0.0040008095639654274,Esophagogastric Adenocarcinoma,iodoantipyrine,,
Esophagogastric Adenocarcinoma,BRD-K69688083-004-23-1::2.5::HTS,5.860706169920059,0.015802366856017405,Other Types,mestinon,cholinesterase inhibitor,"ACHE, BCHE"
Esophagogastric Adenocarcinoma,BRD-K70778732-003-26-7::2.5::HTS,6.9142847282147635,0.008785986845672413,Esophagogastric Adenocarcinoma,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4"
Esophagogastric Adenocarcinoma,BRD-K70912147-001-01-8::2.5::HTS,5.691555018588318,0.017380528554628842,Esophagogastric Adenocarcinoma,co-102862,,"SCN4A, SCN9A"
Esophagogastric Adenocarcinoma,BRD-K71125014-001-27-1::2.5::HTS,6.793257347465266,0.009394773483598651,Esophagogastric Adenocarcinoma,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K71289571-001-11-4::2.5::HTS,4.863159172000185,0.02784165101648224,Esophagogastric Adenocarcinoma,zafirlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2"
Esophagogastric Adenocarcinoma,BRD-K71480163-001-01-4::2.5::HTS,5.086426279492899,0.0244990777780029,Other Types,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Esophagogastric Adenocarcinoma,BRD-K72166146-066-05-4::2.5::HTS,6.018152704476261,0.014466502735337457,Other Types,dihydroergotamine,serotonin receptor agonist,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7"
Esophagogastric Adenocarcinoma,BRD-K72687424-001-02-6::2.5::HTS,4.584137382625667,0.03270101595173632,Esophagogastric Adenocarcinoma,VU0364439,glutamate receptor positive allosteric modulator,GRM4
Esophagogastric Adenocarcinoma,BRD-K72723676-003-17-8::2.5::HTS,3.86911969112645,0.04967824274138916,Other Types,benzethonium,sodium channel blocker,SCN10A
Esophagogastric Adenocarcinoma,BRD-K73923631-003-02-9::2.5::HTS,4.122368787586428,0.042792690038506116,Other Types,difloxacin,bacterial DNA gyrase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K74141488-003-11-2::2.5::HTS,4.589267264608994,0.032601798964604974,Other Types,naftifine,fungal squalene epoxidase inhibitor,SQLE
Esophagogastric Adenocarcinoma,BRD-K75516118-001-03-3::2.5::HTS,5.542610962221014,0.01890826043299164,Esophagogastric Adenocarcinoma,rolipram-R(-),phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A"
Esophagogastric Adenocarcinoma,BRD-K77115421-001-02-6::2.5::HTS,7.063920240729167,0.008093102243139038,Esophagogastric Adenocarcinoma,phthalylsulfacetamide,,
Esophagogastric Adenocarcinoma,BRD-K77345217-001-05-0::2.5::HTS,6.431297013685937,0.011490293526673806,Esophagogastric Adenocarcinoma,gallic-acid,"beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist","CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP"
Esophagogastric Adenocarcinoma,BRD-K77396579-300-01-0::2.5::HTS,4.602178342233079,0.03236777986484014,Esophagogastric Adenocarcinoma,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4
Esophagogastric Adenocarcinoma,BRD-K77597856-003-02-5::2.5::HTS,6.641476799000516,0.010220626603467328,Esophagogastric Adenocarcinoma,detomidine,adrenergic receptor agonist,ADRA2A
Esophagogastric Adenocarcinoma,BRD-K77634909-001-03-5::2.5::HTS,5.8781887089045615,0.01564616103614916,Esophagogastric Adenocarcinoma,AEG3482,HSP inducer,
Esophagogastric Adenocarcinoma,BRD-K77791657-001-01-1::2.5::HTS,5.346649870034911,0.021122598909876597,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Esophagogastric Adenocarcinoma,BRD-K77791657-003-01-7::2.67::HTS,5.822633321573882,0.016160866604617942,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Esophagogastric Adenocarcinoma,BRD-K77950083-001-03-3::2.5::HTS,3.9507781796033385,0.04734154685225972,Esophagogastric Adenocarcinoma,UPF-1069,PARP inhibitor,PARP2
Esophagogastric Adenocarcinoma,BRD-K78294846-001-12-4::2.5::HTS,4.392728430249343,0.03654566271008507,Esophagogastric Adenocarcinoma,osthol,calcium channel blocker,
Esophagogastric Adenocarcinoma,BRD-K78781788-003-01-9::2.5::HTS,6.204604159405291,0.013034571629887198,Esophagogastric Adenocarcinoma,barnidipine,calcium channel blocker,
Esophagogastric Adenocarcinoma,BRD-K78960041-001-03-2::2.5::HTS,10.027130218115321,0.0016316226892428784,Other Types,oxaliplatin,DNA inhibitor,
Esophagogastric Adenocarcinoma,BRD-K79259477-001-04-9::2.5::HTS,7.205223569793714,0.007484362678909854,Other Types,NVP-BHG712,ephrin inhibitor,EPHB4
Esophagogastric Adenocarcinoma,BRD-K79315489-001-07-8::2.5::HTS,7.669793854297755,0.0058128512623888545,Other Types,erythritol,,
Esophagogastric Adenocarcinoma,BRD-K79684402-300-02-8::2.5::HTS,4.727927033335832,0.030163358786013273,Esophagogastric Adenocarcinoma,Ro-10-5824,dopamine receptor agonist,DRD4
Esophagogastric Adenocarcinoma,BRD-K79892937-001-02-5::2.5::HTS,5.023254576435539,0.02540151480212238,Esophagogastric Adenocarcinoma,phenolsulfonphthalein,,
Esophagogastric Adenocarcinoma,BRD-K79930101-300-03-7::2.5::HTS,11.272405717160986,0.0008398922925513534,Other Types,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Esophagogastric Adenocarcinoma,BRD-K79989959-001-01-4::2.5::HTS,6.802616157906601,0.009344512640806471,Esophagogastric Adenocarcinoma,nesbuvir,RNA polymerase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K80025777-001-01-4::2.5::HTS,3.8745855155631417,0.0495178982617502,Esophagogastric Adenocarcinoma,"cis-9,trans-11-Conjugated-linoleic-acid",,
Esophagogastric Adenocarcinoma,BRD-K80396088-001-12-0::2.5::HTS,4.379535835847872,0.03683990638089868,Other Types,gliquidone,sulfonylurea,"ABCC8, KCNJ10, KCNJ8"
Esophagogastric Adenocarcinoma,BRD-K81144366-003-19-7::2.5::HTS,4.368588201133712,0.037057757195300155,Esophagogastric Adenocarcinoma,moxisylyte,adrenergic receptor antagonist,
Esophagogastric Adenocarcinoma,BRD-K81376179-001-04-8::2.5::HTS,3.9546397097623274,0.04723032198406402,Esophagogastric Adenocarcinoma,TCS-359,FLT3 inhibitor,FLT3
Esophagogastric Adenocarcinoma,BRD-K81839095-001-25-1::2.6::HTS,4.044581092895756,0.04482112347751099,Esophagogastric Adenocarcinoma,estrone,"estrogen receptor agonist, estrogenic hormone","ESR1, ESR2"
Esophagogastric Adenocarcinoma,BRD-K82104468-001-05-0::2.5::HTS,6.60800133967539,0.010408451758624955,Other Types,ethyl-vanillin,,
Esophagogastric Adenocarcinoma,BRD-K82143716-001-19-9::2.5::HTS,10.95031360988892,0.000997126466408002,Esophagogastric Adenocarcinoma,flucytosine,other antifungal,DNMT1
Esophagogastric Adenocarcinoma,BRD-K82818427-001-04-8::2.5::HTS,9.73961220112922,0.0018964902713078503,Other Types,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Esophagogastric Adenocarcinoma,BRD-K83192048-050-02-7::2.5::HTS,8.019873561689996,0.004795544537749453,Esophagogastric Adenocarcinoma,dimethindene-(S)-(+),acetylcholine receptor antagonist,HRH1
Esophagogastric Adenocarcinoma,BRD-K83607951-001-02-2::2.5::HTS,4.71830521109456,0.030262716578601967,Esophagogastric Adenocarcinoma,skepinone-l,p38 MAPK inhibitor,MAPK14
Esophagogastric Adenocarcinoma,BRD-K84748119-050-01-1::2.5::HTS,4.6470268881392105,0.031543622501707766,Esophagogastric Adenocarcinoma,vicriviroc,CC chemokine receptor antagonist,CCR5
Esophagogastric Adenocarcinoma,BRD-K85606544-001-09-1::2.5::HTS,7.086585345660392,0.007998174977533946,Other Types,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Esophagogastric Adenocarcinoma,BRD-K85757157-001-01-7::2.5::HTS,5.220815718182739,0.022692491471333242,Esophagogastric Adenocarcinoma,nifursol,bacterial DNA inhibitor,
Esophagogastric Adenocarcinoma,BRD-K85920262-001-02-1::2.5::HTS,12.006972822687812,0.0005707626041333067,Other Types,WAY-600,mTOR inhibitor,MTOR
Esophagogastric Adenocarcinoma,BRD-K86118762-001-01-8::2.5::HTS,11.107281966207635,0.0009184717419510028,Esophagogastric Adenocarcinoma,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Esophagogastric Adenocarcinoma,BRD-K86307448-001-19-1::2.5::HTS,8.032093723138072,0.004771481054083428,Other Types,allopurinol,xanthine oxidase inhibitor,XDH
Esophagogastric Adenocarcinoma,BRD-K86892782-001-17-0::2.5::HTS,4.101288582351737,0.043336578733703585,Esophagogastric Adenocarcinoma,edoxudine,DNA directed DNA polymerase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K87156652-001-12-7::2.5::HTS,5.236807509541588,0.02249500074830278,Esophagogastric Adenocarcinoma,carbimazole,antithyroid agent,TPO
Esophagogastric Adenocarcinoma,BRD-K87492696-001-16-5::2.5::HTS,7.604951337917703,0.0060115539907436176,Esophagogastric Adenocarcinoma,sulfameter,dihydrofolate reductase inhibitor,DHFR
Esophagogastric Adenocarcinoma,BRD-K87700323-003-05-1::2.5::HTS,5.7312372933961075,0.016995479976626995,Other Types,cetylpyridinium,,
Esophagogastric Adenocarcinoma,BRD-K87827419-001-16-8::2.5::HTS,7.746711181529544,0.005567436176718702,Other Types,melphalan,"DNA alkylating agent, DNA inhibitor",
Esophagogastric Adenocarcinoma,BRD-K88172511-003-21-1::2.5::HTS,7.09574598117228,0.007950416933102653,Other Types,naltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1, SIGMAR1"
Esophagogastric Adenocarcinoma,BRD-K89210380-001-13-7::2.5::HTS,6.185009538326832,0.013181825403880864,Esophagogastric Adenocarcinoma,biotin,vitamin B,"ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6"
Esophagogastric Adenocarcinoma,BRD-K89732114-300-14-7::2.5::HTS,4.106487598281068,0.04319755418779887,Other Types,trifluoperazine,dopamine receptor antagonist,"ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1"
Esophagogastric Adenocarcinoma,BRD-K90027355-001-13-3::2.44::HTS,7.195247081095414,0.0075387151549819375,Other Types,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG"
Esophagogastric Adenocarcinoma,BRD-K90647725-001-07-3::2.5::HTS,6.259766429573435,0.012653612402220833,Other Types,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
Esophagogastric Adenocarcinoma,BRD-K91111634-001-01-2::2.5::HTS,4.102902470536116,0.04328424518158792,Esophagogastric Adenocarcinoma,rotigotine,dopamine receptor agonist,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A"
Esophagogastric Adenocarcinoma,BRD-K93618743-001-21-0::2.5::HTS,6.06773526611717,0.014069699603444253,Esophagogastric Adenocarcinoma,ipriflavone,bone resorption inhibitor,
Esophagogastric Adenocarcinoma,BRD-K94379058-001-06-8::2.5::HTS,7.416108823445048,0.006668817241347747,Esophagogastric Adenocarcinoma,BML-190,cannabinoid receptor inverse agonist,CNR2
Esophagogastric Adenocarcinoma,BRD-K95053546-001-03-5::2.5::HTS,3.861219570566173,0.04993826617758731,Other Types,tempol,free radical scavenger,
Esophagogastric Adenocarcinoma,BRD-K95237249-001-26-5::2.5::HTS,4.408147672177157,0.036214570386526326,Esophagogastric Adenocarcinoma,probenecid,uricosuric blocker,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1"
Esophagogastric Adenocarcinoma,BRD-K95773607-004-03-8::2.5::HTS,5.65345221384998,0.01775454429694217,Other Types,darifenacin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Esophagogastric Adenocarcinoma,BRD-K96029467-003-01-9::2.5::HTS,7.659995925056814,0.0058336440638992616,Esophagogastric Adenocarcinoma,alagebrium,glycosylation inhibitor,
Esophagogastric Adenocarcinoma,BRD-K96263742-001-14-8::2.5::HTS,6.013391959205043,0.0145051511250529,Other Types,GW-7647,PPAR receptor agonist,PPARA
Esophagogastric Adenocarcinoma,BRD-K96740444-001-02-1::2.5::HTS,4.007604274188429,0.04577729955916982,Esophagogastric Adenocarcinoma,itopride,dopamine receptor antagonist,"CHRM3, DRD2"
Esophagogastric Adenocarcinoma,BRD-K97197005-001-03-2::2.5::HTS,3.992952555988115,0.04617747024919425,Esophagogastric Adenocarcinoma,gestodene,contraceptive agent,
Esophagogastric Adenocarcinoma,BRD-K97472745-001-01-8::2.5::HTS,5.908158455662788,0.01538271827563073,Esophagogastric Adenocarcinoma,gestrinone,progesterone receptor antagonist,"AR, ESR1, PGR"
Esophagogastric Adenocarcinoma,BRD-K97752965-001-16-4::2.5::HTS,5.001670188415915,0.025742885676525475,Other Types,nicorandil,"nitric oxide donor, potassium channel activator",KCNJ11
Esophagogastric Adenocarcinoma,BRD-K98572433-001-02-9::2.5::HTS,4.589556198024153,0.032597884203984316,Other Types,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Esophagogastric Adenocarcinoma,BRD-K99023089-001-03-7::2.5::HTS,6.980844346211469,0.008469446701292896,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Esophagogastric Adenocarcinoma,BRD-K99063460-001-13-1::2.5::HTS,5.65326309576593,0.01777798820158413,Other Types,didanosine,nucleoside reverse transcriptase inhibitor,PNP
Esophagogastric Adenocarcinoma,BRD-K99174507-003-02-0::2.5::HTS,9.173376892121356,0.0025700242436792423,Esophagogastric Adenocarcinoma,cardiogenol-c,cardiomyogenesis inducer,
Esophagogastric Adenocarcinoma,BRD-K99383816-001-03-5::2.5::HTS,5.433272736197552,0.02012449626590597,Other Types,ftorafur,thymidylate synthase inhibitor,TYMS
Esophagogastric Adenocarcinoma,BRD-K99741577-001-01-7::2.5::HTS,4.5878140536805025,0.03262922096654154,Esophagogastric Adenocarcinoma,SANT-1,smoothened receptor antagonist,"SHH, SMO"
Esophagogastric Adenocarcinoma,BRD-K99749624-001-07-0::2.5::HTS,5.010348002366635,0.02558911083760001,Other Types,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Esophagogastric Adenocarcinoma,BRD-M02075109-001-01-1::2.5::HTS,13.589641206217669,0.0002498127276131237,Esophagogastric Adenocarcinoma,chromanol-(+/-),potassium channel blocker,
Esophagogastric Adenocarcinoma,BRD-M41245765-001-04-2::2.5::HTS,6.239113034724665,0.012799063974083414,Esophagogastric Adenocarcinoma,lithium-citrate,,
Esophagogastric Adenocarcinoma,BRD-U08520523-000-01-0::2.5::HTS,4.4284220161993,0.03582547619968273,Esophagogastric Adenocarcinoma,colesevalam,,
Esophagogastric Adenocarcinoma,BRD-A40546373-001-01-8::2.500029443::MTS004,6.466911553359435,0.011268535340720046,Esophagogastric Adenocarcinoma,morinidazole,other antibiotic,CYP51A1
Esophagogastric Adenocarcinoma,BRD-A53077924-001-01-2::2.499990763::MTS004,8.500836129734964,0.0036978118617576688,Esophagogastric Adenocarcinoma,tianeptine,selective serotonin reuptake enhancer (SSRE),"OPRD1, OPRK1, OPRM1"
Esophagogastric Adenocarcinoma,BRD-A59961917-001-01-0::2.5::MTS004,4.138626407586717,0.042405094371802926,Esophagogastric Adenocarcinoma,BQ-123,endothelin receptor antagonist,EDNRA
Esophagogastric Adenocarcinoma,BRD-A72401848-001-02-2::2.551316459::MTS004,4.435384167107603,0.03566310601359426,Esophagogastric Adenocarcinoma,gadoteridol,radiopaque medium,
Esophagogastric Adenocarcinoma,BRD-K04701033-001-04-7::2.499987566::MTS004,8.180070777503893,0.004399498404114737,Other Types,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Esophagogastric Adenocarcinoma,BRD-K08255599-365-01-1::2.656154742::MTS004,4.0701261589251,0.04414405647411872,Esophagogastric Adenocarcinoma,frovatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D"
Esophagogastric Adenocarcinoma,BRD-K10667240-001-01-7::2.485820406::MTS004,9.385750957767755,0.0022963098467155625,Esophagogastric Adenocarcinoma,ethacizin,anticonvulsant,
Esophagogastric Adenocarcinoma,BRD-K11851476-003-01-7::2.499993171::MTS004,4.0844266442754575,0.04377398602849937,Other Types,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Esophagogastric Adenocarcinoma,BRD-K13414800-001-01-3::2.499970601::MTS004,4.556888557929675,0.03323700670575423,Other Types,vesnarinone,phosphodiesterase inhibitor,"KCNH2, PDE3A"
Esophagogastric Adenocarcinoma,BRD-K16180792-001-01-7::2.5::MTS004,11.989720645080403,0.0005774380582950146,Esophagogastric Adenocarcinoma,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Esophagogastric Adenocarcinoma,BRD-K16505263-003-02-9::2.49996754::MTS004,5.825756976133678,0.016125564151885548,Esophagogastric Adenocarcinoma,forodesine,purinergic receptor antagonist,PNP
Esophagogastric Adenocarcinoma,BRD-K18749874-003-08-9::2.5::MTS004,6.857633279945216,0.00907471177932962,Esophagogastric Adenocarcinoma,melevodopa,"dopamine precursor, dopamine receptor agonist",DDC
Esophagogastric Adenocarcinoma,BRD-K22514639-001-05-7::2.500015058::MTS004,5.287998836158517,0.02185424037826197,Other Types,EGF816,EGFR inhibitor,EGFR
Esophagogastric Adenocarcinoma,BRD-K22525962-001-05-0::2.500010949::MTS004,4.191845199563694,0.041103084523333645,Esophagogastric Adenocarcinoma,dihydrotestosterone,androgen receptor agonist,"AR, HSD17B1"
Esophagogastric Adenocarcinoma,BRD-K24497734-001-01-6::2.499993902::MTS004,5.774938245166506,0.016593816862433355,Esophagogastric Adenocarcinoma,setipiprant,prostaglandin inhibitor,PTGDR2
Esophagogastric Adenocarcinoma,BRD-K26026438-001-01-0::2.499979456::MTS004,8.990024530540333,0.002840067469804803,Other Types,tucatinib,EGFR inhibitor,ERBB2
Esophagogastric Adenocarcinoma,BRD-K30159788-001-01-9::2.49998123::MTS004,6.371822962813858,0.011881227457949903,Esophagogastric Adenocarcinoma,RSV604,RSV replication inhibitor,
Esophagogastric Adenocarcinoma,BRD-K32256160-001-01-9::2.499998021::MTS004,12.752020953121734,0.0003874937530637202,Esophagogastric Adenocarcinoma,solithromycin,protein synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K38168441-001-03-7::2.422985058::MTS004,7.2025399550228695,0.007504283464208197,Other Types,dabigatran,thrombin inhibitor,F2
Esophagogastric Adenocarcinoma,BRD-K41592905-001-01-6::2.5::MTS004,5.273203690238502,0.02203886225707011,Esophagogastric Adenocarcinoma,7-methylxanthine,adenosine receptor antagonist,
Esophagogastric Adenocarcinoma,BRD-K42140276-402-01-4::2.500009363::MTS004,4.701555302648185,0.030572091833077353,Other Types,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
Esophagogastric Adenocarcinoma,BRD-K43890836-001-01-6::2.5::MTS004,6.3930001728621155,0.011741457801653143,Esophagogastric Adenocarcinoma,gemcadiol,antilipemic,
Esophagogastric Adenocarcinoma,BRD-K47492008-001-02-7::2.5::MTS004,8.479805968159734,0.0037398420265749768,Esophagogastric Adenocarcinoma,alclofenac,cyclooxygenase inhibitor,PTGS1
Esophagogastric Adenocarcinoma,BRD-K48429278-001-01-3::2.5::MTS004,4.084228346181463,0.04377908251176414,Esophagogastric Adenocarcinoma,pipotiazine-palmitate,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, DRD2, HTR1A, HTR2A"
Esophagogastric Adenocarcinoma,BRD-K53236343-003-03-7::2.625172304::MTS004,5.111806755017129,0.024162195300318608,Esophagogastric Adenocarcinoma,aprindine,voltage-gated sodium channel blocker,"CALM1, SCN5A"
Esophagogastric Adenocarcinoma,BRD-K56740996-001-01-3::2.601527794::MTS004,4.848225800392584,0.028098219618030815,Esophagogastric Adenocarcinoma,flindokalner,potassium channel agonist,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5"
Esophagogastric Adenocarcinoma,BRD-K66845263-001-03-0::2.5::MTS004,4.894663774345986,0.02735826102527796,Esophagogastric Adenocarcinoma,sophocarpine,,
Esophagogastric Adenocarcinoma,BRD-K68432770-236-23-1::2.500029469::MTS004,3.9798643272845506,0.04655030540781713,Esophagogastric Adenocarcinoma,ampicillin,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K68544925-001-01-1::2.500014712::MTS004,5.0836203376157245,0.02455418529167089,Esophagogastric Adenocarcinoma,avatrombopag,thrombopoietin receptor agonist,MPL
Esophagogastric Adenocarcinoma,BRD-K70601687-001-01-3::2.500008826::MTS004,8.44839176337701,0.003804244092873086,Other Types,enasidenib,isocitrate dehydrogenase inhibitor,IDH1
Esophagogastric Adenocarcinoma,BRD-K72280606-001-01-2::2.499993939::MTS004,4.229653588835542,0.04020433577164718,Esophagogastric Adenocarcinoma,gilteritinib,FLT3 inhibitor,FLT3
Esophagogastric Adenocarcinoma,BRD-K73132780-001-01-2::2.5::MTS004,7.408387375469483,0.006702093351233063,Other Types,pyronaridine,antimalarial agent,
Esophagogastric Adenocarcinoma,BRD-K74671368-001-01-8::2.5::MTS004,4.167873656162367,0.0416838581600211,Esophagogastric Adenocarcinoma,idronoxil,XIAP inhibitor,"ENOX2, SPHK1"
Esophagogastric Adenocarcinoma,BRD-K74759733-065-01-4::2.5::MTS004,7.464109940349462,0.006500543575773544,Esophagogastric Adenocarcinoma,isepamicin,protein synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K76594255-001-01-6::2.5000235::MTS004,4.402231459552335,0.036357700479383866,Other Types,maropitant,neurokinin receptor antagonist,TACR1
Esophagogastric Adenocarcinoma,BRD-K77073709-435-01-2::2.5::MTS004,4.093930234996548,0.04353046563858891,Esophagogastric Adenocarcinoma,cefminox,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K78841970-001-13-8::2.388586862::MTS004,4.300893781735736,0.03856661852274444,Esophagogastric Adenocarcinoma,aspartame,,"TAS1R2, TRPV1"
Esophagogastric Adenocarcinoma,BRD-K79710622-001-02-9::2.5::MTS004,4.0865378988705965,0.0437206817046009,Esophagogastric Adenocarcinoma,GKT137831,NADPH oxidase inhibitor,"NOX1, NOX4"
Esophagogastric Adenocarcinoma,BRD-K82687598-001-01-6::2.5::MTS004,5.487037321117006,0.019520908611921114,Other Types,tolonidine,adrenergic receptor antagonist,ADRA2A
Esophagogastric Adenocarcinoma,BRD-K86873305-236-14-7::2.448463554::MTS004,4.1914013552073355,0.04111466109989498,Esophagogastric Adenocarcinoma,piperacillin,bacterial cell wall synthesis inhibitor,
Esophagogastric Adenocarcinoma,BRD-K90069354-001-03-7::2.5::MTS004,4.694002667922795,0.030706346664487256,Esophagogastric Adenocarcinoma,isovaleramide,alcohol dehydrogenase inhibitor,
Esophagogastric Adenocarcinoma,BRD-K96206066-001-07-9::2.591957442::MTS004,3.8883047868913754,0.049134363802528475,Esophagogastric Adenocarcinoma,difenpiramide,"cyclooxygenase inhibitor, prostaglandin inhibitor",
Esophagogastric Adenocarcinoma,BRD-K96471533-001-09-0::2.592774962::MTS004,6.50704157976764,0.011020022339569852,Esophagogastric Adenocarcinoma,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
Rhabdomyosarcoma,BRD-A01412266-001-01-0::2.5::HTS,9.905807353462858,0.0017365052777293547,Other Types,hydroxypropyl-beta-cyclodextrin,,
Rhabdomyosarcoma,BRD-A02006392-001-16-4::2.5::HTS,6.19696661817714,0.013085053909706873,Rhabdomyosarcoma,nitrendipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4"
Rhabdomyosarcoma,BRD-A04352665-001-05-3::2.5::HTS,4.141614535961374,0.04232999210604041,Other Types,maraviroc,CC chemokine receptor antagonist,CCR5
Rhabdomyosarcoma,BRD-A07704283-001-01-3::2.5::HTS,6.867843313455237,0.009016491084344432,Rhabdomyosarcoma,isofloxythepin,dopamine receptor antagonist,
Rhabdomyosarcoma,BRD-A07893380-213-01-7::2.5::HTS,5.688291382943405,0.01743032215829518,Other Types,vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1"
Rhabdomyosarcoma,BRD-A08079565-001-01-8::2.5::HTS,4.850747191724856,0.028051339324458253,Rhabdomyosarcoma,CDBA,,
Rhabdomyosarcoma,BRD-A08660406-001-05-9::2.5::HTS,5.997797612007878,0.014657274757507973,Rhabdomyosarcoma,iodixanol,radiopaque medium,
Rhabdomyosarcoma,BRD-A08715367-001-01-7::2.87::HTS,9.678849006034275,0.001959995062438751,Rhabdomyosarcoma,L-Theanine,glutamate receptor antagonist,
Rhabdomyosarcoma,BRD-A10977446-001-12-1::2.5::HTS,6.728843646151093,0.00974462316858627,Rhabdomyosarcoma,carvedilol,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA"
Rhabdomyosarcoma,BRD-A11132253-001-08-2::2.5::HTS,9.448878737246105,0.002220337401578085,Rhabdomyosarcoma,nadide,electron acceptor,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2"
Rhabdomyosarcoma,BRD-A11815689-001-01-1::2.5::HTS,3.9599532773870636,0.047083428501502766,Rhabdomyosarcoma,proscillaridin-a,,
Rhabdomyosarcoma,BRD-A12077521-003-01-5::2.5::HTS,5.8166218973312755,0.016208607508147545,Rhabdomyosarcoma,cefepime,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-A13084692-001-17-3::2.5::HTS,4.839357517538565,0.028230199782680623,Other Types,troglitazone,"insulin sensitizer, PPAR receptor agonist","ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3"
Rhabdomyosarcoma,BRD-A14886633-001-01-6::2.5::HTS,15.039259038416313,0.00011793693846461014,Other Types,norgestrel,progesterone receptor agonist,PGR
Rhabdomyosarcoma,BRD-A15415227-003-02-9::2.5::HTS,7.275586888424669,0.0071996438035611555,Other Types,GW-1929,PPAR receptor agonist,PPARG
Rhabdomyosarcoma,BRD-A16997652-001-02-3::2.5::HTS,5.312901332054547,0.021535493395092857,Rhabdomyosarcoma,protirelin,thyrotropin releasing hormone receptor agonist,TRHR
Rhabdomyosarcoma,BRD-A17453586-003-02-3::2.5::HTS,8.172816916080665,0.004410063192904456,Rhabdomyosarcoma,MDL-72832,serotonin receptor agonist,HTR1A
Rhabdomyosarcoma,BRD-A18233884-003-02-7::2.5::HTS,11.951711327025448,0.0005880355533777174,Other Types,bevantolol,adrenergic receptor antagonist,"ADRA1A, ADRB1, ADRB2"
Rhabdomyosarcoma,BRD-A19633847-050-32-1::2.5::HTS,3.9952196073925488,0.04611065547713387,Rhabdomyosarcoma,perhexiline,carnitine palmitoyltransferase inhibitor,"CPT1A, CPT2"
Rhabdomyosarcoma,BRD-A19795905-001-08-0::2.5::HTS,4.712123030035496,0.03037457908821678,Rhabdomyosarcoma,atovaquone,mitochondrial electron transport inhibitor,DHODH
Rhabdomyosarcoma,BRD-A19958636-065-04-4::2.5::HTS,5.890458625430133,0.015539242202991901,Rhabdomyosarcoma,tuaminoheptane,,
Rhabdomyosarcoma,BRD-A20348246-001-15-8::2.5::HTS,6.830251200435853,0.009204059413467072,Rhabdomyosarcoma,chlormezanone,GABA receptor modulator,"GABRA1, TSPO"
Rhabdomyosarcoma,BRD-A21276153-001-01-1::2.5::HTS,6.581877288650973,0.010577184980013605,Other Types,"2,6-dimethylpiperidine",,
Rhabdomyosarcoma,BRD-A21607826-003-05-1::2.5::HTS,4.884291348316076,0.02751020563085747,Rhabdomyosarcoma,medetomidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Rhabdomyosarcoma,BRD-A22256192-003-22-7::2.5::HTS,6.435191920654834,0.01145845929767117,Other Types,terazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7"
Rhabdomyosarcoma,BRD-A24514565-001-09-7::2.5::HTS,4.130549609751748,0.042592137443509245,Rhabdomyosarcoma,warfarin,vitamin K antagonist,VKORC1
Rhabdomyosarcoma,BRD-A25004090-001-08-4::2.5::HTS,4.34901310076702,0.037484213567256966,Other Types,erastin,ion channel antagonist,VDAC2
Rhabdomyosarcoma,BRD-A25234499-001-18-3::2.5::HTS,3.953414910180736,0.047264452987713146,Other Types,aminoglutethimide,glucocorticoid receptor antagonist,"CYP11A1, CYP19A1"
Rhabdomyosarcoma,BRD-A26387268-050-04-4::2.5::HTS,4.716796715998678,0.030289801308387588,Other Types,ergonovine,"adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E"
Rhabdomyosarcoma,BRD-A26503646-001-16-6::2.5::HTS,5.71034681971036,0.017193800832904633,Rhabdomyosarcoma,formestane,aromatase inhibitor,CYP19A1
Rhabdomyosarcoma,BRD-A29289453-001-04-7::2.5::HTS,4.174721747085425,0.04149967035669539,Other Types,PCA-4248,platelet activating factor receptor antagonist,PTAFR
Rhabdomyosarcoma,BRD-A29700858-304-02-6::2.5::HTS,5.405268038819438,0.020431325325310782,Rhabdomyosarcoma,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3"
Rhabdomyosarcoma,BRD-A29731977-001-04-5::2.5::HTS,10.024811577424114,0.0016286186359267356,Rhabdomyosarcoma,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Rhabdomyosarcoma,BRD-A30403214-001-03-3::0.25::HTS,6.24641741533439,0.012731714705029335,Rhabdomyosarcoma,edelfosine,phospholipase inhibitor,
Rhabdomyosarcoma,BRD-A30590053-003-02-9::2.5::HTS,8.77980587800587,0.0031747883554521053,Rhabdomyosarcoma,MR-16728,acetylcholine release enhancer,
Rhabdomyosarcoma,BRD-A30693873-003-12-8::2.5::HTS,6.942631895103298,0.008650375636241648,Rhabdomyosarcoma,diperodon,local anesthetic,
Rhabdomyosarcoma,BRD-A32673558-003-03-9::2.5::HTS,7.335175579610772,0.0069696838956675835,Rhabdomyosarcoma,aceclidine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdomyosarcoma,BRD-A33514596-003-01-2::2.5::HTS,13.596928042644093,0.0002489515888310633,Other Types,N-benzylnaltrindole,opioid receptor antagonist,
Rhabdomyosarcoma,BRD-A34358106-003-01-6::2.5::HTS,4.70705600947858,0.030463455248281177,Rhabdomyosarcoma,sarpogrelate,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Rhabdomyosarcoma,BRD-A35623999-001-05-7::2.5::HTS,4.639129095052012,0.031679192692797245,Other Types,CGP-37157,"mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor",SLC8A1
Rhabdomyosarcoma,BRD-A35868371-005-01-6::2.5::HTS,9.10584757203508,0.0026654629205509588,Other Types,troventol,,
Rhabdomyosarcoma,BRD-A36331462-001-02-1::2.5::HTS,6.919020704689863,0.008766457899856864,Rhabdomyosarcoma,oprozomib,proteasome inhibitor,
Rhabdomyosarcoma,BRD-A39255369-001-03-1::2.5::HTS,5.908044058859431,0.015384824267210426,Rhabdomyosarcoma,DCPIB,"chloride channel blocker, gap junction modulator, glutamate inhibitor",SLC1A2
Rhabdomyosarcoma,BRD-A40084411-003-07-7::2.5::HTS,4.0654508950749495,0.044258174099643575,Rhabdomyosarcoma,CGP-12177,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Rhabdomyosarcoma,BRD-A40787240-066-04-6::2.5::HTS,5.075955251427968,0.024656021005253572,Other Types,gemifloxacin,bacterial DNA gyrase inhibitor,
Rhabdomyosarcoma,BRD-A41692738-001-07-6::2.5::HTS,3.9587634514462056,0.04711912261549253,Rhabdomyosarcoma,TGX-221,PI3K inhibitor,"PIK3CB, PIK3CD"
Rhabdomyosarcoma,BRD-A41774846-001-01-4::2.5::HTS,6.556262353984405,0.010711738071613984,Rhabdomyosarcoma,algestone-acetophenide,,
Rhabdomyosarcoma,BRD-A42167015-003-10-2::2.5::HTS,9.159674278884834,0.0025879792852402297,Rhabdomyosarcoma,carteolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Rhabdomyosarcoma,BRD-A42571354-300-12-0::2.5::HTS,3.86381326522645,0.04983354728405645,Rhabdomyosarcoma,cetirizine,histamine receptor antagonist,HRH1
Rhabdomyosarcoma,BRD-A44448661-001-04-8::2.5::HTS,6.760374168910569,0.009565534679037079,Other Types,pentobarbital,"barbiturate antiepileptic, GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Rhabdomyosarcoma,BRD-A44863528-001-13-2::2.5::HTS,3.985920655659598,0.04637268346032679,Other Types,proglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Rhabdomyosarcoma,BRD-A46393198-003-16-6::2.5::HTS,6.340645153364731,0.012079414931303432,Other Types,tetramisole,immunostimulant,
Rhabdomyosarcoma,BRD-A48015106-004-08-9::2.5::HTS,6.290944061575449,0.012416270616922201,Rhabdomyosarcoma,8-hydroxy-DPAT,serotonin receptor agonist,"CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG"
Rhabdomyosarcoma,BRD-A49447682-001-02-4::2.5::HTS,6.449138222750081,0.011371351208770454,Rhabdomyosarcoma,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Rhabdomyosarcoma,BRD-A49622760-001-01-9::2.5::HTS,6.754391196345207,0.009604506047680574,Other Types,faropenem,lactamase inhibitor,
Rhabdomyosarcoma,BRD-A50028488-001-01-6::2.5::HTS,4.5251845616696595,0.03383820112396933,Rhabdomyosarcoma,TCS2002,glycogen synthase kinase inhibitor,GSK3B
Rhabdomyosarcoma,BRD-A50675702-001-07-1::2.5::HTS,19.28564136839514,1.3494566870571064e-05,Rhabdomyosarcoma,fipronil,"chloride channel blocker, GABA gated chloride channel blocker",
Rhabdomyosarcoma,BRD-A51713165-003-02-6::2.5::HTS,12.126128842697758,0.0005360831039124404,Rhabdomyosarcoma,3-CPMT,dopamine reuptake inhibitor,
Rhabdomyosarcoma,BRD-A52588987-004-08-2::2.5::HTS,11.378711403755927,0.0007943467809199983,Other Types,SKF-83566,dopamine receptor antagonist,"DRD1, DRD5"
Rhabdomyosarcoma,BRD-A53037300-001-01-0::2.5::HTS,5.460206148810596,0.019806635249379506,Other Types,2-fluoro-2-deoxy-D-galactose,,LCT
Rhabdomyosarcoma,BRD-A53134341-001-03-2::2.5::HTS,10.219144429372898,0.0014721642035749867,Other Types,Ro-106-9920,NFkB pathway inhibitor,
Rhabdomyosarcoma,BRD-A53952395-003-25-1::2.5::HTS,7.5031398081533,0.006356440294021172,Other Types,prilocaine,local anesthetic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Rhabdomyosarcoma,BRD-A54275602-001-01-0::2.5::HTS,3.8890393228837694,0.04910100033860308,Other Types,lanoconazole,sterol demethylase inhibitor,
Rhabdomyosarcoma,BRD-A55664972-236-02-6::2.5::HTS,6.2654908930826805,0.012596398555907247,Other Types,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Rhabdomyosarcoma,BRD-A56152450-001-02-0::2.5::HTS,4.061750823127989,0.044371199087149746,Other Types,dimercaprol,chelating agent,
Rhabdomyosarcoma,BRD-A56359832-001-11-1::2.5::HTS,8.195050194997897,0.004357121316357878,Other Types,zileuton,"leukotriene synthesis inhibitor, lipoxygenase inhibitor",ALOX5
Rhabdomyosarcoma,BRD-A56371469-001-03-3::2.5::HTS,4.6236246919949275,0.03196197950214229,Rhabdomyosarcoma,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1
Rhabdomyosarcoma,BRD-A57798559-004-02-3::2.5::HTS,3.972938592132933,0.04672700169071513,Rhabdomyosarcoma,bicuculline-methochloride-(-),GABA receptor antagonist,
Rhabdomyosarcoma,BRD-A57833392-001-01-7::2.5::HTS,3.951632289297446,0.04731770326487454,Rhabdomyosarcoma,oxymatrine,,
Rhabdomyosarcoma,BRD-A57957888-001-08-0::2.5::HTS,3.907224471689644,0.048571746624923036,Rhabdomyosarcoma,citiolone,"lipotropic, mucolytic agent",
Rhabdomyosarcoma,BRD-A59198242-003-02-9::2.5::HTS,7.285137522934955,0.007162338439530346,Other Types,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Rhabdomyosarcoma,BRD-A60217728-001-11-2::2.5::HTS,4.119253987862005,0.04287264695548634,Rhabdomyosarcoma,iohexol,radiopaque medium,
Rhabdomyosarcoma,BRD-A61154809-001-15-9::2.5::HTS,8.253885746385674,0.004220131273788993,Other Types,gliclazide,"ATP channel blocker, insulin secretagogue","ABCC8, VEGFA"
Rhabdomyosarcoma,BRD-A62428732-300-06-3::2.5::HTS,4.653513504972451,0.031413268060357116,Rhabdomyosarcoma,hydroxyzine,antihistamine,HRH1
Rhabdomyosarcoma,BRD-A63752151-001-01-2::2.5::HTS,12.515163707259925,0.0004370216417878132,Rhabdomyosarcoma,fidarestat,aldose reductase inhibitor,AKR1B1
Rhabdomyosarcoma,BRD-A64064900-001-02-3::2.5::HTS,5.933021629126247,0.015178571146316945,Rhabdomyosarcoma,sangivamycin,DNA inhibitor,
Rhabdomyosarcoma,BRD-A64698388-003-01-7::2.5::HTS,11.08175826043624,0.0009306099195999177,Rhabdomyosarcoma,levo-phencynonate,acetylcholine receptor antagonist,CHRM1
Rhabdomyosarcoma,BRD-A64743628-001-01-5::2.5::HTS,7.073214962781947,0.008047695539957163,Other Types,isometheptene-mucate,,"ADRA1A, SLC18A2"
Rhabdomyosarcoma,BRD-A65449987-001-10-4::2.5::HTS,5.557372168895716,0.018747335941310228,Rhabdomyosarcoma,flunisolide,cytochrome P450 inhibitor,NR3C1
Rhabdomyosarcoma,BRD-A65597028-003-07-3::2.5::HTS,5.110955791647852,0.02416379815758906,Other Types,RX-821002,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Rhabdomyosarcoma,BRD-A65797496-048-09-3::2.5::HTS,4.526405499113293,0.0338103594217012,Other Types,deptropine,histamine receptor antagonist,HRH1
Rhabdomyosarcoma,BRD-A66419424-001-02-4::2.5::HTS,6.293061538352817,0.012406717845673145,Rhabdomyosarcoma,ixazomib-citrate,proteasome inhibitor,
Rhabdomyosarcoma,BRD-A66435872-332-01-8::2.5::HTS,7.1694587201625035,0.007632295581368432,Other Types,HTMT,histamine receptor agonist,HRH4
Rhabdomyosarcoma,BRD-A66920069-001-01-3::2.5::HTS,6.213348985356673,0.012965851288288185,Rhabdomyosarcoma,fenigam,benzodiazepine receptor agonist,"GABBR1, GABBR2"
Rhabdomyosarcoma,BRD-A67482312-001-02-6::2.5::HTS,3.9977079694225814,0.04604744525004978,Other Types,4-P-PDOT,melatonin receptor antagonist,"MTNR1A, MTNR1B"
Rhabdomyosarcoma,BRD-A68969091-001-12-7::2.57::HTS,7.827170819165116,0.005328324982787003,Rhabdomyosarcoma,echinomycin,DNA intercalating agent,
Rhabdomyosarcoma,BRD-A69275535-001-01-5::2.5::HTS,6.408372917502175,0.011630773907558577,Other Types,pinitol,gamma secretase inhibitor,
Rhabdomyosarcoma,BRD-A69651145-003-07-2::2.5::HTS,4.375282318712399,0.03693468833132933,Other Types,minocycline,bacterial 30S ribosomal subunit inhibitor,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA"
Rhabdomyosarcoma,BRD-A69917777-065-02-2::2.5::HTS,9.04526197813243,0.0027526646674414543,Other Types,aminopentamide,acetylcholine receptor antagonist,CHRM1
Rhabdomyosarcoma,BRD-A70083328-001-24-3::2.5::HTS,10.159763366470587,0.0015186248747287774,Rhabdomyosarcoma,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Rhabdomyosarcoma,BRD-A73556557-001-06-4::2.5::HTS,5.178799360029179,0.023238972447119345,Other Types,tagatose,phosphorylase inhibitor,PYGL
Rhabdomyosarcoma,BRD-A74667430-001-23-6::2.5::HTS,10.108215883681677,0.0015573551489904025,Other Types,etodolac,cyclooxygenase inhibitor,"PTGS1, PTGS2, RXRA"
Rhabdomyosarcoma,BRD-A79981887-003-16-4::2.5::HTS,4.321975869715811,0.03807618718383273,Rhabdomyosarcoma,midodrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D"
Rhabdomyosarcoma,BRD-A83650191-004-02-8::2.5::HTS,6.146529048937497,0.013490395490795348,Other Types,A61603,adrenergic receptor agonist,ADRA1A
Rhabdomyosarcoma,BRD-A84389633-001-05-7::2.5::HTS,4.208719469081251,0.04067960198350198,Other Types,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,"HTR3A, HTR3B"
Rhabdomyosarcoma,BRD-A85548292-001-01-8::2.5::HTS,7.795246029415386,0.00542431996731144,Rhabdomyosarcoma,piketoprofen,cyclooxygenase inhibitor,
Rhabdomyosarcoma,BRD-A86044036-001-26-5::2.5::HTS,4.42896275617261,0.03578547790918711,Rhabdomyosarcoma,flurbiprofen-(+/-),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Rhabdomyosarcoma,BRD-A89164055-001-03-3::2.5::HTS,5.527986749820686,0.019060914557292714,Rhabdomyosarcoma,sorbinil,aldose reductase inhibitor,AKR1B1
Rhabdomyosarcoma,BRD-A89337244-001-02-9::2.5::HTS,6.168689110523484,0.013297685490182391,Other Types,PD-102807,acetylcholine receptor antagonist,CHRM4
Rhabdomyosarcoma,BRD-A90515964-001-16-5::2.5::HTS,7.74696908447352,0.005562942783242117,Rhabdomyosarcoma,guaifenesin,expectorant,
Rhabdomyosarcoma,BRD-A90625545-001-02-0::2.5::HTS,8.498486002329832,0.003696896557790267,Rhabdomyosarcoma,clinofibrate,lipase clearing factor inhibitor,LPL
Rhabdomyosarcoma,BRD-A91452556-001-04-0::2.5::HTS,4.552630937626319,0.03330365289619344,Other Types,estradiol-cypionate,estrogen receptor agonist,ESR1
Rhabdomyosarcoma,BRD-A93236127-001-04-5::2.5::HTS,5.016957750813091,0.025493908944052613,Rhabdomyosarcoma,digitoxin,ATPase inhibitor,ATP1A1
Rhabdomyosarcoma,BRD-A94756469-001-04-7::2.5::HTS,5.615672710068587,0.018137324212800163,Rhabdomyosarcoma,digoxin,ATPase inhibitor,ATP1A1
Rhabdomyosarcoma,BRD-A96456596-001-02-2::2.5::HTS,4.261828056051991,0.039436229032752,Rhabdomyosarcoma,FPL-55712,leukotriene receptor antagonist,
Rhabdomyosarcoma,BRD-A96485169-001-14-3::2.5::HTS,12.624714110360214,0.00041267312649385045,Other Types,EBPC,aldose reductase inhibitor,AKR1B1
Rhabdomyosarcoma,BRD-A97701745-001-16-0::2.5::HTS,6.299770330813972,0.01235529646453928,Rhabdomyosarcoma,pindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B"
Rhabdomyosarcoma,BRD-A97739905-001-26-5::2.5::HTS,6.167401737492771,0.013316626356457797,Rhabdomyosarcoma,ketoprofen,cyclooxygenase inhibitor,"CXCR1, PTGS1, PTGS2, SLC5A8"
Rhabdomyosarcoma,BRD-A99888680-001-04-6::2.5::HTS,5.378989592567261,0.020740842380274252,Rhabdomyosarcoma,paliperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C"
Rhabdomyosarcoma,BRD-K00312224-001-09-5::2.5::HTS,13.976947974741018,0.0002043717596578958,Other Types,PPT,estrogen receptor agonist,ESR1
Rhabdomyosarcoma,BRD-K00573984-003-01-5::2.5::HTS,10.727759949840802,0.0011215918273382625,Other Types,delapril,angiotensin converting enzyme inhibitor,ACE
Rhabdomyosarcoma,BRD-K00673382-001-18-9::2.5::HTS,7.108480844232114,0.007896472795935182,Rhabdomyosarcoma,famotidine,histamine receptor antagonist,HRH2
Rhabdomyosarcoma,BRD-K00674894-001-01-4::2.5::HTS,11.291361334466197,0.0008338308579223943,Other Types,orteronel,"androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor",CYP17A1
Rhabdomyosarcoma,BRD-K01815685-001-15-5::2.5::HTS,7.8838713111988525,0.005163555085608616,Other Types,indole-3-carbinol,"aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor",AHR
Rhabdomyosarcoma,BRD-K01902415-001-11-7::2.5::HTS,7.996063902291398,0.004858085623141943,Other Types,pirinixic-acid,PPAR receptor agonist,PPARA
Rhabdomyosarcoma,BRD-K01942991-005-08-2::2.5::HTS,7.5641211559047905,0.006148772470817211,Rhabdomyosarcoma,oxotremorine-m,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Rhabdomyosarcoma,BRD-K02079473-001-01-3::2.5::HTS,3.902811780479617,0.0486985366120586,Other Types,oxatomide,histamine receptor antagonist,HRH1
Rhabdomyosarcoma,BRD-K02908048-003-06-4::2.5::HTS,8.544308019858148,0.0036071245046940255,Other Types,preclamol,dopamine receptor agonist,DRD2
Rhabdomyosarcoma,BRD-K02965346-001-07-5::2.5::HTS,5.977832546645793,0.014797220756422582,Other Types,SU-11274,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor",MET
Rhabdomyosarcoma,BRD-K03095347-001-06-1::2.5::HTS,4.162631669867933,0.04179881184516064,Rhabdomyosarcoma,levosimendan,calcium sensitizer,"KCNJ11, KCNJ8, PDE3A, TNNC1"
Rhabdomyosarcoma,BRD-K04176066-001-08-3::2.5::HTS,5.434828619875646,0.020092931378481296,Other Types,bergenin,interleukin inhibitor,"IL1B, TNF"
Rhabdomyosarcoma,BRD-K04414442-001-08-3::2.5::HTS,8.01993244457907,0.004795390893726849,Other Types,SB-222200,tachykinin antagonist,TACR3
Rhabdomyosarcoma,BRD-K04548931-003-16-5::2.5::HTS,4.937751355388163,0.02667356382332166,Rhabdomyosarcoma,epirubicin,topoisomerase inhibitor,"CHD1, TOP2A"
Rhabdomyosarcoma,BRD-K04851519-001-06-8::2.5::HTS,4.829497155105115,0.028385461254441396,Rhabdomyosarcoma,aloe-emodin,anticancer agent,CASP8
Rhabdomyosarcoma,BRD-K05236810-001-19-0::2.5::HTS,5.859365373513743,0.015813702594606436,Other Types,luteolin,glucosidase inhibitor,TOP1
Rhabdomyosarcoma,BRD-K05361803-001-03-9::2.5::HTS,4.681994051301508,0.030903996945291883,Rhabdomyosarcoma,SC-10,protein kinase activator,PRKCA
Rhabdomyosarcoma,BRD-K06221026-001-06-8::2.5::HTS,4.327048968095973,0.03796537177078394,Rhabdomyosarcoma,DUP-697,cyclooxygenase inhibitor,PTGS2
Rhabdomyosarcoma,BRD-K06222852-001-03-2::2.5::HTS,5.191869693151631,0.023072554100136543,Rhabdomyosarcoma,posaconazole,sterol demethylase inhibitor,CYP3A4
Rhabdomyosarcoma,BRD-K06900071-001-01-2::2.5::HTS,8.656319946971518,0.0033949337848395546,Other Types,tebipenem,bacterial cell wall synthesis inhibitor,CNR1
Rhabdomyosarcoma,BRD-K08037784-001-12-6::2.5::HTS,4.721039731133815,0.03023063258552355,Rhabdomyosarcoma,arbutin,melanin inhibitor,TYR
Rhabdomyosarcoma,BRD-K08223200-001-01-1::2.5::HTS,4.692169217699354,0.030727693040174944,Other Types,WAY-200070,estrogen receptor agonist,"ERBB2, ERBB3, ERBB4, ESR2"
Rhabdomyosarcoma,BRD-K08251020-001-01-0::2.5::HTS,4.311331467517899,0.03832655273831712,Rhabdomyosarcoma,falecalcitriol,vitamin D receptor agonist,VDR
Rhabdomyosarcoma,BRD-K08288352-001-03-6::2.5::HTS,9.849637734885242,0.001790373206659409,Rhabdomyosarcoma,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,
Rhabdomyosarcoma,BRD-K08493205-001-04-9::2.5::HTS,4.30418495869069,0.03847734092326342,Other Types,salicyl-alcohol,,
Rhabdomyosarcoma,BRD-K08681769-323-03-7::2.5::HTS,5.441611414375931,0.020037299100948036,Rhabdomyosarcoma,ibandronate,bone resorption inhibitor,FDPS
Rhabdomyosarcoma,BRD-K09090949-001-01-9::2.5::HTS,9.26761163389846,0.0024462973234815758,Rhabdomyosarcoma,"CP-945,598",cannabinoid receptor antagonist,CNR1
Rhabdomyosarcoma,BRD-K09397065-003-06-1::2.5::HTS,7.92810345297775,0.005045455561956525,Rhabdomyosarcoma,SR-57227A,serotonin receptor agonist,HTR3A
Rhabdomyosarcoma,BRD-K09619578-001-01-3::2.5::HTS,7.682976888532098,0.005760160180485899,Other Types,DS2-(806622),,
Rhabdomyosarcoma,BRD-K09778810-001-10-6::2.5::HTS,13.3288734049065,0.00028574821776104536,Other Types,FGIN-1-27,inositol monophosphatase inhibitor,TSPO
Rhabdomyosarcoma,BRD-K10029415-005-06-9::2.5::HTS,6.775452174618355,0.009486908508994179,Rhabdomyosarcoma,enisamium-iodide,,
Rhabdomyosarcoma,BRD-K10065684-001-07-4::2.5::HTS,5.513320364684979,0.019221019970684792,Other Types,dantron,laxative,
Rhabdomyosarcoma,BRD-K10852020-001-04-5::2.5::HTS,7.151470841032361,0.007717590091589089,Rhabdomyosarcoma,tolcapone,catechol O methyltransferase inhibitor,COMT
Rhabdomyosarcoma,BRD-K10878147-001-02-2::2.5::HTS,6.864970331699575,0.009029085849390557,Other Types,OAC1,Oct activator,
Rhabdomyosarcoma,BRD-K11196887-001-22-0::2.49::HTS,6.8140597540422805,0.009301170872648623,Other Types,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A
Rhabdomyosarcoma,BRD-K11411329-001-01-3::2.5::HTS,15.009365038542423,0.00011958037992814476,Other Types,NOV-002,,"GSR, GSTM2"
Rhabdomyosarcoma,BRD-K11595419-001-01-4::2.5::HTS,4.1889726099998015,0.04115739986620733,Other Types,dipeptamin,,
Rhabdomyosarcoma,BRD-K11796549-001-04-5::2.5::HTS,4.627362806266973,0.03189147832381273,Other Types,NBQX,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B"
Rhabdomyosarcoma,BRD-K12120659-305-02-2::2.5::HTS,5.756442920856361,0.016758841162456725,Other Types,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Rhabdomyosarcoma,BRD-K12968785-001-13-3::2.5::HTS,4.144336165793773,0.04225626647156505,Rhabdomyosarcoma,bergapten,,
Rhabdomyosarcoma,BRD-K13087974-001-02-5::2.5::HTS,10.519222432482685,0.001252917232280599,Other Types,CGP-52411,EGFR inhibitor,EGFR
Rhabdomyosarcoma,BRD-K13211965-003-02-8::2.5::HTS,4.1621212329649335,0.0418070698704405,Other Types,L-741742,dopamine receptor antagonist,"DRD3, DRD4, SCN1A, SCN3A"
Rhabdomyosarcoma,BRD-K13238168-001-02-0::2.5::HTS,8.69874005371001,0.003316824207422304,Other Types,haloprogin,other antifungal,
Rhabdomyosarcoma,BRD-K13888115-003-02-2::2.5::HTS,5.612795627544872,0.018171704735456404,Rhabdomyosarcoma,LY2365109,Glycine transporter 1 inhibitor,SLC6A9
Rhabdomyosarcoma,BRD-K14560436-001-01-4::2.5::HTS,5.263597937971626,0.02214583459032559,Rhabdomyosarcoma,TG-02,"CDK inhibitor, FLT3 inhibitor, JAK inhibitor","CDK1, CDK2, CDK7, CDK9, FLT3, JAK2"
Rhabdomyosarcoma,BRD-K14765469-003-12-2::2.5::HTS,6.557170864689416,0.010706800775624664,Other Types,vesamicol,acetylcholinesterase inhibitor,SLC18A3
Rhabdomyosarcoma,BRD-K14807180-001-02-5::2.5::HTS,11.249548757489215,0.000851082480665608,Other Types,SB-221284,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Rhabdomyosarcoma,BRD-K15071410-001-01-1::2.5::HTS,8.528689900420074,0.0036387685800223675,Rhabdomyosarcoma,tiotidine,histamine receptor antagonist,HRH2
Rhabdomyosarcoma,BRD-K15179879-001-03-2::2.5::HTS,7.547725174561831,0.006209682795886861,Rhabdomyosarcoma,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Rhabdomyosarcoma,BRD-K15231341-001-01-5::2.5::HTS,6.746890460909685,0.009638984282334137,Rhabdomyosarcoma,hemomex-s,,PPARG
Rhabdomyosarcoma,BRD-K15976406-001-03-3::2.5::HTS,5.2971856875815515,0.021726105656069018,Other Types,telbivudine,DNA polymerase inhibitor,TK2
Rhabdomyosarcoma,BRD-K16195444-003-26-0::2.5::HTS,4.5645031623244146,0.03307395532778588,Other Types,oxymetazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C"
Rhabdomyosarcoma,BRD-K16551357-001-03-2::2.5::HTS,4.066128341909435,0.044259178038279626,Rhabdomyosarcoma,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Rhabdomyosarcoma,BRD-K16810791-001-01-0::2.5::HTS,6.268622814090058,0.012571859251464187,Other Types,LGK-974,porcupine inhibitor,PORCN
Rhabdomyosarcoma,BRD-K17205817-001-06-1::2.5::HTS,5.082219034309456,0.02455666410625883,Other Types,sulfametopyrazine,PABA antagonist,
Rhabdomyosarcoma,BRD-K17518951-001-03-0::2.5::HTS,5.031626574458414,0.02530561261661986,Other Types,penicillamine-(D),chelating agent,
Rhabdomyosarcoma,BRD-K17705806-003-04-4::2.5::HTS,4.649302116460322,0.031491286046360506,Rhabdomyosarcoma,JTC-801,opioid receptor antagonist,OPRL1
Rhabdomyosarcoma,BRD-K17894950-001-14-3::2.5::HTS,6.976413145236671,0.008489764015388594,Rhabdomyosarcoma,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A"
Rhabdomyosarcoma,BRD-K17977438-048-02-4::2.5::HTS,8.392187139121864,0.003916230898022368,Rhabdomyosarcoma,oxelaidin,antitussive,
Rhabdomyosarcoma,BRD-K18172896-001-02-5::2.5::HTS,5.103764616045775,0.02425971424113091,Other Types,eltanolone,membrane integrity inhibitor,"GABRA1, GABRB2, GABRG2"
Rhabdomyosarcoma,BRD-K18895904-001-16-1::2.5::HTS,8.63401723243927,0.0034368429516592977,Other Types,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Rhabdomyosarcoma,BRD-K19672466-001-02-3::2.5::HTS,6.903672754183858,0.008836791518411392,Other Types,ethimizol,,
Rhabdomyosarcoma,BRD-K19939891-001-05-4::2.5::HTS,6.709773141534449,0.009837382024618355,Other Types,TIC10,"AKT inhibitor, TRAIL modulator","AKT1, MAPK1"
Rhabdomyosarcoma,BRD-K20714604-003-02-9::2.5::HTS,7.454538685149114,0.006527255959555308,Other Types,RS-56812,serotonin receptor partial agonist,HTR3A
Rhabdomyosarcoma,BRD-K20755323-001-05-9::2.5::HTS,9.067869064283336,0.0027189572758184472,Other Types,SKI-II,sphingosine kinase inhibitor,SPHK1
Rhabdomyosarcoma,BRD-K21160401-065-01-0::2.5::HTS,6.638516386926033,0.010233731588004495,Rhabdomyosarcoma,dextroamphetamine,monoamine oxidase inhibitor,"ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1"
Rhabdomyosarcoma,BRD-K21906513-001-04-0::2.36::HTS,4.727188940126607,0.030132764005922203,Rhabdomyosarcoma,UNC669,L3MBTL antagonist,L3MBTL1
Rhabdomyosarcoma,BRD-K22503835-001-11-0::2.5::HTS,4.849570637470342,0.028060582566610884,Other Types,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Rhabdomyosarcoma,BRD-K23363278-001-02-1::2.5::HTS,4.262695512208939,0.03941625538639418,Rhabdomyosarcoma,CYT-997,tubulin polymerization inhibitor,TUBB
Rhabdomyosarcoma,BRD-K23586533-001-03-6::2.5::HTS,6.808813112861899,0.009322902300858518,Rhabdomyosarcoma,clindamycin,protein synthesis inhibitor,
Rhabdomyosarcoma,BRD-K24242599-001-02-8::2.5::HTS,4.8687877270146425,0.02775251398569824,Rhabdomyosarcoma,GW-2580,cFMS kinase inhibitor,CSF1R
Rhabdomyosarcoma,BRD-K24556407-001-02-3::2.5::HTS,6.542125649585435,0.01079758529242153,Other Types,ETP-46464,ATR kinase inhibitor,
Rhabdomyosarcoma,BRD-K24603946-001-02-1::2.5::HTS,9.506163426222088,0.0021490480134528298,Rhabdomyosarcoma,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3
Rhabdomyosarcoma,BRD-K24723746-036-02-5::2.5::HTS,8.601686367100497,0.0034966698105081606,Rhabdomyosarcoma,solifenacin-succinate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdomyosarcoma,BRD-K26349472-001-01-3::2.5::HTS,5.560510008110519,0.018733713719749343,Rhabdomyosarcoma,OG-L002,histone lysine demethylase inhibitor,KDM1A
Rhabdomyosarcoma,BRD-K26373640-001-05-1::2.5::HTS,4.178095552535619,0.0414152673379588,Other Types,IKK-2-inhibitor,"IKK inhibitor, SYK inhibitor",IKBKB
Rhabdomyosarcoma,BRD-K27382019-418-01-9::2.5::HTS,6.021725491046257,0.014438683941982252,Other Types,piperaquine-phosphate,antimalarial agent,
Rhabdomyosarcoma,BRD-K27871792-001-01-8::2.5::HTS,10.885126454145846,0.0010307597284822721,Other Types,flucloxacillin,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K28115081-001-02-7::2.5::HTS,5.832421307231817,0.016056243392123817,Rhabdomyosarcoma,apafant,platelet activating factor receptor antagonist,PTAFR
Rhabdomyosarcoma,BRD-K28217197-001-01-4::2.5::HTS,4.05397632515965,0.0445436382585088,Rhabdomyosarcoma,ganaxolone,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6"
Rhabdomyosarcoma,BRD-K28307902-001-21-7::2.5::HTS,5.857445456449236,0.015831934697085864,Rhabdomyosarcoma,flutamide,androgen receptor antagonist,"AHR, AR"
Rhabdomyosarcoma,BRD-K28542495-003-13-5::2.5::HTS,5.081716938126281,0.02457499751948681,Rhabdomyosarcoma,benzydamine,prostanoid receptor antagonist,
Rhabdomyosarcoma,BRD-K28578425-001-07-0::2.5::HTS,8.607528631713759,0.0034863981735192982,Rhabdomyosarcoma,cilostamide,phosphodiesterase inhibitor,"PDE3A, PDE3B"
Rhabdomyosarcoma,BRD-K28822270-001-01-1::2.5::HTS,4.5235610774580195,0.03387243349358574,Other Types,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Rhabdomyosarcoma,BRD-K28912512-001-23-2::2.5::HTS,4.029735005086914,0.04519100778294342,Other Types,nicotinamide,protein synthesis stimulant,"BST1, LDHA, PARP1, SIRT5"
Rhabdomyosarcoma,BRD-K29133151-001-03-2::2.5::HTS,4.8934859103592485,0.027365401508172925,Rhabdomyosarcoma,"ICI-185,282",thromboxane receptor antagonist,
Rhabdomyosarcoma,BRD-K29546239-001-02-3::2.5::HTS,7.695524196409548,0.005723508843632253,Other Types,SNC-80,,OPRD1
Rhabdomyosarcoma,BRD-K29895144-001-01-0::2.5::HTS,6.675213487259787,0.010028958367392331,Other Types,SKLB1002,VEGFR inhibitor,KDR
Rhabdomyosarcoma,BRD-K30126819-304-02-7::2.5::HTS,4.910850960116646,0.027090450838183712,Rhabdomyosarcoma,dimesna,tubulin polymerization inhibitor,
Rhabdomyosarcoma,BRD-K30933884-001-01-0::2.5::HTS,4.185931927446355,0.041228190684585865,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Rhabdomyosarcoma,BRD-K31054881-300-04-7::2.5::HTS,4.282067702225719,0.038975414440110996,Other Types,BMY-7378,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A"
Rhabdomyosarcoma,BRD-K31111078-001-04-2::2.5::HTS,5.331734006191305,0.02130891610228645,Other Types,dimethyl-fumarate,"nuclear factor erythroid derived, like (NRF2) activator",KEAP1
Rhabdomyosarcoma,BRD-K31385749-003-01-3::2.5::HTS,4.745221521406397,0.029802183205025822,Other Types,ivabradine,"HCN channel antagonist, potassium channel blocker, sodium channel blocker","HCN1, HCN3, HCN4"
Rhabdomyosarcoma,BRD-K31560319-001-01-5::2.5::HTS,6.196194531762126,0.013092252668353531,Other Types,olvanil,TRPV agonist,"CNR1, GPR119, TRPV1"
Rhabdomyosarcoma,BRD-K32247306-001-29-4::2.5::HTS,6.631881278576203,0.010276098736616392,Rhabdomyosarcoma,primidone,GABA receptor antagonist,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Rhabdomyosarcoma,BRD-K33183200-303-02-4::2.5::HTS,7.432810410688108,0.006605467633042975,Other Types,imetit,histamine receptor agonist,"HRH3, HRH4"
Rhabdomyosarcoma,BRD-K33459542-001-07-4::2.5::HTS,4.085484279026926,0.043733432726182866,Rhabdomyosarcoma,ditolylguanidine,sigma receptor agonist,"GRIN1, GRIN2A, GRIN2B, SIGMAR1"
Rhabdomyosarcoma,BRD-K33732501-004-01-0::2.5::HTS,7.47116562570455,0.0064705838082999905,Rhabdomyosarcoma,methylnaltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Rhabdomyosarcoma,BRD-K33743361-003-02-6::2.5::HTS,6.51730875761019,0.010946067637738312,Rhabdomyosarcoma,ML133,potassium channel blocker,
Rhabdomyosarcoma,BRD-K33852358-001-09-9::2.5::HTS,7.0503074484064,0.008154037673471165,Other Types,arofylline,phosphodiesterase inhibitor,PDE4A
Rhabdomyosarcoma,BRD-K34341643-001-01-4::2.5::HTS,9.623944644667684,0.0020187748178490885,Other Types,glasdegib,hedgehog pathway inhibitor,SMO
Rhabdomyosarcoma,BRD-K34608650-001-02-4::2.5::HTS,4.090816501183569,0.04359846599647221,Other Types,GP2a,cannabinoid receptor agonist,CNR2
Rhabdomyosarcoma,BRD-K34801930-001-01-9::2.5::HTS,8.970196919121296,0.002865734011744691,Rhabdomyosarcoma,AZD5069,CC chemokine receptor antagonist,CXCR2
Rhabdomyosarcoma,BRD-K35430135-003-02-3::2.5::HTS,3.954137277834927,0.04724257552391524,Rhabdomyosarcoma,SR-59230A,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Rhabdomyosarcoma,BRD-K35586044-003-15-4::2.5::HTS,7.742656462853875,0.005577727928550572,Other Types,yohimbine,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
Rhabdomyosarcoma,BRD-K35629949-001-02-0::2.5::HTS,4.809374417484893,0.028721789427010713,Rhabdomyosarcoma,SR-27897,CCK receptor antagonist,CCKAR
Rhabdomyosarcoma,BRD-K35775715-001-03-1::2.5::HTS,7.714883516789531,0.005660283310590022,Rhabdomyosarcoma,liranaftate,fungal squalene epoxidase inhibitor,
Rhabdomyosarcoma,BRD-K36016295-001-04-5::2.5::HTS,6.639966685156637,0.01022918886459301,Other Types,KU-60019,ATM kinase inhibitor,ATM
Rhabdomyosarcoma,BRD-K37130656-001-04-6::2.5::HTS,5.741540346520255,0.016903756832968832,Rhabdomyosarcoma,rivaroxaban,coagulation factor inhibitor,F10
Rhabdomyosarcoma,BRD-K37270826-001-31-8::2.5::HTS,3.9881672984807426,0.046306943856813186,Rhabdomyosarcoma,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Rhabdomyosarcoma,BRD-K37694030-003-12-7::2.5::HTS,4.661563045317412,0.031269094582068134,Rhabdomyosarcoma,doxepin,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4"
Rhabdomyosarcoma,BRD-K37846922-001-09-4::0.25::HTS,4.497069815992269,0.034403171798023886,Rhabdomyosarcoma,"3,3'-diindolylmethane","CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor","AR, HIF1A, IFNG, PI3"
Rhabdomyosarcoma,BRD-K37890730-001-15-1::2.5::HTS,6.692325478940546,0.009940315343498684,Rhabdomyosarcoma,camptothecin,topoisomerase inhibitor,TOP1
Rhabdomyosarcoma,BRD-K38684403-001-05-4::2.5::HTS,4.600775775822813,0.03238548442693924,Other Types,roxithromycin,bacterial 50S ribosomal subunit inhibitor,"ABCB1, MLNR"
Rhabdomyosarcoma,BRD-K38911213-003-01-6::2.5::HTS,8.365918589474465,0.003972382095514389,Rhabdomyosarcoma,apraclonidine,adrenergic receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C"
Rhabdomyosarcoma,BRD-K39079086-001-07-6::2.5::HTS,4.907067059966229,0.027152966411546867,Rhabdomyosarcoma,cinchonidine,P glycoprotein inhibitor,
Rhabdomyosarcoma,BRD-K39160765-003-02-9::2.5::HTS,4.321397648055287,0.038093095898715915,Rhabdomyosarcoma,4-chlorophenylguanidine,urokinase inhibitor,PLAUR
Rhabdomyosarcoma,BRD-K39467894-001-06-7::2.5::HTS,8.50588813958332,0.003687444015876169,Rhabdomyosarcoma,nithiamide,bacterial DNA inhibitor,
Rhabdomyosarcoma,BRD-K39693230-001-01-2::2.5::HTS,9.281941831140593,0.002424855901878542,Other Types,N-salicoylaminophenol,ribonucleotide reductase inhibitor,
Rhabdomyosarcoma,BRD-K40175214-001-11-6::2.5::HTS,4.83672949221403,0.028266240145041324,Rhabdomyosarcoma,torin-1,mTOR inhibitor,MTOR
Rhabdomyosarcoma,BRD-K40992116-001-09-7::2.5::HTS,4.264754130314523,0.039388464478432306,Rhabdomyosarcoma,parachlorophenol,antiinfective drug,
Rhabdomyosarcoma,BRD-K41104902-001-01-3::2.5::HTS,7.261502556860749,0.007255582864744817,Other Types,GSK2656157,PERK inhibitor,
Rhabdomyosarcoma,BRD-K41278234-001-03-0::2.5::HTS,3.8979011688602845,0.04884272017625397,Other Types,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Rhabdomyosarcoma,BRD-K41337261-001-03-0::2.5::HTS,5.261306604817525,0.022172747176356793,Rhabdomyosarcoma,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Rhabdomyosarcoma,BRD-K41410256-304-02-2::2.5::HTS,6.730460270673498,0.009732582134184932,Rhabdomyosarcoma,balsalazide,cyclooxygenase inhibitor,"ALOX5, PPARG, PTGS1, PTGS2"
Rhabdomyosarcoma,BRD-K42098891-003-20-5::2.5::HTS,4.374437146145109,0.0369433542066494,Rhabdomyosarcoma,protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4"
Rhabdomyosarcoma,BRD-K42748308-300-02-0::2.5::HTS,6.207955003202042,0.013009140661984935,Other Types,XE-991,potassium channel blocker,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5"
Rhabdomyosarcoma,BRD-K43002771-034-01-6::2.5::HTS,4.153483141928554,0.04203039571692208,Rhabdomyosarcoma,SR-33805,calcium channel blocker,
Rhabdomyosarcoma,BRD-K43055376-001-01-2::2.5::HTS,9.058466991010333,0.002733823827334669,Other Types,ADD-233089,benzodiazepine receptor agonist,
Rhabdomyosarcoma,BRD-K43389675-003-20-9::2.5::HTS,10.109885313263868,0.0015567105326459308,Rhabdomyosarcoma,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Rhabdomyosarcoma,BRD-K43860855-065-11-9::2.5::HTS,7.871512725090872,0.005199101617533513,Other Types,iobenguane,antineoplastic agent,
Rhabdomyosarcoma,BRD-K43880410-001-14-4::2.5::HTS,4.160675415625248,0.04183998562330763,Rhabdomyosarcoma,pregnenolone,glutamate receptor modulator,"CYP17A1, SULT2B1"
Rhabdomyosarcoma,BRD-K44309363-003-02-1::2.5::HTS,4.476848628202952,0.034809071185222605,Rhabdomyosarcoma,dexniguldipine,calmodulin antagonist,ADORA3
Rhabdomyosarcoma,BRD-K44942188-001-09-1::2.5::HTS,5.468690723050451,0.019716125771676127,Other Types,fomocaine,voltage-gated sodium channel modulator,
Rhabdomyosarcoma,BRD-K44974079-001-01-3::2.5::HTS,11.131970540662603,0.0009057120324286471,Other Types,ticagrelor,purinergic receptor antagonist,P2RY12
Rhabdomyosarcoma,BRD-K45033733-001-12-2::2.5::HTS,9.903153285719712,0.001738966691989042,Rhabdomyosarcoma,famciclovir,DNA polymerase inhibitor,
Rhabdomyosarcoma,BRD-K45245728-335-01-4::2.5::HTS,5.326697916455339,0.021369970208751653,Other Types,ursodeoxycholyltaurine,cholesterol inhibitor,
Rhabdomyosarcoma,BRD-K45435259-003-11-1::2.5::HTS,5.009887707882928,0.02559585306301526,Other Types,SCH-23390,dopamine receptor antagonist,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
Rhabdomyosarcoma,BRD-K45479396-050-01-5::2.5::HTS,3.9775375293954096,0.04659355074698342,Rhabdomyosarcoma,BP-554,serotonin receptor agonist,HTR1A
Rhabdomyosarcoma,BRD-K45503887-001-01-1::2.5::HTS,6.457984648684208,0.011317992205558227,Other Types,delivert,angiotensin receptor agonist,"AGTR1, AGTR2"
Rhabdomyosarcoma,BRD-K46290096-001-01-1::2.5::HTS,6.552431488833439,0.010739294564141978,Other Types,preladenant,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Rhabdomyosarcoma,BRD-K46585355-001-14-3::2.5::HTS,7.412119728643766,0.006680836809659789,Other Types,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,
Rhabdomyosarcoma,BRD-K47049295-300-01-5::2.5::HTS,7.490742220668565,0.006427056707119023,Rhabdomyosarcoma,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1
Rhabdomyosarcoma,BRD-K47264279-001-08-9::2.5::HTS,9.230197106684619,0.002492757650417036,Rhabdomyosarcoma,psoralen,,"MAOA, MAOB"
Rhabdomyosarcoma,BRD-K47642186-001-01-3::2.5::HTS,7.063314825748704,0.008095802330059474,Other Types,piclamilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Rhabdomyosarcoma,BRD-K48888725-001-01-9::2.5::HTS,5.195423165542078,0.02303145367082331,Rhabdomyosarcoma,CG-400549,FABI inhibitor,
Rhabdomyosarcoma,BRD-K48988407-001-01-2::2.5::HTS,5.178526073774719,0.023250082050857684,Other Types,cytochlor,,
Rhabdomyosarcoma,BRD-K49049886-001-08-7::2.5::HTS,4.027455570963304,0.04525076950980062,Rhabdomyosarcoma,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Rhabdomyosarcoma,BRD-K49055432-001-04-2::2.5::HTS,4.041419942450647,0.04487714607384922,Rhabdomyosarcoma,A66,PI3K inhibitor,PIK3CA
Rhabdomyosarcoma,BRD-K49338325-001-03-4::2.5::HTS,4.945170550290193,0.02657199584648029,Rhabdomyosarcoma,etofibrate,PPAR receptor agonist,PPARA
Rhabdomyosarcoma,BRD-K49522529-001-02-9::2.53::HTS,4.1491179784515,0.04215447041092082,Rhabdomyosarcoma,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Rhabdomyosarcoma,BRD-K49685476-001-15-9::2.5::HTS,6.618488161007767,0.010352716731186026,Other Types,TTNPB,retinoid receptor agonist,"RARA, RARB, RARG"
Rhabdomyosarcoma,BRD-K49759007-001-11-9::2.5::HTS,6.5640874902761235,0.010666222772844179,Other Types,4-hydroxy-phenazone,,
Rhabdomyosarcoma,BRD-K49811169-004-06-6::2.5::HTS,3.9566964468321566,0.047173942846436986,Rhabdomyosarcoma,NSC-9965,acetylcholine receptor antagonist,"CHRNA4, CHRNB2"
Rhabdomyosarcoma,BRD-K49880111-236-09-2::2.5::HTS,9.109879335855773,0.00265862461927098,Other Types,cephapirin,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K50406511-001-26-0::2.5::HTS,4.122416700536078,0.0427931871403027,Other Types,hycanthone,RNA synthesis inhibitor,
Rhabdomyosarcoma,BRD-K50422030-001-05-3::2.5::HTS,8.120186713747202,0.0045409546508099275,Other Types,clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1
Rhabdomyosarcoma,BRD-K50631926-001-02-3::2.5::HTS,15.959359176566096,7.332728565743957e-05,Other Types,PIK-294,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Rhabdomyosarcoma,BRD-K51247865-001-01-2::2.5::HTS,5.486266760061238,0.019514526899635818,Rhabdomyosarcoma,ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2
Rhabdomyosarcoma,BRD-K51333959-003-01-3::2.5::HTS,4.150727190830778,0.04208458886815819,Rhabdomyosarcoma,siramesine,sigma receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Rhabdomyosarcoma,BRD-K51677086-001-12-0::2.5::HTS,5.514788322191479,0.019216738693109026,Other Types,erythromycin-ethylsuccinate,"cytochrome P450 inhibitor, protein synthesis inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1"
Rhabdomyosarcoma,BRD-K51911221-001-01-2::2.5::HTS,6.652679082157433,0.010153667728441442,Rhabdomyosarcoma,nemorubicin,topoisomerase inhibitor,"TOP1, TOP2A"
Rhabdomyosarcoma,BRD-K52172416-001-11-4::2.5::HTS,14.938042783004805,0.00012418516214834322,Other Types,anastrozole,aromatase inhibitor,CYP19A1
Rhabdomyosarcoma,BRD-K52459643-001-17-7::2.5::HTS,4.049252904110313,0.04467178840804896,Rhabdomyosarcoma,alprostadil,prostanoid receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR"
Rhabdomyosarcoma,BRD-K52523550-001-01-5::2.5::HTS,7.148210610983946,0.007726050899617646,Other Types,N-acetylcarnosine,,
Rhabdomyosarcoma,BRD-K52818472-001-02-2::2.5::HTS,3.9854430820048528,0.046381323723456484,Other Types,ivacaftor,CFTR channel potentiator,CFTR
Rhabdomyosarcoma,BRD-K53508936-001-01-0::2.5::HTS,11.06842651297773,0.000936534859285765,Other Types,CTS-1027,metalloproteinase inhibitor,"MMP1, MMP13, MMP2, MMP3, MMP9"
Rhabdomyosarcoma,BRD-K53963539-004-02-0::2.5::HTS,10.766913081988305,0.0011001633799752372,Rhabdomyosarcoma,vortioxetine,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4"
Rhabdomyosarcoma,BRD-K54496168-003-01-2::2.5::HTS,7.497313644502663,0.006378561141932743,Other Types,propacetamol,cyclooxygenase inhibitor,PTGS2
Rhabdomyosarcoma,BRD-K54634444-001-05-9::2.5::HTS,7.814857766937104,0.0053596288901041934,Other Types,artesunate,DNA synthesis inhibitor,
Rhabdomyosarcoma,BRD-K55160477-001-04-7::2.5::HTS,7.793638908381665,0.00542667245550752,Rhabdomyosarcoma,benzo[d]thiazole-2(3h)-thione,,
Rhabdomyosarcoma,BRD-K55191674-237-18-3::2.5::HTS,12.224632299349897,0.0005092230940674773,Rhabdomyosarcoma,benzylpenicillin,penicillin binding protein inhibitor,
Rhabdomyosarcoma,BRD-K55250441-001-13-0::2.5::HTS,8.341298933699715,0.004026027200687822,Rhabdomyosarcoma,sulfadoxine,dihydropteroate synthase inhibitor,
Rhabdomyosarcoma,BRD-K55781385-001-01-7::2.5::HTS,7.281417597622685,0.007176615409944766,Other Types,BMS-927711,calcitonin antagonist,CALCA
Rhabdomyosarcoma,BRD-K56033645-001-07-5::2.5::HTS,10.085913936826657,0.0015759765141088646,Rhabdomyosarcoma,5-methylhydantoin-(L),,
Rhabdomyosarcoma,BRD-K56195681-001-01-0::2.5::HTS,13.36702330144152,0.0002801270298093223,Other Types,losmapimod,p38 MAPK inhibitor,MAPK14
Rhabdomyosarcoma,BRD-K56301217-001-07-4::2.5::HTS,6.258148767171793,0.012645559156423503,Other Types,ABT-737,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Rhabdomyosarcoma,BRD-K56542719-065-01-4::2.5::HTS,4.986410821371128,0.025942200206195806,Rhabdomyosarcoma,cefpirome,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K56558538-003-11-9::2.5::HTS,6.106681518600051,0.013762578208942385,Other Types,ambroxol,sodium channel blocker,CYP3A4
Rhabdomyosarcoma,BRD-K56810756-001-03-0::2.5::HTS,14.702938599303332,0.0001400835522692896,Other Types,fomepizole,alcohol dehydrogenase inhibitor,"ADH1A, ADH1B, ADH1C, AKR1A1, CAT"
Rhabdomyosarcoma,BRD-K57275767-001-02-4::2.61::HTS,4.626828740389329,0.03192877781283213,Other Types,geniposide,GLP receptor agonist,GLP1R
Rhabdomyosarcoma,BRD-K57275767-001-03-2::2.5::HTS,5.005082786319958,0.025669902067854685,Rhabdomyosarcoma,geniposide,GLP receptor agonist,GLP1R
Rhabdomyosarcoma,BRD-K57597776-001-01-2::2.5::HTS,4.281479882771108,0.0389912678429308,Rhabdomyosarcoma,org-27569,cannabinoid receptor modulator,CNR1
Rhabdomyosarcoma,BRD-K58148589-001-03-6::2.5::HTS,3.8770583790342816,0.04944553497675459,Rhabdomyosarcoma,betamethasone-dipropionate,anti-inflammatory agent,
Rhabdomyosarcoma,BRD-K58160573-001-05-4::2.5::HTS,5.748956486458212,0.016829649284784285,Other Types,dapagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Rhabdomyosarcoma,BRD-K59227464-334-02-4::2.5::HTS,5.118881111252821,0.02404780441243869,Other Types,LY2228820,p38 MAPK inhibitor,MAPK14
Rhabdomyosarcoma,BRD-K59390331-045-01-5::2.5::HTS,16.343874566530204,6.0197156821886186e-05,Other Types,tarafenacin,acetylcholine receptor antagonist,CHRM3
Rhabdomyosarcoma,BRD-K59436580-001-01-7::2.5::HTS,5.478273785189895,0.019603068344400836,Other Types,tedizolid,bacterial 50S ribosomal subunit inhibitor,
Rhabdomyosarcoma,BRD-K59506194-015-04-9::2.5::HTS,9.245847282959586,0.002470683857932003,Other Types,targinine,nitric oxide synthase inhibitor,NOS3
Rhabdomyosarcoma,BRD-K59522102-001-14-6::2.5::HTS,4.304287649683561,0.03849037100139821,Other Types,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Rhabdomyosarcoma,BRD-K59715032-362-01-4::2.5::HTS,5.021627137173375,0.025422378870691823,Rhabdomyosarcoma,pasireotide,somatostatin receptor agonist,"SSTR1, SSTR2, SSTR3, SSTR5"
Rhabdomyosarcoma,BRD-K59998349-003-01-4::2.5::HTS,6.0739774610803465,0.014022261201727216,Other Types,aminolevulinic-acid-benzyl-ester,,
Rhabdomyosarcoma,BRD-K60005752-001-01-9::2.5::HTS,5.035581605097301,0.025222314340634044,Other Types,S-111,PARP inhibitor,PARP1
Rhabdomyosarcoma,BRD-K60441002-001-04-8::2.5::HTS,4.1720588526859,0.04156866837079003,Rhabdomyosarcoma,muscimol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Rhabdomyosarcoma,BRD-K60585088-001-01-5::2.5::HTS,8.53735663197117,0.003619693900916202,Rhabdomyosarcoma,paricalcitol,vitamin D receptor agonist,VDR
Rhabdomyosarcoma,BRD-K60984070-001-01-0::2.5::HTS,4.931535253184741,0.026771667043253653,Rhabdomyosarcoma,PD-166793,"collagenase inhibitor, metalloproteinase inhibitor","MMP13, MMP2, MMP3"
Rhabdomyosarcoma,BRD-K61397605-001-03-4::2.5::HTS,6.284627852801355,0.012462119032725682,Rhabdomyosarcoma,romidepsin,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Rhabdomyosarcoma,BRD-K61585876-001-01-0::2.5::HTS,10.650886236749411,0.0011670162965135749,Other Types,3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,"GRM1, GRM5"
Rhabdomyosarcoma,BRD-K61988078-001-01-2::2.5::HTS,8.03549024486644,0.004753450161185072,Other Types,moxidectin,chloride channel antagonist,
Rhabdomyosarcoma,BRD-K62196610-001-01-6::2.5::HTS,5.53203739014071,0.019021681745618472,Other Types,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Rhabdomyosarcoma,BRD-K62213621-001-01-6::2.5::HTS,4.423474052777085,0.03589816456410795,Other Types,dihydroartemisinin,antimalarial agent,
Rhabdomyosarcoma,BRD-K62387885-001-01-9::2.5::HTS,5.174183929818215,0.023304943346003044,Rhabdomyosarcoma,basimglurant,glutamate receptor antagonist,GRM5
Rhabdomyosarcoma,BRD-K62414032-001-12-0::2.5::HTS,11.785266922847184,0.0006409757305683503,Other Types,NMDA,glutamate receptor agonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Rhabdomyosarcoma,BRD-K62676709-065-05-5::2.5::HTS,6.344182042157074,0.012053137563192425,Other Types,guanethidine,adrenergic inhibitor,SLC6A2
Rhabdomyosarcoma,BRD-K62685538-001-01-7::2.5::HTS,7.941957260789807,0.005003326706877318,Other Types,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR
Rhabdomyosarcoma,BRD-K62736196-015-13-6::2.5::HTS,6.57033667916535,0.010628347148146563,Other Types,guanaben-acetate,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Rhabdomyosarcoma,BRD-K62762455-001-01-3::2.5::HTS,5.8938338210372,0.015512679393747385,Other Types,RU-58841,androgen receptor antagonist,AR
Rhabdomyosarcoma,BRD-K63178091-001-01-1::2.5::HTS,5.014125109799957,0.02553245263254492,Other Types,telotristat,tryptophan hydroxylase inhibitor,TPH1
Rhabdomyosarcoma,BRD-K63430059-001-17-2::2.5::HTS,14.58245691833027,0.0001496586711304725,Other Types,methoxsalen,DNA synthesis inhibitor,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4"
Rhabdomyosarcoma,BRD-K63533170-001-02-9::2.5::HTS,8.19061420274679,0.004369053189564105,Rhabdomyosarcoma,AM-630,cannabinoid receptor antagonist,"CNR1, CNR2"
Rhabdomyosarcoma,BRD-K63932022-001-01-5::2.5::HTS,9.931066245960652,0.001712136465051536,Rhabdomyosarcoma,2'-MeCCPA,adenosine receptor agonist,ADORA1
Rhabdomyosarcoma,BRD-K64137799-003-02-5::2.5::HTS,4.507958294200868,0.034173860060139505,Other Types,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6"
Rhabdomyosarcoma,BRD-K64835161-001-02-8::2.5::HTS,5.065758895240133,0.02479083454797181,Rhabdomyosarcoma,ML167,"CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B"
Rhabdomyosarcoma,BRD-K64994968-001-32-5::2.5::HTS,10.193668855925575,0.0014895007391699975,Rhabdomyosarcoma,progesterone,progesterone receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5"
Rhabdomyosarcoma,BRD-K65275554-001-04-7::2.5::HTS,13.268819788655346,0.00029482891209798906,Rhabdomyosarcoma,NPC-15199,ICAM1 antagonist,PPARG
Rhabdomyosarcoma,BRD-K65428967-001-08-4::2.5::HTS,11.362692827549475,0.0008017577453550391,Other Types,cordycepin,DNA inhibitor,
Rhabdomyosarcoma,BRD-K65503129-001-06-3::2.5::HTS,4.46955285880586,0.03495020249255528,Rhabdomyosarcoma,CCT018159,HSP inhibitor,"HSP90AA1, HSP90AB1"
Rhabdomyosarcoma,BRD-K65639003-001-09-0::2.5::HTS,7.612298810868383,0.005988826442464041,Rhabdomyosarcoma,icariin,phosphodiesterase inhibitor,PDE5A
Rhabdomyosarcoma,BRD-K66093087-001-03-1::2.5::HTS,13.282167585791317,0.0002927856861346694,Other Types,FGIN-1-43,benzodiazepine receptor agonist,TSPO
Rhabdomyosarcoma,BRD-K66097663-001-01-8::2.5::HTS,6.304500543835829,0.012322746005017583,Rhabdomyosarcoma,TMC-353121,RSV fusion inhibitor,
Rhabdomyosarcoma,BRD-K66404838-310-01-1::2.5::HTS,6.256933893451337,0.012654136305411973,Other Types,nalbuphine,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Rhabdomyosarcoma,BRD-K66465025-001-05-1::2.5::HTS,6.652649805540489,0.0101561153123427,Rhabdomyosarcoma,ACPC,glutamate receptor antagonist,
Rhabdomyosarcoma,BRD-K66538826-001-07-2::2.5::HTS,5.6576498716427,0.017718587866276583,Other Types,amuvatinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor","KIT, MET"
Rhabdomyosarcoma,BRD-K66615216-003-14-8::2.5::HTS,6.778949912558323,0.009472580337641614,Other Types,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A
Rhabdomyosarcoma,BRD-K66715657-050-01-0::2.5::HTS,5.969170790400929,0.01487041188910998,Other Types,UH-232-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4, HTR1A"
Rhabdomyosarcoma,BRD-K66876909-001-12-6::2.5::HTS,4.5728763576691875,0.03292030972044101,Other Types,linezolid,bacterial 50S ribosomal subunit inhibitor,"MAOA, MAOB"
Rhabdomyosarcoma,BRD-K67298865-001-09-0::2.5::HTS,3.9776240834624415,0.04659376616866023,Rhabdomyosarcoma,SB-431542,TGF beta receptor inhibitor,"ACVR1C, TGFBR1"
Rhabdomyosarcoma,BRD-K67578145-001-09-7::2.38::HTS,4.917914872564623,0.027004504277156584,Other Types,GDC-0879,RAF inhibitor,BRAF
Rhabdomyosarcoma,BRD-K68232650-001-02-2::2.5::HTS,5.073607480462884,0.024679185697106643,Rhabdomyosarcoma,lacosamide,"collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Rhabdomyosarcoma,BRD-K68392338-003-02-0::2.5::HTS,8.342107406010387,0.004023448428455713,Rhabdomyosarcoma,ZK-93426,benzodiazepine receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA5"
Rhabdomyosarcoma,BRD-K68538666-001-12-3::2.5::HTS,6.493994571986348,0.011091223163274712,Rhabdomyosarcoma,aceclofenac,prostanoid receptor antagonist,PTGS2
Rhabdomyosarcoma,BRD-K68693535-001-03-4::2.5::HTS,6.371273554671797,0.011873550594580276,Rhabdomyosarcoma,lidamidine,adrenergic receptor agonist,
Rhabdomyosarcoma,BRD-K68770713-001-01-8::2.5::HTS,4.419725547469761,0.035980569070345955,Other Types,azosemide,electrolyte reabsorption inhibitor,"SLC12A1, SLC12A2"
Rhabdomyosarcoma,BRD-K69035426-001-01-3::2.5::HTS,4.274991320304787,0.03914257020142645,Other Types,omeprazole-sulfide,ATPase inhibitor,
Rhabdomyosarcoma,BRD-K69195780-004-08-4::2.5::HTS,4.769136636986247,0.029387060204508125,Other Types,NAN-190,serotonin receptor agonist,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F"
Rhabdomyosarcoma,BRD-K69346723-001-04-8::2.5::HTS,4.519344387929746,0.033977093467431975,Other Types,glutathione,antioxidant,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12"
Rhabdomyosarcoma,BRD-K69469734-003-02-5::2.5::HTS,5.1973225554908815,0.02300654354105272,Rhabdomyosarcoma,trospium,acetylcholine receptor antagonist,CHRM1
Rhabdomyosarcoma,BRD-K70281171-050-08-9::2.5::HTS,11.86671257372108,0.0006148912367623772,Other Types,U-99194,dopamine receptor antagonist,DRD3
Rhabdomyosarcoma,BRD-K70402238-001-02-8::2.5::HTS,7.153901410026046,0.0076990988386634015,Other Types,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Rhabdomyosarcoma,BRD-K70557564-305-03-6::2.5::HTS,9.865028684915247,0.0017734103928987285,Rhabdomyosarcoma,zosuquidar,P glycoprotein inhibitor,"ABCB1, ABCB4"
Rhabdomyosarcoma,BRD-K70778732-003-26-7::2.5::HTS,8.500927009613617,0.0036917587964315946,Rhabdomyosarcoma,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4"
Rhabdomyosarcoma,BRD-K70898774-001-03-5::2.5::HTS,4.84316115941357,0.02816931038969882,Other Types,naloxone-benzoylhydrazone,opioid receptor antagonist,"OPRK1, OPRM1"
Rhabdomyosarcoma,BRD-K71534238-001-10-0::2.5::HTS,4.036131431546092,0.045016084813241215,Other Types,GW-9508,"free fatty acid receptor agonist, G protein-coupled receptor agonist","FFAR1, FFAR4"
Rhabdomyosarcoma,BRD-K72004355-001-01-9::2.5::HTS,4.531085745594292,0.033718781566516025,Other Types,CFTRinh-172,chloride channel blocker,CFTR
Rhabdomyosarcoma,BRD-K72093555-001-01-0::2.5::HTS,11.602562162423363,0.0007059399605363064,Other Types,procyanidin-b-2,,
Rhabdomyosarcoma,BRD-K72339976-065-04-7::2.5::HTS,10.029216360260499,0.0016258797988478579,Other Types,cefoselis,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K72414522-001-06-7::2.5::HTS,4.346853323048201,0.03752977635912572,Rhabdomyosarcoma,AZD5438,CDK inhibitor,KCNH2
Rhabdomyosarcoma,BRD-K73073971-001-01-7::2.5::HTS,10.671048367422419,0.0011549632304813802,Rhabdomyosarcoma,ZLN005,,
Rhabdomyosarcoma,BRD-K73196317-003-14-8::2.5::HTS,6.542947695878826,0.010792184981061392,Rhabdomyosarcoma,urapidil,adrenergic receptor antagonist,HTR1A
Rhabdomyosarcoma,BRD-K73290745-003-02-6::2.5::HTS,11.656424736757947,0.0006868003883770958,Other Types,ICI-199441,opioid receptor agonist,"CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R"
Rhabdomyosarcoma,BRD-K73303757-001-21-6::2.5::HTS,4.402094871463077,0.03634711817148446,Rhabdomyosarcoma,4-methylgenistein,protein tyrosine kinase inhibitor,"CYP19A1, ESRRA, ESRRB, ESRRG, FASN"
Rhabdomyosarcoma,BRD-K73524797-001-01-1::2.5::HTS,8.026022032923395,0.004776503939930049,Rhabdomyosarcoma,ST-1859,antiamyloidogenic agent,
Rhabdomyosarcoma,BRD-K73589491-001-11-2::2.5::HTS,4.166989476597214,0.04168970766215653,Rhabdomyosarcoma,nizatidine,histamine receptor antagonist,HRH2
Rhabdomyosarcoma,BRD-K73700643-001-11-2::2.5::HTS,15.097810910800469,0.00011424652611126469,Other Types,N-acetyltryptamine,melatonin receptor agonist,
Rhabdomyosarcoma,BRD-K74186897-001-13-2::2.5::HTS,9.78820954410144,0.0018473690135769663,Other Types,cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4"
Rhabdomyosarcoma,BRD-K74195153-050-12-1::2.5::HTS,4.3627365202855355,0.0371907662340348,Rhabdomyosarcoma,irsogladine,phosphodiesterase inhibitor,PDE4A
Rhabdomyosarcoma,BRD-K74363950-004-01-0::2.5::HTS,10.798224292667113,0.0010795491422546312,Rhabdomyosarcoma,aclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdomyosarcoma,BRD-K74501079-001-18-1::2.5::HTS,6.838124520424323,0.009167148620380622,Other Types,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR
Rhabdomyosarcoma,BRD-K75089421-003-24-5::2.5::HTS,10.902783704066401,0.00102229264961406,Other Types,procainamide,sodium channel blocker,"DNMT1, SCN5A"
Rhabdomyosarcoma,BRD-K75516118-001-03-3::2.5::HTS,8.243454135314288,0.004246914130078403,Other Types,rolipram-R(-),phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A"
Rhabdomyosarcoma,BRD-K75855670-001-14-2::2.5::HTS,5.590463503637707,0.018400540500088228,Rhabdomyosarcoma,iodoquinol,antiseptic,
Rhabdomyosarcoma,BRD-K75958195-037-09-4::2.5::HTS,12.689605220936837,0.00039907470457159103,Other Types,pizotifen,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C"
Rhabdomyosarcoma,BRD-K76011241-001-01-8::2.5::HTS,4.580400917064756,0.03277256870460175,Other Types,oseltamivir-phosphate,neuraminidase inhibitor,"CES1, NEU1, NEU2"
Rhabdomyosarcoma,BRD-K76037122-001-02-5::2.5::HTS,6.565538433797488,0.010656701642503937,Other Types,guanidine,HSP inhibitor,"ALDH2, DLG4, GAMT, RNASE1"
Rhabdomyosarcoma,BRD-K76606751-001-01-7::2.5::HTS,3.865000773423562,0.049795019738520796,Other Types,mebicar,anxiolytic,
Rhabdomyosarcoma,BRD-K76677554-003-02-1::2.5::HTS,4.125920009902904,0.04270112761188214,Other Types,AJ76-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Rhabdomyosarcoma,BRD-K76703230-004-04-1::2.5::HTS,4.561744037749977,0.03312916502462733,Rhabdomyosarcoma,YM-155,survivin inhibitor,BIRC5
Rhabdomyosarcoma,BRD-K77300776-001-02-5::2.5::HTS,4.197800281806041,0.040953925345638055,Rhabdomyosarcoma,choline,acetylcholine precursor,"ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2"
Rhabdomyosarcoma,BRD-K77396579-300-01-0::2.5::HTS,10.042342396189776,0.001614699095784956,Other Types,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4
Rhabdomyosarcoma,BRD-K77634909-001-03-5::2.5::HTS,4.209298128856096,0.040669155885139606,Rhabdomyosarcoma,AEG3482,HSP inducer,
Rhabdomyosarcoma,BRD-K77638923-001-02-0::2.5::HTS,4.906794966964344,0.02716852654772997,Rhabdomyosarcoma,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Rhabdomyosarcoma,BRD-K77943374-001-02-8::2.5::HTS,3.9020791559330674,0.04871522963252773,Rhabdomyosarcoma,NVP-BVU972,MET inhibitor,MET
Rhabdomyosarcoma,BRD-K78113049-001-16-2::2.5::HTS,5.6064792154556145,0.018237893326235082,Other Types,enoxacin,topoisomerase inhibitor,TOP2A
Rhabdomyosarcoma,BRD-K78126613-001-28-5::2.5::HTS,7.272928375830033,0.00721016872927537,Other Types,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Rhabdomyosarcoma,BRD-K78513633-001-15-7::2.5::HTS,4.081608156013612,0.0438348357712774,Rhabdomyosarcoma,lonidamine,glucokinase inhibitor,GCK
Rhabdomyosarcoma,BRD-K78692225-001-24-5::2.5::HTS,4.0669730649963665,0.04422041219989581,Other Types,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor","AHR, DHODH, PTK2B"
Rhabdomyosarcoma,BRD-K78809024-001-05-7::2.5::HTS,6.934341420682111,0.008688379675505781,Other Types,SB-590885,RAF inhibitor,BRAF
Rhabdomyosarcoma,BRD-K78959463-001-13-2::2.5::HTS,4.9118945793288535,0.027079341935917656,Other Types,FPL-64176,calcium channel activator,"CACNA1C, CACNA1S"
Rhabdomyosarcoma,BRD-K79753741-001-01-7::2.5::HTS,4.238181741923434,0.03999147538430745,Rhabdomyosarcoma,UBP-302,glutamate receptor antagonist,GRIK1
Rhabdomyosarcoma,BRD-K79989959-001-01-4::2.5::HTS,4.172548370330887,0.04155001740003495,Rhabdomyosarcoma,nesbuvir,RNA polymerase inhibitor,
Rhabdomyosarcoma,BRD-K80028314-303-02-6::2.5::HTS,10.002588106386023,0.0016475757956613021,Other Types,alpha-methylhistamine-dihydrobromide-(R)-(-),histamine receptor agonist,HRH3
Rhabdomyosarcoma,BRD-K80315159-051-02-0::2.5::HTS,7.872498696833123,0.005196308109035283,Other Types,DPPE,histamine receptor antagonist,"ABCB1, HRH1"
Rhabdomyosarcoma,BRD-K81101512-234-01-9::2.5::HTS,5.091359043910655,0.024435725454895914,Other Types,fosfomycin,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K81136890-003-01-6::2.5::HTS,6.387533237850664,0.01177151779178334,Other Types,leucylleucine-methyl-ester,,
Rhabdomyosarcoma,BRD-K81572616-001-01-9::2.5::HTS,5.026277560170024,0.025356916721212663,Other Types,CK-636,actin related protein inhibitor,"ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5"
Rhabdomyosarcoma,BRD-K82002057-001-01-2::2.5::HTS,8.379303362726146,0.003943400892477245,Other Types,DFB,glutamate receptor agonist,GRM5
Rhabdomyosarcoma,BRD-K82104468-001-05-0::2.5::HTS,3.9815869978199663,0.04648249031147339,Rhabdomyosarcoma,ethyl-vanillin,,
Rhabdomyosarcoma,BRD-K82800842-001-01-9::2.5::HTS,13.892590260172927,0.00021351449370861765,Other Types,inositol-hexanicotinate,,
Rhabdomyosarcoma,BRD-K82818427-001-04-8::2.5::HTS,4.110227452631461,0.04309858263465307,Other Types,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Rhabdomyosarcoma,BRD-K82823076-001-02-6::2.5::HTS,4.583377857361829,0.032719293905444057,Rhabdomyosarcoma,Ro-15-4513,,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2"
Rhabdomyosarcoma,BRD-K82941592-238-04-5::2.5::HTS,6.271970998251517,0.01256048690494747,Rhabdomyosarcoma,rosuvastatin,HMGCR inhibitor,HMGCR
Rhabdomyosarcoma,BRD-K82983861-001-04-3::2.5::HTS,7.543063374975028,0.0062182848025048336,Other Types,GW-0742,PPAR receptor agonist,PPARD
Rhabdomyosarcoma,BRD-K83063356-003-02-5::2.5::HTS,4.42405398732982,0.035886067586472184,Rhabdomyosarcoma,RS-102895,CCR antagonist,CCR2
Rhabdomyosarcoma,BRD-K83186168-001-01-8::2.5::HTS,6.341867010360442,0.01207842273440527,Rhabdomyosarcoma,AZD1981,CRTH receptor antagonist,PTGDR2
Rhabdomyosarcoma,BRD-K83322645-050-01-9::2.5::HTS,14.47011535914701,0.00015812436896236643,Rhabdomyosarcoma,L-693403,"sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1"
Rhabdomyosarcoma,BRD-K83405785-001-01-5::2.5::HTS,6.335004147450994,0.012124693005385387,Rhabdomyosarcoma,pimavanserin,serotonin receptor inverse agonist,"DRD2, HTR2A"
Rhabdomyosarcoma,BRD-K83636919-001-04-8::2.5::HTS,7.1038371396215085,0.007915470275384048,Other Types,entacapone,catechol O methyltransferase inhibitor,COMT
Rhabdomyosarcoma,BRD-K83896451-001-06-7::2.5::HTS,5.764318198259707,0.01669973500865455,Rhabdomyosarcoma,glutamine-(l),,"CTPS1, GLUL, GPRC6A, PPAT"
Rhabdomyosarcoma,BRD-K84075000-001-05-5::2.5::HTS,3.9240657890090174,0.048091047070379596,Other Types,2-Chloropyrazine,,
Rhabdomyosarcoma,BRD-K84266862-001-03-2::2.5::HTS,9.932415754669588,0.0017112207318281474,Other Types,BRL-50481,phosphodiesterase inhibitor,"PDE7A, PDE7B"
Rhabdomyosarcoma,BRD-K84783599-001-01-0::2.5::HTS,5.2970363668574265,0.021742256347360638,Rhabdomyosarcoma,riociguat,guanylate cyclase stimulant,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3"
Rhabdomyosarcoma,BRD-K85014146-001-02-5::2.5::HTS,5.255331124909787,0.022302600146693292,Other Types,AZD2461,PARP inhibitor,
Rhabdomyosarcoma,BRD-K85066592-001-01-6::2.5::HTS,3.9887514340342296,0.04629720236525377,Other Types,gly-gln,,
Rhabdomyosarcoma,BRD-K85307935-236-09-5::2.5::HTS,21.192888495595206,5.185161143628838e-06,Rhabdomyosarcoma,novobiocin,bacterial DNA gyrase inhibitor,
Rhabdomyosarcoma,BRD-K85554912-001-08-9::2.5::HTS,6.701026633767198,0.009889713265713713,Other Types,ivermectin,benzodiazepine receptor agonist,"CHRNA7, GABRB3, GLRA3, P2RX7"
Rhabdomyosarcoma,BRD-K86436199-003-01-3::2.5::HTS,6.615300165024375,0.010371040714560863,Rhabdomyosarcoma,landiolol,adrenergic receptor antagonist,ADRB1
Rhabdomyosarcoma,BRD-K86799112-001-02-0::2.5::HTS,5.779332051026936,0.016544256847480412,Other Types,5-HMF,,
Rhabdomyosarcoma,BRD-K88358234-003-04-8::2.5::HTS,5.491260046497722,0.01946129595450813,Rhabdomyosarcoma,xaliproden,serotonin receptor agonist,HTR1A
Rhabdomyosarcoma,BRD-K88510285-001-11-1::2.5::HTS,7.866827864193769,0.005210156317197568,Rhabdomyosarcoma,bortezomib,"NFkB pathway inhibitor, proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA"
Rhabdomyosarcoma,BRD-K88759641-003-02-8::2.5::HTS,3.9347801329286556,0.047790509759598344,Other Types,EMD-66684,angiotensin receptor antagonist,AGTR1
Rhabdomyosarcoma,BRD-K88807631-001-01-3::2.5::HTS,7.624540155593338,0.005947832772926262,Rhabdomyosarcoma,elacridar,P glycoprotein inhibitor,ABCB1
Rhabdomyosarcoma,BRD-K89162000-001-06-4::2.5::HTS,10.186707238161352,0.0014940078202280947,Rhabdomyosarcoma,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB"
Rhabdomyosarcoma,BRD-K89272762-001-12-7::2.5::HTS,4.864248424891155,0.02782279101169254,Other Types,NPPB,chloride channel blocker,"ANO1, CLCN2, CLCN7, TRPA1"
Rhabdomyosarcoma,BRD-K89274813-001-02-3::2.5::HTS,26.156274639368736,4.333039695049286e-07,Other Types,DMP-543,acetylcholine release enhancer,
Rhabdomyosarcoma,BRD-K89348303-001-14-7::2.5::HTS,10.829633780727459,0.001061847738258138,Rhabdomyosarcoma,ramipril,angiotensin converting enzyme inhibitor,ACE
Rhabdomyosarcoma,BRD-K89561498-001-01-7::2.5::HTS,4.731424889274753,0.030036219686809022,Rhabdomyosarcoma,SN-38,topoisomerase inhibitor,TOP1
Rhabdomyosarcoma,BRD-K90027121-003-01-7::2.5::HTS,5.596488352555985,0.018336783105380224,Rhabdomyosarcoma,amprolium,thiamine uptake blocker,
Rhabdomyosarcoma,BRD-K90195324-003-02-5::2.5::HTS,9.102419332168289,0.002668890095636656,Other Types,bazedoxifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2"
Rhabdomyosarcoma,BRD-K90948141-001-01-4::2.5::HTS,6.802714968269956,0.00937585630277288,Other Types,indiplon,benzodiazepine receptor agonist,GABRA1
Rhabdomyosarcoma,BRD-K91308639-001-02-7::2.5::HTS,6.526707194145668,0.010890466928908207,Other Types,apalutamide,androgen receptor antagonist,
Rhabdomyosarcoma,BRD-K91868854-001-03-6::2.5::HTS,4.562352916435187,0.03312143838216943,Other Types,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4
Rhabdomyosarcoma,BRD-K92041145-001-09-5::2.5::HTS,3.8750236985767876,0.04950329367423184,Other Types,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Rhabdomyosarcoma,BRD-K92492521-001-02-9::2.5::HTS,7.712179205067639,0.005669648677814308,Other Types,LY255283,leukotriene receptor antagonist,"LTB4R, LTB4R2"
Rhabdomyosarcoma,BRD-K92613113-066-02-7::2.5::HTS,15.974360776946536,7.27645015268147e-05,Rhabdomyosarcoma,safinamide,"dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor",MAOB
Rhabdomyosarcoma,BRD-K92872987-001-02-9::2.5::HTS,4.789088170991637,0.029070642138649898,Rhabdomyosarcoma,cefpiramide,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K92980438-001-03-3::2.5::HTS,4.957627808498724,0.02639690167848209,Other Types,3-bromopyruvate,hexokinase inhibitor,HK2
Rhabdomyosarcoma,BRD-K92988025-001-01-9::2.5::HTS,4.370966274214805,0.03703381546517036,Rhabdomyosarcoma,perflubron,contrast agent,
Rhabdomyosarcoma,BRD-K93631643-001-02-4::2.5::HTS,5.51831987227495,0.019168606613299114,Rhabdomyosarcoma,hordenine,,
Rhabdomyosarcoma,BRD-K94288301-001-01-7::2.5::HTS,7.106874539118708,0.007899841774870455,Rhabdomyosarcoma,letermovir,CMV terminase inhibitor,
Rhabdomyosarcoma,BRD-K95053546-001-01-9::2.5::HTS,5.741616684768808,0.016893446927150724,Rhabdomyosarcoma,tempol,free radical scavenger,
Rhabdomyosarcoma,BRD-K95110148-003-01-5::2.5::HTS,12.227026946939423,0.0005084464176259235,Rhabdomyosarcoma,beta-funaltrexamine,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Rhabdomyosarcoma,BRD-K96029467-003-01-9::2.5::HTS,5.317905768926719,0.02147366924066953,Other Types,alagebrium,glycosylation inhibitor,
Rhabdomyosarcoma,BRD-K96055017-003-02-7::2.5::HTS,9.425413254847987,0.002243343388641094,Other Types,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,
Rhabdomyosarcoma,BRD-K96104201-001-01-5::2.5::HTS,5.8943358378124175,0.015505435216814845,Rhabdomyosarcoma,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,
Rhabdomyosarcoma,BRD-K96188950-001-16-9::2.5::HTS,4.942409128556036,0.026609633376832576,Other Types,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA
Rhabdomyosarcoma,BRD-K96436774-001-01-8::2.5::HTS,3.9539587253231154,0.04725017240427536,Rhabdomyosarcoma,pelanserin,serotonin receptor antagonist,HTR2A
Rhabdomyosarcoma,BRD-K96786677-236-02-4::2.5::HTS,4.297468069242369,0.038643742565684445,Rhabdomyosarcoma,oxacillin,bacterial cell wall synthesis inhibitor,
Rhabdomyosarcoma,BRD-K96799727-001-06-6::2.5::HTS,8.898046821943383,0.0029795478166344553,Rhabdomyosarcoma,pifithrin-mu,HSP inhibitor,"HSPA1A, TP53"
Rhabdomyosarcoma,BRD-K97025174-001-01-4::2.5::HTS,5.451972025386621,0.019899265678279016,Rhabdomyosarcoma,capadenoson,adenosine receptor agonist,ADORA1
Rhabdomyosarcoma,BRD-K97072811-001-11-4::2.5::HTS,4.1597645604573135,0.04186482861881013,Rhabdomyosarcoma,TG-003,CLK inhibitor,"CLK1, CLK4, DYRK1A, DYRK1B"
Rhabdomyosarcoma,BRD-K97118047-001-03-8::2.5::HTS,4.343751011519314,0.03759847384043345,Rhabdomyosarcoma,"4,5,6,7-tetrabromobenzotriazole",casein kinase inhibitor,"AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1"
Rhabdomyosarcoma,BRD-K97428065-001-01-2::2.5::HTS,4.447145267432635,0.03540305247072433,Rhabdomyosarcoma,netupitant,tachykinin antagonist,TACR1
Rhabdomyosarcoma,BRD-K97440753-066-18-1::2.5::HTS,4.824895504771517,0.02845919933859484,Rhabdomyosarcoma,dihydroergocristine,"adrenergic receptor antagonist, prolactin inhibitor","ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
Rhabdomyosarcoma,BRD-K97564742-050-32-7::2.5::HTS,7.5457845213155785,0.006207985305096744,Other Types,mepyramine,histamine receptor antagonist,HRH1
Rhabdomyosarcoma,BRD-K97643133-003-09-3::2.5::HTS,5.254626013795451,0.022257208147113225,Other Types,amiprilose,CD antagonist,
Rhabdomyosarcoma,BRD-K97883416-001-01-4::2.5::HTS,11.202632883089452,0.00087523445271169,Rhabdomyosarcoma,BMS-626529,HIV attachment inhibitor,
Rhabdomyosarcoma,BRD-K97963946-001-01-3::2.5::HTS,5.394294412011509,0.02055892599036293,Rhabdomyosarcoma,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET
Rhabdomyosarcoma,BRD-K98372770-001-08-2::2.5::HTS,3.984015596023729,0.04642298529562731,Rhabdomyosarcoma,L-165041,PPAR receptor agonist,PPARD
Rhabdomyosarcoma,BRD-K98521173-001-19-4::2.5::HTS,11.571982273486158,0.0007171417637859086,Other Types,desoxycortone,mineralocorticoid receptor agonist,"NR3C1, NR3C2"
Rhabdomyosarcoma,BRD-K98548675-001-05-9::2.5::HTS,10.509700986756341,0.0012578383067636636,Other Types,parthenolide,NFkB pathway inhibitor,
Rhabdomyosarcoma,BRD-K99092662-001-01-1::2.5::HTS,11.311691843236561,0.0008230361778894017,Rhabdomyosarcoma,PS178990,androgen receptor modulator,AR
Rhabdomyosarcoma,BRD-K99615199-001-18-5::2.5::HTS,9.512620181802454,0.0021416273293095177,Rhabdomyosarcoma,medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR"
Rhabdomyosarcoma,BRD-M08274809-001-01-7::2.5::HTS,4.136196657222349,0.04247671793928749,Other Types,indium(iii)-isopropoxide,,
Rhabdomyosarcoma,BRD-M29182745-001-01-4::2.5::HTS,5.253543866208259,0.022309428034763136,Rhabdomyosarcoma,ammonium-lactate,,HCAR1
Rhabdomyosarcoma,BRD-M29936662-001-02-0::2.5::HTS,7.01875808749443,0.008292943915330432,Other Types,cis-ACPD,glutamate receptor agonist,"GRM2, GRM3, GRM6, GRM7, GRM8"
Rhabdomyosarcoma,BRD-M77041484-001-01-8::2.5::HTS,4.13163134142754,0.04256772764519571,Other Types,TBOA-(DL),excitatory amino acid transporter inhibitor,"SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7"
Rhabdomyosarcoma,BRD-U51753822-000-01-1::2.5::HTS,5.330761631443086,0.02131671798244376,Rhabdomyosarcoma,phosphatidylcholine,,PCTP
Rhabdomyosarcoma,BRD-A48420483-001-02-3::2.5::MTS004,6.288121187571418,0.012447876224723504,Rhabdomyosarcoma,bupranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Rhabdomyosarcoma,BRD-A59961917-001-01-0::2.5::MTS004,5.675039701520076,0.01755442923367047,Other Types,BQ-123,endothelin receptor antagonist,EDNRA
Rhabdomyosarcoma,BRD-A85295731-001-06-4::2.500008824::MTS004,4.063080326029504,0.044326221720556676,Other Types,tiopronin,"chelating agent, reducing agent",
Rhabdomyosarcoma,BRD-A88254928-001-07-9::2.5::MTS004,4.299339644146946,0.03860247006956142,Other Types,albuterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Rhabdomyosarcoma,BRD-A99899486-004-01-9::2.293696319::MTS004,3.932067574096934,0.047880821813881466,Rhabdomyosarcoma,cimetropium,acetylcholine receptor antagonist,CHRM1
Rhabdomyosarcoma,BRD-K03503561-001-01-4::2.339952449::MTS004,3.979312133598502,0.04656545153384323,Rhabdomyosarcoma,ravuconazole,sterol demethylase inhibitor,
Rhabdomyosarcoma,BRD-K10415035-001-04-4::2.5::MTS004,4.70295942400869,0.030547350679816038,Other Types,tasuldine,mucolytic agent,
Rhabdomyosarcoma,BRD-K11792081-001-01-4::2.500009305::MTS004,3.975582447443788,0.04666788968295962,Rhabdomyosarcoma,ABT-639,calcium channel blocker,"CACNA1G, CACNA1H, CACNA1I"
Rhabdomyosarcoma,BRD-K15327298-001-05-5::2.444207768::MTS004,5.509019877607818,0.01928226435781497,Rhabdomyosarcoma,fmoc-l-leucine,PPAR receptor agonist,
Rhabdomyosarcoma,BRD-K25243230-001-01-2::2.5::MTS004,7.937423567771429,0.005019915561898796,Rhabdomyosarcoma,oxytocin,oxytocin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Rhabdomyosarcoma,BRD-K35367061-001-01-1::2.5::MTS004,4.282429552893333,0.03898423292172133,Rhabdomyosarcoma,LY223982,leukotriene receptor antagonist,LTB4R
Rhabdomyosarcoma,BRD-K43639297-001-01-9::2.500038533::MTS004,9.194153133573435,0.002544914109666584,Rhabdomyosarcoma,hemoglobin-modulators-1,hemoglobin modulator,
Rhabdomyosarcoma,BRD-K45906612-001-01-8::2.499991411::MTS004,4.328039443173175,0.03796205129127066,Rhabdomyosarcoma,presatovir,RSV fusion inhibitor,
Rhabdomyosarcoma,BRD-K46862739-001-14-3::2.499952208::MTS004,5.584428222902345,0.018475538153863526,Other Types,metyrapone,cytochrome P450 inhibitor,CYP11B1
Rhabdomyosarcoma,BRD-K49659468-436-01-2::2.500002467::MTS004,6.426850623961731,0.011522379030344528,Rhabdomyosarcoma,TMC647055,RNA polymerase inhibitor,
Rhabdomyosarcoma,BRD-K57774929-001-01-3::2.643351543::MTS004,4.206944027731162,0.040741656388045264,Rhabdomyosarcoma,foropafant,platelet activating factor receptor antagonist,PTAFR
Rhabdomyosarcoma,BRD-K59256312-066-15-7::2.431061328::MTS004,4.556533314939545,0.033244680652821226,Rhabdomyosarcoma,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Rhabdomyosarcoma,BRD-K60284353-001-01-3::2.5::MTS004,4.572245860155049,0.032942913842821935,Rhabdomyosarcoma,titanocene-dichloride,apoptosis stimulant,
Rhabdomyosarcoma,BRD-K62971431-001-01-9::2.5::MTS004,4.392864437482845,0.03655539897774538,Rhabdomyosarcoma,tasimelteon,melatonin receptor agonist,"MTNR1A, MTNR1B"
Rhabdomyosarcoma,BRD-K67482377-001-01-8::2.500004112::MTS004,6.4036837514220455,0.011671854576835342,Rhabdomyosarcoma,itacitinib,JAK inhibitor,JAK1
Rhabdomyosarcoma,BRD-K75385383-001-01-5::2.548558667::MTS004,7.303205053187916,0.007100171775628867,Rhabdomyosarcoma,DIPT,"dopamine reuptake inhibitor, serotonin reuptake inhibitor","HTR1A, HTR2A, HTR2C"
Rhabdomyosarcoma,BRD-K77175907-001-08-0::2.555048691::MTS004,4.468268756562598,0.03498869898549504,Rhabdomyosarcoma,calcifediol,vitamin D receptor agonist,VDR
Rhabdomyosarcoma,BRD-K80359953-001-01-3::2.500041136::MTS004,8.3571145714086,0.003996709958416266,Rhabdomyosarcoma,talampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Rhabdomyosarcoma,BRD-K81616657-001-01-4::2.665005855::MTS004,4.198569695388837,0.04094170159430719,Rhabdomyosarcoma,PNU-142633,serotonin receptor agonist,HTR1D
Rhabdomyosarcoma,BRD-K82687598-001-01-6::2.5::MTS004,5.618038070003467,0.018127518036833316,Rhabdomyosarcoma,tolonidine,adrenergic receptor antagonist,ADRA2A
Rhabdomyosarcoma,BRD-K86171477-001-01-3::2.5::MTS004,9.059399195750002,0.0027358044491585087,Rhabdomyosarcoma,eltoprazine,serotonin receptor agonist,"HTR1A, HTR1B"
Rhabdomyosarcoma,BRD-K91244729-003-01-3::2.316613157::MTS004,5.917057238544573,0.015319361153426135,Rhabdomyosarcoma,propiverine,acetylcholine receptor antagonist,CHRM1
Rhabdomyosarcoma,BRD-K91543828-001-02-0::2.500044381::MTS004,4.034375800822577,0.04508043866544382,Rhabdomyosarcoma,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Rhabdomyosarcoma,BRD-K94072573-001-09-9::2.5::MTS004,6.797558812695568,0.009381099273194148,Rhabdomyosarcoma,medronic-acid,bone resorption inhibitor,
Rhabdomyosarcoma,BRD-K94146583-001-01-6::2.500085506::MTS004,4.447854075786316,0.03540577793519993,Rhabdomyosarcoma,didox,ribonucleotide reductase inhibitor,RRM1
Rhabdomyosarcoma,BRD-K99616396-001-05-1::2.499991421::MTS004,4.353243226454193,0.03740797980876126,Rhabdomyosarcoma,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT1, FLT4, KDR, KIT"
Neuroblastoma,BRD-A00077618-236-07-6::2.5::HTS,5.932120116721349,0.015179930900577145,Other Types,8-bromo-cGMP,PKA activator,PRKG1
Neuroblastoma,BRD-A00147595-001-01-5::2.5::HTS,5.93602157860698,0.015146725130760867,Other Types,balaglitazone,"insulin sensitizer, PPAR receptor partial agonist",PPARG
Neuroblastoma,BRD-A02743701-001-03-6::2.5::HTS,3.9096587093360595,0.048501069741105754,Neuroblastoma,cilnidipine,calcium channel blocker,CACNA1B
Neuroblastoma,BRD-A02759312-003-24-5::2.5::HTS,9.584258264855265,0.002060844104873077,Other Types,betaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Neuroblastoma,BRD-A03506276-001-01-5::2.5::HTS,11.765961998925672,0.0006479249956135993,Neuroblastoma,XL888,HSP inhibitor,
Neuroblastoma,BRD-A03623303-045-09-5::2.5::HTS,5.638890461795128,0.0179040972656947,Neuroblastoma,metoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Neuroblastoma,BRD-A06352508-001-03-7::2.5::HTS,12.941365787340786,0.00034994455412721073,Other Types,SB-218078,CHK inhibitor,CHEK1
Neuroblastoma,BRD-A07000685-001-04-4::2.5::HTS,4.355399273980223,0.037345869196601905,Neuroblastoma,hydrocortisone-hemisuccinate,,
Neuroblastoma,BRD-A09349126-001-10-7::2.5::HTS,5.176904151381986,0.023281566698399994,Neuroblastoma,norethindrone-acetate,progesterone receptor agonist,
Neuroblastoma,BRD-A09370961-001-01-0::2.5::HTS,5.497858073938159,0.01940171630533334,Neuroblastoma,ioxilan,radiopaque medium,
Neuroblastoma,BRD-A11815689-001-01-1::2.5::HTS,7.158194205138799,0.007681721278645244,Neuroblastoma,proscillaridin-a,,
Neuroblastoma,BRD-A11990600-001-03-4::2.5::HTS,17.279789204511918,3.7520748074209206e-05,Neuroblastoma,lorazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Neuroblastoma,BRD-A12077521-003-01-5::2.5::HTS,9.675217810830569,0.0019665180533559026,Neuroblastoma,cefepime,bacterial cell wall synthesis inhibitor,
Neuroblastoma,BRD-A12896037-001-04-3::2.5::HTS,10.501622496301076,0.001266310382662462,Neuroblastoma,cisapride,serotonin receptor agonist,"HTR2A, HTR3A, HTR4, KCNH2"
Neuroblastoma,BRD-A13946108-001-17-1::2.5::HTS,5.379361946356044,0.02073906691166579,Other Types,sulindac,cyclooxygenase inhibitor,"AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2"
Neuroblastoma,BRD-A13964793-001-02-6::2.5::HTS,7.07119414116502,0.008058679433872597,Neuroblastoma,TC1,beta-secretase inhibitor,BACE1
Neuroblastoma,BRD-A14262390-065-01-8::2.5::HTS,3.890784232013611,0.0490624219802824,Neuroblastoma,guanadrel,adrenergic inhibitor,SLC6A2
Neuroblastoma,BRD-A17428743-003-09-0::2.5::HTS,4.294235151527663,0.03870131068900603,Other Types,BW-723C86,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C"
Neuroblastoma,BRD-A17846016-001-13-9::2.5::HTS,5.724617968327449,0.01705899213780484,Neuroblastoma,trolox,antioxidant,
Neuroblastoma,BRD-A18795974-004-07-3::2.5::HTS,7.221468696973117,0.007418184529815685,Other Types,7-hydroxy-DPAT,dopamine receptor agonist,"DRD2, DRD3"
Neuroblastoma,BRD-A19952358-001-11-3::2.5::HTS,4.46945030059117,0.03495228297609275,Other Types,closantel,"chitinase inhibitor, NFkB pathway inhibitor",
Neuroblastoma,BRD-A22152765-003-10-0::2.5::HTS,7.557279964324595,0.006169040257498196,Neuroblastoma,tridihexethyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Neuroblastoma,BRD-A24587114-066-22-5::2.5::HTS,4.116601142726699,0.042938564611613446,Neuroblastoma,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Neuroblastoma,BRD-A28467416-002-01-0::2.5::HTS,5.997321520947543,0.014640944404991531,Neuroblastoma,PKI-179,"mTOR inhibitor, PI3K inhibitor",MTOR
Neuroblastoma,BRD-A28940325-001-24-0::2.5::HTS,8.478704249138593,0.003737215684734354,Neuroblastoma,trichlormethiazide,chloride channel blocker,"ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3"
Neuroblastoma,BRD-A28970875-300-04-9::2.5::HTS,10.624566631240445,0.0011863588140560034,Neuroblastoma,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Neuroblastoma,BRD-A29485665-001-12-8::2.5::HTS,10.050594251534676,0.0016071474728105053,Neuroblastoma,bicalutamide,androgen receptor antagonist,AR
Neuroblastoma,BRD-A29700858-304-02-6::2.5::HTS,4.6522138401874065,0.0314368565789129,Other Types,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3"
Neuroblastoma,BRD-A30051119-002-01-8::2.5::HTS,5.290002725868941,0.02181834149644628,Neuroblastoma,amikacin,bacterial 30S ribosomal subunit inhibitor,
Neuroblastoma,BRD-A31454688-001-01-6::2.5::HTS,6.2342105236431395,0.012824067873441434,Other Types,monostearin,,
Neuroblastoma,BRD-A31521121-001-26-4::2.5::HTS,4.217488797048228,0.04052575786886886,Neuroblastoma,methocarbamol,muscle relaxant,CA1
Neuroblastoma,BRD-A32172948-001-07-6::2.5::HTS,4.371518444537041,0.03699948124796763,Other Types,methiopril,angiotensin converting enzyme inhibitor,ACE
Neuroblastoma,BRD-A32673558-003-03-9::2.5::HTS,4.869217271585432,0.02774712822559493,Other Types,aceclidine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Neuroblastoma,BRD-A34358106-003-01-6::2.5::HTS,7.066640796892571,0.008080152990552114,Neuroblastoma,sarpogrelate,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Neuroblastoma,BRD-A34716233-004-03-5::2.5::HTS,4.839240164141342,0.028229132596092284,Other Types,AMPA-(RS),glutamate receptor agonist,GRIN1
Neuroblastoma,BRD-A35623999-001-05-7::2.5::HTS,3.8744100868441413,0.04952303608358273,Neuroblastoma,CGP-37157,"mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor",SLC8A1
Neuroblastoma,BRD-A35989968-001-04-2::2.5::HTS,9.554160087162193,0.0020952337058431384,Neuroblastoma,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Neuroblastoma,BRD-A36010170-001-04-0::2.5::HTS,4.770726345935251,0.029363883623263948,Neuroblastoma,amcinonide,glucocorticoid receptor agonist,"ANXA1, NR3C1"
Neuroblastoma,BRD-A36267905-003-18-4::2.5::HTS,11.364270246629099,0.0008023812417263824,Neuroblastoma,buphenine,adrenergic receptor agonist,ADRB2
Neuroblastoma,BRD-A36331462-001-02-1::2.5::HTS,4.862538327008811,0.02785747215466073,Neuroblastoma,oprozomib,proteasome inhibitor,
Neuroblastoma,BRD-A37347161-003-02-6::2.5::HTS,4.072315023999784,0.044068696355125024,Other Types,BRL-52537,opioid receptor agonist,OPRK1
Neuroblastoma,BRD-A37441042-003-04-8::2.5::HTS,6.06270670954775,0.014107736317964784,Other Types,tulobuterol,adrenergic receptor agonist,ADRB2
Neuroblastoma,BRD-A38747044-001-02-3::2.5::HTS,4.543078008894293,0.03348920906301085,Other Types,KU14R,imidazoline receptor antagonist,
Neuroblastoma,BRD-A41692738-001-07-6::2.5::HTS,9.933198635678067,0.001710985564875205,Neuroblastoma,TGX-221,PI3K inhibitor,"PIK3CB, PIK3CD"
Neuroblastoma,BRD-A42699921-001-02-8::2.5::HTS,15.317102548062993,0.00010205531374822304,Neuroblastoma,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH
Neuroblastoma,BRD-A44008656-036-25-8::2.5::HTS,4.701070800820643,0.030566494232205556,Neuroblastoma,doxylamine,histamine receptor antagonist,"CHRM1, HRH1"
Neuroblastoma,BRD-A44448661-001-04-8::2.5::HTS,9.210396402604525,0.00251778365148237,Neuroblastoma,pentobarbital,"barbiturate antiepileptic, GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Neuroblastoma,BRD-A44696962-001-01-4::2.5::HTS,4.093983642873654,0.04351315423789271,Neuroblastoma,acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,"HSD11B1, HSD11B2"
Neuroblastoma,BRD-A45498368-001-07-1::2.5::HTS,5.340807938394687,0.02119540407884391,Neuroblastoma,WYE-125132,mTOR inhibitor,MTOR
Neuroblastoma,BRD-A46179541-311-02-0::2.5::HTS,6.421122471612284,0.011552479064124408,Neuroblastoma,doxapram,potassium channel blocker,"KCNK3, KCNK9"
Neuroblastoma,BRD-A47598013-004-16-0::2.5::HTS,4.553397611557806,0.03328965316401166,Neuroblastoma,citalopram,selective serotonin reuptake inhibitor (SSRI),"SLC6A2, SLC6A4"
Neuroblastoma,BRD-A47953250-001-01-7::2.5::HTS,5.535235796942426,0.018995767309826026,Neuroblastoma,ecamsule-triethanolamine,,
Neuroblastoma,BRD-A49399758-015-01-8::2.5::HTS,5.018749418152171,0.025471357574224633,Neuroblastoma,desmopressin-acetate,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Neuroblastoma,BRD-A50157456-065-20-6::2.5::HTS,10.601186391177723,0.001199584757210062,Neuroblastoma,terbutaline,adrenergic receptor agonist,ADRB2
Neuroblastoma,BRD-A52588987-004-08-2::2.5::HTS,7.206706481552076,0.007478648466492099,Neuroblastoma,SKF-83566,dopamine receptor antagonist,"DRD1, DRD5"
Neuroblastoma,BRD-A53037300-001-01-0::2.5::HTS,11.246456152654616,0.0008517741638169753,Other Types,2-fluoro-2-deoxy-D-galactose,,LCT
Neuroblastoma,BRD-A53951045-004-01-6::2.5::HTS,6.3590226875071085,0.011957867061409284,Neuroblastoma,butylscopolamine-bromide,cholinergic receptor antagonist,
Neuroblastoma,BRD-A55272860-001-14-6::2.5::HTS,4.928910629825976,0.02681127155611826,Other Types,sulpiride,dopamine receptor antagonist,
Neuroblastoma,BRD-A55484088-050-02-5::2.5::HTS,15.35175908539325,0.00010029046555220419,Neuroblastoma,BNTX,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Neuroblastoma,BRD-A56592690-001-04-3::2.5::HTS,6.313933906231862,0.01225809488551202,Other Types,PX-12,thioredoxin inhibitor,"TXN, TXNRD1"
Neuroblastoma,BRD-A58193911-003-18-7::2.5::HTS,4.073805866427903,0.04404783534234826,Neuroblastoma,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Neuroblastoma,BRD-A59303141-001-10-4::2.5::HTS,6.748188190980491,0.009640843950198447,Neuroblastoma,quinethazone,thiazide diuretic,"CA1, CA2, SLC12A1, SLC12A2, SLC12A3"
Neuroblastoma,BRD-A60786380-412-01-5::2.5::HTS,4.260202207543412,0.039505105877122554,Neuroblastoma,sodium-stibogluconate,tyrosine phosphatase inhibitor,"PTPN6, TOP1"
Neuroblastoma,BRD-A62731508-001-05-8::2.5::HTS,4.766537748780182,0.029434035877701284,Neuroblastoma,cortisone,glucocorticoid receptor agonist,NR3C1
Neuroblastoma,BRD-A63752151-001-01-2::2.5::HTS,9.391410666627408,0.0022846266190854163,Neuroblastoma,fidarestat,aldose reductase inhibitor,AKR1B1
Neuroblastoma,BRD-A64064900-001-02-3::2.5::HTS,13.311534915592002,0.00028908213981373933,Neuroblastoma,sangivamycin,DNA inhibitor,
Neuroblastoma,BRD-A64227845-004-09-3::2.5::HTS,6.088077614105947,0.013906627160915052,Neuroblastoma,SKF-77434,dopamine receptor agonist,DRD1
Neuroblastoma,BRD-A64242993-001-05-6::2.5::HTS,9.474916296429278,0.0021853314248092316,Neuroblastoma,lanatoside-c,cardiac glycoside,
Neuroblastoma,BRD-A65013509-003-24-4::2.5::HTS,7.1031212257939975,0.007918187747217852,Other Types,oxybutynin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Neuroblastoma,BRD-A65615053-003-02-2::2.5::HTS,4.566597049405141,0.03303858130320914,Neuroblastoma,zacopride,serotonin receptor antagonist,"HTR3A, HTR3B, HTR4, HTR5A"
Neuroblastoma,BRD-A66419424-001-02-4::2.5::HTS,10.446222305951123,0.0013023068755978974,Neuroblastoma,ixazomib-citrate,proteasome inhibitor,
Neuroblastoma,BRD-A67616246-001-07-9::2.5::HTS,12.192854819886845,0.0005177804149108317,Other Types,levomequitazine,histamine receptor antagonist,HRH1
Neuroblastoma,BRD-A68589262-001-04-3::2.5::HTS,4.177456795348674,0.04144441959151277,Other Types,troxipide,glucosamine synthetase stimulant,
Neuroblastoma,BRD-A68631409-001-05-4::2.5::HTS,5.644266586881819,0.01785167897579837,Neuroblastoma,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1
Neuroblastoma,BRD-A70083328-001-23-5::2.5::HTS,4.743914967213422,0.029823857460389985,Neuroblastoma,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Neuroblastoma,BRD-A71774530-001-05-9::2.5::HTS,5.227461308636989,0.022606770197897648,Other Types,lufenuron,chitin inhibitor,
Neuroblastoma,BRD-A72716251-001-01-5::0.91::HTS,5.988062798774495,0.014712576876731933,Neuroblastoma,peruvoside,cardiac glycoside,
Neuroblastoma,BRD-A73930134-001-03-0::2.5::HTS,4.299208332157476,0.038614439401512386,Neuroblastoma,5-hydroxytryptophan,neurotransmitter,"SLC36A1, SLC36A2"
Neuroblastoma,BRD-A78093359-001-06-3::2.5::HTS,9.878873289088197,0.0017613206891788464,Neuroblastoma,MRS1845,calcium channel blocker,
Neuroblastoma,BRD-A78341343-001-01-6::2.5::HTS,6.2265215027300425,0.012870816770353545,Neuroblastoma,regadenoson,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Neuroblastoma,BRD-A81129465-001-03-8::2.5::HTS,6.864773037323393,0.009038988011200772,Neuroblastoma,fenoprofen,prostaglandin inhibitor,"PTGS1, PTGS2, SLC5A8"
Neuroblastoma,BRD-A81541225-001-06-8::2.5::HTS,4.0572296716656755,0.0444654116910649,Neuroblastoma,oligomycin-a,"ATP synthase inhibitor, ATPase inhibitor",ATP5A1
Neuroblastoma,BRD-A83644949-236-01-6::2.5::HTS,7.011444951343731,0.008333163604298924,Neuroblastoma,ardeparin,thrombin inhibitor,"SERPINC1, SERPIND1"
Neuroblastoma,BRD-A83650191-004-02-8::2.5::HTS,4.827103818713686,0.028466485976146615,Neuroblastoma,A61603,adrenergic receptor agonist,ADRA1A
Neuroblastoma,BRD-A83937277-001-10-5::2.5::HTS,4.1732431130987075,0.041553021684043914,Neuroblastoma,mephenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Neuroblastoma,BRD-A85025557-001-02-5::2.5::HTS,6.254727789403139,0.012675411508550902,Neuroblastoma,NCS-382,GABA receptor antagonist,"GABBR1, GABBR2, SLC52A2"
Neuroblastoma,BRD-A85216385-003-02-4::2.5::HTS,4.354497865592279,0.037363851861847645,Neuroblastoma,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,"CHRM1, SLC6A2, SLC6A3, SLC6A4"
Neuroblastoma,BRD-A85587465-001-03-3::2.5::HTS,5.006698921831133,0.025640508712079194,Neuroblastoma,bemesetron,serotonin receptor antagonist,"HTR3A, HTR3B"
Neuroblastoma,BRD-A87479750-001-02-7::2.5::HTS,5.783959096543191,0.016497684415391553,Neuroblastoma,tenidap,cyclooxygenase inhibitor,"KCNJ4, PTGS1"
Neuroblastoma,BRD-A89196962-300-01-7::2.5::HTS,4.936091649366979,0.02669895969678025,Neuroblastoma,dalargin,opioid receptor agonist,OPRM1
Neuroblastoma,BRD-A89337244-001-02-9::2.5::HTS,4.883210318308401,0.02752728309089497,Neuroblastoma,PD-102807,acetylcholine receptor antagonist,CHRM4
Neuroblastoma,BRD-A90515964-001-16-5::2.5::HTS,4.3667922247537945,0.03709895326679862,Neuroblastoma,guaifenesin,expectorant,
Neuroblastoma,BRD-A91452556-001-04-0::2.5::HTS,9.853513610767237,0.0017846742190393474,Neuroblastoma,estradiol-cypionate,estrogen receptor agonist,ESR1
Neuroblastoma,BRD-A93236127-001-04-5::2.5::HTS,8.549867344500868,0.0035960383332108124,Neuroblastoma,digitoxin,ATPase inhibitor,ATP1A1
Neuroblastoma,BRD-A93353767-008-02-2::2.5::HTS,6.147483630182054,0.013453062626608836,Neuroblastoma,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1
Neuroblastoma,BRD-A93695607-322-02-5::2.47::HTS,5.157962446481753,0.02354179458573027,Neuroblastoma,nicotine,acetylcholine receptor agonist,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1"
Neuroblastoma,BRD-A93699261-236-03-4::2.5::HTS,5.318316849578069,0.02148882567366085,Other Types,sodium-danshensu,,
Neuroblastoma,BRD-A94756469-001-04-7::2.5::HTS,8.254499676710235,0.004218725250906428,Neuroblastoma,digoxin,ATPase inhibitor,ATP1A1
Neuroblastoma,BRD-A94993966-001-05-1::2.63::HTS,4.519792395903746,0.03395880487565555,Neuroblastoma,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Neuroblastoma,BRD-A95121829-001-08-9::2.5::HTS,5.735966210595925,0.016952045463567825,Neuroblastoma,ginkgolide-a,GABA receptor antagonist,"GLRA1, GLRB"
Neuroblastoma,BRD-A95869247-001-26-9::2.5::HTS,5.0248956609664805,0.025376271812865985,Other Types,indapamide,thiazide diuretic,"KCNE1, KCNQ1, SLC12A3"
Neuroblastoma,BRD-A96977263-001-03-7::2.5::HTS,4.285268181663775,0.03892964478007436,Neuroblastoma,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1
Neuroblastoma,BRD-A97479839-003-13-3::2.5::HTS,4.90280024259514,0.027213726119873292,Neuroblastoma,piperidolate,acetylcholine receptor antagonist,CHRM1
Neuroblastoma,BRD-A97730597-003-11-5::2.5::HTS,6.622494932908495,0.01032879082216868,Other Types,hexylcaine,sodium channel blocker,"SCN10A, SCN5A"
Neuroblastoma,BRD-A98174560-001-02-1::2.5::HTS,5.3816944684077,0.020709026464861627,Other Types,chloralose,,
Neuroblastoma,BRD-A98378129-001-02-2::2.5::HTS,5.292678240706768,0.021791286825343384,Neuroblastoma,talniflumate,cyclooxygenase inhibitor,CLCA1
Neuroblastoma,BRD-K00152668-001-01-5::2.5::HTS,10.429768079631687,0.0013130678865018565,Neuroblastoma,adarotene,retinoid receptor agonist,"RARB, RARG"
Neuroblastoma,BRD-K00535541-001-05-5::2.5::HTS,4.2264208706163915,0.040280365953429195,Neuroblastoma,9-aminoacridine,,
Neuroblastoma,BRD-K00535541-001-06-3::2.5::HTS,7.266607724228249,0.007248899801767091,Neuroblastoma,9-aminoacridine,,
Neuroblastoma,BRD-K00627859-003-03-7::2.5::HTS,6.953476093326881,0.008598750626388887,Other Types,tubastatin-a,HDAC inhibitor,HDAC6
Neuroblastoma,BRD-K01663662-003-20-2::2.5::HTS,6.27052943962332,0.012561550270423017,Other Types,diphenidol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Neuroblastoma,BRD-K01683783-001-02-6::2.5::HTS,4.0356140817910315,0.04503064695221089,Neuroblastoma,TAK-901,Aurora kinase inhibitor,AURKB
Neuroblastoma,BRD-K02130563-001-11-4::2.5::HTS,8.475743794504345,0.003743997866775114,Neuroblastoma,panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K02241333-001-02-7::2.5::HTS,6.191389022840601,0.013127972613816189,Neuroblastoma,CHIR-124,CHK inhibitor,CHEK1
Neuroblastoma,BRD-K02265150-001-26-5::2.5::HTS,4.394070996495934,0.036517133974548886,Other Types,amoxapine,norepinephrine reputake inhibitor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4"
Neuroblastoma,BRD-K02389548-001-02-5::2.5::HTS,3.9703330106634245,0.046797935146171664,Other Types,RG2833,HDAC inhibitor,"HDAC1, HDAC3"
Neuroblastoma,BRD-K02637541-001-18-0::2.5::HTS,7.951582139955312,0.00497654081056404,Neuroblastoma,celecoxib,cyclooxygenase inhibitor,"CA12, PDPK1, PTGS2"
Neuroblastoma,BRD-K03155172-001-02-2::2.5::HTS,8.105166922762917,0.004576101919187073,Other Types,GSK3787,PPAR receptor antagonist,PPARD
Neuroblastoma,BRD-K03353589-236-01-4::2.5::HTS,8.811073173211774,0.0031228337571906416,Neuroblastoma,ecabet,"gastrin inhibitor, urease inhibitor",NOXO1
Neuroblastoma,BRD-K03601870-001-01-2::2.5::HTS,17.74538752669257,2.9450775418229888e-05,Neuroblastoma,ixabepilone,microtubule stabilizing agent,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8"
Neuroblastoma,BRD-K04196797-001-24-4::2.5::HTS,5.851415897960198,0.015883373453897617,Neuroblastoma,oxcarbazepine,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Neuroblastoma,BRD-K04264130-001-01-4::2.5::HTS,6.352430083795959,0.012000351905046822,Other Types,favipiravir,RNA polymerase inhibitor,
Neuroblastoma,BRD-K04548931-003-16-5::2.5::HTS,11.84119426788873,0.0006223962356312933,Neuroblastoma,epirubicin,topoisomerase inhibitor,"CHD1, TOP2A"
Neuroblastoma,BRD-K04691817-001-01-8::2.5::HTS,8.064160924109036,0.004679886700384479,Other Types,AGI-6780,isocitrate dehydrogenase inhibitor,IDH2
Neuroblastoma,BRD-K05445342-001-05-3::2.57::HTS,8.298238435357428,0.004129623285913366,Neuroblastoma,WP1066,STAT inhibitor,STAT3
Neuroblastoma,BRD-K05638300-001-01-2::2.5::HTS,10.942338093778131,0.0010039529572464176,Neuroblastoma,sevoflurane,membrane integrity inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1"
Neuroblastoma,BRD-K06208435-003-08-2::2.5::HTS,4.037115562418803,0.04498746939056793,Other Types,YS-035,calcium channel blocker,
Neuroblastoma,BRD-K06542892-001-01-9::2.5::HTS,9.070534073194956,0.002717006496046107,Other Types,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Neuroblastoma,BRD-K06749501-001-02-1::2.5::HTS,12.814570268563779,0.0003738991701804623,Other Types,GSK1838705A,insulin growth factor receptor inhibitor,"ALK, IGF1R, INSR, RPS6KA1"
Neuroblastoma,BRD-K06753942-001-14-5::2.5::HTS,4.952585999580146,0.026453418407148255,Neuroblastoma,nobiletin,MEK inhibitor,MAP2K1
Neuroblastoma,BRD-K06878038-001-18-6::2.5::HTS,4.397328096522826,0.03644801966866657,Neuroblastoma,deferiprone,chelating agent,UGT1A6
Neuroblastoma,BRD-K07310275-001-02-5::2.5::HTS,12.304923216578308,0.0004882341261327449,Neuroblastoma,PF-04691502,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Neuroblastoma,BRD-K07359318-001-03-9::2.45::HTS,4.3550821022773825,0.03737774095291135,Neuroblastoma,benfotiamine,antioxidant,AGER
Neuroblastoma,BRD-K07442505-001-03-6::2.5::HTS,3.9062599229271475,0.048595914213743395,Neuroblastoma,BAM7,BAX activator,BAX
Neuroblastoma,BRD-K07612980-001-05-3::2.59::HTS,21.998198974654418,3.4798180116056734e-06,Neuroblastoma,sparfloxacin,bacterial DNA gyrase inhibitor,TOP2A
Neuroblastoma,BRD-K07881437-001-03-8::2.5::HTS,4.150918666730828,0.04209985458934173,Neuroblastoma,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Neuroblastoma,BRD-K07955840-001-02-3::2.5::HTS,14.29906620288555,0.0001727635040457941,Neuroblastoma,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Neuroblastoma,BRD-K07972848-001-02-0::2.5::HTS,20.496600296164683,7.306928876358563e-06,Neuroblastoma,GSK2126458,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Neuroblastoma,BRD-K08037784-001-12-6::2.5::HTS,4.361281057505349,0.037233345635998505,Neuroblastoma,arbutin,melanin inhibitor,TYR
Neuroblastoma,BRD-K08111240-001-02-8::2.5::HTS,4.515618377185266,0.0340287245220091,Other Types,danoprevir,HCV inhibitor,
Neuroblastoma,BRD-K08248804-001-01-8::2.5::HTS,4.428110500595991,0.03581411047811331,Neuroblastoma,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Neuroblastoma,BRD-K08356259-003-24-7::2.5::HTS,5.134617726493536,0.02383617646112729,Neuroblastoma,xylometazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Neuroblastoma,BRD-K08837089-236-01-6::2.5::HTS,9.845849531507358,0.0017913452635859484,Other Types,actinoquinol,,
Neuroblastoma,BRD-K09426783-300-01-0::2.5::HTS,7.597441475967621,0.006043092844640727,Neuroblastoma,TAS-103,topoisomerase inhibitor,TOP1
Neuroblastoma,BRD-K09549677-300-03-4::2.5::HTS,6.725288676903277,0.009764302097384483,Neuroblastoma,mibefradil,T-type calcium channel blocker,"ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4"
Neuroblastoma,BRD-K09711437-001-04-3::2.5::HTS,5.4057291270845695,0.020441182867130578,Neuroblastoma,varespladib,secretory phospholipase inhibitor,PLA2G2A
Neuroblastoma,BRD-K09900591-001-26-7::2.5::HTS,11.787685268831153,0.0006430559860197862,Neuroblastoma,caffeic-acid,"HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF"
Neuroblastoma,BRD-K09951645-001-06-8::2.5::HTS,6.201099358560187,0.013067210407568206,Neuroblastoma,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Neuroblastoma,BRD-K10071630-001-01-0::2.5::HTS,8.147179067623034,0.004472214554627735,Other Types,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Neuroblastoma,BRD-K10176267-001-03-3::2.5::HTS,5.566252935449889,0.018652822545263445,Other Types,L-701252,glutamate receptor antagonist,GRIN1
Neuroblastoma,BRD-K10362825-001-03-4::2.5::HTS,5.100724620850253,0.024323120149151542,Neuroblastoma,teniposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Neuroblastoma,BRD-K10598093-303-06-1::2.5::HTS,4.507581181285237,0.034231634406920404,Neuroblastoma,hexamethonium,cholinergic receptor antagonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6"
Neuroblastoma,BRD-K10670311-001-15-5::2.5::HTS,6.290384455964948,0.012432178435990303,Neuroblastoma,sulfasalazine,cyclooxygenase inhibitor,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1"
Neuroblastoma,BRD-K10843433-001-22-7::2.5::HTS,7.030791360301841,0.00824780821279636,Neuroblastoma,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Neuroblastoma,BRD-K10961822-001-05-1::2.5::HTS,4.461988942920544,0.03511644602688077,Neuroblastoma,latanoprost,prostanoid receptor agonist,PTGFR
Neuroblastoma,BRD-K11267252-001-04-4::2.5::HTS,4.952652630678519,0.026463612094766574,Other Types,alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Neuroblastoma,BRD-K11433652-001-17-0::2.5::HTS,8.204912291582259,0.004340571467126206,Neuroblastoma,aspirin,cyclooxygenase inhibitor,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53"
Neuroblastoma,BRD-K11558771-001-13-9::2.5::HTS,10.480053931252876,0.0012783221067904542,Other Types,droxinostat,HDAC inhibitor,"HDAC6, HDAC8"
Neuroblastoma,BRD-K11590034-002-03-4::2.49::HTS,4.800390154099384,0.028889600495489078,Neuroblastoma,morin,cytochrome P450 inhibitor,"ADORA2A, ESR2, FASN, MCL1, SLC22A12"
Neuroblastoma,BRD-K11696279-003-02-3::2.5::HTS,4.416311753886638,0.03604387835582137,Neuroblastoma,BU-239,"imidazoline receptor ligand, imidazoline receptor agonist",
Neuroblastoma,BRD-K11853856-001-01-7::2.5::HTS,4.377464720584187,0.036865179704825814,Neuroblastoma,PJ-34,PARP inhibitor,"EEF2, PARP1, PARP15, PARP3"
Neuroblastoma,BRD-K11973162-003-01-8::2.5::HTS,12.077875372619731,0.0005514951847175745,Neuroblastoma,tipiracil,thymidine phosphorylase inhibitor,TYMP
Neuroblastoma,BRD-K12068470-001-02-5::2.36::HTS,5.485342894847333,0.019547228971311115,Neuroblastoma,LY2608204,glucokinase activator,GCK
Neuroblastoma,BRD-K12251893-065-04-7::2.5::HTS,4.376246448018877,0.03689780863622841,Neuroblastoma,vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB"
Neuroblastoma,BRD-K12513978-001-24-1::2.5::HTS,6.874604132971692,0.008990034389071153,Neuroblastoma,fenbufen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Neuroblastoma,BRD-K12539581-001-23-7::2.5::HTS,6.149705143595258,0.01343531519008119,Neuroblastoma,nocodazole,tubulin polymerization inhibitor,HPGDS
Neuroblastoma,BRD-K12762134-001-06-2::2.5::HTS,10.262923990051794,0.0014353142089763061,Neuroblastoma,XAV-939,tankyrase inhibitor,"TNKS, TNKS2"
Neuroblastoma,BRD-K12867552-001-04-7::2.5::HTS,4.195885880776598,0.04100603098199361,Neuroblastoma,PCI-24781,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6"
Neuroblastoma,BRD-K13387373-004-14-5::2.5::HTS,5.2074229270523436,0.022868991595471146,Neuroblastoma,thonzonium,ATPase inhibitor,
Neuroblastoma,BRD-K13390322-001-06-3::2.5::HTS,3.8814953517170436,0.04932595494190016,Neuroblastoma,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Neuroblastoma,BRD-K13646352-001-03-8::2.5::HTS,4.454931043969799,0.03524813388160863,Neuroblastoma,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Neuroblastoma,BRD-K13662825-001-07-5::2.5::HTS,5.352910430656697,0.02104762512535372,Neuroblastoma,dinaciclib,CDK inhibitor,"CDK1, CDK2, CDK5, CDK9"
Neuroblastoma,BRD-K13800121-001-01-5::2.5::HTS,7.418904063606433,0.00665786147154133,Neuroblastoma,parecoxib,cyclooxygenase inhibitor,LTF
Neuroblastoma,BRD-K13810148-311-03-2::2.5::HTS,7.738718582375166,0.005586418941312148,Neuroblastoma,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K14496212-066-04-8::2.5::HTS,6.834477255997159,0.009188349589161097,Other Types,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Neuroblastoma,BRD-K14711741-001-02-1::2.5::HTS,10.188023517157754,0.00149253051738713,Other Types,PF-4708671,ribosomal protein inhibitor,RPS6KB1
Neuroblastoma,BRD-K14796088-003-26-8::2.5::HTS,6.088621631613125,0.01390239285946356,Neuroblastoma,berberine,LDL receptor activator,LDLR
Neuroblastoma,BRD-K15108141-001-06-6::2.5::HTS,6.708718871476205,0.009853807499518839,Neuroblastoma,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Neuroblastoma,BRD-K15164005-001-05-6::2.5::HTS,6.405639114167634,0.011651454672733994,Other Types,apoptosis-activator-II,carboxylesterase inhibitor,"BCHE, CES1"
Neuroblastoma,BRD-K15179513-001-03-4::2.5::HTS,8.790621680803843,0.0031581882631050028,Other Types,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
Neuroblastoma,BRD-K15179879-001-03-2::2.5::HTS,8.555328489155789,0.003590166618313729,Neuroblastoma,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Neuroblastoma,BRD-K15409150-001-05-8::2.5::HTS,10.219399758151898,0.0014711887346189766,Neuroblastoma,penfluridol,T-type calcium channel blocker,CACNA1G
Neuroblastoma,BRD-K15507868-001-03-7::2.5::HTS,9.163320564324168,0.002582706264037539,Neuroblastoma,tesaglitazar,"insulin sensitizer, PPAR receptor agonist","PPARA, PPARG"
Neuroblastoma,BRD-K15588452-003-02-7::2.5::HTS,5.582984661136513,0.01848033212373271,Neuroblastoma,R-96544,serotonin receptor antagonist,HTR2A
Neuroblastoma,BRD-K15600710-066-04-1::2.5::HTS,12.626214292096725,0.0004128233456296947,Neuroblastoma,obatoclax,BCL inhibitor,BCL2
Neuroblastoma,BRD-K15601958-001-03-9::2.5::HTS,5.76846302312204,0.016641656686752257,Other Types,SEW-2871,lysophospholipid receptor agonist,S1PR1
Neuroblastoma,BRD-K15791587-003-02-5::2.5::HTS,5.503231605443335,0.019331092128945696,Neuroblastoma,L-733060,tachykinin antagonist,TACR1
Neuroblastoma,BRD-K16136380-001-01-7::2.5::HTS,14.497827691553105,0.00015679085882887127,Neuroblastoma,pyrithione-zinc,ATP synthase inhibitor,"KCNQ1, KCNQ2, KCNQ4, KCNQ5"
Neuroblastoma,BRD-K16338837-001-02-6::2.5::HTS,4.050721497790656,0.0446358414471171,Neuroblastoma,CCMI,acetylcholine receptor allosteric modulator,CHRNA7
Neuroblastoma,BRD-K16478699-001-09-2::2.5::HTS,4.592172644976031,0.03255324819083058,Neuroblastoma,PLX-4720,RAF inhibitor,"BRAF, KDR"
Neuroblastoma,BRD-K16758059-001-01-8::2.5::HTS,6.950186235258563,0.008627718172468372,Neuroblastoma,perfluamine,,
Neuroblastoma,BRD-K16761703-001-03-8::2.5::HTS,5.505630500433259,0.019302982341639796,Other Types,sotrastaurin,PKC inhibitor,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ"
Neuroblastoma,BRD-K17008822-303-02-1::2.5::HTS,5.60447198378163,0.01825733680550584,Neuroblastoma,BD-1008,sigma receptor antagonist,
Neuroblastoma,BRD-K17061841-001-03-5::2.5::HTS,9.155683849341854,0.0025929203420218447,Neuroblastoma,stattic,,
Neuroblastoma,BRD-K17068645-003-04-2::2.5::HTS,6.8482904602105235,0.0091122855427781,Other Types,bendamustine,DNA inhibitor,
Neuroblastoma,BRD-K17368287-001-18-3::2.5::HTS,5.354013158823258,0.021034447968629598,Neuroblastoma,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,"HSD11B1, HSD11B2"
Neuroblastoma,BRD-K17497770-001-03-6::2.5::HTS,13.919710993887154,0.00021027554684873177,Other Types,butein,"EGFR inhibitor, src inhibitor",ACE
Neuroblastoma,BRD-K17953908-001-01-7::2.5::HTS,3.985718938324056,0.046371179046808784,Neuroblastoma,LY2886721,beta-secretase inhibitor,BACE1
Neuroblastoma,BRD-K17977438-048-02-4::2.5::HTS,4.571222014718086,0.03294712134647709,Other Types,oxelaidin,antitussive,
Neuroblastoma,BRD-K18163608-001-05-6::2.48::HTS,3.9112120000465738,0.04848454380579157,Neuroblastoma,HA14-1,BCL inhibitor,BCL2
Neuroblastoma,BRD-K18424115-003-01-3::2.5::HTS,6.536896847130482,0.010831378006724287,Other Types,TG-100572,"src inhibitor, VEGFR inhibitor","KDR, SRC"
Neuroblastoma,BRD-K18518344-001-15-9::2.5::HTS,3.9666032580845174,0.04690182516198455,Neuroblastoma,digitoxigenin,ATPase inhibitor,ATP1A1
Neuroblastoma,BRD-K18613660-001-05-5::2.5::HTS,4.427887069247671,0.03580540819239371,Other Types,mexeneone,,
Neuroblastoma,BRD-K18850819-001-04-6::2.5::HTS,5.817103449164818,0.016190537190091635,Neuroblastoma,MK-0752,gamma secretase inhibitor,
Neuroblastoma,BRD-K19333160-001-01-3::2.5::HTS,19.523935726060383,1.193903017110153e-05,Other Types,RKI-1447,rho associated kinase inhibitor,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2"
Neuroblastoma,BRD-K19456237-001-27-6::2.5::HTS,5.318346799107299,0.02147027635763514,Neuroblastoma,piracetam,acetylcholine receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Neuroblastoma,BRD-K19477839-001-07-6::2.5::HTS,6.941237307625802,0.0086587369131588,Neuroblastoma,SGX523,hepatocyte growth factor receptor inhibitor,MET
Neuroblastoma,BRD-K19796430-001-05-6::2.5::HTS,5.385486053706011,0.020661947219993565,Neuroblastoma,sonidegib,smoothened receptor antagonist,SMO
Neuroblastoma,BRD-K20338176-001-17-7::2.5::HTS,5.618576163790926,0.01811063599616621,Neuroblastoma,cefaclor,bacterial cell wall synthesis inhibitor,
Neuroblastoma,BRD-K20482099-001-09-4::2.5::HTS,4.038425202571659,0.04498360679508654,Neuroblastoma,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Neuroblastoma,BRD-K20548681-001-01-3::2.5::HTS,4.1779926573762225,0.041417762633234996,Neuroblastoma,SCP-1,analgesic agent,
Neuroblastoma,BRD-K20605374-001-05-4::2.5::HTS,7.723197137313693,0.0056339801252094064,Neuroblastoma,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N
Neuroblastoma,BRD-K20655524-003-12-0::2.5::HTS,13.13064887495238,0.00031800371775586144,Neuroblastoma,mefexamide,psychoactive drug,
Neuroblastoma,BRD-K20755323-001-05-9::2.5::HTS,11.645795490398406,0.0006900500376363246,Other Types,SKI-II,sphingosine kinase inhibitor,SPHK1
Neuroblastoma,BRD-K20958582-001-01-4::2.5::HTS,4.839570759426329,0.028225993700733462,Neuroblastoma,TH-302,DNA alkylating agent,
Neuroblastoma,BRD-K21025364-001-04-9::2.5::HTS,7.863793547406792,0.0052253443938430925,Neuroblastoma,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Neuroblastoma,BRD-K21283037-001-21-5::2.5::HTS,4.673157885026071,0.031065070575021166,Neuroblastoma,riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11"
Neuroblastoma,BRD-K21361524-001-01-1::2.5::HTS,4.35705405633576,0.037305855359201216,Neuroblastoma,selinexor,exportin antagonist,XPO1
Neuroblastoma,BRD-K21528677-001-02-8::2.44::HTS,14.571094506486196,0.0001509687142446469,Neuroblastoma,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Neuroblastoma,BRD-K21565985-001-22-5::2.5::HTS,6.706318923736387,0.009858021165127222,Neuroblastoma,xylazine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Neuroblastoma,BRD-K21680192-300-14-4::2.5::HTS,5.096520880442222,0.02436238070189908,Neuroblastoma,mitoxantrone,topoisomerase inhibitor,TOP2A
Neuroblastoma,BRD-K21733600-001-14-1::2.5::HTS,4.3943868269498925,0.03651707231861375,Other Types,rofecoxib,cyclooxygenase inhibitor,"ELN, PTGS2"
Neuroblastoma,BRD-K21782625-001-02-4::2.5::HTS,5.253519997465202,0.022287001698455346,Neuroblastoma,AMG458,MET inhibitor,MET
Neuroblastoma,BRD-K22127577-001-03-7::2.58::HTS,10.782618115135966,0.0010924626782153723,Neuroblastoma,crenolanib,PDGFR tyrosine kinase receptor inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB"
Neuroblastoma,BRD-K22134346-001-24-9::2.42::HTS,6.948726674934623,0.008634666832405638,Neuroblastoma,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Neuroblastoma,BRD-K22503835-001-11-0::2.5::HTS,14.045321642344769,0.00019700919120724415,Other Types,scriptaid,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K23163214-050-15-1::2.5::HTS,7.44854666146667,0.006548729259586822,Other Types,dizocilpine-(-),glutamate receptor antagonist,
Neuroblastoma,BRD-K23204545-001-16-4::2.5::HTS,6.084152331350488,0.01394152815689292,Other Types,busulfan,DNA inhibitor,
Neuroblastoma,BRD-K23228615-001-02-8::2.5::HTS,13.809748866928249,0.00022289538107705573,Neuroblastoma,GDC-0980,"mTOR inhibitor, PI3K inhibitor","FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK"
Neuroblastoma,BRD-K23541596-300-07-2::2.5::HTS,3.89061619552717,0.0490534566550848,Other Types,dimaprit,histamine receptor agonist,"HRH2, HRH3, HRH4"
Neuroblastoma,BRD-K23728141-001-01-2::2.5::HTS,6.404905257277605,0.011652273020274113,Neuroblastoma,tafamidis-meglumine,transthyretin amyloid inhibitor,TTR
Neuroblastoma,BRD-K23925186-001-01-0::2.5::HTS,11.902283891480693,0.0006033460471460358,Other Types,oridonin,BCL inhibitor,BCL2
Neuroblastoma,BRD-K23925186-001-02-8::2.51::HTS,4.737956650129254,0.029946445752931265,Neuroblastoma,oridonin,BCL inhibitor,BCL2
Neuroblastoma,BRD-K24242599-001-02-8::2.5::HTS,7.478879965896705,0.00644076422655381,Other Types,GW-2580,cFMS kinase inhibitor,CSF1R
Neuroblastoma,BRD-K24556098-001-19-1::2.5::HTS,4.1608829171187285,0.04183909658078795,Neuroblastoma,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Neuroblastoma,BRD-K24576554-001-04-8::2.5::HTS,7.652849393027146,0.005857505218279156,Neuroblastoma,AT-9283,"Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A"
Neuroblastoma,BRD-K24593301-001-02-3::2.54::HTS,6.869372903839218,0.009021236413899856,Neuroblastoma,AZD3463,"ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor","ALK, IGF1R"
Neuroblastoma,BRD-K24689407-001-06-3::2.5::HTS,3.8743674718578416,0.04952251016747966,Other Types,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Neuroblastoma,BRD-K24696047-001-02-3::2.5::HTS,12.75237438044498,0.0003864770818596428,Other Types,NVP-AEW541,IGF-1 inhibitor,"IGF1R, INSR"
Neuroblastoma,BRD-K24715592-406-02-1::2.53::HTS,7.9943785453795515,0.004870353167461731,Neuroblastoma,ethacridine-lactate-monohydrate,DNA intercalating agent,
Neuroblastoma,BRD-K25279140-001-01-5::2.5::HTS,9.516865026753935,0.002141358297606921,Other Types,MK-8745,Aurora kinase inhibitor,AURKA
Neuroblastoma,BRD-K25630527-001-03-8::2.5::HTS,5.124502331458263,0.023970758972913647,Other Types,LY2784544,JAK inhibitor,"JAK2, JAK3"
Neuroblastoma,BRD-K25837718-001-03-8::2.5::HTS,10.171861341778545,0.0015077982606600654,Neuroblastoma,josamycin,bacterial 50S ribosomal subunit inhibitor,
Neuroblastoma,BRD-K25943794-001-02-3::2.5::HTS,6.024826211540505,0.014412505177315134,Other Types,blonanserin,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Neuroblastoma,BRD-K26262077-238-01-5::2.5::HTS,8.64418619392864,0.00342482803712908,Other Types,acamprosate,glutamate receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5"
Neuroblastoma,BRD-K26502378-001-07-9::2.5::HTS,11.44966654971308,0.0007652628105595903,Other Types,vanitiolide,,
Neuroblastoma,BRD-K26581543-001-01-6::2.5::HTS,5.302675436942316,0.021663712358796498,Other Types,bifendate,,
Neuroblastoma,BRD-K26712974-001-01-5::2.5::HTS,4.4323976383014445,0.035706090449479734,Neuroblastoma,VX-765,caspase inhibitor,CASP1
Neuroblastoma,BRD-K27182532-001-02-3::2.5::HTS,9.097268864404816,0.002675665135097628,Neuroblastoma,metatinib,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Neuroblastoma,BRD-K27406233-001-07-7::2.5::HTS,6.58385298103661,0.010551219684868789,Other Types,acetyl-l-leucine,,
Neuroblastoma,BRD-K27911943-001-02-8::2.5::HTS,4.888240404213016,0.027447914706969424,Neuroblastoma,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,
Neuroblastoma,BRD-K27955832-001-02-9::2.5::HTS,8.35459082261321,0.003996578712722737,Other Types,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Neuroblastoma,BRD-K28143534-001-02-2::2.5::HTS,7.215215044253722,0.007451765622564919,Neuroblastoma,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Neuroblastoma,BRD-K28308851-303-01-8::2.5::HTS,5.1798533958563,0.02322567998435806,Neuroblastoma,alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3
Neuroblastoma,BRD-K28456624-001-01-1::2.5::HTS,6.367196990720021,0.01190354280672812,Neuroblastoma,seocalcitol,vitamin D receptor agonist,VDR
Neuroblastoma,BRD-K28492574-001-01-6::2.5::HTS,3.970922223238585,0.0467790519875409,Other Types,piconol,,
Neuroblastoma,BRD-K28907958-001-04-3::2.5::HTS,4.843875189471941,0.02815257012316938,Neuroblastoma,CD-437,retinoid receptor agonist,RARG
Neuroblastoma,BRD-K28971625-003-01-4::2.5::HTS,4.951619161497841,0.026473980044453196,Other Types,ZD-7114,adrenergic receptor agonist,ADRB3
Neuroblastoma,BRD-K29220403-001-10-8::2.5::HTS,5.644668469468494,0.017857098192518468,Neuroblastoma,eszopiclone,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Neuroblastoma,BRD-K29254801-001-14-7::2.5::HTS,4.58152247951618,0.03275208500130367,Neuroblastoma,thiram,,JAK2
Neuroblastoma,BRD-K29392254-001-02-2::2.5::HTS,11.153155212299362,0.0008980406398389647,Neuroblastoma,pantothenic-acid,coenzyme A precursor,
Neuroblastoma,BRD-K29415052-050-04-8::2.5::HTS,25.832586468393046,5.077656516797601e-07,Neuroblastoma,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Neuroblastoma,BRD-K29458283-001-29-9::2.5::HTS,4.84040173760423,0.028212517498561133,Other Types,chlorambucil,DNA inhibitor,
Neuroblastoma,BRD-K29713308-077-04-1::2.5::HTS,16.31403248337954,6.123811647004856e-05,Neuroblastoma,"mebhydroline-1,5-naphtalenedisulfonate",,
Neuroblastoma,BRD-K29834313-001-01-4::2.5::HTS,6.163225124889848,0.013338357507094433,Neuroblastoma,myricitrin,PKC inhibitor,"NOS1, PRKCA"
Neuroblastoma,BRD-K29968218-001-03-2::2.5::HTS,5.9064081782799605,0.015402368241121742,Neuroblastoma,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Neuroblastoma,BRD-K31560319-001-01-5::2.5::HTS,8.034022330920342,0.0047566470848342856,Other Types,olvanil,TRPV agonist,"CNR1, GPR119, TRPV1"
Neuroblastoma,BRD-K31843556-001-04-1::2.5::HTS,9.738754515457298,0.0018982124994141743,Other Types,T-0070907,PPAR receptor antagonist,PPARG
Neuroblastoma,BRD-K31866293-001-01-6::2.5::HTS,5.305804145702469,0.02162122209532787,Other Types,TAK-632,RAF inhibitor,BRAF
Neuroblastoma,BRD-K32289541-001-01-0::2.5::HTS,4.975004134010226,0.026112950130274693,Other Types,EHop-016,Ras GTPase inhibitor,"RAC1, RAC3"
Neuroblastoma,BRD-K33151569-003-09-7::2.5::HTS,4.4158751342258205,0.03605544342007529,Neuroblastoma,deoxyepinephrine,"adrenergic receptor agonist, dopamine receptor agonist","ADRA1A, DRD1, DRD2"
Neuroblastoma,BRD-K33277808-331-01-3::2.5::HTS,10.266317091935885,0.0014321578059861488,Neuroblastoma,ouabain,ATPase inhibitor,ATP1A1
Neuroblastoma,BRD-K33622447-066-01-9::2.5::HTS,4.937110222476155,0.026686225755654096,Other Types,abemaciclib,CDK inhibitor,"CDK4, CDK6"
Neuroblastoma,BRD-K33852358-001-09-9::2.5::HTS,4.031366886464275,0.045148528322249054,Neuroblastoma,arofylline,phosphodiesterase inhibitor,PDE4A
Neuroblastoma,BRD-K34341643-001-01-4::2.5::HTS,4.160064752778285,0.04186342840315649,Neuroblastoma,glasdegib,hedgehog pathway inhibitor,SMO
Neuroblastoma,BRD-K34672903-001-01-7::2.5::HTS,9.312050739659934,0.0023845981644495104,Neuroblastoma,HEMADO,,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Neuroblastoma,BRD-K35240538-001-26-2::2.5::HTS,6.520951617760662,0.010935716328140376,Neuroblastoma,methylprednisolone,glucocorticoid receptor agonist,NR3C1
Neuroblastoma,BRD-K36016295-001-04-5::2.5::HTS,10.51010997691807,0.0012585981236994063,Neuroblastoma,KU-60019,ATM kinase inhibitor,ATM
Neuroblastoma,BRD-K36040345-001-01-1::2.5::HTS,4.024729018012733,0.04531649865091149,Other Types,TXA127,angiotensin receptor agonist,
Neuroblastoma,BRD-K36198571-001-02-0::2.5::HTS,4.981309731712171,0.026039787914550132,Other Types,WAY-170523,metalloproteinase inhibitor,MMP13
Neuroblastoma,BRD-K36207157-001-09-6::2.5::HTS,3.9229597899155912,0.04811982539056285,Neuroblastoma,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Neuroblastoma,BRD-K36467523-001-02-8::2.5::HTS,6.518108634261825,0.010945992209660584,Neuroblastoma,bindarit,NFkB pathway inhibitor,"CCL2, CCL7, CCL8"
Neuroblastoma,BRD-K36529613-001-02-6::2.5::HTS,11.06582420134668,0.0009367634703228809,Neuroblastoma,PU-H71,HSP inhibitor,HSP90AA1
Neuroblastoma,BRD-K36889451-001-01-1::2.5::HTS,8.726568033773507,0.0032712399875067504,Neuroblastoma,tetramethylthiuram-monosulfide,,
Neuroblastoma,BRD-K37355418-236-01-6::2.5::HTS,5.362220466953978,0.0209471941394562,Neuroblastoma,efaproxiral,haemoglobin oxygen release stimulant,"HBA1, HBB"
Neuroblastoma,BRD-K37379014-001-01-2::2.5::HTS,9.177588467109166,0.002564214377358898,Neuroblastoma,filanesib,"kinesin inhibitor, kinesin-like spindle protein inhibitor",KIF11
Neuroblastoma,BRD-K37590257-001-02-8::2.5::HTS,8.854613951929583,0.0030529457466688093,Neuroblastoma,GSK256066,phosphodiesterase inhibitor,PDE4A
Neuroblastoma,BRD-K37865504-001-04-1::2.5::HTS,4.491831638698494,0.034501321848804896,Neuroblastoma,LY2183240,"FAAH inhibitor, FAAH reuptake inhibitor",FAAH
Neuroblastoma,BRD-K38323065-001-19-9::2.5::HTS,5.407586737506784,0.02040766497575737,Neuroblastoma,phenacetin,cyclooxygenase inhibitor,PTGS1
Neuroblastoma,BRD-K38332599-001-01-3::2.5::HTS,9.823626844353292,0.001813226675044198,Neuroblastoma,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Neuroblastoma,BRD-K38580127-003-15-4::2.5::HTS,5.12669697033459,0.023951917052328693,Neuroblastoma,serotonin,growth factor receptor activator,"DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1"
Neuroblastoma,BRD-K38852836-001-02-1::2.5::HTS,5.930980396316439,0.015186853296297867,Neuroblastoma,ganetespib,HSP inhibitor,HSP90AA1
Neuroblastoma,BRD-K38903228-001-13-5::2.5::HTS,4.832118303223918,0.028341265022542746,Neuroblastoma,hesperidin,flavanone glycoside,CACNA1B
Neuroblastoma,BRD-K39171998-001-01-1::2.5::HTS,5.900832150702489,0.015448394513976617,Neuroblastoma,STF-118804,NAMPT inhibitor,NAMPT
Neuroblastoma,BRD-K39484304-001-16-5::2.5::HTS,11.839998882421185,0.0006229448671307862,Neuroblastoma,triptolide,RNA polymerase inhibitor,RELA
Neuroblastoma,BRD-K39624409-003-02-6::2.5::HTS,4.451041526392945,0.035327833743873355,Neuroblastoma,ADL5859,opioid receptor agonist,OPRD1
Neuroblastoma,BRD-K39733634-001-02-6::2.5::HTS,6.113506937021466,0.013712238360975881,Other Types,L-161982,prostanoid receptor antagonist,PTGER4
Neuroblastoma,BRD-K39805756-001-01-6::2.5::HTS,7.194603574050327,0.007529378726690181,Neuroblastoma,TPPS4,,
Neuroblastoma,BRD-K40175214-001-11-6::2.5::HTS,8.362109394950123,0.0039795194854614566,Neuroblastoma,torin-1,mTOR inhibitor,MTOR
Neuroblastoma,BRD-K40331046-305-01-5::2.5::HTS,24.30930248364844,1.08315001905404e-06,Neuroblastoma,CR8-(R),CDK inhibitor,CCNA2
Neuroblastoma,BRD-K40438880-305-06-6::2.5::HTS,5.344393237927142,0.02118972460089008,Other Types,spermidine,glutamate receptor modulator,"KCNJ4, TXNRD1"
Neuroblastoma,BRD-K40738845-001-05-0::2.5::HTS,4.091514839130225,0.043585892597007174,Neuroblastoma,BMS-777607,"AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor","AXL, MERTK, MET, MST1R, TYRO3"
Neuroblastoma,BRD-K41141507-001-16-2::2.5::HTS,10.127078623068718,0.001542072712959904,Neuroblastoma,cyproterone-acetate,androgen receptor antagonist,"ADORA1, AR"
Neuroblastoma,BRD-K41772907-001-01-2::2.5::HTS,6.557547067418131,0.01070409825429937,Neuroblastoma,tolimidone,src activator,"LYN, SRC"
Neuroblastoma,BRD-K41859756-001-06-8::2.5::HTS,11.590704082059085,0.0007108010624101304,Neuroblastoma,NVP-AUY922,HSP inhibitor,"HSP90AA1, HSP90AB1"
Neuroblastoma,BRD-K42348709-003-13-1::2.5::HTS,4.624723585230743,0.03195266097756592,Neuroblastoma,cyclobenzaprine,"adrenergic receptor agonist, serotonin receptor agonist",HTR2A
Neuroblastoma,BRD-K42495768-001-01-7::2.5::HTS,7.152049230783586,0.007712201953949093,Other Types,tasisulam,apoptosis stimulant,
Neuroblastoma,BRD-K42500029-001-03-5::2.5::HTS,5.25362617920263,0.022271861692837538,Neuroblastoma,CGP-57380,MAP kinase inhibitor,"AURKB, LCK, MKNK1, MKNK2, SGK1"
Neuroblastoma,BRD-K42859542-001-03-3::2.5::HTS,12.502133142620837,0.00044032165012650377,Other Types,CFM-2,glutamate receptor antagonist,
Neuroblastoma,BRD-K42938903-332-01-1::2.5::HTS,17.405940604829894,3.518404980178364e-05,Neuroblastoma,acetophenazine,dopamine receptor antagonist,"DRD1, DRD2"
Neuroblastoma,BRD-K43055376-001-01-2::2.5::HTS,5.052577606440099,0.0249818682833779,Neuroblastoma,ADD-233089,benzodiazepine receptor agonist,
Neuroblastoma,BRD-K43164539-001-11-5::2.5::HTS,5.283075832241581,0.021910585365602912,Other Types,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Neuroblastoma,BRD-K43236057-001-07-1::2.6::HTS,4.370677970996241,0.037040028118152296,Neuroblastoma,polydatin,ICAM1 expression inhibitor,ICAM1
Neuroblastoma,BRD-K43389675-003-16-7::2.35::HTS,9.298672513404851,0.002408243653646857,Neuroblastoma,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Neuroblastoma,BRD-K43389675-003-20-9::2.5::HTS,6.932862530489443,0.008697579771732218,Neuroblastoma,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Neuroblastoma,BRD-K43389698-001-09-9::2.4::HTS,7.775689636681457,0.005486426481254943,Neuroblastoma,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Neuroblastoma,BRD-K43644456-001-04-0::2.38::HTS,7.62624947603328,0.005952783055019441,Neuroblastoma,WP1130,deubiquitinase inhibitor,"JAK2, UCHL5, USP14, USP9X"
Neuroblastoma,BRD-K44408410-001-17-6::2.5::HTS,4.144090305664565,0.042248611940697005,Other Types,2-methoxyestradiol,hypoxia inducible factor inhibitor,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB"
Neuroblastoma,BRD-K44665581-001-01-8::2.5::HTS,4.0081856310801935,0.04576336218342878,Other Types,bromosporine,bromodomain inhibitor,
Neuroblastoma,BRD-K45033733-001-12-2::2.5::HTS,11.059096040153412,0.0009411656058708636,Neuroblastoma,famciclovir,DNA polymerase inhibitor,
Neuroblastoma,BRD-K45158365-001-11-4::2.5::HTS,6.204804361295661,0.013036344753516185,Other Types,valsartan,angiotensin receptor antagonist,AGTR1
Neuroblastoma,BRD-K45293975-001-02-0::2.5::HTS,11.712231456811953,0.0006674415832987687,Neuroblastoma,7-hydroxystaurosporine,"CDK inhibitor, CHK inhibitor, PKC inhibitor","CHEK1, MARK3, PDPK1"
Neuroblastoma,BRD-K45437867-005-03-3::2.5::HTS,4.653918338954451,0.03140592423021632,Neuroblastoma,5-methylfurmethiodide,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Neuroblastoma,BRD-K45528773-001-07-2::2.59::HTS,8.728171526335764,0.0032730681887556817,Neuroblastoma,M-344,HDAC inhibitor,
Neuroblastoma,BRD-K45724504-001-01-6::1.36::HTS,8.20431669797456,0.0043366626521736595,Neuroblastoma,anguidine,protein synthesis inhibitor,SLC5A1
Neuroblastoma,BRD-K46211610-003-26-7::2.5::HTS,4.322500767458136,0.03806860851302496,Neuroblastoma,tolazoline,adrenergic receptor antagonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2"
Neuroblastoma,BRD-K46585355-001-14-3::2.5::HTS,5.642361122136353,0.017867843964685156,Neuroblastoma,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,
Neuroblastoma,BRD-K47557313-001-02-7::2.5::HTS,7.293125810844438,0.007132107655396222,Neuroblastoma,LY2109761,TGF beta receptor inhibitor,"TGFBR1, TGFBR2"
Neuroblastoma,BRD-K47832606-001-30-1::2.5::HTS,8.115960106041856,0.00455080155007367,Neuroblastoma,floxuridine,DNA synthesis inhibitor,TYMS
Neuroblastoma,BRD-K47869605-001-32-0::2.5::HTS,4.44134420262484,0.03553394955161556,Neuroblastoma,podophyllotoxin,"microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB"
Neuroblastoma,BRD-K48443249-001-01-0::2.5::HTS,5.484055458086045,0.019540855418505736,Other Types,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Neuroblastoma,BRD-K48578705-001-17-6::2.5::HTS,8.260410932935596,0.004211817024300355,Other Types,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Neuroblastoma,BRD-K48684885-001-04-2::2.5::HTS,11.097389196872872,0.0009220944827861211,Neuroblastoma,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Neuroblastoma,BRD-K48812570-001-02-3::2.5::HTS,3.8937598406569656,0.04896968232667782,Neuroblastoma,macitentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Neuroblastoma,BRD-K49071277-001-04-7::2.5::HTS,4.580854795389429,0.032763962595129675,Other Types,securinine,"GABA receptor antagonist, TP53 activator",GABRA1
Neuroblastoma,BRD-K49328571-001-15-0::2.5::HTS,5.977424416699573,0.0148017371449751,Neuroblastoma,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Neuroblastoma,BRD-K49338325-001-03-4::2.5::HTS,4.023968845678044,0.04535081546707222,Neuroblastoma,etofibrate,PPAR receptor agonist,PPARA
Neuroblastoma,BRD-K49371609-003-03-8::2.5::HTS,8.651414287045043,0.003404687717258365,Neuroblastoma,PIK-75,"DNA protein kinase inhibitor, PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Neuroblastoma,BRD-K50140147-001-10-1::2.5::HTS,4.659494907999877,0.03131105947620168,Neuroblastoma,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,"ALK, INSR"
Neuroblastoma,BRD-K50677762-001-01-5::2.5::HTS,4.0998475249950355,0.043366216138981124,Neuroblastoma,oxiracetam,acetylcholine receptor agonist,
Neuroblastoma,BRD-K50938786-003-11-8::2.5::HTS,3.8772321884780716,0.0494369191793576,Neuroblastoma,ropivacaine,sodium channel blocker,SCN10A
Neuroblastoma,BRD-K51318897-001-15-3::2.5::HTS,7.103636124252694,0.007923443466388432,Neuroblastoma,fenbendazole,tubulin polymerization inhibitor,TUBB
Neuroblastoma,BRD-K51541829-050-01-0::2.5::HTS,3.988283185251272,0.046302042115673125,Other Types,Ro-25-6981,,GRIN2B
Neuroblastoma,BRD-K51579475-003-02-4::2.5::HTS,4.814305439233872,0.02863377138156063,Neuroblastoma,dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4"
Neuroblastoma,BRD-K51662849-001-05-4::2.5::HTS,3.8912540957570507,0.049048801325119136,Neuroblastoma,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Neuroblastoma,BRD-K51747290-001-12-3::2.5::HTS,10.387427709158821,0.0013470966551184596,Neuroblastoma,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Neuroblastoma,BRD-K51770398-001-01-9::2.5::HTS,5.982868436084399,0.014756619242968403,Neuroblastoma,JNJ-17203212,TRPV antagonist,TRPV1
Neuroblastoma,BRD-K51791723-003-01-7::2.5::HTS,15.771350037504762,8.081657622044441e-05,Neuroblastoma,P276-00,CDK inhibitor,"CDK1, CDK4, CDK9"
Neuroblastoma,BRD-K51911221-001-01-2::2.5::HTS,11.468759092045115,0.000757236642653445,Neuroblastoma,nemorubicin,topoisomerase inhibitor,"TOP1, TOP2A"
Neuroblastoma,BRD-K51967704-001-03-6::2.5::HTS,5.23638694792726,0.02249283923393093,Neuroblastoma,BIIB021,HSP inhibitor,HSP90AA1
Neuroblastoma,BRD-K52219182-001-02-4::2.5::HTS,5.02495420333394,0.02537966390350104,Neuroblastoma,ICI-63197,phosphodiesterase inhibitor,
Neuroblastoma,BRD-K52233191-001-02-4::2.5::HTS,10.374125909352225,0.0013540078886452177,Neuroblastoma,R547,CDK inhibitor,"CDK1, CDK2, CDK4, CDK7"
Neuroblastoma,BRD-K52313696-001-12-3::2.5::HTS,4.261365887687718,0.03946645497784025,Other Types,tacedinaline,HDAC inhibitor,HDAC1
Neuroblastoma,BRD-K52762805-001-01-2::2.5::HTS,10.999195623387878,0.0009712322650743218,Neuroblastoma,epothilone-d,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Neuroblastoma,BRD-K53097745-001-01-5::2.5::HTS,8.229538771858262,0.004276278190834267,Other Types,pterostilbene,"cyclooxygenase inhibitor, PPAR receptor agonist",PTGS2
Neuroblastoma,BRD-K53318339-001-24-9::2.5::HTS,6.209746578084498,0.013004271179908997,Neuroblastoma,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C"
Neuroblastoma,BRD-K53414658-001-08-2::2.5::HTS,5.083953122262769,0.024548772628419518,Neuroblastoma,tivozanib,VEGFR inhibitor,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Neuroblastoma,BRD-K53417444-003-03-1::2.5::HTS,14.786904900656351,0.00013474594535592375,Neuroblastoma,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK
Neuroblastoma,BRD-K54006094-051-01-7::2.5::HTS,5.921546923279362,0.01527086502027347,Other Types,formoterol,adrenergic receptor agonist,ADRB2
Neuroblastoma,BRD-K54142781-003-11-8::2.5::HTS,4.267302815589948,0.03931280761223171,Other Types,cirazoline,adrenergic receptor agonist,ADRA1A
Neuroblastoma,BRD-K54256913-001-08-7::2.5::HTS,6.21943658962621,0.012924423112994736,Neuroblastoma,MK-1775,WEE1 kinase inhibitor,WEE1
Neuroblastoma,BRD-K54262262-001-09-0::2.5::HTS,11.886114377558496,0.0006087337467096,Other Types,monobenzone,melanin inhibitor,TYR
Neuroblastoma,BRD-K54634444-001-05-9::2.5::HTS,5.713684789408232,0.01716265349550456,Other Types,artesunate,DNA synthesis inhibitor,
Neuroblastoma,BRD-K54824716-001-04-0::2.5::HTS,4.585200600629222,0.032681680322693724,Other Types,procodazole,immunostimulant,
Neuroblastoma,BRD-K55044200-001-15-3::2.5::HTS,11.778308753017216,0.0006433262650246984,Neuroblastoma,amoxicillin,penicillin binding protein inhibitor,"CYP2C19, SLC15A1, SLC15A2, SLC22A6"
Neuroblastoma,BRD-K55187425-236-05-2::2.5::HTS,5.079189485545703,0.02460197429323815,Neuroblastoma,rigosertib,"cell cycle inhibitor, PLK inhibitor",PLK1
Neuroblastoma,BRD-K55424922-003-02-8::2.5::HTS,14.598337715897683,0.00014795012106399451,Other Types,anpirtoline,serotonin receptor agonist,HTR1B
Neuroblastoma,BRD-K55462201-001-07-3::2.5::HTS,15.774714538198484,8.071189843936687e-05,Other Types,AM-404,"cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist","CNR1, CNR2, FAAH, TRPV1"
Neuroblastoma,BRD-K55703048-001-07-7::2.5::HTS,6.004640876917028,0.014572068443368008,Neuroblastoma,latrepirdine,glutamate receptor antagonist,"HRH1, HTR6"
Neuroblastoma,BRD-K55773932-001-02-0::2.5::HTS,5.699005849856019,0.017306464435813202,Neuroblastoma,BMS-806,HIV attachment inhibitor,
Neuroblastoma,BRD-K55781385-001-01-7::2.5::HTS,6.252309477986614,0.012686840108124087,Neuroblastoma,BMS-927711,calcitonin antagonist,CALCA
Neuroblastoma,BRD-K55930204-236-24-3::2.5::HTS,6.397956686912562,0.01169743975111533,Neuroblastoma,phenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Neuroblastoma,BRD-K56104152-008-04-1::2.5::HTS,4.6999361115152904,0.030582738016607127,Neuroblastoma,oxiconazole,bacterial cell wall synthesis inhibitor,
Neuroblastoma,BRD-K56291712-001-01-0::2.5::HTS,4.549108596307039,0.03336855088015325,Neuroblastoma,voxtalisib,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Neuroblastoma,BRD-K56301217-001-07-4::2.5::HTS,6.726414441842891,0.009747113303382073,Other Types,ABT-737,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Neuroblastoma,BRD-K56343971-001-10-6::2.5::HTS,5.156591151547886,0.023535833967409155,Neuroblastoma,vemurafenib,RAF inhibitor,"BRAF, RAF1"
Neuroblastoma,BRD-K56558538-003-11-9::2.5::HTS,8.78719645927412,0.003162151687975942,Neuroblastoma,ambroxol,sodium channel blocker,CYP3A4
Neuroblastoma,BRD-K56957086-001-06-3::2.5::HTS,14.37548064609809,0.0001659412689431349,Neuroblastoma,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K58122457-001-02-2::2.5::HTS,13.303745254632867,0.0002897406300752837,Neuroblastoma,hesperadin,Aurora kinase inhibitor,AURKB
Neuroblastoma,BRD-K58435339-001-03-0::2.5::HTS,9.136164210126621,0.0026206887511227295,Neuroblastoma,AT13387,HSP antagonist,HSP90AA1
Neuroblastoma,BRD-K58550667-001-08-7::2.5::HTS,9.650249496526259,0.0019898546371645573,Neuroblastoma,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT
Neuroblastoma,BRD-K58770988-001-01-8::2.5::HTS,7.549527683354439,0.006196318129597093,Neuroblastoma,NMS-E973,HSP inhibitor,
Neuroblastoma,BRD-K59325863-001-02-8::2.5::HTS,8.563632582101683,0.003568607150384636,Neuroblastoma,delanzomib,proteasome inhibitor,"CMA1, CTSG, CYP3A4, ELANE"
Neuroblastoma,BRD-K59325863-001-03-6::2.46::HTS,24.769344865423122,8.759806744039799e-07,Neuroblastoma,delanzomib,proteasome inhibitor,"CMA1, CTSG, CYP3A4, ELANE"
Neuroblastoma,BRD-K59369769-001-20-3::2.5::HTS,4.124445670997506,0.04273806821909789,Other Types,tozasertib,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor","AURKA, AURKB, AURKC, LCK"
Neuroblastoma,BRD-K60005752-001-01-9::2.5::HTS,3.8740827201122205,0.04953085110049527,Neuroblastoma,S-111,PARP inhibitor,PARP1
Neuroblastoma,BRD-K60102752-001-02-2::2.5::HTS,5.388632724458918,0.020630248453231373,Other Types,alibendol,antispasmodic,
Neuroblastoma,BRD-K60212747-236-01-1::2.5::HTS,3.9642871194059746,0.046990095969658016,Neuroblastoma,neridronic-acid,bone resorption inhibitor,FDPS
Neuroblastoma,BRD-K60230970-001-17-5::2.4::HTS,11.596477872565673,0.0007114468202771392,Neuroblastoma,MG-132,proteasome inhibitor,PSMB1
Neuroblastoma,BRD-K60446698-001-01-2::2.5::HTS,8.008406126575855,0.004823724650527487,Neuroblastoma,ONX-0914,proteasome inhibitor,
Neuroblastoma,BRD-K60914966-001-01-4::2.5::HTS,12.445908113025647,0.00045341142968515906,Other Types,etosalamide,anti-inflammatory agent,
Neuroblastoma,BRD-K60984070-001-01-0::2.5::HTS,7.209902019738639,0.007465905575543146,Neuroblastoma,PD-166793,"collagenase inhibitor, metalloproteinase inhibitor","MMP13, MMP2, MMP3"
Neuroblastoma,BRD-K61177364-003-02-9::2.5::HTS,6.43006257812692,0.011492186304051208,Other Types,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1
Neuroblastoma,BRD-K61228301-001-01-2::2.5::HTS,4.7322533804224385,0.030020377222789784,Neuroblastoma,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Neuroblastoma,BRD-K61250484-001-02-3::2.5::HTS,4.588286959899572,0.03262337547886964,Neuroblastoma,FPH1-(BRD-6125),hepatocyte function enhancer,
Neuroblastoma,BRD-K61250553-003-32-2::2.5::HTS,3.9009344879260093,0.048748190885219686,Neuroblastoma,loperamide,opioid receptor agonist,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC"
Neuroblastoma,BRD-K61323504-001-04-0::2.5::HTS,4.867413276112962,0.02777958785621402,Other Types,SB-225002,CC chemokine receptor antagonist,CXCR2
Neuroblastoma,BRD-K61397605-001-03-4::2.5::HTS,10.631050068917284,0.001179854221949252,Neuroblastoma,romidepsin,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K61665160-001-01-5::2.5::HTS,4.461420642143189,0.03511557556220311,Other Types,BYK-204165,PARP inhibitor,PARP1
Neuroblastoma,BRD-K61688984-001-02-9::2.5::HTS,15.693564081997573,8.413184430386305e-05,Other Types,RGFP966,HDAC inhibitor,HDAC3
Neuroblastoma,BRD-K61691541-001-01-1::2.5::HTS,5.587781524378712,0.018428447741061952,Other Types,PF-03084014,gamma secretase inhibitor,
Neuroblastoma,BRD-K61717546-001-05-0::2.47::HTS,5.964520846577931,0.014917415214816153,Other Types,fleroxacin,topoisomerase inhibitor,
Neuroblastoma,BRD-K61937613-001-01-1::2.5::HTS,5.739630455277959,0.01693343435234063,Neuroblastoma,doconexent-ethyl-ester,omega 3 fatty acid stimulant,
Neuroblastoma,BRD-K62008436-001-22-1::2.5::HTS,5.211370149772231,0.022817627567411784,Neuroblastoma,paclitaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1"
Neuroblastoma,BRD-K62196610-001-01-6::2.5::HTS,12.762689908379832,0.0003845142486740415,Other Types,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Neuroblastoma,BRD-K62213621-001-01-6::2.5::HTS,9.452701259003504,0.002212259969701507,Other Types,dihydroartemisinin,antimalarial agent,
Neuroblastoma,BRD-K62374253-001-07-8::2.5::HTS,6.378977078053368,0.011824199641503006,Neuroblastoma,rufloxacin,bacterial DNA gyrase inhibitor,
Neuroblastoma,BRD-K62427771-001-01-0::2.5::HTS,5.489799526442619,0.01948056212761811,Other Types,AS-77,potassium channel blocker,"KCNA3, KCNA5, KCNN4"
Neuroblastoma,BRD-K62814476-001-03-3::2.5::HTS,7.138451786408735,0.0077668482330897,Neuroblastoma,BMS-265246,CDK inhibitor,"CDK1, CDK2"
Neuroblastoma,BRD-K63068307-001-08-9::2.5::HTS,4.138132815732763,0.04240319817862144,Neuroblastoma,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Neuroblastoma,BRD-K63165456-001-10-8::2.5::HTS,4.163219742075255,0.04178441619126987,Other Types,norcyclobenzaprine,"adrenergic receptor agonist, serotonin receptor antagonist",
Neuroblastoma,BRD-K63550407-001-12-7::2.5::HTS,7.959292569371482,0.004955066301917795,Other Types,erythromycin,NFkB pathway inhibitor,MLNR
Neuroblastoma,BRD-K63736853-001-04-8::2.5::HTS,7.297644807568964,0.007119071893214736,Neuroblastoma,acipimox,cholesterol inhibitor,HCAR2
Neuroblastoma,BRD-K63750851-001-20-7::2.5::HTS,6.070720468065589,0.01404349529756929,Other Types,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Neuroblastoma,BRD-K63784565-001-06-2::2.51::HTS,10.17039398775771,0.0015118127100646594,Neuroblastoma,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1
Neuroblastoma,BRD-K63932022-001-01-5::2.5::HTS,20.952460674452176,5.806342848483907e-06,Other Types,2'-MeCCPA,adenosine receptor agonist,ADORA1
Neuroblastoma,BRD-K64157027-003-02-7::2.5::HTS,5.882801541917024,0.015606803139624469,Neuroblastoma,ZD-2079,adrenergic receptor agonist,ADRB3
Neuroblastoma,BRD-K64191834-001-03-1::2.5::HTS,8.21848508753222,0.004306618248341976,Other Types,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,
Neuroblastoma,BRD-K64341947-003-02-4::2.5::HTS,4.723544883956458,0.03017219449112793,Neuroblastoma,CFM-1571,guanylate cyclase activator,
Neuroblastoma,BRD-K64422603-300-02-7::2.5::HTS,5.81981442264764,0.016168159938632104,Neuroblastoma,N-alpha-Methylhistamine-dihydrochloride,histamine receptor agonist,HRH4
Neuroblastoma,BRD-K64888243-001-03-7::2.5::HTS,4.903464181596849,0.027204792590672627,Other Types,AZ960,JAK inhibitor,JAK2
Neuroblastoma,BRD-K64990126-004-01-1::2.5::HTS,4.0078977045590864,0.04576767581655039,Other Types,scopolamine,acetylcholine receptor antagonist,
Neuroblastoma,BRD-K64990520-001-08-4::2.5::HTS,5.0657870441819695,0.02479394360572161,Neuroblastoma,apocynin,NADPH oxidase inhibitor,NOX4
Neuroblastoma,BRD-K65377893-001-07-4::2.58::HTS,5.300879062896829,0.021702763842636124,Neuroblastoma,7-aminocephalosporanic-acid,beta lactamase inhibitor,
Neuroblastoma,BRD-K65877271-001-01-8::2.5::HTS,4.820850067801148,0.028537455979820693,Neuroblastoma,halobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Neuroblastoma,BRD-K65928735-001-04-3::2.5::HTS,4.0257624571502575,0.045293249875422506,Neuroblastoma,AZD1480,JAK inhibitor,"JAK1, JAK2, JAK3"
Neuroblastoma,BRD-K66093087-001-03-1::2.5::HTS,4.476651321956558,0.03480016813843643,Neuroblastoma,FGIN-1-43,benzodiazepine receptor agonist,TSPO
Neuroblastoma,BRD-K66296774-236-11-3::2.63::HTS,13.529102675434165,0.00025845917313201643,Neuroblastoma,fluvastatin,HMGCR inhibitor,HMGCR
Neuroblastoma,BRD-K66876909-001-12-6::2.5::HTS,6.4425778625431835,0.011415395677559765,Neuroblastoma,linezolid,bacterial 50S ribosomal subunit inhibitor,"MAOA, MAOB"
Neuroblastoma,BRD-K67511046-001-02-3::2.5::HTS,12.764655443805792,0.00038488537650360104,Neuroblastoma,naloxone,opioid receptor antagonist,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4"
Neuroblastoma,BRD-K67537649-001-04-5::2.5::HTS,3.9537290377228866,0.04726461047663132,Neuroblastoma,PQ-401,IGF-1 inhibitor,IGF1R
Neuroblastoma,BRD-K67578145-001-12-1::2.5::HTS,8.486349712423673,0.003722566117365586,Neuroblastoma,GDC-0879,RAF inhibitor,BRAF
Neuroblastoma,BRD-K67868012-001-07-6::2.5::HTS,9.684956459695004,0.0019522215166253541,Neuroblastoma,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Neuroblastoma,BRD-K68095457-001-10-1::2.5::HTS,5.604793081810176,0.018254025670937934,Neuroblastoma,palmitoylethanolamide,cannabinoid receptor agonist,"CNR2, GPR119, GPR55"
Neuroblastoma,BRD-K68174511-001-06-6::2.5::HTS,4.041053424926882,0.04488339551912643,Neuroblastoma,torin-2,mTOR inhibitor,MTOR
Neuroblastoma,BRD-K68202742-001-16-5::2.63::HTS,10.456598850973776,0.0012985265422125066,Neuroblastoma,trichostatin-a,HDAC inhibitor,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Neuroblastoma,BRD-K68507560-003-24-6::2.5::HTS,4.680527101289864,0.03093400799507205,Other Types,dicycloverine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Neuroblastoma,BRD-K68756823-001-07-1::2.5::HTS,6.338400942857334,0.012096051510963067,Other Types,FR-180204,MAP kinase inhibitor,"MAPK1, MAPK3"
Neuroblastoma,BRD-K68867920-051-11-5::2.5::HTS,7.192461178287519,0.007537085393955608,Neuroblastoma,quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2"
Neuroblastoma,BRD-K68870568-066-01-5::2.5::HTS,5.814295927184686,0.01621727649501563,Other Types,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Neuroblastoma,BRD-K68904758-001-03-5::2.5::HTS,4.074202074223422,0.04402417856891077,Neuroblastoma,cephalomannine,DNA polymerase inhibitor,
Neuroblastoma,BRD-K69001009-001-02-8::2.5::HTS,4.302562506215019,0.038516256364871285,Neuroblastoma,golvatinib,VEGFR inhibitor,"KDR, MET"
Neuroblastoma,BRD-K69035426-001-01-3::2.5::HTS,4.159098978470384,0.04188711913460421,Neuroblastoma,omeprazole-sulfide,ATPase inhibitor,
Neuroblastoma,BRD-K69650333-003-13-2::2.48::HTS,6.392911876891821,0.01174798752000294,Neuroblastoma,idarubicin,topoisomerase inhibitor,TOP2A
Neuroblastoma,BRD-K69650333-003-14-0::2.5::HTS,5.802869193524606,0.016325376729992017,Neuroblastoma,idarubicin,topoisomerase inhibitor,TOP2A
Neuroblastoma,BRD-K69694239-001-02-2::2.5::HTS,5.8071302213424945,0.016281643461747826,Neuroblastoma,bardoxolone-methyl,"nuclear factor erythroid derived, like (NRF2) activator","PPARG, STAT3"
Neuroblastoma,BRD-K69907333-001-10-6::2.5::HTS,10.473778921987591,0.001286741360125959,Neuroblastoma,flurbiprofen-(S)-(+),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Neuroblastoma,BRD-K69932463-001-10-6::2.5::HTS,8.641750570649311,0.0034225112420391206,Neuroblastoma,AZD8055,mTOR inhibitor,MTOR
Neuroblastoma,BRD-K70163715-300-05-7::2.42::HTS,8.630577197019177,0.0034517650839183344,Neuroblastoma,vatalanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR, PDGFRB"
Neuroblastoma,BRD-K70401845-003-09-6::2.5::HTS,6.445783656294345,0.011391132432933052,Neuroblastoma,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Neuroblastoma,BRD-K70402238-001-02-8::2.5::HTS,5.656413715556543,0.017726688414637103,Other Types,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Neuroblastoma,BRD-K70592483-001-01-0::2.5::HTS,4.50725089557108,0.03419419197123145,Neuroblastoma,phenylacetylglutamine,"DNA methylase inhibitor, protein synthesis inhibitor",
Neuroblastoma,BRD-K71103788-003-12-0::2.5::HTS,9.22683473155762,0.0024972634092795595,Neuroblastoma,duloxetine,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4"
Neuroblastoma,BRD-K71125014-001-27-1::2.5::HTS,4.936785507251377,0.026691194494785683,Other Types,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Neuroblastoma,BRD-K71221037-001-01-6::2.5::HTS,7.086354474846646,0.00799044266553419,Neuroblastoma,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Neuroblastoma,BRD-K71281111-001-04-3::2.5::HTS,6.7530253265003175,0.009605413124108248,Neuroblastoma,SNX-2112,HSP inhibitor,
Neuroblastoma,BRD-K71467466-001-02-3::2.5::HTS,19.3222829033005,1.3204764094480993e-05,Neuroblastoma,KPT-185,exportin antagonist,XPO1
Neuroblastoma,BRD-K71534238-001-10-0::2.5::HTS,4.900298762217738,0.02725497591896269,Other Types,GW-9508,"free fatty acid receptor agonist, G protein-coupled receptor agonist","FFAR1, FFAR4"
Neuroblastoma,BRD-K71823332-001-03-7::2.5::HTS,5.339147503261386,0.021218038324936773,Neuroblastoma,epothilone-a,microtubule stabilizing agent,
Neuroblastoma,BRD-K72093555-001-01-0::2.5::HTS,4.29172343827158,0.03875641890067533,Other Types,procyanidin-b-2,,
Neuroblastoma,BRD-K72414522-001-06-7::2.5::HTS,4.778012958351046,0.02923873769757317,Neuroblastoma,AZD5438,CDK inhibitor,KCNH2
Neuroblastoma,BRD-K72542090-304-02-4::2.5::HTS,4.126043827680785,0.042730231858787354,Neuroblastoma,clodronic-acid,bone resorption inhibitor,"SLC25A4, SLC25A5, SLC25A6"
Neuroblastoma,BRD-K72687424-001-02-6::2.5::HTS,4.944554520920401,0.026571862117921896,Neuroblastoma,VU0364439,glutamate receptor positive allosteric modulator,GRM4
Neuroblastoma,BRD-K72723676-003-17-8::2.5::HTS,10.052232939556097,0.00160528433824192,Neuroblastoma,benzethonium,sodium channel blocker,SCN10A
Neuroblastoma,BRD-K72827473-001-01-0::2.5::HTS,18.21273002776775,2.3198071239556996e-05,Other Types,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Neuroblastoma,BRD-K73197500-001-02-2::2.5::HTS,10.43416034803955,0.0013098739152594089,Neuroblastoma,SNX-5422,HSP inhibitor,HSP90AA1
Neuroblastoma,BRD-K73293050-001-03-1::2.5::HTS,8.666293970382556,0.003377428879367886,Neuroblastoma,WZ-3146,EGFR inhibitor,EGFR
Neuroblastoma,BRD-K73309154-003-02-8::2.5::HTS,4.4647109520347135,0.03504220034302455,Neuroblastoma,OSI-420,EGFR inhibitor,EGFR
Neuroblastoma,BRD-K73319509-001-08-0::2.5::HTS,7.188864407203137,0.007552012693767184,Neuroblastoma,PF-04217903,c-Met inhibitor,MET
Neuroblastoma,BRD-K73425385-065-04-8::2.5::HTS,6.909109868847481,0.00882035884827959,Neuroblastoma,bekanamycin,bacterial 30S ribosomal subunit inhibitor,
Neuroblastoma,BRD-K73838513-003-05-5::2.5::HTS,4.59147338376163,0.03256641790641343,Neuroblastoma,cinacalcet,calcium channel activator,CASR
Neuroblastoma,BRD-K74193284-001-04-8::2.5::HTS,11.693812123987195,0.0006755743799430695,Neuroblastoma,phenylmercuric-acetate,other antifungal,
Neuroblastoma,BRD-K74236708-001-01-9::2.5::HTS,5.243659895854438,0.02240192730068892,Other Types,acitazanolast,mediator release inhibitor,
Neuroblastoma,BRD-K74514084-001-03-9::2.5::HTS,4.907427726570379,0.02715330785752085,Neuroblastoma,pazopanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3"
Neuroblastoma,BRD-K74765201-001-16-7::0.25::HTS,4.407714816216903,0.03622209401898425,Neuroblastoma,tomelukast,leukotriene receptor antagonist,CYSLTR1
Neuroblastoma,BRD-K75009076-001-02-1::2.43::HTS,5.378511494702513,0.020766996178310855,Other Types,SCH-900776,CHK inhibitor,"CDK2, CHEK1"
Neuroblastoma,BRD-K75037734-003-13-9::2.5::HTS,13.302152724079125,0.0002918076325747653,Neuroblastoma,carbachol,cholinergic receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Neuroblastoma,BRD-K75282704-001-02-4::2.5::HTS,8.387642748642657,0.003926155070914656,Other Types,BL-5583,hypercalcaemic agent,
Neuroblastoma,BRD-K75295174-001-05-0::2.5::HTS,4.866940508775657,0.027790896497339315,Other Types,alisertib,Aurora kinase inhibitor,AURKA
Neuroblastoma,BRD-K75308783-001-07-0::2.5::HTS,7.020487708324678,0.008287915760284422,Neuroblastoma,SAR-245409,PI3K inhibitor,"MTOR, PIK3CG"
Neuroblastoma,BRD-K75649340-001-13-1::2.5::HTS,4.660635794989364,0.0312843290376945,Other Types,tioguanine,purine antagonist,
Neuroblastoma,BRD-K75868704-001-05-3::2.5::HTS,4.220539105436729,0.040401837467927214,Other Types,iopamidol,radiopaque medium,
Neuroblastoma,BRD-K75958195-037-09-4::2.5::HTS,8.254766974012528,0.004218945213892692,Other Types,pizotifen,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C"
Neuroblastoma,BRD-K75958547-238-01-0::2.5::HTS,7.739789655651568,0.005583805197747024,Neuroblastoma,pitavastatin,HMGCR inhibitor,HMGCR
Neuroblastoma,BRD-K76452401-001-03-6::2.5::HTS,7.702977544899969,0.005697885661970218,Neuroblastoma,piperonyl-butoxide,cytochrome P450 inhibitor,
Neuroblastoma,BRD-K76568384-001-02-2::2.5::HTS,7.170752323195957,0.007629217977750739,Neuroblastoma,PHTPP,estrogen receptor antagonist,ESR2
Neuroblastoma,BRD-K76674262-001-03-3::2.5::HTS,5.758075897525223,0.016737538436835234,Neuroblastoma,homoharringtonine,protein synthesis inhibitor,RPL3
Neuroblastoma,BRD-K76703230-004-03-3::2.5::HTS,9.238455284362685,0.002481726357940766,Neuroblastoma,YM-155,survivin inhibitor,BIRC5
Neuroblastoma,BRD-K76703230-004-04-1::2.5::HTS,4.840916666045979,0.028201946634735537,Neuroblastoma,YM-155,survivin inhibitor,BIRC5
Neuroblastoma,BRD-K76810206-001-08-1::2.5::HTS,4.353427722951717,0.03738472673528594,Neuroblastoma,nicergoline,adrenergic receptor antagonist,ADRA1A
Neuroblastoma,BRD-K76973696-001-12-6::2.01::HTS,4.073017863799978,0.04405481410910162,Neuroblastoma,tryptanthrin,cyclooxygenase inhibitor,IDO1
Neuroblastoma,BRD-K77554836-001-11-6::2.57::HTS,4.639672650097955,0.03169280943524912,Neuroblastoma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Neuroblastoma,BRD-K77638923-001-02-0::2.5::HTS,22.52549893094607,2.660359578492242e-06,Neuroblastoma,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Neuroblastoma,BRD-K77867004-001-02-7::2.5::HTS,5.76086330275343,0.016711282723538234,Neuroblastoma,U-104,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA9"
Neuroblastoma,BRD-K77943374-001-02-8::2.5::HTS,4.936516362522683,0.026692458579522182,Neuroblastoma,NVP-BVU972,MET inhibitor,MET
Neuroblastoma,BRD-K77987382-001-13-2::2.5::HTS,5.854587808480872,0.01585280116894497,Other Types,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Neuroblastoma,BRD-K78126613-001-28-5::2.5::HTS,8.103121219709093,0.004580320404020678,Other Types,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Neuroblastoma,BRD-K78177893-001-02-4::2.5::HTS,14.746818658875158,0.00013704667820139485,Neuroblastoma,A-674563,AKT inhibitor,"AKT1, PKIA, PRKACA"
Neuroblastoma,BRD-K78431006-001-10-2::2.5::HTS,6.899669848355556,0.008856353530870074,Other Types,crizotinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Neuroblastoma,BRD-K78643075-001-11-6::2.5::HTS,3.9198436441149584,0.04821020238360565,Other Types,bromperidol,dopamine receptor antagonist,DRD2
Neuroblastoma,BRD-K79095980-001-09-6::2.5::HTS,4.776888857761287,0.0292569257674082,Other Types,broxuridine,antimetabolite,
Neuroblastoma,BRD-K79753741-001-01-7::2.5::HTS,5.475927650766758,0.01963419090109404,Other Types,UBP-302,glutamate receptor antagonist,GRIK1
Neuroblastoma,BRD-K79759585-048-04-8::2.5::HTS,8.04564395709033,0.004729086402656118,Neuroblastoma,sildenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
Neuroblastoma,BRD-K79892937-001-02-5::2.5::HTS,4.516663494545708,0.034004944086604295,Neuroblastoma,phenolsulfonphthalein,,
Neuroblastoma,BRD-K80343549-001-02-6::2.5::HTS,3.9179890943925733,0.04828035070177102,Neuroblastoma,TAK-285,EGFR inhibitor,ERBB2
Neuroblastoma,BRD-K80451230-051-02-6::2.5::HTS,6.571388344111685,0.010624479788650219,Other Types,zamifenacin,acetylcholine receptor antagonist,CHRM3
Neuroblastoma,BRD-K80725821-300-02-9::2.5::HTS,16.882476435016347,4.572168220062466e-05,Other Types,RS-16566,serotonin receptor antagonist,
Neuroblastoma,BRD-K81016934-001-02-0::2.5::HTS,4.914262808967003,0.027052410881931152,Neuroblastoma,INC-280,c-Met inhibitor,MET
Neuroblastoma,BRD-K81473043-001-14-6::2.5::HTS,5.395790939049748,0.02056447301729176,Neuroblastoma,tanespimycin,HSP inhibitor,HSP90AA1
Neuroblastoma,BRD-K81645907-001-01-1::2.5::HTS,6.348393729803791,0.0120427463894218,Neuroblastoma,captamine,,
Neuroblastoma,BRD-K81694556-003-01-9::2.5::HTS,39.11945393451789,8.123738532748303e-10,Neuroblastoma,VTP-27999,renin inhibitor,REN
Neuroblastoma,BRD-K81916719-001-13-9::2.5::HTS,13.260629121326144,0.0002971913822636079,Neuroblastoma,triclabendazole,microtubule inhibitor,DNMT1
Neuroblastoma,BRD-K82135108-001-04-3::2.5::HTS,10.119886242947901,0.001547993521995046,Neuroblastoma,elesclomol,oxidative stress inducer,HSPA1A
Neuroblastoma,BRD-K82225283-001-03-1::2.5::HTS,3.9801192667159286,0.04654331442928164,Other Types,isosorbide-mononitrate,nitric oxide stimulant,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3"
Neuroblastoma,BRD-K82522873-001-01-1::2.5::HTS,4.939474741829513,0.02665888407960106,Neuroblastoma,N6022,alcohol dehydrogenase inhibitor,ADH5
Neuroblastoma,BRD-K82767007-001-01-1::2.5::HTS,4.137555048889347,0.04242454167289824,Neuroblastoma,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Neuroblastoma,BRD-K82823804-001-04-1::2.5::HTS,7.170478712549503,0.007631964248128678,Other Types,PD-407824,PKC inhibitor,WEE1
Neuroblastoma,BRD-K82928847-001-04-7::2.5::HTS,4.054650855706106,0.04453994481067863,Other Types,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Neuroblastoma,BRD-K83186168-001-01-8::2.5::HTS,13.372591608997151,0.0002801812027590887,Other Types,AZD1981,CRTH receptor antagonist,PTGDR2
Neuroblastoma,BRD-K83794243-001-01-8::2.5::HTS,4.933228366721894,0.026759840451270306,Other Types,palovarotene,retinoid receptor agonist,RARG
Neuroblastoma,BRD-K83837640-001-04-8::2.5::HTS,5.543030349895529,0.018912228145302398,Neuroblastoma,JNJ-26481585,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2"
Neuroblastoma,BRD-K84011460-051-01-7::2.5::HTS,4.850270950153969,0.028064443857009125,Neuroblastoma,nizofenone,ion channel antagonist,
Neuroblastoma,BRD-K84683831-001-01-0::2.5::HTS,4.592783922022011,0.03254812255785311,Neuroblastoma,radezolid,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor",
Neuroblastoma,BRD-K84798689-236-02-9::2.5::HTS,4.699809128021562,0.030602889331114023,Neuroblastoma,sodium-tanshinone-ii-a-sulfonate,potassium channel activator,
Neuroblastoma,BRD-K84810405-003-01-1::2.5::HTS,10.544748362970857,0.0012379351590222146,Neuroblastoma,almorexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Neuroblastoma,BRD-K84925803-001-01-9::2.5::HTS,6.277693013483148,0.012516686385984091,Other Types,T-5224,AP inhibitor,JUN
Neuroblastoma,BRD-K85402309-001-06-6::2.5::HTS,8.818291591139248,0.0031114017588056474,Neuroblastoma,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Neuroblastoma,BRD-K85406984-001-01-0::2.5::HTS,5.536244996873065,0.018985597822045817,Neuroblastoma,sobetirome,thyroid hormone receptor agonist,"THRA, THRB"
Neuroblastoma,BRD-K85872723-001-15-9::2.5::HTS,5.840690076771151,0.015977162691694472,Neuroblastoma,kynurenic-acid,glutamate receptor antagonist,"GPR35, GRIN1, GRIN2A, GRIN2B"
Neuroblastoma,BRD-K86118762-001-01-8::2.5::HTS,7.885696177118809,0.005162011128270718,Other Types,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Neuroblastoma,BRD-K86301799-001-34-8::2.5::HTS,4.358066531693512,0.037287908174962234,Neuroblastoma,dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1"
Neuroblastoma,BRD-K86525559-001-04-5::2.5::HTS,4.8554576919561505,0.02798096288019446,Neuroblastoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Neuroblastoma,BRD-K86525559-001-07-8::2.52::HTS,7.945566708630053,0.005001433010201537,Neuroblastoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Neuroblastoma,BRD-K86687746-001-01-3::2.5::HTS,7.305646538977581,0.007087863143046382,Neuroblastoma,R306465,HDAC inhibitor,
Neuroblastoma,BRD-K86797399-001-05-1::2.55::HTS,12.418156665325471,0.0004620829706597224,Neuroblastoma,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Neuroblastoma,BRD-K86887724-001-10-6::2.59::HTS,11.545216782320567,0.0007294241318670617,Neuroblastoma,dofetilide,potassium channel blocker,"KCNH1, KCNH2, KCNJ12, KCNK2"
Neuroblastoma,BRD-K87510569-001-02-8::2.5::HTS,4.635463128681935,0.031745591409726104,Neuroblastoma,RS-504393,CC chemokine receptor antagonist,"CCL2, CCR2"
Neuroblastoma,BRD-K87696786-003-04-4::2.5::HTS,4.299787398049336,0.03857864993790271,Neuroblastoma,LY456236,glutamate receptor antagonist,GRM1
Neuroblastoma,BRD-K87909389-003-03-4::2.5::HTS,11.195620014399191,0.0008749526746549402,Neuroblastoma,alvocidib,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM"
Neuroblastoma,BRD-K88172511-003-20-3::2.42::HTS,6.903368976639696,0.008853494259172909,Neuroblastoma,naltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1, SIGMAR1"
Neuroblastoma,BRD-K88358234-003-04-8::2.5::HTS,14.416048452127097,0.00016258112887056246,Neuroblastoma,xaliproden,serotonin receptor agonist,HTR1A
Neuroblastoma,BRD-K88510285-001-11-1::2.5::HTS,26.65534120968451,3.3857474699289435e-07,Neuroblastoma,bortezomib,"NFkB pathway inhibitor, proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA"
Neuroblastoma,BRD-K88742110-001-07-9::2.5::HTS,9.369716995378543,0.0023129098336826417,Other Types,PCI-34051,HDAC inhibitor,"HDAC1, HDAC10, HDAC6, HDAC8"
Neuroblastoma,BRD-K88759641-003-02-8::2.5::HTS,5.807823956917172,0.01627992989497784,Neuroblastoma,EMD-66684,angiotensin receptor antagonist,AGTR1
Neuroblastoma,BRD-K89053832-001-01-0::2.5::HTS,5.78244384167177,0.01651059847602182,Neuroblastoma,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Neuroblastoma,BRD-K89125793-001-26-0::2.5::HTS,4.072882319422381,0.04405486754641713,Other Types,tinidazole,antiprotozoal agent,
Neuroblastoma,BRD-K89306950-001-12-5::2.5::HTS,4.220269273503032,0.04040573101754378,Neuroblastoma,ML130,NOD1 inhibitor,
Neuroblastoma,BRD-K89391146-001-08-0::2.5::HTS,4.855127692568509,0.02798705280952516,Neuroblastoma,RG108,DNA methyltransferase inhibitor,"DNMT1, DNMT3B"
Neuroblastoma,BRD-K89561498-001-01-7::2.5::HTS,7.576987650472976,0.006104581801841606,Neuroblastoma,SN-38,topoisomerase inhibitor,TOP1
Neuroblastoma,BRD-K89634775-001-09-9::2.5::HTS,4.139485304304962,0.042366179898065466,Neuroblastoma,allylthiourea,nitrification inhibitor,
Neuroblastoma,BRD-K90382497-001-10-7::2.5::HTS,4.707100465712284,0.03046421461710893,Other Types,GW-843682X,PLK inhibitor,"PLK1, PLK3"
Neuroblastoma,BRD-K90777969-300-01-2::2.5::HTS,5.1034353905093655,0.024262892353552626,Neuroblastoma,cutamesine,sigma receptor agonist,SIGMAR1
Neuroblastoma,BRD-K91147684-001-01-5::2.5::HTS,3.905791448858645,0.048617351607603235,Neuroblastoma,m-THP,,
Neuroblastoma,BRD-K91308639-001-02-7::2.5::HTS,12.314689780603391,0.00048560830900998866,Other Types,apalutamide,androgen receptor antagonist,
Neuroblastoma,BRD-K91370081-001-25-1::2.5::HTS,10.899324287941877,0.001023937586551605,Neuroblastoma,anisomycin,DNA synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Neuroblastoma,BRD-K91422571-001-01-8::2.5::HTS,4.39109556736044,0.03657794700037834,Neuroblastoma,tromaril,prostanoid receptor antagonist,
Neuroblastoma,BRD-K91495480-001-02-2::2.5::HTS,5.20092806215602,0.02294836201119597,Other Types,AGP-103,membrane permeability inhibitor,
Neuroblastoma,BRD-K91614056-001-02-2::2.5::HTS,7.813226065704674,0.005375274629829453,Neuroblastoma,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,
Neuroblastoma,BRD-K92093830-003-30-8::2.5::HTS,11.828460534502636,0.0006268152914569168,Neuroblastoma,doxorubicin,topoisomerase inhibitor,TOP2A
Neuroblastoma,BRD-K92150287-066-01-2::2.5::HTS,15.551000128604516,9.06097116587107e-05,Neuroblastoma,exatecan-mesylate,topoisomerase inhibitor,TOP1
Neuroblastoma,BRD-K92657060-001-05-7::2.5::HTS,6.437816399663197,0.011440772698544877,Neuroblastoma,zaleplon,benzodiazepine receptor agonist,"GABRA1, GABRB1, GABRG2, TSPO"
Neuroblastoma,BRD-K92731339-227-04-9::2.5::HTS,4.558876150822325,0.033184218208826576,Neuroblastoma,perindopril,angiotensin converting enzyme inhibitor,ACE
Neuroblastoma,BRD-K92838188-001-01-9::2.5::HTS,4.050995198296161,0.0446260545289069,Neuroblastoma,rifaximin,RNA synthesis inhibitor,NR1I2
Neuroblastoma,BRD-K92976206-001-01-5::2.5::HTS,6.5471533958838055,0.010769853217367483,Other Types,guanosine,,PNP
Neuroblastoma,BRD-K93034159-001-25-8::2.5::HTS,4.393964251754351,0.036514541131532297,Neuroblastoma,cladribine,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B"
Neuroblastoma,BRD-K93240442-001-08-4::2.5::HTS,7.557094117839479,0.006171406270191764,Neuroblastoma,dinitolmide,,
Neuroblastoma,BRD-K93468883-001-02-0::2.5::HTS,7.897957027624121,0.0051215561802087405,Neuroblastoma,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Neuroblastoma,BRD-K93568044-001-32-0::2.5::HTS,6.618757806007513,0.010351168392118344,Neuroblastoma,hydrocortisone,glucocorticoid receptor agonist,
Neuroblastoma,BRD-K93611241-001-02-2::2.5::HTS,4.638998485905572,0.03168081429054615,Other Types,diacetamate,,
Neuroblastoma,BRD-K94144010-001-13-9::2.5::HTS,4.489846545595513,0.034538675188325825,Neuroblastoma,cotinine,nicotine metabolite,
Neuroblastoma,BRD-K94420399-001-01-9::2.5::HTS,9.019570464364582,0.0027899101818482075,Neuroblastoma,PF-04136309,CC chemokine receptor antagonist,
Neuroblastoma,BRD-K94441233-001-13-0::2.6::HTS,3.911755040878035,0.04846900111355882,Neuroblastoma,mevastatin,HMGCR inhibitor,HMGCR
Neuroblastoma,BRD-K94534639-001-02-5::2.5::HTS,9.315311325104588,0.0023798451141580045,Neuroblastoma,LY2811376,beta-secretase inhibitor,BACE1
Neuroblastoma,BRD-K94559059-091-01-6::2.5::HTS,4.140980242905599,0.04233248151737204,Neuroblastoma,telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1
Neuroblastoma,BRD-K95309561-001-24-7::2.5::HTS,7.221837964299482,0.007417453675141035,Neuroblastoma,dienestrol,estrogen receptor agonist,ESR1
Neuroblastoma,BRD-K95435023-001-08-5::2.5::HTS,9.561476851444644,0.0020920366473811815,Neuroblastoma,PHA-665752,c-Met inhibitor,MET
Neuroblastoma,BRD-K95523387-001-09-6::2.5::HTS,22.267318471531148,3.001190770993333e-06,Other Types,OLDA,TRPV agonist,GPR119
Neuroblastoma,BRD-K95785537-001-23-1::2.5::HTS,8.541100503986081,0.0036152079150875756,Neuroblastoma,PP-2,src inhibitor,"ABL1, LCK, LYN, RIPK2, SRC"
Neuroblastoma,BRD-K95957366-001-02-6::2.5::HTS,4.542118500868608,0.0335070425318809,Neuroblastoma,isaxonine,nerve growth factor agonist,
Neuroblastoma,BRD-K96104201-001-01-5::2.5::HTS,6.655773571603955,0.010138540698131717,Neuroblastoma,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,
Neuroblastoma,BRD-K96188950-001-16-9::2.5::HTS,15.848307144338872,7.780278389183656e-05,Other Types,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA
Neuroblastoma,BRD-K96358241-001-01-9::0.94::HTS,7.309655508720393,0.007068029753875355,Neuroblastoma,harringtonine,protein synthesis inhibitor,
Neuroblastoma,BRD-K96550715-001-02-6::2.5::HTS,5.897959899188439,0.015472208138816161,Other Types,linagliptin,dipeptidyl peptidase inhibitor,DPP4
Neuroblastoma,BRD-K96631475-001-02-4::2.43::HTS,5.519819378287729,0.019169644944417016,Neuroblastoma,10-deacetylbaccatin,antitumor agent,
Neuroblastoma,BRD-K96671969-001-03-1::2.5::HTS,5.991288936446712,0.014682661584388648,Other Types,PA-824,nitric oxide donor,FASN
Neuroblastoma,BRD-K97101532-001-02-8::2.5::HTS,6.560402969299175,0.010687135111755085,Other Types,tezacaftor,CFTR channel agonist,
Neuroblastoma,BRD-K97163964-001-03-3::2.5::HTS,3.8921804559649544,0.04900544809048342,Neuroblastoma,L-Aspartic-Acid,metallic radical formation stimulant,"ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13"
Neuroblastoma,BRD-K97752965-001-16-4::2.5::HTS,5.364158732830036,0.02093971607836363,Neuroblastoma,nicorandil,"nitric oxide donor, potassium channel activator",KCNJ11
Neuroblastoma,BRD-K97764662-001-17-3::2.5::HTS,4.131532364471106,0.042567601650239754,Neuroblastoma,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Neuroblastoma,BRD-K98684188-001-02-9::2.5::HTS,7.759658309119397,0.005525529263506669,Neuroblastoma,GSK-0660,PPAR receptor antagonist,PPARD
Neuroblastoma,BRD-K98763141-001-30-8::2.5::HTS,5.392072525023223,0.020588719403466564,Other Types,niflumic-acid,cyclooxygenase inhibitor,"ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9"
Neuroblastoma,BRD-K98795921-001-01-7::2.5::HTS,6.771084209010592,0.009512541019775259,Neuroblastoma,SB-2343,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Neuroblastoma,BRD-K99498722-001-02-6::2.5::HTS,5.662747784589711,0.01766647047965078,Neuroblastoma,plinabulin,tubulin polymerization inhibitor,
Neuroblastoma,BRD-K99621550-300-01-8::2.5::HTS,5.542395814455004,0.01890741540243457,Neuroblastoma,tubocurarine,acetylcholine receptor antagonist,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN"
Neuroblastoma,BRD-M02179497-001-01-1::2.5::HTS,3.967192183992968,0.04691167560644208,Other Types,bismuth-oxalate,,
Neuroblastoma,BRD-A16263897-001-06-6::2.5::MTS004,4.800101014963736,0.028885482433737997,Other Types,misonidazole,,
Neuroblastoma,BRD-A84810646-001-01-6::2.500007302::MTS004,5.354467402209389,0.02104511639263792,Neuroblastoma,ginsenoside-rd,calcium channel blocker,
Neuroblastoma,BRD-A89207210-001-01-6::2.378054241::MTS004,4.171077506347329,0.04160664292867739,Neuroblastoma,terguride,"dopamine receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Neuroblastoma,BRD-K05858796-001-01-7::2.500017956::MTS004,6.021455716597014,0.014449501344383256,Neuroblastoma,GSK2330672,bile acid transporter inhibitor,SLC10A2
Neuroblastoma,BRD-K06519765-001-01-1::2.5::MTS004,4.478541170885016,0.03478078230962867,Other Types,vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1"
Neuroblastoma,BRD-K10415035-001-04-4::2.5::MTS004,4.733172329100703,0.03002002855151628,Other Types,tasuldine,mucolytic agent,
Neuroblastoma,BRD-K12261274-001-02-4::2.499953183::MTS004,4.4712863349014285,0.03492834079518068,Neuroblastoma,zaltidine,histamine receptor antagonist,HRH2
Neuroblastoma,BRD-K17610631-001-03-3::2.421190843::MTS004,8.757269413096944,0.003219247394295474,Other Types,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Neuroblastoma,BRD-K21237892-376-01-3::2.5::MTS004,4.1508521990809095,0.04210149397972079,Other Types,semapimod,"cytokine production inhibitor, p38 MAPK inhibitor",MAPK14
Neuroblastoma,BRD-K24497734-001-01-6::2.499993902::MTS004,7.034962795568165,0.008229311328930813,Neuroblastoma,setipiprant,prostaglandin inhibitor,PTGDR2
Neuroblastoma,BRD-K26530649-001-01-6::2.568078778::MTS004,6.278289638214014,0.012516852692128438,Other Types,carboxypyridine-disulfide,,
Neuroblastoma,BRD-K28537285-001-01-8::2.499968715::MTS004,9.948885458004302,0.0016991904894898707,Other Types,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Neuroblastoma,BRD-K30485548-050-01-6::2.479775098::MTS004,6.7659723755864265,0.00954643800819943,Other Types,sumanirole,dopamine receptor agonist,DRD2
Neuroblastoma,BRD-K35304636-001-01-0::2.5::MTS004,5.560558257809214,0.01872575838184678,Other Types,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Neuroblastoma,BRD-K39009484-001-01-4::2.5::MTS004,5.270978935016306,0.022067477479437988,Other Types,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Neuroblastoma,BRD-K41267922-001-01-4::2.5::MTS004,4.806310269092331,0.028782521319236837,Other Types,F351,TGF beta receptor inhibitor,TGFB1
Neuroblastoma,BRD-K54955827-001-02-2::2.49997945::MTS004,7.141853978488402,0.007758530379183211,Other Types,niraparib,PARP inhibitor,PARP1
Neuroblastoma,BRD-K67482377-001-01-8::2.500004112::MTS004,4.770299897219842,0.02938502244138044,Other Types,itacitinib,JAK inhibitor,JAK1
Neuroblastoma,BRD-K69636617-001-01-7::2.49998713::MTS004,6.846308191887005,0.009131674606679196,Neuroblastoma,testolactone,aromatase inhibitor,CYP19A1
Neuroblastoma,BRD-K72280606-001-01-2::2.499993939::MTS004,7.695048036496427,0.005729211092984572,Other Types,gilteritinib,FLT3 inhibitor,FLT3
Neuroblastoma,BRD-K74671368-001-01-8::2.5::MTS004,9.611302326434105,0.0020348901112168184,Other Types,idronoxil,XIAP inhibitor,"ENOX2, SPHK1"
Neuroblastoma,BRD-K78666663-001-01-6::2.499978008::MTS004,5.955000637947716,0.014997273239011866,Neuroblastoma,lemborexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Neuroblastoma,BRD-K80738081-001-46-8::2.500037854::MTS004,4.314413637422513,0.038263818435489705,Neuroblastoma,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Neuroblastoma,BRD-K87948281-001-01-9::2.499985333::MTS004,7.060667703676919,0.008113156776175296,Neuroblastoma,F-11440,serotonin receptor agonist,HTR1A
Osteosarcoma,BRD-A00100033-001-08-9::2.5::HTS,7.82608218301841,0.0053262738274822054,Osteosarcoma,nifurtimox,DNA inhibitor,
Osteosarcoma,BRD-A00376169-001-01-6::2.5::HTS,14.038302223476991,0.00019790129215793435,Osteosarcoma,KBG,neprilysin inhibitor,MME
Osteosarcoma,BRD-A00578795-001-04-3::2.5::HTS,4.531195695833379,0.033716633310164064,Osteosarcoma,zaltoprofen,cyclooxygenase inhibitor,
Osteosarcoma,BRD-A02990301-003-06-6::2.5::HTS,5.278670119413848,0.021958077482807575,Osteosarcoma,lofexidine,adrenergic receptor agonist,ADRA2A
Osteosarcoma,BRD-A03216249-003-24-3::2.5::HTS,9.51258296433061,0.002142223238682056,Osteosarcoma,mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A
Osteosarcoma,BRD-A03623303-045-09-5::2.5::HTS,4.565381893458735,0.033059468806046564,Osteosarcoma,metoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Osteosarcoma,BRD-A03880619-001-01-0::2.5::HTS,3.9660346362547814,0.046943686188877884,Other Types,bismuth-subcitrate-potassium,,
Osteosarcoma,BRD-A04497688-001-04-2::2.5::HTS,4.341027929761152,0.03765979992039148,Other Types,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,"ESR1, ESR2, HSD3B1, HSD3B2"
Osteosarcoma,BRD-A07395371-003-10-0::2.5::HTS,7.149968482428903,0.007716574605229217,Osteosarcoma,esmolol,adrenergic receptor antagonist,ADRB1
Osteosarcoma,BRD-A07893380-213-01-7::2.5::HTS,10.664618921830364,0.0011629073547036594,Other Types,vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1"
Osteosarcoma,BRD-A08545410-311-03-4::2.5::HTS,7.320514714528276,0.007037560510690647,Osteosarcoma,doxycycline,metalloproteinase inhibitor,MMP8
Osteosarcoma,BRD-A10420615-001-04-4::2.5::HTS,4.371519152963353,0.03699946599170155,Other Types,cyclopiazonic-acid,ATPase inhibitor,ATP2A1
Osteosarcoma,BRD-A11815689-001-01-1::2.5::HTS,4.781569621237062,0.02918116725411985,Osteosarcoma,proscillaridin-a,,
Osteosarcoma,BRD-A12417644-001-07-6::2.31::HTS,6.301207864759465,0.012363497971282224,Other Types,usniacin-(+),MAP kinase activator,PTPN1
Osteosarcoma,BRD-A13964793-001-02-6::2.5::HTS,4.501782418894881,0.0343003962660393,Other Types,TC1,beta-secretase inhibitor,BACE1
Osteosarcoma,BRD-A14344385-001-03-2::2.5::HTS,6.137604799469796,0.013529177823354907,Osteosarcoma,IDRA-21,glutamate receptor positive allosteric modulator,"GRIA1, GRIA2, GRIA3, GRIA4"
Osteosarcoma,BRD-A14395271-074-17-8::2.5::HTS,7.518590658341619,0.006302524693805426,Other Types,mesoridazine,dopamine receptor antagonist,"DRD2, HTR2A"
Osteosarcoma,BRD-A16700644-003-04-4::2.5::HTS,6.4197237092888475,0.011558990044513556,Osteosarcoma,isoxsuprine,adrenergic receptor agonist,ADRB2
Osteosarcoma,BRD-A19195498-050-14-1::2.5::HTS,4.226071202410731,0.0402721989676403,Osteosarcoma,trimipramine,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4"
Osteosarcoma,BRD-A20781140-001-01-7::2.5::HTS,13.973635666362274,0.00020494280648567065,Osteosarcoma,plovamer-acetate,,"TAT, TH, YARS, YARS2"
Osteosarcoma,BRD-A21858158-001-23-5::2.5::HTS,3.879789639606709,0.04936842315566126,Other Types,praziquantel,anthelmintic agent,
Osteosarcoma,BRD-A22305049-003-13-6::2.5::HTS,3.9033580913781196,0.048685492805328745,Other Types,benfluorex,gluconeogenesis inhibitor,HMGCR
Osteosarcoma,BRD-A22642447-001-01-9::2.5::HTS,4.358198456905765,0.03728750434885734,Osteosarcoma,licarbazepine,voltage-gated sodium channel blocker,SCN5A
Osteosarcoma,BRD-A22769835-300-05-7::2.5::HTS,4.497560210973376,0.034384487681598866,Osteosarcoma,homochlorcyclizine,antihistamine,HRH1
Osteosarcoma,BRD-A23127772-001-02-3::2.5::HTS,4.217560373959159,0.04048074553933938,Osteosarcoma,sclareol,,
Osteosarcoma,BRD-A23603052-001-03-2::2.5::HTS,5.298508714620099,0.021711744958552562,Osteosarcoma,rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3"
Osteosarcoma,BRD-A25687296-300-04-3::2.5::HTS,5.654909370778835,0.01774295124577646,Osteosarcoma,emetine,protein synthesis inhibitor,RPS2
Osteosarcoma,BRD-A27732521-003-08-3::2.5::HTS,4.222117705811154,0.04037562727855107,Osteosarcoma,tolperisone,voltage-gated sodium channel blocker,"CYP2C19, CYP2D6"
Osteosarcoma,BRD-A29944538-003-08-3::2.5::HTS,8.929955794662053,0.002928978993041134,Osteosarcoma,proxodolol,adrenergic receptor antagonist,
Osteosarcoma,BRD-A30051119-002-01-8::2.5::HTS,5.307142593119036,0.021606764608551224,Other Types,amikacin,bacterial 30S ribosomal subunit inhibitor,
Osteosarcoma,BRD-A32988684-003-08-7::2.5::HTS,6.173884202894028,0.013257542636479137,Osteosarcoma,heptaminol,vasoconstrictor,
Osteosarcoma,BRD-A34716233-004-03-5::2.5::HTS,3.9657479119521417,0.046922836917968266,Osteosarcoma,AMPA-(RS),glutamate receptor agonist,GRIN1
Osteosarcoma,BRD-A37390343-003-03-5::2.5::HTS,5.99706097076992,0.014635767727709983,Osteosarcoma,amorolfine,membrane integrity inhibitor,
Osteosarcoma,BRD-A41385909-001-01-3::2.5::HTS,12.626578772037405,0.00041438663109352004,Other Types,bornyl-acetate,,
Osteosarcoma,BRD-A42270467-001-04-4::2.5::HTS,7.762510282455502,0.005515941563518761,Osteosarcoma,tenatoprazole,ATPase inhibitor,IDO1
Osteosarcoma,BRD-A42759514-001-20-5::2.5::HTS,6.141098191195209,0.013500136276261974,Osteosarcoma,ornidazole,antiprotozoal agent,
Osteosarcoma,BRD-A43082555-001-01-1::2.5::HTS,4.471600892953447,0.03491522750428096,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Osteosarcoma,BRD-A43082555-001-02-9::2.5::HTS,6.275757970368742,0.012524447849381058,Osteosarcoma,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Osteosarcoma,BRD-A43671941-003-11-9::2.5::HTS,4.87368263279991,0.027675337139243555,Other Types,oxprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Osteosarcoma,BRD-A43999749-004-04-1::2.5::HTS,4.6410708072631275,0.03164367672183033,Osteosarcoma,homatropine-methylbromide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Osteosarcoma,BRD-A44133049-003-07-8::2.5::HTS,6.173105609507933,0.013264904093198962,Other Types,azasetron,serotonin receptor antagonist,"HTR3A, HTR3B"
Osteosarcoma,BRD-A45889380-300-07-1::2.5::HTS,4.504280451591256,0.03425963591543222,Osteosarcoma,mepacrine,"cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B, PLA2G4A, PLA2G6, PLCL1"
Osteosarcoma,BRD-A46179541-311-02-0::2.5::HTS,7.287084065170699,0.007158121555712709,Other Types,doxapram,potassium channel blocker,"KCNK3, KCNK9"
Osteosarcoma,BRD-A47342814-003-01-8::2.5::HTS,9.562004108160771,0.002086819946795577,Osteosarcoma,naltrindole,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Osteosarcoma,BRD-A47790386-001-03-6::2.61::HTS,4.213365617263215,0.04062661767519329,Other Types,balofloxacin,bacterial DNA gyrase inhibitor,
Osteosarcoma,BRD-A49035384-003-28-9::2.39::HTS,4.716840798439736,0.03031296447547972,Osteosarcoma,methacycline,protein synthesis inhibitor,
Osteosarcoma,BRD-A49447682-001-02-4::2.5::HTS,4.594663628167854,0.032504033765310116,Other Types,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Osteosarcoma,BRD-A50675702-001-07-1::2.5::HTS,5.788304760710504,0.016460915449400225,Other Types,fipronil,"chloride channel blocker, GABA gated chloride channel blocker",
Osteosarcoma,BRD-A51382177-236-03-0::2.5::HTS,3.8734926687077595,0.04954550179157142,Other Types,fosinopril,angiotensin converting enzyme inhibitor,ACE
Osteosarcoma,BRD-A59198242-003-02-9::2.5::HTS,3.9535669790647794,0.04725760177660349,Other Types,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Osteosarcoma,BRD-A60786380-412-01-5::2.5::HTS,7.350342647650655,0.006924182760364033,Other Types,sodium-stibogluconate,tyrosine phosphatase inhibitor,"PTPN6, TOP1"
Osteosarcoma,BRD-A62071884-001-04-6::2.5::HTS,6.401925935820429,0.011672104016239901,Other Types,siguazodan,phosphodiesterase inhibitor,PDE3A
Osteosarcoma,BRD-A62209527-001-04-5::2.5::HTS,8.5113329711818,0.003671281557047483,Other Types,ZM-226600,Kir6 channel (KATP) activator,
Osteosarcoma,BRD-A64610707-001-04-4::2.5::HTS,3.9105012100638867,0.0484778221255231,Other Types,pranoprofen,cyclooxygenase inhibitor,
Osteosarcoma,BRD-A67482312-001-02-6::2.5::HTS,4.165578464107668,0.04172417621498719,Osteosarcoma,4-P-PDOT,melatonin receptor antagonist,"MTNR1A, MTNR1B"
Osteosarcoma,BRD-A68509429-003-03-9::2.5::HTS,5.365319604200637,0.02090241254947667,Other Types,ethylnorepinephrine,bronchodilator,
Osteosarcoma,BRD-A70083328-001-23-5::2.5::HTS,4.777560835628435,0.0292515911019239,Osteosarcoma,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Osteosarcoma,BRD-A72711497-236-03-8::2.5::HTS,4.360305033119612,0.03723690408092422,Osteosarcoma,lasalocid,bacterial permeability inducer,
Osteosarcoma,BRD-A73908300-001-06-7::2.5::HTS,6.4290246234780595,0.011496882318612829,Other Types,EX-527,SIRT inhibitor,SIRT1
Osteosarcoma,BRD-A75817871-001-06-7::2.5::HTS,4.1482300997743105,0.04215298993505183,Other Types,blebbistatin-(+/-),ATPase inhibitor,MYH2
Osteosarcoma,BRD-A77218119-001-03-5::2.5::HTS,4.89297565949256,0.027369766766967993,Osteosarcoma,SYM-2206,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Osteosarcoma,BRD-A79981887-003-16-4::2.5::HTS,5.602639880799933,0.01827134640920987,Osteosarcoma,midodrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D"
Osteosarcoma,BRD-A81233518-004-16-1::2.5::HTS,8.932613099170998,0.002924119472798413,Other Types,glycopyrrolate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Osteosarcoma,BRD-A82035391-001-02-7::2.5::HTS,5.005314604013512,0.025662234976527882,Osteosarcoma,tolvaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2"
Osteosarcoma,BRD-A87435144-001-01-6::2.5::HTS,6.0278611517479765,0.014385267642080287,Osteosarcoma,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1
Osteosarcoma,BRD-A87479750-001-02-7::2.5::HTS,4.500520080008058,0.034324723572448,Osteosarcoma,tenidap,cyclooxygenase inhibitor,"KCNJ4, PTGS1"
Osteosarcoma,BRD-A90926615-001-01-9::2.5::HTS,4.4102699350730505,0.03617070899187895,Other Types,adrafinil,adrenergic receptor agonist,
Osteosarcoma,BRD-A91452556-001-04-0::2.5::HTS,6.810286511116911,0.009306686445021577,Other Types,estradiol-cypionate,estrogen receptor agonist,ESR1
Osteosarcoma,BRD-A93407926-001-01-1::2.5::HTS,10.74410387806839,0.0011119185964546256,Osteosarcoma,allopurinol-riboside,anti-leishmanial agent,
Osteosarcoma,BRD-A94993966-001-05-1::2.63::HTS,6.031870943371072,0.014364276783017929,Other Types,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Osteosarcoma,BRD-A95121829-001-08-9::2.5::HTS,5.1694642311102434,0.02336911728037829,Osteosarcoma,ginkgolide-a,GABA receptor antagonist,"GLRA1, GLRB"
Osteosarcoma,BRD-A97730597-003-11-5::2.5::HTS,6.325412446040796,0.012183929686286996,Other Types,hexylcaine,sodium channel blocker,"SCN10A, SCN5A"
Osteosarcoma,BRD-A98378129-001-02-2::2.5::HTS,5.036133384966963,0.0252236737324232,Osteosarcoma,talniflumate,cyclooxygenase inhibitor,CLCA1
Osteosarcoma,BRD-A99117172-065-04-0::2.5::HTS,16.660729992663423,5.122635063340488e-05,Other Types,hydroxychloroquine,antimalarial agent,"TLR7, TLR9"
Osteosarcoma,BRD-K00077635-304-01-2::2.5::HTS,6.15076731802628,0.013429968437029762,Osteosarcoma,estramustine-phosphate,"DNA synthesis inhibitor, microtubule inhibitor","ESR1, ESR2, MAP1A, MAP2"
Osteosarcoma,BRD-K00603606-003-24-0::2.5::HTS,5.270351644701726,0.022062228867867847,Osteosarcoma,ticlopidine,purinergic receptor antagonist,P2RY12
Osteosarcoma,BRD-K00627859-003-03-7::2.5::HTS,3.9475655606777553,0.04742781467798521,Other Types,tubastatin-a,HDAC inhibitor,HDAC6
Osteosarcoma,BRD-K01614093-001-02-6::2.5::HTS,6.529520162792514,0.010887958427978659,Other Types,dihydromyricetin,,
Osteosarcoma,BRD-K01815685-001-15-5::2.5::HTS,5.592679810008882,0.018379368634303173,Osteosarcoma,indole-3-carbinol,"aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor",AHR
Osteosarcoma,BRD-K01824921-001-18-5::2.5::HTS,4.147468154577637,0.042187784124870134,Other Types,DPCPX,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Osteosarcoma,BRD-K01995783-001-01-6::2.5::HTS,5.652321963779991,0.017770706439213673,Osteosarcoma,AMG-9810,TRPV antagonist,TRPV1
Osteosarcoma,BRD-K02123250-001-06-7::2.5::HTS,7.927699455105255,0.005042016213548175,Osteosarcoma,JNJ-38877605,tyrosine kinase inhibitor,MET
Osteosarcoma,BRD-K02404261-001-16-7::2.5::HTS,7.115646574134945,0.007863759806862991,Osteosarcoma,caffeine,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3"
Osteosarcoma,BRD-K02950022-001-02-9::2.5::HTS,21.193130112769577,5.1483656353242075e-06,Osteosarcoma,BMS-299897,gamma secretase inhibitor,
Osteosarcoma,BRD-K02992638-001-11-8::2.5::HTS,4.541595174051267,0.03352035750950754,Osteosarcoma,lamivudine,nucleoside reverse transcriptase inhibitor,
Osteosarcoma,BRD-K04568635-300-01-4::2.5::HTS,4.3995983120302835,0.03640156963378387,Osteosarcoma,octenidine,membrane integrity inhibitor,
Osteosarcoma,BRD-K05674516-001-02-5::2.5::HTS,4.151449357427376,0.04207098609340169,Osteosarcoma,sofosbuvir,RNA polymerase inhibitor,
Osteosarcoma,BRD-K06181161-048-15-1::2.5::HTS,7.391525059207562,0.0067570986030694915,Other Types,carbetapentane,acetylcholine receptor antagonist,CHRM2
Osteosarcoma,BRD-K07237224-001-19-6::2.5::HTS,8.329546623262676,0.004051763463576024,Osteosarcoma,moclobemide,monoamine oxidase inhibitor,"MAOA, MAOB"
Osteosarcoma,BRD-K07762753-001-04-4::2.5::HTS,4.536903550349593,0.03361158047363818,Osteosarcoma,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor","CDK1, CDK2, CDK5, CDK6"
Osteosarcoma,BRD-K07857022-002-01-1::2.5::HTS,6.0529371655455435,0.014182978152164993,Other Types,alvimopan,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Osteosarcoma,BRD-K08109516-001-07-8::2.5::HTS,5.209245195313674,0.0228418731889599,Osteosarcoma,L-701324,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Osteosarcoma,BRD-K08287586-001-14-3::2.5::HTS,7.968769262820579,0.0049289456522149,Other Types,butyl-paraben,DNA synthesis inhibitor,
Osteosarcoma,BRD-K08791496-001-01-0::2.5::HTS,6.481283179602576,0.01118201656765542,Other Types,fenaclon,,
Osteosarcoma,BRD-K09659835-003-01-4::2.5::HTS,8.198354266309329,0.004352169973276014,Osteosarcoma,loreclezole,benzodiazepine receptor agonist,"GABRB2, GABRB3"
Osteosarcoma,BRD-K09757388-065-04-0::2.5::HTS,4.433496982812056,0.03568727094161426,Osteosarcoma,atazanavir,HIV protease inhibitor,
Osteosarcoma,BRD-K10575656-034-01-0::2.5::HTS,9.262279843425407,0.0024501791770193465,Other Types,MRS3777,adenosine receptor antagonist,ADORA2A
Osteosarcoma,BRD-K10673031-004-02-0::2.5::HTS,4.47171894654823,0.034902297168939486,Other Types,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Osteosarcoma,BRD-K10843433-001-22-7::2.5::HTS,6.583836660403814,0.010560057649965626,Other Types,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Osteosarcoma,BRD-K10852020-001-05-2::2.57::HTS,4.424197642728318,0.035905276836113074,Other Types,tolcapone,catechol O methyltransferase inhibitor,COMT
Osteosarcoma,BRD-K10878147-001-02-2::2.5::HTS,3.909816677071874,0.04849566397046241,Osteosarcoma,OAC1,Oct activator,
Osteosarcoma,BRD-K11099631-001-07-6::2.5::HTS,4.010658199950592,0.04571384867248835,Other Types,gadoterate-meglumine,radiopaque medium,
Osteosarcoma,BRD-K11510141-001-01-8::2.5::HTS,8.04074653196889,0.0047392758098700055,Osteosarcoma,teprenone,mucus protecting agent,
Osteosarcoma,BRD-K11590034-002-03-4::2.49::HTS,6.710643172280547,0.009848747721360412,Osteosarcoma,morin,cytochrome P450 inhibitor,"ADORA2A, ESR2, FASN, MCL1, SLC22A12"
Osteosarcoma,BRD-K11853856-001-01-7::2.5::HTS,4.036131416099276,0.04501351920322787,Osteosarcoma,PJ-34,PARP inhibitor,"EEF2, PARP1, PARP15, PARP3"
Osteosarcoma,BRD-K11900042-001-14-4::2.5::HTS,4.2916053517952415,0.03877610814536403,Osteosarcoma,methylthiouracil,,
Osteosarcoma,BRD-K12079898-001-02-6::2.5::HTS,7.295280570403844,0.007124051030990486,Osteosarcoma,PD-160170,neuropeptide receptor antagonist,NPY1R
Osteosarcoma,BRD-K12867552-001-04-7::2.5::HTS,6.498107182790069,0.011074857749073675,Osteosarcoma,PCI-24781,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6"
Osteosarcoma,BRD-K13078532-001-28-4::2.5::HTS,6.618970057739463,0.010349949780697738,Osteosarcoma,hydrochlorothiazide,thiazide diuretic,"CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3"
Osteosarcoma,BRD-K13183738-317-10-2::2.5::HTS,4.015472610600711,0.04556834735054122,Osteosarcoma,pentamidine,anti-pneumocystis agent,TRDMT1
Osteosarcoma,BRD-K13662825-001-07-5::2.5::HTS,6.526246878888971,0.0108918371813974,Osteosarcoma,dinaciclib,CDK inhibitor,"CDK1, CDK2, CDK5, CDK9"
Osteosarcoma,BRD-K13829090-303-02-9::2.5::HTS,5.549057823112991,0.01883506894688563,Osteosarcoma,IEM1460,glutamate receptor antagonist,GRIA2
Osteosarcoma,BRD-K13949769-001-01-7::2.5::HTS,5.532626495100203,0.019009092891363735,Osteosarcoma,tenovin-6,SIRT inhibitor,"SIRT1, SIRT2, SIRT3"
Osteosarcoma,BRD-K14796088-003-26-8::2.5::HTS,6.200577603942944,0.01305868265153927,Osteosarcoma,berberine,LDL receptor activator,LDLR
Osteosarcoma,BRD-K14880289-001-02-2::2.5::HTS,5.794693233832984,0.01640065660191332,Other Types,GW-501516,PPAR receptor agonist,"PPARA, PPARD"
Osteosarcoma,BRD-K14965640-001-12-4::2.5::HTS,4.259380409873443,0.03949510819834844,Other Types,ibuprofen-(s),cyclooxygenase inhibitor,"ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD"
Osteosarcoma,BRD-K15164005-001-05-6::2.5::HTS,5.5243148088661975,0.019103695303492638,Other Types,apoptosis-activator-II,carboxylesterase inhibitor,"BCHE, CES1"
Osteosarcoma,BRD-K15179513-001-03-4::2.5::HTS,10.783548688266098,0.0010886818671481478,Other Types,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
Osteosarcoma,BRD-K15424032-001-03-6::2.5::HTS,6.294884021050329,0.012394115057197572,Osteosarcoma,SB-228357,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Osteosarcoma,BRD-K15697815-001-16-2::2.5::HTS,4.757254908692519,0.029591056067253877,Other Types,ursodiol,"nuclear factor erythroid derived, like (NRF2) activator",NR1H4
Osteosarcoma,BRD-K15933101-003-06-1::2.5::HTS,12.684080324462126,0.0004006386368083656,Other Types,ropinirole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Osteosarcoma,BRD-K15976406-001-03-3::2.5::HTS,4.022481431627124,0.045378185947199376,Other Types,telbivudine,DNA polymerase inhibitor,TK2
Osteosarcoma,BRD-K16295392-003-01-3::2.5::HTS,3.8764130179838836,0.04946175386850226,Other Types,atrasentan,endothelin receptor antagonist,EDNRA
Osteosarcoma,BRD-K16508793-001-05-9::2.5::HTS,4.7955502686089355,0.0289458512625424,Osteosarcoma,diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Osteosarcoma,BRD-K16898998-001-01-6::2.5::HTS,7.206588406354337,0.007478746830728832,Other Types,bevirimat-dimeglumine,HIV capsid assembly inhibitor,
Osteosarcoma,BRD-K17008822-303-02-1::2.5::HTS,5.57595544974682,0.018553892228362,Osteosarcoma,BD-1008,sigma receptor antagonist,
Osteosarcoma,BRD-K17378184-300-05-9::2.5::HTS,5.5041489710367,0.019322955338332316,Osteosarcoma,BP-897,dopamine receptor agonist,"ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B"
Osteosarcoma,BRD-K17498618-344-02-6::2.5::HTS,4.935256030022364,0.026713178233196345,Other Types,betaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Osteosarcoma,BRD-K17702546-001-03-2::2.5::HTS,4.68873098940838,0.030781079371886944,Osteosarcoma,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Osteosarcoma,BRD-K17743125-001-08-4::2.5::HTS,6.139136755928417,0.0135160032869411,Osteosarcoma,belinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Osteosarcoma,BRD-K17849083-001-31-1::2.5::HTS,5.264712148334116,0.022136500026307942,Other Types,tranilast,angiogenesis inhibitor,"HPGDS, HRH1"
Osteosarcoma,BRD-K18895904-001-16-1::2.5::HTS,5.947788058510609,0.015048724900555253,Osteosarcoma,olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Osteosarcoma,BRD-K19061412-001-02-4::2.5::HTS,4.0077766130601615,0.04577787767473351,Osteosarcoma,mubritinib,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Osteosarcoma,BRD-K19203487-001-01-4::2.5::HTS,4.164647198666289,0.041745255211623304,Other Types,SPP301,endothelin receptor antagonist,EDNRA
Osteosarcoma,BRD-K19605405-001-02-7::2.5::HTS,4.046693791726991,0.04473905288337533,Osteosarcoma,ZM-241385,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Osteosarcoma,BRD-K20285085-001-07-1::2.5::HTS,4.385557205931863,0.03671108953342468,Other Types,R406,SYK inhibitor,"RET, SYK"
Osteosarcoma,BRD-K20290250-001-02-1::2.38::HTS,8.295699026213239,0.004135930809244364,Other Types,BIX-02188,MEK inhibitor,MAP2K5
Osteosarcoma,BRD-K20417253-001-01-9::2.5::HTS,9.366462902015224,0.002316173194123131,Other Types,oxiniacic-acid,,
Osteosarcoma,BRD-K20714604-003-02-9::2.5::HTS,4.720735707251843,0.030220341802022942,Osteosarcoma,RS-56812,serotonin receptor partial agonist,HTR3A
Osteosarcoma,BRD-K20742498-003-02-9::2.5::HTS,5.220162988348072,0.022700929216614187,Osteosarcoma,RS-39604,serotonin receptor antagonist,HTR4
Osteosarcoma,BRD-K21450440-001-14-6::2.5::HTS,5.608356935399777,0.018212429632299635,Osteosarcoma,benzthiazide,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA4, CA9, SLC12A3"
Osteosarcoma,BRD-K21733600-001-14-1::2.5::HTS,4.26198688234911,0.03944601557533324,Osteosarcoma,rofecoxib,cyclooxygenase inhibitor,"ELN, PTGS2"
Osteosarcoma,BRD-K21937671-001-10-0::2.5::HTS,4.10117022798366,0.0433282746671233,Other Types,loxistatin-acid,cysteine peptidase inhibitor,CTSB
Osteosarcoma,BRD-K22024824-001-03-7::2.5::HTS,4.30944520179898,0.03835948414808658,Osteosarcoma,RG4733,gamma secretase inhibitor,PSEN1
Osteosarcoma,BRD-K23922020-075-02-9::2.5::HTS,5.169529698136219,0.023363469665491757,Osteosarcoma,arecaidine-propargyl-ester,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Osteosarcoma,BRD-K24258499-001-05-8::2.5::HTS,4.179850103565119,0.04138639558964454,Other Types,vanillin,,"ABAT, ALDH5A1"
Osteosarcoma,BRD-K24312986-001-01-2::2.5::HTS,10.795732526314014,0.0010810913199226133,Osteosarcoma,tecovirimat,orthopoxvirus egress inhibitor,
Osteosarcoma,BRD-K24689407-001-06-3::2.5::HTS,8.106241063224838,0.004573430368455159,Other Types,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Osteosarcoma,BRD-K24844714-001-24-5::2.5::HTS,4.251697569261273,0.039689894824617274,Osteosarcoma,5-fluorouracil,thymidylate synthase inhibitor,"DPYD, TYMS"
Osteosarcoma,BRD-K25317177-065-01-4::2.5::HTS,6.124459630476895,0.01362954680475434,Other Types,modaline,,
Osteosarcoma,BRD-K25835157-001-01-4::2.5::HTS,8.853011321283741,0.003052538411537328,Other Types,PRT062070,"JAK inhibitor, syk inhibitor",SYK
Osteosarcoma,BRD-K26253904-001-01-5::2.5::HTS,4.431995399629408,0.03571761849731293,Osteosarcoma,NMS-873,ATPase inhibitor,VCP
Osteosarcoma,BRD-K26502378-001-07-9::2.5::HTS,4.147778425206664,0.04216074084270547,Other Types,vanitiolide,,
Osteosarcoma,BRD-K26619122-001-02-1::2.5::HTS,11.877719635232255,0.0006118309615113851,Other Types,thiocolchicoside,GABA receptor antagonist,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB"
Osteosarcoma,BRD-K26701552-001-01-8::2.5::HTS,7.886117130825501,0.005155654255610552,Osteosarcoma,tegobuvir,"HCV inhibitor, protease inhibitor",
Osteosarcoma,BRD-K26989966-001-03-5::2.5::HTS,4.75373675678845,0.02965182654112638,Other Types,UNC1999,histone lysine methyltransferase inhibitor,EZH2
Osteosarcoma,BRD-K27911943-001-02-8::2.5::HTS,7.694990823381917,0.005724152180611384,Osteosarcoma,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,
Osteosarcoma,BRD-K28217197-001-01-4::2.5::HTS,5.56331780930444,0.01868196394054265,Osteosarcoma,ganaxolone,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6"
Osteosarcoma,BRD-K28307902-001-21-7::2.5::HTS,4.6958746871306865,0.030660540365418442,Osteosarcoma,flutamide,androgen receptor antagonist,"AHR, AR"
Osteosarcoma,BRD-K28308851-303-01-8::2.5::HTS,4.131884049314829,0.0425520375759449,Other Types,alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3
Osteosarcoma,BRD-K28343777-001-01-6::2.5::HTS,9.264520526675192,0.002447233271524417,Osteosarcoma,20-hydroxyecdysone,ecdysone receptor modulator,
Osteosarcoma,BRD-K28383148-001-01-4::2.5::HTS,7.1266184572419675,0.007815998052459881,Osteosarcoma,AP1903,,
Osteosarcoma,BRD-K28824103-001-04-4::2.5::HTS,5.534499223341671,0.01899394343600941,Osteosarcoma,genipin,choleretic agent,
Osteosarcoma,BRD-K28849549-001-13-4::2.5::HTS,5.680642075235721,0.017505638254094024,Other Types,mesalazine,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2"
Osteosarcoma,BRD-K30237152-300-02-5::2.5::HTS,4.568158306516972,0.03301032453230628,Osteosarcoma,1400W,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Osteosarcoma,BRD-K31111078-001-04-2::2.5::HTS,6.192369705498171,0.013123953195001568,Osteosarcoma,dimethyl-fumarate,"nuclear factor erythroid derived, like (NRF2) activator",KEAP1
Osteosarcoma,BRD-K31313613-003-04-2::2.5::HTS,8.563700148315087,0.0035692339177692506,Osteosarcoma,BS-181,CDK inhibitor,CDK7
Osteosarcoma,BRD-K31920458-001-23-6::2.5::HTS,4.910901404325071,0.027106950580211446,Osteosarcoma,mestranol,estrogen receptor agonist,ESR1
Osteosarcoma,BRD-K32218650-001-01-6::2.5::HTS,7.032188529755604,0.008235039342838873,Osteosarcoma,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119
Osteosarcoma,BRD-K32285926-001-02-1::2.5::HTS,3.9971043351317963,0.04606821765963922,Osteosarcoma,AMG-208,tyrosine kinase inhibitor,MET
Osteosarcoma,BRD-K32405725-001-02-8::2.5::HTS,4.971374566500237,0.02617162544925053,Osteosarcoma,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A
Osteosarcoma,BRD-K33510429-001-03-1::2.5::HTS,6.544707342945252,0.01079866466304832,Other Types,vanillylacetone,,
Osteosarcoma,BRD-K33681278-036-01-2::2.5::HTS,8.063347853304817,0.004685622135336934,Other Types,prucalopride,serotonin receptor agonist,HTR4
Osteosarcoma,BRD-K33882852-003-02-8::2.5::HTS,6.0765088884934055,0.014002404610480487,Osteosarcoma,ZK-93423,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
Osteosarcoma,BRD-K34058848-304-03-1::2.5::HTS,4.617497148620206,0.032077696910503085,Osteosarcoma,cefonicid,bacterial cell wall synthesis inhibitor,
Osteosarcoma,BRD-K34415467-003-13-0::2.5::HTS,6.865624983767021,0.009026682187051351,Osteosarcoma,trimethobenzamide,histamine receptor antagonist,DRD2
Osteosarcoma,BRD-K34870043-001-01-8::2.5::HTS,4.832459382547588,0.028340850788519764,Other Types,adoprazine,"dopamine receptor antagonist, serotonin receptor agonist","DRD2, HTR1A"
Osteosarcoma,BRD-K35189033-001-26-1::2.5::HTS,3.9025325413421315,0.048703927721543375,Osteosarcoma,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Osteosarcoma,BRD-K35781423-001-01-6::2.5::HTS,10.40942805092601,0.0013270705280279589,Osteosarcoma,SANT-2,smoothened receptor antagonist,"SHH, SMO"
Osteosarcoma,BRD-K37723606-001-01-5::2.5::HTS,4.935831732466864,0.026708691395636648,Osteosarcoma,dioscin,apoptosis stimulant,CXCR3
Osteosarcoma,BRD-K38350380-001-01-8::2.5::HTS,5.354321750460541,0.02103597144668799,Osteosarcoma,FK-3311,cyclooxygenase inhibitor,PTGS2
Osteosarcoma,BRD-K38797369-003-01-1::2.46::HTS,4.918986769927929,0.026987914298394356,Other Types,PD-128907,dopamine receptor agonist,"DRD2, DRD3"
Osteosarcoma,BRD-K38904395-001-02-3::2.5::HTS,21.53766243397613,4.32195339724133e-06,Other Types,SAR131675,VEGFR inhibitor,FLT4
Osteosarcoma,BRD-K39061174-001-01-0::2.62::HTS,10.790563461691347,0.0010878779869436706,Other Types,beta-glycerophosphoric-acid,,
Osteosarcoma,BRD-K39166528-001-01-0::2.5::HTS,8.30201284308359,0.0041121680077555916,Osteosarcoma,ID-8,,
Osteosarcoma,BRD-K39484304-001-16-5::2.5::HTS,4.491138378477931,0.03451043222613427,Osteosarcoma,triptolide,RNA polymerase inhibitor,RELA
Osteosarcoma,BRD-K39974922-001-04-3::2.5::HTS,13.09697719640932,0.0003232641458437662,Other Types,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Osteosarcoma,BRD-K39987650-001-24-1::2.5::HTS,4.492723495010347,0.034481083605321775,Osteosarcoma,bisacodyl,laxative,
Osteosarcoma,BRD-K40302533-001-02-9::2.5::HTS,8.490054152079843,0.003713549819843988,Other Types,PF-5274857,smoothened receptor antagonist,SMO
Osteosarcoma,BRD-K40438880-305-06-6::2.5::HTS,10.076973237745413,0.0015927525322193142,Osteosarcoma,spermidine,glutamate receptor modulator,"KCNJ4, TXNRD1"
Osteosarcoma,BRD-K41104902-001-01-3::2.5::HTS,10.342389254920914,0.0013748150519662294,Osteosarcoma,GSK2656157,PERK inhibitor,
Osteosarcoma,BRD-K41141507-001-16-2::2.5::HTS,4.226716494763855,0.04025534770208372,Other Types,cyproterone-acetate,androgen receptor antagonist,"ADORA1, AR"
Osteosarcoma,BRD-K41410256-304-02-2::2.5::HTS,4.628757576303662,0.03187826913800766,Other Types,balsalazide,cyclooxygenase inhibitor,"ALOX5, PPARG, PTGS1, PTGS2"
Osteosarcoma,BRD-K41567364-001-04-6::2.5::HTS,5.365733076303035,0.020900122580957213,Osteosarcoma,SB-334867,orexin receptor antagonist,"HCRTR1, HCRTR2"
Osteosarcoma,BRD-K41713976-300-02-6::2.5::HTS,5.399049996050556,0.020508679403889885,Osteosarcoma,E-4031,potassium channel blocker,"KCNH1, KCNH2"
Osteosarcoma,BRD-K42352790-001-05-3::2.5::HTS,7.508922094392713,0.0063403381424077315,Osteosarcoma,anandamide,cannabinoid receptor agonist,"CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1"
Osteosarcoma,BRD-K42563464-001-01-9::2.5::HTS,6.922355873818216,0.00875295896352228,Osteosarcoma,YM-58483,calcium channel blocker,"TRPC3, TRPC5, TRPM4"
Osteosarcoma,BRD-K43786866-300-02-3::2.5::HTS,4.682159760748637,0.030905654311677296,Other Types,opipramol,sigma receptor agonist,
Osteosarcoma,BRD-K43802723-340-01-9::2.5::HTS,4.243138741239019,0.039869157004405416,Osteosarcoma,AMG-837,free fatty acid receptor agonist,FFAR1
Osteosarcoma,BRD-K43860855-065-11-9::2.5::HTS,5.663973862154559,0.017655480442761037,Osteosarcoma,iobenguane,antineoplastic agent,
Osteosarcoma,BRD-K44009692-001-02-3::2.5::HTS,6.585586934861588,0.010542962101568415,Other Types,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
Osteosarcoma,BRD-K44067360-001-30-3::2.5::HTS,7.238126482935756,0.007358530809826581,Osteosarcoma,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Osteosarcoma,BRD-K44227013-001-06-4::2.5::HTS,7.700448499684039,0.005706098770460896,Osteosarcoma,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Osteosarcoma,BRD-K44309363-003-02-1::2.5::HTS,6.393592917483675,0.011733922998989153,Other Types,dexniguldipine,calmodulin antagonist,ADORA3
Osteosarcoma,BRD-K45158365-001-11-4::2.5::HTS,3.87782579812919,0.04943308505700154,Other Types,valsartan,angiotensin receptor antagonist,AGTR1
Osteosarcoma,BRD-K45216060-001-11-8::2.5::HTS,3.898842397600402,0.04883512676601099,Other Types,mequinol,,TYR
Osteosarcoma,BRD-K45245728-335-01-4::2.5::HTS,5.241812701950322,0.02242685745788605,Osteosarcoma,ursodeoxycholyltaurine,cholesterol inhibitor,
Osteosarcoma,BRD-K45275534-001-01-3::2.5::HTS,4.122183666465969,0.04279480987266769,Osteosarcoma,betrixaban,coagulation factor inhibitor,KCNH2
Osteosarcoma,BRD-K45542189-048-22-1::2.5::HTS,5.4405786561325415,0.020030093499655763,Other Types,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Osteosarcoma,BRD-K45662124-050-01-5::2.5::HTS,5.869670332207562,0.015720666098856674,Osteosarcoma,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2
Osteosarcoma,BRD-K45724504-001-01-6::1.36::HTS,4.141351814190135,0.042320698890911515,Osteosarcoma,anguidine,protein synthesis inhibitor,SLC5A1
Osteosarcoma,BRD-K46392623-001-02-5::2.5::HTS,8.904591407791663,0.00296816128330202,Other Types,TG-100713,PI3K inhibitor,
Osteosarcoma,BRD-K46428823-001-02-5::2.5::HTS,5.311106092604566,0.021556817009311703,Other Types,liothyronine-(isomer),,
Osteosarcoma,BRD-K46690591-001-01-2::2.5::HTS,4.673918338642081,0.031052990200618462,Osteosarcoma,KP-1212,,
Osteosarcoma,BRD-K46766488-003-02-0::2.5::HTS,6.383958146747238,0.011792946180455881,Other Types,S-14506,serotonin receptor agonist,HTR1A
Osteosarcoma,BRD-K47177710-001-03-1::2.5::HTS,13.498258224062617,0.00026179903617779704,Osteosarcoma,DAPT,gamma secretase inhibitor,
Osteosarcoma,BRD-K47192521-001-05-4::0.25::HTS,5.355596714015406,0.021018777433272223,Osteosarcoma,icosapent,platelet aggregation inhibitor,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1"
Osteosarcoma,BRD-K47264279-001-08-9::2.5::HTS,6.4092852346947415,0.011627832112068468,Osteosarcoma,psoralen,,"MAOA, MAOB"
Osteosarcoma,BRD-K47407372-001-17-1::2.5::HTS,10.916719585317955,0.0010142153983185003,Other Types,nifenazone,analgesic agent,
Osteosarcoma,BRD-K47827687-001-02-2::2.5::HTS,5.421663334517388,0.02024929398958439,Osteosarcoma,amprenavir,HIV protease inhibitor,
Osteosarcoma,BRD-K48195801-001-01-6::2.5::HTS,5.448515598867015,0.019947385249177725,Osteosarcoma,tecastemizole,histamine receptor antagonist,KCNH2
Osteosarcoma,BRD-K48488978-001-05-3::2.5::HTS,3.8838104221296943,0.04925210126068255,Osteosarcoma,YM-201636,PI3K inhibitor,
Osteosarcoma,BRD-K48535733-003-01-2::2.5::HTS,5.741498302623408,0.016896917876643564,Osteosarcoma,VU0155069,phospholipase inhibitor,PLD1
Osteosarcoma,BRD-K48894757-001-01-8::2.5::HTS,4.7644165571605726,0.02947917082332463,Other Types,laropiprant,prostanoid receptor antagonist,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R"
Osteosarcoma,BRD-K49075727-001-08-5::2.5::HTS,7.630302589539972,0.0059308498457588555,Other Types,nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Osteosarcoma,BRD-K49111258-003-29-7::2.5::HTS,7.48818720943603,0.00640943754084644,Osteosarcoma,prazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7"
Osteosarcoma,BRD-K49481516-004-18-3::2.5::HTS,10.745481505386348,0.0011109860472652742,Osteosarcoma,galantamine,acetylcholinesterase inhibitor,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG"
Osteosarcoma,BRD-K49657628-001-14-8::2.5::HTS,6.446965475820327,0.011387569108671149,Osteosarcoma,tyrphostin-AG-18,"EGFR inhibitor, tyrosine kinase inhibitor",EGFR
Osteosarcoma,BRD-K49840922-001-05-1::2.5::HTS,6.541391608105418,0.010805336640782303,Osteosarcoma,etofylline-clofibrate,platelet aggregation inhibitor,PPARA
Osteosarcoma,BRD-K50406511-001-26-0::2.5::HTS,6.769131444859314,0.00952148342243417,Osteosarcoma,hycanthone,RNA synthesis inhibitor,
Osteosarcoma,BRD-K50498985-001-03-3::2.5::HTS,4.556821926062607,0.033228464166031764,Other Types,taladegib,smoothened receptor antagonist,"DHH, IHH, SMO"
Osteosarcoma,BRD-K50891186-001-04-4::2.5::HTS,8.169566749097092,0.004419288049909831,Osteosarcoma,GR-103691,dopamine receptor antagonist,DRD3
Osteosarcoma,BRD-K50938287-036-13-8::2.5::HTS,5.399409766801042,0.020502544877715925,Osteosarcoma,sumatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7"
Osteosarcoma,BRD-K50938786-003-11-8::2.5::HTS,5.262320308228775,0.022160617958497362,Other Types,ropivacaine,sodium channel blocker,SCN10A
Osteosarcoma,BRD-K51199656-003-01-4::2.5::HTS,6.22419956296084,0.012892718615237973,Other Types,fluoromethylcholine,,
Osteosarcoma,BRD-K51247865-001-01-2::2.5::HTS,7.818645023138347,0.005347929005537132,Other Types,ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2
Osteosarcoma,BRD-K51431759-001-02-9::2.5::HTS,8.232389180380107,0.004271920763687841,Other Types,dextrose,,
Osteosarcoma,BRD-K51474575-001-10-4::2.5::HTS,11.495861082422165,0.0007472167639762271,Other Types,taurine,antioxidant,
Osteosarcoma,BRD-K52075040-001-09-7::5.6::HTS,5.535227456907405,0.018986120739688174,Osteosarcoma,cerulenin,fatty acid synthase inhibitor,FASN
Osteosarcoma,BRD-K52394958-001-02-7::2.5::HTS,7.3272577279487505,0.007001946173143233,Other Types,GR-159897,tachykinin antagonist,"TAC1, TACR2"
Osteosarcoma,BRD-K52459643-001-17-7::2.5::HTS,6.522034355437368,0.010919731614768802,Other Types,alprostadil,prostanoid receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR"
Osteosarcoma,BRD-K52989797-003-26-4::2.5::HTS,4.204437884592613,0.04078162364399756,Osteosarcoma,clomipramine,serotonin transporter (SERT) inhibitor,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Osteosarcoma,BRD-K53234107-001-01-6::2.5::HTS,5.007456953387234,0.025631488571118057,Osteosarcoma,IWP-L6,porcupine inhibitor,PORCN
Osteosarcoma,BRD-K53318339-001-24-9::2.5::HTS,5.352081237954857,0.02107294300551332,Other Types,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C"
Osteosarcoma,BRD-K53397409-001-12-3::2.5::HTS,4.562221682846355,0.03311612617835092,Osteosarcoma,benzoic-acid,food preservative,"DAO, HRSP12, PRDX5, RAB9A"
Osteosarcoma,BRD-K53523901-001-04-4::2.5::HTS,7.158381881832229,0.0076821240856754245,Osteosarcoma,arctigenin,MEK inhibitor,"CHUK, MAP2K1"
Osteosarcoma,BRD-K53720352-001-03-2::2.5::HTS,4.989883590772294,0.025894953275905897,Osteosarcoma,cinalukast,leukotriene receptor antagonist,CYSLTR1
Osteosarcoma,BRD-K53852914-001-01-8::2.5::HTS,5.13944187030869,0.023769964464803693,Osteosarcoma,menbutone,,
Osteosarcoma,BRD-K53979406-003-02-8::2.5::HTS,4.2570932842273805,0.03956503338751953,Other Types,ALX-5407,Glycine transporter 1 inhibitor,SLC6A9
Osteosarcoma,BRD-K54416256-001-19-9::2.5::HTS,5.688065982042667,0.017414157284415217,Osteosarcoma,methimazole,antithyroid agent,TPO
Osteosarcoma,BRD-K54496168-003-01-2::2.5::HTS,5.196935358906444,0.023007425652956538,Osteosarcoma,propacetamol,cyclooxygenase inhibitor,PTGS2
Osteosarcoma,BRD-K55462201-001-07-3::2.5::HTS,5.936014130000684,0.015146788455118448,Osteosarcoma,AM-404,"cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist","CNR1, CNR2, FAAH, TRPV1"
Osteosarcoma,BRD-K56277358-001-07-5::2.5::HTS,6.198086732187151,0.013078941138180892,Other Types,MGCD-265,VEGFR inhibitor,"AXL, MET"
Osteosarcoma,BRD-K56542719-065-01-4::2.5::HTS,10.707011371631324,0.0011331451812844411,Osteosarcoma,cefpirome,bacterial cell wall synthesis inhibitor,
Osteosarcoma,BRD-K56691760-001-01-2::2.5::HTS,7.925209329209908,0.005047601830866415,Osteosarcoma,pikamilone,,
Osteosarcoma,BRD-K57631554-003-06-2::2.5::HTS,3.950373161995604,0.04734585052511402,Other Types,5-aminolevulinic-acid,oxidizing agent,ALAD
Osteosarcoma,BRD-K58148589-001-03-6::2.5::HTS,3.9192841667811114,0.0482270142950713,Osteosarcoma,betamethasone-dipropionate,anti-inflammatory agent,
Osteosarcoma,BRD-K58299615-001-03-5::2.5::HTS,8.211729770692369,0.004328596110406615,Other Types,Ro-90-7501,,APP
Osteosarcoma,BRD-K58819470-001-05-9::2.5::HTS,4.189330824917555,0.041147086828053986,Other Types,2-thiouracil,,
Osteosarcoma,BRD-K58968598-001-03-6::2.5::HTS,4.028840678635972,0.04522102734166385,Other Types,sucralose,,
Osteosarcoma,BRD-K59632282-052-03-1::2.5::HTS,4.253604343447769,0.03962611432268783,Other Types,quinidine,sodium channel blocker,"KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4"
Osteosarcoma,BRD-K60025295-003-06-6::2.5::HTS,4.059039108588684,0.04441554812711973,Osteosarcoma,crystal-violet,other antibiotic,
Osteosarcoma,BRD-K60348325-065-09-9::2.5::HTS,4.577727981616279,0.03283283392280466,Osteosarcoma,brilliant-green,,
Osteosarcoma,BRD-K60441002-001-04-8::2.5::HTS,19.171566325544756,1.428755193767183e-05,Other Types,muscimol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Osteosarcoma,BRD-K60443845-001-08-6::2.5::HTS,5.406488993276106,0.020432377192066437,Osteosarcoma,chlormidazole,fungal lanosterol demethylase inhibitor,
Osteosarcoma,BRD-K60567437-001-10-2::2.5::HTS,8.53169554594686,0.0036344415262095646,Osteosarcoma,dimpylate,acetylcholinesterase inhibitor,ACHE
Osteosarcoma,BRD-K61314889-001-05-1::2.5::HTS,4.313844523455832,0.03826368981970347,Osteosarcoma,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Osteosarcoma,BRD-K62398570-300-01-2::2.5::HTS,4.361909625310256,0.03722859584304776,Osteosarcoma,lerisetron,serotonin receptor antagonist,HTR3A
Osteosarcoma,BRD-K62929068-001-16-5::2.5::HTS,4.132663987034049,0.042534259598613365,Osteosarcoma,6-benzylaminopurine,purinergic receptor activator,
Osteosarcoma,BRD-K63001556-001-09-6::2.57::HTS,5.7521622551697265,0.0168079319096273,Other Types,orbifloxacin,bacterial DNA gyrase inhibitor,
Osteosarcoma,BRD-K63343048-001-12-2::2.5::HTS,4.110391360326452,0.04310220068240343,Osteosarcoma,orlistat,lipase inhibitor,"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP"
Osteosarcoma,BRD-K63712959-001-01-8::2.5::HTS,4.05305559277841,0.04457203455169187,Other Types,temoporfin,radical formation stimulant,
Osteosarcoma,BRD-K63915849-001-03-7::2.5::HTS,5.676656055559196,0.01752598350337922,Other Types,AS-604850,PI3K inhibitor,"PIK3CA, PIK3CG"
Osteosarcoma,BRD-K64052750-001-17-5::2.5::HTS,8.408809255610603,0.0038827329626067012,Osteosarcoma,gefitinib,EGFR inhibitor,EGFR
Osteosarcoma,BRD-K64137799-003-02-5::2.5::HTS,4.2805841151747375,0.03900672448950679,Other Types,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6"
Osteosarcoma,BRD-K64178227-001-09-0::2.5::HTS,7.541242219368075,0.006226253755721896,Osteosarcoma,BTS,,
Osteosarcoma,BRD-K64381438-001-03-8::2.5::HTS,6.152188843848483,0.013423060871185858,Osteosarcoma,ulipristal,progesterone receptor antagonist,PGR
Osteosarcoma,BRD-K64514229-001-05-2::2.5::HTS,4.2246148711119895,0.040307338162358895,Osteosarcoma,toltrazuril,antiprotozoal agent,
Osteosarcoma,BRD-K65275554-001-04-7::2.5::HTS,4.720405522388445,0.030223852302302467,Other Types,NPC-15199,ICAM1 antagonist,PPARG
Osteosarcoma,BRD-K65428967-001-08-4::2.5::HTS,8.228156946322784,0.004282320793493644,Osteosarcoma,cordycepin,DNA inhibitor,
Osteosarcoma,BRD-K65639003-001-09-0::2.5::HTS,4.278172199040741,0.03906828398864695,Other Types,icariin,phosphodiesterase inhibitor,PDE5A
Osteosarcoma,BRD-K65814004-003-02-9::2.5::HTS,4.529964923134802,0.033746970868143114,Osteosarcoma,diphenyleneiodonium,nitric oxide synthase inhibitor,"NOS2, NOS3"
Osteosarcoma,BRD-K65820248-001-01-8::2.5::HTS,4.407752517576217,0.03622937858151157,Osteosarcoma,SDZ-NKT-343,tachykinin antagonist,TACR1
Osteosarcoma,BRD-K66911501-003-01-2::2.5::HTS,8.084793141461923,0.004627669000691285,Osteosarcoma,MK-3207,calcitonin antagonist,CALCA
Osteosarcoma,BRD-K67783091-001-26-1::2.5::HTS,9.290496935408205,0.0024127439486082577,Osteosarcoma,haloperidol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1"
Osteosarcoma,BRD-K67966701-001-11-6::2.5::HTS,6.682301827425874,0.00998918195114472,Osteosarcoma,lisinopril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Osteosarcoma,BRD-K68552125-001-05-3::2.03::HTS,5.384195087424721,0.020678370046067814,Osteosarcoma,12-O-tetradecanoylphorbol-13-acetate,PKC activator,"KCNT2, TRPV4"
Osteosarcoma,BRD-K68756823-001-07-1::2.5::HTS,4.6296261681522575,0.03185594185158357,Other Types,FR-180204,MAP kinase inhibitor,"MAPK1, MAPK3"
Osteosarcoma,BRD-K68870568-066-01-5::2.5::HTS,9.110546050972266,0.0026570412736817285,Other Types,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Osteosarcoma,BRD-K68938568-001-01-7::2.5::HTS,5.2672642029016385,0.022099023784879764,Osteosarcoma,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Osteosarcoma,BRD-K69470111-236-08-9::2.5::HTS,4.974729956068533,0.026125791709271394,Osteosarcoma,montelukast,leukotriene receptor antagonist,"ALOX5, CYSLTR1"
Osteosarcoma,BRD-K69650333-003-14-0::2.5::HTS,4.141706097350042,0.042314474610245775,Osteosarcoma,idarubicin,topoisomerase inhibitor,TOP2A
Osteosarcoma,BRD-K70163715-300-05-7::2.42::HTS,11.042957724744896,0.0009526891600264957,Other Types,vatalanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR, PDGFRB"
Osteosarcoma,BRD-K70281171-050-08-9::2.5::HTS,4.2189816291860165,0.04044454659981806,Other Types,U-99194,dopamine receptor antagonist,DRD3
Osteosarcoma,BRD-K71035033-001-07-1::2.5::HTS,10.045746722687884,0.0016103887247135029,Other Types,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor","FGFR3, KIT, PDGFRA, PDGFRB"
Osteosarcoma,BRD-K71289571-001-11-4::2.5::HTS,4.09154979524556,0.04357281457119703,Osteosarcoma,zafirlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2"
Osteosarcoma,BRD-K72005722-001-01-2::2.5::HTS,4.034952339067084,0.04504645767675662,Other Types,VT-464,cytochrome P450 inhibitor,CYP17A1
Osteosarcoma,BRD-K73157543-001-04-1::2.5::HTS,4.787805289219511,0.029076630342913686,Other Types,phenyl-aminosalicylate,,
Osteosarcoma,BRD-K73309154-003-02-8::2.5::HTS,7.044604908223181,0.008175599766771423,Osteosarcoma,OSI-420,EGFR inhibitor,EGFR
Osteosarcoma,BRD-K73541271-001-03-6::2.5::HTS,5.576877008733807,0.018545485092199186,Osteosarcoma,etofenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Osteosarcoma,BRD-K73771095-001-02-5::2.44::HTS,6.489857679214792,0.011131530270958772,Other Types,geniposidic-acid,cyclooxygenase inhibitor,
Osteosarcoma,BRD-K74339692-001-01-9::2.5::HTS,5.2140330091039555,0.02278441633984248,Other Types,tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Osteosarcoma,BRD-K74514084-001-03-9::2.5::HTS,6.44453621508994,0.01140598766946015,Other Types,pazopanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3"
Osteosarcoma,BRD-K75516118-001-03-3::2.5::HTS,4.7498878504856155,0.029722184325620862,Other Types,rolipram-R(-),phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A"
Osteosarcoma,BRD-K75956464-237-01-5::2.5::HTS,4.02183811036928,0.04539622878500749,Other Types,VCH-916,HCV inhibitor,
Osteosarcoma,BRD-K77554836-001-11-6::2.57::HTS,4.795521849415866,0.028970590651937526,Other Types,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Osteosarcoma,BRD-K77841042-001-14-1::2.5::HTS,4.729468660044497,0.030073914170526416,Osteosarcoma,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Osteosarcoma,BRD-K78781788-003-01-9::2.5::HTS,3.9297700060258483,0.047933826361909695,Other Types,barnidipine,calcium channel blocker,
Osteosarcoma,BRD-K78809024-001-05-7::2.5::HTS,4.87676270814284,0.02762353894156168,Osteosarcoma,SB-590885,RAF inhibitor,BRAF
Osteosarcoma,BRD-K79132813-001-09-0::2.5::HTS,7.679546798923201,0.005772318388604206,Osteosarcoma,pibenzimol,DNA inhibitor,
Osteosarcoma,BRD-K79501723-001-04-6::2.5::HTS,5.000887549223026,0.025733060301967366,Osteosarcoma,cyclizine,histamine receptor modulator,"HRH1, SULT1E1"
Osteosarcoma,BRD-K79555887-001-01-0::2.5::HTS,4.429514863077055,0.03576833881658121,Osteosarcoma,RI-1,,RAD51
Osteosarcoma,BRD-K79684402-300-02-8::2.5::HTS,4.361828789406838,0.03727806884066927,Osteosarcoma,Ro-10-5824,dopamine receptor agonist,DRD4
Osteosarcoma,BRD-K79759585-048-04-8::2.5::HTS,5.419885177695656,0.020269719500149615,Osteosarcoma,sildenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
Osteosarcoma,BRD-K79966802-034-01-2::2.5::HTS,8.066849231140033,0.004673048944782041,Osteosarcoma,rivanicline,acetylcholine receptor agonist,"CHRNA4, CHRNB2, CXCL8"
Osteosarcoma,BRD-K80315159-051-02-0::2.5::HTS,5.058290589893081,0.024901834394678315,Osteosarcoma,DPPE,histamine receptor antagonist,"ABCB1, HRH1"
Osteosarcoma,BRD-K80935598-001-01-1::2.5::HTS,12.239874796028333,0.0005051008017895961,Other Types,AZ191,DYRK inhibitor,DYRK1B
Osteosarcoma,BRD-K81376179-001-04-8::2.5::HTS,5.0268260198942105,0.025349664278906333,Other Types,TCS-359,FLT3 inhibitor,FLT3
Osteosarcoma,BRD-K82122102-323-01-1::2.5::HTS,9.838614854788789,0.0018009402861158437,Other Types,amfenac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Osteosarcoma,BRD-K82181219-001-04-3::2.5::HTS,5.225451554436818,0.022632658396875335,Osteosarcoma,pyritinol,,
Osteosarcoma,BRD-K82818427-001-02-2::2.39::HTS,4.399087188770047,0.036433066137548945,Osteosarcoma,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Osteosarcoma,BRD-K82861010-001-02-5::2.5::HTS,9.681625283146925,0.0019663225897657813,Osteosarcoma,daclatasvir,HCV inhibitor,
Osteosarcoma,BRD-K82928892-001-02-5::2.46::HTS,3.940230235662062,0.047661339648957156,Osteosarcoma,doxercalciferol,vitamin D receptor agonist,VDR
Osteosarcoma,BRD-K82983861-001-04-3::2.5::HTS,4.426525324736864,0.035830534162443875,Osteosarcoma,GW-0742,PPAR receptor agonist,PPARD
Osteosarcoma,BRD-K83036479-001-09-2::2.5::HTS,5.516073062533444,0.01919235986429911,Osteosarcoma,salicylanilide,other antibiotic,
Osteosarcoma,BRD-K83186168-001-01-8::2.5::HTS,4.858693616543103,0.027925898093399876,Osteosarcoma,AZD1981,CRTH receptor antagonist,PTGDR2
Osteosarcoma,BRD-K83245588-001-01-4::2.5::HTS,4.665763876004766,0.0312018470547208,Other Types,pilsicainide,sodium channel blocker,SCN5A
Osteosarcoma,BRD-K83335125-001-07-0::2.5::HTS,5.889672053402876,0.015552503267975195,Osteosarcoma,chloroxoquinoline,,
Osteosarcoma,BRD-K83551379-001-02-6::2.5::HTS,8.304631500735798,0.004109983128318174,Other Types,levodropropizine,antitussive,
Osteosarcoma,BRD-K84564571-001-02-4::2.5::HTS,4.82467288161458,0.028474811087087583,Other Types,telatinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Osteosarcoma,BRD-K84996356-001-01-1::2.5::HTS,3.9669569708860117,0.04689923883118754,Osteosarcoma,AZD3514,androgen receptor modulator,AR
Osteosarcoma,BRD-K85015012-003-02-9::2.5::HTS,4.647785846447155,0.031525051399787014,Osteosarcoma,NNC-05-2090,"GABA uptake inhibitor, GAT inhibitor",SLC6A12
Osteosarcoma,BRD-K85146014-314-05-4::2.5::HTS,5.809134734024889,0.016285281749460426,Osteosarcoma,foscarnet,DNA polymerase inhibitor,
Osteosarcoma,BRD-K85178109-001-02-3::2.5::HTS,9.826610956323453,0.001810502705595133,Other Types,fostamatinib,SYK inhibitor,SYK
Osteosarcoma,BRD-K85554912-001-06-3::2.5::HTS,6.508419938617225,0.011018421624662407,Osteosarcoma,ivermectin,benzodiazepine receptor agonist,"CHRNA7, GABRB3, GLRA3, P2RX7"
Osteosarcoma,BRD-K85606544-001-09-1::2.5::HTS,5.263581184009803,0.022159806220094638,Osteosarcoma,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Osteosarcoma,BRD-K86109159-001-02-6::2.5::HTS,6.293584123967306,0.012397999947096833,Osteosarcoma,VU0357121,glutamate receptor positive allosteric modulator,GRM5
Osteosarcoma,BRD-K87696786-003-04-4::2.5::HTS,4.642481580982804,0.03162021991184749,Other Types,LY456236,glutamate receptor antagonist,GRM1
Osteosarcoma,BRD-K88405679-003-03-1::2.5::HTS,5.169228082610512,0.023370202565398526,Osteosarcoma,thonzylamine,antihistamine,
Osteosarcoma,BRD-K88560311-011-06-3::2.5::HTS,7.306419036164212,0.007081746679197255,Osteosarcoma,rucaparib,PARP inhibitor,"PARP1, PARP2"
Osteosarcoma,BRD-K88789588-001-14-9::2.5::HTS,9.138076265488023,0.002618620344619434,Osteosarcoma,letrozole,aromatase inhibitor,CYP19A1
Osteosarcoma,BRD-K89375097-300-08-8::2.5::HTS,4.5520260789037215,0.03331454004005922,Osteosarcoma,pirenzepine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Osteosarcoma,BRD-K89704198-001-12-3::2.5::HTS,3.861495602762478,0.04990282104643407,Osteosarcoma,vincamine,adrenergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Osteosarcoma,BRD-K89839824-001-05-3::2.5::HTS,4.166049712051766,0.04171521325959326,Osteosarcoma,raltitrexed,thymidylate synthase inhibitor,"FPGS, TYMS"
Osteosarcoma,BRD-K90195324-003-02-5::2.5::HTS,5.9921957564475905,0.014675746897364023,Other Types,bazedoxifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2"
Osteosarcoma,BRD-K90574421-001-03-5::2.5::HTS,4.107667417240204,0.04316765852645579,Osteosarcoma,ipsapirone,serotonin receptor agonist,HTR1A
Osteosarcoma,BRD-K90993449-001-02-7::2.5::HTS,13.055159001174784,0.0003298210379910344,Other Types,KRN-633,VEGFR inhibitor,"FLT1, FLT4, KDR"
Osteosarcoma,BRD-K91159026-001-01-7::2.5::HTS,8.333470475979022,0.0040426065475750225,Osteosarcoma,telcagepant,calcitonin antagonist,"CALCRL, RAMP1"
Osteosarcoma,BRD-K91263825-003-21-4::2.5::HTS,7.251335663992278,0.0072973817068752896,Osteosarcoma,nortriptyline,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4"
Osteosarcoma,BRD-K91290917-300-01-8::2.5::HTS,7.20884123539041,0.007470651899730933,Other Types,amodiaquine,histamine receptor agonist,HNMT
Osteosarcoma,BRD-K91336023-003-01-0::2.5::HTS,4.428875000761701,0.035779258055728624,Osteosarcoma,mesulergine,dopamine receptor agonist,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7"
Osteosarcoma,BRD-K91740057-001-19-8::2.5::HTS,5.2841172749784535,0.021888828436888347,Other Types,felbinac,cyclooxygenase inhibitor,CTSL
Osteosarcoma,BRD-K91825936-001-01-2::2.5::HTS,4.8538639061036735,0.027991449088849818,Osteosarcoma,ZK811752,CC chemokine receptor antagonist,CCR1
Osteosarcoma,BRD-K91904471-001-02-4::2.5::HTS,5.479131114439102,0.019603800687096253,Osteosarcoma,SD-169,p38 MAPK inhibitor,MAPK14
Osteosarcoma,BRD-K92588747-051-02-7::2.5::HTS,6.065774939673802,0.014086801908989866,Osteosarcoma,2-CMDO,dopamine receptor antagonist,"DRD2, DRD4"
Osteosarcoma,BRD-K92731339-227-04-9::2.5::HTS,8.730488435527116,0.003261631090434541,Osteosarcoma,perindopril,angiotensin converting enzyme inhibitor,ACE
Osteosarcoma,BRD-K92830582-003-10-5::2.5::HTS,4.075678581893567,0.043986012785647254,Other Types,propranolol-(R),adrenergic receptor antagonist,"ADRB2, ADRB3"
Osteosarcoma,BRD-K93035859-001-07-6::2.5::HTS,4.954653853429037,0.026419921563621735,Other Types,butylated-hydroxyanisole,antioxidant,
Osteosarcoma,BRD-K93188295-300-02-2::2.5::HTS,4.03475624055413,0.04505251266733804,Osteosarcoma,ARC-239,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C"
Osteosarcoma,BRD-K93502141-001-01-6::2.5::HTS,6.6017626167118655,0.010461171436451765,Other Types,amylene-hydrate,local anesthetic,
Osteosarcoma,BRD-K93611241-001-02-2::2.5::HTS,6.851123821482731,0.009098887021123407,Other Types,diacetamate,,
Osteosarcoma,BRD-K95053546-001-02-7::2.5::HTS,4.626716592629957,0.031911114749745804,Osteosarcoma,tempol,free radical scavenger,
Osteosarcoma,BRD-K95763993-001-19-3::2.5::HTS,5.846384100704954,0.01592608916513773,Other Types,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA
Osteosarcoma,BRD-K95785537-001-23-1::2.5::HTS,4.803780997459062,0.028816621627851993,Other Types,PP-2,src inhibitor,"ABL1, LCK, LYN, RIPK2, SRC"
Osteosarcoma,BRD-K95880107-001-02-4::2.5::HTS,5.097818718176894,0.024338788571707924,Osteosarcoma,PH-797804,p38 MAPK inhibitor,"MAPK11, MAPK14"
Osteosarcoma,BRD-K95901403-001-04-5::2.5::HTS,4.685770122984289,0.030835217399871398,Osteosarcoma,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Osteosarcoma,BRD-K96631475-001-04-0::2.5::HTS,3.917678929940629,0.04827541696313598,Osteosarcoma,10-deacetylbaccatin,antitumor agent,
Osteosarcoma,BRD-K97056771-001-13-1::2.5::HTS,5.172072633815663,0.023328944508394796,Osteosarcoma,GNF-2,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Osteosarcoma,BRD-K98157055-001-10-9::2.5::HTS,10.117455067553252,0.0015504446836501393,Osteosarcoma,SIB-1757,glutamate receptor antagonist,GRM5
Osteosarcoma,BRD-K98384930-003-01-5::2.5::HTS,5.284462984904783,0.021887854873694355,Other Types,finafloxacin,bacterial DNA gyrase inhibitor,
Osteosarcoma,BRD-K98763141-001-30-8::2.5::HTS,7.398074961824326,0.006733602260086197,Osteosarcoma,niflumic-acid,cyclooxygenase inhibitor,"ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9"
Osteosarcoma,BRD-K99092662-001-01-1::2.5::HTS,4.026752166369871,0.045266016799293096,Other Types,PS178990,androgen receptor modulator,AR
Osteosarcoma,BRD-K99107520-001-24-1::2.5::HTS,4.8496844343382834,0.028060214006093504,Osteosarcoma,felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Osteosarcoma,BRD-K99984802-100-13-5::2.5::HTS,5.5822631812455885,0.018485390563212613,Other Types,flunixin-meglumin,prostanoid receptor antagonist,
Osteosarcoma,BRD-M92352362-002-02-3::2.5::HTS,5.804291914075726,0.016328386213291815,Other Types,talc,,
Osteosarcoma,BRD-A14577621-001-01-5::2.5::MTS004,12.24166976461873,0.0005060468414628009,Other Types,peficitinib,JAK inhibitor,"JAK1, JAK2, JAK3"
Osteosarcoma,BRD-A15739803-001-01-0::2.726366321::MTS004,4.742860308365042,0.02985296095447014,Osteosarcoma,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3
Osteosarcoma,BRD-A86665761-001-01-1::2.5::MTS004,4.481850212491994,0.03471408262103133,Osteosarcoma,gabapentin-enacarbil,adrenergic receptor agonist,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8"
Osteosarcoma,BRD-K11443721-003-01-6::2.403980733::MTS004,4.168495855822409,0.04166957985240466,Other Types,NE-100,sigma receptor antagonist,SIGMAR1
Osteosarcoma,BRD-K15691453-236-01-6::2.499981005::MTS004,7.604632650902286,0.006019748171379126,Other Types,GSK2190915,lipoxygenase inhibitor,ALOX5AP
Osteosarcoma,BRD-K20463415-300-01-4::2.499966791::MTS004,3.945498301314115,0.04750293516723687,Other Types,LY2606368,CHK inhibitor,CHEK1
Osteosarcoma,BRD-K20468903-001-01-6::2.49996519::MTS004,5.012123977587735,0.02557771820047661,Other Types,BNC105,tubulin polymerization inhibitor,
Osteosarcoma,BRD-K26813177-001-03-2::2.46430412::MTS004,3.914156085183826,0.04839068280805023,Other Types,daltroban,thromboxane receptor antagonist,TBXA2R
Osteosarcoma,BRD-K27755542-001-01-6::2.49693186::MTS004,7.926345589629933,0.0050502875235167,Other Types,PF-04937319,glucokinase activator,GCK
Osteosarcoma,BRD-K43837174-003-01-3::2.479237222::MTS004,4.823466745769756,0.028500022253048783,Osteosarcoma,pruvanserin,serotonin receptor antagonist,"HTR2A, HTR2C"
Osteosarcoma,BRD-K56740996-001-01-3::2.601527794::MTS004,4.4741326045273135,0.034870706674750986,Other Types,flindokalner,potassium channel agonist,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5"
Osteosarcoma,BRD-K59866480-001-07-3::2.379655165::MTS004,3.96524075290896,0.04695317913386522,Other Types,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Osteosarcoma,BRD-K62040061-001-01-0::2.500015381::MTS004,7.089090832011872,0.007987581979398077,Other Types,toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB"
Osteosarcoma,BRD-K62490786-001-01-1::2.495325825::MTS004,7.879876945395319,0.0051797495094769806,Osteosarcoma,ibrolipim,lipoprotein lipase activator,LPL
Osteosarcoma,BRD-K70504253-001-01-3::2.500017504::MTS004,7.6777802378366315,0.005783500627326061,Other Types,fruquintinib,VEGFR inhibitor,KDR
Osteosarcoma,BRD-K73585091-001-02-3::2.499988098::MTS004,8.622103638362914,0.003463188681154893,Other Types,GS-9620,toll-like receptor agonist,TLR7
Osteosarcoma,BRD-K76315403-015-02-5::2.5::MTS004,4.779756887859848,0.029225529780823874,Other Types,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,"GNRHR, LHCGR"
Osteosarcoma,BRD-K76594255-001-01-6::2.5000235::MTS004,5.097539353922781,0.024359792096638244,Other Types,maropitant,neurokinin receptor antagonist,TACR1
Osteosarcoma,BRD-K84868168-001-01-0::2.500006364::MTS004,9.1080920754037,0.0026653417548951033,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Osteosarcoma,BRD-K90171280-001-01-4::2.328630918::MTS004,6.360098034833181,0.011959048439246242,Osteosarcoma,LY2452473,androgen receptor modulator,AR
Osteosarcoma,BRD-K91405252-001-01-9::2.500076093::MTS004,5.438239504466926,0.020068618960838672,Osteosarcoma,MK-0354,niacin receptor agonist,"HCAR2, HCAR3"
Osteosarcoma,BRD-K93900986-001-15-0::2.613957824::MTS004,4.262031527949156,0.039452009677470694,Osteosarcoma,stetaderm,,
Osteosarcoma,BRD-K96691275-001-01-2::2.5::MTS004,5.021209031572537,0.02544588854841042,Other Types,mebrofenin,,
Pleural Mesothelioma,BRD-A02743701-001-03-6::2.5::HTS,8.237810263528603,0.004258235590248079,Other Types,cilnidipine,calcium channel blocker,CACNA1B
Pleural Mesothelioma,BRD-A04327189-001-15-1::2.5::HTS,10.842221036917767,0.0010549059424690293,Other Types,synephrine,adrenergic receptor agonist,ADRA1A
Pleural Mesothelioma,BRD-A05906449-004-01-1::2.5::HTS,4.256417905172932,0.03956767326890121,Other Types,lappaconite,sodium channel blocker,
Pleural Mesothelioma,BRD-A06352508-001-03-7::2.5::HTS,7.936583596296989,0.005016110809371702,Pleural Mesothelioma,SB-218078,CHK inhibitor,CHEK1
Pleural Mesothelioma,BRD-A06771424-004-01-7::2.5::HTS,4.336280387792172,0.03777330817393326,Other Types,anisotropine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Pleural Mesothelioma,BRD-A07000685-001-04-4::2.5::HTS,7.612515282082311,0.005987077425489928,Other Types,hydrocortisone-hemisuccinate,,
Pleural Mesothelioma,BRD-A08187463-001-12-9::2.5::HTS,8.36984949489901,0.003969230533685595,Pleural Mesothelioma,racecadotril,enkephalinase inhibitor,MME
Pleural Mesothelioma,BRD-A11070335-236-02-1::2.5::HTS,4.370748538474093,0.0370103792096375,Other Types,carbazochrome,,
Pleural Mesothelioma,BRD-A11813248-003-02-4::2.5::HTS,9.56464328632342,0.002082601139972637,Other Types,AM-92016,potassium channel blocker,GRIN1
Pleural Mesothelioma,BRD-A14966924-003-07-7::2.5::HTS,10.546786590501858,0.0012333085861147253,Other Types,alaproclate,serotonin receptor antagonist,SLC6A4
Pleural Mesothelioma,BRD-A15415227-003-02-9::2.5::HTS,7.788167381603602,0.005437617201032119,Other Types,GW-1929,PPAR receptor agonist,PPARG
Pleural Mesothelioma,BRD-A15435692-003-02-3::2.5::HTS,6.341557260000338,0.012074795149880968,Other Types,BMY-14802,sigma receptor antagonist,HTR1A
Pleural Mesothelioma,BRD-A17407635-001-04-0::2.5::HTS,7.693690254504115,0.005728220903575631,Other Types,alclometasone-dipropionate,glucocorticoid receptor agonist,"CYP3A4, NR3C1, SERPINA6"
Pleural Mesothelioma,BRD-A18056626-003-22-3::2.5::HTS,3.8588243777202416,0.04998176001297604,Other Types,methacholine,acetylcholine receptor agonist,"CHRM2, CHRM3, CHRM4"
Pleural Mesothelioma,BRD-A19102171-066-01-4::2.5::HTS,5.182676766664869,0.023190344743993316,Other Types,naltriben,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Pleural Mesothelioma,BRD-A22707317-001-10-8::2.5::HTS,4.852725933998382,0.028009027588974698,Pleural Mesothelioma,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Pleural Mesothelioma,BRD-A23067620-300-01-3::2.5::HTS,8.557644771625526,0.0035817095071220798,Pleural Mesothelioma,itraconazole,cytochrome P450 inhibitor,CYP51A1
Pleural Mesothelioma,BRD-A24397426-001-10-4::2.5::HTS,5.943576212471518,0.015112820714466443,Other Types,nadifloxacin,bacterial DNA gyrase inhibitor,
Pleural Mesothelioma,BRD-A24560335-300-01-2::2.5::HTS,6.807536063283304,0.009322623703923316,Pleural Mesothelioma,efatutazone,PPAR receptor agonist,PPARG
Pleural Mesothelioma,BRD-A26334849-001-06-2::2.5::HTS,4.705682837070985,0.030481534347048637,Other Types,propafenone,antiarrhythmic,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A"
Pleural Mesothelioma,BRD-A28958257-001-01-2::2.5::HTS,5.02671094466706,0.02534853666255332,Other Types,centpropazine,inositol monophosphatase inhibitor,
Pleural Mesothelioma,BRD-A29349577-001-23-0::2.5::HTS,5.864692781321918,0.015765848928540036,Other Types,dropropizine,antitussive,
Pleural Mesothelioma,BRD-A29734509-011-13-6::2.5::HTS,8.22270587777351,0.004292172292720403,Other Types,disopyramide,sodium channel blocker,"CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A"
Pleural Mesothelioma,BRD-A30886737-001-02-9::2.5::HTS,4.17812441995987,0.041418750933074455,Pleural Mesothelioma,florfenicol,protein synthesis inhibitor,
Pleural Mesothelioma,BRD-A31521121-001-26-4::2.5::HTS,5.765769573723625,0.016703300463789844,Other Types,methocarbamol,muscle relaxant,CA1
Pleural Mesothelioma,BRD-A31811760-001-06-7::2.5::HTS,7.385334065499814,0.006782322490091236,Other Types,miltefosine,membrane integrity inhibitor,PLA2G1B
Pleural Mesothelioma,BRD-A33514596-003-01-2::2.5::HTS,4.101933371252487,0.0433148966574403,Other Types,N-benzylnaltrindole,opioid receptor antagonist,
Pleural Mesothelioma,BRD-A33697453-008-02-4::2.5::HTS,4.180544174267162,0.04136265995577326,Other Types,fenticonazole,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-A34205397-001-04-5::2.5::HTS,4.3347600811523455,0.03779676538848104,Other Types,suloctidil,adrenergic receptor antagonist,
Pleural Mesothelioma,BRD-A35868371-005-01-6::2.5::HTS,5.809193753848868,0.016268569621719978,Other Types,troventol,,
Pleural Mesothelioma,BRD-A36010170-001-04-0::2.5::HTS,6.464599864263078,0.01127397976693157,Other Types,amcinonide,glucocorticoid receptor agonist,"ANXA1, NR3C1"
Pleural Mesothelioma,BRD-A36074203-003-07-6::2.5::HTS,8.76719120707485,0.0031971789239605528,Other Types,remacemide,glutamate receptor antagonist,GRIN1
Pleural Mesothelioma,BRD-A37347161-003-02-6::2.5::HTS,16.16683203747103,6.596347916236052e-05,Other Types,BRL-52537,opioid receptor agonist,OPRK1
Pleural Mesothelioma,BRD-A40639672-234-18-0::2.5::HTS,5.078662193920364,0.024617920155474406,Other Types,ketorolac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Pleural Mesothelioma,BRD-A41692738-001-07-6::2.5::HTS,9.28809688491859,0.0024164543194091065,Other Types,TGX-221,PI3K inhibitor,"PIK3CB, PIK3CD"
Pleural Mesothelioma,BRD-A42699921-001-02-8::2.5::HTS,4.017856612583682,0.04550100391604904,Other Types,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH
Pleural Mesothelioma,BRD-A43082555-001-01-1::2.5::HTS,9.347229302290136,0.0023425782469660554,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Pleural Mesothelioma,BRD-A43882281-001-15-5::2.5::HTS,4.912459217615611,0.027075053147191965,Other Types,pinacidil,"ATP channel activator, potassium channel activator","ABCC8, ABCC9"
Pleural Mesothelioma,BRD-A43930669-003-02-8::2.5::HTS,6.513331203226521,0.010972187488716936,Other Types,L-368899,oxytocin receptor antagonist,"AVPR1A, AVPR2, OXTR"
Pleural Mesothelioma,BRD-A44448661-001-04-8::2.5::HTS,4.1631154000190715,0.041780221296312404,Other Types,pentobarbital,"barbiturate antiepileptic, GABA receptor modulator","CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Pleural Mesothelioma,BRD-A44863528-001-13-2::2.5::HTS,4.665766820219333,0.031199441688813657,Other Types,proglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Pleural Mesothelioma,BRD-A45107007-001-03-4::2.5::HTS,5.459817886743437,0.019814181860677172,Pleural Mesothelioma,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1
Pleural Mesothelioma,BRD-A46186775-369-02-0::2.5::HTS,4.246614465398144,0.03979239709731073,Other Types,hydrocortisone-phosphate,,"ANXA1, NOS2, NR3C1"
Pleural Mesothelioma,BRD-A46717658-236-02-5::2.5::HTS,4.217174993898367,0.040492470869591624,Other Types,azlocillin,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-A46876182-003-02-8::2.5::HTS,5.492713895455688,0.019445910017901538,Other Types,levobunolol-(+/-),adrenergic receptor antagonist,
Pleural Mesothelioma,BRD-A49035384-003-28-9::2.39::HTS,5.57429913004537,0.018588328258560136,Pleural Mesothelioma,methacycline,protein synthesis inhibitor,
Pleural Mesothelioma,BRD-A49447682-001-02-4::2.5::HTS,4.255007191039776,0.039597778458689135,Other Types,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Pleural Mesothelioma,BRD-A49622760-001-01-9::2.5::HTS,6.087768531938707,0.0139177706585438,Other Types,faropenem,lactamase inhibitor,
Pleural Mesothelioma,BRD-A49765801-001-04-1::2.5::HTS,6.300712825382062,0.012353896350125385,Other Types,fludroxycortide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Pleural Mesothelioma,BRD-A50064262-001-04-7::2.5::HTS,4.037003883931435,0.044994716068884034,Other Types,flumethasone-pivalate,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Pleural Mesothelioma,BRD-A50311610-300-10-4::2.5::HTS,5.269639550052128,0.02207865535871826,Other Types,meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3"
Pleural Mesothelioma,BRD-A51382177-236-03-0::2.5::HTS,6.9558273222914675,0.008585931573747372,Other Types,fosinopril,angiotensin converting enzyme inhibitor,ACE
Pleural Mesothelioma,BRD-A53151380-001-01-2::2.5::HTS,7.4244229879577865,0.006636643150686188,Other Types,prednisolone-tebutate,anti-inflammatory agent,
Pleural Mesothelioma,BRD-A53576514-048-14-3::2.5::HTS,7.796201101878325,0.005415440202872085,Pleural Mesothelioma,orphenadrine,acetylcholine receptor antagonist,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2"
Pleural Mesothelioma,BRD-A55312468-001-04-7::1.24::HTS,6.667830211756884,0.010072385030091308,Pleural Mesothelioma,k-strophanthidin,ATPase inhibitor,ATP1A1
Pleural Mesothelioma,BRD-A55455283-001-01-3::2.5::HTS,7.09001891290231,0.00798792520078889,Other Types,"2-ethyl-1,3-hexanediol",,
Pleural Mesothelioma,BRD-A56359832-001-11-1::2.5::HTS,5.781748074794091,0.016515910955210884,Other Types,zileuton,"leukotriene synthesis inhibitor, lipoxygenase inhibitor",ALOX5
Pleural Mesothelioma,BRD-A57798112-001-03-7::2.5::HTS,6.012921321520676,0.014507315135616906,Pleural Mesothelioma,PD-318088,MEK inhibitor,MAP2K1
Pleural Mesothelioma,BRD-A57900429-003-05-8::2.5::HTS,6.0174293904435805,0.014470157889067378,Other Types,hydrastinine,haemostatic agent,
Pleural Mesothelioma,BRD-A58955223-001-03-8::2.5::HTS,6.263331278821541,0.012609037275943842,Pleural Mesothelioma,sulforaphane,"anticancer agent, aryl hydrocarbon receptor antagonist",NFE2L2
Pleural Mesothelioma,BRD-A62428732-300-06-3::2.5::HTS,6.186962041338476,0.013158405195179643,Other Types,hydroxyzine,antihistamine,HRH1
Pleural Mesothelioma,BRD-A64011898-001-01-0::2.5::HTS,4.803307671030081,0.028826776095096884,Other Types,androstenone,steroid,
Pleural Mesothelioma,BRD-A65013509-003-24-4::2.5::HTS,4.3752296686992445,0.036917196713215736,Other Types,oxybutynin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Pleural Mesothelioma,BRD-A65449987-001-10-4::2.5::HTS,6.1239432223815795,0.013632414798123733,Other Types,flunisolide,cytochrome P450 inhibitor,NR3C1
Pleural Mesothelioma,BRD-A65767837-001-04-4::2.5::HTS,6.234406935560893,0.012816840774231739,Other Types,hydrocortisone-acetate,glucocorticoid receptor agonist,"NR3C1, NR3C2"
Pleural Mesothelioma,BRD-A66869276-001-02-9::2.5::HTS,10.220624047820486,0.001466845288006301,Other Types,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-A68589262-001-04-3::2.5::HTS,4.2513664314015545,0.039691425539764576,Other Types,troxipide,glucosamine synthetase stimulant,
Pleural Mesothelioma,BRD-A69917777-065-02-2::2.5::HTS,5.909739244733672,0.015371875669127205,Other Types,aminopentamide,acetylcholine receptor antagonist,CHRM1
Pleural Mesothelioma,BRD-A70514680-003-11-2::2.5::HTS,4.888483365622747,0.02745007209402874,Other Types,articaine,local anesthetic,
Pleural Mesothelioma,BRD-A72703248-003-04-9::2.5::HTS,9.66678709178483,0.001972153879829638,Pleural Mesothelioma,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Pleural Mesothelioma,BRD-A72716251-001-01-5::0.91::HTS,4.03644833253937,0.045012033005762335,Pleural Mesothelioma,peruvoside,cardiac glycoside,
Pleural Mesothelioma,BRD-A73368467-003-17-6::2.5::HTS,5.90322220388162,0.015426544051076768,Other Types,fexofenadine,histamine receptor antagonist,HRH1
Pleural Mesothelioma,BRD-A74387232-001-02-5::2.5::HTS,5.191179693751369,0.023100379631041393,Other Types,PMPA,glutamate receptor antagonist,FOLH1
Pleural Mesothelioma,BRD-A75305484-001-01-3::2.5::HTS,6.166132315812918,0.013312487664986142,Other Types,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",
Pleural Mesothelioma,BRD-A75479906-001-02-4::2.5::HTS,5.216693572368565,0.022743158633636684,Other Types,rimantadine,"antiviral, RNA synthesis inhibitor",
Pleural Mesothelioma,BRD-A77577770-003-08-9::2.5::HTS,4.18766768532626,0.04118382619501621,Other Types,palmitoylcarnitine,protein kinase inhibitor,
Pleural Mesothelioma,BRD-A78952587-001-01-5::2.5::HTS,4.009343855965366,0.04573566169308636,Pleural Mesothelioma,A740003,purinergic receptor antagonist,P2RX7
Pleural Mesothelioma,BRD-A79768653-001-12-0::2.5::HTS,9.38489399784896,0.0022945501117588273,Pleural Mesothelioma,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Pleural Mesothelioma,BRD-A83802939-304-04-2::2.5::HTS,11.414944325486625,0.0007794961225971537,Other Types,dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-A85651701-001-19-7::2.5::HTS,4.229697429545801,0.040243985257986656,Other Types,clopamide,sodium/chloride cotransporter inhibitor,
Pleural Mesothelioma,BRD-A86248581-001-01-4::2.5::HTS,5.9658520720495885,0.014905686233607936,Pleural Mesothelioma,tetrahydrouridine,cytidine deaminase inhibitor,CDA
Pleural Mesothelioma,BRD-A88138582-001-04-8::2.5::HTS,4.079294416330747,0.04389974860008738,Other Types,halcinonide,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-A89594340-003-11-5::2.5::HTS,4.506640205939669,0.034206301373349304,Pleural Mesothelioma,carnitine-(D/L),,
Pleural Mesothelioma,BRD-A90272038-001-01-7::2.5::HTS,8.489595535964796,0.0037155083131050815,Other Types,CGP-37849,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Pleural Mesothelioma,BRD-A90926615-001-01-9::2.5::HTS,13.31579541390666,0.00028783684178100804,Pleural Mesothelioma,adrafinil,adrenergic receptor agonist,
Pleural Mesothelioma,BRD-A94276798-001-01-4::2.5::HTS,3.9684317536579963,0.046846038815439486,Other Types,talinolol,adrenergic receptor antagonist,ADRB1
Pleural Mesothelioma,BRD-A94323479-001-02-8::2.5::HTS,11.68530579412518,0.000675595311135201,Other Types,ki16198,lipoprotein antagonist,LPA
Pleural Mesothelioma,BRD-A94523291-304-02-7::2.5::HTS,9.199050067584032,0.0025341968659941365,Other Types,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-A94543220-001-24-7::2.5::HTS,4.683092306777172,0.030881397746209415,Other Types,bifonazole,sterol demethylase inhibitor,CYP2B6
Pleural Mesothelioma,BRD-A94993966-001-05-1::2.63::HTS,5.703160772964195,0.017277697537772384,Other Types,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Pleural Mesothelioma,BRD-A96456596-001-02-2::2.5::HTS,6.415486198985171,0.011583840007641469,Other Types,FPL-55712,leukotriene receptor antagonist,
Pleural Mesothelioma,BRD-A97701745-001-16-0::2.5::HTS,5.442744435266244,0.020001712210345066,Other Types,pindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B"
Pleural Mesothelioma,BRD-A99888680-001-04-6::2.5::HTS,4.957649958602644,0.026373881546339607,Other Types,paliperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C"
Pleural Mesothelioma,BRD-K00535541-001-05-5::2.5::HTS,4.020917949809744,0.045438702121939435,Pleural Mesothelioma,9-aminoacridine,,
Pleural Mesothelioma,BRD-K00603606-003-24-0::2.5::HTS,4.507867962089167,0.03417957293957472,Pleural Mesothelioma,ticlopidine,purinergic receptor antagonist,P2RY12
Pleural Mesothelioma,BRD-K00938507-001-17-8::2.5::HTS,6.8859340005056735,0.008925521258375636,Other Types,sulfamethoxypyridazine,bacterial antifolate,
Pleural Mesothelioma,BRD-K01663662-003-20-2::2.5::HTS,5.303897861007912,0.021645988676268327,Pleural Mesothelioma,diphenidol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Pleural Mesothelioma,BRD-K01902415-001-11-7::2.5::HTS,5.192253459246956,0.02306888790471278,Other Types,pirinixic-acid,PPAR receptor agonist,PPARA
Pleural Mesothelioma,BRD-K02715688-001-02-1::2.5::HTS,4.010227746393507,0.04570924665856408,Other Types,"hydrastine-(1r,-9s)",tyrosine hydroxylase inhibitor,
Pleural Mesothelioma,BRD-K02943813-001-01-9::2.5::HTS,4.3729092326175145,0.036982220055900114,Other Types,dasabuvir,HCV inhibitor,
Pleural Mesothelioma,BRD-K02950022-001-02-9::2.5::HTS,8.164697155479114,0.004430994316696545,Pleural Mesothelioma,BMS-299897,gamma secretase inhibitor,
Pleural Mesothelioma,BRD-K03109492-001-02-2::2.5::HTS,12.818350982410117,0.0003733834288573336,Pleural Mesothelioma,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Pleural Mesothelioma,BRD-K04430056-001-17-7::2.5::HTS,5.43048039626771,0.020141260606235743,Other Types,7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Pleural Mesothelioma,BRD-K04623885-001-07-5::2.5::HTS,3.9180813107699817,0.04826574108470323,Other Types,BIBR-1532,telomerase inhibitor,TERT
Pleural Mesothelioma,BRD-K04993719-001-01-7::2.5::HTS,12.88714302543053,0.00036015431203907997,Pleural Mesothelioma,LY2334737,"antitumor agent, ribonucleotide reductase inhibitor",
Pleural Mesothelioma,BRD-K05181084-003-03-7::2.5::HTS,8.013478229014343,0.004810426804927512,Other Types,NGB-2904,dopamine receptor antagonist,DRD3
Pleural Mesothelioma,BRD-K05444225-001-01-7::2.5::HTS,5.885313807169099,0.015590620354222803,Other Types,E7449,PARP inhibitor,"PARP1, PARP2, TNKS, TNKS2"
Pleural Mesothelioma,BRD-K05446112-001-01-8::2.5::HTS,14.507686141596892,0.00015510938105806502,Pleural Mesothelioma,ledipasvir,HCV inhibitor,
Pleural Mesothelioma,BRD-K05619559-001-12-7::2.5::HTS,5.632596540721518,0.017964807045263917,Other Types,tobramycin,bacterial 30S ribosomal subunit inhibitor,
Pleural Mesothelioma,BRD-K05804044-001-06-0::2.5::HTS,5.557751869058296,0.01874393131123977,Pleural Mesothelioma,AZ-628,RAF inhibitor,"BRAF, RAF1"
Pleural Mesothelioma,BRD-K06408664-001-03-5::2.5::HTS,8.549017732604351,0.0035974368003485724,Other Types,fludrocortisone-acetate,,"AR, NR3C1, NR3C2"
Pleural Mesothelioma,BRD-K06542892-001-01-9::2.5::HTS,4.696429516012034,0.030653828403399756,Other Types,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
Pleural Mesothelioma,BRD-K06543683-066-02-1::2.5::HTS,6.301574545608653,0.012344378720295634,Pleural Mesothelioma,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Pleural Mesothelioma,BRD-K07940445-310-02-9::2.5::HTS,5.8785832680489305,0.01564212437368636,Other Types,quinine,hemozoin biocrystallization inhibitor,"GP9, KCNB2, KCNN4, SLC29A4"
Pleural Mesothelioma,BRD-K08078237-001-19-8::2.5::HTS,4.369810283494394,0.03705873254413874,Pleural Mesothelioma,tetrandrine,calcium channel blocker,SLC6A3
Pleural Mesothelioma,BRD-K08248804-001-01-8::2.5::HTS,8.766317210065935,0.003203574358433648,Pleural Mesothelioma,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Pleural Mesothelioma,BRD-K08288352-001-03-6::2.5::HTS,7.549088369910872,0.0062024565032581455,Other Types,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,
Pleural Mesothelioma,BRD-K08547377-394-03-5::2.5::HTS,7.794825366985659,0.005425564676499867,Pleural Mesothelioma,irinotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Pleural Mesothelioma,BRD-K08864679-001-02-2::2.5::HTS,4.813986168228,0.02864123454681799,Other Types,fexaramine,FXR agonist,NR1H4
Pleural Mesothelioma,BRD-K08924299-003-06-1::2.5::HTS,8.692460076017735,0.0033338234075154776,Other Types,palonosetron,serotonin receptor antagonist,HTR3A
Pleural Mesothelioma,BRD-K08976401-001-18-5::2.5::HTS,4.387792944360446,0.036663380268521395,Pleural Mesothelioma,azelaic-acid,tyrosinase inhibitor,"AKR1D1, SRD5A2, TYR"
Pleural Mesothelioma,BRD-K09711437-001-04-3::2.5::HTS,4.034922201134912,0.045065956044084164,Other Types,varespladib,secretory phospholipase inhibitor,PLA2G2A
Pleural Mesothelioma,BRD-K10671814-001-14-8::2.5::HTS,6.776470105972392,0.009482891335642939,Other Types,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS
Pleural Mesothelioma,BRD-K11071038-001-01-7::2.5::HTS,4.556493522676397,0.03324544641043975,Other Types,ICI-162846,histamine receptor antagonist,HRH2
Pleural Mesothelioma,BRD-K11742128-003-23-4::2.5::HTS,5.545949580773417,0.01886945023447199,Other Types,triprolidine,histamine receptor antagonist,HRH1
Pleural Mesothelioma,BRD-K12068470-001-04-1::2.5::HTS,4.5587150276103605,0.03318343214681218,Other Types,LY2608204,glucokinase activator,GCK
Pleural Mesothelioma,BRD-K12343256-001-08-9::2.5::HTS,4.514970203493081,0.03403833883413234,Pleural Mesothelioma,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Pleural Mesothelioma,BRD-K12630395-001-14-9::2.5::HTS,3.949609025210678,0.0473715542194787,Pleural Mesothelioma,harmane,monoamine oxidase inhibitor,"MAOA, MAOB"
Pleural Mesothelioma,BRD-K12762134-001-06-2::2.5::HTS,5.979343135926479,0.01478469074192733,Other Types,XAV-939,tankyrase inhibitor,"TNKS, TNKS2"
Pleural Mesothelioma,BRD-K12807006-001-18-5::2.5::HTS,4.308055902396045,0.038388933132285745,Other Types,kaempferol,"bone resorption inhibitor, estrogen-related receptor inverse agonist","AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1"
Pleural Mesothelioma,BRD-K12885236-001-02-7::2.5::HTS,6.395637967844278,0.011716504341434522,Pleural Mesothelioma,dapivirine,non-nucleoside reverse transcriptase inhibitor,"CYP3A4, CYP3A5"
Pleural Mesothelioma,BRD-K12932420-001-02-3::2.5::HTS,5.787505225184635,0.016483932976540664,Pleural Mesothelioma,YM-976,phosphodiesterase inhibitor,PDE4A
Pleural Mesothelioma,BRD-K13112821-001-17-4::2.5::HTS,5.034870037797954,0.025236115567593767,Pleural Mesothelioma,artemisinin,DNA synthesis inhibitor,CYP2B6
Pleural Mesothelioma,BRD-K13514097-001-05-3::2.5::HTS,4.980721863380227,0.026028283697159493,Pleural Mesothelioma,everolimus,mTOR inhibitor,MTOR
Pleural Mesothelioma,BRD-K13606314-001-01-3::2.5::HTS,6.357483544562718,0.011964129117532073,Pleural Mesothelioma,P5091,ubiquitin specific protease inhibitor,USP7
Pleural Mesothelioma,BRD-K13756951-001-01-4::2.5::HTS,4.6535146237371885,0.03141324776309793,Pleural Mesothelioma,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Pleural Mesothelioma,BRD-K13819402-003-10-2::2.4::HTS,6.507305491291496,0.011007090294520584,Other Types,desoxypeganine,"acetylcholinesterase inhibitor, monoamine oxidase inhibitor",ACHE
Pleural Mesothelioma,BRD-K13994703-003-15-8::2.5::HTS,5.408258419926107,0.020401836566912957,Other Types,propranolol-(S),adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1"
Pleural Mesothelioma,BRD-K14796088-003-26-8::2.5::HTS,4.602342799253956,0.03235614701805643,Pleural Mesothelioma,berberine,LDL receptor activator,LDLR
Pleural Mesothelioma,BRD-K15025317-001-15-1::2.5::HTS,4.311923805531131,0.03830656496412439,Pleural Mesothelioma,BAY-11-7082,NFkB pathway inhibitor,RELA
Pleural Mesothelioma,BRD-K15108141-001-06-6::2.5::HTS,5.025077975621743,0.02538888577788927,Pleural Mesothelioma,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Pleural Mesothelioma,BRD-K15424032-001-03-6::2.5::HTS,9.179013555865625,0.0025626703283961614,Pleural Mesothelioma,SB-228357,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Pleural Mesothelioma,BRD-K15766189-001-09-8::2.5::HTS,7.536607594408562,0.006239952179587405,Other Types,cefdinir,bacterial cell wall synthesis inhibitor,MPO
Pleural Mesothelioma,BRD-K15891719-001-05-1::2.45::HTS,6.096614631522568,0.01385948919970055,Other Types,tenofovir,"HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor",
Pleural Mesothelioma,BRD-K15933101-003-06-1::2.5::HTS,9.120563712623843,0.0026444557541298926,Other Types,ropinirole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Pleural Mesothelioma,BRD-K16898998-001-01-6::2.5::HTS,4.0591256963819395,0.044410713869018736,Other Types,bevirimat-dimeglumine,HIV capsid assembly inhibitor,
Pleural Mesothelioma,BRD-K17565903-066-23-1::2.5::HTS,6.8113632508699835,0.009301584402107987,Other Types,pridinol,muscle relaxant,
Pleural Mesothelioma,BRD-K17743697-066-03-6::2.5::HTS,7.227026223459581,0.0073982852687339146,Pleural Mesothelioma,KB-R7943,sodium/calcium exchange inhibitor,"SLC8A1, TRPC3, TRPC5, TRPC6"
Pleural Mesothelioma,BRD-K18518344-001-15-9::2.5::HTS,4.962357003625752,0.026305719917483237,Pleural Mesothelioma,digitoxigenin,ATPase inhibitor,ATP1A1
Pleural Mesothelioma,BRD-K18619710-001-14-4::2.5::HTS,4.880938950149798,0.027563200837672743,Pleural Mesothelioma,digoxigenin,steroid,
Pleural Mesothelioma,BRD-K19034817-001-01-4::2.5::HTS,5.748516194777952,0.01683024967342088,Pleural Mesothelioma,pacritinib,"FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3"
Pleural Mesothelioma,BRD-K19669037-001-01-1::2.5::HTS,5.91352489671281,0.0153461765739806,Other Types,GGTI-298,GGTase inhibitor,CDKN1A
Pleural Mesothelioma,BRD-K20001883-001-02-7::2.5::HTS,5.59788482675414,0.018325400456873198,Pleural Mesothelioma,apabetalone,apolipoprotein expression enhancer,BRD3
Pleural Mesothelioma,BRD-K20013301-001-02-6::2.5::HTS,6.603310410741154,0.010437896987265936,Pleural Mesothelioma,LY411575,gamma secretase inhibitor,
Pleural Mesothelioma,BRD-K20285085-001-07-1::2.5::HTS,7.590518074097835,0.0060660148413223935,Other Types,R406,SYK inhibitor,"RET, SYK"
Pleural Mesothelioma,BRD-K20290250-001-02-1::2.38::HTS,5.44984819648496,0.01994545636129108,Other Types,BIX-02188,MEK inhibitor,MAP2K5
Pleural Mesothelioma,BRD-K20742498-003-02-9::2.5::HTS,5.353025814379782,0.021048832782759305,Other Types,RS-39604,serotonin receptor antagonist,HTR4
Pleural Mesothelioma,BRD-K21372554-003-01-7::2.5::HTS,4.229746952367415,0.04019080696769337,Other Types,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-K21528677-001-03-6::2.5::HTS,5.379047335917297,0.020744088152083878,Other Types,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Pleural Mesothelioma,BRD-K21548250-003-19-1::2.5::HTS,12.728494810606836,0.0003913299212209973,Other Types,moracizine,sodium channel blocker,SCN5A
Pleural Mesothelioma,BRD-K21908111-001-01-8::2.5::HTS,10.391474486794518,0.001340065080753894,Other Types,AZD1208,Pim kinase inhibitor,"PIM1, PIM2, PIM3"
Pleural Mesothelioma,BRD-K22024824-001-03-7::2.5::HTS,7.945886303977112,0.004991066275079837,Pleural Mesothelioma,RG4733,gamma secretase inhibitor,PSEN1
Pleural Mesothelioma,BRD-K22025381-003-01-9::2.5::HTS,4.02902362076373,0.0452047015136581,Pleural Mesothelioma,U-18666A,oxidosqualene cyclase inhibitor,
Pleural Mesothelioma,BRD-K23067689-001-02-1::2.4::HTS,4.96818629431315,0.026237769154629827,Other Types,zanamivir,neuraminidase inhibitor,NEU2
Pleural Mesothelioma,BRD-K23925186-001-02-8::2.51::HTS,5.468522304738978,0.01973423823632365,Pleural Mesothelioma,oridonin,BCL inhibitor,BCL2
Pleural Mesothelioma,BRD-K24219278-001-01-6::2.5::HTS,4.691813298489552,0.03073245723067149,Pleural Mesothelioma,amineptine,dopamine receptor agonist,"SLC6A2, SLC6A4"
Pleural Mesothelioma,BRD-K24443618-001-10-2::2.5::HTS,4.9303511185784075,0.026789851640444676,Other Types,etebenecid,uricosuric blocker,
Pleural Mesothelioma,BRD-K24566386-001-01-9::2.5::HTS,5.966748498645,0.014891198396173328,Pleural Mesothelioma,SD-208,TGF beta receptor inhibitor,TGFBR1
Pleural Mesothelioma,BRD-K24844714-001-24-5::2.5::HTS,4.428698062819952,0.0358018875542277,Pleural Mesothelioma,5-fluorouracil,thymidylate synthase inhibitor,"DPYD, TYMS"
Pleural Mesothelioma,BRD-K25204779-001-01-1::2.5::HTS,6.5013302052809205,0.011045133523069928,Other Types,pritelivir,helicase primase inhibitor,
Pleural Mesothelioma,BRD-K25340465-001-11-1::2.58::HTS,6.6538312453503945,0.010163557028347312,Pleural Mesothelioma,OSI-930,"KIT inhibitor, VEGFR inhibitor","KDR, KIT"
Pleural Mesothelioma,BRD-K25412176-001-01-9::2.5::HTS,7.861231146642584,0.005227676716931491,Pleural Mesothelioma,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Pleural Mesothelioma,BRD-K25991633-001-01-9::2.5::HTS,4.655305164569312,0.03138845691031361,Other Types,BMS-649,retinoid receptor agonist,RXRA
Pleural Mesothelioma,BRD-K26160755-003-02-6::2.5::HTS,5.48342846356863,0.019547795181342392,Other Types,RS-45041-190,imidazoline receptor agonist,
Pleural Mesothelioma,BRD-K26222048-001-01-7::2.5::HTS,3.8640483766232125,0.04983019561548214,Pleural Mesothelioma,"trans-10,cis-12-Conjugated-linoleic-acid",,
Pleural Mesothelioma,BRD-K26667523-001-02-5::2.5::HTS,3.9882014996679764,0.04630864516038807,Pleural Mesothelioma,TAK-733,MEK inhibitor,MAP2K1
Pleural Mesothelioma,BRD-K26712974-001-01-5::2.5::HTS,7.601597104464747,0.006021225405522212,Other Types,VX-765,caspase inhibitor,CASP1
Pleural Mesothelioma,BRD-K26818574-305-04-3::2.5::HTS,4.6649974802531275,0.03120790971175571,Pleural Mesothelioma,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Pleural Mesothelioma,BRD-K27316855-001-13-3::2.44::HTS,4.4384628432989945,0.0356090214707145,Pleural Mesothelioma,calcitriol,vitamin D receptor agonist,VDR
Pleural Mesothelioma,BRD-K28143534-003-25-9::2.5::HTS,11.952431901459878,0.0005872743153665276,Other Types,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Pleural Mesothelioma,BRD-K28210218-236-08-1::2.5::HTS,6.4618559265617295,0.011291197170054518,Other Types,cephalothin,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-K28428262-001-04-1::2.5::HTS,5.22970496251013,0.022581291848074444,Pleural Mesothelioma,brivanib,"FGFR inhibitor, VEGFR inhibitor","CYP3A4, FGFR1, FLT1, KCNH2, KDR"
Pleural Mesothelioma,BRD-K29359156-001-30-1::2.5::HTS,4.867709393367226,0.027767536001621535,Other Types,ebselen,"cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor",ALB
Pleural Mesothelioma,BRD-K29656036-001-02-5::2.5::HTS,4.17563522739929,0.041477478061510836,Pleural Mesothelioma,MK-8245,stearoyl-CoA desaturase inhibitor,SCD
Pleural Mesothelioma,BRD-K30114692-001-15-9::2.5::HTS,5.9137807894427254,0.015343381970589936,Other Types,methenamine,bacterial DNA inhibitor,
Pleural Mesothelioma,BRD-K30550578-001-01-3::2.5::HTS,4.414065557217631,0.03609583450774231,Other Types,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1
Pleural Mesothelioma,BRD-K30572193-001-02-0::2.5::HTS,4.188059470729499,0.041174382429062586,Other Types,CTEP,glutamate receptor antagonist,GRM5
Pleural Mesothelioma,BRD-K30707190-001-04-1::2.5::HTS,4.872273185510583,0.027700684639671246,Other Types,PNU-74654,beta-catenin inhibitor,"CTNNB1, TCF4"
Pleural Mesothelioma,BRD-K30867024-003-03-3::2.5::HTS,7.445269646077356,0.006563059983477789,Pleural Mesothelioma,SB-216641,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Pleural Mesothelioma,BRD-K31092604-003-03-5::2.5::HTS,4.704729827698401,0.030504347781180764,Other Types,donitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6"
Pleural Mesothelioma,BRD-K31519811-001-02-2::2.5::HTS,10.350154861568438,0.0013702423857802144,Other Types,PF-02545920,phosphodiesterase inhibitor,PDE10A
Pleural Mesothelioma,BRD-K31731454-237-02-5::2.5::HTS,5.556725031981188,0.018757951892426294,Other Types,pemirolast,mediator release inhibitor,HRH1
Pleural Mesothelioma,BRD-K31866293-001-01-6::2.5::HTS,8.1847414960109,0.004382724087377512,Pleural Mesothelioma,TAK-632,RAF inhibitor,BRAF
Pleural Mesothelioma,BRD-K32164935-001-30-8::2.5::HTS,6.517733843046521,0.010947299920785398,Other Types,tolazamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ10, KCNJ11"
Pleural Mesothelioma,BRD-K32273377-001-17-9::2.5::HTS,4.851946667591139,0.02802524139251127,Pleural Mesothelioma,sulfadiazine,bacterial antifolate,
Pleural Mesothelioma,BRD-K32730239-001-01-0::2.5::HTS,8.628347958906367,0.0034461441192544435,Pleural Mesothelioma,SU3327,JNK inhibitor,MAPK8
Pleural Mesothelioma,BRD-K33226500-001-01-0::2.5::HTS,10.010470774344247,0.0016423684875600053,Other Types,indinavir,HIV protease inhibitor,"CYP3A4, CYP3A5, CYP3A7"
Pleural Mesothelioma,BRD-K33720171-001-01-0::2.5::HTS,7.474701767774796,0.00646028344296812,Other Types,difluprednate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-K33813875-003-01-8::2.5::HTS,6.096714252133497,0.013848277568768887,Pleural Mesothelioma,valnemulin,bacterial 50S ribosomal subunit inhibitor,
Pleural Mesothelioma,BRD-K33814251-001-02-2::2.5::HTS,10.150564646066458,0.001524081189434688,Other Types,lubiprostone,chloride channel activator,CLCN2
Pleural Mesothelioma,BRD-K34032314-001-04-1::2.5::HTS,6.224710425808125,0.012886417590295044,Other Types,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-K34157611-001-16-0::2.5::HTS,5.543879919337222,0.018894695683749647,Pleural Mesothelioma,cimetidine,histamine receptor antagonist,"HRH2, SLC29A4, SLC47A1, SLC47A2"
Pleural Mesothelioma,BRD-K34591242-001-04-3::2.5::HTS,4.903941572806262,0.027198784318172263,Other Types,methoprene-(s),,
Pleural Mesothelioma,BRD-K34851558-001-02-3::2.5::HTS,4.2471550082561755,0.03978234596599561,Pleural Mesothelioma,parthenolide-(-),NFkB pathway inhibitor,HDAC1
Pleural Mesothelioma,BRD-K35245662-001-01-2::2.5::HTS,4.0191953061214605,0.04546602632005667,Other Types,ciclesonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Pleural Mesothelioma,BRD-K36363294-001-04-2::2.5::HTS,5.973551505040688,0.014841473462504447,Pleural Mesothelioma,I-BET151,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Pleural Mesothelioma,BRD-K36660044-001-24-2::2.5::HTS,6.517515194431101,0.010947185284117665,Other Types,bufexamac,cyclooxygenase inhibitor,"HDAC10, HDAC6"
Pleural Mesothelioma,BRD-K37687387-237-01-7::2.5::HTS,5.878526500087515,0.015645485467801153,Pleural Mesothelioma,RU-28318,cytochrome P450 inhibitor,NR3C2
Pleural Mesothelioma,BRD-K37720887-001-07-8::2.5::HTS,11.501052497221304,0.0007449025766072779,Pleural Mesothelioma,SB-525334,TGF beta receptor inhibitor,TGFBR1
Pleural Mesothelioma,BRD-K38003476-001-09-1::2.5::HTS,7.798947730892411,0.00540571876637243,Other Types,clocortolone-pivalate,steroid,"NR3C1, PLA2G1B"
Pleural Mesothelioma,BRD-K38140108-002-01-2::2.5::HTS,12.43252748087699,0.00045640942946512277,Other Types,gadodiamide,radiopaque medium,
Pleural Mesothelioma,BRD-K39166528-001-01-0::2.5::HTS,14.275849929183916,0.00017482192878115146,Other Types,ID-8,,
Pleural Mesothelioma,BRD-K39252998-003-01-5::2.5::HTS,5.7532937512569085,0.016792236828206183,Pleural Mesothelioma,atipamezole,adrenergic receptor antagonist,
Pleural Mesothelioma,BRD-K39339537-001-21-0::2.5::HTS,4.387857272704679,0.03665602332953349,Other Types,epirizole,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Pleural Mesothelioma,BRD-K39670393-303-02-1::2.5::HTS,5.487471771911564,0.019501214504089325,Other Types,amthamine,histamine receptor agonist,HRH2
Pleural Mesothelioma,BRD-K39974922-001-04-3::2.5::HTS,5.745081342714727,0.016870078319300538,Other Types,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Pleural Mesothelioma,BRD-K40255344-001-17-6::2.5::HTS,7.197373416959055,0.007515974937629084,Pleural Mesothelioma,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Pleural Mesothelioma,BRD-K41260949-236-16-8::2.5::HTS,10.893706449442416,0.001027913787375532,Other Types,valproic-acid,HDAC inhibitor,"ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A"
Pleural Mesothelioma,BRD-K41564320-001-02-0::2.5::HTS,5.476100984993056,0.019629087616023895,Other Types,purvalanol-b,tyrosine kinase inhibitor,"CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2"
Pleural Mesothelioma,BRD-K41567533-001-08-3::2.5::HTS,4.985150144811383,0.02597036509185904,Other Types,coumophos,cholinesterase inhibitor,
Pleural Mesothelioma,BRD-K42098891-003-20-5::2.5::HTS,18.43794992678836,2.0774754186774753e-05,Other Types,protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4"
Pleural Mesothelioma,BRD-K42348709-003-13-1::2.5::HTS,9.021352832671958,0.002790757220014606,Other Types,cyclobenzaprine,"adrenergic receptor agonist, serotonin receptor agonist",HTR2A
Pleural Mesothelioma,BRD-K42948882-305-01-1::2.5::HTS,17.724188855117784,2.9860773863357247e-05,Other Types,AMD11070,CC chemokine receptor antagonist,CXCR4
Pleural Mesothelioma,BRD-K43187796-001-02-3::2.5::HTS,4.2152182159749305,0.04052526294996045,Other Types,3-indolebutyric-acid,,"B2M, HLA-A, TRAC, TRBC1"
Pleural Mesothelioma,BRD-K43578482-001-01-4::2.5::HTS,7.00369812371613,0.008368832509124053,Pleural Mesothelioma,defactinib,focal adhesion kinase inhibitor,PTK2
Pleural Mesothelioma,BRD-K44067360-001-30-3::2.5::HTS,5.863628569752694,0.015785953409559864,Pleural Mesothelioma,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Pleural Mesothelioma,BRD-K44084986-300-08-4::2.5::HTS,5.946885902023174,0.015056344830340079,Pleural Mesothelioma,Y-27632,rho associated kinase inhibitor,"PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2"
Pleural Mesothelioma,BRD-K44824027-001-02-1::2.5::HTS,5.411983934311635,0.02035618834217199,Other Types,beclamide,anticonvulsant,
Pleural Mesothelioma,BRD-K44844162-001-01-6::2.5::HTS,6.698826683459618,0.009901773600821282,Pleural Mesothelioma,taselisib,PI3K inhibitor,PIK3CA
Pleural Mesothelioma,BRD-K45117373-001-02-9::2.5::HTS,4.499173303972592,0.03436123446135884,Other Types,Y-26763,potassium channel activator,KCNJ8
Pleural Mesothelioma,BRD-K45252063-001-13-6::2.5::HTS,9.040319054705797,0.002761087926547137,Pleural Mesothelioma,clofibrate,PPAR receptor agonist,"LPL, PPARA"
Pleural Mesothelioma,BRD-K45462423-001-03-7::2.5::HTS,5.893743736877374,0.01551230956863354,Pleural Mesothelioma,VU0361737,glutamate receptor positive allosteric modulator,GRM4
Pleural Mesothelioma,BRD-K45519571-001-01-8::2.5::HTS,5.445325512455533,0.019977564284899326,Other Types,RN-1747,TRPV agonist,TRPV4
Pleural Mesothelioma,BRD-K46317332-003-17-8::2.5::HTS,5.378226950529236,0.02074982206985086,Other Types,proadifen,nitric oxide synthase inhibitor,NOS1
Pleural Mesothelioma,BRD-K46556543-001-01-4::2.5::HTS,4.386888430211248,0.036665968674000717,Other Types,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2
Pleural Mesothelioma,BRD-K46692793-004-01-8::2.5::HTS,4.255018158959293,0.03960172333940969,Other Types,umeclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Pleural Mesothelioma,BRD-K46863940-001-06-2::2.5::HTS,3.8603174469505492,0.049964919205687276,Other Types,dibenzothiophene,,
Pleural Mesothelioma,BRD-K47177710-001-03-1::2.5::HTS,5.379367999095923,0.020736388349186657,Pleural Mesothelioma,DAPT,gamma secretase inhibitor,
Pleural Mesothelioma,BRD-K47192521-001-05-4::0.25::HTS,7.08649659507994,0.007991026268976483,Other Types,icosapent,platelet aggregation inhibitor,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1"
Pleural Mesothelioma,BRD-K48068743-001-01-6::2.5::HTS,4.9090408571592254,0.027128193199536226,Other Types,teneligliptin,dipeptidyl peptidase inhibitor,DPP4
Pleural Mesothelioma,BRD-K48578705-001-16-8::2.5::HTS,5.529628488274319,0.019052136295176037,Other Types,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Pleural Mesothelioma,BRD-K48722258-300-10-2::2.5::HTS,14.505137166655,0.00015563859651516473,Other Types,dilazep,adenosine reuptake inhibitor,SLC29A1
Pleural Mesothelioma,BRD-K48888725-001-01-9::2.5::HTS,5.161000978240114,0.023487786895178112,Other Types,CG-400549,FABI inhibitor,
Pleural Mesothelioma,BRD-K49215523-001-04-2::2.5::HTS,7.177436522750239,0.00760280785515674,Other Types,GSK2636771,PI3K inhibitor,PIK3CB
Pleural Mesothelioma,BRD-K49236613-001-02-3::2.5::HTS,4.62749072668004,0.03189527592349083,Pleural Mesothelioma,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1
Pleural Mesothelioma,BRD-K49554218-001-01-0::2.5::HTS,11.716680903489687,0.0006653651343303571,Other Types,carebastine,histamine receptor antagonist,HRH1
Pleural Mesothelioma,BRD-K49555808-001-03-9::2.5::HTS,4.125755424558106,0.04271903900653052,Pleural Mesothelioma,BMS-707035,HIV integrase inhibitor,
Pleural Mesothelioma,BRD-K49865102-001-08-4::2.5::HTS,4.79766160361451,0.02891670694918175,Pleural Mesothelioma,PD-0325901,MEK inhibitor,MAP2K1
Pleural Mesothelioma,BRD-K50866992-003-10-3::2.5::HTS,4.7786155767160015,0.029233081185071997,Other Types,tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4"
Pleural Mesothelioma,BRD-K51431759-001-02-9::2.5::HTS,4.51678136932532,0.03400579280339587,Pleural Mesothelioma,dextrose,,
Pleural Mesothelioma,BRD-K53234107-001-01-6::2.5::HTS,5.077599693518401,0.024623638741005302,Other Types,IWP-L6,porcupine inhibitor,PORCN
Pleural Mesothelioma,BRD-K53814070-310-01-3::2.5::HTS,8.511403588759526,0.003674822974069446,Other Types,ripasudil,rho associated kinase inhibitor,"ROCK1, ROCK2"
Pleural Mesothelioma,BRD-K53852914-001-01-8::2.5::HTS,11.888316132299625,0.0006074761448947977,Other Types,menbutone,,
Pleural Mesothelioma,BRD-K54187111-001-09-2::2.5::HTS,4.584194168514994,0.03270071655618,Other Types,dichlorisone-acetate,,
Pleural Mesothelioma,BRD-K54262262-001-09-0::2.5::HTS,5.303549577568248,0.02165362532696961,Pleural Mesothelioma,monobenzone,melanin inhibitor,TYR
Pleural Mesothelioma,BRD-K54314721-001-10-2::2.5::HTS,5.441278425760653,0.02001834053093186,Other Types,zolmitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Pleural Mesothelioma,BRD-K54316499-046-04-5::2.5::HTS,3.9579240657058055,0.047149654696118946,Other Types,tolterodine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Pleural Mesothelioma,BRD-K54759182-003-08-0::2.5::HTS,4.076921004209985,0.043947916104239655,Other Types,dosulepin,"norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4"
Pleural Mesothelioma,BRD-K54770957-001-04-3::2.5::HTS,7.386293566097941,0.006781038889085114,Other Types,etoricoxib,cyclooxygenase inhibitor,PTGS2
Pleural Mesothelioma,BRD-K54838207-001-02-0::2.5::HTS,6.226398734818987,0.01287169916907455,Other Types,fudosteine,mucolytic agent,
Pleural Mesothelioma,BRD-K55013654-003-02-3::2.5::HTS,7.546161376969141,0.0062084489013132585,Other Types,lorcaserin,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C"
Pleural Mesothelioma,BRD-K55677650-003-02-9::2.5::HTS,5.9617271050849965,0.014931495780450067,Pleural Mesothelioma,CO-101244,glutamate receptor antagonist,GRIN2B
Pleural Mesothelioma,BRD-K55703048-001-07-7::2.5::HTS,6.629968057041714,0.010282370497780266,Other Types,latrepirdine,glutamate receptor antagonist,"HRH1, HTR6"
Pleural Mesothelioma,BRD-K56156805-001-09-6::2.5::HTS,7.28691171985148,0.00716115493343318,Other Types,benznidazole,DNA synthesis inhibitor,
Pleural Mesothelioma,BRD-K57080016-001-15-9::2.5::HTS,4.1758397147314135,0.04147000967119718,Pleural Mesothelioma,selumetinib,MEK inhibitor,MAP2K1
Pleural Mesothelioma,BRD-K57853941-304-02-5::2.5::HTS,6.779586161182293,0.009464353640715434,Other Types,olsalazine,cyclooxygenase inhibitor,"IFNG, TPMT"
Pleural Mesothelioma,BRD-K58010567-003-02-2::2.5::HTS,5.228059965389657,0.02259639798608832,Other Types,vilazodone,serotonin reuptake inhibitor,"DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4"
Pleural Mesothelioma,BRD-K58046914-001-03-8::2.5::HTS,3.9732482552649446,0.04671149408142931,Other Types,HA-966-(R)-(+),glutamate receptor agonist,GRIA1
Pleural Mesothelioma,BRD-K58049875-001-04-7::2.5::HTS,10.076300832372505,0.0015846709507406278,Pleural Mesothelioma,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Pleural Mesothelioma,BRD-K58968598-001-03-6::2.5::HTS,9.294918848725292,0.0024092502051004006,Other Types,sucralose,,
Pleural Mesothelioma,BRD-K59058747-001-18-3::2.5::HTS,4.920630060495815,0.02696250138585312,Other Types,acetylcysteine,mucolytic agent,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11"
Pleural Mesothelioma,BRD-K59058747-001-20-9::2.5::HTS,3.9209518985201974,0.04818400255209303,Other Types,acetylcysteine,mucolytic agent,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11"
Pleural Mesothelioma,BRD-K59204667-001-03-1::2.5::HTS,6.8965979845694765,0.008872666307540841,Pleural Mesothelioma,DBeQ,ATPase inhibitor,CASP3
Pleural Mesothelioma,BRD-K59436580-001-01-7::2.5::HTS,6.630960951605049,0.010276708872380056,Pleural Mesothelioma,tedizolid,bacterial 50S ribosomal subunit inhibitor,
Pleural Mesothelioma,BRD-K59522102-001-15-3::2.46::HTS,6.5974593434995095,0.010486165792658942,Other Types,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Pleural Mesothelioma,BRD-K60443845-001-08-6::2.5::HTS,7.407265411233872,0.006706216631070442,Pleural Mesothelioma,chlormidazole,fungal lanosterol demethylase inhibitor,
Pleural Mesothelioma,BRD-K60511616-236-08-9::2.5::HTS,9.763211728619124,0.0018735617187426456,Other Types,pravastatin,HMGCR inhibitor,"HMGCR, SLCO1B1"
Pleural Mesothelioma,BRD-K61192372-001-08-9::2.5::HTS,5.747635894498846,0.016838009102712603,Other Types,capecitabine,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS
Pleural Mesothelioma,BRD-K61228301-001-01-2::2.5::HTS,6.959640270773352,0.0085691278160937,Pleural Mesothelioma,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Pleural Mesothelioma,BRD-K61691541-001-01-1::2.5::HTS,16.463665816544715,5.667851207116811e-05,Pleural Mesothelioma,PF-03084014,gamma secretase inhibitor,
Pleural Mesothelioma,BRD-K62213621-001-01-6::2.5::HTS,4.785912250648074,0.029110575213492917,Pleural Mesothelioma,dihydroartemisinin,antimalarial agent,
Pleural Mesothelioma,BRD-K62304154-001-04-2::2.5::HTS,12.032474984252378,0.0005646271431657693,Pleural Mesothelioma,deforolimus,mTOR inhibitor,MTOR
Pleural Mesothelioma,BRD-K62627508-001-01-5::2.5::HTS,8.609162105186822,0.0034818213896154458,Other Types,idasanutlin,MDM inhibitor,"MDM2, TP53"
Pleural Mesothelioma,BRD-K62696033-001-01-4::2.5::HTS,3.992925760147937,0.046175585782126966,Pleural Mesothelioma,G-1,G protein-coupled receptor agonist,GPER1
Pleural Mesothelioma,BRD-K63068307-001-08-9::2.5::HTS,5.548876660653271,0.018840116956315017,Pleural Mesothelioma,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Pleural Mesothelioma,BRD-K63550407-001-13-5::2.5::HTS,5.554725668659306,0.018795051231992335,Other Types,erythromycin,NFkB pathway inhibitor,MLNR
Pleural Mesothelioma,BRD-K63736853-001-04-8::2.5::HTS,5.815852061981971,0.016211338086974746,Other Types,acipimox,cholesterol inhibitor,HCAR2
Pleural Mesothelioma,BRD-K63750851-001-20-7::2.5::HTS,4.0768610084251105,0.043950314174657654,Pleural Mesothelioma,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Pleural Mesothelioma,BRD-K64191834-001-03-1::2.5::HTS,7.197963320487946,0.007519875467850707,Other Types,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,
Pleural Mesothelioma,BRD-K64381438-001-03-8::2.5::HTS,5.906246869039628,0.015406073706537307,Other Types,ulipristal,progesterone receptor antagonist,PGR
Pleural Mesothelioma,BRD-K64538373-001-01-4::2.5::HTS,5.215814412351645,0.02275790059665344,Pleural Mesothelioma,Ro-4987655,MEK inhibitor,MAP2K1
Pleural Mesothelioma,BRD-K64881305-001-03-7::2.5::HTS,6.554434514328149,0.010724492649360514,Pleural Mesothelioma,ispinesib,kinesin inhibitor,KIF11
Pleural Mesothelioma,BRD-K64925568-001-01-8::2.5::HTS,4.527297588647031,0.03379679113702551,Other Types,AMG-232,MDM inhibitor,MDM2
Pleural Mesothelioma,BRD-K65285700-001-02-3::2.5::HTS,6.479412966031979,0.011184434395072477,Pleural Mesothelioma,GP1a,cannabinoid receptor agonist,CNR2
Pleural Mesothelioma,BRD-K65781196-001-03-0::2.5::HTS,11.922058745687144,0.0005972667156000062,Other Types,avanafil,phosphodiesterase inhibitor,PDE5A
Pleural Mesothelioma,BRD-K65820248-001-01-8::2.5::HTS,4.262258322021242,0.03943463147860415,Other Types,SDZ-NKT-343,tachykinin antagonist,TACR1
Pleural Mesothelioma,BRD-K66615216-003-14-8::2.5::HTS,4.285000036850164,0.03891543832318439,Pleural Mesothelioma,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A
Pleural Mesothelioma,BRD-K66788707-001-14-3::2.5::HTS,5.313911812867085,0.021524458430473844,Pleural Mesothelioma,fludarabine,ribonucleotide reductase inhibitor,"ADA, RRM1, RRM2"
Pleural Mesothelioma,BRD-K67525671-001-02-5::2.5::HTS,8.235971667986796,0.00426594118165812,Other Types,ZK-200775,kainate receptor antagonist,
Pleural Mesothelioma,BRD-K67578145-001-09-7::2.38::HTS,7.679810083801577,0.005781142731826054,Pleural Mesothelioma,GDC-0879,RAF inhibitor,BRAF
Pleural Mesothelioma,BRD-K67578145-001-12-1::2.5::HTS,3.961360560866181,0.04704702033427117,Pleural Mesothelioma,GDC-0879,RAF inhibitor,BRAF
Pleural Mesothelioma,BRD-K67868012-001-07-6::2.5::HTS,4.117716454927489,0.04290710191916373,Pleural Mesothelioma,PI-103,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Pleural Mesothelioma,BRD-K67977190-066-02-3::2.5::HTS,4.139732136424408,0.04237043980702082,Pleural Mesothelioma,eprosartan,angiotensin receptor antagonist,AGTR1
Pleural Mesothelioma,BRD-K68065987-300-09-1::2.5::HTS,7.159338648427453,0.00767848222885955,Pleural Mesothelioma,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Pleural Mesothelioma,BRD-K68164687-001-01-6::2.5::HTS,5.549662911292781,0.018828007757615582,Pleural Mesothelioma,epothilone-b,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Pleural Mesothelioma,BRD-K68474068-001-01-8::2.5::HTS,5.176852565531181,0.0232681495110053,Other Types,MM-102,WDR5/MLL interaction inhibitor,
Pleural Mesothelioma,BRD-K69216798-001-01-9::2.5::HTS,5.304372664654178,0.021646908175155202,Other Types,iodoantipyrine,,
Pleural Mesothelioma,BRD-K69577666-001-01-3::2.5::HTS,7.802497381180816,0.005395257490283591,Other Types,SGC-0946,histone lysine methyltransferase inhibitor,
Pleural Mesothelioma,BRD-K69837166-003-02-0::2.5::HTS,4.150240986230516,0.042110309901682824,Other Types,trap-101,"nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist",OPRL1
Pleural Mesothelioma,BRD-K70246307-001-04-1::2.5::HTS,5.726126940247882,0.0170438983408774,Other Types,riboflavin,vitamin B2,"BLVRB, RFK"
Pleural Mesothelioma,BRD-K70301876-034-13-7::2.5::HTS,5.667195057833767,0.01762220003009218,Other Types,escitalopram,selective serotonin reuptake inhibitor (SSRI),"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4"
Pleural Mesothelioma,BRD-K70778732-003-26-7::2.5::HTS,6.395436840368978,0.011714841179515573,Other Types,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4"
Pleural Mesothelioma,BRD-K71106091-001-06-1::2.5::HTS,4.184525816088175,0.041266363858752646,Pleural Mesothelioma,fludarabine-phosphate,ribonucleotide reductase inhibitor,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Pleural Mesothelioma,BRD-K71221037-001-01-6::2.5::HTS,5.547239048218132,0.018853836084732484,Pleural Mesothelioma,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Pleural Mesothelioma,BRD-K71480163-001-01-4::2.5::HTS,6.720022550516865,0.009782574779132686,Pleural Mesothelioma,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Pleural Mesothelioma,BRD-K71799949-001-36-4::2.5::HTS,5.45777624708961,0.01983329276969518,Other Types,carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Pleural Mesothelioma,BRD-K72004355-001-01-9::2.5::HTS,9.331993209579878,0.002358632072558875,Other Types,CFTRinh-172,chloride channel blocker,CFTR
Pleural Mesothelioma,BRD-K73157543-001-04-1::2.5::HTS,4.2125884913429195,0.0405917988873037,Other Types,phenyl-aminosalicylate,,
Pleural Mesothelioma,BRD-K73191876-001-11-2::2.5::HTS,4.689680788066903,0.030776541675804882,Other Types,alizarin,,
Pleural Mesothelioma,BRD-K73440166-001-01-3::2.5::HTS,9.053965184870808,0.00273873668136845,Other Types,cinaciguat,guanylate cyclase activator,"GUCY1A3, GUCY1B3"
Pleural Mesothelioma,BRD-K73524797-001-01-1::2.5::HTS,3.9665636360001693,0.04689593259448532,Other Types,ST-1859,antiamyloidogenic agent,
Pleural Mesothelioma,BRD-K73529671-001-04-5::2.5::HTS,3.9605381738943564,0.04706631649381249,Other Types,troxerutin,antioxidant,
Pleural Mesothelioma,BRD-K73642618-001-13-3::2.5::HTS,8.10298764721613,0.004582114909940973,Other Types,bromopride,dopamine receptor antagonist,DRD2
Pleural Mesothelioma,BRD-K73982490-001-02-9::2.5::HTS,11.374175649444716,0.000796916707843231,Pleural Mesothelioma,BI-78D3,JNK inhibitor,MAPK8
Pleural Mesothelioma,BRD-K73999723-001-11-3::2.5::HTS,4.164705322303204,0.04174132657594285,Other Types,telmisartan,angiotensin receptor antagonist,"AGTR1, PPARG"
Pleural Mesothelioma,BRD-K74065929-001-07-2::2.5::HTS,7.161806760707919,0.007664502576022815,Other Types,doramapimod,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK13, MAPK14"
Pleural Mesothelioma,BRD-K74339692-001-01-9::2.5::HTS,4.008323955633704,0.045764895498967825,Other Types,tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Pleural Mesothelioma,BRD-K75009076-001-02-1::2.43::HTS,4.684155054335295,0.03088958513516729,Pleural Mesothelioma,SCH-900776,CHK inhibitor,"CDK2, CHEK1"
Pleural Mesothelioma,BRD-K75615183-300-03-9::2.5::HTS,4.035273955007812,0.045040521426978494,Other Types,talipexole,"adrenergic receptor agonist, dopamine receptor agonist","ADRA2A, DRD2, HTR3A"
Pleural Mesothelioma,BRD-K75958547-238-01-0::2.5::HTS,3.984873108598993,0.04639429425099642,Other Types,pitavastatin,HMGCR inhibitor,HMGCR
Pleural Mesothelioma,BRD-K76406695-001-02-9::2.5::HTS,4.953086946245191,0.026442939655831863,Pleural Mesothelioma,CCT128930,AKT inhibitor,"PKIA, PRKACA"
Pleural Mesothelioma,BRD-K76568384-001-02-2::2.5::HTS,3.911188309183136,0.04845903791893682,Other Types,PHTPP,estrogen receptor antagonist,ESR2
Pleural Mesothelioma,BRD-K76973696-001-12-6::2.01::HTS,7.36664222750905,0.006851472005140219,Pleural Mesothelioma,tryptanthrin,cyclooxygenase inhibitor,IDO1
Pleural Mesothelioma,BRD-K77251551-304-02-9::2.5::HTS,5.712301532718691,0.01717486445231398,Other Types,sodium-picosulfate,,
Pleural Mesothelioma,BRD-K77627880-001-04-0::2.5::HTS,7.073579145938684,0.008047690544800347,Other Types,A205804,ICAM1 expression inhibitor,"ICAM1, SELE"
Pleural Mesothelioma,BRD-K77641333-003-27-1::2.5::HTS,4.555867673035118,0.03323818905289594,Other Types,naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A"
Pleural Mesothelioma,BRD-K78126613-001-28-5::2.5::HTS,6.145426360877007,0.01346749953421432,Pleural Mesothelioma,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Pleural Mesothelioma,BRD-K78303961-001-02-3::2.5::HTS,5.777365635387501,0.01655671079233291,Other Types,glycitein,tumor necrosis factor release inhibitor,TNF
Pleural Mesothelioma,BRD-K79239947-001-06-8::2.5::HTS,5.137238877302968,0.023802628010790885,Pleural Mesothelioma,PF-573228,focal adhesion kinase inhibitor,"CDK1, CDK2, CDK7, GSK3B, IKBKB"
Pleural Mesothelioma,BRD-K79404599-001-09-3::2.5::HTS,6.6423098739688715,0.010212222984902026,Other Types,enzastaurin,PKC inhibitor,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG"
Pleural Mesothelioma,BRD-K79425933-001-09-3::2.5::HTS,4.630129841116593,0.031846671776120855,Pleural Mesothelioma,benperidol,dopamine receptor antagonist,DRD2
Pleural Mesothelioma,BRD-K80431395-001-07-3::2.49::HTS,5.737014850040915,0.016958391703231768,Pleural Mesothelioma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Pleural Mesothelioma,BRD-K80431395-001-09-9::2.5::HTS,7.694944029727141,0.005733943349506486,Pleural Mesothelioma,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Pleural Mesothelioma,BRD-K80608265-001-01-6::2.5::HTS,6.8553504127054445,0.009096301867422904,Pleural Mesothelioma,erteberel,estrogen receptor agonist,"ESR1, ESR2"
Pleural Mesothelioma,BRD-K81092066-311-01-6::2.5::HTS,5.879347583673464,0.015642957384909492,Other Types,phenacaine,local anesthetic,
Pleural Mesothelioma,BRD-K81136890-003-01-6::2.5::HTS,9.475864019881636,0.0021857296402528047,Other Types,leucylleucine-methyl-ester,,
Pleural Mesothelioma,BRD-K81197548-003-01-4::2.5::HTS,3.9471683672854776,0.04743892920017972,Pleural Mesothelioma,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Pleural Mesothelioma,BRD-K81272440-236-13-5::2.5::HTS,13.049186252406946,0.00033141888363535146,Other Types,dantrolene,calcium channel blocker,"RYR1, RYR3"
Pleural Mesothelioma,BRD-K81326768-001-04-0::2.5::HTS,4.1780789542587575,0.041419853511073704,Other Types,zomepirac,prostaglandin synthesis inhibitor,PTGDR2
Pleural Mesothelioma,BRD-K81807412-001-10-6::2.5::HTS,6.3464061573707715,0.012046340628601817,Other Types,N6-methyladenosine,,
Pleural Mesothelioma,BRD-K81957469-001-01-0::2.5::HTS,7.241734187941784,0.007335612053558115,Pleural Mesothelioma,semagacestat,gamma secretase inhibitor,PSEN1
Pleural Mesothelioma,BRD-K82142815-001-19-1::2.5::HTS,6.010255160289127,0.014528460098739029,Other Types,betamipron,panipenem uptake inhibitor,
Pleural Mesothelioma,BRD-K82244583-001-01-3::2.5::HTS,5.998308733443736,0.01463692936759622,Pleural Mesothelioma,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Pleural Mesothelioma,BRD-K82343404-003-02-4::2.5::HTS,3.907277641962837,0.048582936515430136,Other Types,adrenalone,adrenergic receptor agonist,ADRA1A
Pleural Mesothelioma,BRD-K82767007-001-01-1::2.5::HTS,6.3098824102503315,0.012294035743384587,Other Types,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Pleural Mesothelioma,BRD-K82818427-001-02-2::2.39::HTS,12.704585077497606,0.0003978450184435466,Pleural Mesothelioma,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Pleural Mesothelioma,BRD-K82846253-001-15-4::2.5::HTS,4.082727756506315,0.04382323607789096,Other Types,repaglinide,insulin secretagogue,"ABCC8, KCNJ11, PPARG"
Pleural Mesothelioma,BRD-K82861010-001-02-5::2.5::HTS,3.873620991840664,0.04959614067653906,Pleural Mesothelioma,daclatasvir,HCV inhibitor,
Pleural Mesothelioma,BRD-K83720053-001-03-8::2.5::HTS,4.1590193088743606,0.041900559366828856,Pleural Mesothelioma,avagacestat,gamma secretase inhibitor,PSEN1
Pleural Mesothelioma,BRD-K84011460-051-01-7::2.5::HTS,4.492347735654829,0.03450337250905464,Other Types,nizofenone,ion channel antagonist,
Pleural Mesothelioma,BRD-K84466663-001-05-4::2.5::HTS,7.976427939062127,0.0049121887862047945,Other Types,nelarabine,"DNA synthesis inhibitor, T cell inhibitor",POLA1
Pleural Mesothelioma,BRD-K85119730-001-28-9::2.5::HTS,7.852475810575621,0.005255314955337614,Other Types,tolbutamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ11, KCNJ8"
Pleural Mesothelioma,BRD-K86003836-001-10-5::2.5::HTS,4.488681650498282,0.03456122975838806,Pleural Mesothelioma,flubendazole,tubulin polymerization inhibitor,TUBB
Pleural Mesothelioma,BRD-K86301799-001-34-8::2.5::HTS,5.507023277067876,0.019289647119044837,Other Types,dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1"
Pleural Mesothelioma,BRD-K86600316-003-02-0::2.5::HTS,4.136202896673077,0.0424469375014087,Other Types,RS-79948,adrenergic receptor antagonist,ADRA2A
Pleural Mesothelioma,BRD-K86816506-001-01-8::2.5::HTS,5.261757396463603,0.022184960622969485,Other Types,PF-04457845,FAAH inhibitor,FAAH
Pleural Mesothelioma,BRD-K86930074-001-05-0::2.5::HTS,10.354825347040983,0.0013679684713777576,Other Types,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Pleural Mesothelioma,BRD-K87024524-065-17-7::2.5::HTS,4.462184239611219,0.035112465843289746,Other Types,phenelzine,monoamine oxidase inhibitor,"ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4"
Pleural Mesothelioma,BRD-K87158025-001-01-6::2.5::HTS,3.9432482273974236,0.047549651504054456,Other Types,benzamil,sodium channel blocker,"ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1"
Pleural Mesothelioma,BRD-K88429204-001-35-1::2.5::HTS,4.165530107853359,0.041723671650178276,Pleural Mesothelioma,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Pleural Mesothelioma,BRD-K89048337-001-06-9::2.5::HTS,4.260949108301089,0.03946310446749689,Pleural Mesothelioma,puerarin,serotonin receptor antagonist,
Pleural Mesothelioma,BRD-K89348303-001-14-7::2.5::HTS,4.705264974733638,0.030491131218688277,Other Types,ramipril,angiotensin converting enzyme inhibitor,ACE
Pleural Mesothelioma,BRD-K89997465-003-43-0::2.5::HTS,4.803758051533102,0.028809487817461114,Other Types,chlorpromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5"
Pleural Mesothelioma,BRD-K90868879-001-03-8::2.5::HTS,7.4727394756549685,0.006461404998022993,Other Types,canagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Pleural Mesothelioma,BRD-K90948141-001-01-4::2.5::HTS,4.542583639350434,0.03355166197162235,Other Types,indiplon,benzodiazepine receptor agonist,GABRA1
Pleural Mesothelioma,BRD-K91065602-003-05-5::2.5::HTS,6.061536029037855,0.014123635400215002,Other Types,vancomycin,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-K91111634-001-01-2::2.5::HTS,5.741223888798335,0.016898941045287733,Other Types,rotigotine,dopamine receptor agonist,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A"
Pleural Mesothelioma,BRD-K92015269-300-01-2::2.5::HTS,3.9577671296486474,0.0471468140192939,Other Types,GBR-12783,dopamine uptake inhibitor,
Pleural Mesothelioma,BRD-K92116564-001-01-4::2.5::HTS,9.885077610344217,0.0017554967421184934,Pleural Mesothelioma,isoxepac,anti-inflammatory agent,
Pleural Mesothelioma,BRD-K92241597-001-06-0::2.5::HTS,7.5544491668903895,0.006178607353313637,Pleural Mesothelioma,tosedostat,peptidase inhibitor,"ANPEP, LAP3, NPEPPS"
Pleural Mesothelioma,BRD-K92731339-227-04-9::2.5::HTS,3.9954247030718935,0.04610940804965594,Other Types,perindopril,angiotensin converting enzyme inhibitor,ACE
Pleural Mesothelioma,BRD-K92988025-001-01-9::2.5::HTS,6.36646581352867,0.01192218132263697,Other Types,perflubron,contrast agent,
Pleural Mesothelioma,BRD-K93188295-300-02-2::2.5::HTS,11.469679476982908,0.0007571402698156802,Other Types,ARC-239,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C"
Pleural Mesothelioma,BRD-K93524252-001-24-7::2.5::HTS,4.371687414466581,0.03699502163908967,Pleural Mesothelioma,sulfamerazine,bacterial antifolate,
Pleural Mesothelioma,BRD-K93645900-001-11-3::2.5::HTS,4.011094682032288,0.04568161450640828,Other Types,tadalafil,phosphodiesterase inhibitor,"PDE11A, PDE5A"
Pleural Mesothelioma,BRD-K93944989-001-08-0::0.25::HTS,5.368899171972508,0.020858685598020017,Other Types,safingol,PKC inhibitor,TRPM3
Pleural Mesothelioma,BRD-K94358652-001-02-1::2.5::HTS,7.040806840851349,0.008208263071757335,Other Types,daptomycin,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-K94485812-001-02-9::2.55::HTS,4.9169359003739554,0.027019665327564626,Pleural Mesothelioma,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Pleural Mesothelioma,BRD-K94559059-091-01-6::2.5::HTS,3.867808380120956,0.04971948091565867,Other Types,telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1
Pleural Mesothelioma,BRD-K94720315-001-10-4::2.5::HTS,11.06960650688524,0.0009354164596565403,Other Types,chromocarb,antispasmodic,
Pleural Mesothelioma,BRD-K95581532-001-01-5::2.5::HTS,7.26961030504218,0.007226382954608364,Other Types,RN-1734,TRPV antagonist,TRPV4
Pleural Mesothelioma,BRD-K95763993-001-19-3::2.5::HTS,5.5429171870479275,0.018898751243845203,Other Types,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA
Pleural Mesothelioma,BRD-K96631475-001-04-0::2.5::HTS,4.883974502765063,0.027515209820412265,Pleural Mesothelioma,10-deacetylbaccatin,antitumor agent,
Pleural Mesothelioma,BRD-K97233161-003-01-5::2.5::HTS,6.759263220294106,0.009578644375680054,Other Types,ABT-491,platelet activating factor receptor antagonist,PTAFR
Pleural Mesothelioma,BRD-K97764662-001-17-3::2.5::HTS,6.9377478100679335,0.008675431593720313,Other Types,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Pleural Mesothelioma,BRD-K97810537-001-12-8::2.54::HTS,4.074203271812542,0.04404787353315784,Other Types,beclomethasone-dipropionate,glucocorticoid receptor agonist,"GPR97, NR3C1"
Pleural Mesothelioma,BRD-K98357249-001-02-9::2.5::HTS,4.494425700514909,0.03444945011740309,Other Types,IRL-2500,endothelin receptor antagonist,EDNRB
Pleural Mesothelioma,BRD-K98769987-001-23-7::2.5::HTS,3.8639746557831125,0.04983968613264056,Other Types,flumazenil,benzodiazepine receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
Pleural Mesothelioma,BRD-K99023089-001-03-7::2.5::HTS,7.461484101514429,0.006502456252755816,Pleural Mesothelioma,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Pleural Mesothelioma,BRD-K99048103-001-18-4::2.5::HTS,4.730608291440891,0.030049604844611038,Other Types,acetarsol,,
Pleural Mesothelioma,BRD-K99615199-001-18-5::2.5::HTS,4.075628043593793,0.043983865712573775,Other Types,medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR"
Pleural Mesothelioma,BRD-M89827113-001-01-5::2.5::HTS,4.924579265248004,0.026887514391556226,Other Types,cromakalim,,KCNJ8
Pleural Mesothelioma,BRD-U08520523-000-01-0::2.5::HTS,3.9836584867951563,0.046465765255123324,Other Types,colesevalam,,
Pleural Mesothelioma,BRD-A00055058-001-01-0::2.325889319::MTS004,8.448988347494263,0.003802733786850283,Other Types,RS-0481,immunostimulant,
Pleural Mesothelioma,BRD-A02232681-001-01-8::2.5::MTS004,4.537282664571288,0.033616462977291775,Other Types,isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2"
Pleural Mesothelioma,BRD-A04447196-001-01-8::2.5::MTS004,4.012409379383939,0.045666761130654245,Other Types,gepefrine,adrenergic receptor agonist,
Pleural Mesothelioma,BRD-A42881122-001-01-1::2.648380541::MTS004,4.8998039289644035,0.027278478143357827,Other Types,cyamemazine,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C, HTR7"
Pleural Mesothelioma,BRD-A44511856-001-01-4::2.499987042::MTS004,6.536797045978123,0.010839912763428787,Other Types,ginsenoside-rg3,"angiogenesis inhibitor, apoptosis stimulant",KCNH2
Pleural Mesothelioma,BRD-A44971162-001-02-7::2.5::MTS004,5.018908479073449,0.02547939525333753,Other Types,ODM-201,androgen receptor antagonist,AR
Pleural Mesothelioma,BRD-A53077924-001-01-2::2.499990763::MTS004,8.697885046802865,0.003324335003702839,Other Types,tianeptine,selective serotonin reuptake enhancer (SSRE),"OPRD1, OPRK1, OPRM1"
Pleural Mesothelioma,BRD-A56241705-003-01-2::2.639158457::MTS004,5.2694905789689495,0.02208616429817685,Other Types,trimethoquinol,adrenergic receptor antagonist,"ADRB2, ADRB3"
Pleural Mesothelioma,BRD-A56892734-001-09-4::2.5::MTS004,6.789225214162506,0.009424433504242517,Other Types,omeprazole-magnesium,proton pump inhibitor,"ATP4A, ATP4B"
Pleural Mesothelioma,BRD-A61633223-001-02-8::2.678394161::MTS004,5.429254679513363,0.02017106191147188,Pleural Mesothelioma,ulifloxacin,,
Pleural Mesothelioma,BRD-A92177080-001-02-1::2.5::MTS004,7.660083903242826,0.005839683870702352,Other Types,betamethasone-acetate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-K02528732-001-02-4::2.425128585::MTS004,8.641654184382785,0.0034268097964121414,Other Types,fluorometholone-acetate,,NR3C1
Pleural Mesothelioma,BRD-K06182768-001-02-3::2.5::MTS004,6.601885482110299,0.010455350697885344,Pleural Mesothelioma,A-366,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Pleural Mesothelioma,BRD-K13060017-001-02-1::2.499994836::MTS004,9.018570143585757,0.002796548206119315,Pleural Mesothelioma,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Pleural Mesothelioma,BRD-K17295893-001-01-0::2.499987615::MTS004,11.610284164439074,0.0007049581827554344,Other Types,nastorazepide,CCK receptor antagonist,CCKBR
Pleural Mesothelioma,BRD-K18135438-001-14-2::2.5::MTS004,4.631642658697725,0.03183169477908732,Other Types,chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4"
Pleural Mesothelioma,BRD-K21612934-001-01-1::2.473727942::MTS004,5.170087585187967,0.023372194352650214,Other Types,leteprinim,nerve growth factor agonist,
Pleural Mesothelioma,BRD-K24666289-001-04-9::2.499988887::MTS004,5.117572344933479,0.02408207821743778,Pleural Mesothelioma,copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Pleural Mesothelioma,BRD-K27515606-003-01-3::2.5::MTS004,4.585529367294722,0.032690732767979465,Pleural Mesothelioma,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
Pleural Mesothelioma,BRD-K28061410-001-06-6::2.5::MTS004,4.127102863395207,0.0426915895616668,Pleural Mesothelioma,beta-lapachone,topoisomerase inhibitor,TOP1
Pleural Mesothelioma,BRD-K28687144-001-08-7::2.5::MTS004,6.702170513431097,0.009889605325359124,Other Types,fosfosal,phosphodiesterase inhibitor,"PTGS1, PTGS2"
Pleural Mesothelioma,BRD-K30159788-001-01-9::2.49998123::MTS004,4.092336618143055,0.043572118101456905,Other Types,RSV604,RSV replication inhibitor,
Pleural Mesothelioma,BRD-K30764557-001-01-5::2.5::MTS004,6.118311456525791,0.013685928885710132,Other Types,miocamycin,other antibiotic,
Pleural Mesothelioma,BRD-K31802667-001-01-9::2.530781625::MTS004,6.953767503196475,0.00860608500721472,Other Types,JNJ-37822681,dopamine receptor antagonist,DRD2
Pleural Mesothelioma,BRD-K35304636-001-01-0::2.5::MTS004,6.199515093294388,0.013078775569869083,Other Types,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Pleural Mesothelioma,BRD-K36524108-065-04-0::2.500001799::MTS004,6.485011862170627,0.011155739106527708,Other Types,paromomycin,bacterial 30S ribosomal subunit inhibitor,
Pleural Mesothelioma,BRD-K38527262-300-01-0::2.300987371::MTS004,4.035572295032285,0.04504965817895858,Pleural Mesothelioma,atiprimod,"JAK inhibitor, STAT inhibitor","JAK2, STAT3"
Pleural Mesothelioma,BRD-K44471774-001-01-8::2.670187358::MTS004,7.130885568610335,0.007805496442926624,Other Types,bay-w-9798,antioxidant,
Pleural Mesothelioma,BRD-K55808645-001-01-4::2.500006596::MTS004,5.059995114288146,0.024887841203083558,Other Types,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Pleural Mesothelioma,BRD-K57886322-001-16-6::2.5::MTS004,7.691952316773807,0.005739265458504392,Other Types,fluocinonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6, SMO"
Pleural Mesothelioma,BRD-K58810291-001-16-2::2.564588683::MTS004,7.466269938501022,0.00649285700639232,Other Types,clobetasone-butyrate,corticosteroid agonist,NR3C1
Pleural Mesothelioma,BRD-K59256312-066-15-7::2.431061328::MTS004,4.304563664079317,0.038485058958340555,Other Types,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Pleural Mesothelioma,BRD-K59753975-001-02-6::2.5::MTS004,7.962204249810126,0.004952649773002005,Other Types,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Pleural Mesothelioma,BRD-K61496577-001-19-4::2.5::MTS004,11.864832848541171,0.0006166565268927045,Other Types,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Pleural Mesothelioma,BRD-K67186445-001-02-1::2.500004874::MTS004,6.995466297120241,0.008410426266182288,Other Types,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE
Pleural Mesothelioma,BRD-K70330032-001-01-1::2.50000853::MTS004,10.904884667366204,0.001022681729491813,Other Types,JNJ-42165279,FAAH inhibitor,FAAH
Pleural Mesothelioma,BRD-K76594255-001-01-6::2.5000235::MTS004,6.236268621985449,0.012813726573396543,Other Types,maropitant,neurokinin receptor antagonist,TACR1
Pleural Mesothelioma,BRD-K80419150-001-02-4::2.5::MTS004,7.956465039476307,0.0049681460995912715,Other Types,debrisoquin,adrenergic neuron blocker,SLC6A2
Pleural Mesothelioma,BRD-K80762071-236-02-5::2.5::MTS004,4.238511742217289,0.03999677433483897,Other Types,indocyanine-green,contrast agent,SLCO1B1
Pleural Mesothelioma,BRD-K80859331-001-01-5::2.5::MTS004,10.305457671512606,0.0014055253380990762,Pleural Mesothelioma,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Pleural Mesothelioma,BRD-K82103381-003-09-4::2.500073689::MTS004,3.971278572427474,0.046786394493217864,Pleural Mesothelioma,hydralazine,vasodilator,"AOC3, P4HA1"
Pleural Mesothelioma,BRD-K88143662-001-01-5::2.5::MTS004,4.24990731013646,0.03973141450838393,Pleural Mesothelioma,metharbital,GABA receptor modulator,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2"
Pleural Mesothelioma,BRD-K89121095-001-01-7::2.499999138::MTS004,4.192325332694559,0.04109153949878701,Pleural Mesothelioma,tedizolid-phosphate,protein synthesis inhibitor,
Pleural Mesothelioma,BRD-K92908289-001-01-8::2.501017998::MTS004,4.580080486875815,0.032794766182674934,Other Types,medica-16,ATP citrase lyase inhibitor,FFAR1
Pleural Mesothelioma,BRD-K95941975-001-01-5::2.5::MTS004,6.333673312122409,0.012135826685802152,Other Types,piperazinedione,DNA synthesis inhibitor,
Pleural Mesothelioma,BRD-K96344439-002-02-7::2.500011072::MTS004,8.693826866168108,0.0033316248543282484,Pleural Mesothelioma,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK
Pleural Mesothelioma,BRD-K99199077-001-16-1::2.603211317::MTS004,5.842925901172316,0.01597067664760176,Other Types,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1
Pleural Mesothelioma,BRD-K99447003-335-04-1::2.37737659::MTS004,4.959959806798488,0.026353061321407908,Other Types,enalaprilat,angiotensin converting enzyme inhibitor,ACE
Prostate Adenocarcinoma,BRD-A08660406-001-05-9::2.5::HTS,7.772746650372039,0.005500879004017101,Other Types,iodixanol,radiopaque medium,
Prostate Adenocarcinoma,BRD-A15435692-003-02-3::2.5::HTS,4.030140253478774,0.045179357832719126,Prostate Adenocarcinoma,BMY-14802,sigma receptor antagonist,HTR1A
Prostate Adenocarcinoma,BRD-A20839672-003-01-5::2.5::HTS,4.553385503223804,0.033288323746259306,Prostate Adenocarcinoma,cefmenoxime,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-A26387268-050-04-4::2.5::HTS,3.974484281612752,0.04668093868994295,Other Types,ergonovine,"adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E"
Prostate Adenocarcinoma,BRD-A26845397-051-01-9::2.5::HTS,8.793560467208835,0.003152007736145709,Prostate Adenocarcinoma,isamoltane,adrenergic receptor antagonist,"HTR1A, HTR1B"
Prostate Adenocarcinoma,BRD-A29260609-003-26-0::2.5::HTS,4.016615132753955,0.04553684774294163,Prostate Adenocarcinoma,acebutolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Prostate Adenocarcinoma,BRD-A29731977-001-04-5::2.5::HTS,4.089465808637146,0.04362701410613356,Other Types,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Prostate Adenocarcinoma,BRD-A30655177-001-14-0::2.5::HTS,4.434745811694805,0.03566380940615723,Other Types,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Prostate Adenocarcinoma,BRD-A39189014-003-22-7::2.5::HTS,6.225653502689791,0.012879633528174958,Other Types,methoxamine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D"
Prostate Adenocarcinoma,BRD-A41304429-001-14-8::2.5::HTS,4.805415619052215,0.02878203063701237,Other Types,practolol,adrenergic receptor antagonist,ADRB1
Prostate Adenocarcinoma,BRD-A41774846-001-01-4::2.5::HTS,5.181914399253785,0.023198406519675054,Other Types,algestone-acetophenide,,
Prostate Adenocarcinoma,BRD-A50737080-001-03-0::2.5::HTS,4.203454125052663,0.04080842793826302,Other Types,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR"
Prostate Adenocarcinoma,BRD-A51382177-236-03-0::2.5::HTS,7.41406383210723,0.006672631329445183,Other Types,fosinopril,angiotensin converting enzyme inhibitor,ACE
Prostate Adenocarcinoma,BRD-A61793559-001-15-6::2.5::HTS,10.731435127005197,0.0011188052468939012,Other Types,metolazone,carbonic anhydrase inhibitor,SLC12A3
Prostate Adenocarcinoma,BRD-A63780829-001-11-4::2.5::HTS,4.5326650728094835,0.0336894905170633,Other Types,hyperin,aldose reductase inhibitor,"ACE, AKR1B1"
Prostate Adenocarcinoma,BRD-A65671304-001-07-5::2.5::HTS,5.763737328999193,0.01668895061493402,Other Types,candesartan-cilextil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Prostate Adenocarcinoma,BRD-A72711497-236-03-8::2.5::HTS,6.12233863660532,0.013643594153367598,Other Types,lasalocid,bacterial permeability inducer,
Prostate Adenocarcinoma,BRD-A78952587-001-01-5::2.5::HTS,4.40176857599765,0.0363540157253862,Other Types,A740003,purinergic receptor antagonist,P2RX7
Prostate Adenocarcinoma,BRD-A79431551-001-01-1::2.5::HTS,4.07661319723937,0.04395501696579282,Other Types,3-deazaadenosine,adenosylhomocysteinase inhibitor,AHCY
Prostate Adenocarcinoma,BRD-A85587465-001-03-3::2.5::HTS,5.367672882552063,0.020871928014499934,Other Types,bemesetron,serotonin receptor antagonist,"HTR3A, HTR3B"
Prostate Adenocarcinoma,BRD-A89164055-001-03-3::2.5::HTS,6.682108534516016,0.009990704800637464,Prostate Adenocarcinoma,sorbinil,aldose reductase inhibitor,AKR1B1
Prostate Adenocarcinoma,BRD-A89196962-300-01-7::2.5::HTS,7.175339030058565,0.00760763976734696,Other Types,dalargin,opioid receptor agonist,OPRM1
Prostate Adenocarcinoma,BRD-A94033181-001-01-4::2.5::HTS,5.4103507247753955,0.02037764074934423,Prostate Adenocarcinoma,AZD6765,glutamate receptor antagonist,GRIN1
Prostate Adenocarcinoma,BRD-A94709349-001-08-3::2.5::HTS,7.002083322821807,0.008371207727027817,Other Types,metaxalone,muscle relaxant,
Prostate Adenocarcinoma,BRD-A95869247-001-26-9::2.5::HTS,4.05697467158871,0.044466898572712,Prostate Adenocarcinoma,indapamide,thiazide diuretic,"KCNE1, KCNQ1, SLC12A3"
Prostate Adenocarcinoma,BRD-A96485169-001-14-3::2.5::HTS,3.909823708281404,0.04849284052188594,Prostate Adenocarcinoma,EBPC,aldose reductase inhibitor,AKR1B1
Prostate Adenocarcinoma,BRD-K00519864-341-03-3::2.39::HTS,8.615280973544497,0.0034787036867113996,Other Types,peramivir,neuraminidase inhibitor,
Prostate Adenocarcinoma,BRD-K01244426-236-12-1::2.5::HTS,5.509196885385215,0.019265929960696915,Other Types,cloxacillin,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K01493881-001-29-4::2.5::HTS,4.236387624571162,0.040035121892712425,Other Types,apigenin,"casein kinase inhibitor, cell proliferation inhibitor","AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1"
Prostate Adenocarcinoma,BRD-K01577834-001-15-1::2.5::HTS,5.908231425406482,0.01539544290167212,Prostate Adenocarcinoma,adenosine,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4"
Prostate Adenocarcinoma,BRD-K02130563-001-11-4::2.5::HTS,4.965394051027571,0.026259987227154346,Prostate Adenocarcinoma,panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9"
Prostate Adenocarcinoma,BRD-K03109492-001-02-2::2.5::HTS,4.1791258047886695,0.041397020414309926,Prostate Adenocarcinoma,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Prostate Adenocarcinoma,BRD-K03294269-001-08-0::2.5::HTS,4.270145666849625,0.03924514913717543,Other Types,NU6027,CDK inhibitor,"CCNA2, CDK2"
Prostate Adenocarcinoma,BRD-K04176066-001-08-3::2.5::HTS,7.8018051128549395,0.005397936459738927,Other Types,bergenin,interleukin inhibitor,"IL1B, TNF"
Prostate Adenocarcinoma,BRD-K05236810-001-19-0::2.5::HTS,4.791625253688658,0.029013530991126038,Prostate Adenocarcinoma,luteolin,glucosidase inhibitor,TOP1
Prostate Adenocarcinoma,BRD-K05524748-003-04-4::2.5::HTS,5.103812210818694,0.02427495448067176,Other Types,dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A"
Prostate Adenocarcinoma,BRD-K06152156-001-01-8::2.5::HTS,4.471134310591106,0.03498275050535343,Prostate Adenocarcinoma,methoxyflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1"
Prostate Adenocarcinoma,BRD-K08619574-334-05-4::2.5::HTS,4.065165078945791,0.044253365590251635,Other Types,thioproperazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A"
Prostate Adenocarcinoma,BRD-K08893438-001-04-9::2.52::HTS,7.0737992477372105,0.008064188117010646,Other Types,CCG-50014,G protein signaling inhibitor,"RGS4, RGS8"
Prostate Adenocarcinoma,BRD-K10071630-001-01-0::2.5::HTS,4.4150236429473235,0.0360692833326924,Other Types,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Prostate Adenocarcinoma,BRD-K10799896-001-26-2::2.5::HTS,3.9627210221879423,0.047004903186243,Other Types,clobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Prostate Adenocarcinoma,BRD-K11672787-001-01-5::2.5::HTS,3.99130889077587,0.046219585246079525,Prostate Adenocarcinoma,rostafuroxine,ATPase inhibitor,ATP1A1
Prostate Adenocarcinoma,BRD-K13050303-001-17-3::2.5::HTS,7.104728917821461,0.00792351399554528,Other Types,uridine,dopamine receptor agonist,"LSM6, TYMP"
Prostate Adenocarcinoma,BRD-K13112821-001-17-4::2.5::HTS,4.340268648121251,0.03767893193478304,Other Types,artemisinin,DNA synthesis inhibitor,CYP2B6
Prostate Adenocarcinoma,BRD-K13646352-001-03-8::2.5::HTS,4.535506467616095,0.033638795299515606,Prostate Adenocarcinoma,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Prostate Adenocarcinoma,BRD-K14920963-304-02-7::2.5::HTS,5.019654638392785,0.02545530653337189,Other Types,erythrosine,coloring agent,
Prostate Adenocarcinoma,BRD-K16484091-001-01-1::2.5::HTS,5.33581402773504,0.021253020248157388,Other Types,metocurine,acetylcholine receptor antagonist,"CHRM2, CHRNA2"
Prostate Adenocarcinoma,BRD-K17203476-001-01-9::2.5::HTS,5.266110592480789,0.022113533927254625,Prostate Adenocarcinoma,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Prostate Adenocarcinoma,BRD-K17953908-001-01-7::2.5::HTS,5.526877724701159,0.01907225849393772,Other Types,LY2886721,beta-secretase inhibitor,BACE1
Prostate Adenocarcinoma,BRD-K18324993-001-01-6::2.5::HTS,4.997728123721243,0.02577392896199742,Other Types,budipine,glutamate receptor antagonist,GRIN1
Prostate Adenocarcinoma,BRD-K21528677-001-02-8::2.44::HTS,5.01761648762545,0.025505968976333792,Other Types,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Prostate Adenocarcinoma,BRD-K23335153-300-02-5::2.5::HTS,4.558968556380955,0.03318480555493558,Prostate Adenocarcinoma,AMN-082,glutamate receptor modulator,GRM7
Prostate Adenocarcinoma,BRD-K23586533-001-03-6::2.5::HTS,3.8653165750649032,0.049806718837473125,Prostate Adenocarcinoma,clindamycin,protein synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K24255045-001-05-3::2.5::HTS,5.7466260811207475,0.01685055339532111,Other Types,fluoxymesterone,androgen receptor modulator,"AR, ESR1, NR3C1, PRLR"
Prostate Adenocarcinoma,BRD-K24312986-001-01-2::2.5::HTS,4.9043344365372326,0.02719193078909807,Prostate Adenocarcinoma,tecovirimat,orthopoxvirus egress inhibitor,
Prostate Adenocarcinoma,BRD-K25224017-001-25-0::2.5::HTS,4.536080008707916,0.03362762006815671,Prostate Adenocarcinoma,pirenperone,serotonin receptor antagonist,"HTR2A, HTR7"
Prostate Adenocarcinoma,BRD-K27141178-003-07-3::2.5::HTS,4.844196302896451,0.028152559977845226,Other Types,SB-203186,serotonin receptor antagonist,HTR4
Prostate Adenocarcinoma,BRD-K27168049-001-02-8::2.5::HTS,4.989969982551777,0.025895853540967437,Other Types,SDZ-220-581,glutamate receptor antagonist,GRIN1
Prostate Adenocarcinoma,BRD-K28059174-334-01-2::2.5::HTS,4.847223512118171,0.02810818096295645,Prostate Adenocarcinoma,INCB-003284,CC chemokine receptor antagonist,
Prostate Adenocarcinoma,BRD-K28121004-001-01-1::2.5::HTS,4.617533903518653,0.03207318101343611,Other Types,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,
Prostate Adenocarcinoma,BRD-K28570407-001-02-0::2.5::HTS,8.373787800238368,0.003956833444710091,Other Types,A-803467,sodium channel blocker,SCN10A
Prostate Adenocarcinoma,BRD-K29542628-001-03-9::2.5::HTS,4.514727007876351,0.034047915403281476,Other Types,1-naphthyl-PP1,src inhibitor,SRC
Prostate Adenocarcinoma,BRD-K30020243-051-02-5::2.5::HTS,4.522750000552669,0.033888358762904205,Other Types,aliskiren-hemifumarate,renin inhibitor,REN
Prostate Adenocarcinoma,BRD-K33864865-001-02-5::2.5::HTS,4.083695365359898,0.04377509593299801,Prostate Adenocarcinoma,LY225910,CCK receptor antagonist,CCKBR
Prostate Adenocarcinoma,BRD-K34713073-001-01-3::2.5::HTS,4.391613013770173,0.03656451993044355,Other Types,PD-123319,angiotensin antagonist,AGTR2
Prostate Adenocarcinoma,BRD-K35687421-001-02-5::2.5::HTS,4.3019168819319,0.0385258141101977,Other Types,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD
Prostate Adenocarcinoma,BRD-K35952844-238-01-2::2.5::HTS,5.291506374994706,0.021806501614166352,Other Types,calcium-gluceptate,,
Prostate Adenocarcinoma,BRD-K36040345-001-01-1::2.5::HTS,4.807136795897479,0.028751348344070782,Other Types,TXA127,angiotensin receptor agonist,
Prostate Adenocarcinoma,BRD-K36262466-001-06-3::2.5::HTS,4.968338605984046,0.02621213859942488,Other Types,aceneuramic-acid,,"AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1"
Prostate Adenocarcinoma,BRD-K36269323-300-02-6::2.5::HTS,3.8977546480044434,0.04884965318525033,Other Types,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,"NOS2, NOS3"
Prostate Adenocarcinoma,BRD-K37720887-001-07-8::2.5::HTS,5.211616411551353,0.022812386339312343,Other Types,SB-525334,TGF beta receptor inhibitor,TGFBR1
Prostate Adenocarcinoma,BRD-K39023557-001-01-7::2.5::HTS,5.136485503297335,0.023811474739657185,Other Types,octocrylene,,
Prostate Adenocarcinoma,BRD-K39987650-001-24-1::2.5::HTS,5.02026954374172,0.025445642995047174,Other Types,bisacodyl,laxative,
Prostate Adenocarcinoma,BRD-K40227168-001-12-9::1.7::HTS,4.875482424904559,0.027655688751639165,Prostate Adenocarcinoma,vinburnine,adrenergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Prostate Adenocarcinoma,BRD-K40255344-001-17-6::2.5::HTS,4.9592340186044535,0.02634711153782566,Other Types,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Prostate Adenocarcinoma,BRD-K40738845-001-05-0::2.5::HTS,4.874973582630735,0.027663768962221075,Prostate Adenocarcinoma,BMS-777607,"AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor","AXL, MERTK, MET, MST1R, TYRO3"
Prostate Adenocarcinoma,BRD-K41445866-001-18-8::2.5::HTS,8.839987776592908,0.0030735934517183462,Prostate Adenocarcinoma,alfaxalone,"chloride channel agonist, benzodiazepine receptor agonist",GABBR1
Prostate Adenocarcinoma,BRD-K43806473-066-02-1::2.5::HTS,5.560813045553801,0.018711516811970558,Other Types,camostat-mesilate,protease inhibitor,PRSS1
Prostate Adenocarcinoma,BRD-K45114938-236-01-8::2.35::HTS,7.219859005456642,0.0074387482109345105,Prostate Adenocarcinoma,mezlocillin,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K45924332-001-16-8::2.5::HTS,7.102785499323936,0.007924177754152287,Other Types,amrinone,phosphodiesterase inhibitor,"PDE3A, PDE3B, PDE4B, TNF"
Prostate Adenocarcinoma,BRD-K49807096-003-15-5::2.5::HTS,4.745377595211542,0.029799503864096712,Other Types,benazepril,angiotensin converting enzyme inhibitor,ACE
Prostate Adenocarcinoma,BRD-K49962337-001-02-9::2.56::HTS,3.989607189080096,0.046294394679018865,Prostate Adenocarcinoma,baicalin,beta glucuronidase inhibitor,PREP
Prostate Adenocarcinoma,BRD-K51040301-001-02-1::2.5::HTS,4.748583312382751,0.029737002742886123,Other Types,cobicistat,cytochrome P450 inhibitor,"CYP3A4, CYP3A43, CYP3A5, CYP3A7"
Prostate Adenocarcinoma,BRD-K54520417-001-01-2::2.5::HTS,4.216593869402631,0.04049267163344089,Other Types,LXR-623,LXR agonist,"AR, NR1H2, NR1H3, NR1I2, NR3C1"
Prostate Adenocarcinoma,BRD-K56195681-001-01-0::2.5::HTS,3.9865222123210367,0.0463475156957589,Other Types,losmapimod,p38 MAPK inhibitor,MAPK14
Prostate Adenocarcinoma,BRD-K56542719-065-01-4::2.5::HTS,9.362151683367289,0.0023213433516055533,Prostate Adenocarcinoma,cefpirome,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K56851771-001-06-8::2.5::HTS,6.5912662582591315,0.010506496102796135,Other Types,enzalutamide,androgen receptor antagonist,AR
Prostate Adenocarcinoma,BRD-K58513245-304-02-7::2.5::HTS,4.618451816743231,0.03208366897240497,Other Types,pamidronate,bone resorption inhibitor,FDPS
Prostate Adenocarcinoma,BRD-K58772419-001-07-0::2.5::HTS,4.451243696096151,0.035320471693007165,Other Types,AZD6482,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Prostate Adenocarcinoma,BRD-K59506194-015-04-9::2.5::HTS,5.192192571053828,0.023064230785711744,Prostate Adenocarcinoma,targinine,nitric oxide synthase inhibitor,NOS3
Prostate Adenocarcinoma,BRD-K63001556-001-09-6::2.57::HTS,8.593556563989035,0.0035170168615433163,Other Types,orbifloxacin,bacterial DNA gyrase inhibitor,
Prostate Adenocarcinoma,BRD-K63630713-001-25-8::2.5::HTS,4.396860787764309,0.03645548549442487,Other Types,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,"ATP1A1, SLC12A1"
Prostate Adenocarcinoma,BRD-K65377893-001-07-4::2.58::HTS,5.066726356688712,0.024799947074792637,Other Types,7-aminocephalosporanic-acid,beta lactamase inhibitor,
Prostate Adenocarcinoma,BRD-K65428967-001-08-4::2.5::HTS,5.134699361312885,0.023838542669023438,Other Types,cordycepin,DNA inhibitor,
Prostate Adenocarcinoma,BRD-K65518078-002-01-1::2.5::HTS,4.9500467165240725,0.026491943550103324,Prostate Adenocarcinoma,cilazapril,angiotensin converting enzyme inhibitor,ACE
Prostate Adenocarcinoma,BRD-K67566344-001-07-5::2.5::HTS,4.376710942174279,0.036887835837162306,Other Types,ku-0063794,mTOR inhibitor,MTOR
Prostate Adenocarcinoma,BRD-K68065987-300-09-1::2.5::HTS,5.259820640825151,0.022197513226629884,Other Types,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Prostate Adenocarcinoma,BRD-K69812556-305-02-0::2.5::HTS,4.271434406674132,0.03921891308114451,Other Types,WAY-100635,serotonin receptor antagonist,HTR1A
Prostate Adenocarcinoma,BRD-K70586315-001-02-4::2.5::HTS,4.889020815105713,0.027433422535748982,Prostate Adenocarcinoma,1-EBIO,potassium channel activator,"KCNN1, KCNN2, KCNN3, KCNN4"
Prostate Adenocarcinoma,BRD-K71059170-001-11-6::2.5::HTS,4.357859269532423,0.03729486940427219,Other Types,cefixime,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K72542090-304-02-4::2.5::HTS,5.639627808001438,0.017916616473193484,Prostate Adenocarcinoma,clodronic-acid,bone resorption inhibitor,"SLC25A4, SLC25A5, SLC25A6"
Prostate Adenocarcinoma,BRD-K73196317-003-14-8::2.5::HTS,3.9235315913853803,0.04810358221009221,Other Types,urapidil,adrenergic receptor antagonist,HTR1A
Prostate Adenocarcinoma,BRD-K73234506-235-02-1::2.5::HTS,6.629968115667474,0.010285598707084665,Other Types,lithium-acetoacetate,,
Prostate Adenocarcinoma,BRD-K73383190-001-02-3::2.56::HTS,5.4496513205495845,0.019946254088757068,Other Types,C646,histone acetyltransferase inhibitor,EP300
Prostate Adenocarcinoma,BRD-K77947974-001-16-3::2.5::HTS,8.6539669878908,0.0034009986551195594,Other Types,fluspirilene,dopamine receptor antagonist,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A"
Prostate Adenocarcinoma,BRD-K78061844-050-01-9::2.5::HTS,4.391081357814494,0.03657423305798492,Other Types,4-PPBP,sigma receptor ligand,SIGMAR1
Prostate Adenocarcinoma,BRD-K78496197-001-03-9::2.5::HTS,5.688038803851852,0.017414424195592974,Other Types,SCS,,
Prostate Adenocarcinoma,BRD-K78844995-001-02-6::2.5::HTS,5.51343646943099,0.01922292602861033,Other Types,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,
Prostate Adenocarcinoma,BRD-K81092066-311-01-6::2.5::HTS,4.2430851553669156,0.03988389814645564,Other Types,phenacaine,local anesthetic,
Prostate Adenocarcinoma,BRD-K81957469-001-01-0::2.5::HTS,4.3898117747589565,0.03660285633257467,Other Types,semagacestat,gamma secretase inhibitor,PSEN1
Prostate Adenocarcinoma,BRD-K82002057-001-01-2::2.5::HTS,4.283978678376046,0.038931969749705246,Prostate Adenocarcinoma,DFB,glutamate receptor agonist,GRM5
Prostate Adenocarcinoma,BRD-K82091397-001-03-0::2.5::HTS,3.9198461880744895,0.04821367695016132,Other Types,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Prostate Adenocarcinoma,BRD-K82166906-236-02-8::2.5::HTS,4.9584683862081995,0.026365853663158044,Other Types,sodium-oxybate,benzodiazepine receptor agonist,"GABRB1, HCAR1, SLC52A2"
Prostate Adenocarcinoma,BRD-K83551379-001-02-6::2.5::HTS,4.3126931708697045,0.03829613814659285,Other Types,levodropropizine,antitussive,
Prostate Adenocarcinoma,BRD-K83837640-001-04-8::2.5::HTS,7.060525181787681,0.008113793732340963,Prostate Adenocarcinoma,JNJ-26481585,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2"
Prostate Adenocarcinoma,BRD-K83896451-001-06-7::2.5::HTS,4.086022269625508,0.043743295235891995,Prostate Adenocarcinoma,glutamine-(l),,"CTPS1, GLUL, GPRC6A, PPAT"
Prostate Adenocarcinoma,BRD-K84996356-001-01-1::2.5::HTS,5.241521495274072,0.02243472419766974,Other Types,AZD3514,androgen receptor modulator,AR
Prostate Adenocarcinoma,BRD-K85554912-001-06-3::2.5::HTS,3.906424084837642,0.04862378875510869,Other Types,ivermectin,benzodiazepine receptor agonist,"CHRNA7, GABRB3, GLRA3, P2RX7"
Prostate Adenocarcinoma,BRD-K86161929-001-13-3::2.5::HTS,5.063995985331318,0.02481722447509499,Prostate Adenocarcinoma,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Prostate Adenocarcinoma,BRD-K86525559-001-07-8::2.52::HTS,10.147753440387516,0.0015301345089513807,Prostate Adenocarcinoma,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Prostate Adenocarcinoma,BRD-K87932577-001-02-4::2.5::HTS,4.2714227500367326,0.039222510269066764,Other Types,CDK1-5-inhibitor,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3B"
Prostate Adenocarcinoma,BRD-K88646909-004-16-2::2.5::HTS,4.192478187928095,0.04107220204971911,Other Types,arecoline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Prostate Adenocarcinoma,BRD-K91422571-001-01-8::2.5::HTS,4.3876214098486574,0.036651951571530346,Other Types,tromaril,prostanoid receptor antagonist,
Prostate Adenocarcinoma,BRD-K92976206-001-01-5::2.5::HTS,5.33771341291805,0.021235329541031113,Prostate Adenocarcinoma,guanosine,,PNP
Prostate Adenocarcinoma,BRD-K93468883-001-02-0::2.5::HTS,4.2110811928561125,0.04062344183125162,Other Types,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Prostate Adenocarcinoma,BRD-K93779381-001-01-9::2.5::HTS,6.464148619728175,0.011274399644558869,Other Types,ingenol-mebutate,PKC activator,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG"
Prostate Adenocarcinoma,BRD-K94830329-001-03-0::2.5::HTS,4.862068304078989,0.02785910244092687,Prostate Adenocarcinoma,ataluren,"CFTR channel agonist, dystrophin stimulant",DMD
Prostate Adenocarcinoma,BRD-K95015809-001-02-8::5::HTS,4.807941675773168,0.028755533158116433,Prostate Adenocarcinoma,2-cyanopyrimidine,cathepsin inhibitor,
Prostate Adenocarcinoma,BRD-K95309561-001-24-7::2.5::HTS,4.4341015301788795,0.03567473779108525,Other Types,dienestrol,estrogen receptor agonist,ESR1
Prostate Adenocarcinoma,BRD-K95901403-001-04-5::2.5::HTS,6.358135304037488,0.011960773112568513,Other Types,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Prostate Adenocarcinoma,BRD-K96153583-001-05-1::2.52::HTS,4.459534679808403,0.035177879060373306,Other Types,cidofovir,DNA polymerase inhibitor,
Prostate Adenocarcinoma,BRD-K99383816-001-02-7::2.5::HTS,5.529358209136839,0.019046129832587067,Prostate Adenocarcinoma,ftorafur,thymidylate synthase inhibitor,TYMS
Prostate Adenocarcinoma,BRD-M80207679-001-01-5::2.5::HTS,6.442734615743642,0.01142103387075796,Other Types,nemonapride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Prostate Adenocarcinoma,BRD-U51753822-000-01-1::2.5::HTS,4.868733962479966,0.027754099606752146,Other Types,phosphatidylcholine,,PCTP
Prostate Adenocarcinoma,BRD-A04447196-001-01-8::2.5::MTS004,4.373996717209195,0.03695882556472884,Other Types,gepefrine,adrenergic receptor agonist,
Prostate Adenocarcinoma,BRD-A15687940-001-05-6::2.5::MTS004,4.596798655487106,0.03247837592748685,Other Types,clofedanol,histamine receptor antagonist,HRH1
Prostate Adenocarcinoma,BRD-A21280314-001-06-8::2.5::MTS004,3.9387403083606167,0.04769268189872372,Other Types,nifenalol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Prostate Adenocarcinoma,BRD-A44971162-001-02-7::2.5::MTS004,8.221883742677276,0.0043010812003526685,Other Types,ODM-201,androgen receptor antagonist,AR
Prostate Adenocarcinoma,BRD-A67305656-001-01-5::2.5::MTS004,4.9475197248373695,0.026541557201661833,Other Types,spiramycin,bacterial 50S ribosomal subunit inhibitor,
Prostate Adenocarcinoma,BRD-K00739965-001-01-9::2.675904798::MTS004,4.273063480849831,0.039198773027114636,Other Types,guacetisal,immunosuppressant,
Prostate Adenocarcinoma,BRD-K06388517-001-01-2::2.5::MTS004,5.5421467535469855,0.018921679040026736,Other Types,lofemizole,cyclooxygenase inhibitor,
Prostate Adenocarcinoma,BRD-K18135438-001-14-2::2.5::MTS004,3.9186671962016737,0.04826197193440884,Other Types,chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4"
Prostate Adenocarcinoma,BRD-K22514639-001-05-7::2.500015058::MTS004,4.697189156582183,0.030649158962482034,Prostate Adenocarcinoma,EGF816,EGFR inhibitor,EGFR
Prostate Adenocarcinoma,BRD-K25243230-001-01-2::2.5::MTS004,4.8064561400011545,0.028780107118134668,Other Types,oxytocin,oxytocin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Prostate Adenocarcinoma,BRD-K26813177-001-03-2::2.46430412::MTS004,3.859790268398765,0.04997075491504242,Other Types,daltroban,thromboxane receptor antagonist,TBXA2R
Prostate Adenocarcinoma,BRD-K30764557-001-01-5::2.5::MTS004,5.185485826969272,0.023167262492160307,Other Types,miocamycin,other antibiotic,
Prostate Adenocarcinoma,BRD-K32804101-001-01-8::2.5::MTS004,4.54326546395792,0.03350019180371758,Other Types,valrocemide,,
Prostate Adenocarcinoma,BRD-K33245965-001-03-4::2.50001558::MTS004,4.558733190595542,0.033202375241725486,Other Types,BMS-833923,smoothened receptor antagonist,SMO
Prostate Adenocarcinoma,BRD-K41458421-034-01-6::2.500006592::MTS004,4.567306505200895,0.03303720412508996,Other Types,naloxegol,opioid receptor antagonist,OPRM1
Prostate Adenocarcinoma,BRD-K42673188-001-01-1::2.363355746::MTS004,3.9870411384786575,0.04635392565154953,Other Types,verubulin,tubulin polymerization inhibitor,TUBB
Prostate Adenocarcinoma,BRD-K50660797-001-05-1::2.499989832::MTS004,5.847988634557024,0.015925298061618326,Other Types,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,"BACE1, FASN"
Prostate Adenocarcinoma,BRD-K58529924-001-01-5::2.648577938::MTS004,5.468727385476108,0.019724328018032474,Other Types,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Prostate Adenocarcinoma,BRD-K59391348-001-01-7::2.5::MTS004,5.190610443569669,0.023099715659277556,Other Types,lixivaptan,vasopressin receptor antagonist,AVPR2
Prostate Adenocarcinoma,BRD-K62490786-001-01-1::2.495325825::MTS004,5.234799846061232,0.022525688850121964,Other Types,ibrolipim,lipoprotein lipase activator,LPL
Prostate Adenocarcinoma,BRD-K62971431-001-01-9::2.5::MTS004,4.877516486234533,0.027628809414627763,Other Types,tasimelteon,melatonin receptor agonist,"MTNR1A, MTNR1B"
Prostate Adenocarcinoma,BRD-K64034691-001-01-9::2.499981916::MTS004,4.231495935226934,0.04016196765649126,Other Types,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Prostate Adenocarcinoma,BRD-K71026158-304-01-0::2.397404387::MTS004,5.626145473732147,0.018044744797744993,Other Types,carumonam,bacterial cell wall synthesis inhibitor,
Prostate Adenocarcinoma,BRD-K80353807-001-25-3::2.5::MTS004,4.876899238371891,0.027638600192109317,Other Types,khellin,vasodilator,
Prostate Adenocarcinoma,BRD-K82908348-001-01-9::2.434467427::MTS004,4.645477781988941,0.03157753177353141,Other Types,darglitazone,PPAR receptor antagonist,PPARG
Prostate Adenocarcinoma,BRD-K84173274-001-01-6::2.5::MTS004,4.559317926770757,0.03319030168835213,Other Types,ufenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Prostate Adenocarcinoma,BRD-K88143662-001-01-5::2.5::MTS004,4.003529140018458,0.04590607253306339,Other Types,metharbital,GABA receptor modulator,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2"
Prostate Adenocarcinoma,BRD-K90629600-001-01-4::2.5::MTS004,3.9675849012937396,0.04688835141836148,Other Types,emorfazone,"antiinflammatory agent, cyclooxygenase inhibitor",
Prostate Adenocarcinoma,BRD-K95941975-001-01-5::2.5::MTS004,8.5043825862241,0.0036904481380013432,Other Types,piperazinedione,DNA synthesis inhibitor,
Rhabdoid Cancer,BRD-A00147595-001-01-5::2.5::HTS,6.208100004606958,0.013006511125387655,Rhabdoid Cancer,balaglitazone,"insulin sensitizer, PPAR receptor partial agonist",PPARG
Rhabdoid Cancer,BRD-A00827783-001-24-6::2.5::HTS,9.149997931274223,0.0026018914294349215,Rhabdoid Cancer,dyphylline,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B"
Rhabdoid Cancer,BRD-A01907367-001-01-7::2.5::HTS,4.40954198443127,0.03618763105787915,Rhabdoid Cancer,FK-33-824,opioid receptor agonist,OPRM1
Rhabdoid Cancer,BRD-A02990301-003-06-6::2.5::HTS,9.97770012435857,0.0016703715608567147,Rhabdoid Cancer,lofexidine,adrenergic receptor agonist,ADRA2A
Rhabdoid Cancer,BRD-A04322457-003-17-9::2.5::HTS,6.438232249539393,0.011440553209879962,Rhabdoid Cancer,isoprenaline,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3"
Rhabdoid Cancer,BRD-A04327189-003-03-3::2.5::HTS,4.189800878927453,0.04115227942522304,Rhabdoid Cancer,synephrine,adrenergic receptor agonist,ADRA1A
Rhabdoid Cancer,BRD-A06352508-001-03-7::2.5::HTS,5.468165086784367,0.019718157385543715,Other Types,SB-218078,CHK inhibitor,CHEK1
Rhabdoid Cancer,BRD-A07932845-050-15-8::2.5::HTS,6.958792086864422,0.008572307086214405,Other Types,metitepine,anti-HCVE2,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
Rhabdoid Cancer,BRD-A08715367-001-01-7::2.87::HTS,4.916681611882989,0.027003616840695608,Rhabdoid Cancer,L-Theanine,glutamate receptor antagonist,
Rhabdoid Cancer,BRD-A09094913-065-01-0::2.5::HTS,4.556937415785277,0.033221489280359055,Rhabdoid Cancer,strychnine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB"
Rhabdoid Cancer,BRD-A09925278-003-05-6::2.5::HTS,6.793361067960692,0.009392484773259446,Rhabdoid Cancer,etilefrine,adrenergic receptor agonist,"ADRA1A, ADRB1"
Rhabdoid Cancer,BRD-A10420615-001-04-4::2.5::HTS,4.7339027159275915,0.029995636102739195,Rhabdoid Cancer,cyclopiazonic-acid,ATPase inhibitor,ATP2A1
Rhabdoid Cancer,BRD-A11070335-236-02-1::2.5::HTS,3.957615095477252,0.04714490627281249,Rhabdoid Cancer,carbazochrome,,
Rhabdoid Cancer,BRD-A11662333-001-03-3::2.5::HTS,4.130574812988812,0.04261689756660087,Rhabdoid Cancer,meparfylon,,
Rhabdoid Cancer,BRD-A12230535-001-06-7::2.5::HTS,7.139480856688382,0.007768667307485615,Other Types,nutlin-3,MDM inhibitor,"MDM2, TP53"
Rhabdoid Cancer,BRD-A14208071-004-19-8::2.5::HTS,12.759163113933973,0.00038499469034728465,Other Types,oxyphenonium,cholinergic receptor antagonist,CHRM1
Rhabdoid Cancer,BRD-A15397381-001-02-5::2.5::HTS,5.4289469497755265,0.020194134678627795,Rhabdoid Cancer,L-Cystine,,"CTNS, SLC3A1, SLC7A11, SLC7A9"
Rhabdoid Cancer,BRD-A15909516-001-06-6::2.5::HTS,6.197175728754274,0.013084558488297026,Other Types,rebamipide,free radical scavenger,FPR1
Rhabdoid Cancer,BRD-A16347691-001-13-1::2.5::HTS,4.168341465556936,0.04165502361561452,Rhabdoid Cancer,thioctic-acid,reducing agent,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6"
Rhabdoid Cancer,BRD-A18611368-001-01-5::2.5::HTS,6.466098424043527,0.011264588157396217,Rhabdoid Cancer,tazobactam,beta lactamase inhibitor,
Rhabdoid Cancer,BRD-A23359898-003-10-0::2.5::HTS,7.071343726195172,0.008057608908687997,Rhabdoid Cancer,sibutramine,serotonin-norepinephrine reuptake inhibitor (SNRI),"SLC6A2, SLC6A3, SLC6A4"
Rhabdoid Cancer,BRD-A24514565-001-09-7::2.5::HTS,6.329214478226687,0.012158137837797406,Rhabdoid Cancer,warfarin,vitamin K antagonist,VKORC1
Rhabdoid Cancer,BRD-A24560335-300-01-2::2.5::HTS,5.596761158059011,0.01833703729693352,Rhabdoid Cancer,efatutazone,PPAR receptor agonist,PPARG
Rhabdoid Cancer,BRD-A29426959-050-13-2::2.5::HTS,6.244113472863227,0.012747579823013796,Rhabdoid Cancer,carbinoxamine,histamine receptor antagonist,HRH1
Rhabdoid Cancer,BRD-A29700858-304-01-8::2.5::HTS,4.693766132457269,0.03072312914470241,Rhabdoid Cancer,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3"
Rhabdoid Cancer,BRD-A29731977-001-04-5::2.5::HTS,7.5981826821726495,0.006033509848868247,Other Types,17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR"
Rhabdoid Cancer,BRD-A30590053-003-02-9::2.5::HTS,4.394819375481151,0.036494785370520866,Other Types,MR-16728,acetylcholine release enhancer,
Rhabdoid Cancer,BRD-A34006693-001-15-4::2.5::HTS,4.2887003059059365,0.03883235444005648,Rhabdoid Cancer,suprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Rhabdoid Cancer,BRD-A34255068-001-34-5::2.5::HTS,7.33467916153881,0.006972717047996555,Rhabdoid Cancer,rolipram,phosphodiesterase inhibitor,
Rhabdoid Cancer,BRD-A38076815-003-10-3::2.5::HTS,4.439717412698045,0.03555455533455414,Other Types,glafenine,DeltaF508-CFTR Correctors,CFTR
Rhabdoid Cancer,BRD-A38350138-001-04-9::2.5::HTS,5.63788000557317,0.017923693757961493,Other Types,ketoconazole,sterol demethylase inhibitor,"AR, CYP19A1, CYP21A2, KCNA10"
Rhabdoid Cancer,BRD-A38747044-001-02-3::2.5::HTS,3.9496194430021383,0.04737126310906812,Rhabdoid Cancer,KU14R,imidazoline receptor antagonist,
Rhabdoid Cancer,BRD-A43082555-001-01-1::2.5::HTS,13.039263110999752,0.00033313803192701086,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Rhabdoid Cancer,BRD-A44090213-001-25-6::2.5::HTS,4.544459398693987,0.033494469058003414,Other Types,indoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist","CXCR1, CXCR2, PTGS1, PTGS2"
Rhabdoid Cancer,BRD-A45543382-001-10-0::2.5::HTS,3.8838583889391454,0.049249804483094,Rhabdoid Cancer,metrizamide,radiopaque medium,
Rhabdoid Cancer,BRD-A47494775-003-11-3::2.5::HTS,7.346960663197037,0.006925871800917949,Rhabdoid Cancer,dipivefrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE"
Rhabdoid Cancer,BRD-A48180038-003-24-3::2.5::HTS,4.6952885268107885,0.03066861336126679,Rhabdoid Cancer,trihexyphenidyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdoid Cancer,BRD-A49035384-003-28-9::2.39::HTS,4.015607928942224,0.045591311835471965,Other Types,methacycline,protein synthesis inhibitor,
Rhabdoid Cancer,BRD-A49035384-003-30-5::2.5::HTS,4.914880318231269,0.027037481663769045,Other Types,methacycline,protein synthesis inhibitor,
Rhabdoid Cancer,BRD-A49622760-001-01-9::2.5::HTS,5.229564140435549,0.02258794813037872,Rhabdoid Cancer,faropenem,lactamase inhibitor,
Rhabdoid Cancer,BRD-A49838158-001-01-1::2.5::HTS,4.208558406783151,0.04068759493009661,Rhabdoid Cancer,phenprocoumon,vitamin K antagonist,VKORC1
Rhabdoid Cancer,BRD-A50311610-300-10-4::2.5::HTS,5.531260426933178,0.019033906120591672,Other Types,meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3"
Rhabdoid Cancer,BRD-A51078674-003-01-0::2.5::HTS,4.248410077568626,0.03974654529009606,Other Types,diclofensine,dopamine reuptake inhibitor,"DRD1, MAOA, MAOB"
Rhabdoid Cancer,BRD-A51355958-003-01-9::2.5::HTS,7.352511170312965,0.006904806472518196,Rhabdoid Cancer,nebracetam,acetylcholine receptor agonist,CHRM1
Rhabdoid Cancer,BRD-A51714012-003-13-6::2.5::HTS,4.9602138055840514,0.026349227225768074,Rhabdoid Cancer,venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4"
Rhabdoid Cancer,BRD-A51964809-003-12-6::2.5::HTS,7.476779127567408,0.0064471170749344645,Other Types,halofantrine,antimalarial agent,"KCNH2, KCNN4"
Rhabdoid Cancer,BRD-A53037217-001-02-0::2.5::HTS,4.184093925137073,0.04127679772212463,Other Types,BTZ043-racemate,DPRE1 inhibitor,
Rhabdoid Cancer,BRD-A57886255-001-01-1::2.5::HTS,4.211887263634272,0.04060845015045753,Other Types,golgicide-a,ARF inhibitor,GBF1
Rhabdoid Cancer,BRD-A59174698-003-18-5::2.5::HTS,4.174345065266546,0.04150798789791668,Rhabdoid Cancer,ritodrine,adrenergic receptor agonist,ADRB2
Rhabdoid Cancer,BRD-A59198242-003-02-9::2.5::HTS,4.792904635069797,0.028988474973938104,Rhabdoid Cancer,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Rhabdoid Cancer,BRD-A61221616-001-04-3::2.5::HTS,3.870387664044873,0.049636582398900585,Rhabdoid Cancer,medroxyprogesterone-acetate,progesterone receptor agonist,
Rhabdoid Cancer,BRD-A62021152-003-03-4::2.5::HTS,5.218564246512377,0.022724321188711583,Rhabdoid Cancer,WAY-161503,serotonin receptor agonist,HTR2C
Rhabdoid Cancer,BRD-A64610707-001-04-4::2.5::HTS,3.870679531126472,0.049632427534695614,Rhabdoid Cancer,pranoprofen,cyclooxygenase inhibitor,
Rhabdoid Cancer,BRD-A65145453-001-06-1::2.5::HTS,6.089215082695438,0.013903725061362459,Rhabdoid Cancer,ATPA,glutamate receptor agonist,"GRIA2, GRIK1"
Rhabdoid Cancer,BRD-A65671304-001-07-5::2.5::HTS,8.332608169041672,0.004045868802365773,Rhabdoid Cancer,candesartan-cilextil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Rhabdoid Cancer,BRD-A67181951-001-01-2::2.5::HTS,4.175950397603524,0.04146898710195329,Rhabdoid Cancer,gadobutrol,radiopaque medium,
Rhabdoid Cancer,BRD-A67521319-001-01-6::2.5::HTS,8.279210143798158,0.004164749672980456,Rhabdoid Cancer,pimonidazole,,
Rhabdoid Cancer,BRD-A68304895-003-02-2::2.5::HTS,7.425872449627504,0.006630280616286889,Other Types,BTS-54505,dopamine reuptake inhibitor,"SLC6A2, SLC6A3, SLC6A4"
Rhabdoid Cancer,BRD-A69815203-001-07-6::2.5::HTS,4.169636833220999,0.04166452286327589,Rhabdoid Cancer,cyclosporin-a,calcineurin inhibitor,PPP3CA
Rhabdoid Cancer,BRD-A70407468-001-02-0::2.5::HTS,5.586342291189845,0.018445301505806515,Other Types,PSB-36,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Rhabdoid Cancer,BRD-A72703248-003-04-9::2.5::HTS,4.097523170737284,0.04342283605342511,Rhabdoid Cancer,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Rhabdoid Cancer,BRD-A73709786-001-01-3::2.5::HTS,4.192691310085482,0.041076528051774606,Rhabdoid Cancer,LB-100,protein phosphatase inhibitor,
Rhabdoid Cancer,BRD-A74208568-003-01-5::2.5::HTS,5.869513729693848,0.015723191129698347,Rhabdoid Cancer,CGP-54626,GABA receptor antagonist,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8"
Rhabdoid Cancer,BRD-A85025557-001-02-5::2.5::HTS,4.002510915089657,0.04592267524708981,Other Types,NCS-382,GABA receptor antagonist,"GABBR1, GABBR2, SLC52A2"
Rhabdoid Cancer,BRD-A86044036-001-26-5::2.5::HTS,5.915377206619928,0.015326142553329784,Rhabdoid Cancer,flurbiprofen-(+/-),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Rhabdoid Cancer,BRD-A86414188-003-01-5::2.5::HTS,3.911922576990539,0.0484398083839077,Rhabdoid Cancer,ractopamine,adrenergic receptor agonist,
Rhabdoid Cancer,BRD-A87435144-001-01-6::2.5::HTS,11.840571796460091,0.0006228362922139273,Other Types,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1
Rhabdoid Cancer,BRD-A88369366-001-01-7::2.5::HTS,5.699386352754728,0.017302156196737663,Rhabdoid Cancer,trelagliptin,dipeptidyl peptidase inhibitor,DPP4
Rhabdoid Cancer,BRD-A89164055-001-03-3::2.5::HTS,4.013770806772848,0.04561228186217948,Other Types,sorbinil,aldose reductase inhibitor,AKR1B1
Rhabdoid Cancer,BRD-A91366704-001-01-9::2.5::HTS,4.271081939526449,0.0392269843204544,Rhabdoid Cancer,eprinomectin,benzodiazepine receptor agonist,
Rhabdoid Cancer,BRD-A92872453-001-01-8::2.5::HTS,4.046582633976427,0.0447445846761559,Rhabdoid Cancer,N-acetylmannosamine,,CHIT1
Rhabdoid Cancer,BRD-A93477898-001-04-2::2.5::HTS,3.9418184142754957,0.04759243776152123,Rhabdoid Cancer,PETCM,caspase activator,CASP3
Rhabdoid Cancer,BRD-A95886749-001-03-5::2.5::HTS,5.213848032678082,0.022792406385302125,Rhabdoid Cancer,colfosceril-palmitate,pulmonary surfactant,
Rhabdoid Cancer,BRD-K00337317-001-06-6::2.5::HTS,5.970813538034925,0.014853348051693588,Other Types,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
Rhabdoid Cancer,BRD-K01674964-300-06-3::2.5::HTS,6.535073786577505,0.010842351590721357,Rhabdoid Cancer,histamine,histamine receptor agonist,"HRH1, HRH2, HRH3, HRH4"
Rhabdoid Cancer,BRD-K02017404-300-06-2::2.5::HTS,4.876998893419639,0.02762268645303863,Other Types,NVP-BSK805,JAK inhibitor,JAK2
Rhabdoid Cancer,BRD-K02953697-001-09-2::2.5::HTS,7.500800801784807,0.006366027588569731,Rhabdoid Cancer,naringin,cytochrome P450 inhibitor,SLCO1A2
Rhabdoid Cancer,BRD-K03739921-001-06-8::2.5::HTS,4.484215629678535,0.034654087851982415,Other Types,hypoxanthine,PARP inhibitor,PNP
Rhabdoid Cancer,BRD-K04923131-001-15-4::2.5::HTS,5.708935093337055,0.01721346518710458,Rhabdoid Cancer,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Rhabdoid Cancer,BRD-K05236810-001-19-0::2.5::HTS,6.844338722154795,0.00913395090779675,Rhabdoid Cancer,luteolin,glucosidase inhibitor,TOP1
Rhabdoid Cancer,BRD-K05464208-001-05-7::2.5::HTS,4.470470910620498,0.03492838251688533,Rhabdoid Cancer,JX-401,p38 MAPK inhibitor,MAPK14
Rhabdoid Cancer,BRD-K05674516-001-02-5::2.5::HTS,8.539396158158771,0.003616465291144176,Rhabdoid Cancer,sofosbuvir,RNA polymerase inhibitor,
Rhabdoid Cancer,BRD-K06147391-300-06-8::2.5::HTS,4.500935866173746,0.03431723929811684,Rhabdoid Cancer,telenzepine,acetylcholine receptor antagonist,CHRM1
Rhabdoid Cancer,BRD-K06674495-334-03-2::2.5::HTS,3.9511730892926,0.047327869843918735,Rhabdoid Cancer,nafamostat,serine protease inhibitor,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7"
Rhabdoid Cancer,BRD-K07220430-001-18-4::2.5::HTS,5.014834764473048,0.02552489942354288,Rhabdoid Cancer,cinnarazine,calcium channel blocker,
Rhabdoid Cancer,BRD-K07359318-001-03-9::2.45::HTS,4.648664133911671,0.03152870447649213,Rhabdoid Cancer,benfotiamine,antioxidant,AGER
Rhabdoid Cancer,BRD-K07609981-001-01-7::2.5::HTS,6.591697930095266,0.010505378142077682,Other Types,dexloxiglumide,CCK receptor antagonist,CCKAR
Rhabdoid Cancer,BRD-K07753030-003-17-6::2.5::HTS,7.897569508478687,0.005124199498971557,Rhabdoid Cancer,acecainide,polarization inhibitor,SCN5A
Rhabdoid Cancer,BRD-K08223200-001-01-1::2.5::HTS,7.197586441088516,0.007519013240211214,Other Types,WAY-200070,estrogen receptor agonist,"ERBB2, ERBB3, ERBB4, ESR2"
Rhabdoid Cancer,BRD-K08231299-001-08-1::2.5::HTS,4.085925849837543,0.04372913924746092,Rhabdoid Cancer,propoxur,,
Rhabdoid Cancer,BRD-K08586861-001-01-1::2.5::HTS,11.327274375296302,0.0008182896226314165,Rhabdoid Cancer,ramatroban,prostanoid receptor antagonist,"PTGDR2, TBXA2R"
Rhabdoid Cancer,BRD-K08681769-323-03-7::2.5::HTS,8.273479122386819,0.00418542106751709,Rhabdoid Cancer,ibandronate,bone resorption inhibitor,FDPS
Rhabdoid Cancer,BRD-K08996725-332-01-7::2.5::HTS,4.458895513507496,0.035164680606299924,Other Types,zolantidine,histamine receptor antagonist,
Rhabdoid Cancer,BRD-K09255212-001-16-6::2.5::HTS,8.453823725507995,0.00379279494176426,Rhabdoid Cancer,clioquinol,chelating agent,OPRK1
Rhabdoid Cancer,BRD-K09338665-001-07-1::2.5::HTS,4.70532589544888,0.03051480784389491,Rhabdoid Cancer,1-octanol,,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1"
Rhabdoid Cancer,BRD-K09785578-001-01-2::2.5::HTS,6.662609177421571,0.010100191912194785,Rhabdoid Cancer,bakuchiol,DNA polymerase inhibitor,HIF1A
Rhabdoid Cancer,BRD-K10670311-001-15-5::2.5::HTS,6.175690510889937,0.01325397411849517,Rhabdoid Cancer,sulfasalazine,cyclooxygenase inhibitor,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1"
Rhabdoid Cancer,BRD-K10759144-001-04-3::2.5::HTS,8.974024031580276,0.0028670470062515095,Rhabdoid Cancer,xylose,,
Rhabdoid Cancer,BRD-K11073688-001-01-6::2.5::HTS,5.164130229962676,0.023451699091321103,Rhabdoid Cancer,CPI-1189,tumor necrosis factor release inhibitor,TNF
Rhabdoid Cancer,BRD-K11196887-001-21-2::2.5::HTS,7.471172182930878,0.006475446401516418,Rhabdoid Cancer,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A
Rhabdoid Cancer,BRD-K11411329-001-01-3::2.5::HTS,4.9277791552598345,0.02682653259304504,Rhabdoid Cancer,NOV-002,,"GSR, GSTM2"
Rhabdoid Cancer,BRD-K11595419-001-01-4::2.5::HTS,4.274850411309827,0.03914243759039505,Rhabdoid Cancer,dipeptamin,,
Rhabdoid Cancer,BRD-K11672787-001-01-5::2.5::HTS,4.405774790551035,0.03626537553219027,Other Types,rostafuroxine,ATPase inhibitor,ATP1A1
Rhabdoid Cancer,BRD-K11900042-001-14-4::2.5::HTS,9.26940040517448,0.0024439502088290654,Rhabdoid Cancer,methylthiouracil,,
Rhabdoid Cancer,BRD-K11927976-050-02-9::2.5::HTS,4.539414328032,0.03356918287026068,Rhabdoid Cancer,ER-27319,"mediator release inhibitor, SYK inhibitor",SYK
Rhabdoid Cancer,BRD-K13296708-001-05-8::2.5::HTS,4.288763669421029,0.03882755127451684,Rhabdoid Cancer,rimonabant,cannabinoid receptor antagonist,"CNR1, GPR55"
Rhabdoid Cancer,BRD-K13495773-001-11-4::2.5::HTS,4.0250820125655355,0.0453220302982607,Rhabdoid Cancer,creatinine,,
Rhabdoid Cancer,BRD-K13949769-001-01-7::2.5::HTS,9.013484658083794,0.002799065750603763,Other Types,tenovin-6,SIRT inhibitor,"SIRT1, SIRT2, SIRT3"
Rhabdoid Cancer,BRD-K14116214-001-09-6::2.5::HTS,6.501122047134073,0.011046890097220676,Rhabdoid Cancer,sulfamonomethoxine,bacterial antifolate,
Rhabdoid Cancer,BRD-K14763542-001-02-3::2.5::HTS,7.347792214773944,0.006933037665764884,Rhabdoid Cancer,flurothyl,,
Rhabdoid Cancer,BRD-K14796088-003-26-8::2.5::HTS,7.05096500754199,0.008146987121494509,Other Types,berberine,LDL receptor activator,LDLR
Rhabdoid Cancer,BRD-K15179879-001-03-2::2.5::HTS,5.402373395644067,0.020480117734709934,Rhabdoid Cancer,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Rhabdoid Cancer,BRD-K15791587-003-02-5::2.5::HTS,4.253805445125221,0.0396255841522103,Other Types,L-733060,tachykinin antagonist,TACR1
Rhabdoid Cancer,BRD-K16189898-003-03-3::2.5::HTS,4.677786373119027,0.030976108421928085,Rhabdoid Cancer,CHIR-99021,glycogen synthase kinase inhibitor,"CDK1, GSK3A, GSK3B, MAPK1"
Rhabdoid Cancer,BRD-K16730910-001-07-3::2.5::HTS,16.000092251035834,7.184093013789515e-05,Other Types,regorafenib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK"
Rhabdoid Cancer,BRD-K16810791-001-01-0::2.5::HTS,11.83855509905559,0.0006232605959960603,Other Types,LGK-974,porcupine inhibitor,PORCN
Rhabdoid Cancer,BRD-K17008822-303-02-1::2.5::HTS,4.04170113107644,0.04487319941910624,Rhabdoid Cancer,BD-1008,sigma receptor antagonist,
Rhabdoid Cancer,BRD-K17075857-001-17-6::2.5::HTS,7.398196133957313,0.006731685916168254,Rhabdoid Cancer,chloroxine,opioid receptor antagonist,OPRK1
Rhabdoid Cancer,BRD-K17075857-001-18-4::2.5::HTS,19.788362191998257,1.0513346288346216e-05,Rhabdoid Cancer,chloroxine,opioid receptor antagonist,OPRK1
Rhabdoid Cancer,BRD-K17203476-001-01-9::2.5::HTS,5.530112086104461,0.019037388022269265,Other Types,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Rhabdoid Cancer,BRD-K17415526-001-03-5::2.5::HTS,7.739283177866888,0.005587337897530607,Rhabdoid Cancer,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR
Rhabdoid Cancer,BRD-K17561142-003-32-5::2.5::HTS,5.117751374604084,0.024064683804464845,Other Types,amiodarone,potassium channel blocker,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2"
Rhabdoid Cancer,BRD-K18131774-001-17-6::2.5::HTS,5.942714580802847,0.015091629126089225,Other Types,ethoxzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9"
Rhabdoid Cancer,BRD-K18135438-001-16-7::2.5::HTS,4.467320240874006,0.03499311492899433,Rhabdoid Cancer,chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4"
Rhabdoid Cancer,BRD-K18948558-001-01-9::2.5::HTS,7.529829407191012,0.006262456681895141,Rhabdoid Cancer,clevudine,DNA polymerase inhibitor,
Rhabdoid Cancer,BRD-K19034817-001-01-4::2.5::HTS,4.652587371255608,0.0314331145232844,Other Types,pacritinib,"FLT3 inhibitor, JAK inhibitor","FLT3, JAK1, JAK2, JAK3"
Rhabdoid Cancer,BRD-K19061412-001-02-4::2.5::HTS,3.996135571515771,0.04609273791579774,Other Types,mubritinib,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Rhabdoid Cancer,BRD-K19227686-001-18-6::2.5::HTS,4.211829100358025,0.04062543789444858,Rhabdoid Cancer,phenolphthalein,indicator dye,UGT1A9
Rhabdoid Cancer,BRD-K19318328-001-01-3::2.5::HTS,6.494336614583386,0.011115610547779462,Rhabdoid Cancer,FR-139317,endothelin receptor antagonist,EDNRA
Rhabdoid Cancer,BRD-K20079257-001-09-6::2.5::HTS,7.619966572949361,0.005963765721446428,Rhabdoid Cancer,rufinamide,voltage-gated sodium channel blocker,"GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Rhabdoid Cancer,BRD-K20285085-001-07-1::2.5::HTS,12.237336044030949,0.0005071233911743424,Other Types,R406,SYK inhibitor,"RET, SYK"
Rhabdoid Cancer,BRD-K20285085-074-04-5::2.5::HTS,8.303372874497557,0.004118147693341138,Other Types,R406,SYK inhibitor,"RET, SYK"
Rhabdoid Cancer,BRD-K20290250-001-01-3::2.5::HTS,4.609698028200389,0.032222656323958404,Other Types,BIX-02188,MEK inhibitor,MAP2K5
Rhabdoid Cancer,BRD-K20313525-001-04-6::2.5::HTS,8.911906237214161,0.0029564829861028603,Rhabdoid Cancer,rosmarinic-acid,GABA transaminase inhibitor,"MCL1, TYR"
Rhabdoid Cancer,BRD-K20722021-001-02-1::2.5::HTS,6.321084731710566,0.01222124860526128,Other Types,CEP-32496,RAF inhibitor,"BRAF, RAF1"
Rhabdoid Cancer,BRD-K20995441-001-02-5::2.5::HTS,3.8872216428705864,0.04915198142786965,Rhabdoid Cancer,U-54494A,opioid receptor agonist,OPRK1
Rhabdoid Cancer,BRD-K21452876-003-01-8::2.5::HTS,6.4477884396047225,0.011388981626518514,Rhabdoid Cancer,chlorazanil,,
Rhabdoid Cancer,BRD-K21782625-001-02-4::2.5::HTS,4.825175075605731,0.028472051780233872,Other Types,AMG458,MET inhibitor,MET
Rhabdoid Cancer,BRD-K22662557-300-01-7::2.5::HTS,4.066714153758028,0.04421567189385402,Other Types,WIN-64338,bradykinin receptor antagonist,BDKRB2
Rhabdoid Cancer,BRD-K23403298-003-01-9::2.5::HTS,5.4546786458795875,0.01987719162701449,Other Types,benzyldimethylhexadecylammonium,cationic surfactant,
Rhabdoid Cancer,BRD-K23922020-075-02-9::2.5::HTS,4.839111106881266,0.02822829772774923,Other Types,arecaidine-propargyl-ester,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Rhabdoid Cancer,BRD-K23984367-075-15-2::2.5::HTS,6.090621935958068,0.013891137053940066,Other Types,sorafenib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET"
Rhabdoid Cancer,BRD-K24048528-001-01-7::2.59::HTS,4.903680499729691,0.02722582401277258,Rhabdoid Cancer,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1
Rhabdoid Cancer,BRD-K24227647-364-01-5::2.5::HTS,5.871137120927642,0.015711742096958466,Rhabdoid Cancer,TC2559,acetylcholine receptor agonist,CHRNA4
Rhabdoid Cancer,BRD-K24820488-001-01-7::2.5::HTS,4.275800994356765,0.03911824175159562,Other Types,CH-170,,
Rhabdoid Cancer,BRD-K24968862-001-01-0::2.5::HTS,4.521469255207569,0.0339072288284849,Rhabdoid Cancer,SB-683698,integrin antagonist,"ITGA4, ITGAV, ITGB1, ITGB7"
Rhabdoid Cancer,BRD-K25114078-003-08-1::2.5::HTS,6.080750229648953,0.013965391963426142,Rhabdoid Cancer,aminoguanidine,nitric oxide synthase inhibitor,NOS2
Rhabdoid Cancer,BRD-K25244359-066-03-4::2.68::HTS,10.22332222596606,0.0014698455119924712,Other Types,apatinib,RET tyrosine kinase inhibitor,"CSK, KDR, KIT, RET"
Rhabdoid Cancer,BRD-K25279140-001-01-5::2.5::HTS,5.336225553638529,0.02126705407033812,Other Types,MK-8745,Aurora kinase inhibitor,AURKA
Rhabdoid Cancer,BRD-K25317177-065-01-4::2.5::HTS,4.823314733771614,0.02848948721779033,Rhabdoid Cancer,modaline,,
Rhabdoid Cancer,BRD-K25699529-003-01-1::2.5::HTS,3.9295628032805614,0.04793435796857543,Rhabdoid Cancer,tapentadol,opioid receptor agonist,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4"
Rhabdoid Cancer,BRD-K26011976-001-01-0::2.5::HTS,5.863755809383401,0.0157962365302678,Rhabdoid Cancer,licochalcone-a,topoisomerase inhibitor,PTPN1
Rhabdoid Cancer,BRD-K26253904-001-01-5::2.5::HTS,4.6772180918355355,0.03098929358009487,Other Types,NMS-873,ATPase inhibitor,VCP
Rhabdoid Cancer,BRD-K26667523-001-02-5::2.5::HTS,6.04432362177907,0.014255934039204254,Other Types,TAK-733,MEK inhibitor,MAP2K1
Rhabdoid Cancer,BRD-K27217864-001-22-3::2.5::HTS,5.155880380087052,0.023550151848174796,Rhabdoid Cancer,butamben,sodium channel blocker,
Rhabdoid Cancer,BRD-K27335680-001-10-0::2.5::HTS,6.896551992019478,0.008875040138397074,Rhabdoid Cancer,rhein,,HSP90AA1
Rhabdoid Cancer,BRD-K27382019-418-01-9::2.5::HTS,4.6092431712144295,0.03223504248687283,Rhabdoid Cancer,piperaquine-phosphate,antimalarial agent,
Rhabdoid Cancer,BRD-K27871792-001-01-8::2.5::HTS,5.902519065774548,0.015431518216923781,Other Types,flucloxacillin,bacterial cell wall synthesis inhibitor,
Rhabdoid Cancer,BRD-K28343777-001-01-6::2.5::HTS,4.942008321611364,0.026614285471915508,Rhabdoid Cancer,20-hydroxyecdysone,ecdysone receptor modulator,
Rhabdoid Cancer,BRD-K28392481-001-05-1::2.5::HTS,10.953027727622816,0.0009953574987371142,Other Types,AZD4547,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR"
Rhabdoid Cancer,BRD-K28428262-001-04-1::2.5::HTS,7.214317508073754,0.007449759743275635,Other Types,brivanib,"FGFR inhibitor, VEGFR inhibitor","CYP3A4, FGFR1, FLT1, KCNH2, KDR"
Rhabdoid Cancer,BRD-K28494619-001-28-2::2.5::HTS,7.11478825317203,0.007867477296481127,Rhabdoid Cancer,sulfamethoxazole,PABA antagonist,
Rhabdoid Cancer,BRD-K28595280-001-04-5::2.5::HTS,4.712510565439024,0.030365505811011995,Rhabdoid Cancer,meglumine,excipient,
Rhabdoid Cancer,BRD-K28863208-001-02-0::2.5::HTS,6.072477700689431,0.01403293860468051,Rhabdoid Cancer,PNU-282987,cholinergic receptor agonist,CHRNA7
Rhabdoid Cancer,BRD-K29220403-001-10-8::2.5::HTS,4.440336074597262,0.03556068467992471,Rhabdoid Cancer,eszopiclone,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Rhabdoid Cancer,BRD-K29895144-001-01-0::2.5::HTS,4.918098569778537,0.026978049680151935,Other Types,SKLB1002,VEGFR inhibitor,KDR
Rhabdoid Cancer,BRD-K30550578-001-01-3::2.5::HTS,7.69894159558668,0.005712150503442303,Rhabdoid Cancer,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1
Rhabdoid Cancer,BRD-K31309378-001-01-5::2.5::HTS,20.668822887863772,6.714328581607641e-06,Other Types,lucitanib,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET"
Rhabdoid Cancer,BRD-K31468676-237-01-8::2.5::HTS,5.999761609413449,0.014625608473402208,Rhabdoid Cancer,oxonic-acid,uricase inhibitor,
Rhabdoid Cancer,BRD-K33622447-066-01-9::2.5::HTS,5.1018214117631056,0.024285957289428152,Other Types,abemaciclib,CDK inhibitor,"CDK4, CDK6"
Rhabdoid Cancer,BRD-K33882852-003-02-8::2.5::HTS,4.577139208430484,0.032839200661174045,Other Types,ZK-93423,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
Rhabdoid Cancer,BRD-K34332569-001-01-3::2.5::HTS,7.487686446580816,0.006411557775965091,Rhabdoid Cancer,imidapril,angiotensin converting enzyme inhibitor,ACE
Rhabdoid Cancer,BRD-K34388247-236-08-2::2.5::HTS,4.189517613409299,0.04114342956372758,Rhabdoid Cancer,methicillin,bacterial cell wall synthesis inhibitor,
Rhabdoid Cancer,BRD-K34568562-001-04-3::2.5::HTS,5.918354768790105,0.015297126979209296,Rhabdoid Cancer,tilorone,interferon inducer,
Rhabdoid Cancer,BRD-K34591242-001-04-3::2.5::HTS,6.238327153392389,0.01278830428019105,Rhabdoid Cancer,methoprene-(s),,
Rhabdoid Cancer,BRD-K34801930-001-01-9::2.5::HTS,10.166836544813691,0.0015099015227371107,Rhabdoid Cancer,AZD5069,CC chemokine receptor antagonist,CXCR2
Rhabdoid Cancer,BRD-K36207157-001-07-0::2.52::HTS,4.239347558325686,0.039987257777951105,Other Types,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Rhabdoid Cancer,BRD-K36207157-001-09-6::2.5::HTS,5.214497175648255,0.0227729650354435,Rhabdoid Cancer,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Rhabdoid Cancer,BRD-K36775483-001-01-4::2.5::HTS,4.096428166016136,0.043453340813468445,Rhabdoid Cancer,DMeOB,,GRM5
Rhabdoid Cancer,BRD-K37083340-001-02-3::2.5::HTS,5.474591817059657,0.0196665450736785,Other Types,lycopene,free radical scavenger,
Rhabdoid Cancer,BRD-K37687095-001-06-9::2.5::HTS,11.390569141860906,0.0007891147274672932,Other Types,AZD8330,MEK inhibitor,
Rhabdoid Cancer,BRD-K38380126-001-01-4::2.5::HTS,4.0576111690341286,0.0444511206210245,Other Types,thiamet-g,GLCNAC phosphotransferase inhibitor,MGEA5
Rhabdoid Cancer,BRD-K38797369-003-01-1::2.46::HTS,13.798105509896825,0.00022522009153885133,Rhabdoid Cancer,PD-128907,dopamine receptor agonist,"DRD2, DRD3"
Rhabdoid Cancer,BRD-K38904395-001-02-3::2.5::HTS,12.103602165149233,0.0005422440188857421,Other Types,SAR131675,VEGFR inhibitor,FLT4
Rhabdoid Cancer,BRD-K39252998-003-01-5::2.5::HTS,4.330100784431848,0.03790955469259443,Rhabdoid Cancer,atipamezole,adrenergic receptor antagonist,
Rhabdoid Cancer,BRD-K39841531-001-02-1::2.5::HTS,4.305935624987721,0.03843725207684556,Other Types,TG-101209,JAK inhibitor,"JAK2, JAK3"
Rhabdoid Cancer,BRD-K39974922-001-04-3::2.5::HTS,24.866588799145134,8.266246136419297e-07,Other Types,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Rhabdoid Cancer,BRD-K39987650-001-24-1::2.5::HTS,10.580638253056433,0.00121196810380252,Other Types,bisacodyl,laxative,
Rhabdoid Cancer,BRD-K41337261-001-03-0::2.5::HTS,5.342125081522576,0.021176958403245003,Other Types,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Rhabdoid Cancer,BRD-K41876534-001-13-7::2.5::HTS,5.922565810722454,0.015261566633276014,Rhabdoid Cancer,tioxolone,carbonic anhydrase inhibitor,CA2
Rhabdoid Cancer,BRD-K42417338-045-01-9::2.5::HTS,6.462125008340266,0.011294968127317067,Rhabdoid Cancer,butorphanol-(+)-tartrate,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Rhabdoid Cancer,BRD-K42756753-001-01-9::2.5::HTS,10.440496434141872,0.0013080765001669851,Rhabdoid Cancer,epiandrosterone,steroid,G6PD
Rhabdoid Cancer,BRD-K42859542-001-03-3::2.5::HTS,5.903942466925663,0.015421998191391102,Rhabdoid Cancer,CFM-2,glutamate receptor antagonist,
Rhabdoid Cancer,BRD-K42973005-001-04-0::2.5::HTS,4.058481312618834,0.04442753728697312,Rhabdoid Cancer,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Rhabdoid Cancer,BRD-K42981054-001-01-9::2.5::HTS,4.256221817393821,0.03957903191726867,Other Types,mibampator,glutamate receptor modulator,GRIA1
Rhabdoid Cancer,BRD-K43164539-001-11-5::2.5::HTS,4.230011332055111,0.04018976088284669,Rhabdoid Cancer,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Rhabdoid Cancer,BRD-K43192255-048-03-6::2.5::HTS,9.836695530362372,0.0018009407082125674,Rhabdoid Cancer,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7
Rhabdoid Cancer,BRD-K43621685-001-02-5::2.5::HTS,4.093573025248702,0.04352364479646129,Other Types,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K44009692-001-02-3::2.5::HTS,7.230137187845098,0.007385249948385583,Rhabdoid Cancer,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
Rhabdoid Cancer,BRD-K44133266-001-10-0::2.5::HTS,6.445641066281699,0.011402589316241914,Rhabdoid Cancer,sulbactam,beta lactamase inhibitor,
Rhabdoid Cancer,BRD-K44227013-001-06-4::2.5::HTS,7.435494180847549,0.006596481585206756,Other Types,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Rhabdoid Cancer,BRD-K44442813-001-12-9::2.5::HTS,5.582402144292691,0.018481496463584542,Rhabdoid Cancer,pidotimod,"interferon receptor agonist, interleukin receptor agonist",
Rhabdoid Cancer,BRD-K44665581-001-01-8::2.5::HTS,5.707637474892437,0.017222448397205527,Other Types,bromosporine,bromodomain inhibitor,
Rhabdoid Cancer,BRD-K44777625-001-03-5::2.5::HTS,5.844133283008004,0.015947966319732696,Rhabdoid Cancer,FH1,hepatocyte function enhancer,
Rhabdoid Cancer,BRD-K44844162-001-01-6::2.5::HTS,8.355955337460557,0.003995536016779192,Other Types,taselisib,PI3K inhibitor,PIK3CA
Rhabdoid Cancer,BRD-K44974079-001-01-3::2.5::HTS,5.4201176274583025,0.020267048158724647,Rhabdoid Cancer,ticagrelor,purinergic receptor antagonist,P2RY12
Rhabdoid Cancer,BRD-K45528773-001-07-2::2.59::HTS,4.6203014900001715,0.03204940057050405,Rhabdoid Cancer,M-344,HDAC inhibitor,
Rhabdoid Cancer,BRD-K45861246-001-13-4::2.5::HTS,5.178615948967079,0.023253102953384595,Rhabdoid Cancer,azaperone,dopamine receptor antagonist,"DRD2, DRD3"
Rhabdoid Cancer,BRD-K45916615-066-02-5::2.5::HTS,6.241465508524022,0.012772245895181304,Rhabdoid Cancer,danofloxacin,bacterial DNA gyrase inhibitor,
Rhabdoid Cancer,BRD-K46211610-003-26-7::2.5::HTS,8.170038276931107,0.004418156198659729,Rhabdoid Cancer,tolazoline,adrenergic receptor antagonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2"
Rhabdoid Cancer,BRD-K46435977-003-11-1::2.5::HTS,4.573655455304568,0.032903885645722414,Rhabdoid Cancer,valaciclovir,DNA polymerase inhibitor,
Rhabdoid Cancer,BRD-K46556543-237-10-5::2.55::HTS,6.22525053771984,0.012898444745634646,Rhabdoid Cancer,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2
Rhabdoid Cancer,BRD-K46654563-238-01-0::2.5::HTS,4.601921820004033,0.032371789539401605,Rhabdoid Cancer,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE
Rhabdoid Cancer,BRD-K46692793-004-01-8::2.5::HTS,6.5204863237856285,0.010931542286935724,Other Types,umeclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Rhabdoid Cancer,BRD-K46839850-050-04-2::2.5::HTS,5.552364371727546,0.018808099967374137,Rhabdoid Cancer,cinepazide,calcium channel activator,
Rhabdoid Cancer,BRD-K46982791-001-09-4::2.5::HTS,5.867752712236629,0.01573875951320177,Rhabdoid Cancer,cloxyquin,potassium channel activator,KCNK18
Rhabdoid Cancer,BRD-K47029922-003-10-9::2.5::HTS,5.765050614382236,0.016676614066491183,Rhabdoid Cancer,tranylcypromine,monoamine oxidase inhibitor,"KDM1A, MAOA, MAOB"
Rhabdoid Cancer,BRD-K47195926-001-06-6::2.5::HTS,4.795742098122694,0.028944140364868476,Rhabdoid Cancer,acedoben,,
Rhabdoid Cancer,BRD-K47371940-001-01-6::2.5::HTS,5.2138944725133225,0.022780784984772116,Rhabdoid Cancer,ecabapide,,
Rhabdoid Cancer,BRD-K47407372-001-17-1::2.5::HTS,5.52157925947554,0.01913139603766825,Rhabdoid Cancer,nifenazone,analgesic agent,
Rhabdoid Cancer,BRD-K47631482-003-06-2::2.5::HTS,5.9092220102670145,0.01537805058740462,Rhabdoid Cancer,bromhexine,mucolytic agent,
Rhabdoid Cancer,BRD-K48213016-001-01-8::2.5::HTS,5.212387546186209,0.022805780491406143,Rhabdoid Cancer,CC-930,JNK inhibitor,
Rhabdoid Cancer,BRD-K48578705-001-17-6::2.5::HTS,8.268932690496875,0.004192395185068275,Rhabdoid Cancer,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Rhabdoid Cancer,BRD-K48722833-001-07-6::2.5::HTS,7.883215602818197,0.0051644459862307205,Rhabdoid Cancer,iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7"
Rhabdoid Cancer,BRD-K49049886-001-08-7::2.5::HTS,4.0351509161653825,0.04504639405636534,Rhabdoid Cancer,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Rhabdoid Cancer,BRD-K49071277-001-04-7::2.5::HTS,8.600171815013022,0.0034992837515623485,Other Types,securinine,"GABA receptor antagonist, TP53 activator",GABRA1
Rhabdoid Cancer,BRD-K49075727-001-08-5::2.5::HTS,8.506019436593457,0.0036836744584686047,Other Types,nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K49555808-001-03-9::2.5::HTS,4.555480044028559,0.03325833200615948,Other Types,BMS-707035,HIV integrase inhibitor,
Rhabdoid Cancer,BRD-K49738308-065-04-9::2.5::HTS,6.917916093701711,0.00878269832604865,Other Types,agmatine,nitric oxide synthase inhibitor,"ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH"
Rhabdoid Cancer,BRD-K49962337-001-02-9::2.56::HTS,4.445380191272644,0.035466288784088654,Rhabdoid Cancer,baicalin,beta glucuronidase inhibitor,PREP
Rhabdoid Cancer,BRD-K50163129-001-01-4::2.5::HTS,4.762821138809048,0.02949935000249495,Rhabdoid Cancer,acrivastine,histamine receptor antagonist,HRH1
Rhabdoid Cancer,BRD-K50293352-300-02-1::2.5::HTS,6.159578951071946,0.013362917143040933,Rhabdoid Cancer,MM77,serotonin receptor antagonist,HTR1A
Rhabdoid Cancer,BRD-K50325075-001-02-1::2.5::HTS,6.554704777367668,0.010722883182457357,Rhabdoid Cancer,UCL-2077,slow afterhyperpolarization channel blocker,
Rhabdoid Cancer,BRD-K50495309-001-02-0::2.5::HTS,6.218482321084149,0.012930274047621598,Rhabdoid Cancer,SRC-kinase-inhibitor-I,src inhibitor,"CSK, LCK, RIPK2"
Rhabdoid Cancer,BRD-K50590187-001-19-9::2.5::HTS,12.234735901980693,0.0005068800333621957,Rhabdoid Cancer,capsaicin,TRPV agonist,"CFTR, TRPV1"
Rhabdoid Cancer,BRD-K50850824-237-04-8::2.5::HTS,4.1332084933103035,0.04254926458116274,Rhabdoid Cancer,acesulfame-potassium,,
Rhabdoid Cancer,BRD-K50866992-003-09-5::2.5::HTS,4.7364728317302465,0.029951245959870844,Rhabdoid Cancer,tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4"
Rhabdoid Cancer,BRD-K51544265-001-04-2::2.5::HTS,5.731711110007226,0.016998848902094972,Other Types,cabozantinib,"RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET"
Rhabdoid Cancer,BRD-K51751936-001-09-1::2.5::HTS,6.748705613487208,0.009627529736466557,Rhabdoid Cancer,alfadolone-acetate,benzodiazepine receptor agonist,
Rhabdoid Cancer,BRD-K52219182-001-02-4::2.5::HTS,6.4111179716759965,0.011615976769784616,Rhabdoid Cancer,ICI-63197,phosphodiesterase inhibitor,
Rhabdoid Cancer,BRD-K52256627-300-06-6::2.5::HTS,4.343336673226631,0.0376091808774131,Other Types,chlorhexidine,membrane integrity inhibitor,
Rhabdoid Cancer,BRD-K52396582-001-06-7::2.5::HTS,5.906698193085759,0.01539814945562827,Rhabdoid Cancer,CF102,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Rhabdoid Cancer,BRD-K52911425-001-09-8::2.5::HTS,7.634271706820075,0.005914568525986734,Other Types,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Rhabdoid Cancer,BRD-K53318339-001-24-9::2.5::HTS,4.563234845641694,0.03311514301905239,Other Types,vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C"
Rhabdoid Cancer,BRD-K53414658-001-08-2::2.5::HTS,6.745492484639189,0.009655237421332587,Other Types,tivozanib,VEGFR inhibitor,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K53737926-003-27-8::2.5::HTS,3.9618490716558004,0.047026477364326094,Other Types,amitriptyline,"norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin-norepinephrine reuptake inhibitor (SNRI)","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4"
Rhabdoid Cancer,BRD-K53913732-001-05-9::2.5::HTS,4.281675127644661,0.038988492923389094,Rhabdoid Cancer,SB-408124,orexin receptor antagonist,"HCRTR1, HCRTR2"
Rhabdoid Cancer,BRD-K53963539-004-02-0::2.5::HTS,3.964366123534445,0.04697739139411288,Other Types,vortioxetine,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4"
Rhabdoid Cancer,BRD-K54057105-001-01-2::2.5::HTS,5.5157045674575595,0.01921500994844416,Rhabdoid Cancer,isobutyramide,gene expression stimulant,"HBE1, HBG1"
Rhabdoid Cancer,BRD-K54496168-003-01-2::2.5::HTS,6.113446720872543,0.01371594152499413,Rhabdoid Cancer,propacetamol,cyclooxygenase inhibitor,PTGS2
Rhabdoid Cancer,BRD-K54529596-001-26-3::2.5::HTS,5.42116140731273,0.020270826181879666,Rhabdoid Cancer,captopril,angiotensin converting enzyme inhibitor,"ACE, LTA4H, MMP2, MMP9"
Rhabdoid Cancer,BRD-K54997624-001-06-0::2.5::HTS,7.574964089683579,0.006109616461723271,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Rhabdoid Cancer,BRD-K55424922-003-02-8::2.5::HTS,6.086249135592,0.01392246932072628,Rhabdoid Cancer,anpirtoline,serotonin receptor agonist,HTR1B
Rhabdoid Cancer,BRD-K56277358-001-07-5::2.5::HTS,10.333842594591403,0.0013816249020264734,Other Types,MGCD-265,VEGFR inhibitor,"AXL, MET"
Rhabdoid Cancer,BRD-K56291712-001-01-0::2.5::HTS,6.017517857927607,0.014467262134663645,Other Types,voxtalisib,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Rhabdoid Cancer,BRD-K56405753-001-02-4::2.5::HTS,18.285802974379873,2.233953559335979e-05,Other Types,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Rhabdoid Cancer,BRD-K56543881-001-02-7::2.5::HTS,4.238716243620298,0.039975634998078706,Other Types,ADX-47273,glutamate receptor modulator,GRM5
Rhabdoid Cancer,BRD-K56851771-001-06-8::2.5::HTS,9.089931358457585,0.002686666469551842,Rhabdoid Cancer,enzalutamide,androgen receptor antagonist,AR
Rhabdoid Cancer,BRD-K57179821-001-15-4::2.5::HTS,4.054484836853775,0.04453374102097169,Rhabdoid Cancer,crotamiton,antipruritic,
Rhabdoid Cancer,BRD-K57222227-001-30-1::2.5::HTS,4.744167458464331,0.029814238677952225,Rhabdoid Cancer,indomethacin,cyclooxygenase inhibitor,"GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1"
Rhabdoid Cancer,BRD-K57275767-001-02-4::2.61::HTS,8.279586320113449,0.0041715867027042434,Rhabdoid Cancer,geniposide,GLP receptor agonist,GLP1R
Rhabdoid Cancer,BRD-K58466253-003-14-0::2.5::HTS,7.665383158796709,0.005817514284721779,Other Types,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
Rhabdoid Cancer,BRD-K59110290-238-01-7::2.5::HTS,5.369029018569627,0.020857148055567615,Other Types,fosamprenavir,HIV protease inhibitor,
Rhabdoid Cancer,BRD-K59184148-001-21-6::2.5::HTS,4.396223909230891,0.03647143466170838,Rhabdoid Cancer,SB-216763,glycogen synthase kinase inhibitor,"CCNA2, CDK2, GSK3A, GSK3B"
Rhabdoid Cancer,BRD-K59284035-001-07-9::2.5::HTS,4.364581229242696,0.03715001956706817,Rhabdoid Cancer,chrysophanic-acid,EGFR inhibitor,"EGFR, MTOR"
Rhabdoid Cancer,BRD-K59332007-300-02-7::2.5::HTS,4.41834832266676,0.035998843551517376,Rhabdoid Cancer,linopirdine,potassium channel blocker,"KCNQ2, KCNQ3, KCNQ4, KCNQ5"
Rhabdoid Cancer,BRD-K59436580-001-01-7::2.5::HTS,6.5735169347209395,0.010609596694689144,Other Types,tedizolid,bacterial 50S ribosomal subunit inhibitor,
Rhabdoid Cancer,BRD-K59522102-001-15-3::2.46::HTS,4.167747562914896,0.04169708009495815,Rhabdoid Cancer,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Rhabdoid Cancer,BRD-K60150510-001-15-6::2.5::HTS,4.457362371378104,0.03519840953113613,Rhabdoid Cancer,N6-cyclopentyladenosine,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1"
Rhabdoid Cancer,BRD-K60212747-236-01-1::2.5::HTS,5.575570257213189,0.018574985135206133,Rhabdoid Cancer,neridronic-acid,bone resorption inhibitor,FDPS
Rhabdoid Cancer,BRD-K60341624-001-02-2::2.5::HTS,11.757776690993493,0.0006504753705033523,Other Types,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR
Rhabdoid Cancer,BRD-K60443845-001-08-6::2.5::HTS,12.951158785581583,0.0003491916460871934,Other Types,chlormidazole,fungal lanosterol demethylase inhibitor,
Rhabdoid Cancer,BRD-K61177364-003-02-9::2.5::HTS,4.115564154632502,0.04296469439113709,Rhabdoid Cancer,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1
Rhabdoid Cancer,BRD-K61295575-001-03-6::2.5::HTS,7.82993001769851,0.0053151051009899175,Other Types,blebbistatin-(-),ATPase inhibitor,
Rhabdoid Cancer,BRD-K62562723-003-02-7::2.5::HTS,5.645117246737367,0.017838268415846875,Other Types,SR-2640,leukotriene receptor antagonist,CYSLTR1
Rhabdoid Cancer,BRD-K62627508-001-01-5::2.5::HTS,15.477507612471074,9.398312655355321e-05,Other Types,idasanutlin,MDM inhibitor,"MDM2, TP53"
Rhabdoid Cancer,BRD-K62762455-001-01-3::2.5::HTS,6.865913684490722,0.00902742581437555,Other Types,RU-58841,androgen receptor antagonist,AR
Rhabdoid Cancer,BRD-K62782754-337-02-5::2.5::HTS,4.287385036128994,0.03886558397706202,Rhabdoid Cancer,tiotropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Rhabdoid Cancer,BRD-K62929068-001-16-5::2.5::HTS,6.139833055543043,0.013510741157754722,Other Types,6-benzylaminopurine,purinergic receptor activator,
Rhabdoid Cancer,BRD-K62996583-001-10-3::2.5::HTS,5.584585714465799,0.018461758891116647,Other Types,lidoflazine,calcium channel blocker,"SCN1A, SCN3A, SLC29A1"
Rhabdoid Cancer,BRD-K63550407-001-13-5::2.5::HTS,4.42741529932067,0.035838228309388154,Rhabdoid Cancer,erythromycin,NFkB pathway inhibitor,MLNR
Rhabdoid Cancer,BRD-K63736853-001-04-8::2.5::HTS,4.564165947592521,0.03309152837166639,Rhabdoid Cancer,acipimox,cholesterol inhibitor,HCAR2
Rhabdoid Cancer,BRD-K63828191-003-32-1::2.5::HTS,8.161028474623635,0.004438399899541515,Rhabdoid Cancer,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2"
Rhabdoid Cancer,BRD-K64838454-001-01-0::2.5::HTS,4.635040187765805,0.03175800912072995,Other Types,dipraglurant,glutamate receptor negative allosteric modulator,GRM5
Rhabdoid Cancer,BRD-K64925568-001-01-8::2.5::HTS,11.368138298959414,0.0007989790634083594,Other Types,AMG-232,MDM inhibitor,MDM2
Rhabdoid Cancer,BRD-K65146499-001-27-9::2.5::HTS,5.040062110281018,0.02517993710966855,Rhabdoid Cancer,nabumetone,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Rhabdoid Cancer,BRD-K65544384-001-15-8::2.5::HTS,8.362586417068734,0.003979834032104905,Rhabdoid Cancer,4-aminohippuric-acid,,SLC22A6
Rhabdoid Cancer,BRD-K65678996-001-05-5::2.5::HTS,7.518267260346199,0.006306149320249095,Rhabdoid Cancer,nefiracetam,"acetylcholine receptor agonist, benzodiazepine receptor agonist",CHRM1
Rhabdoid Cancer,BRD-K65856711-001-04-4::2.5::HTS,5.543105775252816,0.01890296983851104,Rhabdoid Cancer,rolipram-S(+),phosphodiesterase inhibitor,
Rhabdoid Cancer,BRD-K65928735-001-04-3::2.5::HTS,4.781441653458699,0.029183316656679534,Other Types,AZD1480,JAK inhibitor,"JAK1, JAK2, JAK3"
Rhabdoid Cancer,BRD-K66538826-001-07-2::2.5::HTS,8.176498268329738,0.004404133059583174,Other Types,amuvatinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor","KIT, MET"
Rhabdoid Cancer,BRD-K66808046-065-03-7::2.5::HTS,4.086140031152458,0.043729976133864354,Other Types,oxyquinoline,chelating agent,METAP2
Rhabdoid Cancer,BRD-K67637637-003-12-6::2.5::HTS,7.585435014037075,0.006077479586021902,Other Types,olopatadine,histamine receptor antagonist,"HRH1, S100A1, S100A12, S100A13, S100A2, S100B"
Rhabdoid Cancer,BRD-K67772619-001-05-1::2.5::HTS,7.078562577877382,0.008028079620372658,Rhabdoid Cancer,rheochrysidin,protein tyrosine kinase inhibitor,PTPN1
Rhabdoid Cancer,BRD-K67943528-050-01-4::2.5::HTS,5.2724536205977905,0.022035862732986678,Other Types,lisuride,dopamine receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6"
Rhabdoid Cancer,BRD-K67977190-066-02-3::2.5::HTS,4.790859805254374,0.029033930855507546,Other Types,eprosartan,angiotensin receptor antagonist,AGTR1
Rhabdoid Cancer,BRD-K68264559-045-04-0::2.58::HTS,3.8693569930389895,0.04968784303545075,Rhabdoid Cancer,brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Rhabdoid Cancer,BRD-K68395654-001-03-1::2.5::HTS,8.717839311540867,0.0032827873142601267,Other Types,EVP4593,NFkB pathway inhibitor,
Rhabdoid Cancer,BRD-K68488863-001-04-9::2.5::HTS,4.79192578773259,0.02900554393502289,Other Types,ENMD-2076,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor","AURKA, FLT3, KDR, PDGFRA, PTK2, SRC"
Rhabdoid Cancer,BRD-K68870568-066-01-5::2.5::HTS,6.96058083641925,0.008564263716559292,Other Types,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Rhabdoid Cancer,BRD-K69001009-001-02-8::2.5::HTS,7.599266628647274,0.006031667386432648,Other Types,golvatinib,VEGFR inhibitor,"KDR, MET"
Rhabdoid Cancer,BRD-K69726595-001-01-2::2.5::HTS,4.57420200298962,0.03288879473560866,Other Types,mericitabine,HCV inhibitor,
Rhabdoid Cancer,BRD-K70463136-001-01-5::2.5::HTS,5.471807830049922,0.019676250445963845,Other Types,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A
Rhabdoid Cancer,BRD-K71055333-224-05-8::2.5::HTS,9.438337549003144,0.0022309069191385456,Rhabdoid Cancer,etamsylate,haemostatic agent,
Rhabdoid Cancer,BRD-K71125014-001-27-1::2.5::HTS,4.594172054985362,0.032512500970064376,Rhabdoid Cancer,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Rhabdoid Cancer,BRD-K71221037-001-01-6::2.5::HTS,5.690729803821394,0.017386225913180533,Other Types,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Rhabdoid Cancer,BRD-K71926323-001-14-6::2.52::HTS,6.462494037910408,0.011296762609882641,Rhabdoid Cancer,marbofloxacin,bacterial DNA gyrase inhibitor,
Rhabdoid Cancer,BRD-K72029282-001-22-0::2.5::HTS,11.779044686918718,0.0006437278632066371,Rhabdoid Cancer,probucol,atherogenesis inhibitor,"ABCA1, ABCB11, CES1"
Rhabdoid Cancer,BRD-K72167406-001-03-9::2.5::HTS,7.519672411858137,0.00629808745297837,Rhabdoid Cancer,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,
Rhabdoid Cancer,BRD-K72827473-001-01-0::2.5::HTS,6.137297408360191,0.013529913917720965,Rhabdoid Cancer,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Rhabdoid Cancer,BRD-K73107279-003-12-5::2.5::HTS,4.3506996309827555,0.037451517020815624,Rhabdoid Cancer,levamisole,acetylcholine receptor agonist,"ALPL, ALPPL2, CHRNA3"
Rhabdoid Cancer,BRD-K73440166-001-01-3::2.5::HTS,5.24682192809778,0.02235629670006746,Rhabdoid Cancer,cinaciguat,guanylate cyclase activator,"GUCY1A3, GUCY1B3"
Rhabdoid Cancer,BRD-K74236708-001-01-9::2.5::HTS,3.91627206055018,0.04831554010273508,Rhabdoid Cancer,acitazanolast,mediator release inhibitor,
Rhabdoid Cancer,BRD-K74514084-001-03-9::2.5::HTS,14.09451127169388,0.00019249574283458453,Other Types,pazopanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3"
Rhabdoid Cancer,BRD-K74913225-001-12-4::2.5::HTS,3.937861352249656,0.047710918792521685,Rhabdoid Cancer,brinzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7"
Rhabdoid Cancer,BRD-K76406695-001-02-9::2.5::HTS,7.915695357819803,0.005073521971944031,Other Types,CCT128930,AKT inhibitor,"PKIA, PRKACA"
Rhabdoid Cancer,BRD-K78055238-001-01-8::2.5::HTS,5.501174212765772,0.01935679798945211,Rhabdoid Cancer,LY2090314,glycogen synthase kinase inhibitor,GSK3B
Rhabdoid Cancer,BRD-K78096648-001-05-7::2.5::HTS,11.692687213116189,0.0006738181005071483,Other Types,oxiperomide,dopamine receptor antagonist,
Rhabdoid Cancer,BRD-K78303961-001-02-3::2.5::HTS,4.280444427987448,0.03900990500777542,Rhabdoid Cancer,glycitein,tumor necrosis factor release inhibitor,TNF
Rhabdoid Cancer,BRD-K78342372-001-02-4::2.5::HTS,13.891400461237577,0.00021357191212503286,Other Types,hematoxylin,,
Rhabdoid Cancer,BRD-K78637815-001-02-2::2.5::HTS,4.8453098135724355,0.02813305873440513,Rhabdoid Cancer,LY320135,cannabinoid receptor antagonist,CNR1
Rhabdoid Cancer,BRD-K78643075-001-11-6::2.5::HTS,3.9155075312780294,0.048333809299495344,Other Types,bromperidol,dopamine receptor antagonist,DRD2
Rhabdoid Cancer,BRD-K79584249-001-01-3::2.5::HTS,15.003940218532529,0.00012010513851648052,Other Types,CGM097,MDM inhibitor,MDM2
Rhabdoid Cancer,BRD-K79633074-001-01-8::2.5::HTS,4.13964850747251,0.04235876223759984,Rhabdoid Cancer,xilobam,,
Rhabdoid Cancer,BRD-K80025777-001-01-4::2.5::HTS,5.1981926439850605,0.022987525023319445,Rhabdoid Cancer,"cis-9,trans-11-Conjugated-linoleic-acid",,
Rhabdoid Cancer,BRD-K80262108-001-07-0::2.5::HTS,4.898368023854066,0.02728519173076081,Rhabdoid Cancer,amifampridine,potassium channel blocker,
Rhabdoid Cancer,BRD-K80267133-001-17-7::2.5::HTS,3.891703325636169,0.04903578255989416,Other Types,aminosalicylate,cyclooxygenase inhibitor,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2"
Rhabdoid Cancer,BRD-K80700417-001-04-2::2.5::HTS,4.351083807824592,0.037437409740604444,Other Types,SGI-1776,Pim kinase inhibitor,"FLT3, PIM1, PIM2, PIM3"
Rhabdoid Cancer,BRD-K80778372-001-02-5::2.5::HTS,9.067036330639226,0.002721249638646503,Rhabdoid Cancer,Ro-19-4605,,"GABRA1, GABRA2, GABRA3, GABRA5"
Rhabdoid Cancer,BRD-K81528515-001-13-8::2.5::HTS,3.9169168809566304,0.048312818133603566,Other Types,nilotinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor","ABL1, KIT"
Rhabdoid Cancer,BRD-K81613478-001-01-8::2.5::HTS,4.2036540700403275,0.04080702779426138,Other Types,gastrodin,,
Rhabdoid Cancer,BRD-K81645297-236-01-1::2.5::HTS,4.1895251415710995,0.04114073444768959,Rhabdoid Cancer,NKP-1339,HSP inhibitor,
Rhabdoid Cancer,BRD-K82677201-001-01-6::2.5::HTS,3.9940831239349692,0.04614325321822601,Other Types,almitrine,neurotransmitter agonist,ATP1A1
Rhabdoid Cancer,BRD-K82767007-001-01-1::2.5::HTS,8.789735334813923,0.0031616306480843647,Rhabdoid Cancer,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Rhabdoid Cancer,BRD-K82967685-300-01-2::2.5::HTS,5.003070217664634,0.025710564544831453,Rhabdoid Cancer,mirodenafil,phosphodiesterase inhibitor,PDE5A
Rhabdoid Cancer,BRD-K83023055-001-02-7::2.5::HTS,5.580021768443546,0.0185082081134813,Other Types,GR-135531,melatonin receptor agonist,
Rhabdoid Cancer,BRD-K84091759-001-07-1::2.5::HTS,4.375094579429596,0.03694317144803205,Rhabdoid Cancer,candesartan,angiotensin receptor antagonist,AGTR1
Rhabdoid Cancer,BRD-K84163249-001-01-9::2.5::HTS,7.197070054023119,0.007526882602297956,Rhabdoid Cancer,ercalcitriol,vitamin D receptor agonist,VDR
Rhabdoid Cancer,BRD-K84564571-001-02-4::2.5::HTS,4.566606643647521,0.03304481527048266,Other Types,telatinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Rhabdoid Cancer,BRD-K84996356-001-01-1::2.5::HTS,5.103250723326372,0.02427462496812718,Other Types,AZD3514,androgen receptor modulator,AR
Rhabdoid Cancer,BRD-K85090592-008-22-7::2.5::HTS,9.977951871647615,0.0016761771692113917,Rhabdoid Cancer,pilocarpine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdoid Cancer,BRD-K85178109-001-02-3::2.5::HTS,8.152062432305986,0.004461225657998015,Other Types,fostamatinib,SYK inhibitor,SYK
Rhabdoid Cancer,BRD-K85307935-236-09-5::2.5::HTS,4.375424818878633,0.03692812716390599,Other Types,novobiocin,bacterial DNA gyrase inhibitor,
Rhabdoid Cancer,BRD-K85307935-236-10-3::2.5::HTS,6.688294479100718,0.009971373661364273,Rhabdoid Cancer,novobiocin,bacterial DNA gyrase inhibitor,
Rhabdoid Cancer,BRD-K85849709-001-01-5::2.5::HTS,7.959624076908593,0.0049535539907803825,Rhabdoid Cancer,AZD2858,glycogen synthase kinase inhibitor,GSK3B
Rhabdoid Cancer,BRD-K86525559-001-04-5::2.5::HTS,5.22893633352132,0.022600995505072226,Rhabdoid Cancer,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Rhabdoid Cancer,BRD-K86687746-001-01-3::2.5::HTS,4.05253293941552,0.04459542257314795,Rhabdoid Cancer,R306465,HDAC inhibitor,
Rhabdoid Cancer,BRD-K86930074-001-05-0::2.5::HTS,20.225536942444727,8.412252177637118e-06,Other Types,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K87782578-001-01-4::2.5::HTS,3.997694317747948,0.046046077829004425,Other Types,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,"BTK, YES1"
Rhabdoid Cancer,BRD-K88544581-001-06-1::2.5::HTS,4.18752342162595,0.041187304164771496,Other Types,CI-976,ACAT inhibitor,"ACAT1, CES1"
Rhabdoid Cancer,BRD-K88625236-001-04-2::2.5::HTS,6.027148964256286,0.014391555722756367,Other Types,nonoxynol-9,membrane integrity inhibitor,
Rhabdoid Cancer,BRD-K88742110-001-07-9::2.5::HTS,6.061018995914581,0.014123260016922736,Other Types,PCI-34051,HDAC inhibitor,"HDAC1, HDAC10, HDAC6, HDAC8"
Rhabdoid Cancer,BRD-K88956297-003-01-9::2.5::HTS,4.870731928728874,0.027731220649691253,Rhabdoid Cancer,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,
Rhabdoid Cancer,BRD-K89162000-001-06-4::2.5::HTS,7.084721127092651,0.007998037749636448,Other Types,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB"
Rhabdoid Cancer,BRD-K89375097-300-08-8::2.5::HTS,7.854652114678135,0.005244862005833544,Rhabdoid Cancer,pirenzepine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Rhabdoid Cancer,BRD-K90374350-001-09-2::2.5::HTS,6.695318380743473,0.009923848377165761,Rhabdoid Cancer,chlorquinaldol,other antibiotic,
Rhabdoid Cancer,BRD-K90630139-003-05-9::2.5::HTS,5.647930159609983,0.017819785991914406,Rhabdoid Cancer,butenafine,fungal squalene epoxidase inhibitor,SQLE
Rhabdoid Cancer,BRD-K90789829-001-07-8::2.5::HTS,4.8427241141533335,0.028172667875602537,Rhabdoid Cancer,nefazodone,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Rhabdoid Cancer,BRD-K91263825-003-21-4::2.5::HTS,8.2470097926927,0.004236745388231377,Other Types,nortriptyline,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4"
Rhabdoid Cancer,BRD-K91301684-003-05-5::2.5::HTS,4.721903778043682,0.03019775722546642,Rhabdoid Cancer,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor",SIGMAR1
Rhabdoid Cancer,BRD-K91336023-003-01-0::2.5::HTS,6.437091503045424,0.011445388347069835,Other Types,mesulergine,dopamine receptor agonist,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7"
Rhabdoid Cancer,BRD-K91614056-001-02-2::2.5::HTS,6.385040172409173,0.011799560741097448,Rhabdoid Cancer,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,
Rhabdoid Cancer,BRD-K91825936-001-01-2::2.5::HTS,5.977550893574049,0.014796770906299862,Other Types,ZK811752,CC chemokine receptor antagonist,CCR1
Rhabdoid Cancer,BRD-K92107055-001-01-9::2.5::HTS,12.886766754156476,0.00035985000431672026,Other Types,pimecrolimus,calcineurin inhibitor,"FKBP1A, MTOR"
Rhabdoid Cancer,BRD-K92446736-003-02-2::2.5::HTS,10.85364899066946,0.001048654717136892,Rhabdoid Cancer,zatebradine,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Rhabdoid Cancer,BRD-K92778217-001-32-7::2.5::HTS,4.294691476614671,0.03870725546136815,Rhabdoid Cancer,mefenamic-acid,cyclooxygenase inhibitor,"KCNQ1, PTGS1, PTGS2, TRPM3"
Rhabdoid Cancer,BRD-K92844263-001-09-8::2.5::HTS,4.260164335447312,0.039478686638798985,Rhabdoid Cancer,triacetin,,
Rhabdoid Cancer,BRD-K92968657-001-01-6::2.5::HTS,5.387851951121167,0.020634223527194556,Other Types,tirapazamine,DNA inhibitor,
Rhabdoid Cancer,BRD-K92976206-001-01-5::2.5::HTS,5.5978034553516,0.01832624289133371,Other Types,guanosine,,PNP
Rhabdoid Cancer,BRD-K92991072-001-04-9::2.5::HTS,11.307372951310981,0.0008268187094728041,Rhabdoid Cancer,PAC-1,caspase activator,CASP3
Rhabdoid Cancer,BRD-K93441486-067-12-8::2.5::HTS,4.198226041401672,0.04093011883004769,Rhabdoid Cancer,diphemanil,acetylcholine receptor antagonist,CHRM3
Rhabdoid Cancer,BRD-K93468883-001-02-0::2.5::HTS,8.448531798837655,0.0037974626621197706,Other Types,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Rhabdoid Cancer,BRD-K93754473-048-20-2::2.5::HTS,7.355935048009172,0.0068892359955383484,Rhabdoid Cancer,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
Rhabdoid Cancer,BRD-K94689771-001-09-0::1.95::HTS,5.107427345230643,0.024212525906840223,Rhabdoid Cancer,pinocembrin,cytochrome P450 inhibitor,CYP1B1
Rhabdoid Cancer,BRD-K95739795-001-03-7::2.5::HTS,4.2619361510903255,0.03943373950545157,Other Types,tetrabenazine,vesicular monoamine transporter inhibitor,"DRD2, SLC18A1, SLC18A2"
Rhabdoid Cancer,BRD-K95785537-001-23-1::2.5::HTS,5.069663014930851,0.024742650423959938,Other Types,PP-2,src inhibitor,"ABL1, LCK, LYN, RIPK2, SRC"
Rhabdoid Cancer,BRD-K95901403-001-04-5::2.5::HTS,4.16286609127689,0.041787992837280324,Other Types,XL-147,PI3K inhibitor,"PIK3CA, PIK3CD, PIK3CG"
Rhabdoid Cancer,BRD-K95926480-003-03-6::2.5::HTS,5.387137812271691,0.02064775526759329,Other Types,SRT1720,SIRT activator,SIRT1
Rhabdoid Cancer,BRD-K97009491-238-03-8::2.58::HTS,4.243351079577794,0.039893859374714666,Rhabdoid Cancer,calcium-levofolinate,,
Rhabdoid Cancer,BRD-K97233161-003-01-5::2.5::HTS,4.130394549861269,0.0426029984834224,Rhabdoid Cancer,ABT-491,platelet activating factor receptor antagonist,PTAFR
Rhabdoid Cancer,BRD-K97764662-001-17-3::2.5::HTS,14.295723352750551,0.00017318875025518644,Other Types,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K97799481-230-01-7::2.5::HTS,6.102854539517155,0.013799114986417036,Other Types,aminophylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D"
Rhabdoid Cancer,BRD-K98624455-074-02-8::2.5::HTS,4.499481936557752,0.03435508574989265,Rhabdoid Cancer,bepotastine,histamine receptor antagonist,HRH1
Rhabdoid Cancer,BRD-K99023089-001-03-7::2.5::HTS,6.218668526667461,0.012928929519233103,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Rhabdoid Cancer,BRD-K99749624-001-07-0::2.5::HTS,5.930955911499903,0.015188731287497023,Other Types,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Rhabdoid Cancer,BRD-M02179497-001-01-1::2.5::HTS,4.828125082545591,0.02843433730838902,Rhabdoid Cancer,bismuth-oxalate,,
Rhabdoid Cancer,BRD-M08274809-001-01-7::2.5::HTS,8.033779885504531,0.004767783553352125,Rhabdoid Cancer,indium(iii)-isopropoxide,,
Rhabdoid Cancer,BRD-M56276249-001-01-1::2.5::HTS,4.171465080676676,0.04159094188019823,Other Types,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,
Rhabdoid Cancer,BRD-M98279124-300-01-1::2.5::HTS,6.936036964053885,0.008682350177527477,Rhabdoid Cancer,cevimeline,acetylcholine receptor agonist,"CHRM1, CHRM3"
Rhabdoid Cancer,BRD-A02232681-001-01-8::2.5::MTS004,5.257691866660904,0.02223416828747552,Rhabdoid Cancer,isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2"
Rhabdoid Cancer,BRD-A14577621-001-01-5::2.5::MTS004,11.494043354902844,0.0007494443259188818,Other Types,peficitinib,JAK inhibitor,"JAK1, JAK2, JAK3"
Rhabdoid Cancer,BRD-A23418262-001-01-5::2.519094866::MTS004,5.2566761489382205,0.022247019547211724,Rhabdoid Cancer,floctafenine,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Rhabdoid Cancer,BRD-A50675490-001-01-0::2.412483069::MTS004,4.626067537601339,0.031933556869643276,Rhabdoid Cancer,carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Rhabdoid Cancer,BRD-A60498477-001-01-2::2.508127434::MTS004,7.9856657878119925,0.004890141802174324,Other Types,tolamolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Rhabdoid Cancer,BRD-K03765900-001-01-9::2.499986292::MTS004,5.5262500877681475,0.019093217641310157,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Rhabdoid Cancer,BRD-K09735259-001-01-3::2.500007896::MTS004,3.915061831148476,0.048364810969284466,Other Types,elbasvir,HCV inhibitor,
Rhabdoid Cancer,BRD-K14681867-001-01-6::2.5::MTS004,5.261394838071621,0.022187382131182248,Rhabdoid Cancer,somatostatin,somatostatin receptor agonist,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
Rhabdoid Cancer,BRD-K26818574-305-07-6::2.5::MTS004,4.663232719722605,0.031255505340097786,Rhabdoid Cancer,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Rhabdoid Cancer,BRD-K29626940-001-01-5::2.682001852::MTS004,4.473604485541578,0.034881393015355186,Rhabdoid Cancer,imidafenacin,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Rhabdoid Cancer,BRD-K39009484-001-01-4::2.5::MTS004,9.75793132388317,0.0018816731949332975,Other Types,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Rhabdoid Cancer,BRD-K39560679-001-01-1::2.500010466::MTS004,4.895565840282397,0.02734410506278018,Rhabdoid Cancer,eluxadoline,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Rhabdoid Cancer,BRD-K47929404-001-01-0::2.500019706::MTS004,5.175247002817197,0.023303565149927777,Other Types,vercirnon,CC chemokine receptor antagonist,CCR9
Rhabdoid Cancer,BRD-K48429278-001-01-3::2.5::MTS004,6.521166959837439,0.01093389646754222,Other Types,pipotiazine-palmitate,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, DRD2, HTR1A, HTR2A"
Rhabdoid Cancer,BRD-K55696337-003-24-4::2.50001813::MTS004,4.289541021430087,0.03882282902786566,Rhabdoid Cancer,topotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Rhabdoid Cancer,BRD-K58529924-001-01-5::2.648577938::MTS004,4.617932760349042,0.032084012994458164,Other Types,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Rhabdoid Cancer,BRD-K62040061-001-01-0::2.500015381::MTS004,4.998740609684602,0.025775108146068412,Other Types,toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB"
Rhabdoid Cancer,BRD-K65498798-001-01-7::2.5::MTS004,5.185230002809337,0.023170639851738624,Other Types,abametapir,metalloproteinase inhibitor,MMP9
Rhabdoid Cancer,BRD-K68544925-001-01-1::2.500014712::MTS004,7.953420886987164,0.0049767170270558275,Other Types,avatrombopag,thrombopoietin receptor agonist,MPL
Rhabdoid Cancer,BRD-K69636617-001-01-7::2.49998713::MTS004,4.636015732954132,0.03175056401146189,Rhabdoid Cancer,testolactone,aromatase inhibitor,CYP19A1
Rhabdoid Cancer,BRD-K70504253-001-01-3::2.500017504::MTS004,4.902365070737851,0.02723765148070668,Other Types,fruquintinib,VEGFR inhibitor,KDR
Rhabdoid Cancer,BRD-K70650177-001-01-7::2.500008535::MTS004,4.849038145568444,0.028085111509099907,Other Types,testosterone-undecanoate,androgen receptor agonist,AR
Rhabdoid Cancer,BRD-K76634210-001-12-1::2.5::MTS004,4.648458070154324,0.03152405843914339,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Rhabdoid Cancer,BRD-K80738081-001-46-8::2.500037854::MTS004,5.92872913698974,0.015219341319883666,Other Types,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Rhabdoid Cancer,BRD-K81616657-001-01-4::2.665005855::MTS004,6.888702420738679,0.008920307242501669,Rhabdoid Cancer,PNU-142633,serotonin receptor agonist,HTR1D
Rhabdoid Cancer,BRD-K81981783-236-02-9::2.570718613::MTS004,4.306089535262733,0.03844995380589512,Other Types,gavestinel,glutamate receptor antagonist,GLRB
Rhabdoid Cancer,BRD-K82967180-001-01-6::2.500024493::MTS004,6.797294162424878,0.009382472286506306,Rhabdoid Cancer,LY3023414,"PI3K inhibitor, mTOR inhibitor",MTOR
Rhabdoid Cancer,BRD-K84868168-001-01-0::2.500006364::MTS004,9.89495798580065,0.0017489477856836098,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Rhabdoid Cancer,BRD-K86410485-046-01-0::2.499987354::MTS004,3.8806662929419686,0.04935765161895166,Other Types,eliglustat,Glycosyl transferase inhibitor,UGCG
Rhabdoid Cancer,BRD-K91543828-001-02-0::2.500044381::MTS004,6.00699598191235,0.014565847296323882,Rhabdoid Cancer,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Rhabdoid Cancer,BRD-K92908289-001-01-8::2.501017998::MTS004,4.295175934790087,0.03869632018775506,Other Types,medica-16,ATP citrase lyase inhibitor,FFAR1
Rhabdoid Cancer,BRD-K98054437-001-09-9::2.494413182::MTS004,4.6869536133511485,0.030830624692246383,Other Types,epalrestat,aldose reductase inhibitor,AKR1B1
Rhabdoid Cancer,BRD-K99616396-001-05-1::2.499991421::MTS004,5.0630469320054665,0.024843726726001554,Other Types,motesanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT1, FLT4, KDR, KIT"
Adenosquamous Carcinoma of the Pancreas,BRD-A00376169-001-01-6::2.5::HTS,4.187985781101342,0.04118287630579126,Other Types,KBG,neprilysin inhibitor,MME
Adenosquamous Carcinoma of the Pancreas,BRD-A01636364-003-15-1::2.5::HTS,3.8757174687409903,0.049484760057716966,Other Types,bupivacaine,sodium channel blocker,"KCNA5, PTGER1, SCN10A, SCN4A"
Adenosquamous Carcinoma of the Pancreas,BRD-A03216249-003-24-3::2.5::HTS,4.719520029675766,0.03024455728325155,Other Types,mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A
Adenosquamous Carcinoma of the Pancreas,BRD-A09062839-003-10-0::2.5::HTS,13.80912847646589,0.00022266318619041436,Other Types,amyleine,local anesthetic,
Adenosquamous Carcinoma of the Pancreas,BRD-A21607826-003-05-1::2.5::HTS,5.453447207757622,0.01988583149192969,Other Types,medetomidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Adenosquamous Carcinoma of the Pancreas,BRD-A28329383-001-02-1::2.5::HTS,8.355402651246285,0.00399618157170998,Other Types,MTPG,glutamate receptor antagonist,"GRM2, GRM3"
Adenosquamous Carcinoma of the Pancreas,BRD-A29944538-003-08-3::2.5::HTS,6.292549698531437,0.01240768454713424,Other Types,proxodolol,adrenergic receptor antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-A32505112-001-04-4::2.5::HTS,10.083009479065327,0.0015790150086370488,Other Types,trandolapril,angiotensin converting enzyme inhibitor,ACE
Adenosquamous Carcinoma of the Pancreas,BRD-A36074203-003-07-6::2.5::HTS,10.432918024588142,0.0013106064291220547,Other Types,remacemide,glutamate receptor antagonist,GRIN1
Adenosquamous Carcinoma of the Pancreas,BRD-A42270467-001-04-4::2.5::HTS,5.44453061548004,0.019984638452581485,Other Types,tenatoprazole,ATPase inhibitor,IDO1
Adenosquamous Carcinoma of the Pancreas,BRD-A50028488-001-01-6::2.5::HTS,4.175182220971725,0.041490165293710184,Other Types,TCS2002,glycogen synthase kinase inhibitor,GSK3B
Adenosquamous Carcinoma of the Pancreas,BRD-A50737080-001-03-0::2.5::HTS,4.5111815058670075,0.03411318333608936,Other Types,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR"
Adenosquamous Carcinoma of the Pancreas,BRD-A51820102-008-28-9::2.5::HTS,6.028277173301361,0.014383558254677518,Other Types,econazole,"lanosterol demethylase inhibitor, sterol demethylase inhibitor","CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5"
Adenosquamous Carcinoma of the Pancreas,BRD-A51831848-001-01-7::2.5::HTS,5.982588544461102,0.014774377469689232,Adenosquamous Carcinoma of the Pancreas,enflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4"
Adenosquamous Carcinoma of the Pancreas,BRD-A53561827-004-23-1::2.5::HTS,4.359543420545113,0.03725585520152339,Other Types,pipenzolate,cholinergic receptor antagonist,CHRM1
Adenosquamous Carcinoma of the Pancreas,BRD-A67516570-001-02-8::2.5::HTS,5.2031883414169755,0.022922183861739238,Other Types,lafutidine,histamine receptor antagonist,HRH2
Adenosquamous Carcinoma of the Pancreas,BRD-A87715314-003-14-4::2.5::HTS,3.879881483151705,0.04936664296414046,Other Types,pronethalol,adrenergic receptor antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-A89175223-051-14-8::2.5::HTS,4.569875800458769,0.03297358382831289,Adenosquamous Carcinoma of the Pancreas,bisoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Adenosquamous Carcinoma of the Pancreas,BRD-A89672324-001-03-0::2.5::HTS,8.774209336507818,0.0031867579691625264,Other Types,CGP-55845,GABA receptor antagonist,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8"
Adenosquamous Carcinoma of the Pancreas,BRD-A92800748-001-05-5::2.5::HTS,5.4844955951309755,0.01953724621671736,Other Types,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,"KDR, MAPK14"
Adenosquamous Carcinoma of the Pancreas,BRD-A94008949-001-01-9::2.5::HTS,3.9904209363887815,0.04624463612452635,Other Types,telithromycin,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Adenosquamous Carcinoma of the Pancreas,BRD-K00317371-001-06-1::2.4::HTS,6.512021362444453,0.010995334774920302,Other Types,RITA,MDM inhibitor,MDM2
Adenosquamous Carcinoma of the Pancreas,BRD-K01174345-001-01-9::2.5::HTS,3.8997539237630616,0.048789277553670726,Other Types,anamorelin,growth hormone secretagogue receptor agonist,GHSR
Adenosquamous Carcinoma of the Pancreas,BRD-K02292852-001-02-1::2.5::HTS,12.265405126191261,0.0004986582443814556,Other Types,cefoperazone,bacterial cell wall synthesis inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K02965577-001-03-4::0.25::HTS,4.432259984932882,0.03571293011761623,Other Types,secalciferol,vitamin D receptor agonist,VDR
Adenosquamous Carcinoma of the Pancreas,BRD-K03095347-001-06-1::2.5::HTS,6.400689181367758,0.011683603514793214,Other Types,levosimendan,calcium sensitizer,"KCNJ11, KCNJ8, PDE3A, TNNC1"
Adenosquamous Carcinoma of the Pancreas,BRD-K04623885-001-07-5::2.5::HTS,4.235031963760731,0.04006685259456386,Other Types,BIBR-1532,telomerase inhibitor,TERT
Adenosquamous Carcinoma of the Pancreas,BRD-K05524748-003-04-4::2.5::HTS,11.092015831343573,0.0009268080413665399,Other Types,dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A"
Adenosquamous Carcinoma of the Pancreas,BRD-K06208435-003-08-2::2.5::HTS,5.302039260256254,0.021664928436762702,Other Types,YS-035,calcium channel blocker,
Adenosquamous Carcinoma of the Pancreas,BRD-K06388322-312-02-6::2.5::HTS,4.800222886986742,0.02886962068335699,Adenosquamous Carcinoma of the Pancreas,pramipexole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Adenosquamous Carcinoma of the Pancreas,BRD-K06593056-001-04-8::2.5::HTS,4.3555613678227045,0.037344805908175294,Other Types,LE-135,retinoid receptor agonist,RARB
Adenosquamous Carcinoma of the Pancreas,BRD-K06749501-001-02-1::2.5::HTS,4.664057330065144,0.031225615845983445,Other Types,GSK1838705A,insulin growth factor receptor inhibitor,"ALK, IGF1R, INSR, RPS6KA1"
Adenosquamous Carcinoma of the Pancreas,BRD-K07106112-003-03-8::2.5::HTS,4.862115825664389,0.027860531212677193,Other Types,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Adenosquamous Carcinoma of the Pancreas,BRD-K07507905-236-02-6::2.5::HTS,5.102999338642263,0.024269625632230882,Other Types,BRL-37344,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Adenosquamous Carcinoma of the Pancreas,BRD-K08703257-001-12-1::2.5::HTS,11.587477059698944,0.0007136592088828893,Other Types,3-amino-benzamide,PARP inhibitor,PARP1
Adenosquamous Carcinoma of the Pancreas,BRD-K09353376-001-03-9::2.5::HTS,4.713076881334981,0.030378787703579102,Other Types,tariquidar,P glycoprotein inhibitor,ABCB1
Adenosquamous Carcinoma of the Pancreas,BRD-K09785578-001-01-2::2.5::HTS,5.13988814812162,0.023764599333342542,Other Types,bakuchiol,DNA polymerase inhibitor,HIF1A
Adenosquamous Carcinoma of the Pancreas,BRD-K11373525-003-02-1::2.5::HTS,4.1845911984631305,0.041262241142392075,Adenosquamous Carcinoma of the Pancreas,ZD-7155,angiotensin receptor antagonist,AGTR1
Adenosquamous Carcinoma of the Pancreas,BRD-K14329163-001-03-9::2.5::HTS,4.921476209402046,0.026990039683993397,Other Types,BAY-K-8644-(s)-(-),L-type calcium channel activator,CACNA1C
Adenosquamous Carcinoma of the Pancreas,BRD-K16664969-001-03-3::2.5::HTS,4.402353112414371,0.03634166019473129,Other Types,GTP-14564,"FLT3 inhibitor, tyrosine kinase inhibitor","CSF1R, FLT3, KIT, PDGFRB"
Adenosquamous Carcinoma of the Pancreas,BRD-K17061841-001-03-5::2.5::HTS,4.8251263432567235,0.02845542227891862,Adenosquamous Carcinoma of the Pancreas,stattic,,
Adenosquamous Carcinoma of the Pancreas,BRD-K17205817-001-06-1::2.5::HTS,4.381282646038341,0.03678335771824382,Other Types,sulfametopyrazine,PABA antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K17513304-001-01-9::2.5::HTS,6.487843080651886,0.011127773824157037,Adenosquamous Carcinoma of the Pancreas,firategrast,integrin antagonist,ITGA4
Adenosquamous Carcinoma of the Pancreas,BRD-K17561142-003-32-5::2.5::HTS,4.972040515360082,0.026155897781818344,Other Types,amiodarone,potassium channel blocker,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2"
Adenosquamous Carcinoma of the Pancreas,BRD-K18172896-001-02-5::2.5::HTS,4.839324592244629,0.028227762865831316,Other Types,eltanolone,membrane integrity inhibitor,"GABRA1, GABRB2, GABRG2"
Adenosquamous Carcinoma of the Pancreas,BRD-K18324993-001-01-6::2.5::HTS,3.963730102306553,0.0469760753453224,Other Types,budipine,glutamate receptor antagonist,GRIN1
Adenosquamous Carcinoma of the Pancreas,BRD-K18910433-001-36-6::2.58::HTS,4.279400246518766,0.03906313494750142,Other Types,estradiol,estrogen receptor agonist,"ESR1, ESR2, GPER1, KCNMA1, NR1I2"
Adenosquamous Carcinoma of the Pancreas,BRD-K19180152-001-02-6::2.5::HTS,4.356052692674883,0.03733412285537247,Other Types,meprobamate,,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
Adenosquamous Carcinoma of the Pancreas,BRD-K20285085-074-04-5::2.5::HTS,4.660280291043477,0.031318011607488115,Other Types,R406,SYK inhibitor,"RET, SYK"
Adenosquamous Carcinoma of the Pancreas,BRD-K21283037-001-21-5::2.5::HTS,8.047106654510143,0.0047244093801339865,Other Types,riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11"
Adenosquamous Carcinoma of the Pancreas,BRD-K21565985-001-22-5::2.5::HTS,4.206509441833666,0.040735552262663816,Other Types,xylazine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Adenosquamous Carcinoma of the Pancreas,BRD-K22314899-001-02-4::2.5::HTS,4.794502184918787,0.028968554450392828,Adenosquamous Carcinoma of the Pancreas,CH223191,aryl hydrocarbon receptor antagonist,AHR
Adenosquamous Carcinoma of the Pancreas,BRD-K22685337-001-13-4::2.5::HTS,4.678085153052403,0.030974552453074164,Adenosquamous Carcinoma of the Pancreas,roxarsone,antiprotozoal agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K24084088-001-11-3::2.5::HTS,5.385716559722057,0.020662457815038233,Other Types,paraxanthine,adenosine receptor antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K24227647-364-01-5::2.5::HTS,5.048056273796038,0.025047958322707408,Adenosquamous Carcinoma of the Pancreas,TC2559,acetylcholine receptor agonist,CHRNA4
Adenosquamous Carcinoma of the Pancreas,BRD-K24556098-001-16-7::2.45::HTS,5.105849966615517,0.02425206911243149,Other Types,deoxycorticosterone-acetate,progestogen hormone,NR3C2
Adenosquamous Carcinoma of the Pancreas,BRD-K24601397-001-01-1::2.5::HTS,4.156558332667896,0.04194778958155477,Adenosquamous Carcinoma of the Pancreas,phlorizin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A11, SLC5A2, SLC5A3"
Adenosquamous Carcinoma of the Pancreas,BRD-K24689407-001-06-3::2.5::HTS,5.626263299778022,0.01803097472592618,Other Types,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Adenosquamous Carcinoma of the Pancreas,BRD-K24771047-001-01-6::2.5::HTS,4.022334403111957,0.04538732175011872,Other Types,ampalex,glutamate receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Adenosquamous Carcinoma of the Pancreas,BRD-K25699529-003-01-1::2.5::HTS,6.383876464295324,0.011791485486331757,Other Types,tapentadol,opioid receptor agonist,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4"
Adenosquamous Carcinoma of the Pancreas,BRD-K26060080-065-05-6::2.5::HTS,4.520147008466541,0.03393952081414443,Other Types,adenine,protein synthesis stimulant,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2"
Adenosquamous Carcinoma of the Pancreas,BRD-K26756394-001-02-2::2.5::HTS,5.643531312721988,0.01785604533119454,Other Types,VE-821,ATR kinase inhibitor,ATR
Adenosquamous Carcinoma of the Pancreas,BRD-K26989966-001-03-5::2.5::HTS,4.19864248263797,0.04092347414269491,Other Types,UNC1999,histone lysine methyltransferase inhibitor,EZH2
Adenosquamous Carcinoma of the Pancreas,BRD-K27204852-001-01-9::2.5::HTS,3.930971643450488,0.04791179694860492,Other Types,balicatib,cathepsin inhibitor,CTSK
Adenosquamous Carcinoma of the Pancreas,BRD-K27911943-001-02-8::2.5::HTS,4.303024112623897,0.03850588822888186,Other Types,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,
Adenosquamous Carcinoma of the Pancreas,BRD-K28307902-001-21-7::2.5::HTS,3.9795282985627503,0.04654588967791189,Other Types,flutamide,androgen receptor antagonist,"AHR, AR"
Adenosquamous Carcinoma of the Pancreas,BRD-K28492574-001-01-6::2.5::HTS,4.541153938817494,0.03352576949093032,Other Types,piconol,,
Adenosquamous Carcinoma of the Pancreas,BRD-K29668683-300-02-2::2.5::HTS,6.711888502596441,0.009827201425136965,Other Types,BD-1063,sigma receptor antagonist,SIGMAR1
Adenosquamous Carcinoma of the Pancreas,BRD-K30550578-001-01-3::2.5::HTS,4.651535041827638,0.03145608586628659,Other Types,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1
Adenosquamous Carcinoma of the Pancreas,BRD-K30867024-003-03-3::2.5::HTS,4.404237026774289,0.03630350953763317,Other Types,SB-216641,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Adenosquamous Carcinoma of the Pancreas,BRD-K32289541-001-01-0::2.5::HTS,7.202176543705868,0.007497692795759169,Other Types,EHop-016,Ras GTPase inhibitor,"RAC1, RAC3"
Adenosquamous Carcinoma of the Pancreas,BRD-K33141550-003-05-7::2.5::HTS,6.18041427561452,0.013207679395978517,Adenosquamous Carcinoma of the Pancreas,L-NAME,nitric oxide synthase inhibitor,NOS3
Adenosquamous Carcinoma of the Pancreas,BRD-K34568562-001-04-3::2.5::HTS,5.590110118125826,0.018403600250855086,Other Types,tilorone,interferon inducer,
Adenosquamous Carcinoma of the Pancreas,BRD-K35189033-001-26-1::2.5::HTS,5.530603510820168,0.01903209563319672,Other Types,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Adenosquamous Carcinoma of the Pancreas,BRD-K37249724-001-25-7::2.5::HTS,7.381136756603338,0.006795716829328686,Other Types,astemizole,histamine receptor antagonist,"HRH1, KCNH1, KCNH2"
Adenosquamous Carcinoma of the Pancreas,BRD-K37561857-001-15-5::2.5::HTS,7.62938165514943,0.00593595578892232,Other Types,zardaverine,phosphodiesterase inhibitor,PDE4D
Adenosquamous Carcinoma of the Pancreas,BRD-K38197229-001-29-9::2.5::HTS,5.3549243235359665,0.02102485457033763,Adenosquamous Carcinoma of the Pancreas,bumetanide,solute carrier family member inhibitor,"CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5"
Adenosquamous Carcinoma of the Pancreas,BRD-K39462424-050-09-8::2.5::HTS,5.747174862730723,0.016843561362152048,Other Types,dexchlorpheniramine,histamine receptor antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K39495750-001-01-2::2.5::HTS,4.778288446721794,0.029259200218640345,Adenosquamous Carcinoma of the Pancreas,chlorobutanol,,
Adenosquamous Carcinoma of the Pancreas,BRD-K41234004-001-03-1::0.03::HTS,5.781483153814702,0.016521279296052568,Other Types,icomucret,mucin production enhancer,LTB4R2
Adenosquamous Carcinoma of the Pancreas,BRD-K42981054-001-01-9::2.5::HTS,6.516040910155804,0.010961534116943512,Adenosquamous Carcinoma of the Pancreas,mibampator,glutamate receptor modulator,GRIA1
Adenosquamous Carcinoma of the Pancreas,BRD-K43164539-001-11-5::2.5::HTS,4.9906854768938045,0.025888192771868872,Adenosquamous Carcinoma of the Pancreas,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Adenosquamous Carcinoma of the Pancreas,BRD-K43449605-001-01-0::2.5::HTS,14.223510158253408,0.00017978849635571026,Other Types,oncrasin-1,apoptosis stimulant,
Adenosquamous Carcinoma of the Pancreas,BRD-K43927145-001-01-2::2.5::HTS,4.8597163547356494,0.02789531990319114,Other Types,BIBN4096,calcitonin antagonist,"CALCA, CALCRL, RAMP1"
Adenosquamous Carcinoma of the Pancreas,BRD-K44777625-001-03-5::2.5::HTS,4.452956131110547,0.035284568244759056,Adenosquamous Carcinoma of the Pancreas,FH1,hepatocyte function enhancer,
Adenosquamous Carcinoma of the Pancreas,BRD-K45479396-050-01-5::2.5::HTS,7.954208074745894,0.004966962298611181,Other Types,BP-554,serotonin receptor agonist,HTR1A
Adenosquamous Carcinoma of the Pancreas,BRD-K46493214-001-06-7::2.5::HTS,11.218930540070483,0.0008643457179181622,Other Types,saccharin,DNA polymerase inhibitor,"CA1, CA12, CA2, CA9"
Adenosquamous Carcinoma of the Pancreas,BRD-K47878171-086-06-0::2.5::HTS,4.942034417502692,0.026653929353555688,Other Types,bephenium-hydroxynaphthoate,anthelmintic agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K48195008-001-19-9::2.5::HTS,4.794298948339299,0.02898203929850918,Other Types,ethinyl-estradiol,"estrogen receptor agonist, estrogenic hormone","ESR1, ESR2, NR1I2"
Adenosquamous Carcinoma of the Pancreas,BRD-K49049886-001-08-7::2.5::HTS,5.183350490798609,0.02318485213371152,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Adenosquamous Carcinoma of the Pancreas,BRD-K50325075-001-02-1::2.5::HTS,10.535529536475812,0.0012412107232570883,Other Types,UCL-2077,slow afterhyperpolarization channel blocker,
Adenosquamous Carcinoma of the Pancreas,BRD-K50866992-003-09-5::2.5::HTS,4.495314190758395,0.03443170237327418,Other Types,tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4"
Adenosquamous Carcinoma of the Pancreas,BRD-K50938786-003-11-8::2.5::HTS,4.512861738143726,0.0340776183542575,Adenosquamous Carcinoma of the Pancreas,ropivacaine,sodium channel blocker,SCN10A
Adenosquamous Carcinoma of the Pancreas,BRD-K52523550-001-01-5::2.5::HTS,7.4697482064087515,0.006475610807896586,Other Types,N-acetylcarnosine,,
Adenosquamous Carcinoma of the Pancreas,BRD-K52756523-001-24-7::2.5::HTS,4.175074479423424,0.04149193970078468,Other Types,dirithromycin,bacterial 50S ribosomal subunit inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K53972329-001-07-0::2.5::HTS,4.220134570359369,0.040415591532267134,Other Types,ruxolitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Adenosquamous Carcinoma of the Pancreas,BRD-K54314721-001-10-2::2.5::HTS,3.930427989800001,0.04790639349022825,Adenosquamous Carcinoma of the Pancreas,zolmitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Adenosquamous Carcinoma of the Pancreas,BRD-K54838207-001-02-0::2.5::HTS,4.5405846245284405,0.033533716250964046,Other Types,fudosteine,mucolytic agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K55773932-001-02-0::2.5::HTS,5.641553014264936,0.017876601206288086,Other Types,BMS-806,HIV attachment inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K57304726-003-06-9::2.5::HTS,5.524422472714155,0.019097538521618083,Other Types,PRE-084,sigma receptor agonist,SIGMAR1
Adenosquamous Carcinoma of the Pancreas,BRD-K58343622-001-01-6::2.5::HTS,6.453708409806049,0.011341508181451836,Other Types,DY131,estrogen-related receptor agonist,"ESRRB, ESRRG"
Adenosquamous Carcinoma of the Pancreas,BRD-K60212747-236-01-1::2.5::HTS,4.350596896467463,0.03747546143125295,Adenosquamous Carcinoma of the Pancreas,neridronic-acid,bone resorption inhibitor,FDPS
Adenosquamous Carcinoma of the Pancreas,BRD-K60237333-001-27-1::2.5::HTS,9.848490352160677,0.0017888202736352536,Other Types,niacin,"NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT"
Adenosquamous Carcinoma of the Pancreas,BRD-K60567437-001-10-2::2.5::HTS,4.069170440502777,0.04416156812115279,Other Types,dimpylate,acetylcholinesterase inhibitor,ACHE
Adenosquamous Carcinoma of the Pancreas,BRD-K61236135-001-08-2::2.5::HTS,6.84344907438415,0.009142897301836941,Adenosquamous Carcinoma of the Pancreas,tiratricol,thyroid hormone stimulant,"THRA, THRB"
Adenosquamous Carcinoma of the Pancreas,BRD-K61250553-003-32-2::2.5::HTS,4.6599286873671595,0.03129710543335859,Other Types,loperamide,opioid receptor agonist,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC"
Adenosquamous Carcinoma of the Pancreas,BRD-K62200014-003-10-5::2.5::HTS,6.514193647764077,0.010970316637953588,Other Types,anagrelide,phosphodiesterase inhibitor,PDE3A
Adenosquamous Carcinoma of the Pancreas,BRD-K62996583-001-10-3::2.5::HTS,4.289330634731142,0.03881221519435844,Other Types,lidoflazine,calcium channel blocker,"SCN1A, SCN3A, SLC29A1"
Adenosquamous Carcinoma of the Pancreas,BRD-K63430059-001-17-2::2.5::HTS,4.01992374101211,0.04546252070433768,Other Types,methoxsalen,DNA synthesis inhibitor,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4"
Adenosquamous Carcinoma of the Pancreas,BRD-K63915849-001-03-7::2.5::HTS,5.660178881716169,0.017689666284743832,Other Types,AS-604850,PI3K inhibitor,"PIK3CA, PIK3CG"
Adenosquamous Carcinoma of the Pancreas,BRD-K64994968-001-32-5::2.5::HTS,5.614763682558738,0.01815276070811494,Other Types,progesterone,progesterone receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5"
Adenosquamous Carcinoma of the Pancreas,BRD-K66480997-003-10-0::2.5::HTS,7.412747387784616,0.0066774506888228075,Adenosquamous Carcinoma of the Pancreas,isoguvacine,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Adenosquamous Carcinoma of the Pancreas,BRD-K67261995-001-11-7::2.5::HTS,5.9898848806554605,0.01469588087947834,Other Types,iodipamide,radiopaque medium,ALB
Adenosquamous Carcinoma of the Pancreas,BRD-K67860401-001-05-6::2.5::HTS,6.364490157724326,0.011918997964829259,Other Types,AR-A014418,glycogen synthase kinase inhibitor,GSK3B
Adenosquamous Carcinoma of the Pancreas,BRD-K67943528-050-01-4::2.5::HTS,4.711371297897801,0.03038545982690364,Other Types,lisuride,dopamine receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6"
Adenosquamous Carcinoma of the Pancreas,BRD-K68132782-003-13-8::2.5::HTS,7.147784605722114,0.00772466812561237,Other Types,terbinafine,fungal squalene epoxidase inhibitor,SQLE
Adenosquamous Carcinoma of the Pancreas,BRD-K68552125-001-05-3::2.03::HTS,8.143934918205344,0.004480393539292685,Other Types,12-O-tetradecanoylphorbol-13-acetate,PKC activator,"KCNT2, TRPV4"
Adenosquamous Carcinoma of the Pancreas,BRD-K68653965-001-01-1::2.5::HTS,17.63125029208252,3.120576491133022e-05,Other Types,picolamine,,
Adenosquamous Carcinoma of the Pancreas,BRD-K68693535-001-03-4::2.5::HTS,9.303753088560168,0.002395046478417131,Other Types,lidamidine,adrenergic receptor agonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K70159787-001-01-1::2.5::HTS,5.568291186509795,0.018631341127327658,Other Types,SMI-4a,Pim kinase inhibitor,PIM1
Adenosquamous Carcinoma of the Pancreas,BRD-K70778732-003-26-7::2.5::HTS,4.752273134452581,0.029675342366104345,Adenosquamous Carcinoma of the Pancreas,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4"
Adenosquamous Carcinoma of the Pancreas,BRD-K70792160-003-04-6::2.5::HTS,10.271832275612978,0.001427402799182634,Other Types,10-DEBC,AKT inhibitor,PIM1
Adenosquamous Carcinoma of the Pancreas,BRD-K71075609-003-01-0::2.5::HTS,10.13751849364373,0.0015335194647240848,Other Types,dorzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7"
Adenosquamous Carcinoma of the Pancreas,BRD-K72726508-001-02-1::2.5::HTS,5.422317871669023,0.020239821328950563,Other Types,arcyriaflavin-a,CDK inhibitor,"CCND1, CDK4"
Adenosquamous Carcinoma of the Pancreas,BRD-K74501079-001-18-1::2.5::HTS,4.909624667532467,0.027114626297274923,Other Types,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR
Adenosquamous Carcinoma of the Pancreas,BRD-K76022557-003-02-7::2.5::HTS,3.938511284546205,0.04768808457081722,Other Types,r(-)-apomorphine,dopamine receptor agonist,"DRD2, HTR5A"
Adenosquamous Carcinoma of the Pancreas,BRD-K76205745-237-16-5::2.5::HTS,5.213620533741672,0.02279115197672911,Other Types,losartan,angiotensin receptor antagonist,AGTR1
Adenosquamous Carcinoma of the Pancreas,BRD-K76609936-001-08-4::2.5::HTS,5.476962963188291,0.01962987363835286,Other Types,imidacloprid,acetylcholine receptor antagonist,CHRFAM7A
Adenosquamous Carcinoma of the Pancreas,BRD-K78633253-001-10-3::2.5::HTS,6.208503573253777,0.013005155553425513,Other Types,EXO-1,ARF inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K78941306-001-02-4::2.5::HTS,3.9599206630415575,0.04707998506940347,Adenosquamous Carcinoma of the Pancreas,SB-742457,serotonin receptor antagonist,HTR6
Adenosquamous Carcinoma of the Pancreas,BRD-K79277568-003-04-7::2.5::HTS,5.487310186315083,0.019525477235777963,Other Types,methoxyamine,DNA repair enzyme inhibitor,APEX1
Adenosquamous Carcinoma of the Pancreas,BRD-K79612754-001-21-7::2.5::HTS,7.618342228022605,0.005966322047156953,Adenosquamous Carcinoma of the Pancreas,inosine,neurotrophic agent,"PARP1, PNP"
Adenosquamous Carcinoma of the Pancreas,BRD-K80082640-001-01-0::2.5::HTS,5.7066112240186815,0.01723972056059749,Other Types,otamixaban,coagulation factor inhibitor,F10
Adenosquamous Carcinoma of the Pancreas,BRD-K80353138-001-12-1::2.5::HTS,5.407571773936416,0.020407194386098445,Other Types,silibinin,cytochrome P450 inhibitor,ALOX5
Adenosquamous Carcinoma of the Pancreas,BRD-K80935598-001-01-1::2.5::HTS,8.197318450558038,0.004352889020343029,Other Types,AZ191,DYRK inhibitor,DYRK1B
Adenosquamous Carcinoma of the Pancreas,BRD-K81316007-001-01-8::2.5::HTS,7.890593942644648,0.005144034254687102,Other Types,4-mu-8C,IRE1 inhibitor,ERN1
Adenosquamous Carcinoma of the Pancreas,BRD-K82028950-300-02-9::2.5::HTS,6.9675556206151965,0.008533880901976343,Other Types,CGH2466,adenosine receptor antagonist,"ADORA1, ADORA2B, ADORA3"
Adenosquamous Carcinoma of the Pancreas,BRD-K82236108-001-04-9::2.5::HTS,5.99243026332806,0.014674368525143167,Other Types,"N-methyl-(-)ephedrine-[1r,2s]",,
Adenosquamous Carcinoma of the Pancreas,BRD-K82522873-001-01-1::2.5::HTS,6.877661175762442,0.00897168377237084,Other Types,N6022,alcohol dehydrogenase inhibitor,ADH5
Adenosquamous Carcinoma of the Pancreas,BRD-K83636919-001-04-8::2.5::HTS,3.8763431750169715,0.049467343975919086,Other Types,entacapone,catechol O methyltransferase inhibitor,COMT
Adenosquamous Carcinoma of the Pancreas,BRD-K86161929-001-11-7::2.52::HTS,4.548416297065254,0.033409841967733674,Other Types,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Adenosquamous Carcinoma of the Pancreas,BRD-K87349602-001-03-8::2.5::HTS,4.350036779630733,0.037458636972418774,Adenosquamous Carcinoma of the Pancreas,beta-CCB,benzodiazepine receptor ligand,"GABRA1, GABRG2"
Adenosquamous Carcinoma of the Pancreas,BRD-K87696786-003-04-4::2.5::HTS,5.562619980525629,0.018694281691418235,Other Types,LY456236,glutamate receptor antagonist,GRM1
Adenosquamous Carcinoma of the Pancreas,BRD-K87932577-001-02-4::2.5::HTS,4.527721854427762,0.033790861028139885,Other Types,CDK1-5-inhibitor,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3B"
Adenosquamous Carcinoma of the Pancreas,BRD-K88172511-003-21-1::2.5::HTS,5.3755068170030045,0.020782531947070304,Adenosquamous Carcinoma of the Pancreas,naltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1, SIGMAR1"
Adenosquamous Carcinoma of the Pancreas,BRD-K88429204-001-35-1::2.5::HTS,4.507420086781384,0.034186872180631815,Other Types,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Adenosquamous Carcinoma of the Pancreas,BRD-K88759641-003-02-8::2.5::HTS,4.659985276298745,0.03130219570004169,Other Types,EMD-66684,angiotensin receptor antagonist,AGTR1
Adenosquamous Carcinoma of the Pancreas,BRD-K88807631-001-01-3::2.5::HTS,9.894898413974763,0.00174583194634469,Other Types,elacridar,P glycoprotein inhibitor,ABCB1
Adenosquamous Carcinoma of the Pancreas,BRD-K89125793-001-26-0::2.5::HTS,8.219407734175471,0.004300989894684873,Other Types,tinidazole,antiprotozoal agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K89299012-001-06-0::2.5::HTS,7.162098074888922,0.007667235238049964,Other Types,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Adenosquamous Carcinoma of the Pancreas,BRD-K89712525-001-02-1::2.57::HTS,3.8810820830603556,0.04935722131515771,Adenosquamous Carcinoma of the Pancreas,2-oxoglutaric-acid,,OXGR1
Adenosquamous Carcinoma of the Pancreas,BRD-K93502141-001-01-6::2.5::HTS,5.133944591504874,0.02386642116657484,Adenosquamous Carcinoma of the Pancreas,amylene-hydrate,local anesthetic,
Adenosquamous Carcinoma of the Pancreas,BRD-K93618743-001-21-0::2.5::HTS,4.562748253582139,0.033111481344014114,Adenosquamous Carcinoma of the Pancreas,ipriflavone,bone resorption inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K94266545-001-24-1::2.5::HTS,5.458765537942262,0.019823442542019835,Other Types,ronidazole,antiprotozoal agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K95739795-001-03-7::2.5::HTS,8.516741643142202,0.00365978818629082,Adenosquamous Carcinoma of the Pancreas,tetrabenazine,vesicular monoamine transporter inhibitor,"DRD2, SLC18A1, SLC18A2"
Adenosquamous Carcinoma of the Pancreas,BRD-K96758128-001-01-8::2.5::HTS,4.381526526322061,0.036781350952945664,Other Types,WAY-213613,glutamate inhibitor,SLC1A2
Adenosquamous Carcinoma of the Pancreas,BRD-K99451608-001-07-3::2.5::HTS,5.985485928401049,0.014731069003609936,Other Types,lopinavir,HIV protease inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K99741577-001-01-7::2.5::HTS,3.9543412959159245,0.047235159153797474,Other Types,SANT-1,smoothened receptor antagonist,"SHH, SMO"
Adenosquamous Carcinoma of the Pancreas,BRD-K99922388-001-02-0::2.5::HTS,4.242135566039783,0.03989583713460053,Other Types,DPO-1,potassium channel blocker,KCNA5
Adenosquamous Carcinoma of the Pancreas,BRD-U45393375-000-01-6::2.5::HTS,5.8983361117618145,0.015507448051400289,Adenosquamous Carcinoma of the Pancreas,sevelamer,phosphate antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-U48018661-000-01-9::2.5::HTS,4.445468068119538,0.0354391503591472,Other Types,tyloxapol,NFkB pathway inhibitor,"LPL, NFKB2"
Adenosquamous Carcinoma of the Pancreas,BRD-A02232681-001-01-8::2.5::MTS004,7.224383896866988,0.0074143097630908605,Adenosquamous Carcinoma of the Pancreas,isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2"
Adenosquamous Carcinoma of the Pancreas,BRD-A04971881-003-01-3::2.65294603::MTS004,10.632780002418542,0.0011813367051534697,Adenosquamous Carcinoma of the Pancreas,cloranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Adenosquamous Carcinoma of the Pancreas,BRD-A10773072-001-03-4::2.496712929::MTS004,5.045951879104038,0.025088406003569562,Adenosquamous Carcinoma of the Pancreas,glycerol-monolaurate,beta lactamase inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-A15687940-001-05-6::2.5::MTS004,5.091179870082124,0.024447664277457447,Adenosquamous Carcinoma of the Pancreas,clofedanol,histamine receptor antagonist,HRH1
Adenosquamous Carcinoma of the Pancreas,BRD-A17009129-001-01-3::2.499993124::MTS004,7.156487786948867,0.007696744985297024,Adenosquamous Carcinoma of the Pancreas,isavuconazole,cytochrome P450 inhibitor,CYP3A4
Adenosquamous Carcinoma of the Pancreas,BRD-A19777893-236-01-9::2.596350183::MTS004,4.433104327859426,0.03571122440259554,Other Types,menadione-bisulfite,vitamin K,"GGCX, VKORC1, VKORC1L1"
Adenosquamous Carcinoma of the Pancreas,BRD-A23418262-001-01-5::2.519094866::MTS004,3.86493617346296,0.04981792639497168,Adenosquamous Carcinoma of the Pancreas,floctafenine,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Adenosquamous Carcinoma of the Pancreas,BRD-A25492003-003-14-1::2.568211596::MTS004,5.1449255741289655,0.02370991836240813,Other Types,chlortetracycline,protein synthesis inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-A48420483-001-02-3::2.5::MTS004,5.1978052842241285,0.02300522692498129,Adenosquamous Carcinoma of the Pancreas,bupranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Adenosquamous Carcinoma of the Pancreas,BRD-A48938994-001-14-1::2.5::MTS004,4.0756627122302085,0.04399982775438359,Adenosquamous Carcinoma of the Pancreas,monoctanoin,,
Adenosquamous Carcinoma of the Pancreas,BRD-A50675490-001-01-0::2.412483069::MTS004,3.962038933081363,0.047041879061675354,Adenosquamous Carcinoma of the Pancreas,carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Adenosquamous Carcinoma of the Pancreas,BRD-A84810646-001-01-6::2.500007302::MTS004,7.669397892715996,0.0058104066131587015,Adenosquamous Carcinoma of the Pancreas,ginsenoside-rd,calcium channel blocker,
Adenosquamous Carcinoma of the Pancreas,BRD-A92177080-001-02-1::2.5::MTS004,6.482617510952531,0.011170593099272359,Other Types,betamethasone-acetate,glucocorticoid receptor agonist,NR3C1
Adenosquamous Carcinoma of the Pancreas,BRD-K01638814-011-01-4::2.587084236::MTS004,12.943714685092207,0.00035060650892041395,Adenosquamous Carcinoma of the Pancreas,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A
Adenosquamous Carcinoma of the Pancreas,BRD-K01662324-001-01-8::2.618953925::MTS004,4.441035888378554,0.03554709379882545,Adenosquamous Carcinoma of the Pancreas,priralfinamide,sodium channel blocker,CACNA1B
Adenosquamous Carcinoma of the Pancreas,BRD-K07070922-001-01-4::2.5::MTS004,6.355848298654756,0.011986847765651289,Adenosquamous Carcinoma of the Pancreas,PF-03049423,phosphodiesterase inhibitor,PDE5A
Adenosquamous Carcinoma of the Pancreas,BRD-K11443721-003-01-6::2.403980733::MTS004,5.7399613670762415,0.016923805175501946,Other Types,NE-100,sigma receptor antagonist,SIGMAR1
Adenosquamous Carcinoma of the Pancreas,BRD-K13394247-003-01-4::2.499991328::MTS004,12.506619659877265,0.00044051347181188753,Adenosquamous Carcinoma of the Pancreas,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3
Adenosquamous Carcinoma of the Pancreas,BRD-K13664493-316-02-5::2.500014041::MTS004,7.669888994475584,0.005808848008398108,Adenosquamous Carcinoma of the Pancreas,naphthoquine-phosphate,antimalarial agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K16546375-001-01-4::2.393310671::MTS004,9.131212238415804,0.0026324298908418377,Adenosquamous Carcinoma of the Pancreas,bicyclol,NFkB pathway inhibitor,"HSPA1A, HSPB1"
Adenosquamous Carcinoma of the Pancreas,BRD-K17480742-001-01-1::2.5::MTS004,7.770899292083646,0.005496843236933315,Other Types,delamanid,bacterial cell wall synthesis inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K17828029-001-01-5::2.536141856::MTS004,7.125847800257913,0.007827594144905787,Adenosquamous Carcinoma of the Pancreas,cinoxate,,
Adenosquamous Carcinoma of the Pancreas,BRD-K18749874-003-08-9::2.5::MTS004,4.841393334916603,0.028207933538494413,Adenosquamous Carcinoma of the Pancreas,melevodopa,"dopamine precursor, dopamine receptor agonist",DDC
Adenosquamous Carcinoma of the Pancreas,BRD-K21586122-001-01-9::2.50000801::MTS004,4.246356431451612,0.03981479363901513,Other Types,fimasartan,angiotensin receptor antagonist,AGTR1
Adenosquamous Carcinoma of the Pancreas,BRD-K21612934-001-01-1::2.473727942::MTS004,4.882107557722488,0.027556880927465274,Adenosquamous Carcinoma of the Pancreas,leteprinim,nerve growth factor agonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K24864897-001-01-0::2.5::MTS004,7.199221858500339,0.007517564783874537,Adenosquamous Carcinoma of the Pancreas,JNJ-26990990,anticonvulsant,
Adenosquamous Carcinoma of the Pancreas,BRD-K25570267-001-01-4::2.436963824::MTS004,4.896608088200408,0.02732775876341435,Adenosquamous Carcinoma of the Pancreas,ezutromid,utrophin enhancer,UTRN
Adenosquamous Carcinoma of the Pancreas,BRD-K27755542-001-01-6::2.49693186::MTS004,4.293878088029211,0.03872473890793485,Adenosquamous Carcinoma of the Pancreas,PF-04937319,glucokinase activator,GCK
Adenosquamous Carcinoma of the Pancreas,BRD-K32804101-001-01-8::2.5::MTS004,4.703172177112457,0.030543603715989864,Other Types,valrocemide,,
Adenosquamous Carcinoma of the Pancreas,BRD-K34508702-001-02-4::2.499975465::MTS004,4.112652181035383,0.04305490563071198,Adenosquamous Carcinoma of the Pancreas,CHF5074,gamma secretase modulator,PSEN1
Adenosquamous Carcinoma of the Pancreas,BRD-K35304636-001-01-0::2.5::MTS004,4.7415555700932055,0.029875404208519175,Adenosquamous Carcinoma of the Pancreas,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Adenosquamous Carcinoma of the Pancreas,BRD-K39009484-001-01-4::2.5::MTS004,6.799130897802889,0.009373419930077948,Other Types,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Adenosquamous Carcinoma of the Pancreas,BRD-K39560679-001-01-1::2.500010466::MTS004,4.069404611104607,0.04416184802478261,Other Types,eluxadoline,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Adenosquamous Carcinoma of the Pancreas,BRD-K41662846-003-01-5::2.517380705::MTS004,5.086918954395663,0.024507971224488587,Adenosquamous Carcinoma of the Pancreas,tecalcet,calcium-sensing receptor agonist,CASR
Adenosquamous Carcinoma of the Pancreas,BRD-K42140276-402-01-4::2.500009363::MTS004,4.077024227655856,0.0439646617187401,Adenosquamous Carcinoma of the Pancreas,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
Adenosquamous Carcinoma of the Pancreas,BRD-K43230258-001-01-4::2.50004725::MTS004,7.376853700557804,0.006818976972670322,Adenosquamous Carcinoma of the Pancreas,crisaborole,phosphodiesterase inhibitor,PDE4B
Adenosquamous Carcinoma of the Pancreas,BRD-K46580984-001-03-6::2.584121204::MTS004,4.106492569397774,0.04321167450291151,Adenosquamous Carcinoma of the Pancreas,phenserine,"acetylcholinesterase inhibitor, beta amyloid synthesis inhibitor","ACHE, BCHE"
Adenosquamous Carcinoma of the Pancreas,BRD-K46843573-001-01-9::2.5::MTS004,4.746425060197579,0.029791732219879054,Adenosquamous Carcinoma of the Pancreas,zotarolimus,mTOR inhibitor,FKBP1A
Adenosquamous Carcinoma of the Pancreas,BRD-K56107812-001-01-7::2.499996486::MTS004,4.545958512128263,0.03344883247823694,Adenosquamous Carcinoma of the Pancreas,carbetocin,oxytocin receptor agonist,OXTR
Adenosquamous Carcinoma of the Pancreas,BRD-K56429665-001-09-6::2.500032186::MTS004,5.004717219803719,0.025686344599108315,Adenosquamous Carcinoma of the Pancreas,calcipotriol,vitamin D receptor agonist,VDR
Adenosquamous Carcinoma of the Pancreas,BRD-K56807945-001-01-2::2.500001454::MTS004,5.113744248705985,0.024134749868446347,Adenosquamous Carcinoma of the Pancreas,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,"EGLN1, EGLN2, HIF1A"
Adenosquamous Carcinoma of the Pancreas,BRD-K60284353-001-01-3::2.5::MTS004,4.319927726860845,0.03814103962262104,Adenosquamous Carcinoma of the Pancreas,titanocene-dichloride,apoptosis stimulant,
Adenosquamous Carcinoma of the Pancreas,BRD-K62240499-001-05-9::2.500058444::MTS004,5.323232968223942,0.021421009852573926,Adenosquamous Carcinoma of the Pancreas,huperzine-a,acetylcholinesterase inhibitor,ACHE
Adenosquamous Carcinoma of the Pancreas,BRD-K66437909-001-01-0::2.49636183::MTS004,6.245840877503103,0.012744913852784045,Adenosquamous Carcinoma of the Pancreas,KT-433,uricosuric agent,
Adenosquamous Carcinoma of the Pancreas,BRD-K68544925-001-01-1::2.500014712::MTS004,3.881014531732141,0.049347492106554265,Other Types,avatrombopag,thrombopoietin receptor agonist,MPL
Adenosquamous Carcinoma of the Pancreas,BRD-K68764924-001-03-2::2.5::MTS004,4.316517937502857,0.03821691433299948,Adenosquamous Carcinoma of the Pancreas,pantethine,coenzyme A precursor,
Adenosquamous Carcinoma of the Pancreas,BRD-K72259270-003-25-6::2.444857586::MTS004,6.126540281822389,0.013623100119935972,Adenosquamous Carcinoma of the Pancreas,dyclonine,sodium channel blocker,"SCN10A, SCN5A"
Adenosquamous Carcinoma of the Pancreas,BRD-K73504359-001-01-3::2.5::MTS004,4.975433091626158,0.026120551020215654,Adenosquamous Carcinoma of the Pancreas,bivalirudin,thrombin inhibitor,F2
Adenosquamous Carcinoma of the Pancreas,BRD-K73585091-001-02-3::2.499988098::MTS004,3.9533003756886624,0.04728580624625794,Adenosquamous Carcinoma of the Pancreas,GS-9620,toll-like receptor agonist,TLR7
Adenosquamous Carcinoma of the Pancreas,BRD-K74759733-065-01-4::2.5::MTS004,4.181673688084563,0.041348467929687716,Adenosquamous Carcinoma of the Pancreas,isepamicin,protein synthesis inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K75445017-001-01-1::2.5::MTS004,4.578171496510066,0.03283016765045301,Adenosquamous Carcinoma of the Pancreas,estetrol,selective estrogen receptor modulator (SERM),ESR1
Adenosquamous Carcinoma of the Pancreas,BRD-K76927775-001-11-8::2.500019441::MTS004,5.160204446502117,0.023503512032885254,Other Types,nitrofurantoin,DNA inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K77320845-001-01-2::2.29566066::MTS004,5.141935813464941,0.02374964690374601,Other Types,secoisolariciresinol-diglucoside,antioxidant,
Adenosquamous Carcinoma of the Pancreas,BRD-K77564118-001-03-1::2.67296817::MTS004,6.457244020321133,0.011329261178134872,Adenosquamous Carcinoma of the Pancreas,fenoverine,acetylcholine receptor antagonist,
Adenosquamous Carcinoma of the Pancreas,BRD-K78841970-001-13-8::2.388586862::MTS004,5.265773375284323,0.022132192339154578,Adenosquamous Carcinoma of the Pancreas,aspartame,,"TAS1R2, TRPV1"
Adenosquamous Carcinoma of the Pancreas,BRD-K80076813-001-08-8::2.356620242::MTS004,5.557526044543489,0.01875854428279828,Adenosquamous Carcinoma of the Pancreas,diftalone,cyclooxygenase inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K80762071-236-02-5::2.5::MTS004,9.448961430665564,0.002219632329023958,Adenosquamous Carcinoma of the Pancreas,indocyanine-green,contrast agent,SLCO1B1
Adenosquamous Carcinoma of the Pancreas,BRD-K80859331-001-01-5::2.5::MTS004,5.234041148844988,0.022536138359165844,Adenosquamous Carcinoma of the Pancreas,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Adenosquamous Carcinoma of the Pancreas,BRD-K82687598-001-01-6::2.5::MTS004,5.277860415522164,0.021980578990220708,Adenosquamous Carcinoma of the Pancreas,tolonidine,adrenergic receptor antagonist,ADRA2A
Adenosquamous Carcinoma of the Pancreas,BRD-K85882401-323-01-5::2.500009065::MTS004,4.420580232239195,0.035971149306547094,Adenosquamous Carcinoma of the Pancreas,avibactam,beta lactamase inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K87573013-001-01-0::2.5::MTS004,5.023340697415022,0.025414125793634425,Adenosquamous Carcinoma of the Pancreas,CL-225385,,
Adenosquamous Carcinoma of the Pancreas,BRD-K90069354-001-03-7::2.5::MTS004,4.576882772568173,0.03285548859797367,Other Types,isovaleramide,alcohol dehydrogenase inhibitor,
Adenosquamous Carcinoma of the Pancreas,BRD-K91543828-001-02-0::2.500044381::MTS004,5.045368874752001,0.025096015806725193,Adenosquamous Carcinoma of the Pancreas,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Adenosquamous Carcinoma of the Pancreas,BRD-K92581468-001-01-6::2.389082227::MTS004,8.886439878718582,0.003002713270657363,Adenosquamous Carcinoma of the Pancreas,ocinaplon,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5"
Adenosquamous Carcinoma of the Pancreas,BRD-K92908289-001-01-8::2.501017998::MTS004,7.20047240203966,0.007512817459511226,Other Types,medica-16,ATP citrase lyase inhibitor,FFAR1
Adenosquamous Carcinoma of the Pancreas,BRD-K94146583-001-01-6::2.500085506::MTS004,5.804883554739939,0.01631596581726249,Adenosquamous Carcinoma of the Pancreas,didox,ribonucleotide reductase inhibitor,RRM1
Adenosquamous Carcinoma of the Pancreas,BRD-K96669468-300-01-1::2.5::MTS004,9.674720183080542,0.0019670412502199417,Adenosquamous Carcinoma of the Pancreas,pyridoxamine,AGE inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A00218260-001-03-4::2.5::HTS,4.118090775009221,0.04290448515731839,Other Types,flutrimazole,sterol demethylase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A03359064-001-02-3::2.5::HTS,5.22203580243636,0.02267943758236316,Other Types,ICI-89406,adrenergic receptor antagonist,"ADRB1, ADRB2"
Head and Neck Squamous Cell Carcinoma,BRD-A03506276-001-01-5::2.5::HTS,3.9735538663894623,0.046707419020127004,Other Types,XL888,HSP inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A04553218-050-16-2::2.5::HTS,3.8870230703536146,0.049155071782236756,Other Types,chlorphenamine,histamine receptor antagonist,"HRH1, SLC6A2, SLC6A3, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-A05457250-001-08-4::2.5::HTS,6.969675863732963,0.00852138497151506,Other Types,BAY-K-8644-(+/-),L-type calcium channel activator,
Head and Neck Squamous Cell Carcinoma,BRD-A06426627-001-03-5::2.5::HTS,6.068259548029174,0.014066117980091471,Other Types,diclazuril,antiprotozoal agent,
Head and Neck Squamous Cell Carcinoma,BRD-A06627858-236-03-0::2.5::HTS,4.062310275906788,0.04432938226500644,Other Types,monensin,bacterial permeability inducer,
Head and Neck Squamous Cell Carcinoma,BRD-A07164067-001-01-2::2.5::HTS,6.7735247025950684,0.009497474836808418,Other Types,meluadrine,,
Head and Neck Squamous Cell Carcinoma,BRD-A08545410-003-07-8::2.38::HTS,13.867396467635775,0.00021727197600338288,Other Types,doxycycline,metalloproteinase inhibitor,MMP8
Head and Neck Squamous Cell Carcinoma,BRD-A10967948-003-06-3::2.5::HTS,5.58028929422269,0.01851812849043754,Other Types,granisetron,serotonin receptor antagonist,HTR3A
Head and Neck Squamous Cell Carcinoma,BRD-A11132253-001-08-2::2.5::HTS,4.429601304054494,0.035785697533774655,Other Types,nadide,electron acceptor,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2"
Head and Neck Squamous Cell Carcinoma,BRD-A12454076-001-01-9::2.5::HTS,3.9572461713966782,0.04718649265268113,Head and Neck Squamous Cell Carcinoma,L-Hydroxyproline,,
Head and Neck Squamous Cell Carcinoma,BRD-A13323580-001-04-8::2.5::HTS,6.773104366493667,0.009508845796044826,Other Types,perillyl-alcohol,"apoptosis stimulant, farnesyltransferase inhibitor",FNTA
Head and Neck Squamous Cell Carcinoma,BRD-A14344385-001-03-2::2.5::HTS,4.983997656819977,0.025979498853687295,Other Types,IDRA-21,glutamate receptor positive allosteric modulator,"GRIA1, GRIA2, GRIA3, GRIA4"
Head and Neck Squamous Cell Carcinoma,BRD-A17453586-003-02-3::2.5::HTS,4.531132897531975,0.03371786027355845,Other Types,MDL-72832,serotonin receptor agonist,HTR1A
Head and Neck Squamous Cell Carcinoma,BRD-A17883755-001-06-1::2.5::HTS,4.153019576006933,0.04202976342742521,Other Types,lenalidomide,anticancer agent,"CDH5, CRBN, PTGS2, TNF, TNFSF11"
Head and Neck Squamous Cell Carcinoma,BRD-A21607826-003-05-1::2.5::HTS,4.733520214794716,0.030002248404677336,Other Types,medetomidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Head and Neck Squamous Cell Carcinoma,BRD-A22380646-236-05-8::2.51::HTS,5.771294946792534,0.01661808589749961,Other Types,pantoprazole,ATPase inhibitor,ATP4A
Head and Neck Squamous Cell Carcinoma,BRD-A22642447-001-01-9::2.5::HTS,5.0392360131056355,0.025173179134162137,Other Types,licarbazepine,voltage-gated sodium channel blocker,SCN5A
Head and Neck Squamous Cell Carcinoma,BRD-A22707317-001-10-8::2.5::HTS,5.437189895727279,0.02006605299474859,Other Types,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Head and Neck Squamous Cell Carcinoma,BRD-A23067620-300-01-3::2.5::HTS,7.119376386285323,0.007848836776628483,Other Types,itraconazole,cytochrome P450 inhibitor,CYP51A1
Head and Neck Squamous Cell Carcinoma,BRD-A24587114-066-22-5::2.5::HTS,7.165191751800301,0.007651803963737237,Other Types,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Head and Neck Squamous Cell Carcinoma,BRD-A25004090-001-08-4::2.5::HTS,4.440751085581221,0.03553638614438403,Head and Neck Squamous Cell Carcinoma,erastin,ion channel antagonist,VDAC2
Head and Neck Squamous Cell Carcinoma,BRD-A26032986-050-02-1::2.5::HTS,5.618201135610943,0.018113253310221636,Other Types,zaldaride,calmodulin antagonist,CALM1
Head and Neck Squamous Cell Carcinoma,BRD-A26690767-066-01-9::2.5::HTS,4.955232689388773,0.02641044183498277,Other Types,saquinavir,HIV protease inhibitor,CYP3A4
Head and Neck Squamous Cell Carcinoma,BRD-A27376179-001-01-3::2.5::HTS,4.990416963508787,0.02589217260888621,Other Types,lestaurtinib,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor","FLT3, NTRK1"
Head and Neck Squamous Cell Carcinoma,BRD-A28318179-003-08-5::2.5::HTS,3.9569418788043977,0.047166238882817214,Other Types,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2
Head and Neck Squamous Cell Carcinoma,BRD-A29426959-050-13-2::2.5::HTS,6.545623246126734,0.010777576021460967,Other Types,carbinoxamine,histamine receptor antagonist,HRH1
Head and Neck Squamous Cell Carcinoma,BRD-A29844814-300-01-5::2.5::HTS,4.276365002641002,0.03910951615634791,Other Types,ABT-202,acetylcholine receptor agonist,
Head and Neck Squamous Cell Carcinoma,BRD-A36010170-001-04-0::2.5::HTS,5.380235646279697,0.02072682763355835,Other Types,amcinonide,glucocorticoid receptor agonist,"ANXA1, NR3C1"
Head and Neck Squamous Cell Carcinoma,BRD-A36318220-001-08-8::2.5::HTS,5.045096479738487,0.02508543129352502,Head and Neck Squamous Cell Carcinoma,necrostatin-1,RIPK inhibitor,RIPK1
Head and Neck Squamous Cell Carcinoma,BRD-A40639672-234-18-0::2.5::HTS,4.26314863250179,0.03941926770685249,Other Types,ketorolac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-A44133049-003-07-8::2.5::HTS,5.287130622004224,0.02185467547514129,Other Types,azasetron,serotonin receptor antagonist,"HTR3A, HTR3B"
Head and Neck Squamous Cell Carcinoma,BRD-A44500574-001-01-8::2.5::HTS,8.688540785752114,0.0033361109024467525,Head and Neck Squamous Cell Carcinoma,FLI-06,notch signaling inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A47598013-004-16-0::2.5::HTS,8.064326193640774,0.004679466039686381,Other Types,citalopram,selective serotonin reuptake inhibitor (SSRI),"SLC6A2, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-A48180038-003-24-3::2.5::HTS,3.9737342057948197,0.04670245463906238,Other Types,trihexyphenidyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Head and Neck Squamous Cell Carcinoma,BRD-A49035384-003-28-9::2.39::HTS,14.965573410255837,0.00012317332707148876,Other Types,methacycline,protein synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A49358627-001-14-6::2.5::HTS,6.252499039462198,0.012688055324588034,Other Types,ciprofibrate,PPAR receptor agonist,PPARA
Head and Neck Squamous Cell Carcinoma,BRD-A49447682-001-02-4::2.5::HTS,5.3768281223241035,0.02076695170747455,Other Types,desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Head and Neck Squamous Cell Carcinoma,BRD-A50028488-001-01-6::2.5::HTS,10.760502241067796,0.001101700536738082,Head and Neck Squamous Cell Carcinoma,TCS2002,glycogen synthase kinase inhibitor,GSK3B
Head and Neck Squamous Cell Carcinoma,BRD-A53539450-004-01-7::2.5::HTS,12.053900475406218,0.0005567241209508148,Other Types,neo-gilurytmal,,
Head and Neck Squamous Cell Carcinoma,BRD-A53566267-001-01-9::2.5::HTS,5.784551024140111,0.016493359851858954,Other Types,anecortave-acetate,angiogenesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A53813595-001-01-8::2.5::HTS,5.379213122151568,0.020735641000205647,Other Types,PGL5001,JNK inhibitor,"MAPK10, MAPK8, MAPK9"
Head and Neck Squamous Cell Carcinoma,BRD-A55393291-001-09-9::2.5::HTS,5.757523630912212,0.01674390852585552,Other Types,testosterone,androgen receptor agonist,AR
Head and Neck Squamous Cell Carcinoma,BRD-A55484088-050-02-5::2.5::HTS,5.394612244821591,0.020557135528917903,Other Types,BNTX,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Head and Neck Squamous Cell Carcinoma,BRD-A55962179-001-22-1::2.5::HTS,6.295362796390223,0.012386711600592324,Other Types,omeprazole,ATPase inhibitor,"ATP4A, CLCN2"
Head and Neck Squamous Cell Carcinoma,BRD-A57798112-001-03-7::2.5::HTS,12.14994361769077,0.0005295675535917284,Other Types,PD-318088,MEK inhibitor,MAP2K1
Head and Neck Squamous Cell Carcinoma,BRD-A58193911-003-18-7::2.5::HTS,7.419683712182941,0.006660723138367638,Other Types,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Head and Neck Squamous Cell Carcinoma,BRD-A59337442-051-05-3::2.5::HTS,4.4625648744433635,0.03508825536640259,Other Types,xamoterol,adrenergic receptor agonist,ADRB1
Head and Neck Squamous Cell Carcinoma,BRD-A59413292-001-08-2::2.5::HTS,7.5368252671193945,0.006240261950042548,Other Types,dexpanthenol,,
Head and Neck Squamous Cell Carcinoma,BRD-A60786380-412-01-5::2.5::HTS,4.8062207470427785,0.028794572668286715,Other Types,sodium-stibogluconate,tyrosine phosphatase inhibitor,"PTPN6, TOP1"
Head and Neck Squamous Cell Carcinoma,BRD-A64064900-001-02-3::2.5::HTS,4.040007987244919,0.04492500264389546,Other Types,sangivamycin,DNA inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A64977602-001-15-9::2.5::HTS,4.672246563271244,0.03107910804973,Other Types,mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-A65145453-001-06-1::2.5::HTS,7.697331479024818,0.005717860919165766,Other Types,ATPA,glutamate receptor agonist,"GRIA2, GRIK1"
Head and Neck Squamous Cell Carcinoma,BRD-A65440446-001-04-1::2.5::HTS,5.1576969811162225,0.02352645606686338,Other Types,cimaterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Head and Neck Squamous Cell Carcinoma,BRD-A66966115-001-01-0::2.5::HTS,12.11462280244858,0.0005392584535586922,Other Types,NM107,RNA polymerase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A67101513-001-03-7::2.5::HTS,6.287502568254076,0.01244215179289412,Other Types,hygromycin-b,polypeptide synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A67975844-001-01-8::2.5::HTS,4.706020086888494,0.030477855529274754,Other Types,NSC-405020,matrix metalloprotease inhibitor,MMP1
Head and Neck Squamous Cell Carcinoma,BRD-A68281735-001-18-6::0.25::HTS,5.029247492491877,0.025313169387171427,Other Types,REV-5901,"leukotriene receptor antagonist, lipoxygenase inhibitor",ALOX5
Head and Neck Squamous Cell Carcinoma,BRD-A70649075-008-30-8::2.5::HTS,7.286599920770172,0.0071577203175988815,Head and Neck Squamous Cell Carcinoma,sulconazole,sterol demethylase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-A78341343-001-01-6::2.5::HTS,4.282304918505852,0.03896756612302064,Other Types,regadenoson,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Head and Neck Squamous Cell Carcinoma,BRD-A83937277-001-10-5::2.5::HTS,7.050836798716246,0.008157213410514045,Other Types,mephenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Head and Neck Squamous Cell Carcinoma,BRD-A89594340-003-11-5::2.5::HTS,5.7879853056296415,0.01646268769135032,Other Types,carnitine-(D/L),,
Head and Neck Squamous Cell Carcinoma,BRD-A91699651-316-10-9::2.5::HTS,7.180984731088198,0.007585211241064023,Other Types,chloroquine,antimalarial agent,"GSTA2, MRGPRX1, TLR9, TNF"
Head and Neck Squamous Cell Carcinoma,BRD-A92872453-001-01-8::2.5::HTS,4.144538462584612,0.04224428683519439,Other Types,N-acetylmannosamine,,CHIT1
Head and Neck Squamous Cell Carcinoma,BRD-A94523291-304-02-7::2.5::HTS,4.60055534909723,0.03239346153277995,Other Types,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Head and Neck Squamous Cell Carcinoma,BRD-A94709349-001-08-3::2.5::HTS,4.388893795625574,0.03662402031017223,Head and Neck Squamous Cell Carcinoma,metaxalone,muscle relaxant,
Head and Neck Squamous Cell Carcinoma,BRD-A95340155-001-09-7::2.5::HTS,4.31554925528813,0.03821912102386552,Other Types,methyclothiazide,chloride reabsorption inhibitor,"CA1, CA2, CA4, SLC12A1, SLC12A3"
Head and Neck Squamous Cell Carcinoma,BRD-K00317371-001-06-1::2.4::HTS,9.169850079049032,0.0025806130160921587,Head and Neck Squamous Cell Carcinoma,RITA,MDM inhibitor,MDM2
Head and Neck Squamous Cell Carcinoma,BRD-K01292756-001-25-0::2.5::HTS,8.254927340176833,0.0042199847979522654,Other Types,pimozide,dopamine receptor antagonist,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2"
Head and Neck Squamous Cell Carcinoma,BRD-K01295354-001-02-8::2.5::HTS,7.154102824950129,0.007697851931515631,Other Types,uric-acid,,PYGL
Head and Neck Squamous Cell Carcinoma,BRD-K01683783-001-02-6::2.5::HTS,4.677557516243896,0.030983223482474866,Other Types,TAK-901,Aurora kinase inhibitor,AURKB
Head and Neck Squamous Cell Carcinoma,BRD-K02898090-001-02-7::2.5::HTS,3.861925062503767,0.04990015238079678,Head and Neck Squamous Cell Carcinoma,kifunensine,mannosidase inhibitor,"MAN1B1, MAN2A1"
Head and Neck Squamous Cell Carcinoma,BRD-K03063480-001-05-8::2.5::HTS,3.8851099478600704,0.049206293634979616,Head and Neck Squamous Cell Carcinoma,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Head and Neck Squamous Cell Carcinoma,BRD-K03109492-001-02-2::2.5::HTS,10.20948012233127,0.0014767241589023789,Other Types,NSC-663284,CDC inhibitor,"CDC25A, CDC25B, CDC25C"
Head and Neck Squamous Cell Carcinoma,BRD-K03273112-001-01-8::2.5::HTS,11.88861262230831,0.0006073035464939726,Head and Neck Squamous Cell Carcinoma,1-azakenpaullone,glycogen synthase kinase inhibitor,"CCNB1, CDK1, CDK5, GSK3B"
Head and Neck Squamous Cell Carcinoma,BRD-K03390685-001-01-7::2.5::HTS,14.949502244085378,0.00012352618386507111,Other Types,cobimetinib,MEK inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K04548931-003-16-5::2.5::HTS,5.265001899874176,0.02212617164036206,Other Types,epirubicin,topoisomerase inhibitor,"CHD1, TOP2A"
Head and Neck Squamous Cell Carcinoma,BRD-K04833372-001-06-2::2.5::HTS,4.5834696123955805,0.032717556998371776,Other Types,GSK1904529A,"IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR"
Head and Neck Squamous Cell Carcinoma,BRD-K04923131-001-15-4::2.5::HTS,7.791913031074267,0.005429771205605512,Head and Neck Squamous Cell Carcinoma,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Head and Neck Squamous Cell Carcinoma,BRD-K04956647-003-02-5::2.5::HTS,7.7988716190034655,0.0054075544735347385,Other Types,nebivolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Head and Neck Squamous Cell Carcinoma,BRD-K05444225-001-01-7::2.5::HTS,4.3309963670225695,0.0378897771260702,Head and Neck Squamous Cell Carcinoma,E7449,PARP inhibitor,"PARP1, PARP2, TNKS, TNKS2"
Head and Neck Squamous Cell Carcinoma,BRD-K05638300-001-01-2::2.5::HTS,13.943787773616759,0.00020883756692938356,Other Types,sevoflurane,membrane integrity inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1"
Head and Neck Squamous Cell Carcinoma,BRD-K05658747-001-02-9::2.5::HTS,4.983886372499158,0.025983307353980564,Other Types,raltegravir,HIV integrase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K05906022-001-05-1::2.5::HTS,9.321853706716881,0.002373268494311346,Other Types,limonin,HIV protease inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K06208435-003-08-2::2.5::HTS,4.1068993728208945,0.04318029948829012,Head and Neck Squamous Cell Carcinoma,YS-035,calcium channel blocker,
Head and Neck Squamous Cell Carcinoma,BRD-K06426971-001-02-7::2.5::HTS,4.95170524446719,0.026463887938366796,Other Types,ryuvidine,histone lysine methyltransferase inhibitor,"CDK2, CDK4"
Head and Neck Squamous Cell Carcinoma,BRD-K06557128-001-07-0::2.5::HTS,5.424064942882303,0.020217844833502318,Other Types,voriconazole,cytochrome P450 inhibitor,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1"
Head and Neck Squamous Cell Carcinoma,BRD-K06674495-334-03-2::2.5::HTS,4.755822248309579,0.029616980162154093,Other Types,nafamostat,serine protease inhibitor,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7"
Head and Neck Squamous Cell Carcinoma,BRD-K07106112-003-03-8::2.5::HTS,32.38142742621807,2.0495638019770663e-08,Other Types,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Head and Neck Squamous Cell Carcinoma,BRD-K07265709-003-05-6::2.61::HTS,4.158208938585343,0.04193061361913287,Other Types,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Head and Neck Squamous Cell Carcinoma,BRD-K07955840-001-02-3::2.5::HTS,8.354720044211856,0.0039965691157422024,Other Types,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Head and Neck Squamous Cell Carcinoma,BRD-K08109215-001-06-4::2.5::HTS,3.9396287165879786,0.0476676920085186,Other Types,I-BET-762,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Head and Neck Squamous Cell Carcinoma,BRD-K08287586-001-14-3::2.5::HTS,4.8273127772093165,0.02842259899984791,Other Types,butyl-paraben,DNA synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K08799216-001-05-3::2.5::HTS,16.551088936121136,5.4436728841009855e-05,Other Types,pelitinib,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K09635314-001-03-4::2.5::HTS,3.992974442435843,0.046180403548831656,Other Types,m-3M3FBS,,"PLCB2, PLCB3, PLCD1, PLCG1, PLCG2"
Head and Neck Squamous Cell Carcinoma,BRD-K10029415-005-06-9::2.5::HTS,4.170014586432417,0.04161338770554019,Other Types,enisamium-iodide,,
Head and Neck Squamous Cell Carcinoma,BRD-K10065684-001-07-4::2.5::HTS,5.442972835706797,0.020002290845787484,Head and Neck Squamous Cell Carcinoma,dantron,laxative,
Head and Neck Squamous Cell Carcinoma,BRD-K10759144-001-04-3::2.5::HTS,6.501825727670484,0.011057772472164105,Head and Neck Squamous Cell Carcinoma,xylose,,
Head and Neck Squamous Cell Carcinoma,BRD-K10843433-001-22-7::2.5::HTS,6.0991532014624,0.013833367197383005,Other Types,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K10845183-304-01-6::2.5::HTS,5.278428630826965,0.021973478215826295,Other Types,tiludronate,"bone resorption inhibitor, osteoclast inhibitor","ATP6V1A, MMP2, PTPN1"
Head and Neck Squamous Cell Carcinoma,BRD-K11071038-001-01-7::2.5::HTS,3.959647845833687,0.04710917390482847,Other Types,ICI-162846,histamine receptor antagonist,HRH2
Head and Neck Squamous Cell Carcinoma,BRD-K11073688-001-01-6::2.5::HTS,7.992059498264325,0.004873158875778593,Other Types,CPI-1189,tumor necrosis factor release inhibitor,TNF
Head and Neck Squamous Cell Carcinoma,BRD-K12343256-001-08-9::2.5::HTS,11.808158119318163,0.0006336235582684319,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Head and Neck Squamous Cell Carcinoma,BRD-K12539581-001-23-7::2.5::HTS,5.214873181745671,0.0227667550533769,Other Types,nocodazole,tubulin polymerization inhibitor,HPGDS
Head and Neck Squamous Cell Carcinoma,BRD-K13387373-004-14-5::2.5::HTS,11.539325415008863,0.0007302992146470325,Other Types,thonzonium,ATPase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K14385366-001-04-4::2.59::HTS,5.435485901414891,0.020111281927609918,Other Types,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2
Head and Neck Squamous Cell Carcinoma,BRD-K14796088-003-26-8::2.5::HTS,12.656424779979725,0.00040588479432090253,Other Types,berberine,LDL receptor activator,LDLR
Head and Neck Squamous Cell Carcinoma,BRD-K15045219-001-01-8::2.5::HTS,6.296537784948148,0.012385839594084855,Other Types,salazodine,,
Head and Neck Squamous Cell Carcinoma,BRD-K15502390-001-20-9::2.5::HTS,4.15883428500945,0.041886811823936394,Other Types,nevirapine,non-nucleoside reverse transcriptase inhibitor,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5"
Head and Neck Squamous Cell Carcinoma,BRD-K15507868-001-03-7::2.5::HTS,4.164943418737994,0.041737173770292985,Head and Neck Squamous Cell Carcinoma,tesaglitazar,"insulin sensitizer, PPAR receptor agonist","PPARA, PPARG"
Head and Neck Squamous Cell Carcinoma,BRD-K16189898-003-03-3::2.5::HTS,11.042039560897221,0.0009486211191482136,Head and Neck Squamous Cell Carcinoma,CHIR-99021,glycogen synthase kinase inhibitor,"CDK1, GSK3A, GSK3B, MAPK1"
Head and Neck Squamous Cell Carcinoma,BRD-K17061841-001-03-5::2.5::HTS,12.661294241792785,0.0004048524406791074,Other Types,stattic,,
Head and Neck Squamous Cell Carcinoma,BRD-K17203476-001-01-9::2.5::HTS,6.221219133150973,0.01291001099277475,Other Types,LY2874455,FGFR antagonist,"FGFR1, FGFR2, FGFR3, FGFR4, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K17555800-003-01-5::2.5::HTS,21.25744499816502,4.979002410129884e-06,Other Types,talmapimod,p38 MAPK inhibitor,"MAPK11, MAPK14"
Head and Neck Squamous Cell Carcinoma,BRD-K17702546-001-03-2::2.5::HTS,24.94203222625111,7.897130297354782e-07,Other Types,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Head and Neck Squamous Cell Carcinoma,BRD-K17849083-001-31-1::2.5::HTS,9.714099042630187,0.001923745400737446,Other Types,tranilast,angiogenesis inhibitor,"HPGDS, HRH1"
Head and Neck Squamous Cell Carcinoma,BRD-K18059238-001-10-4::0.25::HTS,6.756738886816058,0.009587019418927036,Head and Neck Squamous Cell Carcinoma,gamma-linolenic-acid,"cyclooxygenase inhibitor, prostanoid receptor agonist","PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K18163608-001-05-6::2.48::HTS,4.25879930504528,0.03953561357147764,Other Types,HA14-1,BCL inhibitor,BCL2
Head and Neck Squamous Cell Carcinoma,BRD-K18574842-236-17-7::2.5::HTS,7.161632115646286,0.007674572878561018,Other Types,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Head and Neck Squamous Cell Carcinoma,BRD-K18678457-003-02-8::2.5::HTS,4.253306451517784,0.0396346518615315,Other Types,ZD-7288,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Head and Neck Squamous Cell Carcinoma,BRD-K18834913-001-01-1::2.5::HTS,18.450692863163294,2.056167308628186e-05,Other Types,LB42708,farnesyltransferase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K18922609-004-23-1::2.5::HTS,4.088623954840499,0.043652883232266834,Other Types,neostigmine,acetylcholinesterase inhibitor,ACHE
Head and Neck Squamous Cell Carcinoma,BRD-K19136521-001-08-9::2.5::HTS,4.879599543582082,0.027584404143626413,Head and Neck Squamous Cell Carcinoma,indirubin-3-monoxime,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B"
Head and Neck Squamous Cell Carcinoma,BRD-K19462402-003-24-6::2.5::HTS,6.192931854863643,0.013118767755088918,Other Types,buflomedil,"adrenergic receptor antagonist, calcium channel blocker",ADRA1A
Head and Neck Squamous Cell Carcinoma,BRD-K19540840-001-09-4::2.5::HTS,19.18759718316905,1.4136756609368516e-05,Other Types,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Head and Neck Squamous Cell Carcinoma,BRD-K19601669-001-03-5::2.5::HTS,18.444449358731685,2.0609220151560534e-05,Other Types,ruxolitinib-(S),JAK inhibitor,"JAK1, JAK2"
Head and Neck Squamous Cell Carcinoma,BRD-K19687926-379-07-4::2.5::HTS,18.952399810311924,1.5945415617608885e-05,Other Types,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K19761926-001-02-8::2.5::HTS,4.8677910678088265,0.027772074752155193,Other Types,eplerenone,cytochrome P450 inhibitor,NR3C2
Head and Neck Squamous Cell Carcinoma,BRD-K21025364-001-04-9::2.5::HTS,4.000293141681901,0.045993607825137,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Head and Neck Squamous Cell Carcinoma,BRD-K21025364-001-05-6::2.44::HTS,22.175411700769963,3.184771320799397e-06,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Head and Neck Squamous Cell Carcinoma,BRD-K21565985-001-22-5::2.5::HTS,9.094313873115953,0.0026807621170879515,Other Types,xylazine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Head and Neck Squamous Cell Carcinoma,BRD-K21672174-001-03-0::2.5::HTS,5.8645652760163145,0.01576583587697381,Other Types,Ro-28-1675,glucokinase activator,GCK
Head and Neck Squamous Cell Carcinoma,BRD-K21718444-001-06-8::2.5::HTS,8.56526036814383,0.0035649666500176813,Other Types,KW-2449,"Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor","ABL1, AURKA, AURKB, FLT3"
Head and Neck Squamous Cell Carcinoma,BRD-K21782625-001-02-4::2.5::HTS,3.8693474351024406,0.04968812389081114,Other Types,AMG458,MET inhibitor,MET
Head and Neck Squamous Cell Carcinoma,BRD-K21908111-001-01-8::2.5::HTS,4.122343758036043,0.0427950179929296,Head and Neck Squamous Cell Carcinoma,AZD1208,Pim kinase inhibitor,"PIM1, PIM2, PIM3"
Head and Neck Squamous Cell Carcinoma,BRD-K21913543-001-02-4::2.5::HTS,8.262922466913372,0.00420115218537049,Head and Neck Squamous Cell Carcinoma,fluorescein,,SLC22A6
Head and Neck Squamous Cell Carcinoma,BRD-K22009844-001-12-5::2.5::HTS,4.43068994027289,0.03574154088416403,Other Types,phenprobamate,muscle relaxant,
Head and Neck Squamous Cell Carcinoma,BRD-K22025381-003-01-9::2.5::HTS,6.284712055426741,0.0124610249614371,Other Types,U-18666A,oxidosqualene cyclase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K22127577-001-03-7::2.58::HTS,5.111957119703777,0.024167689577247662,Other Types,crenolanib,PDGFR tyrosine kinase receptor inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB"
Head and Neck Squamous Cell Carcinoma,BRD-K22193694-001-13-6::2.5::HTS,4.131961488409603,0.04255432455567332,Other Types,dioxybenzone,topical sunscreen agent,
Head and Neck Squamous Cell Carcinoma,BRD-K23082237-003-01-5::2.5::HTS,4.507049676381053,0.034198181462386,Other Types,butaclamol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A"
Head and Neck Squamous Cell Carcinoma,BRD-K23190681-001-01-1::2.5::HTS,40.233259426991694,4.684268959003213e-10,Other Types,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K24187789-001-01-7::2.5::HTS,4.276275939341464,0.03910739781387469,Other Types,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Head and Neck Squamous Cell Carcinoma,BRD-K24443618-001-10-2::2.5::HTS,5.46643013482704,0.019737547000734386,Other Types,etebenecid,uricosuric blocker,
Head and Neck Squamous Cell Carcinoma,BRD-K24593301-001-02-3::2.54::HTS,4.859126624617676,0.027930873198342723,Other Types,AZD3463,"ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor","ALK, IGF1R"
Head and Neck Squamous Cell Carcinoma,BRD-K24601397-001-01-1::2.5::HTS,8.218349837393653,0.004304601911476206,Other Types,phlorizin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A11, SLC5A2, SLC5A3"
Head and Neck Squamous Cell Carcinoma,BRD-K24715592-406-02-1::2.53::HTS,23.08497667474957,2.022810766674719e-06,Other Types,ethacridine-lactate-monohydrate,DNA intercalating agent,
Head and Neck Squamous Cell Carcinoma,BRD-K26603252-003-04-9::2.5::HTS,26.874199526866725,3.062582512784878e-07,Other Types,PD-153035,EGFR inhibitor,"EGFR, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K26667523-001-02-5::2.5::HTS,10.400777739589897,0.0013338613138992761,Other Types,TAK-733,MEK inhibitor,MAP2K1
Head and Neck Squamous Cell Carcinoma,BRD-K26833429-001-02-8::2.5::HTS,5.402003066409194,0.020474352633389693,Other Types,costunolide,telomerase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K26838195-075-04-9::2.5::HTS,7.410761078833202,0.006684729099544791,Other Types,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K27316855-001-13-3::2.44::HTS,7.124727155123996,0.007836800696153131,Other Types,calcitriol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K27316855-001-19-0::2.5::HTS,9.919110002146281,0.0017230968667859092,Other Types,calcitriol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K28007504-051-01-2::2.5::HTS,5.297645378874153,0.02172440356128162,Other Types,Ro-60-0175,,"HTR2A, HTR2B, HTR2C"
Head and Neck Squamous Cell Carcinoma,BRD-K28120222-001-08-4::2.5::HTS,4.472068868643858,0.034899203679374796,Other Types,parthenolide-(alternate-stereo),NFkB pathway inhibitor,"IKBKB, RELA"
Head and Neck Squamous Cell Carcinoma,BRD-K28343777-001-01-6::2.5::HTS,4.053079086161373,0.044574023675361375,Other Types,20-hydroxyecdysone,ecdysone receptor modulator,
Head and Neck Squamous Cell Carcinoma,BRD-K28352084-001-02-3::2.5::HTS,12.021601123863922,0.0005663948772988298,Other Types,CH5132799,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Head and Neck Squamous Cell Carcinoma,BRD-K28456624-001-01-1::2.5::HTS,4.96375249303311,0.026284695956152255,Other Types,seocalcitol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K28936863-051-33-0::2.5::HTS,5.404263411172234,0.02044811845652981,Other Types,ketotifen,"histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor","HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD"
Head and Neck Squamous Cell Carcinoma,BRD-K28965160-001-01-1::2.5::HTS,8.280415282442796,0.004162027697748572,Other Types,BVD-523,MAP kinase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K29322660-001-01-9::2.5::HTS,6.864459605987972,0.009030352123626243,Other Types,edoxaban,coagulation factor inhibitor,F10
Head and Neck Squamous Cell Carcinoma,BRD-K29392254-001-02-2::2.5::HTS,5.306387502102388,0.02163421001171158,Other Types,pantothenic-acid,coenzyme A precursor,
Head and Neck Squamous Cell Carcinoma,BRD-K29713308-077-04-1::2.5::HTS,4.132934613884753,0.04253261840697498,Other Types,"mebhydroline-1,5-naphtalenedisulfonate",,
Head and Neck Squamous Cell Carcinoma,BRD-K29735307-001-02-9::2.5::HTS,4.886956471792529,0.027462334575192846,Other Types,ostarine,androgen receptor modulator,AR
Head and Neck Squamous Cell Carcinoma,BRD-K30331124-001-01-7::2.5::HTS,10.767040428363371,0.0010976543305147252,Other Types,ASC-J9,androgen receptor enhancer,AR
Head and Neck Squamous Cell Carcinoma,BRD-K30466858-001-09-6::2.5::HTS,4.6086361459531515,0.03224090123162779,Head and Neck Squamous Cell Carcinoma,ellagic-acid,"glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor","CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK"
Head and Neck Squamous Cell Carcinoma,BRD-K31086665-005-04-6::2.5::HTS,4.689934314195126,0.030761972350978217,Other Types,NH125,eukaryotic translation elongation factor 2 inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K31283835-048-04-4::2.5::HTS,6.141542301976161,0.013502648823176281,Other Types,tofacitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Head and Neck Squamous Cell Carcinoma,BRD-K31698212-001-02-9::2.5::HTS,9.859771438097011,0.0017782351669252093,Other Types,icotinib,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K32101625-001-01-6::2.5::HTS,4.264664398008769,0.03937259786412497,Head and Neck Squamous Cell Carcinoma,LX1031,tryptophan hydroxylase inhibitor,TPH1
Head and Neck Squamous Cell Carcinoma,BRD-K32372024-001-01-0::2.5::HTS,4.135060351311094,0.04250885877612488,Other Types,D-7193,,
Head and Neck Squamous Cell Carcinoma,BRD-K32572029-001-04-4::2.5::HTS,4.353072448086999,0.03739897274912457,Other Types,orotic-acid,,DHODH
Head and Neck Squamous Cell Carcinoma,BRD-K33453211-003-11-5::2.5::HTS,3.9692149780431474,0.04682441369633715,Other Types,levocabastine,histamine receptor antagonist,"HRH1, NTSR2"
Head and Neck Squamous Cell Carcinoma,BRD-K33681278-036-01-2::2.5::HTS,3.9382980466841473,0.0476995454701728,Head and Neck Squamous Cell Carcinoma,prucalopride,serotonin receptor agonist,HTR4
Head and Neck Squamous Cell Carcinoma,BRD-K34032314-001-04-1::2.5::HTS,5.506487872477097,0.019295493789336805,Other Types,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1
Head and Neck Squamous Cell Carcinoma,BRD-K34341643-001-01-4::2.5::HTS,4.029483123160706,0.04519858575272593,Head and Neck Squamous Cell Carcinoma,glasdegib,hedgehog pathway inhibitor,SMO
Head and Neck Squamous Cell Carcinoma,BRD-K34469523-003-03-0::2.5::HTS,5.762322844795447,0.0167046480875368,Other Types,levalbuterol,adrenergic receptor agonist,ADRB2
Head and Neck Squamous Cell Carcinoma,BRD-K35007173-001-07-5::2.5::HTS,7.391583869440525,0.006757249238647528,Other Types,enprofylline,phosphodiesterase inhibitor,"ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B"
Head and Neck Squamous Cell Carcinoma,BRD-K35034482-001-01-8::2.5::HTS,5.016260569722058,0.02550196795698541,Other Types,bunazosin,adrenergic receptor antagonist,ADRA1A
Head and Neck Squamous Cell Carcinoma,BRD-K35520305-001-17-7::2.5::HTS,4.232333295525867,0.04013009665667416,Other Types,dacarbazine,DNA alkylating agent,"PGD, POLA2"
Head and Neck Squamous Cell Carcinoma,BRD-K35601925-001-01-9::2.5::HTS,4.126681385269699,0.042688857826383445,Other Types,CS-917,fructose biphosphate inhibitor,FBP1
Head and Neck Squamous Cell Carcinoma,BRD-K35687421-001-02-5::2.5::HTS,4.931204486752338,0.026775310917411456,Other Types,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD
Head and Neck Squamous Cell Carcinoma,BRD-K35952844-238-01-2::2.5::HTS,6.390659785786132,0.0117536151917901,Other Types,calcium-gluceptate,,
Head and Neck Squamous Cell Carcinoma,BRD-K36529613-001-02-6::2.5::HTS,4.6763470767526405,0.031001852141309915,Other Types,PU-H71,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K36788280-001-01-2::2.5::HTS,3.90910430840117,0.0485205092096431,Other Types,ribociclib,CDK inhibitor,"CDK4, CDK6"
Head and Neck Squamous Cell Carcinoma,BRD-K37237504-001-02-7::2.5::HTS,12.29108674487972,0.0004914534912449519,Other Types,CEP-33779,JAK inhibitor,JAK2
Head and Neck Squamous Cell Carcinoma,BRD-K37289225-001-36-4::2.5::HTS,4.747260265295497,0.02977185175325982,Other Types,clozapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7"
Head and Neck Squamous Cell Carcinoma,BRD-K37618799-001-03-0::2.5::HTS,5.866150304279575,0.015752939545012806,Head and Neck Squamous Cell Carcinoma,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Head and Neck Squamous Cell Carcinoma,BRD-K37682401-213-01-1::2.5::HTS,9.45378421129139,0.0022139052801810584,Other Types,piromidic-acid,bacterial DNA gyrase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,7.589475620493195,0.006061291372309377,Other Types,AZD8330,MEK inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K37890730-001-15-1::2.5::HTS,4.451597042234796,0.035323009673744694,Other Types,camptothecin,topoisomerase inhibitor,TOP1
Head and Neck Squamous Cell Carcinoma,BRD-K38332599-001-01-3::2.5::HTS,5.597677882553053,0.018324463405097607,Other Types,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Head and Neck Squamous Cell Carcinoma,BRD-K38852836-001-02-1::2.5::HTS,4.615370058276163,0.032113328421920447,Other Types,ganetespib,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K38904395-001-02-3::2.5::HTS,4.850011520087708,0.028051295427771884,Other Types,SAR131675,VEGFR inhibitor,FLT4
Head and Neck Squamous Cell Carcinoma,BRD-K38913877-300-01-9::2.5::HTS,6.950706257328222,0.00861148680783461,Other Types,azimilide,potassium channel blocker,"KCNA5, KCNE1, KCNH2, KCNQ1"
Head and Neck Squamous Cell Carcinoma,BRD-K39079086-001-07-6::2.5::HTS,4.233371624075916,0.04010405524574431,Other Types,cinchonidine,P glycoprotein inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K39252998-003-01-5::2.5::HTS,5.915488325083994,0.015328681289503215,Other Types,atipamezole,adrenergic receptor antagonist,
Head and Neck Squamous Cell Carcinoma,BRD-K39339537-001-21-0::2.5::HTS,4.84457709406688,0.028150950250673115,Other Types,epirizole,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K40331046-305-01-5::2.5::HTS,6.93017775029045,0.008709635401317995,Other Types,CR8-(R),CDK inhibitor,CCNA2
Head and Neck Squamous Cell Carcinoma,BRD-K40718343-001-02-6::2.5::HTS,20.269702458119422,8.181101384998783e-06,Other Types,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K41213548-001-02-0::2.5::HTS,9.614468480016633,0.002030134724364439,Other Types,KW-2478,HSP inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K41337261-001-03-0::2.5::HTS,7.370604398755231,0.006833630728887848,Other Types,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K41599323-001-02-3::2.5::HTS,3.9609495998656783,0.04705315701988417,Other Types,lonafarnib,farnesyltransferase inhibitor,"FNTA, HRAS, KRAS, NRAS"
Head and Neck Squamous Cell Carcinoma,BRD-K41779183-001-01-2::2.5::HTS,3.8893579342539364,0.04908462412100758,Other Types,CB-03-01,androgen receptor antagonist,AR
Head and Neck Squamous Cell Carcinoma,BRD-K42191735-001-05-3::2.5::HTS,7.24995709937744,0.007301770420899276,Other Types,buparlisib,PI3K inhibitor,"PIK3CA, PIK3CG"
Head and Neck Squamous Cell Carcinoma,BRD-K42221274-003-07-7::2.5::HTS,5.916257485103931,0.015317422166814277,Other Types,NNC-711,GABA uptake inhibitor,"SIGMAR1, SLC6A1"
Head and Neck Squamous Cell Carcinoma,BRD-K42805893-001-04-9::2.5::HTS,23.838052817071464,1.3676348111950236e-06,Other Types,osimertinib,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K42973005-001-04-0::2.5::HTS,10.83305907995293,0.0010598085116270718,Head and Neck Squamous Cell Carcinoma,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Head and Neck Squamous Cell Carcinoma,BRD-K43236057-001-07-1::2.6::HTS,5.55856676128565,0.01875429686101805,Other Types,polydatin,ICAM1 expression inhibitor,ICAM1
Head and Neck Squamous Cell Carcinoma,BRD-K43887077-003-26-3::2.5::HTS,5.763973957980632,0.01669155977446619,Head and Neck Squamous Cell Carcinoma,dopamine,dopamine receptor agonist,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-K43966364-237-04-8::2.5::HTS,7.239113677443954,0.007351684089763888,Head and Neck Squamous Cell Carcinoma,penicillin-v-potassium,bacterial cell wall synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K44009692-001-02-3::2.5::HTS,6.034363462300728,0.014336252011777323,Other Types,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K44133266-001-10-0::2.5::HTS,4.990780000597771,0.025892051022322973,Other Types,sulbactam,beta lactamase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K44227013-001-06-4::2.5::HTS,15.525819029352547,9.173273904408028e-05,Other Types,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Head and Neck Squamous Cell Carcinoma,BRD-K44276885-001-07-4::2.5::HTS,10.23427300847411,0.0014569337582571852,Other Types,acarbose,glucosidase inhibitor,"AMY2A, GAA, MGAM, SI"
Head and Neck Squamous Cell Carcinoma,BRD-K44366189-001-01-9::2.5::HTS,5.111619625434231,0.0241477132275873,Head and Neck Squamous Cell Carcinoma,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Head and Neck Squamous Cell Carcinoma,BRD-K44825564-065-01-4::2.5::HTS,9.058106540724918,0.0027402881455289114,Other Types,ZAPA,,
Head and Neck Squamous Cell Carcinoma,BRD-K44844162-001-01-6::2.5::HTS,30.6782689781002,4.7183464877509036e-08,Other Types,taselisib,PI3K inhibitor,PIK3CA
Head and Neck Squamous Cell Carcinoma,BRD-K44876623-001-03-7::2.5::HTS,18.41869482631095,2.094127637524241e-05,Other Types,zolpidem,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3"
Head and Neck Squamous Cell Carcinoma,BRD-K45503887-001-01-1::2.5::HTS,6.187219174786506,0.013161770388448853,Head and Neck Squamous Cell Carcinoma,delivert,angiotensin receptor agonist,"AGTR1, AGTR2"
Head and Neck Squamous Cell Carcinoma,BRD-K45724504-001-01-6::1.36::HTS,4.4329427509140755,0.035698765038666334,Other Types,anguidine,protein synthesis inhibitor,SLC5A1
Head and Neck Squamous Cell Carcinoma,BRD-K45746021-003-01-9::2.5::HTS,5.550138112110276,0.018827944951116428,Other Types,CC-401,JNK inhibitor,MAPK8
Head and Neck Squamous Cell Carcinoma,BRD-K46386702-001-02-1::2.5::HTS,22.400714538617137,2.8096377775283888e-06,Other Types,ARRY-334543,EGFR inhibitor,ERBB2
Head and Neck Squamous Cell Carcinoma,BRD-K46585355-001-14-3::2.5::HTS,4.784385949301419,0.029132417285721517,Other Types,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K47000838-001-01-6::1.04::HTS,8.475212696994705,0.0037491481098164085,Other Types,cytochalasin-b,microtubule inhibitor,ACTB
Head and Neck Squamous Cell Carcinoma,BRD-K47049295-300-01-5::2.5::HTS,5.187291414060818,0.023182625642104614,Other Types,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1
Head and Neck Squamous Cell Carcinoma,BRD-K47079459-004-04-6::2.5::HTS,5.4349410239833995,0.020100751256939754,Other Types,cetrimonium,,
Head and Neck Squamous Cell Carcinoma,BRD-K47095176-001-01-6::2.5::HTS,6.732821250649521,0.009719868706705569,Head and Neck Squamous Cell Carcinoma,talnetant,tachykinin antagonist,"TACR2, TACR3"
Head and Neck Squamous Cell Carcinoma,BRD-K47337578-034-02-5::2.5::HTS,5.204249259881042,0.02291037674914923,Other Types,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,serotonin receptor antagonist,HTR2A
Head and Neck Squamous Cell Carcinoma,BRD-K47635719-001-21-1::2.5::HTS,6.236309140498114,0.012801690153145901,Other Types,dexamethasone-acetate,glucocorticoid receptor agonist,
Head and Neck Squamous Cell Carcinoma,BRD-K48578705-001-17-6::2.5::HTS,5.273216932250958,0.022038696293447513,Other Types,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Head and Neck Squamous Cell Carcinoma,BRD-K48892307-001-04-1::2.5::HTS,4.87130315670536,0.027722126869656114,Head and Neck Squamous Cell Carcinoma,sasapyrine,NFkB pathway inhibitor,"PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K48988407-001-01-2::2.5::HTS,6.885798500972779,0.008928789873505505,Other Types,cytochlor,,
Head and Neck Squamous Cell Carcinoma,BRD-K49049886-001-08-7::2.5::HTS,5.05875661147906,0.024893778444209754,Head and Neck Squamous Cell Carcinoma,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Head and Neck Squamous Cell Carcinoma,BRD-K49055432-001-04-2::2.5::HTS,4.427401479608881,0.03581309491342901,Other Types,A66,PI3K inhibitor,PIK3CA
Head and Neck Squamous Cell Carcinoma,BRD-K49294207-300-03-8::2.5::HTS,13.709448662345276,0.00023481299205382222,Other Types,BIBU-1361,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K49328571-001-15-0::2.5::HTS,16.002686288982353,7.187401252120361e-05,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Head and Neck Squamous Cell Carcinoma,BRD-K49371609-003-03-8::2.5::HTS,5.541986295368033,0.01891367630737358,Other Types,PIK-75,"DNA protein kinase inhibitor, PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Head and Neck Squamous Cell Carcinoma,BRD-K49481516-004-18-3::2.5::HTS,8.774884799128671,0.003185356343517407,Other Types,galantamine,acetylcholinesterase inhibitor,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG"
Head and Neck Squamous Cell Carcinoma,BRD-K49522529-001-02-9::2.53::HTS,3.9752645119089394,0.04668713017685943,Other Types,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Head and Neck Squamous Cell Carcinoma,BRD-K49522529-001-03-7::2.5::HTS,14.678171626881326,0.0001420222183802136,Other Types,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Head and Neck Squamous Cell Carcinoma,BRD-K49865102-001-08-4::2.5::HTS,10.53470040359931,0.0012426647560915946,Other Types,PD-0325901,MEK inhibitor,MAP2K1
Head and Neck Squamous Cell Carcinoma,BRD-K50050533-001-02-1::2.5::HTS,7.651775014196603,0.005870342669269761,Other Types,docosanol,lipase clearing factor inhibitor,TLR7
Head and Neck Squamous Cell Carcinoma,BRD-K50071428-001-03-3::2.5::HTS,4.1026480960908325,0.04329499535493465,Other Types,abiraterone,androgen biosynthesis inhibitor,"CYP11B1, CYP17A1"
Head and Neck Squamous Cell Carcinoma,BRD-K50168500-001-07-9::2.5::HTS,18.516867583732974,1.98937651536933e-05,Other Types,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Head and Neck Squamous Cell Carcinoma,BRD-K50325075-001-02-1::2.5::HTS,4.805417197852233,0.02878274349806885,Other Types,UCL-2077,slow afterhyperpolarization channel blocker,
Head and Neck Squamous Cell Carcinoma,BRD-K50388907-001-30-4::2.5::HTS,10.780537945590693,0.0010922538493723826,Other Types,fenofibrate,PPAR receptor agonist,"MMP25, PPARA"
Head and Neck Squamous Cell Carcinoma,BRD-K50495309-001-02-0::2.5::HTS,17.320228618302608,3.656003207959905e-05,Other Types,SRC-kinase-inhibitor-I,src inhibitor,"CSK, LCK, RIPK2"
Head and Neck Squamous Cell Carcinoma,BRD-K50677762-001-01-5::2.5::HTS,5.542035135861631,0.01891315385567405,Other Types,oxiracetam,acetylcholine receptor agonist,
Head and Neck Squamous Cell Carcinoma,BRD-K51040301-001-02-1::2.5::HTS,5.081780458932208,0.024562818799775284,Other Types,cobicistat,cytochrome P450 inhibitor,"CYP3A4, CYP3A43, CYP3A5, CYP3A7"
Head and Neck Squamous Cell Carcinoma,BRD-K51313569-003-03-3::2.5::HTS,5.3709833070891655,0.020835963075312814,Other Types,palbociclib,CDK inhibitor,"CDK4, CDK6"
Head and Neck Squamous Cell Carcinoma,BRD-K51575138-001-13-2::2.5::HTS,5.78474400870267,0.016488079125598184,Other Types,TPCA-1,IKK inhibitor,IKBKB
Head and Neck Squamous Cell Carcinoma,BRD-K51579475-003-02-4::2.5::HTS,4.26220231205308,0.03942842802964716,Other Types,dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-K51662849-001-05-4::2.5::HTS,6.482470576101976,0.011171505311384335,Other Types,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Head and Neck Squamous Cell Carcinoma,BRD-K51747290-001-13-1::2.5::HTS,9.55897277961303,0.002092666172797344,Other Types,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Head and Neck Squamous Cell Carcinoma,BRD-K51967704-001-03-6::2.5::HTS,8.184960395135763,0.004382489808172217,Other Types,BIIB021,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K52408781-001-02-8::2.5::HTS,5.937407739551571,0.015136642042641799,Other Types,clobazam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
Head and Neck Squamous Cell Carcinoma,BRD-K52751261-001-06-1::2.5::HTS,5.215255381454542,0.022765148429222795,Other Types,TAK-715,p38 MAPK inhibitor,MAPK14
Head and Neck Squamous Cell Carcinoma,BRD-K53153417-001-10-4::2.5::HTS,4.066928064721691,0.0442066936305247,Head and Neck Squamous Cell Carcinoma,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2
Head and Neck Squamous Cell Carcinoma,BRD-K53417444-003-03-1::2.5::HTS,5.161132558179816,0.023491078558614095,Other Types,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK
Head and Neck Squamous Cell Carcinoma,BRD-K53532120-003-09-5::2.5::HTS,4.711922250327741,0.030378095625791152,Other Types,U-50488-(-),opioid receptor agonist,OPRK1
Head and Neck Squamous Cell Carcinoma,BRD-K53581288-001-02-9::2.5::HTS,4.032284056081809,0.04511550967891002,Other Types,baricitinib,JAK inhibitor,"JAK1, JAK2"
Head and Neck Squamous Cell Carcinoma,BRD-K53972329-001-07-0::2.5::HTS,7.04965867530528,0.008156122037355518,Other Types,ruxolitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Head and Neck Squamous Cell Carcinoma,BRD-K54057105-001-01-2::2.5::HTS,5.341708703179427,0.021206004771527575,Other Types,isobutyramide,gene expression stimulant,"HBE1, HBG1"
Head and Neck Squamous Cell Carcinoma,BRD-K54416256-001-19-9::2.5::HTS,10.933372124104146,0.0010053154022942894,Other Types,methimazole,antithyroid agent,TPO
Head and Neck Squamous Cell Carcinoma,BRD-K54838207-001-02-0::2.5::HTS,5.626202919782784,0.018029781368533615,Other Types,fudosteine,mucolytic agent,
Head and Neck Squamous Cell Carcinoma,BRD-K54997624-001-06-0::2.5::HTS,5.392727365125328,0.020577214878427393,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Head and Neck Squamous Cell Carcinoma,BRD-K55344148-003-02-6::2.5::HTS,7.198247150477371,0.007513524204600167,Other Types,BU-224,imidazoline receptor ligand,"MAOA, MAOB"
Head and Neck Squamous Cell Carcinoma,BRD-K55462201-001-07-3::2.5::HTS,4.717593234841276,0.030276650737315124,Head and Neck Squamous Cell Carcinoma,AM-404,"cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist","CNR1, CNR2, FAAH, TRPV1"
Head and Neck Squamous Cell Carcinoma,BRD-K55512740-001-01-6::2.5::HTS,6.4589334441977675,0.011308111502512505,Other Types,MK-8033,c-Met inhibitor,MET
Head and Neck Squamous Cell Carcinoma,BRD-K55675242-001-03-0::2.5::HTS,6.9620976085309385,0.008563073228714657,Other Types,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Head and Neck Squamous Cell Carcinoma,BRD-K55781385-001-01-7::2.5::HTS,10.54322798473829,0.001235641156920432,Other Types,BMS-927711,calcitonin antagonist,CALCA
Head and Neck Squamous Cell Carcinoma,BRD-K55892330-001-01-8::2.5::HTS,3.9339627506120016,0.04783787792442076,Other Types,sorbic-acid,,
Head and Neck Squamous Cell Carcinoma,BRD-K56032964-001-02-1::2.5::HTS,15.637387003443687,8.656091831072043e-05,Other Types,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Head and Neck Squamous Cell Carcinoma,BRD-K56033645-001-07-5::2.5::HTS,5.020084812390791,0.025444825380104816,Other Types,5-methylhydantoin-(L),,
Head and Neck Squamous Cell Carcinoma,BRD-K56343971-001-10-6::2.5::HTS,4.422792635350213,0.03590596359785038,Head and Neck Squamous Cell Carcinoma,vemurafenib,RAF inhibitor,"BRAF, RAF1"
Head and Neck Squamous Cell Carcinoma,BRD-K56851771-001-06-8::2.5::HTS,4.647788730261868,0.031518825800680404,Other Types,enzalutamide,androgen receptor antagonist,AR
Head and Neck Squamous Cell Carcinoma,BRD-K56957086-001-06-3::2.5::HTS,5.78679723572475,0.01646903293562586,Other Types,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Head and Neck Squamous Cell Carcinoma,BRD-K57041787-001-02-6::2.5::HTS,4.441630921335945,0.03551505294393294,Other Types,dabigatran-etexilate,thrombin inhibitor,F2
Head and Neck Squamous Cell Carcinoma,BRD-K57080016-001-15-9::2.5::HTS,6.331649590909819,0.012137624008433916,Other Types,selumetinib,MEK inhibitor,MAP2K1
Head and Neck Squamous Cell Carcinoma,BRD-K57169635-001-04-5::2.5::HTS,21.24738016236835,5.000517626568053e-06,Other Types,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Head and Neck Squamous Cell Carcinoma,BRD-K58049875-001-04-7::2.5::HTS,7.527259851903159,0.006272676040947275,Other Types,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Head and Neck Squamous Cell Carcinoma,BRD-K58148589-001-03-6::2.5::HTS,8.200342636880345,0.004346031376096158,Other Types,betamethasone-dipropionate,anti-inflammatory agent,
Head and Neck Squamous Cell Carcinoma,BRD-K58262659-001-09-7::2.5::HTS,7.761867042533698,0.005523999804575405,Other Types,doxifluridine,thymidylate synthase inhibitor,TYMS
Head and Neck Squamous Cell Carcinoma,BRD-K58435339-001-03-0::2.5::HTS,5.05536876042411,0.024937824388873632,Other Types,AT13387,HSP antagonist,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K58466253-003-14-0::2.5::HTS,3.902974280545721,0.048696533801520815,Head and Neck Squamous Cell Carcinoma,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
Head and Neck Squamous Cell Carcinoma,BRD-K58568447-001-01-1::2.5::HTS,6.71543067092541,0.009807937472897153,Head and Neck Squamous Cell Carcinoma,K02288,bone morphogenic protein inhibitor,BMP1
Head and Neck Squamous Cell Carcinoma,BRD-K58685305-001-20-4::2.5::HTS,4.352790087603602,0.03740595001903043,Other Types,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1
Head and Neck Squamous Cell Carcinoma,BRD-K58770988-001-01-8::2.5::HTS,14.660563483475938,0.00014326636397215756,Other Types,NMS-E973,HSP inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K59325863-001-03-6::2.46::HTS,4.679337105283305,0.030975545531139653,Other Types,delanzomib,proteasome inhibitor,"CMA1, CTSG, CYP3A4, ELANE"
Head and Neck Squamous Cell Carcinoma,BRD-K60585088-001-01-5::2.5::HTS,8.07496842629792,0.0046515712836870384,Other Types,paricalcitol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K60907894-003-23-5::2.5::HTS,7.301604966364956,0.007099348063422032,Other Types,adiphenine,acetylcholine receptor antagonist,CHRNA1
Head and Neck Squamous Cell Carcinoma,BRD-K61192372-001-05-5::2.54::HTS,9.548238261034905,0.0021069055668690617,Other Types,capecitabine,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS
Head and Neck Squamous Cell Carcinoma,BRD-K61228301-001-01-2::2.5::HTS,5.134589763837414,0.023835183598929274,Other Types,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Head and Neck Squamous Cell Carcinoma,BRD-K61536336-001-01-7::2.5::HTS,4.083094845982732,0.04379053697577481,Other Types,SB-366791,TRPV antagonist,TRPV1
Head and Neck Squamous Cell Carcinoma,BRD-K61665160-001-01-5::2.5::HTS,4.063934492168523,0.04429055061597287,Other Types,BYK-204165,PARP inhibitor,PARP1
Head and Neck Squamous Cell Carcinoma,BRD-K61688984-001-02-9::2.5::HTS,3.93407762260207,0.04780678915628674,Head and Neck Squamous Cell Carcinoma,RGFP966,HDAC inhibitor,HDAC3
Head and Neck Squamous Cell Carcinoma,BRD-K62456038-003-07-1::2.5::HTS,4.7804252184747265,0.02920416438070575,Other Types,PD-128907,dopamine receptor agonist,"DRD2, DRD3"
Head and Neck Squamous Cell Carcinoma,BRD-K62627508-001-01-5::2.5::HTS,6.971849770032781,0.00851116870557414,Head and Neck Squamous Cell Carcinoma,idasanutlin,MDM inhibitor,"MDM2, TP53"
Head and Neck Squamous Cell Carcinoma,BRD-K62965247-001-04-9::2.5::HTS,13.160249979879888,0.000312233900980226,Other Types,tipifarnib,farnesyltransferase inhibitor,"FNTA, FNTB"
Head and Neck Squamous Cell Carcinoma,BRD-K63750851-001-20-7::2.5::HTS,4.975974660986878,0.026097017509117422,Other Types,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Head and Neck Squamous Cell Carcinoma,BRD-K63784565-001-06-2::2.51::HTS,5.523210757829094,0.019132913605211695,Other Types,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1
Head and Neck Squamous Cell Carcinoma,BRD-K63828191-003-32-1::2.5::HTS,6.138175360382087,0.013522222143930422,Other Types,raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2"
Head and Neck Squamous Cell Carcinoma,BRD-K63861289-001-19-6::2.5::HTS,5.59108517516144,0.018394077971341474,Other Types,molsidomine,guanylate cyclase stimulant,GUCY1A3
Head and Neck Squamous Cell Carcinoma,BRD-K63874012-001-02-9::2.5::HTS,9.54209500613409,0.002107361023934978,Other Types,thioperamide,histamine receptor antagonist,"HRH3, HRH4"
Head and Neck Squamous Cell Carcinoma,BRD-K63923597-001-10-0::2.5::HTS,4.2270043603131215,0.04025359311785118,Other Types,barasertib-HQPA,Aurora kinase inhibitor,AURKB
Head and Neck Squamous Cell Carcinoma,BRD-K64052750-001-17-5::2.5::HTS,23.658327889034148,1.5027443852453035e-06,Other Types,gefitinib,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K64191834-001-03-1::2.5::HTS,4.368522318751308,0.03707074345878293,Head and Neck Squamous Cell Carcinoma,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,
Head and Neck Squamous Cell Carcinoma,BRD-K64381438-001-03-8::2.5::HTS,5.485843507688197,0.019526823036642584,Head and Neck Squamous Cell Carcinoma,ulipristal,progesterone receptor antagonist,PGR
Head and Neck Squamous Cell Carcinoma,BRD-K64538373-001-01-4::2.5::HTS,14.990093735370918,0.00012089398228258334,Other Types,Ro-4987655,MEK inhibitor,MAP2K1
Head and Neck Squamous Cell Carcinoma,BRD-K65146499-001-27-9::2.5::HTS,5.064632984207713,0.024828844681970726,Other Types,nabumetone,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K66035042-001-10-1::2.5::HTS,4.242458823447203,0.03988913449900433,Other Types,sorbitol,mucolytic agent,
Head and Neck Squamous Cell Carcinoma,BRD-K66175015-001-09-0::2.5::HTS,8.223629694641799,0.004294609967436568,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Head and Neck Squamous Cell Carcinoma,BRD-K66296774-236-11-3::2.63::HTS,3.907964286890883,0.04856699176113957,Other Types,fluvastatin,HMGCR inhibitor,HMGCR
Head and Neck Squamous Cell Carcinoma,BRD-K66480997-003-10-0::2.5::HTS,8.75518567242885,0.0032172574459875584,Other Types,isoguvacine,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Head and Neck Squamous Cell Carcinoma,BRD-K66615216-003-14-8::2.5::HTS,4.238942036833337,0.03997625642655723,Head and Neck Squamous Cell Carcinoma,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A
Head and Neck Squamous Cell Carcinoma,BRD-K66937583-001-01-2::2.5::HTS,9.170363964228313,0.0025735644257531822,Other Types,lodoxamide,histamine receptor antagonist,
Head and Neck Squamous Cell Carcinoma,BRD-K67102207-236-07-7::2.5::HTS,4.1323379761238135,0.04254749958744859,Other Types,phenylbutyrate,HDAC inhibitor,HDAC1
Head and Neck Squamous Cell Carcinoma,BRD-K67298865-001-09-0::2.5::HTS,4.2301317970523655,0.040175882678192436,Other Types,SB-431542,TGF beta receptor inhibitor,"ACVR1C, TGFBR1"
Head and Neck Squamous Cell Carcinoma,BRD-K67783091-001-26-1::2.5::HTS,6.392558228000752,0.01173511403193387,Other Types,haloperidol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1"
Head and Neck Squamous Cell Carcinoma,BRD-K68164687-001-01-6::2.5::HTS,5.623899560045979,0.01805445251192323,Other Types,epothilone-b,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Head and Neck Squamous Cell Carcinoma,BRD-K68174511-001-06-6::2.5::HTS,6.949851311412425,0.00861430099390964,Other Types,torin-2,mTOR inhibitor,MTOR
Head and Neck Squamous Cell Carcinoma,BRD-K68336408-001-10-9::2.5::HTS,25.2741303211917,6.710923746577929e-07,Other Types,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Head and Neck Squamous Cell Carcinoma,BRD-K68408467-065-01-8::2.5::HTS,5.601893922826277,0.018281478641820743,Other Types,proflavine-hemisulfate,topical anesthetic,F2
Head and Neck Squamous Cell Carcinoma,BRD-K68558722-001-04-0::2.5::HTS,5.13771059481518,0.023793458009881478,Other Types,deracoxib,cyclooxygenase inhibitor,PTGS2
Head and Neck Squamous Cell Carcinoma,BRD-K69116396-001-04-1::2.5::HTS,7.433641854164292,0.006604283191350538,Other Types,sertindole,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2"
Head and Neck Squamous Cell Carcinoma,BRD-K69812556-305-02-0::2.5::HTS,4.160268772108589,0.041853306508768215,Other Types,WAY-100635,serotonin receptor antagonist,HTR1A
Head and Neck Squamous Cell Carcinoma,BRD-K69837166-003-02-0::2.5::HTS,3.960979227897335,0.047064799684895915,Other Types,trap-101,"nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist",OPRL1
Head and Neck Squamous Cell Carcinoma,BRD-K70053378-001-01-1::2.5::HTS,6.609062723506889,0.010413314154952327,Head and Neck Squamous Cell Carcinoma,SM-108,,
Head and Neck Squamous Cell Carcinoma,BRD-K70281171-050-08-9::2.5::HTS,4.806651988539825,0.0287667961956699,Other Types,U-99194,dopamine receptor antagonist,DRD3
Head and Neck Squamous Cell Carcinoma,BRD-K70301465-001-02-6::2.5::HTS,21.550176583538537,4.308206849468685e-06,Other Types,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK"
Head and Neck Squamous Cell Carcinoma,BRD-K70401845-003-09-6::2.5::HTS,17.349839940842212,3.600247632451147e-05,Other Types,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Head and Neck Squamous Cell Carcinoma,BRD-K70507123-001-09-7::2.5::HTS,4.241156625889008,0.039917009064505314,Other Types,doxofylline,adenosine receptor antagonist,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D"
Head and Neck Squamous Cell Carcinoma,BRD-K70778732-003-26-7::2.5::HTS,10.121780330217543,0.0015464320614011996,Other Types,trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4"
Head and Neck Squamous Cell Carcinoma,BRD-K70821460-300-02-4::2.5::HTS,5.082242435935232,0.024561896972584398,Other Types,4-methylhistamine,histamine receptor agonist,HRH4
Head and Neck Squamous Cell Carcinoma,BRD-K70914287-300-02-8::2.5::HTS,22.81391889698741,2.282130159263771e-06,Other Types,BIBX-1382,EGFR inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K71281111-001-04-3::2.5::HTS,6.398598309599619,0.011694238233320905,Other Types,SNX-2112,HSP inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K71698503-003-01-6::2.5::HTS,4.246818523205772,0.03978352310238818,Other Types,I-BZA2,,
Head and Neck Squamous Cell Carcinoma,BRD-K71731651-001-04-3::2.5::HTS,10.10896752493248,0.001559149590612122,Other Types,PNU-120596,acetylcholine receptor agonist,CHRNA7
Head and Neck Squamous Cell Carcinoma,BRD-K71926323-001-13-8::2.5::HTS,4.426293774106238,0.03583535615189563,Other Types,marbofloxacin,bacterial DNA gyrase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K72231366-001-02-3::2.5::HTS,8.064550793289932,0.004677414361000349,Head and Neck Squamous Cell Carcinoma,TAME,,
Head and Neck Squamous Cell Carcinoma,BRD-K72384124-001-08-0::2.5::HTS,3.8638032151484336,0.04983384359992438,Other Types,sulbentine,other antifungal,
Head and Neck Squamous Cell Carcinoma,BRD-K72414522-001-06-7::2.5::HTS,3.8628058793917552,0.04986148719910503,Other Types,AZD5438,CDK inhibitor,KCNH2
Head and Neck Squamous Cell Carcinoma,BRD-K72420232-001-12-3::2.5::HTS,4.198645125403379,0.0409267871683965,Other Types,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K72723676-003-17-8::2.5::HTS,7.655136748388005,0.0058491598801484945,Other Types,benzethonium,sodium channel blocker,SCN10A
Head and Neck Squamous Cell Carcinoma,BRD-K72815923-034-01-2::2.5::HTS,10.010617613968064,0.0016409929783603762,Other Types,xanomeline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Head and Neck Squamous Cell Carcinoma,BRD-K73073971-001-01-7::2.5::HTS,4.196335664516947,0.0409779142939664,Other Types,ZLN005,,
Head and Neck Squamous Cell Carcinoma,BRD-K73197500-001-02-2::2.5::HTS,7.777242179248774,0.0054714361441918396,Other Types,SNX-5422,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K73237276-001-01-0::2.5::HTS,10.428264506542911,0.0013137192885894263,Other Types,tacalcitol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K73293050-001-03-1::2.5::HTS,4.085617496423511,0.043730011802574714,Other Types,WZ-3146,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K73309154-003-02-8::2.5::HTS,28.429381134878092,1.4099646667432084e-07,Other Types,OSI-420,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K73789395-001-10-7::2.5::HTS,4.9228166200538475,0.02691023393595404,Other Types,ZM-336372,RAF inhibitor,"BRAF, LCK, MAPK14, RAF1"
Head and Neck Squamous Cell Carcinoma,BRD-K74193284-001-04-8::2.5::HTS,7.2202859610540076,0.0074356958604285235,Other Types,phenylmercuric-acetate,other antifungal,
Head and Neck Squamous Cell Carcinoma,BRD-K74236708-001-01-9::2.5::HTS,6.2226325152753414,0.012902947845790453,Other Types,acitazanolast,mediator release inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K74664543-213-01-2::2.5::HTS,5.0868580833551675,0.024516435792869322,Other Types,selenomethionine,,
Head and Neck Squamous Cell Carcinoma,BRD-K75352575-001-01-3::2.5::HTS,8.41500392506211,0.003867850712999539,Other Types,KPT-276,exportin antagonist,XPO1
Head and Neck Squamous Cell Carcinoma,BRD-K75911534-001-01-6::2.5::HTS,3.91975108744366,0.048218177200262856,Other Types,SU014813,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",KDR
Head and Neck Squamous Cell Carcinoma,BRD-K76210423-001-01-6::2.5::HTS,9.246076484448137,0.0024732456992132487,Head and Neck Squamous Cell Carcinoma,resiquimod,toll-like receptor agonist,"TLR7, TLR8"
Head and Neck Squamous Cell Carcinoma,BRD-K76239644-001-01-8::2.5::HTS,16.843347912219706,4.664575479029266e-05,Other Types,BMS-690514,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K76606751-001-01-7::2.5::HTS,5.202983100618849,0.022921504960178442,Other Types,mebicar,anxiolytic,
Head and Neck Squamous Cell Carcinoma,BRD-K76617868-003-11-9::2.5::HTS,5.978850022084237,0.01478434555282738,Head and Neck Squamous Cell Carcinoma,fasudil,rho associated kinase inhibitor,"PKIA, PRKACA, ROCK1, ROCK2"
Head and Neck Squamous Cell Carcinoma,BRD-K77625799-001-07-7::2.5::HTS,19.05716140051412,1.510251132310269e-05,Other Types,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Head and Neck Squamous Cell Carcinoma,BRD-K77638923-001-02-0::2.5::HTS,6.307821621294664,0.012311918171441035,Other Types,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Head and Neck Squamous Cell Carcinoma,BRD-K77685957-300-09-1::2.5::HTS,5.663864746444345,0.017660300894229673,Other Types,dequalinium,PKC inhibitor,"KCNN1, KCNN3"
Head and Neck Squamous Cell Carcinoma,BRD-K77841042-001-14-1::2.5::HTS,4.640586827338644,0.03165641026357318,Other Types,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Head and Neck Squamous Cell Carcinoma,BRD-K78055238-001-01-8::2.5::HTS,18.360060185131868,2.1574206066509827e-05,Head and Neck Squamous Cell Carcinoma,LY2090314,glycogen synthase kinase inhibitor,GSK3B
Head and Neck Squamous Cell Carcinoma,BRD-K78809024-001-05-7::2.5::HTS,4.185387172923352,0.041238841970625904,Head and Neck Squamous Cell Carcinoma,SB-590885,RAF inhibitor,BRAF
Head and Neck Squamous Cell Carcinoma,BRD-K79095980-001-09-6::2.5::HTS,5.884957747209796,0.015585072041230002,Other Types,broxuridine,antimetabolite,
Head and Neck Squamous Cell Carcinoma,BRD-K79277568-003-04-7::2.5::HTS,8.171120737097626,0.004424392009333756,Other Types,methoxyamine,DNA repair enzyme inhibitor,APEX1
Head and Neck Squamous Cell Carcinoma,BRD-K79584249-001-01-3::2.5::HTS,5.1186277425052555,0.024056797075154446,Head and Neck Squamous Cell Carcinoma,CGM097,MDM inhibitor,MDM2
Head and Neck Squamous Cell Carcinoma,BRD-K79930101-300-03-7::2.5::HTS,20.926612173435295,5.875934295234342e-06,Other Types,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Head and Neck Squamous Cell Carcinoma,BRD-K81197548-003-01-4::2.5::HTS,7.695456870263759,0.0057213462528751665,Other Types,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Head and Neck Squamous Cell Carcinoma,BRD-K81473043-001-14-6::2.5::HTS,5.876827343074283,0.0156761963790719,Other Types,tanespimycin,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K81645907-001-01-1::2.5::HTS,4.478187856322065,0.03479746368370009,Other Types,captamine,,
Head and Neck Squamous Cell Carcinoma,BRD-K81728688-001-04-4::2.5::HTS,13.09667326080025,0.00032290690005921843,Other Types,WZ8040,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K81807412-001-10-6::2.5::HTS,11.463526014903684,0.0007608125851317901,Other Types,N6-methyladenosine,,
Head and Neck Squamous Cell Carcinoma,BRD-K81855038-003-13-9::2.5::HTS,5.004062994868217,0.02568203798561493,Other Types,roxatidine-acetate,histamine receptor antagonist,HRH2
Head and Neck Squamous Cell Carcinoma,BRD-K82091397-001-03-0::2.5::HTS,4.956162680037705,0.02639925326064598,Other Types,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K82244583-001-01-3::2.5::HTS,14.320634868212185,0.00017145390396379568,Other Types,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Head and Neck Squamous Cell Carcinoma,BRD-K82746043-001-15-1::2.5::HTS,4.660794890710666,0.03128296673883351,Head and Neck Squamous Cell Carcinoma,navitoclax,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Head and Neck Squamous Cell Carcinoma,BRD-K82818427-001-02-2::2.39::HTS,8.667335738709792,0.003382294472148281,Other Types,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Head and Neck Squamous Cell Carcinoma,BRD-K82823804-001-04-1::2.5::HTS,3.8781594804653086,0.0494178382329934,Head and Neck Squamous Cell Carcinoma,PD-407824,PKC inhibitor,WEE1
Head and Neck Squamous Cell Carcinoma,BRD-K82928847-001-04-7::2.5::HTS,3.907963548339031,0.048560479586282145,Other Types,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Head and Neck Squamous Cell Carcinoma,BRD-K82928892-001-02-5::2.46::HTS,5.07121808820202,0.02473639637175673,Other Types,doxercalciferol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K82983861-001-04-3::2.5::HTS,4.069734664303091,0.04413555540672904,Head and Neck Squamous Cell Carcinoma,GW-0742,PPAR receptor agonist,PPARD
Head and Neck Squamous Cell Carcinoma,BRD-K83063356-003-02-5::2.5::HTS,13.221198040744154,0.0003026150270738694,Other Types,RS-102895,CCR antagonist,CCR2
Head and Neck Squamous Cell Carcinoma,BRD-K83607951-001-02-2::2.5::HTS,9.143076404551035,0.0026111743404706135,Other Types,skepinone-l,p38 MAPK inhibitor,MAPK14
Head and Neck Squamous Cell Carcinoma,BRD-K83834509-001-01-1::2.5::HTS,9.313136845059365,0.0023832084669839094,Other Types,PTC-209,BMI-1 inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K83988098-001-02-0::2.5::HTS,5.220697577948145,0.02269809832125499,Other Types,alvespimycin,HSP inhibitor,HSP90AA1
Head and Neck Squamous Cell Carcinoma,BRD-K84163249-001-01-9::2.5::HTS,13.43891932008114,0.00027091135897689664,Other Types,ercalcitriol,vitamin D receptor agonist,VDR
Head and Neck Squamous Cell Carcinoma,BRD-K84794093-001-07-5::2.5::HTS,4.864383041478964,0.027837914926035445,Other Types,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K85046107-003-01-2::2.5::HTS,6.222560198807327,0.012900346257050952,Other Types,ramosetron,serotonin receptor antagonist,HTR3A
Head and Neck Squamous Cell Carcinoma,BRD-K85606544-001-09-1::2.5::HTS,33.04103407693826,1.5116254713697533e-08,Other Types,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K85849709-001-01-5::2.5::HTS,6.625326488960755,0.01031071733122982,Head and Neck Squamous Cell Carcinoma,AZD2858,glycogen synthase kinase inhibitor,GSK3B
Head and Neck Squamous Cell Carcinoma,BRD-K85883481-001-25-7::2.5::HTS,4.355434765873633,0.037354256578002634,Other Types,prednisone,glucocorticoid receptor agonist,"HSD11B1, NR3C1"
Head and Neck Squamous Cell Carcinoma,BRD-K85920262-001-02-1::2.5::HTS,3.8944660340909616,0.0489384085544898,Other Types,WAY-600,mTOR inhibitor,MTOR
Head and Neck Squamous Cell Carcinoma,BRD-K86109159-001-02-6::2.5::HTS,4.03449700519205,0.045056816364271765,Other Types,VU0357121,glutamate receptor positive allosteric modulator,GRM5
Head and Neck Squamous Cell Carcinoma,BRD-K86294588-001-01-9::2.5::HTS,5.264090864840563,0.022137644885662958,Other Types,schisandrin-b,antioxidant,ATR
Head and Neck Squamous Cell Carcinoma,BRD-K86436199-003-01-3::2.5::HTS,4.7576826991030945,0.029589050667795425,Other Types,landiolol,adrenergic receptor antagonist,ADRB1
Head and Neck Squamous Cell Carcinoma,BRD-K86525559-001-07-8::2.52::HTS,13.52429899205947,0.0002596131222958829,Other Types,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Head and Neck Squamous Cell Carcinoma,BRD-K86882815-001-03-2::2.5::HTS,6.096427972243122,0.013854472821265375,Other Types,cabergoline,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7"
Head and Neck Squamous Cell Carcinoma,BRD-K86887724-001-10-6::2.59::HTS,4.064259584017654,0.0442955228567809,Other Types,dofetilide,potassium channel blocker,"KCNH1, KCNH2, KCNJ12, KCNK2"
Head and Neck Squamous Cell Carcinoma,BRD-K87124298-001-03-4::2.5::HTS,7.340123046240631,0.006950406375217452,Other Types,OSI-027,mTOR inhibitor,MTOR
Head and Neck Squamous Cell Carcinoma,BRD-K87510569-001-02-8::2.5::HTS,5.413226384828825,0.02034184908211711,Other Types,RS-504393,CC chemokine receptor antagonist,"CCL2, CCR2"
Head and Neck Squamous Cell Carcinoma,BRD-K87700323-003-05-1::2.5::HTS,7.6542862439716215,0.005851879961929334,Other Types,cetylpyridinium,,
Head and Neck Squamous Cell Carcinoma,BRD-K87827419-001-16-8::2.5::HTS,12.191723001877595,0.0005188737615394461,Head and Neck Squamous Cell Carcinoma,melphalan,"DNA alkylating agent, DNA inhibitor",
Head and Neck Squamous Cell Carcinoma,BRD-K88025533-003-03-3::2.5::HTS,3.918292868757414,0.048255253109063395,Other Types,fingolimod,"immunosuppressant, sphingosine phosphate receptor agonist","S1PR1, S1PR5"
Head and Neck Squamous Cell Carcinoma,BRD-K88544581-001-06-1::2.5::HTS,4.012452387528801,0.04564511737762965,Other Types,CI-976,ACAT inhibitor,"ACAT1, CES1"
Head and Neck Squamous Cell Carcinoma,BRD-K89014967-001-04-3::2.5::HTS,12.31202502877117,0.00048642033175410915,Other Types,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Head and Neck Squamous Cell Carcinoma,BRD-K89053832-001-01-0::2.5::HTS,4.544072000828062,0.03346758867955708,Other Types,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Head and Neck Squamous Cell Carcinoma,BRD-K89162000-001-06-4::2.5::HTS,3.9406611820812287,0.04762053458884425,Other Types,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB"
Head and Neck Squamous Cell Carcinoma,BRD-K90027355-001-13-3::2.44::HTS,9.306423631831953,0.002398254203179063,Other Types,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG"
Head and Neck Squamous Cell Carcinoma,BRD-K91065602-003-05-5::2.5::HTS,6.2665142151487965,0.012594977703799965,Head and Neck Squamous Cell Carcinoma,vancomycin,bacterial cell wall synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K92049597-001-20-8::2.5::HTS,7.410716434297658,0.006685980328101829,Head and Neck Squamous Cell Carcinoma,triamterene,sodium channel blocker,"SCNN1A, SCNN1B, SCNN1D, SCNN1G"
Head and Neck Squamous Cell Carcinoma,BRD-K92093830-003-30-8::2.5::HTS,10.525753997718745,0.0012475417665656237,Other Types,doxorubicin,topoisomerase inhibitor,TOP2A
Head and Neck Squamous Cell Carcinoma,BRD-K92116564-001-01-4::2.5::HTS,7.560520308041813,0.006160901251910603,Other Types,isoxepac,anti-inflammatory agent,
Head and Neck Squamous Cell Carcinoma,BRD-K92968657-001-01-6::2.5::HTS,6.510664782482112,0.010986558753311606,Head and Neck Squamous Cell Carcinoma,tirapazamine,DNA inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K92980438-001-03-3::2.5::HTS,9.675131897433818,0.0019686972919129337,Other Types,3-bromopyruvate,hexokinase inhibitor,HK2
Head and Neck Squamous Cell Carcinoma,BRD-K93045741-001-01-0::2.5::HTS,6.523398260202326,0.010910507057478093,Other Types,tozadenant,adenosine receptor antagonist,ADORA2A
Head and Neck Squamous Cell Carcinoma,BRD-K93441486-067-12-8::2.5::HTS,4.345965474998816,0.037547579480451926,Other Types,diphemanil,acetylcholine receptor antagonist,CHRM3
Head and Neck Squamous Cell Carcinoma,BRD-K93568044-001-32-0::2.5::HTS,4.21012485812691,0.040654565991574944,Other Types,hydrocortisone,glucocorticoid receptor agonist,
Head and Neck Squamous Cell Carcinoma,BRD-K94266545-001-24-1::2.5::HTS,6.383706029218418,0.01179260469708888,Other Types,ronidazole,antiprotozoal agent,
Head and Neck Squamous Cell Carcinoma,BRD-K94353609-001-21-6::2.5::HTS,4.04003025470658,0.044914701571367885,Other Types,fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Head and Neck Squamous Cell Carcinoma,BRD-K94455792-001-01-8::2.5::HTS,4.86434550346633,0.0278241414898008,Other Types,ICG-001,beta-catenin inhibitor,CTNNB1
Head and Neck Squamous Cell Carcinoma,BRD-K94485812-001-02-9::2.55::HTS,4.366944218112861,0.03712058583236994,Head and Neck Squamous Cell Carcinoma,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K94649603-001-10-6::2.5::HTS,7.618987041678693,0.005966961156291091,Other Types,taxifolin,opioid receptor antagonist,ADIPOR2
Head and Neck Squamous Cell Carcinoma,BRD-K94780074-001-06-7::2.5::HTS,4.096132595226505,0.04348451371750191,Head and Neck Squamous Cell Carcinoma,S-Nitrosoglutathione,nitric oxide stimulant,PTPN1
Head and Neck Squamous Cell Carcinoma,BRD-K95237249-001-26-5::2.5::HTS,5.573894748576597,0.018571803376118672,Other Types,probenecid,uricosuric blocker,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1"
Head and Neck Squamous Cell Carcinoma,BRD-K95581532-001-01-5::2.5::HTS,10.53890941702404,0.0012395003066617094,Other Types,RN-1734,TRPV antagonist,TRPV4
Head and Neck Squamous Cell Carcinoma,BRD-K95921201-001-14-6::2.5::HTS,7.902815711889757,0.00510863131829568,Other Types,reserpine,vesicular monoamine transporter inhibitor,"SLC18A1, SLC18A2"
Head and Neck Squamous Cell Carcinoma,BRD-K96263742-001-14-8::2.5::HTS,3.918657761661489,0.04824752202727622,Head and Neck Squamous Cell Carcinoma,GW-7647,PPAR receptor agonist,PPARA
Head and Neck Squamous Cell Carcinoma,BRD-K96436774-001-01-8::2.5::HTS,6.269436228231908,0.01256869975212817,Other Types,pelanserin,serotonin receptor antagonist,HTR2A
Head and Neck Squamous Cell Carcinoma,BRD-K96809896-300-02-3::2.5::HTS,4.240585408739158,0.039935342724697676,Other Types,SKF-86002,p38 MAPK inhibitor,"ALOX5, MAPK14"
Head and Neck Squamous Cell Carcinoma,BRD-K97365803-001-02-1::2.5::HTS,7.400577914780305,0.006726229633909416,Head and Neck Squamous Cell Carcinoma,PI-828,PI3K inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K97417064-001-02-4::2.5::HTS,5.491811010564937,0.019455853691868363,Head and Neck Squamous Cell Carcinoma,acedapsone,,
Head and Neck Squamous Cell Carcinoma,BRD-K97472745-001-01-8::2.5::HTS,5.658344495192979,0.017705591287116535,Head and Neck Squamous Cell Carcinoma,gestrinone,progesterone receptor antagonist,"AR, ESR1, PGR"
Head and Neck Squamous Cell Carcinoma,BRD-K97530723-001-20-9::2.5::HTS,3.9302357445831126,0.04791183042651478,Other Types,melatonin,"melatonin receptor agonist, nitric oxide synthase inhibitor","ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB"
Head and Neck Squamous Cell Carcinoma,BRD-K97746869-001-27-0::2.5::HTS,7.892087204582083,0.005137969035958576,Other Types,chlorpropamide,ATP channel blocker,"ABCC8, KCNJ10, KCNJ11"
Head and Neck Squamous Cell Carcinoma,BRD-K98004573-051-02-8::2.5::HTS,4.035642358959725,0.04502647020167307,Head and Neck Squamous Cell Carcinoma,rupatadine,"histamine receptor antagonist, platelet activating factor receptor antagonist","HRH1, PTAFR"
Head and Neck Squamous Cell Carcinoma,BRD-K98530306-003-18-3::2.5::HTS,5.218618009459461,0.02272091393564369,Head and Neck Squamous Cell Carcinoma,clonidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Head and Neck Squamous Cell Carcinoma,BRD-K98572433-001-02-9::2.5::HTS,21.574498715598022,4.246011211313663e-06,Other Types,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Head and Neck Squamous Cell Carcinoma,BRD-K98684188-001-02-9::2.5::HTS,6.4136502836653095,0.01159961659609119,Other Types,GSK-0660,PPAR receptor antagonist,PPARD
Head and Neck Squamous Cell Carcinoma,BRD-K99023089-001-03-7::2.5::HTS,3.9376049441500003,0.04770649644098677,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Head and Neck Squamous Cell Carcinoma,BRD-K99170882-001-04-3::2.5::HTS,5.616272068360296,0.01813360662578151,Other Types,NSC-319726,p53 activator,
Head and Neck Squamous Cell Carcinoma,BRD-K99383816-001-03-5::2.5::HTS,14.94294686931883,0.00012432485704653399,Other Types,ftorafur,thymidylate synthase inhibitor,TYMS
Head and Neck Squamous Cell Carcinoma,BRD-K99615199-001-18-5::2.5::HTS,6.110486564042305,0.013735430019837677,Other Types,medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR"
Head and Neck Squamous Cell Carcinoma,BRD-K99964838-001-11-9::2.5::HTS,18.45930274406113,2.0466047755775836e-05,Other Types,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Head and Neck Squamous Cell Carcinoma,BRD-A18992208-003-02-7::2.5::MTS004,4.250694211374706,0.039713159070006304,Other Types,lercanidipine,calcium channel blocker,"CACNA2D1, CACNG1"
Head and Neck Squamous Cell Carcinoma,BRD-A21280314-001-06-8::2.5::MTS004,5.293968904485502,0.02178019828945565,Head and Neck Squamous Cell Carcinoma,nifenalol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Head and Neck Squamous Cell Carcinoma,BRD-A33894669-065-01-9::2.312630829::MTS004,3.8730553761206634,0.04958024666287917,Head and Neck Squamous Cell Carcinoma,hexoprenaline,adrenergic receptor agonist,ADRB2
Head and Neck Squamous Cell Carcinoma,BRD-A55416093-001-06-4::2.5::MTS004,5.960224615493794,0.014953398607513484,Head and Neck Squamous Cell Carcinoma,colforsin,adenylyl cyclase activator,"ADCY2, ADCY5"
Head and Neck Squamous Cell Carcinoma,BRD-A56241705-003-01-2::2.639158457::MTS004,7.7484506563948345,0.005564945074318676,Head and Neck Squamous Cell Carcinoma,trimethoquinol,adrenergic receptor antagonist,"ADRB2, ADRB3"
Head and Neck Squamous Cell Carcinoma,BRD-A60498477-001-01-2::2.508127434::MTS004,4.870332107011164,0.02774377601802057,Head and Neck Squamous Cell Carcinoma,tolamolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Head and Neck Squamous Cell Carcinoma,BRD-A72401848-001-02-2::2.551316459::MTS004,3.8914631729313287,0.04904274177450413,Head and Neck Squamous Cell Carcinoma,gadoteridol,radiopaque medium,
Head and Neck Squamous Cell Carcinoma,BRD-A89082344-001-08-7::2.500026693::MTS004,4.824088852762785,0.028490624922434617,Head and Neck Squamous Cell Carcinoma,perifosine,AKT inhibitor,AKT1
Head and Neck Squamous Cell Carcinoma,BRD-A91444184-300-01-9::2.5::MTS004,6.837954227399937,0.009173928624480396,Other Types,buclizine,histamine receptor antagonist,"CHRM1, HRH1"
Head and Neck Squamous Cell Carcinoma,BRD-K00634421-001-01-0::2.500042819::MTS004,10.849529930372574,0.001053202504921678,Other Types,brivaracetam,voltage-gated sodium channel blocker,SV2A
Head and Neck Squamous Cell Carcinoma,BRD-K03765900-001-01-9::2.499986292::MTS004,70.6594511048959,3.8172766370774537e-16,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Head and Neck Squamous Cell Carcinoma,BRD-K10415035-001-04-4::2.5::MTS004,5.366400099645072,0.020902365578860178,Other Types,tasuldine,mucolytic agent,
Head and Neck Squamous Cell Carcinoma,BRD-K11851476-003-01-7::2.499993171::MTS004,11.52544966076209,0.000737055500247082,Other Types,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Head and Neck Squamous Cell Carcinoma,BRD-K14658796-003-01-6::2.368766292::MTS004,11.062054946265826,0.0009412490814472005,Other Types,drotaverine,phosphodiesterase inhibitor,"CACNA1C, PDE4A"
Head and Neck Squamous Cell Carcinoma,BRD-K14681867-001-01-6::2.5::MTS004,4.358241119107322,0.03729929201473931,Other Types,somatostatin,somatostatin receptor agonist,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
Head and Neck Squamous Cell Carcinoma,BRD-K16180792-001-01-7::2.5::MTS004,5.923374878261017,0.015265139454286763,Head and Neck Squamous Cell Carcinoma,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Head and Neck Squamous Cell Carcinoma,BRD-K17610631-001-03-3::2.421190843::MTS004,6.21134804731656,0.012992649157144254,Other Types,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Head and Neck Squamous Cell Carcinoma,BRD-K21077415-001-01-5::2.656085278::MTS004,4.6256027519462455,0.031942133351059915,Head and Neck Squamous Cell Carcinoma,AMG-319,PI3K inhibitor,PIK3CD
Head and Neck Squamous Cell Carcinoma,BRD-K21191422-001-01-5::2.499985534::MTS004,4.974408860764428,0.02613664076934508,Head and Neck Squamous Cell Carcinoma,selexipag,"platelet aggregation inhibitor, IP1 prostacyclin receptor agonist",PTGIR
Head and Neck Squamous Cell Carcinoma,BRD-K22514639-001-05-7::2.500015058::MTS004,6.02671236954766,0.014405840483767075,Other Types,EGF816,EGFR inhibitor,EGFR
Head and Neck Squamous Cell Carcinoma,BRD-K24497734-001-01-6::2.499993902::MTS004,4.492300082580457,0.03450517571504762,Head and Neck Squamous Cell Carcinoma,setipiprant,prostaglandin inhibitor,PTGDR2
Head and Neck Squamous Cell Carcinoma,BRD-K24666289-001-04-9::2.499988887::MTS004,25.631584455108143,5.680726723583413e-07,Other Types,copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Head and Neck Squamous Cell Carcinoma,BRD-K35798650-001-01-4::2.5::MTS004,6.179018142123356,0.013229359044409625,Other Types,polidocanol,local anesthetic,
Head and Neck Squamous Cell Carcinoma,BRD-K37708699-001-01-4::2.530276706::MTS004,4.479641494257885,0.03475944033366971,Head and Neck Squamous Cell Carcinoma,exisulind,phosphodiesterase inhibitor,PDE5A
Head and Neck Squamous Cell Carcinoma,BRD-K39009484-001-01-4::2.5::MTS004,12.850949616677871,0.0003679911102939583,Other Types,entrectinib,"ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor","ALK, NTRK1, NTRK2, NTRK3, ROS1"
Head and Neck Squamous Cell Carcinoma,BRD-K44030614-001-01-6::2.500000065::MTS004,4.897852175647118,0.027308260219947526,Other Types,ponesimod,sphingosine 1 phosphate receptor agonist,S1PR1
Head and Neck Squamous Cell Carcinoma,BRD-K44471774-001-01-8::2.670187358::MTS004,7.635236593495694,0.0059195147006624324,Other Types,bay-w-9798,antioxidant,
Head and Neck Squamous Cell Carcinoma,BRD-K49372556-001-04-1::2.5::MTS004,7.8482443176669285,0.005269815219416422,Other Types,mofezolac,cyclooxygenase inhibitor,PTGS1
Head and Neck Squamous Cell Carcinoma,BRD-K50010139-001-02-3::2.5::MTS004,54.0704295810867,7.23410864006663e-13,Other Types,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Head and Neck Squamous Cell Carcinoma,BRD-K56912469-003-02-0::2.499992214::MTS004,5.516222151452464,0.019201157084828904,Head and Neck Squamous Cell Carcinoma,SAR407899,rho associated kinase inhibitor,ROCK1
Head and Neck Squamous Cell Carcinoma,BRD-K56981171-001-01-0::2.500008954::MTS004,8.059298914706655,0.00469816662603289,Other Types,brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR"
Head and Neck Squamous Cell Carcinoma,BRD-K60421517-001-01-4::2.499975038::MTS004,18.842910494425457,1.696115835526263e-05,Other Types,olmutinib,"EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR"
Head and Neck Squamous Cell Carcinoma,BRD-K62374002-001-01-5::2.499972663::MTS004,19.621891991444596,1.1434931694059057e-05,Other Types,PI3K-IN-2,PI3K inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K63772874-001-02-2::2.499989061::MTS004,5.533863906379719,0.019010510269912267,Other Types,icatibant-acetate,bradykinin receptor antagonist,"ANPEP, BDKRB2"
Head and Neck Squamous Cell Carcinoma,BRD-K69636617-001-01-7::2.49998713::MTS004,4.50566930576548,0.03423790624145931,Other Types,testolactone,aromatase inhibitor,CYP19A1
Head and Neck Squamous Cell Carcinoma,BRD-K70262971-001-01-9::2.499966077::MTS004,4.05224799306856,0.044609265950071655,Other Types,AGN-194310,retinoid receptor antagonist,"RXRA, RXRB, RXRG"
Head and Neck Squamous Cell Carcinoma,BRD-K72280606-001-01-2::2.499993939::MTS004,7.5395662579843306,0.0062374676503479795,Other Types,gilteritinib,FLT3 inhibitor,FLT3
Head and Neck Squamous Cell Carcinoma,BRD-K73027814-003-01-0::2.693425643::MTS004,6.019836471719857,0.014462022911401565,Head and Neck Squamous Cell Carcinoma,oxyfedrine,adrenergic receptor agonist,
Head and Neck Squamous Cell Carcinoma,BRD-K73132780-001-01-2::2.5::MTS004,5.804418492833041,0.01632023436540784,Other Types,pyronaridine,antimalarial agent,
Head and Neck Squamous Cell Carcinoma,BRD-K73881242-003-04-6::2.500023768::MTS004,8.042727339735885,0.0047406892056989815,Other Types,arbidol,cytochrome P450 inhibitor,CYP3A4
Head and Neck Squamous Cell Carcinoma,BRD-K76634210-001-12-1::2.5::MTS004,4.862920970219207,0.027862080319835406,Other Types,idoxuridine,DNA directed DNA polymerase inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K76719364-001-02-5::2.466617435::MTS004,6.81033319678564,0.009315541173669766,Other Types,GS-9973,syk inhibitor,SYK
Head and Neck Squamous Cell Carcinoma,BRD-K79710622-001-02-9::2.5::MTS004,5.068862103016408,0.02476206388606963,Head and Neck Squamous Cell Carcinoma,GKT137831,NADPH oxidase inhibitor,"NOX1, NOX4"
Head and Neck Squamous Cell Carcinoma,BRD-K80353807-001-25-3::2.5::MTS004,6.252205852451127,0.012699734074827263,Head and Neck Squamous Cell Carcinoma,khellin,vasodilator,
Head and Neck Squamous Cell Carcinoma,BRD-K82908348-001-01-9::2.434467427::MTS004,6.546128986441795,0.010783386754116081,Head and Neck Squamous Cell Carcinoma,darglitazone,PPAR receptor antagonist,PPARG
Head and Neck Squamous Cell Carcinoma,BRD-K84173274-001-01-6::2.5::MTS004,6.814045363440962,0.009295972327841682,Other Types,ufenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Head and Neck Squamous Cell Carcinoma,BRD-K86864073-001-01-1::2.5::MTS004,3.9286018771693207,0.04797979197934127,Other Types,chloroprocaine,sodium channel blocker,"ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3"
Head and Neck Squamous Cell Carcinoma,BRD-K87465484-001-02-7::2.5::MTS004,5.324701533937387,0.02140385194596007,Other Types,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
Head and Neck Squamous Cell Carcinoma,BRD-K88854110-001-01-5::2.499975441::MTS004,6.937450998526243,0.008683911793656063,Head and Neck Squamous Cell Carcinoma,taprenepag,prostaglandin receptor agonist,PTGER2
Head and Neck Squamous Cell Carcinoma,BRD-K89121095-001-01-7::2.499999138::MTS004,11.439610894052718,0.0007711451438737336,Other Types,tedizolid-phosphate,protein synthesis inhibitor,
Head and Neck Squamous Cell Carcinoma,BRD-K89413285-074-01-5::2.500023482::MTS004,4.885303941597217,0.027506376277486602,Head and Neck Squamous Cell Carcinoma,remimazolam,benzodiazepine receptor agonist,GABBR1
Head and Neck Squamous Cell Carcinoma,BRD-K96669468-300-01-1::2.5::MTS004,4.289650552118254,0.03882034859173891,Other Types,pyridoxamine,AGE inhibitor,
Anaplastic Thyroid Cancer,BRD-A00520476-001-07-4::2.5::HTS,4.567702872961543,0.03301508235644664,Other Types,otenzepad,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Anaplastic Thyroid Cancer,BRD-A05523972-001-01-5::2.5::HTS,3.8774806012362117,0.04943319070846762,Other Types,telmesteine,mucolytic agent,
Anaplastic Thyroid Cancer,BRD-A08255417-001-14-7::2.5::HTS,4.340464535617084,0.03767134604150804,Other Types,famprofazone,cyclooxygenase inhibitor,
Anaplastic Thyroid Cancer,BRD-A08840375-001-01-3::2.5::HTS,5.8292212650133495,0.016089914085831873,Other Types,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Anaplastic Thyroid Cancer,BRD-A09472452-015-23-4::2.5::HTS,7.646197039129647,0.005884163575167254,Other Types,flecainide,sodium channel blocker,"KCNA5, KCNA7, SCN4A, SCN5A"
Anaplastic Thyroid Cancer,BRD-A09554849-236-07-6::2.5::HTS,6.831109458158348,0.00920056373158162,Other Types,8-bromo-cAMP,PKA activator,
Anaplastic Thyroid Cancer,BRD-A09735281-001-02-5::2.5::HTS,5.241176299733262,0.022429589375769183,Other Types,boceprevir,HCV inhibitor,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS"
Anaplastic Thyroid Cancer,BRD-A12994259-001-02-1::2.5::HTS,5.110083861664207,0.024185226106866325,Other Types,pomalidomide,"angiogenesis inhibitor, tumor necrosis factor production inhibitor","CRBN, PTGS2, TNF"
Anaplastic Thyroid Cancer,BRD-A13084692-001-17-3::2.5::HTS,5.274960403263009,0.022007146193373694,Other Types,troglitazone,"insulin sensitizer, PPAR receptor agonist","ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3"
Anaplastic Thyroid Cancer,BRD-A14262390-065-01-8::2.5::HTS,5.3890818526502855,0.02063509056486788,Other Types,guanadrel,adrenergic inhibitor,SLC6A2
Anaplastic Thyroid Cancer,BRD-A14886633-001-01-6::2.5::HTS,4.397692124031323,0.03644030369403317,Other Types,norgestrel,progesterone receptor agonist,PGR
Anaplastic Thyroid Cancer,BRD-A18056626-003-22-3::2.5::HTS,5.352226713227943,0.02105903959324564,Other Types,methacholine,acetylcholine receptor agonist,"CHRM2, CHRM3, CHRM4"
Anaplastic Thyroid Cancer,BRD-A25800195-001-02-2::2.5::HTS,7.3855585773100545,0.0067917705600765935,Other Types,L-Cysteinesulfinic-acid,glutamate receptor agonist,"GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2"
Anaplastic Thyroid Cancer,BRD-A28887267-001-19-3::2.5::HTS,6.1394829408490414,0.013514444136967082,Other Types,proxyphylline,,
Anaplastic Thyroid Cancer,BRD-A30815329-001-10-5::2.5::HTS,4.947729429028677,0.02652715169526108,Other Types,felodipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2"
Anaplastic Thyroid Cancer,BRD-A34006693-001-15-4::2.5::HTS,5.898451036625891,0.015473665627082023,Other Types,suprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Anaplastic Thyroid Cancer,BRD-A38592941-001-02-7::2.5::HTS,6.082954156917888,0.013946570382744376,Anaplastic Thyroid Cancer,timonacic,antioxidant,ANXA5
Anaplastic Thyroid Cancer,BRD-A41450521-075-10-8::2.5::HTS,5.37031832233716,0.020847114012424384,Other Types,tosufloxacin,bacterial DNA gyrase inhibitor,
Anaplastic Thyroid Cancer,BRD-A51714012-003-13-6::2.5::HTS,5.715290985769127,0.017159996960652152,Other Types,venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4"
Anaplastic Thyroid Cancer,BRD-A55962179-001-22-1::2.5::HTS,4.098144033934564,0.04340445772767912,Other Types,omeprazole,ATPase inhibitor,"ATP4A, CLCN2"
Anaplastic Thyroid Cancer,BRD-A56085258-001-01-8::2.5::HTS,4.790091359050987,0.02903617940078821,Other Types,LGX818,RAF inhibitor,BRAF
Anaplastic Thyroid Cancer,BRD-A59001851-001-02-1::2.5::HTS,3.876628628844691,0.04947465613198495,Other Types,ginkgolide-b,platelet activating factor receptor antagonist,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B"
Anaplastic Thyroid Cancer,BRD-A62428732-300-06-3::2.5::HTS,7.482455591180166,0.006427094537639195,Other Types,hydroxyzine,antihistamine,HRH1
Anaplastic Thyroid Cancer,BRD-A64698388-003-01-7::2.5::HTS,5.516719244144216,0.019191126241696575,Other Types,levo-phencynonate,acetylcholine receptor antagonist,CHRM1
Anaplastic Thyroid Cancer,BRD-A68304895-003-02-2::2.5::HTS,7.535704366777705,0.0062430388742127285,Other Types,BTS-54505,dopamine reuptake inhibitor,"SLC6A2, SLC6A3, SLC6A4"
Anaplastic Thyroid Cancer,BRD-A69777949-001-24-2::2.5::HTS,5.924035964959295,0.01525531059170789,Other Types,flumequine,topoisomerase inhibitor,
Anaplastic Thyroid Cancer,BRD-A72767275-003-01-6::2.5::HTS,5.560059967574763,0.01872135797864162,Other Types,nalmefene,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Anaplastic Thyroid Cancer,BRD-A73556557-001-06-4::2.5::HTS,4.24648562360422,0.039790444917479524,Other Types,tagatose,phosphorylase inhibitor,PYGL
Anaplastic Thyroid Cancer,BRD-A77577770-003-08-9::2.5::HTS,4.103996645216823,0.043253922933879634,Other Types,palmitoylcarnitine,protein kinase inhibitor,
Anaplastic Thyroid Cancer,BRD-A78341343-001-01-6::2.5::HTS,5.4663082505756275,0.019736394784669802,Other Types,regadenoson,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Anaplastic Thyroid Cancer,BRD-A84174393-236-07-1::2.5::HTS,8.509097384971781,0.0036810487391823994,Other Types,meloxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Anaplastic Thyroid Cancer,BRD-A86619021-001-04-8::2.5::HTS,4.6768372775185885,0.030996868055166726,Other Types,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Anaplastic Thyroid Cancer,BRD-A87479750-001-02-7::2.5::HTS,4.190241970418839,0.041125149637429456,Other Types,tenidap,cyclooxygenase inhibitor,"KCNJ4, PTGS1"
Anaplastic Thyroid Cancer,BRD-A92872453-001-01-8::2.5::HTS,5.031872939306765,0.025279414205416875,Other Types,N-acetylmannosamine,,CHIT1
Anaplastic Thyroid Cancer,BRD-A95121829-001-08-9::2.5::HTS,4.440118788099478,0.03555266353305981,Other Types,ginkgolide-a,GABA receptor antagonist,"GLRA1, GLRB"
Anaplastic Thyroid Cancer,BRD-A95869247-001-26-9::2.5::HTS,5.41210981102308,0.020353455866495233,Other Types,indapamide,thiazide diuretic,"KCNE1, KCNQ1, SLC12A3"
Anaplastic Thyroid Cancer,BRD-A96977263-001-03-7::2.5::HTS,5.9191895723530505,0.01530781819213794,Other Types,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1
Anaplastic Thyroid Cancer,BRD-A98990573-003-01-3::2.5::HTS,3.935266499368152,0.04777768683447413,Other Types,epinastine,histamine receptor antagonist,"ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7"
Anaplastic Thyroid Cancer,BRD-K00494077-066-01-9::2.5::HTS,4.031113118285889,0.04516702012790368,Other Types,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A
Anaplastic Thyroid Cancer,BRD-K01292756-001-25-0::2.5::HTS,3.876293064167065,0.04947060267422789,Other Types,pimozide,dopamine receptor antagonist,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2"
Anaplastic Thyroid Cancer,BRD-K02404261-001-16-7::2.5::HTS,5.214862736422927,0.02277024050444455,Other Types,caffeine,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3"
Anaplastic Thyroid Cancer,BRD-K03063480-001-06-6::2.42::HTS,6.843121033500665,0.00915299909521102,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Anaplastic Thyroid Cancer,BRD-K04176066-001-08-3::2.5::HTS,5.816021934032261,0.016201536659026555,Other Types,bergenin,interleukin inhibitor,"IL1B, TNF"
Anaplastic Thyroid Cancer,BRD-K05804044-001-06-0::2.5::HTS,4.283532557387659,0.038943756809754766,Other Types,AZ-628,RAF inhibitor,"BRAF, RAF1"
Anaplastic Thyroid Cancer,BRD-K05878375-236-05-7::2.5::HTS,4.829720559786189,0.028406631457935025,Other Types,sodium-butyrate,HDAC inhibitor,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8"
Anaplastic Thyroid Cancer,BRD-K06208435-003-08-2::2.5::HTS,4.310928024910254,0.038322249996728175,Other Types,YS-035,calcium channel blocker,
Anaplastic Thyroid Cancer,BRD-K06335600-003-20-7::2.5::HTS,4.483948929009803,0.0346570508730007,Other Types,tizanidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, NISCH"
Anaplastic Thyroid Cancer,BRD-K06858286-001-01-3::2.5::HTS,5.212959286983541,0.022794942458373685,Other Types,cabazitaxel,microtubule inhibitor,"TUBA4A, TUBB, TUBB1"
Anaplastic Thyroid Cancer,BRD-K08037784-001-12-6::2.5::HTS,4.166236521408701,0.04172383619861545,Other Types,arbutin,melanin inhibitor,TYR
Anaplastic Thyroid Cancer,BRD-K08206212-002-01-0::2.5::HTS,7.100887827635092,0.007935440314951428,Other Types,entecavir,"DNA replication inhibitor, nucleoside reverse transcriptase inhibitor",
Anaplastic Thyroid Cancer,BRD-K08542803-001-03-1::0.8::HTS,5.813305112636255,0.016228053717245096,Other Types,gambogic-acid,caspase activator,BCL2
Anaplastic Thyroid Cancer,BRD-K09090523-001-02-1::2.5::HTS,6.158807089506033,0.013369211305951667,Other Types,firocoxib,cyclooxygenase inhibitor,PTGS2
Anaplastic Thyroid Cancer,BRD-K09951645-001-06-8::2.5::HTS,11.449231817844195,0.0007672461061991661,Other Types,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Anaplastic Thyroid Cancer,BRD-K11717138-001-30-3::2.5::HTS,7.288945652073279,0.007155973976382361,Other Types,benzbromarone,chloride channel blocker,ABCC1
Anaplastic Thyroid Cancer,BRD-K11927976-050-02-9::2.5::HTS,4.720925176556571,0.030227042737259784,Other Types,ER-27319,"mediator release inhibitor, SYK inhibitor",SYK
Anaplastic Thyroid Cancer,BRD-K12120659-305-02-2::2.5::HTS,7.915108911867968,0.005077037325692851,Other Types,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Anaplastic Thyroid Cancer,BRD-K12539581-001-23-7::2.5::HTS,5.4166070046888795,0.020300339492722398,Other Types,nocodazole,tubulin polymerization inhibitor,HPGDS
Anaplastic Thyroid Cancer,BRD-K12968785-001-13-3::2.5::HTS,4.444123089583049,0.035476647037347195,Other Types,bergapten,,
Anaplastic Thyroid Cancer,BRD-K13112821-001-17-4::2.5::HTS,4.5663209037060115,0.03304386272029489,Other Types,artemisinin,DNA synthesis inhibitor,CYP2B6
Anaplastic Thyroid Cancer,BRD-K14765469-003-12-2::2.5::HTS,4.4888411217543585,0.03455566968852442,Other Types,vesamicol,acetylcholinesterase inhibitor,SLC18A3
Anaplastic Thyroid Cancer,BRD-K15010214-364-02-7::2.5::HTS,11.606088472459481,0.0007065163626003309,Other Types,emedastine,histamine receptor antagonist,HRH1
Anaplastic Thyroid Cancer,BRD-K15898725-001-01-7::2.5::HTS,5.8387494514423,0.015996318822554548,Other Types,maytansinol-isobutyrate,,
Anaplastic Thyroid Cancer,BRD-K16478699-001-09-2::2.5::HTS,9.10069622606904,0.002672426387095354,Other Types,PLX-4720,RAF inhibitor,"BRAF, KDR"
Anaplastic Thyroid Cancer,BRD-K18135438-001-16-7::2.5::HTS,5.288619757864228,0.021834173636089776,Other Types,chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4"
Anaplastic Thyroid Cancer,BRD-K19477839-001-07-6::2.5::HTS,6.468863727077602,0.011248743716915494,Other Types,SGX523,hepatocyte growth factor receptor inhibitor,MET
Anaplastic Thyroid Cancer,BRD-K20482099-001-11-0::2.5::HTS,4.251068418174387,0.039684862641936554,Other Types,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Anaplastic Thyroid Cancer,BRD-K20545304-001-01-6::2.5::HTS,6.571368748048198,0.010626017881015793,Other Types,bardoxolone,"nuclear factor erythroid derived, like (NRF2) activator","NOS2, PPARG"
Anaplastic Thyroid Cancer,BRD-K20958582-001-01-4::2.5::HTS,6.197052779490017,0.013088602013357277,Other Types,TH-302,DNA alkylating agent,
Anaplastic Thyroid Cancer,BRD-K21071223-001-02-8::2.5::HTS,3.878260544498261,0.04941307997435977,Other Types,VP-20629,beta amyloid antagonist,"PLA2G2E, SLC36A1"
Anaplastic Thyroid Cancer,BRD-K21670884-001-01-9::2.5::HTS,4.286911410427405,0.03887037592194086,Other Types,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1
Anaplastic Thyroid Cancer,BRD-K22314899-001-02-4::2.5::HTS,3.915172643682023,0.048348713619511395,Other Types,CH223191,aryl hydrocarbon receptor antagonist,AHR
Anaplastic Thyroid Cancer,BRD-K22685337-001-13-4::2.5::HTS,5.897710808058272,0.015476069361638175,Other Types,roxarsone,antiprotozoal agent,
Anaplastic Thyroid Cancer,BRD-K23672206-001-01-4::2.5::HTS,11.32802748808191,0.0008161641869128269,Other Types,BCI-540,glutamate receptor agonist,
Anaplastic Thyroid Cancer,BRD-K24187789-001-01-7::2.5::HTS,5.798048128407268,0.016366799499467233,Other Types,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Anaplastic Thyroid Cancer,BRD-K26341917-001-01-3::2.5::HTS,4.792749128538905,0.028995523635047125,Other Types,L-ergothioneine,free radical scavenger,
Anaplastic Thyroid Cancer,BRD-K27141178-003-07-3::2.5::HTS,4.53507967711667,0.03364871098061796,Other Types,SB-203186,serotonin receptor antagonist,HTR4
Anaplastic Thyroid Cancer,BRD-K27168049-001-02-8::2.5::HTS,6.4306393771955115,0.011492468873628765,Other Types,SDZ-220-581,glutamate receptor antagonist,GRIN1
Anaplastic Thyroid Cancer,BRD-K27393415-001-01-0::2.5::HTS,6.47778809469059,0.011194047863262615,Other Types,xipamide,carbonic anhydrase inhibitor,SLC12A3
Anaplastic Thyroid Cancer,BRD-K28029915-001-02-2::2.5::HTS,4.033507823081083,0.04508733618223378,Other Types,dolasetron,serotonin receptor antagonist,HTR3A
Anaplastic Thyroid Cancer,BRD-K28307902-001-21-7::2.5::HTS,5.012661738710152,0.02555879954672968,Other Types,flutamide,androgen receptor antagonist,"AHR, AR"
Anaplastic Thyroid Cancer,BRD-K28907958-001-04-3::2.5::HTS,4.215452826994307,0.04052218657201997,Other Types,CD-437,retinoid receptor agonist,RARG
Anaplastic Thyroid Cancer,BRD-K29968218-001-03-2::2.5::HTS,4.757041586032138,0.02959845342294227,Other Types,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Anaplastic Thyroid Cancer,BRD-K30213273-001-01-6::2.5::HTS,4.312673895174538,0.03828651111871574,Anaplastic Thyroid Cancer,fenofibric-acid,cytochrome P450 inhibitor,"CLCN1, PPARA"
Anaplastic Thyroid Cancer,BRD-K30431096-004-01-3::2.5::HTS,5.575021188076833,0.018568766326760165,Other Types,domiphen,,
Anaplastic Thyroid Cancer,BRD-K30577245-001-04-3::2.5::HTS,6.237075773595747,0.01280740156867547,Other Types,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Anaplastic Thyroid Cancer,BRD-K31553034-001-03-0::2.5::HTS,5.915717325076341,0.01531979703881585,Other Types,zibotentan,endothelin receptor antagonist,EDNRA
Anaplastic Thyroid Cancer,BRD-K32101625-001-01-6::2.5::HTS,5.448358765106476,0.019939422335924845,Other Types,LX1031,tryptophan hydroxylase inhibitor,TPH1
Anaplastic Thyroid Cancer,BRD-K32289541-001-01-0::2.5::HTS,5.042358954692111,0.02512543482286443,Other Types,EHop-016,Ras GTPase inhibitor,"RAC1, RAC3"
Anaplastic Thyroid Cancer,BRD-K32372024-001-01-0::2.5::HTS,5.137867073562937,0.023817739837884565,Other Types,D-7193,,
Anaplastic Thyroid Cancer,BRD-K33211335-004-01-7::2.5::HTS,8.578425423873203,0.0035421982260541197,Other Types,dextromethorphan,"glutamate receptor antagonist, sigma receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4"
Anaplastic Thyroid Cancer,BRD-K34441861-003-07-0::2.47::HTS,4.268132169945189,0.03932082544304752,Other Types,moexipril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Anaplastic Thyroid Cancer,BRD-K34713073-001-01-3::2.5::HTS,4.570347651522128,0.032962247833365356,Other Types,PD-123319,angiotensin antagonist,AGTR2
Anaplastic Thyroid Cancer,BRD-K35952844-238-01-2::2.5::HTS,6.121340798105889,0.01365937267327507,Other Types,calcium-gluceptate,,
Anaplastic Thyroid Cancer,BRD-K36660044-001-24-2::2.5::HTS,15.190662635236487,0.0001090146445275169,Other Types,bufexamac,cyclooxygenase inhibitor,"HDAC10, HDAC6"
Anaplastic Thyroid Cancer,BRD-K37249724-001-25-7::2.5::HTS,3.8658532690689906,0.04977343856910735,Other Types,astemizole,histamine receptor antagonist,"HRH1, KCNH1, KCNH2"
Anaplastic Thyroid Cancer,BRD-K37890730-001-15-1::2.5::HTS,3.8961457395921872,0.048900691259808116,Other Types,camptothecin,topoisomerase inhibitor,TOP1
Anaplastic Thyroid Cancer,BRD-K38332599-001-01-3::2.5::HTS,4.820714919653132,0.028529887931858025,Other Types,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Anaplastic Thyroid Cancer,BRD-K38860038-001-01-2::2.5::HTS,4.391968501726033,0.036563465354884604,Other Types,JK-184,hedgehog pathway inhibitor,
Anaplastic Thyroid Cancer,BRD-K39467894-001-06-7::2.5::HTS,5.050916497496534,0.025016557939040156,Anaplastic Thyroid Cancer,nithiamide,bacterial DNA inhibitor,
Anaplastic Thyroid Cancer,BRD-K40269473-001-02-2::2.5::HTS,4.440495660882859,0.03554732818786144,Anaplastic Thyroid Cancer,cathepsin-inhibitor-1,cathepsin inhibitor,"CTSB, CTSL, CTSV"
Anaplastic Thyroid Cancer,BRD-K40331046-305-01-5::2.5::HTS,5.995515064894859,0.014648458772966744,Other Types,CR8-(R),CDK inhibitor,CCNA2
Anaplastic Thyroid Cancer,BRD-K40718343-001-02-6::2.5::HTS,4.21626200535579,0.040500531469677165,Anaplastic Thyroid Cancer,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Anaplastic Thyroid Cancer,BRD-K41185545-001-02-3::2.5::HTS,4.614430883875198,0.032143295738653245,Other Types,ambrisentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Anaplastic Thyroid Cancer,BRD-K41567364-001-04-6::2.5::HTS,4.699162187395176,0.030602455977537663,Other Types,SB-334867,orexin receptor antagonist,"HCRTR1, HCRTR2"
Anaplastic Thyroid Cancer,BRD-K41567533-001-08-3::2.5::HTS,6.255162421572387,0.012674997282405318,Other Types,coumophos,cholinesterase inhibitor,
Anaplastic Thyroid Cancer,BRD-K41859756-001-06-8::2.5::HTS,5.96273271087794,0.014923075075852773,Other Types,NVP-AUY922,HSP inhibitor,"HSP90AA1, HSP90AB1"
Anaplastic Thyroid Cancer,BRD-K42352790-001-05-3::2.5::HTS,5.375440686524659,0.020790607696853116,Other Types,anandamide,cannabinoid receptor agonist,"CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1"
Anaplastic Thyroid Cancer,BRD-K42563464-001-01-9::2.5::HTS,5.000176952917891,0.02574792125757559,Other Types,YM-58483,calcium channel blocker,"TRPC3, TRPC5, TRPM4"
Anaplastic Thyroid Cancer,BRD-K42805893-001-04-9::2.5::HTS,3.9566123517912057,0.04717193107539233,Anaplastic Thyroid Cancer,osimertinib,EGFR inhibitor,EGFR
Anaplastic Thyroid Cancer,BRD-K43410529-001-02-3::2.5::HTS,4.877261275479189,0.027627460667353793,Other Types,MLN2480,RAF inhibitor,
Anaplastic Thyroid Cancer,BRD-K44366189-001-01-9::2.5::HTS,4.671854637606045,0.0310823493812993,Anaplastic Thyroid Cancer,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Anaplastic Thyroid Cancer,BRD-K45033733-001-12-2::2.5::HTS,8.80385923844356,0.0031361917265631516,Other Types,famciclovir,DNA polymerase inhibitor,
Anaplastic Thyroid Cancer,BRD-K45293975-001-02-0::2.5::HTS,4.839623015273748,0.02823119680820864,Other Types,7-hydroxystaurosporine,"CDK inhibitor, CHK inhibitor, PKC inhibitor","CHEK1, MARK3, PDPK1"
Anaplastic Thyroid Cancer,BRD-K46133855-304-03-8::2.5::HTS,5.2526400700214655,0.022293217726731155,Other Types,NXY-059,free radical scavenger,
Anaplastic Thyroid Cancer,BRD-K46384212-001-02-9::2.5::HTS,6.597337716845679,0.010474434945238328,Other Types,o-3M3FBS,phospholipase activator,
Anaplastic Thyroid Cancer,BRD-K46914825-300-01-0::2.5::HTS,4.201056032169974,0.040869949746728085,Other Types,zimelidine,selective serotonin reuptake inhibitor (SSRI),"MAOA, MAOB, SLC6A4"
Anaplastic Thyroid Cancer,BRD-K46982791-001-09-4::2.5::HTS,4.142229078973596,0.04229894223927402,Other Types,cloxyquin,potassium channel activator,KCNK18
Anaplastic Thyroid Cancer,BRD-K47832606-001-30-1::2.5::HTS,7.489941463108332,0.00640364262152022,Other Types,floxuridine,DNA synthesis inhibitor,TYMS
Anaplastic Thyroid Cancer,BRD-K48173020-001-01-8::2.5::HTS,4.119586334189782,0.0428642897938406,Other Types,ameltolide,anticonvulsant,
Anaplastic Thyroid Cancer,BRD-K49215523-001-04-2::2.5::HTS,4.626358326041872,0.03191772208210405,Other Types,GSK2636771,PI3K inhibitor,PIK3CB
Anaplastic Thyroid Cancer,BRD-K49328571-001-15-0::2.5::HTS,7.778571842060072,0.005469444504895404,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Anaplastic Thyroid Cancer,BRD-K49880111-236-09-2::2.5::HTS,9.27710339440438,0.0024301549460616057,Other Types,cephapirin,bacterial cell wall synthesis inhibitor,
Anaplastic Thyroid Cancer,BRD-K50293352-300-02-1::2.5::HTS,4.809707264166164,0.028711067524581326,Other Types,MM77,serotonin receptor antagonist,HTR1A
Anaplastic Thyroid Cancer,BRD-K50325075-001-02-1::2.5::HTS,4.061378720588801,0.04435365752892884,Other Types,UCL-2077,slow afterhyperpolarization channel blocker,
Anaplastic Thyroid Cancer,BRD-K50422030-001-05-3::2.5::HTS,4.833948291398202,0.028318849637313855,Other Types,clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1
Anaplastic Thyroid Cancer,BRD-K50938786-003-11-8::2.5::HTS,4.4241413574395105,0.03587861924486552,Other Types,ropivacaine,sodium channel blocker,SCN10A
Anaplastic Thyroid Cancer,BRD-K51318897-001-15-3::2.5::HTS,4.486150765706925,0.03462759763551194,Other Types,fenbendazole,tubulin polymerization inhibitor,TUBB
Anaplastic Thyroid Cancer,BRD-K51333959-003-01-3::2.5::HTS,3.9501426633647254,0.047352288726102254,Other Types,siramesine,sigma receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Anaplastic Thyroid Cancer,BRD-K51350053-048-16-5::2.5::HTS,8.318134393719713,0.00407555253821814,Other Types,toremifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",ESR1
Anaplastic Thyroid Cancer,BRD-K52559566-001-02-9::2.5::HTS,6.991418122145408,0.008425695034762185,Other Types,monosodium-alpha-luminol,,
Anaplastic Thyroid Cancer,BRD-K52818472-001-02-2::2.5::HTS,4.044164536246371,0.04480563768088937,Other Types,ivacaftor,CFTR channel potentiator,CFTR
Anaplastic Thyroid Cancer,BRD-K53414658-001-08-2::2.5::HTS,4.557351466139158,0.033228101911736176,Other Types,tivozanib,VEGFR inhibitor,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Anaplastic Thyroid Cancer,BRD-K54028654-001-02-6::2.5::HTS,4.9244622506715645,0.0268946578361276,Other Types,cabaletta,pharmacological chaperone,
Anaplastic Thyroid Cancer,BRD-K54095730-001-03-1::2.5::HTS,4.738247271114468,0.029918364226364486,Other Types,CMPD-1,p38 MAPK inhibitor,"GNRHR, MAPK14"
Anaplastic Thyroid Cancer,BRD-K58501140-002-01-0::2.5::HTS,5.553531174041208,0.018786864046081035,Other Types,TAK-875,insulin secretagogue,FFAR1
Anaplastic Thyroid Cancer,BRD-K59524082-001-01-3::2.5::HTS,3.914777299157572,0.04835290259693026,Other Types,maribavir,"cytomegalovirus inhibitor, protein kinase inhibitor",PYGM
Anaplastic Thyroid Cancer,BRD-K59632282-052-03-1::2.5::HTS,3.898043373047834,0.048831547072178697,Other Types,quinidine,sodium channel blocker,"KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4"
Anaplastic Thyroid Cancer,BRD-K60348325-065-09-9::2.5::HTS,3.874679426532609,0.04952513749791491,Other Types,brilliant-green,,
Anaplastic Thyroid Cancer,BRD-K61295575-001-03-6::2.5::HTS,5.6070991048262036,0.01822537522700554,Other Types,blebbistatin-(-),ATPase inhibitor,
Anaplastic Thyroid Cancer,BRD-K62200014-003-10-5::2.5::HTS,8.74985242830732,0.0032291621132304765,Other Types,anagrelide,phosphodiesterase inhibitor,PDE3A
Anaplastic Thyroid Cancer,BRD-K62562723-003-02-7::2.5::HTS,4.139970338657773,0.04235077111687197,Other Types,SR-2640,leukotriene receptor antagonist,CYSLTR1
Anaplastic Thyroid Cancer,BRD-K64557645-001-02-4::2.5::HTS,11.619374273083906,0.0006994608020036325,Other Types,zotepine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4"
Anaplastic Thyroid Cancer,BRD-K64636206-001-02-7::2.5::HTS,5.05162054918168,0.025001307018892856,Other Types,D-alpha-tocopheryl-succinate,,
Anaplastic Thyroid Cancer,BRD-K66094457-001-01-5::2.5::HTS,7.262890543375152,0.00725910117690575,Other Types,CPP,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Anaplastic Thyroid Cancer,BRD-K66715657-050-01-0::2.5::HTS,4.026356056811992,0.04528181107199015,Other Types,UH-232-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4, HTR1A"
Anaplastic Thyroid Cancer,BRD-K67121414-001-03-3::2.5::HTS,5.27816118341996,0.021967794019082377,Other Types,apixaban,coagulation factor inhibitor,F10
Anaplastic Thyroid Cancer,BRD-K67277431-002-10-5::2.5::HTS,9.102700053962067,0.002670411000919413,Other Types,picotamide,"thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXA2R
Anaplastic Thyroid Cancer,BRD-K67578145-001-09-7::2.38::HTS,18.329618669862658,2.2071580094772307e-05,Other Types,GDC-0879,RAF inhibitor,BRAF
Anaplastic Thyroid Cancer,BRD-K67578145-001-12-1::2.5::HTS,6.051670662368744,0.014197391123690563,Other Types,GDC-0879,RAF inhibitor,BRAF
Anaplastic Thyroid Cancer,BRD-K67901620-001-02-0::2.5::HTS,5.450199145208448,0.019918636108537915,Anaplastic Thyroid Cancer,avasimibe,ACAT inhibitor,CES1
Anaplastic Thyroid Cancer,BRD-K68392338-003-02-0::2.5::HTS,5.802589728955224,0.016324446027753542,Anaplastic Thyroid Cancer,ZK-93426,benzodiazepine receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA5"
Anaplastic Thyroid Cancer,BRD-K69812556-305-02-0::2.5::HTS,4.302903226052053,0.038505292942896945,Other Types,WAY-100635,serotonin receptor antagonist,HTR1A
Anaplastic Thyroid Cancer,BRD-K69932463-001-10-6::2.5::HTS,4.423356456351779,0.03590061805471893,Other Types,AZD8055,mTOR inhibitor,MTOR
Anaplastic Thyroid Cancer,BRD-K71281111-001-04-3::2.5::HTS,3.893915656014027,0.04895256792989317,Other Types,SNX-2112,HSP inhibitor,
Anaplastic Thyroid Cancer,BRD-K71799949-001-36-4::2.5::HTS,4.085131891273037,0.043737331134718976,Other Types,carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Anaplastic Thyroid Cancer,BRD-K72231366-001-02-3::2.5::HTS,4.091963632709595,0.04356053789479083,Other Types,TAME,,
Anaplastic Thyroid Cancer,BRD-K72815923-034-01-2::2.5::HTS,7.522744118761302,0.006287853250712417,Other Types,xanomeline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Anaplastic Thyroid Cancer,BRD-K73440166-001-01-3::2.5::HTS,4.100753907403368,0.043336326853444296,Other Types,cinaciguat,guanylate cyclase activator,"GUCY1A3, GUCY1B3"
Anaplastic Thyroid Cancer,BRD-K73541271-001-03-6::2.5::HTS,4.701355401418824,0.0305653119370659,Other Types,etofenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Anaplastic Thyroid Cancer,BRD-K74305673-001-06-2::2.5::HTS,3.998564162583008,0.04602863131560571,Other Types,IKK-2-inhibitor-V,"IKK inhibitor, NFkB pathway inhibitor",IKBKB
Anaplastic Thyroid Cancer,BRD-K74763371-002-04-0::2.5::HTS,4.781488176105168,0.02917883391188793,Other Types,bosentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Anaplastic Thyroid Cancer,BRD-K76205745-237-16-5::2.5::HTS,4.521152326197639,0.03392296706977685,Other Types,losartan,angiotensin receptor antagonist,AGTR1
Anaplastic Thyroid Cancer,BRD-K76304753-003-20-3::2.5::HTS,5.6054307387802265,0.01825767242763741,Other Types,phenazopyridine,local anesthetic,SCN1A
Anaplastic Thyroid Cancer,BRD-K76677554-003-02-1::2.5::HTS,6.510141643292764,0.010989753517715986,Other Types,AJ76-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Anaplastic Thyroid Cancer,BRD-K76810206-001-08-1::2.5::HTS,4.761830075718986,0.029510966792420042,Other Types,nicergoline,adrenergic receptor antagonist,ADRA1A
Anaplastic Thyroid Cancer,BRD-K76908866-001-07-6::2.5::HTS,5.418910859328606,0.0202751003831197,Other Types,CP-724714,"EGFR inhibitor, protein tyrosine kinase inhibitor",ERBB2
Anaplastic Thyroid Cancer,BRD-K76973696-001-12-6::2.01::HTS,6.9045644350233415,0.008835850840495492,Other Types,tryptanthrin,cyclooxygenase inhibitor,IDO1
Anaplastic Thyroid Cancer,BRD-K77171813-034-01-8::2.5::HTS,4.19138422131427,0.041101899379051086,Other Types,proxyfan,histamine receptor modulator,HRH3
Anaplastic Thyroid Cancer,BRD-K77396579-300-01-0::2.5::HTS,6.50581590401049,0.011021503145552149,Other Types,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4
Anaplastic Thyroid Cancer,BRD-K77638923-001-02-0::2.5::HTS,5.0802208573894605,0.02460116056031871,Other Types,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Anaplastic Thyroid Cancer,BRD-K77821588-364-01-2::2.5::HTS,8.05058342861834,0.004717945340859658,Other Types,azatadine,histamine receptor antagonist,HRH1
Anaplastic Thyroid Cancer,BRD-K77841042-001-14-1::2.5::HTS,4.136682032138726,0.04244100279781907,Other Types,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Anaplastic Thyroid Cancer,BRD-K77947974-001-16-3::2.5::HTS,4.664846644024846,0.03121758472244092,Other Types,fluspirilene,dopamine receptor antagonist,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A"
Anaplastic Thyroid Cancer,BRD-K77987382-001-13-2::2.5::HTS,4.806493244326167,0.028761994039188447,Other Types,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Anaplastic Thyroid Cancer,BRD-K78086729-001-02-7::2.5::HTS,6.306509717158161,0.012308946841933581,Other Types,GW-788388,ALK tyrosine kinase receptor inhibitor,"LCK, MAPK14, TGFBR1"
Anaplastic Thyroid Cancer,BRD-K78567475-001-01-4::2.5::HTS,6.090126354564729,0.013896085619238314,Other Types,dolastatin-10,tubulin polymerization inhibitor,TUBB
Anaplastic Thyroid Cancer,BRD-K78659596-001-03-9::2.5::HTS,4.3490580745081,0.037488170541983196,Other Types,ixazomib,proteasome inhibitor,
Anaplastic Thyroid Cancer,BRD-K78666826-003-01-6::2.5::HTS,6.841079547733708,0.009149986119112148,Other Types,procaterol,adrenergic receptor agonist,ADRB2
Anaplastic Thyroid Cancer,BRD-K78720403-001-01-6::2.5::HTS,4.656127661887888,0.03136815166154553,Other Types,SB-328437,CCR antagonist,
Anaplastic Thyroid Cancer,BRD-K79131256-001-17-9::2.5::HTS,5.99440188766568,0.014655963364156858,Other Types,albendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Anaplastic Thyroid Cancer,BRD-K79501723-001-04-6::2.5::HTS,6.102614694276803,0.013799314652379869,Other Types,cyclizine,histamine receptor modulator,"HRH1, SULT1E1"
Anaplastic Thyroid Cancer,BRD-K79753741-001-01-7::2.5::HTS,4.152033856225823,0.04205913776114255,Other Types,UBP-302,glutamate receptor antagonist,GRIK1
Anaplastic Thyroid Cancer,BRD-K81473089-003-26-1::2.5::HTS,4.2439533064308375,0.03986982887396301,Other Types,tacrine,acetylcholinesterase inhibitor,"ACHE, BCHE"
Anaplastic Thyroid Cancer,BRD-K81729199-001-02-8::2.5::HTS,9.972963914161186,0.0016742846472444068,Other Types,AQ-RA741,acetylcholine receptor antagonist,CHRM2
Anaplastic Thyroid Cancer,BRD-K82002057-001-01-2::2.5::HTS,4.268328498461368,0.03928927067322692,Other Types,DFB,glutamate receptor agonist,GRM5
Anaplastic Thyroid Cancer,BRD-K82036761-003-20-3::2.5::HTS,4.022848847105046,0.045368375829791224,Other Types,sertraline,selective serotonin reuptake inhibitor (SSRI),"SLC6A3, SLC6A4"
Anaplastic Thyroid Cancer,BRD-K82234479-001-09-4::2.5::HTS,5.2120791013069345,0.022820409163682182,Other Types,tramiprosate,beta amyloid protein neurotoxicity inhibitor,APP
Anaplastic Thyroid Cancer,BRD-K82381502-003-23-1::2.5::HTS,5.75131729715134,0.016801377795105262,Other Types,acetylcholine,acetylcholine receptor agonist,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Anaplastic Thyroid Cancer,BRD-K82983861-001-04-3::2.5::HTS,4.94015901142087,0.026638903687067738,Other Types,GW-0742,PPAR receptor agonist,PPARD
Anaplastic Thyroid Cancer,BRD-K83189926-001-03-1::2.5::HTS,8.565284829789437,0.003564919481413234,Other Types,UNC1215,L3MBTL antagonist,L3MBTL3
Anaplastic Thyroid Cancer,BRD-K83766205-001-03-8::2.5::HTS,4.66558623726799,0.031199597221618563,Anaplastic Thyroid Cancer,metirosine,tyrosine hydroxylase inhibitor,TH
Anaplastic Thyroid Cancer,BRD-K83988098-001-02-0::2.5::HTS,4.388015593344837,0.03664763863581088,Other Types,alvespimycin,HSP inhibitor,HSP90AA1
Anaplastic Thyroid Cancer,BRD-K84748119-050-01-1::2.5::HTS,7.832734824759519,0.005312183225547557,Other Types,vicriviroc,CC chemokine receptor antagonist,CCR5
Anaplastic Thyroid Cancer,BRD-K85307935-236-09-5::2.5::HTS,6.525715129464623,0.010906312858871912,Other Types,novobiocin,bacterial DNA gyrase inhibitor,
Anaplastic Thyroid Cancer,BRD-K85751432-001-03-3::2.5::HTS,4.6439571297574105,0.03159959456209847,Other Types,refametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Anaplastic Thyroid Cancer,BRD-K86525559-001-07-8::2.52::HTS,3.9656308159910703,0.046952899777278186,Other Types,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Anaplastic Thyroid Cancer,BRD-K86972824-001-01-4::2.5::HTS,3.942282995545585,0.047593112725235635,Other Types,oltipraz,"nuclear factor erythroid derived, like (NRF2) activator",ANG
Anaplastic Thyroid Cancer,BRD-K87349602-001-03-8::2.5::HTS,4.3328724001549235,0.037835120746340004,Other Types,beta-CCB,benzodiazepine receptor ligand,"GABRA1, GABRG2"
Anaplastic Thyroid Cancer,BRD-K88510285-001-11-1::2.5::HTS,6.930690818448816,0.008707168436591122,Other Types,bortezomib,"NFkB pathway inhibitor, proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA"
Anaplastic Thyroid Cancer,BRD-K88677950-001-03-9::2.5::HTS,4.161930273015619,0.041812589126394614,Other Types,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Anaplastic Thyroid Cancer,BRD-K88759641-003-02-8::2.5::HTS,4.364253847961886,0.03715627546199974,Other Types,EMD-66684,angiotensin receptor antagonist,AGTR1
Anaplastic Thyroid Cancer,BRD-K89053832-001-01-0::2.5::HTS,8.194090444909314,0.004359957892012448,Other Types,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Anaplastic Thyroid Cancer,BRD-K89208535-051-01-5::2.5::HTS,4.634357104101233,0.031765118286355185,Other Types,indacaterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Anaplastic Thyroid Cancer,BRD-K89299012-001-06-0::2.5::HTS,8.029346320156861,0.004770891703900964,Other Types,DCEBIO,potassium channel activator,"KCNN2, KCNN3, KCNN4"
Anaplastic Thyroid Cancer,BRD-K90382497-001-10-7::2.5::HTS,9.082439125258151,0.002699229122792707,Other Types,GW-843682X,PLK inhibitor,"PLK1, PLK3"
Anaplastic Thyroid Cancer,BRD-K91370081-001-25-1::2.5::HTS,6.440974553929831,0.011424588158921709,Other Types,anisomycin,DNA synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Anaplastic Thyroid Cancer,BRD-K91822704-003-07-2::2.5::HTS,5.672268658728966,0.017576784309779724,Anaplastic Thyroid Cancer,torcitabine,DNA polymerase inhibitor,"DCK, TK2"
Anaplastic Thyroid Cancer,BRD-K92301463-001-05-5::0.25::HTS,6.804588446706861,0.009334755827274444,Anaplastic Thyroid Cancer,"16,16-dimethylprostaglandin-e2",prostanoid receptor agonist,HPGD
Anaplastic Thyroid Cancer,BRD-K92731339-227-04-9::2.5::HTS,4.0559720712885525,0.04449568752980386,Other Types,perindopril,angiotensin converting enzyme inhibitor,ACE
Anaplastic Thyroid Cancer,BRD-K92760278-001-07-3::2.43::HTS,4.8885408191991155,0.027463297427272527,Other Types,riboflavin,vitamin B2,"BLVRB, RFK"
Anaplastic Thyroid Cancer,BRD-K93255255-001-02-1::2.5::HTS,4.148959272092165,0.04213327173129042,Anaplastic Thyroid Cancer,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Anaplastic Thyroid Cancer,BRD-K94239562-001-05-5::2.5::HTS,4.399869029885623,0.036394197492617415,Other Types,paeonol,anti-inflammatory agent,
Anaplastic Thyroid Cancer,BRD-K95435023-001-08-5::2.5::HTS,5.497919696662743,0.0194086030791525,Other Types,PHA-665752,c-Met inhibitor,MET
Anaplastic Thyroid Cancer,BRD-K95773607-004-03-8::2.5::HTS,3.9986700721521893,0.0460170421152918,Other Types,darifenacin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Anaplastic Thyroid Cancer,BRD-K96104201-001-01-5::2.5::HTS,5.864452823269467,0.015767975302019867,Other Types,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,
Anaplastic Thyroid Cancer,BRD-K96358241-001-01-9::0.94::HTS,4.102215387597429,0.04330340944748043,Other Types,harringtonine,protein synthesis inhibitor,
Anaplastic Thyroid Cancer,BRD-K97010173-001-04-1::2.5::HTS,4.512678046088667,0.03408124771690802,Anaplastic Thyroid Cancer,deferasirox,chelating agent,CYP3A4
Anaplastic Thyroid Cancer,BRD-K97799481-230-01-7::2.5::HTS,5.954406830642729,0.014995798105880736,Other Types,aminophylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D"
Anaplastic Thyroid Cancer,BRD-K97884852-001-05-4::2.5::HTS,8.941609684834031,0.0029095397928722284,Other Types,malotilate,protein synthesis stimulant,
Anaplastic Thyroid Cancer,BRD-K98572433-001-02-9::2.5::HTS,4.666372226582749,0.031182391376388046,Anaplastic Thyroid Cancer,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Anaplastic Thyroid Cancer,BRD-K99451608-001-07-3::2.5::HTS,5.302082607557108,0.02166635546726814,Other Types,lopinavir,HIV protease inhibitor,
Anaplastic Thyroid Cancer,BRD-K99504665-001-01-2::2.5::HTS,4.814156096426475,0.028635501172010015,Other Types,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,"GNRHR, LHCGR"
Anaplastic Thyroid Cancer,BRD-M77041484-001-01-8::2.5::HTS,5.935191719525547,0.015157195642035022,Other Types,TBOA-(DL),excitatory amino acid transporter inhibitor,"SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7"
Anaplastic Thyroid Cancer,BRD-A44181516-001-01-8::2.666476303::MTS004,4.082203499109615,0.04383207840200389,Other Types,flumecinol,,
Anaplastic Thyroid Cancer,BRD-K10995081-001-27-9::2.316458322::MTS004,5.886326220695913,0.015585965818944775,Other Types,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Anaplastic Thyroid Cancer,BRD-K17828029-001-01-5::2.536141856::MTS004,5.802451184725046,0.016338927877977142,Other Types,cinoxate,,
Anaplastic Thyroid Cancer,BRD-K20463415-300-01-4::2.499966791::MTS004,3.881367844621466,0.04933623542888612,Other Types,LY2606368,CHK inhibitor,CHEK1
Anaplastic Thyroid Cancer,BRD-K33131085-001-07-2::2.644499841::MTS004,4.040088470830268,0.04493019012911442,Anaplastic Thyroid Cancer,gentiopicrin,glutamate receptor downregulator,GRIN2B
Anaplastic Thyroid Cancer,BRD-K49372556-001-04-1::2.5::MTS004,3.9154629906518927,0.04835241083485682,Other Types,mofezolac,cyclooxygenase inhibitor,PTGS1
Anaplastic Thyroid Cancer,BRD-K57886322-001-16-6::2.5::MTS004,8.617262834283908,0.003472256948272809,Anaplastic Thyroid Cancer,fluocinonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6, SMO"
Anaplastic Thyroid Cancer,BRD-K76315403-015-02-5::2.5::MTS004,6.401875411651249,0.011683605915298037,Other Types,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,"GNRHR, LHCGR"
Endometrial Carcinoma,BRD-A01643550-001-04-9::2.5::HTS,6.90352523751385,0.008847595529544257,Other Types,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Endometrial Carcinoma,BRD-A07704283-001-01-3::2.5::HTS,6.897530011531843,0.00886981437373601,Other Types,isofloxythepin,dopamine receptor antagonist,
Endometrial Carcinoma,BRD-A08545410-311-03-4::2.5::HTS,4.022142126628213,0.04541640166260818,Other Types,doxycycline,metalloproteinase inhibitor,MMP8
Endometrial Carcinoma,BRD-A16439188-001-01-1::2.5::HTS,4.432327579218887,0.035710725102031535,Other Types,quinestrol,estrogen receptor agonist,ESR1
Endometrial Carcinoma,BRD-A17462676-003-11-6::2.5::HTS,4.63490467934446,0.03175430551703913,Endometrial Carcinoma,bambuterol,adrenergic receptor agonist,"ADRB2, BCHE"
Endometrial Carcinoma,BRD-A18043272-001-09-9::2.5::HTS,4.1051118049479856,0.04322730969455205,Endometrial Carcinoma,phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Endometrial Carcinoma,BRD-A26032986-050-02-1::2.5::HTS,4.205916859620165,0.040748840478566854,Other Types,zaldaride,calmodulin antagonist,CALM1
Endometrial Carcinoma,BRD-A26503646-001-16-6::2.5::HTS,5.666598968203151,0.017623312153098012,Other Types,formestane,aromatase inhibitor,CYP19A1
Endometrial Carcinoma,BRD-A31095847-001-02-3::2.5::HTS,6.800035999413268,0.00936137879651909,Other Types,mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2"
Endometrial Carcinoma,BRD-A35989968-001-04-2::2.5::HTS,6.3340445123590445,0.01212545343435412,Other Types,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Endometrial Carcinoma,BRD-A37288617-003-02-2::2.5::HTS,4.346849113753629,0.037528256501670465,Endometrial Carcinoma,amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3"
Endometrial Carcinoma,BRD-A37347161-003-02-6::2.5::HTS,4.550482556298539,0.03334433286577912,Endometrial Carcinoma,BRL-52537,opioid receptor agonist,OPRK1
Endometrial Carcinoma,BRD-A40084411-003-07-7::2.5::HTS,3.967593684330137,0.04688164060923383,Other Types,CGP-12177,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Endometrial Carcinoma,BRD-A40940854-001-01-1::2.5::HTS,5.167772289579233,0.02338961037169975,Other Types,ibuproxam,"cyclooxygenase inhibitor, prostaglandin inhibitor",ALOX5
Endometrial Carcinoma,BRD-A47953250-001-01-7::2.5::HTS,5.361830056825557,0.02095665118839509,Other Types,ecamsule-triethanolamine,,
Endometrial Carcinoma,BRD-A50311610-300-10-4::2.5::HTS,12.059978816567675,0.0005559951733439018,Other Types,meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3"
Endometrial Carcinoma,BRD-A50998626-001-02-1::2.5::HTS,4.888611377432018,0.02744133473663436,Other Types,palomid-529,"AKT inhibitor, mTOR inhibitor",MTOR
Endometrial Carcinoma,BRD-A51407134-001-01-9::2.5::HTS,17.193819482833483,3.9322161850781286e-05,Other Types,2-octyldodecan-1-ol,,
Endometrial Carcinoma,BRD-A52588987-004-08-2::2.5::HTS,5.813139468533079,0.01622840749842043,Other Types,SKF-83566,dopamine receptor antagonist,"DRD1, DRD5"
Endometrial Carcinoma,BRD-A57133233-003-11-0::2.5::HTS,6.755256632634997,0.009596237690339128,Other Types,chlorcyclizine,histamine receptor antagonist,HRH1
Endometrial Carcinoma,BRD-A62057054-001-03-1::2.5::HTS,6.318487710200116,0.012228511862574367,Endometrial Carcinoma,MDL-11939,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Endometrial Carcinoma,BRD-A64064900-001-02-3::2.5::HTS,6.349820319976832,0.012023450951612735,Other Types,sangivamycin,DNA inhibitor,
Endometrial Carcinoma,BRD-A64227845-004-09-3::2.5::HTS,6.399779488327365,0.011685573857033215,Other Types,SKF-77434,dopamine receptor agonist,DRD1
Endometrial Carcinoma,BRD-A67097164-001-18-7::2.5::HTS,5.8684143253031475,0.01573579926076558,Other Types,ifosfamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1"
Endometrial Carcinoma,BRD-A68888262-003-15-1::2.5::HTS,4.095527506625562,0.04347117774682337,Endometrial Carcinoma,azelastine,histamine receptor antagonist,HRH1
Endometrial Carcinoma,BRD-A70858459-001-01-7::2.5::HTS,7.1564778013669805,0.007687796609450614,Other Types,estramustine,DNA alkylating agent,"ESR1, ESR2, MAP1A, MAP2"
Endometrial Carcinoma,BRD-A72703248-003-04-9::2.5::HTS,7.649478384554211,0.005867280810904084,Other Types,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Endometrial Carcinoma,BRD-A81129465-001-03-8::2.5::HTS,4.808583743723184,0.028744918754924104,Other Types,fenoprofen,prostaglandin inhibitor,"PTGS1, PTGS2, SLC5A8"
Endometrial Carcinoma,BRD-A86619021-001-04-8::2.5::HTS,4.075856248161882,0.04397882851897353,Other Types,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Endometrial Carcinoma,BRD-A93477898-001-04-2::2.5::HTS,4.883268850918819,0.02752635814486879,Other Types,PETCM,caspase activator,CASP3
Endometrial Carcinoma,BRD-A94993966-001-04-4::2.5::HTS,4.315871208757073,0.03821194707836673,Endometrial Carcinoma,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Endometrial Carcinoma,BRD-A97739905-001-26-5::2.5::HTS,5.823168499629591,0.016150293499476776,Endometrial Carcinoma,ketoprofen,cyclooxygenase inhibitor,"CXCR1, PTGS1, PTGS2, SLC5A8"
Endometrial Carcinoma,BRD-K00312224-001-09-5::2.5::HTS,4.431165654771616,0.035739702676344645,Other Types,PPT,estrogen receptor agonist,ESR1
Endometrial Carcinoma,BRD-K00573984-003-01-5::2.5::HTS,4.188134987718498,0.04118098987537914,Endometrial Carcinoma,delapril,angiotensin converting enzyme inhibitor,ACE
Endometrial Carcinoma,BRD-K01507359-001-22-9::2.5::HTS,4.870365220819049,0.02775124837689117,Other Types,rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3"
Endometrial Carcinoma,BRD-K01624185-001-05-7::2.5::HTS,5.558998287949652,0.018733858752225236,Other Types,maltobionic-acid,matrix metalloprotease inhibitor,
Endometrial Carcinoma,BRD-K02241333-001-02-7::2.5::HTS,6.396170629651875,0.011711040204139146,Other Types,CHIR-124,CHK inhibitor,CHEK1
Endometrial Carcinoma,BRD-K03063480-001-05-8::2.5::HTS,7.694130818936825,0.005724163212465293,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Endometrial Carcinoma,BRD-K03063480-001-06-6::2.42::HTS,10.431450896419571,0.0013159755371284715,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Endometrial Carcinoma,BRD-K03390685-001-01-7::2.5::HTS,9.05581791144591,0.002737722908538778,Endometrial Carcinoma,cobimetinib,MEK inhibitor,
Endometrial Carcinoma,BRD-K04552268-001-02-4::5::HTS,8.654093672439037,0.0034036023454133944,Other Types,4-pyrimidinecarbonitrile,,
Endometrial Carcinoma,BRD-K04851519-001-06-8::2.5::HTS,8.143194955782203,0.0044821955830657515,Endometrial Carcinoma,aloe-emodin,anticancer agent,CASP8
Endometrial Carcinoma,BRD-K05445342-001-05-3::2.57::HTS,5.509046428611963,0.01928681030497685,Other Types,WP1066,STAT inhibitor,STAT3
Endometrial Carcinoma,BRD-K06543683-066-02-1::2.5::HTS,14.205853646411047,0.00018127782428817646,Other Types,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Endometrial Carcinoma,BRD-K07487750-001-03-3::2.5::HTS,4.149366492058227,0.04212152083184181,Other Types,WHI-P154,JAK inhibitor,"EGFR, JAK1, JAK2, JAK3"
Endometrial Carcinoma,BRD-K08111712-001-16-7::2.5::HTS,5.7775101261535875,0.0165600419492384,Other Types,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55
Endometrial Carcinoma,BRD-K08893438-001-04-9::2.52::HTS,4.812321370645293,0.028700525902067925,Other Types,CCG-50014,G protein signaling inhibitor,"RGS4, RGS8"
Endometrial Carcinoma,BRD-K09090949-001-01-9::2.5::HTS,8.162688661251796,0.0044412161814747384,Other Types,"CP-945,598",cannabinoid receptor antagonist,CNR1
Endometrial Carcinoma,BRD-K09372874-001-01-0::2.5::HTS,4.174592108036688,0.04152021906094674,Other Types,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
Endometrial Carcinoma,BRD-K09426783-300-01-0::2.5::HTS,12.900410939039842,0.0003585584817353582,Other Types,TAS-103,topoisomerase inhibitor,TOP1
Endometrial Carcinoma,BRD-K10071630-001-01-0::2.5::HTS,4.0715732642626445,0.04408620191369575,Other Types,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Endometrial Carcinoma,BRD-K10362825-001-03-4::2.5::HTS,8.400082947345378,0.003907976992149732,Other Types,teniposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Endometrial Carcinoma,BRD-K10673031-004-02-0::2.5::HTS,9.344331894063805,0.002343643598302146,Endometrial Carcinoma,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Endometrial Carcinoma,BRD-K10784860-003-02-3::2.5::HTS,4.559190006164181,0.03318055122753632,Other Types,temocapril,angiotensin converting enzyme inhibitor,ACE
Endometrial Carcinoma,BRD-K11900042-001-14-4::2.5::HTS,5.698042878978282,0.017327607294258977,Other Types,methylthiouracil,,
Endometrial Carcinoma,BRD-K11911061-003-11-9::2.5::HTS,6.562064863576374,0.010678208952456025,Other Types,GR-127935,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6"
Endometrial Carcinoma,BRD-K12040459-001-06-0::2.5::HTS,6.092045321110223,0.013878448574093004,Other Types,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Endometrial Carcinoma,BRD-K12343256-001-08-9::2.5::HTS,6.985796514211791,0.008446753735994978,Endometrial Carcinoma,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Endometrial Carcinoma,BRD-K12502280-001-08-0::2.5::HTS,5.975498233412349,0.014825283175645175,Other Types,TG-101348,"FLT3 inhibitor, JAK inhibitor","BRD4, JAK1, JAK2, JAK3, TYK2"
Endometrial Carcinoma,BRD-K12867552-001-04-7::2.5::HTS,11.621276567385115,0.0007007996583472322,Other Types,PCI-24781,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6"
Endometrial Carcinoma,BRD-K13169950-001-14-4::2.5::HTS,8.560056169217898,0.0035770415637107165,Other Types,NSC-3852,HDAC inhibitor,HDAC1
Endometrial Carcinoma,BRD-K13238168-001-02-0::2.5::HTS,4.2398679963610535,0.03994543485796414,Other Types,haloprogin,other antifungal,
Endometrial Carcinoma,BRD-K13390322-001-06-3::2.5::HTS,6.71437177260925,0.009819671982253714,Other Types,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Endometrial Carcinoma,BRD-K13810148-311-03-2::2.5::HTS,6.219724197561413,0.01291976663483801,Other Types,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Endometrial Carcinoma,BRD-K14618467-001-04-6::2.5::HTS,3.9189647433811188,0.048231732633685305,Other Types,IKK-16,IKK inhibitor,IKBKB
Endometrial Carcinoma,BRD-K14763542-001-02-3::2.5::HTS,5.105286103211995,0.024259875183752395,Other Types,flurothyl,,
Endometrial Carcinoma,BRD-K15025317-001-15-1::2.5::HTS,7.73299885260241,0.005606543980715439,Other Types,BAY-11-7082,NFkB pathway inhibitor,RELA
Endometrial Carcinoma,BRD-K15409150-001-05-8::2.5::HTS,4.198467900210008,0.040944139621755506,Other Types,penfluridol,T-type calcium channel blocker,CACNA1G
Endometrial Carcinoma,BRD-K15600710-066-04-1::2.5::HTS,4.512925542925487,0.03408188369479013,Other Types,obatoclax,BCL inhibitor,BCL2
Endometrial Carcinoma,BRD-K15834839-001-02-3::2.5::HTS,4.531858281883534,0.033707593989792055,Other Types,lobendazole,anthelmintic agent,
Endometrial Carcinoma,BRD-K16508793-001-05-9::2.5::HTS,4.507565658143368,0.03418398671557092,Other Types,diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Endometrial Carcinoma,BRD-K17294426-050-12-3::2.5::HTS,4.209986320482289,0.04064946697899965,Endometrial Carcinoma,clebopride,dopamine receptor antagonist,"ACHE, DRD2"
Endometrial Carcinoma,BRD-K17498618-344-02-6::2.5::HTS,4.345518842650572,0.03755896249432977,Other Types,betaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Endometrial Carcinoma,BRD-K17979676-001-01-2::2.5::HTS,6.278459120842069,0.012515121410310642,Other Types,eprobemide,monoamine oxidase inhibitor,MAOA
Endometrial Carcinoma,BRD-K18157228-001-01-7::2.5::HTS,4.085727409128902,0.04372203807890059,Endometrial Carcinoma,fdcyd,DNA methyltransferase inhibitor,
Endometrial Carcinoma,BRD-K18574842-323-10-8::2.51::HTS,5.57145396095483,0.01861823023501387,Other Types,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Endometrial Carcinoma,BRD-K18779551-003-07-8::2.5::HTS,5.446961355690897,0.019954589751259952,Other Types,bifemelane,acetylcholine release enhancer,"MAOA, MAOB"
Endometrial Carcinoma,BRD-K18787491-001-08-6::2.5::HTS,5.298349011338165,0.021715714797231916,Endometrial Carcinoma,U-0126,MEK inhibitor,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
Endometrial Carcinoma,BRD-K19601669-001-03-5::2.5::HTS,6.187363672337909,0.013155452373923768,Endometrial Carcinoma,ruxolitinib-(S),JAK inhibitor,"JAK1, JAK2"
Endometrial Carcinoma,BRD-K19615002-001-02-3::2.5::HTS,4.391820284767314,0.03656252926171516,Other Types,creatine,,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8"
Endometrial Carcinoma,BRD-K19761926-001-03-6::2.45::HTS,4.162482099994258,0.04181567001881655,Other Types,eplerenone,cytochrome P450 inhibitor,NR3C2
Endometrial Carcinoma,BRD-K23190681-001-01-1::2.5::HTS,10.153821921533325,0.0015211412280395128,Other Types,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Endometrial Carcinoma,BRD-K23779958-001-05-8::2.5::HTS,6.1837165444294175,0.013200994812314225,Other Types,dichlorvos,acetylcholinesterase inhibitor,
Endometrial Carcinoma,BRD-K24187789-001-01-7::2.5::HTS,5.419723557061549,0.020266395442375858,Other Types,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
Endometrial Carcinoma,BRD-K24715592-406-02-1::2.53::HTS,4.872111523140835,0.027723445888376556,Endometrial Carcinoma,ethacridine-lactate-monohydrate,DNA intercalating agent,
Endometrial Carcinoma,BRD-K25412176-001-01-9::2.5::HTS,20.907348403820066,5.9505690335333886e-06,Other Types,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Endometrial Carcinoma,BRD-K25433859-003-25-4::2.5::HTS,6.33562856732048,0.012124785136813672,Other Types,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2"
Endometrial Carcinoma,BRD-K25837718-001-03-8::2.5::HTS,8.018093323513522,0.004802065178203016,Other Types,josamycin,bacterial 50S ribosomal subunit inhibitor,
Endometrial Carcinoma,BRD-K26253904-001-01-5::2.5::HTS,6.269019267255413,0.012571111298853058,Other Types,NMS-873,ATPase inhibitor,VCP
Endometrial Carcinoma,BRD-K26667523-001-02-5::2.5::HTS,4.234047161663586,0.04008822430747661,Endometrial Carcinoma,TAK-733,MEK inhibitor,MAP2K1
Endometrial Carcinoma,BRD-K27204852-001-01-9::2.5::HTS,5.5030773267436945,0.019344495428555118,Endometrial Carcinoma,balicatib,cathepsin inhibitor,CTSK
Endometrial Carcinoma,BRD-K27217864-001-22-3::2.5::HTS,4.112530293240009,0.043043805167132417,Other Types,butamben,sodium channel blocker,
Endometrial Carcinoma,BRD-K27406233-001-07-7::2.5::HTS,4.880878438466949,0.02756195467785539,Endometrial Carcinoma,acetyl-l-leucine,,
Endometrial Carcinoma,BRD-K27799744-001-02-8::2.52::HTS,7.152056684138152,0.007719870293227704,Other Types,cyclovirobuxin-d,calcium channel modulator,
Endometrial Carcinoma,BRD-K28824103-001-02-8::2.5::HTS,5.467906866548201,0.01974111568931871,Other Types,genipin,choleretic agent,
Endometrial Carcinoma,BRD-K30431096-004-01-3::2.5::HTS,4.822693579407984,0.028507228196891724,Other Types,domiphen,,
Endometrial Carcinoma,BRD-K30933884-001-01-0::2.5::HTS,12.277105813780306,0.0004952697582433931,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Endometrial Carcinoma,BRD-K31491153-003-05-9::2.5::HTS,6.271443205618749,0.012553610465046203,Other Types,1-phenylbiguanide,serotonin receptor agonist,"HTR3A, HTR3B"
Endometrial Carcinoma,BRD-K32318651-001-24-5::2.5::HTS,4.614691248643387,0.032144172706655726,Other Types,acyclovir,DNA polymerase inhibitor,PNP
Endometrial Carcinoma,BRD-K32372024-001-01-0::2.5::HTS,5.078732882126831,0.02463516997476555,Other Types,D-7193,,
Endometrial Carcinoma,BRD-K32730239-001-01-0::2.5::HTS,4.826333791133121,0.02843786514495175,Other Types,SU3327,JNK inhibitor,MAPK8
Endometrial Carcinoma,BRD-K33141550-003-05-7::2.5::HTS,4.259328570007173,0.03949547993504222,Endometrial Carcinoma,L-NAME,nitric oxide synthase inhibitor,NOS3
Endometrial Carcinoma,BRD-K33277808-331-01-3::2.5::HTS,3.9238625240809655,0.04809593734608215,Other Types,ouabain,ATPase inhibitor,ATP1A1
Endometrial Carcinoma,BRD-K33610132-001-02-9::2.5::HTS,7.944345935340906,0.004996506402489883,Other Types,rociletinib,EGFR inhibitor,EGFR
Endometrial Carcinoma,BRD-K34388247-236-08-2::2.5::HTS,4.711771502738828,0.03037844876725145,Other Types,methicillin,bacterial cell wall synthesis inhibitor,
Endometrial Carcinoma,BRD-K34730807-001-17-6::2.5::HTS,4.199352659667611,0.0409349185059251,Endometrial Carcinoma,levodopa,dopamine precursor,"DRD1, DRD2, DRD3, DRD4, DRD5, GPR143"
Endometrial Carcinoma,BRD-K35629949-001-02-0::2.5::HTS,5.214123328826628,0.02278324426067716,Other Types,SR-27897,CCK receptor antagonist,CCKAR
Endometrial Carcinoma,BRD-K36055864-001-19-2::2.5::HTS,6.37236435791585,0.011867329473586749,Other Types,cycloheximide,protein synthesis inhibitor,RPL3
Endometrial Carcinoma,BRD-K36207157-001-07-0::2.52::HTS,4.85365116050645,0.028018825957058898,Other Types,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Endometrial Carcinoma,BRD-K37069697-001-01-3::2.5::HTS,5.969396190705701,0.01486853206949275,Other Types,fexinidazole,,
Endometrial Carcinoma,BRD-K37682401-001-09-3::2.44::HTS,4.630761736338152,0.031856326073264656,Other Types,piromidic-acid,bacterial DNA gyrase inhibitor,
Endometrial Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,5.828898134794471,0.016083471694395078,Endometrial Carcinoma,AZD8330,MEK inhibitor,
Endometrial Carcinoma,BRD-K37764012-001-04-1::2.5::HTS,5.910637513455085,0.0153624333420598,Other Types,PF-03758309,p21 activated kinase inhibitor,PAK4
Endometrial Carcinoma,BRD-K38332599-001-01-3::2.5::HTS,4.448326121175844,0.03537957339847936,Other Types,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Endometrial Carcinoma,BRD-K38913877-300-01-9::2.5::HTS,6.959104407531101,0.008571662473240494,Endometrial Carcinoma,azimilide,potassium channel blocker,"KCNA5, KCNE1, KCNH2, KCNQ1"
Endometrial Carcinoma,BRD-K40255344-001-17-6::2.5::HTS,3.921486435945748,0.04815996424838098,Other Types,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Endometrial Carcinoma,BRD-K41260949-236-16-8::2.5::HTS,4.756131309556749,0.029620137318603842,Endometrial Carcinoma,valproic-acid,HDAC inhibitor,"ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A"
Endometrial Carcinoma,BRD-K41278234-001-03-0::2.5::HTS,7.7931955705563505,0.005425311796355937,Other Types,CUDC-101,EGFR inhibitor,"EGFR, ERBB2"
Endometrial Carcinoma,BRD-K42205652-001-02-7::2.5::HTS,7.928616534335153,0.0050366948789002655,Other Types,"MNS-(3,4-Methylenedioxy-nitrostyrene)","src inhibitor, syk inhibitor","SRC, SYK"
Endometrial Carcinoma,BRD-K42495768-001-01-7::2.5::HTS,5.277853561139754,0.02197575054543241,Other Types,tasisulam,apoptosis stimulant,
Endometrial Carcinoma,BRD-K43236057-001-07-1::2.6::HTS,5.482053757867828,0.01958365209363151,Other Types,polydatin,ICAM1 expression inhibitor,ICAM1
Endometrial Carcinoma,BRD-K43449605-001-01-0::2.5::HTS,4.216413722073452,0.04050362030986367,Other Types,oncrasin-1,apoptosis stimulant,
Endometrial Carcinoma,BRD-K45086103-001-16-3::2.5::HTS,5.0139190733035885,0.025553747560862566,Other Types,sulfaguanidine,bacterial antifolate,
Endometrial Carcinoma,BRD-K45152786-001-08-4::2.5::HTS,4.760470568121576,0.029546220865524768,Other Types,merbarone,topoisomerase inhibitor,TOP2A
Endometrial Carcinoma,BRD-K45528773-001-06-4::2.5::HTS,4.361114090877407,0.037236964516509256,Other Types,M-344,HDAC inhibitor,
Endometrial Carcinoma,BRD-K47376733-001-08-1::2.5::HTS,4.80750115363619,0.0287467870885114,Endometrial Carcinoma,JNJ-1661010,FAAH inhibitor,FAAH
Endometrial Carcinoma,BRD-K47869605-001-32-0::2.5::HTS,11.001207107201896,0.0009710907794147904,Other Types,podophyllotoxin,"microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB"
Endometrial Carcinoma,BRD-K48443249-001-01-0::2.5::HTS,8.547403819822568,0.003600325077333199,Other Types,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Endometrial Carcinoma,BRD-K48488978-001-05-3::2.5::HTS,4.284868580247777,0.038916738524299783,Other Types,YM-201636,PI3K inhibitor,
Endometrial Carcinoma,BRD-K49328571-001-15-0::2.5::HTS,4.766714436244418,0.029435570222116115,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Endometrial Carcinoma,BRD-K49865102-001-08-4::2.5::HTS,5.731054566376376,0.01700083287608389,Endometrial Carcinoma,PD-0325901,MEK inhibitor,MAP2K1
Endometrial Carcinoma,BRD-K49962337-001-02-9::2.56::HTS,5.193591908446587,0.02306866149705883,Other Types,baicalin,beta glucuronidase inhibitor,PREP
Endometrial Carcinoma,BRD-K50168500-001-07-9::2.5::HTS,4.894343872810039,0.02734973312344741,Other Types,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Endometrial Carcinoma,BRD-K51313569-003-03-3::2.5::HTS,9.791510318308001,0.001844941056238167,Endometrial Carcinoma,palbociclib,CDK inhibitor,"CDK4, CDK6"
Endometrial Carcinoma,BRD-K51747290-001-13-1::2.5::HTS,4.624174566280657,0.031968502111135846,Other Types,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Endometrial Carcinoma,BRD-K51918615-303-02-9::2.5::HTS,5.686251792318306,0.01743624371948707,Other Types,iodophenpropit,histamine receptor antagonist,"HRH3, HRH4"
Endometrial Carcinoma,BRD-K52080565-001-09-2::2.5::HTS,4.297255753527944,0.038629081902144306,Endometrial Carcinoma,nandrolone,imidazoline receptor agonist,"AR, CYP19A1, MAOA, MAOB"
Endometrial Carcinoma,BRD-K53397409-001-12-3::2.5::HTS,3.992691487129192,0.0461793727757928,Endometrial Carcinoma,benzoic-acid,food preservative,"DAO, HRSP12, PRDX5, RAB9A"
Endometrial Carcinoma,BRD-K53561341-001-07-5::2.5::HTS,4.698092988968201,0.03061828083281707,Other Types,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
Endometrial Carcinoma,BRD-K53857191-001-22-7::2.5::HTS,8.440819704679294,0.003819584390012754,Other Types,risperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7"
Endometrial Carcinoma,BRD-K54314721-001-10-2::2.5::HTS,6.461763123606375,0.011289368627681264,Other Types,zolmitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Endometrial Carcinoma,BRD-K55187425-236-05-2::2.5::HTS,4.58909786653804,0.03260807460359286,Other Types,rigosertib,"cell cycle inhibitor, PLK inhibitor",PLK1
Endometrial Carcinoma,BRD-K55250441-001-13-0::2.5::HTS,7.256790350192665,0.007276304846690062,Other Types,sulfadoxine,dihydropteroate synthase inhibitor,
Endometrial Carcinoma,BRD-K59333713-003-02-0::2.5::HTS,6.188691703377824,0.013148296576364493,Other Types,niguldipine-(S)-(+),adrenergic receptor antagonist,ADRA1A
Endometrial Carcinoma,BRD-K60287130-001-05-7::2.5::HTS,6.904184785464194,0.008834292448393581,Other Types,"5,7-dichlorokynurenic-acid",glutamate receptor antagonist,"GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Endometrial Carcinoma,BRD-K60446698-001-01-2::2.5::HTS,6.880233918393988,0.008953675490651309,Other Types,ONX-0914,proteasome inhibitor,
Endometrial Carcinoma,BRD-K62056274-332-01-8::2.5::HTS,5.040376928453014,0.025151143777839974,Endometrial Carcinoma,N-methylquipazine,serotonin receptor agonist,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4"
Endometrial Carcinoma,BRD-K62621335-001-01-7::2.5::HTS,5.046707344488066,0.025063033374188068,Other Types,SRPIN340,serine arginine protein kinase inhibitor,"SRPK1, SRPK2"
Endometrial Carcinoma,BRD-K62685538-001-01-7::2.5::HTS,6.488120580039979,0.011129935202789504,Other Types,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR
Endometrial Carcinoma,BRD-K62734952-001-01-0::2.5::HTS,14.990858362786563,0.00012096692921140898,Other Types,arglabin,farnesyltransferase inhibitor,"FNTA, NFKB1"
Endometrial Carcinoma,BRD-K63123526-001-01-2::2.5::HTS,5.454952132783741,0.019868881723316103,Endometrial Carcinoma,S-methylcysteine,,"CTSD, MGMT"
Endometrial Carcinoma,BRD-K64137799-003-02-5::2.5::HTS,5.361896632682038,0.020940492744732746,Other Types,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6"
Endometrial Carcinoma,BRD-K64538373-001-01-4::2.5::HTS,4.069193452123672,0.04415130820089084,Endometrial Carcinoma,Ro-4987655,MEK inhibitor,MAP2K1
Endometrial Carcinoma,BRD-K64755930-003-03-2::2.5::HTS,5.31378730635748,0.021520720065367902,Other Types,etazolate,phosphodiesterase inhibitor,"GABRB3, PDE4A"
Endometrial Carcinoma,BRD-K64800655-001-07-4::2.5::HTS,4.531035323932631,0.033719766775187926,Other Types,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Endometrial Carcinoma,BRD-K65285700-001-02-3::2.5::HTS,5.080648764316992,0.024586398995851542,Other Types,GP1a,cannabinoid receptor agonist,CNR2
Endometrial Carcinoma,BRD-K65428967-001-08-4::2.5::HTS,4.522079033993994,0.03390314052545863,Other Types,cordycepin,DNA inhibitor,
Endometrial Carcinoma,BRD-K65781196-001-03-0::2.5::HTS,7.650352735453979,0.00586619618025908,Other Types,avanafil,phosphodiesterase inhibitor,PDE5A
Endometrial Carcinoma,BRD-K65924316-001-03-1::2.5::HTS,7.449213822574272,0.0065481520026984845,Other Types,serdemetan,MDM inhibitor,MDM2
Endometrial Carcinoma,BRD-K66175015-001-09-0::2.5::HTS,4.770549717961763,0.029375271869443532,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Endometrial Carcinoma,BRD-K68346641-001-01-4::2.5::HTS,8.172147021711035,0.004413968208940253,Other Types,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Endometrial Carcinoma,BRD-K68997413-001-05-1::2.5::HTS,4.199030492396858,0.0409141841934424,Other Types,PF-3845,FAAH inhibitor,FAAH
Endometrial Carcinoma,BRD-K69608737-001-10-2::2.5::HTS,9.258920990611355,0.002453396925995614,Other Types,tacrolimus,calcineurin inhibitor,FKBP1A
Endometrial Carcinoma,BRD-K69776681-001-03-8::2.5::HTS,6.066147508200434,0.014079501716482905,Other Types,volasertib,PLK inhibitor,PLK1
Endometrial Carcinoma,BRD-K69907333-001-10-6::2.5::HTS,4.254162278904417,0.03964278965401943,Other Types,flurbiprofen-(S)-(+),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Endometrial Carcinoma,BRD-K71480163-001-01-4::2.5::HTS,16.511108638910688,5.5278777904424675e-05,Other Types,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Endometrial Carcinoma,BRD-K72005722-001-01-2::2.5::HTS,6.852275130131307,0.009092235336983306,Other Types,VT-464,cytochrome P450 inhibitor,CYP17A1
Endometrial Carcinoma,BRD-K72420232-001-12-3::2.5::HTS,5.7320035177117425,0.016989935135770746,Other Types,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Endometrial Carcinoma,BRD-K72723676-003-17-8::2.5::HTS,6.691504761202568,0.009939723838510115,Other Types,benzethonium,sodium channel blocker,SCN10A
Endometrial Carcinoma,BRD-K72726508-001-02-1::2.5::HTS,5.481028437173974,0.019577554993760366,Endometrial Carcinoma,arcyriaflavin-a,CDK inhibitor,"CCND1, CDK4"
Endometrial Carcinoma,BRD-K72827473-001-01-0::2.5::HTS,4.546690438202696,0.03341686800706623,Endometrial Carcinoma,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
Endometrial Carcinoma,BRD-K72951360-001-01-4::2.5::HTS,8.337663326726704,0.0040347954583547984,Other Types,valrubicin,"DNA inhibitor, topoisomerase inhibitor",TOP2A
Endometrial Carcinoma,BRD-K73293050-001-03-1::2.5::HTS,8.182271598164442,0.004389762049382024,Other Types,WZ-3146,EGFR inhibitor,EGFR
Endometrial Carcinoma,BRD-K73700643-001-11-2::2.5::HTS,5.899904125414634,0.015454200621191386,Other Types,N-acetyltryptamine,melatonin receptor agonist,
Endometrial Carcinoma,BRD-K73982490-001-02-9::2.5::HTS,5.652650413839353,0.01776864298544769,Other Types,BI-78D3,JNK inhibitor,MAPK8
Endometrial Carcinoma,BRD-K74195153-050-12-1::2.5::HTS,4.477108329457214,0.03479890618932824,Other Types,irsogladine,phosphodiesterase inhibitor,PDE4A
Endometrial Carcinoma,BRD-K75615183-300-03-9::2.5::HTS,9.750752405241517,0.0018855675126389052,Other Types,talipexole,"adrenergic receptor agonist, dopamine receptor agonist","ADRA2A, DRD2, HTR3A"
Endometrial Carcinoma,BRD-K76011241-001-01-8::2.5::HTS,5.946146799830128,0.015060337727552813,Other Types,oseltamivir-phosphate,neuraminidase inhibitor,"CES1, NEU1, NEU2"
Endometrial Carcinoma,BRD-K76406695-001-02-9::2.5::HTS,8.919661667469061,0.002945043985761664,Other Types,CCT128930,AKT inhibitor,"PKIA, PRKACA"
Endometrial Carcinoma,BRD-K77625799-001-07-7::2.5::HTS,4.988677326436955,0.025906439107499835,Other Types,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Endometrial Carcinoma,BRD-K79145749-003-02-2::2.5::HTS,5.351877099080718,0.02107055920718861,Other Types,dibenzepine,norepinephrine reputake inhibitor,
Endometrial Carcinoma,BRD-K79239947-001-06-8::2.5::HTS,6.953826738652733,0.008598779411804312,Other Types,PF-573228,focal adhesion kinase inhibitor,"CDK1, CDK2, CDK7, GSK3B, IKBKB"
Endometrial Carcinoma,BRD-K79259477-001-04-9::2.5::HTS,4.453820177072353,0.03526607494208188,Other Types,NVP-BHG712,ephrin inhibitor,EPHB4
Endometrial Carcinoma,BRD-K79612754-001-19-1::2.62::HTS,5.825506229639141,0.016134788606392142,Other Types,inosine,neurotrophic agent,"PARP1, PNP"
Endometrial Carcinoma,BRD-K79633074-001-01-8::2.5::HTS,4.7897186966942185,0.029040937177659622,Other Types,xilobam,,
Endometrial Carcinoma,BRD-K79966802-034-01-2::2.5::HTS,4.0954332540014065,0.04347614054937497,Other Types,rivanicline,acetylcholine receptor agonist,"CHRNA4, CHRNB2, CXCL8"
Endometrial Carcinoma,BRD-K80725821-300-02-9::2.5::HTS,5.703001538361727,0.01726692461417238,Endometrial Carcinoma,RS-16566,serotonin receptor antagonist,
Endometrial Carcinoma,BRD-K81197548-003-01-4::2.5::HTS,4.778720817803633,0.029228310125349703,Other Types,NSC-632839,ubiquitin specific protease inhibitor,"SENP2, USP1, USP2, USP7"
Endometrial Carcinoma,BRD-K81418486-001-47-5::2.5::HTS,5.148419658009348,0.023670221875371756,Other Types,vorinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9"
Endometrial Carcinoma,BRD-K81623406-004-08-3::2.5::HTS,5.035665380157727,0.02522535255051754,Other Types,EIT-hydrobromide,nitric oxide synthase inhibitor,"NOS2, NOS3"
Endometrial Carcinoma,BRD-K83257731-003-23-5::2.5::HTS,8.553674842052141,0.00358838581626683,Other Types,chloropyramine,histamine receptor antagonist,HRH1
Endometrial Carcinoma,BRD-K83508485-001-02-7::2.5::HTS,9.397007453648724,0.002280877758872131,Other Types,FK-888,tachykinin antagonist,"TACR1, TACR2"
Endometrial Carcinoma,BRD-K83597974-003-22-2::2.5::HTS,3.9249699287585695,0.04808180453530072,Endometrial Carcinoma,pargyline,monoamine oxidase inhibitor,"MAOA, MAOB"
Endometrial Carcinoma,BRD-K84544951-236-01-0::2.5::HTS,4.566887496189083,0.033029110066987236,Endometrial Carcinoma,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Endometrial Carcinoma,BRD-K85066592-001-01-6::2.5::HTS,4.85437186074955,0.027989956342063593,Other Types,gly-gln,,
Endometrial Carcinoma,BRD-K85333151-003-13-4::2.5::HTS,4.975726178123892,0.026116167629077893,Endometrial Carcinoma,ramifenazone,cyclooxygenase inhibitor,
Endometrial Carcinoma,BRD-K85757157-001-01-7::2.5::HTS,4.497481584826474,0.034385263800774876,Endometrial Carcinoma,nifursol,bacterial DNA inhibitor,
Endometrial Carcinoma,BRD-K86344238-003-04-6::2.5::HTS,4.434710551912342,0.03565971910491656,Other Types,linsidomine,nitric oxide donor,
Endometrial Carcinoma,BRD-K86816506-001-01-8::2.5::HTS,7.232426667351364,0.007382862771323622,Other Types,PF-04457845,FAAH inhibitor,FAAH
Endometrial Carcinoma,BRD-K86930074-001-05-0::2.5::HTS,8.52933692500499,0.0036390808934524763,Other Types,cediranib,"KIT inhibitor, VEGFR inhibitor","CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB"
Endometrial Carcinoma,BRD-K87112191-001-04-5::2.5::HTS,4.000775047220918,0.0459617495942429,Other Types,PP242,mTOR inhibitor,"MTOR, PASK"
Endometrial Carcinoma,BRD-K87782578-001-01-4::2.5::HTS,4.2496513646811716,0.039720198522391274,Other Types,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,"BTK, YES1"
Endometrial Carcinoma,BRD-K88677950-001-03-9::2.5::HTS,4.4311399796829845,0.03573537661236105,Endometrial Carcinoma,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Endometrial Carcinoma,BRD-K89208535-051-01-5::2.5::HTS,4.023603761108858,0.04534908668123244,Endometrial Carcinoma,indacaterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Endometrial Carcinoma,BRD-K90647725-001-07-3::2.5::HTS,7.623235142102156,0.005963364866485741,Other Types,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
Endometrial Carcinoma,BRD-K91188791-001-18-3::2.5::HTS,6.595270911873893,0.010483634195163289,Endometrial Carcinoma,aloxistatin,protease inhibitor,CTSG
Endometrial Carcinoma,BRD-K91699951-001-10-2::2.5::HTS,5.932375740541198,0.015177752957633182,Other Types,benzonatate,local anesthetic,SCN5A
Endometrial Carcinoma,BRD-K92838188-001-01-9::2.5::HTS,7.1494632967692295,0.00771872041360906,Other Types,rifaximin,RNA synthesis inhibitor,NR1I2
Endometrial Carcinoma,BRD-K93632104-001-18-0::2.5::HTS,4.951568105594426,0.02646668579420458,Other Types,sodium-salicylate,prostanoid receptor antagonist,"ASIC3, PTGS1, PTGS2"
Endometrial Carcinoma,BRD-K94176593-001-09-4::2.5::HTS,6.228585984761482,0.012860129242907067,Other Types,TWS-119,glycogen synthase kinase inhibitor,"GSK3B, JUN, MYC"
Endometrial Carcinoma,BRD-K94266545-001-24-1::2.5::HTS,4.09228804216159,0.043555635094616185,Endometrial Carcinoma,ronidazole,antiprotozoal agent,
Endometrial Carcinoma,BRD-K95237249-001-26-5::2.5::HTS,4.562049608449014,0.033120968954331094,Other Types,probenecid,uricosuric blocker,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1"
Endometrial Carcinoma,BRD-K95573441-001-01-2::2.5::HTS,3.9396883409213763,0.047647879595787694,Other Types,PFK-015,phosphofructokinase inhibitor,PFKFB3
Endometrial Carcinoma,BRD-K96159438-001-06-3::2.5::HTS,5.047527163232428,0.02505553711056759,Endometrial Carcinoma,adefovir-dipivoxil,DNA polymerase inhibitor,
Endometrial Carcinoma,BRD-K96615647-001-01-2::2.5::HTS,8.419468019699027,0.0038577198428118567,Endometrial Carcinoma,AV-608,tachykinin antagonist,TACR1
Endometrial Carcinoma,BRD-K97056771-001-13-1::2.5::HTS,5.814543116241759,0.01621387563558608,Other Types,GNF-2,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Endometrial Carcinoma,BRD-K97061094-001-21-4::2.63::HTS,10.882767682720559,0.001038032307563215,Other Types,azacyclonol,histamine receptor antagonist,HRH1
Endometrial Carcinoma,BRD-K97764662-001-17-3::2.5::HTS,7.955059205951425,0.004967126350154923,Other Types,PD-173074,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Endometrial Carcinoma,BRD-K99023089-001-03-7::2.5::HTS,17.294076226481796,3.705128063643929e-05,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Endometrial Carcinoma,BRD-K99545815-001-06-3::2.5::HTS,6.4352628078119585,0.011457040755029452,Other Types,PF-562271,focal adhesion kinase inhibitor,"PTK2, PTK2B"
Endometrial Carcinoma,BRD-K99984802-100-13-5::2.5::HTS,4.871701941014675,0.02770683357277964,Other Types,flunixin-meglumin,prostanoid receptor antagonist,
Endometrial Carcinoma,BRD-U48018661-000-01-9::2.5::HTS,6.216894733156469,0.012942261775524192,Other Types,tyloxapol,NFkB pathway inhibitor,"LPL, NFKB2"
Endometrial Carcinoma,BRD-A44511856-001-01-4::2.499987042::MTS004,5.518894755778146,0.019172819703151524,Other Types,ginsenoside-rg3,"angiogenesis inhibitor, apoptosis stimulant",KCNH2
Endometrial Carcinoma,BRD-A59961917-001-01-0::2.5::MTS004,10.638025823043078,0.0011780559312436958,Other Types,BQ-123,endothelin receptor antagonist,EDNRA
Endometrial Carcinoma,BRD-A73679382-236-01-8::2.499981367::MTS004,4.033709909003559,0.04509809511714986,Endometrial Carcinoma,MK-571,leukotriene receptor antagonist,"ABCC2, CYSLTR1"
Endometrial Carcinoma,BRD-A78277353-001-01-9::2.492599937::MTS004,4.104761404243019,0.04325466919456978,Other Types,metazosin,adrenergic receptor antagonist,ADRA1A
Endometrial Carcinoma,BRD-K03165895-001-01-9::2.499970324::MTS004,8.972787861283049,0.0028662977181224372,Other Types,elafibranor,PPAR receptor agonist,"PPARA, PPARD"
Endometrial Carcinoma,BRD-K03765900-001-01-9::2.499986292::MTS004,4.790407583750006,0.029047785112176656,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Endometrial Carcinoma,BRD-K04701033-001-04-7::2.499987566::MTS004,4.7291166506480495,0.03009025797781849,Other Types,VE-822,ATR kinase inhibitor,"ATM, ATR, MTOR, PIK3CG"
Endometrial Carcinoma,BRD-K06328344-015-01-7::2.500004254::MTS004,4.703686714207393,0.03053535664459283,Other Types,bremelanotide,melanocortin receptor agonist,"MC1R, MC2R, MC3R, MC4R, MC5R"
Endometrial Carcinoma,BRD-K06467130-304-02-7::2.5::MTS004,6.5730418212697055,0.010623501121227634,Other Types,CL316243,adrenergic receptor agonist,"ADRB3, UCP1, UCP2, UCP3"
Endometrial Carcinoma,BRD-K07785030-001-01-6::2.29884119::MTS004,4.250448576726218,0.039718856636717294,Other Types,7-keto-DHEA,steroid,
Endometrial Carcinoma,BRD-K09436144-001-01-7::2.487366457::MTS004,5.885893517962007,0.015590364019189689,Other Types,YM022,CCK receptor antagonist,CCKBR
Endometrial Carcinoma,BRD-K10995081-001-27-9::2.316458322::MTS004,4.891979431968816,0.027400431183836654,Other Types,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Endometrial Carcinoma,BRD-K12261274-001-02-4::2.499953183::MTS004,4.767936535852208,0.02942582410483646,Other Types,zaltidine,histamine receptor antagonist,HRH2
Endometrial Carcinoma,BRD-K16180792-001-01-7::2.5::MTS004,19.33485187679592,1.3219422171419886e-05,Other Types,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Endometrial Carcinoma,BRD-K32842773-434-01-8::2.5::MTS004,4.157796487092292,0.0419305798771076,Endometrial Carcinoma,pemetrexed,"dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS"
Endometrial Carcinoma,BRD-K35882976-001-04-7::2.444346727::MTS004,6.210646822529468,0.012997736696976625,Other Types,mitoflaxone,antitumor agent,VWF
Endometrial Carcinoma,BRD-K38168441-001-03-7::2.422985058::MTS004,5.046430061260256,0.025081549020612617,Other Types,dabigatran,thrombin inhibitor,F2
Endometrial Carcinoma,BRD-K46862739-001-14-3::2.499952208::MTS004,4.451161156633127,0.03533871751194972,Other Types,metyrapone,cytochrome P450 inhibitor,CYP11B1
Endometrial Carcinoma,BRD-K52914072-001-01-5::2.5::MTS004,5.508619003704339,0.019283931169720474,Other Types,LTA,,
Endometrial Carcinoma,BRD-K58810291-001-16-2::2.564588683::MTS004,4.537080703630043,0.03362039530611202,Other Types,clobetasone-butyrate,corticosteroid agonist,NR3C1
Endometrial Carcinoma,BRD-K64034691-001-01-9::2.499981916::MTS004,8.047997530959831,0.004727123436366684,Other Types,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Endometrial Carcinoma,BRD-K71026158-304-01-0::2.397404387::MTS004,4.600435489070358,0.032410152668110113,Other Types,carumonam,bacterial cell wall synthesis inhibitor,
Endometrial Carcinoma,BRD-K74236984-001-04-8::2.5::MTS004,4.581999305218494,0.03275838556751393,Other Types,UNC0321,histone lysine methyltransferase inhibitor,EHMT2
Endometrial Carcinoma,BRD-K76594255-001-01-6::2.5000235::MTS004,5.596365157530188,0.018351384235899642,Other Types,maropitant,neurokinin receptor antagonist,TACR1
Endometrial Carcinoma,BRD-K79710622-001-02-9::2.5::MTS004,4.029685768435421,0.04520588053666488,Other Types,GKT137831,NADPH oxidase inhibitor,"NOX1, NOX4"
Endometrial Carcinoma,BRD-K84868168-001-01-0::2.500006364::MTS004,3.93809926711859,0.047711664715900264,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Endometrial Carcinoma,BRD-K87573013-001-01-0::2.5::MTS004,4.020413908891244,0.045452178567829515,Other Types,CL-225385,,
Endometrial Carcinoma,BRD-K89085489-001-23-2::2.499967871::MTS004,4.384355833842606,0.036736752992202415,Other Types,fenretinide,"apoptosis stimulant, retinoid receptor agonist",RARA
Endometrial Carcinoma,BRD-K92490248-001-06-6::2.500037393::MTS004,4.89057277426779,0.027422556399122902,Other Types,anethole-trithione,glutathione transferase stimulant,
Endometrial Carcinoma,BRD-K96874295-015-01-0::2.500009134::MTS004,7.015406003032907,0.008318041941834529,Other Types,gonadorelin,gonadotropin releasing factor hormone receptor agonist,"GNRHR, GNRHR2"
Endometrial Carcinoma,BRD-K99199077-001-16-1::2.603211317::MTS004,4.370331673059656,0.03703773190621579,Other Types,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A00520476-001-07-4::2.5::HTS,4.605187490309317,0.0323068048745599,Intraductal Papillary Neoplasm of the Bile Duct,otenzepad,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A00546892-001-02-6::2.5::HTS,5.247792233376475,0.02234727533907062,Intraductal Papillary Neoplasm of the Bile Duct,biperiden,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A01493904-003-12-1::2.5::HTS,4.311756489763325,0.0383061789273675,Intraductal Papillary Neoplasm of the Bile Duct,WB-4101,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A07207424-001-13-2::2.5::HTS,5.663503731944027,0.017654118438077064,Other Types,Ro-20-1724,phosphodiesterase inhibitor,"PDE3A, PDE4A, PDE4B, PDE4C, PDE4D"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A08187463-001-12-9::2.5::HTS,5.52781930880897,0.019075609659016706,Intraductal Papillary Neoplasm of the Bile Duct,racecadotril,enkephalinase inhibitor,MME
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A08840375-001-01-3::2.5::HTS,5.008402670143028,0.025626996573243504,Intraductal Papillary Neoplasm of the Bile Duct,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A09467419-003-22-4::2.5::HTS,4.423190823054228,0.03591662544775582,Other Types,mebeverine,acetylcholine receptor antagonist,CHRM1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A09722536-002-18-0::2.5::HTS,6.9322375534695535,0.008700581378190334,Intraductal Papillary Neoplasm of the Bile Duct,cyclophosphamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A09735281-001-02-5::2.5::HTS,5.012638008517076,0.025554892482788857,Intraductal Papillary Neoplasm of the Bile Duct,boceprevir,HCV inhibitor,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A12077521-003-01-5::2.5::HTS,3.87258877199293,0.049592975131494216,Intraductal Papillary Neoplasm of the Bile Duct,cefepime,bacterial cell wall synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A13561534-003-02-0::2.5::HTS,4.13430139947681,0.0425220197813601,Other Types,ornithine,NFkB pathway modulator,"ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A13964793-001-02-6::2.5::HTS,4.545523072846153,0.033441814477559215,Intraductal Papillary Neoplasm of the Bile Duct,TC1,beta-secretase inhibitor,BACE1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A15415227-003-02-9::2.5::HTS,4.572048935388381,0.0329282648437763,Other Types,GW-1929,PPAR receptor agonist,PPARG
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A16700644-003-04-4::2.5::HTS,4.32738691490803,0.0379603430846036,Intraductal Papillary Neoplasm of the Bile Duct,isoxsuprine,adrenergic receptor agonist,ADRB2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A18763547-300-05-5::2.5::HTS,4.072818849591807,0.044057369233048156,Intraductal Papillary Neoplasm of the Bile Duct,BAX-channel-blocker,cytochrome C release inhibitor,BAX
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A20239487-001-24-9::2.5::HTS,4.293036306644199,0.03874112454990811,Intraductal Papillary Neoplasm of the Bile Duct,atenolol-(+/-),adrenergic receptor antagonist,"ADRB1, ADRB2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A21607826-003-05-1::2.5::HTS,7.674385358248501,0.005788963859002154,Other Types,medetomidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A26387268-050-04-4::2.5::HTS,4.789687580910857,0.02904440762632953,Intraductal Papillary Neoplasm of the Bile Duct,ergonovine,"adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A26845397-051-01-9::2.5::HTS,4.919709519886396,0.02695313203531268,Other Types,isamoltane,adrenergic receptor antagonist,"HTR1A, HTR1B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A28970875-300-04-9::2.5::HTS,4.4984201625673,0.0343820972436076,Intraductal Papillary Neoplasm of the Bile Duct,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A29426959-050-13-2::2.5::HTS,9.275854558421502,0.0024317848818701695,Other Types,carbinoxamine,histamine receptor antagonist,HRH1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A29844814-300-01-5::2.5::HTS,7.7723992964318205,0.005487234923992975,Other Types,ABT-202,acetylcholine receptor agonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A30815329-001-10-5::2.5::HTS,15.54163765113186,9.104717338252276e-05,Intraductal Papillary Neoplasm of the Bile Duct,felodipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A32988684-003-08-7::2.5::HTS,4.2148933117210685,0.040537119548034746,Intraductal Papillary Neoplasm of the Bile Duct,heptaminol,vasoconstrictor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A38350138-001-04-9::2.5::HTS,5.0893719240160955,0.02447069904896511,Other Types,ketoconazole,sterol demethylase inhibitor,"AR, CYP19A1, CYP21A2, KCNA10"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A44500574-001-01-8::2.5::HTS,5.299850157977543,0.021694531355531656,Intraductal Papillary Neoplasm of the Bile Duct,FLI-06,notch signaling inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A50998626-001-02-1::2.5::HTS,4.317043906267866,0.03819155393470616,Intraductal Papillary Neoplasm of the Bile Duct,palomid-529,"AKT inhibitor, mTOR inhibitor",MTOR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A54927599-001-16-9::2.5::HTS,5.052187953836727,0.02498885967717684,Intraductal Papillary Neoplasm of the Bile Duct,KF-38789,P selectin inhibitor,SELP
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A63546914-003-02-0::2.5::HTS,4.987885402637902,0.025923874898257225,Intraductal Papillary Neoplasm of the Bile Duct,Ro-04-5595,,GRIN2B
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A64064900-001-02-3::2.5::HTS,4.357795392623779,0.0373029508857915,Intraductal Papillary Neoplasm of the Bile Duct,sangivamycin,DNA inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A65671304-001-07-5::2.5::HTS,5.7757964266306585,0.016576025325795878,Intraductal Papillary Neoplasm of the Bile Duct,candesartan-cilextil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A67006024-001-04-8::2.5::HTS,6.559885734446231,0.010708086891562999,Other Types,SNAP,nitric oxide donor,PTPN1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A67748489-001-10-0::2.5::HTS,4.566612589062313,0.03303828412619619,Intraductal Papillary Neoplasm of the Bile Duct,K-858,kinesin-like spindle protein inhibitor,KIF11
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A68723818-050-32-5::2.5::HTS,5.865016565951207,0.015762407794096357,Other Types,brompheniramine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A69275535-001-01-5::2.5::HTS,4.083564711822962,0.04377760369503435,Other Types,pinitol,gamma secretase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A70083328-001-24-3::2.5::HTS,3.9556229973367714,0.047220153374567274,Intraductal Papillary Neoplasm of the Bile Duct,secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A70268693-050-01-2::2.5::HTS,11.492666373197023,0.0007486599332750761,Other Types,PG-9,acetylcholine receptor agonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A72711497-236-03-8::2.5::HTS,4.410030019558454,0.036174954762983866,Intraductal Papillary Neoplasm of the Bile Duct,lasalocid,bacterial permeability inducer,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A73930134-001-03-0::2.5::HTS,5.579329443562131,0.018535582704290135,Other Types,5-hydroxytryptophan,neurotransmitter,"SLC36A1, SLC36A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A83029242-001-05-3::2.5::HTS,6.9629502592435175,0.008555594908063372,Other Types,prasugrel,purinergic receptor antagonist,P2RY12
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A83802939-304-04-2::2.5::HTS,3.9188010350462585,0.04824077494057588,Other Types,dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A86619021-001-04-8::2.5::HTS,4.09958005914917,0.04337044128082345,Intraductal Papillary Neoplasm of the Bile Duct,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A86871940-001-01-9::2.5::HTS,6.025644680783554,0.01441622861845275,Intraductal Papillary Neoplasm of the Bile Duct,nicaraven,free radical scavenger,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A87983072-001-01-1::2.5::HTS,6.51262575364648,0.010976968395007222,Intraductal Papillary Neoplasm of the Bile Duct,benzotript,CCK receptor antagonist,"CCKAR, CCKBR"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A93407926-001-01-1::2.5::HTS,5.516835161157866,0.01918599129651579,Intraductal Papillary Neoplasm of the Bile Duct,allopurinol-riboside,anti-leishmanial agent,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A94323479-001-02-8::2.5::HTS,4.35590253244565,0.037330881608293294,Other Types,ki16198,lipoprotein antagonist,LPA
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A98174560-001-02-1::2.5::HTS,3.9372970602649144,0.04771604153309714,Other Types,chloralose,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K00259736-001-16-4::2.5::HTS,8.365459568112563,0.003974458045129067,Intraductal Papillary Neoplasm of the Bile Duct,colchicine,microtubule inhibitor,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01095011-001-15-9::2.5::HTS,6.51653758330105,0.01095851007110543,Other Types,finasteride,5 alpha reductase inhibitor,"AKR1D1, SRD5A1, SRD5A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01567962-001-23-0::2.5::HTS,8.560353593511769,0.0035754463452170203,Other Types,pyrazolanthrone,JNK inhibitor,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01614093-001-02-6::2.5::HTS,4.201278926022642,0.04088508807571063,Other Types,dihydromyricetin,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01674964-300-06-3::2.5::HTS,4.187648210465618,0.04119101390990133,Other Types,histamine,histamine receptor agonist,"HRH1, HRH2, HRH3, HRH4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01815685-001-15-5::2.5::HTS,15.344767848801547,0.00010075643051473678,Intraductal Papillary Neoplasm of the Bile Duct,indole-3-carbinol,"aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor",AHR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K02464583-001-02-2::2.5::HTS,6.119945354043779,0.013660817895435474,Intraductal Papillary Neoplasm of the Bile Duct,ethyl-paraben,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K02594908-001-16-4::2.5::HTS,5.230175448251047,0.022580088387750826,Intraductal Papillary Neoplasm of the Bile Duct,sulfanilamide,carbonic anhydrase inhibitor,"CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K02764365-001-13-6::2.5::HTS,5.199491511520489,0.022967155545796022,Intraductal Papillary Neoplasm of the Bile Duct,methiazole,anthelmintic agent,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K02943813-001-01-9::2.5::HTS,3.867197120211542,0.0497513526341129,Intraductal Papillary Neoplasm of the Bile Duct,dasabuvir,HCV inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K03194791-001-04-8::2.5::HTS,5.077334964234352,0.0246308624204111,Other Types,roflumilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K03406345-001-27-8::2.5::HTS,5.101121746951658,0.024296356669583755,Intraductal Papillary Neoplasm of the Bile Duct,azacitidine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K04185004-003-11-9::2.5::HTS,4.656560823442425,0.03136183549653867,Intraductal Papillary Neoplasm of the Bile Duct,oxybuprocaine,local anesthetic,SCN10A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K05673000-236-12-1::2.5::HTS,4.482500394482205,0.034686190572485405,Intraductal Papillary Neoplasm of the Bile Duct,dicloxacillin,bacterial cell wall synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K05850076-001-01-5::2.5::HTS,7.581802869866944,0.006089217392225026,Other Types,sotagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K07265709-003-05-6::2.61::HTS,4.542030004545302,0.03353359501745426,Intraductal Papillary Neoplasm of the Bile Duct,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K08188887-001-02-4::2.5::HTS,5.7068498594145955,0.017233102158106514,Intraductal Papillary Neoplasm of the Bile Duct,astragaloside-a,antiinflammatory agent,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K08231299-001-08-1::2.5::HTS,5.261676952430775,0.022178888464999186,Other Types,propoxur,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K08248804-001-01-8::2.5::HTS,5.891827710087526,0.01553788802235642,Intraductal Papillary Neoplasm of the Bile Duct,LCL-161,XIAP inhibitor,"BIRC2, XIAP"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K08832567-001-11-5::2.5::HTS,10.542094259318016,0.0012394044881060213,Intraductal Papillary Neoplasm of the Bile Duct,naringenin,"aromatase inhibitor, TRPV antagonist","CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K09338665-001-07-1::2.5::HTS,4.937981188931163,0.026695690241285878,Other Types,1-octanol,,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K09619322-001-03-8::2.5::HTS,3.959474192328943,0.047095855682756246,Intraductal Papillary Neoplasm of the Bile Duct,CD-1530,retinoid receptor agonist,RARG
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K10071630-001-01-0::2.5::HTS,5.4671007706658905,0.01972816037260216,Intraductal Papillary Neoplasm of the Bile Duct,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K10177585-003-02-4::2.5::HTS,5.223757257170732,0.02265721515073073,Intraductal Papillary Neoplasm of the Bile Duct,PSB-11,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA3"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K11244467-001-08-5::2.5::HTS,3.930373788231093,0.04790792631261109,Other Types,ambazone,DNA damage inducer,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K11411329-001-01-3::2.5::HTS,4.402453367523486,0.03633309514972037,Other Types,NOV-002,,"GSR, GSTM2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K11853856-001-01-7::2.5::HTS,5.492047439660165,0.019450750409941098,Intraductal Papillary Neoplasm of the Bile Duct,PJ-34,PARP inhibitor,"EEF2, PARP1, PARP15, PARP3"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12047401-001-01-5::2.5::HTS,4.715348776757182,0.030339039031409512,Intraductal Papillary Neoplasm of the Bile Duct,palifosfamide,DNA alkylating agent,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12120659-305-02-2::2.5::HTS,4.548016102871179,0.03339752358719413,Intraductal Papillary Neoplasm of the Bile Duct,GR-144053,integrin antagonist,"ITGA2B, ITGB3"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12219985-001-26-1::2.5::HTS,7.1235973767470835,0.007836865232051807,Intraductal Papillary Neoplasm of the Bile Duct,glipizide,sulfonylurea,"ABCC8, KCNJ10, KCNJ11, PPARG"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12244279-001-05-8::2.5::HTS,3.9277811361205823,0.047988341351835606,Other Types,MEK1-2-inhibitor,MEK inhibitor,MAP2K2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12735121-001-01-4::2.5::HTS,4.787096836823708,0.029102364609222615,Intraductal Papillary Neoplasm of the Bile Duct,TG-100801,"src inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, SRC"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K12787259-001-04-3::2.5::HTS,5.644397568822257,0.017859827931505458,Intraductal Papillary Neoplasm of the Bile Duct,CX-5461,RNA polymerase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K13756951-001-01-4::2.5::HTS,5.582480541054875,0.018480677573067435,Intraductal Papillary Neoplasm of the Bile Duct,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K14175878-001-01-6::2.5::HTS,3.9807430893667792,0.046526212573484556,Intraductal Papillary Neoplasm of the Bile Duct,MK-0812,CC chemokine receptor antagonist,CCR2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K14496212-066-04-8::2.5::HTS,6.943587684162558,0.008650981654206077,Other Types,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K14965640-001-12-4::2.5::HTS,4.459294004867316,0.035154952416564744,Other Types,ibuprofen-(s),cyclooxygenase inhibitor,"ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K15025317-001-15-1::2.5::HTS,5.44222172686051,0.020012736696202214,Intraductal Papillary Neoplasm of the Bile Duct,BAY-11-7082,NFkB pathway inhibitor,RELA
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K15409150-001-05-8::2.5::HTS,4.115573512195326,0.04298119600628496,Intraductal Papillary Neoplasm of the Bile Duct,penfluridol,T-type calcium channel blocker,CACNA1G
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K15898725-001-01-7::2.5::HTS,5.889527570963122,0.015546236442475509,Intraductal Papillary Neoplasm of the Bile Duct,maytansinol-isobutyrate,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K16037980-001-01-1::2.5::HTS,5.451084302806456,0.0199086466755318,Other Types,Z160,N-type calcium channel blocker,CACNA2D1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K17513304-001-01-9::2.5::HTS,4.933175960684618,0.026745058461231215,Other Types,firategrast,integrin antagonist,ITGA4
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K17953908-001-01-7::2.5::HTS,4.154114810227635,0.04200279841128544,Other Types,LY2886721,beta-secretase inhibitor,BACE1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K17979676-001-01-2::2.5::HTS,4.336079682185414,0.03778377153110988,Intraductal Papillary Neoplasm of the Bile Duct,eprobemide,monoamine oxidase inhibitor,MAOA
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K18059238-001-10-4::0.25::HTS,6.579203840320215,0.010578483752130673,Intraductal Papillary Neoplasm of the Bile Duct,gamma-linolenic-acid,"cyclooxygenase inhibitor, prostanoid receptor agonist","PTGS1, PTGS2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K18673820-001-15-5::2.5::HTS,6.7089222962348805,0.009842913812174715,Intraductal Papillary Neoplasm of the Bile Duct,folic-acid,folate receptor ligand,"FOLR2, FOLR3, SLC19A1, SLC46A1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K19761926-001-02-8::2.5::HTS,4.837363165045443,0.02826182751380642,Intraductal Papillary Neoplasm of the Bile Duct,eplerenone,cytochrome P450 inhibitor,NR3C2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K20745393-003-01-0::2.5::HTS,4.344778009942131,0.03758008292459352,Other Types,olprinone,phosphodiesterase inhibitor,PDE3A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K21283037-001-21-5::2.5::HTS,4.948345974412905,0.026517779336344034,Intraductal Papillary Neoplasm of the Bile Duct,riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K21547160-001-01-4::2.5::HTS,4.611529138247299,0.03220297259265424,Intraductal Papillary Neoplasm of the Bile Duct,sufentanil,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K21782625-001-02-4::2.5::HTS,5.406481087380542,0.020432468788911713,Other Types,AMG458,MET inhibitor,MET
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K22009844-001-12-5::2.5::HTS,4.045620812778541,0.044763002278970114,Other Types,phenprobamate,muscle relaxant,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K22822991-001-02-3::2.5::HTS,6.479198139102213,0.01119184138843775,Intraductal Papillary Neoplasm of the Bile Duct,odanacatib,cathepsin inhibitor,CTSK
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K23190681-001-01-1::2.5::HTS,5.38792318460017,0.020638555904499534,Intraductal Papillary Neoplasm of the Bile Duct,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K23925186-001-02-8::2.51::HTS,7.160872880064066,0.007682532892569226,Intraductal Papillary Neoplasm of the Bile Duct,oridonin,BCL inhibitor,BCL2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K24179883-001-16-7::2.5::HTS,4.925544771985181,0.026864516380719624,Intraductal Papillary Neoplasm of the Bile Duct,arsanilic-acid,,LYZ
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K24548560-342-02-1::2.5::HTS,12.517053060539912,0.00043658962948075585,Other Types,evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K24689407-001-06-3::2.5::HTS,4.0470118580943355,0.04472896416409044,Intraductal Papillary Neoplasm of the Bile Duct,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K24943235-001-01-3::2.5::HTS,4.8285095968873515,0.028400124306217987,Intraductal Papillary Neoplasm of the Bile Duct,grazoprevir,HCV inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25015158-001-01-2::2.5::HTS,4.742148140380283,0.02985346702782944,Other Types,limaprost-alfadex,prostanoid receptor agonist,PTGER1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25186396-001-09-6::2.5::HTS,4.609586930849134,0.032227064003600696,Other Types,tangeritin,cell cycle inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25279140-001-01-5::2.5::HTS,4.4769613902321375,0.03481696694011889,Intraductal Papillary Neoplasm of the Bile Duct,MK-8745,Aurora kinase inhibitor,AURKA
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25699529-003-01-1::2.5::HTS,6.808019271144973,0.009318365095562758,Other Types,tapentadol,opioid receptor agonist,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25906698-303-02-7::2.5::HTS,6.793313422598062,0.009394042252874879,Other Types,immepip,histamine receptor agonist,"HRH3, HRH4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25943794-001-02-3::2.5::HTS,6.009421311138685,0.014537466929077312,Intraductal Papillary Neoplasm of the Bile Duct,blonanserin,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26548821-003-10-5::2.5::HTS,4.876361376445729,0.02763352992135817,Intraductal Papillary Neoplasm of the Bile Duct,quinpirol-(-),dopamine receptor agonist,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26619122-001-02-1::2.5::HTS,4.686144789975967,0.030839384402638267,Intraductal Papillary Neoplasm of the Bile Duct,thiocolchicoside,GABA receptor antagonist,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26634012-001-04-9::2.5::HTS,6.230218728021918,0.012852673464010428,Intraductal Papillary Neoplasm of the Bile Duct,tilmicosin,bacterial 50S ribosomal subunit inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26657438-001-15-2::2.5::HTS,12.180779050500625,0.0005209302859591514,Other Types,imiquimod,"interferon inducer, toll-like receptor agonist","TLR7, TLR8"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26739552-003-15-4::2.5::HTS,6.070054493316616,0.014060448286627109,Intraductal Papillary Neoplasm of the Bile Duct,fenspiride,bronchodilator,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26997899-001-02-2::2.5::HTS,6.033836877196548,0.014335557989485008,Intraductal Papillary Neoplasm of the Bile Duct,D-64131,microtubule inhibitor,TUBB
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K27062708-001-23-1::2.5::HTS,8.079654060645291,0.004641516077927083,Other Types,chlorotrianisene,estrogenic hormone,"ESR1, ESR2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K28120222-001-08-4::2.5::HTS,4.641240837954891,0.03164289087632898,Intraductal Papillary Neoplasm of the Bile Duct,parthenolide-(alternate-stereo),NFkB pathway inhibitor,"IKBKB, RELA"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K28392481-001-05-1::2.5::HTS,6.385035929363976,0.011786374512927784,Intraductal Papillary Neoplasm of the Bile Duct,AZD4547,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K28912512-001-23-2::2.5::HTS,5.256897874525195,0.022234460642820957,Intraductal Papillary Neoplasm of the Bile Duct,nicotinamide,protein synthesis stimulant,"BST1, LDHA, PARP1, SIRT5"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K29322660-001-01-9::2.5::HTS,6.939093535652167,0.008665613280492071,Other Types,edoxaban,coagulation factor inhibitor,F10
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K29673530-001-05-4::2.5::HTS,5.202126880563855,0.02293469972989941,Intraductal Papillary Neoplasm of the Bile Duct,hypericin,tyrosine kinase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K29968218-001-03-2::2.5::HTS,5.8339942311508555,0.016042047890214708,Intraductal Papillary Neoplasm of the Bile Duct,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K30480208-001-18-5::2.5::HTS,5.800842360371107,0.016339355928237154,Other Types,torasemide,"electrolyte reabsorption inhibitor, thromboxane receptor antagonist",SLC12A1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K30634073-046-01-0::2.5::HTS,3.884200422037782,0.04923716593357362,Other Types,levallorphan,opioid antagonist,"CHRNA2, OPRM1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K31092604-003-03-5::2.5::HTS,5.87694074092073,0.015659431293319426,Other Types,donitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K31313613-003-04-2::2.5::HTS,4.37379444636719,0.03694804764672013,Intraductal Papillary Neoplasm of the Bile Duct,BS-181,CDK inhibitor,CDK7
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K31491153-003-05-9::2.5::HTS,5.227843059277737,0.022601185945349433,Intraductal Papillary Neoplasm of the Bile Duct,1-phenylbiguanide,serotonin receptor agonist,"HTR3A, HTR3B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K32007074-001-02-9::3.16::HTS,6.557216135557282,0.01071722164167434,Intraductal Papillary Neoplasm of the Bile Duct,enocitabine,DNA synthesis inhibitor,"CMPK1, RRM1, TYMS"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K32273377-001-17-9::2.5::HTS,4.555159028663162,0.03325728985076388,Intraductal Papillary Neoplasm of the Bile Duct,sulfadiazine,bacterial antifolate,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K32730239-001-01-0::2.5::HTS,6.149464115491511,0.01343869922589713,Intraductal Papillary Neoplasm of the Bile Duct,SU3327,JNK inhibitor,MAPK8
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K33226500-001-01-0::2.5::HTS,5.065746075403235,0.024796659573420025,Intraductal Papillary Neoplasm of the Bile Duct,indinavir,HIV protease inhibitor,"CYP3A4, CYP3A5, CYP3A7"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K33379087-001-07-5::2.5::HTS,4.100747385534169,0.043345055870425336,Intraductal Papillary Neoplasm of the Bile Duct,tivantinib,tyrosine kinase inhibitor,MET
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K33852358-001-09-9::2.5::HTS,4.182778592452507,0.04131030294866764,Other Types,arofylline,phosphodiesterase inhibitor,PDE4A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K34321528-003-01-2::2.5::HTS,10.953252510447056,0.0009947939688873695,Intraductal Papillary Neoplasm of the Bile Duct,CGP-71683,neuropeptide receptor antagonist,NPY5R
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K34411947-001-12-5::2.5::HTS,4.14156329835877,0.04231545288767464,Intraductal Papillary Neoplasm of the Bile Duct,streptozotocin,DNA alkylating agent,SLC2A2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K34851558-001-02-3::2.5::HTS,10.309748730840246,0.0014000032238139397,Intraductal Papillary Neoplasm of the Bile Duct,parthenolide-(-),NFkB pathway inhibitor,HDAC1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K34870043-001-01-8::2.5::HTS,5.614190058815843,0.01815678206463294,Intraductal Papillary Neoplasm of the Bile Duct,adoprazine,"dopamine receptor antagonist, serotonin receptor agonist","DRD2, HTR1A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K35698076-001-01-2::2.5::HTS,4.273989062824335,0.03916129319664048,Intraductal Papillary Neoplasm of the Bile Duct,laurocapram,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K35960502-001-20-0::2.5::HTS,6.496171047391524,0.011077813138166463,Intraductal Papillary Neoplasm of the Bile Duct,niclosamide,"DNA replication inhibitor, STAT inhibitor",STAT3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K37270826-001-31-8::2.5::HTS,4.650962690538114,0.0314633893631475,Other Types,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K37714784-305-02-1::2.5::HTS,8.933643811458062,0.002922496092178305,Other Types,ABT-724,dopamine receptor agonist,DRD4
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K37793595-003-01-7::2.5::HTS,6.319459415302884,0.012221889148940807,Other Types,afobazole,anxiolytic,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K38140108-002-01-2::2.5::HTS,4.865242271632541,0.027807633777477036,Intraductal Papillary Neoplasm of the Bile Duct,gadodiamide,radiopaque medium,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K38436528-003-26-1::2.5::HTS,7.045697715449937,0.008177313179212088,Other Types,imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K38852836-001-02-1::2.5::HTS,3.8933672919652165,0.048966686730194414,Intraductal Papillary Neoplasm of the Bile Duct,ganetespib,HSP inhibitor,HSP90AA1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K38860038-001-01-2::2.5::HTS,3.915944379477922,0.04832668440715974,Intraductal Papillary Neoplasm of the Bile Duct,JK-184,hedgehog pathway inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K38903228-001-13-5::2.5::HTS,5.125971363163671,0.023950666525561524,Other Types,hesperidin,flavanone glycoside,CACNA1B
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K40255344-001-17-6::2.5::HTS,6.252259681230803,0.012687192743829994,Intraductal Papillary Neoplasm of the Bile Duct,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K40269473-001-02-2::2.5::HTS,3.9544151422345433,0.04724278279493041,Intraductal Papillary Neoplasm of the Bile Duct,cathepsin-inhibitor-1,cathepsin inhibitor,"CTSB, CTSL, CTSV"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K40496271-396-01-1::2.34::HTS,4.728037228168938,0.030118041839303,Intraductal Papillary Neoplasm of the Bile Duct,eltrombopag,thrombopoietin receptor agonist,MPL
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K40654626-236-01-5::2.5::HTS,8.72089011679923,0.0032859496297662325,Other Types,ditiocarb-sodium-trihydrate,immunostimulant,"CA1, CA2, CA4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K40901640-003-01-6::2.5::HTS,5.442019548598367,0.020012462941736225,Other Types,cinanserin,serotonin receptor antagonist,HTR2A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K41141507-001-16-2::2.5::HTS,4.741488532703894,0.029860293132683284,Other Types,cyproterone-acetate,androgen receptor antagonist,"ADORA1, AR"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K41160163-001-06-8::2.5::HTS,4.11493743752604,0.0429787984865662,Other Types,fenobam,glutamate receptor antagonist,GRM5
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K41337261-001-03-0::2.5::HTS,6.403069813449607,0.011664186192994282,Intraductal Papillary Neoplasm of the Bile Duct,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K41779183-001-01-2::2.5::HTS,4.49006628141722,0.03453190215921609,Other Types,CB-03-01,androgen receptor antagonist,AR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K42348709-003-13-1::2.5::HTS,3.8948483367047744,0.048938194409800184,Other Types,cyclobenzaprine,"adrenergic receptor agonist, serotonin receptor agonist",HTR2A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K43164539-001-11-5::2.5::HTS,4.866741210384991,0.027794838603496907,Other Types,cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K43873574-001-01-8::2.5::HTS,4.065788033051542,0.044237168842724106,Other Types,ilepcimide,anticonvulsant,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K44273375-001-25-0::2.5::HTS,5.418099469282087,0.02029357045608036,Other Types,tolnaftate,fungal squalene epoxidase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K44309363-003-02-1::2.5::HTS,4.658004737693634,0.03134430657921895,Other Types,dexniguldipine,calmodulin antagonist,ADORA3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K44408410-001-17-6::2.5::HTS,7.807399140577024,0.005380845402177325,Intraductal Papillary Neoplasm of the Bile Duct,2-methoxyestradiol,hypoxia inducible factor inhibitor,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K45163704-001-01-5::2.5::HTS,8.8573364827415,0.003052419360328528,Intraductal Papillary Neoplasm of the Bile Duct,midafotel,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K45401373-001-22-5::2.5::HTS,3.9208168169805666,0.04819330197892897,Other Types,betulinic-acid,"apoptosis stimulant, NFkB pathway inhibitor",GPBAR1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K45841694-001-11-7::2.65::HTS,4.951855333524653,0.026484326819720714,Other Types,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K46654563-238-01-0::2.5::HTS,4.0493359208776365,0.044673967916048656,Other Types,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K46766488-003-02-0::2.5::HTS,10.064019561463057,0.0015956880683894094,Other Types,S-14506,serotonin receptor agonist,HTR1A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K47376733-001-08-1::2.5::HTS,4.029209577067106,0.045198896819613414,Other Types,JNJ-1661010,FAAH inhibitor,FAAH
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K47598052-001-15-8::2.5::HTS,7.3568977678011365,0.006890108826739072,Other Types,PP-1,src inhibitor,"HCK, RET"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K47832606-001-30-1::2.5::HTS,4.852295091592697,0.028020373892192484,Intraductal Papillary Neoplasm of the Bile Duct,floxuridine,DNA synthesis inhibitor,TYMS
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K48247567-001-01-9::2.5::HTS,4.21660504762689,0.0404974004039832,Other Types,diatrizoic-acid,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K48535733-003-01-2::2.5::HTS,9.90063405414937,0.0017403343377678957,Other Types,VU0155069,phospholipase inhibitor,PLD1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K48619321-004-16-8::2.54::HTS,4.273750708471142,0.03919211183436517,Other Types,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K48692744-001-02-0::2.5::HTS,6.0788814794357275,0.013984372560916392,Other Types,NU-1025,PARP inhibitor,PARP1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K50018155-003-02-1::2.5::HTS,3.979039148729986,0.04655492630192601,Intraductal Papillary Neoplasm of the Bile Duct,RS-67506,serotonin receptor partial agonist,HTR4
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K50406511-001-26-0::2.5::HTS,4.433035825027356,0.035696834523110954,Intraductal Papillary Neoplasm of the Bile Duct,hycanthone,RNA synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K50677762-001-01-5::2.5::HTS,6.308762782904188,0.012297541740338003,Intraductal Papillary Neoplasm of the Bile Duct,oxiracetam,acetylcholine receptor agonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K50817623-303-05-7::2.5::HTS,5.459337501027731,0.01983713612208754,Other Types,pancuronium,acetylcholine receptor antagonist,"CHRM2, CHRM3, CHRNA1, CHRNA2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K51199656-003-01-4::2.5::HTS,5.759698283290727,0.016728147540700275,Other Types,fluoromethylcholine,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K52075715-001-06-7::2.5::HTS,4.696730368302263,0.03063934588654995,Intraductal Papillary Neoplasm of the Bile Duct,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K52762805-001-01-2::2.5::HTS,4.554375782406295,0.03327316742940426,Intraductal Papillary Neoplasm of the Bile Duct,epothilone-d,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K53234107-001-01-6::2.5::HTS,10.863934609328313,0.0010427309944521985,Other Types,IWP-L6,porcupine inhibitor,PORCN
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K53561341-001-07-5::2.5::HTS,4.344920398670742,0.037573682740731876,Intraductal Papillary Neoplasm of the Bile Duct,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K54095730-001-03-1::2.5::HTS,7.958782391570038,0.004956133593101449,Intraductal Papillary Neoplasm of the Bile Duct,CMPD-1,p38 MAPK inhibitor,"GNRHR, MAPK14"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K54262262-001-09-0::2.5::HTS,6.792879112537394,0.009399863400703482,Intraductal Papillary Neoplasm of the Bile Duct,monobenzone,melanin inhibitor,TYR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K54472332-001-03-4::2.5::HTS,4.750967766564355,0.02969618253173706,Intraductal Papillary Neoplasm of the Bile Duct,elvitegravir,HIV integrase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K55013654-003-02-3::2.5::HTS,5.650728888016506,0.017784860440786816,Other Types,lorcaserin,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K55567017-001-12-3::2.5::HTS,5.542753104109002,0.018905475402481768,Other Types,formononetin,alcohol dehydrogenase inhibitor,"ADH1C, SLC5A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K55675242-001-03-0::2.5::HTS,3.9693858574965675,0.04683214393591724,Intraductal Papillary Neoplasm of the Bile Duct,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K55703048-001-07-7::2.5::HTS,4.511545584820113,0.034102853302617614,Intraductal Papillary Neoplasm of the Bile Duct,latrepirdine,glutamate receptor antagonist,"HRH1, HTR6"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K57179821-001-15-4::2.5::HTS,5.107518964295472,0.024207068156269808,Intraductal Papillary Neoplasm of the Bile Duct,crotamiton,antipruritic,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K57291914-003-09-4::2.5::HTS,5.835691237097739,0.016027332376438296,Other Types,moroxydine,antiviral,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K57718010-001-11-9::2.5::HTS,5.458811165039164,0.01982041021522389,Other Types,pentylenetetrazol,GABA receptor antagonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K58262659-001-09-7::2.5::HTS,5.373219360373155,0.020821633738891263,Intraductal Papillary Neoplasm of the Bile Duct,doxifluridine,thymidylate synthase inhibitor,TYMS
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K59036917-001-16-7::2.5::HTS,4.706426901324762,0.030468456504838044,Other Types,ML161,protease-activated receptor inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K59110290-238-01-7::2.5::HTS,5.327870593659213,0.021350455961019057,Other Types,fosamprenavir,HIV protease inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K59390331-045-01-5::2.5::HTS,16.4944962868174,5.572522378166448e-05,Other Types,tarafenacin,acetylcholine receptor antagonist,CHRM3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K59506194-015-04-9::2.5::HTS,8.468113319325905,0.003757923417535722,Other Types,targinine,nitric oxide synthase inhibitor,NOS3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K59745944-001-02-0::2.5::HTS,13.412116070809677,0.0002739783567287132,Other Types,PHT-427,"AKT inhibitor, pyruvate dehydrogenase inhibitor","AKT2, PDPK1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K60038276-001-09-0::2.5::HTS,4.314663591970875,0.03824294005045362,Other Types,irbesartan,angiotensin receptor antagonist,"AGTR1, JUN, SLC10A1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K61128465-001-09-9::2.5::HTS,7.418293650980914,0.006658255529655669,Intraductal Papillary Neoplasm of the Bile Duct,mdivi-1,dynamin inhibitor,DNM1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K61192372-001-08-9::2.5::HTS,6.268188303923774,0.012576430159107126,Other Types,capecitabine,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K61323504-001-04-0::2.5::HTS,6.475698034852851,0.011207062761121695,Intraductal Papillary Neoplasm of the Bile Duct,SB-225002,CC chemokine receptor antagonist,CXCR2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K62196610-001-01-6::2.5::HTS,4.38535833665252,0.036704336646056726,Intraductal Papillary Neoplasm of the Bile Duct,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K62696033-001-01-4::2.5::HTS,7.194040685303606,0.007530928461764606,Intraductal Papillary Neoplasm of the Bile Duct,G-1,G protein-coupled receptor agonist,GPER1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K62858456-001-01-8::2.5::HTS,4.407224181168683,0.03623643335878568,Intraductal Papillary Neoplasm of the Bile Duct,lomerizine,calcium channel blocker,"CACNA1B, SCN5A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63123526-001-01-2::2.5::HTS,4.155428803297357,0.04197555837100012,Other Types,S-methylcysteine,,"CTSD, MGMT"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63165456-001-10-8::2.5::HTS,5.326356803448088,0.021372777034318523,Intraductal Papillary Neoplasm of the Bile Duct,norcyclobenzaprine,"adrenergic receptor agonist, serotonin receptor antagonist",
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63169195-001-01-5::2.5::HTS,8.35011412710403,0.004007653679954436,Other Types,U-0124,MEK inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63630713-001-25-8::2.5::HTS,4.749168319742522,0.029730709978831964,Intraductal Papillary Neoplasm of the Bile Duct,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,"ATP1A1, SLC12A1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63750851-001-20-7::2.5::HTS,4.769583928526363,0.029380969022607725,Intraductal Papillary Neoplasm of the Bile Duct,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K63919159-003-07-0::2.5::HTS,6.451755115959771,0.011362333938826921,Other Types,aptiganel,glutamate receptor antagonist,GRIN1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K64157027-003-02-7::2.5::HTS,6.579704827556701,0.010576013643424578,Other Types,ZD-2079,adrenergic receptor agonist,ADRB3
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K64881305-001-03-7::2.5::HTS,6.934830964584998,0.008687709539180006,Intraductal Papillary Neoplasm of the Bile Duct,ispinesib,kinesin inhibitor,KIF11
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K65781196-001-03-0::2.5::HTS,4.275670955019529,0.03912704529153054,Intraductal Papillary Neoplasm of the Bile Duct,avanafil,phosphodiesterase inhibitor,PDE5A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K66788707-001-14-3::2.5::HTS,4.185399727371953,0.04124525991868084,Intraductal Papillary Neoplasm of the Bile Duct,fludarabine,ribonucleotide reductase inhibitor,"ADA, RRM1, RRM2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K67304264-001-08-5::2.5::HTS,4.247611309457179,0.0397675680280284,Other Types,SKA-31,potassium channel activator,KCNN4
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68095457-001-10-1::2.5::HTS,4.540782156360672,0.033536147055934495,Intraductal Papillary Neoplasm of the Bile Duct,palmitoylethanolamide,cannabinoid receptor agonist,"CNR2, GPR119, GPR55"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68132782-003-13-8::2.5::HTS,4.178458901785895,0.04140812144959267,Intraductal Papillary Neoplasm of the Bile Duct,terbinafine,fungal squalene epoxidase inhibitor,SQLE
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68188368-001-09-4::2.5::HTS,5.799526950266999,0.016353764802685234,Intraductal Papillary Neoplasm of the Bile Duct,nifuroxazide,bacterial DNA inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68402494-003-03-5::2.5::HTS,7.659104713979109,0.005836147440859006,Intraductal Papillary Neoplasm of the Bile Duct,ML-9,myosin light chain kinase inhibitor,TRPC6
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68532323-003-02-8::2.5::HTS,4.78292377753671,0.029156204356154965,Intraductal Papillary Neoplasm of the Bile Duct,SB-743921,kinesin-like spindle protein inhibitor,KIF11
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68552125-001-05-3::2.03::HTS,4.061556150830473,0.044347320636044726,Intraductal Papillary Neoplasm of the Bile Duct,12-O-tetradecanoylphorbol-13-acetate,PKC activator,"KCNT2, TRPV4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68567222-001-01-2::2.5::HTS,5.478133525649704,0.019609037993952333,Intraductal Papillary Neoplasm of the Bile Duct,BVT-948,tyrosine phosphatase inhibitor,"PTPN1, PTPN11, PTPN2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68653965-001-01-1::2.5::HTS,3.958356357275742,0.047126911120607295,Other Types,picolamine,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68904758-001-03-5::2.5::HTS,6.193401133212641,0.013115328957964547,Intraductal Papillary Neoplasm of the Bile Duct,cephalomannine,DNA polymerase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68938568-001-01-7::2.5::HTS,6.143646180245519,0.01348196176959127,Intraductal Papillary Neoplasm of the Bile Duct,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K69726595-001-01-2::2.5::HTS,5.346754983990236,0.021122628604650247,Intraductal Papillary Neoplasm of the Bile Duct,mericitabine,HCV inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K70327191-001-02-2::2.5::HTS,4.438997138789567,0.035573414655946704,Intraductal Papillary Neoplasm of the Bile Duct,benzoxiquine,antiinfective drug,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K71059170-001-11-6::2.5::HTS,3.9991013400115394,0.04601230485388018,Other Types,cefixime,bacterial cell wall synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K71125014-001-27-1::2.5::HTS,4.884795132097087,0.027499320503519293,Other Types,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K71221037-001-01-6::2.5::HTS,8.963035476760407,0.0028765883953245234,Intraductal Papillary Neoplasm of the Bile Duct,birinapant,XIAP inhibitor,"BIRC2, XIAP"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K71926323-001-13-8::2.5::HTS,4.710957243045273,0.030391203769219076,Other Types,marbofloxacin,bacterial DNA gyrase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K72106461-001-02-1::2.5::HTS,4.544423590443775,0.03348715612160816,Other Types,SYM-2081,kainate receptor antagonist,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K72369578-001-04-1::2.5::HTS,5.337661815973,0.021254049940847904,Other Types,AZD4282,glutamate receptor antagonist,"AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K73982490-001-02-9::2.5::HTS,4.194884762269987,0.041018645025134186,Intraductal Papillary Neoplasm of the Bile Duct,BI-78D3,JNK inhibitor,MAPK8
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K74195153-050-12-1::2.5::HTS,5.273476033617376,0.022026412853992754,Other Types,irsogladine,phosphodiesterase inhibitor,PDE4A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K74305673-001-06-2::2.5::HTS,8.555594836595168,0.0035861989852994623,Intraductal Papillary Neoplasm of the Bile Duct,IKK-2-inhibitor-V,"IKK inhibitor, NFkB pathway inhibitor",IKBKB
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K76534306-001-22-7::2.5::HTS,3.9526948543757796,0.047284530672839054,Intraductal Papillary Neoplasm of the Bile Duct,enrofloxacin,bacterial DNA gyrase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K77115421-001-02-6::2.5::HTS,5.943109722161552,0.015089422663077914,Intraductal Papillary Neoplasm of the Bile Duct,phthalylsulfacetamide,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K77634909-001-03-5::2.5::HTS,4.898743736031131,0.027280032911241422,Intraductal Papillary Neoplasm of the Bile Duct,AEG3482,HSP inducer,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K77841042-001-14-1::2.5::HTS,3.9657031897487247,0.046928497557702405,Intraductal Papillary Neoplasm of the Bile Duct,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K78122587-300-02-7::2.5::HTS,3.8822074615058626,0.049293445026703554,Other Types,NNC-55-0396,T-type calcium channel blocker,"CATSPER1, CATSPER2, CATSPER3, CATSPER4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K78126613-001-28-5::2.5::HTS,4.0572327749133255,0.044458451674772415,Intraductal Papillary Neoplasm of the Bile Duct,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K78692225-001-24-5::2.5::HTS,7.81403416651431,0.005367311347539869,Other Types,leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor","AHR, DHODH, PTK2B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K79095980-001-09-6::2.5::HTS,4.488239439633455,0.03456773406708468,Intraductal Papillary Neoplasm of the Bile Duct,broxuridine,antimetabolite,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K79145749-003-02-2::2.5::HTS,4.695877137473419,0.030666741206159635,Other Types,dibenzepine,norepinephrine reputake inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K79753741-001-01-7::2.5::HTS,5.18534108879447,0.023158561773859186,Intraductal Papillary Neoplasm of the Bile Duct,UBP-302,glutamate receptor antagonist,GRIK1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K80129304-001-08-1::2.5::HTS,7.888310227093444,0.005153671520036853,Intraductal Papillary Neoplasm of the Bile Duct,uracil,,"DPYD, UCKL1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K82142815-001-19-1::2.5::HTS,4.237670068822447,0.040000083474159204,Other Types,betamipron,panipenem uptake inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K82746043-001-15-1::2.5::HTS,6.147590334468675,0.013452259969591608,Intraductal Papillary Neoplasm of the Bile Duct,navitoclax,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K82818427-001-02-2::2.39::HTS,4.48014603879351,0.03475796448404845,Intraductal Papillary Neoplasm of the Bile Duct,batimastat,matrix metalloprotease inhibitor,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K83022601-001-01-0::2.5::HTS,5.336133484452959,0.021255728070978155,Intraductal Papillary Neoplasm of the Bile Duct,CI-844,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K83257731-003-23-5::2.5::HTS,4.683921433441439,0.030869644279421106,Intraductal Papillary Neoplasm of the Bile Duct,chloropyramine,histamine receptor antagonist,HRH1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K84925803-001-01-9::2.5::HTS,3.881134066669769,0.049336491489887,Other Types,T-5224,AP inhibitor,JUN
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K85066592-001-01-6::2.5::HTS,4.265315003161061,0.039366008304247226,Intraductal Papillary Neoplasm of the Bile Duct,gly-gln,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K85503079-001-02-8::2.5::HTS,4.346942930283311,0.0375343817817245,Other Types,perospirone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, DRD3, DRD4"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K86307448-001-17-5::2.5::HTS,3.991756049152976,0.046225387948452254,Other Types,allopurinol,xanthine oxidase inhibitor,XDH
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K87112191-001-04-5::2.5::HTS,3.946613479258692,0.047452714448399165,Intraductal Papillary Neoplasm of the Bile Duct,PP242,mTOR inhibitor,"MTOR, PASK"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K87512222-019-01-7::2.5::HTS,5.649462439937875,0.017795766476054055,Intraductal Papillary Neoplasm of the Bile Duct,taltobulin,tubulin polymerization inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K87535339-001-01-6::2.53::HTS,4.597531790657695,0.03245566512197099,Intraductal Papillary Neoplasm of the Bile Duct,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K87990216-001-10-2::2.5::HTS,5.401668381009953,0.020476291817591197,Intraductal Papillary Neoplasm of the Bile Duct,piretanide,glucocorticoid receptor agonist,"SLC12A1, SLC12A2"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K88090157-050-10-8::2.5::HTS,7.279145569853241,0.007187092363770914,Other Types,pimethixene,antihistamine,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K90065682-300-02-6::2.5::HTS,4.425346720507365,0.0358542876371446,Intraductal Papillary Neoplasm of the Bile Duct,5-iodo-A-85380,acetylcholine receptor agonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K90374350-001-09-2::2.5::HTS,5.026038759605495,0.02536972175101971,Intraductal Papillary Neoplasm of the Bile Duct,chlorquinaldol,other antibiotic,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K91623615-001-05-0::2.46::HTS,6.158524455701802,0.013388061335672165,Intraductal Papillary Neoplasm of the Bile Duct,ABT-751,tubulin polymerization inhibitor,TUBB
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K92241597-001-06-0::2.5::HTS,5.07595809150201,0.024644678604997108,Intraductal Papillary Neoplasm of the Bile Duct,tosedostat,peptidase inhibitor,"ANPEP, LAP3, NPEPPS"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K92760278-001-07-3::2.43::HTS,4.369332863977294,0.03706902833582998,Intraductal Papillary Neoplasm of the Bile Duct,riboflavin,vitamin B2,"BLVRB, RFK"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K92848252-001-01-9::2.5::HTS,3.885125135477858,0.049207603833757,Intraductal Papillary Neoplasm of the Bile Duct,diminazene-aceturate,angiotensin converting enzyme activator,"AOC1, PRDX5, PRSS1"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K93460210-001-23-7::2.5::HTS,4.906613257169161,0.027155678467838094,Other Types,lamotrigine,"serotonin receptor antagonist, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K94080537-001-09-7::2.5::HTS,5.177336426988845,0.023261731811794174,Other Types,diethyltoluamide,ionotropic receptor IR40a activator,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K95015809-001-02-8::5::HTS,3.910918080046833,0.04848234669844025,Intraductal Papillary Neoplasm of the Bile Duct,2-cyanopyrimidine,cathepsin inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K95899059-003-02-8::2.5::HTS,11.70374856192417,0.0006697374076805533,Intraductal Papillary Neoplasm of the Bile Duct,LY344864,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K96123349-236-02-8::2.5::HTS,4.976823167461154,0.026082927091998456,Intraductal Papillary Neoplasm of the Bile Duct,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K96615647-001-01-2::2.5::HTS,4.355318107563491,0.03734358975239424,Intraductal Papillary Neoplasm of the Bile Duct,AV-608,tachykinin antagonist,TACR1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K96862998-001-15-5::2.5::HTS,4.641159555591417,0.031638239180586177,Intraductal Papillary Neoplasm of the Bile Duct,pirfenidone,TGF beta receptor inhibitor,"FURIN, TNF"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K97010173-001-04-1::2.5::HTS,3.9828109876663005,0.0464498365673729,Intraductal Papillary Neoplasm of the Bile Duct,deferasirox,chelating agent,CYP3A4
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K98548675-001-05-9::2.5::HTS,6.110681676739951,0.013731806841536279,Intraductal Papillary Neoplasm of the Bile Duct,parthenolide,NFkB pathway inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K99107520-001-24-1::2.5::HTS,4.3094911908498315,0.0383584554296291,Other Types,felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K99383816-001-03-5::2.5::HTS,4.833486996405249,0.028336369147033937,Intraductal Papillary Neoplasm of the Bile Duct,ftorafur,thymidylate synthase inhibitor,TYMS
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K99545815-001-06-3::2.5::HTS,7.567708764844861,0.006133925249820962,Intraductal Papillary Neoplasm of the Bile Duct,PF-562271,focal adhesion kinase inhibitor,"PTK2, PTK2B"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-M02075109-001-01-1::2.5::HTS,5.5189242826714535,0.019162051894865008,Other Types,chromanol-(+/-),potassium channel blocker,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-M08274809-001-01-7::2.5::HTS,3.8974461655626205,0.0488822930908877,Other Types,indium(iii)-isopropoxide,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-M17926088-001-01-3::2.5::HTS,5.784349515264199,0.01651256778074428,Intraductal Papillary Neoplasm of the Bile Duct,FPA-124,AKT inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A10773072-001-03-4::2.496712929::MTS004,4.479996875040889,0.03475227529309086,Intraductal Papillary Neoplasm of the Bile Duct,glycerol-monolaurate,beta lactamase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A21446384-001-01-1::2.5::MTS004,5.635470365225054,0.017950025368234326,Intraductal Papillary Neoplasm of the Bile Duct,xibenolol,adrenergic receptor antagonist,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A25492003-003-14-1::2.568211596::MTS004,5.338001683021493,0.02124278136607744,Intraductal Papillary Neoplasm of the Bile Duct,chlortetracycline,protein synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-A48938994-001-14-1::2.5::MTS004,5.407201867053006,0.020424119665294813,Other Types,monoctanoin,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K00634421-001-01-0::2.500042819::MTS004,4.116266574279384,0.042964642124742526,Intraductal Papillary Neoplasm of the Bile Duct,brivaracetam,voltage-gated sodium channel blocker,SV2A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K01638814-011-01-4::2.587084236::MTS004,8.893363753667348,0.002991778107240869,Intraductal Papillary Neoplasm of the Bile Duct,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K02554563-001-01-6::2.5::MTS004,5.156767458946449,0.023549615380736317,Other Types,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K06357403-001-01-4::2.49996939::MTS004,4.370337391851284,0.03703847940812256,Intraductal Papillary Neoplasm of the Bile Duct,velneperit,neuropeptide receptor antagonist,NPY5R
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K06388517-001-01-2::2.5::MTS004,4.220905893266557,0.04041042211718811,Other Types,lofemizole,cyclooxygenase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K15262564-001-15-0::2.500002693::MTS004,5.2994215543100545,0.021712801030633038,Intraductal Papillary Neoplasm of the Bile Duct,mupirocin,isoleucyl-tRNA synthetase inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K17828029-001-01-5::2.536141856::MTS004,5.483102068831208,0.019565121383981452,Intraductal Papillary Neoplasm of the Bile Duct,cinoxate,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K24452555-001-01-7::2.599377769::MTS004,4.749679197072432,0.029735953242159097,Other Types,methylprednisolone-aceponate,"anti-inflammatory agent, glucocorticoid receptor agonist",NR3C1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25154476-001-01-4::2.5::MTS004,4.348487609516577,0.03751170790191534,Other Types,cinflumide,muscle relaxant,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K25494650-003-01-8::2.660853131::MTS004,4.202968124528332,0.04083740285452019,Intraductal Papillary Neoplasm of the Bile Duct,chlorproguanil,dihydrofolate reductase inhibitor,DHFR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26323068-001-01-8::2.5::MTS004,7.482035473837728,0.006437034982808555,Intraductal Papillary Neoplasm of the Bile Duct,leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K26530649-001-01-6::2.568078778::MTS004,5.048595481012869,0.025050522000331515,Intraductal Papillary Neoplasm of the Bile Duct,carboxypyridine-disulfide,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K27755542-001-01-6::2.49693186::MTS004,4.041502593523625,0.04489192481036798,Other Types,PF-04937319,glucokinase activator,GCK
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K31802667-001-01-9::2.530781625::MTS004,4.326435312893661,0.03799755012340665,Other Types,JNJ-37822681,dopamine receptor antagonist,DRD2
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K32891457-001-15-5::2.719791572::MTS004,4.03317001496604,0.045112416037265554,Other Types,cortodoxone,androgen receptor antagonist,AR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K46862739-001-14-3::2.499952208::MTS004,6.031708395811086,0.014366171420097905,Intraductal Papillary Neoplasm of the Bile Duct,metyrapone,cytochrome P450 inhibitor,CYP11B1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K51956333-001-03-8::2.52122192::MTS004,7.717597123322111,0.005659458602497688,Intraductal Papillary Neoplasm of the Bile Duct,iopodic-acid,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K55808645-001-01-4::2.500006596::MTS004,4.187419687176587,0.04121056082498375,Intraductal Papillary Neoplasm of the Bile Duct,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K56807945-001-01-2::2.500001454::MTS004,8.288054027998916,0.004149148100283988,Other Types,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,"EGLN1, EGLN2, HIF1A"
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K66845263-001-03-0::2.5::MTS004,3.9128600979373713,0.0484267805738022,Other Types,sophocarpine,,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K68432770-236-23-1::2.500029469::MTS004,8.209470863573111,0.004329845860705422,Other Types,ampicillin,bacterial cell wall synthesis inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K80762071-236-02-5::2.5::MTS004,5.578292141455318,0.01853903560605694,Other Types,indocyanine-green,contrast agent,SLCO1B1
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K96669468-300-01-1::2.5::MTS004,4.158689464059484,0.04190865488870942,Intraductal Papillary Neoplasm of the Bile Duct,pyridoxamine,AGE inhibitor,
Intraductal Papillary Neoplasm of the Bile Duct,BRD-K96874295-015-01-0::2.500009134::MTS004,10.854441469699172,0.0010503457947065638,Intraductal Papillary Neoplasm of the Bile Duct,gonadorelin,gonadotropin releasing factor hormone receptor agonist,"GNRHR, GNRHR2"
Embryonal Tumor,BRD-A03216249-003-24-3::2.5::HTS,4.6272155705309475,0.031899568720486667,Other Types,mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A
Embryonal Tumor,BRD-A09735281-001-02-5::2.5::HTS,4.170373882100225,0.04160463206647883,Embryonal Tumor,boceprevir,HCV inhibitor,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS"
Embryonal Tumor,BRD-A12230535-001-06-7::2.5::HTS,7.907240046005462,0.00510311043489585,Other Types,nutlin-3,MDM inhibitor,"MDM2, TP53"
Embryonal Tumor,BRD-A17411484-001-11-9::2.5::HTS,4.093964502224444,0.043511085120557416,Other Types,carprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Embryonal Tumor,BRD-A26032986-050-02-1::2.5::HTS,4.335958530088356,0.037769564764004004,Other Types,zaldaride,calmodulin antagonist,CALM1
Embryonal Tumor,BRD-A27883417-300-01-6::2.5::HTS,4.639448095466772,0.03168199799976547,Other Types,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1
Embryonal Tumor,BRD-A49544621-003-02-8::2.5::HTS,5.589598023102333,0.01841645518500662,Other Types,AC-7954-(+/-),urotensin receptor agonist,UTS2R
Embryonal Tumor,BRD-A96407378-001-15-1::2.5::HTS,5.170105521553526,0.023358513137606243,Other Types,allantoin,cosmetic,
Embryonal Tumor,BRD-K00494077-066-01-9::2.5::HTS,6.220165716968518,0.012928850003563646,Other Types,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A
Embryonal Tumor,BRD-K01109406-001-03-7::2.5::HTS,4.41279575091299,0.036121672143960476,Other Types,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD
Embryonal Tumor,BRD-K02475039-001-01-0::2.5::HTS,4.340577392689646,0.03766968626061598,Other Types,ethopabate,antiprotozoal agent,
Embryonal Tumor,BRD-K03243820-001-25-3::2.5::HTS,7.268747507554076,0.007232956312958886,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Embryonal Tumor,BRD-K03289018-001-02-7::2.5::HTS,6.937939540581775,0.008671136194217641,Other Types,CCT137690,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Embryonal Tumor,BRD-K07972848-001-02-0::2.5::HTS,3.8689949435961606,0.049681019316843905,Other Types,GSK2126458,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Embryonal Tumor,BRD-K08033334-003-04-3::2.5::HTS,9.469650044056548,0.002191694047941126,Other Types,lincomycin,bacterial 30S ribosomal subunit inhibitor,
Embryonal Tumor,BRD-K10598093-303-06-1::2.5::HTS,4.1183180091654545,0.04294619164865558,Other Types,hexamethonium,cholinergic receptor antagonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6"
Embryonal Tumor,BRD-K13810148-311-03-2::2.5::HTS,5.464374840282358,0.01975802597415172,Other Types,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Embryonal Tumor,BRD-K14109347-001-03-4::2.5::HTS,3.8600379941302165,0.049944988611125,Other Types,LY2603618,CHK inhibitor,CHEK1
Embryonal Tumor,BRD-K14991967-001-02-6::2.5::HTS,4.0557393240089965,0.044504378729058366,Other Types,GSK650394,serum/glucocorticoid regulated kinase inhibitor,"SGK1, SGK2"
Embryonal Tumor,BRD-K18961567-001-01-1::2.5::HTS,4.258456174849257,0.03952059908771436,Other Types,LY2801653,MET inhibitor,MET
Embryonal Tumor,BRD-K24576554-001-04-8::2.5::HTS,8.462602780740772,0.0037707271194931087,Other Types,AT-9283,"Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A"
Embryonal Tumor,BRD-K29254801-001-14-7::2.5::HTS,4.180834571008211,0.041353083522455356,Other Types,thiram,,JAK2
Embryonal Tumor,BRD-K30933884-001-01-0::2.5::HTS,4.6291270357023615,0.03186126474638979,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Embryonal Tumor,BRD-K38548312-001-01-0::2.5::HTS,4.365697273442187,0.037120985878893314,Other Types,VER-49009,HSP inhibitor,HSP90AA1
Embryonal Tumor,BRD-K42436189-001-01-2::2.5::HTS,8.970464217903688,0.002864665350969416,Other Types,AZ20,ATR kinase inhibitor,"ATR, MTOR"
Embryonal Tumor,BRD-K44067360-001-30-3::2.5::HTS,3.9129785875759513,0.048423392463582404,Other Types,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Embryonal Tumor,BRD-K55305701-001-01-2::2.5::HTS,4.0593340576630474,0.04440357480684582,Other Types,SC-144,P glycoprotein inhibitor,
Embryonal Tumor,BRD-K58122457-001-02-2::2.5::HTS,8.801273480030918,0.003139385770679712,Other Types,hesperadin,Aurora kinase inhibitor,AURKB
Embryonal Tumor,BRD-K59831625-001-01-6::2.5::HTS,4.689993312209212,0.03075866798056399,Other Types,LDN-212854,bone morphogenic protein inhibitor,"ABL1, ACVR1, RIPK2"
Embryonal Tumor,BRD-K66296774-236-11-3::2.63::HTS,7.271649117356897,0.0072242654545011655,Other Types,fluvastatin,HMGCR inhibitor,HMGCR
Embryonal Tumor,BRD-K72703948-001-10-1::2.5::HTS,5.872464040367176,0.015698870635184027,Other Types,ZM-447439,Aurora kinase inhibitor,"AURKA, AURKB"
Embryonal Tumor,BRD-K75352575-001-01-3::2.5::HTS,4.376923051051916,0.036879211586149215,Other Types,KPT-276,exportin antagonist,XPO1
Embryonal Tumor,BRD-K75958547-238-01-0::2.5::HTS,4.020745208101899,0.045424574025038626,Other Types,pitavastatin,HMGCR inhibitor,HMGCR
Embryonal Tumor,BRD-K77638923-001-02-0::2.5::HTS,4.912855132511834,0.027074258846363167,Other Types,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Embryonal Tumor,BRD-K79989959-001-01-4::2.5::HTS,5.426563372677099,0.020186043600403505,Other Types,nesbuvir,RNA polymerase inhibitor,
Embryonal Tumor,BRD-K81613478-001-01-8::2.5::HTS,7.568496094511411,0.0061340691962591225,Other Types,gastrodin,,
Embryonal Tumor,BRD-K87909389-003-03-4::2.5::HTS,3.906595472716184,0.048588033624567754,Other Types,alvocidib,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM"
Embryonal Tumor,BRD-K89272762-001-12-7::2.5::HTS,4.5507888052461425,0.033336094865960716,Other Types,NPPB,chloride channel blocker,"ANO1, CLCN2, CLCN7, TRPA1"
Embryonal Tumor,BRD-K89714990-001-01-5::2.5::HTS,8.563673696300768,0.0035690316707258315,Other Types,tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5
Embryonal Tumor,BRD-K90825648-001-02-0::2.5::HTS,5.590085959134745,0.0184014138858865,Other Types,RS-127445,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Embryonal Tumor,BRD-K96233303-001-01-9::2.5::HTS,4.107520007045631,0.04316626124412614,Other Types,TMS,,
Embryonal Tumor,BRD-K97010173-001-04-1::2.5::HTS,6.0459273653406855,0.01423931674962882,Other Types,deferasirox,chelating agent,CYP3A4
Embryonal Tumor,BRD-K97181089-003-24-7::2.5::HTS,5.005932050252402,0.02565176669174765,Other Types,amiloride,sodium channel blocker,"AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2"
Embryonal Tumor,BRD-K99107520-001-24-1::2.5::HTS,7.974997272819166,0.004912565410226138,Other Types,felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Embryonal Tumor,BRD-K09821361-066-25-8::2.499990088::MTS004,4.046684943813909,0.04475536715636076,Other Types,deferoxamine-mesylate,chelating agent,
Embryonal Tumor,BRD-K14171291-001-01-4::2.499985403::MTS004,5.230533504761946,0.022581177386932938,Other Types,omarigliptin,dipeptidyl peptidase inhibitor,DPP4
Embryonal Tumor,BRD-K28537285-001-01-8::2.499968715::MTS004,5.524009508178938,0.01911675931323195,Other Types,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Embryonal Tumor,BRD-K38564664-001-01-1::2.5::MTS004,3.9723634596693054,0.04675649276028753,Other Types,rolziracetam,,
Embryonal Tumor,BRD-K46843573-001-01-9::2.5::MTS004,4.844827865960727,0.028152330295279356,Other Types,zotarolimus,mTOR inhibitor,FKBP1A
Embryonal Tumor,BRD-K55696337-003-24-4::2.50001813::MTS004,4.5313780331012365,0.033731629730554706,Other Types,topotecan,topoisomerase inhibitor,"TOP1, TOP1MT"
Embryonal Tumor,BRD-K91543828-001-02-0::2.500044381::MTS004,4.322368442663712,0.03808682601758995,Other Types,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Embryonal Tumor,BRD-K99879819-001-02-1::2.5187366::MTS004,8.35627496316139,0.003998528475509797,Other Types,lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK
Hepatocellular Carcinoma,BRD-A00218260-001-03-4::2.5::HTS,6.685993438208679,0.009971502878560098,Other Types,flutrimazole,sterol demethylase inhibitor,
Hepatocellular Carcinoma,BRD-A07563059-035-01-3::2.5::HTS,4.447279101818583,0.035404300581739004,Hepatocellular Carcinoma,bopindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B"
Hepatocellular Carcinoma,BRD-A07780951-065-10-0::2.58::HTS,6.143051152150946,0.013505502713805776,Hepatocellular Carcinoma,metaproterenol,adrenergic receptor agonist,ADRB2
Hepatocellular Carcinoma,BRD-A07893380-213-01-7::2.5::HTS,4.4468535673025,0.03543596475021925,Hepatocellular Carcinoma,vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1"
Hepatocellular Carcinoma,BRD-A07986123-001-02-8::2.5::HTS,4.022358558595394,0.04540300536744798,Hepatocellular Carcinoma,galeterone,androgen receptor modulator,"AR, CYP17A1"
Hepatocellular Carcinoma,BRD-A08079565-001-01-8::2.5::HTS,4.3095292977473605,0.03836684450592931,Hepatocellular Carcinoma,CDBA,,
Hepatocellular Carcinoma,BRD-A11132253-001-08-2::2.5::HTS,6.281943457008695,0.012492478051461897,Hepatocellular Carcinoma,nadide,electron acceptor,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2"
Hepatocellular Carcinoma,BRD-A11662333-001-03-3::2.5::HTS,6.564770405339209,0.010679103971576473,Hepatocellular Carcinoma,meparfylon,,
Hepatocellular Carcinoma,BRD-A15297126-001-04-3::2.5::HTS,3.8845945945475284,0.049242224871788,Hepatocellular Carcinoma,fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Hepatocellular Carcinoma,BRD-A17453586-003-02-3::2.5::HTS,4.727999789828748,0.030091825755506757,Hepatocellular Carcinoma,MDL-72832,serotonin receptor agonist,HTR1A
Hepatocellular Carcinoma,BRD-A18396475-001-15-3::2.56::HTS,8.955713006745714,0.0028954351002526695,Hepatocellular Carcinoma,malic-acid,,"CS, ME2, PKD2L1"
Hepatocellular Carcinoma,BRD-A18627414-001-04-9::2.5::HTS,4.413548875836098,0.036099428574288106,Hepatocellular Carcinoma,cyanocobalamin,"methylmalonyl CoA mutase stimulant, vitamin B","MMAA, MMACHC, MTHFR, MTR, MTRR, MUT"
Hepatocellular Carcinoma,BRD-A20119038-003-07-8::2.5::HTS,3.995173800998031,0.046116222348845375,Other Types,mecamylamine,acetylcholine receptor antagonist,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Hepatocellular Carcinoma,BRD-A23127772-001-02-3::2.5::HTS,4.937538591108016,0.02668624717360833,Other Types,sclareol,,
Hepatocellular Carcinoma,BRD-A24191444-046-03-9::2.4::HTS,5.410343107278835,0.020395505249589056,Hepatocellular Carcinoma,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Hepatocellular Carcinoma,BRD-A25234499-001-18-3::2.5::HTS,5.598247394522857,0.01831917953559474,Other Types,aminoglutethimide,glucocorticoid receptor antagonist,"CYP11A1, CYP19A1"
Hepatocellular Carcinoma,BRD-A26334849-001-06-2::2.5::HTS,6.54370776542574,0.010786692507100907,Hepatocellular Carcinoma,propafenone,antiarrhythmic,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A"
Hepatocellular Carcinoma,BRD-A28301258-001-03-0::2.5::HTS,5.632507551844209,0.017970567169067322,Other Types,salinomycin,,
Hepatocellular Carcinoma,BRD-A28970875-300-04-9::2.5::HTS,9.436212375713557,0.0022348445471592248,Hepatocellular Carcinoma,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Hepatocellular Carcinoma,BRD-A29111201-001-04-8::2.5::HTS,6.956360378990437,0.00858549357597328,Hepatocellular Carcinoma,ethisterone,progestogen hormone,TYR
Hepatocellular Carcinoma,BRD-A29281099-003-03-2::2.5::HTS,4.296034273902242,0.03866997674851898,Hepatocellular Carcinoma,clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2"
Hepatocellular Carcinoma,BRD-A29520968-001-02-7::2.5::HTS,6.513818951292679,0.010971138739325556,Hepatocellular Carcinoma,acifran,cholesterol inhibitor,"HCAR2, HCAR3"
Hepatocellular Carcinoma,BRD-A30582499-003-05-1::2.5::HTS,5.37596460540317,0.020789224786140044,Hepatocellular Carcinoma,tiletamine,glutamate receptor antagonist,
Hepatocellular Carcinoma,BRD-A31095847-001-02-3::2.5::HTS,4.628441622605121,0.0318777544850098,Hepatocellular Carcinoma,mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2"
Hepatocellular Carcinoma,BRD-A32269193-001-01-5::2.5::HTS,4.168444480684466,0.04165167223682728,Hepatocellular Carcinoma,VGX-1027,tumor necrosis factor receptor antagonist,TLR4
Hepatocellular Carcinoma,BRD-A35623999-001-05-7::2.5::HTS,5.387515267903503,0.020641378384087514,Hepatocellular Carcinoma,CGP-37157,"mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor",SLC8A1
Hepatocellular Carcinoma,BRD-A41385909-001-01-3::2.5::HTS,9.445738893200023,0.002225728825200385,Hepatocellular Carcinoma,bornyl-acetate,,
Hepatocellular Carcinoma,BRD-A42746051-001-02-9::2.5::HTS,5.051197159050068,0.024999473171267893,Hepatocellular Carcinoma,melengestrol-acetate,progesterone receptor agonist,
Hepatocellular Carcinoma,BRD-A43809092-003-02-1::2.5::HTS,3.9892677919772352,0.04627956643154924,Other Types,clobutinol,antitussive,
Hepatocellular Carcinoma,BRD-A44008656-036-25-8::2.5::HTS,15.24543964254155,0.00010598023141206013,Other Types,doxylamine,histamine receptor antagonist,"CHRM1, HRH1"
Hepatocellular Carcinoma,BRD-A44500574-001-01-8::2.5::HTS,4.649007441772014,0.031498172653401,Other Types,FLI-06,notch signaling inhibitor,
Hepatocellular Carcinoma,BRD-A48300215-001-04-8::2.5::HTS,6.819622440590904,0.009264116855994738,Hepatocellular Carcinoma,ajmaline,sodium channel blocker,SCN5A
Hepatocellular Carcinoma,BRD-A49544621-003-02-8::2.5::HTS,4.296517864888594,0.03865907068198553,Hepatocellular Carcinoma,AC-7954-(+/-),urotensin receptor agonist,UTS2R
Hepatocellular Carcinoma,BRD-A51964809-003-12-6::2.5::HTS,3.9565968174220933,0.04717236326093041,Hepatocellular Carcinoma,halofantrine,antimalarial agent,"KCNH2, KCNN4"
Hepatocellular Carcinoma,BRD-A52922642-001-03-7::2.5::HTS,4.419081380074742,0.03598350632206556,Other Types,gallopamil,L-type calcium channel blocker,ATP2A2
Hepatocellular Carcinoma,BRD-A55272860-001-14-6::2.5::HTS,4.459336878981627,0.035154077301041975,Hepatocellular Carcinoma,sulpiride,dopamine receptor antagonist,
Hepatocellular Carcinoma,BRD-A55464252-001-01-2::2.5::HTS,4.31494232342856,0.03824767598418544,Hepatocellular Carcinoma,3-(4-methylbenzylidene)camphor,endocrine disruptor,
Hepatocellular Carcinoma,BRD-A56152450-001-02-0::2.5::HTS,6.5385975478928255,0.010834283192006189,Hepatocellular Carcinoma,dimercaprol,chelating agent,
Hepatocellular Carcinoma,BRD-A57133233-003-11-0::2.5::HTS,4.315297302640239,0.038231293729756595,Hepatocellular Carcinoma,chlorcyclizine,histamine receptor antagonist,HRH1
Hepatocellular Carcinoma,BRD-A58193911-003-18-7::2.5::HTS,11.9501065048474,0.0005895708113054281,Hepatocellular Carcinoma,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Hepatocellular Carcinoma,BRD-A59413292-001-08-2::2.5::HTS,5.53647538607498,0.018970839704304354,Hepatocellular Carcinoma,dexpanthenol,,
Hepatocellular Carcinoma,BRD-A61154809-001-15-9::2.5::HTS,11.11040326625107,0.0009149423033060267,Hepatocellular Carcinoma,gliclazide,"ATP channel blocker, insulin secretagogue","ABCC8, VEGFA"
Hepatocellular Carcinoma,BRD-A61194565-003-27-0::2.5::HTS,6.952420056783487,0.008605457565492941,Other Types,benserazide,DOPA decarboxylase inhibitor,DDC
Hepatocellular Carcinoma,BRD-A64092382-003-18-3::2.5::HTS,4.009054606426975,0.04575981651017542,Hepatocellular Carcinoma,mexiletine,sodium channel blocker,"AHR, SCN4A, SCN5A"
Hepatocellular Carcinoma,BRD-A66869276-001-02-9::2.5::HTS,3.8946611245174703,0.04892925513556088,Hepatocellular Carcinoma,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1
Hepatocellular Carcinoma,BRD-A66920069-001-01-3::2.5::HTS,4.100231701269073,0.0433496125437973,Hepatocellular Carcinoma,fenigam,benzodiazepine receptor agonist,"GABBR1, GABBR2"
Hepatocellular Carcinoma,BRD-A69777949-001-24-2::2.5::HTS,7.034946164757752,0.008225908073061764,Hepatocellular Carcinoma,flumequine,topoisomerase inhibitor,
Hepatocellular Carcinoma,BRD-A69815203-001-07-6::2.5::HTS,4.492858246952039,0.034515393795492046,Hepatocellular Carcinoma,cyclosporin-a,calcineurin inhibitor,PPP3CA
Hepatocellular Carcinoma,BRD-A70858459-001-01-7::2.5::HTS,7.347497694698779,0.00692158474513704,Hepatocellular Carcinoma,estramustine,DNA alkylating agent,"ESR1, ESR2, MAP1A, MAP2"
Hepatocellular Carcinoma,BRD-A72212290-300-01-4::2.5::HTS,7.693158937607323,0.005732642991145769,Hepatocellular Carcinoma,eprazinone,mucolytic agent,
Hepatocellular Carcinoma,BRD-A72711497-236-03-8::2.5::HTS,6.6350961032096425,0.010254076917984667,Other Types,lasalocid,bacterial permeability inducer,
Hepatocellular Carcinoma,BRD-A74387232-001-02-5::2.5::HTS,9.615947960022739,0.0020319722873018775,Hepatocellular Carcinoma,PMPA,glutamate receptor antagonist,FOLH1
Hepatocellular Carcinoma,BRD-A74391928-051-02-1::2.64::HTS,8.594676718661086,0.003517634524135615,Hepatocellular Carcinoma,ibutilide,potassium channel blocker,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6"
Hepatocellular Carcinoma,BRD-A74914197-001-02-9::2.5::HTS,4.621157332711925,0.03201380285582921,Hepatocellular Carcinoma,pralatrexate,dihydrofolate reductase inhibitor,"DHFR, TYMS"
Hepatocellular Carcinoma,BRD-A75552914-001-15-0::2.5::HTS,6.077741901087231,0.013991644443662838,Other Types,isoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatocellular Carcinoma,BRD-A75850590-213-01-0::2.5::HTS,5.658207478960091,0.01772382648898792,Hepatocellular Carcinoma,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A
Hepatocellular Carcinoma,BRD-A78093359-001-06-3::2.5::HTS,4.436602855425501,0.035625353257468274,Hepatocellular Carcinoma,MRS1845,calcium channel blocker,
Hepatocellular Carcinoma,BRD-A79768653-001-12-0::2.5::HTS,15.44566731830929,9.569681164709175e-05,Other Types,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Hepatocellular Carcinoma,BRD-A81129465-001-03-8::2.5::HTS,4.068878405216854,0.04417550000225677,Hepatocellular Carcinoma,fenoprofen,prostaglandin inhibitor,"PTGS1, PTGS2, SLC5A8"
Hepatocellular Carcinoma,BRD-A81233518-004-16-1::2.5::HTS,5.274906282905643,0.02200315097707222,Other Types,glycopyrrolate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Hepatocellular Carcinoma,BRD-A81513827-001-03-6::2.5::HTS,5.619710170269875,0.018102749728817442,Hepatocellular Carcinoma,saxagliptin,dipeptidyl peptidase inhibitor,DPP4
Hepatocellular Carcinoma,BRD-A84481105-003-31-3::2.5::HTS,5.710098360351812,0.017197386810188196,Hepatocellular Carcinoma,thioridazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2"
Hepatocellular Carcinoma,BRD-A85242401-001-12-3::2.5::HTS,4.294646866013996,0.038691191469834935,Hepatocellular Carcinoma,ascorbic-acid,antioxidant,"ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE"
Hepatocellular Carcinoma,BRD-A85472596-001-02-2::2.5::HTS,6.044315181174326,0.014256001439008308,Hepatocellular Carcinoma,L-670596,prostanoid receptor antagonist,
Hepatocellular Carcinoma,BRD-A91452556-001-04-0::2.5::HTS,10.369429472193763,0.0013557259139395637,Hepatocellular Carcinoma,estradiol-cypionate,estrogen receptor agonist,ESR1
Hepatocellular Carcinoma,BRD-A92800748-001-05-5::2.5::HTS,5.693892253134896,0.01735703636477157,Hepatocellular Carcinoma,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,"KDR, MAPK14"
Hepatocellular Carcinoma,BRD-A96292436-003-16-1::2.5::HTS,5.575893810972454,0.018550218622798098,Hepatocellular Carcinoma,eflornithine,ornithine decarboxylase inhibitor,"ARG2, ODC1"
Hepatocellular Carcinoma,BRD-A99888680-001-04-6::2.5::HTS,4.474371609300337,0.034849396439204774,Other Types,paliperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C"
Hepatocellular Carcinoma,BRD-K00337317-001-06-6::2.5::HTS,6.607327436973689,0.010414191716651687,Other Types,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
Hepatocellular Carcinoma,BRD-K00521308-019-01-9::2.5::HTS,8.32963658514901,0.0040515658204295394,Other Types,ATN-161,integrin antagonist,"ITGA5, ITGAV, ITGB1, ITGB3"
Hepatocellular Carcinoma,BRD-K01174345-001-01-9::2.5::HTS,4.83753583323256,0.028259023041669273,Other Types,anamorelin,growth hormone secretagogue receptor agonist,GHSR
Hepatocellular Carcinoma,BRD-K01567962-001-23-0::2.5::HTS,5.753469919919221,0.01678335442707324,Hepatocellular Carcinoma,pyrazolanthrone,JNK inhibitor,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK"
Hepatocellular Carcinoma,BRD-K02943813-001-01-9::2.5::HTS,8.327356195682714,0.004061682319687388,Hepatocellular Carcinoma,dasabuvir,HCV inhibitor,
Hepatocellular Carcinoma,BRD-K02992638-001-11-8::2.5::HTS,5.865009377159007,0.01576477355393354,Hepatocellular Carcinoma,lamivudine,nucleoside reverse transcriptase inhibitor,
Hepatocellular Carcinoma,BRD-K03243820-001-25-3::2.5::HTS,7.997308151183893,0.004856682384775598,Hepatocellular Carcinoma,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Hepatocellular Carcinoma,BRD-K03294269-001-08-0::2.5::HTS,11.037434488808435,0.0009509344774487159,Other Types,NU6027,CDK inhibitor,"CCNA2, CDK2"
Hepatocellular Carcinoma,BRD-K03406345-001-27-8::2.5::HTS,3.9274267740428948,0.04799571902649664,Hepatocellular Carcinoma,azacitidine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Hepatocellular Carcinoma,BRD-K03549949-001-01-0::2.5::HTS,5.005249650285415,0.025661788924580303,Other Types,XL388,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K04176066-001-08-3::2.5::HTS,4.664850562104769,0.031209797753294743,Hepatocellular Carcinoma,bergenin,interleukin inhibitor,"IL1B, TNF"
Hepatocellular Carcinoma,BRD-K04623885-001-07-5::2.5::HTS,3.873433401609225,0.049556142978956226,Other Types,BIBR-1532,telomerase inhibitor,TERT
Hepatocellular Carcinoma,BRD-K04923131-001-15-4::2.5::HTS,4.126970184421426,0.0426833579174263,Other Types,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Hepatocellular Carcinoma,BRD-K05446112-001-01-8::2.5::HTS,5.7298656070547835,0.017008621124789337,Hepatocellular Carcinoma,ledipasvir,HCV inhibitor,
Hepatocellular Carcinoma,BRD-K05878375-236-05-7::2.5::HTS,4.1245901644195095,0.04276475489305411,Hepatocellular Carcinoma,sodium-butyrate,HDAC inhibitor,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8"
Hepatocellular Carcinoma,BRD-K06240250-001-01-6::2.5::HTS,4.429274371272867,0.03577494080179158,Hepatocellular Carcinoma,rilpivirine,non-nucleoside reverse transcriptase inhibitor,"NR1I2, SCN10A"
Hepatocellular Carcinoma,BRD-K06388322-312-02-6::2.5::HTS,4.123803040065518,0.04275840579501336,Other Types,pramipexole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Hepatocellular Carcinoma,BRD-K06980535-003-25-9::2.5::HTS,5.443922685441058,0.020003415479560752,Hepatocellular Carcinoma,promazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C"
Hepatocellular Carcinoma,BRD-K07955840-001-02-3::2.5::HTS,5.066754179183249,0.02477743182277825,Hepatocellular Carcinoma,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Hepatocellular Carcinoma,BRD-K08078237-001-19-8::2.5::HTS,4.752689944631896,0.02969345824851281,Other Types,tetrandrine,calcium channel blocker,SLC6A3
Hepatocellular Carcinoma,BRD-K08586861-001-01-1::2.5::HTS,5.0052394331070005,0.0256794301336703,Hepatocellular Carcinoma,ramatroban,prostanoid receptor antagonist,"PTGDR2, TBXA2R"
Hepatocellular Carcinoma,BRD-K08864679-001-02-2::2.5::HTS,6.889264395896166,0.008909113638394075,Hepatocellular Carcinoma,fexaramine,FXR agonist,NR1H4
Hepatocellular Carcinoma,BRD-K08998509-001-02-4::2.5::HTS,4.729507078000538,0.030068682752502494,Hepatocellular Carcinoma,fananserin,"dopamine receptor antagonist, serotonin receptor antagonist",HTR2A
Hepatocellular Carcinoma,BRD-K09471561-001-18-2::2.5::HTS,6.984850648578773,0.008459352322200976,Hepatocellular Carcinoma,levofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Hepatocellular Carcinoma,BRD-K09635314-001-03-4::2.5::HTS,3.8942434095577494,0.04895021055486576,Hepatocellular Carcinoma,m-3M3FBS,,"PLCB2, PLCB3, PLCD1, PLCG1, PLCG2"
Hepatocellular Carcinoma,BRD-K09711437-001-04-3::2.5::HTS,8.451830065681762,0.0037968895805695914,Hepatocellular Carcinoma,varespladib,secretory phospholipase inhibitor,PLA2G2A
Hepatocellular Carcinoma,BRD-K09778810-001-10-6::2.5::HTS,6.715335217749679,0.009807115997032035,Hepatocellular Carcinoma,FGIN-1-27,inositol monophosphatase inhibitor,TSPO
Hepatocellular Carcinoma,BRD-K09900591-001-26-7::2.5::HTS,6.432433354375514,0.011492540782688215,Hepatocellular Carcinoma,caffeic-acid,"HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF"
Hepatocellular Carcinoma,BRD-K09951645-001-06-8::2.5::HTS,6.096669565645844,0.01385260045182412,Hepatocellular Carcinoma,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Hepatocellular Carcinoma,BRD-K10759144-001-04-3::2.5::HTS,4.28833355797473,0.03886010116329612,Other Types,xylose,,
Hepatocellular Carcinoma,BRD-K10974103-001-21-1::2.5::HTS,4.301509697984703,0.03853742665522638,Other Types,diloxanide,protein synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K10990317-001-04-5::2.5::HTS,6.450926310501233,0.011361518703753664,Other Types,clotiapine,,
Hepatocellular Carcinoma,BRD-K11071038-001-01-7::2.5::HTS,7.4258535709099265,0.006638629152236165,Hepatocellular Carcinoma,ICI-162846,histamine receptor antagonist,HRH2
Hepatocellular Carcinoma,BRD-K11099631-001-07-6::2.5::HTS,5.667522865311205,0.01762835378572599,Hepatocellular Carcinoma,gadoterate-meglumine,radiopaque medium,
Hepatocellular Carcinoma,BRD-K11129031-001-27-5::2.5::HTS,5.085647405247618,0.02452954663400734,Hepatocellular Carcinoma,gemfibrozil,lipoprotein lipase activator,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1"
Hepatocellular Carcinoma,BRD-K11672787-001-01-5::2.5::HTS,4.403431935800001,0.03631481850030809,Other Types,rostafuroxine,ATPase inhibitor,ATP1A1
Hepatocellular Carcinoma,BRD-K12047401-001-01-5::2.5::HTS,7.137343267130157,0.007782598059435084,Hepatocellular Carcinoma,palifosfamide,DNA alkylating agent,
Hepatocellular Carcinoma,BRD-K12102668-001-25-5::2.5::HTS,3.8969622087740303,0.04886626758550512,Hepatocellular Carcinoma,nialamide,monoamine oxidase inhibitor,"COMT, MAOA, MAOB"
Hepatocellular Carcinoma,BRD-K12184916-001-15-4::2.5::HTS,8.202491844954691,0.004340109757798977,Other Types,NVP-BEZ235,"mTOR inhibitor, PI3K inhibitor","ATR, MTOR, PIK3CA, PIK3CD, PIK3CG"
Hepatocellular Carcinoma,BRD-K12343256-001-08-9::2.5::HTS,4.110168908841856,0.04310091338116321,Other Types,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Hepatocellular Carcinoma,BRD-K12539416-001-01-4::2.5::HTS,6.306057266213677,0.012324031829527515,Hepatocellular Carcinoma,sulbutiamine,acetylcholine receptor antagonist,
Hepatocellular Carcinoma,BRD-K12737986-001-01-4::2.5::HTS,4.02650256041933,0.04528966962912462,Hepatocellular Carcinoma,veliparib,PARP inhibitor,"PARP1, PARP2"
Hepatocellular Carcinoma,BRD-K13044802-213-20-7::2.5::HTS,4.201601469157022,0.04084935813671452,Hepatocellular Carcinoma,ciclopirox,membrane integrity inhibitor,ATP1A1
Hepatocellular Carcinoma,BRD-K13078532-001-28-4::2.5::HTS,4.04697470949933,0.0447360255049935,Other Types,hydrochlorothiazide,thiazide diuretic,"CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3"
Hepatocellular Carcinoma,BRD-K13087974-001-02-5::2.5::HTS,5.946143254428018,0.015064331621719548,Other Types,CGP-52411,EGFR inhibitor,EGFR
Hepatocellular Carcinoma,BRD-K13094524-001-07-5::2.63::HTS,4.024528666763738,0.04535269463585007,Hepatocellular Carcinoma,PFI-1,bromodomain inhibitor,BRD4
Hepatocellular Carcinoma,BRD-K13249881-001-02-3::2.5::HTS,7.472363770975896,0.006471221636697422,Hepatocellular Carcinoma,piperazine,benzodiazepine receptor agonist,GABRB3
Hepatocellular Carcinoma,BRD-K13387373-004-14-5::2.5::HTS,10.068060684928255,0.0015922549834171287,Hepatocellular Carcinoma,thonzonium,ATPase inhibitor,
Hepatocellular Carcinoma,BRD-K13390322-001-06-3::2.5::HTS,4.603340480030615,0.03235003823452433,Hepatocellular Carcinoma,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Hepatocellular Carcinoma,BRD-K13514097-001-05-3::2.5::HTS,7.6970910221693085,0.005716575320735452,Other Types,everolimus,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K13606314-001-01-3::2.5::HTS,5.545124310585648,0.01887517199865964,Other Types,P5091,ubiquitin specific protease inhibitor,USP7
Hepatocellular Carcinoma,BRD-K13646352-001-03-8::2.5::HTS,4.037810135378217,0.04497599650462632,Other Types,midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG"
Hepatocellular Carcinoma,BRD-K13662825-001-07-5::2.5::HTS,4.5536505487087355,0.0332808916689227,Hepatocellular Carcinoma,dinaciclib,CDK inhibitor,"CDK1, CDK2, CDK5, CDK9"
Hepatocellular Carcinoma,BRD-K13756951-001-01-4::2.5::HTS,5.11927558175812,0.02404238933270508,Hepatocellular Carcinoma,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Hepatocellular Carcinoma,BRD-K13829090-303-02-9::2.5::HTS,6.823839286422755,0.009236752585567215,Hepatocellular Carcinoma,IEM1460,glutamate receptor antagonist,GRIA2
Hepatocellular Carcinoma,BRD-K14003026-003-09-0::2.46::HTS,4.017014130191741,0.045604682625209815,Hepatocellular Carcinoma,ritodrine,adrenergic receptor agonist,ADRB2
Hepatocellular Carcinoma,BRD-K14619660-001-01-5::2.5::HTS,4.900432969182991,0.02725432647728423,Hepatocellular Carcinoma,altrenogest,progestogen hormone,PGR
Hepatocellular Carcinoma,BRD-K14705039-001-16-4::2.5::HTS,7.919187638498084,0.005064189282508079,Other Types,sulfathiazole,dihydropteroate synthase inhibitor,
Hepatocellular Carcinoma,BRD-K14763542-001-02-3::2.5::HTS,9.139324278800986,0.0026232678129631945,Hepatocellular Carcinoma,flurothyl,,
Hepatocellular Carcinoma,BRD-K15170068-001-03-2::2.89::HTS,5.7926142568330965,0.01642896656832702,Hepatocellular Carcinoma,swainsonine,alpha mannosidase inhibitor,MAN2A1
Hepatocellular Carcinoma,BRD-K15337272-001-01-3::2.5::HTS,9.501118168548409,0.002154133485953428,Hepatocellular Carcinoma,C-751,,
Hepatocellular Carcinoma,BRD-K15791587-003-02-5::2.5::HTS,6.241222116588275,0.012768170639603197,Other Types,L-733060,tachykinin antagonist,TACR1
Hepatocellular Carcinoma,BRD-K16757695-050-02-5::2.5::HTS,8.370997934385628,0.003960923963600369,Other Types,PRX-08066,serotonin receptor antagonist,HTR2B
Hepatocellular Carcinoma,BRD-K16758059-001-01-8::2.5::HTS,4.5237202813179405,0.03389106964651047,Hepatocellular Carcinoma,perfluamine,,
Hepatocellular Carcinoma,BRD-K17223896-001-10-0::2.5::HTS,9.94050196721497,0.001703852718846306,Other Types,chloroxylenol,ATP synthase inhibitor,
Hepatocellular Carcinoma,BRD-K17518951-001-03-0::2.5::HTS,4.215113055421862,0.040561323819260794,Hepatocellular Carcinoma,penicillamine-(D),chelating agent,
Hepatocellular Carcinoma,BRD-K17894950-001-14-3::2.5::HTS,4.654633970274219,0.0313944603831185,Other Types,indirubin,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A"
Hepatocellular Carcinoma,BRD-K18323388-001-01-1::2.5::HTS,4.618010371211165,0.032070515457257934,Hepatocellular Carcinoma,uridine-triacetate,,
Hepatocellular Carcinoma,BRD-K18922609-004-23-1::2.5::HTS,4.886444481971871,0.027476224647011136,Hepatocellular Carcinoma,neostigmine,acetylcholinesterase inhibitor,ACHE
Hepatocellular Carcinoma,BRD-K19462402-003-24-6::2.5::HTS,5.568046943213247,0.018637016863649315,Hepatocellular Carcinoma,buflomedil,"adrenergic receptor antagonist, calcium channel blocker",ADRA1A
Hepatocellular Carcinoma,BRD-K19601669-001-03-5::2.5::HTS,5.032631654059024,0.025262819972921187,Hepatocellular Carcinoma,ruxolitinib-(S),JAK inhibitor,"JAK1, JAK2"
Hepatocellular Carcinoma,BRD-K19605405-001-02-7::2.5::HTS,12.688745429277336,0.0003993698533524443,Other Types,ZM-241385,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatocellular Carcinoma,BRD-K19741547-003-01-7::2.5::HTS,4.493889772349401,0.03447253334734543,Hepatocellular Carcinoma,vernakalant,potassium channel blocker,KCNA5
Hepatocellular Carcinoma,BRD-K20079257-001-09-6::2.5::HTS,4.44745896539384,0.035401411057798336,Hepatocellular Carcinoma,rufinamide,voltage-gated sodium channel blocker,"GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Hepatocellular Carcinoma,BRD-K20168442-004-06-3::2.5::HTS,3.975998263957919,0.046640177116682634,Hepatocellular Carcinoma,vecuronium,acetylcholine receptor antagonist,CHRNA2
Hepatocellular Carcinoma,BRD-K20372197-001-03-1::2.5::HTS,6.14523317963583,0.013487857015604215,Hepatocellular Carcinoma,droxidopa,norepinephrine precursor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH"
Hepatocellular Carcinoma,BRD-K20745393-003-01-0::2.5::HTS,12.04197647250481,0.0005606647456628635,Hepatocellular Carcinoma,olprinone,phosphodiesterase inhibitor,PDE3A
Hepatocellular Carcinoma,BRD-K21283037-001-21-5::2.5::HTS,4.57530762131494,0.03287244048754625,Hepatocellular Carcinoma,riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11"
Hepatocellular Carcinoma,BRD-K21528677-001-02-8::2.44::HTS,12.232861383614232,0.0005091421009203604,Hepatocellular Carcinoma,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Hepatocellular Carcinoma,BRD-K21548250-003-19-1::2.5::HTS,4.710668818610537,0.030400058364034095,Hepatocellular Carcinoma,moracizine,sodium channel blocker,SCN5A
Hepatocellular Carcinoma,BRD-K21782625-001-02-4::2.5::HTS,7.678801811052684,0.005780274222457661,Hepatocellular Carcinoma,AMG458,MET inhibitor,MET
Hepatocellular Carcinoma,BRD-K21906513-001-04-0::2.36::HTS,4.175289500944235,0.041513401852511206,Hepatocellular Carcinoma,UNC669,L3MBTL antagonist,L3MBTL1
Hepatocellular Carcinoma,BRD-K22097830-001-01-9::2.5::HTS,14.110686106347197,0.00019061246696898583,Other Types,OCO-1112,cholesterol inhibitor,
Hepatocellular Carcinoma,BRD-K23403298-003-01-9::2.5::HTS,11.004973137403374,0.000969158941485612,Hepatocellular Carcinoma,benzyldimethylhexadecylammonium,cationic surfactant,
Hepatocellular Carcinoma,BRD-K23566484-001-15-1::2.5::HTS,5.424793864263658,0.020208849425447255,Hepatocellular Carcinoma,nilutamide,androgen receptor antagonist,AR
Hepatocellular Carcinoma,BRD-K23976833-001-01-0::2.5::HTS,4.838995908216658,0.028233095704399816,Hepatocellular Carcinoma,travoprost,prostanoid receptor agonist,PTGFR
Hepatocellular Carcinoma,BRD-K24048528-001-02-5::2.5::HTS,4.950346610463289,0.026520436604826874,Hepatocellular Carcinoma,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1
Hepatocellular Carcinoma,BRD-K24242599-001-02-8::2.5::HTS,6.508346467416396,0.011002146348667008,Hepatocellular Carcinoma,GW-2580,cFMS kinase inhibitor,CSF1R
Hepatocellular Carcinoma,BRD-K24258499-001-05-8::2.5::HTS,4.20114852699949,0.04087378484653546,Other Types,vanillin,,"ABAT, ALDH5A1"
Hepatocellular Carcinoma,BRD-K24556407-001-02-3::2.5::HTS,4.7669480764322065,0.029426337165108524,Other Types,ETP-46464,ATR kinase inhibitor,
Hepatocellular Carcinoma,BRD-K24576554-001-04-8::2.5::HTS,3.950539418258654,0.04734821445965635,Other Types,AT-9283,"Aurora kinase inhibitor, JAK inhibitor","AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A"
Hepatocellular Carcinoma,BRD-K24603946-001-02-1::2.5::HTS,6.322839395725929,0.012199384813183103,Other Types,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3
Hepatocellular Carcinoma,BRD-K25359048-001-02-6::2.5::HTS,8.381288072987616,0.003938363250013383,Hepatocellular Carcinoma,WZ811,CC chemokine receptor antagonist,CXCR4
Hepatocellular Carcinoma,BRD-K25837718-001-03-8::2.5::HTS,5.051417607817803,0.025004207638581497,Hepatocellular Carcinoma,josamycin,bacterial 50S ribosomal subunit inhibitor,
Hepatocellular Carcinoma,BRD-K26349472-001-01-3::2.5::HTS,8.043716411005114,0.004741427019242933,Hepatocellular Carcinoma,OG-L002,histone lysine demethylase inhibitor,KDM1A
Hepatocellular Carcinoma,BRD-K26531771-001-01-4::2.5::HTS,4.832812205268527,0.028329961837749437,Hepatocellular Carcinoma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Hepatocellular Carcinoma,BRD-K26531771-001-02-2::2.35::HTS,6.922975685722775,0.008758211488393028,Hepatocellular Carcinoma,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Hepatocellular Carcinoma,BRD-K26573499-300-02-1::2.5::HTS,5.661563617535418,0.017676453438964106,Hepatocellular Carcinoma,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7
Hepatocellular Carcinoma,BRD-K26619122-001-02-1::2.5::HTS,4.636565632316172,0.031734793346980525,Hepatocellular Carcinoma,thiocolchicoside,GABA receptor antagonist,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB"
Hepatocellular Carcinoma,BRD-K26667523-001-02-5::2.5::HTS,8.246356431108895,0.004239658829282979,Other Types,TAK-733,MEK inhibitor,MAP2K1
Hepatocellular Carcinoma,BRD-K26739552-003-15-4::2.5::HTS,5.738699210729067,0.01693520471440626,Hepatocellular Carcinoma,fenspiride,bronchodilator,
Hepatocellular Carcinoma,BRD-K27217864-001-22-3::2.5::HTS,6.716871433979251,0.009801921670989925,Other Types,butamben,sodium channel blocker,
Hepatocellular Carcinoma,BRD-K27406233-001-07-7::2.5::HTS,5.713561833069822,0.01716562358657609,Hepatocellular Carcinoma,acetyl-l-leucine,,
Hepatocellular Carcinoma,BRD-K27871792-001-01-8::2.5::HTS,5.282675926177673,0.021904809594321527,Hepatocellular Carcinoma,flucloxacillin,bacterial cell wall synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K28143534-001-02-2::2.5::HTS,4.028252077805087,0.045243087809174444,Hepatocellular Carcinoma,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K28383148-001-01-4::2.5::HTS,6.060134564364092,0.014128071800139622,Hepatocellular Carcinoma,AP1903,,
Hepatocellular Carcinoma,BRD-K28405228-001-06-7::2.5::HTS,4.298745222024884,0.03860210893046305,Other Types,mecarbinate,,
Hepatocellular Carcinoma,BRD-K28849549-001-13-4::2.5::HTS,11.666575929422836,0.0006853176168292079,Hepatocellular Carcinoma,mesalazine,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2"
Hepatocellular Carcinoma,BRD-K29735307-001-02-9::2.5::HTS,14.91510656393419,0.00012554202800192023,Hepatocellular Carcinoma,ostarine,androgen receptor modulator,AR
Hepatocellular Carcinoma,BRD-K30019776-003-01-5::2.5::HTS,6.8365318071625705,0.009186380920315863,Hepatocellular Carcinoma,dexfosfoserine,membrane integrity inhibitor,"CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2"
Hepatocellular Carcinoma,BRD-K30685142-001-15-4::2.5::HTS,5.803613700154784,0.016318539485736843,Other Types,levothyroxine,thyroid hormone stimulant,"THRA, THRB"
Hepatocellular Carcinoma,BRD-K31086665-005-04-6::2.5::HTS,4.100786212556568,0.04333804182220348,Hepatocellular Carcinoma,NH125,eukaryotic translation elongation factor 2 inhibitor,
Hepatocellular Carcinoma,BRD-K31468676-237-01-8::2.5::HTS,5.8354139222785095,0.016038873445274868,Hepatocellular Carcinoma,oxonic-acid,uricase inhibitor,
Hepatocellular Carcinoma,BRD-K31476763-001-01-5::2.5::HTS,4.209206573636952,0.04067555363123593,Hepatocellular Carcinoma,AZD9668,elastase inhibitor,ELANE
Hepatocellular Carcinoma,BRD-K31495718-001-01-1::2.5::HTS,6.651643415430134,0.010163173964036591,Hepatocellular Carcinoma,AZD7687,diacylglycerol O acyltransferase inhibitor,DGAT1
Hepatocellular Carcinoma,BRD-K32107296-001-16-9::2.5::HTS,4.092732178662995,0.043547721646653895,Hepatocellular Carcinoma,temozolomide,DNA alkylating agent,MGMT
Hepatocellular Carcinoma,BRD-K32372024-001-01-0::2.5::HTS,4.673058422829982,0.031093109296477326,Hepatocellular Carcinoma,D-7193,,
Hepatocellular Carcinoma,BRD-K32768103-051-02-6::2.5::HTS,15.57399525333988,8.944909141528767e-05,Hepatocellular Carcinoma,vonoprazan,potassium-competitive acid antagonist,ATP4A
Hepatocellular Carcinoma,BRD-K33211335-004-01-7::2.5::HTS,4.88756561800985,0.02746002834913124,Other Types,dextromethorphan,"glutamate receptor antagonist, sigma receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4"
Hepatocellular Carcinoma,BRD-K33720171-001-01-0::2.5::HTS,4.172217122584149,0.04157175105935828,Hepatocellular Carcinoma,difluprednate,glucocorticoid receptor agonist,NR3C1
Hepatocellular Carcinoma,BRD-K33809398-001-01-8::2.5::HTS,19.516182434067368,1.2108697553242263e-05,Hepatocellular Carcinoma,SCMC-Lys,mucolytic agent,GSTP1
Hepatocellular Carcinoma,BRD-K33892651-001-02-4::2.5::HTS,4.70260676056868,0.03053866939607317,Hepatocellular Carcinoma,ML347,ALK tyrosine kinase receptor inhibitor,"ACVR1, ACVRL1, BMPR1A"
Hepatocellular Carcinoma,BRD-K34441861-003-07-0::2.47::HTS,6.4633810211882965,0.01129650824820073,Hepatocellular Carcinoma,moexipril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Hepatocellular Carcinoma,BRD-K34672903-001-01-7::2.5::HTS,6.027572873554278,0.014387591591960916,Hepatocellular Carcinoma,HEMADO,,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatocellular Carcinoma,BRD-K34888156-213-01-4::2.5::HTS,5.3747783017543265,0.020793088693414553,Hepatocellular Carcinoma,theobromine,phosphodiesterase inhibitor,"ADORA1, ADORA2A, PDE4B"
Hepatocellular Carcinoma,BRD-K35170555-001-09-5::2.5::HTS,3.9471135147140766,0.04746825012114241,Hepatocellular Carcinoma,caprylic-acid,,
Hepatocellular Carcinoma,BRD-K35240538-001-26-2::2.5::HTS,6.317885588292629,0.012243597864388868,Hepatocellular Carcinoma,methylprednisolone,glucocorticoid receptor agonist,NR3C1
Hepatocellular Carcinoma,BRD-K36198571-001-02-0::2.5::HTS,5.542424723707022,0.018924801289741226,Other Types,WAY-170523,metalloproteinase inhibitor,MMP13
Hepatocellular Carcinoma,BRD-K36207157-001-09-6::2.5::HTS,4.468167845289372,0.03497352121515644,Hepatocellular Carcinoma,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Hepatocellular Carcinoma,BRD-K36234266-001-09-8::2.5::HTS,5.532568444704997,0.019031940351800676,Hepatocellular Carcinoma,carmustine,"DNA alkylating agent, DNA inhibitor",GSR
Hepatocellular Carcinoma,BRD-K36627727-001-05-4::2.5::HTS,5.129583560764493,0.02390269589448342,Other Types,tamibarotene,retinoid receptor agonist,"RARA, RARB"
Hepatocellular Carcinoma,BRD-K37590257-001-02-8::2.5::HTS,4.494619119343018,0.034452099143900655,Hepatocellular Carcinoma,GSK256066,phosphodiesterase inhibitor,PDE4A
Hepatocellular Carcinoma,BRD-K37618799-001-03-0::2.5::HTS,12.122932699969287,0.0005371261096906492,Other Types,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Hepatocellular Carcinoma,BRD-K37687095-001-06-9::2.5::HTS,5.000094480035103,0.025737633525064033,Other Types,AZD8330,MEK inhibitor,
Hepatocellular Carcinoma,BRD-K37890730-001-15-1::2.5::HTS,4.70813006190159,0.03045082126608461,Hepatocellular Carcinoma,camptothecin,topoisomerase inhibitor,TOP1
Hepatocellular Carcinoma,BRD-K38140108-002-01-2::2.5::HTS,4.916556518420773,0.02700049013366386,Other Types,gadodiamide,radiopaque medium,
Hepatocellular Carcinoma,BRD-K38350380-001-01-8::2.5::HTS,4.954033715735385,0.02643148029244712,Other Types,FK-3311,cyclooxygenase inhibitor,PTGS2
Hepatocellular Carcinoma,BRD-K38458514-001-01-8::2.5::HTS,6.109272990812471,0.013755284095458085,Hepatocellular Carcinoma,diazooxonorleucine,glutamate receptor antagonist,
Hepatocellular Carcinoma,BRD-K38602774-001-03-2::2.5::HTS,3.9843344586589082,0.046411628849117814,Other Types,sulisobenzone,,
Hepatocellular Carcinoma,BRD-K39061174-001-01-0::2.62::HTS,13.960267357052757,0.0002070618969059182,Hepatocellular Carcinoma,beta-glycerophosphoric-acid,,
Hepatocellular Carcinoma,BRD-K39252998-003-01-5::2.5::HTS,4.637839381046691,0.0317114519537031,Hepatocellular Carcinoma,atipamezole,adrenergic receptor antagonist,
Hepatocellular Carcinoma,BRD-K39915878-036-24-4::2.5::HTS,3.876557410888883,0.049470172053890496,Hepatocellular Carcinoma,loxapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4"
Hepatocellular Carcinoma,BRD-K39987650-001-24-1::2.5::HTS,5.025044541860792,0.025376219839706705,Hepatocellular Carcinoma,bisacodyl,laxative,
Hepatocellular Carcinoma,BRD-K40227168-001-12-9::1.7::HTS,8.997324022952116,0.00282707828413385,Hepatocellular Carcinoma,vinburnine,adrenergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Hepatocellular Carcinoma,BRD-K40496271-396-01-1::2.34::HTS,4.1594057396341855,0.04190123693480485,Hepatocellular Carcinoma,eltrombopag,thrombopoietin receptor agonist,MPL
Hepatocellular Carcinoma,BRD-K40901640-003-01-6::2.5::HTS,3.937984302974317,0.04769669355389569,Hepatocellular Carcinoma,cinanserin,serotonin receptor antagonist,HTR2A
Hepatocellular Carcinoma,BRD-K41024817-325-01-0::2.5::HTS,5.671198017945658,0.01758740137930909,Other Types,4-phenolsulfonic-acid,,
Hepatocellular Carcinoma,BRD-K41213548-001-02-0::2.5::HTS,6.676315472521494,0.010028880840695642,Hepatocellular Carcinoma,KW-2478,HSP inhibitor,
Hepatocellular Carcinoma,BRD-K41256143-001-12-7::2.5::HTS,3.987617959074828,0.0463317341761606,Hepatocellular Carcinoma,dehydroepiandrosterone,protein synthesis stimulant,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1"
Hepatocellular Carcinoma,BRD-K41438959-001-01-7::2.5::HTS,8.424042006791053,0.0038481724058062683,Hepatocellular Carcinoma,perampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Hepatocellular Carcinoma,BRD-K41876534-001-13-7::2.5::HTS,7.913256736309093,0.005080581122019686,Other Types,tioxolone,carbonic anhydrase inhibitor,CA2
Hepatocellular Carcinoma,BRD-K42205652-001-02-7::2.5::HTS,8.99240288595787,0.002831018798011463,Hepatocellular Carcinoma,"MNS-(3,4-Methylenedioxy-nitrostyrene)","src inhibitor, syk inhibitor","SRC, SYK"
Hepatocellular Carcinoma,BRD-K42452249-001-02-5::2.5::HTS,4.1567396821874185,0.04194505281416056,Other Types,EO-1428,p38 MAPK inhibitor,"MAPK11, MAPK14"
Hepatocellular Carcinoma,BRD-K42898655-001-01-8::2.5::HTS,7.796470172080657,0.00541303274223981,Other Types,temsirolimus,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K42959922-001-01-5::2.5::HTS,6.03036361340682,0.014372359845110299,Hepatocellular Carcinoma,trans-2-Undecenoic-acid,,
Hepatocellular Carcinoma,BRD-K42973005-001-04-0::2.5::HTS,8.139959545924299,0.0044900835346027195,Other Types,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Hepatocellular Carcinoma,BRD-K43106192-320-11-8::2.5::HTS,7.908262315967277,0.0051040383826000514,Hepatocellular Carcinoma,gallamine-triethiodide,acetylcholine receptor antagonist,"ACHE, CHRM2, CHRNA1, CHRNA2"
Hepatocellular Carcinoma,BRD-K43187018-001-03-3::2.52::HTS,4.313528481802557,0.038293435134834374,Other Types,GDC-0349,Pim kinase inhibitor,PIK3CA
Hepatocellular Carcinoma,BRD-K43236057-001-07-1::2.6::HTS,13.300000422243379,0.00029171673883696467,Hepatocellular Carcinoma,polydatin,ICAM1 expression inhibitor,ICAM1
Hepatocellular Carcinoma,BRD-K43449605-001-01-0::2.5::HTS,5.2130333943148015,0.022796020192830658,Other Types,oncrasin-1,apoptosis stimulant,
Hepatocellular Carcinoma,BRD-K43621685-001-02-5::2.5::HTS,4.214714919195405,0.040541348945032384,Hepatocellular Carcinoma,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Hepatocellular Carcinoma,BRD-K43802723-340-01-9::2.5::HTS,6.746133987775059,0.009641248230550535,Other Types,AMG-837,free fatty acid receptor agonist,FFAR1
Hepatocellular Carcinoma,BRD-K43887077-003-26-3::2.5::HTS,5.469548617144357,0.019710470190837548,Hepatocellular Carcinoma,dopamine,dopamine receptor agonist,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4"
Hepatocellular Carcinoma,BRD-K44067360-001-30-3::2.5::HTS,4.131272589236722,0.042587357313156854,Hepatocellular Carcinoma,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Hepatocellular Carcinoma,BRD-K44353683-001-08-3::2.5::HTS,12.437450397269455,0.0004562044229263959,Hepatocellular Carcinoma,nateglinide,insulin secretagogue,"ABCC8, KCNJ10, KCNJ11, PPARG"
Hepatocellular Carcinoma,BRD-K44366189-001-01-9::2.5::HTS,6.724302567658888,0.009758521581126755,Hepatocellular Carcinoma,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Hepatocellular Carcinoma,BRD-K44665581-001-01-8::2.5::HTS,9.542224720512207,0.0021079354991115225,Hepatocellular Carcinoma,bromosporine,bromodomain inhibitor,
Hepatocellular Carcinoma,BRD-K45158365-001-11-4::2.5::HTS,6.567997682880949,0.01064979637204999,Hepatocellular Carcinoma,valsartan,angiotensin receptor antagonist,AGTR1
Hepatocellular Carcinoma,BRD-K45216060-001-10-0::2.5::HTS,3.9664029125118483,0.0469047208078401,Other Types,mequinol,,TYR
Hepatocellular Carcinoma,BRD-K46435528-001-04-4::2.5::HTS,4.142109198466551,0.042327915339015254,Hepatocellular Carcinoma,trichloroethylene,,
Hepatocellular Carcinoma,BRD-K46523383-003-22-9::2.5::HTS,5.096139297372896,0.024364899180060524,Hepatocellular Carcinoma,pramoxine,topical anesthetic,
Hepatocellular Carcinoma,BRD-K46654563-238-01-0::2.5::HTS,3.993090869158807,0.04617723693924214,Hepatocellular Carcinoma,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE
Hepatocellular Carcinoma,BRD-K46937689-001-15-0::2.5::HTS,6.700066852956517,0.009898729194218166,Hepatocellular Carcinoma,phenazone,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatocellular Carcinoma,BRD-K47079459-004-04-6::2.5::HTS,25.32463058821635,6.58708254238469e-07,Hepatocellular Carcinoma,cetrimonium,,
Hepatocellular Carcinoma,BRD-K47105409-001-14-5::2.5::HTS,4.01650142556719,0.04554338432492206,Hepatocellular Carcinoma,AG-490,"EGFR inhibitor, JAK inhibitor","EGFR, JAK2, JAK3"
Hepatocellular Carcinoma,BRD-K47323024-003-24-4::2.5::HTS,4.114907076800841,0.04298125996126826,Hepatocellular Carcinoma,methapyrilene,histamine receptor antagonist,HRH1
Hepatocellular Carcinoma,BRD-K47635719-001-21-1::2.5::HTS,7.4984696657805445,0.006371655097993595,Hepatocellular Carcinoma,dexamethasone-acetate,glucocorticoid receptor agonist,
Hepatocellular Carcinoma,BRD-K48195801-001-01-6::2.5::HTS,9.403217601007062,0.002273496546904726,Hepatocellular Carcinoma,tecastemizole,histamine receptor antagonist,KCNH2
Hepatocellular Carcinoma,BRD-K48488978-001-05-3::2.5::HTS,5.167918538916579,0.02339041434122081,Other Types,YM-201636,PI3K inhibitor,
Hepatocellular Carcinoma,BRD-K48684885-001-04-2::2.5::HTS,3.9509533405329704,0.0473366559704732,Hepatocellular Carcinoma,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Hepatocellular Carcinoma,BRD-K49049886-001-08-7::2.5::HTS,7.360562264076868,0.0068743675161695925,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatocellular Carcinoma,BRD-K49294207-300-03-8::2.5::HTS,3.9756305751391814,0.046654701112916204,Other Types,BIBU-1361,EGFR inhibitor,EGFR
Hepatocellular Carcinoma,BRD-K49522529-001-02-9::2.53::HTS,8.202549169315942,0.004349570487627379,Hepatocellular Carcinoma,alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR"
Hepatocellular Carcinoma,BRD-K49840922-001-05-1::2.5::HTS,4.257690830215105,0.039539955609214264,Other Types,etofylline-clofibrate,platelet aggregation inhibitor,PPARA
Hepatocellular Carcinoma,BRD-K49865102-001-08-4::2.5::HTS,5.606292458032724,0.018240443021544248,Other Types,PD-0325901,MEK inhibitor,MAP2K1
Hepatocellular Carcinoma,BRD-K49945136-001-10-0::2.5::HTS,4.835179398804359,0.028299571897246783,Hepatocellular Carcinoma,GR-113808,serotonin receptor antagonist,HTR4
Hepatocellular Carcinoma,BRD-K50677762-001-01-5::2.5::HTS,4.873849940812832,0.027675616005346796,Hepatocellular Carcinoma,oxiracetam,acetylcholine receptor agonist,
Hepatocellular Carcinoma,BRD-K50938287-036-13-8::2.5::HTS,5.456828381834957,0.0198458491070884,Hepatocellular Carcinoma,sumatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K51350053-048-16-5::2.5::HTS,6.585544404920752,0.010538991150565488,Hepatocellular Carcinoma,toremifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",ESR1
Hepatocellular Carcinoma,BRD-K51662849-001-05-4::2.5::HTS,5.551189170000722,0.018825192697885972,Hepatocellular Carcinoma,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Hepatocellular Carcinoma,BRD-K51662849-001-08-8::2.61::HTS,3.929734466805075,0.047959339099279075,Hepatocellular Carcinoma,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Hepatocellular Carcinoma,BRD-K52618540-001-09-9::2.5::HTS,17.23646071558168,3.8358936788023274e-05,Hepatocellular Carcinoma,inositol,insulin sensitizer,"CDIPT, GBA"
Hepatocellular Carcinoma,BRD-K52989797-003-26-4::2.5::HTS,5.975696536864053,0.014810519198062585,Hepatocellular Carcinoma,clomipramine,serotonin transporter (SERT) inhibitor,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Hepatocellular Carcinoma,BRD-K53234107-001-01-6::2.5::HTS,5.309597528942487,0.021573992638613537,Other Types,IWP-L6,porcupine inhibitor,PORCN
Hepatocellular Carcinoma,BRD-K54187111-001-08-4::2.51::HTS,3.8878198820624577,0.049159098933675024,Hepatocellular Carcinoma,dichlorisone-acetate,,
Hepatocellular Carcinoma,BRD-K54606188-001-13-1::2.5::HTS,4.649403653361951,0.03148792398764575,Hepatocellular Carcinoma,JQ1-(+),bromodomain inhibitor,"BRD4, BRDT"
Hepatocellular Carcinoma,BRD-K54665485-001-07-9::2.5::HTS,4.058690462807858,0.04442465030088155,Hepatocellular Carcinoma,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA
Hepatocellular Carcinoma,BRD-K54790157-001-15-5::2.5::HTS,5.4755981164824234,0.0196359430328897,Other Types,trioxsalen,DNA synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K54824716-001-04-0::2.5::HTS,4.523761212112318,0.03386533752130956,Hepatocellular Carcinoma,procodazole,immunostimulant,
Hepatocellular Carcinoma,BRD-K55013654-003-02-3::2.5::HTS,6.069584869102937,0.0140540473666963,Hepatocellular Carcinoma,lorcaserin,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C"
Hepatocellular Carcinoma,BRD-K55044200-001-14-6::2.5::HTS,4.810444107850022,0.0287230883611121,Hepatocellular Carcinoma,amoxicillin,penicillin binding protein inhibitor,"CYP2C19, SLC15A1, SLC15A2, SLC22A6"
Hepatocellular Carcinoma,BRD-K55468218-001-26-1::2.5::HTS,4.681218649498238,0.030917828582944156,Hepatocellular Carcinoma,spiperone,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K55847762-304-01-7::2.5::HTS,5.663901175971918,0.017650159637253755,Hepatocellular Carcinoma,lobenzarit,immunosuppressant,
Hepatocellular Carcinoma,BRD-K57284066-001-01-6::2.5::HTS,4.596763128965417,0.0324607351969195,Hepatocellular Carcinoma,Ro-9187,HCV inhibitor,
Hepatocellular Carcinoma,BRD-K57304726-003-06-9::2.5::HTS,12.969705513359063,0.00034459987230715854,Hepatocellular Carcinoma,PRE-084,sigma receptor agonist,SIGMAR1
Hepatocellular Carcinoma,BRD-K57313110-001-06-8::2.5::HTS,5.329423645897271,0.02133292910910551,Hepatocellular Carcinoma,pidolic-acid,,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA"
Hepatocellular Carcinoma,BRD-K57432881-003-21-8::2.5::HTS,4.91065194088026,0.027091394229371908,Hepatocellular Carcinoma,tiapride,dopamine receptor antagonist,"DRD2, DRD3"
Hepatocellular Carcinoma,BRD-K57545991-050-23-1::2.5::HTS,5.666089406405006,0.01762837989334678,Hepatocellular Carcinoma,enalapril,angiotensin converting enzyme inhibitor,ACE
Hepatocellular Carcinoma,BRD-K58513245-304-02-7::2.5::HTS,4.725890490151993,0.03015531337360454,Hepatocellular Carcinoma,pamidronate,bone resorption inhibitor,FDPS
Hepatocellular Carcinoma,BRD-K59037100-001-14-7::2.5::HTS,4.205183171088973,0.04076384559667666,Hepatocellular Carcinoma,oxybenzone,lipase inhibitor,LIPE
Hepatocellular Carcinoma,BRD-K59184148-001-21-6::2.5::HTS,4.614680887199698,0.032132298133185924,Other Types,SB-216763,glycogen synthase kinase inhibitor,"CCNA2, CDK2, GSK3A, GSK3B"
Hepatocellular Carcinoma,BRD-K60038276-001-09-0::2.5::HTS,6.300955461568059,0.012349655985937865,Other Types,irbesartan,angiotensin receptor antagonist,"AGTR1, JUN, SLC10A1"
Hepatocellular Carcinoma,BRD-K61177364-003-02-9::2.5::HTS,5.44615186603105,0.019965646335540342,Hepatocellular Carcinoma,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1
Hepatocellular Carcinoma,BRD-K61250484-001-02-3::2.5::HTS,7.706708067737776,0.005686284916859544,Hepatocellular Carcinoma,FPH1-(BRD-6125),hepatocyte function enhancer,
Hepatocellular Carcinoma,BRD-K61314889-001-05-1::2.5::HTS,8.95182062129787,0.0028953553309109775,Other Types,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Hepatocellular Carcinoma,BRD-K61717546-001-04-3::2.5::HTS,7.11827624764828,0.007853592306196451,Other Types,fleroxacin,topoisomerase inhibitor,
Hepatocellular Carcinoma,BRD-K62736196-015-11-0::2.41::HTS,5.800000943830593,0.016367836004033562,Hepatocellular Carcinoma,guanaben-acetate,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Hepatocellular Carcinoma,BRD-K62779383-001-05-5::2.38::HTS,7.500232097106149,0.006377500455337026,Hepatocellular Carcinoma,cholecalciferol,,VDR
Hepatocellular Carcinoma,BRD-K63123526-001-01-2::2.5::HTS,3.887662217726574,0.049139182191386764,Hepatocellular Carcinoma,S-methylcysteine,,"CTSD, MGMT"
Hepatocellular Carcinoma,BRD-K63126190-003-01-6::2.5::HTS,3.9486093692019932,0.04741120112033044,Hepatocellular Carcinoma,epinephrine,"adrenergic receptor agonist, neurotransmitter","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF"
Hepatocellular Carcinoma,BRD-K63516691-003-02-0::2.5::HTS,11.552435575830607,0.0007252729809454343,Hepatocellular Carcinoma,T-0156,phosphodiesterase inhibitor,PDE5A
Hepatocellular Carcinoma,BRD-K64341947-003-02-4::2.5::HTS,4.712021640896971,0.03037331058789343,Hepatocellular Carcinoma,CFM-1571,guanylate cyclase activator,
Hepatocellular Carcinoma,BRD-K64557645-001-02-4::2.5::HTS,3.9859477475305494,0.04636320557232881,Hepatocellular Carcinoma,zotepine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4"
Hepatocellular Carcinoma,BRD-K64785675-001-04-0::2.5::HTS,4.082084239941882,0.043813990242972216,Other Types,TG100-115,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Hepatocellular Carcinoma,BRD-K64990126-004-01-1::2.5::HTS,6.012528917529882,0.014507774676278966,Hepatocellular Carcinoma,scopolamine,acetylcholine receptor antagonist,
Hepatocellular Carcinoma,BRD-K65359424-001-01-3::2.5::HTS,6.556860980651177,0.010719841462144419,Hepatocellular Carcinoma,eglumetad,glutamate receptor agonist,"GRM2, GRM3, GRM6, GRM8"
Hepatocellular Carcinoma,BRD-K66035042-001-10-1::2.5::HTS,5.593003048401895,0.01837415570946941,Other Types,sorbitol,mucolytic agent,
Hepatocellular Carcinoma,BRD-K67102207-236-07-7::2.5::HTS,5.8864516657660095,0.015575980398354674,Hepatocellular Carcinoma,phenylbutyrate,HDAC inhibitor,HDAC1
Hepatocellular Carcinoma,BRD-K67173685-001-06-9::2.39::HTS,8.24051319363849,0.004260910566167125,Hepatocellular Carcinoma,4E1RCat,protein synthesis inhibitor,"EIF4E, EIF4G1"
Hepatocellular Carcinoma,BRD-K67511046-001-02-3::2.5::HTS,4.435196352456035,0.03566699671128521,Hepatocellular Carcinoma,naloxone,opioid receptor antagonist,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4"
Hepatocellular Carcinoma,BRD-K67536197-003-11-4::2.5::HTS,5.2177103611279865,0.022732663139036227,Hepatocellular Carcinoma,cyclocytidine,"DNA synthesis inhibitor, RNA synthesis inhibitor",
Hepatocellular Carcinoma,BRD-K67566344-001-07-5::2.5::HTS,13.6441395208607,0.00024283547607747034,Other Types,ku-0063794,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K68474068-001-01-8::2.5::HTS,6.434444151951371,0.011464201753834086,Hepatocellular Carcinoma,MM-102,WDR5/MLL interaction inhibitor,
Hepatocellular Carcinoma,BRD-K68553471-003-12-3::2.5::HTS,4.830063113985592,0.02837843207057755,Hepatocellular Carcinoma,todralazine,antihypertensive agent,
Hepatocellular Carcinoma,BRD-K68870568-066-01-5::2.5::HTS,5.734343380433179,0.016963990688688462,Hepatocellular Carcinoma,flumatinib,Bcr-Abl kinase inhibitor,"ABL1, PDGFRB"
Hepatocellular Carcinoma,BRD-K69236721-001-02-7::2.5::HTS,4.482757325461748,0.034678645828347204,Hepatocellular Carcinoma,lumacaftor,CFTR channel agonist,CFTR
Hepatocellular Carcinoma,BRD-K69346723-001-04-8::2.5::HTS,4.513718777814152,0.034088021352701565,Hepatocellular Carcinoma,glutathione,antioxidant,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12"
Hepatocellular Carcinoma,BRD-K69577666-001-01-3::2.5::HTS,6.184510822086378,0.013176441564235976,Other Types,SGC-0946,histone lysine methyltransferase inhibitor,
Hepatocellular Carcinoma,BRD-K70358946-001-15-7::2.5::HTS,5.110867727729859,0.024159449196637015,Hepatocellular Carcinoma,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K70401845-003-09-6::2.5::HTS,6.383878646879735,0.011790483356131753,Other Types,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Hepatocellular Carcinoma,BRD-K71058253-001-01-9::2.5::HTS,7.538573707121592,0.00623323857747009,Other Types,luliconazole,sterol demethylase inhibitor,
Hepatocellular Carcinoma,BRD-K71467466-001-02-3::2.5::HTS,4.533074738902883,0.03367994189809131,Hepatocellular Carcinoma,KPT-185,exportin antagonist,XPO1
Hepatocellular Carcinoma,BRD-K71480163-001-01-4::2.5::HTS,4.569360446083728,0.03298108881739751,Hepatocellular Carcinoma,GDC-0068,AKT inhibitor,"AKT1, AKT2, AKT3, PRKG1"
Hepatocellular Carcinoma,BRD-K72215350-001-06-5::2.5::HTS,4.722090862150056,0.030195992225582467,Hepatocellular Carcinoma,acexamic-acid,5 alpha reductase inhibitor,GAST
Hepatocellular Carcinoma,BRD-K72726508-001-02-1::2.5::HTS,4.91325882450647,0.027056686942463725,Other Types,arcyriaflavin-a,CDK inhibitor,"CCND1, CDK4"
Hepatocellular Carcinoma,BRD-K72728560-001-01-4::2.5::HTS,4.564989095329336,0.03306620593316422,Hepatocellular Carcinoma,dimetridazole,bacterial DNA inhibitor,
Hepatocellular Carcinoma,BRD-K72912098-001-02-3::2.5::HTS,8.087307134160673,0.004630422662912938,Hepatocellular Carcinoma,telaprevir,HCV inhibitor,"CTSA, PGR"
Hepatocellular Carcinoma,BRD-K73234506-235-02-1::2.5::HTS,5.328871626978105,0.021341597489082847,Hepatocellular Carcinoma,lithium-acetoacetate,,
Hepatocellular Carcinoma,BRD-K73368362-001-07-5::2.5::HTS,13.928951405011212,0.00020945062920958582,Hepatocellular Carcinoma,BIX-02189,MEK inhibitor,"MAP2K5, MAPK7"
Hepatocellular Carcinoma,BRD-K73383190-001-02-3::2.56::HTS,5.242700086895114,0.022432690499808186,Hepatocellular Carcinoma,C646,histone acetyltransferase inhibitor,EP300
Hepatocellular Carcinoma,BRD-K73383190-001-03-1::2.5::HTS,5.6132620805663676,0.01816445998442737,Hepatocellular Carcinoma,C646,histone acetyltransferase inhibitor,EP300
Hepatocellular Carcinoma,BRD-K73524797-001-01-1::2.5::HTS,4.736214272737828,0.029949695173696847,Hepatocellular Carcinoma,ST-1859,antiamyloidogenic agent,
Hepatocellular Carcinoma,BRD-K74190368-001-04-3::2.5::HTS,5.486988066167033,0.01951288057836959,Other Types,resorcinol,phosphodiesterase inhibitor,"CA12, CA14, CA2, PTGS1"
Hepatocellular Carcinoma,BRD-K74339692-001-01-9::2.5::HTS,4.11626784303108,0.04295212146367835,Other Types,tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D"
Hepatocellular Carcinoma,BRD-K75360161-001-18-0::2.5::HTS,4.488089447993022,0.0345731054633831,Hepatocellular Carcinoma,protionamide,,
Hepatocellular Carcinoma,BRD-K75478907-001-02-3::2.5::HTS,3.9634311975397165,0.04698961786195083,Other Types,GS-39783,GABA receptor modulator,GABBR1
Hepatocellular Carcinoma,BRD-K76022557-003-02-7::2.5::HTS,12.467979646027533,0.0004486476346253854,Other Types,r(-)-apomorphine,dopamine receptor agonist,"DRD2, HTR5A"
Hepatocellular Carcinoma,BRD-K76304753-003-21-1::2.5::HTS,7.716877766217488,0.00566532865062937,Hepatocellular Carcinoma,phenazopyridine,local anesthetic,SCN1A
Hepatocellular Carcinoma,BRD-K76674262-001-03-3::2.5::HTS,6.128815183154788,0.013593201855855044,Hepatocellular Carcinoma,homoharringtonine,protein synthesis inhibitor,RPL3
Hepatocellular Carcinoma,BRD-K76703230-004-04-1::2.5::HTS,5.061892366237383,0.024847083663742768,Hepatocellular Carcinoma,YM-155,survivin inhibitor,BIRC5
Hepatocellular Carcinoma,BRD-K77008974-001-03-2::2.5::HTS,7.856668133016236,0.005240698392065665,Other Types,WYE-354,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K77554836-001-11-6::2.57::HTS,8.393369409588702,0.0039222066772156075,Hepatocellular Carcinoma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Hepatocellular Carcinoma,BRD-K78086729-001-02-7::2.5::HTS,18.957001518472204,1.5889017657050467e-05,Hepatocellular Carcinoma,GW-788388,ALK tyrosine kinase receptor inhibitor,"LCK, MAPK14, TGFBR1"
Hepatocellular Carcinoma,BRD-K78118466-001-03-3::2.5::HTS,12.618644386425405,0.00041398552372152135,Hepatocellular Carcinoma,LY2157299,TGF beta receptor inhibitor,TGFBR1
Hepatocellular Carcinoma,BRD-K78318619-001-02-7::2.5::HTS,5.12458760755209,0.023969592143370234,Hepatocellular Carcinoma,PF-4981517,cytochrome P450 inhibitor,CYP3A4
Hepatocellular Carcinoma,BRD-K78431006-001-10-2::2.5::HTS,3.9834752032141907,0.04643080022290069,Hepatocellular Carcinoma,crizotinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Hepatocellular Carcinoma,BRD-K78844995-001-02-6::2.5::HTS,4.9190559360405866,0.026968336641803578,Other Types,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,
Hepatocellular Carcinoma,BRD-K79254416-001-22-6::2.5::HTS,4.735960995665774,0.029958561045676842,Hepatocellular Carcinoma,decitabine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Hepatocellular Carcinoma,BRD-K79425933-001-09-3::2.5::HTS,4.164858695768442,0.041744323155541455,Other Types,benperidol,dopamine receptor antagonist,DRD2
Hepatocellular Carcinoma,BRD-K79437791-001-05-7::2.5::HTS,3.963495388752393,0.046985194061183184,Other Types,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG
Hepatocellular Carcinoma,BRD-K79684402-300-02-8::2.5::HTS,4.684410343932575,0.03092885114076024,Other Types,Ro-10-5824,dopamine receptor agonist,DRD4
Hepatocellular Carcinoma,BRD-K80262108-001-07-0::2.5::HTS,4.671780351110467,0.031085948410654537,Hepatocellular Carcinoma,amifampridine,potassium channel blocker,
Hepatocellular Carcinoma,BRD-K80725821-300-02-9::2.5::HTS,4.783719640803328,0.029143591551318546,Hepatocellular Carcinoma,RS-16566,serotonin receptor antagonist,
Hepatocellular Carcinoma,BRD-K81225797-001-02-3::2.5::HTS,12.77399519154522,0.0003818541589821224,Other Types,SCH-58261,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatocellular Carcinoma,BRD-K81332461-001-01-4::2.5::HTS,4.247499164391225,0.039787336328573814,Hepatocellular Carcinoma,maxacalcitol,vitamin D receptor agonist,VDR
Hepatocellular Carcinoma,BRD-K81473089-003-26-1::2.5::HTS,5.590885409897672,0.018407611382898974,Hepatocellular Carcinoma,tacrine,acetylcholinesterase inhibitor,"ACHE, BCHE"
Hepatocellular Carcinoma,BRD-K81572616-001-01-9::2.5::HTS,8.509684840026756,0.0036745575414249346,Hepatocellular Carcinoma,CK-636,actin related protein inhibitor,"ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5"
Hepatocellular Carcinoma,BRD-K82002057-001-01-2::2.5::HTS,9.450352955481492,0.0022141039366912352,Hepatocellular Carcinoma,DFB,glutamate receptor agonist,GRM5
Hepatocellular Carcinoma,BRD-K82181219-001-04-3::2.5::HTS,5.127966811143433,0.02392613327328841,Hepatocellular Carcinoma,pyritinol,,
Hepatocellular Carcinoma,BRD-K82381502-003-23-1::2.5::HTS,4.909652910545658,0.027106927534524,Hepatocellular Carcinoma,acetylcholine,acetylcholine receptor agonist,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Hepatocellular Carcinoma,BRD-K82467063-001-02-7::2.5::HTS,4.511970826620544,0.03411307926171872,Hepatocellular Carcinoma,SB-271046,serotonin receptor antagonist,HTR6
Hepatocellular Carcinoma,BRD-K82562631-236-04-6::2.5::HTS,5.528782980137043,0.019053576361469197,Other Types,tolmetin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatocellular Carcinoma,BRD-K82767007-001-01-1::2.5::HTS,5.124356772285778,0.02398392539931661,Other Types,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Hepatocellular Carcinoma,BRD-K82928892-001-02-5::2.46::HTS,9.958511861102771,0.0016923829485163125,Hepatocellular Carcinoma,doxercalciferol,vitamin D receptor agonist,VDR
Hepatocellular Carcinoma,BRD-K82960980-003-01-9::2.5::HTS,5.586299420420189,0.01844327304630119,Hepatocellular Carcinoma,ceftiofur,bacterial cell wall synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K83459933-001-05-4::2.5::HTS,6.097830718959209,0.013835209902609644,Other Types,sinomenine,angiogenesis inhibitor,
Hepatocellular Carcinoma,BRD-K83896451-001-06-7::2.5::HTS,4.765547062002433,0.029474511954826768,Hepatocellular Carcinoma,glutamine-(l),,"CTPS1, GLUL, GPRC6A, PPAT"
Hepatocellular Carcinoma,BRD-K84163249-001-01-9::2.5::HTS,3.915968553418072,0.048338925909101334,Hepatocellular Carcinoma,ercalcitriol,vitamin D receptor agonist,VDR
Hepatocellular Carcinoma,BRD-K84748119-050-01-1::2.5::HTS,7.240727978161284,0.00734516523331242,Hepatocellular Carcinoma,vicriviroc,CC chemokine receptor antagonist,CCR5
Hepatocellular Carcinoma,BRD-K84810405-003-01-1::2.5::HTS,8.354783833705332,0.004002343344548271,Hepatocellular Carcinoma,almorexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Hepatocellular Carcinoma,BRD-K85066592-001-01-6::2.5::HTS,4.692399382813058,0.03072516994959089,Other Types,gly-gln,,
Hepatocellular Carcinoma,BRD-K85307935-236-09-5::2.5::HTS,8.31493147160299,0.004089127769418077,Hepatocellular Carcinoma,novobiocin,bacterial DNA gyrase inhibitor,
Hepatocellular Carcinoma,BRD-K85606544-001-09-1::2.5::HTS,7.161240681245383,0.007676225431966836,Hepatocellular Carcinoma,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Hepatocellular Carcinoma,BRD-K86161929-001-11-7::2.52::HTS,5.986381069511107,0.014741768828110083,Hepatocellular Carcinoma,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
Hepatocellular Carcinoma,BRD-K86307448-001-19-1::2.5::HTS,3.911676105676015,0.048471260036874644,Hepatocellular Carcinoma,allopurinol,xanthine oxidase inhibitor,XDH
Hepatocellular Carcinoma,BRD-K86600316-003-02-0::2.5::HTS,5.720079377157794,0.017101494508847518,Other Types,RS-79948,adrenergic receptor antagonist,ADRA2A
Hepatocellular Carcinoma,BRD-K86882815-001-03-2::2.5::HTS,6.521635097548843,0.010931054007634751,Hepatocellular Carcinoma,cabergoline,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7"
Hepatocellular Carcinoma,BRD-K87124298-001-03-4::2.5::HTS,8.727230928447222,0.0032671322940863103,Other Types,OSI-027,mTOR inhibitor,MTOR
Hepatocellular Carcinoma,BRD-K87158025-001-01-6::2.5::HTS,4.097427237846726,0.04342528136505392,Other Types,benzamil,sodium channel blocker,"ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1"
Hepatocellular Carcinoma,BRD-K87700323-003-05-1::2.5::HTS,7.771959612827465,0.005487562742786285,Hepatocellular Carcinoma,cetylpyridinium,,
Hepatocellular Carcinoma,BRD-K88061624-001-21-4::2.5::HTS,4.447217444770584,0.03543027070633853,Hepatocellular Carcinoma,mizoribine,"immunosuppressant, inosine monophosphate dehydrogenase inhibitor",IMPDH1
Hepatocellular Carcinoma,BRD-K88090157-050-10-8::2.5::HTS,5.102243246686246,0.024280107341104064,Hepatocellular Carcinoma,pimethixene,antihistamine,
Hepatocellular Carcinoma,BRD-K88186167-001-04-8::2.5::HTS,6.444619633327155,0.011397547613145879,Other Types,GW-4064,FXR agonist,NR1H4
Hepatocellular Carcinoma,BRD-K88553858-001-02-7::2.5::HTS,6.074485386565814,0.014015539889579879,Hepatocellular Carcinoma,benurestat,urease inhibitor,
Hepatocellular Carcinoma,BRD-K88611939-001-22-4::2.5::HTS,4.875944916079878,0.027638681122409296,Hepatocellular Carcinoma,aniracetam,glutamate receptor agonist,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A"
Hepatocellular Carcinoma,BRD-K89015388-001-01-7::2.5::HTS,10.181481161723323,0.001498461666169472,Hepatocellular Carcinoma,GSK923295,centromere associated protein inhibitor,CENPE
Hepatocellular Carcinoma,BRD-K89053832-001-01-0::2.5::HTS,6.880291701575812,0.0089525338855008,Hepatocellular Carcinoma,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14
Hepatocellular Carcinoma,BRD-K89208535-051-01-5::2.5::HTS,5.949496021640416,0.015031501347148245,Hepatocellular Carcinoma,indacaterol,adrenergic receptor agonist,"ADRB1, ADRB2"
Hepatocellular Carcinoma,BRD-K89375097-300-08-8::2.5::HTS,5.856181706380053,0.01584030536096004,Other Types,pirenzepine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Hepatocellular Carcinoma,BRD-K89714990-001-01-5::2.5::HTS,8.037619995670074,0.004747644476893272,Other Types,tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5
Hepatocellular Carcinoma,BRD-K90027355-001-19-0::2.5::HTS,4.470771050967464,0.034919141815122234,Hepatocellular Carcinoma,spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG"
Hepatocellular Carcinoma,BRD-K90825648-001-02-0::2.5::HTS,9.079292523033311,0.0027016659886340013,Hepatocellular Carcinoma,RS-127445,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Hepatocellular Carcinoma,BRD-K90885812-004-24-2::2.5::HTS,7.234966662653296,0.00736410953174455,Other Types,propantheline,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Hepatocellular Carcinoma,BRD-K91336023-003-01-0::2.5::HTS,4.1818496769022575,0.04132433483763565,Hepatocellular Carcinoma,mesulergine,dopamine receptor agonist,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K91614056-001-02-2::2.5::HTS,4.314700294868251,0.038267291961623484,Hepatocellular Carcinoma,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,
Hepatocellular Carcinoma,BRD-K92848252-001-01-9::2.5::HTS,5.424283606223245,0.020213421791723342,Other Types,diminazene-aceturate,angiotensin converting enzyme activator,"AOC1, PRDX5, PRSS1"
Hepatocellular Carcinoma,BRD-K92976206-001-01-5::2.5::HTS,8.552937384846818,0.003590839902593493,Other Types,guanosine,,PNP
Hepatocellular Carcinoma,BRD-K93035859-001-07-6::2.5::HTS,4.91383936800724,0.02704549059551095,Other Types,butylated-hydroxyanisole,antioxidant,
Hepatocellular Carcinoma,BRD-K93468883-001-02-0::2.5::HTS,3.9757512974054423,0.046642628950764466,Hepatocellular Carcinoma,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Hepatocellular Carcinoma,BRD-K93645900-001-11-3::2.5::HTS,4.733306671738343,0.02999992336986937,Hepatocellular Carcinoma,tadalafil,phosphodiesterase inhibitor,"PDE11A, PDE5A"
Hepatocellular Carcinoma,BRD-K93880783-001-26-6::2.5::HTS,3.883420524476663,0.049259874136631264,Other Types,stavudine,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor",
Hepatocellular Carcinoma,BRD-K94080537-001-09-7::2.5::HTS,7.306031458965972,0.00708173207706139,Hepatocellular Carcinoma,diethyltoluamide,ionotropic receptor IR40a activator,
Hepatocellular Carcinoma,BRD-K94358652-001-02-1::2.5::HTS,4.898228950550756,0.02731271280724668,Hepatocellular Carcinoma,daptomycin,bacterial cell wall synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K95828359-001-01-0::2.5::HTS,8.201598649086792,0.004342498701303628,Hepatocellular Carcinoma,MK-3697,orexin receptor antagonist,HCRTR2
Hepatocellular Carcinoma,BRD-K95926480-003-03-6::2.5::HTS,4.814691237243025,0.02863259996792046,Other Types,SRT1720,SIRT activator,SIRT1
Hepatocellular Carcinoma,BRD-K96358241-001-01-9::0.94::HTS,12.045912400617311,0.0005592845367936575,Hepatocellular Carcinoma,harringtonine,protein synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K96631475-001-02-4::2.43::HTS,8.244723044002605,0.0042511933875471865,Hepatocellular Carcinoma,10-deacetylbaccatin,antitumor agent,
Hepatocellular Carcinoma,BRD-K97019106-005-02-9::2.5::HTS,4.42933235697601,0.035769749571153565,Hepatocellular Carcinoma,"4-acetyl-1,1-dimethylpiperazinium",acetylcholine receptor agonist,
Hepatocellular Carcinoma,BRD-K97365803-001-02-1::2.5::HTS,11.21742060900206,0.0008657442134153175,Other Types,PI-828,PI3K inhibitor,
Hepatocellular Carcinoma,BRD-K97464279-001-03-5::2.5::HTS,7.583695792047726,0.0060822158283591506,Other Types,diaveridine,dihydrofolate reductase inhibitor,
Hepatocellular Carcinoma,BRD-K98684188-001-02-9::2.5::HTS,3.9363562909782015,0.047746077702552694,Other Types,GSK-0660,PPAR receptor antagonist,PPARD
Hepatocellular Carcinoma,BRD-K98795921-001-01-7::2.5::HTS,7.947323789051488,0.004988095521313129,Other Types,SB-2343,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Hepatocellular Carcinoma,BRD-K99063460-001-13-1::2.5::HTS,7.633188240240147,0.005930256172591912,Hepatocellular Carcinoma,didanosine,nucleoside reverse transcriptase inhibitor,PNP
Hepatocellular Carcinoma,BRD-K99121711-003-19-7::2.5::HTS,4.720857994356839,0.03021596912727033,Hepatocellular Carcinoma,cinchocaine,sodium channel blocker,"CALM1, SCN10A, SCN5A"
Hepatocellular Carcinoma,BRD-K99451608-001-07-3::2.5::HTS,4.111828819651604,0.0430581056136102,Hepatocellular Carcinoma,lopinavir,HIV protease inhibitor,
Hepatocellular Carcinoma,BRD-K99792991-001-34-9::2.5::HTS,12.398592939677442,0.0004647226520128604,Other Types,hexachlorophene,potassium channel activator,"GLUD1, SDHD"
Hepatocellular Carcinoma,BRD-M30288325-001-01-4::2.5::HTS,5.4418676741194005,0.020013549714460347,Hepatocellular Carcinoma,G-15,estrogen receptor antagonist,GPER1
Hepatocellular Carcinoma,BRD-U45393375-000-01-6::2.5::HTS,4.338481356249412,0.037768741090189246,Hepatocellular Carcinoma,sevelamer,phosphate antagonist,
Hepatocellular Carcinoma,BRD-A13116749-003-01-6::2.713967431::MTS004,4.170861983038346,0.041611893242448676,Hepatocellular Carcinoma,mabuterol,adrenergic receptor agonist,ADRB2
Hepatocellular Carcinoma,BRD-A34603619-001-01-9::2.427905848::MTS004,8.143553155071118,0.004487609724493469,Other Types,tropesin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatocellular Carcinoma,BRD-A38706605-001-01-2::2.5::MTS004,3.992017465468666,0.04622014343682398,Other Types,dromostanolone-propionate,androgen receptor modulator,AR
Hepatocellular Carcinoma,BRD-A40302156-001-01-9::2.503151999::MTS004,8.060789926822968,0.004694039713010181,Other Types,A-33903,,
Hepatocellular Carcinoma,BRD-A56613951-004-01-1::2.642522873::MTS004,4.555174221389632,0.03327000654469468,Hepatocellular Carcinoma,valethamate,acetylcholine receptor antagonist,"CHRM1, CHRM4, CHRM5"
Hepatocellular Carcinoma,BRD-A92341659-001-04-0::2.499993321::MTS004,7.188030963577479,0.007563960436885133,Other Types,prulifloxacin,bacterial DNA gyrase inhibitor,
Hepatocellular Carcinoma,BRD-K00634421-001-01-0::2.500042819::MTS004,5.014984259043432,0.025536656197821406,Hepatocellular Carcinoma,brivaracetam,voltage-gated sodium channel blocker,SV2A
Hepatocellular Carcinoma,BRD-K06182768-001-02-3::2.5::MTS004,5.837621355713729,0.01601898423352666,Hepatocellular Carcinoma,A-366,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Hepatocellular Carcinoma,BRD-K06883221-001-01-9::2.686662955::MTS004,4.693417968343103,0.030716702633890945,Other Types,apratastat,"matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor","ADAM17, MMP1, MMP13, MMP9"
Hepatocellular Carcinoma,BRD-K09436144-001-01-7::2.487366457::MTS004,5.9193915707506815,0.015299908245729759,Hepatocellular Carcinoma,YM022,CCK receptor antagonist,CCKBR
Hepatocellular Carcinoma,BRD-K09735259-001-01-3::2.500007896::MTS004,8.039327800158366,0.004749460915532412,Hepatocellular Carcinoma,elbasvir,HCV inhibitor,
Hepatocellular Carcinoma,BRD-K10995081-001-27-9::2.316458322::MTS004,8.413561439481644,0.003876367310084855,Hepatocellular Carcinoma,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Hepatocellular Carcinoma,BRD-K11851476-003-01-7::2.499993171::MTS004,6.036857822154151,0.014324214159877996,Hepatocellular Carcinoma,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Hepatocellular Carcinoma,BRD-K13060017-001-02-1::2.499994836::MTS004,3.9986302694759432,0.046038657909587166,Hepatocellular Carcinoma,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
Hepatocellular Carcinoma,BRD-K13769342-001-01-5::2.50001379::MTS004,4.468688100409739,0.034981039691059,Hepatocellular Carcinoma,danirixin,CC chemokine receptor antagonist,CXCR2
Hepatocellular Carcinoma,BRD-K15691453-236-01-6::2.499981005::MTS004,4.116825735309349,0.04295055477362676,Hepatocellular Carcinoma,GSK2190915,lipoxygenase inhibitor,ALOX5AP
Hepatocellular Carcinoma,BRD-K21586122-001-01-9::2.50000801::MTS004,4.773077783627709,0.0293388798257932,Hepatocellular Carcinoma,fimasartan,angiotensin receptor antagonist,AGTR1
Hepatocellular Carcinoma,BRD-K22064724-001-01-8::2.499989634::MTS004,4.492389942580185,0.03450252802861186,Hepatocellular Carcinoma,napabucasin,STAT inhibitor,STAT3
Hepatocellular Carcinoma,BRD-K27798832-001-01-5::2.350625651::MTS004,7.26072807871479,0.0072681399417122,Hepatocellular Carcinoma,cefetamet,bacterial cell wall synthesis inhibitor,
Hepatocellular Carcinoma,BRD-K28061410-001-06-6::2.5::MTS004,8.748578682255227,0.0032343755201262926,Hepatocellular Carcinoma,beta-lapachone,topoisomerase inhibitor,TOP1
Hepatocellular Carcinoma,BRD-K29812331-011-01-7::2.472474424::MTS004,4.743650302166282,0.029840186421278378,Hepatocellular Carcinoma,dimemorfan,sigma receptor agonist,SIGMAR1
Hepatocellular Carcinoma,BRD-K43837174-003-01-3::2.479237222::MTS004,4.327885349061214,0.03796458180346595,Hepatocellular Carcinoma,pruvanserin,serotonin receptor antagonist,"HTR2A, HTR2C"
Hepatocellular Carcinoma,BRD-K46843573-001-01-9::2.5::MTS004,6.503535095690829,0.011041510206631668,Other Types,zotarolimus,mTOR inhibitor,FKBP1A
Hepatocellular Carcinoma,BRD-K52579889-001-01-9::2.499985811::MTS004,6.422108593508453,0.011553340603746935,Other Types,TGR-1202,PI3K inhibitor,
Hepatocellular Carcinoma,BRD-K53236343-003-03-7::2.625172304::MTS004,4.664754190174392,0.03122888997652764,Hepatocellular Carcinoma,aprindine,voltage-gated sodium channel blocker,"CALM1, SCN5A"
Hepatocellular Carcinoma,BRD-K55808645-001-01-4::2.500006596::MTS004,6.346784472915264,0.012048050536858545,Other Types,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
Hepatocellular Carcinoma,BRD-K56107812-001-01-7::2.499996486::MTS004,7.5654641988954126,0.006150084278305073,Other Types,carbetocin,oxytocin receptor agonist,OXTR
Hepatocellular Carcinoma,BRD-K56740996-001-01-3::2.601527794::MTS004,4.350528150790576,0.03746803740995212,Other Types,flindokalner,potassium channel agonist,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5"
Hepatocellular Carcinoma,BRD-K62040061-001-01-0::2.500015381::MTS004,4.881028498839058,0.027573952497683494,Hepatocellular Carcinoma,toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB"
Hepatocellular Carcinoma,BRD-K68408772-001-05-4::2.420640995::MTS004,5.801187097901413,0.016350549575271708,Other Types,carboxyamidotriazole,calcium channel blocker,CXCL8
Hepatocellular Carcinoma,BRD-K73132780-001-01-2::2.5::MTS004,5.273839425766846,0.022030895977851107,Hepatocellular Carcinoma,pyronaridine,antimalarial agent,
Hepatocellular Carcinoma,BRD-K74236984-001-04-8::2.5::MTS004,9.300213074567138,0.0024040897595233655,Other Types,UNC0321,histone lysine methyltransferase inhibitor,EHMT2
Hepatocellular Carcinoma,BRD-K76594255-001-01-6::2.5000235::MTS004,8.06605651375627,0.004680938726088347,Hepatocellular Carcinoma,maropitant,neurokinin receptor antagonist,TACR1
Hepatocellular Carcinoma,BRD-K76927775-001-11-8::2.500019441::MTS004,6.4326690661853965,0.011485148381433496,Hepatocellular Carcinoma,nitrofurantoin,DNA inhibitor,
Hepatocellular Carcinoma,BRD-K77038618-356-01-3::2.500022896::MTS004,6.971887727873762,0.008520044699628863,Hepatocellular Carcinoma,garenoxacin,topoisomerase inhibitor,TOP2A
Hepatocellular Carcinoma,BRD-K80859331-001-01-5::2.5::MTS004,4.809708591988266,0.028727127355395007,Hepatocellular Carcinoma,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Hepatocellular Carcinoma,BRD-K84459715-001-01-6::2.403005639::MTS004,5.816811339090472,0.01620688088578399,Hepatocellular Carcinoma,zopolrestat,,
Hepatocellular Carcinoma,BRD-K87465484-001-02-7::2.5::MTS004,6.5780354644817995,0.010594607627190234,Hepatocellular Carcinoma,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
Hepatocellular Carcinoma,BRD-K92581468-001-01-6::2.389082227::MTS004,5.589218494724332,0.018424951850335467,Hepatocellular Carcinoma,ocinaplon,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5"
Hepatocellular Carcinoma,BRD-K92902018-001-01-9::2.507952536::MTS004,4.20383934920478,0.040815700287648055,Other Types,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR
Hepatocellular Carcinoma,BRD-K96471533-001-09-0::2.592774962::MTS004,13.649364707530802,0.00024280513805952672,Other Types,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
Hepatocellular Carcinoma,BRD-K99199077-001-16-1::2.603211317::MTS004,5.2535561056396975,0.022286543857790185,Hepatocellular Carcinoma,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1
Lung Neuroendocrine Tumor,BRD-A00758722-001-04-9::2.5::HTS,5.365221260782317,0.020916354521604487,Lung Neuroendocrine Tumor,noretynodrel,progestogen hormone,PGR
Lung Neuroendocrine Tumor,BRD-A03880619-001-01-0::2.5::HTS,5.748432244578078,0.016851050616446317,Lung Neuroendocrine Tumor,bismuth-subcitrate-potassium,,
Lung Neuroendocrine Tumor,BRD-A04252265-003-01-4::2.5::HTS,4.273978645444585,0.03916571477623337,Other Types,eperisone,acetylcholine receptor antagonist,CYP2J2
Lung Neuroendocrine Tumor,BRD-A04506385-001-01-2::2.5::HTS,9.1582286153114,0.002591879053694934,Other Types,stepronin,mucolytic agent,
Lung Neuroendocrine Tumor,BRD-A05515753-001-03-2::2.5::HTS,3.952141262928373,0.047300850067150665,Other Types,erdosteine,mucolytic agent,
Lung Neuroendocrine Tumor,BRD-A10652366-238-04-1::2.5::HTS,5.054833409834704,0.02496903534464703,Lung Neuroendocrine Tumor,fosfomycin,bacterial cell wall synthesis inhibitor,
Lung Neuroendocrine Tumor,BRD-A14344385-001-03-2::2.5::HTS,8.08917345239835,0.004616659777029986,Lung Neuroendocrine Tumor,IDRA-21,glutamate receptor positive allosteric modulator,"GRIA1, GRIA2, GRIA3, GRIA4"
Lung Neuroendocrine Tumor,BRD-A15415227-003-02-9::2.5::HTS,8.248224457076159,0.004233119326714442,Lung Neuroendocrine Tumor,GW-1929,PPAR receptor agonist,PPARG
Lung Neuroendocrine Tumor,BRD-A15530910-001-02-1::2.5::HTS,4.3444621219868855,0.03758209072511162,Other Types,SDZ-21009,"adrenergic receptor antagonist, serotonin receptor antagonist","HTR1A, HTR1B"
Lung Neuroendocrine Tumor,BRD-A17462676-003-11-6::2.5::HTS,4.638872834449971,0.031681584639486136,Other Types,bambuterol,adrenergic receptor agonist,"ADRB2, BCHE"
Lung Neuroendocrine Tumor,BRD-A21858158-001-23-5::2.5::HTS,5.478438648901298,0.01960628916359846,Other Types,praziquantel,anthelmintic agent,
Lung Neuroendocrine Tumor,BRD-A23127772-001-02-3::2.5::HTS,4.189537811540586,0.04114978118016441,Other Types,sclareol,,
Lung Neuroendocrine Tumor,BRD-A26384407-001-25-1::2.5::HTS,4.413648646507812,0.03609733461791858,Other Types,chlorthalidone,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3"
Lung Neuroendocrine Tumor,BRD-A27143604-001-02-0::2.5::HTS,5.727192757172714,0.01703605148546591,Lung Neuroendocrine Tumor,diarylpropionitrile,estrogen receptor agonist,ESR2
Lung Neuroendocrine Tumor,BRD-A29944538-003-08-3::2.5::HTS,5.623427098948973,0.018061092548908322,Lung Neuroendocrine Tumor,proxodolol,adrenergic receptor antagonist,
Lung Neuroendocrine Tumor,BRD-A33697453-008-02-4::2.5::HTS,4.20454535796851,0.04078575660529304,Lung Neuroendocrine Tumor,fenticonazole,bacterial cell wall synthesis inhibitor,
Lung Neuroendocrine Tumor,BRD-A37288617-003-02-2::2.5::HTS,3.873228994536102,0.049553229390800216,Other Types,amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3"
Lung Neuroendocrine Tumor,BRD-A39935389-001-05-9::2.5::HTS,8.389640280442482,0.003921372083394554,Other Types,teroxirone,DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-A40940854-001-01-1::2.5::HTS,4.751466473030859,0.029691378142498913,Other Types,ibuproxam,"cyclooxygenase inhibitor, prostaglandin inhibitor",ALOX5
Lung Neuroendocrine Tumor,BRD-A43999749-004-04-1::2.5::HTS,4.516515510506305,0.034008650029159156,Other Types,homatropine-methylbromide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Lung Neuroendocrine Tumor,BRD-A55469827-001-07-4::2.5::HTS,5.388299597312375,0.020631546774461468,Lung Neuroendocrine Tumor,mephenesin,muscle relaxant,
Lung Neuroendocrine Tumor,BRD-A55664972-236-02-6::2.5::HTS,5.6277463992757655,0.018017096912800293,Lung Neuroendocrine Tumor,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Lung Neuroendocrine Tumor,BRD-A57957888-001-08-0::2.5::HTS,5.079021011818124,0.02460503962474746,Other Types,citiolone,"lipotropic, mucolytic agent",
Lung Neuroendocrine Tumor,BRD-A61194565-003-27-0::2.5::HTS,3.9098826257400043,0.04849820795880093,Other Types,benserazide,DOPA decarboxylase inhibitor,DDC
Lung Neuroendocrine Tumor,BRD-A64064900-001-02-3::2.5::HTS,5.225843255179921,0.02263584988855943,Lung Neuroendocrine Tumor,sangivamycin,DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-A66419424-001-02-4::2.5::HTS,4.469232738057321,0.034958315823612786,Lung Neuroendocrine Tumor,ixazomib-citrate,proteasome inhibitor,
Lung Neuroendocrine Tumor,BRD-A67862938-034-14-9::2.5::HTS,15.140593151540292,0.00011182008603072616,Lung Neuroendocrine Tumor,naftidrofuryl,adrenergic receptor antagonist,
Lung Neuroendocrine Tumor,BRD-A67975844-001-01-8::2.5::HTS,4.6109123108928145,0.032198497754520786,Other Types,NSC-405020,matrix metalloprotease inhibitor,MMP1
Lung Neuroendocrine Tumor,BRD-A68589262-001-04-3::2.5::HTS,5.328315295577603,0.021354404805643972,Lung Neuroendocrine Tumor,troxipide,glucosamine synthetase stimulant,
Lung Neuroendocrine Tumor,BRD-A71157293-003-10-0::2.5::HTS,5.708716458240029,0.017209611567368926,Lung Neuroendocrine Tumor,fursultiamine,vitamin B,
Lung Neuroendocrine Tumor,BRD-A72212290-300-01-4::2.5::HTS,4.949148538886214,0.026511487707028117,Lung Neuroendocrine Tumor,eprazinone,mucolytic agent,
Lung Neuroendocrine Tumor,BRD-A72716251-001-01-5::0.91::HTS,7.428789038461142,0.0066218763417956366,Lung Neuroendocrine Tumor,peruvoside,cardiac glycoside,
Lung Neuroendocrine Tumor,BRD-A74667430-001-23-6::2.5::HTS,4.8387184024274905,0.028233944236494446,Other Types,etodolac,cyclooxygenase inhibitor,"PTGS1, PTGS2, RXRA"
Lung Neuroendocrine Tumor,BRD-A75726477-003-21-3::2.5::HTS,5.825473810582857,0.01611448014955285,Lung Neuroendocrine Tumor,clenbuterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3, NGF, TNF"
Lung Neuroendocrine Tumor,BRD-A79672927-001-20-7::2.5::HTS,5.82155034336493,0.01615295897508911,Other Types,tropicamide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Lung Neuroendocrine Tumor,BRD-A81233518-004-16-1::2.5::HTS,3.9517869770209315,0.047308113269210805,Lung Neuroendocrine Tumor,glycopyrrolate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Lung Neuroendocrine Tumor,BRD-A81370665-001-03-6::2.5::HTS,5.153893610405179,0.023572077803148427,Other Types,BI-D1870,ribosomal protein inhibitor,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6"
Lung Neuroendocrine Tumor,BRD-A83650191-004-02-8::2.5::HTS,4.5355028635743375,0.033678787168538664,Other Types,A61603,adrenergic receptor agonist,ADRA1A
Lung Neuroendocrine Tumor,BRD-A87130939-001-07-9::2.5::HTS,4.6241685789545315,0.03197026934234893,Lung Neuroendocrine Tumor,masoprocol,lipoxygenase inhibitor,ALOX5
Lung Neuroendocrine Tumor,BRD-A92670106-003-05-4::2.5::HTS,4.3356504121654,0.03777716151875379,Other Types,tocainide,sodium channel blocker,SCN5A
Lung Neuroendocrine Tumor,BRD-A93000692-001-08-1::2.5::HTS,4.603016851136238,0.03234429988032986,Lung Neuroendocrine Tumor,ciglitazone,PPAR receptor agonist,PPARG
Lung Neuroendocrine Tumor,BRD-K01950558-001-14-7::2.5::HTS,5.312385991474971,0.02154048158623013,Other Types,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR
Lung Neuroendocrine Tumor,BRD-K02389548-001-02-5::2.5::HTS,4.294588272019405,0.03869499629622947,Other Types,RG2833,HDAC inhibitor,"HDAC1, HDAC3"
Lung Neuroendocrine Tumor,BRD-K02908048-003-06-4::2.5::HTS,4.104697522271745,0.04324123134186849,Other Types,preclamol,dopamine receptor agonist,DRD2
Lung Neuroendocrine Tumor,BRD-K03243820-001-23-8::2.37::HTS,4.67589553530156,0.03103710217453998,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Lung Neuroendocrine Tumor,BRD-K03384561-001-02-7::2.5::HTS,6.9608361748416225,0.008564312449920645,Lung Neuroendocrine Tumor,roquinimex,"angiogenesis inhibitor, tumor necrosis factor production inhibitor",
Lung Neuroendocrine Tumor,BRD-K03390685-001-01-7::2.5::HTS,5.757510042120551,0.016747576239944353,Lung Neuroendocrine Tumor,cobimetinib,MEK inhibitor,
Lung Neuroendocrine Tumor,BRD-K03601870-001-01-2::2.5::HTS,4.516086523547017,0.03401710800485237,Lung Neuroendocrine Tumor,ixabepilone,microtubule stabilizing agent,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8"
Lung Neuroendocrine Tumor,BRD-K04548931-003-16-5::2.5::HTS,7.780757084602204,0.005459655438364998,Lung Neuroendocrine Tumor,epirubicin,topoisomerase inhibitor,"CHD1, TOP2A"
Lung Neuroendocrine Tumor,BRD-K04833372-001-06-2::2.5::HTS,11.02151471611146,0.0009598350364268326,Other Types,GSK1904529A,"IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand","IGF1R, INSR"
Lung Neuroendocrine Tumor,BRD-K07220430-001-18-4::2.5::HTS,9.2884655163972,0.002415376509169733,Lung Neuroendocrine Tumor,cinnarazine,calcium channel blocker,
Lung Neuroendocrine Tumor,BRD-K07972848-001-02-0::2.5::HTS,3.9831083148569553,0.04644429830670889,Lung Neuroendocrine Tumor,GSK2126458,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Lung Neuroendocrine Tumor,BRD-K10670311-001-15-5::2.5::HTS,4.223597041238851,0.04034690336038161,Lung Neuroendocrine Tumor,sulfasalazine,cyclooxygenase inhibitor,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1"
Lung Neuroendocrine Tumor,BRD-K11796549-001-04-5::2.5::HTS,3.973418954456962,0.04670679429355929,Other Types,NBQX,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B"
Lung Neuroendocrine Tumor,BRD-K11927976-050-02-9::2.5::HTS,6.116443135349766,0.013696280301410308,Lung Neuroendocrine Tumor,ER-27319,"mediator release inhibitor, SYK inhibitor",SYK
Lung Neuroendocrine Tumor,BRD-K12219985-001-26-1::2.5::HTS,4.453226217398269,0.03529552000173951,Lung Neuroendocrine Tumor,glipizide,sulfonylurea,"ABCC8, KCNJ10, KCNJ11, PPARG"
Lung Neuroendocrine Tumor,BRD-K12343256-001-08-9::2.5::HTS,5.165092693936641,0.023424694170544463,Lung Neuroendocrine Tumor,trametinib,MEK inhibitor,"MAP2K1, MAP2K2"
Lung Neuroendocrine Tumor,BRD-K12787259-001-04-3::2.5::HTS,4.005954500238744,0.04584058082827907,Other Types,CX-5461,RNA polymerase inhibitor,
Lung Neuroendocrine Tumor,BRD-K13049116-001-05-7::2.5::HTS,4.8209781818723725,0.028529278371676334,Other Types,BMS-754807,IGF-1 inhibitor,"AKT1, IGF1R"
Lung Neuroendocrine Tumor,BRD-K13050541-001-01-9::2.8::HTS,11.35398887749895,0.0008052533484727431,Lung Neuroendocrine Tumor,acivicin,gamma glutamyltransferase Inhibitors,CTPS1
Lung Neuroendocrine Tumor,BRD-K13390322-001-06-3::2.5::HTS,8.358903038418525,0.003990834819942449,Lung Neuroendocrine Tumor,AT-7519,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9"
Lung Neuroendocrine Tumor,BRD-K13800121-001-01-5::2.5::HTS,4.879757587193886,0.027581901368971876,Lung Neuroendocrine Tumor,parecoxib,cyclooxygenase inhibitor,LTF
Lung Neuroendocrine Tumor,BRD-K13810148-311-03-2::2.5::HTS,6.3215685134358965,0.012206027387084754,Lung Neuroendocrine Tumor,givinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Lung Neuroendocrine Tumor,BRD-K13888115-003-02-2::2.5::HTS,7.010658072325912,0.008333377278337717,Lung Neuroendocrine Tumor,LY2365109,Glycine transporter 1 inhibitor,SLC6A9
Lung Neuroendocrine Tumor,BRD-K14385366-001-04-4::2.59::HTS,7.296204891864155,0.007134642955374839,Lung Neuroendocrine Tumor,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2
Lung Neuroendocrine Tumor,BRD-K14496212-066-04-8::2.5::HTS,4.312219968678659,0.03830670456884025,Lung Neuroendocrine Tumor,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Lung Neuroendocrine Tumor,BRD-K14767410-001-02-3::2.5::HTS,5.075775577205232,0.024649319152446763,Other Types,SC-560,cyclooxygenase inhibitor,PTGS1
Lung Neuroendocrine Tumor,BRD-K15045219-001-01-8::2.5::HTS,5.10728109365615,0.024218831611320008,Lung Neuroendocrine Tumor,salazodine,,
Lung Neuroendocrine Tumor,BRD-K15766189-001-09-8::2.5::HTS,4.919623317301086,0.026953747000173424,Lung Neuroendocrine Tumor,cefdinir,bacterial cell wall synthesis inhibitor,MPO
Lung Neuroendocrine Tumor,BRD-K15933101-003-06-1::2.5::HTS,3.992366174652687,0.046196951134247224,Other Types,ropinirole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Lung Neuroendocrine Tumor,BRD-K16485616-001-08-9::2.5::HTS,5.421332192107756,0.020251136254834514,Lung Neuroendocrine Tumor,mocetinostat,HDAC inhibitor,"HDAC1, HDAC11, HDAC2, HDAC3"
Lung Neuroendocrine Tumor,BRD-K18172896-001-02-5::2.5::HTS,4.51251895864369,0.0340875321555723,Lung Neuroendocrine Tumor,eltanolone,membrane integrity inhibitor,"GABRA1, GABRB2, GABRG2"
Lung Neuroendocrine Tumor,BRD-K18574842-236-17-7::2.5::HTS,9.23926947288653,0.0024837939550305583,Lung Neuroendocrine Tumor,nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6"
Lung Neuroendocrine Tumor,BRD-K18849474-001-04-4::2.61::HTS,6.1338567304027,0.01357388500199257,Other Types,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Lung Neuroendocrine Tumor,BRD-K20482099-001-11-0::2.5::HTS,4.8551523667409455,0.02796855900326998,Lung Neuroendocrine Tumor,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Lung Neuroendocrine Tumor,BRD-K20755323-001-05-9::2.5::HTS,9.785331785296943,0.0018507082933959577,Other Types,SKI-II,sphingosine kinase inhibitor,SPHK1
Lung Neuroendocrine Tumor,BRD-K20920669-304-09-1::2.5::HTS,6.15777205876872,0.0133753740221724,Lung Neuroendocrine Tumor,cromoglicic-acid,immunosuppressant,"KCNMA1, S100P"
Lung Neuroendocrine Tumor,BRD-K20995441-001-02-5::2.5::HTS,5.968260511505065,0.014876874093022827,Lung Neuroendocrine Tumor,U-54494A,opioid receptor agonist,OPRK1
Lung Neuroendocrine Tumor,BRD-K21164796-001-02-8::2.5::HTS,5.018710872729615,0.025467640402369877,Lung Neuroendocrine Tumor,beta-naphthol,,
Lung Neuroendocrine Tumor,BRD-K21565985-001-22-5::2.5::HTS,3.9234174741657784,0.048108576907656415,Lung Neuroendocrine Tumor,xylazine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Lung Neuroendocrine Tumor,BRD-K21680192-300-14-4::2.5::HTS,8.631550135541728,0.0034414279335149207,Lung Neuroendocrine Tumor,mitoxantrone,topoisomerase inhibitor,TOP2A
Lung Neuroendocrine Tumor,BRD-K22482860-001-21-4::2.5::HTS,6.895333911107024,0.008881013450733805,Lung Neuroendocrine Tumor,dalfampridine,potassium channel blocker,"KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2"
Lung Neuroendocrine Tumor,BRD-K23913458-001-20-7::2.5::HTS,9.471560555127503,0.002189451268271784,Lung Neuroendocrine Tumor,coumarin,vitamin K antagonist,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6"
Lung Neuroendocrine Tumor,BRD-K24548560-342-02-1::2.5::HTS,5.0411612520677895,0.02513986361427363,Lung Neuroendocrine Tumor,evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1"
Lung Neuroendocrine Tumor,BRD-K25244359-066-03-4::2.68::HTS,4.0728467709560725,0.04408297380404055,Other Types,apatinib,RET tyrosine kinase inhibitor,"CSK, KDR, KIT, RET"
Lung Neuroendocrine Tumor,BRD-K26667523-001-02-5::2.5::HTS,10.055714014455171,0.001602767577696033,Lung Neuroendocrine Tumor,TAK-733,MEK inhibitor,MAP2K1
Lung Neuroendocrine Tumor,BRD-K27184429-300-01-3::2.5::HTS,4.7502625572208155,0.029708249128212898,Lung Neuroendocrine Tumor,levocetirizine,histamine receptor antagonist,HRH1
Lung Neuroendocrine Tumor,BRD-K27393415-001-01-0::2.5::HTS,11.395914776437651,0.0007878327299732333,Other Types,xipamide,carbonic anhydrase inhibitor,SLC12A3
Lung Neuroendocrine Tumor,BRD-K27853494-003-04-7::2.5::HTS,4.7987301109474005,0.02890826639635593,Lung Neuroendocrine Tumor,"1s,2r-phenylpropanolamine",adrenergic receptor agonist,"ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1"
Lung Neuroendocrine Tumor,BRD-K27938825-001-02-4::2.5::HTS,5.368182255641046,0.020867822332536753,Other Types,ASA-404,angiogenesis inhibitor,
Lung Neuroendocrine Tumor,BRD-K28143534-003-25-9::2.5::HTS,4.993857197558746,0.025831820464284738,Other Types,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Lung Neuroendocrine Tumor,BRD-K28183345-003-11-4::2.5::HTS,4.900038144068937,0.02725689733827929,Lung Neuroendocrine Tumor,proguanil,dihydrofolate reductase inhibitor,DHFR
Lung Neuroendocrine Tumor,BRD-K28824103-001-04-4::2.5::HTS,8.557389934198007,0.003582203180102592,Lung Neuroendocrine Tumor,genipin,choleretic agent,
Lung Neuroendocrine Tumor,BRD-K29322660-001-01-9::2.5::HTS,4.151405256171132,0.04206786908438334,Lung Neuroendocrine Tumor,edoxaban,coagulation factor inhibitor,F10
Lung Neuroendocrine Tumor,BRD-K29392254-001-02-2::2.5::HTS,5.460546238890739,0.01982285560527832,Lung Neuroendocrine Tumor,pantothenic-acid,coenzyme A precursor,
Lung Neuroendocrine Tumor,BRD-K29415052-050-04-8::2.5::HTS,9.676924736429825,0.0019606271354718624,Lung Neuroendocrine Tumor,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Lung Neuroendocrine Tumor,BRD-K29458283-001-29-9::2.5::HTS,9.96586400452847,0.0016814259190138618,Other Types,chlorambucil,DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-K30020243-051-02-5::2.5::HTS,4.057156111929051,0.04446733415877233,Other Types,aliskiren-hemifumarate,renin inhibitor,REN
Lung Neuroendocrine Tumor,BRD-K30114692-001-15-9::2.5::HTS,4.328740623776033,0.03793961250860573,Lung Neuroendocrine Tumor,methenamine,bacterial DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-K30331124-001-01-7::2.5::HTS,5.7063307045902345,0.01723454608492056,Other Types,ASC-J9,androgen receptor enhancer,AR
Lung Neuroendocrine Tumor,BRD-K30933884-001-01-0::2.5::HTS,7.891275636007681,0.0051411778684154535,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Lung Neuroendocrine Tumor,BRD-K31313613-003-04-2::2.5::HTS,5.646224929430433,0.017830127185330374,Lung Neuroendocrine Tumor,BS-181,CDK inhibitor,CDK7
Lung Neuroendocrine Tumor,BRD-K31928526-001-02-1::2.5::HTS,5.139888167171376,0.023764599075033244,Other Types,barasertib,Aurora kinase inhibitor,"AURKA, AURKB"
Lung Neuroendocrine Tumor,BRD-K33277808-331-01-3::2.5::HTS,6.6227481912649475,0.010325474526252194,Lung Neuroendocrine Tumor,ouabain,ATPase inhibitor,ATP1A1
Lung Neuroendocrine Tumor,BRD-K33882852-003-02-8::2.5::HTS,8.03065560912368,0.004767494484487189,Other Types,ZK-93423,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
Lung Neuroendocrine Tumor,BRD-K37379014-001-01-2::2.5::HTS,6.437435253419252,0.011447105346543533,Lung Neuroendocrine Tumor,filanesib,"kinesin inhibitor, kinesin-like spindle protein inhibitor",KIF11
Lung Neuroendocrine Tumor,BRD-K37687095-001-06-9::2.5::HTS,6.563635558828402,0.010667967930122448,Lung Neuroendocrine Tumor,AZD8330,MEK inhibitor,
Lung Neuroendocrine Tumor,BRD-K37991163-003-13-4::2.5::HTS,5.25174786376272,0.0223045385593257,Lung Neuroendocrine Tumor,paroxetine,selective serotonin reuptake inhibitor (SSRI),"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4"
Lung Neuroendocrine Tumor,BRD-K38350380-001-01-8::2.5::HTS,7.035090999981937,0.008221874031868514,Other Types,FK-3311,cyclooxygenase inhibitor,PTGS2
Lung Neuroendocrine Tumor,BRD-K38852836-001-02-1::2.5::HTS,8.415239022805935,0.0038665686773372587,Lung Neuroendocrine Tumor,ganetespib,HSP inhibitor,HSP90AA1
Lung Neuroendocrine Tumor,BRD-K38938675-001-01-4::2.5::HTS,8.954796607006783,0.0028911703204540966,Other Types,morniflumate,anti-inflammatory agent,
Lung Neuroendocrine Tumor,BRD-K39160765-003-02-9::2.5::HTS,7.861841986212662,0.005224974686321491,Lung Neuroendocrine Tumor,4-chlorophenylguanidine,urokinase inhibitor,PLAUR
Lung Neuroendocrine Tumor,BRD-K40175214-001-11-6::2.5::HTS,4.413002018931361,0.036110908104771036,Lung Neuroendocrine Tumor,torin-1,mTOR inhibitor,MTOR
Lung Neuroendocrine Tumor,BRD-K40331046-305-01-5::2.5::HTS,9.431270247177839,0.00223687006391723,Lung Neuroendocrine Tumor,CR8-(R),CDK inhibitor,CCNA2
Lung Neuroendocrine Tumor,BRD-K40496271-396-01-1::2.34::HTS,4.260044907116309,0.0395068758243079,Other Types,eltrombopag,thrombopoietin receptor agonist,MPL
Lung Neuroendocrine Tumor,BRD-K41185545-001-02-3::2.5::HTS,11.608157431216009,0.0007050120815757731,Lung Neuroendocrine Tumor,ambrisentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Lung Neuroendocrine Tumor,BRD-K41312087-001-02-7::2.5::HTS,16.52683968801053,5.4873956453105845e-05,Lung Neuroendocrine Tumor,GW-441756,growth factor receptor inhibitor,NTRK1
Lung Neuroendocrine Tumor,BRD-K41567364-001-04-6::2.5::HTS,5.871597983117851,0.015706512368723707,Lung Neuroendocrine Tumor,SB-334867,orexin receptor antagonist,"HCRTR1, HCRTR2"
Lung Neuroendocrine Tumor,BRD-K42756753-001-01-9::2.5::HTS,8.601787452144807,0.0035011414785795013,Lung Neuroendocrine Tumor,epiandrosterone,steroid,G6PD
Lung Neuroendocrine Tumor,BRD-K42973005-001-04-0::2.5::HTS,5.95590534378924,0.014976984113333331,Lung Neuroendocrine Tumor,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Lung Neuroendocrine Tumor,BRD-K43389675-003-20-9::2.5::HTS,6.456103699969091,0.01132737860894263,Lung Neuroendocrine Tumor,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Lung Neuroendocrine Tumor,BRD-K43389698-001-09-9::2.4::HTS,5.247630495531728,0.022369854525470474,Lung Neuroendocrine Tumor,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Lung Neuroendocrine Tumor,BRD-K44084986-300-08-4::2.5::HTS,4.658665729870344,0.031326053469525945,Other Types,Y-27632,rho associated kinase inhibitor,"PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2"
Lung Neuroendocrine Tumor,BRD-K44227013-001-06-4::2.5::HTS,5.855643839818213,0.01584624111295983,Lung Neuroendocrine Tumor,ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK"
Lung Neuroendocrine Tumor,BRD-K44974079-001-01-3::2.5::HTS,7.713985404717144,0.005666083501007361,Other Types,ticagrelor,purinergic receptor antagonist,P2RY12
Lung Neuroendocrine Tumor,BRD-K45216060-001-10-0::2.5::HTS,7.736312739234549,0.005595407352819256,Other Types,mequinol,,TYR
Lung Neuroendocrine Tumor,BRD-K45252063-001-13-6::2.5::HTS,9.470486617104894,0.002191654064919063,Other Types,clofibrate,PPAR receptor agonist,"LPL, PPARA"
Lung Neuroendocrine Tumor,BRD-K45401373-001-20-9::2.5::HTS,7.863110211649434,0.005231113769194223,Other Types,betulinic-acid,"apoptosis stimulant, NFkB pathway inhibitor",GPBAR1
Lung Neuroendocrine Tumor,BRD-K45528773-001-07-2::2.59::HTS,4.179993337389222,0.04139927533065989,Lung Neuroendocrine Tumor,M-344,HDAC inhibitor,
Lung Neuroendocrine Tumor,BRD-K45662124-050-01-5::2.5::HTS,5.924868413116317,0.015240726218701928,Other Types,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2
Lung Neuroendocrine Tumor,BRD-K45746021-003-01-9::2.5::HTS,4.500157280530599,0.0343367380368299,Other Types,CC-401,JNK inhibitor,MAPK8
Lung Neuroendocrine Tumor,BRD-K47079459-004-04-6::2.5::HTS,4.739006313671382,0.02991374192817214,Other Types,cetrimonium,,
Lung Neuroendocrine Tumor,BRD-K47659338-003-02-8::2.5::HTS,5.977653239678795,0.01479870879730574,Lung Neuroendocrine Tumor,EMD-386088,serotonin receptor agonist,HTR6
Lung Neuroendocrine Tumor,BRD-K48722258-300-10-2::2.5::HTS,5.537366699187949,0.018968283342320563,Lung Neuroendocrine Tumor,dilazep,adenosine reuptake inhibitor,SLC29A1
Lung Neuroendocrine Tumor,BRD-K48888725-001-01-9::2.5::HTS,4.463489537423953,0.03507998051742395,Lung Neuroendocrine Tumor,CG-400549,FABI inhibitor,
Lung Neuroendocrine Tumor,BRD-K48892307-001-04-1::2.5::HTS,4.791893993598074,0.029016661037469017,Lung Neuroendocrine Tumor,sasapyrine,NFkB pathway inhibitor,"PTGS1, PTGS2"
Lung Neuroendocrine Tumor,BRD-K48996094-001-01-3::2.5::HTS,3.8739926814064263,0.049539754754520195,Other Types,pentacosanoic-acid,,
Lung Neuroendocrine Tumor,BRD-K49865102-001-08-4::2.5::HTS,6.25059463961522,0.012704680609268795,Lung Neuroendocrine Tumor,PD-0325901,MEK inhibitor,MAP2K1
Lung Neuroendocrine Tumor,BRD-K51677086-001-12-0::2.5::HTS,4.759214694677308,0.029573133390445195,Lung Neuroendocrine Tumor,erythromycin-ethylsuccinate,"cytochrome P450 inhibitor, protein synthesis inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1"
Lung Neuroendocrine Tumor,BRD-K51791723-003-01-7::2.5::HTS,4.149950594763036,0.04210626102158484,Lung Neuroendocrine Tumor,P276-00,CDK inhibitor,"CDK1, CDK4, CDK9"
Lung Neuroendocrine Tumor,BRD-K52233191-001-02-4::2.5::HTS,5.752182452740078,0.016802748516918924,Lung Neuroendocrine Tumor,R547,CDK inhibitor,"CDK1, CDK2, CDK4, CDK7"
Lung Neuroendocrine Tumor,BRD-K53508936-001-01-0::2.5::HTS,4.0493152211608265,0.04467451155292115,Other Types,CTS-1027,metalloproteinase inhibitor,"MMP1, MMP13, MMP2, MMP3, MMP9"
Lung Neuroendocrine Tumor,BRD-K53523901-001-04-4::2.5::HTS,4.083397885554229,0.04378704661815568,Other Types,arctigenin,MEK inhibitor,"CHUK, MAP2K1"
Lung Neuroendocrine Tumor,BRD-K55966568-001-05-4::2.5::HTS,4.983828898550682,0.025979880086314966,Lung Neuroendocrine Tumor,orantinib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB"
Lung Neuroendocrine Tumor,BRD-K56483981-342-06-4::2.5::HTS,4.4355453572932495,0.0356408429923011,Lung Neuroendocrine Tumor,chicago-sky-blue-6b,"glutamate inhibitor, macrophage migration inhibiting factor inhibitor",MIF
Lung Neuroendocrine Tumor,BRD-K56614220-001-19-0::2.5::HTS,4.230147282739842,0.04017469036657952,Other Types,clofazimine,GK0582 inhibitor,
Lung Neuroendocrine Tumor,BRD-K56957086-001-06-3::2.5::HTS,8.65739027166238,0.00339175216469693,Lung Neuroendocrine Tumor,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Lung Neuroendocrine Tumor,BRD-K58435339-001-03-0::2.5::HTS,4.202883654621985,0.04082038132267326,Lung Neuroendocrine Tumor,AT13387,HSP antagonist,HSP90AA1
Lung Neuroendocrine Tumor,BRD-K58466253-003-14-0::2.5::HTS,4.535617593705816,0.033636629745741345,Other Types,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
Lung Neuroendocrine Tumor,BRD-K58736316-001-09-5::2.5::HTS,4.210689915094608,0.04063356623603919,Lung Neuroendocrine Tumor,cianidanol,fatty acid synthase inhibitor,PTGS1
Lung Neuroendocrine Tumor,BRD-K59013864-001-01-1::2.5::HTS,6.5906184422695295,0.010509349875160057,Lung Neuroendocrine Tumor,AM-24,lipoxygenase inhibitor,ALOX5
Lung Neuroendocrine Tumor,BRD-K59325863-001-03-6::2.46::HTS,3.990234039039799,0.04627730995100406,Lung Neuroendocrine Tumor,delanzomib,proteasome inhibitor,"CMA1, CTSG, CYP3A4, ELANE"
Lung Neuroendocrine Tumor,BRD-K59333713-003-02-0::2.5::HTS,4.254116146144176,0.03961839326182224,Other Types,niguldipine-(S)-(+),adrenergic receptor antagonist,ADRA1A
Lung Neuroendocrine Tumor,BRD-K59390331-045-01-5::2.5::HTS,4.774135859547474,0.029302595307743713,Lung Neuroendocrine Tumor,tarafenacin,acetylcholine receptor antagonist,CHRM3
Lung Neuroendocrine Tumor,BRD-K59522102-001-15-3::2.46::HTS,4.060102414752485,0.04441418714016923,Lung Neuroendocrine Tumor,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Lung Neuroendocrine Tumor,BRD-K60230970-001-17-5::2.4::HTS,6.315371637936359,0.01226857964851227,Lung Neuroendocrine Tumor,MG-132,proteasome inhibitor,PSMB1
Lung Neuroendocrine Tumor,BRD-K60348325-065-09-9::2.5::HTS,4.494939502854457,0.034445698649895766,Lung Neuroendocrine Tumor,brilliant-green,,
Lung Neuroendocrine Tumor,BRD-K60443845-001-08-6::2.5::HTS,10.500844500491153,0.00126683336977834,Other Types,chlormidazole,fungal lanosterol demethylase inhibitor,
Lung Neuroendocrine Tumor,BRD-K60446698-001-01-2::2.5::HTS,4.116991914253524,0.04292872239171207,Lung Neuroendocrine Tumor,ONX-0914,proteasome inhibitor,
Lung Neuroendocrine Tumor,BRD-K60690191-001-03-3::2.5::HTS,4.012475412775728,0.0456462133798761,Lung Neuroendocrine Tumor,MPEP,glutamate receptor antagonist,"GRM1, GRM4, GRM5"
Lung Neuroendocrine Tumor,BRD-K62196610-001-01-6::2.5::HTS,8.30512804358342,0.004107169856185788,Other Types,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Lung Neuroendocrine Tumor,BRD-K62391742-001-03-0::2.5::HTS,4.019130695450978,0.04548009576999985,Other Types,venetoclax,BCL inhibitor,BCL2
Lung Neuroendocrine Tumor,BRD-K64538373-001-01-4::2.5::HTS,7.712058554501797,0.005670022352768521,Lung Neuroendocrine Tumor,Ro-4987655,MEK inhibitor,MAP2K1
Lung Neuroendocrine Tumor,BRD-K64890080-001-13-8::2.5::HTS,6.841216454754469,0.009151493277620496,Other Types,BI-2536,PLK inhibitor,"BRD4, PLK1, PLK2, PLK3"
Lung Neuroendocrine Tumor,BRD-K64925568-001-01-8::2.5::HTS,4.166547932232713,0.04170049058747152,Lung Neuroendocrine Tumor,AMG-232,MDM inhibitor,MDM2
Lung Neuroendocrine Tumor,BRD-K66480997-003-10-0::2.5::HTS,5.158242813270213,0.023513671055359637,Lung Neuroendocrine Tumor,isoguvacine,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Lung Neuroendocrine Tumor,BRD-K66538826-001-07-2::2.5::HTS,7.8897097431551115,0.005147791300594345,Other Types,amuvatinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor","KIT, MET"
Lung Neuroendocrine Tumor,BRD-K68395654-001-03-1::2.5::HTS,5.441415474063567,0.020016785443086518,Other Types,EVP4593,NFkB pathway inhibitor,
Lung Neuroendocrine Tumor,BRD-K69216798-001-01-9::2.5::HTS,5.426516583658414,0.02019696406089752,Lung Neuroendocrine Tumor,iodoantipyrine,,
Lung Neuroendocrine Tumor,BRD-K69650333-003-14-0::2.5::HTS,4.2387979533296365,0.0399770771322333,Lung Neuroendocrine Tumor,idarubicin,topoisomerase inhibitor,TOP2A
Lung Neuroendocrine Tumor,BRD-K69694239-001-02-2::2.5::HTS,6.347247961691738,0.01203256131700113,Lung Neuroendocrine Tumor,bardoxolone-methyl,"nuclear factor erythroid derived, like (NRF2) activator","PPARG, STAT3"
Lung Neuroendocrine Tumor,BRD-K69932463-001-10-6::2.5::HTS,3.8743681992815096,0.04952694808651627,Lung Neuroendocrine Tumor,AZD8055,mTOR inhibitor,MTOR
Lung Neuroendocrine Tumor,BRD-K70301465-001-02-6::2.5::HTS,4.248151508118323,0.03975919281615611,Lung Neuroendocrine Tumor,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK"
Lung Neuroendocrine Tumor,BRD-K70463136-001-01-5::2.5::HTS,3.953017059540157,0.04727380063810179,Other Types,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A
Lung Neuroendocrine Tumor,BRD-K71698503-003-01-6::2.5::HTS,4.895742580021724,0.027324178396188985,Lung Neuroendocrine Tumor,I-BZA2,,
Lung Neuroendocrine Tumor,BRD-K72166146-066-05-4::2.5::HTS,10.25059114109599,0.0014447641611543217,Lung Neuroendocrine Tumor,dihydroergotamine,serotonin receptor agonist,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7"
Lung Neuroendocrine Tumor,BRD-K73191876-001-11-2::2.5::HTS,5.688616390090872,0.01741549270522476,Lung Neuroendocrine Tumor,alizarin,,
Lung Neuroendocrine Tumor,BRD-K73391359-003-10-2::2.5::HTS,5.434208581791966,0.020103839774885,Lung Neuroendocrine Tumor,dimethisoquin,local anesthetic,
Lung Neuroendocrine Tumor,BRD-K73771095-001-03-3::2.5::HTS,5.501637395912394,0.01935044542205464,Lung Neuroendocrine Tumor,geniposidic-acid,cyclooxygenase inhibitor,
Lung Neuroendocrine Tumor,BRD-K74763371-002-04-0::2.5::HTS,7.1021500166881735,0.007920425522568891,Lung Neuroendocrine Tumor,bosentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Lung Neuroendocrine Tumor,BRD-K76037122-001-02-5::2.5::HTS,4.790603938184626,0.02902614615719603,Lung Neuroendocrine Tumor,guanidine,HSP inhibitor,"ALDH2, DLG4, GAMT, RNASE1"
Lung Neuroendocrine Tumor,BRD-K76180386-001-01-6::2.5::HTS,7.134587950029148,0.007781383543131585,Other Types,JIB04,histone lysine demethylase inhibitor,KDM4E
Lung Neuroendocrine Tumor,BRD-K76674262-001-03-3::2.5::HTS,4.872329798321699,0.02769394877352651,Lung Neuroendocrine Tumor,homoharringtonine,protein synthesis inhibitor,RPL3
Lung Neuroendocrine Tumor,BRD-K77943374-001-02-8::2.5::HTS,9.525271648735288,0.0021264375043301116,Lung Neuroendocrine Tumor,NVP-BVU972,MET inhibitor,MET
Lung Neuroendocrine Tumor,BRD-K78096648-001-05-7::2.5::HTS,10.988057598094759,0.0009771925550227118,Other Types,oxiperomide,dopamine receptor antagonist,
Lung Neuroendocrine Tumor,BRD-K78126613-001-28-5::2.5::HTS,4.116657381744801,0.04293376932045378,Other Types,menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
Lung Neuroendocrine Tumor,BRD-K78299798-001-02-2::2.5::HTS,6.452035482890215,0.01135451153938421,Lung Neuroendocrine Tumor,mepiroxol,,
Lung Neuroendocrine Tumor,BRD-K78318619-001-02-7::2.5::HTS,4.3554019950680845,0.03734176536439627,Lung Neuroendocrine Tumor,PF-4981517,cytochrome P450 inhibitor,CYP3A4
Lung Neuroendocrine Tumor,BRD-K78513633-001-15-7::2.5::HTS,5.3054552157262185,0.021629508283259397,Other Types,lonidamine,glucokinase inhibitor,GCK
Lung Neuroendocrine Tumor,BRD-K78815826-001-14-6::2.5::HTS,4.8488236738142465,0.02807336084588527,Lung Neuroendocrine Tumor,suxibuzone,cyclooxygenase inhibitor,
Lung Neuroendocrine Tumor,BRD-K78960041-001-03-2::2.5::HTS,5.724268114024004,0.017080563311980115,Other Types,oxaliplatin,DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-K78960041-001-05-7::2.54::HTS,5.462656631670793,0.019799887642055716,Other Types,oxaliplatin,DNA inhibitor,
Lung Neuroendocrine Tumor,BRD-K79404599-001-09-3::2.5::HTS,5.143440679608932,0.02371307137607378,Lung Neuroendocrine Tumor,enzastaurin,PKC inhibitor,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG"
Lung Neuroendocrine Tumor,BRD-K79555887-001-01-0::2.5::HTS,4.46714055400622,0.03499517426967697,Lung Neuroendocrine Tumor,RI-1,,RAD51
Lung Neuroendocrine Tumor,BRD-K79759585-048-04-8::2.5::HTS,4.112244380901996,0.043054493741897105,Other Types,sildenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
Lung Neuroendocrine Tumor,BRD-K81528515-001-13-8::2.5::HTS,5.219314072725136,0.022726592353557264,Other Types,nilotinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor","ABL1, KIT"
Lung Neuroendocrine Tumor,BRD-K82181219-001-04-3::2.5::HTS,5.571714343238772,0.01859593720404391,Lung Neuroendocrine Tumor,pyritinol,,
Lung Neuroendocrine Tumor,BRD-K82244583-001-01-3::2.5::HTS,3.895492131366929,0.048926127744075634,Lung Neuroendocrine Tumor,MEK162,MEK inhibitor,"MAP2K1, MAP2K2"
Lung Neuroendocrine Tumor,BRD-K82255054-001-15-9::2.5::HTS,3.8922798262385068,0.04900168393093915,Lung Neuroendocrine Tumor,propofol,benzodiazepine receptor agonist,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A"
Lung Neuroendocrine Tumor,BRD-K82846253-001-15-4::2.5::HTS,4.11636829121233,0.042966698451398534,Lung Neuroendocrine Tumor,repaglinide,insulin secretagogue,"ABCC8, KCNJ11, PPARG"
Lung Neuroendocrine Tumor,BRD-K82941592-238-04-5::2.5::HTS,4.097812035542474,0.043431409790200125,Lung Neuroendocrine Tumor,rosuvastatin,HMGCR inhibitor,HMGCR
Lung Neuroendocrine Tumor,BRD-K83551379-001-02-6::2.5::HTS,3.988735221885091,0.04630125347010879,Other Types,levodropropizine,antitussive,
Lung Neuroendocrine Tumor,BRD-K84937637-001-09-9::2.5::HTS,4.0562905593241645,0.04451376320064939,Other Types,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Lung Neuroendocrine Tumor,BRD-K84996356-001-01-1::2.5::HTS,8.487328339277001,0.003722730870036544,Other Types,AZD3514,androgen receptor modulator,AR
Lung Neuroendocrine Tumor,BRD-K85066592-001-01-6::2.5::HTS,6.500763152958771,0.011052986041427647,Other Types,gly-gln,,
Lung Neuroendocrine Tumor,BRD-K85402309-389-03-2::2.5::HTS,3.997424740240167,0.04605252476397911,Other Types,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Lung Neuroendocrine Tumor,BRD-K86118762-001-01-8::2.5::HTS,4.835535634458805,0.028299901482600243,Other Types,linsitinib,IGF-1 inhibitor,"IGF1R, INSR, INSRR"
Lung Neuroendocrine Tumor,BRD-K86687746-001-01-3::2.5::HTS,6.144155605316503,0.01348567664942518,Lung Neuroendocrine Tumor,R306465,HDAC inhibitor,
Lung Neuroendocrine Tumor,BRD-K87349682-347-03-8::2.36::HTS,6.951543385916834,0.008621262215186935,Lung Neuroendocrine Tumor,norepinephrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2"
Lung Neuroendocrine Tumor,BRD-K87827419-001-16-8::2.5::HTS,8.874981187495125,0.003019617898606453,Other Types,melphalan,"DNA alkylating agent, DNA inhibitor",
Lung Neuroendocrine Tumor,BRD-K88611939-001-22-4::2.5::HTS,3.9345593351917407,0.04779232267081873,Other Types,aniracetam,glutamate receptor agonist,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A"
Lung Neuroendocrine Tumor,BRD-K88677950-001-03-9::2.5::HTS,5.443642241795546,0.019994065266028885,Lung Neuroendocrine Tumor,PD-198306,"MAP kinase inhibitor, MEK inhibitor","MAP2K1, MAP2K2"
Lung Neuroendocrine Tumor,BRD-K88701661-001-02-9::2.5::HTS,4.22646429090399,0.0402950293166046,Lung Neuroendocrine Tumor,dimercaptosuccinic-acid,chelating agent,DNMT1
Lung Neuroendocrine Tumor,BRD-K89014967-001-04-3::2.5::HTS,8.923243120802173,0.0029395910000644654,Lung Neuroendocrine Tumor,AS-703026,MEK inhibitor,"MAP2K1, MAP2K2"
Lung Neuroendocrine Tumor,BRD-K89391146-001-08-0::2.5::HTS,6.824121742877534,0.009244803933267055,Lung Neuroendocrine Tumor,RG108,DNA methyltransferase inhibitor,"DNMT1, DNMT3B"
Lung Neuroendocrine Tumor,BRD-K91456750-238-01-7::2.5::HTS,6.908282698727639,0.008814317899315515,Lung Neuroendocrine Tumor,sacubitril,neprilysin inhibitor,MME
Lung Neuroendocrine Tumor,BRD-K91825936-001-01-2::2.5::HTS,4.327142320764501,0.03796411945688731,Other Types,ZK811752,CC chemokine receptor antagonist,CCR1
Lung Neuroendocrine Tumor,BRD-K91904471-001-02-4::2.5::HTS,10.746995595926153,0.0011109514773711261,Lung Neuroendocrine Tumor,SD-169,p38 MAPK inhibitor,MAPK14
Lung Neuroendocrine Tumor,BRD-K92093830-003-30-8::2.5::HTS,9.682418039598176,0.001955388210657132,Lung Neuroendocrine Tumor,doxorubicin,topoisomerase inhibitor,TOP2A
Lung Neuroendocrine Tumor,BRD-K92150287-066-01-2::2.5::HTS,6.855354375997843,0.009079377109199753,Lung Neuroendocrine Tumor,exatecan-mesylate,topoisomerase inhibitor,TOP1
Lung Neuroendocrine Tumor,BRD-K93767137-001-01-1::2.5::HTS,3.928549653320373,0.047961282634574255,Other Types,oseltamivir-carboxylate,neuraminidase inhibitor,
Lung Neuroendocrine Tumor,BRD-K93918653-001-08-9::2.5::HTS,9.041592778261126,0.002757674247363375,Other Types,quizartinib,FLT3 inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET"
Lung Neuroendocrine Tumor,BRD-K94436377-001-10-2::2.5::HTS,4.357444527367914,0.03729737319319453,Lung Neuroendocrine Tumor,diosmin,"aryl hydrocarbon receptor agonist, capillary stabilizing agent",AHR
Lung Neuroendocrine Tumor,BRD-K94485812-001-02-9::2.55::HTS,5.704590287879618,0.017270957796588757,Other Types,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Lung Neuroendocrine Tumor,BRD-K95053546-001-01-9::2.5::HTS,4.096010027350105,0.04345717602765287,Lung Neuroendocrine Tumor,tempol,free radical scavenger,
Lung Neuroendocrine Tumor,BRD-K95581532-001-01-5::2.5::HTS,4.146620175271161,0.042192778951131556,Lung Neuroendocrine Tumor,RN-1734,TRPV antagonist,TRPV4
Lung Neuroendocrine Tumor,BRD-K95785345-300-14-8::2.5::HTS,7.509358593384621,0.0063330623195504195,Lung Neuroendocrine Tumor,thiamine,vitamin B,"SLC19A2, SLC19A3, TPK1"
Lung Neuroendocrine Tumor,BRD-K96153583-001-05-1::2.52::HTS,6.5142656754440775,0.010982711115567013,Other Types,cidofovir,DNA polymerase inhibitor,
Lung Neuroendocrine Tumor,BRD-K96436774-001-01-8::2.5::HTS,7.306128632486072,0.007081732581747882,Lung Neuroendocrine Tumor,pelanserin,serotonin receptor antagonist,HTR2A
Lung Neuroendocrine Tumor,BRD-K97181089-003-24-7::2.5::HTS,5.141753150109544,0.023735915608090807,Other Types,amiloride,sodium channel blocker,"AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2"
Lung Neuroendocrine Tumor,BRD-K97746869-001-27-0::2.5::HTS,4.455386978389643,0.03523242537736189,Lung Neuroendocrine Tumor,chlorpropamide,ATP channel blocker,"ABCC8, KCNJ10, KCNJ11"
Lung Neuroendocrine Tumor,BRD-K97799481-001-16-0::2.5::HTS,4.483148217329937,0.034669212649381435,Lung Neuroendocrine Tumor,theophylline,adenosine receptor antagonist,
Lung Neuroendocrine Tumor,BRD-K98157055-001-10-9::2.5::HTS,6.330244037060509,0.012149639977785898,Lung Neuroendocrine Tumor,SIB-1757,glutamate receptor antagonist,GRM5
Lung Neuroendocrine Tumor,BRD-K98203492-003-04-1::2.5::HTS,4.125746141806954,0.04273015632215368,Other Types,GSK-J4,histone lysine demethylase inhibitor,"KDM6A, KDM6B"
Lung Neuroendocrine Tumor,BRD-M02075109-001-01-1::2.5::HTS,8.856609280798118,0.003047775129058205,Lung Neuroendocrine Tumor,chromanol-(+/-),potassium channel blocker,
Lung Neuroendocrine Tumor,BRD-A18992208-003-02-7::2.5::MTS004,4.063329692913396,0.04431972824094062,Lung Neuroendocrine Tumor,lercanidipine,calcium channel blocker,"CACNA2D1, CACNG1"
Lung Neuroendocrine Tumor,BRD-A65683612-001-07-7::2.499972087::MTS004,4.29361436877346,0.03873157977268037,Lung Neuroendocrine Tumor,phenylpiracetam,noradrenaline uptake inhibitor,
Lung Neuroendocrine Tumor,BRD-K07625016-001-01-2::2.50703254::MTS004,4.545878555023429,0.033450381083893824,Lung Neuroendocrine Tumor,norethisterone-enanthate,contraceptive agent,
Lung Neuroendocrine Tumor,BRD-K15014948-001-10-3::2.500062642::MTS004,4.402068228474881,0.03636028568180122,Lung Neuroendocrine Tumor,tranexamic-acid,"antifibrinolytic, plasminogen activator inhibitor",PLG
Lung Neuroendocrine Tumor,BRD-K16505263-003-02-9::2.49996754::MTS004,4.152375501095279,0.04206393941497718,Lung Neuroendocrine Tumor,forodesine,purinergic receptor antagonist,PNP
Lung Neuroendocrine Tumor,BRD-K22149900-001-03-9::2.371298578::MTS004,5.059030316431526,0.02490081628546109,Lung Neuroendocrine Tumor,ceritinib,ALK tyrosine kinase receptor inhibitor,"ALK, FLT3, IGF1R, INSR, TSSK1B"
Lung Neuroendocrine Tumor,BRD-K24666289-001-04-9::2.499988887::MTS004,3.935862955659209,0.04777371368299366,Lung Neuroendocrine Tumor,copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Lung Neuroendocrine Tumor,BRD-K28537285-001-01-8::2.499968715::MTS004,6.541361303418226,0.010811968104292408,Other Types,chidamide,HDAC inhibitor,"HDAC10, HDAC3"
Lung Neuroendocrine Tumor,BRD-K32256160-001-01-9::2.499998021::MTS004,4.164291913136429,0.04177228072070309,Other Types,solithromycin,protein synthesis inhibitor,
Lung Neuroendocrine Tumor,BRD-K42140276-402-01-4::2.500009363::MTS004,13.182308753436176,0.00030956093093124774,Lung Neuroendocrine Tumor,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
Lung Neuroendocrine Tumor,BRD-K49659468-436-01-2::2.500002467::MTS004,3.866390787177762,0.049775084354889615,Other Types,TMC647055,RNA polymerase inhibitor,
Lung Neuroendocrine Tumor,BRD-K50010139-001-02-3::2.5::MTS004,5.205791326273643,0.022900817932729436,Lung Neuroendocrine Tumor,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Lung Neuroendocrine Tumor,BRD-K54955827-001-02-2::2.49997945::MTS004,6.080629851362416,0.01397747832297513,Other Types,niraparib,PARP inhibitor,PARP1
Lung Neuroendocrine Tumor,BRD-K56211775-001-03-8::2.5::MTS004,14.180044322974021,0.0001844298926706874,Lung Neuroendocrine Tumor,RTA-408,nitric oxide production inhibitor,NFE2L2
Lung Neuroendocrine Tumor,BRD-K56807945-001-01-2::2.500001454::MTS004,6.247613196603648,0.012732316980384364,Other Types,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,"EGLN1, EGLN2, HIF1A"
Lung Neuroendocrine Tumor,BRD-K58529924-001-01-5::2.648577938::MTS004,5.092568942517826,0.024428279694189047,Other Types,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Lung Neuroendocrine Tumor,BRD-K59391348-001-01-7::2.5::MTS004,4.631593207279158,0.03183177862754731,Lung Neuroendocrine Tumor,lixivaptan,vasopressin receptor antagonist,AVPR2
Lung Neuroendocrine Tumor,BRD-K59895502-001-01-9::2.591975371::MTS004,3.97565481193767,0.04666683635622778,Other Types,caramiphen,cholinergic receptor antagonist,"CHRM1, CHRM2"
Lung Neuroendocrine Tumor,BRD-K62050508-001-01-0::2.499980818::MTS004,4.33798112896371,0.03774282138945048,Other Types,grapiprant,prostaglandin inhibitor,PTGER4
Lung Neuroendocrine Tumor,BRD-K67628093-001-01-9::2.500004949::MTS004,4.895772485923229,0.02734164244471163,Lung Neuroendocrine Tumor,INCB-3284,CC chemokine receptor antagonist,CCR2
Lung Neuroendocrine Tumor,BRD-K79450420-001-02-6::2.5::MTS004,4.411048912499324,0.03617181964083385,Other Types,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Lung Neuroendocrine Tumor,BRD-K79803033-300-01-3::2.5::MTS004,5.286566743855437,0.021872040355340645,Lung Neuroendocrine Tumor,pozanicline,acetylcholine receptor antagonist,"CHRNA4, CHRNB2"
Lung Neuroendocrine Tumor,BRD-K80607346-001-01-1::2.5::MTS004,5.704783079449795,0.017261907866392156,Other Types,FK-962,somatostatin receptor agonist,
Lung Neuroendocrine Tumor,BRD-K81981783-236-02-9::2.570718613::MTS004,5.12079761857871,0.024037793797328236,Lung Neuroendocrine Tumor,gavestinel,glutamate receptor antagonist,GLRB
Lung Neuroendocrine Tumor,BRD-K82103381-003-09-4::2.500073689::MTS004,6.46698592572638,0.011268069477806047,Lung Neuroendocrine Tumor,hydralazine,vasodilator,"AOC3, P4HA1"
Lung Neuroendocrine Tumor,BRD-K87573013-001-01-0::2.5::MTS004,4.419637955445384,0.03599085069364932,Lung Neuroendocrine Tumor,CL-225385,,
Lung Neuroendocrine Tumor,BRD-K91543828-001-02-0::2.500044381::MTS004,6.2291895436022715,0.012863893615607044,Lung Neuroendocrine Tumor,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Esophageal Squamous Cell Carcinoma,BRD-A00100033-001-08-9::2.5::HTS,4.754136792877696,0.029642021583159765,Esophageal Squamous Cell Carcinoma,nifurtimox,DNA inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A00578795-001-04-3::2.5::HTS,3.9629237424312245,0.04699668629933129,Esophageal Squamous Cell Carcinoma,zaltoprofen,cyclooxygenase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A01643550-001-04-9::2.5::HTS,4.261991359295067,0.039452045665484964,Other Types,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Esophageal Squamous Cell Carcinoma,BRD-A01907367-001-01-7::2.5::HTS,5.8093095049357615,0.01626457411225904,Other Types,FK-33-824,opioid receptor agonist,OPRM1
Esophageal Squamous Cell Carcinoma,BRD-A03506276-001-01-5::2.5::HTS,6.022238945531649,0.014431756570089495,Other Types,XL888,HSP inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A07870296-001-07-4::2.5::HTS,4.266218978596954,0.039341854697081666,Esophageal Squamous Cell Carcinoma,bicuculline-(+),GABA receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1"
Esophageal Squamous Cell Carcinoma,BRD-A11815689-001-01-1::2.5::HTS,5.742888548844188,0.01688428032367858,Other Types,proscillaridin-a,,
Esophageal Squamous Cell Carcinoma,BRD-A15297126-001-04-3::2.5::HTS,4.621573907621747,0.03201657691687376,Other Types,fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Esophageal Squamous Cell Carcinoma,BRD-A17655518-001-24-4::2.5::HTS,7.1371669446676185,0.00776994827948055,Esophageal Squamous Cell Carcinoma,ibuprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Esophageal Squamous Cell Carcinoma,BRD-A18043272-001-09-9::2.5::HTS,4.15637780915745,0.041947140396140635,Other Types,phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Esophageal Squamous Cell Carcinoma,BRD-A19585813-003-03-3::2.5::HTS,4.875084804887555,0.02765306275756758,Other Types,methylphenidate,dopamine-norepinephrine reuptake inhibitor,"SLC6A2, SLC6A3, SLC6A4"
Esophageal Squamous Cell Carcinoma,BRD-A20119038-003-07-8::2.5::HTS,4.888764558008045,0.027437458157891375,Esophageal Squamous Cell Carcinoma,mecamylamine,acetylcholine receptor antagonist,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Esophageal Squamous Cell Carcinoma,BRD-A22707317-001-10-8::2.5::HTS,3.9781719510875484,0.04657785749592426,Other Types,SB-205384,GABA receptor modulator,"GABRA3, GABRA5, GABRA6"
Esophageal Squamous Cell Carcinoma,BRD-A29281099-003-03-2::2.5::HTS,6.526343801883797,0.010898979396598408,Other Types,clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2"
Esophageal Squamous Cell Carcinoma,BRD-A31095847-001-02-3::2.5::HTS,6.63842283244657,0.010237950049095676,Other Types,mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2"
Esophageal Squamous Cell Carcinoma,BRD-A36331462-001-02-1::2.5::HTS,5.1654798114262395,0.0234236576817379,Other Types,oprozomib,proteasome inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A37704979-001-10-7::2.5::HTS,4.053066884799125,0.04457173868474879,Other Types,SB-203580,p38 MAPK inhibitor,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
Esophageal Squamous Cell Carcinoma,BRD-A42746051-001-02-9::2.5::HTS,3.9264046216806454,0.04802468928531444,Other Types,melengestrol-acetate,progesterone receptor agonist,
Esophageal Squamous Cell Carcinoma,BRD-A43999749-004-04-1::2.5::HTS,4.866455841748693,0.02779116815730333,Other Types,homatropine-methylbromide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Esophageal Squamous Cell Carcinoma,BRD-A45543382-001-10-0::2.5::HTS,3.96038966694049,0.04707396112192075,Esophageal Squamous Cell Carcinoma,metrizamide,radiopaque medium,
Esophageal Squamous Cell Carcinoma,BRD-A47449001-004-13-7::2.5::HTS,5.080819332600739,0.02457631226359581,Esophageal Squamous Cell Carcinoma,ipratropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Esophageal Squamous Cell Carcinoma,BRD-A50028488-001-01-6::2.5::HTS,4.802078266737757,0.02883882267837682,Esophageal Squamous Cell Carcinoma,TCS2002,glycogen synthase kinase inhibitor,GSK3B
Esophageal Squamous Cell Carcinoma,BRD-A55484088-050-02-5::2.5::HTS,4.589883648967819,0.032592480862530034,Other Types,BNTX,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Esophageal Squamous Cell Carcinoma,BRD-A57900429-003-05-8::2.5::HTS,5.403618473949621,0.02045300849225267,Esophageal Squamous Cell Carcinoma,hydrastinine,haemostatic agent,
Esophageal Squamous Cell Carcinoma,BRD-A58193911-003-18-7::2.5::HTS,5.283517627289844,0.021909989086392773,Other Types,oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3"
Esophageal Squamous Cell Carcinoma,BRD-A61221616-001-04-3::2.5::HTS,5.826949402496598,0.016101110576029358,Other Types,medroxyprogesterone-acetate,progesterone receptor agonist,
Esophageal Squamous Cell Carcinoma,BRD-A66419424-001-02-4::2.5::HTS,7.354988467134012,0.006896183674662087,Other Types,ixazomib-citrate,proteasome inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A67514145-003-05-8::2.5::HTS,4.2529411119875045,0.0396549377068115,Esophageal Squamous Cell Carcinoma,furaltadone,bacterial DNA inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A69815203-001-07-6::2.5::HTS,6.84997593212359,0.009125368385523358,Other Types,cyclosporin-a,calcineurin inhibitor,PPP3CA
Esophageal Squamous Cell Carcinoma,BRD-A72703248-003-04-9::2.5::HTS,5.437291373077386,0.020066809024378233,Other Types,SKF-96365,calcium channel blocker,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2"
Esophageal Squamous Cell Carcinoma,BRD-A78093359-001-06-3::2.5::HTS,4.121278511967059,0.04282433812105351,Esophageal Squamous Cell Carcinoma,MRS1845,calcium channel blocker,
Esophageal Squamous Cell Carcinoma,BRD-A89164055-001-03-3::2.5::HTS,5.059289430673218,0.024882684320770742,Other Types,sorbinil,aldose reductase inhibitor,AKR1B1
Esophageal Squamous Cell Carcinoma,BRD-A92800748-001-05-5::2.5::HTS,8.3762817208214,0.003950401980339131,Other Types,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,"KDR, MAPK14"
Esophageal Squamous Cell Carcinoma,BRD-A94276798-001-01-4::2.5::HTS,6.674154910823113,0.010034390945185212,Esophageal Squamous Cell Carcinoma,talinolol,adrenergic receptor antagonist,ADRB1
Esophageal Squamous Cell Carcinoma,BRD-A94756469-001-04-7::2.5::HTS,4.123309612455513,0.04276655595802678,Other Types,digoxin,ATPase inhibitor,ATP1A1
Esophageal Squamous Cell Carcinoma,BRD-A94993966-001-04-4::2.5::HTS,4.474261235063966,0.03484847465488051,Other Types,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Esophageal Squamous Cell Carcinoma,BRD-A99939097-001-24-2::2.5::HTS,4.834760268193649,0.028300441306250382,Esophageal Squamous Cell Carcinoma,carisoprodol,acetylcholine receptor antagonist,CYP2C19
Esophageal Squamous Cell Carcinoma,BRD-K00535541-001-06-3::2.5::HTS,8.07187082083834,0.004669424479192614,Other Types,9-aminoacridine,,
Esophageal Squamous Cell Carcinoma,BRD-K01109406-001-03-7::2.5::HTS,4.442811327704707,0.03549710218307431,Esophageal Squamous Cell Carcinoma,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD
Esophageal Squamous Cell Carcinoma,BRD-K01295354-001-02-8::2.5::HTS,8.864181137348492,0.0030339823168213215,Esophageal Squamous Cell Carcinoma,uric-acid,,PYGL
Esophageal Squamous Cell Carcinoma,BRD-K01567962-001-23-0::2.5::HTS,9.749019237727406,0.0018871458564534978,Other Types,pyrazolanthrone,JNK inhibitor,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK"
Esophageal Squamous Cell Carcinoma,BRD-K01624185-001-05-7::2.5::HTS,4.422325070716385,0.03592377840080519,Other Types,maltobionic-acid,matrix metalloprotease inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K01942991-005-08-2::2.5::HTS,6.0029710843206185,0.014590121772848418,Esophageal Squamous Cell Carcinoma,oxotremorine-m,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Esophageal Squamous Cell Carcinoma,BRD-K02733959-236-07-7::2.5::HTS,5.378309908712024,0.020748845087422998,Other Types,cefuroxime,bacterial cell wall synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K04430056-236-02-1::2.5::HTS,4.980348837911166,0.026037448925311322,Other Types,7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Esophageal Squamous Cell Carcinoma,BRD-K05446112-001-01-8::2.5::HTS,7.319290431961685,0.007030733928915305,Other Types,ledipasvir,HCV inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K06408664-001-03-5::2.5::HTS,4.888372226622714,0.027442909854870613,Other Types,fludrocortisone-acetate,,"AR, NR3C1, NR3C2"
Esophageal Squamous Cell Carcinoma,BRD-K07106112-003-03-8::2.5::HTS,18.880121695091333,1.6545496633811002e-05,Other Types,BMS-599626,"EGFR inhibitor, protein tyrosine kinase inhibitor","EGFR, ERBB2, ERBB4"
Esophageal Squamous Cell Carcinoma,BRD-K07507905-236-02-6::2.5::HTS,6.275894100152656,0.012522984877038647,Esophageal Squamous Cell Carcinoma,BRL-37344,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Esophageal Squamous Cell Carcinoma,BRD-K07762753-001-04-4::2.5::HTS,5.574637986279935,0.01856771309586169,Other Types,aminopurvalanol-a,"CDK inhibitor, tyrosine kinase inhibitor","CDK1, CDK2, CDK5, CDK6"
Esophageal Squamous Cell Carcinoma,BRD-K07955840-001-02-3::2.5::HTS,5.375931801856263,0.020776870532526977,Other Types,PF-05212384,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Esophageal Squamous Cell Carcinoma,BRD-K08288352-001-03-6::2.5::HTS,5.3453037020040215,0.021149351732547228,Esophageal Squamous Cell Carcinoma,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,
Esophageal Squamous Cell Carcinoma,BRD-K08525451-003-05-2::2.5::HTS,4.890667721266341,0.027409700152223514,Other Types,sarafloxacin,bacterial DNA gyrase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K08799216-001-05-3::2.5::HTS,6.430686899346917,0.011497817802200539,Other Types,pelitinib,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K09372874-001-01-0::2.5::HTS,5.718787216580167,0.01712622700502673,Other Types,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
Esophageal Squamous Cell Carcinoma,BRD-K09877029-001-01-2::2.5::HTS,6.937742785477159,0.00867333335628815,Other Types,VS-4718,focal adhesion kinase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K10961822-001-05-1::2.5::HTS,6.716013391240284,0.009814087454955232,Other Types,latanoprost,prostanoid receptor agonist,PTGFR
Esophageal Squamous Cell Carcinoma,BRD-K11267252-001-04-4::2.5::HTS,9.880936654566622,0.0017619067335556027,Other Types,alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET"
Esophageal Squamous Cell Carcinoma,BRD-K11292736-300-02-8::2.5::HTS,3.9073850776756123,0.048569809085517675,Esophageal Squamous Cell Carcinoma,ambenonium,cholinesterase inhibitor,ACHE
Esophageal Squamous Cell Carcinoma,BRD-K11630072-001-13-2::2.5::HTS,4.515877171609901,0.03404541651424538,Other Types,carmofur,thymidylate synthase inhibitor,TYMS
Esophageal Squamous Cell Carcinoma,BRD-K12502280-001-08-0::2.5::HTS,4.535181289414339,0.03365740189967449,Other Types,TG-101348,"FLT3 inhibitor, JAK inhibitor","BRD4, JAK1, JAK2, JAK3, TYK2"
Esophageal Squamous Cell Carcinoma,BRD-K13606314-001-01-3::2.5::HTS,3.893106656297841,0.048974230793917786,Esophageal Squamous Cell Carcinoma,P5091,ubiquitin specific protease inhibitor,USP7
Esophageal Squamous Cell Carcinoma,BRD-K13756951-001-01-4::2.5::HTS,10.84643844668518,0.0010520978964913945,Other Types,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Esophageal Squamous Cell Carcinoma,BRD-K14496212-066-04-8::2.5::HTS,6.980814646369586,0.008475113438402767,Esophageal Squamous Cell Carcinoma,bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Esophageal Squamous Cell Carcinoma,BRD-K14991967-001-02-6::2.5::HTS,9.87959614867582,0.0017606411368846762,Other Types,GSK650394,serum/glucocorticoid regulated kinase inhibitor,"SGK1, SGK2"
Esophageal Squamous Cell Carcinoma,BRD-K15025317-001-15-1::2.5::HTS,4.459534027491746,0.0351540580703818,Other Types,BAY-11-7082,NFkB pathway inhibitor,RELA
Esophageal Squamous Cell Carcinoma,BRD-K16757695-050-02-5::2.5::HTS,3.8618061796809,0.049890989764419795,Esophageal Squamous Cell Carcinoma,PRX-08066,serotonin receptor antagonist,HTR2B
Esophageal Squamous Cell Carcinoma,BRD-K16761703-001-03-8::2.5::HTS,5.80600996452987,0.01629305846355398,Esophageal Squamous Cell Carcinoma,sotrastaurin,PKC inhibitor,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ"
Esophageal Squamous Cell Carcinoma,BRD-K17061841-001-03-5::2.5::HTS,7.831098135700833,0.005311719262345559,Other Types,stattic,,
Esophageal Squamous Cell Carcinoma,BRD-K17555800-003-01-5::2.5::HTS,4.8998386395074345,0.02726145261460481,Other Types,talmapimod,p38 MAPK inhibitor,"MAPK11, MAPK14"
Esophageal Squamous Cell Carcinoma,BRD-K17702546-001-03-2::2.5::HTS,26.69360293887714,3.3166587509067014e-07,Other Types,PD-168393,EGFR inhibitor,"EGFR, ERBB2, SRC"
Esophageal Squamous Cell Carcinoma,BRD-K18910433-001-36-6::2.58::HTS,3.9742585064360907,0.046714808814405574,Esophageal Squamous Cell Carcinoma,estradiol,estrogen receptor agonist,"ESR1, ESR2, GPER1, KCNMA1, NR1I2"
Esophageal Squamous Cell Carcinoma,BRD-K18961567-001-01-1::2.5::HTS,8.114912492448607,0.00455339357699224,Other Types,LY2801653,MET inhibitor,MET
Esophageal Squamous Cell Carcinoma,BRD-K19540840-001-09-4::2.5::HTS,19.64809919032173,1.1198071233683294e-05,Other Types,saracatinib,src inhibitor,"ABL1, LCK, SRC, YES1"
Esophageal Squamous Cell Carcinoma,BRD-K19601669-001-03-5::2.5::HTS,4.843402041998775,0.02815804338248514,Other Types,ruxolitinib-(S),JAK inhibitor,"JAK1, JAK2"
Esophageal Squamous Cell Carcinoma,BRD-K19687926-379-07-4::2.5::HTS,20.86970938320377,6.0554041426289e-06,Other Types,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K20958582-001-01-4::2.5::HTS,4.353968156644984,0.03737946976925336,Other Types,TH-302,DNA alkylating agent,
Esophageal Squamous Cell Carcinoma,BRD-K21025364-001-04-9::2.5::HTS,6.136664763122729,0.013546205755032454,Other Types,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
Esophageal Squamous Cell Carcinoma,BRD-K21071223-001-02-8::2.5::HTS,4.854478289924538,0.027985251758279355,Esophageal Squamous Cell Carcinoma,VP-20629,beta amyloid antagonist,"PLA2G2E, SLC36A1"
Esophageal Squamous Cell Carcinoma,BRD-K21361524-001-01-1::2.5::HTS,5.2014866653151,0.022941058457342553,Other Types,selinexor,exportin antagonist,XPO1
Esophageal Squamous Cell Carcinoma,BRD-K21670884-001-01-9::2.5::HTS,6.462930725797361,0.011286409853437445,Other Types,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1
Esophageal Squamous Cell Carcinoma,BRD-K23190681-001-01-1::2.5::HTS,17.693989388544743,3.0256587595329445e-05,Other Types,AV-412,protein tyrosine kinase inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K23228615-001-02-8::2.5::HTS,4.002912245906578,0.04591093659153922,Other Types,GDC-0980,"mTOR inhibitor, PI3K inhibitor","FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK"
Esophageal Squamous Cell Carcinoma,BRD-K24084088-001-11-3::2.5::HTS,5.197662803892855,0.02299446640952444,Esophageal Squamous Cell Carcinoma,paraxanthine,adenosine receptor antagonist,
Esophageal Squamous Cell Carcinoma,BRD-K24566386-001-01-9::2.5::HTS,7.8877858876868805,0.005153513932781941,Other Types,SD-208,TGF beta receptor inhibitor,TGFBR1
Esophageal Squamous Cell Carcinoma,BRD-K25412176-001-01-9::2.5::HTS,4.550018967124191,0.03335721745222823,Other Types,GSK2110183,AKT inhibitor,"AKT1, AKT2, AKT3"
Esophageal Squamous Cell Carcinoma,BRD-K25630527-001-03-8::2.5::HTS,3.9499697563713423,0.04735711890702,Other Types,LY2784544,JAK inhibitor,"JAK2, JAK3"
Esophageal Squamous Cell Carcinoma,BRD-K25835157-001-01-4::2.5::HTS,7.131995821150038,0.007792495720861726,Other Types,PRT062070,"JAK inhibitor, syk inhibitor",SYK
Esophageal Squamous Cell Carcinoma,BRD-K25991633-001-01-9::2.5::HTS,6.28795694270315,0.012442087369840163,Esophageal Squamous Cell Carcinoma,BMS-649,retinoid receptor agonist,RXRA
Esophageal Squamous Cell Carcinoma,BRD-K26531771-001-02-2::2.35::HTS,9.140214737348197,0.002622013430587735,Other Types,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
Esophageal Squamous Cell Carcinoma,BRD-K26603252-003-04-9::2.5::HTS,37.29576263803592,1.9287978221619375e-09,Other Types,PD-153035,EGFR inhibitor,"EGFR, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K26838195-075-04-9::2.5::HTS,20.606624492149898,6.903173156042414e-06,Other Types,AST-1306,EGFR inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K27217864-001-22-3::2.5::HTS,4.824190151672973,0.02847589556558932,Other Types,butamben,sodium channel blocker,
Esophageal Squamous Cell Carcinoma,BRD-K27335680-001-10-0::2.5::HTS,4.335078053498655,0.037793052501388695,Esophageal Squamous Cell Carcinoma,rhein,,HSP90AA1
Esophageal Squamous Cell Carcinoma,BRD-K28120222-001-08-4::2.5::HTS,6.209378160440495,0.012998804683656787,Other Types,parthenolide-(alternate-stereo),NFkB pathway inhibitor,"IKBKB, RELA"
Esophageal Squamous Cell Carcinoma,BRD-K28352084-001-02-3::2.5::HTS,6.569388972080069,0.010635808559421206,Other Types,CH5132799,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Esophageal Squamous Cell Carcinoma,BRD-K29173907-001-09-2::2.5::HTS,4.876282320721239,0.027632602016864103,Other Types,isoflupredone-acetate,,NR3C1
Esophageal Squamous Cell Carcinoma,BRD-K29415052-050-04-8::2.5::HTS,4.555825714455882,0.03323899665723679,Other Types,BGT226,PI3K inhibitor,"MTOR, PIK3CA, PIK3CB, PIK3CG"
Esophageal Squamous Cell Carcinoma,BRD-K29582115-066-01-2::2.5::HTS,5.207813624014089,0.022869458984900816,Other Types,ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4"
Esophageal Squamous Cell Carcinoma,BRD-K31283835-048-04-4::2.5::HTS,4.922755627431606,0.026911913505802448,Other Types,tofacitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Esophageal Squamous Cell Carcinoma,BRD-K31698212-001-02-9::2.5::HTS,14.635514258728167,0.00014507921277408147,Other Types,icotinib,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K33610132-001-02-9::2.5::HTS,18.637917560544068,1.8730572644548444e-05,Other Types,rociletinib,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K33809398-001-01-8::2.5::HTS,6.688646961946274,0.00996942747372115,Esophageal Squamous Cell Carcinoma,SCMC-Lys,mucolytic agent,GSTP1
Esophageal Squamous Cell Carcinoma,BRD-K34185671-001-02-8::2.5::HTS,4.534226547826897,0.03366374808779132,Other Types,AMG-517,TRPV antagonist,TRPV1
Esophageal Squamous Cell Carcinoma,BRD-K34851558-001-02-3::2.5::HTS,5.958382756330011,0.014959535884743774,Other Types,parthenolide-(-),NFkB pathway inhibitor,HDAC1
Esophageal Squamous Cell Carcinoma,BRD-K35169477-001-01-9::2.5::HTS,4.040913894341898,0.044893977562592884,Other Types,taranabant,cannabinoid receptor inverse agonist,CNR1
Esophageal Squamous Cell Carcinoma,BRD-K35240538-001-26-2::2.5::HTS,4.441712120985684,0.03553313694912136,Other Types,methylprednisolone,glucocorticoid receptor agonist,NR3C1
Esophageal Squamous Cell Carcinoma,BRD-K35589454-003-01-1::2.5::HTS,4.22287870821004,0.04035249789318568,Other Types,danegaptide,gap junction modulator,
Esophageal Squamous Cell Carcinoma,BRD-K35687421-001-02-5::2.5::HTS,4.222904530120029,0.0403451664099727,Esophageal Squamous Cell Carcinoma,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD
Esophageal Squamous Cell Carcinoma,BRD-K35952844-236-01-6::2.5::HTS,4.6856679834163915,0.03084786860191442,Esophageal Squamous Cell Carcinoma,sodium-glucoheptonate,,
Esophageal Squamous Cell Carcinoma,BRD-K36529613-001-02-6::2.5::HTS,5.765828929778871,0.01666461494862757,Other Types,PU-H71,HSP inhibitor,HSP90AA1
Esophageal Squamous Cell Carcinoma,BRD-K37237504-001-02-7::2.5::HTS,5.3997363032044285,0.02049554497293305,Other Types,CEP-33779,JAK inhibitor,JAK2
Esophageal Squamous Cell Carcinoma,BRD-K37618799-001-03-0::2.5::HTS,10.508034739266524,0.001259594557055823,Other Types,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Esophageal Squamous Cell Carcinoma,BRD-K38548312-001-01-0::2.5::HTS,7.198787094030203,0.007511293175908882,Other Types,VER-49009,HSP inhibitor,HSP90AA1
Esophageal Squamous Cell Carcinoma,BRD-K39252998-003-01-5::2.5::HTS,10.306933372386275,0.0014032448865598367,Other Types,atipamezole,adrenergic receptor antagonist,
Esophageal Squamous Cell Carcinoma,BRD-K39484304-001-16-5::2.5::HTS,4.170984703605983,0.04158975147488942,Other Types,triptolide,RNA polymerase inhibitor,RELA
Esophageal Squamous Cell Carcinoma,BRD-K40718343-001-02-6::2.5::HTS,36.57725787207556,2.678175413720828e-09,Other Types,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K41337261-001-03-0::2.5::HTS,17.237421897861754,3.810948284840293e-05,Other Types,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K42563464-001-01-9::2.5::HTS,10.35764616796808,0.0013659190134482691,Esophageal Squamous Cell Carcinoma,YM-58483,calcium channel blocker,"TRPC3, TRPC5, TRPM4"
Esophageal Squamous Cell Carcinoma,BRD-K42805893-001-04-9::2.5::HTS,25.11836155198873,7.235204988768166e-07,Other Types,osimertinib,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K43621685-001-02-5::2.5::HTS,6.146664736844169,0.013460809919781375,Other Types,CP-673451,PDGFR tyrosine kinase receptor inhibitor,"KIT, PDGFRA, PDGFRB"
Esophageal Squamous Cell Carcinoma,BRD-K44067360-001-30-3::2.5::HTS,8.823664821270393,0.0031060269011813266,Other Types,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Esophageal Squamous Cell Carcinoma,BRD-K44844162-001-01-6::2.5::HTS,18.195505179789276,2.3455442297555804e-05,Other Types,taselisib,PI3K inhibitor,PIK3CA
Esophageal Squamous Cell Carcinoma,BRD-K45293975-001-02-0::2.5::HTS,6.7379092090615424,0.009692529019342744,Other Types,7-hydroxystaurosporine,"CDK inhibitor, CHK inhibitor, PKC inhibitor","CHEK1, MARK3, PDPK1"
Esophageal Squamous Cell Carcinoma,BRD-K45519571-001-01-8::2.5::HTS,6.273592489855962,0.012541135645083698,Esophageal Squamous Cell Carcinoma,RN-1747,TRPV agonist,TRPV4
Esophageal Squamous Cell Carcinoma,BRD-K46386702-001-02-1::2.5::HTS,32.18476976965046,2.2553016457189748e-08,Other Types,ARRY-334543,EGFR inhibitor,ERBB2
Esophageal Squamous Cell Carcinoma,BRD-K47049295-300-01-5::2.5::HTS,3.8986464867375816,0.0488860764979472,Other Types,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1
Esophageal Squamous Cell Carcinoma,BRD-K47371940-001-01-6::2.5::HTS,5.046352691485196,0.025066719855117534,Esophageal Squamous Cell Carcinoma,ecabapide,,
Esophageal Squamous Cell Carcinoma,BRD-K47557313-001-02-7::2.5::HTS,11.280187574530462,0.0008368366009622759,Other Types,LY2109761,TGF beta receptor inhibitor,"TGFBR1, TGFBR2"
Esophageal Squamous Cell Carcinoma,BRD-K48367671-001-05-9::2.5::HTS,4.250661932362981,0.03970261719250226,Esophageal Squamous Cell Carcinoma,febuxostat,xanthine oxidase inhibitor,XDH
Esophageal Squamous Cell Carcinoma,BRD-K48684885-001-04-2::2.5::HTS,5.214130404509856,0.02278178046713246,Other Types,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Esophageal Squamous Cell Carcinoma,BRD-K49049886-001-08-7::2.5::HTS,5.032628004894862,0.025268498598782607,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Esophageal Squamous Cell Carcinoma,BRD-K49075727-001-08-5::2.5::HTS,4.929674062969792,0.026804621984797657,Other Types,nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
Esophageal Squamous Cell Carcinoma,BRD-K49294207-300-03-8::2.5::HTS,20.288212554691565,8.133263473637317e-06,Other Types,BIBU-1361,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K49328571-001-15-0::2.5::HTS,8.823562479662248,0.003103042025548369,Other Types,dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1"
Esophageal Squamous Cell Carcinoma,BRD-K49350383-001-13-7::2.5::HTS,4.058374465055527,0.04443725462912713,Other Types,thioguanine,purine antagonist,"IMPDH1, IMPDH2"
Esophageal Squamous Cell Carcinoma,BRD-K50140147-001-10-1::2.5::HTS,5.145064433723875,0.023696591601161963,Other Types,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,"ALK, INSR"
Esophageal Squamous Cell Carcinoma,BRD-K50168500-001-07-9::2.5::HTS,32.891932206526924,1.5992462031069103e-08,Other Types,canertinib,EGFR inhibitor,"AKT1, EGFR, ERBB2, ERBB4"
Esophageal Squamous Cell Carcinoma,BRD-K50417881-003-17-4::2.5::HTS,3.9862313780147782,0.04636242292949726,Other Types,eticlopride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Esophageal Squamous Cell Carcinoma,BRD-K50564936-001-01-6::2.5::HTS,10.499238431444427,0.0012661488702956781,Other Types,E-2012,gamma secretase modulator,"APH1A, APH1B, PSENEN"
Esophageal Squamous Cell Carcinoma,BRD-K50850824-237-04-8::2.5::HTS,6.361790611368416,0.011953251457463362,Other Types,acesulfame-potassium,,
Esophageal Squamous Cell Carcinoma,BRD-K51911221-001-01-2::2.5::HTS,4.8315194930343,0.028351023010847097,Other Types,nemorubicin,topoisomerase inhibitor,"TOP1, TOP2A"
Esophageal Squamous Cell Carcinoma,BRD-K53448858-001-07-0::2.5::HTS,5.330746311966436,0.021339139865543588,Other Types,acadesine,AMPK activator,
Esophageal Squamous Cell Carcinoma,BRD-K53972329-001-07-0::2.5::HTS,5.951910724761632,0.015013954081648441,Other Types,ruxolitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2"
Esophageal Squamous Cell Carcinoma,BRD-K54006094-051-01-7::2.5::HTS,3.8959833476081087,0.048896317974011644,Esophageal Squamous Cell Carcinoma,formoterol,adrenergic receptor agonist,ADRB2
Esophageal Squamous Cell Carcinoma,BRD-K54256913-001-08-7::2.5::HTS,7.142779043048122,0.007747169897706231,Other Types,MK-1775,WEE1 kinase inhibitor,WEE1
Esophageal Squamous Cell Carcinoma,BRD-K54838207-001-03-8::2.5::HTS,3.8824286211454244,0.04930530900979523,Other Types,fudosteine,mucolytic agent,
Esophageal Squamous Cell Carcinoma,BRD-K55187425-236-05-2::2.5::HTS,3.904667412632534,0.04864429183900172,Esophageal Squamous Cell Carcinoma,rigosertib,"cell cycle inhibitor, PLK inhibitor",PLK1
Esophageal Squamous Cell Carcinoma,BRD-K55250441-001-13-0::2.5::HTS,6.393594713843673,0.011728343653406385,Other Types,sulfadoxine,dihydropteroate synthase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K56032964-001-02-1::2.5::HTS,4.106716138669123,0.04318662936556667,Other Types,AP26113,ALK tyrosine kinase receptor inhibitor,"ALK, EGFR"
Esophageal Squamous Cell Carcinoma,BRD-K57169635-001-04-5::2.5::HTS,14.407404409941266,0.00016322123936357436,Other Types,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Esophageal Squamous Cell Carcinoma,BRD-K58299615-001-03-5::2.5::HTS,6.199061050089279,0.013089546650834933,Esophageal Squamous Cell Carcinoma,Ro-90-7501,,APP
Esophageal Squamous Cell Carcinoma,BRD-K58568447-001-01-1::2.5::HTS,5.327598416993858,0.021354410094962865,Other Types,K02288,bone morphogenic protein inhibitor,BMP1
Esophageal Squamous Cell Carcinoma,BRD-K61314889-001-04-4::2.5::HTS,4.166552782842538,0.041696179544362846,Esophageal Squamous Cell Carcinoma,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Esophageal Squamous Cell Carcinoma,BRD-K61314889-001-05-1::2.5::HTS,9.149735606185773,0.002602887133808947,Esophageal Squamous Cell Carcinoma,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Esophageal Squamous Cell Carcinoma,BRD-K62186992-334-02-8::2.5::HTS,3.9410884053404036,0.04762016551203704,Esophageal Squamous Cell Carcinoma,hydroxystilbamidine,,
Esophageal Squamous Cell Carcinoma,BRD-K62196610-001-01-6::2.5::HTS,6.114649100293801,0.013706719023920046,Other Types,AVN-944,inosine monophosphate dehydrogenase inhibitor,"IMPDH1, IMPDH2"
Esophageal Squamous Cell Carcinoma,BRD-K62594868-082-08-6::2.5::HTS,5.451235876669522,0.019905678820190013,Esophageal Squamous Cell Carcinoma,GR125487,serotonin receptor antagonist,HTR4
Esophageal Squamous Cell Carcinoma,BRD-K62627508-001-01-5::2.5::HTS,4.96204611263391,0.026306102196226037,Esophageal Squamous Cell Carcinoma,idasanutlin,MDM inhibitor,"MDM2, TP53"
Esophageal Squamous Cell Carcinoma,BRD-K62696033-001-01-4::2.5::HTS,3.865476809087899,0.04978363844528163,Other Types,G-1,G protein-coupled receptor agonist,GPER1
Esophageal Squamous Cell Carcinoma,BRD-K62814476-001-03-3::2.5::HTS,8.92288687638528,0.0029408342337738642,Other Types,BMS-265246,CDK inhibitor,"CDK1, CDK2"
Esophageal Squamous Cell Carcinoma,BRD-K64052750-001-17-5::2.5::HTS,30.737238299107972,4.5844588880128165e-08,Other Types,gefitinib,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K64925568-001-01-8::2.5::HTS,4.365136483443411,0.03713473087458949,Esophageal Squamous Cell Carcinoma,AMG-232,MDM inhibitor,MDM2
Esophageal Squamous Cell Carcinoma,BRD-K66094457-001-01-5::2.5::HTS,3.8911289683211105,0.04905242819318866,Esophageal Squamous Cell Carcinoma,CPP,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Esophageal Squamous Cell Carcinoma,BRD-K66175015-001-09-0::2.5::HTS,18.19236559812439,2.3534020541558355e-05,Other Types,afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Esophageal Squamous Cell Carcinoma,BRD-K67966701-001-12-4::2.5::HTS,4.800734580064545,0.028874959132698743,Esophageal Squamous Cell Carcinoma,lisinopril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Esophageal Squamous Cell Carcinoma,BRD-K67977190-066-02-3::2.5::HTS,4.991102395247082,0.025882014577464182,Other Types,eprosartan,angiotensin receptor antagonist,AGTR1
Esophageal Squamous Cell Carcinoma,BRD-K68336408-001-10-9::2.5::HTS,26.855259722087926,3.069259786393934e-07,Other Types,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Esophageal Squamous Cell Carcinoma,BRD-K68346641-001-01-4::2.5::HTS,4.660119687454436,0.03129976657561706,Other Types,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Esophageal Squamous Cell Carcinoma,BRD-K68502831-001-01-2::2.5::HTS,5.001343163924499,0.025744513172876137,Esophageal Squamous Cell Carcinoma,dianhydrogalactitol,DNA alkylating agent,
Esophageal Squamous Cell Carcinoma,BRD-K68693535-001-03-4::2.5::HTS,4.724620844101204,0.03015198519049677,Other Types,lidamidine,adrenergic receptor agonist,
Esophageal Squamous Cell Carcinoma,BRD-K68904758-001-03-5::2.5::HTS,4.755861476453464,0.02961857661181347,Other Types,cephalomannine,DNA polymerase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K69650333-003-14-0::2.5::HTS,5.206442027429591,0.02288177438639188,Other Types,idarubicin,topoisomerase inhibitor,TOP2A
Esophageal Squamous Cell Carcinoma,BRD-K70301465-001-02-6::2.5::HTS,34.67697521433855,6.752703364930196e-09,Other Types,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK"
Esophageal Squamous Cell Carcinoma,BRD-K70401845-003-09-6::2.5::HTS,15.943546281704991,7.395759198087077e-05,Other Types,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Esophageal Squamous Cell Carcinoma,BRD-K70402238-001-02-8::2.5::HTS,6.43155447351287,0.01148216170948265,Other Types,nexturastat-a,HDAC inhibitor,"HDAC1, HDAC6"
Esophageal Squamous Cell Carcinoma,BRD-K70914287-300-02-8::2.5::HTS,15.16019258058448,0.00011067366463137839,Other Types,BIBX-1382,EGFR inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K71106091-001-06-1::2.5::HTS,5.882953157858392,0.01560662348822927,Esophageal Squamous Cell Carcinoma,fludarabine-phosphate,ribonucleotide reductase inhibitor,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Esophageal Squamous Cell Carcinoma,BRD-K71467466-001-02-3::2.5::HTS,8.82325891825543,0.003101222360222872,Other Types,KPT-185,exportin antagonist,XPO1
Esophageal Squamous Cell Carcinoma,BRD-K72106461-001-02-1::2.5::HTS,6.368390760239594,0.011909412837820205,Esophageal Squamous Cell Carcinoma,SYM-2081,kainate receptor antagonist,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2"
Esophageal Squamous Cell Carcinoma,BRD-K72327355-001-14-7::2.5::HTS,4.500236702029606,0.03433354790124848,Esophageal Squamous Cell Carcinoma,baicalein,lipoxygenase inhibitor,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH"
Esophageal Squamous Cell Carcinoma,BRD-K72339976-065-03-9::2.5::HTS,4.236219174740087,0.04006040023320906,Esophageal Squamous Cell Carcinoma,cefoselis,bacterial cell wall synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K72420232-001-12-3::2.5::HTS,5.800714810658427,0.016345178395647062,Other Types,WZ-4002,EGFR inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K73293050-001-03-1::2.5::HTS,11.663557019308644,0.0006840541977773413,Other Types,WZ-3146,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K73309154-003-02-8::2.5::HTS,35.83239360856002,3.835081767310834e-09,Other Types,OSI-420,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K73383190-001-02-3::2.56::HTS,4.579328324709676,0.03281755882838141,Other Types,C646,histone acetyltransferase inhibitor,EP300
Esophageal Squamous Cell Carcinoma,BRD-K75352575-001-01-3::2.5::HTS,4.336453393115569,0.03775867531155006,Other Types,KPT-276,exportin antagonist,XPO1
Esophageal Squamous Cell Carcinoma,BRD-K75649340-001-13-1::2.5::HTS,5.234497822739982,0.02251371061034653,Other Types,tioguanine,purine antagonist,
Esophageal Squamous Cell Carcinoma,BRD-K76064317-001-07-3::2.5::HTS,5.61175758757062,0.018179292609118273,Esophageal Squamous Cell Carcinoma,tyrphostin-AG-1296,FLT3 inhibitor,FLT3
Esophageal Squamous Cell Carcinoma,BRD-K76239644-001-01-8::2.5::HTS,27.032223402097635,2.8109269095492515e-07,Other Types,BMS-690514,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, FLT3, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K77625799-001-07-7::2.5::HTS,19.684417022506576,1.0994338803524029e-05,Other Types,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Esophageal Squamous Cell Carcinoma,BRD-K77634909-001-03-5::2.5::HTS,6.637329910791796,0.010242299330598868,Other Types,AEG3482,HSP inducer,
Esophageal Squamous Cell Carcinoma,BRD-K77791657-001-01-1::2.5::HTS,5.978777229034511,0.014784949189700185,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Esophageal Squamous Cell Carcinoma,BRD-K77791657-003-01-7::2.67::HTS,4.639125552562394,0.03170282340322518,Other Types,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
Esophageal Squamous Cell Carcinoma,BRD-K77841042-001-14-1::2.5::HTS,4.032021135140074,0.045131156609852494,Other Types,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Esophageal Squamous Cell Carcinoma,BRD-K78086729-001-02-7::2.5::HTS,5.23473717106509,0.022510642507752025,Other Types,GW-788388,ALK tyrosine kinase receptor inhibitor,"LCK, MAPK14, TGFBR1"
Esophageal Squamous Cell Carcinoma,BRD-K78118466-001-03-3::2.5::HTS,11.899754678366714,0.0006035263107574362,Other Types,LY2157299,TGF beta receptor inhibitor,TGFBR1
Esophageal Squamous Cell Carcinoma,BRD-K78659596-001-03-9::2.5::HTS,3.953176400221962,0.04727641238187327,Other Types,ixazomib,proteasome inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K79584249-001-01-3::2.5::HTS,6.521916904628146,0.010921887047195896,Esophageal Squamous Cell Carcinoma,CGM097,MDM inhibitor,MDM2
Esophageal Squamous Cell Carcinoma,BRD-K79930101-300-03-7::2.5::HTS,22.078255857078812,3.295349170645957e-06,Other Types,GW-583340,EGFR inhibitor,"EGFR, ERBB2"
Esophageal Squamous Cell Carcinoma,BRD-K80343549-001-02-6::2.5::HTS,7.4419572191887,0.006579916342877938,Other Types,TAK-285,EGFR inhibitor,ERBB2
Esophageal Squamous Cell Carcinoma,BRD-K81728688-001-04-4::2.5::HTS,21.697011629926433,4.00223458810463e-06,Other Types,WZ8040,EGFR inhibitor,EGFR
Esophageal Squamous Cell Carcinoma,BRD-K83607951-001-02-2::2.5::HTS,5.464505748030578,0.019758444397814424,Other Types,skepinone-l,p38 MAPK inhibitor,MAPK14
Esophageal Squamous Cell Carcinoma,BRD-K84986517-001-01-8::2.5::HTS,4.725884635496043,0.03014076784986111,Esophageal Squamous Cell Carcinoma,darunavir,HIV protease inhibitor,CYP3A4
Esophageal Squamous Cell Carcinoma,BRD-K85606544-001-09-1::2.5::HTS,25.37499708078384,6.449787352730668e-07,Other Types,neratinib,EGFR inhibitor,"EGFR, ERBB2, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K86525559-001-04-5::2.5::HTS,8.772903300433235,0.003192214556930248,Other Types,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Esophageal Squamous Cell Carcinoma,BRD-K88429204-001-35-1::2.5::HTS,15.42963699480287,9.634802008321225e-05,Other Types,pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1"
Esophageal Squamous Cell Carcinoma,BRD-K88560311-011-06-3::2.5::HTS,6.609857748565538,0.010401453370353482,Esophageal Squamous Cell Carcinoma,rucaparib,PARP inhibitor,"PARP1, PARP2"
Esophageal Squamous Cell Carcinoma,BRD-K88742110-001-07-9::2.5::HTS,6.965585195193635,0.0085431644080931,Esophageal Squamous Cell Carcinoma,PCI-34051,HDAC inhibitor,"HDAC1, HDAC10, HDAC6, HDAC8"
Esophageal Squamous Cell Carcinoma,BRD-K92049597-001-20-8::2.5::HTS,21.25554985223994,4.9856181510977345e-06,Other Types,triamterene,sodium channel blocker,"SCNN1A, SCNN1B, SCNN1D, SCNN1G"
Esophageal Squamous Cell Carcinoma,BRD-K92150287-066-01-2::2.5::HTS,4.475620316628032,0.03482734962642239,Other Types,exatecan-mesylate,topoisomerase inhibitor,TOP1
Esophageal Squamous Cell Carcinoma,BRD-K92844263-001-09-8::2.5::HTS,4.410629923853846,0.03616474784395641,Other Types,triacetin,,
Esophageal Squamous Cell Carcinoma,BRD-K93045741-001-01-0::2.5::HTS,6.215293911105357,0.012953318873956893,Other Types,tozadenant,adenosine receptor antagonist,ADORA2A
Esophageal Squamous Cell Carcinoma,BRD-K96631475-001-04-0::2.5::HTS,4.915607093043876,0.027020265486682706,Other Types,10-deacetylbaccatin,antitumor agent,
Esophageal Squamous Cell Carcinoma,BRD-K97045029-001-04-3::2.5::HTS,5.892251177060876,0.015520781666993128,Other Types,pranlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF"
Esophageal Squamous Cell Carcinoma,BRD-K97101532-001-02-8::2.5::HTS,4.877115898958889,0.027617937097566738,Esophageal Squamous Cell Carcinoma,tezacaftor,CFTR channel agonist,
Esophageal Squamous Cell Carcinoma,BRD-K97799481-001-16-0::2.5::HTS,5.456081565719072,0.019851091260697073,Other Types,theophylline,adenosine receptor antagonist,
Esophageal Squamous Cell Carcinoma,BRD-K98572433-001-02-9::2.5::HTS,25.67997206878882,5.482248363783696e-07,Other Types,AZD8931,EGFR inhibitor,"EGFR, ERBB2, ERBB3"
Esophageal Squamous Cell Carcinoma,BRD-K99383816-001-03-5::2.5::HTS,4.900160203387305,0.0272721250023885,Other Types,ftorafur,thymidylate synthase inhibitor,TYMS
Esophageal Squamous Cell Carcinoma,BRD-K99475619-001-01-2::2.5::HTS,3.96649179055206,0.046912100439062236,Other Types,genz-644282,topoisomerase inhibitor,TOP1
Esophageal Squamous Cell Carcinoma,BRD-K99964838-001-11-9::2.5::HTS,6.051677011624867,0.014194068117339947,Other Types,bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK"
Esophageal Squamous Cell Carcinoma,BRD-M80207679-001-01-5::2.5::HTS,3.931760710350322,0.04788949280433023,Other Types,nemonapride,dopamine receptor antagonist,"DRD2, DRD3, DRD4"
Esophageal Squamous Cell Carcinoma,BRD-A21474126-001-01-6::2.5::MTS004,7.207265208342591,0.007484398689618163,Esophageal Squamous Cell Carcinoma,methoxyphenamine,adrenergic receptor agonist,
Esophageal Squamous Cell Carcinoma,BRD-A25492003-003-14-1::2.568211596::MTS004,5.854450994830868,0.01586818325301944,Esophageal Squamous Cell Carcinoma,chlortetracycline,protein synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A33479817-003-03-7::2.490825408::MTS004,4.757844117297193,0.029596478729530275,Esophageal Squamous Cell Carcinoma,terodiline,cholinergic receptor antagonist,
Esophageal Squamous Cell Carcinoma,BRD-A40546373-001-01-8::2.500029443::MTS004,5.610405272004182,0.018205805196575345,Esophageal Squamous Cell Carcinoma,morinidazole,other antibiotic,CYP51A1
Esophageal Squamous Cell Carcinoma,BRD-A41698174-003-12-0::2.499982171::MTS004,4.343886604113546,0.03761235134804801,Esophageal Squamous Cell Carcinoma,bacampicillin,bacterial cell wall synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A44188509-001-01-2::2.639346634::MTS004,8.945042486443862,0.002909428085895975,Esophageal Squamous Cell Carcinoma,AZD1446,acetylcholine receptor agonist,"CHRNA4, CHRNB2"
Esophageal Squamous Cell Carcinoma,BRD-A63431791-001-01-9::2.5::MTS004,8.818166017997607,0.0031152475661958717,Esophageal Squamous Cell Carcinoma,sulbactam-pivoxil,beta lactamase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A67182178-001-01-7::2.5::MTS004,4.23243405620073,0.04013906291683201,Esophageal Squamous Cell Carcinoma,toloxatone,monoamine oxidase inhibitor,"MAOA, MAOB"
Esophageal Squamous Cell Carcinoma,BRD-A67305656-001-01-5::2.5::MTS004,6.547603172411536,0.010774565036322362,Esophageal Squamous Cell Carcinoma,spiramycin,bacterial 50S ribosomal subunit inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-A72988804-001-11-1::2.5::MTS004,5.01641238977261,0.025515043869722566,Esophageal Squamous Cell Carcinoma,tiaprofenic-acid,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Esophageal Squamous Cell Carcinoma,BRD-A74975734-004-09-9::2.5::MTS004,6.19346311433894,0.013123613841177972,Esophageal Squamous Cell Carcinoma,homatropine,acetylcholine receptor antagonist,"CES1, CHRM1"
Esophageal Squamous Cell Carcinoma,BRD-K01773083-001-01-4::2.303758671::MTS004,3.873174974590592,0.049576740576304665,Esophageal Squamous Cell Carcinoma,denotivir,antiviral,
Esophageal Squamous Cell Carcinoma,BRD-K03765900-001-01-9::2.499986292::MTS004,17.08113398346437,4.1533237493543864e-05,Other Types,XL-647,"EGFR inhibitor, VEGFR inhibitor","EGFR, EPHB4, ERBB2, FLT4, KDR"
Esophageal Squamous Cell Carcinoma,BRD-K07070922-001-01-4::2.5::MTS004,5.3724238018289014,0.02083103549264442,Esophageal Squamous Cell Carcinoma,PF-03049423,phosphodiesterase inhibitor,PDE5A
Esophageal Squamous Cell Carcinoma,BRD-K10995081-001-27-9::2.316458322::MTS004,7.8370230859436765,0.005302148266048913,Esophageal Squamous Cell Carcinoma,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Esophageal Squamous Cell Carcinoma,BRD-K13664493-316-02-5::2.500014041::MTS004,3.9232398630586043,0.04813187452130443,Esophageal Squamous Cell Carcinoma,naphthoquine-phosphate,antimalarial agent,
Esophageal Squamous Cell Carcinoma,BRD-K14171291-001-01-4::2.499985403::MTS004,4.989589003164369,0.025910471690624857,Esophageal Squamous Cell Carcinoma,omarigliptin,dipeptidyl peptidase inhibitor,DPP4
Esophageal Squamous Cell Carcinoma,BRD-K16180792-001-01-7::2.5::MTS004,3.9695520238632303,0.04683402344383796,Esophageal Squamous Cell Carcinoma,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
Esophageal Squamous Cell Carcinoma,BRD-K16505263-003-02-9::2.49996754::MTS004,4.688265152836634,0.030807309805835625,Esophageal Squamous Cell Carcinoma,forodesine,purinergic receptor antagonist,PNP
Esophageal Squamous Cell Carcinoma,BRD-K18898553-001-01-1::2.5::MTS004,4.495286916201484,0.034444616851798567,Esophageal Squamous Cell Carcinoma,salvianolic-acid-B,"metalloproteinase inhibitor, EGFR inhibitor",MMP9
Esophageal Squamous Cell Carcinoma,BRD-K20463415-300-01-4::2.499966791::MTS004,4.769094137252665,0.029405422914392788,Esophageal Squamous Cell Carcinoma,LY2606368,CHK inhibitor,CHEK1
Esophageal Squamous Cell Carcinoma,BRD-K22518984-001-01-8::2.5::MTS004,7.0992202450206685,0.007942728720196716,Esophageal Squamous Cell Carcinoma,metacresol,,INS
Esophageal Squamous Cell Carcinoma,BRD-K22525962-001-05-0::2.500010949::MTS004,6.646512503685696,0.01019932132901504,Esophageal Squamous Cell Carcinoma,dihydrotestosterone,androgen receptor agonist,"AR, HSD17B1"
Esophageal Squamous Cell Carcinoma,BRD-K23848629-401-03-7::2.5::MTS004,8.381764045308554,0.0039436959471534465,Other Types,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1
Esophageal Squamous Cell Carcinoma,BRD-K25494650-003-01-8::2.660853131::MTS004,4.4066810346870895,0.03626377390091127,Esophageal Squamous Cell Carcinoma,chlorproguanil,dihydrofolate reductase inhibitor,DHFR
Esophageal Squamous Cell Carcinoma,BRD-K27625831-001-02-9::2.499990597::MTS004,4.1007711584848625,0.04335605860366038,Esophageal Squamous Cell Carcinoma,pleconaril,,
Esophageal Squamous Cell Carcinoma,BRD-K28687144-001-08-7::2.5::MTS004,6.861535602615499,0.009055168576856067,Esophageal Squamous Cell Carcinoma,fosfosal,phosphodiesterase inhibitor,"PTGS1, PTGS2"
Esophageal Squamous Cell Carcinoma,BRD-K29570907-001-07-3::2.420672872::MTS004,4.21150757419984,0.04063397415342685,Esophageal Squamous Cell Carcinoma,sulmetozine,gastrin inhibitor,GAST
Esophageal Squamous Cell Carcinoma,BRD-K35882976-001-04-7::2.444346727::MTS004,3.927712909428626,0.04800402640770408,Esophageal Squamous Cell Carcinoma,mitoflaxone,antitumor agent,VWF
Esophageal Squamous Cell Carcinoma,BRD-K36524108-065-04-0::2.500001799::MTS004,7.034799604150697,0.008229610828846396,Esophageal Squamous Cell Carcinoma,paromomycin,bacterial 30S ribosomal subunit inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K36574127-001-01-3::2.5::MTS004,8.446236754644177,0.003808401392162101,Esophageal Squamous Cell Carcinoma,LOXO-101,tropomyosin receptor kinase inhibitor,"NTRK1, NTRK2, NTRK3"
Esophageal Squamous Cell Carcinoma,BRD-K37543758-001-01-3::2.588829083::MTS004,9.678444355102167,0.001963315263273595,Esophageal Squamous Cell Carcinoma,trepibutone,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Esophageal Squamous Cell Carcinoma,BRD-K41267922-001-01-4::2.5::MTS004,4.743180507004127,0.02984745580032934,Esophageal Squamous Cell Carcinoma,F351,TGF beta receptor inhibitor,TGFB1
Esophageal Squamous Cell Carcinoma,BRD-K43890836-001-01-6::2.5::MTS004,6.502205909478023,0.011049666778214912,Esophageal Squamous Cell Carcinoma,gemcadiol,antilipemic,
Esophageal Squamous Cell Carcinoma,BRD-K44164034-003-01-1::2.54181785::MTS004,7.855998163176153,0.005247932843657097,Esophageal Squamous Cell Carcinoma,pumosetrag,serotonin receptor agonist,"HTR3A, HTR4"
Esophageal Squamous Cell Carcinoma,BRD-K46862739-001-14-3::2.499952208::MTS004,6.695140199743916,0.00992867370953238,Esophageal Squamous Cell Carcinoma,metyrapone,cytochrome P450 inhibitor,CYP11B1
Esophageal Squamous Cell Carcinoma,BRD-K49659468-436-01-2::2.500002467::MTS004,4.315484370113264,0.038239944625360386,Esophageal Squamous Cell Carcinoma,TMC647055,RNA polymerase inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K50010139-001-02-3::2.5::MTS004,17.583357955924455,3.214384828483786e-05,Other Types,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Esophageal Squamous Cell Carcinoma,BRD-K57155378-001-01-1::2.499996307::MTS004,8.883280604330956,0.0030078280442587097,Esophageal Squamous Cell Carcinoma,TAK-063,phosphodiesterase inhibitor,PDE10A
Esophageal Squamous Cell Carcinoma,BRD-K58529924-001-01-5::2.648577938::MTS004,5.418596362885591,0.02029260129012948,Esophageal Squamous Cell Carcinoma,ONC201,"AKT inhibitor, MAP kinase inhibitor",TNFSF10
Esophageal Squamous Cell Carcinoma,BRD-K59391348-001-01-7::2.5::MTS004,5.970568577226984,0.014866316912819416,Esophageal Squamous Cell Carcinoma,lixivaptan,vasopressin receptor antagonist,AVPR2
Esophageal Squamous Cell Carcinoma,BRD-K65900713-003-01-0::2.686421113::MTS004,5.240156381139008,0.022457840411551355,Esophageal Squamous Cell Carcinoma,caroverine,"glutamate receptor antagonist, calcium channel blocker",
Esophageal Squamous Cell Carcinoma,BRD-K66295376-001-13-1::2.5::MTS004,4.033197864814942,0.045111677190629244,Esophageal Squamous Cell Carcinoma,ferulic-acid,antioxidant,"CA1, CA12, CA14, CA2, CA4, CA6, CA9"
Esophageal Squamous Cell Carcinoma,BRD-K70504253-001-01-3::2.500017504::MTS004,4.466945811036292,0.03501557040051923,Esophageal Squamous Cell Carcinoma,fruquintinib,VEGFR inhibitor,KDR
Esophageal Squamous Cell Carcinoma,BRD-K70592963-001-31-6::2.5::MTS004,3.9195071257832885,0.04823710172911126,Esophageal Squamous Cell Carcinoma,phenindione,vitamin K antagonist,VKORC1
Esophageal Squamous Cell Carcinoma,BRD-K73451719-001-01-2::2.5::MTS004,8.40073559900064,0.003903382761058901,Esophageal Squamous Cell Carcinoma,terlipressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2"
Esophageal Squamous Cell Carcinoma,BRD-K76204040-001-03-8::2.5::MTS004,5.236608110947733,0.022502517479806264,Esophageal Squamous Cell Carcinoma,pyridoxal,,PDXK
Esophageal Squamous Cell Carcinoma,BRD-K76315403-015-02-5::2.5::MTS004,4.185341830149342,0.04125979810565164,Esophageal Squamous Cell Carcinoma,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,"GNRHR, LHCGR"
Esophageal Squamous Cell Carcinoma,BRD-K76594255-001-01-6::2.5000235::MTS004,3.9824710272737454,0.04647981188720973,Other Types,maropitant,neurokinin receptor antagonist,TACR1
Esophageal Squamous Cell Carcinoma,BRD-K77073709-435-01-2::2.5::MTS004,6.029654508757455,0.014382119865404315,Esophageal Squamous Cell Carcinoma,cefminox,bacterial cell wall synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K79450420-001-01-8::2.499997604::MTS004,4.197039482051172,0.04097836683150918,Esophageal Squamous Cell Carcinoma,INCB-024360,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Esophageal Squamous Cell Carcinoma,BRD-K80353807-001-25-3::2.5::MTS004,4.123180644336853,0.04278988035144366,Esophageal Squamous Cell Carcinoma,khellin,vasodilator,
Esophageal Squamous Cell Carcinoma,BRD-K80738081-001-46-8::2.500037854::MTS004,5.800263130252717,0.016358425461563443,Esophageal Squamous Cell Carcinoma,resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2"
Esophageal Squamous Cell Carcinoma,BRD-K80762071-236-02-5::2.5::MTS004,4.585062939123639,0.03269955334773605,Other Types,indocyanine-green,contrast agent,SLCO1B1
Esophageal Squamous Cell Carcinoma,BRD-K86410485-046-01-0::2.499987354::MTS004,10.561487737983825,0.0012268543103745064,Esophageal Squamous Cell Carcinoma,eliglustat,Glycosyl transferase inhibitor,UGCG
Esophageal Squamous Cell Carcinoma,BRD-K87465484-001-02-7::2.5::MTS004,5.239222081764092,0.022469784629715026,Other Types,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
Esophageal Squamous Cell Carcinoma,BRD-K89121095-001-01-7::2.499999138::MTS004,8.561089355629836,0.00357900332483361,Other Types,tedizolid-phosphate,protein synthesis inhibitor,
Esophageal Squamous Cell Carcinoma,BRD-K90629600-001-01-4::2.5::MTS004,9.010276334336352,0.002809054357738287,Esophageal Squamous Cell Carcinoma,emorfazone,"antiinflammatory agent, cyclooxygenase inhibitor",
Esophageal Squamous Cell Carcinoma,BRD-K99447003-335-04-1::2.37737659::MTS004,4.882206992994085,0.027554526796556036,Esophageal Squamous Cell Carcinoma,enalaprilat,angiotensin converting enzyme inhibitor,ACE
Esophageal Squamous Cell Carcinoma,BRD-K99506538-001-03-8::2.5::MTS004,7.102354184367216,0.007929037065716118,Esophageal Squamous Cell Carcinoma,xenalipin,,
Chondrosarcoma,BRD-A00578795-001-04-3::2.5::HTS,5.998993710793749,0.014618277961391554,Chondrosarcoma,zaltoprofen,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-A00827783-001-24-6::2.5::HTS,6.987809492318449,0.008437795466373904,Other Types,dyphylline,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B"
Chondrosarcoma,BRD-A02006392-001-16-4::2.5::HTS,3.9267761670529113,0.048009783304882855,Other Types,nitrendipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4"
Chondrosarcoma,BRD-A02759312-003-24-5::2.5::HTS,6.497457239030711,0.011068936386524652,Other Types,betaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Chondrosarcoma,BRD-A03061970-003-07-3::2.5::HTS,4.215980463628083,0.04051135498250853,Other Types,alizapride,dopamine receptor antagonist,DRD2
Chondrosarcoma,BRD-A04327189-003-03-3::2.5::HTS,4.755286391325246,0.029640096542326317,Other Types,synephrine,adrenergic receptor agonist,ADRA1A
Chondrosarcoma,BRD-A05186015-003-19-8::2.5::HTS,5.7906868581756035,0.01643591220226716,Chondrosarcoma,bupropion,dopamine uptake inhibitor,"CHRNA3, SLC6A2, SLC6A3"
Chondrosarcoma,BRD-A05729358-001-02-0::2.5::HTS,4.5532476456002975,0.03329254420147512,Other Types,CPCCOEt,glutamate receptor antagonist,GRM1
Chondrosarcoma,BRD-A06935312-001-04-3::2.5::HTS,4.569758698030539,0.032975818854859645,Other Types,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
Chondrosarcoma,BRD-A07232941-001-02-7::2.5::HTS,5.971990461321502,0.014844101993197039,Other Types,8-M-PDOT,melatonin receptor agonist,"MTNR1A, MTNR1B"
Chondrosarcoma,BRD-A07780951-001-08-9::2.5::HTS,11.112474496391783,0.0009146669750549338,Other Types,metaproterenol,adrenergic receptor agonist,ADRB2
Chondrosarcoma,BRD-A07780951-065-10-0::2.58::HTS,8.064140249225757,0.004689750843816713,Other Types,metaproterenol,adrenergic receptor agonist,ADRB2
Chondrosarcoma,BRD-A07893380-213-01-7::2.5::HTS,3.9051315912168207,0.04865893556224352,Other Types,vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1"
Chondrosarcoma,BRD-A08302182-001-01-7::2.5::HTS,5.372478608581558,0.02082024735072302,Chondrosarcoma,etonogestrel,progesterone receptor agonist,"ESR1, PGR"
Chondrosarcoma,BRD-A08545410-311-01-8::2.5::HTS,3.8912940528296853,0.04904764321343953,Other Types,doxycycline,metalloproteinase inhibitor,MMP8
Chondrosarcoma,BRD-A09056319-003-07-7::2.5::HTS,5.405575869380794,0.020430311252781618,Other Types,alfuzosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2"
Chondrosarcoma,BRD-A09925278-003-05-6::2.5::HTS,4.146345618133882,0.04219279900275948,Other Types,etilefrine,adrenergic receptor agonist,"ADRA1A, ADRB1"
Chondrosarcoma,BRD-A10523515-001-07-9::2.5::HTS,7.20821569813114,0.007473222195339156,Other Types,GSK429286A,rho associated kinase inhibitor,ROCK1
Chondrosarcoma,BRD-A13598753-001-01-2::2.5::HTS,4.168860464763884,0.04164236365586072,Other Types,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1
Chondrosarcoma,BRD-A14208071-004-19-8::2.5::HTS,4.486293444373608,0.03461073795563401,Other Types,oxyphenonium,cholinergic receptor antagonist,CHRM1
Chondrosarcoma,BRD-A16665823-001-02-0::2.5::HTS,7.382834892894574,0.0067886533860578345,Other Types,butoconazole,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-A17411484-001-11-9::2.5::HTS,3.904861839323615,0.04863694565298536,Other Types,carprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-A18043272-001-09-9::2.5::HTS,3.893018095496959,0.048978544218101085,Chondrosarcoma,phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Chondrosarcoma,BRD-A18056626-003-22-3::2.5::HTS,5.373204543971624,0.020809708311257256,Other Types,methacholine,acetylcholine receptor agonist,"CHRM2, CHRM3, CHRM4"
Chondrosarcoma,BRD-A18074780-003-02-0::2.5::HTS,4.437544793537672,0.0356034419248613,Other Types,AGN-192403,imidazoline receptor ligand,NISCH
Chondrosarcoma,BRD-A18396475-001-15-3::2.56::HTS,6.011427749670494,0.01453633672795412,Other Types,malic-acid,,"CS, ME2, PKD2L1"
Chondrosarcoma,BRD-A19195498-050-14-1::2.5::HTS,4.532341334358942,0.03369737476816797,Other Types,trimipramine,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-A19661776-003-27-6::2.5::HTS,13.660214255101671,0.00024077488886628203,Other Types,mianserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-A20758144-001-04-5::2.5::HTS,4.231455960450427,0.04015584272155633,Other Types,prasterone-acetate,,
Chondrosarcoma,BRD-A21276153-001-01-1::2.5::HTS,9.054072911352673,0.0027462366315501637,Other Types,"2,6-dimethylpiperidine",,
Chondrosarcoma,BRD-A22032524-074-06-5::2.5::HTS,4.34716642203498,0.03752132030968157,Other Types,amlodipine,calcium channel blocker,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1"
Chondrosarcoma,BRD-A22642447-001-01-9::2.5::HTS,4.722683727380709,0.030190213291676087,Chondrosarcoma,licarbazepine,voltage-gated sodium channel blocker,SCN5A
Chondrosarcoma,BRD-A24191444-046-03-9::2.4::HTS,6.883566890533247,0.008950807516974135,Other Types,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Chondrosarcoma,BRD-A24228527-213-01-9::2.5::HTS,10.90978310272619,0.0010179461677611008,Other Types,ofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Chondrosarcoma,BRD-A24587114-066-22-5::2.5::HTS,10.045958350743975,0.0016105104375210317,Other Types,isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2"
Chondrosarcoma,BRD-A25143711-001-02-2::2.5::HTS,6.4800218347999685,0.011177712965768345,Chondrosarcoma,hydrocortisone-valerate,glucocorticoid receptor agonist,
Chondrosarcoma,BRD-A26384407-001-25-1::2.5::HTS,4.223192663465789,0.04033671940450443,Other Types,chlorthalidone,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3"
Chondrosarcoma,BRD-A26690767-066-01-9::2.5::HTS,5.1473563981075685,0.02366287062427928,Chondrosarcoma,saquinavir,HIV protease inhibitor,CYP3A4
Chondrosarcoma,BRD-A27887842-001-04-0::2.5::HTS,6.986356777517207,0.008452329467278998,Chondrosarcoma,prednisolone,glucocorticoid receptor agonist,"NR3C1, NR3C2, SERPINA6"
Chondrosarcoma,BRD-A27924917-001-03-3::2.5::HTS,16.377544932945934,5.920791722312548e-05,Other Types,2-hydroxysaclofen,GABA receptor antagonist,"GABBR1, GABBR2"
Chondrosarcoma,BRD-A28301258-001-03-0::2.5::HTS,3.9589069814988895,0.04711513481142082,Chondrosarcoma,salinomycin,,
Chondrosarcoma,BRD-A28856712-003-26-0::2.5::HTS,5.819708129982587,0.016169705994365176,Other Types,tetrahydrozoline,adrenergic receptor agonist,
Chondrosarcoma,BRD-A29111201-001-04-8::2.5::HTS,3.8856958929920835,0.04919365345447744,Chondrosarcoma,ethisterone,progestogen hormone,TYR
Chondrosarcoma,BRD-A29485665-001-12-8::2.5::HTS,13.739237232374636,0.00023112883142659325,Chondrosarcoma,bicalutamide,androgen receptor antagonist,AR
Chondrosarcoma,BRD-A30886737-001-02-9::2.5::HTS,4.439853316917445,0.03555572560602481,Chondrosarcoma,florfenicol,protein synthesis inhibitor,
Chondrosarcoma,BRD-A32172948-001-07-6::2.5::HTS,4.752826957727229,0.02967038679086423,Other Types,methiopril,angiotensin converting enzyme inhibitor,ACE
Chondrosarcoma,BRD-A32505112-001-04-4::2.5::HTS,5.431237828299305,0.020135150102664243,Other Types,trandolapril,angiotensin converting enzyme inhibitor,ACE
Chondrosarcoma,BRD-A32673558-003-03-9::2.5::HTS,6.7723946149026055,0.009504303382183561,Other Types,aceclidine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Chondrosarcoma,BRD-A33692381-001-01-9::2.5::HTS,10.005733733150244,0.0016460492040417008,Other Types,zidovudine,nucleoside reverse transcriptase inhibitor,TERT
Chondrosarcoma,BRD-A36217750-001-16-3::2.5::HTS,5.0795180285576,0.024598053063035155,Other Types,sulfinpyrazone,uricosuric blocker,"ABCC1, ABCC2, FPR1, SLC22A12"
Chondrosarcoma,BRD-A36456202-001-01-3::2.5::HTS,5.161726184236025,0.023483129618142286,Other Types,colistin-b-sulfate,bacterial permeability inducer,
Chondrosarcoma,BRD-A37288617-003-02-2::2.5::HTS,8.730797784578261,0.003259896920992763,Other Types,amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3"
Chondrosarcoma,BRD-A39052811-048-11-0::2.5::HTS,5.5841393399070265,0.0184664165864737,Other Types,mosapride,serotonin receptor agonist,HTR4
Chondrosarcoma,BRD-A39791822-001-05-1::2.5::HTS,5.084893424065777,0.02452192703307823,Chondrosarcoma,hydroxyprogesterone,progesterone receptor agonist,PGR
Chondrosarcoma,BRD-A40777960-001-04-2::2.5::HTS,4.620657601712023,0.032019149220444784,Other Types,aminohydroxybutyric-acid,,
Chondrosarcoma,BRD-A40787240-066-04-6::2.5::HTS,4.039261949661998,0.04494471478026256,Other Types,gemifloxacin,bacterial DNA gyrase inhibitor,
Chondrosarcoma,BRD-A41250306-001-11-7::2.5::HTS,6.178072499238603,0.013223937054923285,Chondrosarcoma,cyclopenthiazide,thiazide diuretic,
Chondrosarcoma,BRD-A41451487-001-11-2::2.5::HTS,3.8595805906205447,0.0499694133405802,Other Types,PK-11195,benzodiazepine receptor antagonist,TSPO
Chondrosarcoma,BRD-A42628519-001-12-4::2.5::HTS,6.115209264887301,0.01371026595024316,Chondrosarcoma,iopanic-acid,thyroid hormone inhibitor,
Chondrosarcoma,BRD-A43882281-001-15-5::2.5::HTS,14.568815402188834,0.00015059887720288392,Other Types,pinacidil,"ATP channel activator, potassium channel activator","ABCC8, ABCC9"
Chondrosarcoma,BRD-A45543382-001-10-0::2.5::HTS,4.380800468656481,0.03680015482487645,Chondrosarcoma,metrizamide,radiopaque medium,
Chondrosarcoma,BRD-A46813902-001-01-6::2.5::HTS,5.439921981055547,0.020035634295361593,Chondrosarcoma,iododexetimide,acetylcholine receptor antagonist,
Chondrosarcoma,BRD-A46876182-003-02-8::2.5::HTS,6.132243732154221,0.013569269413954177,Other Types,levobunolol-(+/-),adrenergic receptor antagonist,
Chondrosarcoma,BRD-A47884604-051-01-2::2.5::HTS,5.7459392848778785,0.01685707335935954,Other Types,cyanopindolol,adrenergic receptor antagonist,"ADRB1, HTR1A, HTR1D"
Chondrosarcoma,BRD-A48015106-004-08-9::2.5::HTS,6.241629415833078,0.012762702740495329,Other Types,8-hydroxy-DPAT,serotonin receptor agonist,"CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG"
Chondrosarcoma,BRD-A48300215-001-04-8::2.5::HTS,8.27577276672461,0.004174812787101472,Chondrosarcoma,ajmaline,sodium channel blocker,SCN5A
Chondrosarcoma,BRD-A50028488-001-01-6::2.5::HTS,6.7177594628600055,0.00979619439198447,Other Types,TCS2002,glycogen synthase kinase inhibitor,GSK3B
Chondrosarcoma,BRD-A50684349-003-02-9::2.5::HTS,11.144773782082309,0.0008989812371112931,Chondrosarcoma,fenoldopam,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5"
Chondrosarcoma,BRD-A50764878-003-02-8::2.5::HTS,5.5193604219140715,0.019155431795088006,Other Types,MDL-73005EF,serotonin receptor antagonist,HTR1A
Chondrosarcoma,BRD-A50922295-001-01-3::2.5::HTS,3.968908679257088,0.046831141859916874,Chondrosarcoma,valganciclovir,DNA synthesis inhibitor,
Chondrosarcoma,BRD-A51078674-003-01-0::2.5::HTS,7.298313724052419,0.007110309558933203,Other Types,diclofensine,dopamine reuptake inhibitor,"DRD1, MAOA, MAOB"
Chondrosarcoma,BRD-A51407134-001-01-9::2.5::HTS,8.193725659036112,0.004370445130856087,Chondrosarcoma,2-octyldodecan-1-ol,,
Chondrosarcoma,BRD-A51714012-003-13-6::2.5::HTS,9.307348639300773,0.002394693571730083,Chondrosarcoma,venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-A51831848-001-01-7::2.5::HTS,4.247757424973289,0.03979319086677365,Other Types,enflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4"
Chondrosarcoma,BRD-A53037300-001-01-0::2.5::HTS,11.584974482291342,0.0007125097753357904,Other Types,2-fluoro-2-deoxy-D-galactose,,LCT
Chondrosarcoma,BRD-A53576514-048-14-3::2.5::HTS,7.69565231666386,0.005721070626663648,Other Types,orphenadrine,acetylcholine receptor antagonist,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2"
Chondrosarcoma,BRD-A53952395-003-25-1::2.5::HTS,8.81760329926391,0.003111853566988076,Other Types,prilocaine,local anesthetic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Chondrosarcoma,BRD-A54490543-066-11-9::2.5::HTS,3.9643532241601247,0.04695968846910521,Other Types,pirlindole,monoamine oxidase inhibitor,MAOA
Chondrosarcoma,BRD-A55393291-001-09-9::2.5::HTS,5.092207845404663,0.024418293289931826,Chondrosarcoma,testosterone,androgen receptor agonist,AR
Chondrosarcoma,BRD-A55464252-001-01-2::2.5::HTS,9.180720321612588,0.002562026751046872,Other Types,3-(4-methylbenzylidene)camphor,endocrine disruptor,
Chondrosarcoma,BRD-A55469827-001-07-4::2.5::HTS,5.912216659989539,0.01534994051580673,Other Types,mephenesin,muscle relaxant,
Chondrosarcoma,BRD-A55664972-236-02-6::2.5::HTS,5.411687229703445,0.020360257336747692,Other Types,sodium-tetradecyl-sulfate,,"PROC, PROS1"
Chondrosarcoma,BRD-A57133233-003-11-0::2.5::HTS,3.943367286657539,0.04754896595357632,Chondrosarcoma,chlorcyclizine,histamine receptor antagonist,HRH1
Chondrosarcoma,BRD-A57798559-004-02-3::2.5::HTS,4.3979907562042015,0.03643397512805482,Other Types,bicuculline-methochloride-(-),GABA receptor antagonist,
Chondrosarcoma,BRD-A57957888-001-08-0::2.5::HTS,4.88796247517195,0.027450093628957683,Chondrosarcoma,citiolone,"lipotropic, mucolytic agent",
Chondrosarcoma,BRD-A58048407-001-18-8::2.5::HTS,6.009099460296537,0.014535691399520472,Other Types,nimodipine,calcium channel blocker,"AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2"
Chondrosarcoma,BRD-A59198242-003-02-9::2.5::HTS,4.095215076802767,0.04347830535097721,Other Types,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
Chondrosarcoma,BRD-A60217728-001-11-2::2.5::HTS,8.769801297137878,0.003193150687613554,Other Types,iohexol,radiopaque medium,
Chondrosarcoma,BRD-A60594020-034-01-1::2.5::HTS,10.58474807413467,0.0012097080770536884,Other Types,8-hydroxy-PIPAT,dopamine receptor ligand,"DRD2, DRD3"
Chondrosarcoma,BRD-A61194565-003-27-0::2.5::HTS,4.978099764321435,0.026069557786898623,Other Types,benserazide,DOPA decarboxylase inhibitor,DDC
Chondrosarcoma,BRD-A62731508-001-05-8::2.5::HTS,3.8603187283052756,0.04993669260514161,Chondrosarcoma,cortisone,glucocorticoid receptor agonist,NR3C1
Chondrosarcoma,BRD-A63444178-001-01-5::2.5::HTS,9.210190495992316,0.0025186671123480575,Other Types,ME0328,PARP inhibitor,PARP3
Chondrosarcoma,BRD-A64743628-001-01-5::2.5::HTS,7.541484577616307,0.006222617554558375,Chondrosarcoma,isometheptene-mucate,,"ADRA1A, SLC18A2"
Chondrosarcoma,BRD-A65671304-001-07-5::2.5::HTS,10.02005393685643,0.0016335282392983203,Chondrosarcoma,candesartan-cilextil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Chondrosarcoma,BRD-A67363467-001-01-3::2.5::HTS,6.030059604559751,0.014367557592960628,Other Types,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,
Chondrosarcoma,BRD-A67516570-001-02-8::2.5::HTS,9.030604218622884,0.0027744640477498726,Other Types,lafutidine,histamine receptor antagonist,HRH2
Chondrosarcoma,BRD-A67521319-001-01-6::2.5::HTS,5.445858566291957,0.019971530119765355,Chondrosarcoma,pimonidazole,,
Chondrosarcoma,BRD-A68509429-003-03-9::2.5::HTS,5.7997133202452416,0.01635204976146237,Other Types,ethylnorepinephrine,bronchodilator,
Chondrosarcoma,BRD-A68631409-001-05-4::2.5::HTS,7.951255454638229,0.0049774262764955045,Chondrosarcoma,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1
Chondrosarcoma,BRD-A68723818-050-32-5::2.5::HTS,9.900329105757436,0.0017406176609094303,Other Types,brompheniramine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1"
Chondrosarcoma,BRD-A69777949-001-24-2::2.5::HTS,4.630732183703605,0.03184192101356316,Other Types,flumequine,topoisomerase inhibitor,
Chondrosarcoma,BRD-A70649075-008-30-8::2.5::HTS,6.515170754355251,0.010960977210736928,Other Types,sulconazole,sterol demethylase inhibitor,
Chondrosarcoma,BRD-A72066420-001-04-5::2.5::HTS,5.845733245359696,0.015936513244483134,Chondrosarcoma,mifobate,PPAR receptor antagonist,PPARG
Chondrosarcoma,BRD-A73427433-240-01-3::2.5::HTS,6.8652019940317235,0.009036846332623003,Chondrosarcoma,adaprev,TGF beta receptor inhibitor,"IGF2R, M6PR"
Chondrosarcoma,BRD-A73709786-001-01-3::2.5::HTS,7.148333947505845,0.007727983636492423,Other Types,LB-100,protein phosphatase inhibitor,
Chondrosarcoma,BRD-A74391928-051-01-3::2.5::HTS,6.926283169004186,0.00872712554158261,Chondrosarcoma,ibutilide,potassium channel blocker,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6"
Chondrosarcoma,BRD-A75479906-001-02-4::2.5::HTS,5.715656823269726,0.017142410208776063,Other Types,rimantadine,"antiviral, RNA synthesis inhibitor",
Chondrosarcoma,BRD-A75552914-001-15-0::2.5::HTS,5.743258194458354,0.01688255075324257,Chondrosarcoma,isoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-A75919782-399-02-6::2.5::HTS,8.84853467329966,0.0030610718360586414,Other Types,leucovorin,folate receptor ligand,TYMS
Chondrosarcoma,BRD-A80871782-004-06-9::2.5::HTS,4.151340064279014,0.04206947628649092,Other Types,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1
Chondrosarcoma,BRD-A81513827-001-03-6::2.5::HTS,7.712388407122629,0.005671027737401418,Chondrosarcoma,saxagliptin,dipeptidyl peptidase inhibitor,DPP4
Chondrosarcoma,BRD-A82035391-001-02-7::2.5::HTS,5.49515535926079,0.01941779505026922,Other Types,tolvaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2"
Chondrosarcoma,BRD-A82522119-001-01-7::2.5::HTS,4.034491479913934,0.04505696280892542,Chondrosarcoma,tibolone,"androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist",ESR1
Chondrosarcoma,BRD-A82772293-001-03-2::2.5::HTS,5.633628893703633,0.0179686895911561,Other Types,mepazine,MALT1 inhibitor (JH),MALT1
Chondrosarcoma,BRD-A83029242-001-05-3::2.5::HTS,5.23233893070747,0.022546770633405943,Other Types,prasugrel,purinergic receptor antagonist,P2RY12
Chondrosarcoma,BRD-A84389633-001-05-7::2.5::HTS,4.242440819210256,0.03988542054262557,Other Types,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,"HTR3A, HTR3B"
Chondrosarcoma,BRD-A85216385-003-02-4::2.5::HTS,6.2627285530901835,0.012614803818047493,Chondrosarcoma,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,"CHRM1, SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-A85548292-001-01-8::2.5::HTS,6.244215013311291,0.01275648108755362,Other Types,piketoprofen,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-A86216746-046-02-6::2.5::HTS,8.412846289807787,0.0038767370966802934,Other Types,varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Chondrosarcoma,BRD-A87983072-001-01-1::2.5::HTS,5.597559313995263,0.018326916236587547,Other Types,benzotript,CCK receptor antagonist,"CCKAR, CCKBR"
Chondrosarcoma,BRD-A88369366-001-01-7::2.5::HTS,8.805026087732598,0.003132570294084532,Other Types,trelagliptin,dipeptidyl peptidase inhibitor,DPP4
Chondrosarcoma,BRD-A90515964-001-16-5::2.5::HTS,7.671892482991329,0.005795834755032925,Other Types,guaifenesin,expectorant,
Chondrosarcoma,BRD-A90547603-001-02-5::2.5::HTS,12.01805932518852,0.0005673749960061591,Other Types,eptifibatide,platelet aggregation inhibitor,"ITGA2B, ITGB3"
Chondrosarcoma,BRD-A91699651-316-10-9::2.5::HTS,7.640420931234387,0.0058957258788751,Other Types,chloroquine,antimalarial agent,"GSTA2, MRGPRX1, TLR9, TNF"
Chondrosarcoma,BRD-A91733352-300-04-5::2.5::HTS,6.072628878930314,0.014029573869968618,Other Types,camylofine-chlorhydrate,,
Chondrosarcoma,BRD-A91822151-001-05-0::2.5::HTS,5.549070508693511,0.018843159685022027,Other Types,picrotin,GABA receptor antagonist,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB"
Chondrosarcoma,BRD-A92439610-001-05-7::2.5::HTS,8.691979622402824,0.0033294374424026646,Chondrosarcoma,triamcinolone-acetonide,"glucocorticoid receptor agonist, immunosuppressant",NR3C1
Chondrosarcoma,BRD-A92630576-050-24-1::2.5::HTS,4.381849776263277,0.03677121982486458,Other Types,trimebutine,opioid receptor agonist,"OPRD1, OPRK1, OPRM1"
Chondrosarcoma,BRD-A92872453-001-01-8::2.5::HTS,6.056000158769364,0.01416300895854638,Chondrosarcoma,N-acetylmannosamine,,CHIT1
Chondrosarcoma,BRD-A93699261-236-03-4::2.5::HTS,10.298839011402341,0.0014120077279455943,Other Types,sodium-danshensu,,
Chondrosarcoma,BRD-A94008949-001-01-9::2.5::HTS,4.043331190140884,0.04482673565691184,Other Types,telithromycin,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Chondrosarcoma,BRD-A94323479-001-02-8::2.5::HTS,10.204037398858372,0.0014798569314853033,Other Types,ki16198,lipoprotein antagonist,LPA
Chondrosarcoma,BRD-A94993966-001-05-1::2.63::HTS,4.0413137672766055,0.044896908782351565,Other Types,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Chondrosarcoma,BRD-A95340155-001-09-7::2.5::HTS,8.956922251059419,0.002885637272106643,Chondrosarcoma,methyclothiazide,chloride reabsorption inhibitor,"CA1, CA2, CA4, SLC12A1, SLC12A3"
Chondrosarcoma,BRD-A96407378-001-15-1::2.5::HTS,5.152931169253134,0.023588422964493982,Chondrosarcoma,allantoin,cosmetic,
Chondrosarcoma,BRD-A97701745-001-16-0::2.5::HTS,8.493574552445885,0.003705968043577583,Chondrosarcoma,pindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B"
Chondrosarcoma,BRD-A97739905-001-26-5::2.5::HTS,6.811413986429881,0.009310449019993016,Other Types,ketoprofen,cyclooxygenase inhibitor,"CXCR1, PTGS1, PTGS2, SLC5A8"
Chondrosarcoma,BRD-A98174560-001-02-1::2.5::HTS,4.962932043315119,0.0262941754672712,Other Types,chloralose,,
Chondrosarcoma,BRD-A99633051-001-07-0::2.5::HTS,6.049398423090797,0.014213279409961045,Other Types,ethosuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I"
Chondrosarcoma,BRD-A99833829-003-27-1::2.5::HTS,4.040503175089155,0.044928689738275907,Other Types,bethanechol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Chondrosarcoma,BRD-A99939097-001-24-2::2.5::HTS,5.266479083419108,0.022109559658322796,Other Types,carisoprodol,acetylcholine receptor antagonist,CYP2C19
Chondrosarcoma,BRD-K00486786-001-02-2::2.5::HTS,5.411131056090763,0.02036539665143884,Chondrosarcoma,Ro-08-2750,,NGF
Chondrosarcoma,BRD-K01174345-001-01-9::2.5::HTS,6.140071120367468,0.013512136990085013,Other Types,anamorelin,growth hormone secretagogue receptor agonist,GHSR
Chondrosarcoma,BRD-K01294196-001-01-5::2.5::HTS,5.434818907155793,0.020102142512048674,Chondrosarcoma,sucrose-octaacetate,,
Chondrosarcoma,BRD-K01507359-001-22-9::2.5::HTS,5.180549415734599,0.023240698103780825,Other Types,rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3"
Chondrosarcoma,BRD-K01649396-003-07-1::2.5::HTS,14.425924661110617,0.00016175221021222532,Other Types,indatraline,norepinephrine transporter inhibitor,"MAOA, MAOB"
Chondrosarcoma,BRD-K01674964-300-06-3::2.5::HTS,3.9185808590328977,0.048249712995628434,Chondrosarcoma,histamine,histamine receptor agonist,"HRH1, HRH2, HRH3, HRH4"
Chondrosarcoma,BRD-K01950558-001-14-7::2.5::HTS,5.091832478351777,0.02442491192975169,Other Types,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR
Chondrosarcoma,BRD-K02292852-001-02-1::2.5::HTS,9.84356081461546,0.0017948443318845958,Chondrosarcoma,cefoperazone,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K02867583-300-08-9::2.5::HTS,4.064263089814414,0.0442819995026044,Other Types,minaprine,serotonin reuptake inhibitor,"ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4"
Chondrosarcoma,BRD-K02953697-001-09-2::2.5::HTS,5.552414967879126,0.01880308823489484,Chondrosarcoma,naringin,cytochrome P450 inhibitor,SLCO1A2
Chondrosarcoma,BRD-K03155172-001-02-2::2.5::HTS,5.2929766058235534,0.021778824227158343,Other Types,GSK3787,PPAR receptor antagonist,PPARD
Chondrosarcoma,BRD-K03301001-003-02-5::2.5::HTS,7.255735905100795,0.007278614776318849,Chondrosarcoma,A-7,calmodulin antagonist,
Chondrosarcoma,BRD-K03353589-236-01-4::2.5::HTS,4.338000149814017,0.03772629232238742,Other Types,ecabet,"gastrin inhibitor, urease inhibitor",NOXO1
Chondrosarcoma,BRD-K04185004-003-11-9::2.5::HTS,5.087512531398532,0.02448595769232375,Chondrosarcoma,oxybuprocaine,local anesthetic,SCN10A
Chondrosarcoma,BRD-K04497194-001-02-1::2.5::HTS,6.151656562689332,0.013420663268718262,Other Types,lithocholic-acid,"FXR antagonist, vitamin D receptor agonist","GPBAR1, NR1H4, NR1I2, VDR"
Chondrosarcoma,BRD-K05151076-001-02-6::2.5::HTS,7.0920950987481435,0.007966420743828568,Other Types,ZK-164015,estrogen receptor antagonist,"ESR1, ESR2"
Chondrosarcoma,BRD-K05236810-001-19-0::2.5::HTS,4.267303949359701,0.03931526780297039,Other Types,luteolin,glucosidase inhibitor,TOP1
Chondrosarcoma,BRD-K05361803-001-03-9::2.5::HTS,6.239625717375009,0.01277903706847366,Other Types,SC-10,protein kinase activator,PRKCA
Chondrosarcoma,BRD-K05395900-322-05-4::2.5::HTS,4.60744641406574,0.03226775782588636,Other Types,nicotine,acetylcholine receptor agonist,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1"
Chondrosarcoma,BRD-K05673000-236-12-1::2.5::HTS,5.656919109550921,0.01772284009101984,Other Types,dicloxacillin,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K06408664-001-03-5::2.5::HTS,5.696772594310978,0.01732827085426321,Chondrosarcoma,fludrocortisone-acetate,,"AR, NR3C1, NR3C2"
Chondrosarcoma,BRD-K06543683-066-02-1::2.5::HTS,5.648331308532184,0.017807732955158646,Other Types,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Chondrosarcoma,BRD-K06814349-304-01-9::2.5::HTS,4.285619264410371,0.03889885695190842,Chondrosarcoma,fosbretabulin,"tubulin polymerization inhibitor, VE-cadherin antagonist",CDH5
Chondrosarcoma,BRD-K06878038-001-18-6::2.5::HTS,5.4487978128421455,0.019938291807266965,Other Types,deferiprone,chelating agent,UGT1A6
Chondrosarcoma,BRD-K06900071-001-01-2::2.5::HTS,6.650563250015933,0.010167871926683898,Other Types,tebipenem,bacterial cell wall synthesis inhibitor,CNR1
Chondrosarcoma,BRD-K06902185-003-01-7::2.5::HTS,7.512609434741615,0.0063235582951378325,Other Types,minoxidil,"KATP activator, Kir6 channel (KATP) activator, vasodilator","ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1"
Chondrosarcoma,BRD-K07202345-001-19-4::2.5::HTS,5.278915839644938,0.021953022491384002,Other Types,frentizole,immunosuppressant,
Chondrosarcoma,BRD-K07237224-001-19-6::2.5::HTS,9.192148597621907,0.0025436117690730135,Other Types,moclobemide,monoamine oxidase inhibitor,"MAOA, MAOB"
Chondrosarcoma,BRD-K08206212-002-01-0::2.5::HTS,16.389698692818918,5.912356848012628e-05,Chondrosarcoma,entecavir,"DNA replication inhibitor, nucleoside reverse transcriptase inhibitor",
Chondrosarcoma,BRD-K08231299-001-08-1::2.5::HTS,4.793508695453512,0.02898971872661953,Chondrosarcoma,propoxur,,
Chondrosarcoma,BRD-K08251020-001-01-0::2.5::HTS,9.6706473200366,0.0019700418301489705,Other Types,falecalcitriol,vitamin D receptor agonist,VDR
Chondrosarcoma,BRD-K08310154-001-03-8::2.5::HTS,4.733084592043362,0.030009780876286272,Other Types,AG-1024,insulin growth factor receptor inhibitor,IGF1R
Chondrosarcoma,BRD-K08586861-001-01-1::2.5::HTS,5.179637279582968,0.023245331918454976,Other Types,ramatroban,prostanoid receptor antagonist,"PTGDR2, TBXA2R"
Chondrosarcoma,BRD-K08837089-236-01-6::2.5::HTS,8.119713417410484,0.004539188345409215,Other Types,actinoquinol,,
Chondrosarcoma,BRD-K08859203-001-01-9::2.5::HTS,7.85443925680442,0.005256241666641859,Other Types,DU-728,structural glycoprotein antagonist,"ITGA2B, ITGB3"
Chondrosarcoma,BRD-K08864679-001-02-2::2.5::HTS,6.381081465622215,0.011809853467764437,Other Types,fexaramine,FXR agonist,NR1H4
Chondrosarcoma,BRD-K09126848-003-01-9::2.5::HTS,6.586606315985659,0.01053652361263544,Chondrosarcoma,nepicastat,dopamine beta hydroxylase inhibitor,DBH
Chondrosarcoma,BRD-K09353376-001-03-9::2.5::HTS,4.757398687647344,0.02961307558064057,Other Types,tariquidar,P glycoprotein inhibitor,ABCB1
Chondrosarcoma,BRD-K09785578-001-01-2::2.5::HTS,4.165300861747202,0.041730961086795346,Other Types,bakuchiol,DNA polymerase inhibitor,HIF1A
Chondrosarcoma,BRD-K09951645-001-06-8::2.5::HTS,4.222537281151667,0.040371904160270686,Chondrosarcoma,dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1"
Chondrosarcoma,BRD-K10071630-001-01-0::2.5::HTS,3.9937598487585166,0.04615117883989986,Other Types,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Chondrosarcoma,BRD-K10575656-034-01-0::2.5::HTS,6.307309482146272,0.012307510267211969,Other Types,MRS3777,adenosine receptor antagonist,ADORA2A
Chondrosarcoma,BRD-K10673031-004-02-0::2.5::HTS,4.823639004172271,0.028481960152180266,Other Types,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Chondrosarcoma,BRD-K10843433-001-22-7::2.5::HTS,4.951186697098927,0.02648584847169078,Chondrosarcoma,phenylbutazone,"cyclooxygenase inhibitor, prostanoid receptor antagonist","PTGIS, PTGS1, PTGS2"
Chondrosarcoma,BRD-K10859802-001-01-0::2.5::HTS,4.767003862976419,0.0294408237159994,Chondrosarcoma,APD668,glucose dependent insulinotropic receptor agonist,GPR119
Chondrosarcoma,BRD-K10990317-001-04-5::2.5::HTS,4.304921558616456,0.038463300530553336,Other Types,clotiapine,,
Chondrosarcoma,BRD-K11124378-001-04-6::2.5::HTS,8.664931018214613,0.0033789313314747317,Other Types,ceftibuten,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K11129031-001-27-5::2.5::HTS,4.510909437292625,0.034139197633490076,Other Types,gemfibrozil,lipoprotein lipase activator,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1"
Chondrosarcoma,BRD-K11373525-003-02-1::2.5::HTS,4.4674992558237285,0.034989478913129785,Chondrosarcoma,ZD-7155,angiotensin receptor antagonist,AGTR1
Chondrosarcoma,BRD-K11663430-001-02-3::2.5::HTS,4.184111241653001,0.04127215510878374,Other Types,pyroxamide,HDAC inhibitor,HDAC1
Chondrosarcoma,BRD-K11696279-003-02-3::2.5::HTS,4.416112936953293,0.03604804450992949,Other Types,BU-239,"imidazoline receptor ligand, imidazoline receptor agonist",
Chondrosarcoma,BRD-K11853856-001-01-7::2.5::HTS,6.389598274420861,0.011752009638619372,Chondrosarcoma,PJ-34,PARP inhibitor,"EEF2, PARP1, PARP15, PARP3"
Chondrosarcoma,BRD-K11900042-001-14-4::2.5::HTS,9.95722867860255,0.0016916478224558687,Chondrosarcoma,methylthiouracil,,
Chondrosarcoma,BRD-K12219985-001-26-1::2.5::HTS,6.484549409183858,0.01115860647109543,Chondrosarcoma,glipizide,sulfonylurea,"ABCC8, KCNJ10, KCNJ11, PPARG"
Chondrosarcoma,BRD-K12251893-065-04-7::2.5::HTS,4.03805484955121,0.044969524023168526,Chondrosarcoma,vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB"
Chondrosarcoma,BRD-K12513978-001-24-1::2.5::HTS,5.4369627893849195,0.02008245767446519,Chondrosarcoma,fenbufen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K12568846-001-14-6::2.5::HTS,6.554811740874658,0.010720371189856708,Chondrosarcoma,amidopyrine,analgesic agent,
Chondrosarcoma,BRD-K12735121-001-01-4::2.5::HTS,12.522073289606901,0.00043690142799552754,Other Types,TG-100801,"src inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, SRC"
Chondrosarcoma,BRD-K12762134-001-06-2::2.5::HTS,4.269671817433992,0.039262623966435845,Other Types,XAV-939,tankyrase inhibitor,"TNKS, TNKS2"
Chondrosarcoma,BRD-K12968785-001-13-3::2.5::HTS,4.63885052718872,0.031692935534455145,Other Types,bergapten,,
Chondrosarcoma,BRD-K13050303-001-18-1::2.5::HTS,4.600167568338277,0.032403069488405704,Other Types,uridine,dopamine receptor agonist,"LSM6, TYMP"
Chondrosarcoma,BRD-K13356952-001-25-1::2.5::HTS,5.814954068938845,0.016219527873334215,Other Types,methazolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7"
Chondrosarcoma,BRD-K13486660-001-01-0::2.5::HTS,4.81242848192676,0.02866396858802077,Other Types,sulfacarbamide,,
Chondrosarcoma,BRD-K13888115-003-02-2::2.5::HTS,5.168064751673205,0.023387772108377815,Other Types,LY2365109,Glycine transporter 1 inhibitor,SLC6A9
Chondrosarcoma,BRD-K14395568-001-16-3::2.5::HTS,5.870436883493153,0.015716763468089708,Other Types,NECA,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1"
Chondrosarcoma,BRD-K14529030-001-01-9::2.5::HTS,7.6013303256273295,0.006025212939194732,Other Types,meisoindigo,STAT inhibitor,STAT3
Chondrosarcoma,BRD-K14618467-001-04-6::2.5::HTS,5.308319920467432,0.021587708321482144,Other Types,IKK-16,IKK inhibitor,IKBKB
Chondrosarcoma,BRD-K14619660-001-01-5::2.5::HTS,4.18054675506754,0.04136005214201578,Chondrosarcoma,altrenogest,progestogen hormone,PGR
Chondrosarcoma,BRD-K14704277-001-22-6::2.5::HTS,4.4587844690993075,0.035166947856940065,Other Types,cinoxacin,topoisomerase inhibitor,
Chondrosarcoma,BRD-K14705039-001-16-4::2.5::HTS,6.511018697534581,0.010986775673671578,Other Types,sulfathiazole,dihydropteroate synthase inhibitor,
Chondrosarcoma,BRD-K14870255-001-02-3::2.5::HTS,8.088979716622998,0.004615677674697369,Other Types,R-428,AXL kinase inhibitor,AXL
Chondrosarcoma,BRD-K15164005-001-05-6::2.5::HTS,17.09235893387465,4.1123010323143076e-05,Other Types,apoptosis-activator-II,carboxylesterase inhibitor,"BCHE, CES1"
Chondrosarcoma,BRD-K15231341-001-01-5::2.5::HTS,4.542378709397544,0.03350199246426854,Other Types,hemomex-s,,PPARG
Chondrosarcoma,BRD-K15318383-201-01-5::2.5::HTS,7.099125829425842,0.007943573688799338,Other Types,ammonium-glycyrrhizinate,thrombin inhibitor,"HSD11B1, HSD11B2, SLCO1B1, SLCO1B3"
Chondrosarcoma,BRD-K15600710-066-04-1::2.5::HTS,7.203088678588833,0.007495503040813447,Chondrosarcoma,obatoclax,BCL inhibitor,BCL2
Chondrosarcoma,BRD-K15601958-001-03-9::2.5::HTS,4.808502142825685,0.028730975952483192,Other Types,SEW-2871,lysophospholipid receptor agonist,S1PR1
Chondrosarcoma,BRD-K15976406-001-03-3::2.5::HTS,8.549434972067521,0.0035961186997380693,Chondrosarcoma,telbivudine,DNA polymerase inhibitor,TK2
Chondrosarcoma,BRD-K16295392-003-01-3::2.5::HTS,4.984662542481176,0.025967479396409487,Other Types,atrasentan,endothelin receptor antagonist,EDNRA
Chondrosarcoma,BRD-K16444452-001-09-1::2.5::HTS,5.076355989248889,0.024640452588598573,Chondrosarcoma,ibudilast,"leukotriene receptor antagonist, phosphodiesterase inhibitor","IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A"
Chondrosarcoma,BRD-K16761703-001-03-8::2.5::HTS,7.05615776843179,0.008124508499528635,Other Types,sotrastaurin,PKC inhibitor,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ"
Chondrosarcoma,BRD-K17223896-001-10-0::2.5::HTS,5.151273028505724,0.023610744429470545,Other Types,chloroxylenol,ATP synthase inhibitor,
Chondrosarcoma,BRD-K17415526-001-03-5::2.5::HTS,6.245895183777472,0.01273646802059805,Chondrosarcoma,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR
Chondrosarcoma,BRD-K17555800-003-01-5::2.5::HTS,4.063284716998867,0.0443022927966286,Chondrosarcoma,talmapimod,p38 MAPK inhibitor,"MAPK11, MAPK14"
Chondrosarcoma,BRD-K17850764-236-11-9::2.5::HTS,4.0225791788549685,0.045380785086137736,Chondrosarcoma,cloprostenol-(+/-),prostaglandin receptor agonist,"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R"
Chondrosarcoma,BRD-K17977438-048-02-4::2.5::HTS,6.899371312467065,0.008859509994500915,Other Types,oxelaidin,antitussive,
Chondrosarcoma,BRD-K18194590-065-08-0::2.5::HTS,11.174080660730104,0.0008848643996713119,Chondrosarcoma,mephentermine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3"
Chondrosarcoma,BRD-K18613660-001-05-5::2.5::HTS,4.304607156845138,0.03846952201096271,Chondrosarcoma,mexeneone,,
Chondrosarcoma,BRD-K18678457-003-02-8::2.5::HTS,9.109034659056572,0.0026592019352188016,Chondrosarcoma,ZD-7288,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Chondrosarcoma,BRD-K18905250-003-02-4::2.5::HTS,4.468495399408371,0.03496845666748805,Other Types,ST-91,adrenergic receptor agonist,
Chondrosarcoma,BRD-K18948558-001-01-9::2.5::HTS,4.7340885799981125,0.029986407420942898,Chondrosarcoma,clevudine,DNA polymerase inhibitor,
Chondrosarcoma,BRD-K18961567-001-01-1::2.5::HTS,5.271223658557049,0.022053298335001352,Chondrosarcoma,LY2801653,MET inhibitor,MET
Chondrosarcoma,BRD-K19136521-001-08-9::2.5::HTS,4.56746383593809,0.033022009343472054,Other Types,indirubin-3-monoxime,"CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B"
Chondrosarcoma,BRD-K19333160-001-01-3::2.5::HTS,12.99362982846278,0.0003405282529640008,Other Types,RKI-1447,rho associated kinase inhibitor,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2"
Chondrosarcoma,BRD-K19352500-070-12-4::2.5::HTS,5.891618269639859,0.01552912281812741,Chondrosarcoma,prochlorperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4"
Chondrosarcoma,BRD-K19412355-001-01-0::2.5::HTS,6.796128849432704,0.009388520421148825,Chondrosarcoma,SB-242235,p38 MAPK inhibitor,"HSPB1, MAPK14"
Chondrosarcoma,BRD-K19507340-001-22-1::2.38::HTS,4.46813956413525,0.03500089339996915,Chondrosarcoma,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Chondrosarcoma,BRD-K19672466-001-02-3::2.5::HTS,4.180876027216313,0.04134789838692636,Other Types,ethimizol,,
Chondrosarcoma,BRD-K19741547-003-01-7::2.5::HTS,7.965804540337799,0.004942953930061984,Chondrosarcoma,vernakalant,potassium channel blocker,KCNA5
Chondrosarcoma,BRD-K19761926-001-03-6::2.45::HTS,5.526835062881499,0.019086231694276982,Chondrosarcoma,eplerenone,cytochrome P450 inhibitor,NR3C2
Chondrosarcoma,BRD-K19972289-001-01-4::2.5::HTS,4.1354987375254755,0.04246531134861671,Chondrosarcoma,octinoxate,,
Chondrosarcoma,BRD-K20152659-001-04-6::2.5::HTS,8.10018792222028,0.004589094722428206,Other Types,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K20285085-001-07-1::2.5::HTS,6.023567016717293,0.014431244166527543,Other Types,R406,SYK inhibitor,"RET, SYK"
Chondrosarcoma,BRD-K20290250-001-01-3::2.5::HTS,6.879704066227429,0.008956727464298235,Other Types,BIX-02188,MEK inhibitor,MAP2K5
Chondrosarcoma,BRD-K20338176-001-17-7::2.5::HTS,4.023398484316432,0.045356294722745154,Chondrosarcoma,cefaclor,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K20417253-001-01-9::2.5::HTS,3.8824640489327398,0.04928685143931327,Chondrosarcoma,oxiniacic-acid,,
Chondrosarcoma,BRD-K20545304-001-01-6::2.5::HTS,4.557706303769503,0.033209065920448186,Chondrosarcoma,bardoxolone,"nuclear factor erythroid derived, like (NRF2) activator","NOS2, PPARG"
Chondrosarcoma,BRD-K20548681-001-01-3::2.5::HTS,6.193229190504341,0.013112406418811253,Other Types,SCP-1,analgesic agent,
Chondrosarcoma,BRD-K20714604-003-02-9::2.5::HTS,5.163194058317917,0.02344939014005545,Other Types,RS-56812,serotonin receptor partial agonist,HTR3A
Chondrosarcoma,BRD-K20738689-001-01-2::2.5::HTS,7.466326372774608,0.0064870308571053584,Other Types,dazmegrel,thromboxane synthase inhibitor,TBXAS1
Chondrosarcoma,BRD-K20920669-304-09-1::2.5::HTS,8.145584933253799,0.004476090564515713,Chondrosarcoma,cromoglicic-acid,immunosuppressant,"KCNMA1, S100P"
Chondrosarcoma,BRD-K21283037-001-21-5::2.5::HTS,4.778316569769077,0.029238112770563283,Other Types,riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11"
Chondrosarcoma,BRD-K21295289-001-01-6::2.5::HTS,11.43234656989993,0.0007741024374094891,Other Types,senicapoc,intermediate conductance potassium channel blocker,KCNN4
Chondrosarcoma,BRD-K21528677-001-02-8::2.44::HTS,4.262508874919279,0.03945009343954257,Chondrosarcoma,desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Chondrosarcoma,BRD-K21680192-300-14-4::2.5::HTS,5.228899546812515,0.022590967507229498,Chondrosarcoma,mitoxantrone,topoisomerase inhibitor,TOP2A
Chondrosarcoma,BRD-K21733600-001-14-1::2.5::HTS,3.981184565883965,0.04650766060474183,Chondrosarcoma,rofecoxib,cyclooxygenase inhibitor,"ELN, PTGS2"
Chondrosarcoma,BRD-K22009844-001-12-5::2.5::HTS,4.203286998906777,0.04080909288602322,Chondrosarcoma,phenprobamate,muscle relaxant,
Chondrosarcoma,BRD-K22261391-001-01-2::2.5::HTS,4.5703467444156205,0.032960724448317186,Other Types,pirodavir,,
Chondrosarcoma,BRD-K22520627-001-01-7::2.5::HTS,4.395547731307091,0.03648578124103935,Chondrosarcoma,DVD-111,,
Chondrosarcoma,BRD-K22662435-001-18-3::2.5::HTS,4.267143666427337,0.039320619826338304,Chondrosarcoma,ganciclovir,DNA polymerase inhibitor,
Chondrosarcoma,BRD-K22749967-046-02-3::2.5::HTS,4.329712610376747,0.03790892491696009,Chondrosarcoma,ABT-239,histamine receptor antagonist,"HRH1, HRH2, HRH3"
Chondrosarcoma,BRD-K23301018-001-11-7::2.63::HTS,6.06033023835829,0.014143716707644598,Other Types,broxyquinoline,antiprotozoal agent,
Chondrosarcoma,BRD-K24048528-001-01-7::2.59::HTS,4.661929923156916,0.03128821039872534,Other Types,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1
Chondrosarcoma,BRD-K24443618-001-10-2::2.5::HTS,13.04814823588135,0.0003309787826151702,Chondrosarcoma,etebenecid,uricosuric blocker,
Chondrosarcoma,BRD-K24697665-001-01-4::2.5::HTS,6.120513239558575,0.013676705947761821,Chondrosarcoma,bucillamine,immunosuppressant,
Chondrosarcoma,BRD-K25114078-003-08-1::2.5::HTS,6.614945984357569,0.010369800650261987,Chondrosarcoma,aminoguanidine,nitric oxide synthase inhibitor,NOS2
Chondrosarcoma,BRD-K25394294-001-14-9::2.5::HTS,11.466982536368088,0.0007579462498505622,Chondrosarcoma,oxaprozin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K25433859-003-25-4::2.5::HTS,7.089490791881404,0.007987133052128786,Chondrosarcoma,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2"
Chondrosarcoma,BRD-K25596805-001-01-8::2.5::HTS,4.471884240193302,0.03490294339131593,Other Types,JNJ-16259685,glutamate receptor antagonist,GRM1
Chondrosarcoma,BRD-K25875056-001-02-0::2.5::HTS,4.887521349436548,0.0274563172052012,Other Types,SC-9,protein tyrosine kinase activator,PRKCA
Chondrosarcoma,BRD-K26349472-001-01-3::2.5::HTS,4.495697011572801,0.03444594493558116,Other Types,OG-L002,histone lysine demethylase inhibitor,KDM1A
Chondrosarcoma,BRD-K28007504-051-01-2::2.5::HTS,6.947478933037523,0.008628957541626119,Other Types,Ro-60-0175,,"HTR2A, HTR2B, HTR2C"
Chondrosarcoma,BRD-K28143534-001-02-2::2.5::HTS,4.649506770682941,0.031504153581506475,Chondrosarcoma,cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Chondrosarcoma,BRD-K28210218-236-08-1::2.5::HTS,17.560337488430623,3.236287392150958e-05,Other Types,cephalothin,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K28217197-001-01-4::2.5::HTS,8.246255819947043,0.004237645305487712,Chondrosarcoma,ganaxolone,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6"
Chondrosarcoma,BRD-K28308851-303-01-8::2.5::HTS,6.417333051968752,0.01157193783854679,Other Types,alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3
Chondrosarcoma,BRD-K28360340-001-08-3::2.31::HTS,6.726481400024966,0.009762783947612676,Chondrosarcoma,TW-37,BCL inhibitor,"BCL2, BCL2L1, MCL1"
Chondrosarcoma,BRD-K28494619-001-28-2::2.5::HTS,4.920546862369837,0.026941632784698275,Other Types,sulfamethoxazole,PABA antagonist,
Chondrosarcoma,BRD-K28595280-001-04-5::2.5::HTS,7.384538688967515,0.006783414822920067,Other Types,meglumine,excipient,
Chondrosarcoma,BRD-K29322660-001-01-9::2.5::HTS,4.235009918906232,0.04005901490141412,Chondrosarcoma,edoxaban,coagulation factor inhibitor,F10
Chondrosarcoma,BRD-K29392254-001-02-2::2.5::HTS,4.429349660573374,0.035797090416705625,Other Types,pantothenic-acid,coenzyme A precursor,
Chondrosarcoma,BRD-K29673530-001-05-4::2.5::HTS,5.33622961592016,0.02124994745841341,Other Types,hypericin,tyrosine kinase inhibitor,
Chondrosarcoma,BRD-K30126819-304-02-7::2.5::HTS,5.663445921787782,0.01765648521744183,Other Types,dimesna,tubulin polymerization inhibitor,
Chondrosarcoma,BRD-K30213273-001-01-6::2.5::HTS,8.555404762544145,0.0035850296760489846,Other Types,fenofibric-acid,cytochrome P450 inhibitor,"CLCN1, PPARA"
Chondrosarcoma,BRD-K30649484-003-13-7::2.5::HTS,6.94813128673033,0.008624577140431744,Other Types,mafenide,carbonic anhydrase inhibitor,"CA12, CA14, CA2, CA4, CA6, CA9"
Chondrosarcoma,BRD-K30707190-001-04-1::2.5::HTS,6.167709297163642,0.013304969458010992,Other Types,PNU-74654,beta-catenin inhibitor,"CTNNB1, TCF4"
Chondrosarcoma,BRD-K31560319-001-01-5::2.5::HTS,13.444829150034675,0.000269135860666062,Other Types,olvanil,TRPV agonist,"CNR1, GPR119, TRPV1"
Chondrosarcoma,BRD-K32007074-001-02-9::3.16::HTS,4.113129199941324,0.04304286061641427,Chondrosarcoma,enocitabine,DNA synthesis inhibitor,"CMPK1, RRM1, TYMS"
Chondrosarcoma,BRD-K32101625-001-01-6::2.5::HTS,5.184952365671501,0.02315960788938281,Chondrosarcoma,LX1031,tryptophan hydroxylase inhibitor,TPH1
Chondrosarcoma,BRD-K32292990-001-03-6::2.5::HTS,5.9241266731727364,0.01524990172371286,Other Types,CGP-53353,"EGFR inhibitor, PKC inhibitor","EGFR, PRKCB"
Chondrosarcoma,BRD-K32318651-001-23-7::2.5::HTS,4.084292046438513,0.043762330985128724,Other Types,acyclovir,DNA polymerase inhibitor,PNP
Chondrosarcoma,BRD-K32830106-001-02-6::2.5::HTS,5.557032840714528,0.018751553467450256,Chondrosarcoma,guanfacine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Chondrosarcoma,BRD-K33219225-001-01-9::2.5::HTS,8.86431953945105,0.00304146813927451,Other Types,allylisothiocyanate,TRPV agonist,TRPA1
Chondrosarcoma,BRD-K33814251-001-01-4::2.6::HTS,8.913227416484492,0.0029624103244044503,Other Types,lubiprostone,chloride channel activator,CLCN2
Chondrosarcoma,BRD-K34154330-003-06-4::2.5::HTS,6.0931035012699,0.013868622489463255,Other Types,tracazolate,GABA receptor modulator,GABRA1
Chondrosarcoma,BRD-K34313798-001-01-6::2.5::HTS,6.171449768110515,0.013277719319372237,Other Types,LY215490,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1"
Chondrosarcoma,BRD-K34441861-003-07-0::2.47::HTS,4.366614983735014,0.037127698065435255,Other Types,moexipril,angiotensin converting enzyme inhibitor,"ACE, ACE2"
Chondrosarcoma,BRD-K34685430-050-12-5::2.5::HTS,4.389393112504424,0.03662927366024383,Other Types,methylergometrine,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C"
Chondrosarcoma,BRD-K35170555-001-09-5::2.5::HTS,7.130780195205166,0.0078107468370115455,Chondrosarcoma,caprylic-acid,,
Chondrosarcoma,BRD-K35189033-001-26-1::2.5::HTS,8.951676549691378,0.0028942424847248783,Chondrosarcoma,levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1"
Chondrosarcoma,BRD-K35240538-001-26-2::2.5::HTS,5.555877802489301,0.018776028879611696,Chondrosarcoma,methylprednisolone,glucocorticoid receptor agonist,NR3C1
Chondrosarcoma,BRD-K35698076-001-01-2::2.5::HTS,4.823736149315358,0.02848184398691665,Chondrosarcoma,laurocapram,,
Chondrosarcoma,BRD-K35775715-001-03-1::2.5::HTS,4.383378299764926,0.036740127184626555,Chondrosarcoma,liranaftate,fungal squalene epoxidase inhibitor,
Chondrosarcoma,BRD-K36116267-001-15-3::2.5::HTS,6.3908973038982015,0.011745971667316057,Other Types,pyrithyldione,psychoactive drug,
Chondrosarcoma,BRD-K36395411-003-02-2::2.5::HTS,8.863214732682948,0.0030351108763261737,Other Types,SB-206553,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C"
Chondrosarcoma,BRD-K36660044-001-24-2::2.5::HTS,4.9087093987972805,0.027125203988449254,Other Types,bufexamac,cyclooxygenase inhibitor,"HDAC10, HDAC6"
Chondrosarcoma,BRD-K36775483-001-01-4::2.5::HTS,7.009922250867161,0.008336759279026195,Other Types,DMeOB,,GRM5
Chondrosarcoma,BRD-K36859431-300-02-3::2.5::HTS,7.088528686720999,0.007981279106326681,Other Types,sapropterin,phenylalanine 4-hydroxylase stimulant,"NOS3, PAH, TH, TPH1"
Chondrosarcoma,BRD-K36864847-303-02-5::2.5::HTS,3.8780630693221756,0.049414393778708876,Chondrosarcoma,BD-1047,adrenergic receptor antagonist,SIGMAR1
Chondrosarcoma,BRD-K36984403-001-02-7::2.5::HTS,8.918011085235399,0.0029467723035466226,Other Types,go-6983,protein kinase inhibitor,"PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ"
Chondrosarcoma,BRD-K37130656-001-04-6::2.5::HTS,3.988193843053649,0.046316020497471154,Chondrosarcoma,rivaroxaban,coagulation factor inhibitor,F10
Chondrosarcoma,BRD-K37270826-001-31-8::2.5::HTS,6.152045153615158,0.013420377100385293,Chondrosarcoma,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Chondrosarcoma,BRD-K37385792-003-02-1::2.5::HTS,4.793222901300758,0.028996824464379015,Chondrosarcoma,conivaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2"
Chondrosarcoma,BRD-K37687387-237-01-7::2.5::HTS,4.251023395239705,0.03969254531950498,Other Types,RU-28318,cytochrome P450 inhibitor,NR3C2
Chondrosarcoma,BRD-K37694030-003-12-7::2.5::HTS,4.002611895824867,0.04591206121911361,Other Types,doxepin,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4"
Chondrosarcoma,BRD-K37793595-003-01-7::2.5::HTS,4.0312810275469895,0.04514470746230927,Other Types,afobazole,anxiolytic,
Chondrosarcoma,BRD-K37846922-001-09-4::0.25::HTS,4.178364935464694,0.041422392316106775,Other Types,"3,3'-diindolylmethane","CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor","AR, HIF1A, IFNG, PI3"
Chondrosarcoma,BRD-K37991163-003-13-4::2.5::HTS,4.238211449671971,0.0399976312913692,Other Types,paroxetine,selective serotonin reuptake inhibitor (SSRI),"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4"
Chondrosarcoma,BRD-K38003476-001-09-1::2.5::HTS,6.30172336117048,0.01234184616768226,Chondrosarcoma,clocortolone-pivalate,steroid,"NR3C1, PLA2G1B"
Chondrosarcoma,BRD-K38140108-002-01-2::2.5::HTS,7.46016091550655,0.006506458130713586,Chondrosarcoma,gadodiamide,radiopaque medium,
Chondrosarcoma,BRD-K38287497-001-01-2::2.5::HTS,3.8924666931434024,0.048996272060832874,Chondrosarcoma,narlaprevir,HCV inhibitor,
Chondrosarcoma,BRD-K38797369-003-01-1::2.46::HTS,5.9379602850947055,0.015147461212022484,Chondrosarcoma,PD-128907,dopamine receptor agonist,"DRD2, DRD3"
Chondrosarcoma,BRD-K39023557-001-01-7::2.5::HTS,4.861434607516104,0.027872170099077012,Chondrosarcoma,octocrylene,,
Chondrosarcoma,BRD-K39061174-001-01-0::2.62::HTS,7.690625848911663,0.005747101827617839,Other Types,beta-glycerophosphoric-acid,,
Chondrosarcoma,BRD-K39381259-001-01-0::2.5::HTS,4.972540116464162,0.02614983375592495,Chondrosarcoma,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1
Chondrosarcoma,BRD-K39503511-001-03-9::2.5::HTS,5.07070181273105,0.024720202484995246,Chondrosarcoma,quiflapon,leukotriene synthesis inhibitor,"ALOX5, ALOX5AP"
Chondrosarcoma,BRD-K39733634-001-02-6::2.5::HTS,6.573969137778718,0.01060879809951521,Other Types,L-161982,prostanoid receptor antagonist,PTGER4
Chondrosarcoma,BRD-K39974922-001-04-3::2.5::HTS,4.144863476603009,0.04224321063478349,Other Types,lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR"
Chondrosarcoma,BRD-K40269473-001-02-2::2.5::HTS,6.520754127580828,0.010930404130724443,Other Types,cathepsin-inhibitor-1,cathepsin inhibitor,"CTSB, CTSL, CTSV"
Chondrosarcoma,BRD-K40302533-001-02-9::2.5::HTS,5.678443411695687,0.017507126870584745,Other Types,PF-5274857,smoothened receptor antagonist,SMO
Chondrosarcoma,BRD-K40438880-305-06-6::2.5::HTS,5.698862735629043,0.01734209742319226,Other Types,spermidine,glutamate receptor modulator,"KCNJ4, TXNRD1"
Chondrosarcoma,BRD-K40621224-001-06-7::2.5::HTS,5.253333244947441,0.022276241350652395,Other Types,pentetic-acid,chelating agent,PGD
Chondrosarcoma,BRD-K40654626-236-01-5::2.5::HTS,5.9532786823334645,0.015017883791733548,Other Types,ditiocarb-sodium-trihydrate,immunostimulant,"CA1, CA2, CA4"
Chondrosarcoma,BRD-K40758068-001-08-2::2.5::HTS,12.91275682013077,0.00035586233196141347,Other Types,efavirenz,HIV protease inhibitor,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4"
Chondrosarcoma,BRD-K40797222-001-01-8::2.5::HTS,8.505046526420962,0.003683536714283171,Other Types,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A
Chondrosarcoma,BRD-K40901640-003-01-6::2.5::HTS,3.938085039067183,0.04769385822308373,Other Types,cinanserin,serotonin receptor antagonist,HTR2A
Chondrosarcoma,BRD-K41024817-325-01-0::2.5::HTS,12.366774999248937,0.00047340037644417977,Chondrosarcoma,4-phenolsulfonic-acid,,
Chondrosarcoma,BRD-K41185545-001-02-3::2.5::HTS,4.565059931213641,0.033074410169224654,Other Types,ambrisentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Chondrosarcoma,BRD-K41298358-395-03-4::2.46::HTS,5.0515010391182065,0.025016628423863766,Other Types,tetraethylenepentamine,superoxide dismutase inhibitor,"SOD1, SOD2"
Chondrosarcoma,BRD-K41406082-001-16-2::2.5::HTS,8.574922860077843,0.0035476369944877247,Other Types,sulfapyridine,PABA antagonist,
Chondrosarcoma,BRD-K41410256-304-02-2::2.5::HTS,16.271437762636126,6.27081523734937e-05,Other Types,balsalazide,cyclooxygenase inhibitor,"ALOX5, PPARG, PTGS1, PTGS2"
Chondrosarcoma,BRD-K41779183-001-01-2::2.5::HTS,4.346908159075367,0.037528577561959486,Chondrosarcoma,CB-03-01,androgen receptor antagonist,AR
Chondrosarcoma,BRD-K42417338-045-01-9::2.5::HTS,3.9353922202236316,0.0477804808948863,Other Types,butorphanol-(+)-tartrate,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Chondrosarcoma,BRD-K42981054-001-01-9::2.5::HTS,4.51849860249171,0.033978443881532136,Chondrosarcoma,mibampator,glutamate receptor modulator,GRIA1
Chondrosarcoma,BRD-K43002771-034-01-6::2.5::HTS,12.061495837066033,0.0005555527664633008,Other Types,SR-33805,calcium channel blocker,
Chondrosarcoma,BRD-K43149758-001-22-7::2.5::HTS,7.126448978033004,0.007818334793618388,Other Types,myricetin,"androgen receptor agonist, cytochrome P450 inhibitor",PIK3CG
Chondrosarcoma,BRD-K43383936-001-05-2::2.5::HTS,7.253924513831196,0.007292096830662863,Chondrosarcoma,flopropione,serotonin receptor antagonist,HTR1A
Chondrosarcoma,BRD-K43389675-003-16-7::2.35::HTS,4.740606328802988,0.029900782132305372,Chondrosarcoma,daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B"
Chondrosarcoma,BRD-K43389698-001-09-9::2.4::HTS,4.328832026405455,0.03795348629624622,Chondrosarcoma,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Chondrosarcoma,BRD-K43457670-001-27-8::2.5::HTS,17.386984436885392,3.597709017274923e-05,Other Types,acetazolamide,carbonic anhydrase inhibitor,"AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7"
Chondrosarcoma,BRD-K43873574-001-01-8::2.5::HTS,4.726385609303832,0.03012132818896979,Other Types,ilepcimide,anticonvulsant,
Chondrosarcoma,BRD-K43887077-003-26-3::2.5::HTS,7.509526055193522,0.006338241809387099,Other Types,dopamine,dopamine receptor agonist,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-K44133266-001-10-0::2.5::HTS,11.834688171231104,0.0006264137581034274,Chondrosarcoma,sulbactam,beta lactamase inhibitor,
Chondrosarcoma,BRD-K44771174-066-01-0::2.5::HTS,3.8765537457940367,0.049471207114020053,Chondrosarcoma,ibutamoren,growth hormone secretagogue receptor agonist,"GHR, GHSR"
Chondrosarcoma,BRD-K44849676-001-10-5::2.5::HTS,4.488404409793835,0.03456678885918777,Other Types,capsazepine,TRPV agonist,"TRPV1, TRPV4"
Chondrosarcoma,BRD-K45158365-001-11-4::2.5::HTS,6.003476848055914,0.014590520480616142,Other Types,valsartan,angiotensin receptor antagonist,AGTR1
Chondrosarcoma,BRD-K45385835-001-02-4::2.5::HTS,10.209942672355657,0.0014756382249953477,Chondrosarcoma,SX-011,MAP kinase inhibitor,MAPK14
Chondrosarcoma,BRD-K45401373-001-20-9::2.5::HTS,3.988328427371643,0.04632926787076235,Chondrosarcoma,betulinic-acid,"apoptosis stimulant, NFkB pathway inhibitor",GPBAR1
Chondrosarcoma,BRD-K45435259-003-11-1::2.5::HTS,6.00083066243374,0.014604868189190491,Other Types,SCH-23390,dopamine receptor antagonist,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
Chondrosarcoma,BRD-K45542189-048-22-1::2.5::HTS,9.163216672907568,0.0025836774818417648,Chondrosarcoma,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Chondrosarcoma,BRD-K46018455-001-27-6::2.5::HTS,11.601167921855579,0.0007076108057783297,Other Types,bezafibrate,PPAR receptor agonist,"PPARA, PPARD, PPARG"
Chondrosarcoma,BRD-K46142322-003-02-4::2.5::HTS,13.89883961937731,0.00021256580307683621,Other Types,RS-67333,serotonin receptor partial agonist,HTR4
Chondrosarcoma,BRD-K46211610-003-26-7::2.5::HTS,5.989733258327882,0.014697130339599648,Other Types,tolazoline,adrenergic receptor antagonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2"
Chondrosarcoma,BRD-K46317332-003-17-8::2.5::HTS,3.9312465728762653,0.04788674002558707,Other Types,proadifen,nitric oxide synthase inhibitor,NOS1
Chondrosarcoma,BRD-K46839850-050-04-2::2.5::HTS,7.537738082806425,0.006241105316078116,Other Types,cinepazide,calcium channel activator,
Chondrosarcoma,BRD-K46982791-001-09-4::2.5::HTS,4.045734489886057,0.04476429501103255,Other Types,cloxyquin,potassium channel activator,KCNK18
Chondrosarcoma,BRD-K47079459-004-04-6::2.5::HTS,7.877131898898497,0.005185161001969736,Chondrosarcoma,cetrimonium,,
Chondrosarcoma,BRD-K47323024-003-24-4::2.5::HTS,7.530857127804346,0.006260332890843673,Other Types,methapyrilene,histamine receptor antagonist,HRH1
Chondrosarcoma,BRD-K47371940-001-01-6::2.5::HTS,5.822851824034625,0.01613940814664984,Chondrosarcoma,ecabapide,,
Chondrosarcoma,BRD-K47539947-001-03-7::2.5::HTS,13.942679809751288,0.00020785559458561697,Other Types,tetradecylthioacetic-acid,lipid peroxidase inhibitor,
Chondrosarcoma,BRD-K47631482-003-06-2::2.5::HTS,6.45067467658073,0.011363109013223288,Chondrosarcoma,bromhexine,mucolytic agent,
Chondrosarcoma,BRD-K47635719-001-21-1::2.5::HTS,7.765287819944888,0.0055066037979094925,Chondrosarcoma,dexamethasone-acetate,glucocorticoid receptor agonist,
Chondrosarcoma,BRD-K48168960-001-19-2::2.5::HTS,3.9082214901317327,0.04853876077399537,Other Types,propylthiouracil,thyroid peroxidase inhibitor,"DIO1, TPO"
Chondrosarcoma,BRD-K48812570-001-02-3::2.5::HTS,5.208015135649237,0.022866834203801988,Other Types,macitentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Chondrosarcoma,BRD-K48826825-001-01-8::2.5::HTS,8.357389646802169,0.003993265465938872,Chondrosarcoma,S26948,PPAR receptor agonist,PPARG
Chondrosarcoma,BRD-K48830578-001-01-9::2.5::HTS,6.793211483319133,0.009396786969323886,Other Types,OMDM-2,FAAH inhibitor,GPR119
Chondrosarcoma,BRD-K49236613-001-02-3::2.5::HTS,4.575114860785114,0.03287610761595889,Chondrosarcoma,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1
Chondrosarcoma,BRD-K49338325-001-03-4::2.5::HTS,5.7465374267927585,0.01685624961434307,Other Types,etofibrate,PPAR receptor agonist,PPARA
Chondrosarcoma,BRD-K49545903-003-01-4::2.5::HTS,7.317658102387753,0.007038177783924297,Chondrosarcoma,"4,4-pentamethylenepiperidine",M2 channel blocker,
Chondrosarcoma,BRD-K49738308-065-04-9::2.5::HTS,3.9339128386914504,0.0478392865836887,Other Types,agmatine,nitric oxide synthase inhibitor,"ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH"
Chondrosarcoma,BRD-K49962337-001-01-1::2.5::HTS,4.03160078618408,0.045133648130431164,Chondrosarcoma,baicalin,beta glucuronidase inhibitor,PREP
Chondrosarcoma,BRD-K50325075-001-02-1::2.5::HTS,5.718450313806288,0.017117796701364384,Chondrosarcoma,UCL-2077,slow afterhyperpolarization channel blocker,
Chondrosarcoma,BRD-K50631926-001-02-3::2.5::HTS,7.0722373480483345,0.008052032009300034,Other Types,PIK-294,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Chondrosarcoma,BRD-K50938786-003-11-8::2.5::HTS,7.570866291920368,0.006123677587211077,Chondrosarcoma,ropivacaine,sodium channel blocker,SCN10A
Chondrosarcoma,BRD-K51033547-003-02-6::2.5::HTS,7.179169255649618,0.007591623786130773,Other Types,tramadol,"norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor","CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4"
Chondrosarcoma,BRD-K51541829-050-01-0::2.5::HTS,5.44121003386328,0.020021011431041943,Chondrosarcoma,Ro-25-6981,,GRIN2B
Chondrosarcoma,BRD-K51662849-001-08-8::2.61::HTS,4.890709531679421,0.027430776985064142,Other Types,ilomastat,matrix metalloprotease inhibitor,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
Chondrosarcoma,BRD-K51671335-001-10-6::2.5::HTS,14.881010364474282,0.00012784562284492727,Other Types,levosulpiride,dopamine receptor antagonist,"CA1, CA12, CA7, DRD2, DRD3"
Chondrosarcoma,BRD-K51677086-001-12-0::2.5::HTS,3.9626667655155217,0.047024472278861716,Other Types,erythromycin-ethylsuccinate,"cytochrome P450 inhibitor, protein synthesis inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1"
Chondrosarcoma,BRD-K51751936-001-09-1::2.5::HTS,6.581521355620099,0.010562553928919555,Other Types,alfadolone-acetate,benzodiazepine receptor agonist,
Chondrosarcoma,BRD-K52219182-001-02-4::2.5::HTS,15.852673787348152,7.759394931141034e-05,Other Types,ICI-63197,phosphodiesterase inhibitor,
Chondrosarcoma,BRD-K52313696-001-12-3::2.5::HTS,4.208343700721948,0.040708321673312294,Other Types,tacedinaline,HDAC inhibitor,HDAC1
Chondrosarcoma,BRD-K52396582-001-06-7::2.5::HTS,18.515919965457,1.9903338676038287e-05,Other Types,CF102,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Chondrosarcoma,BRD-K52751261-001-06-1::2.5::HTS,4.089706282730847,0.04362256425067532,Chondrosarcoma,TAK-715,p38 MAPK inhibitor,MAPK14
Chondrosarcoma,BRD-K52911425-001-09-8::2.5::HTS,5.794723219490789,0.01639572294436087,Chondrosarcoma,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Chondrosarcoma,BRD-K52959329-238-01-9::2.5::HTS,9.904728330797703,0.0017358995495420115,Other Types,mitiglinide,insulin secretagogue,"ABCC8, KCNJ10, PPARG"
Chondrosarcoma,BRD-K52989797-003-26-4::2.5::HTS,11.669068147218464,0.0006813952219001061,Other Types,clomipramine,serotonin transporter (SERT) inhibitor,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4"
Chondrosarcoma,BRD-K53124401-001-03-8::0.03::HTS,6.696996867767285,0.00990952176013665,Other Types,LTB4,leukocyte activator,"LTB4R, LTB4R2"
Chondrosarcoma,BRD-K53205568-001-02-6::2.5::HTS,4.288145183733135,0.03883824616176578,Other Types,afalanine,dopamine receptor agonist,DRD2
Chondrosarcoma,BRD-K53234107-001-01-6::2.5::HTS,3.9324322978680724,0.047852360140937224,Other Types,IWP-L6,porcupine inhibitor,PORCN
Chondrosarcoma,BRD-K53397409-001-12-3::2.5::HTS,5.574014038592937,0.018569331668120574,Other Types,benzoic-acid,food preservative,"DAO, HRSP12, PRDX5, RAB9A"
Chondrosarcoma,BRD-K53734668-003-04-6::2.5::HTS,5.204503160475118,0.022903668268835473,Other Types,PRT062607,syk inhibitor,"FGR, MAP3K9, SYK"
Chondrosarcoma,BRD-K53737926-003-27-8::2.5::HTS,6.934332431733268,0.008688422797831215,Chondrosarcoma,amitriptyline,"norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin-norepinephrine reuptake inhibitor (SNRI)","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4"
Chondrosarcoma,BRD-K53814070-310-01-3::2.5::HTS,7.392962995554668,0.006756667088862418,Other Types,ripasudil,rho associated kinase inhibitor,"ROCK1, ROCK2"
Chondrosarcoma,BRD-K53852914-001-01-8::2.5::HTS,11.820525470737836,0.0006295161463259923,Other Types,menbutone,,
Chondrosarcoma,BRD-K54006094-051-01-7::2.5::HTS,6.510498660474088,0.010990431970663045,Other Types,formoterol,adrenergic receptor agonist,ADRB2
Chondrosarcoma,BRD-K54028654-001-02-6::2.5::HTS,12.754851700724648,0.00038686071427230666,Other Types,cabaletta,pharmacological chaperone,
Chondrosarcoma,BRD-K54142781-003-11-8::2.5::HTS,7.409672329322638,0.0066898099355350215,Other Types,cirazoline,adrenergic receptor agonist,ADRA1A
Chondrosarcoma,BRD-K54529596-001-26-3::2.5::HTS,4.4193135410753595,0.03600730196755898,Other Types,captopril,angiotensin converting enzyme inhibitor,"ACE, LTA4H, MMP2, MMP9"
Chondrosarcoma,BRD-K54665485-001-07-9::2.5::HTS,5.674999422411847,0.017542970838191212,Other Types,R-59022,"diacylglycerol kinase inhibitor, protein kinase inhibitor",DGKA
Chondrosarcoma,BRD-K54708045-001-02-1::2.5::HTS,7.690087540523231,0.005738492121405119,Other Types,nTZDpa,PPAR receptor agonist,PPARG
Chondrosarcoma,BRD-K54770957-001-04-3::2.5::HTS,7.284168169444085,0.0071719529019118634,Other Types,etoricoxib,cyclooxygenase inhibitor,PTGS2
Chondrosarcoma,BRD-K54790157-001-15-5::2.5::HTS,17.95243139416515,2.6504374711781588e-05,Other Types,trioxsalen,DNA synthesis inhibitor,
Chondrosarcoma,BRD-K54838207-001-02-0::2.5::HTS,4.154365028599621,0.04199496873837227,Other Types,fudosteine,mucolytic agent,
Chondrosarcoma,BRD-K54997624-001-06-0::2.5::HTS,4.05059335695472,0.04463231700339145,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Chondrosarcoma,BRD-K55044200-001-14-6::2.5::HTS,4.01369593956002,0.04564262728230521,Other Types,amoxicillin,penicillin binding protein inhibitor,"CYP2C19, SLC15A1, SLC15A2, SLC22A6"
Chondrosarcoma,BRD-K55127134-300-11-2::2.5::HTS,4.977839831734871,0.026071283375567418,Chondrosarcoma,fluphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7"
Chondrosarcoma,BRD-K55191674-237-18-3::2.5::HTS,13.07975091739987,0.0003256177284238563,Other Types,benzylpenicillin,penicillin binding protein inhibitor,
Chondrosarcoma,BRD-K55675242-001-03-0::2.5::HTS,19.332834849670416,1.3201994122895013e-05,Chondrosarcoma,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Chondrosarcoma,BRD-K56277358-001-07-5::2.5::HTS,6.978371219434893,0.008481427709460473,Other Types,MGCD-265,VEGFR inhibitor,"AXL, MET"
Chondrosarcoma,BRD-K56515112-001-21-6::2.5::HTS,8.804960839909901,0.0031331472262174117,Chondrosarcoma,medrysone,glucocorticoid receptor agonist,NR3C1
Chondrosarcoma,BRD-K56543881-001-02-7::2.5::HTS,10.265938078870972,0.001432446677841974,Other Types,ADX-47273,glutamate receptor modulator,GRM5
Chondrosarcoma,BRD-K56707426-001-02-0::2.5::HTS,5.714264687525138,0.017160623907854288,Other Types,nitarsone,,
Chondrosarcoma,BRD-K57222227-001-30-1::2.5::HTS,6.553150711120011,0.010731199982397096,Chondrosarcoma,indomethacin,cyclooxygenase inhibitor,"GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1"
Chondrosarcoma,BRD-K57275767-001-02-4::2.61::HTS,9.269312675308063,0.0024464676379948444,Other Types,geniposide,GLP receptor agonist,GLP1R
Chondrosarcoma,BRD-K57291914-003-09-4::2.5::HTS,4.551427549383079,0.03333081382749398,Other Types,moroxydine,antiviral,
Chondrosarcoma,BRD-K57631554-003-06-2::2.5::HTS,5.082393540687635,0.02455421563896782,Other Types,5-aminolevulinic-acid,oxidizing agent,ALAD
Chondrosarcoma,BRD-K58299615-001-03-5::2.5::HTS,9.902763102006627,0.0017437977024389226,Chondrosarcoma,Ro-90-7501,,APP
Chondrosarcoma,BRD-K58435339-001-03-0::2.5::HTS,4.285267121906806,0.03890188665515972,Chondrosarcoma,AT13387,HSP antagonist,HSP90AA1
Chondrosarcoma,BRD-K58648841-001-04-7::2.5::HTS,14.884118299206706,0.00012766542984919606,Other Types,cresopirine,,
Chondrosarcoma,BRD-K58685305-001-20-4::2.5::HTS,3.9768142029393476,0.04662128023104123,Chondrosarcoma,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1
Chondrosarcoma,BRD-K58794715-001-01-8::2.5::HTS,4.65887528731325,0.03132226334190004,Chondrosarcoma,bentiromide,,HPN
Chondrosarcoma,BRD-K58968598-001-03-6::2.5::HTS,7.283334623780749,0.007175236845958231,Other Types,sucralose,,
Chondrosarcoma,BRD-K59045783-001-01-1::2.5::HTS,8.473735436633602,0.0037480703824647747,Other Types,faropenem-medoxomil,lactamase inhibitor,
Chondrosarcoma,BRD-K59110290-238-01-7::2.5::HTS,13.64601468037101,0.00024235706845454348,Chondrosarcoma,fosamprenavir,HIV protease inhibitor,
Chondrosarcoma,BRD-K59204667-001-03-1::2.5::HTS,6.141716933372915,0.013497042153674267,Other Types,DBeQ,ATPase inhibitor,CASP3
Chondrosarcoma,BRD-K59333713-003-02-0::2.5::HTS,5.783352068777387,0.016503907523710715,Chondrosarcoma,niguldipine-(S)-(+),adrenergic receptor antagonist,ADRA1A
Chondrosarcoma,BRD-K59419204-001-02-7::2.5::HTS,5.162890050205008,0.023454820079300456,Other Types,AM-281,cannabinoid receptor antagonist,"CNR1, CNR2, GPR55"
Chondrosarcoma,BRD-K59506194-015-04-9::2.5::HTS,6.369022617572261,0.011888447528165749,Other Types,targinine,nitric oxide synthase inhibitor,NOS3
Chondrosarcoma,BRD-K59715032-362-01-4::2.5::HTS,7.011348875715433,0.008326899346637053,Chondrosarcoma,pasireotide,somatostatin receptor agonist,"SSTR1, SSTR2, SSTR3, SSTR5"
Chondrosarcoma,BRD-K60036103-003-01-6::2.5::HTS,5.164803017139096,0.02342924700560619,Chondrosarcoma,L-NIL,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Chondrosarcoma,BRD-K60237333-001-27-1::2.5::HTS,14.497256662996586,0.0001558048376274232,Chondrosarcoma,niacin,"NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT"
Chondrosarcoma,BRD-K61269089-001-05-5::2.5::HTS,8.639211234045206,0.003429241796853426,Other Types,daphnetin,protein kinase inhibitor,
Chondrosarcoma,BRD-K61585876-001-01-0::2.5::HTS,8.899181393034443,0.0029768287310566652,Other Types,3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,"GRM1, GRM5"
Chondrosarcoma,BRD-K62427771-001-01-0::2.5::HTS,4.871891065733023,0.027706763479951418,Other Types,AS-77,potassium channel blocker,"KCNA3, KCNA5, KCNN4"
Chondrosarcoma,BRD-K62581435-001-03-8::2.5::HTS,4.682002125465691,0.03090083268356174,Other Types,3-MPPI,adrenergic receptor ligand,ADRA1A
Chondrosarcoma,BRD-K62737565-003-02-6::2.5::HTS,5.279527738902233,0.02194736875138429,Other Types,gabapentin,calcium channel blocker,"ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Chondrosarcoma,BRD-K63001556-001-08-8::2.5::HTS,7.00480718665574,0.008359471596717101,Other Types,orbifloxacin,bacterial DNA gyrase inhibitor,
Chondrosarcoma,BRD-K63550407-001-13-5::2.5::HTS,4.81754484634513,0.02860609110009536,Other Types,erythromycin,NFkB pathway inhibitor,MLNR
Chondrosarcoma,BRD-K63915849-001-03-7::2.5::HTS,5.546730505922743,0.01886049643251059,Other Types,AS-604850,PI3K inhibitor,"PIK3CA, PIK3CG"
Chondrosarcoma,BRD-K63919159-003-07-0::2.5::HTS,4.686662249965465,0.030833377243362714,Other Types,aptiganel,glutamate receptor antagonist,GRIN1
Chondrosarcoma,BRD-K64054020-001-03-5::0.25::HTS,5.7571258779859384,0.01674942032512279,Other Types,epoprostenol,prostacyclin analog,"P2RY12, PTGER1, PTGER4, PTGIR, PTGIS"
Chondrosarcoma,BRD-K64341947-003-02-4::2.5::HTS,5.155573402302731,0.023552214817991985,Other Types,CFM-1571,guanylate cyclase activator,
Chondrosarcoma,BRD-K64422603-300-02-7::2.5::HTS,13.734595374175969,0.0002315303550012365,Other Types,N-alpha-Methylhistamine-dihydrochloride,histamine receptor agonist,HRH4
Chondrosarcoma,BRD-K64514229-001-05-2::2.5::HTS,5.271076337505728,0.02205313498343058,Other Types,toltrazuril,antiprotozoal agent,
Chondrosarcoma,BRD-K64835161-001-02-8::2.5::HTS,5.629852960258447,0.017994464998266183,Other Types,ML167,"CLK inhibitor, DYRK inhibitor","CLK4, DYRK1B"
Chondrosarcoma,BRD-K65503129-001-06-3::2.5::HTS,8.355802626835477,0.003995315291087598,Other Types,CCT018159,HSP inhibitor,"HSP90AA1, HSP90AB1"
Chondrosarcoma,BRD-K65667145-001-14-0::2.5::HTS,8.19381606785972,0.004379315956105513,Other Types,kinetin,cell division inducer,
Chondrosarcoma,BRD-K65716359-001-02-1::2.5::HTS,4.098483164291135,0.04340095769637848,Other Types,exifone,nootropic agent,TYR
Chondrosarcoma,BRD-K65814004-003-02-9::2.5::HTS,4.830099992885402,0.028380059301267763,Chondrosarcoma,diphenyleneiodonium,nitric oxide synthase inhibitor,"NOS2, NOS3"
Chondrosarcoma,BRD-K65890018-236-01-1::2.5::HTS,5.4010589477216575,0.0204827273023679,Other Types,SSR128129E,,
Chondrosarcoma,BRD-K66404838-310-01-1::2.5::HTS,4.871857687731476,0.027701458536276567,Other Types,nalbuphine,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1"
Chondrosarcoma,BRD-K66465025-001-05-1::2.5::HTS,13.940637373567991,0.00020807599508176875,Other Types,ACPC,glutamate receptor antagonist,
Chondrosarcoma,BRD-K66956375-001-11-3::2.5::HTS,8.583175311472086,0.003531088797539941,Chondrosarcoma,oleoylethanolamide,"cannabinoid receptor agonist, glucose dependent insulinotropic receptor agonist, potassium channel blocker, PPAR receptor agonist","CNR1, GPR119, GPR55, PPARA"
Chondrosarcoma,BRD-K67304264-001-08-5::2.5::HTS,7.514641210862862,0.006315817538976652,Other Types,SKA-31,potassium channel activator,KCNN4
Chondrosarcoma,BRD-K67525671-001-02-5::2.5::HTS,4.09139109699158,0.04358905876135935,Chondrosarcoma,ZK-200775,kainate receptor antagonist,
Chondrosarcoma,BRD-K67789209-001-01-0::2.5::HTS,18.292515823172167,2.2276006899769986e-05,Other Types,adatanserin,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR2A"
Chondrosarcoma,BRD-K67977190-066-02-3::2.5::HTS,7.313854157286462,0.007055997049117726,Chondrosarcoma,eprosartan,angiotensin receptor antagonist,AGTR1
Chondrosarcoma,BRD-K68095457-001-10-1::2.5::HTS,8.918304950483426,0.0029481027211539393,Chondrosarcoma,palmitoylethanolamide,cannabinoid receptor agonist,"CNR2, GPR119, GPR55"
Chondrosarcoma,BRD-K68938568-001-01-7::2.5::HTS,5.417075285926666,0.020296217302969502,Chondrosarcoma,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Chondrosarcoma,BRD-K69837166-003-02-0::2.5::HTS,12.211326604016557,0.000513568750983023,Other Types,trap-101,"nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist",OPRL1
Chondrosarcoma,BRD-K69907333-001-10-6::2.5::HTS,6.314414376050855,0.012272847743986197,Chondrosarcoma,flurbiprofen-(S)-(+),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K70053378-001-01-1::2.5::HTS,8.261367404231244,0.004209632571773722,Other Types,SM-108,,
Chondrosarcoma,BRD-K70163715-300-05-7::2.42::HTS,10.778481350697573,0.001095654013862252,Chondrosarcoma,vatalanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR, PDGFRB"
Chondrosarcoma,BRD-K70327191-001-02-2::2.5::HTS,10.502237614529657,0.001263478325851107,Other Types,benzoxiquine,antiinfective drug,
Chondrosarcoma,BRD-K70507123-001-09-7::2.5::HTS,7.293170960144743,0.007131175026695234,Other Types,doxofylline,adenosine receptor antagonist,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D"
Chondrosarcoma,BRD-K71035033-001-07-1::2.5::HTS,9.078043373412243,0.002703903320627337,Other Types,masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor","FGFR3, KIT, PDGFRA, PDGFRB"
Chondrosarcoma,BRD-K71125014-001-27-1::2.5::HTS,10.393904565125856,0.0013382003928063206,Other Types,sulphadimethoxine,dihydropteroate synthetase inhibitor,
Chondrosarcoma,BRD-K71799949-001-36-4::2.5::HTS,5.140312889124627,0.023756787350741767,Chondrosarcoma,carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Chondrosarcoma,BRD-K71847383-001-12-5::2.5::HTS,4.734863547713633,0.029980563995293343,Other Types,cytarabine,ribonucleotide reductase inhibitor,"POLA1, POLB, POLD1, POLE"
Chondrosarcoma,BRD-K71926323-001-14-6::2.52::HTS,5.382245043208552,0.02071597243969855,Chondrosarcoma,marbofloxacin,bacterial DNA gyrase inhibitor,
Chondrosarcoma,BRD-K72106461-001-02-1::2.5::HTS,3.904562826707974,0.048675282189441775,Chondrosarcoma,SYM-2081,kainate receptor antagonist,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2"
Chondrosarcoma,BRD-K72728560-001-01-4::2.5::HTS,6.106013419393207,0.013769851031662598,Other Types,dimetridazole,bacterial DNA inhibitor,
Chondrosarcoma,BRD-K73157543-001-04-1::2.5::HTS,11.081343162722794,0.000929630261392066,Other Types,phenyl-aminosalicylate,,
Chondrosarcoma,BRD-K73191876-001-11-2::2.5::HTS,6.267117566636064,0.012590739239824074,Other Types,alizarin,,
Chondrosarcoma,BRD-K73234506-235-02-1::2.5::HTS,4.515788049518248,0.034024580445968754,Other Types,lithium-acetoacetate,,
Chondrosarcoma,BRD-K73303757-001-21-6::2.5::HTS,12.410799447666687,0.0004620838608688294,Chondrosarcoma,4-methylgenistein,protein tyrosine kinase inhibitor,"CYP19A1, ESRRA, ESRRB, ESRRG, FASN"
Chondrosarcoma,BRD-K73391359-003-10-2::2.5::HTS,3.898045338976291,0.048838559373369964,Other Types,dimethisoquin,local anesthetic,
Chondrosarcoma,BRD-K73477617-001-08-5::2.5::HTS,6.401606290659053,0.011675653060583461,Other Types,dibutyl-phthalate,,TRPA1
Chondrosarcoma,BRD-K73529671-001-02-9::2.5::HTS,4.404446037776679,0.03632155653636458,Chondrosarcoma,troxerutin,antioxidant,
Chondrosarcoma,BRD-K73642618-001-13-3::2.5::HTS,4.445038873468762,0.03544878656669216,Other Types,bromopride,dopamine receptor antagonist,DRD2
Chondrosarcoma,BRD-K73771095-001-03-3::2.5::HTS,6.961669044610943,0.008561645838003788,Other Types,geniposidic-acid,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-K74065929-001-07-2::2.5::HTS,9.415988307690148,0.002254709767096986,Chondrosarcoma,doramapimod,p38 MAPK inhibitor,"MAPK11, MAPK12, MAPK13, MAPK14"
Chondrosarcoma,BRD-K74763371-002-04-0::2.5::HTS,4.94830431769478,0.02651267645793861,Other Types,bosentan,endothelin receptor antagonist,"EDNRA, EDNRB"
Chondrosarcoma,BRD-K75250001-001-01-3::2.5::HTS,5.453952756857437,0.01987631046738039,Chondrosarcoma,tiracizine,sodium channel blocker,SCN5A
Chondrosarcoma,BRD-K75282704-001-02-4::2.5::HTS,7.602810952625537,0.0060189418944313604,Chondrosarcoma,BL-5583,hypercalcaemic agent,
Chondrosarcoma,BRD-K75478907-001-02-3::2.5::HTS,9.85960618583084,0.0017795320922545045,Other Types,GS-39783,GABA receptor modulator,GABBR1
Chondrosarcoma,BRD-K75506300-001-01-6::2.5::HTS,5.249578117198579,0.022323901986093277,Other Types,NPS-2143,calcium receptor antagonist,CASR
Chondrosarcoma,BRD-K75868704-001-05-3::2.5::HTS,16.619481612120897,5.230695877494371e-05,Other Types,iopamidol,radiopaque medium,
Chondrosarcoma,BRD-K75923785-003-02-1::2.5::HTS,5.557708977395584,0.018751356014211275,Other Types,scopine,,
Chondrosarcoma,BRD-K76568384-001-02-2::2.5::HTS,6.012904855428098,0.014508001184133312,Other Types,PHTPP,estrogen receptor antagonist,ESR2
Chondrosarcoma,BRD-K76592088-001-02-1::2.5::HTS,8.75207309031088,0.003222667636645013,Other Types,3-carboxy-4-hydroxyphenylglycine-(R),glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C"
Chondrosarcoma,BRD-K77060810-001-01-5::2.5::HTS,4.200767355388138,0.04087179026276669,Other Types,AZD1283,purinergic receptor antagonist,P2RY12
Chondrosarcoma,BRD-K77554836-001-11-6::2.57::HTS,3.935395811494938,0.0477974515043911,Chondrosarcoma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Chondrosarcoma,BRD-K77554836-001-14-0::2.5::HTS,4.813738358832703,0.028654379537506398,Chondrosarcoma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Chondrosarcoma,BRD-K77625799-001-07-7::2.5::HTS,4.119843892888703,0.042853585927849394,Chondrosarcoma,vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA"
Chondrosarcoma,BRD-K77771411-003-10-7::2.5::HTS,4.510015247032642,0.034137046965811,Chondrosarcoma,moxonidine,imidazoline receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Chondrosarcoma,BRD-K78643075-001-11-6::2.5::HTS,14.367053514514426,0.00016678755514188404,Other Types,bromperidol,dopamine receptor antagonist,DRD2
Chondrosarcoma,BRD-K78666826-003-01-6::2.5::HTS,9.686890469219351,0.001951061526647215,Other Types,procaterol,adrenergic receptor agonist,ADRB2
Chondrosarcoma,BRD-K78815826-001-14-6::2.5::HTS,6.088755234406024,0.013903489743599336,Other Types,suxibuzone,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-K79425933-001-09-3::2.5::HTS,4.531922775997565,0.03370871036173469,Other Types,benperidol,dopamine receptor antagonist,DRD2
Chondrosarcoma,BRD-K79612754-001-19-1::2.62::HTS,6.3091585507303165,0.012308841679681227,Other Types,inosine,neurotrophic agent,"PARP1, PNP"
Chondrosarcoma,BRD-K79884267-001-01-4::2.5::HTS,8.152569725846584,0.004461161664451409,Other Types,retinaldehyde,,
Chondrosarcoma,BRD-K80129304-001-08-1::2.5::HTS,5.708244753016833,0.017223855552051307,Chondrosarcoma,uracil,,"DPYD, UCKL1"
Chondrosarcoma,BRD-K80262108-001-07-0::2.5::HTS,7.801624431060338,0.005398790640519939,Other Types,amifampridine,potassium channel blocker,
Chondrosarcoma,BRD-K80267133-001-19-3::2.5::HTS,7.673932746728501,0.005799727183279553,Other Types,aminosalicylate,cyclooxygenase inhibitor,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2"
Chondrosarcoma,BRD-K80653534-001-01-7::2.5::HTS,9.074348929671245,0.0027116571046152506,Other Types,N-acetyl-D-glucosamine,,"B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP"
Chondrosarcoma,BRD-K81016934-001-02-0::2.5::HTS,10.97569101241213,0.0009850923869495212,Chondrosarcoma,INC-280,c-Met inhibitor,MET
Chondrosarcoma,BRD-K81330143-001-04-8::2.38::HTS,7.725488803329586,0.005638765892453732,Other Types,tideglusib,glycogen synthase kinase inhibitor,GSK3B
Chondrosarcoma,BRD-K81332461-001-01-4::2.5::HTS,4.732047834207315,0.03003948348119998,Chondrosarcoma,maxacalcitol,vitamin D receptor agonist,VDR
Chondrosarcoma,BRD-K81572616-001-01-9::2.5::HTS,13.583820996762329,0.0002503629327930656,Chondrosarcoma,CK-636,actin related protein inhibitor,"ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5"
Chondrosarcoma,BRD-K81613478-001-01-8::2.5::HTS,9.11062739449129,0.0026581925057513538,Chondrosarcoma,gastrodin,,
Chondrosarcoma,BRD-K81645907-001-01-1::2.5::HTS,4.533427493809209,0.03370105362230533,Chondrosarcoma,captamine,,
Chondrosarcoma,BRD-K81795818-019-01-4::2.5::HTS,5.642184775830914,0.017877655198022067,Other Types,exherin,cadherin antagonist,CDH2
Chondrosarcoma,BRD-K81807412-001-10-6::2.5::HTS,12.244580513698246,0.0005046950794712587,Other Types,N6-methyladenosine,,
Chondrosarcoma,BRD-K82091397-001-03-0::2.5::HTS,4.588542654271894,0.0326216752729246,Chondrosarcoma,SB-239063,p38 MAPK inhibitor,"MAPK11, MAPK14, PTGS2"
Chondrosarcoma,BRD-K82255054-001-15-9::2.5::HTS,5.040936806044915,0.025145878421516752,Other Types,propofol,benzodiazepine receptor agonist,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A"
Chondrosarcoma,BRD-K82343404-003-02-4::2.5::HTS,21.807430905249372,3.803731815456415e-06,Other Types,adrenalone,adrenergic receptor agonist,ADRA1A
Chondrosarcoma,BRD-K82357231-001-17-5::2.5::HTS,12.076383038509189,0.0005501194411461647,Other Types,desloratadine,histamine receptor antagonist,HRH1
Chondrosarcoma,BRD-K82467063-001-02-7::2.5::HTS,4.421442152939794,0.03595313794057385,Other Types,SB-271046,serotonin receptor antagonist,HTR6
Chondrosarcoma,BRD-K82484965-003-03-5::2.5::HTS,4.893402303425618,0.027364517119492227,Other Types,carmoxirole,dopamine receptor agonist,DRD2
Chondrosarcoma,BRD-K82522873-001-01-1::2.5::HTS,12.833580721241148,0.00037087665945445764,Other Types,N6022,alcohol dehydrogenase inhibitor,ADH5
Chondrosarcoma,BRD-K82767007-001-01-1::2.5::HTS,5.040735857648344,0.02515737653632954,Other Types,dazoxiben,thromboxane synthase inhibitor,TBXAS1
Chondrosarcoma,BRD-K82823076-001-02-6::2.5::HTS,8.586115751670725,0.0035269900150819594,Other Types,Ro-15-4513,,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2"
Chondrosarcoma,BRD-K82941592-238-04-5::2.5::HTS,7.229792657101163,0.007392304915921676,Other Types,rosuvastatin,HMGCR inhibitor,HMGCR
Chondrosarcoma,BRD-K82960980-003-02-7::2.36::HTS,4.34681089238938,0.037558157151591,Other Types,ceftiofur,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K83023055-001-02-7::2.5::HTS,3.934157973468322,0.04780364534938361,Other Types,GR-135531,melatonin receptor agonist,
Chondrosarcoma,BRD-K83189926-001-03-1::2.5::HTS,8.862762016654845,0.0030358518442329535,Other Types,UNC1215,L3MBTL antagonist,L3MBTL3
Chondrosarcoma,BRD-K83322645-050-01-9::2.5::HTS,6.645294243622249,0.010197161445669263,Chondrosarcoma,L-693403,"sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1"
Chondrosarcoma,BRD-K83551379-001-01-8::2.5::HTS,10.110239418238256,0.0015633866926574704,Other Types,levodropropizine,antitussive,
Chondrosarcoma,BRD-K84011460-051-01-7::2.5::HTS,8.852905848612936,0.003057459350639438,Chondrosarcoma,nizofenone,ion channel antagonist,
Chondrosarcoma,BRD-K84794093-001-07-5::2.5::HTS,7.68097917597399,0.005773403659817357,Chondrosarcoma,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,
Chondrosarcoma,BRD-K84810405-003-01-1::2.5::HTS,8.620198262858501,0.003467022788003483,Chondrosarcoma,almorexant,orexin receptor antagonist,"HCRTR1, HCRTR2"
Chondrosarcoma,BRD-K84895041-001-02-4::2.5::HTS,7.4027644136912665,0.006714839014870382,Other Types,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR
Chondrosarcoma,BRD-K84925803-001-01-9::2.5::HTS,3.863883847117574,0.049842363487783946,Other Types,T-5224,AP inhibitor,JUN
Chondrosarcoma,BRD-K85178109-001-02-3::2.5::HTS,5.450581146807194,0.019915591438557968,Other Types,fostamatinib,SYK inhibitor,SYK
Chondrosarcoma,BRD-K85307935-236-09-5::2.5::HTS,4.642311871083824,0.03163531658380467,Other Types,novobiocin,bacterial DNA gyrase inhibitor,
Chondrosarcoma,BRD-K85333151-003-13-4::2.5::HTS,5.629366654984086,0.01801196662452654,Other Types,ramifenazone,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-K85554912-001-06-3::2.5::HTS,7.113634773111458,0.007885675507355453,Other Types,ivermectin,benzodiazepine receptor agonist,"CHRNA7, GABRB3, GLRA3, P2RX7"
Chondrosarcoma,BRD-K86294588-001-01-9::2.5::HTS,7.536320563323636,0.006240236820099619,Chondrosarcoma,schisandrin-b,antioxidant,ATR
Chondrosarcoma,BRD-K86307448-001-17-5::2.5::HTS,5.987575369118733,0.014725248489163952,Chondrosarcoma,allopurinol,xanthine oxidase inhibitor,XDH
Chondrosarcoma,BRD-K87202646-061-04-9::2.5::HTS,6.1619065851965,0.01334659519990432,Chondrosarcoma,pasiniazid,cyclooxygenase inhibitor,
Chondrosarcoma,BRD-K87696786-003-04-4::2.5::HTS,9.861123641170607,0.00177809086291492,Chondrosarcoma,LY456236,glutamate receptor antagonist,GRM1
Chondrosarcoma,BRD-K87737963-001-06-0::2.5::HTS,4.719796040883706,0.030237470137453225,Other Types,cyt387,,"JAK1, JAK2, JAK3"
Chondrosarcoma,BRD-K87782578-001-01-4::2.5::HTS,7.131697223070783,0.007793776823774833,Other Types,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,"BTK, YES1"
Chondrosarcoma,BRD-K88366685-300-06-0::2.5::HTS,5.404484971558808,0.0204423156963622,Other Types,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2
Chondrosarcoma,BRD-K88405679-003-03-1::2.5::HTS,12.89639596102298,0.0003583109239871684,Other Types,thonzylamine,antihistamine,
Chondrosarcoma,BRD-K88611939-001-22-4::2.5::HTS,6.197935016658028,0.01307952854325932,Other Types,aniracetam,glutamate receptor agonist,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A"
Chondrosarcoma,BRD-K88646909-004-16-2::2.5::HTS,10.69917886298324,0.001138102405952382,Chondrosarcoma,arecoline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Chondrosarcoma,BRD-K88742110-001-07-9::2.5::HTS,7.2677544148203514,0.007233755177163219,Other Types,PCI-34051,HDAC inhibitor,"HDAC1, HDAC10, HDAC6, HDAC8"
Chondrosarcoma,BRD-K89056082-001-07-7::2.5::HTS,4.7249903503329405,0.03014781991419134,Other Types,chlorocresol,ryanodine receptor activator,
Chondrosarcoma,BRD-K89272762-001-12-7::2.5::HTS,4.565699668564621,0.033049511720484814,Chondrosarcoma,NPPB,chloride channel blocker,"ANO1, CLCN2, CLCN7, TRPA1"
Chondrosarcoma,BRD-K89274813-001-02-3::2.5::HTS,7.593769015333027,0.006048096443905948,Chondrosarcoma,DMP-543,acetylcholine release enhancer,
Chondrosarcoma,BRD-K89997465-003-43-0::2.5::HTS,4.091349114468536,0.04357879895575077,Other Types,chlorpromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5"
Chondrosarcoma,BRD-K90168339-001-08-6::2.5::HTS,6.934356160470408,0.00868998720345825,Other Types,thiophanate,,
Chondrosarcoma,BRD-K90497590-001-04-2::2.5::HTS,5.697260099761682,0.017325913873368286,Chondrosarcoma,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1
Chondrosarcoma,BRD-K91315211-300-05-7::2.5::HTS,17.372932652157736,3.5589900712585315e-05,Other Types,betahistine,"histamine receptor agonist, histamine receptor antagonist","HRH1, HRH3"
Chondrosarcoma,BRD-K91509126-001-23-6::2.5::HTS,4.581088990226776,0.032756437371352524,Other Types,piceatannol,SYK inhibitor,"ATP5A1, ATP5B, ATP5C1, IRF3"
Chondrosarcoma,BRD-K91544578-001-03-8::2.5::HTS,6.228753132188673,0.01285529891812154,Other Types,nikethamide,immunostimulant,
Chondrosarcoma,BRD-K91758890-001-10-0::2.5::HTS,6.213981850272368,0.012963853898363428,Other Types,4-HQN,PARP inhibitor,PARP1
Chondrosarcoma,BRD-K91904471-001-02-4::2.5::HTS,4.329943765689795,0.0379130233282521,Other Types,SD-169,p38 MAPK inhibitor,MAPK14
Chondrosarcoma,BRD-K92015269-300-01-2::2.5::HTS,4.0569055909403975,0.044473882128645045,Chondrosarcoma,GBR-12783,dopamine uptake inhibitor,
Chondrosarcoma,BRD-K92041145-001-09-5::2.5::HTS,6.559636012284366,0.010693089706812728,Other Types,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Chondrosarcoma,BRD-K92213669-001-01-3::2.5::HTS,7.9607191145758796,0.004965673056832464,Chondrosarcoma,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP
Chondrosarcoma,BRD-K92657060-001-05-7::2.5::HTS,10.36692983253702,0.0013569892282710668,Chondrosarcoma,zaleplon,benzodiazepine receptor agonist,"GABRA1, GABRB1, GABRG2, TSPO"
Chondrosarcoma,BRD-K92976206-001-01-5::2.5::HTS,6.290502806876039,0.012423397966326162,Chondrosarcoma,guanosine,,PNP
Chondrosarcoma,BRD-K93188295-300-02-2::2.5::HTS,13.312163011149696,0.0002883819001941378,Other Types,ARC-239,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C"
Chondrosarcoma,BRD-K93441486-067-12-8::2.5::HTS,7.527617389187332,0.006270047128172414,Chondrosarcoma,diphemanil,acetylcholine receptor antagonist,CHRM3
Chondrosarcoma,BRD-K93460210-001-23-7::2.5::HTS,5.69090376122087,0.01738452035009817,Other Types,lamotrigine,"serotonin receptor antagonist, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Chondrosarcoma,BRD-K93524252-001-24-7::2.5::HTS,4.424822824583692,0.035869224504235825,Other Types,sulfamerazine,bacterial antifolate,
Chondrosarcoma,BRD-K93611241-001-02-2::2.5::HTS,6.190966120629948,0.013131074880824644,Chondrosarcoma,diacetamate,,
Chondrosarcoma,BRD-K93618743-001-21-0::2.5::HTS,5.474824108991005,0.019645826293448812,Chondrosarcoma,ipriflavone,bone resorption inhibitor,
Chondrosarcoma,BRD-K93645900-001-11-3::2.5::HTS,12.894832251427891,0.0003583374781304136,Chondrosarcoma,tadalafil,phosphodiesterase inhibitor,"PDE11A, PDE5A"
Chondrosarcoma,BRD-K93754473-048-20-2::2.5::HTS,7.525285655226295,0.0062784071894964434,Other Types,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
Chondrosarcoma,BRD-K94455792-001-01-8::2.5::HTS,6.353092868964166,0.011995420366453067,Other Types,ICG-001,beta-catenin inhibitor,CTNNB1
Chondrosarcoma,BRD-K94832621-001-02-3::2.5::HTS,5.949198147253291,0.015034571829067101,Other Types,Y-134,estrogen receptor antagonist,"ESR1, ESR2"
Chondrosarcoma,BRD-K95309561-001-24-7::2.5::HTS,5.6416821086229,0.01787590537113788,Other Types,dienestrol,estrogen receptor agonist,ESR1
Chondrosarcoma,BRD-K95600043-001-01-5::2.5::HTS,11.734291484612887,0.0006586452576965589,Other Types,NPY-5RA972,neuropeptide receptor antagonist,NPY5R
Chondrosarcoma,BRD-K95609758-001-03-7::2.5::HTS,6.495771342749207,0.011079793550182824,Other Types,BMS-191011,potassium channel activator,KCNMA1
Chondrosarcoma,BRD-K95785345-300-14-8::2.5::HTS,4.341142592546213,0.03765322830686106,Other Types,thiamine,vitamin B,"SLC19A2, SLC19A3, TPK1"
Chondrosarcoma,BRD-K95828359-001-01-0::2.5::HTS,9.329671307171926,0.0023621537504775357,Other Types,MK-3697,orexin receptor antagonist,HCRTR2
Chondrosarcoma,BRD-K95837862-300-01-7::2.5::HTS,8.269804338122436,0.004184656594279351,Other Types,JDTic,opioid receptor antagonist,OPRK1
Chondrosarcoma,BRD-K95957366-001-02-6::2.5::HTS,4.549597412233698,0.033362210992917404,Other Types,isaxonine,nerve growth factor agonist,
Chondrosarcoma,BRD-K96615647-001-01-2::2.5::HTS,5.588778007188264,0.01841502024809325,Other Types,AV-608,tachykinin antagonist,TACR1
Chondrosarcoma,BRD-K96671969-001-03-1::2.5::HTS,5.100513859632416,0.024302720229407725,Other Types,PA-824,nitric oxide donor,FASN
Chondrosarcoma,BRD-K96714749-001-01-0::2.5::HTS,13.678066170445154,0.0002384319366833944,Chondrosarcoma,isobutamben,local anesthetic,
Chondrosarcoma,BRD-K96720755-001-02-6::2.5::HTS,9.218616872345509,0.002507088987007073,Other Types,relcovaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2, OXTR"
Chondrosarcoma,BRD-K96758128-001-01-8::2.5::HTS,6.009335451727849,0.014535951736586415,Other Types,WAY-213613,glutamate inhibitor,SLC1A2
Chondrosarcoma,BRD-K96862998-001-15-5::2.5::HTS,5.51834765270464,0.01916330450311338,Chondrosarcoma,pirfenidone,TGF beta receptor inhibitor,"FURIN, TNF"
Chondrosarcoma,BRD-K97028990-001-04-4::2.5::HTS,7.21602435013439,0.007445575126083097,Chondrosarcoma,quinine-ethyl-carbonate,,
Chondrosarcoma,BRD-K97045029-001-02-7::2.5::HTS,5.622724774986614,0.018065830798535597,Other Types,pranlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF"
Chondrosarcoma,BRD-K97072811-001-11-4::2.5::HTS,3.88190245918669,0.04930233542925196,Other Types,TG-003,CLK inhibitor,"CLK1, CLK4, DYRK1A, DYRK1B"
Chondrosarcoma,BRD-K97118047-001-03-8::2.5::HTS,8.604175849372913,0.0034914681214824354,Other Types,"4,5,6,7-tetrabromobenzotriazole",casein kinase inhibitor,"AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1"
Chondrosarcoma,BRD-K98143539-001-02-2::2.5::HTS,4.197099856964752,0.04096043053901721,Other Types,compound-w,beta-secretase inhibitor,BACE1
Chondrosarcoma,BRD-K98251413-001-04-0::2.5::HTS,5.852023386507938,0.01587567295561945,Chondrosarcoma,IOX2,hypoxia inducible factor inhibitor,"EGLN1, KDM2A, KDM5C"
Chondrosarcoma,BRD-K98453471-001-01-7::2.5::HTS,5.6846598403188775,0.01744764128384499,Other Types,salirasib,mTOR inhibitor,TRPA1
Chondrosarcoma,BRD-K99048103-001-18-4::2.5::HTS,3.866788050446667,0.04974592090312073,Other Types,acetarsol,,
Chondrosarcoma,BRD-M54096567-001-01-9::2.5::HTS,10.39949815388626,0.0013384900961885995,Other Types,sodium-gluconate,,
Chondrosarcoma,BRD-M92352362-002-02-3::2.5::HTS,9.439064536164478,0.002233698683949288,Chondrosarcoma,talc,,
Chondrosarcoma,BRD-A04971881-003-01-3::2.65294603::MTS004,7.367511551544295,0.006854402591556484,Other Types,cloranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Chondrosarcoma,BRD-A23418262-001-01-5::2.519094866::MTS004,6.781888685259984,0.009462753280235008,Chondrosarcoma,floctafenine,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-A31362467-065-01-3::2.499984736::MTS004,5.878791007276853,0.01565267751514862,Chondrosarcoma,capreomycin,protein synthesis inhibitor,
Chondrosarcoma,BRD-A40546373-001-01-8::2.500029443::MTS004,4.298255291911557,0.03862600525546355,Other Types,morinidazole,other antibiotic,CYP51A1
Chondrosarcoma,BRD-A42881122-001-01-1::2.648380541::MTS004,7.8732344742465745,0.005198870701983917,Chondrosarcoma,cyamemazine,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C, HTR7"
Chondrosarcoma,BRD-A44181516-001-01-8::2.666476303::MTS004,6.106849242046819,0.013774518910237106,Other Types,flumecinol,,
Chondrosarcoma,BRD-A50675490-001-01-0::2.412483069::MTS004,4.551675035888111,0.033337470126857706,Other Types,carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Chondrosarcoma,BRD-A63431791-001-01-9::2.5::MTS004,6.273110107196362,0.012552509909862727,Other Types,sulbactam-pivoxil,beta lactamase inhibitor,
Chondrosarcoma,BRD-A73385064-001-01-5::2.603473418::MTS004,5.612391195208757,0.018185402573462052,Chondrosarcoma,beclomethasone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Chondrosarcoma,BRD-A75975749-001-01-4::2.5::MTS004,4.080355614349485,0.04387966119602378,Chondrosarcoma,bafetinib,"Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor","ABL1, BCR, LYN"
Chondrosarcoma,BRD-A91444184-300-01-9::2.5::MTS004,3.8703090650115834,0.04965987528590179,Other Types,buclizine,histamine receptor antagonist,"CHRM1, HRH1"
Chondrosarcoma,BRD-A99899486-004-01-9::2.293696319::MTS004,4.737033310735817,0.029953329740805355,Chondrosarcoma,cimetropium,acetylcholine receptor antagonist,CHRM1
Chondrosarcoma,BRD-K00739965-001-01-9::2.675904798::MTS004,4.849970182632664,0.028070079898663138,Other Types,guacetisal,immunosuppressant,
Chondrosarcoma,BRD-K01666412-001-02-0::2.5::MTS004,8.310254507247636,0.004099507883596752,Chondrosarcoma,L-proline,glutamate receptor agonist,"EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7"
Chondrosarcoma,BRD-K01773083-001-01-4::2.303758671::MTS004,5.799949695316177,0.01636193422540373,Other Types,denotivir,antiviral,
Chondrosarcoma,BRD-K07070922-001-01-4::2.5::MTS004,4.723733220562117,0.03018374456455102,Other Types,PF-03049423,phosphodiesterase inhibitor,PDE5A
Chondrosarcoma,BRD-K09821361-066-25-8::2.499990088::MTS004,4.346572797557403,0.037553558513801946,Other Types,deferoxamine-mesylate,chelating agent,
Chondrosarcoma,BRD-K10415035-001-04-4::2.5::MTS004,5.413930600599988,0.020346348218953772,Chondrosarcoma,tasuldine,mucolytic agent,
Chondrosarcoma,BRD-K10995081-001-27-9::2.316458322::MTS004,14.247376532048007,0.00017807824809014565,Chondrosarcoma,perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7"
Chondrosarcoma,BRD-K14571191-001-01-6::2.5::MTS004,6.512833489903945,0.010984623511831399,Chondrosarcoma,zometapine,,
Chondrosarcoma,BRD-K14681867-001-01-6::2.5::MTS004,4.301293927598102,0.038557620488130585,Chondrosarcoma,somatostatin,somatostatin receptor agonist,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
Chondrosarcoma,BRD-K15360631-325-01-4::2.404560312::MTS004,4.6713895137648365,0.03110953533113443,Chondrosarcoma,dehydroepiandrosterone-sulfate,"androgen receptor agonist, estrogen receptor agonist","AR, ESR1, ESR2"
Chondrosarcoma,BRD-K18898553-001-01-1::2.5::MTS004,6.782295833069187,0.009460622496444495,Chondrosarcoma,salvianolic-acid-B,"metalloproteinase inhibitor, EGFR inhibitor",MMP9
Chondrosarcoma,BRD-K19515365-001-02-6::2.33859482::MTS004,5.551301628843872,0.018824661653802467,Other Types,bendazac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K21612934-001-01-1::2.473727942::MTS004,8.04092928722998,0.004745326591384766,Other Types,leteprinim,nerve growth factor agonist,
Chondrosarcoma,BRD-K22588750-001-07-0::2.654665484::MTS004,3.878767286134385,0.04941309220882785,Other Types,gidazepam,GABA benzodiazepine site receptor agonist,
Chondrosarcoma,BRD-K24452555-001-01-7::2.599377769::MTS004,6.553117924486698,0.010741629853215404,Chondrosarcoma,methylprednisolone-aceponate,"anti-inflammatory agent, glucocorticoid receptor agonist",NR3C1
Chondrosarcoma,BRD-K24476327-001-01-3::2.50002878::MTS004,6.205038992941347,0.013039056372328557,Other Types,icaritin,PPAR receptor antagonist,PDE5A
Chondrosarcoma,BRD-K24610819-003-01-8::2.33438271::MTS004,4.875051245825798,0.027668717473479276,Other Types,amibegron,adrenergic receptor agonist,ADRB3
Chondrosarcoma,BRD-K26818574-305-07-6::2.5::MTS004,4.271908789556705,0.039224310920894845,Chondrosarcoma,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Chondrosarcoma,BRD-K27798832-001-01-5::2.350625651::MTS004,8.38647173927517,0.003933940974258386,Chondrosarcoma,cefetamet,bacterial cell wall synthesis inhibitor,
Chondrosarcoma,BRD-K28687144-001-08-7::2.5::MTS004,5.98327552684765,0.014760783837426236,Chondrosarcoma,fosfosal,phosphodiesterase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K29626940-001-01-5::2.682001852::MTS004,5.828724720532636,0.016099299942560003,Other Types,imidafenacin,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Chondrosarcoma,BRD-K29812331-011-01-7::2.472474424::MTS004,5.6929790191863985,0.017377778978445113,Other Types,dimemorfan,sigma receptor agonist,SIGMAR1
Chondrosarcoma,BRD-K32891457-001-15-5::2.719791572::MTS004,4.607421612218911,0.032279520802883314,Chondrosarcoma,cortodoxone,androgen receptor antagonist,AR
Chondrosarcoma,BRD-K34251960-036-01-6::2.459743274::MTS004,4.280856718120466,0.03902002564610975,Chondrosarcoma,cibenzoline,sodium channel blocker,
Chondrosarcoma,BRD-K35304636-001-01-0::2.5::MTS004,6.305416610980292,0.012328433460875005,Chondrosarcoma,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Chondrosarcoma,BRD-K36741660-001-01-1::2.499963039::MTS004,9.131361496568939,0.0026326705127924627,Chondrosarcoma,verinurad,urate transporter inhibitor,SLC22A12
Chondrosarcoma,BRD-K39560679-001-01-1::2.500010466::MTS004,12.972742741189698,0.0003452831882583412,Chondrosarcoma,eluxadoline,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Chondrosarcoma,BRD-K41267922-001-01-4::2.5::MTS004,6.915207407574883,0.00879071899424406,Chondrosarcoma,F351,TGF beta receptor inhibitor,TGFB1
Chondrosarcoma,BRD-K43975632-001-01-1::2.499995729::MTS004,7.363077218925328,0.006870694906158431,Chondrosarcoma,terutroban,prostanoid receptor antagonist,TBXA2R
Chondrosarcoma,BRD-K44471774-001-01-8::2.670187358::MTS004,7.327166896435176,0.007007402854734074,Chondrosarcoma,bay-w-9798,antioxidant,
Chondrosarcoma,BRD-K47929404-001-01-0::2.500019706::MTS004,4.828880733794693,0.028412268435270976,Other Types,vercirnon,CC chemokine receptor antagonist,CCR9
Chondrosarcoma,BRD-K50010139-001-02-3::2.5::MTS004,3.9321628424279997,0.04787813017277346,Chondrosarcoma,poziotinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Chondrosarcoma,BRD-K50122911-001-01-2::2.5::MTS004,9.326853918729412,0.0023697702751936263,Chondrosarcoma,boronophenylalanine,,
Chondrosarcoma,BRD-K50660797-001-05-1::2.499989832::MTS004,6.310758877326748,0.012291778854685279,Chondrosarcoma,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,"BACE1, FASN"
Chondrosarcoma,BRD-K53156626-001-01-3::2.5::MTS004,4.887767737904551,0.027466732271042835,Chondrosarcoma,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE
Chondrosarcoma,BRD-K54863166-001-01-9::2.693644572::MTS004,5.913843385944175,0.015347020660482713,Chondrosarcoma,darusentan,endothelin receptor antagonist,EDNRA
Chondrosarcoma,BRD-K54907283-001-01-2::2.4999956::MTS004,14.160849185777932,0.00018627200705952123,Other Types,AKBA,lipoxygenase inhibitor,ALOX5
Chondrosarcoma,BRD-K58810291-001-16-2::2.564588683::MTS004,8.611479523497085,0.003482855146154356,Chondrosarcoma,clobetasone-butyrate,corticosteroid agonist,NR3C1
Chondrosarcoma,BRD-K59895502-001-01-9::2.591975371::MTS004,3.8851974482377156,0.04922563272457356,Chondrosarcoma,caramiphen,cholinergic receptor antagonist,"CHRM1, CHRM2"
Chondrosarcoma,BRD-K60798049-001-03-8::2.665505334::MTS004,5.004256682050839,0.02569311462937474,Chondrosarcoma,fanetizole,neutrophil superoxide production,
Chondrosarcoma,BRD-K61496577-001-19-4::2.5::MTS004,4.4524589284280385,0.03531210240373428,Chondrosarcoma,flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B"
Chondrosarcoma,BRD-K62040061-001-01-0::2.500015381::MTS004,5.2473039485152295,0.02236668294787819,Other Types,toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB"
Chondrosarcoma,BRD-K65498798-001-01-7::2.5::MTS004,3.8762790363904567,0.04948488313798435,Other Types,abametapir,metalloproteinase inhibitor,MMP9
Chondrosarcoma,BRD-K67186445-001-02-1::2.500004874::MTS004,8.538948137487584,0.0036223765728904526,Chondrosarcoma,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE
Chondrosarcoma,BRD-K67628093-001-01-9::2.500004949::MTS004,4.616558481500172,0.03211033214719516,Other Types,INCB-3284,CC chemokine receptor antagonist,CCR2
Chondrosarcoma,BRD-K74236984-001-04-8::2.5::MTS004,4.862210299421253,0.027873452418285753,Chondrosarcoma,UNC0321,histone lysine methyltransferase inhibitor,EHMT2
Chondrosarcoma,BRD-K75445017-001-01-1::2.5::MTS004,5.259236566159258,0.022214638928245607,Chondrosarcoma,estetrol,selective estrogen receptor modulator (SERM),ESR1
Chondrosarcoma,BRD-K79710622-001-02-9::2.5::MTS004,6.527599284087091,0.010895417989682169,Other Types,GKT137831,NADPH oxidase inhibitor,"NOX1, NOX4"
Chondrosarcoma,BRD-K80859331-001-01-5::2.5::MTS004,6.941704305515005,0.008663554908689934,Chondrosarcoma,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Chondrosarcoma,BRD-K82118441-001-03-7::2.646883368::MTS004,9.670354641851224,0.0019718238072346786,Other Types,pyrantel,nicotinic receptor agonist,
Chondrosarcoma,BRD-K84173274-001-01-6::2.5::MTS004,6.200615307734429,0.013070742867159934,Chondrosarcoma,ufenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Chondrosarcoma,BRD-K84868168-001-01-0::2.500006364::MTS004,5.456339172433388,0.01986388610541752,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Chondrosarcoma,BRD-K89413285-074-01-5::2.500023482::MTS004,10.46655161410723,0.0012902461022541497,Other Types,remimazolam,benzodiazepine receptor agonist,GABBR1
Chondrosarcoma,BRD-K89490285-001-08-1::2.521612095::MTS004,5.854908154491232,0.015863492126104002,Chondrosarcoma,bentazepam,benzodiazepine receptor agonist,
Chondrosarcoma,BRD-K91405252-001-01-9::2.500076093::MTS004,6.541616925482617,0.010810942784548621,Other Types,MK-0354,niacin receptor agonist,"HCAR2, HCAR3"
Chondrosarcoma,BRD-K91543828-001-02-0::2.500044381::MTS004,11.046172602844416,0.000949067020731685,Chondrosarcoma,pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA
Chondrosarcoma,BRD-K92490248-001-06-6::2.500037393::MTS004,3.976978392533406,0.04662952130967891,Other Types,anethole-trithione,glutathione transferase stimulant,
Chondrosarcoma,BRD-K96344439-002-02-7::2.500011072::MTS004,4.316322532687884,0.03822214728268348,Other Types,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK
Chondrosarcoma,BRD-K96471533-001-09-0::2.592774962::MTS004,6.6156810718926575,0.010375162803796498,Chondrosarcoma,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
Chondrosarcoma,BRD-K96734425-304-01-7::2.500007729::MTS004,4.460844618746041,0.035139777084292674,Chondrosarcoma,ceftriaxone,bacterial cell wall synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A00218260-001-03-4::2.5::HTS,4.983633498698129,0.025987070262754715,Uterine Sarcoma/Mesenchymal,flutrimazole,sterol demethylase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A01643550-001-04-9::2.5::HTS,6.054985299971406,0.014179554320640803,Other Types,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
Uterine Sarcoma/Mesenchymal,BRD-A04661934-001-02-9::2.5::HTS,8.48811808816728,0.0037169308604257222,Other Types,2-PMDQ,adrenergic receptor antagonist,ADRA1A
Uterine Sarcoma/Mesenchymal,BRD-A06916187-001-02-9::2.5::HTS,4.610913476709101,0.03220002019549055,Other Types,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1
Uterine Sarcoma/Mesenchymal,BRD-A07947329-001-01-4::2.5::HTS,12.839363703501176,0.0003688710092084599,Other Types,buparvaquone,antiprotozoal agent,
Uterine Sarcoma/Mesenchymal,BRD-A08715367-001-01-7::2.87::HTS,7.120693454487111,0.007843147418258088,Other Types,L-Theanine,glutamate receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-A09094913-065-01-0::2.5::HTS,8.183215153497615,0.004386646000428894,Uterine Sarcoma/Mesenchymal,strychnine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB"
Uterine Sarcoma/Mesenchymal,BRD-A09735281-001-02-5::2.5::HTS,4.747680667558657,0.02975395420747081,Other Types,boceprevir,HCV inhibitor,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS"
Uterine Sarcoma/Mesenchymal,BRD-A10903566-003-07-7::2.5::HTS,11.556118597717452,0.0007252496570915234,Other Types,imiloxan,adrenergic receptor antagonist,"ADRA2A, ADRA2B"
Uterine Sarcoma/Mesenchymal,BRD-A18233884-003-02-7::2.5::HTS,5.848166133969977,0.015915900125749647,Uterine Sarcoma/Mesenchymal,bevantolol,adrenergic receptor antagonist,"ADRA1A, ADRB1, ADRB2"
Uterine Sarcoma/Mesenchymal,BRD-A22032524-074-06-5::2.5::HTS,4.224339758345947,0.040309674177908206,Other Types,amlodipine,calcium channel blocker,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1"
Uterine Sarcoma/Mesenchymal,BRD-A22081593-001-11-1::2.5::HTS,7.179437039409141,0.007599788742830064,Other Types,sulmazole,adenosine receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-A23603052-001-03-2::2.5::HTS,7.915538718072557,0.005074267765621675,Other Types,rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3"
Uterine Sarcoma/Mesenchymal,BRD-A24191444-046-02-1::2.5::HTS,6.545256856175117,0.010781202614768193,Other Types,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Uterine Sarcoma/Mesenchymal,BRD-A28970875-300-04-9::2.5::HTS,4.922794523020932,0.026920386541155,Other Types,puromycin,protein synthesis inhibitor,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
Uterine Sarcoma/Mesenchymal,BRD-A29700858-304-02-6::2.5::HTS,5.176210477628912,0.023273968670291554,Other Types,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3"
Uterine Sarcoma/Mesenchymal,BRD-A33692381-001-01-9::2.5::HTS,12.792549402529403,0.00037844967396177706,Other Types,zidovudine,nucleoside reverse transcriptase inhibitor,TERT
Uterine Sarcoma/Mesenchymal,BRD-A35588707-001-05-5::2.5::HTS,7.2418651176209075,0.0073358517986992005,Other Types,teniposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Uterine Sarcoma/Mesenchymal,BRD-A41450521-075-10-8::2.5::HTS,4.2225438832716575,0.04036039776467819,Other Types,tosufloxacin,bacterial DNA gyrase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A43435802-001-02-0::2.5::HTS,11.499336109140204,0.0007451283048941903,Other Types,mercaptosuccinic-acid,,
Uterine Sarcoma/Mesenchymal,BRD-A44500574-001-01-8::2.5::HTS,4.095473211436461,0.043474265248748284,Other Types,FLI-06,notch signaling inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A46813902-001-01-6::2.5::HTS,4.535111513431025,0.03364254993839227,Uterine Sarcoma/Mesenchymal,iododexetimide,acetylcholine receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-A47790386-001-03-6::2.61::HTS,4.593357025991891,0.03257800067069825,Other Types,balofloxacin,bacterial DNA gyrase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A49160188-003-12-7::2.5::HTS,5.660454946250949,0.01769056711206763,Other Types,donepezil,acetylcholinesterase inhibitor,"ACHE, HTR2A"
Uterine Sarcoma/Mesenchymal,BRD-A49172652-001-27-1::2.5::HTS,4.513116608908422,0.034074934469628955,Uterine Sarcoma/Mesenchymal,lansoprazole,ATPase inhibitor,"ATP4A, ATP4B"
Uterine Sarcoma/Mesenchymal,BRD-A50737080-001-03-0::2.5::HTS,5.784986028951679,0.016488150535802607,Other Types,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR"
Uterine Sarcoma/Mesenchymal,BRD-A50922295-001-01-3::2.5::HTS,3.874160477720111,0.049525935769042045,Uterine Sarcoma/Mesenchymal,valganciclovir,DNA synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A55424491-001-19-9::2.5::HTS,4.4628692378043535,0.03508849361162731,Other Types,methotrexate,dihydrofolate reductase inhibitor,DHFR
Uterine Sarcoma/Mesenchymal,BRD-A58048407-001-18-8::2.5::HTS,4.118087234224423,0.04289776984671619,Other Types,nimodipine,calcium channel blocker,"AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2"
Uterine Sarcoma/Mesenchymal,BRD-A64406146-001-01-2::2.5::HTS,3.9793083515109804,0.04655458981570608,Other Types,timofibrate,"cholesterol inhibitor, lipase clearing factor inhibitor",LPL
Uterine Sarcoma/Mesenchymal,BRD-A65797496-048-09-3::2.5::HTS,4.8508771048861075,0.028037346904004733,Other Types,deptropine,histamine receptor antagonist,HRH1
Uterine Sarcoma/Mesenchymal,BRD-A71033472-003-23-9::2.5::HTS,5.13194271417183,0.02387328209390698,Uterine Sarcoma/Mesenchymal,fendiline,calcium channel blocker,HTR2B
Uterine Sarcoma/Mesenchymal,BRD-A71262238-001-08-4::2.5::HTS,5.9205687816558275,0.015280391533543927,Other Types,nafadotride,dopamine receptor antagonist,"DRD2, DRD3, HTR1A"
Uterine Sarcoma/Mesenchymal,BRD-A71774530-001-05-9::2.5::HTS,5.138170495888447,0.023787214760746318,Uterine Sarcoma/Mesenchymal,lufenuron,chitin inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A75140635-003-10-9::2.5::HTS,8.629265884272169,0.003444188761081024,Other Types,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",,
Uterine Sarcoma/Mesenchymal,BRD-A75850590-213-01-0::2.5::HTS,9.00817832930426,0.0028131689362466804,Uterine Sarcoma/Mesenchymal,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A
Uterine Sarcoma/Mesenchymal,BRD-A79768653-001-12-0::2.5::HTS,4.524481457747901,0.03385597238081184,Other Types,sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR"
Uterine Sarcoma/Mesenchymal,BRD-A80213327-305-08-3::2.5::HTS,3.8989862233407884,0.04880874003328046,Other Types,NSC-23766,Ras GTPase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A84575140-001-02-4::2.5::HTS,6.093679158157512,0.01387181488161092,Other Types,pimobendan,"calcium sensitizer, phosphodiesterase inhibitor",PDE3A
Uterine Sarcoma/Mesenchymal,BRD-A87479750-001-02-7::2.5::HTS,4.29092612298789,0.038775275224229494,Uterine Sarcoma/Mesenchymal,tenidap,cyclooxygenase inhibitor,"KCNJ4, PTGS1"
Uterine Sarcoma/Mesenchymal,BRD-A90272038-001-01-7::2.5::HTS,4.465984011313138,0.035021067778500385,Other Types,CGP-37849,glutamate receptor antagonist,"GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Uterine Sarcoma/Mesenchymal,BRD-A92630576-050-24-1::2.5::HTS,5.816994818057791,0.016191526699552525,Other Types,trimebutine,opioid receptor agonist,"OPRD1, OPRK1, OPRM1"
Uterine Sarcoma/Mesenchymal,BRD-A97104540-004-15-0::2.5::HTS,4.221440212197821,0.04037972519420528,Uterine Sarcoma/Mesenchymal,fenoterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Uterine Sarcoma/Mesenchymal,BRD-K00337317-001-06-6::2.5::HTS,5.1066349066578915,0.024219291444370492,Other Types,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
Uterine Sarcoma/Mesenchymal,BRD-K00494077-066-01-9::2.5::HTS,4.968363689130014,0.026226513402817602,Other Types,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A
Uterine Sarcoma/Mesenchymal,BRD-K00911807-003-01-2::2.5::HTS,8.69766251526994,0.0033199579000751985,Uterine Sarcoma/Mesenchymal,D-Phenylalanine,enkephalinase inhibitor,"CCBL1, CRH, HCAR3"
Uterine Sarcoma/Mesenchymal,BRD-K01669786-001-02-2::2.5::HTS,6.163925804269172,0.013347724042074495,Other Types,triapine,ribonucleotide reductase inhibitor,"RRM1, RRM2"
Uterine Sarcoma/Mesenchymal,BRD-K02637541-001-18-0::2.5::HTS,4.568393353952308,0.03300424770441113,Other Types,celecoxib,cyclooxygenase inhibitor,"CA12, PDPK1, PTGS2"
Uterine Sarcoma/Mesenchymal,BRD-K02867583-300-08-9::2.5::HTS,4.428821451032249,0.03578678405392314,Other Types,minaprine,serotonin reuptake inhibitor,"ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4"
Uterine Sarcoma/Mesenchymal,BRD-K02898090-001-02-7::2.5::HTS,8.643897717326736,0.00342057102706049,Other Types,kifunensine,mannosidase inhibitor,"MAN1B1, MAN2A1"
Uterine Sarcoma/Mesenchymal,BRD-K03063480-001-05-8::2.5::HTS,4.273004971014405,0.039179687702559265,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Uterine Sarcoma/Mesenchymal,BRD-K03063480-001-06-6::2.42::HTS,8.052266061293414,0.004719442828328417,Other Types,PF-477736,CHK inhibitor,"CHEK1, CHEK2"
Uterine Sarcoma/Mesenchymal,BRD-K03194791-001-04-8::2.5::HTS,10.71271345124912,0.0011303281028962797,Other Types,roflumilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Uterine Sarcoma/Mesenchymal,BRD-K03243820-001-23-8::2.37::HTS,8.176792248213514,0.004410793287931293,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Uterine Sarcoma/Mesenchymal,BRD-K03243820-001-25-3::2.5::HTS,7.1121272581608475,0.007883526943728942,Other Types,trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS
Uterine Sarcoma/Mesenchymal,BRD-K03289534-001-01-4::2.5::HTS,4.689433685185495,0.030773907157827463,Uterine Sarcoma/Mesenchymal,lersivirine,non-nucleoside reverse transcriptase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K04552268-001-02-4::5::HTS,5.651082699393601,0.01779259106809942,Other Types,4-pyrimidinecarbonitrile,,
Uterine Sarcoma/Mesenchymal,BRD-K04956647-003-02-5::2.5::HTS,4.267565270116274,0.039308437920278196,Other Types,nebivolol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Uterine Sarcoma/Mesenchymal,BRD-K05878375-236-05-7::2.5::HTS,3.929304701296472,0.04796953090793835,Uterine Sarcoma/Mesenchymal,sodium-butyrate,HDAC inhibitor,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8"
Uterine Sarcoma/Mesenchymal,BRD-K06753942-001-14-5::2.5::HTS,4.3103593483189995,0.03834152481688969,Other Types,nobiletin,MEK inhibitor,MAP2K1
Uterine Sarcoma/Mesenchymal,BRD-K06878038-001-18-6::2.5::HTS,5.371424812675496,0.020832704650063257,Other Types,deferiprone,chelating agent,UGT1A6
Uterine Sarcoma/Mesenchymal,BRD-K07265709-003-05-6::2.61::HTS,3.9388162864803027,0.04770110650237777,Other Types,dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B"
Uterine Sarcoma/Mesenchymal,BRD-K07753030-003-17-6::2.5::HTS,4.361264057157806,0.037218548663000645,Uterine Sarcoma/Mesenchymal,acecainide,polarization inhibitor,SCN5A
Uterine Sarcoma/Mesenchymal,BRD-K07881437-001-04-6::2.41::HTS,8.553684372888483,0.0035964149731835806,Other Types,danusertib,"Aurora kinase inhibitor, growth factor receptor inhibitor","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK"
Uterine Sarcoma/Mesenchymal,BRD-K08893438-001-04-9::2.52::HTS,8.36280252759171,0.003990745694143699,Other Types,CCG-50014,G protein signaling inhibitor,"RGS4, RGS8"
Uterine Sarcoma/Mesenchymal,BRD-K10362825-001-03-4::2.5::HTS,4.27430023173053,0.03917954677232404,Other Types,teniposide,topoisomerase inhibitor,"TOP2A, TOP2B"
Uterine Sarcoma/Mesenchymal,BRD-K10673031-004-02-0::2.5::HTS,5.120303030319233,0.024030339384531738,Uterine Sarcoma/Mesenchymal,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Uterine Sarcoma/Mesenchymal,BRD-K11215326-001-03-7::2.31::HTS,6.84524376717736,0.009142271629820996,Other Types,tazemetostat,histone lysine methyltransferase inhibitor,EZH2
Uterine Sarcoma/Mesenchymal,BRD-K11292736-300-02-8::2.5::HTS,5.622640569123386,0.01807095857954336,Uterine Sarcoma/Mesenchymal,ambenonium,cholinesterase inhibitor,ACHE
Uterine Sarcoma/Mesenchymal,BRD-K11510141-001-01-8::2.5::HTS,6.712957806838576,0.009821381958416692,Uterine Sarcoma/Mesenchymal,teprenone,mucus protecting agent,
Uterine Sarcoma/Mesenchymal,BRD-K11672787-001-01-5::2.5::HTS,6.0189492462510445,0.014457290342044696,Uterine Sarcoma/Mesenchymal,rostafuroxine,ATPase inhibitor,ATP1A1
Uterine Sarcoma/Mesenchymal,BRD-K12040459-001-06-0::2.5::HTS,5.3393407931354355,0.021213730486649186,Other Types,AT7867,AKT inhibitor,"AKT2, GSK3B, PKIA, PRKACA"
Uterine Sarcoma/Mesenchymal,BRD-K12068470-001-04-1::2.5::HTS,4.38546891677446,0.03669386087803852,Other Types,LY2608204,glucokinase activator,GCK
Uterine Sarcoma/Mesenchymal,BRD-K12079898-001-02-6::2.5::HTS,5.409434408468979,0.020386289057413826,Other Types,PD-160170,neuropeptide receptor antagonist,NPY1R
Uterine Sarcoma/Mesenchymal,BRD-K12251893-065-04-7::2.5::HTS,6.444259941089731,0.01140372719258381,Other Types,vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB"
Uterine Sarcoma/Mesenchymal,BRD-K12829205-003-02-8::2.5::HTS,9.583188505023296,0.00206788197346818,Other Types,mechlorethamine,DNA inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K13238168-001-02-0::2.5::HTS,5.577888241748779,0.018528709718143143,Other Types,haloprogin,other antifungal,
Uterine Sarcoma/Mesenchymal,BRD-K13296708-001-05-8::2.5::HTS,10.386184427821851,0.0013442472673782467,Other Types,rimonabant,cannabinoid receptor antagonist,"CNR1, GPR55"
Uterine Sarcoma/Mesenchymal,BRD-K13511380-001-01-4::2.5::HTS,5.225904535088057,0.022629527445539716,Uterine Sarcoma/Mesenchymal,naringin-dihydrochalcone,cytochrome P450 inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K13994703-003-15-8::2.5::HTS,9.622056874895248,0.0020204552538507967,Other Types,propranolol-(S),adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1"
Uterine Sarcoma/Mesenchymal,BRD-K14763542-001-02-3::2.5::HTS,6.007009577457969,0.014572358508256033,Other Types,flurothyl,,
Uterine Sarcoma/Mesenchymal,BRD-K14765469-003-12-2::2.5::HTS,4.522417843353579,0.03388936771921939,Other Types,vesamicol,acetylcholinesterase inhibitor,SLC18A3
Uterine Sarcoma/Mesenchymal,BRD-K15108141-001-06-6::2.5::HTS,4.428228416614599,0.03581165714663916,Other Types,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Uterine Sarcoma/Mesenchymal,BRD-K15601958-001-03-9::2.5::HTS,4.76726655052706,0.029420941521119175,Other Types,SEW-2871,lysophospholipid receptor agonist,S1PR1
Uterine Sarcoma/Mesenchymal,BRD-K16195444-003-26-0::2.5::HTS,8.49409366070535,0.0037054386894500406,Other Types,oxymetazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C"
Uterine Sarcoma/Mesenchymal,BRD-K17294426-050-12-3::2.5::HTS,8.927639987787638,0.002931522091167208,Other Types,clebopride,dopamine receptor antagonist,"ACHE, DRD2"
Uterine Sarcoma/Mesenchymal,BRD-K18613660-001-05-5::2.5::HTS,4.260890528227675,0.03946361573290978,Other Types,mexeneone,,
Uterine Sarcoma/Mesenchymal,BRD-K19462402-003-24-6::2.5::HTS,13.180958919950807,0.0003090270492942953,Other Types,buflomedil,"adrenergic receptor antagonist, calcium channel blocker",ADRA1A
Uterine Sarcoma/Mesenchymal,BRD-K19741547-003-01-7::2.5::HTS,4.371176780881105,0.03701952152507733,Other Types,vernakalant,potassium channel blocker,KCNA5
Uterine Sarcoma/Mesenchymal,BRD-K20001883-001-02-7::2.5::HTS,7.34633956351142,0.006928233096664735,Other Types,apabetalone,apolipoprotein expression enhancer,BRD3
Uterine Sarcoma/Mesenchymal,BRD-K20313525-001-04-6::2.5::HTS,5.653753968983872,0.017751520831902137,Other Types,rosmarinic-acid,GABA transaminase inhibitor,"MCL1, TYR"
Uterine Sarcoma/Mesenchymal,BRD-K20338176-001-17-7::2.5::HTS,7.5758980853127875,0.006108222519611681,Uterine Sarcoma/Mesenchymal,cefaclor,bacterial cell wall synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K22134346-001-24-9::2.42::HTS,4.602267797081096,0.03238514725341173,Other Types,simvastatin,HMGCR inhibitor,"HMGCR, ITGB2"
Uterine Sarcoma/Mesenchymal,BRD-K23677682-003-01-2::2.5::HTS,4.708685427631157,0.030428796048584596,Other Types,voreloxin,topoisomerase inhibitor,TOP2A
Uterine Sarcoma/Mesenchymal,BRD-K23922020-075-02-9::2.5::HTS,8.248342451902117,0.004233125115198418,Other Types,arecaidine-propargyl-ester,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Uterine Sarcoma/Mesenchymal,BRD-K24219278-001-01-6::2.5::HTS,5.351110798884333,0.02107436201095481,Other Types,amineptine,dopamine receptor agonist,"SLC6A2, SLC6A4"
Uterine Sarcoma/Mesenchymal,BRD-K24507548-001-01-8::2.5::HTS,4.649846237743808,0.0314798754803831,Other Types,cintriamide,,
Uterine Sarcoma/Mesenchymal,BRD-K24548560-342-02-1::2.5::HTS,4.042712399174317,0.04483962659111878,Uterine Sarcoma/Mesenchymal,evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1"
Uterine Sarcoma/Mesenchymal,BRD-K25015158-001-01-2::2.5::HTS,4.124929585912549,0.04273273566472807,Other Types,limaprost-alfadex,prostanoid receptor agonist,PTGER1
Uterine Sarcoma/Mesenchymal,BRD-K25596805-001-01-8::2.5::HTS,6.384752732605045,0.011787729545433856,Other Types,JNJ-16259685,glutamate receptor antagonist,GRM1
Uterine Sarcoma/Mesenchymal,BRD-K26548821-003-10-5::2.5::HTS,4.014732607405043,0.04558819914041772,Uterine Sarcoma/Mesenchymal,quinpirol-(-),dopamine receptor agonist,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C"
Uterine Sarcoma/Mesenchymal,BRD-K26573499-300-02-1::2.5::HTS,18.17125875657841,2.3712443623065382e-05,Other Types,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7
Uterine Sarcoma/Mesenchymal,BRD-K26712974-001-01-5::2.5::HTS,4.705433726235934,0.030485914086838737,Other Types,VX-765,caspase inhibitor,CASP1
Uterine Sarcoma/Mesenchymal,BRD-K26901728-001-06-2::2.5::HTS,5.975801266072778,0.014811298457704621,Uterine Sarcoma/Mesenchymal,lumiracoxib,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Uterine Sarcoma/Mesenchymal,BRD-K27799744-001-02-8::2.52::HTS,5.386383487476452,0.020674477219529305,Other Types,cyclovirobuxin-d,calcium channel modulator,
Uterine Sarcoma/Mesenchymal,BRD-K28360340-001-08-3::2.31::HTS,16.973542368184017,4.399713564050837e-05,Other Types,TW-37,BCL inhibitor,"BCL2, BCL2L1, MCL1"
Uterine Sarcoma/Mesenchymal,BRD-K28570407-001-02-0::2.5::HTS,5.441431887369921,0.02002234517114266,Other Types,A-803467,sodium channel blocker,SCN10A
Uterine Sarcoma/Mesenchymal,BRD-K28690501-001-02-1::2.5::HTS,4.825131723457135,0.028461231382898255,Other Types,diosgenin,steroid,
Uterine Sarcoma/Mesenchymal,BRD-K28824103-001-02-8::2.5::HTS,6.863841945857888,0.009048834285158042,Other Types,genipin,choleretic agent,
Uterine Sarcoma/Mesenchymal,BRD-K29395450-001-06-8::2.5::HTS,7.251758506772788,0.007296454128631182,Other Types,PIK-93,PI3K inhibitor,"PI4KB, PIK3C3, PIK3CG"
Uterine Sarcoma/Mesenchymal,BRD-K29735307-001-02-9::2.5::HTS,3.9037064006362683,0.04866841296434267,Uterine Sarcoma/Mesenchymal,ostarine,androgen receptor modulator,AR
Uterine Sarcoma/Mesenchymal,BRD-K29918010-003-04-1::2.5::HTS,3.897453725734094,0.04885296097760809,Uterine Sarcoma/Mesenchymal,glucosamine,glycosylated protein precursor,"IFNG, IL1B, MMP9, NFKB2, TNF"
Uterine Sarcoma/Mesenchymal,BRD-K29968218-001-03-2::2.5::HTS,4.236642396941604,0.040027467213380144,Other Types,KX2-391,"src inhibitor, tubulin polymerization inhibitor",SRC
Uterine Sarcoma/Mesenchymal,BRD-K30572193-001-02-0::2.5::HTS,8.842105416243625,0.0030698577132874543,Other Types,CTEP,glutamate receptor antagonist,GRM5
Uterine Sarcoma/Mesenchymal,BRD-K30652337-004-02-1::2.5::HTS,6.023939326474672,0.014416372020794599,Other Types,eletriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7"
Uterine Sarcoma/Mesenchymal,BRD-K30933884-001-01-0::2.5::HTS,6.656255715007122,0.010134913834623978,Other Types,UNBS-5162,CC chemokine receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-K31054881-300-04-7::2.5::HTS,5.023529858395891,0.025396810888438728,Uterine Sarcoma/Mesenchymal,BMY-7378,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A"
Uterine Sarcoma/Mesenchymal,BRD-K31476763-001-01-5::2.5::HTS,6.5153647020009835,0.010962205220513077,Other Types,AZD9668,elastase inhibitor,ELANE
Uterine Sarcoma/Mesenchymal,BRD-K32821942-001-21-3::2.5::HTS,4.508169945959894,0.034171226955216905,Other Types,azathioprine,dehydrogenase inhibitor,"HPRT1, IMPDH1, PPAT"
Uterine Sarcoma/Mesenchymal,BRD-K34022604-001-06-6::2.5::HTS,4.911100303151598,0.02708585657932779,Other Types,clofarabine,ribonucleotide reductase inhibitor,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Uterine Sarcoma/Mesenchymal,BRD-K34185671-001-02-8::2.5::HTS,4.407294941293097,0.036237379219235824,Uterine Sarcoma/Mesenchymal,AMG-517,TRPV antagonist,TRPV1
Uterine Sarcoma/Mesenchymal,BRD-K34608650-001-02-4::2.5::HTS,7.914132837862113,0.0050797378996997175,Other Types,GP2a,cannabinoid receptor agonist,CNR2
Uterine Sarcoma/Mesenchymal,BRD-K34801930-001-01-9::2.5::HTS,7.93001510038216,0.005033782152749072,Uterine Sarcoma/Mesenchymal,AZD5069,CC chemokine receptor antagonist,CXCR2
Uterine Sarcoma/Mesenchymal,BRD-K36116267-001-15-3::2.5::HTS,8.779669628722207,0.003176192035099941,Uterine Sarcoma/Mesenchymal,pyrithyldione,psychoactive drug,
Uterine Sarcoma/Mesenchymal,BRD-K36970462-001-01-6::2.5::HTS,5.069930598286363,0.024733889485306085,Other Types,tonabersat,"gap junction modulator, nitric oxide production inhibitor",
Uterine Sarcoma/Mesenchymal,BRD-K37069697-001-01-3::2.5::HTS,5.120383016566683,0.024034108361708266,Other Types,fexinidazole,,
Uterine Sarcoma/Mesenchymal,BRD-K37688416-003-13-1::2.5::HTS,3.881696362859251,0.049310115762885784,Other Types,fipexide,psychoactive drug,
Uterine Sarcoma/Mesenchymal,BRD-K39252998-003-01-5::2.5::HTS,4.155166016158054,0.041988978473428015,Uterine Sarcoma/Mesenchymal,atipamezole,adrenergic receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-K39467894-001-05-9::2.5::HTS,5.882220140592277,0.015611330028754478,Other Types,nithiamide,bacterial DNA inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K39670393-303-02-1::2.5::HTS,4.403846316030448,0.03630367331163212,Other Types,amthamine,histamine receptor agonist,HRH2
Uterine Sarcoma/Mesenchymal,BRD-K40255344-001-17-6::2.5::HTS,4.750008258568187,0.029712601602418783,Other Types,tyrphostin-A9,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor",
Uterine Sarcoma/Mesenchymal,BRD-K40496271-396-01-1::2.34::HTS,9.30097870589837,0.0024052670700890114,Other Types,eltrombopag,thrombopoietin receptor agonist,MPL
Uterine Sarcoma/Mesenchymal,BRD-K41024817-325-01-0::2.5::HTS,6.21367527784547,0.012971928532843211,Other Types,4-phenolsulfonic-acid,,
Uterine Sarcoma/Mesenchymal,BRD-K41160163-001-06-8::2.5::HTS,10.739818320178626,0.0011134885825421139,Other Types,fenobam,glutamate receptor antagonist,GRM5
Uterine Sarcoma/Mesenchymal,BRD-K42679050-001-02-1::2.5::HTS,4.376406203899918,0.036901048156114086,Uterine Sarcoma/Mesenchymal,Y-27152,potassium channel activator,KCNJ8
Uterine Sarcoma/Mesenchymal,BRD-K42859542-001-03-3::2.5::HTS,6.0944234174372145,0.01385998933298102,Other Types,CFM-2,glutamate receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-K43002771-034-01-6::2.5::HTS,4.1130819291935685,0.043037749136455215,Other Types,SR-33805,calcium channel blocker,
Uterine Sarcoma/Mesenchymal,BRD-K44067360-001-30-3::2.5::HTS,5.618376723327945,0.018124052667919454,Other Types,flufenamic-acid,chloride channel blocker,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5"
Uterine Sarcoma/Mesenchymal,BRD-K44844162-001-01-6::2.5::HTS,5.044024250854519,0.025105771833076662,Other Types,taselisib,PI3K inhibitor,PIK3CA
Uterine Sarcoma/Mesenchymal,BRD-K45435259-003-11-1::2.5::HTS,5.157920206184622,0.02352002847043329,Other Types,SCH-23390,dopamine receptor antagonist,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
Uterine Sarcoma/Mesenchymal,BRD-K45479396-050-01-5::2.5::HTS,4.45337151493178,0.03527368648050891,Other Types,BP-554,serotonin receptor agonist,HTR1A
Uterine Sarcoma/Mesenchymal,BRD-K45746021-003-01-9::2.5::HTS,3.9279212761165168,0.04798616206853535,Other Types,CC-401,JNK inhibitor,MAPK8
Uterine Sarcoma/Mesenchymal,BRD-K47000838-001-01-6::1.04::HTS,6.714198822379365,0.009823952721017102,Other Types,cytochalasin-b,microtubule inhibitor,ACTB
Uterine Sarcoma/Mesenchymal,BRD-K48692744-001-02-0::2.5::HTS,7.835753092102376,0.005301790375681319,Other Types,NU-1025,PARP inhibitor,PARP1
Uterine Sarcoma/Mesenchymal,BRD-K48888725-001-01-9::2.5::HTS,5.511976462749389,0.01924269613053555,Other Types,CG-400549,FABI inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K49055432-001-04-2::2.5::HTS,8.569355293223403,0.003558081643074737,Other Types,A66,PI3K inhibitor,PIK3CA
Uterine Sarcoma/Mesenchymal,BRD-K49371609-003-03-8::2.5::HTS,4.318097955461842,0.038168922224088346,Other Types,PIK-75,"DNA protein kinase inhibitor, PI3K inhibitor","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
Uterine Sarcoma/Mesenchymal,BRD-K49404994-001-10-9::2.5::HTS,4.281683558745806,0.03899509487477272,Uterine Sarcoma/Mesenchymal,levetiracetam,calcium channel blocker,"CACNA1B, SCN1A, SV2A"
Uterine Sarcoma/Mesenchymal,BRD-K49456274-001-01-9::2.5::HTS,3.891721554890015,0.04902870339423599,Other Types,pilaralisib,PI3K inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K49759007-001-11-9::2.5::HTS,7.136137931404202,0.0077743510625803685,Other Types,4-hydroxy-phenazone,,
Uterine Sarcoma/Mesenchymal,BRD-K49945136-001-10-0::2.5::HTS,7.432068555054778,0.006611093833636869,Other Types,GR-113808,serotonin receptor antagonist,HTR4
Uterine Sarcoma/Mesenchymal,BRD-K50495309-001-02-0::2.5::HTS,4.00818335597404,0.04576255779323879,Uterine Sarcoma/Mesenchymal,SRC-kinase-inhibitor-I,src inhibitor,"CSK, LCK, RIPK2"
Uterine Sarcoma/Mesenchymal,BRD-K51040301-001-02-1::2.5::HTS,6.2491466332177135,0.01270925786279913,Other Types,cobicistat,cytochrome P450 inhibitor,"CYP3A4, CYP3A43, CYP3A5, CYP3A7"
Uterine Sarcoma/Mesenchymal,BRD-K52523550-001-01-5::2.5::HTS,4.718966486360883,0.030256510474769408,Other Types,N-acetylcarnosine,,
Uterine Sarcoma/Mesenchymal,BRD-K53448858-001-07-0::2.5::HTS,7.687517146796134,0.005757618003283494,Other Types,acadesine,AMPK activator,
Uterine Sarcoma/Mesenchymal,BRD-K53720352-001-03-2::2.5::HTS,5.841558573306863,0.015974545743765056,Other Types,cinalukast,leukotriene receptor antagonist,CYSLTR1
Uterine Sarcoma/Mesenchymal,BRD-K53765467-001-02-1::2.5::HTS,3.9120343633957835,0.048429557690523116,Uterine Sarcoma/Mesenchymal,empagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2"
Uterine Sarcoma/Mesenchymal,BRD-K53913732-001-05-9::2.5::HTS,14.5782647505452,0.0001496345020248243,Other Types,SB-408124,orexin receptor antagonist,"HCRTR1, HCRTR2"
Uterine Sarcoma/Mesenchymal,BRD-K54006094-051-01-7::2.5::HTS,12.087903951607046,0.000547164226350007,Other Types,formoterol,adrenergic receptor agonist,ADRB2
Uterine Sarcoma/Mesenchymal,BRD-K54824716-001-04-0::2.5::HTS,4.007764464248322,0.04577471080323591,Other Types,procodazole,immunostimulant,
Uterine Sarcoma/Mesenchymal,BRD-K54997624-001-06-0::2.5::HTS,9.396905980948858,0.00227790263171021,Other Types,alpelisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Uterine Sarcoma/Mesenchymal,BRD-K55847762-304-01-7::2.5::HTS,14.508895877417432,0.0001548693772323812,Other Types,lobenzarit,immunosuppressant,
Uterine Sarcoma/Mesenchymal,BRD-K56291712-001-01-0::2.5::HTS,6.177889092307089,0.013225292630845853,Other Types,voxtalisib,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Uterine Sarcoma/Mesenchymal,BRD-K56405753-001-02-4::2.5::HTS,5.942418211778941,0.015089661428943366,Other Types,MK-2461,"FGFR inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB"
Uterine Sarcoma/Mesenchymal,BRD-K57284066-001-01-6::2.5::HTS,7.146298135373976,0.007730206386336423,Other Types,Ro-9187,HCV inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K57545991-050-23-1::2.5::HTS,10.471150808854425,0.0012838621414187614,Other Types,enalapril,angiotensin converting enzyme inhibitor,ACE
Uterine Sarcoma/Mesenchymal,BRD-K58568447-001-01-1::2.5::HTS,4.326086132617576,0.03798749779830182,Other Types,K02288,bone morphogenic protein inhibitor,BMP1
Uterine Sarcoma/Mesenchymal,BRD-K59036917-001-16-7::2.5::HTS,8.125129046785181,0.004525844836985495,Other Types,ML161,protease-activated receptor inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K59456551-001-22-6::2.51::HTS,6.164229520600596,0.01334545961379586,Other Types,methotrexate,dihydrofolate reductase inhibitor,DHFR
Uterine Sarcoma/Mesenchymal,BRD-K59469039-001-08-0::2.5::HTS,6.563772085462267,0.010667159193594265,Other Types,tyrphostin-AG-879,tyrosine kinase inhibitor,"ERBB2, KDR, NTRK1"
Uterine Sarcoma/Mesenchymal,BRD-K59524082-001-01-3::2.5::HTS,4.263737380859078,0.03939391780857612,Uterine Sarcoma/Mesenchymal,maribavir,"cytomegalovirus inhibitor, protein kinase inhibitor",PYGM
Uterine Sarcoma/Mesenchymal,BRD-K59929863-001-01-9::2.5::HTS,4.254561336563736,0.03960396800415715,Other Types,CB-10-277,DNA synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K60237333-001-27-1::2.5::HTS,5.743962611077111,0.016871133845821746,Uterine Sarcoma/Mesenchymal,niacin,"NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT"
Uterine Sarcoma/Mesenchymal,BRD-K61097567-001-08-5::2.5::HTS,5.004890419561192,0.025674169797890705,Other Types,SB-218795,tachykinin antagonist,TACR3
Uterine Sarcoma/Mesenchymal,BRD-K61642990-001-01-0::2.5::HTS,4.102921482809762,0.04328804952342101,Uterine Sarcoma/Mesenchymal,FERb-033,EGFR inhibitor,ERBB2
Uterine Sarcoma/Mesenchymal,BRD-K61688984-001-02-9::2.5::HTS,8.51496162623418,0.003664335881325541,Other Types,RGFP966,HDAC inhibitor,HDAC3
Uterine Sarcoma/Mesenchymal,BRD-K62008436-001-22-1::2.5::HTS,5.612455896121273,0.018175191671863607,Other Types,paclitaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1"
Uterine Sarcoma/Mesenchymal,BRD-K62056274-332-01-8::2.5::HTS,5.340014502822909,0.02120236393641642,Other Types,N-methylquipazine,serotonin receptor agonist,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4"
Uterine Sarcoma/Mesenchymal,BRD-K62676709-065-05-5::2.5::HTS,10.189282741998975,0.0014915299687427836,Other Types,guanethidine,adrenergic inhibitor,SLC6A2
Uterine Sarcoma/Mesenchymal,BRD-K63001556-001-09-6::2.57::HTS,4.571859731182189,0.03295111062551812,Uterine Sarcoma/Mesenchymal,orbifloxacin,bacterial DNA gyrase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K64538373-001-01-4::2.5::HTS,4.049924281936545,0.044654159399913414,Uterine Sarcoma/Mesenchymal,Ro-4987655,MEK inhibitor,MAP2K1
Uterine Sarcoma/Mesenchymal,BRD-K64557645-001-02-4::2.5::HTS,4.918238879457985,0.02697373212586379,Other Types,zotepine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4"
Uterine Sarcoma/Mesenchymal,BRD-K64716392-001-01-3::2.5::HTS,5.558303909810726,0.018736843961626403,Uterine Sarcoma/Mesenchymal,nedocromil,histamine receptor antagonist,"CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR"
Uterine Sarcoma/Mesenchymal,BRD-K64755930-003-03-2::2.5::HTS,4.343478627556027,0.037602016770931765,Other Types,etazolate,phosphodiesterase inhibitor,"GABRB3, PDE4A"
Uterine Sarcoma/Mesenchymal,BRD-K64866502-001-03-9::2.5::HTS,3.920053087698004,0.048207787245081464,Other Types,CYC116,Aurora kinase inhibitor,"AURKA, AURKB, KDR"
Uterine Sarcoma/Mesenchymal,BRD-K65786282-001-07-5::2.5::HTS,6.337358730901476,0.012100054584732579,Other Types,CGP-7930,GABA receptor modulator,GABBR1
Uterine Sarcoma/Mesenchymal,BRD-K65924316-001-03-1::2.5::HTS,3.883577917902189,0.04925797152727873,Other Types,serdemetan,MDM inhibitor,MDM2
Uterine Sarcoma/Mesenchymal,BRD-K66850609-001-07-4::2.5::HTS,4.774153392491023,0.029302299524708843,Other Types,voglibose,glucosidase inhibitor,MGAM
Uterine Sarcoma/Mesenchymal,BRD-K67304264-001-08-5::2.5::HTS,5.011294004318839,0.02557525995459531,Other Types,SKA-31,potassium channel activator,KCNN4
Uterine Sarcoma/Mesenchymal,BRD-K67578145-001-12-1::2.5::HTS,5.317921352527604,0.021475467876100093,Uterine Sarcoma/Mesenchymal,GDC-0879,RAF inhibitor,BRAF
Uterine Sarcoma/Mesenchymal,BRD-K67789209-001-01-0::2.5::HTS,6.635325564773915,0.010252771972773361,Other Types,adatanserin,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR2A"
Uterine Sarcoma/Mesenchymal,BRD-K68065987-300-09-1::2.5::HTS,3.988159691326726,0.0463106701685658,Other Types,MK-2206,AKT inhibitor,"AKT1, AKT2, AKT3"
Uterine Sarcoma/Mesenchymal,BRD-K68346641-001-01-4::2.5::HTS,4.411909258542532,0.03614029286891669,Other Types,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Uterine Sarcoma/Mesenchymal,BRD-K68346641-001-02-2::2.5::HTS,6.722732683022502,0.009767900805872365,Other Types,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Uterine Sarcoma/Mesenchymal,BRD-K68747584-001-02-0::2.5::HTS,4.675260597998434,0.031022806979606653,Other Types,PF-03814735,Aurora kinase inhibitor,"AURKA, AURKB"
Uterine Sarcoma/Mesenchymal,BRD-K68756823-001-07-1::2.5::HTS,3.9904900266263854,0.04624625875737883,Other Types,FR-180204,MAP kinase inhibitor,"MAPK1, MAPK3"
Uterine Sarcoma/Mesenchymal,BRD-K69346723-001-04-8::2.5::HTS,4.556748605440099,0.03324909827770625,Other Types,glutathione,antioxidant,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12"
Uterine Sarcoma/Mesenchymal,BRD-K69650333-003-13-2::2.48::HTS,4.984846972546223,0.025988698140416072,Other Types,idarubicin,topoisomerase inhibitor,TOP2A
Uterine Sarcoma/Mesenchymal,BRD-K69907333-001-10-6::2.5::HTS,11.135992890095878,0.0009063280941209362,Other Types,flurbiprofen-(S)-(+),cyclooxygenase inhibitor,"PTGS1, PTGS2"
Uterine Sarcoma/Mesenchymal,BRD-K70358946-001-15-7::2.5::HTS,8.253186217387839,0.004222287855169554,Other Types,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Uterine Sarcoma/Mesenchymal,BRD-K70487031-001-02-8::2.5::HTS,6.852547646652675,0.009092162248681306,Other Types,flupentixol,dopamine receptor antagonist,"ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A"
Uterine Sarcoma/Mesenchymal,BRD-K73381198-001-01-1::2.5::HTS,4.758762363206415,0.029570659521708384,Uterine Sarcoma/Mesenchymal,5-fluoro-3-pyridyl-methanol,,
Uterine Sarcoma/Mesenchymal,BRD-K73789395-001-10-7::2.5::HTS,9.437512687156872,0.0022307261421445046,Uterine Sarcoma/Mesenchymal,ZM-336372,RAF inhibitor,"BRAF, LCK, MAPK14, RAF1"
Uterine Sarcoma/Mesenchymal,BRD-K74057757-001-01-9::2.5::HTS,4.7088815389620375,0.030425354817530066,Other Types,indibulin,tubulin polymerization inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K75009076-001-02-1::2.43::HTS,10.06247240111162,0.001601197790245498,Other Types,SCH-900776,CHK inhibitor,"CDK2, CHEK1"
Uterine Sarcoma/Mesenchymal,BRD-K75282704-001-02-4::2.5::HTS,4.391078190364342,0.036578316764795865,Other Types,BL-5583,hypercalcaemic agent,
Uterine Sarcoma/Mesenchymal,BRD-K75844781-003-08-0::2.5::HTS,4.131436464742509,0.04257172302326686,Uterine Sarcoma/Mesenchymal,mCPP,serotonin receptor agonist,"HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6"
Uterine Sarcoma/Mesenchymal,BRD-K75855670-001-14-2::2.5::HTS,4.296062844997553,0.03866006683175249,Other Types,iodoquinol,antiseptic,
Uterine Sarcoma/Mesenchymal,BRD-K75956464-237-01-5::2.5::HTS,4.189659601274187,0.041138331706298215,Uterine Sarcoma/Mesenchymal,VCH-916,HCV inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K75958195-037-09-4::2.5::HTS,5.910026277578505,0.015368269031922292,Uterine Sarcoma/Mesenchymal,pizotifen,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C"
Uterine Sarcoma/Mesenchymal,BRD-K76011241-001-01-8::2.5::HTS,5.479654377751971,0.019590251967619314,Uterine Sarcoma/Mesenchymal,oseltamivir-phosphate,neuraminidase inhibitor,"CES1, NEU1, NEU2"
Uterine Sarcoma/Mesenchymal,BRD-K77561571-001-01-1::2.5::HTS,3.9491928864197847,0.04737882730915978,Other Types,topiroxostat,xanthine oxidase inhibitor,XDH
Uterine Sarcoma/Mesenchymal,BRD-K78113049-001-16-2::2.5::HTS,4.119293494098242,0.04287595904201429,Other Types,enoxacin,topoisomerase inhibitor,TOP2A
Uterine Sarcoma/Mesenchymal,BRD-K78342372-001-02-4::2.5::HTS,4.7569835126439965,0.029599443354133368,Uterine Sarcoma/Mesenchymal,hematoxylin,,
Uterine Sarcoma/Mesenchymal,BRD-K78720403-001-01-6::2.5::HTS,5.110329417411233,0.024167563171860265,Uterine Sarcoma/Mesenchymal,SB-328437,CCR antagonist,
Uterine Sarcoma/Mesenchymal,BRD-K78789465-001-01-6::2.5::HTS,4.67437802660593,0.031049474688098728,Other Types,pentagastrin,CCK receptor agonist,CCKBR
Uterine Sarcoma/Mesenchymal,BRD-K79555887-001-01-0::2.5::HTS,6.306245279213082,0.012312268351921741,Other Types,RI-1,,RAD51
Uterine Sarcoma/Mesenchymal,BRD-K80431395-001-09-9::2.5::HTS,9.805534741977487,0.001836444563757163,Other Types,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Uterine Sarcoma/Mesenchymal,BRD-K80451230-051-02-6::2.5::HTS,6.259719133624243,0.01263703343788094,Other Types,zamifenacin,acetylcholine receptor antagonist,CHRM3
Uterine Sarcoma/Mesenchymal,BRD-K81092066-311-01-6::2.5::HTS,5.3102388944919126,0.02157485862855399,Other Types,phenacaine,local anesthetic,
Uterine Sarcoma/Mesenchymal,BRD-K81916719-001-13-9::2.5::HTS,9.568176650880243,0.0020823847046207216,Other Types,triclabendazole,microtubule inhibitor,DNMT1
Uterine Sarcoma/Mesenchymal,BRD-K82036761-003-20-3::2.5::HTS,9.035700424606457,0.0027662184729181243,Other Types,sertraline,selective serotonin reuptake inhibitor (SSRI),"SLC6A3, SLC6A4"
Uterine Sarcoma/Mesenchymal,BRD-K82823804-001-04-1::2.5::HTS,4.098760477586171,0.043395631918844706,Other Types,PD-407824,PKC inhibitor,WEE1
Uterine Sarcoma/Mesenchymal,BRD-K83794243-001-01-8::2.5::HTS,5.47186308893695,0.019689335647338657,Uterine Sarcoma/Mesenchymal,palovarotene,retinoid receptor agonist,RARG
Uterine Sarcoma/Mesenchymal,BRD-K83988098-001-02-0::2.5::HTS,5.688749806798536,0.017410473081590758,Other Types,alvespimycin,HSP inhibitor,HSP90AA1
Uterine Sarcoma/Mesenchymal,BRD-K83988098-003-03-4::2.5::HTS,4.145387009345456,0.04224670651694231,Other Types,alvespimycin,HSP inhibitor,HSP90AA1
Uterine Sarcoma/Mesenchymal,BRD-K84892605-001-01-1::2.5::HTS,4.414551953352193,0.036097385996475884,Uterine Sarcoma/Mesenchymal,IOWH032,CFTR channel antagonist,CFTR
Uterine Sarcoma/Mesenchymal,BRD-K85014146-001-02-5::2.5::HTS,4.721679119855022,0.030263065221503353,Other Types,AZD2461,PARP inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K85402309-001-06-6::2.5::HTS,5.278869329347836,0.021957597370075563,Other Types,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Uterine Sarcoma/Mesenchymal,BRD-K85402309-389-03-2::2.5::HTS,6.644984553850157,0.010197996027293028,Other Types,dovitinib,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB"
Uterine Sarcoma/Mesenchymal,BRD-K86435560-001-01-0::2.5::HTS,6.998309357082852,0.008387824993052925,Other Types,perchlozone,,
Uterine Sarcoma/Mesenchymal,BRD-K86882815-001-03-2::2.5::HTS,4.202930461549277,0.04083740328051974,Uterine Sarcoma/Mesenchymal,cabergoline,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7"
Uterine Sarcoma/Mesenchymal,BRD-K87036601-001-01-6::2.5::HTS,14.356810131613138,0.00016773562585626272,Other Types,azodicarbonamide,DNA synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K87774949-001-03-9::2.5::HTS,3.9590787573479918,0.04710336567989456,Other Types,istradefylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Uterine Sarcoma/Mesenchymal,BRD-K88560311-011-06-3::2.5::HTS,5.1301220662985045,0.02389948953114403,Other Types,rucaparib,PARP inhibitor,"PARP1, PARP2"
Uterine Sarcoma/Mesenchymal,BRD-K89917372-001-01-2::2.5::HTS,4.160594649291748,0.041845317143956666,Uterine Sarcoma/Mesenchymal,retigabine,potassium channel activator,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5"
Uterine Sarcoma/Mesenchymal,BRD-K91147684-001-01-5::2.5::HTS,8.821680427088413,0.003106192994887768,Other Types,m-THP,,
Uterine Sarcoma/Mesenchymal,BRD-K91290917-300-01-8::2.5::HTS,6.877548658975529,0.008967400831828815,Other Types,amodiaquine,histamine receptor agonist,HNMT
Uterine Sarcoma/Mesenchymal,BRD-K91623615-001-05-0::2.46::HTS,5.920981801813728,0.015292431825660847,Other Types,ABT-751,tubulin polymerization inhibitor,TUBB
Uterine Sarcoma/Mesenchymal,BRD-K92015269-300-01-2::2.5::HTS,8.074954626696561,0.004653392413990537,Other Types,GBR-12783,dopamine uptake inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K92073408-001-16-5::2.5::HTS,4.4916470726217534,0.03450024995799809,Uterine Sarcoma/Mesenchymal,norethindrone,progesterone receptor agonist,PGR
Uterine Sarcoma/Mesenchymal,BRD-K92657060-001-05-7::2.5::HTS,4.692767246608263,0.03070947922768176,Other Types,zaleplon,benzodiazepine receptor agonist,"GABRA1, GABRB1, GABRG2, TSPO"
Uterine Sarcoma/Mesenchymal,BRD-K92872987-001-02-9::2.5::HTS,4.822899702758864,0.02851089964386092,Uterine Sarcoma/Mesenchymal,cefpiramide,bacterial cell wall synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K93255255-001-02-1::2.5::HTS,4.991110682282034,0.02587460953140012,Uterine Sarcoma/Mesenchymal,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Uterine Sarcoma/Mesenchymal,BRD-K93468883-001-02-0::2.5::HTS,15.269091575482772,0.00010459038305828596,Other Types,IPI-145,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Uterine Sarcoma/Mesenchymal,BRD-K93754473-048-20-2::2.5::HTS,3.902067556450071,0.048716435540906385,Other Types,tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
Uterine Sarcoma/Mesenchymal,BRD-K94436377-001-10-2::2.5::HTS,4.196093295524154,0.040981233714887016,Uterine Sarcoma/Mesenchymal,diosmin,"aryl hydrocarbon receptor agonist, capillary stabilizing agent",AHR
Uterine Sarcoma/Mesenchymal,BRD-K94559059-091-01-6::2.5::HTS,3.974132238537709,0.0466941402421622,Other Types,telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1
Uterine Sarcoma/Mesenchymal,BRD-K94720315-001-10-4::2.5::HTS,5.7876573193434755,0.01646396159102808,Uterine Sarcoma/Mesenchymal,chromocarb,antispasmodic,
Uterine Sarcoma/Mesenchymal,BRD-K95260951-050-03-1::2.5::HTS,4.286188049696031,0.038879353953353554,Uterine Sarcoma/Mesenchymal,asenapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
Uterine Sarcoma/Mesenchymal,BRD-K95435023-001-08-5::2.5::HTS,8.879546552380114,0.003016626307239672,Other Types,PHA-665752,c-Met inhibitor,MET
Uterine Sarcoma/Mesenchymal,BRD-K95921201-001-14-6::2.5::HTS,6.049246707583807,0.014213403591357858,Other Types,reserpine,vesicular monoamine transporter inhibitor,"SLC18A1, SLC18A2"
Uterine Sarcoma/Mesenchymal,BRD-K96786677-323-02-0::2.58::HTS,5.07282922886459,0.02470675602295385,Uterine Sarcoma/Mesenchymal,oxacillin,bacterial cell wall synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K97010173-001-04-1::2.5::HTS,5.225163051708014,0.02263437221319383,Other Types,deferasirox,chelating agent,CYP3A4
Uterine Sarcoma/Mesenchymal,BRD-K97056771-001-13-1::2.5::HTS,5.854190167940932,0.015856345446981585,Uterine Sarcoma/Mesenchymal,GNF-2,Bcr-Abl kinase inhibitor,"ABL1, BCR"
Uterine Sarcoma/Mesenchymal,BRD-K97799481-001-16-0::2.5::HTS,3.9251562095271564,0.04805572285862608,Other Types,theophylline,adenosine receptor antagonist,
Uterine Sarcoma/Mesenchymal,BRD-K99023089-001-03-7::2.5::HTS,5.1552183337320185,0.023556303236418163,Other Types,AZD5363,AKT inhibitor,"AKT1, AKT2, AKT3"
Uterine Sarcoma/Mesenchymal,BRD-K99170882-001-04-3::2.5::HTS,6.245920006537643,0.01273421583142064,Other Types,NSC-319726,p53 activator,
Uterine Sarcoma/Mesenchymal,BRD-K99383816-001-02-7::2.5::HTS,10.6527270350623,0.0011662418964211714,Uterine Sarcoma/Mesenchymal,ftorafur,thymidylate synthase inhibitor,TYMS
Uterine Sarcoma/Mesenchymal,BRD-A10773072-001-03-4::2.496712929::MTS004,7.915664199203032,0.005080085481122261,Other Types,glycerol-monolaurate,beta lactamase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-A38706605-001-01-2::2.5::MTS004,5.263885038731356,0.022157409052423235,Other Types,dromostanolone-propionate,androgen receptor modulator,AR
Uterine Sarcoma/Mesenchymal,BRD-K01638814-011-01-4::2.587084236::MTS004,5.067384744315684,0.024782974025578382,Other Types,rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A
Uterine Sarcoma/Mesenchymal,BRD-K01662324-001-01-8::2.618953925::MTS004,5.364311789379812,0.020927851182686745,Other Types,priralfinamide,sodium channel blocker,CACNA1B
Uterine Sarcoma/Mesenchymal,BRD-K02988401-001-01-2::2.5::MTS004,5.108813116602943,0.02420351704281864,Other Types,UNC0737,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Uterine Sarcoma/Mesenchymal,BRD-K03165895-001-01-9::2.499970324::MTS004,5.937013128494606,0.015148763011481655,Other Types,elafibranor,PPAR receptor agonist,"PPARA, PPARD"
Uterine Sarcoma/Mesenchymal,BRD-K06467130-304-02-7::2.5::MTS004,3.936370731567703,0.047759403158003526,Uterine Sarcoma/Mesenchymal,CL316243,adrenergic receptor agonist,"ADRB3, UCP1, UCP2, UCP3"
Uterine Sarcoma/Mesenchymal,BRD-K07790550-001-01-6::2.500001908::MTS004,4.2756362493171345,0.039139074931749486,Other Types,mavoglurant,glutamate receptor antagonist,GRM5
Uterine Sarcoma/Mesenchymal,BRD-K11463116-304-03-5::2.500052374::MTS004,5.613486662221289,0.018174158297233543,Uterine Sarcoma/Mesenchymal,eprodisate,"antiamyloidogenic agent, amyloid protein inhibitor",SAA1
Uterine Sarcoma/Mesenchymal,BRD-K12906202-001-06-2::2.5::MTS004,5.46787920525002,0.01973380422515897,Other Types,carbendazim,"microtubule inhibitor, tubulin polymerization inhibitor","TP53, TUBB"
Uterine Sarcoma/Mesenchymal,BRD-K13277760-001-01-2::2.5::MTS004,6.457527335088319,0.011327998196492947,Other Types,rifamycin-sv,RNA synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K14276241-001-01-2::2.49998187::MTS004,7.143250769937627,0.007752996640738877,Other Types,daucosterol,apoptosis stimulant,
Uterine Sarcoma/Mesenchymal,BRD-K15262564-001-15-0::2.500002693::MTS004,4.452815085462422,0.03530394533709479,Uterine Sarcoma/Mesenchymal,mupirocin,isoleucyl-tRNA synthetase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K16546375-001-01-4::2.393310671::MTS004,4.744593938449929,0.029823973134984177,Other Types,bicyclol,NFkB pathway inhibitor,"HSPA1A, HSPB1"
Uterine Sarcoma/Mesenchymal,BRD-K18749874-003-08-9::2.5::MTS004,5.44231751442559,0.020021616417552807,Other Types,melevodopa,"dopamine precursor, dopamine receptor agonist",DDC
Uterine Sarcoma/Mesenchymal,BRD-K25146005-001-01-0::2.5::MTS004,4.8149961471449405,0.028639135747814487,Uterine Sarcoma/Mesenchymal,cis-urocanic acid,serotonin receptor agonist,HTR2A
Uterine Sarcoma/Mesenchymal,BRD-K26530649-001-01-6::2.568078778::MTS004,9.79970243730306,0.0018401621680978629,Other Types,carboxypyridine-disulfide,,
Uterine Sarcoma/Mesenchymal,BRD-K30485548-050-01-6::2.479775098::MTS004,5.7012762420263785,0.01729605817243183,Uterine Sarcoma/Mesenchymal,sumanirole,dopamine receptor agonist,DRD2
Uterine Sarcoma/Mesenchymal,BRD-K31417912-001-01-9::2.499995989::MTS004,6.5576536475169664,0.010714619272492463,Other Types,PF-3274167,oxytocin receptor antagonist,"AVPR1A, OXTR"
Uterine Sarcoma/Mesenchymal,BRD-K35367061-001-01-1::2.5::MTS004,5.5544671267751164,0.018790341591236822,Other Types,LY223982,leukotriene receptor antagonist,LTB4R
Uterine Sarcoma/Mesenchymal,BRD-K36463073-001-03-9::2.499956047::MTS004,5.5871604717565,0.01844638425543578,Uterine Sarcoma/Mesenchymal,OC000459,CRTH receptor antagonist,PTGDR2
Uterine Sarcoma/Mesenchymal,BRD-K37708699-001-01-4::2.530276706::MTS004,4.620951712883663,0.03202891713031132,Other Types,exisulind,phosphodiesterase inhibitor,PDE5A
Uterine Sarcoma/Mesenchymal,BRD-K45906612-001-01-8::2.499991411::MTS004,4.576783228184387,0.03285738076690781,Other Types,presatovir,RSV fusion inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K49372556-001-04-1::2.5::MTS004,4.063812874980255,0.04430714910381438,Uterine Sarcoma/Mesenchymal,mofezolac,cyclooxygenase inhibitor,PTGS1
Uterine Sarcoma/Mesenchymal,BRD-K51899933-001-02-6::2.500004375::MTS004,5.606518836612075,0.018246458022134076,Other Types,azeliragon,RAGE receptor antagonist,AGER
Uterine Sarcoma/Mesenchymal,BRD-K54955827-001-02-2::2.49997945::MTS004,9.559777841480688,0.0020917647958970356,Other Types,niraparib,PARP inhibitor,PARP1
Uterine Sarcoma/Mesenchymal,BRD-K55029398-001-01-6::2.499962393::MTS004,7.979253074742511,0.004907235976912216,Other Types,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2
Uterine Sarcoma/Mesenchymal,BRD-K59753975-001-02-6::2.5::MTS004,5.137574503865754,0.02380880275484636,Other Types,vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1"
Uterine Sarcoma/Mesenchymal,BRD-K59895502-001-01-9::2.591975371::MTS004,4.888561606403176,0.027455002716390467,Other Types,caramiphen,cholinergic receptor antagonist,"CHRM1, CHRM2"
Uterine Sarcoma/Mesenchymal,BRD-K63772874-001-02-2::2.499989061::MTS004,6.710668212234959,0.009843176814923386,Other Types,icatibant-acetate,bradykinin receptor antagonist,"ANPEP, BDKRB2"
Uterine Sarcoma/Mesenchymal,BRD-K71026158-304-01-0::2.397404387::MTS004,6.9983279788519654,0.008396721947767605,Uterine Sarcoma/Mesenchymal,carumonam,bacterial cell wall synthesis inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K71977764-001-01-2::2.5::MTS004,10.560780383608439,0.0012271784276447247,Uterine Sarcoma/Mesenchymal,piroximone,phosphodiesterase inhibitor,PDE3A
Uterine Sarcoma/Mesenchymal,BRD-K73585091-001-02-3::2.499988098::MTS004,3.8860524576718056,0.049200763304321896,Other Types,GS-9620,toll-like receptor agonist,TLR7
Uterine Sarcoma/Mesenchymal,BRD-K76315403-015-02-5::2.5::MTS004,3.886229227032424,0.0491946726864033,Uterine Sarcoma/Mesenchymal,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,"GNRHR, LHCGR"
Uterine Sarcoma/Mesenchymal,BRD-K76713213-001-02-1::2.499961706::MTS004,7.424046252010002,0.006645207805246244,Other Types,tavaborole,leucyl-tRNA synthetase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K77432251-001-01-2::2.715966218::MTS004,5.209188419727025,0.022856554037023413,Other Types,abafungin,sterol methyltransferase inhibitor,
Uterine Sarcoma/Mesenchymal,BRD-K78841970-001-13-8::2.388586862::MTS004,5.174626901067523,0.023311072099486855,Other Types,aspartame,,"TAS1R2, TRPV1"
Uterine Sarcoma/Mesenchymal,BRD-K84868168-001-01-0::2.500006364::MTS004,9.196039806783281,0.002542337028873357,Other Types,erdafitinib,FGFR inhibitor,"FGFR1, FGFR2, FGFR3, FGFR4"
Uterine Sarcoma/Mesenchymal,BRD-K86410485-046-01-0::2.499987354::MTS004,6.233147983872845,0.012836061089573672,Other Types,eliglustat,Glycosyl transferase inhibitor,UGCG
Uterine Sarcoma/Mesenchymal,BRD-K87573013-001-01-0::2.5::MTS004,6.286351506824687,0.01246016477338872,Uterine Sarcoma/Mesenchymal,CL-225385,,
Uterine Sarcoma/Mesenchymal,BRD-K96344439-002-02-7::2.500011072::MTS004,4.703009337094479,0.030547284559742784,Other Types,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK
Breast Ductal Carcinoma In Situ,BRD-A02710418-003-11-8::2.5::HTS,3.85924277845049,0.04997207865429072,Other Types,meptazinol,opioid receptor agonist,BCHE
Breast Ductal Carcinoma In Situ,BRD-A03506276-001-01-5::2.5::HTS,6.627368567532791,0.010299507859855115,Other Types,XL888,HSP inhibitor,
Breast Ductal Carcinoma In Situ,BRD-A05334458-001-02-8::2.5::HTS,4.273323230168226,0.03917651794480378,Other Types,lisofylline,"interleukin receptor antagonist, STAT inhibitor",
Breast Ductal Carcinoma In Situ,BRD-A07986123-001-02-8::2.5::HTS,4.9463467055424175,0.026561723017682445,Other Types,galeterone,androgen receptor modulator,"AR, CYP17A1"
Breast Ductal Carcinoma In Situ,BRD-A08302182-001-01-7::2.5::HTS,5.3602524098156294,0.02096525446342736,Other Types,etonogestrel,progesterone receptor agonist,"ESR1, PGR"
Breast Ductal Carcinoma In Situ,BRD-A08840375-001-01-3::2.5::HTS,5.695888245926063,0.01734423948805243,Other Types,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
Breast Ductal Carcinoma In Situ,BRD-A10903566-003-07-7::2.5::HTS,4.724681813415229,0.030167249653232468,Other Types,imiloxan,adrenergic receptor antagonist,"ADRA2A, ADRA2B"
Breast Ductal Carcinoma In Situ,BRD-A10967948-003-06-3::2.5::HTS,4.280212053156267,0.03903470615984385,Breast Ductal Carcinoma In Situ,granisetron,serotonin receptor antagonist,HTR3A
Breast Ductal Carcinoma In Situ,BRD-A11551002-001-04-6::2.5::HTS,4.2161691432915935,0.0405224788014209,Other Types,dehydrocholate-acid,,
Breast Ductal Carcinoma In Situ,BRD-A11990600-001-03-4::2.5::HTS,3.9497664127802765,0.04738350941297663,Other Types,lorazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Breast Ductal Carcinoma In Situ,BRD-A12454076-001-01-9::2.5::HTS,4.7557989689096685,0.02964119640707681,Other Types,L-Hydroxyproline,,
Breast Ductal Carcinoma In Situ,BRD-A26387268-050-04-4::2.5::HTS,4.159488080826392,0.04187245285819606,Breast Ductal Carcinoma In Situ,ergonovine,"adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E"
Breast Ductal Carcinoma In Situ,BRD-A43082555-001-01-1::2.5::HTS,4.204680300809056,0.04078943054506555,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Breast Ductal Carcinoma In Situ,BRD-A44863528-001-13-2::2.5::HTS,4.122723224066502,0.04278979724357154,Other Types,proglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Breast Ductal Carcinoma In Situ,BRD-A54927599-001-16-9::2.5::HTS,8.772471054480004,0.0031897481777709825,Other Types,KF-38789,P selectin inhibitor,SELP
Breast Ductal Carcinoma In Situ,BRD-A64064900-001-02-3::2.5::HTS,4.215982537209205,0.04052071330745391,Other Types,sangivamycin,DNA inhibitor,
Breast Ductal Carcinoma In Situ,BRD-A64242993-001-05-6::2.5::HTS,4.23357073027433,0.040096034307357184,Other Types,lanatoside-c,cardiac glycoside,
Breast Ductal Carcinoma In Situ,BRD-A67748489-001-10-0::2.5::HTS,6.203594979406966,0.013040859034160891,Other Types,K-858,kinesin-like spindle protein inhibitor,KIF11
Breast Ductal Carcinoma In Situ,BRD-A68631409-001-05-4::2.5::HTS,7.9135440779171,0.005080731376789472,Other Types,evodiamine,"ATPase inhibitor, TRPV agonist",TRPV1
Breast Ductal Carcinoma In Situ,BRD-A86619021-001-04-8::2.5::HTS,5.108642238993667,0.02419223869594522,Other Types,andrographolide,tumor necrosis factor production inhibitor,NFKB1
Breast Ductal Carcinoma In Situ,BRD-A88080608-001-04-2::2.5::HTS,4.487160091671724,0.03459254444667073,Breast Ductal Carcinoma In Situ,equilin,estrogen receptor agonist,HSD17B1
Breast Ductal Carcinoma In Situ,BRD-A88548664-004-02-7::2.5::HTS,5.107695828034269,0.024203933809677627,Breast Ductal Carcinoma In Situ,SKF-38393,dopamine receptor agonist,"CALY, DRD1, DRD5"
Breast Ductal Carcinoma In Situ,BRD-A96456596-001-02-2::2.5::HTS,12.955113528605587,0.0003472347265377824,Other Types,FPL-55712,leukotriene receptor antagonist,
Breast Ductal Carcinoma In Situ,BRD-K00152668-001-01-5::2.5::HTS,4.976286615352154,0.0260944879313751,Other Types,adarotene,retinoid receptor agonist,"RARB, RARG"
Breast Ductal Carcinoma In Situ,BRD-K00259736-001-16-4::2.5::HTS,9.330897054329828,0.002361581978680788,Other Types,colchicine,microtubule inhibitor,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8"
Breast Ductal Carcinoma In Situ,BRD-K00535541-001-06-3::2.5::HTS,5.560009611036595,0.018739011756103416,Other Types,9-aminoacridine,,
Breast Ductal Carcinoma In Situ,BRD-K01493881-001-29-4::2.5::HTS,4.635851432915316,0.03174312810951096,Other Types,apigenin,"casein kinase inhibitor, cell proliferation inhibitor","AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1"
Breast Ductal Carcinoma In Situ,BRD-K01653460-001-01-1::2.5::HTS,32.40653628150085,2.0562822973521042e-08,Other Types,chlorindanol,,
Breast Ductal Carcinoma In Situ,BRD-K01663662-003-20-2::2.5::HTS,4.503667717210102,0.03426371119281449,Other Types,diphenidol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Breast Ductal Carcinoma In Situ,BRD-K01683783-001-02-6::2.5::HTS,4.255199483968075,0.03959250049523383,Other Types,TAK-901,Aurora kinase inhibitor,AURKB
Breast Ductal Carcinoma In Situ,BRD-K02130563-001-11-4::2.5::HTS,4.969854771215654,0.02619296667282167,Other Types,panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9"
Breast Ductal Carcinoma In Situ,BRD-K02241333-001-02-7::2.5::HTS,7.124937093369691,0.00782323673066897,Other Types,CHIR-124,CHK inhibitor,CHEK1
Breast Ductal Carcinoma In Situ,BRD-K02475039-001-01-0::2.5::HTS,3.9404069103464106,0.04762943486638403,Other Types,ethopabate,antiprotozoal agent,
Breast Ductal Carcinoma In Situ,BRD-K03273112-001-01-8::2.5::HTS,4.131834404442864,0.042555798851923614,Breast Ductal Carcinoma In Situ,1-azakenpaullone,glycogen synthase kinase inhibitor,"CCNB1, CDK1, CDK5, GSK3B"
Breast Ductal Carcinoma In Situ,BRD-K04993719-001-01-7::2.5::HTS,4.555710715840628,0.033246667886852876,Other Types,LY2334737,"antitumor agent, ribonucleotide reductase inhibitor",
Breast Ductal Carcinoma In Situ,BRD-K06543683-066-02-1::2.5::HTS,11.02113571349535,0.0009594875023663762,Other Types,bisindolylmaleimide-ix,PKC inhibitor,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1"
Breast Ductal Carcinoma In Situ,BRD-K07310275-001-02-5::2.5::HTS,9.539163024948287,0.0021115768083399093,Other Types,PF-04691502,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA"
Breast Ductal Carcinoma In Situ,BRD-K07487750-001-03-3::2.5::HTS,3.909646861554815,0.04850140917664732,Other Types,WHI-P154,JAK inhibitor,"EGFR, JAK1, JAK2, JAK3"
Breast Ductal Carcinoma In Situ,BRD-K07572174-001-39-4::2.48::HTS,7.30646648866689,0.007092019732296086,Other Types,curcumin,"cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH"
Breast Ductal Carcinoma In Situ,BRD-K07798980-001-01-9::2.5::HTS,8.900359262296805,0.002976063255781485,Other Types,PSI-6130,RNA polymerase inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K07972848-001-02-0::2.5::HTS,7.901860461082455,0.005111916482184011,Other Types,GSK2126458,"mTOR inhibitor, PI3K inhibitor","MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Breast Ductal Carcinoma In Situ,BRD-K08493205-001-04-9::2.5::HTS,4.392081885272613,0.03655696561253781,Other Types,salicyl-alcohol,,
Breast Ductal Carcinoma In Situ,BRD-K11927976-050-02-9::2.5::HTS,4.437601684570297,0.035611276310017495,Other Types,ER-27319,"mediator release inhibitor, SYK inhibitor",SYK
Breast Ductal Carcinoma In Situ,BRD-K12513978-001-24-1::2.5::HTS,3.945472617325434,0.047503654792432765,Other Types,fenbufen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Breast Ductal Carcinoma In Situ,BRD-K12539581-001-23-7::2.5::HTS,3.884441801346703,0.049225735752771275,Other Types,nocodazole,tubulin polymerization inhibitor,HPGDS
Breast Ductal Carcinoma In Situ,BRD-K13421763-001-06-2::2.5::HTS,4.694017514720892,0.030691108139425445,Other Types,aminothiazole,cyclin D inhibitor,NOS2
Breast Ductal Carcinoma In Situ,BRD-K13756951-001-01-4::2.5::HTS,3.9560078656332545,0.04718875172431554,Other Types,bitopertin,"glycine transporter inhibitor, GlyT-1 inhibitor","SLC6A5, SLC6A9"
Breast Ductal Carcinoma In Situ,BRD-K13800121-001-01-5::2.5::HTS,3.925882515982781,0.04804215648676784,Other Types,parecoxib,cyclooxygenase inhibitor,LTF
Breast Ductal Carcinoma In Situ,BRD-K14109347-001-03-4::2.5::HTS,4.858099924767931,0.02792414209215691,Other Types,LY2603618,CHK inhibitor,CHEK1
Breast Ductal Carcinoma In Situ,BRD-K14993104-001-05-9::2.5::HTS,4.7381709187341885,0.029920435905223582,Other Types,bemegride,chemoreceptor agonist,GABRA1
Breast Ductal Carcinoma In Situ,BRD-K15025317-001-15-1::2.5::HTS,4.730441634350144,0.030055523372088923,Other Types,BAY-11-7082,NFkB pathway inhibitor,RELA
Breast Ductal Carcinoma In Situ,BRD-K15179879-001-03-2::2.5::HTS,4.409616210176574,0.03620109042214575,Other Types,carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9"
Breast Ductal Carcinoma In Situ,BRD-K16485616-001-08-9::2.5::HTS,4.654137079165043,0.03140807752573794,Other Types,mocetinostat,HDAC inhibitor,"HDAC1, HDAC11, HDAC2, HDAC3"
Breast Ductal Carcinoma In Situ,BRD-K16551357-001-03-2::2.5::HTS,6.6428680521167305,0.010226521162265901,Other Types,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP
Breast Ductal Carcinoma In Situ,BRD-K17223896-001-10-0::2.5::HTS,28.63793433841111,1.2767862673345335e-07,Other Types,chloroxylenol,ATP synthase inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K17497770-001-03-6::2.5::HTS,6.0502589315343895,0.014205887777416841,Other Types,butein,"EGFR inhibitor, src inhibitor",ACE
Breast Ductal Carcinoma In Situ,BRD-K17555800-003-01-5::2.5::HTS,8.99125012591126,0.002833210272515571,Other Types,talmapimod,p38 MAPK inhibitor,"MAPK11, MAPK14"
Breast Ductal Carcinoma In Situ,BRD-K18961567-001-01-1::2.5::HTS,4.116058645781712,0.042955660110320475,Other Types,LY2801653,MET inhibitor,MET
Breast Ductal Carcinoma In Situ,BRD-K19416115-001-05-3::2.5::HTS,5.19749459036381,0.023009298905131356,Breast Ductal Carcinoma In Situ,sitagliptin,dipeptidyl peptidase inhibitor,DPP4
Breast Ductal Carcinoma In Situ,BRD-K20958582-001-01-4::2.5::HTS,4.430283461424161,0.03575639513944459,Other Types,TH-302,DNA alkylating agent,
Breast Ductal Carcinoma In Situ,BRD-K21164796-001-02-8::2.5::HTS,30.82848618421529,4.364707495610959e-08,Other Types,beta-naphthol,,
Breast Ductal Carcinoma In Situ,BRD-K21547160-001-01-4::2.5::HTS,4.37579241016577,0.03692022977537043,Breast Ductal Carcinoma In Situ,sufentanil,opioid receptor modulator,"OPRD1, OPRK1, OPRM1"
Breast Ductal Carcinoma In Situ,BRD-K21680192-300-14-4::2.5::HTS,7.474741235483829,0.0064571899882948525,Other Types,mitoxantrone,topoisomerase inhibitor,TOP2A
Breast Ductal Carcinoma In Situ,BRD-K23925186-001-02-8::2.51::HTS,8.738744641441807,0.0032544550512387327,Other Types,oridonin,BCL inhibitor,BCL2
Breast Ductal Carcinoma In Situ,BRD-K24715592-406-02-1::2.53::HTS,9.027698679025447,0.0027854569339822817,Other Types,ethacridine-lactate-monohydrate,DNA intercalating agent,
Breast Ductal Carcinoma In Situ,BRD-K24771047-001-01-6::2.5::HTS,4.235137198487604,0.04006269362325649,Breast Ductal Carcinoma In Situ,ampalex,glutamate receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Breast Ductal Carcinoma In Situ,BRD-K24790130-001-07-1::2.5::HTS,4.120318625302438,0.0428450300128187,Other Types,tricaprylin,,
Breast Ductal Carcinoma In Situ,BRD-K25340465-001-11-1::2.58::HTS,8.152021607486901,0.004470502264539369,Other Types,OSI-930,"KIT inhibitor, VEGFR inhibitor","KDR, KIT"
Breast Ductal Carcinoma In Situ,BRD-K25486274-300-01-0::2.5::HTS,4.291552440038907,0.038760285925482335,Breast Ductal Carcinoma In Situ,DRF053-(R),CDK inhibitor,CSNK1A1
Breast Ductal Carcinoma In Situ,BRD-K26619122-001-02-1::2.5::HTS,6.5844666662380495,0.010552899008073319,Other Types,thiocolchicoside,GABA receptor antagonist,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB"
Breast Ductal Carcinoma In Situ,BRD-K26862302-001-05-2::2.5::HTS,8.017868001955764,0.004800472466715127,Other Types,diosmetin,aryl hydrocarbon receptor agonist,CYP1B1
Breast Ductal Carcinoma In Situ,BRD-K27799744-001-02-8::2.52::HTS,3.9062801224558936,0.04862594381540434,Other Types,cyclovirobuxin-d,calcium channel modulator,
Breast Ductal Carcinoma In Situ,BRD-K28120222-001-08-4::2.5::HTS,9.087999888626712,0.0026907365910335975,Other Types,parthenolide-(alternate-stereo),NFkB pathway inhibitor,"IKBKB, RELA"
Breast Ductal Carcinoma In Situ,BRD-K28822270-001-01-1::2.5::HTS,4.045637651321152,0.044769452062293345,Other Types,resminostat,HDAC inhibitor,"HDAC1, HDAC3, HDAC6, HDAC8"
Breast Ductal Carcinoma In Situ,BRD-K28982731-001-01-6::2.5::HTS,8.921344240120868,0.0029426000270916155,Other Types,emoxipin,,
Breast Ductal Carcinoma In Situ,BRD-K29133151-001-03-2::2.5::HTS,5.075415037826895,0.02465789827142309,Other Types,"ICI-185,282",thromboxane receptor antagonist,
Breast Ductal Carcinoma In Situ,BRD-K30577245-001-04-3::2.5::HTS,4.745959440664912,0.02979972231616934,Other Types,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Breast Ductal Carcinoma In Situ,BRD-K30577245-341-01-9::2.5::HTS,6.929544435219791,0.008713527914900245,Other Types,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Breast Ductal Carcinoma In Situ,BRD-K32730239-001-01-0::2.5::HTS,7.670997804374817,0.005797994828713333,Other Types,SU3327,JNK inhibitor,MAPK8
Breast Ductal Carcinoma In Situ,BRD-K33127281-001-05-6::2.5::HTS,4.597905303482802,0.03244549072164579,Other Types,adapalene,retinoid receptor agonist,"RARA, RARB, RARG, RXRA, RXRB, RXRG"
Breast Ductal Carcinoma In Situ,BRD-K33583600-001-16-1::2.5::HTS,6.725422216028632,0.009756066961595884,Other Types,isoliquiritigenin,guanylate cyclase activator,GABBR1
Breast Ductal Carcinoma In Situ,BRD-K37618799-001-03-0::2.5::HTS,6.874398615809319,0.008983023040986117,Other Types,MRS-1220,adenosine receptor antagonist,"ADORA2B, ADORA3"
Breast Ductal Carcinoma In Situ,BRD-K37764012-001-04-1::2.5::HTS,6.928370677457081,0.008717908935458898,Other Types,PF-03758309,p21 activated kinase inhibitor,PAK4
Breast Ductal Carcinoma In Situ,BRD-K37865504-001-04-1::2.5::HTS,5.7246455350351075,0.017060521797518366,Other Types,LY2183240,"FAAH inhibitor, FAAH reuptake inhibitor",FAAH
Breast Ductal Carcinoma In Situ,BRD-K38332599-001-01-3::2.5::HTS,6.0338838806850985,0.014336804032743365,Other Types,uprosertib,AKT inhibitor,"AKT1, AKT2, AKT3"
Breast Ductal Carcinoma In Situ,BRD-K38548312-001-01-0::2.5::HTS,5.56421928372861,0.018674281066838584,Other Types,VER-49009,HSP inhibitor,HSP90AA1
Breast Ductal Carcinoma In Situ,BRD-K38860038-001-01-2::2.5::HTS,3.961797825643839,0.04703667239382686,Other Types,JK-184,hedgehog pathway inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K39252998-003-01-5::2.5::HTS,17.958201359321457,2.6508775903522843e-05,Other Types,atipamezole,adrenergic receptor antagonist,
Breast Ductal Carcinoma In Situ,BRD-K39484304-001-16-5::2.5::HTS,5.270196499647787,0.022062185790061244,Other Types,triptolide,RNA polymerase inhibitor,RELA
Breast Ductal Carcinoma In Situ,BRD-K41213548-001-02-0::2.5::HTS,4.047040631696689,0.04473963105958856,Other Types,KW-2478,HSP inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K41859756-001-06-8::2.5::HTS,7.031401304558463,0.00823861384485807,Other Types,NVP-AUY922,HSP inhibitor,"HSP90AA1, HSP90AB1"
Breast Ductal Carcinoma In Situ,BRD-K41876534-001-13-7::2.5::HTS,8.1652674445244,0.004429621733657307,Other Types,tioxolone,carbonic anhydrase inhibitor,CA2
Breast Ductal Carcinoma In Situ,BRD-K42495768-001-01-7::2.5::HTS,4.076998629333029,0.04395897673975926,Other Types,tasisulam,apoptosis stimulant,
Breast Ductal Carcinoma In Situ,BRD-K43389698-001-09-9::2.4::HTS,7.882819155674044,0.005175251977864056,Other Types,BMS-387032,"CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor","CDK2, CDK7, CDK9"
Breast Ductal Carcinoma In Situ,BRD-K43802723-340-01-9::2.5::HTS,5.932781595449654,0.015171504961549714,Other Types,AMG-837,free fatty acid receptor agonist,FFAR1
Breast Ductal Carcinoma In Situ,BRD-K44777625-001-03-5::2.5::HTS,4.544101577702757,0.033467794028545876,Other Types,FH1,hepatocyte function enhancer,
Breast Ductal Carcinoma In Situ,BRD-K45435259-003-11-1::2.5::HTS,4.351210579493642,0.037435455129808656,Other Types,SCH-23390,dopamine receptor antagonist,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
Breast Ductal Carcinoma In Situ,BRD-K47177710-001-03-1::2.5::HTS,4.9752683590862725,0.02610899819221812,Other Types,DAPT,gamma secretase inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K47869605-001-32-0::2.5::HTS,7.855516142548094,0.005246612096036234,Other Types,podophyllotoxin,"microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB"
Breast Ductal Carcinoma In Situ,BRD-K48684885-001-04-2::2.5::HTS,4.182111698095527,0.04132472113395765,Other Types,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Breast Ductal Carcinoma In Situ,BRD-K49049886-001-08-7::2.5::HTS,8.027173375516519,0.00477592184746981,Other Types,CGS-15943,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Breast Ductal Carcinoma In Situ,BRD-K50000283-001-04-4::2.5::HTS,11.95018258863207,0.0005877418679035766,Other Types,PHA-767491,CDC inhibitor,"CDK1, RPS6KB1"
Breast Ductal Carcinoma In Situ,BRD-K50406511-001-26-0::2.5::HTS,4.916671036792561,0.027001594638331752,Other Types,hycanthone,RNA synthesis inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K51318897-001-15-3::2.5::HTS,7.89202728349046,0.005145574386983821,Other Types,fenbendazole,tubulin polymerization inhibitor,TUBB
Breast Ductal Carcinoma In Situ,BRD-K51791723-003-01-7::2.5::HTS,4.58875226815047,0.03261382044564628,Other Types,P276-00,CDK inhibitor,"CDK1, CDK4, CDK9"
Breast Ductal Carcinoma In Situ,BRD-K52075715-001-06-7::2.5::HTS,11.524065338625002,0.0007354793303516022,Other Types,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Breast Ductal Carcinoma In Situ,BRD-K52233191-001-02-4::2.5::HTS,4.44364595912071,0.03548647888855927,Other Types,R547,CDK inhibitor,"CDK1, CDK2, CDK4, CDK7"
Breast Ductal Carcinoma In Situ,BRD-K53532120-003-11-1::2.5::HTS,4.254998326853908,0.03960049352114897,Breast Ductal Carcinoma In Situ,U-50488-(-),opioid receptor agonist,OPRK1
Breast Ductal Carcinoma In Situ,BRD-K54247840-004-01-3::2.5::HTS,3.959627611282285,0.047102319960142504,Other Types,halofuginone,collagenase inhibitor,"COL1A1, MMP2"
Breast Ductal Carcinoma In Situ,BRD-K54256913-001-08-7::2.5::HTS,8.88099425423304,0.003007287261939687,Other Types,MK-1775,WEE1 kinase inhibitor,WEE1
Breast Ductal Carcinoma In Situ,BRD-K54262262-001-09-0::2.5::HTS,4.0438167573024515,0.044820047745106215,Other Types,monobenzone,melanin inhibitor,TYR
Breast Ductal Carcinoma In Situ,BRD-K56957086-001-06-3::2.5::HTS,4.372991366970446,0.036961291424078994,Other Types,dacinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
Breast Ductal Carcinoma In Situ,BRD-K57275767-001-03-2::2.5::HTS,3.8750369088793852,0.04950736565028136,Other Types,geniposide,GLP receptor agonist,GLP1R
Breast Ductal Carcinoma In Situ,BRD-K58049875-001-04-7::2.5::HTS,9.559691538059102,0.0020883106023889663,Other Types,thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1
Breast Ductal Carcinoma In Situ,BRD-K60446698-001-01-2::2.5::HTS,4.590341140092154,0.03258463005280995,Other Types,ONX-0914,proteasome inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K61228301-001-01-2::2.5::HTS,7.2106306219581855,0.007462526603992364,Other Types,SGI-1027,DNA methyltransferase inhibitor,"DNMT1, DNMT3A, DNMT3B"
Breast Ductal Carcinoma In Situ,BRD-K61314889-001-04-4::2.5::HTS,4.284646418033573,0.03891434966966975,Breast Ductal Carcinoma In Situ,endo-IWR-1,PARP inhibitor,"TNKS, TNKS2"
Breast Ductal Carcinoma In Situ,BRD-K63784565-001-06-2::2.51::HTS,5.129005700533955,0.023933750905265602,Other Types,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1
Breast Ductal Carcinoma In Situ,BRD-K64137799-003-02-5::2.5::HTS,4.803210803872644,0.028816356572982416,Breast Ductal Carcinoma In Situ,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6"
Breast Ductal Carcinoma In Situ,BRD-K64800655-001-07-4::2.5::HTS,6.031590665012259,0.014353612540184635,Other Types,PHA-793887,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9"
Breast Ductal Carcinoma In Situ,BRD-K64881305-001-03-7::2.5::HTS,11.188498561715061,0.0008783512255260229,Other Types,ispinesib,kinesin inhibitor,KIF11
Breast Ductal Carcinoma In Situ,BRD-K67860401-001-05-6::2.5::HTS,4.441790064839855,0.03551414662699698,Breast Ductal Carcinoma In Situ,AR-A014418,glycogen synthase kinase inhibitor,GSK3B
Breast Ductal Carcinoma In Situ,BRD-K68164687-001-01-6::2.5::HTS,5.997355210964824,0.014632804930502303,Other Types,epothilone-b,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Breast Ductal Carcinoma In Situ,BRD-K70511574-001-06-9::2.5::HTS,4.494308190071837,0.03444703505907015,Other Types,HMN-214,PLK inhibitor,PLK1
Breast Ductal Carcinoma In Situ,BRD-K72414522-001-06-7::2.5::HTS,5.868155786082781,0.015733485067858842,Other Types,AZD5438,CDK inhibitor,KCNH2
Breast Ductal Carcinoma In Situ,BRD-K72815923-034-01-2::2.5::HTS,5.418581361742059,0.020279526778298057,Other Types,xanomeline,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
Breast Ductal Carcinoma In Situ,BRD-K73197500-001-02-2::2.5::HTS,6.791894492266356,0.00940186006588333,Other Types,SNX-5422,HSP inhibitor,HSP90AA1
Breast Ductal Carcinoma In Situ,BRD-K77638923-001-02-0::2.5::HTS,5.246275926928738,0.02237905229812252,Other Types,CUDC-907,PI3K inhibitor,"HDAC2, PIK3R1"
Breast Ductal Carcinoma In Situ,BRD-K77841042-001-14-1::2.5::HTS,4.289937352736319,0.038802648207895786,Other Types,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Breast Ductal Carcinoma In Situ,BRD-K77987382-001-13-2::2.5::HTS,5.070242926053317,0.024725307433360634,Other Types,mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B"
Breast Ductal Carcinoma In Situ,BRD-K78177893-001-02-4::2.5::HTS,5.413313200396768,0.02034084752577559,Other Types,A-674563,AKT inhibitor,"AKT1, PKIA, PRKACA"
Breast Ductal Carcinoma In Situ,BRD-K78815826-001-14-6::2.5::HTS,4.757587906167662,0.029586128197772642,Other Types,suxibuzone,cyclooxygenase inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K79404599-001-09-3::2.5::HTS,4.869164687900019,0.027744336158634836,Breast Ductal Carcinoma In Situ,enzastaurin,PKC inhibitor,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG"
Breast Ductal Carcinoma In Situ,BRD-K80431395-001-09-9::2.5::HTS,7.576220769368379,0.006118206243758158,Other Types,triciribine,AKT inhibitor,"AKT1, AKT2, AKT3"
Breast Ductal Carcinoma In Situ,BRD-K80778372-001-02-5::2.5::HTS,5.3861610795954045,0.02065920204444413,Other Types,Ro-19-4605,,"GABRA1, GABRA2, GABRA3, GABRA5"
Breast Ductal Carcinoma In Situ,BRD-K83699324-001-01-1::2.5::HTS,6.985516247946661,0.008453164610140593,Other Types,NMS-1286937,PLK inhibitor,"FLT3, PLK1, PLK2, PLK3"
Breast Ductal Carcinoma In Situ,BRD-K83834509-001-01-1::2.5::HTS,4.46913745921072,0.03495463329110707,Other Types,PTC-209,BMI-1 inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K86003836-001-10-5::2.5::HTS,7.56646707640427,0.006139479552069273,Other Types,flubendazole,tubulin polymerization inhibitor,TUBB
Breast Ductal Carcinoma In Situ,BRD-K86525559-001-07-8::2.52::HTS,3.8918304425432018,0.04904274473206263,Other Types,AZD7762,CHK inhibitor,"CHEK1, CHEK2"
Breast Ductal Carcinoma In Situ,BRD-K86687746-001-01-3::2.5::HTS,6.796072856972578,0.009385549951412988,Other Types,R306465,HDAC inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K86797399-001-05-1::2.55::HTS,8.501795406820097,0.0036987250255995506,Other Types,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Breast Ductal Carcinoma In Situ,BRD-K87909389-003-03-4::2.5::HTS,4.60257652004475,0.03235407335191787,Other Types,alvocidib,CDK inhibitor,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM"
Breast Ductal Carcinoma In Situ,BRD-K89056082-001-07-7::2.5::HTS,29.561141519602845,8.11818238646587e-08,Other Types,chlorocresol,ryanodine receptor activator,
Breast Ductal Carcinoma In Situ,BRD-K90524085-001-07-8::2.5::HTS,4.082939221444463,0.043795393826326245,Other Types,MY-5445,"phosphodiesterase inhibitor, platelet aggregation inhibitor",PDE5A
Breast Ductal Carcinoma In Situ,BRD-K91111634-001-01-2::2.5::HTS,5.568150532809746,0.01863282267297196,Breast Ductal Carcinoma In Situ,rotigotine,dopamine receptor agonist,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A"
Breast Ductal Carcinoma In Situ,BRD-K92093830-003-30-8::2.5::HTS,6.02615447573838,0.01439903162888816,Other Types,doxorubicin,topoisomerase inhibitor,TOP2A
Breast Ductal Carcinoma In Situ,BRD-K92150287-066-01-2::2.5::HTS,5.258931482755413,0.022208069146090244,Other Types,exatecan-mesylate,topoisomerase inhibitor,TOP1
Breast Ductal Carcinoma In Situ,BRD-K92428153-001-04-4::2.5::HTS,4.6001194878659675,0.0323993106752008,Other Types,mycophenolate-mofetil,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Breast Ductal Carcinoma In Situ,BRD-K93806173-003-01-8::2.5::HTS,5.163620536347305,0.023448504143112777,Other Types,N-MPPP,opioid receptor agonist,
Breast Ductal Carcinoma In Situ,BRD-K94485812-001-02-9::2.55::HTS,4.173043951230083,0.04156800122083172,Breast Ductal Carcinoma In Situ,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K95573441-001-01-2::2.5::HTS,5.562308749914369,0.018694463786044942,Other Types,PFK-015,phosphofructokinase inhibitor,PFKFB3
Breast Ductal Carcinoma In Situ,BRD-K96104201-001-01-5::2.5::HTS,3.8987811839160793,0.048814654086292035,Other Types,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K96259238-001-01-4::2.5::HTS,4.005044933614906,0.04584719583557419,Other Types,Y-320,interleukin inhibitor,IL17A
Breast Ductal Carcinoma In Situ,BRD-K99170882-001-04-3::2.5::HTS,5.3363412914257085,0.02124925220309448,Other Types,NSC-319726,p53 activator,
Breast Ductal Carcinoma In Situ,BRD-K99498722-001-02-6::2.5::HTS,5.278153276816284,0.02196654186905144,Other Types,plinabulin,tubulin polymerization inhibitor,
Breast Ductal Carcinoma In Situ,BRD-A21544762-303-01-5::2.5::MTS004,4.340423591023456,0.037688289236471724,Other Types,pipecuronium,neuromuscular blocker,"CHRM2, CHRM3, CHRNA2"
Breast Ductal Carcinoma In Situ,BRD-A31362467-065-01-3::2.499984736::MTS004,6.473964404141693,0.011224963901862815,Other Types,capreomycin,protein synthesis inhibitor,
Breast Ductal Carcinoma In Situ,BRD-A33479817-003-03-7::2.490825408::MTS004,4.624391291158428,0.031964499228201104,Other Types,terodiline,cholinergic receptor antagonist,
Breast Ductal Carcinoma In Situ,BRD-A46335897-003-27-8::2.499949994::MTS004,5.26318397719168,0.022164813455534393,Other Types,promethazine,histamine receptor antagonist,"ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A"
Breast Ductal Carcinoma In Situ,BRD-A73679382-236-01-8::2.499981367::MTS004,9.210639492259295,0.002522265768373864,Other Types,MK-571,leukotriene receptor antagonist,"ABCC2, CYSLTR1"
Breast Ductal Carcinoma In Situ,BRD-A92177080-001-02-1::2.5::MTS004,4.11284215831269,0.04305010816422365,Other Types,betamethasone-acetate,glucocorticoid receptor agonist,NR3C1
Breast Ductal Carcinoma In Situ,BRD-K00634421-001-01-0::2.500042819::MTS004,6.680979130393073,0.01000686021807127,Other Types,brivaracetam,voltage-gated sodium channel blocker,SV2A
Breast Ductal Carcinoma In Situ,BRD-K03165895-001-01-9::2.499970324::MTS004,3.880109746615849,0.049372941298153804,Other Types,elafibranor,PPAR receptor agonist,"PPARA, PPARD"
Breast Ductal Carcinoma In Situ,BRD-K06328344-015-01-7::2.500004254::MTS004,4.169068260526181,0.04165561679878948,Other Types,bremelanotide,melanocortin receptor agonist,"MC1R, MC2R, MC3R, MC4R, MC5R"
Breast Ductal Carcinoma In Situ,BRD-K10415035-001-04-4::2.5::MTS004,4.331147146461369,0.03789250060870204,Other Types,tasuldine,mucolytic agent,
Breast Ductal Carcinoma In Situ,BRD-K11452913-001-01-9::2.5000112::MTS004,16.679220113246704,5.098405596209237e-05,Other Types,evatanepag,prostaglandin inhibitor,"PTGER2, PTGER4"
Breast Ductal Carcinoma In Situ,BRD-K11851476-003-01-7::2.499993171::MTS004,7.032044594381048,0.008242114110219327,Other Types,pardoprunox,"serotonin receptor agonist, dopamine receptor agonist","DRD2, DRD3, DRD4, HTR1A, HTR7"
Breast Ductal Carcinoma In Situ,BRD-K13277760-001-01-2::2.5::MTS004,6.7842907073588545,0.009450664051235244,Other Types,rifamycin-sv,RNA synthesis inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K16505263-003-02-9::2.49996754::MTS004,5.687722665259485,0.017428704540633715,Other Types,forodesine,purinergic receptor antagonist,PNP
Breast Ductal Carcinoma In Situ,BRD-K17610631-001-03-3::2.421190843::MTS004,12.718146450176835,0.000394347963588392,Other Types,indisulam,CDK inhibitor,"CA1, CA12, CA14, CA2, CA6, CA7, CA9"
Breast Ductal Carcinoma In Situ,BRD-K17641316-001-04-8::2.500015146::MTS004,9.962850806086108,0.001686584356729867,Other Types,decoquinate,antiprotozoal agent,
Breast Ductal Carcinoma In Situ,BRD-K20463415-300-01-4::2.499966791::MTS004,4.689535582784162,0.030784743294276183,Other Types,LY2606368,CHK inhibitor,CHEK1
Breast Ductal Carcinoma In Situ,BRD-K24666289-001-04-9::2.499988887::MTS004,4.554834128816442,0.033276557180102924,Other Types,copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Breast Ductal Carcinoma In Situ,BRD-K26026438-001-01-0::2.499979456::MTS004,7.309159607887459,0.007077407064394414,Other Types,tucatinib,EGFR inhibitor,ERBB2
Breast Ductal Carcinoma In Situ,BRD-K34068325-066-03-7::2.499970684::MTS004,5.17127644084981,0.023355630925157075,Other Types,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4
Breast Ductal Carcinoma In Situ,BRD-K59866480-001-07-3::2.379655165::MTS004,18.271996823404823,2.264868127864918e-05,Other Types,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
Breast Ductal Carcinoma In Situ,BRD-K64120610-001-01-4::2.5::MTS004,7.933545973693687,0.00503052527551938,Other Types,vinflunine,microtubule inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K73753850-003-01-6::2.499957259::MTS004,13.622305607678676,0.00024624158640537366,Other Types,hexaminolevulinate,,
Breast Ductal Carcinoma In Situ,BRD-K74671368-001-01-8::2.5::MTS004,4.0898815674594955,0.04363403361439914,Other Types,idronoxil,XIAP inhibitor,"ENOX2, SPHK1"
Breast Ductal Carcinoma In Situ,BRD-K77038618-356-01-3::2.500022896::MTS004,6.7867355462736105,0.009437419500016064,Other Types,garenoxacin,topoisomerase inhibitor,TOP2A
Breast Ductal Carcinoma In Situ,BRD-K83029223-001-01-3::2.500025378::MTS004,6.582871737269251,0.010566215870164429,Other Types,litronesib,kinesin-like spindle protein inhibitor,KIF11
Breast Ductal Carcinoma In Situ,BRD-K88854110-001-01-5::2.499975441::MTS004,16.587293820955246,5.345151370252892e-05,Other Types,taprenepag,prostaglandin receptor agonist,PTGER2
Breast Ductal Carcinoma In Situ,BRD-K89121095-001-01-7::2.499999138::MTS004,13.627295689686454,0.0002456041780904029,Other Types,tedizolid-phosphate,protein synthesis inhibitor,
Breast Ductal Carcinoma In Situ,BRD-K89490285-001-08-1::2.521612095::MTS004,5.5228338934273475,0.019129475697549345,Other Types,bentazepam,benzodiazepine receptor agonist,
Breast Ductal Carcinoma In Situ,BRD-K92902018-001-01-9::2.507952536::MTS004,4.67753019954513,0.030998685800957194,Other Types,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR
Breast Ductal Carcinoma In Situ,BRD-K96344439-002-02-7::2.500011072::MTS004,14.210208335685842,0.00018157224826365292,Other Types,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK
Breast Ductal Carcinoma In Situ,BRD-K99431849-001-01-7::2.500018158::MTS004,3.8804240800158927,0.049363767696274055,Other Types,peretinoin,retinoid receptor agonist,RXRA
Breast Ductal Carcinoma In Situ,BRD-K99919177-001-01-3::2.5::MTS004,4.17036332627309,0.041623138974189816,Other Types,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Hepatoblastoma,BRD-A02180903-001-04-5::2.5::HTS,6.279879818587625,0.012495681612634,Hepatoblastoma,betamethasone,glucocorticoid receptor agonist,NR3C1
Hepatoblastoma,BRD-A07000685-001-04-4::2.5::HTS,8.618152874040238,0.0034656834778113827,Hepatoblastoma,hydrocortisone-hemisuccinate,,
Hepatoblastoma,BRD-A07207424-001-13-2::2.5::HTS,9.86225007846419,0.0017757224941578047,Hepatoblastoma,Ro-20-1724,phosphodiesterase inhibitor,"PDE3A, PDE4A, PDE4B, PDE4C, PDE4D"
Hepatoblastoma,BRD-A07893380-213-01-7::2.5::HTS,4.355705270671623,0.037364185002808074,Hepatoblastoma,vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1"
Hepatoblastoma,BRD-A07932845-050-15-8::2.5::HTS,5.340788191592693,0.021193692371675524,Hepatoblastoma,metitepine,anti-HCVE2,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
Hepatoblastoma,BRD-A08255417-001-14-7::2.5::HTS,5.781298820770955,0.016522408524806763,Hepatoblastoma,famprofazone,cyclooxygenase inhibitor,
Hepatoblastoma,BRD-A09062839-003-10-0::2.5::HTS,6.436506515359122,0.011450080793549144,Other Types,amyleine,local anesthetic,
Hepatoblastoma,BRD-A09467419-003-22-4::2.5::HTS,3.9581778902217426,0.04714907720099788,Hepatoblastoma,mebeverine,acetylcholine receptor antagonist,CHRM1
Hepatoblastoma,BRD-A11662333-001-03-3::2.5::HTS,5.000907864498749,0.025752514610914014,Hepatoblastoma,meparfylon,,
Hepatoblastoma,BRD-A11813248-003-02-4::2.5::HTS,4.306698753809833,0.03841932938747213,Other Types,AM-92016,potassium channel blocker,GRIN1
Hepatoblastoma,BRD-A13133631-001-04-0::2.5::HTS,5.253231063859598,0.02228022578012671,Hepatoblastoma,fluorometholone,glucocorticoid receptor agonist,NR3C1
Hepatoblastoma,BRD-A14395271-074-17-8::2.5::HTS,5.302439434099752,0.02166261887899746,Hepatoblastoma,mesoridazine,dopamine receptor antagonist,"DRD2, HTR2A"
Hepatoblastoma,BRD-A17453586-003-02-3::2.5::HTS,7.6857772840016745,0.005750353699303193,Other Types,MDL-72832,serotonin receptor agonist,HTR1A
Hepatoblastoma,BRD-A22267103-003-13-1::2.5::HTS,4.637775794123049,0.0317039706639913,Other Types,drofenine,,
Hepatoblastoma,BRD-A24191444-046-02-1::2.5::HTS,5.762505834020083,0.01670052742967519,Hepatoblastoma,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Hepatoblastoma,BRD-A26334849-001-06-2::2.5::HTS,5.829850660200797,0.016074857214777596,Hepatoblastoma,propafenone,antiarrhythmic,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A"
Hepatoblastoma,BRD-A29111201-001-04-8::2.5::HTS,5.8080325751378155,0.01627626333544312,Other Types,ethisterone,progestogen hormone,TYR
Hepatoblastoma,BRD-A29281099-003-03-2::2.5::HTS,4.248332300282486,0.039761830805716734,Other Types,clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2"
Hepatoblastoma,BRD-A29485665-001-12-8::2.5::HTS,4.2627486533455485,0.039421656187308945,Hepatoblastoma,bicalutamide,androgen receptor antagonist,AR
Hepatoblastoma,BRD-A29644307-050-17-0::2.5::HTS,4.059459150349453,0.04440031015606087,Other Types,nomifensine,"dopamine uptake inhibitor, noradrenaline uptake inhibitor","DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3"
Hepatoblastoma,BRD-A30205217-001-11-2::2.5::HTS,4.503293969012694,0.03427034397908821,Hepatoblastoma,ethotoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Hepatoblastoma,BRD-A30655177-001-14-0::2.5::HTS,4.744514680322926,0.029812792921729295,Other Types,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Hepatoblastoma,BRD-A33084557-001-06-6::2.5::HTS,5.345444960380868,0.02114228104400431,Hepatoblastoma,tioconazole,sterol demethylase inhibitor,CYP51A1
Hepatoblastoma,BRD-A38218502-001-01-2::2.5::HTS,4.629650620334987,0.031850860878214295,Hepatoblastoma,metenkephalin,immunostimulant,OPRD1
Hepatoblastoma,BRD-A42571354-300-12-0::2.5::HTS,4.079150891268612,0.043892945027728815,Hepatoblastoma,cetirizine,histamine receptor antagonist,HRH1
Hepatoblastoma,BRD-A43082555-001-02-9::2.5::HTS,7.697722600099711,0.005714603066182412,Other Types,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Hepatoblastoma,BRD-A44863528-001-13-2::2.5::HTS,4.960682693451663,0.026332423545983284,Hepatoblastoma,proglumide,CCK receptor antagonist,"CCKAR, CCKBR"
Hepatoblastoma,BRD-A46066006-004-22-6::2.5::HTS,6.399452214752048,0.011690157689353445,Hepatoblastoma,clidinium,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Hepatoblastoma,BRD-A46813902-001-01-6::2.5::HTS,8.052235659043774,0.004709744704014591,Other Types,iododexetimide,acetylcholine receptor antagonist,
Hepatoblastoma,BRD-A53037300-001-01-0::2.5::HTS,7.582086811424974,0.00608687907678408,Other Types,2-fluoro-2-deoxy-D-galactose,,LCT
Hepatoblastoma,BRD-A53134341-001-03-2::2.5::HTS,4.402688863256227,0.03635152660225438,Hepatoblastoma,Ro-106-9920,NFkB pathway inhibitor,
Hepatoblastoma,BRD-A57957888-001-08-0::2.5::HTS,11.968179072364658,0.0005825875719574121,Hepatoblastoma,citiolone,"lipotropic, mucolytic agent",
Hepatoblastoma,BRD-A60786380-412-01-5::2.5::HTS,5.37759896282798,0.02077920100016901,Hepatoblastoma,sodium-stibogluconate,tyrosine phosphatase inhibitor,"PTPN6, TOP1"
Hepatoblastoma,BRD-A61676498-001-06-6::2.5::HTS,11.521667216611876,0.0007365863846042587,Hepatoblastoma,climbazole,enzyme inducer,
Hepatoblastoma,BRD-A64698388-003-01-7::2.5::HTS,16.155351871019413,6.655258561897638e-05,Hepatoblastoma,levo-phencynonate,acetylcholine receptor antagonist,CHRM1
Hepatoblastoma,BRD-A65145453-001-06-1::2.5::HTS,4.877813391826419,0.02761493536727783,Hepatoblastoma,ATPA,glutamate receptor agonist,"GRIA2, GRIK1"
Hepatoblastoma,BRD-A68969091-001-12-7::2.57::HTS,4.7885480716619595,0.029072573118163237,Hepatoblastoma,echinomycin,DNA intercalating agent,
Hepatoblastoma,BRD-A69777949-001-24-2::2.5::HTS,4.383263335024373,0.03675411646432387,Hepatoblastoma,flumequine,topoisomerase inhibitor,
Hepatoblastoma,BRD-A70268693-050-01-2::2.5::HTS,6.542983895663659,0.010795785628123536,Hepatoblastoma,PG-9,acetylcholine receptor agonist,
Hepatoblastoma,BRD-A73427433-240-01-3::2.5::HTS,5.9459280060470165,0.015073187323607802,Hepatoblastoma,adaprev,TGF beta receptor inhibitor,"IGF2R, M6PR"
Hepatoblastoma,BRD-A75817871-001-06-7::2.5::HTS,3.9209614628601286,0.04818193800613734,Hepatoblastoma,blebbistatin-(+/-),ATPase inhibitor,MYH2
Hepatoblastoma,BRD-A75850590-213-01-0::2.5::HTS,8.219214726524442,0.004308234300902803,Hepatoblastoma,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A
Hepatoblastoma,BRD-A75919782-399-02-6::2.5::HTS,4.642267120558823,0.03162413733601679,Hepatoblastoma,leucovorin,folate receptor ligand,TYMS
Hepatoblastoma,BRD-A76672327-003-02-0::2.5::HTS,4.512910794665055,0.03408866415494455,Hepatoblastoma,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,
Hepatoblastoma,BRD-A77218119-001-03-5::2.5::HTS,4.492977541823234,0.03447442048072042,Other Types,SYM-2206,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Hepatoblastoma,BRD-A78391468-001-02-8::2.5::HTS,4.479471348075733,0.03474720798554756,Hepatoblastoma,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1
Hepatoblastoma,BRD-A79803969-003-16-1::2.5::HTS,5.485216484703219,0.019531180218789024,Hepatoblastoma,memantine,glutamate receptor antagonist,"CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A"
Hepatoblastoma,BRD-A88080608-001-04-2::2.5::HTS,4.246044836619978,0.03980564262575172,Other Types,equilin,estrogen receptor agonist,HSD17B1
Hepatoblastoma,BRD-A91822151-001-05-0::2.5::HTS,7.5285833251535434,0.006272457748698157,Other Types,picrotin,GABA receptor antagonist,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB"
Hepatoblastoma,BRD-A93353767-008-02-2::2.5::HTS,5.687333174617706,0.017419562849406246,Hepatoblastoma,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1
Hepatoblastoma,BRD-A93477898-001-04-2::2.5::HTS,4.13956668624182,0.04236757204433975,Hepatoblastoma,PETCM,caspase activator,CASP3
Hepatoblastoma,BRD-A94008949-001-01-9::2.5::HTS,6.50525542960319,0.01102154126515369,Other Types,telithromycin,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7"
Hepatoblastoma,BRD-A94523291-304-02-7::2.5::HTS,4.766044172967387,0.029443150421095278,Hepatoblastoma,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
Hepatoblastoma,BRD-A94993966-001-04-4::2.5::HTS,7.522472990177086,0.006287736365148402,Hepatoblastoma,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Hepatoblastoma,BRD-A95886749-001-03-5::2.5::HTS,4.748955565769954,0.029744367353236597,Hepatoblastoma,colfosceril-palmitate,pulmonary surfactant,
Hepatoblastoma,BRD-A97674275-001-11-8::2.5::HTS,6.280243253069983,0.012490610666583763,Other Types,ranolazine,sodium channel blocker,"SCN10A, SCN4A, SCN5A, SCN9A"
Hepatoblastoma,BRD-A98845662-036-03-7::2.5::HTS,9.260503520434716,0.002451511681288709,Other Types,desvenlafaxine,serotonin-norepinephrine reuptake inhibitor (SNRI),"SLC6A2, SLC6A3, SLC6A4"
Hepatoblastoma,BRD-K01295354-001-02-8::2.5::HTS,12.919096312143646,0.00035393078645193143,Other Types,uric-acid,,PYGL
Hepatoblastoma,BRD-K01902415-001-11-7::2.5::HTS,4.638781275753981,0.03168944550555798,Hepatoblastoma,pirinixic-acid,PPAR receptor agonist,PPARA
Hepatoblastoma,BRD-K02079473-001-01-3::2.5::HTS,5.880834113464715,0.015623491871629733,Other Types,oxatomide,histamine receptor antagonist,HRH1
Hepatoblastoma,BRD-K02389548-001-02-5::2.5::HTS,4.643745848378321,0.03159636013914459,Other Types,RG2833,HDAC inhibitor,"HDAC1, HDAC3"
Hepatoblastoma,BRD-K03095347-001-06-1::2.5::HTS,4.062057424400811,0.04433943107659548,Hepatoblastoma,levosimendan,calcium sensitizer,"KCNJ11, KCNJ8, PDE3A, TNNC1"
Hepatoblastoma,BRD-K04430056-001-17-7::2.5::HTS,4.809341991996932,0.02871490096042609,Hepatoblastoma,7-nitroindazole,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Hepatoblastoma,BRD-K04657451-001-01-0::2.5::HTS,6.237741789231297,0.012798817204098355,Hepatoblastoma,D-delta-Tocopherol,,
Hepatoblastoma,BRD-K04923131-001-15-4::2.5::HTS,7.412948989370717,0.006680381329477582,Hepatoblastoma,GSK-3-inhibitor-IX,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor","GSK3A, GSK3B"
Hepatoblastoma,BRD-K06388322-312-02-6::2.5::HTS,5.609897398597622,0.018199625222796487,Hepatoblastoma,pramipexole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
Hepatoblastoma,BRD-K06557128-001-07-0::2.5::HTS,4.721014955600732,0.030216985434349877,Other Types,voriconazole,cytochrome P450 inhibitor,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1"
Hepatoblastoma,BRD-K06762493-001-08-1::2.5::HTS,4.220126901191096,0.04041324614917532,Other Types,isbufylline,phosphodiesterase inhibitor,
Hepatoblastoma,BRD-K07220430-001-19-2::2.5::HTS,14.230488102129446,0.00017904279586806275,Other Types,cinnarazine,calcium channel blocker,
Hepatoblastoma,BRD-K07283971-001-01-3::2.5::HTS,4.0731513652172255,0.044048763869684766,Other Types,oxyclozanide,,
Hepatoblastoma,BRD-K07441213-001-18-9::2.5::HTS,4.277486414462047,0.03908059871896002,Other Types,paroxypropione,gonadotropin inhibitor,
Hepatoblastoma,BRD-K07609981-001-01-7::2.5::HTS,5.497863185123118,0.01938992979695551,Other Types,dexloxiglumide,CCK receptor antagonist,CCKAR
Hepatoblastoma,BRD-K07798980-001-01-9::2.5::HTS,5.280688026082574,0.021932889371532666,Other Types,PSI-6130,RNA polymerase inhibitor,
Hepatoblastoma,BRD-K08356259-003-24-7::2.5::HTS,10.435222664850228,0.0013092675703697651,Other Types,xylometazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Hepatoblastoma,BRD-K08837089-236-01-6::2.5::HTS,5.258272053267738,0.022211070864669048,Other Types,actinoquinol,,
Hepatoblastoma,BRD-K09537769-001-04-0::2.5::HTS,4.195208360883174,0.04100246241054905,Other Types,NU-7026,"DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor",PRKDC
Hepatoblastoma,BRD-K10071630-001-01-0::2.5::HTS,4.528173484333167,0.033776510582329784,Other Types,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
Hepatoblastoma,BRD-K10177585-003-02-4::2.5::HTS,3.8841028411302525,0.04924268744244386,Other Types,PSB-11,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA3"
Hepatoblastoma,BRD-K10673031-004-02-0::2.5::HTS,9.751340689316347,0.0018846370673746443,Other Types,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
Hepatoblastoma,BRD-K10705233-001-02-2::2.5::HTS,4.491384777247631,0.03451026570611286,Other Types,GW-405833,cannabinoid receptor agonist,CNR2
Hepatoblastoma,BRD-K10852020-001-04-5::2.5::HTS,3.9365137532421532,0.04775537323170801,Hepatoblastoma,tolcapone,catechol O methyltransferase inhibitor,COMT
Hepatoblastoma,BRD-K11399644-003-11-3::2.5::HTS,7.516466213334343,0.006317206714418215,Other Types,phenformin,AMPK activator,"KCNJ8, PRKAA1"
Hepatoblastoma,BRD-K11663430-001-02-3::2.5::HTS,7.285267982160774,0.007162579979400831,Other Types,pyroxamide,HDAC inhibitor,HDAC1
Hepatoblastoma,BRD-K11742128-003-23-4::2.5::HTS,10.950535503404433,0.0009962252921375992,Hepatoblastoma,triprolidine,histamine receptor antagonist,HRH1
Hepatoblastoma,BRD-K12068470-001-02-5::2.36::HTS,4.956296906139596,0.02641703170272927,Hepatoblastoma,LY2608204,glucokinase activator,GCK
Hepatoblastoma,BRD-K12614344-003-01-8::2.5::HTS,7.376743079397596,0.006811381556153902,Hepatoblastoma,CGS-21680,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatoblastoma,BRD-K13819402-003-10-2::2.4::HTS,7.407447209674261,0.0066968901697184915,Hepatoblastoma,desoxypeganine,"acetylcholinesterase inhibitor, monoamine oxidase inhibitor",ACHE
Hepatoblastoma,BRD-K14401183-001-10-7::2.5::HTS,4.254798757984936,0.039605109793483965,Other Types,avobenzone,UV blocker,TYR
Hepatoblastoma,BRD-K14711741-001-02-1::2.5::HTS,5.374234529228488,0.02079432315905685,Other Types,PF-4708671,ribosomal protein inhibitor,RPS6KB1
Hepatoblastoma,BRD-K15601958-001-03-9::2.5::HTS,4.386771365990567,0.036668466128076595,Other Types,SEW-2871,lysophospholipid receptor agonist,S1PR1
Hepatoblastoma,BRD-K16077845-001-06-1::2.5::HTS,4.7655992728306495,0.02944845746410492,Other Types,fentiazac,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatoblastoma,BRD-K17378184-300-05-9::2.5::HTS,4.270465167383406,0.0392444430508358,Other Types,BP-897,dopamine receptor agonist,"ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B"
Hepatoblastoma,BRD-K17874705-300-03-2::2.5::HTS,5.9038658850102435,0.015429622516900839,Other Types,2-pyridylethylamine,histamine receptor agonist,HRH1
Hepatoblastoma,BRD-K17977438-048-02-4::2.5::HTS,8.09515341078527,0.004601378049504251,Other Types,oxelaidin,antitussive,
Hepatoblastoma,BRD-K18375018-376-02-3::2.5::HTS,5.686255109722176,0.01743195073470577,Hepatoblastoma,spermine,,"CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5"
Hepatoblastoma,BRD-K18678457-003-02-8::2.5::HTS,6.635184609507195,0.010253573563480039,Hepatoblastoma,ZD-7288,HCN channel blocker,"HCN1, HCN2, HCN3, HCN4"
Hepatoblastoma,BRD-K18772613-303-02-4::2.5::HTS,7.749138621963797,0.005556027220418885,Other Types,benzoquinonium-dibromide,cholinergic receptor antagonist,CHRNA1
Hepatoblastoma,BRD-K19111024-001-20-9::2.5::HTS,7.860219366933121,0.0052355324694776315,Hepatoblastoma,clofibric-acid,PPAR receptor agonist,PPARA
Hepatoblastoma,BRD-K19318328-001-01-3::2.5::HTS,5.606546712122612,0.018267808517052498,Other Types,FR-139317,endothelin receptor antagonist,EDNRA
Hepatoblastoma,BRD-K19456237-001-27-6::2.5::HTS,10.941041947690195,0.0010015776687674035,Hepatoblastoma,piracetam,acetylcholine receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Hepatoblastoma,BRD-K20338176-001-17-7::2.5::HTS,7.890262509534522,0.005144647145866261,Hepatoblastoma,cefaclor,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-K20655524-003-12-0::2.5::HTS,4.739100425073151,0.029917683832822433,Hepatoblastoma,mefexamide,psychoactive drug,
Hepatoblastoma,BRD-K20714604-003-02-9::2.5::HTS,6.536128555921648,0.010833614872375726,Hepatoblastoma,RS-56812,serotonin receptor partial agonist,HTR3A
Hepatoblastoma,BRD-K21910317-001-12-3::2.5::HTS,5.69680767946629,0.0173285262807734,Other Types,"2,4-dinitrophenol",ATP synthase inhibitor,APP
Hepatoblastoma,BRD-K22745370-003-02-3::2.5::HTS,6.072494212586408,0.014028485658212781,Other Types,2-BFI,imidazoline receptor ligand,"ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB"
Hepatoblastoma,BRD-K23383398-001-09-9::2.5::HTS,4.863485861478608,0.027840827843857715,Other Types,T-0901317,LXR agonist,"NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB"
Hepatoblastoma,BRD-K24179883-001-16-7::2.5::HTS,5.407075676388666,0.020413581605780072,Hepatoblastoma,arsanilic-acid,,LYZ
Hepatoblastoma,BRD-K24566386-001-01-9::2.5::HTS,8.766300038613533,0.0032006287735648173,Hepatoblastoma,SD-208,TGF beta receptor inhibitor,TGFBR1
Hepatoblastoma,BRD-K25015158-001-01-2::2.5::HTS,6.272397381510526,0.012549499945585893,Hepatoblastoma,limaprost-alfadex,prostanoid receptor agonist,PTGER1
Hepatoblastoma,BRD-K25279140-001-01-5::2.5::HTS,4.016418106505602,0.04556384754165202,Hepatoblastoma,MK-8745,Aurora kinase inhibitor,AURKA
Hepatoblastoma,BRD-K25723200-001-02-7::2.5::HTS,5.898346955495184,0.015476919221447807,Other Types,azilsartan-medoxomil,angiotensin receptor antagonist,"AGTR1, AGTR2"
Hepatoblastoma,BRD-K26373640-001-05-1::2.5::HTS,5.452350564338504,0.019893107890775998,Hepatoblastoma,IKK-2-inhibitor,"IKK inhibitor, SYK inhibitor",IKBKB
Hepatoblastoma,BRD-K27168049-001-02-8::2.5::HTS,8.144677523595483,0.004481517927191943,Other Types,SDZ-220-581,glutamate receptor antagonist,GRIN1
Hepatoblastoma,BRD-K27406233-001-07-7::2.5::HTS,8.450325182138991,0.0037950814669661585,Other Types,acetyl-l-leucine,,
Hepatoblastoma,BRD-K28405228-001-06-7::2.5::HTS,6.6768701449507,0.010022044941497023,Other Types,mecarbinate,,
Hepatoblastoma,BRD-K28492574-001-01-6::2.5::HTS,7.669020335182353,0.0058046017778724465,Other Types,piconol,,
Hepatoblastoma,BRD-K29546239-001-02-3::2.5::HTS,5.336113224382534,0.021256642312655696,Hepatoblastoma,SNC-80,,OPRD1
Hepatoblastoma,BRD-K29653726-001-13-4::2.5::HTS,3.9994014704494685,0.04599980709711261,Other Types,topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist","CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Hepatoblastoma,BRD-K29918010-003-04-1::2.5::HTS,4.529869786753655,0.0337464542183842,Other Types,glucosamine,glycosylated protein precursor,"IFNG, IL1B, MMP9, NFKB2, TNF"
Hepatoblastoma,BRD-K30126819-304-02-7::2.5::HTS,4.683157567894025,0.03088249530751112,Other Types,dimesna,tubulin polymerization inhibitor,
Hepatoblastoma,BRD-K30519779-001-03-1::2.5::HTS,4.122983368787353,0.04277474052574168,Other Types,homoquinolinic-acid,glutamate receptor agonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Hepatoblastoma,BRD-K30577245-341-01-9::2.5::HTS,6.974995692793138,0.008497656971466391,Hepatoblastoma,docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1"
Hepatoblastoma,BRD-K31135544-001-07-0::2.5::HTS,4.519271926133428,0.0339599555175423,Hepatoblastoma,IB-MECA,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatoblastoma,BRD-K31468676-237-01-8::2.5::HTS,10.365734851661724,0.0013612134052949484,Hepatoblastoma,oxonic-acid,uricase inhibitor,
Hepatoblastoma,BRD-K31731454-237-02-5::2.5::HTS,4.754719785076903,0.029639582780235846,Other Types,pemirolast,mediator release inhibitor,HRH1
Hepatoblastoma,BRD-K32101625-001-01-6::2.5::HTS,4.4423845304175495,0.03550108972919552,Hepatoblastoma,LX1031,tryptophan hydroxylase inhibitor,TPH1
Hepatoblastoma,BRD-K33251802-001-01-3::2.5::HTS,6.200029831215667,0.013065274522702888,Other Types,miglustat,Glycosyl transferase inhibitor,UGCG
Hepatoblastoma,BRD-K33425534-001-12-5::2.5::HTS,5.086597518677891,0.024502276785477593,Hepatoblastoma,exemestane,aromatase inhibitor,CYP19A1
Hepatoblastoma,BRD-K33732501-004-01-0::2.5::HTS,4.923832555159715,0.026894560108357123,Hepatoblastoma,methylnaltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1"
Hepatoblastoma,BRD-K33818169-003-04-6::2.5::HTS,6.824210204707655,0.009241105544939286,Other Types,GW-3965,LXR agonist,"NR1H2, NR1H3"
Hepatoblastoma,BRD-K34032314-001-04-1::2.5::HTS,5.177038668556509,0.023266361858885518,Hepatoblastoma,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1
Hepatoblastoma,BRD-K34332569-001-01-3::2.5::HTS,6.216385901201978,0.01294803285773432,Other Types,imidapril,angiotensin converting enzyme inhibitor,ACE
Hepatoblastoma,BRD-K34388247-236-08-2::2.5::HTS,3.867723424885761,0.04971929150649874,Hepatoblastoma,methicillin,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-K34411947-001-12-5::2.5::HTS,7.627107734935121,0.005939487329762035,Hepatoblastoma,streptozotocin,DNA alkylating agent,SLC2A2
Hepatoblastoma,BRD-K34672903-001-01-7::2.5::HTS,6.33998130327942,0.012082880838812772,Other Types,HEMADO,,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Hepatoblastoma,BRD-K34730807-001-17-6::2.5::HTS,6.504763354097309,0.011040819756845835,Hepatoblastoma,levodopa,dopamine precursor,"DRD1, DRD2, DRD3, DRD4, DRD5, GPR143"
Hepatoblastoma,BRD-K36258877-001-03-1::2.5::HTS,6.973571913634157,0.008504335216329475,Other Types,AZ-10417808,caspase inhibitor,CASP3
Hepatoblastoma,BRD-K36270037-001-01-7::2.5::HTS,6.111871281098464,0.01372532813746803,Hepatoblastoma,esculin,antioxidant,
Hepatoblastoma,BRD-K37714784-305-02-1::2.5::HTS,3.8909787566020286,0.0490376189732614,Other Types,ABT-724,dopamine receptor agonist,DRD4
Hepatoblastoma,BRD-K37865504-001-04-1::2.5::HTS,4.3405445114479075,0.037672876939177924,Hepatoblastoma,LY2183240,"FAAH inhibitor, FAAH reuptake inhibitor",FAAH
Hepatoblastoma,BRD-K38684403-001-05-4::2.5::HTS,3.9119476260911354,0.04843203900850917,Other Types,roxithromycin,bacterial 50S ribosomal subunit inhibitor,"ABCB1, MLNR"
Hepatoblastoma,BRD-K38904395-001-02-3::2.5::HTS,5.713095927005419,0.017167174886755458,Other Types,SAR131675,VEGFR inhibitor,FLT4
Hepatoblastoma,BRD-K38911213-003-01-6::2.5::HTS,8.329172899471834,0.004052311005485419,Hepatoblastoma,apraclonidine,adrenergic receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C"
Hepatoblastoma,BRD-K39166528-001-01-0::2.5::HTS,7.083020374140498,0.008005535126568977,Other Types,ID-8,,
Hepatoblastoma,BRD-K39670393-303-02-1::2.5::HTS,4.76202540220258,0.02950764730389888,Hepatoblastoma,amthamine,histamine receptor agonist,HRH2
Hepatoblastoma,BRD-K40366680-001-03-3::2.5::HTS,5.160543438739743,0.023485546265573583,Other Types,CAY10505,PI3K inhibitor,PIK3CG
Hepatoblastoma,BRD-K41160163-001-06-8::2.5::HTS,6.373943597244442,0.011855904904708243,Hepatoblastoma,fenobam,glutamate receptor antagonist,GRM5
Hepatoblastoma,BRD-K41783120-001-02-8::2.5::HTS,4.699882919913116,0.03059597607124038,Other Types,STA-5326,interleukin synthesis inhibitor,IL12A
Hepatoblastoma,BRD-K41869275-001-02-8::2.5::HTS,4.839828263772935,0.02821593906201779,Other Types,2-phenylmelatonin,melatonin receptor agonist,"MTNR1A, MTNR1B"
Hepatoblastoma,BRD-K42098891-003-20-5::2.5::HTS,5.620617614665545,0.018096628266818907,Hepatoblastoma,protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4"
Hepatoblastoma,BRD-K42260897-001-09-2::2.5::HTS,6.1418052912274925,0.013500663500879594,Other Types,ezetimibe,"cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1"
Hepatoblastoma,BRD-K42497885-001-01-1::2.5::HTS,4.9148227391572465,0.02703837456439883,Hepatoblastoma,satraplatin,DNA alkylating agent,
Hepatoblastoma,BRD-K42859542-001-03-3::2.5::HTS,4.512595406498229,0.034086021464720194,Other Types,CFM-2,glutamate receptor antagonist,
Hepatoblastoma,BRD-K42973005-001-04-0::2.5::HTS,6.108785965946989,0.01374743945118638,Hepatoblastoma,CHIR-98014,glycogen synthase kinase inhibitor,"GSK3A, GSK3B"
Hepatoblastoma,BRD-K43880410-001-14-4::2.5::HTS,4.212146701312087,0.04059813150896051,Other Types,pregnenolone,glutamate receptor modulator,"CYP17A1, SULT2B1"
Hepatoblastoma,BRD-K44009692-001-02-3::2.5::HTS,9.390095790654877,0.002287963461165028,Other Types,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
Hepatoblastoma,BRD-K45071273-003-25-6::2.5::HTS,7.170629154582606,0.0076337732106614075,Other Types,tetracaine,membrane integrity inhibitor,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Hepatoblastoma,BRD-K45152786-001-08-4::2.5::HTS,5.845025991125033,0.015947581833230605,Hepatoblastoma,merbarone,topoisomerase inhibitor,TOP2A
Hepatoblastoma,BRD-K45542189-048-22-1::2.5::HTS,5.490466432723648,0.019471935089348347,Hepatoblastoma,diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1"
Hepatoblastoma,BRD-K45724504-001-01-6::1.36::HTS,3.861812696309152,0.04989345920081468,Hepatoblastoma,anguidine,protein synthesis inhibitor,SLC5A1
Hepatoblastoma,BRD-K46585355-001-14-3::2.5::HTS,5.884135945743929,0.015593398730501145,Hepatoblastoma,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,
Hepatoblastoma,BRD-K47539947-001-03-7::2.5::HTS,4.667209463003783,0.031169607442969486,Hepatoblastoma,tetradecylthioacetic-acid,lipid peroxidase inhibitor,
Hepatoblastoma,BRD-K47557313-001-02-7::2.5::HTS,6.811420705327983,0.009300849805930161,Hepatoblastoma,LY2109761,TGF beta receptor inhibitor,"TGFBR1, TGFBR2"
Hepatoblastoma,BRD-K48168960-001-19-2::2.5::HTS,17.30998413196459,3.672355817721802e-05,Other Types,propylthiouracil,thyroid peroxidase inhibitor,"DIO1, TPO"
Hepatoblastoma,BRD-K49519144-001-04-6::2.5::HTS,5.22564681697582,0.022651445651268087,Hepatoblastoma,LY2140023,glutamate receptor agonist,GRM3
Hepatoblastoma,BRD-K49669041-001-08-4::2.5::HTS,3.9202631712859644,0.04820180768286677,Hepatoblastoma,BX-912,pyruvate dehydrogenase kinase inhibitor,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1"
Hepatoblastoma,BRD-K49807096-003-15-5::2.5::HTS,6.414255868363271,0.011596708516912718,Hepatoblastoma,benazepril,angiotensin converting enzyme inhibitor,ACE
Hepatoblastoma,BRD-K50293352-300-02-1::2.5::HTS,5.002866296187521,0.025698929882485462,Other Types,MM77,serotonin receptor antagonist,HTR1A
Hepatoblastoma,BRD-K50631926-001-02-3::2.5::HTS,12.720201294341466,0.0003925723253201436,Other Types,PIK-294,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Hepatoblastoma,BRD-K51937257-001-01-4::2.5::HTS,4.204216590065907,0.04079530626540297,Other Types,bilastine,histamine receptor antagonist,HRH1
Hepatoblastoma,BRD-K52559566-001-02-9::2.5::HTS,8.350507233476124,0.004009033916485785,Hepatoblastoma,monosodium-alpha-luminol,,
Hepatoblastoma,BRD-K52756523-001-24-7::2.5::HTS,4.877748612796372,0.027610798006824044,Other Types,dirithromycin,bacterial 50S ribosomal subunit inhibitor,
Hepatoblastoma,BRD-K54187111-001-09-2::2.5::HTS,5.446126267988647,0.019965935995619022,Hepatoblastoma,dichlorisone-acetate,,
Hepatoblastoma,BRD-K54708045-001-02-1::2.5::HTS,6.360161983758648,0.011948769732059961,Other Types,nTZDpa,PPAR receptor agonist,PPARG
Hepatoblastoma,BRD-K55675242-001-03-0::2.5::HTS,5.527846381053798,0.019070698650308065,Other Types,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Hepatoblastoma,BRD-K56691760-001-01-2::2.5::HTS,6.131254837175415,0.01357730920890557,Hepatoblastoma,pikamilone,,
Hepatoblastoma,BRD-K56940914-001-04-2::2.5::HTS,6.514507805599341,0.010965494369738853,Hepatoblastoma,cresol,,
Hepatoblastoma,BRD-K58114536-001-01-6::2.5::HTS,7.0404252891626635,0.008194459054402855,Other Types,rasagiline,monoamine oxidase inhibitor,"BCL2, MAOB"
Hepatoblastoma,BRD-K58501140-002-01-0::2.5::HTS,4.2247845356602465,0.04030084279195329,Hepatoblastoma,TAK-875,insulin secretagogue,FFAR1
Hepatoblastoma,BRD-K58930050-050-15-8::2.5::HTS,9.202522294165222,0.002529065534383782,Other Types,dizocilpine-(+),glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
Hepatoblastoma,BRD-K59045783-001-01-1::2.5::HTS,6.9768896747785,0.00849004474970761,Other Types,faropenem-medoxomil,lactamase inhibitor,
Hepatoblastoma,BRD-K59146805-001-03-7::2.5::HTS,4.019094717737075,0.04546871794772538,Hepatoblastoma,AZ3146,monopolar spindle 1 kinase inhibitor,
Hepatoblastoma,BRD-K59273480-001-10-6::2.5::HTS,5.536052780680293,0.018972280689747132,Hepatoblastoma,propentofylline,"adenosine reuptake inhibitor, phosphodiesterase inhibitor",PDE1A
Hepatoblastoma,BRD-K59983611-001-21-9::2.5::HTS,5.2925934020539644,0.021869781041475952,Hepatoblastoma,sulfabenzamide,bacterial antifolate,
Hepatoblastoma,BRD-K59998349-003-01-4::2.5::HTS,7.401102185682382,0.006723920443437368,Other Types,aminolevulinic-acid-benzyl-ester,,
Hepatoblastoma,BRD-K60237333-001-27-1::2.5::HTS,6.652921656027923,0.010152302046111672,Hepatoblastoma,niacin,"NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT"
Hepatoblastoma,BRD-K61236135-001-08-2::2.5::HTS,5.221132953551345,0.02269664064045472,Hepatoblastoma,tiratricol,thyroid hormone stimulant,"THRA, THRB"
Hepatoblastoma,BRD-K61337602-003-02-1::2.5::HTS,4.444384563597399,0.03546226143450541,Hepatoblastoma,naratriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Hepatoblastoma,BRD-K61868322-050-01-7::2.5::HTS,5.364604051832342,0.020910905800067353,Other Types,tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2
Hepatoblastoma,BRD-K61951118-001-07-9::2.5::HTS,4.138727490813379,0.04238247680193381,Other Types,FG-7142,GABA benzodiazepine site receptor inverse agonist,
Hepatoblastoma,BRD-K62186992-334-02-8::2.5::HTS,3.9979540486403096,0.04605055675755389,Other Types,hydroxystilbamidine,,
Hepatoblastoma,BRD-K62326629-001-19-0::2.5::HTS,5.116213537952903,0.0240956528446724,Hepatoblastoma,dichlorophen,anticestodal agent,
Hepatoblastoma,BRD-K62858456-001-01-8::2.5::HTS,8.744812958962878,0.0032365069896253913,Other Types,lomerizine,calcium channel blocker,"CACNA1B, SCN5A"
Hepatoblastoma,BRD-K63516691-003-02-0::2.5::HTS,4.4943086999788555,0.03445178793765731,Hepatoblastoma,T-0156,phosphodiesterase inhibitor,PDE5A
Hepatoblastoma,BRD-K63915849-001-03-7::2.5::HTS,5.233329173858903,0.022531360576762857,Other Types,AS-604850,PI3K inhibitor,"PIK3CA, PIK3CG"
Hepatoblastoma,BRD-K64191834-001-03-1::2.5::HTS,6.257055991588564,0.012661613046539759,Hepatoblastoma,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,
Hepatoblastoma,BRD-K64874225-001-04-7::1.13::HTS,4.01217009731697,0.04565701327712082,Hepatoblastoma,NSC-4644,"ACAT inhibitor, sterol regulatory element binding protein (SREBP) inhibitor",PYGM
Hepatoblastoma,BRD-K66715657-050-01-0::2.5::HTS,6.247483410857516,0.012726231644745262,Hepatoblastoma,UH-232-(+),dopamine receptor antagonist,"DRD2, DRD3, DRD4, HTR1A"
Hepatoblastoma,BRD-K67043667-001-26-4::2.5::HTS,6.627925450929693,0.010296326953763623,Other Types,altretamine,DNA synthesis inhibitor,
Hepatoblastoma,BRD-K67680372-003-02-6::2.5::HTS,7.680210892734933,0.005769546467234081,Other Types,CI-966,GAT inhibitor,SLC6A1
Hepatoblastoma,BRD-K67831364-003-03-3::2.5::HTS,4.056599199996415,0.04447501209202792,Hepatoblastoma,ZM-323881,VEGFR inhibitor,KDR
Hepatoblastoma,BRD-K68164687-001-01-6::2.5::HTS,4.628085803384195,0.031879677315354765,Hepatoblastoma,epothilone-b,"microtubule stabilizing agent, tubulin polymerization inhibitor","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
Hepatoblastoma,BRD-K68395654-001-03-1::2.5::HTS,4.29151667021721,0.03875864661909274,Other Types,EVP4593,NFkB pathway inhibitor,
Hepatoblastoma,BRD-K68633617-003-02-9::2.5::HTS,4.477090003212905,0.03479525706268339,Other Types,ACDPP,glutamate receptor antagonist,GRM5
Hepatoblastoma,BRD-K68810443-001-01-9::2.5::HTS,5.253995671713304,0.02226784470993062,Other Types,adiporon,adiponectin receptor agonist,"ADIPOR1, ADIPOR2"
Hepatoblastoma,BRD-K68938568-001-01-7::2.5::HTS,5.373020441599198,0.020809942069004533,Hepatoblastoma,GDC-0152,XIAP inhibitor,"BIRC2, BIRC3, BIRC7, XIAP"
Hepatoblastoma,BRD-K70487031-001-02-8::2.5::HTS,13.337804266215358,0.00028464693064832414,Hepatoblastoma,flupentixol,dopamine receptor antagonist,"ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A"
Hepatoblastoma,BRD-K70610771-001-02-9::2.5::HTS,4.200485053301304,0.040882753188090176,Hepatoblastoma,VX-222,HCV inhibitor,
Hepatoblastoma,BRD-K70924353-001-01-2::2.5::HTS,4.088657080037274,0.043646885467994,Hepatoblastoma,amtolmetin-guacil,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Hepatoblastoma,BRD-K71106091-001-06-1::2.5::HTS,7.437653549933447,0.006589775548178716,Hepatoblastoma,fludarabine-phosphate,ribonucleotide reductase inhibitor,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B"
Hepatoblastoma,BRD-K71926323-001-13-8::2.5::HTS,4.4111467069680135,0.03615227466296725,Other Types,marbofloxacin,bacterial DNA gyrase inhibitor,
Hepatoblastoma,BRD-K72093121-001-16-3::2.5::HTS,4.134716345920749,0.04248821157385003,Hepatoblastoma,vidarabine,antiviral,ADA
Hepatoblastoma,BRD-K72231366-001-02-3::2.5::HTS,6.330602814681132,0.012144708311834066,Hepatoblastoma,TAME,,
Hepatoblastoma,BRD-K72339976-065-02-1::2.5::HTS,6.217922138424808,0.012934838090716048,Other Types,cefoselis,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-K72726508-001-02-1::2.5::HTS,4.105187743651481,0.04323051674318014,Other Types,arcyriaflavin-a,CDK inhibitor,"CCND1, CDK4"
Hepatoblastoma,BRD-K72925150-001-11-1::2.5::HTS,6.011412982021749,0.01452124809026367,Other Types,sclareolide,other antifungal,
Hepatoblastoma,BRD-K73529671-001-04-5::2.5::HTS,7.281592148572104,0.007177438623550185,Other Types,troxerutin,antioxidant,
Hepatoblastoma,BRD-K74190368-001-04-3::2.5::HTS,4.053185534383467,0.04457298681933785,Hepatoblastoma,resorcinol,phosphodiesterase inhibitor,"CA12, CA14, CA2, PTGS1"
Hepatoblastoma,BRD-K74913225-001-12-4::2.5::HTS,3.8725212553125465,0.04958838344574295,Hepatoblastoma,brinzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7"
Hepatoblastoma,BRD-K75923785-003-02-1::2.5::HTS,3.9459137210405366,0.047484805419924274,Hepatoblastoma,scopine,,
Hepatoblastoma,BRD-K76592088-001-02-1::2.5::HTS,5.072290497575636,0.024696389031973208,Hepatoblastoma,3-carboxy-4-hydroxyphenylglycine-(R),glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C"
Hepatoblastoma,BRD-K76606751-001-01-7::2.5::HTS,7.321266722170046,0.007021239001513399,Other Types,mebicar,anxiolytic,
Hepatoblastoma,BRD-K76805682-001-15-9::2.5::HTS,6.349387649117725,0.01202021045974461,Hepatoblastoma,SB-415286,glycogen synthase kinase inhibitor,"GSK3A, GSK3B, RPS6KB1"
Hepatoblastoma,BRD-K77345217-001-05-0::2.5::HTS,4.428501503767852,0.03580003910725022,Other Types,gallic-acid,"beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist","CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP"
Hepatoblastoma,BRD-K77552740-004-01-0::2.5::HTS,4.709173958215853,0.030427812771535213,Other Types,tiquizium,acetylcholine receptor antagonist,
Hepatoblastoma,BRD-K77554836-001-14-0::2.5::HTS,6.689499525389634,0.009955889545832777,Hepatoblastoma,triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Hepatoblastoma,BRD-K77821588-364-01-2::2.5::HTS,5.346339016857352,0.021136921584064123,Hepatoblastoma,azatadine,histamine receptor antagonist,HRH1
Hepatoblastoma,BRD-K78318619-001-02-7::2.5::HTS,4.5505688667137,0.033340341460535126,Hepatoblastoma,PF-4981517,cytochrome P450 inhibitor,CYP3A4
Hepatoblastoma,BRD-K79116891-003-15-1::2.5::HTS,5.077625026036252,0.02462467404114712,Hepatoblastoma,proxymetacaine,sodium channel blocker,"SCN10A, SCN5A"
Hepatoblastoma,BRD-K79595931-312-01-3::2.5::HTS,7.212094965706658,0.007459265608725697,Hepatoblastoma,bavisant,histamine receptor antagonist,HRH3
Hepatoblastoma,BRD-K79989959-001-01-4::2.5::HTS,7.152701715591508,0.007703007255452574,Hepatoblastoma,nesbuvir,RNA polymerase inhibitor,
Hepatoblastoma,BRD-K80129304-001-08-1::2.5::HTS,10.817368883352948,0.0010703031737205237,Hepatoblastoma,uracil,,"DPYD, UCKL1"
Hepatoblastoma,BRD-K80725821-300-02-9::2.5::HTS,8.425744937425518,0.0038454107087955735,Hepatoblastoma,RS-16566,serotonin receptor antagonist,
Hepatoblastoma,BRD-K81130846-001-17-4::2.5::HTS,5.174406442162638,0.023301303249122787,Other Types,salicylamide,analgesic agent,
Hepatoblastoma,BRD-K81807412-001-10-6::2.5::HTS,8.067050116255853,0.004675888112300549,Hepatoblastoma,N6-methyladenosine,,
Hepatoblastoma,BRD-K82036761-003-20-3::2.5::HTS,5.4775036292082335,0.01961287119510072,Hepatoblastoma,sertraline,selective serotonin reuptake inhibitor (SSRI),"SLC6A3, SLC6A4"
Hepatoblastoma,BRD-K82928847-001-04-7::2.5::HTS,4.35182990336725,0.03743274750397148,Other Types,ACY-1215,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8"
Hepatoblastoma,BRD-K83245588-001-01-4::2.5::HTS,4.649117112829968,0.03150318333805566,Other Types,pilsicainide,sodium channel blocker,SCN5A
Hepatoblastoma,BRD-K84794093-001-07-5::2.5::HTS,4.588820981599505,0.03262855615290224,Hepatoblastoma,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,
Hepatoblastoma,BRD-K85119730-001-28-9::2.5::HTS,5.135746271704915,0.023828561774678673,Other Types,tolbutamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ11, KCNJ8"
Hepatoblastoma,BRD-K85307935-236-10-3::2.5::HTS,6.270936424324302,0.012573896119448816,Hepatoblastoma,novobiocin,bacterial DNA gyrase inhibitor,
Hepatoblastoma,BRD-K86600316-003-02-0::2.5::HTS,4.539846624581031,0.033550386280921836,Hepatoblastoma,RS-79948,adrenergic receptor antagonist,ADRA2A
Hepatoblastoma,BRD-K87156652-001-12-7::2.5::HTS,8.266917027449354,0.004194915399062189,Other Types,carbimazole,antithyroid agent,TPO
Hepatoblastoma,BRD-K88172511-003-20-3::2.42::HTS,4.718527963191193,0.030283507826603162,Hepatoblastoma,naltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1, SIGMAR1"
Hepatoblastoma,BRD-K88625236-001-04-2::2.5::HTS,3.979318486955919,0.046548133245203765,Other Types,nonoxynol-9,membrane integrity inhibitor,
Hepatoblastoma,BRD-K89048337-001-06-9::2.5::HTS,5.768569596588875,0.016643604447663055,Other Types,puerarin,serotonin receptor antagonist,
Hepatoblastoma,BRD-K89162000-001-06-4::2.5::HTS,4.80745476865335,0.02874829012804135,Other Types,tandutinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","CSF1R, FLT3, KIT, PDGFD, PDGFRB"
Hepatoblastoma,BRD-K89306950-001-12-5::2.5::HTS,4.6044626975638465,0.03231650309963589,Other Types,ML130,NOD1 inhibitor,
Hepatoblastoma,BRD-K89917372-001-01-2::2.5::HTS,5.551952237632509,0.018804881803780607,Hepatoblastoma,retigabine,potassium channel activator,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5"
Hepatoblastoma,BRD-K90333595-003-21-4::2.5::HTS,5.150000132740227,0.023624492495802035,Hepatoblastoma,phentolamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Hepatoblastoma,BRD-K90524085-001-07-8::2.5::HTS,6.523670047971185,0.010909335101911732,Hepatoblastoma,MY-5445,"phosphodiesterase inhibitor, platelet aggregation inhibitor",PDE5A
Hepatoblastoma,BRD-K91147684-001-01-5::2.5::HTS,5.839896191125919,0.015990070156698667,Other Types,m-THP,,
Hepatoblastoma,BRD-K91188791-001-18-3::2.5::HTS,8.815880708169187,0.0031142812586227035,Hepatoblastoma,aloxistatin,protease inhibitor,CTSG
Hepatoblastoma,BRD-K91825936-001-01-2::2.5::HTS,6.336059992667914,0.012109316016488092,Other Types,ZK811752,CC chemokine receptor antagonist,CCR1
Hepatoblastoma,BRD-K91868854-001-03-6::2.5::HTS,6.682507061701375,0.009991712744031038,Hepatoblastoma,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4
Hepatoblastoma,BRD-K92041145-001-09-5::2.5::HTS,6.071908833318732,0.014034691509570842,Other Types,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
Hepatoblastoma,BRD-K93258693-001-17-3::2.5::HTS,4.175976485665802,0.04146835362361664,Other Types,GW-9662,PPAR receptor antagonist,"NCOA2, PPARG, RXRA"
Hepatoblastoma,BRD-K93568044-001-32-0::2.5::HTS,5.483546110834648,0.01955094692377728,Hepatoblastoma,hydrocortisone,glucocorticoid receptor agonist,
Hepatoblastoma,BRD-K95292280-001-01-3::2.5::HTS,4.276753757935026,0.03910064263051313,Other Types,SB-657510,urotensin receptor antagonist,UTS2R
Hepatoblastoma,BRD-K96233303-001-01-9::2.5::HTS,4.318374106610146,0.03815784521632139,Hepatoblastoma,TMS,,
Hepatoblastoma,BRD-K96714749-001-01-0::2.5::HTS,5.085676727107572,0.024510955597754746,Hepatoblastoma,isobutamben,local anesthetic,
Hepatoblastoma,BRD-K97714174-001-01-3::2.5::HTS,6.27312491731215,0.012540316693605977,Other Types,P22077,ubiquitin specific protease inhibitor,USP7
Hepatoblastoma,BRD-K98530306-003-18-3::2.5::HTS,9.913415088510803,0.0017285017260342782,Other Types,clonidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C"
Hepatoblastoma,BRD-K99107520-001-24-1::2.5::HTS,6.173182573179943,0.013262742256655531,Other Types,felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
Hepatoblastoma,BRD-K99621550-300-01-8::2.5::HTS,5.199887844130516,0.022965330994726803,Hepatoblastoma,tubocurarine,acetylcholine receptor antagonist,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN"
Hepatoblastoma,BRD-K99749624-001-07-0::2.5::HTS,8.156860111512895,0.004449322984708365,Other Types,linifanib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK"
Hepatoblastoma,BRD-M98279124-300-01-1::2.5::HTS,4.043693233628849,0.04481805668434773,Hepatoblastoma,cevimeline,acetylcholine receptor agonist,"CHRM1, CHRM3"
Hepatoblastoma,BRD-A08316590-001-01-3::2.5::MTS004,7.020903012176174,0.00829287803532122,Other Types,broxaterol,adrenergic receptor agonist,ADRB2
Hepatoblastoma,BRD-A10773072-001-03-4::2.496712929::MTS004,5.70307853058868,0.01727913868531847,Other Types,glycerol-monolaurate,beta lactamase inhibitor,
Hepatoblastoma,BRD-A17009129-001-01-3::2.499993124::MTS004,4.475580385549485,0.03484142883556473,Other Types,isavuconazole,cytochrome P450 inhibitor,CYP3A4
Hepatoblastoma,BRD-A19053834-050-09-5::2.5::MTS004,7.763156155469558,0.0055201155469460335,Other Types,clorotepine,"dopamine receptor antagonist, adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6"
Hepatoblastoma,BRD-A21280314-001-06-8::2.5::MTS004,5.946028632067967,0.015072336495418769,Other Types,nifenalol,adrenergic receptor antagonist,"ADRB1, ADRB2"
Hepatoblastoma,BRD-A27274504-001-01-6::2.400106631::MTS004,4.0633269088021295,0.04431980073327492,Other Types,butofilolol,adrenergic receptor antagonist,
Hepatoblastoma,BRD-A41698174-003-12-0::2.499982171::MTS004,4.501825743472651,0.03431427850228645,Other Types,bacampicillin,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-A48420483-001-02-3::2.5::MTS004,6.351542386911117,0.012015628177246225,Other Types,bupranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3"
Hepatoblastoma,BRD-A78277353-001-01-9::2.492599937::MTS004,4.194691423754029,0.04103469561172415,Other Types,metazosin,adrenergic receptor antagonist,ADRA1A
Hepatoblastoma,BRD-A79052425-003-01-5::2.5::MTS004,4.413329976578939,0.03612303175025568,Other Types,SIB-1553A,acetylcholine receptor agonist,CHRNB4
Hepatoblastoma,BRD-A91444184-300-01-9::2.5::MTS004,6.062416231423109,0.014120691051128901,Other Types,buclizine,histamine receptor antagonist,"CHRM1, HRH1"
Hepatoblastoma,BRD-A91728607-236-11-9::2.5::MTS004,8.256688726967944,0.004220329068848567,Other Types,citicoline,"membrane permeability enhancer, glutathione transferase stimulant","ACHE, SLC1A2"
Hepatoblastoma,BRD-A92262698-001-02-5::2.5::MTS004,5.896226935145682,0.015499553273447625,Other Types,chlorphenesin,muscle relaxant,
Hepatoblastoma,BRD-K01291782-001-01-1::2.50002964::MTS004,7.463205441730907,0.006504151730766064,Other Types,molidustat,hypoxia inducible factor inhibitor,EGLN2
Hepatoblastoma,BRD-K03503561-001-01-4::2.339952449::MTS004,9.51550648427488,0.002141924011925485,Other Types,ravuconazole,sterol demethylase inhibitor,
Hepatoblastoma,BRD-K05858796-001-01-7::2.500017956::MTS004,3.991247181309371,0.0462411139511295,Other Types,GSK2330672,bile acid transporter inhibitor,SLC10A2
Hepatoblastoma,BRD-K06467130-304-02-7::2.5::MTS004,4.590621365231568,0.03259460039406496,Other Types,CL316243,adrenergic receptor agonist,"ADRB3, UCP1, UCP2, UCP3"
Hepatoblastoma,BRD-K08255599-365-01-1::2.656154742::MTS004,7.645452876061548,0.005886922199624707,Hepatoblastoma,frovatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D"
Hepatoblastoma,BRD-K12261274-001-02-4::2.499953183::MTS004,4.618201613980635,0.03207985641440395,Hepatoblastoma,zaltidine,histamine receptor antagonist,HRH2
Hepatoblastoma,BRD-K14571191-001-01-6::2.5::MTS004,5.01680557858232,0.025509305502785438,Other Types,zometapine,,
Hepatoblastoma,BRD-K21077415-001-01-5::2.656085278::MTS004,8.930362735287773,0.0029325148127694036,Other Types,AMG-319,PI3K inhibitor,PIK3CD
Hepatoblastoma,BRD-K27515606-003-01-3::2.5::MTS004,7.869654933721302,0.005208680584287462,Other Types,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-K30485548-050-01-6::2.479775098::MTS004,3.9778945412069144,0.046604358552857855,Other Types,sumanirole,dopamine receptor agonist,DRD2
Hepatoblastoma,BRD-K35304636-001-01-0::2.5::MTS004,7.913029478877243,0.005087044454045018,Other Types,examorelin,growth hormone releasing factor agonist,"GHRHR, GHSR"
Hepatoblastoma,BRD-K35798650-001-01-4::2.5::MTS004,5.896583442421435,0.015496450961811934,Other Types,polidocanol,local anesthetic,
Hepatoblastoma,BRD-K43975632-001-01-1::2.499995729::MTS004,9.070826901107274,0.0027190447697285143,Other Types,terutroban,prostanoid receptor antagonist,TBXA2R
Hepatoblastoma,BRD-K47690382-001-03-0::2.5::MTS004,4.998475557944951,0.02577825705946413,Other Types,bipenamol,dipeptidyl peptidase inhibitor,CTSC
Hepatoblastoma,BRD-K53236343-003-03-7::2.625172304::MTS004,7.68211132142864,0.005770195657777023,Other Types,aprindine,voltage-gated sodium channel blocker,"CALM1, SCN5A"
Hepatoblastoma,BRD-K54519451-001-02-9::2.499971332::MTS004,4.0685452034778,0.044184146949957565,Other Types,pexidartinib,tyrosine kinase inhibitor,"CSF1R, FLT3, KIT"
Hepatoblastoma,BRD-K56155962-001-12-1::2.355251659::MTS004,7.274443951013653,0.007213185590307161,Other Types,ergocalciferol,vitamin analog,VDR
Hepatoblastoma,BRD-K59256312-066-15-7::2.431061328::MTS004,4.352243002363963,0.037430645201520105,Other Types,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Hepatoblastoma,BRD-K60284353-001-01-3::2.5::MTS004,9.805299475051417,0.0018344931123652703,Other Types,titanocene-dichloride,apoptosis stimulant,
Hepatoblastoma,BRD-K60762818-003-26-0::2.467864576::MTS004,5.646535911392233,0.017838942324586604,Other Types,desipramine,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1"
Hepatoblastoma,BRD-K61536264-001-01-3::2.499924728::MTS004,6.736418988745634,0.009704328183650445,Other Types,fagomine,glucosidase inhibitor,GLB1
Hepatoblastoma,BRD-K66295376-001-13-1::2.5::MTS004,5.475963908958183,0.019643670347667584,Other Types,ferulic-acid,antioxidant,"CA1, CA12, CA14, CA2, CA4, CA6, CA9"
Hepatoblastoma,BRD-K67117832-001-01-9::2.5::MTS004,4.736754710233464,0.029958944467902517,Hepatoblastoma,dextran,,
Hepatoblastoma,BRD-K68408772-001-05-4::2.420640995::MTS004,4.501893670130593,0.03431377530724045,Other Types,carboxyamidotriazole,calcium channel blocker,CXCL8
Hepatoblastoma,BRD-K70592963-001-31-6::2.5::MTS004,4.296868703581551,0.03865725291848124,Other Types,phenindione,vitamin K antagonist,VKORC1
Hepatoblastoma,BRD-K73504359-001-01-3::2.5::MTS004,4.347661933596307,0.03752974806907779,Other Types,bivalirudin,thrombin inhibitor,F2
Hepatoblastoma,BRD-K77073709-435-01-2::2.5::MTS004,4.413952036317001,0.03610997412845411,Other Types,cefminox,bacterial cell wall synthesis inhibitor,
Hepatoblastoma,BRD-K77428767-001-01-7::2.5::MTS004,3.9598089315686282,0.047104700429980474,Other Types,UNC0224,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Hepatoblastoma,BRD-K77432251-001-01-2::2.715966218::MTS004,15.23394801012356,0.00010701427917210487,Other Types,abafungin,sterol methyltransferase inhibitor,
Hepatoblastoma,BRD-K80359953-001-01-3::2.500041136::MTS004,4.026848867588065,0.04528044499852064,Other Types,talampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4"
Hepatoblastoma,BRD-K80859331-001-01-5::2.5::MTS004,4.686020970245947,0.030848031223708886,Hepatoblastoma,haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A"
Hepatoblastoma,BRD-K83029223-001-01-3::2.500025378::MTS004,4.357976267131454,0.037305916223460446,Hepatoblastoma,litronesib,kinesin-like spindle protein inhibitor,KIF11
Hepatoblastoma,BRD-K83776863-001-08-9::2.5::MTS004,4.0406201684626835,0.04491522098372362,Other Types,tryptophan,serotonin receptor partial agonist,"CASR, IDO1, SLC36A1, WARS, WARS2"
Hepatoblastoma,BRD-K87573013-001-01-0::2.5::MTS004,4.024642544977787,0.04533924908876198,Other Types,CL-225385,,
Hepatoblastoma,BRD-K91244729-003-01-3::2.316613157::MTS004,4.704181901437639,0.030525827211098797,Other Types,propiverine,acetylcholine receptor antagonist,CHRM1
Hepatoblastoma,BRD-K92413528-001-06-9::2.5::MTS004,8.66943396343424,0.0033755251727985115,Other Types,procysteine,glutathione synthase stimulant,
Hepatoblastoma,BRD-K92426617-001-06-3::2.5::MTS004,6.486420013708997,0.01114701276196118,Other Types,esaprazole,,
Hepatoblastoma,BRD-K92902018-001-01-9::2.507952536::MTS004,5.443626006179514,0.020006778214426965,Other Types,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR
Hepatoblastoma,BRD-K94072573-001-09-9::2.5::MTS004,4.188222936935513,0.04119029372051042,Other Types,medronic-acid,bone resorption inhibitor,
Hepatoblastoma,BRD-K99919177-001-01-3::2.5::MTS004,4.613436789375635,0.0321674860909956,Other Types,deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2"
Well-Differentiated Thyroid Cancer,BRD-A00993607-003-24-6::2.5::HTS,4.677675104320706,0.030978097813928986,Well-Differentiated Thyroid Cancer,alprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A"
Well-Differentiated Thyroid Cancer,BRD-A01098288-001-02-9::2.5::HTS,4.013057381365756,0.045642932299418286,Other Types,azelnidipine,calcium channel blocker,CACNA1C
Well-Differentiated Thyroid Cancer,BRD-A01636364-003-15-1::2.5::HTS,4.8853667698914425,0.027491026242505424,Well-Differentiated Thyroid Cancer,bupivacaine,sodium channel blocker,"KCNA5, PTGER1, SCN10A, SCN4A"
Well-Differentiated Thyroid Cancer,BRD-A03932035-004-04-3::2.5::HTS,4.314131843864021,0.03827010410748499,Other Types,methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3"
Well-Differentiated Thyroid Cancer,BRD-A07563059-035-01-3::2.5::HTS,6.172367901521957,0.013269841438728915,Well-Differentiated Thyroid Cancer,bopindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B"
Well-Differentiated Thyroid Cancer,BRD-A08302182-001-01-7::2.5::HTS,10.772721812445512,0.0010949450545843084,Well-Differentiated Thyroid Cancer,etonogestrel,progesterone receptor agonist,"ESR1, PGR"
Well-Differentiated Thyroid Cancer,BRD-A09094913-065-01-0::2.5::HTS,5.359666647754446,0.020970259522365964,Other Types,strychnine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB"
Well-Differentiated Thyroid Cancer,BRD-A09554849-236-07-6::2.5::HTS,4.497163361102935,0.03439240262893384,Well-Differentiated Thyroid Cancer,8-bromo-cAMP,PKA activator,
Well-Differentiated Thyroid Cancer,BRD-A12454076-001-01-9::2.5::HTS,5.224855346847508,0.022662404277718932,Well-Differentiated Thyroid Cancer,L-Hydroxyproline,,
Well-Differentiated Thyroid Cancer,BRD-A15435692-003-02-3::2.5::HTS,9.773699755660573,0.001863090652399126,Other Types,BMY-14802,sigma receptor antagonist,HTR1A
Well-Differentiated Thyroid Cancer,BRD-A17462676-003-11-6::2.5::HTS,4.654956982075301,0.031388604552586116,Well-Differentiated Thyroid Cancer,bambuterol,adrenergic receptor agonist,"ADRB2, BCHE"
Well-Differentiated Thyroid Cancer,BRD-A17655518-001-24-4::2.5::HTS,4.459549024221049,0.035148955171075205,Well-Differentiated Thyroid Cancer,ibuprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Well-Differentiated Thyroid Cancer,BRD-A18074780-003-02-0::2.5::HTS,10.547568767748666,0.0012334300387816866,Well-Differentiated Thyroid Cancer,AGN-192403,imidazoline receptor ligand,NISCH
Well-Differentiated Thyroid Cancer,BRD-A19661776-003-27-6::2.5::HTS,6.066825199743882,0.014076870702555686,Well-Differentiated Thyroid Cancer,mianserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
Well-Differentiated Thyroid Cancer,BRD-A20119038-003-07-8::2.5::HTS,11.682246633498892,0.000677103315599483,Well-Differentiated Thyroid Cancer,mecamylamine,acetylcholine receptor antagonist,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Well-Differentiated Thyroid Cancer,BRD-A28856712-003-26-0::2.5::HTS,5.696290609653044,0.017333579191374036,Well-Differentiated Thyroid Cancer,tetrahydrozoline,adrenergic receptor agonist,
Well-Differentiated Thyroid Cancer,BRD-A28940325-001-24-0::2.5::HTS,6.204701215301908,0.013031226301003186,Well-Differentiated Thyroid Cancer,trichlormethiazide,chloride channel blocker,"ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3"
Well-Differentiated Thyroid Cancer,BRD-A29644307-050-17-0::2.5::HTS,7.815534638668095,0.005357012362444062,Other Types,nomifensine,"dopamine uptake inhibitor, noradrenaline uptake inhibitor","DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3"
Well-Differentiated Thyroid Cancer,BRD-A30655177-001-14-0::2.5::HTS,10.62565195176884,0.001183737276074844,Well-Differentiated Thyroid Cancer,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK
Well-Differentiated Thyroid Cancer,BRD-A31990649-304-02-3::2.5::HTS,4.171446115550935,0.041606897838209984,Other Types,adenosine-triphosphate,adenosine receptor agonist,"ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7"
Well-Differentiated Thyroid Cancer,BRD-A33514596-003-01-2::2.5::HTS,4.02678342125175,0.04527042743632736,Well-Differentiated Thyroid Cancer,N-benzylnaltrindole,opioid receptor antagonist,
Well-Differentiated Thyroid Cancer,BRD-A34751532-001-06-9::2.5::HTS,4.414548013973432,0.03608408156440287,Well-Differentiated Thyroid Cancer,homosalate,HSP inducer,
Well-Differentiated Thyroid Cancer,BRD-A35989968-001-04-2::2.5::HTS,7.528164677645971,0.006270990149518438,Well-Differentiated Thyroid Cancer,megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR"
Well-Differentiated Thyroid Cancer,BRD-A36217750-001-16-3::2.5::HTS,4.101201914569011,0.043329175058477346,Well-Differentiated Thyroid Cancer,sulfinpyrazone,uricosuric blocker,"ABCC1, ABCC2, FPR1, SLC22A12"
Well-Differentiated Thyroid Cancer,BRD-A36456202-001-01-3::2.5::HTS,6.689275852383312,0.009960487806179329,Well-Differentiated Thyroid Cancer,colistin-b-sulfate,bacterial permeability inducer,
Well-Differentiated Thyroid Cancer,BRD-A38218502-001-01-2::2.5::HTS,5.886463973625879,0.015572451527949302,Other Types,metenkephalin,immunostimulant,OPRD1
Well-Differentiated Thyroid Cancer,BRD-A39255369-001-03-1::2.5::HTS,6.685985321009366,0.009968810248720657,Other Types,DCPIB,"chloride channel blocker, gap junction modulator, glutamate inhibitor",SLC1A2
Well-Differentiated Thyroid Cancer,BRD-A39791822-001-05-1::2.5::HTS,6.890284252098048,0.008904095383593017,Well-Differentiated Thyroid Cancer,hydroxyprogesterone,progesterone receptor agonist,PGR
Well-Differentiated Thyroid Cancer,BRD-A43082555-001-01-1::2.5::HTS,5.136053539008078,0.023824384891447205,Well-Differentiated Thyroid Cancer,loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2
Well-Differentiated Thyroid Cancer,BRD-A43930669-003-02-8::2.5::HTS,3.8625215437845934,0.049871647621160795,Well-Differentiated Thyroid Cancer,L-368899,oxytocin receptor antagonist,"AVPR1A, AVPR2, OXTR"
Well-Differentiated Thyroid Cancer,BRD-A43999749-004-04-1::2.5::HTS,4.127277403695443,0.04267136970943768,Other Types,homatropine-methylbromide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Well-Differentiated Thyroid Cancer,BRD-A47364545-003-02-6::2.5::HTS,4.020683012547243,0.045433209830918427,Other Types,SK&F-10047-(+),sigma receptor agonist,SIGMAR1
Well-Differentiated Thyroid Cancer,BRD-A47494775-003-11-3::2.5::HTS,5.32699713820006,0.02136500262914262,Other Types,dipivefrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE"
Well-Differentiated Thyroid Cancer,BRD-A48300215-001-04-8::2.5::HTS,7.2914791696080385,0.007143215476913994,Other Types,ajmaline,sodium channel blocker,SCN5A
Well-Differentiated Thyroid Cancer,BRD-A49358627-001-14-6::2.5::HTS,4.191482346354984,0.04109614617558575,Other Types,ciprofibrate,PPAR receptor agonist,PPARA
Well-Differentiated Thyroid Cancer,BRD-A50737080-001-03-0::2.5::HTS,5.468161273975503,0.019718199975374044,Well-Differentiated Thyroid Cancer,CGK-733,"ATM kinase inhibitor, ATR kinase inhibitor","ATM, ATR"
Well-Differentiated Thyroid Cancer,BRD-A50922295-001-01-3::2.5::HTS,6.570305315772077,0.01062853223308685,Well-Differentiated Thyroid Cancer,valganciclovir,DNA synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-A52922642-001-03-7::2.5::HTS,4.860992840828086,0.027874871747233257,Well-Differentiated Thyroid Cancer,gallopamil,L-type calcium channel blocker,ATP2A2
Well-Differentiated Thyroid Cancer,BRD-A53037300-001-01-0::2.5::HTS,5.060219030465775,0.024869464624288296,Well-Differentiated Thyroid Cancer,2-fluoro-2-deoxy-D-galactose,,LCT
Well-Differentiated Thyroid Cancer,BRD-A64227845-004-09-3::2.5::HTS,4.879906294029192,0.02757372120385858,Other Types,SKF-77434,dopamine receptor agonist,DRD1
Well-Differentiated Thyroid Cancer,BRD-A65440446-001-04-1::2.5::HTS,4.9251944120120745,0.02687209661522512,Other Types,cimaterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Well-Differentiated Thyroid Cancer,BRD-A71157293-003-10-0::2.5::HTS,5.849079769310695,0.015901968796213695,Other Types,fursultiamine,vitamin B,
Well-Differentiated Thyroid Cancer,BRD-A73871920-236-03-6::2.5::HTS,3.8849160499738673,0.049216338816981134,Well-Differentiated Thyroid Cancer,nanchangmycin,other antibiotic,
Well-Differentiated Thyroid Cancer,BRD-A75305484-001-01-3::2.5::HTS,6.525435534229749,0.010896748440862138,Well-Differentiated Thyroid Cancer,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",
Well-Differentiated Thyroid Cancer,BRD-A75850590-213-01-0::2.5::HTS,4.457763027277497,0.03520612908317172,Other Types,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A
Well-Differentiated Thyroid Cancer,BRD-A82522119-001-01-7::2.5::HTS,4.794522282943249,0.028960771079377744,Well-Differentiated Thyroid Cancer,tibolone,"androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist",ESR1
Well-Differentiated Thyroid Cancer,BRD-A83644949-236-01-6::2.5::HTS,5.226439927704666,0.022628161370681334,Other Types,ardeparin,thrombin inhibitor,"SERPINC1, SERPIND1"
Well-Differentiated Thyroid Cancer,BRD-A83650191-004-02-8::2.5::HTS,6.519017450673672,0.01096378400208085,Well-Differentiated Thyroid Cancer,A61603,adrenergic receptor agonist,ADRA1A
Well-Differentiated Thyroid Cancer,BRD-A85548292-001-01-8::2.5::HTS,5.478834791766792,0.01961176657423383,Well-Differentiated Thyroid Cancer,piketoprofen,cyclooxygenase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-A86216746-046-02-6::2.5::HTS,4.384366356632329,0.036733086728193365,Well-Differentiated Thyroid Cancer,varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7"
Well-Differentiated Thyroid Cancer,BRD-A88369366-001-01-7::2.5::HTS,4.967119601771868,0.026230451503925983,Well-Differentiated Thyroid Cancer,trelagliptin,dipeptidyl peptidase inhibitor,DPP4
Well-Differentiated Thyroid Cancer,BRD-A90926615-001-01-9::2.5::HTS,3.949467715250731,0.0473737510876783,Other Types,adrafinil,adrenergic receptor agonist,
Well-Differentiated Thyroid Cancer,BRD-A91008255-003-24-8::2.5::HTS,5.449052572342921,0.019933488179156394,Well-Differentiated Thyroid Cancer,bepridil,calcium channel blocker,"ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1"
Well-Differentiated Thyroid Cancer,BRD-A92826379-001-01-5::2.5::HTS,5.899141589526624,0.01546194177568257,Other Types,lupanine,sodium channel blocker,INS
Well-Differentiated Thyroid Cancer,BRD-A93353767-008-02-2::2.5::HTS,6.714362954487153,0.009813291693342855,Well-Differentiated Thyroid Cancer,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1
Well-Differentiated Thyroid Cancer,BRD-A94993966-001-05-1::2.63::HTS,5.126478605445908,0.02395999733399237,Well-Differentiated Thyroid Cancer,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
Well-Differentiated Thyroid Cancer,BRD-A95869247-001-26-9::2.5::HTS,3.9290665778994844,0.04794664928557126,Well-Differentiated Thyroid Cancer,indapamide,thiazide diuretic,"KCNE1, KCNQ1, SLC12A3"
Well-Differentiated Thyroid Cancer,BRD-K00486786-001-02-2::2.5::HTS,7.890590350887152,0.005143098597631264,Other Types,Ro-08-2750,,NGF
Well-Differentiated Thyroid Cancer,BRD-K00519864-341-03-3::2.39::HTS,4.426959061254635,0.03584772725436645,Other Types,peramivir,neuraminidase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K00674894-001-01-4::2.5::HTS,4.593891518073286,0.032533018976148756,Well-Differentiated Thyroid Cancer,orteronel,"androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor",CYP17A1
Well-Differentiated Thyroid Cancer,BRD-K01095011-001-15-9::2.5::HTS,4.577722914014944,0.03283293019020954,Well-Differentiated Thyroid Cancer,finasteride,5 alpha reductase inhibitor,"AKR1D1, SRD5A1, SRD5A2"
Well-Differentiated Thyroid Cancer,BRD-K01292756-001-25-0::2.5::HTS,4.4038811064418,0.03630938332306986,Well-Differentiated Thyroid Cancer,pimozide,dopamine receptor antagonist,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2"
Well-Differentiated Thyroid Cancer,BRD-K02265150-001-26-5::2.5::HTS,4.4837153094684075,0.03466414834018048,Well-Differentiated Thyroid Cancer,amoxapine,norepinephrine reputake inhibitor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4"
Well-Differentiated Thyroid Cancer,BRD-K02594908-001-16-4::2.5::HTS,4.702854930387492,0.03054358364075032,Other Types,sulfanilamide,carbonic anhydrase inhibitor,"CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4"
Well-Differentiated Thyroid Cancer,BRD-K02733959-236-07-7::2.5::HTS,5.992368825127986,0.014674874045244212,Well-Differentiated Thyroid Cancer,cefuroxime,bacterial cell wall synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K02898090-001-02-7::2.5::HTS,3.937768498039224,0.047713532805803045,Well-Differentiated Thyroid Cancer,kifunensine,mannosidase inhibitor,"MAN1B1, MAN2A1"
Well-Differentiated Thyroid Cancer,BRD-K02950022-001-02-9::2.5::HTS,3.8608348750703025,0.049922334300595846,Well-Differentiated Thyroid Cancer,BMS-299897,gamma secretase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K02992638-001-11-8::2.5::HTS,4.691335510541067,0.030740929229264878,Well-Differentiated Thyroid Cancer,lamivudine,nucleoside reverse transcriptase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K05236810-001-19-0::2.5::HTS,7.353596121136207,0.0068999438456830665,Well-Differentiated Thyroid Cancer,luteolin,glucosidase inhibitor,TOP1
Well-Differentiated Thyroid Cancer,BRD-K05878375-236-05-7::2.5::HTS,3.966883159842099,0.04691826044665522,Well-Differentiated Thyroid Cancer,sodium-butyrate,HDAC inhibitor,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8"
Well-Differentiated Thyroid Cancer,BRD-K05919151-001-01-6::2.5::HTS,5.888715179209676,0.015571905217498398,Well-Differentiated Thyroid Cancer,dixanthogen,,
Well-Differentiated Thyroid Cancer,BRD-K07237224-001-19-6::2.5::HTS,4.345687580561594,0.03755771085223239,Well-Differentiated Thyroid Cancer,moclobemide,monoamine oxidase inhibitor,"MAOA, MAOB"
Well-Differentiated Thyroid Cancer,BRD-K07609981-001-01-7::2.5::HTS,5.075361345283487,0.024656547186241842,Other Types,dexloxiglumide,CCK receptor antagonist,CCKAR
Well-Differentiated Thyroid Cancer,BRD-K08078237-001-19-8::2.5::HTS,5.63919880821262,0.01791959368239886,Well-Differentiated Thyroid Cancer,tetrandrine,calcium channel blocker,SLC6A3
Well-Differentiated Thyroid Cancer,BRD-K09353376-001-03-9::2.5::HTS,4.547011458068663,0.03343702370228981,Well-Differentiated Thyroid Cancer,tariquidar,P glycoprotein inhibitor,ABCB1
Well-Differentiated Thyroid Cancer,BRD-K11411329-001-01-3::2.5::HTS,4.668427203002294,0.031143910466776923,Other Types,NOV-002,,"GSR, GSTM2"
Well-Differentiated Thyroid Cancer,BRD-K12568846-001-14-6::2.5::HTS,4.378023111857822,0.03685320089394352,Well-Differentiated Thyroid Cancer,amidopyrine,analgesic agent,
Well-Differentiated Thyroid Cancer,BRD-K12630395-001-14-9::2.5::HTS,5.348302948929286,0.02110601859135042,Well-Differentiated Thyroid Cancer,harmane,monoamine oxidase inhibitor,"MAOA, MAOB"
Well-Differentiated Thyroid Cancer,BRD-K13049116-001-05-7::2.5::HTS,5.413253886964258,0.02034411732907989,Other Types,BMS-754807,IGF-1 inhibitor,"AKT1, IGF1R"
Well-Differentiated Thyroid Cancer,BRD-K13050541-001-01-9::2.8::HTS,5.033249567178376,0.025259516666752333,Well-Differentiated Thyroid Cancer,acivicin,gamma glutamyltransferase Inhibitors,CTPS1
Well-Differentiated Thyroid Cancer,BRD-K13211965-003-02-8::2.5::HTS,5.044277686193905,0.025097180154209305,Well-Differentiated Thyroid Cancer,L-741742,dopamine receptor antagonist,"DRD3, DRD4, SCN1A, SCN3A"
Well-Differentiated Thyroid Cancer,BRD-K13387373-004-14-5::2.5::HTS,6.42395174619003,0.011533307506252992,Other Types,thonzonium,ATPase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K13421763-001-06-2::2.5::HTS,8.717782442833318,0.0032840828062732645,Well-Differentiated Thyroid Cancer,aminothiazole,cyclin D inhibitor,NOS2
Well-Differentiated Thyroid Cancer,BRD-K13829090-303-02-9::2.5::HTS,5.149523671481707,0.02363294927429951,Well-Differentiated Thyroid Cancer,IEM1460,glutamate receptor antagonist,GRIA2
Well-Differentiated Thyroid Cancer,BRD-K15108141-001-06-6::2.5::HTS,7.800001289763747,0.005410269798769163,Other Types,gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS"
Well-Differentiated Thyroid Cancer,BRD-K15170068-001-03-2::2.89::HTS,4.0805340257844245,0.04387414528089136,Well-Differentiated Thyroid Cancer,swainsonine,alpha mannosidase inhibitor,MAN2A1
Well-Differentiated Thyroid Cancer,BRD-K16037980-001-01-1::2.5::HTS,5.653268687487169,0.017757578328834442,Well-Differentiated Thyroid Cancer,Z160,N-type calcium channel blocker,CACNA2D1
Well-Differentiated Thyroid Cancer,BRD-K16474819-001-09-6::2.5::HTS,5.5942095482147876,0.01836102018436082,Well-Differentiated Thyroid Cancer,metacetamol,analgesic agent,
Well-Differentiated Thyroid Cancer,BRD-K16542329-001-13-5::2.5::HTS,4.200388389880996,0.040880020621540815,Other Types,zaprinast,phosphodiesterase inhibitor,"GPR35, PDE1A, PDE4D, PDE5A, PDE9A"
Well-Differentiated Thyroid Cancer,BRD-K17849083-001-32-9::2.43::HTS,5.27022750235021,0.022076196117584684,Other Types,tranilast,angiogenesis inhibitor,"HPGDS, HRH1"
Well-Differentiated Thyroid Cancer,BRD-K17874705-300-03-2::2.5::HTS,5.421014802096375,0.020260726202401106,Other Types,2-pyridylethylamine,histamine receptor agonist,HRH1
Well-Differentiated Thyroid Cancer,BRD-K18850819-001-04-6::2.5::HTS,5.025352795317416,0.025368241860898758,Well-Differentiated Thyroid Cancer,MK-0752,gamma secretase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K19605405-001-02-7::2.5::HTS,7.609099537179536,0.005998273391923963,Well-Differentiated Thyroid Cancer,ZM-241385,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3"
Well-Differentiated Thyroid Cancer,BRD-K19615002-001-02-3::2.5::HTS,4.112684959306519,0.04303818449888034,Well-Differentiated Thyroid Cancer,creatine,,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8"
Well-Differentiated Thyroid Cancer,BRD-K21733600-001-14-1::2.5::HTS,5.411310173094627,0.020371843049888146,Well-Differentiated Thyroid Cancer,rofecoxib,cyclooxygenase inhibitor,"ELN, PTGS2"
Well-Differentiated Thyroid Cancer,BRD-K21867462-001-02-9::2.5::HTS,5.132529839007824,0.02386667334183622,Other Types,GSK2816126,histone lysine methyltransferase inhibitor,EZH2
Well-Differentiated Thyroid Cancer,BRD-K23403298-003-01-9::2.5::HTS,7.780423976111809,0.005465939508984404,Other Types,benzyldimethylhexadecylammonium,cationic surfactant,
Well-Differentiated Thyroid Cancer,BRD-K24616672-003-20-1::2.5::HTS,4.722401001365648,0.030193609608683454,Well-Differentiated Thyroid Cancer,procaine,HMGCR inhibitor,"CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3"
Well-Differentiated Thyroid Cancer,BRD-K24790130-001-07-1::2.5::HTS,6.447698128259835,0.011379976648255272,Well-Differentiated Thyroid Cancer,tricaprylin,,
Well-Differentiated Thyroid Cancer,BRD-K25433859-003-25-4::2.5::HTS,8.640524504777199,0.0034297017993584946,Other Types,maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2"
Well-Differentiated Thyroid Cancer,BRD-K26818574-305-04-3::2.5::HTS,4.733602125165283,0.029997051553973846,Well-Differentiated Thyroid Cancer,BIX-01294,histone lysine methyltransferase inhibitor,"EHMT1, EHMT2"
Well-Differentiated Thyroid Cancer,BRD-K26824830-001-02-0::2.5::HTS,5.051870074740537,0.02498776013707776,Well-Differentiated Thyroid Cancer,azomycin-(2-nitroimidazole),protein synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K27382019-418-01-9::2.5::HTS,5.766849088920369,0.016660929213196462,Other Types,piperaquine-phosphate,antimalarial agent,
Well-Differentiated Thyroid Cancer,BRD-K28042756-001-01-9::5::HTS,4.0439843121870185,0.044826475396109525,Well-Differentiated Thyroid Cancer,,,
Well-Differentiated Thyroid Cancer,BRD-K28494619-001-28-2::2.5::HTS,5.252599812668527,0.02228621057066493,Other Types,sulfamethoxazole,PABA antagonist,
Well-Differentiated Thyroid Cancer,BRD-K29395450-001-06-8::2.5::HTS,4.70202669393198,0.030549646746041877,Well-Differentiated Thyroid Cancer,PIK-93,PI3K inhibitor,"PI4KB, PIK3C3, PIK3CG"
Well-Differentiated Thyroid Cancer,BRD-K29530284-001-06-2::2.5::HTS,4.070697446734838,0.04411490858993943,Well-Differentiated Thyroid Cancer,amlexanox,histamine receptor modulator,"FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13"
Well-Differentiated Thyroid Cancer,BRD-K30237152-300-02-5::2.5::HTS,3.8916119980835164,0.04902639501090818,Other Types,1400W,nitric oxide synthase inhibitor,"NOS1, NOS2, NOS3"
Well-Differentiated Thyroid Cancer,BRD-K30431096-004-01-3::2.5::HTS,14.419246759202398,0.0001627073802176621,Other Types,domiphen,,
Well-Differentiated Thyroid Cancer,BRD-K30553453-001-13-2::2.5::HTS,6.0891112081868615,0.013902887115694415,Other Types,hesperetin,ACAT inhibitor,"DGAT1, MTTP, SOAT1, SOAT2"
Well-Differentiated Thyroid Cancer,BRD-K31092604-003-03-5::2.5::HTS,5.647181802481274,0.017822331248590333,Well-Differentiated Thyroid Cancer,donitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6"
Well-Differentiated Thyroid Cancer,BRD-K32101625-001-01-6::2.5::HTS,4.1919451031773605,0.04108250506702034,Other Types,LX1031,tryptophan hydroxylase inhibitor,TPH1
Well-Differentiated Thyroid Cancer,BRD-K32218650-001-01-6::2.5::HTS,4.734768776833588,0.029980670124838127,Other Types,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119
Well-Differentiated Thyroid Cancer,BRD-K33814251-001-02-2::2.5::HTS,5.4453476411849575,0.019978610207103797,Other Types,lubiprostone,chloride channel activator,CLCN2
Well-Differentiated Thyroid Cancer,BRD-K34058848-304-03-1::2.5::HTS,4.087392308325159,0.04368187403899468,Other Types,cefonicid,bacterial cell wall synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K34122555-057-11-5::2.5::HTS,6.821528471951696,0.009249000365253546,Well-Differentiated Thyroid Cancer,denatonium-benzoate,,
Well-Differentiated Thyroid Cancer,BRD-K35079116-001-02-5::2.71::HTS,4.947454680486609,0.02655198086383468,Other Types,asiatic-acid,apoptosis stimulant,PYGM
Well-Differentiated Thyroid Cancer,BRD-K35559145-050-08-5::2.5::HTS,6.742283980279997,0.009661823893539936,Other Types,levomepromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C"
Well-Differentiated Thyroid Cancer,BRD-K35698076-001-01-2::2.5::HTS,7.18012461337967,0.007589586464420295,Well-Differentiated Thyroid Cancer,laurocapram,,
Well-Differentiated Thyroid Cancer,BRD-K35952844-236-01-6::2.5::HTS,6.321449336456385,0.012215028886354307,Other Types,sodium-glucoheptonate,,
Well-Differentiated Thyroid Cancer,BRD-K36207157-001-09-6::2.5::HTS,5.3530497467802025,0.021047248665743565,Well-Differentiated Thyroid Cancer,chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
Well-Differentiated Thyroid Cancer,BRD-K36965586-003-08-8::2.5::HTS,6.146291933894937,0.013463085583663626,Other Types,m-Chlorophenylbiguanide,,"HTR3A, HTR3B"
Well-Differentiated Thyroid Cancer,BRD-K37270826-001-31-8::2.5::HTS,4.036955057823501,0.044996008220137565,Well-Differentiated Thyroid Cancer,mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR"
Well-Differentiated Thyroid Cancer,BRD-K37590257-001-02-8::2.5::HTS,10.887411505975116,0.0010313439169314191,Other Types,GSK256066,phosphodiesterase inhibitor,PDE4A
Well-Differentiated Thyroid Cancer,BRD-K38305202-001-17-4::2.5::HTS,5.362074620809858,0.020940957612177107,Other Types,domperidone,dopamine receptor antagonist,"DRD2, DRD3"
Well-Differentiated Thyroid Cancer,BRD-K39166528-001-01-0::2.5::HTS,9.210058970283727,0.0025188450996014742,Well-Differentiated Thyroid Cancer,ID-8,,
Well-Differentiated Thyroid Cancer,BRD-K39733634-001-02-6::2.5::HTS,4.873111414681492,0.02768441666252513,Well-Differentiated Thyroid Cancer,L-161982,prostanoid receptor antagonist,PTGER4
Well-Differentiated Thyroid Cancer,BRD-K40530731-001-11-6::2.5::HTS,7.5628144863049895,0.006170102709448784,Other Types,hyoscyamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Well-Differentiated Thyroid Cancer,BRD-K40901640-003-01-6::2.5::HTS,4.90723375881447,0.027147453985717336,Well-Differentiated Thyroid Cancer,cinanserin,serotonin receptor antagonist,HTR2A
Well-Differentiated Thyroid Cancer,BRD-K41567364-001-04-6::2.5::HTS,4.001057056420534,0.04595934605824147,Well-Differentiated Thyroid Cancer,SB-334867,orexin receptor antagonist,"HCRTR1, HCRTR2"
Well-Differentiated Thyroid Cancer,BRD-K41783120-001-02-8::2.5::HTS,7.335320932265609,0.0069733446579459705,Well-Differentiated Thyroid Cancer,STA-5326,interleukin synthesis inhibitor,IL12A
Well-Differentiated Thyroid Cancer,BRD-K42981054-001-01-9::2.5::HTS,4.5199011321206255,0.033950837484249784,Other Types,mibampator,glutamate receptor modulator,GRIA1
Well-Differentiated Thyroid Cancer,BRD-K43449605-001-01-0::2.5::HTS,3.975253147099977,0.04666330353473695,Well-Differentiated Thyroid Cancer,oncrasin-1,apoptosis stimulant,
Well-Differentiated Thyroid Cancer,BRD-K44827188-001-06-0::2.5::HTS,7.254886991198131,0.007283919853772746,Well-Differentiated Thyroid Cancer,vismodegib,"hedgehog pathway inhibitor, smoothened receptor antagonist",SMO
Well-Differentiated Thyroid Cancer,BRD-K44993696-001-12-3::2.5::HTS,3.866346884721081,0.04975537823624443,Other Types,atenolol-(-),adrenergic receptor antagonist,
Well-Differentiated Thyroid Cancer,BRD-K46392623-001-02-5::2.5::HTS,8.769845517309358,0.003191900405379663,Well-Differentiated Thyroid Cancer,TG-100713,PI3K inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K47079459-004-04-6::2.5::HTS,11.3023982806858,0.0008282722424546309,Other Types,cetrimonium,,
Well-Differentiated Thyroid Cancer,BRD-K47095176-001-01-6::2.5::HTS,3.961489947915202,0.04705063055441718,Other Types,talnetant,tachykinin antagonist,"TACR2, TACR3"
Well-Differentiated Thyroid Cancer,BRD-K47264279-001-08-9::2.5::HTS,4.971316415078035,0.026171044851627478,Well-Differentiated Thyroid Cancer,psoralen,,"MAOA, MAOB"
Well-Differentiated Thyroid Cancer,BRD-K47642186-001-01-3::2.5::HTS,6.624005613936568,0.010321082126431635,Other Types,piclamilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D"
Well-Differentiated Thyroid Cancer,BRD-K47978074-001-02-4::2.5::HTS,8.041505665764756,0.0047412957625435105,Well-Differentiated Thyroid Cancer,trometamol,,"AMD1, CANT1, DCN, NEIL1, VEGFA"
Well-Differentiated Thyroid Cancer,BRD-K48068743-001-01-6::2.5::HTS,4.142537444164746,0.04230083353940927,Well-Differentiated Thyroid Cancer,teneligliptin,dipeptidyl peptidase inhibitor,DPP4
Well-Differentiated Thyroid Cancer,BRD-K48578705-001-17-6::2.5::HTS,6.197705290132063,0.013092000080569956,Well-Differentiated Thyroid Cancer,methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC"
Well-Differentiated Thyroid Cancer,BRD-K49668410-001-18-8::2.5::HTS,11.440819887536847,0.0007686570227043899,Well-Differentiated Thyroid Cancer,clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4
Well-Differentiated Thyroid Cancer,BRD-K50325075-001-02-1::2.5::HTS,7.5913222901518065,0.00605654331627147,Other Types,UCL-2077,slow afterhyperpolarization channel blocker,
Well-Differentiated Thyroid Cancer,BRD-K51747290-001-12-3::2.5::HTS,5.776762080093907,0.01658320608294059,Well-Differentiated Thyroid Cancer,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Well-Differentiated Thyroid Cancer,BRD-K51747290-001-13-1::2.5::HTS,4.4162577297418055,0.036061618648294214,Other Types,hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B"
Well-Differentiated Thyroid Cancer,BRD-K52113681-003-02-1::2.5::HTS,4.1382402351688174,0.0424022537518598,Other Types,CP-339818,potassium channel blocker,KCNA3
Well-Differentiated Thyroid Cancer,BRD-K52459643-001-17-7::2.5::HTS,17.069148105181775,4.1581839708730325e-05,Other Types,alprostadil,prostanoid receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR"
Well-Differentiated Thyroid Cancer,BRD-K52523550-001-01-5::2.5::HTS,4.558642858824226,0.03319265317801699,Well-Differentiated Thyroid Cancer,N-acetylcarnosine,,
Well-Differentiated Thyroid Cancer,BRD-K53263234-001-05-2::2.5::HTS,4.334196794095249,0.03780835853072794,Well-Differentiated Thyroid Cancer,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3
Well-Differentiated Thyroid Cancer,BRD-K53508936-001-01-0::2.5::HTS,7.763519954966155,0.0055145611461581675,Other Types,CTS-1027,metalloproteinase inhibitor,"MMP1, MMP13, MMP2, MMP3, MMP9"
Well-Differentiated Thyroid Cancer,BRD-K53561341-001-07-5::2.5::HTS,5.987954194279584,0.014711245214263351,Well-Differentiated Thyroid Cancer,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
Well-Differentiated Thyroid Cancer,BRD-K55055802-001-10-2::2.5::HTS,4.2843940467208546,0.03892418248658485,Other Types,etomidate,GABA receptor modulator,"ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
Well-Differentiated Thyroid Cancer,BRD-K55160477-001-04-7::2.5::HTS,7.484867970173036,0.006424409303575504,Other Types,benzo[d]thiazole-2(3h)-thione,,
Well-Differentiated Thyroid Cancer,BRD-K55705469-065-01-0::2.5::HTS,3.908732948476725,0.04852848370770248,Other Types,penbutolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B"
Well-Differentiated Thyroid Cancer,BRD-K56104152-008-04-1::2.5::HTS,9.312515968075912,0.002383418702141662,Other Types,oxiconazole,bacterial cell wall synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K56115039-003-02-1::2.5::HTS,11.688252802318567,0.00067496626209106,Well-Differentiated Thyroid Cancer,BU226,imidazoline receptor ligand,
Well-Differentiated Thyroid Cancer,BRD-K57718010-001-11-9::2.5::HTS,5.238944239489591,0.022456784806314304,Other Types,pentylenetetrazol,GABA receptor antagonist,
Well-Differentiated Thyroid Cancer,BRD-K58343622-001-01-6::2.5::HTS,4.601022126894906,0.032383170822272114,Well-Differentiated Thyroid Cancer,DY131,estrogen-related receptor agonist,"ESRRB, ESRRG"
Well-Differentiated Thyroid Cancer,BRD-K59390331-045-01-5::2.5::HTS,10.971069781728385,0.0009849155178411812,Other Types,tarafenacin,acetylcholine receptor antagonist,CHRM3
Well-Differentiated Thyroid Cancer,BRD-K59436580-001-01-7::2.5::HTS,4.474101261086923,0.034851710430322314,Other Types,tedizolid,bacterial 50S ribosomal subunit inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K59574735-001-11-8::2.5::HTS,4.754681632080212,0.0296342015394829,Well-Differentiated Thyroid Cancer,ubenimex,leukotriene synthesis inhibitor,"LTA4H, RNPEP"
Well-Differentiated Thyroid Cancer,BRD-K59745944-001-02-0::2.5::HTS,7.978838033435216,0.004903229162410693,Other Types,PHT-427,"AKT inhibitor, pyruvate dehydrogenase inhibitor","AKT2, PDPK1"
Well-Differentiated Thyroid Cancer,BRD-K59983611-001-21-9::2.5::HTS,14.678014390654226,0.00014551744510961202,Well-Differentiated Thyroid Cancer,sulfabenzamide,bacterial antifolate,
Well-Differentiated Thyroid Cancer,BRD-K60060639-005-02-2::2.5::HTS,7.258773138202612,0.0072683807367702365,Well-Differentiated Thyroid Cancer,N-methyllidocaine-iodide,antiarrhythmic medication,
Well-Differentiated Thyroid Cancer,BRD-K60212747-236-01-1::2.5::HTS,5.985342267665972,0.014750353530325026,Well-Differentiated Thyroid Cancer,neridronic-acid,bone resorption inhibitor,FDPS
Well-Differentiated Thyroid Cancer,BRD-K60441002-001-04-8::2.5::HTS,3.895308579043312,0.04891760737673597,Well-Differentiated Thyroid Cancer,muscimol,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3"
Well-Differentiated Thyroid Cancer,BRD-K62736196-015-13-6::2.5::HTS,7.530145309468732,0.006261373444582537,Other Types,guanaben-acetate,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Well-Differentiated Thyroid Cancer,BRD-K63150726-001-02-1::2.5::HTS,8.175252820875093,0.004404514469433733,Other Types,JTE-907,cannabinoid receptor inverse agonist,CNR2
Well-Differentiated Thyroid Cancer,BRD-K63430059-001-17-2::2.5::HTS,6.725373898486902,0.009761921277611113,Well-Differentiated Thyroid Cancer,methoxsalen,DNA synthesis inhibitor,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4"
Well-Differentiated Thyroid Cancer,BRD-K63516691-003-02-0::2.5::HTS,4.147123544819234,0.04218033400428419,Other Types,T-0156,phosphodiesterase inhibitor,PDE5A
Well-Differentiated Thyroid Cancer,BRD-K63675182-003-23-6::2.5::HTS,3.9247599981236787,0.04807134072318545,Well-Differentiated Thyroid Cancer,triflupromazine,dopamine receptor antagonist,"CHRM1, CHRM2, DRD1, DRD2, HTR2B"
Well-Differentiated Thyroid Cancer,BRD-K64659768-001-12-8::2.5::HTS,5.690426043643661,0.01739039654510153,Other Types,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K64755930-003-03-2::2.5::HTS,6.067709568186066,0.014066121143780716,Well-Differentiated Thyroid Cancer,etazolate,phosphodiesterase inhibitor,"GABRB3, PDE4A"
Well-Differentiated Thyroid Cancer,BRD-K64990520-001-08-4::2.5::HTS,4.882155497465206,0.027543957175670025,Well-Differentiated Thyroid Cancer,apocynin,NADPH oxidase inhibitor,NOX4
Well-Differentiated Thyroid Cancer,BRD-K65786282-001-07-5::2.5::HTS,4.223405537039466,0.0403333494955192,Other Types,CGP-7930,GABA receptor modulator,GABBR1
Well-Differentiated Thyroid Cancer,BRD-K65904673-001-01-4::2.5::HTS,5.079058428909951,0.02460243040263825,Well-Differentiated Thyroid Cancer,tandospirone,serotonin receptor agonist,HTR1A
Well-Differentiated Thyroid Cancer,BRD-K66030860-001-03-6::2.5::HTS,5.31831590865569,0.021470653254964774,Well-Differentiated Thyroid Cancer,salidroside,beta amyloid protein neurotoxicity inhibitor,APP
Well-Differentiated Thyroid Cancer,BRD-K66615216-003-14-8::2.5::HTS,4.475960076110675,0.034822913188304945,Well-Differentiated Thyroid Cancer,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A
Well-Differentiated Thyroid Cancer,BRD-K66937583-001-01-2::2.5::HTS,4.5953550972496275,0.03249103625206294,Well-Differentiated Thyroid Cancer,lodoxamide,histamine receptor antagonist,
Well-Differentiated Thyroid Cancer,BRD-K67783091-001-26-1::2.5::HTS,5.512171019875399,0.019233526893514364,Well-Differentiated Thyroid Cancer,haloperidol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1"
Well-Differentiated Thyroid Cancer,BRD-K68232413-001-01-2::2.5::HTS,6.567197418098623,0.01064782019300852,Well-Differentiated Thyroid Cancer,etizolam,benzodiazepine receptor agonist,GABRA1
Well-Differentiated Thyroid Cancer,BRD-K68264559-045-04-0::2.58::HTS,4.629598816515396,0.031868474433909756,Well-Differentiated Thyroid Cancer,brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C"
Well-Differentiated Thyroid Cancer,BRD-K68567222-001-01-2::2.5::HTS,4.284765142375346,0.03891741471161129,Other Types,BVT-948,tyrosine phosphatase inhibitor,"PTPN1, PTPN11, PTPN2"
Well-Differentiated Thyroid Cancer,BRD-K68810443-001-01-9::2.5::HTS,4.873561133495929,0.027677268112903136,Well-Differentiated Thyroid Cancer,adiporon,adiponectin receptor agonist,"ADIPOR1, ADIPOR2"
Well-Differentiated Thyroid Cancer,BRD-K69195780-004-08-4::2.5::HTS,6.256786912833217,0.012655174412127665,Other Types,NAN-190,serotonin receptor agonist,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F"
Well-Differentiated Thyroid Cancer,BRD-K69726342-238-02-4::2.5::HTS,5.04526881987774,0.025082261739087692,Other Types,atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR"
Well-Differentiated Thyroid Cancer,BRD-K69726595-001-01-2::2.5::HTS,5.161796458637275,0.023467409637072015,Other Types,mericitabine,HCV inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K69812556-305-02-0::2.5::HTS,5.363013260789261,0.020929800535392482,Well-Differentiated Thyroid Cancer,WAY-100635,serotonin receptor antagonist,HTR1A
Well-Differentiated Thyroid Cancer,BRD-K70610771-001-02-9::2.5::HTS,3.9375390043214322,0.04771276559716392,Other Types,VX-222,HCV inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K71731651-001-04-3::2.5::HTS,3.99898936034612,0.04602249223936196,Well-Differentiated Thyroid Cancer,PNU-120596,acetylcholine receptor agonist,CHRNA7
Well-Differentiated Thyroid Cancer,BRD-K72166146-066-05-4::2.5::HTS,4.520229427403332,0.033937899621825,Well-Differentiated Thyroid Cancer,dihydroergotamine,serotonin receptor agonist,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7"
Well-Differentiated Thyroid Cancer,BRD-K72215350-001-06-5::2.5::HTS,8.662593481857398,0.003382713632000662,Well-Differentiated Thyroid Cancer,acexamic-acid,5 alpha reductase inhibitor,GAST
Well-Differentiated Thyroid Cancer,BRD-K73477617-001-08-5::2.5::HTS,3.9848519160974525,0.046396608819126016,Well-Differentiated Thyroid Cancer,dibutyl-phthalate,,TRPA1
Well-Differentiated Thyroid Cancer,BRD-K73771095-001-03-3::2.5::HTS,4.101984553386568,0.04331185862009337,Other Types,geniposidic-acid,cyclooxygenase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K75080769-001-01-6::2.5::HTS,7.996367493453889,0.004854229596759685,Other Types,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,
Well-Differentiated Thyroid Cancer,BRD-K77171813-034-01-8::2.5::HTS,5.677237275174157,0.017523266603391853,Well-Differentiated Thyroid Cancer,proxyfan,histamine receptor modulator,HRH3
Well-Differentiated Thyroid Cancer,BRD-K77627880-001-04-0::2.5::HTS,6.499215225332317,0.01105860429817025,Well-Differentiated Thyroid Cancer,A205804,ICAM1 expression inhibitor,"ICAM1, SELE"
Well-Differentiated Thyroid Cancer,BRD-K77841042-001-14-1::2.5::HTS,7.515516486655422,0.006315292096819477,Well-Differentiated Thyroid Cancer,brefeldin-a,protein synthesis inhibitor,"ARF1, CYTH2"
Well-Differentiated Thyroid Cancer,BRD-K78781788-003-01-9::2.5::HTS,5.266901519975643,0.02210894486811738,Well-Differentiated Thyroid Cancer,barnidipine,calcium channel blocker,
Well-Differentiated Thyroid Cancer,BRD-K79425933-001-09-3::2.5::HTS,3.8804853277759865,0.049348119917106616,Well-Differentiated Thyroid Cancer,benperidol,dopamine receptor antagonist,DRD2
Well-Differentiated Thyroid Cancer,BRD-K79501723-001-04-6::2.5::HTS,4.147344478474293,0.04217659577968841,Well-Differentiated Thyroid Cancer,cyclizine,histamine receptor modulator,"HRH1, SULT1E1"
Well-Differentiated Thyroid Cancer,BRD-K79555887-001-01-0::2.5::HTS,10.113111781697627,0.0015537393056825374,Well-Differentiated Thyroid Cancer,RI-1,,RAD51
Well-Differentiated Thyroid Cancer,BRD-K79633074-001-01-8::2.5::HTS,5.110764733728197,0.02415950383674159,Other Types,xilobam,,
Well-Differentiated Thyroid Cancer,BRD-K79884267-001-01-4::2.5::HTS,6.163363684901105,0.013337324530344759,Other Types,retinaldehyde,,
Well-Differentiated Thyroid Cancer,BRD-K80480517-001-02-4::2.5::HTS,5.694686916612746,0.017348661944291927,Other Types,repsox,TGF beta receptor inhibitor,TGFBR1
Well-Differentiated Thyroid Cancer,BRD-K80935598-001-01-1::2.5::HTS,5.413370658931613,0.020340184677872766,Well-Differentiated Thyroid Cancer,AZ191,DYRK inhibitor,DYRK1B
Well-Differentiated Thyroid Cancer,BRD-K81128206-003-24-4::2.5::HTS,5.290210859800413,0.02181113740928818,Well-Differentiated Thyroid Cancer,edrophonium,acetylcholinesterase inhibitor,"ACHE, BCHE"
Well-Differentiated Thyroid Cancer,BRD-K81623406-004-08-3::2.5::HTS,4.2718393235284475,0.03921381300228193,Well-Differentiated Thyroid Cancer,EIT-hydrobromide,nitric oxide synthase inhibitor,"NOS2, NOS3"
Well-Differentiated Thyroid Cancer,BRD-K82002057-001-01-2::2.5::HTS,4.685828415594736,0.030834936011070374,Well-Differentiated Thyroid Cancer,DFB,glutamate receptor agonist,GRM5
Well-Differentiated Thyroid Cancer,BRD-K82036761-003-20-3::2.5::HTS,6.403422722081987,0.011662869961399784,Well-Differentiated Thyroid Cancer,sertraline,selective serotonin reuptake inhibitor (SSRI),"SLC6A3, SLC6A4"
Well-Differentiated Thyroid Cancer,BRD-K82104468-001-05-0::2.5::HTS,6.816043164012585,0.009275363207424638,Other Types,ethyl-vanillin,,
Well-Differentiated Thyroid Cancer,BRD-K82142815-001-19-1::2.5::HTS,4.701703082973702,0.030554590621929535,Well-Differentiated Thyroid Cancer,betamipron,panipenem uptake inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K82255054-001-15-9::2.5::HTS,5.129516096204269,0.023904986231663313,Well-Differentiated Thyroid Cancer,propofol,benzodiazepine receptor agonist,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A"
Well-Differentiated Thyroid Cancer,BRD-K82746043-001-15-1::2.5::HTS,5.726522353447282,0.01703892000239308,Other Types,navitoclax,BCL inhibitor,"BCL2, BCL2L1, BCL2L2"
Well-Differentiated Thyroid Cancer,BRD-K82960980-003-02-7::2.36::HTS,4.318858840625215,0.038174666086325096,Well-Differentiated Thyroid Cancer,ceftiofur,bacterial cell wall synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K83766205-001-03-8::2.5::HTS,8.470487143106622,0.0037541395770740314,Well-Differentiated Thyroid Cancer,metirosine,tyrosine hydroxylase inhibitor,TH
Well-Differentiated Thyroid Cancer,BRD-K84214706-001-05-7::2.5::HTS,4.970972350458176,0.02617049704640166,Other Types,7-chlorokynurenic-acid,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C"
Well-Differentiated Thyroid Cancer,BRD-K85178109-001-02-3::2.5::HTS,5.51511857223849,0.019200842471954988,Well-Differentiated Thyroid Cancer,fostamatinib,SYK inhibitor,SYK
Well-Differentiated Thyroid Cancer,BRD-K86972824-001-02-2::2.5::HTS,5.725827844652975,0.01705036617252368,Well-Differentiated Thyroid Cancer,oltipraz,"nuclear factor erythroid derived, like (NRF2) activator",ANG
Well-Differentiated Thyroid Cancer,BRD-K87492696-001-16-5::2.5::HTS,8.39993195120788,0.003899830848585574,Well-Differentiated Thyroid Cancer,sulfameter,dihydrofolate reductase inhibitor,DHFR
Well-Differentiated Thyroid Cancer,BRD-K87990216-001-10-2::2.5::HTS,4.1112606026126,0.0430741667078172,Well-Differentiated Thyroid Cancer,piretanide,glucocorticoid receptor agonist,"SLC12A1, SLC12A2"
Well-Differentiated Thyroid Cancer,BRD-K88405679-003-03-1::2.5::HTS,5.0524095498478045,0.02498214975282693,Well-Differentiated Thyroid Cancer,thonzylamine,antihistamine,
Well-Differentiated Thyroid Cancer,BRD-K88682005-001-15-8::2.5::HTS,5.822679118853111,0.01614563231602893,Well-Differentiated Thyroid Cancer,chlorothiazide,diuretic,"CA1, CA2, CA4, SLC12A3"
Well-Differentiated Thyroid Cancer,BRD-K90239174-001-01-8::2.5::HTS,4.3482850807354625,0.03750092805678767,Other Types,AMG-487,CC chemokine receptor antagonist,
Well-Differentiated Thyroid Cancer,BRD-K92303087-001-01-6::2.5::HTS,7.640048334754721,0.0058959144660274436,Other Types,oglemilast,phosphodiesterase inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K92991072-001-04-9::2.5::HTS,7.182758345275605,0.007585921537466482,Well-Differentiated Thyroid Cancer,PAC-1,caspase activator,CASP3
Well-Differentiated Thyroid Cancer,BRD-K93045741-001-01-0::2.5::HTS,4.62788163945997,0.03188420423233246,Well-Differentiated Thyroid Cancer,tozadenant,adenosine receptor antagonist,ADORA2A
Well-Differentiated Thyroid Cancer,BRD-K93255255-001-02-1::2.5::HTS,6.924332184928444,0.0087390669531921,Well-Differentiated Thyroid Cancer,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1
Well-Differentiated Thyroid Cancer,BRD-K93918653-001-08-9::2.5::HTS,6.455955728493266,0.01132733958732266,Well-Differentiated Thyroid Cancer,quizartinib,FLT3 inhibitor,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET"
Well-Differentiated Thyroid Cancer,BRD-K95523387-001-09-6::2.5::HTS,8.011496382211696,0.004815316081811469,Well-Differentiated Thyroid Cancer,OLDA,TRPV agonist,GPR119
Well-Differentiated Thyroid Cancer,BRD-K96259238-001-01-4::2.5::HTS,8.297605487336261,0.004122011013027216,Well-Differentiated Thyroid Cancer,Y-320,interleukin inhibitor,IL17A
Well-Differentiated Thyroid Cancer,BRD-K96714749-001-01-0::2.5::HTS,6.064467317780037,0.01409383429806531,Well-Differentiated Thyroid Cancer,isobutamben,local anesthetic,
Well-Differentiated Thyroid Cancer,BRD-K97010173-001-04-1::2.5::HTS,5.027496014201159,0.02533784873959256,Well-Differentiated Thyroid Cancer,deferasirox,chelating agent,CYP3A4
Well-Differentiated Thyroid Cancer,BRD-K97045029-001-02-7::2.5::HTS,8.155908259049767,0.004451050928332664,Well-Differentiated Thyroid Cancer,pranlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF"
Well-Differentiated Thyroid Cancer,BRD-K97714174-001-01-3::2.5::HTS,4.939671831978286,0.02664420921609879,Well-Differentiated Thyroid Cancer,P22077,ubiquitin specific protease inhibitor,USP7
Well-Differentiated Thyroid Cancer,BRD-K99149715-001-01-6::2.5::HTS,4.2983032313984495,0.03860792845885147,Well-Differentiated Thyroid Cancer,plurisin-#1,stearoyl-CoA desaturase inhibitor,SCD
Well-Differentiated Thyroid Cancer,BRD-K99383816-001-03-5::2.5::HTS,5.846238650385055,0.015940968526412053,Other Types,ftorafur,thymidylate synthase inhibitor,TYMS
Well-Differentiated Thyroid Cancer,BRD-K99621550-300-01-8::2.5::HTS,6.828941374295722,0.009211600244832046,Other Types,tubocurarine,acetylcholine receptor antagonist,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN"
Well-Differentiated Thyroid Cancer,BRD-K99741577-001-01-7::2.5::HTS,3.8774400743795767,0.049429966149308516,Well-Differentiated Thyroid Cancer,SANT-1,smoothened receptor antagonist,"SHH, SMO"
Well-Differentiated Thyroid Cancer,BRD-K99946902-001-07-5::2.5::HTS,7.146226004434158,0.007732884283899155,Other Types,hexylresorcinol,local anesthetic,TYR
Well-Differentiated Thyroid Cancer,BRD-M92675308-003-07-1::2.5::HTS,8.539724849084287,0.003616593849489563,Well-Differentiated Thyroid Cancer,efonidipine-monoethanolate,"L-type calcium channel blocker, T-type calcium channel blocker","CACNA1C, CACNA1G"
Well-Differentiated Thyroid Cancer,BRD-M97302542-001-03-6::2.5::HTS,5.43343545822279,0.020130327008062457,Other Types,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1
Well-Differentiated Thyroid Cancer,BRD-A15739803-001-01-0::2.726366321::MTS004,4.911965308911763,0.027088078923650703,Well-Differentiated Thyroid Cancer,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3
Well-Differentiated Thyroid Cancer,BRD-A78965079-036-01-8::2.640168331::MTS004,5.2209057135129395,0.022704559816041806,Well-Differentiated Thyroid Cancer,tafenoquine,antimalarial agent,
Well-Differentiated Thyroid Cancer,BRD-A91728607-236-11-9::2.5::MTS004,6.439727475973883,0.011440149744864401,Other Types,citicoline,"membrane permeability enhancer, glutathione transferase stimulant","ACHE, SLC1A2"
Well-Differentiated Thyroid Cancer,BRD-K13277760-001-01-2::2.5::MTS004,4.31529441364858,0.03824505905332946,Well-Differentiated Thyroid Cancer,rifamycin-sv,RNA synthesis inhibitor,
Well-Differentiated Thyroid Cancer,BRD-K33240821-001-06-2::2.50000539::MTS004,7.640028670524484,0.005904031971596433,Other Types,plerixafor,CC chemokine receptor antagonist,"ACKR3, CCR4, CXCR4"
Well-Differentiated Thyroid Cancer,BRD-K38168441-001-03-7::2.422985058::MTS004,4.8368259643759,0.028282844017927307,Other Types,dabigatran,thrombin inhibitor,F2
Well-Differentiated Thyroid Cancer,BRD-K44471774-001-01-8::2.670187358::MTS004,4.385316859709624,0.0367162222520121,Well-Differentiated Thyroid Cancer,bay-w-9798,antioxidant,
Well-Differentiated Thyroid Cancer,BRD-K59256312-066-15-7::2.431061328::MTS004,6.1583509348188885,0.013383571542292201,Other Types,gabexate,serine protease inhibitor,"PRSS1, TPSAB1"
Well-Differentiated Thyroid Cancer,BRD-K59391348-001-01-7::2.5::MTS004,4.0395574084150585,0.04494329498142268,Other Types,lixivaptan,vasopressin receptor antagonist,AVPR2
Well-Differentiated Thyroid Cancer,BRD-K62384160-001-02-0::2.499970983::MTS004,5.057242075800902,0.02492702796903625,Well-Differentiated Thyroid Cancer,siponimod,sphingosine phosphate receptor modulator,S1PR1
Well-Differentiated Thyroid Cancer,BRD-K66845263-001-03-0::2.5::MTS004,4.093750274039689,0.04353506366296086,Other Types,sophocarpine,,
Well-Differentiated Thyroid Cancer,BRD-K68764924-001-03-2::2.5::MTS004,3.955902885053294,0.04721236147715628,Other Types,pantethine,coenzyme A precursor,
Well-Differentiated Thyroid Cancer,BRD-K70592963-001-31-6::2.5::MTS004,4.188709604478138,0.04117856543983897,Other Types,phenindione,vitamin K antagonist,VKORC1
Well-Differentiated Thyroid Cancer,BRD-K80353807-001-25-3::2.5::MTS004,4.474959772193756,0.03485312333201514,Other Types,khellin,vasodilator,
Well-Differentiated Thyroid Cancer,BRD-K87573013-001-01-0::2.5::MTS004,7.180736860865238,0.007594358599631277,Other Types,CL-225385,,
Well-Differentiated Thyroid Cancer,BRD-K99077012-001-01-9::2.332734192::MTS004,5.491629388591379,0.01947090962035198,Well-Differentiated Thyroid Cancer,befuraline,,
Well-Differentiated Thyroid Cancer,BRD-K99879819-001-02-1::2.5187366::MTS004,5.565092646703265,0.01867783043087239,Well-Differentiated Thyroid Cancer,lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A00100033-001-08-9::2.5::HTS,6.513464135551065,0.01096947958706925,Other Types,nifurtimox,DNA inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A06627858-236-03-0::2.5::HTS,5.590349846543656,0.01840110741972596,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,monensin,bacterial permeability inducer,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A07000685-001-04-4::2.5::HTS,5.672435109083748,0.01756836607331725,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hydrocortisone-hemisuccinate,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A08255417-001-14-7::2.5::HTS,4.318094029141077,0.038165709061277385,Other Types,famprofazone,cyclooxygenase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A10652366-238-04-1::2.5::HTS,22.49703038003164,2.7121007148319245e-06,Other Types,fosfomycin,bacterial cell wall synthesis inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A10977446-001-12-1::2.5::HTS,6.590635121417953,0.010520301882012528,Other Types,carvedilol,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A11070335-236-02-1::2.5::HTS,3.8796264244955783,0.0493669724896905,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,carbazochrome,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A11132253-001-08-2::2.5::HTS,7.720424361553806,0.005651447604500801,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,nadide,electron acceptor,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A11990600-001-03-4::2.5::HTS,4.672785618815698,0.031083665068010437,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,lorazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A17846016-001-13-9::2.5::HTS,5.115228831984495,0.024101431577094774,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,trolox,antioxidant,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A21276153-001-01-1::2.5::HTS,3.8871896424563053,0.049177409984887385,Other Types,"2,6-dimethylpiperidine",,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A24191444-046-03-9::2.4::HTS,9.752931802886993,0.0018885568036244155,Other Types,ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A25143711-001-02-2::2.5::HTS,4.218914484742661,0.040441907222173584,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hydrocortisone-valerate,glucocorticoid receptor agonist,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A25608658-001-01-1::2.5::HTS,5.262122143469227,0.022165104233258227,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,narasin,antiprotozoal agent,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A28301258-001-03-0::2.5::HTS,4.044201768043415,0.04480726552365681,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,salinomycin,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A33711280-003-03-1::2.5::HTS,9.210671329101682,0.0025178142093845797,Other Types,metixene,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A35912562-001-02-8::2.5::HTS,12.158371163029633,0.0005272313642252633,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,pregnenolone-succinate,GABA receptor negative allosteric modulator,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A36217750-001-16-3::2.5::HTS,4.2338428353324105,0.040090491808942405,Other Types,sulfinpyrazone,uricosuric blocker,"ABCC1, ABCC2, FPR1, SLC22A12"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A37288617-003-02-2::2.5::HTS,10.51995454002779,0.0012510071142683163,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A39189014-003-22-7::2.5::HTS,4.084182904480361,0.043764275582758506,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,methoxamine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A41774846-001-01-4::2.5::HTS,4.485256061275407,0.03462683673614154,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,algestone-acetophenide,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A46186775-369-02-0::2.5::HTS,5.852912122673965,0.015870593285222282,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hydrocortisone-phosphate,,"ANXA1, NOS2, NR3C1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A49225603-045-10-0::2.5::HTS,3.8667259666316838,0.04974863773810078,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,alimemazine,histamine receptor agonist,HRH1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A50684349-003-02-9::2.5::HTS,4.810366444138168,0.028701663103422034,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,fenoldopam,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A52660433-066-02-1::2.5::HTS,6.308512190699963,0.012307180221879814,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,tetrindole,monoamine oxidase inhibitor,MAOA
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A55424491-001-19-9::2.5::HTS,6.341272124498293,0.012078249055462113,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,methotrexate,dihydrofolate reductase inhibitor,DHFR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A55469827-001-07-4::2.5::HTS,3.8864268589173374,0.04917151309331294,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,mephenesin,muscle relaxant,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A61194565-003-27-0::2.5::HTS,4.303910541171656,0.03848598639552612,Other Types,benserazide,DOPA decarboxylase inhibitor,DDC
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A61221616-001-04-3::2.5::HTS,4.952844944977291,0.026443762982898168,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,medroxyprogesterone-acetate,progesterone receptor agonist,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A62421304-004-18-9::2.5::HTS,8.230064396474505,0.004276460903050668,Other Types,mepenzolate,acetylcholine receptor antagonist,"CHRM1, CHRM3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A65248799-001-01-7::2.5::HTS,4.105382233066601,0.0432196048774836,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,EMD-53998,phosphodiesterase inhibitor,TNNC1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A71407503-001-01-8::2.5::HTS,15.751099134099574,8.175092966231338e-05,Other Types,inimur,other antifungal,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A80871782-004-06-9::2.5::HTS,7.613324975194405,0.005982718474679786,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A88080608-001-04-2::2.5::HTS,10.6587238894779,0.0011627828003604194,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,equilin,estrogen receptor agonist,HSD17B1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A93093700-001-02-9::2.5::HTS,4.530066646176397,0.03373870000845167,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,temazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A93236127-001-04-5::2.5::HTS,3.8647540535684226,0.049806707430879345,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,digitoxin,ATPase inhibitor,ATP1A1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-A95602221-003-02-1::2.5::HTS,3.9784230707183874,0.04657621397121899,Other Types,celiprolol,adrenergic receptor antagonist,"ADRA2A, ADRB1, ADRB2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K01614093-001-02-6::2.5::HTS,8.295624329982013,0.004134863301008822,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,dihydromyricetin,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K05524748-003-04-4::2.5::HTS,4.643181237302307,0.031622750050323924,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K05919151-001-01-6::2.5::HTS,7.050542270214878,0.008163452110179345,Other Types,dixanthogen,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K08033334-003-04-3::2.5::HTS,5.2441580196326445,0.0223935516718637,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,lincomycin,bacterial 30S ribosomal subunit inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K08037784-001-12-6::2.5::HTS,6.434582857215618,0.011472929638618573,Other Types,arbutin,melanin inhibitor,TYR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K08252256-236-33-8::2.5::HTS,6.364558342210506,0.011928847371575468,Other Types,diclofenac,cyclooxygenase inhibitor,"AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K08493205-001-04-9::2.5::HTS,4.491575946889062,0.03450404346576658,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,salicyl-alcohol,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K08703257-001-12-1::2.5::HTS,7.090505142201483,0.007982235775161302,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,3-amino-benzamide,PARP inhibitor,PARP1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K09372874-001-01-0::2.5::HTS,5.903471237527688,0.015436639457812566,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K09471561-001-18-2::2.5::HTS,4.4597692238925735,0.03516171759823816,Other Types,levofloxacin,bacterial DNA gyrase inhibitor,TOP2A
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K09877029-001-01-2::2.5::HTS,5.406480810595813,0.020419185058666668,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,VS-4718,focal adhesion kinase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K10759144-001-04-3::2.5::HTS,5.213605915115453,0.022807238254016204,Other Types,xylose,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K10836013-001-01-3::2.5::HTS,4.433178778974155,0.03568988689964702,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,sitafloxacin,bacterial DNA gyrase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K11124378-001-04-6::2.5::HTS,7.921239790263346,0.005058217966273049,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ceftibuten,bacterial cell wall synthesis inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K11153516-001-05-5::2.5::HTS,7.268771475425237,0.007236514269817147,Other Types,iniparib,PARP inhibitor,PARP1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K11433652-001-17-0::2.5::HTS,6.430323529212782,0.011500141916517263,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,aspirin,cyclooxygenase inhibitor,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K12329651-001-18-8::2.5::HTS,10.980308680007631,0.0009801120447971907,Other Types,androsterone,androgen receptor agonist,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K12539581-001-23-7::2.5::HTS,4.195132614810564,0.04100428002097978,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,nocodazole,tubulin polymerization inhibitor,HPGDS
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K12735121-001-01-4::2.5::HTS,5.594166512108333,0.01837352834209095,Other Types,TG-100801,"src inhibitor, VEGFR inhibitor","FGFR1, FLT1, KDR, SRC"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K14003026-003-09-0::2.46::HTS,6.327920810628456,0.012210569987847489,Other Types,ritodrine,adrenergic receptor agonist,ADRB2
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K14109347-001-03-4::2.5::HTS,5.267702235732149,0.022094842163613373,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,LY2603618,CHK inhibitor,CHEK1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K14711741-001-02-1::2.5::HTS,5.400805824634269,0.020483112251142254,Other Types,PF-4708671,ribosomal protein inhibitor,RPS6KB1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K14763542-001-02-3::2.5::HTS,9.828995880932803,0.0018134110627702968,Other Types,flurothyl,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K15409150-001-05-8::2.5::HTS,5.011909814844466,0.025580852350279855,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,penfluridol,T-type calcium channel blocker,CACNA1G
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K15502390-001-20-9::2.5::HTS,6.700537587487191,0.009888745158962115,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,nevirapine,non-nucleoside reverse transcriptase inhibitor,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K15563106-001-18-0::2.5::HTS,5.875403263978341,0.01567296477235337,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,phloretin,sodium/glucose cotransporter inhibitor,"AQP9, CLCN3, SLC23A1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K15868788-003-07-7::2.5::HTS,6.12004051522331,0.013664358077430844,Other Types,SDZ-205-557,serotonin receptor antagonist,"HTR3A, HTR3B"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K17368287-001-18-3::2.5::HTS,10.342219865503433,0.0013749389162632868,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,"HSD11B1, HSD11B2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K17849083-001-32-9::2.43::HTS,6.606053570001499,0.010430708060740663,Other Types,tranilast,angiogenesis inhibitor,"HPGDS, HRH1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K18036262-001-02-8::2.5::HTS,5.7995215561088065,0.016356156691216473,Other Types,L-168049,glucagon receptor antagonist,GCGR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K18059238-001-10-4::0.25::HTS,4.348068253970405,0.03750566455781122,Other Types,gamma-linolenic-acid,"cyclooxygenase inhibitor, prostanoid receptor agonist","PTGS1, PTGS2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K18849474-001-04-4::2.61::HTS,4.599930969886493,0.03242892246797981,Other Types,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K19687926-379-07-4::2.5::HTS,4.769327003815556,0.029386802816179627,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,lapatinib,EGFR inhibitor,"EGFR, ERBB2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K20431737-001-08-1::2.5::HTS,4.352044294136443,0.03741890924914842,Other Types,benzoylpas,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K20482099-001-09-4::2.5::HTS,5.975535173719196,0.014831654713409853,Other Types,rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K20605374-001-05-4::2.5::HTS,4.934831763391885,0.026718254583170592,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K20722021-001-02-1::2.5::HTS,4.536955986663836,0.03362282387838937,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,CEP-32496,RAF inhibitor,"BRAF, RAF1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K21450440-001-14-6::2.5::HTS,4.183437887631782,0.04128592848917593,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,benzthiazide,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA4, CA9, SLC12A3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K21728777-001-02-3::2.5::HTS,5.6260970254499405,0.01803327478622083,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AMG900,Aurora kinase inhibitor,"AURKA, AURKB, AURKC"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K21910317-001-12-3::2.5::HTS,7.30711183282883,0.007077909858829981,Other Types,"2,4-dinitrophenol",ATP synthase inhibitor,APP
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K21913543-001-02-4::2.5::HTS,4.645374602106433,0.03156587480214997,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,fluorescein,,SLC22A6
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K22685337-001-13-4::2.5::HTS,4.598295440762633,0.03243582748610914,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,roxarsone,antiprotozoal agent,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K22829793-001-01-0::2.5::HTS,4.489990123332717,0.03453421526963805,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ZCL-278,CDC inhibitor,CDC42
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K23922020-075-02-9::2.5::HTS,5.200942125159047,0.022948845543995566,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,arecaidine-propargyl-ester,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K24869513-001-02-1::2.5::HTS,9.386358666112999,0.0022908259952494933,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,CNX-2006,EGFR inhibitor,EGFR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K25186396-001-09-6::2.5::HTS,5.579668331082353,0.018514999515700976,Other Types,tangeritin,cell cycle inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K25224017-001-25-0::2.5::HTS,4.187507413187709,0.041194408522337175,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,pirenperone,serotonin receptor antagonist,"HTR2A, HTR7"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K25394294-001-14-9::2.5::HTS,5.142789462969136,0.023721884240503713,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,oxaprozin,cyclooxygenase inhibitor,"PTGS1, PTGS2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K25630527-001-03-8::2.5::HTS,4.612345765930003,0.032169528494444356,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,LY2784544,JAK inhibitor,"JAK2, JAK3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K25991633-001-01-9::2.5::HTS,10.40762662208801,0.0013292879663167757,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BMS-649,retinoid receptor agonist,RXRA
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K26060080-065-05-6::2.5::HTS,6.478096736350762,0.011191144403917112,Other Types,adenine,protein synthesis stimulant,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K26253904-001-01-5::2.5::HTS,5.290771124546389,0.021806815536887476,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,NMS-873,ATPase inhibitor,VCP
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K26349472-001-01-3::2.5::HTS,12.260255662636729,0.0005018902765128491,Other Types,OG-L002,histone lysine demethylase inhibitor,KDM1A
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K28121004-001-01-1::2.5::HTS,5.401899671180484,0.020470404854930516,Other Types,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K29359156-001-30-1::2.5::HTS,8.720657830128742,0.0032777946576934,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ebselen,"cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor",ALB
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K31627533-001-09-5::2.5::HTS,5.858792277312888,0.015818797374426118,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,rimexolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K31843556-001-04-1::2.5::HTS,5.6763964989709,0.01753096840096608,Other Types,T-0070907,PPAR receptor antagonist,PPARG
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K34568562-001-04-3::2.5::HTS,5.200253732008198,0.022959866435128054,Other Types,tilorone,interferon inducer,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K36055864-001-19-2::2.5::HTS,8.253622514191283,0.004221845998496133,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,cycloheximide,protein synthesis inhibitor,RPL3
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K36363294-001-04-2::2.5::HTS,4.50232049532624,0.03430443768781141,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,I-BET151,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K36461289-001-05-8::2.5::HTS,4.753857209249328,0.02965278607209833,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,picrotoxinin,GABA receptor antagonist,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K36862742-001-25-6::2.5::HTS,6.096263694563755,0.013845722137861451,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,"ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K37083340-001-02-3::2.5::HTS,4.171995977839057,0.04159350804051004,Other Types,lycopene,free radical scavenger,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K37687095-001-06-9::2.5::HTS,6.093055559577773,0.01386793143164351,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AZD8330,MEK inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K37814297-050-09-6::2.5::HTS,3.8953821166668696,0.04891280568123934,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,acepromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K38003476-001-09-1::2.5::HTS,5.4595322240449375,0.01981231363418045,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,clocortolone-pivalate,steroid,"NR3C1, PLA2G1B"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K38197229-001-29-9::2.5::HTS,3.870532427976681,0.049634088270375576,Other Types,bumetanide,solute carrier family member inhibitor,"CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K38684403-001-05-4::2.5::HTS,6.349962377866299,0.012014374309253215,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,roxithromycin,bacterial 50S ribosomal subunit inhibitor,"ABCB1, MLNR"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K39467894-001-05-9::2.5::HTS,5.106990465255896,0.024215066930584984,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,nithiamide,bacterial DNA inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K40530731-001-11-6::2.5::HTS,12.23278335897349,0.0005105975189879157,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,hyoscyamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K40718343-001-02-6::2.5::HTS,4.2680782190611755,0.039292553331838065,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AEE788,"EGFR inhibitor, VEGFR inhibitor","EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K40992116-001-09-7::2.5::HTS,4.842928025244507,0.02818307355828417,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,parachlorophenol,antiinfective drug,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K41337261-001-03-0::2.5::HTS,5.384549483435201,0.020672932670426077,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ZM-306416,"Abl kinase inhibitor, src inhibitor, VEGFR inhibitor","EGFR, FLT1, FLT4, KDR"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K42436189-001-01-2::2.5::HTS,4.412376421393464,0.0361240452449466,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AZ20,ATR kinase inhibitor,"ATR, MTOR"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K42898655-001-01-8::2.5::HTS,8.301175373764844,0.004113217005050812,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,temsirolimus,mTOR inhibitor,MTOR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K43471985-001-03-0::2.69::HTS,4.759578483698362,0.02957594144699902,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K43471985-001-05-5::2.5::HTS,4.617515726273484,0.03207658004856485,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,OTX015,bromodomain inhibitor,"BRD2, BRD3, BRD4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K44004064-001-07-3::2.5::HTS,4.99234382283939,0.025857782087037276,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,acefylline,adenosine receptor agonist,ADORA1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K45014108-003-01-8::2.5::HTS,6.489195397075033,0.01112085162778062,Other Types,ephedrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K46435528-001-04-4::2.5::HTS,4.13922279817756,0.04239956312134547,Other Types,trichloroethylene,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K46435977-003-11-1::2.5::HTS,5.930427517785028,0.015196059956337517,Other Types,valaciclovir,DNA polymerase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K47659338-003-02-8::2.5::HTS,15.52517672060204,9.182148744621975e-05,Other Types,EMD-386088,serotonin receptor agonist,HTR6
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K47949423-001-03-1::2.56::HTS,5.552264217302286,0.01882121572033676,Other Types,mirabegron,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K48684885-001-04-2::2.5::HTS,6.3352715053512485,0.012117164912334362,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K49294207-300-03-8::2.5::HTS,6.5474817495042625,0.010768853067096584,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BIBU-1361,EGFR inhibitor,EGFR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K49545903-003-01-4::2.5::HTS,5.73392576780215,0.016971544423493683,Other Types,"4,4-pentamethylenepiperidine",M2 channel blocker,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K50866992-003-09-5::2.5::HTS,4.265445029756898,0.0393596372172105,Other Types,tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K51486818-003-02-8::2.5::HTS,7.081073089703053,0.008016161389065501,Other Types,lazabemide,monoamine oxidase inhibitor,MAOB
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K52075715-001-06-7::2.5::HTS,4.390125066285344,0.03659458720017163,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K52911425-001-09-8::2.5::HTS,5.138320394893909,0.02378245579068028,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,GDC-0941,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K54187111-001-09-2::2.5::HTS,3.9379452580633645,0.047697792564850565,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,dichlorisone-acetate,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K54606188-001-13-1::2.5::HTS,6.047973098994814,0.01422247092869577,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,JQ1-(+),bromodomain inhibitor,"BRD4, BRDT"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K55305701-001-01-2::2.5::HTS,3.925673960421327,0.04804103516787545,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,SC-144,P glycoprotein inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K55847762-304-01-7::2.5::HTS,10.036369978608484,0.001618157890916233,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,lobenzarit,immunosuppressant,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K55930204-236-24-3::2.5::HTS,5.505019000501255,0.019308424371728753,Other Types,phenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K56195681-001-01-0::2.5::HTS,7.775284923210528,0.005475988281636296,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,losmapimod,p38 MAPK inhibitor,MAPK14
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K56515112-001-21-6::2.5::HTS,9.998294070050923,0.0016521238296226285,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,medrysone,glucocorticoid receptor agonist,NR3C1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K57169635-001-04-5::2.5::HTS,7.548088568342979,0.006200159378295427,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,dacomitinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K58046914-001-03-8::2.5::HTS,9.55743072602747,0.00209012313389166,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,HA-966-(R)-(+),glutamate receptor agonist,GRIA1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K58435339-001-03-0::2.5::HTS,5.265568199026223,0.02212035958729804,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AT13387,HSP antagonist,HSP90AA1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K59469039-001-08-0::2.5::HTS,8.22310002873667,0.00429125381452617,Other Types,tyrphostin-AG-879,tyrosine kinase inhibitor,"ERBB2, KDR, NTRK1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K59522102-001-15-3::2.46::HTS,7.05979480349125,0.008121960113191455,Other Types,piperine,monoamine oxidase inhibitor,"MAOA, MAOB, TRPV1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K59831625-001-01-6::2.5::HTS,7.925761374799475,0.005044536506354604,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,LDN-212854,bone morphogenic protein inhibitor,"ABL1, ACVR1, RIPK2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K60184833-001-05-6::2.5::HTS,9.782949501547217,0.0018539052569164216,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K61536336-001-01-7::2.5::HTS,4.024540858582786,0.04532408759684719,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,SB-366791,TRPV antagonist,TRPV1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K61802864-001-08-8::2.5::HTS,4.492382305183067,0.03448711566514211,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,chlorindione,,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K62304154-001-04-2::2.5::HTS,4.071767095655599,0.04410061017239708,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,deforolimus,mTOR inhibitor,MTOR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K62374253-001-07-8::2.5::HTS,11.37410678574439,0.0007964674770928297,Other Types,rufloxacin,bacterial DNA gyrase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K63068307-001-08-9::2.5::HTS,8.34187509880843,0.004025593183330469,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ZSTK-474,PI3K inhibitor,"PIK3CB, PIK3CD, PIK3CG"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K63750851-001-20-7::2.5::HTS,4.450984336251772,0.0353242019023606,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K64614248-001-12-3::2.5::HTS,4.287270868559688,0.0388580661641884,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,salicin,anti-inflammatory agent,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K64881305-001-03-7::2.5::HTS,4.255136415973001,0.03959395905366671,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,ispinesib,kinesin inhibitor,KIF11
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K65503129-001-06-3::2.5::HTS,5.6599087379379025,0.017694792013820567,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,CCT018159,HSP inhibitor,"HSP90AA1, HSP90AB1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K65518078-002-01-1::2.5::HTS,4.17752251028594,0.04143589695282732,Other Types,cilazapril,angiotensin converting enzyme inhibitor,ACE
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K66527818-001-02-6::2.5::HTS,4.440608053011629,0.035536163261942796,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,VU0364770,glutamate receptor positive allosteric modulator,GRM4
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K66788707-001-14-3::2.5::HTS,5.232820737757432,0.022540586482531703,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,fludarabine,ribonucleotide reductase inhibitor,"ADA, RRM1, RRM2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K66808046-065-03-7::2.5::HTS,9.28229197082216,0.002427102365827526,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,oxyquinoline,chelating agent,METAP2
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K67536197-003-11-4::2.5::HTS,5.685471308762731,0.017439058127326785,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,cyclocytidine,"DNA synthesis inhibitor, RNA synthesis inhibitor",
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68188368-001-09-4::2.5::HTS,4.692167171812927,0.030723126750751815,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,nifuroxazide,bacterial DNA inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68336408-001-10-9::2.5::HTS,4.298239947719896,0.038610174654840596,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,tyrphostin-AG-1478,EGFR inhibitor,"EGFR, MAPK14"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68346641-001-02-2::2.5::HTS,4.148552753740913,0.042139927111219964,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68538666-001-12-3::2.5::HTS,4.905918294317093,0.027168677199680174,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,aceclofenac,prostanoid receptor antagonist,PTGS2
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68620903-001-11-4::2.5::HTS,13.545548030849744,0.0002554795787851839,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,dydrogesterone,progesterone receptor agonist,PGR
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K68747584-001-02-0::2.5::HTS,4.882321610161536,0.027536948296357167,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,PF-03814735,Aurora kinase inhibitor,"AURKA, AURKB"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K69070623-003-01-7::2.5::HTS,6.842225559320555,0.009142031118940616,Other Types,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K69346723-001-04-8::2.5::HTS,6.718518546756342,0.00980590638712162,Other Types,glutathione,antioxidant,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K70358946-001-15-7::2.5::HTS,5.350814483277842,0.02107398397286551,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K70401845-003-09-6::2.5::HTS,4.362297705962522,0.03719372396727815,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,erlotinib,EGFR inhibitor,"EGFR, NR1I2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K70821460-300-02-4::2.5::HTS,4.488654727832357,0.03456496001144473,Other Types,4-methylhistamine,histamine receptor agonist,HRH4
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K73303757-001-21-6::2.5::HTS,6.475635942755885,0.011206466108207977,Other Types,4-methylgenistein,protein tyrosine kinase inhibitor,"CYP19A1, ESRRA, ESRRB, ESRRG, FASN"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K73589401-001-23-6::2.5::HTS,7.429689935636786,0.006618606650006543,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,corticosterone,mineralocorticoid receptor agonist,"HSD11B1, NCOA1, NR3C2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K73771095-001-02-5::2.44::HTS,4.962409513505994,0.02632470978312438,Other Types,geniposidic-acid,cyclooxygenase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K74141488-003-11-2::2.5::HTS,5.4725244936876845,0.01966701309303485,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,naftifine,fungal squalene epoxidase inhibitor,SQLE
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K74186897-001-12-4::2.5::HTS,7.259026533842068,0.007279998947125522,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K75699339-057-08-1::2.5::HTS,4.521306153653536,0.03391043451156129,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,rizatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K76011241-001-01-8::2.5::HTS,9.01264263539378,0.0028011989631512206,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,oseltamivir-phosphate,neuraminidase inhibitor,"CES1, NEU1, NEU2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K76634210-001-14-7::2.5::HTS,4.023464091783899,0.045370690902270513,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,idoxuridine,DNA directed DNA polymerase inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K77060810-001-01-5::2.5::HTS,6.45177832982323,0.011353691254641243,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AZD1283,purinergic receptor antagonist,P2RY12
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K77793136-003-03-0::2.5::HTS,10.267108375917951,0.0014321222410243121,Other Types,hydroxyfasudil,rho associated kinase inhibitor,"PKIA, PRKACA, ROCK1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K78637815-001-02-2::2.5::HTS,4.418405110145093,0.03600408108293977,Other Types,LY320135,cannabinoid receptor antagonist,CNR1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K79254416-001-22-6::2.5::HTS,6.685558806189233,0.009972985531258903,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,decitabine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K79753741-001-01-7::2.5::HTS,8.564907644025652,0.0035676689532404566,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,UBP-302,glutamate receptor antagonist,GRIK1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K80653534-001-01-7::2.5::HTS,6.0673516170086454,0.014076040345817671,Other Types,N-acetyl-D-glucosamine,,"B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K81729199-001-02-8::2.5::HTS,4.825560071325969,0.02845051828349467,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AQ-RA741,acetylcholine receptor antagonist,CHRM2
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K82028950-300-02-9::2.5::HTS,4.1782827241440685,0.04141745856366791,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,CGH2466,adenosine receptor antagonist,"ADORA1, ADORA2B, ADORA3"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K82135108-001-04-3::2.5::HTS,6.074966006741388,0.01401015198647206,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,elesclomol,oxidative stress inducer,HSPA1A
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K82381502-003-23-1::2.5::HTS,4.2664025897653834,0.03933101777293114,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,acetylcholine,acetylcholine receptor agonist,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K83189926-001-03-1::2.5::HTS,4.407277391436685,0.03623130881589347,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,UNC1215,L3MBTL antagonist,L3MBTL3
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K86797399-001-04-4::2.5::HTS,6.008635558987978,0.014552471748546804,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,SB-939,HDAC inhibitor,"HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K88025533-003-03-3::2.5::HTS,12.06046806533167,0.0005550271009375231,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,fingolimod,"immunosuppressant, sphingosine phosphate receptor agonist","S1PR1, S1PR5"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K88186167-001-04-8::2.5::HTS,4.517428493455457,0.03398674168896639,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,GW-4064,FXR agonist,NR1H4
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K88366685-300-06-0::2.5::HTS,9.241335367099909,0.0024768787751846193,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K90647725-001-06-5::2.5::HTS,4.544597373733446,0.03346211950434573,Other Types,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K91301684-003-05-5::2.5::HTS,7.892098875484397,0.005137936349166448,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor",SIGMAR1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K91495480-001-02-2::2.5::HTS,3.935599361277171,0.047760385308259885,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AGP-103,membrane permeability inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K92760278-001-07-3::2.43::HTS,3.922624838469447,0.04815899717149188,Other Types,riboflavin,vitamin B2,"BLVRB, RFK"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K93880783-001-26-6::2.5::HTS,4.002491848319634,0.045917906513843365,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,stavudine,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor",
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K94239562-001-05-5::2.5::HTS,4.750658225007933,0.029707472899876432,Other Types,paeonol,anti-inflammatory agent,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K94358652-001-02-1::2.5::HTS,8.270057501346484,0.004193817402540262,Other Types,daptomycin,bacterial cell wall synthesis inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K94720315-001-10-4::2.5::HTS,6.1461864202064485,0.013464410455897458,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,chromocarb,antispasmodic,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K94832621-001-02-3::2.5::HTS,5.556871183896183,0.018752647463259782,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,Y-134,estrogen receptor antagonist,"ESR1, ESR2"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K95581532-001-01-5::2.5::HTS,5.514019519264151,0.019215310291726642,Other Types,RN-1734,TRPV antagonist,TRPV4
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K95880107-001-02-4::2.5::HTS,5.542223687739553,0.018906166368951507,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,PH-797804,p38 MAPK inhibitor,"MAPK11, MAPK14"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K96137854-001-17-1::2.5::HTS,7.615032356240612,0.005978840769735379,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,enoxolone,gap junction modulator,HSD11B1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K96615647-001-01-2::2.5::HTS,7.104967985310483,0.007908141615516836,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,AV-608,tachykinin antagonist,TACR1
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K96786677-323-02-0::2.58::HTS,6.300463679635809,0.01236360944231635,Other Types,oxacillin,bacterial cell wall synthesis inhibitor,
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K97810537-001-12-8::2.54::HTS,3.9519160718873456,0.04733401923091006,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,beclomethasone-dipropionate,glucocorticoid receptor agonist,"GPR97, NR3C1"
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,BRD-K99174507-003-02-0::2.5::HTS,4.641833989501144,0.03163205063845307,Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma,cardiogenol-c,cardiomyogenesis inducer,
